PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kessler, K; Gordon, L; Cessford, K; Lages, M				Kessler, Klaus; Gordon, Lucy; Cessford, Kari; Lages, Martin			Characteristics of Motor Resonance Predict the Pattern of Flash-Lag Effects for Biological Motion	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; FINGER MOVEMENTS; MIRROR NEURONS; MOVING STIMULI; EXTRAPOLATION; IMITATION; MECHANISMS; AREA; MODULATION; OBJECTS	Background: When a moving stimulus and a briefly flashed static stimulus are physically aligned in space the static stimulus is perceived as lagging behind the moving stimulus. This vastly replicated phenomenon is known as the Flash-Lag Effect (FLE). For the first time we employed biological motion as the moving stimulus, which is important for two reasons. Firstly, biological motion is processed by visual as well as somatosensory brain areas, which makes it a prime candidate for elucidating the interplay between the two systems with respect to the FLE. Secondly, discussions about the mechanisms of the FLE tend to recur to evolutionary arguments, while most studies employ highly artificial stimuli with constant velocities. Methodology/Principal Finding: Since biological motion is ecologically valid it follows complex patterns with changing velocity. We therefore compared biological to symbolic motion with the same acceleration profile. Our results with 16 observers revealed a qualitatively different pattern for biological compared to symbolic motion and this pattern was predicted by the characteristics of motor resonance: The amount of anticipatory processing of perceived actions based on the induced perspective and agency modulated the FLE. Conclusions/Significance: Our study provides first evidence for an FLE with non-linear motion in general and with biological motion in particular. Our results suggest that predictive coding within the sensorimotor system alone cannot explain the FLE. Our findings are compatible with visual prediction (Nijhawan, 2008) which assumes that extrapolated motion representations within the visual system generate the FLE. These representations are modulated by sudden visual input (e.g. offset signals) or by input from other systems (e.g. sensorimotor) that can boost or attenuate overshooting representations in accordance with biased neural competition (Desimone & Duncan, 1995).	[Kessler, Klaus] Univ Glasgow, Dept Psychol, CCNi, Glasgow, Lanark, Scotland	University of Glasgow	Kessler, K (corresponding author), Univ Glasgow, Dept Psychol, CCNi, Glasgow, Lanark, Scotland.	k.kessler@psy.gla.ac.uk		Lages, Martin/0000-0002-4962-3116; Kessler, Klaus/0000-0001-7307-9539	ESRC/MRC [RES-060-25-0010]; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish; Medical Research Council [MC_G1001214] Funding Source: researchfish; ESRC [ES/E020933/1] Funding Source: UKRI; MRC [MC_G1001214] Funding Source: UKRI	ESRC/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by ESRC/MRC funding (RES-060-25-0010) to Klaus Kessler and Martin Lages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andino SLG, 2000, HUM BRAIN MAPP, V11, P46; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Baldo MVC, 2002, PERCEPTION, V31, P17, DOI 10.1068/p3302; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Biermann-Ruben K, 2008, EUR J NEUROSCI, V27, P1843, DOI 10.1111/j.1460-9568.2008.06146.x; BIERMANNRUBEN K, 2008, BRAIN COGN; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Iacoboni M., 2005, PERSPECTIVES IMITATI, P77; Ichikawa M, 2006, VISION RES, V46, P2192, DOI 10.1016/j.visres.2005.12.021; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Jonas M, 2007, EXP BRAIN RES, V177, P255, DOI 10.1007/s00221-006-0660-y; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Kerzel D, 2008, BEHAV BRAIN SCI, V31, P206, DOI 10.1017/S0140525X08003907; Kessler K, 2005, CEREB CORTEX, V15, P1075, DOI 10.1093/cercor/bhh208; Kessler K, 2006, NEUROIMAGE, V33, P227, DOI 10.1016/j.neuroimage.2006.06.014; Kessler K, 2010, COGNITION, V114, P72, DOI 10.1016/j.cognition.2009.08.015; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Lages M, 1998, VISION RES, V38, P557, DOI 10.1016/S0042-6989(97)88333-2; Lestou V, 2008, J COGNITIVE NEUROSCI, V20, P324, DOI 10.1162/jocn.2008.20021; Marceglia S, 2009, NEUROSCIENCE, V161, P1027, DOI 10.1016/j.neuroscience.2009.04.018; Maus GW, 2006, VISION RES, V46, P4375, DOI 10.1016/j.visres.2006.08.028; Maus GW, 2008, PSYCHOL SCI, V19, P1087, DOI 10.1111/j.1467-9280.2008.02205.x; Maus GW, 2009, J EXP PSYCHOL HUMAN, V35, P611, DOI 10.1037/a0012317; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Nijhawan R, 2003, CURR BIOL, V13, P749, DOI 10.1016/S0960-9822(03)00248-3; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; POLIAKOFF E, 2009, EXP BRAIN RES; Poliakoff E, 2007, NEUROREPORT, V18, P483, DOI 10.1097/WNR.0b013e32805867a1; Ramachandran VS, 2008, MED HYPOTHESES, V70, P1233, DOI 10.1016/j.mehy.2008.01.008; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Wojtach WT, 2008, P NATL ACAD SCI USA, V105, P16338, DOI 10.1073/pnas.0808916105	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8258	10.1371/journal.pone.0008258	http://dx.doi.org/10.1371/journal.pone.0008258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	541KN	20062543	gold, Green Published, Green Accepted			2022-12-27	WOS:000273414100001
J	Hallstrand, TS; Wurfel, MM; Lai, Y; Ni, ZL; Gelb, MH; Altemeier, WA; Beyer, RP; Aitken, ML; Henderson, WR				Hallstrand, Teal S.; Wurfel, Mark M.; Lai, Ying; Ni, Zhanglin; Gelb, Michael H.; Altemeier, William A.; Beyer, Richard P.; Aitken, Moira L.; Henderson, William R., Jr.			Transglutaminase 2, a Novel Regulator of Eicosanoid Production in Asthma Revealed by Genome-Wide Expression Profiling of Distinct Asthma Phenotypes	PLOS ONE			English	Article							AIRWAY INFLAMMATION; EXERCISE; GENES; IDENTIFICATION; METHACHOLINE; CHALLENGE; CHILDREN; A(2)	Background: A frequent manifestation of asthma, exercise-induced bronchoconstriction (EIB), occurs in 30-50% of asthmatics and is characterized by increased release of inflammatory eicosanoids. The objective of this study was to identify genes differentially expressed in EIB and to understand the function of these genes in the biology of asthma. Methodology/Principal Findings: Genome-wide expression profiling of airway leukocytes and epithelial cells obtained by induced sputum was conducted in two groups of subjects with asthma with and without EIB (n = 7 per group), at baseline and following exercise challenge. Based on the results of the gene expression study, additional comparisons were made with a normal control group (n = 10). Localization studies were conducted on epithelial brushings and biopsies from an additional group of asthmatics with EIB (n = 3). Genes related to epithelial repair and mast cell infiltration including beta-tryptase and carboxypeptidase A3 were upregulated by exercise challenge in the asthma group with EIB. A gene novel to asthma pathogenesis, transglutaminase 2 (TGM2), was the most differentially expressed at baseline between the groups. In vivo studies confirmed the increased expression of TGM2 in airway cells and airway lining fluid, and demonstrate that TGM2 is avidly expressed in the asthmatic airway epithelium. In vitro studies using recombinant human enzymes reveal that TGM2 augments the enzymatic activity of secreted phospholipase A2 (PLA(2)) group X (sPLA(2)-X), an enzyme recently implicated in asthma pathogenesis. Conclusions/Significance: This study found that TGM2, a mediator that is novel to asthma pathogenesis, is overexpressed in asthmatic airways and functions to increase sPLA(2)-X enzymatic activity. Since PLA(2) serves as the first rate-limiting step leading to eicosanoid formation, these results suggest that TGM2 may be a key initiator of the airway inflammatory cascade in asthma.	[Hallstrand, Teal S.; Wurfel, Mark M.; Lai, Ying; Altemeier, William A.; Aitken, Moira L.] Univ Washington, Div Pulm & Crit Care, Dept Med, Seattle, WA 98195 USA; [Henderson, William R., Jr.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Beyer, Richard P.] Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA; [Ni, Zhanglin; Gelb, Michael H.] Univ Washington, Dept Chem & Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hallstrand, TS (corresponding author), Univ Washington, Div Pulm & Crit Care, Dept Med, Seattle, WA 98195 USA.	tealh@u.washington.edu	Ni, Zhanglin/E-5175-2010	gelb, michael/0000-0001-7000-5219; Altemeier, William/0000-0001-8860-405X; Hallstrand, Teal/0000-0002-5059-6872	National Institutes of Health [R01HL089215, R01HL072370, R01HL036253, M01RR000037, P30ES07033]; American Lung Association Career Investigator Award [CI-22138-N]; Royalty Research Fund; National Center for Research Resources [1S10RR019423-01, 1S10RR021108-01]; M.J. Murdoch Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019423, M01RR000037, S10RR021108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089215, R01HL072370, R01HL086883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Career Investigator Award; Royalty Research Fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); M.J. Murdoch Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants R01HL089215, R01HL072370, R01HL036253, M01RR000037, and P30ES07033, an American Lung Association Career Investigator Award CI-22138-N, and a Royalty Research Fund grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Microarray assays were performed at the Center for Array Technologies (CAT) at the University of Washington. The CAT resources were partially funded under the following grants from the National Institutes of Health, National Center for Research Resources 1S10RR019423-01 and 1S10RR021108-01 and an initial grant from the M.J. Murdoch Charitable Trust.	Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Anderson SD, 2002, J ALLERGY CLIN IMMUN, V109, P771, DOI 10.1067/mai.2002.123644; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Cabral ALB, 1999, AM J RESP CRIT CARE, V159, P1819, DOI 10.1164/ajrccm.159.6.9805093; Carraro S, 2005, J ALLERGY CLIN IMMUN, V115, P764, DOI 10.1016/j.jaci.2004.10.043; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; EFTHIMIADIS A, 2002, EUR RESPIR J, V37, P19; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2007, J ALLERGY CLIN IMMUN, V119, P1092, DOI 10.1016/j.jaci.2007.01.005; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Hallstrand TS, 2002, J PEDIATR-US, V141, P343, DOI 10.1067/mpd.2002.125729; HALLSTRAND TS, 2009, ANN ALLERGY IN PRESS; HALLSTRAND TS, 2009, P AM THORAC SOC, V6, P325; HALLSTRAND TS, 2004, AM J RESP CRIT CARE, V167, pA16; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henriksen AH, 2002, PEDIATR ALLERGY IMMU, V13, P203, DOI 10.1034/j.1399-3038.2002.01034.x; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Holzer K, 2002, J ALLERGY CLIN IMMUN, V110, P374, DOI 10.1067/mai.2002.127784; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Mickleborough TD, 2005, MED SCI SPORT EXER, V37, P904, DOI 10.1249/01.mss.0000166949.11296.2b; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Touaibia M, 2007, J MED CHEM, V50, P1618, DOI 10.1021/jm060082n; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vianna EO, 2002, J ALLERGY CLIN IMMUN, V110, P236, DOI 10.1067/mai.2002.125981; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	41	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8583	10.1371/journal.pone.0008583	http://dx.doi.org/10.1371/journal.pone.0008583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052409	Green Published, gold			2022-12-27	WOS:000273338500025
J	Kern, A; Ackermann, B; Clement, AM; Duerk, H; Behl, C				Kern, Andreas; Ackermann, Bianca; Clement, Albrecht M.; Duerk, Heike; Behl, Christian			HSF1-Controlled and Age-Associated Chaperone Capacity in Neurons and Muscle Cells of C. elegans	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CAENORHABDITIS-ELEGANS; STRESS-RESPONSE; AGGREGATION; TOXICITY; DISEASE; HSP70; INDUCTION; FACTOR-1; GENES	Protein stability under changing conditions is of vital importance for the cell and under the control of a fine-tuned network of molecular chaperones. Aging and age-related neurodegenerative diseases are directly associated with enhanced protein instability. Employing C. elegans expressing GFP-tagged luciferase as a reporter for evaluation of protein stability we show that the chaperoning strategy of body wall muscle cells and neurons is significantly different and that both are differently affected by aging. Muscle cells of young worms are largely resistant to heat stress, which is directly mediated by the stress response controlled through Heat Shock Transcription Factor 1. During recovery following heat stress the ability to refold misfolded proteins is missing. Young neurons are highly susceptible to chronic heat stress, but show a high potency to refold or disaggregate proteins during subsequent recovery. The particular proteome instability in neurons results from a delayed induction of the heat shock response. In aged neurons protein stability is increased during heat stress, whereas muscle cells show enhanced protein instability due to a deteriorated heat shock response. An efficient refolding activity is absent in both aged tissues. These results provide molecular insights into the differential protein stabilization capacity in different tissues and during aging.	[Kern, Andreas; Ackermann, Bianca; Clement, Albrecht M.; Duerk, Heike; Behl, Christian] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Kern, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany.	cbehl@uni-mainz.de		Behl, Christian/0000-0001-8453-2378	Fritz and Hildegard Berg-Foundation; Interdisciplinary Neuroscience Program of the Johannes Gutenberg-University	Fritz and Hildegard Berg-Foundation; Interdisciplinary Neuroscience Program of the Johannes Gutenberg-University	This work was supported by grants from the Fritz and Hildegard Berg-Foundation (to C.B.) and from the Interdisciplinary Neuroscience Program of the Johannes Gutenberg-University (to A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Batulan Z, 2003, J NEUROSCI, V23, P5789; BENZVI A, 2009, P NATL ACAD SCI US; BRENNER S, 1974, GENETICS, V77, P71; Chang Hung-Chun, 2007, Cell, V128, P212; Chow AM, 2007, CELL STRESS CHAPERON, V12, P237, DOI 10.1379/CSC-269.1; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dwyer DS, 1996, NEUROCHEM RES, V21, P659, DOI 10.1007/BF02527722; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; MANZERRA P, 1993, J NEUROSCI RES, V36, P480, DOI 10.1002/jnr.490360414; Soti C, 2007, J BIOSCIENCES, V32, P511, DOI 10.1007/s12038-007-0050-z; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Witan H, 2008, HUM MOL GENET, V17, P1373, DOI 10.1093/hmg/ddn025; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	25	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8568	10.1371/journal.pone.0008568	http://dx.doi.org/10.1371/journal.pone.0008568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052290	Green Submitted, gold, Green Published			2022-12-27	WOS:000273338500012
J	Igarashi, M; Ito, K; Yoshida, R; Tomabechi, D; Kida, H; Takada, A				Igarashi, Manabu; Ito, Kimihito; Yoshida, Reiko; Tomabechi, Daisuke; Kida, Hiroshi; Takada, Ayato			Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin	PLOS ONE			English	Article							SWINE; ORIGIN; VACCINE; SOLVATION; MUTATIONS; EVOLUTION; HUMANS; SITES; TOOLS	The pandemic influenza virus (2009 H1N1) was recently introduced into the human population. The hemagglutinin (HA) gene of 2009 H1N1 is derived from "classical swine H1N1'' virus, which likely shares a common ancestor with the human H1N1 virus that caused the pandemic in 1918, whose descendant viruses are still circulating in the human population with highly altered antigenicity of HA. However, information on the structural basis to compare the HA antigenicity among 2009 H1N1, the 1918 pandemic, and seasonal human H1N1 viruses has been lacking. By homology modeling of the HA structure, here we show that HAs of 2009 H1N1 and the 1918 pandemic virus share a significant number of amino acid residues in known antigenic sites, suggesting the existence of common epitopes for neutralizing antibodies cross-reactive to both HAs. It was noted that the early human H1N1 viruses isolated in the 1930s-1940s still harbored some of the original epitopes that are also found in 2009 H1N1. Interestingly, while 2009 H1N1 HA lacks the multiple N-glycosylations that have been found to be associated with an antigenic change of the human H1N1 virus during the early epidemic of this virus, 2009 H1N1 HA still retains unique three-codon motifs, some of which became N-glycosylation sites via a single nucleotide mutation in the human H1N1 virus. We thus hypothesize that the 2009 H1N1 HA antigenic sites involving the conserved amino acids will soon be targeted by antibody-mediated selection pressure in humans. Indeed, amino acid substitutions predicted here are occurring in the recent 2009 H1N1 variants. The present study suggests that antibodies elicited by natural infection with the 1918 pandemic or its early descendant viruses play a role in specific immunity against 2009 H1N1, and provides an insight into future likely antigenic changes in the evolutionary process of 2009 H1N1 in the human population.	[Igarashi, Manabu; Ito, Kimihito; Yoshida, Reiko; Tomabechi, Daisuke; Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Dept Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] OIE Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Igarashi, M (corresponding author), Hokkaido Univ, Dept Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Kida, Hiroshi/F-7244-2012; Igarashi, Manabu/F-6871-2012; YOSHIDA, Reiko/F-6883-2012; Ito, Kimihito/E-9975-2012; Takada, Ayato/A-6679-2012	Ito, Kimihito/0000-0003-4986-1795; 	Japan Society for the Promotion of Science (JSPS) [19300041]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21780272, 05021011]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (B) (19300041) from the Japan Society for the Promotion of Science (JSPS), and for Young Scientists (B) (21780272) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (http://www. mext. go. jp/english/index. htm), and in part, by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (05021011) from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; GALLAGHER P, 1988, J CELL BIOL, V107, P2059, DOI 10.1083/jcb.107.6.2059; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; IGARASHI M, GLYCOMICROBIOLOGY; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; ITOH Y, 2009, NATURE IN PRESS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MS, 2003, J INFECT DIS, V188, P1362, DOI 10.1086/379045; LUOH SM, 1992, J VIROL, V66, P1066, DOI 10.1128/JVI.66.2.1066-1073.1992; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; SUGITA S, 1991, J MOL EVOL, V32, P16, DOI 10.1007/BF02099924; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Vincent AL, 2006, VET MICROBIOL, V118, P212, DOI 10.1016/j.vetmic.2006.07.017	29	125	153	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8553	10.1371/journal.pone.0008553	http://dx.doi.org/10.1371/journal.pone.0008553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049332	Green Published, Green Submitted, gold			2022-12-27	WOS:000273225000016
J	Tsumiyama, K; Miyazaki, Y; Shiozawa, S				Tsumiyama, Ken; Miyazaki, Yumi; Shiozawa, Shunichi			Self-Organized Criticality Theory of Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL-RECEPTOR; RHEUMATOID-ARTHRITIS; V(D)J RECOMBINATION; MICE; DISEASE; SUPERANTIGEN; LYMPHOCYTES; INDUCTION; NEPHRITIS	Background: The cause of autoimmunity, which is unknown, is investigated from a different angle, i.e., the defect in immune 'system', to explain the cause of autoimmunity. Methodology/Principal Findings: Repeated immunization with antigen causes systemic autoimmunity in mice otherwise not prone to spontaneous autoimmune diseases. Overstimulation of CD4(+) T cells led to the development of autoantibody-inducing CD4(+) T (aiCD4(+) T) cell which had undergone T cell receptor (TCR) revision and was capable of inducing autoantibodies. The aiCD4+ T cell was induced by de novo TCR revision but not by cross-reaction, and subsequently overstimulated CD8(+) T cells, driving them to become antigen-specific cytotoxic T lymphocytes (CTL). These CTLs could be further matured by antigen cross-presentation, after which they caused autoimmune tissue injury akin to systemic lupus erythematosus (SLE). Conclusions/Significance: Systemic autoimmunity appears to be the inevitable consequence of over-stimulating the host's immune 'system' by repeated immunization with antigen, to the levels that surpass system's self-organized criticality.	[Tsumiyama, Ken; Miyazaki, Yumi; Shiozawa, Shunichi] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Kobe, Hyogo 657, Japan; [Shiozawa, Shunichi] Kobe Univ, Grad Sch Med, Dept Med, Kobe, Hyogo 657, Japan; [Shiozawa, Shunichi] Kobe Univ Hosp, Ctr Rheumat Dis, Kobe, Hyogo, Japan; [Shiozawa, Shunichi] GCOE, Tokyo, Japan	Kobe University; Kobe University; Kobe University	Tsumiyama, K (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Kobe, Hyogo 657, Japan.	shioz@med.kobe-u.ac.jp	Shiozawa, Shunichi/W-2992-2019		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Organization	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Organization	This work is supported by the Global Center of Excellence (GCOE) Program grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Science and Technology Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Couzi L, 2007, ARTHRITIS RHEUM, V56, P2362, DOI 10.1002/art.22654; de Lema GP, 2005, J AM SOC NEPHROL, V16, P3592, DOI 10.1681/ASN.2005040426; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Haas C, 1997, J IMMUNOL, V158, P5484; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Huang CY, 2002, J IMMUNOL, V168, P3259, DOI 10.4049/jimmunol.168.7.3259; KALLENBACH S, 1992, P NATL ACAD SCI USA, V89, P2799, DOI 10.1073/pnas.89.7.2799; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kuwata N, 1999, J IMMUNOL, V163, P6355; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PALIARD X, 1991, SCIENCE, V253, P325, DOI 10.1126/science.1857971; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Richards HB, 2001, KIDNEY INT, V60, P2173, DOI 10.1046/j.1523-1755.2001.00045.x; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105	25	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8382	10.1371/journal.pone.0008382	http://dx.doi.org/10.1371/journal.pone.0008382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046868	Green Published, gold			2022-12-27	WOS:000273180200001
J	Xu, ZX; Ding, T; Haridas, V; Connolly, F; Gutterman, JU				Xu, Zhi-Xiang; Ding, Tian; Haridas, Valsala; Connolly, Fiona; Gutterman, Jordan U.			Avicin D, a Plant Triterpenoid, Induces Cell Apoptosis by Recruitment of Fas and Downstream Signaling Molecules into Lipid Rafts	PLOS ONE			English	Article							ACACIA-VICTORIAE BENTHAM; DEATH RECEPTOR; ACTIVATION; SAPONINS; CHOLESTEROL; LOCALIZATION; AUTOPHAGY; MEMBRANES; FAS/CD95; ANTIBODY	Avicins, a family of triterpene electrophiles originally identified as potent inhibitors of tumor cell growth, have been shown to be pleiotropic compounds that also possess antioxidant, anti-mutagenic, and anti-inflammatory activities. We previously showed that Jurkat cells, which express a high level of Fas, are very sensitive to treatment with avicins. Thus, we hypothesized that avicins may induce cell apoptosis by activation of the Fas pathway. By using a series of cell lines deficient in cell death receptors, we demonstrated that upon avicin D treatment, Fas translocates to the cholesterol- and sphingolipid-enriched membrane microdomains known as lipid rafts. In the lipid rafts, Fas interacts with Fas-associated death domain (FADD) and Caspase-8 to form death-inducing signaling complex (DISC) and thus mediates cell apoptosis. Interfering with lipid raft organization by using a cholesterol- depleting compound, methyl-beta-cyclodextrin, not only prevents the clustering of Fas and its DISC complex but also reduces the sensitivity of the cells to avicin D. Avicin D activates Fas pathways independent of the association between extracellular Fas ligands and Fas receptors. A deficiency in Fas and its downstream signaling molecules leads to the resistance of the cells to avicin D treatment. Taken together, our results demonstrate that avicin D triggers the redistribution of Fas in the membrane lipid rafts, where Fas activates receptor-mediated cell death.	[Xu, Zhi-Xiang; Haridas, Valsala; Connolly, Fiona; Gutterman, Jordan U.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Xu, Zhi-Xiang] Univ Alabama, Div Hematol & Oncol, Birmingham, AL USA; [Ding, Tian] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Ding, Tian] Genscript Inc, Piscataway, NJ USA	University of Texas System; UTMD Anderson Cancer Center; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Xu, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	zhi-xiang.xu@ccc.uab.edu			Clayton Foundation for Research; Wendy Will Case Cancer Fund, Inc.; National Cancer Institutes [R01CA133053]; NATIONAL CANCER INSTITUTE [R01CA133053] Funding Source: NIH RePORTER	Clayton Foundation for Research; Wendy Will Case Cancer Fund, Inc.; National Cancer Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Clayton Foundation for Research (to J.U.G.), Wendy Will Case Cancer Fund, Inc., and National Cancer Institutes research grant R01CA133053 (to Z.X.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Blackstone NW, 2005, P ROY SOC B-BIOL SCI, V272, P527, DOI 10.1098/rspb.2004.2981; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Gaikwad A, 2005, CLIN CANCER RES, V11, P1953, DOI 10.1158/1078-0432.CCR-04-1704; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gutterman JU, 2005, P NATL ACAD SCI USA, V102, P12771, DOI 10.1073/pnas.0505758102; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Haridas V, 2005, P NATL ACAD SCI USA, V102, P10088, DOI 10.1073/pnas.0504430102; Haridas V, 2004, J CLIN INVEST, V113, P65, DOI 10.1172/JCI200418699; Haridas V, 2001, P NATL ACAD SCI USA, V98, P5821, DOI 10.1073/pnas.101619098; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Li XX, 2005, BIOPHYS J, V88, P2577, DOI 10.1529/biophysj.104.049403; Lincoln JE, 2006, INVEST OPHTH VIS SCI, V47, P2172, DOI 10.1167/iovs.05-1167; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mujoo K, 2001, CANCER RES, V61, P5486; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Schattenberg JM, 2006, LIVER INT, V26, P904, DOI 10.1111/j.1478-3231.2006.01324.x; Scheel-Toellner D, 2004, BIOCHEM SOC T, V32, P679, DOI 10.1042/BST0320679; Scheel-Toellner D, 2003, CANCER BIOL THER, V2, P396, DOI 10.4161/cbt.2.4.455; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; WATANABE SI, 1995, INT IMMUNOL, V7, P1037, DOI 10.1093/intimm/7.7.1037; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; Xu ZX, 2004, J BIOL CHEM, V279, P1838, DOI 10.1074/jbc.M310987200; Xu ZX, 2003, MOL CELL BIOL, V23, P4247, DOI 10.1128/MCB.23.12.4247-4256.2003	35	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8532	10.1371/journal.pone.0008532	http://dx.doi.org/10.1371/journal.pone.0008532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046832	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200013
J	Leszczynska, A; Burzynska, B; Plochocka, D; Kaminska, J; Zimnicka, M; Kania, M; Kiliszek, M; Wysocka-Kapcinska, M; Danikiewicz, W; Szkopinska, A				Leszczynska, Agata; Burzynska, Beata; Plochocka, Danuta; Kaminska, Joanna; Zimnicka, Magdalena; Kania, Magdalena; Kiliszek, Marek; Wysocka-Kapcinska, Monika; Danikiewicz, Witold; Szkopinska, Anna			Investigating the Effects of Statins on Cellular Lipid Metabolism Using a Yeast Expression System	PLOS ONE			English	Article							HMG-COA REDUCTASE; SACCHAROMYCES-CEREVISIAE; PARTICLES; ENZYME; CELLS; PCR	In humans, defects in lipid metabolism are associated with a number of severe diseases such as atherosclerosis, obesity and type II diabetes. Hypercholesterolemia is a primary risk factor for coronary artery disease, the major cause of premature deaths in developed countries. Statins are inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the key enzyme of the sterol synthesis pathway. Since yeast Saccharomyces cerevisiae harbours many counterparts of mammalian enzymes involved in lipid-synthesizing pathways, conclusions drawn from research with this single cell eukaryotic organism can be readily applied to higher eukaryotes. Using a yeast strain with deletions of both HMG; and HMG2 genes (i.e. completely devoid of HMGR activity) with introduced wild-type or mutant form of human HMGR (hHMGR) gene we investigated the effects of statins on the lipid metabolism of the cell. The relative quantification of mRNA demonstrated a different effect of simvastatin on the expression of the wild-type and mutated hHMGR gene. GC/MS analyses showed a significant decrease of sterols and enhanced conversion of squalene and sterol precursors into ergosterol. This was accompanied by the mobilization of ergosterol precursors localized in lipid particles in the form of steryl esters visualized by confocal microscopy. Changes in the level of ergosterol and its precursors in cells treated with simvastatin depend on the mutation in the hHMGR gene. HPLC/MS analyses indicated a reduced level of phospholipids not connected with the mevalonic acid pathway. We detected two significant phenomena. First, cells treated with simvastatin develop an adaptive response compensating the lower activity of HMGR. This includes enhanced conversion of sterol precursors into ergosterol, mobilization of steryl esters and increased expression of the hHMGR gene. Second, statins cause a substantial drop in the level of glycerophospholipids.	[Leszczynska, Agata; Burzynska, Beata; Plochocka, Danuta; Kaminska, Joanna; Wysocka-Kapcinska, Monika; Szkopinska, Anna] Polish Acad Sci, Inst Biochem & Biophys PAS, Warsaw, Poland; [Zimnicka, Magdalena; Kania, Magdalena; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem PAS, Warsaw, Poland; [Kiliszek, Marek] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Medical University of Warsaw	Leszczynska, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys PAS, Warsaw, Poland.	babel@ibb.waw.pl	Burzynska, Beata/A-4691-2013; Kamińska, Joanna/D-1063-2011; Danikiewicz, Witold/H-2257-2016; Zimnicka, Magdalena/AAT-1794-2021	Kamińska, Joanna/0000-0002-0168-7882; Danikiewicz, Witold/0000-0003-0484-2689; Zimnicka, Magdalena/0000-0001-5078-4374; Burzynska, Beata/0000-0003-1595-0036	National Centre for Research and Development (NCBiR) [R13 0001 06]	National Centre for Research and Development (NCBiR)	This work was supported by a grant R13 0001 06 from The National Centre for Research and Development (NCBiR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; BASSON ME, 1988, MOL CELL BIOL, V8, P3797, DOI 10.1128/MCB.8.9.3797; Beltowski J, 2009, CURR DRUG SAF, V4, P209, DOI 10.2174/157488609789006949; Chopra V, 2007, CARDIOVASC DRUG THER, V21, P161, DOI 10.1007/s10557-007-6025-3; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Dietzen DJ, 2007, ARTERIOSCL THROM VAS, V27, P690, DOI 10.1161/01.ATV.0000255949.51053.ce; Duncan RE, 2005, CANCER EPIDEM BIOMAR, V14, P1897, DOI 10.1158/1055-9965.EPI-05-0027; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANK RE, 2009, J INSUR MED, V4, P132; Gerber R, 2004, ANAL BIOCHEM, V329, P28, DOI 10.1016/j.ab.2004.03.023; GREENSPAN P, 1985, J LIPID RES, V26, P781; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LIJNEN P, 1995, J HUM HYPERTENS, V9, P557; Mangravite LM, 2006, PHARMACOGENOMICS J, V6, P360, DOI 10.1038/sj.tpj.6500384; Morikawa S, 2005, J ATHEROSCLER THROMB, V12, P121, DOI 10.5551/jat.12.121; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSE MD, 1990, METHODS YEAST GENET; Vecka M, 2004, TOHOKU J EXP MED, V204, P299, DOI 10.1620/tjem.204.299; Wagner A, 2009, BBA-MOL CELL BIOL L, V1791, P118, DOI 10.1016/j.bbalip.2008.11.004; Wysocka-Kapcinska M, 2009, J APPL MICROBIOL, V106, P895, DOI 10.1111/j.1365-2672.2008.04060.x; YANAGITA T, 1994, CLIN THER, V16, P200; Zhou Q, 2009, CURR PHARM DESIGN, V15, P467, DOI 10.2174/138161209787315684	24	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8499	10.1371/journal.pone.0008499	http://dx.doi.org/10.1371/journal.pone.0008499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041128	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700014
J	van Zyl-Smit, RN; Zwerling, A; Dheda, K; Pai, M				van Zyl-Smit, Richard N.; Zwerling, Alice; Dheda, Keertan; Pai, Madhukar			Within-Subject Variability of Interferon-g Assay Results for Tuberculosis and Boosting Effect of Tuberculin Skin Testing: A Systematic Review	PLOS ONE			English	Article							T-CELL ASSAYS; GAMMA ASSAY; INFECTION; ELISPOT; GOLD	Background: Variability in interferon-gamma release assays (IGRAs) results for tuberculosis has implications for interpretation of results close to the cut-point, and for defining thresholds for test conversion and reversion. However, little is known about the within-subject variability (reproducibility) of IGRAs. Several national guidelines recommend a two-step testing procedure (tuberculin skin test [TST] followed by IGRA) for the diagnosis of LTBI. However, the effect of a preceding TST on subsequent IGRA results has been reported in studies with apparently conflicting results. Methodology/Findings: We conducted a systematic review to synthesize evidence on within-subject variability of IGRA results and the potential boosting effect of TST. We searched several databases and reviewed citations of previous reviews on IGRAs. We included studies using commercial IGRAs, in addition to non-commercial versions of the ELISPOT assay. Four studies, fulfilling our predefined criteria, examined within-subject variability and 13 studies evaluated TST effects on subsequent IGRA responses. Meta-analysis was not considered appropriate because of heterogeneity in study methods, assays, and populations. Although based on limited data, within-subject variability was present in all studies but the magnitude varied (16-80%) across studies. A TST induced "boosting" of IGRA responses was demonstrated in several studies and although more pronounced in IGRA-positive (i.e. sensitized) individuals, also occurred in a smaller but not insignificant proportion of IGRA-negative subjects. The TST appeared to affect IGRA responses only after 3 days and may apparently persist for several months, but evidence for this is weak. Conclusions/Significance: Although reproducibility data are scarce, significant within person IGRA variability has been reported. If confirmed in more studies, this has implications for the interpretation of results close to the cut-point and for definition of conversions and reversions. Although the effect of TST on IGRA results is likely to be inconsequential in IGRA-positive subjects, in IGRA-negative subjects, the interpretation of results may be confounded by a preceding TST if administered more than 3 days prior to an IGRA.	[Zwerling, Alice; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [van Zyl-Smit, Richard N.; Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [van Zyl-Smit, Richard N.; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Zwerling, Alice; Pai, Madhukar] Montreal Chest Inst, Montreal, PQ, Canada; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Dheda, Keertan] Univ Coll Med Sch, Ctr Infect Dis & Int Hlth, London, England	McGill University; University of Cape Town; University of Cape Town; McGill University; University of Cape Town; University of London; University College London	Pai, M (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; van Zyl-Smit, Richard/0000-0002-4115-5362	Canadian Institutes of Health Research (CIHR) [MOP-81362]; European Commission (EU); Stop TB Partnership's New Diagnostics Working Group	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre); Stop TB Partnership's New Diagnostics Working Group	Funding: Funded in part by Canadian Institutes of Health Research (CIHR grant MOP-81362), European Commission (EU FP-7; TBSusgent), and Stop TB Partnership's New Diagnostics Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Canada Communicable Disease Report, V34, P1; BAKER GA, 2009, AM J TROP MED, V30, P628; Belknap R, 2009, AM J RESP CRIT CARE, V179; BELKNAP R, 2009, AM J RESP CRIT CARE, V179, pA1011; CELLESTIES I, 2007, QUANTIFLRON TB GOLD; Choi JC, 2008, CHEST, V133, P1415, DOI 10.1378/chest.07-2193; DEIJEN AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170; Dheda K, 2005, CURR OPIN PULM MED, V11, P195, DOI 10.1097/01.mcp.0000158726.13159.5e; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Franken WPJ, 2007, CLIN VACCINE IMMUNOL, V14, P1239, DOI 10.1128/CVI.00185-07; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Igari H, 2007, INT J TUBERC LUNG D, V11, P788; LEE SS, 2003, SCAND J INFECT DIS, V40, P373; Leyten EMS, 2007, EUR RESPIR J, V29, P1212, DOI 10.1183/09031936.00117506; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; NASCER A, 2007, EUROPEAN RESP J, V20, P1282; Nguyen M, 2005, INT J TUBERC LUNG D, V9, P985; *NIH CLIN EXC, 2006, TUB CLIN DIAGN MAN T; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; PAI M, ANN INTERN MED, V119, P177; PAI M, 2009, GUIDELINES IGRAS CON; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; PERRY S, 2008, CLIN NAT IMMUNOL, V13, P125; Richeldi L, 2008, EUR RESPIR J, V32, P524, DOI 10.1183/09031936.00014508; Richeldi L, 2006, THORAX, V61, P180, DOI 10.1136/thx.2005.049759; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; YILAPLANA C, 2008, SCAND J IMMUNOL, V67, P610; Yoshiyama T, 2009, EPIDEMIOL INFECT, V137, P1691, DOI 10.1017/S0950268809002751	36	167	168	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8517	10.1371/journal.pone.0008517	http://dx.doi.org/10.1371/journal.pone.0008517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041113	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700026
J	Zaman, RU; Alamgir, ASM; Rahman, M; Azziz-Baumgartner, E; Gurley, ES; Sharker, MAY; Brooks, WA; Azim, T; Fry, AM; Lindstrom, S; Gubareva, LV; Xu, XY; Garten, RJ; Hossain, MJ; Khan, SU; Faruque, LI; Ameer, SS; Klimov, AI; Rahman, M; Luby, SP				Zaman, Rashid Uz; Alamgir, A. S. M.; Rahman, Mustafizur; Azziz-Baumgartner, Eduardo; Gurley, Emily S.; Sharker, M. Abu Yushuf; Brooks, W. Abdullah; Azim, Tasnim; Fry, Alicia M.; Lindstrom, Stephen; Gubareva, Larisa V.; Xu, Xiyan; Garten, Rebecca J.; Hossain, M. Jahangir; Khan, Salah Uddin; Faruque, Labib Imran; Ameer, Syeda Shegufta; Klimov, Alexander I.; Rahman, Mahmudur; Luby, Stephen P.			Influenza in Outpatient ILI Case-Patients in National Hospital-Based Surveillance, Bangladesh, 2007-2008	PLOS ONE			English	Article							SEASONAL INFLUENZA; VIRUS; CHILDREN; ILLNESS; BURDEN; IMPACT; EPIDEMIOLOGY; INFECTION; SEVERITY; TRENDS	Background: Recent population-based estimates in a Dhaka low-income community suggest that influenza was prevalent among children. To explore the epidemiology and seasonality of influenza throughout the country and among all age groups, we established nationally representative hospital-based surveillance necessary to guide influenza prevention and control efforts. Methodolgy/Principal Findings: We conducted influenza-like illness and severe acute respiratory illness sentinel surveillance in 12 hospitals across Bangladesh during May 2007-December 2008. We collected specimens from 3,699 patients, 385 (10%) which were influenza positive by real time RT-PCR. Among the sample-positive patients, 192 (51%) were type A and 188 (49%) were type B. Hemagglutinin subtyping of type A viruses detected 137 (71%) A/H1 and 55 (29%) A/H3, but no A/H5 or other novel influenza strains. The frequency of influenza cases was highest among children aged under 5 years (44%), while the proportions of laboratory confirmed cases was highest among participants aged 11-15 (18%). We applied kriging, a geo-statistical technique, to explore the spatial and temporal spread of influenza and found that, during 2008, influenza was first identified in large port cities and then gradually spread to other parts of the country. We identified a distinct influenza peak during the rainy season (May-September). Conclusions/Significance: Our surveillance data confirms that influenza is prevalent throughout Bangladesh, affecting a wide range of ages and causing considerable morbidity and hospital care. A unimodal influenza seasonality may allow Bangladesh to time annual influenza prevention messages and vaccination campaigns to reduce the national influenza burden. To scale-up such national interventions, we need to quantify the national rates of influenza and the economic burden associated with this disease through further studies.	[Zaman, Rashid Uz; Rahman, Mustafizur; Azziz-Baumgartner, Eduardo; Gurley, Emily S.; Sharker, M. Abu Yushuf; Brooks, W. Abdullah; Azim, Tasnim; Hossain, M. Jahangir; Khan, Salah Uddin; Faruque, Labib Imran; Ameer, Syeda Shegufta; Luby, Stephen P.] ICDDR B, Dhaka, Bangladesh; [Alamgir, A. S. M.; Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh; [Azziz-Baumgartner, Eduardo; Fry, Alicia M.; Lindstrom, Stephen; Gubareva, Larisa V.; Xu, Xiyan; Garten, Rebecca J.; Klimov, Alexander I.; Luby, Stephen P.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Gurley, Emily S.; Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zaman, RU (corresponding author), ICDDR B, Dhaka, Bangladesh.	zaman.rashid@gmail.com	Zaman, Rashid/AAM-5209-2020; Brooks, W. Abdullah/AAD-3876-2021; Gurley, Emily S/B-7903-2010; rahman, mustafizur/E-6918-2010	Brooks, W. Abdullah/0000-0001-9871-5546; Gurley, Emily S/0000-0002-8648-9403; Khan, M. Salah Uddin/0000-0001-5928-9257; Zaman, Rashid/0000-0002-8556-4993	Centers for Disease Control and Prevention (CDC) (www.cdc.gov), United States of America [U01 CI000298]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000298] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC) (www.cdc.gov), United States of America(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This surveillance was funded by the Centers for Disease Control and Prevention (CDC) (www.cdc.gov), United States of America, under cooperative agreement U01 CI000298. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed NU, 2006, J HEALTH POPUL NUTR, V24, P456; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; ALSABIR A, 2005, BANGLADESH DEMOGRAPH; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P381; [Anonymous], 2006, HSB (Health Science Bulletin), V4, P1; BBS, 2013, TIM US PIL SURV; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Brooks WA, 2007, EMERG INFECT DIS, V13, P1507, DOI 10.3201/eid1310.070368; Brooks WA, 2009, EMERG INFECT DIS, V15, P1311, DOI 10.3201/eid1508.090283; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; *CDC, 2008, INFL DIS FLU BAS; CHEVEZ AE, 2006, PAN AM HLTH ORG IMMU, V28, P1; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Couch RB, 2000, ANN INTERN MED, V133, P992, DOI 10.7326/0003-4819-133-12-200012190-00015; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; FRANK AL, 1985, J INFECT DIS, V151, P73, DOI 10.1093/infdis/151.1.73; Gachara G, 2006, J CLIN VIROL, V35, P117, DOI 10.1016/j.jcv.2005.10.004; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Jennings JC, 1999, VACCINE, V17, pS115, DOI 10.1016/S0264-410X(99)00260-1; Langley JM, 2004, CAN MED ASSOC J, V171, P1213, DOI 10.1503/cmaj.1031737; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Mereckiene J, 2008, EUROSURVEILLANCE, V13, P1; *MILL PROJ, 2005, INV DEV PRACT PLAN A, P158; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mugglin AS, 2002, STAT MED, V21, P2703, DOI 10.1002/sim.1217; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; NICOLL A, 2008, EUROSURVEILLANCE, V13, P1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ramamurty N, 2005, INDIAN J MED RES, V121, P776; Rao B. L., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P906; RAO BL, 1993, B WORLD HEALTH ORGAN, V71, P177; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Szucs T, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.suppl_2.11; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; *WHO, 2003, 211 WHO; WHO, 2007, REC LAB PROC DET AV; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	49	84	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8452	10.1371/journal.pone.0008452	http://dx.doi.org/10.1371/journal.pone.0008452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041114	gold, Green Published, Green Submitted			2022-12-27	WOS:000273105200003
J	Kawaguchi-Ito, Y; Li, SF; Tagawa, M; Araki, H; Goshono, M; Yamamoto, S; Tanaka, M; Narita, M; Tanaka, K; Liu, SX; Shikata, E; Sano, T				Kawaguchi-Ito, Yoko; Li, Shi-Fang; Tagawa, Masaya; Araki, Hiroyuki; Goshono, Masafumi; Yamamoto, Shingen; Tanaka, Mayumi; Narita, Masako; Tanaka, Kazuaki; Liu, Sheng-Xue; Shikata, Eishiro; Sano, Teruo			Cultivated Grapevines Represent a Symptomless Reservoir for the Transmission of Hop Stunt Viroid to Hop Crops: 15 Years of Evolutionary Analysis	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; PATHOGENICITY DETERMINANT; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; HOST INTERACTIONS; RNA; VARIANTS; CITRUS; IDENTIFICATION; DISEASE	Hop stunt was a mysterious disorder that first emerged in the 1940s in commercial hops in Japan. To investigate the origin of this disorder, we infected hops with natural Hop stunt viroid (HpSVd) isolates derived from four host species ( hop, grapevine, plum and citrus), which except for hop represent possible sources of the ancestral viroid. These plants were maintained for 15 years, then analyzed the HpSVd variants present. Here we show that the variant originally found in cultivated grapevines gave rise to various combinations of mutations at positions 25, 26, 54, 193, and 281. However, upon prolonged infection, these variants underwent convergent evolution resulting in a limited number of adapted mutants. Some of them showed nucleotide sequences identical to those currently responsible for hop stunt epidemics in commercial hops in Japan, China, and the United States. Therefore, these results indicate that we have successfully reproduced the original process by which a natural HpSVd variant naturally introduced into cultivated hops was able to mutate into the HpSVd variants that are currently present in commercial hops. Furthermore, and importantly, we have identified cultivated grapevines as a symptomless reservoir in which HSVd can evolve and be transmitted to hop crops to cause epidemics.	[Kawaguchi-Ito, Yoko] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Li, Shi-Fang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Tagawa, Masaya; Araki, Hiroyuki; Goshono, Masafumi; Yamamoto, Shingen; Tanaka, Mayumi; Narita, Masako; Tanaka, Kazuaki; Sano, Teruo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Liu, Sheng-Xue] Xinjiang Prod & Construct Grp, Key Oasis Ecoagr Lab, Shihezi, Peoples R China; [Shikata, Eishiro] Hokkaido Univ, Grad Sch Agr, Japan Acad, Sapporo, Hokkaido, Japan	Iwate University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hirosaki University; Hokkaido University	Kawaguchi-Ito, Y (corresponding author), Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan.	sfli@ippcaas.cn; sano@cc.hirosaki-u.ac.jp		li, shifang/0000-0003-4614-1768	Japan Society for the Promotion of Science [B18380028, 21380029, 18658016, FY2008]; Grant-in-Aid for Scientific Research of Priority Area, Hirosaki University; Bilateral Joint Projects between Japan and China-NSFC [30811140157]; National Basic Research and Development Program of China [2009CB119200]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant-in-Aid for Scientific Research of Priority Area, Hirosaki University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bilateral Joint Projects between Japan and China-NSFC; National Basic Research and Development Program of China(National Basic Research Program of China)	This work was supported in part by Grant-in-Aid for Scientific Research B18380028, 21380029 and 18658016 from Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research of Priority Area, Hirosaki University 2004-2006, 2008, Japan Society for the Promotion of Science FY2008 Bilateral Joint Projects between Japan and China-NSFC (30811140157), and the National Basic Research and Development Program of China (No. 2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari K, 2001, J GEN VIROL, V82, P953, DOI 10.1099/0022-1317-82-4-953; Astruc N, 1996, EUR J PLANT PATHOL, V102, P837, DOI 10.1007/BF01877053; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; De la Pena M, 2002, J MOL BIOL, V321, P411, DOI 10.1016/S0022-2836(02)00629-0; DIENER TO, 1987, VIROIDS, P9; Ding B, 1997, PLANT J, V12, P931, DOI 10.1046/j.1365-313X.1997.12040931.x; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Duran-Vila N, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P43, DOI 10.1016/B978-0-12-374153-0.00002-3; EASTWELL KC, 2007, ONLINE PLANT HLTH PR, DOI DOI 10.1094/PHP-2007-1127-01-RS; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gas ME, 2007, PLOS PATHOG, V3, P1813, DOI 10.1371/journal.ppat.0030182; Ge LM, 2007, J VIROL, V81, P5902, DOI 10.1128/JVI.02431-06; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; Guo L, 2008, PLANT PATHOL, V57, P764, DOI 10.1111/j.1365-3059.2008.01875.x; Harkins GW, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-104; Hassen IF, 2007, VIROLOGY, V360, P50, DOI 10.1016/j.virol.2006.10.021; James T, 2008, PLANT PATHOL, V57, P400, DOI 10.1111/j.1365-3059.2007.01727.x; Jiang DM, 2009, VIRUS GENES, V38, P178, DOI 10.1007/s11262-008-0306-1; KEESE P, 1985, P NATL ACAD SCI USA, V82, P4582, DOI 10.1073/pnas.82.14.4582; Kofalvi SA, 1997, J GEN VIROL, V78, P3177, DOI 10.1099/0022-1317-78-12-3177; LEE JY, 1988, NUCLEIC ACIDS RES, V16, P8708, DOI 10.1093/nar/16.17.8708; Matousek J, 2007, J VIROL, V81, P11891, DOI 10.1128/JVI.01165-07; Mori Y., 1995, HOP; OHNO T, 1983, NUCLEIC ACIDS RES, V11, P6185, DOI 10.1093/nar/11.18.6185; Owens RA, 1999, ANN APPL BIOL, V134, P73, DOI 10.1111/j.1744-7348.1999.tb05237.x; Owens Robert A., 2008, P83, DOI 10.1007/978-3-540-75763-4_5; Pelchat M, 2003, NUCLEIC ACIDS RES, V31, P444, DOI 10.1093/nar/gkg026; Pita Justin S., 2008, P109, DOI 10.1007/978-3-540-75763-4_6; PUCHTA H, 1988, NUCLEIC ACIDS RES, V16, P2730, DOI 10.1093/nar/16.6.2730; Qi YJ, 2004, PLANT CELL, V16, P1741, DOI 10.1105/tpc.021980; Reanwarakorn K, 1999, PHYTOPATHOLOGY, V89, P568, DOI 10.1094/PHYTO.1999.89.7.568; Rodio ME, 2006, J GEN VIROL, V87, P231, DOI 10.1099/vir.0.81356-0; SANO T, 1992, P NATL ACAD SCI USA, V89, P10104, DOI 10.1073/pnas.89.21.10104; SANO T, 1988, NUCLEIC ACIDS RES, V16, P347, DOI 10.1093/nar/16.1.347; SANO T, 1985, P JPN ACAD B-PHYS, V61, P265, DOI 10.2183/pjab.61.265; Sano T., 2003, Viroids, P165; Sano T., 2003, Viroids, P207; SANO T, 1989, J GEN VIROL, V70, P1311, DOI 10.1099/0022-1317-70-6-1311; Sano T, 1998, VIROLOGY, V240, P238, DOI 10.1006/viro.1997.8899; SANO T, 1986, J GEN VIROL, V67, P1673, DOI 10.1099/0022-1317-67-8-1673; Sano T, 2001, VIRUS GENES, V22, P53, DOI 10.1023/A:1008182302704; SANO T, 1985, SHOKUBUTU BOUEKI, V39, P361; Sano T, 2008, VIRUS GENES, V37, P298, DOI 10.1007/s11262-008-0270-9; Sano Teruo, 2004, Journal of General Plant Pathology, V70, P181, DOI 10.1007/s10327-004-0105-z; SASAKI M, 1977, P JPN ACAD B-PHYS, V53, P109, DOI 10.2183/pjab.53.109; Schneider WL, 2001, J VIROL, V75, P6566, DOI 10.1128/JVI.75.14.6566-6571.2001; SERIO FD, 2007, J PLANT PATHOL, V89, P297; Serra P, 2008, VIRUS RES, V138, P130, DOI 10.1016/j.virusres.2008.08.003; SHIKATA E, 1990, SEMIN VIROL, V1, P107; Szychowski JA, 2005, J GEN VIROL, V86, P473, DOI 10.1099/vir.0.80699-0; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; Ukawa S., 1973, REPT RES LAB KIRIN B, V16, P49; VERHOEVEN JTJ, 2008, PLANT PATHOL, V57, P399; Zhang BL, 2009, EUR J PLANT PATHOL, V125, P665, DOI 10.1007/s10658-009-9504-5; Zhong XH, 2008, PLANT CELL, V20, P35, DOI 10.1105/tpc.107.056606; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	41	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8386	10.1371/journal.pone.0008386	http://dx.doi.org/10.1371/journal.pone.0008386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041179	Green Submitted, Green Published, gold			2022-12-27	WOS:000273104000002
J	Nohr, EA; Timpson, NJ; Andersen, CS; Smith, GD; Olsen, J; Sorensen, TIA				Nohr, Ellen A.; Timpson, Nicholas J.; Andersen, Camilla S.; Smith, George Davey; Olsen, Jorn; Sorensen, Thorkild I. A.			Severe Obesity in Young Women and Reproductive Health: The Danish National Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; WEIGHT-GAIN; METABOLIC RISK; PREGNANCY; COMPLICATIONS; OUTCOMES; GROWTH; ASSOCIATION; CONCEPTION	Background: Little is known about reproductive health in severely obese women. In this study, we present associations between different levels of severe obesity and a wide range of health outcomes in the mother and child. Methods: From the Danish National Birth Cohort, we obtained self-reported information about prepregnant body mass index (BMI) for 2451 severely obese women and 2450 randomly selected women from the remaining cohort who served as a comparison group. Information about maternal and infant outcomes was also self-reported or came from registers. Logistic regression was used to estimate the association between different levels of severe obesity and reproductive outcomes. Principal Findings: Subfecundity was more frequent in severely obese women, and during pregnancy, they had an excess risk of urinary tract infections, gestational diabetes, preeclampsia and other hypertensive disorders which increased with severity of obesity. They tended to have a higher risk of both pre- and post-term birth, and risk of cesarean and instrumental deliveries increased across obesity categories. After birth, severely obese women more often failed to initiate or sustain breastfeeding. Risk of weight retention 1.5 years after birth was similar to that of other women, but after adjustment for gestational weight gain, the risk was increased, especially in women in the lowest obesity category. In infants, increasing maternal obesity was associated with decreased risk of a low birth weight and increased risk of a high birth weight. Estimates for ponderal index showed the same pattern indicating an increasing risk of neonatal fatness with severity of obesity. Infant obesity measured one year after birth was also increased in children of severely obese mothers. Conclusion: Severe obesity is correlated with a substantial disease burden in reproductive health. Although the causal mechanisms remain elusive, these findings are useful for making predictions and planning health care at the individual level.	[Nohr, Ellen A.] Univ Aarhus, Dept Epidemiol, Aarhus, Denmark; [Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Andersen, Camilla S.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; University of Bristol; University of Copenhagen; University of California System; University of California Los Angeles	Nohr, EA (corresponding author), Univ Aarhus, Dept Epidemiol, Aarhus, Denmark.	ean@soci.au.dk	Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Attrill, Lauren/V-1688-2018; Olsen, Jørn/F-8801-2015; Davey Smith, George/A-7407-2013	Timpson, Nicholas John/0000-0002-7141-9189; Olsen, Jørn/0000-0001-7462-5140; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Wellcome Trust [084762/Z/08/Z]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present study is based on an initial sample for the genome-wide association study GOYA ( Genomics of Obesity in Young Adults), supported by the Wellcome Trust ( grant no. 084762/Z/08/Z). The Danish National Research Foundation established the Danish Epidemiology Science Centre, which initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this foundation. Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation and the Augustinus Foundation. The present study is included in the Danish Obesity Research Centre (DanORC, see www. danorc. dk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD NE, 2005, THESIS U AARHUS; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2007, AM J CLIN NUTR, V86, P404, DOI 10.1093/ajcn/86.2.404; Basso O, 2004, JAMA-J AM MED ASSOC, V291, P1564, DOI 10.1001/jama.291.13.1564-c; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bianco AT, 1998, OBSTET GYNECOL, V91, P97, DOI 10.1016/S0029-7844(97)00578-4; Bolumar F, 2000, AM J EPIDEMIOL, V151, P1072, DOI 10.1093/oxfordjournals.aje.a010150; Bonde JP, 2006, EPIDEMIOLOGY, V17, P347, DOI 10.1097/01.ede.0000210239.80406.46; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; *DAN I PUBL HLTH, 2004, DAN HLTH MORB SURV 2; Donath SM, 2008, MATERN CHILD NUTR, V4, P163, DOI 10.1111/j.1740-8709.2008.00134.x; EDWARDS LE, 1978, AM J OBSTET GYNECOL, V131, P479, DOI 10.1016/0002-9378(78)90106-0; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Frisancho AR, 2000, AM J CLIN NUTR, V72, P1186; Gale CR, 2007, J CLIN ENDOCR METAB, V92, P3904, DOI 10.1210/jc.2007-0088; GALTIERDEREURE F, 1995, INT J OBESITY, V19, P443; Griffiths LJ, 2007, INT J EPIDEMIOL, V36, P104, DOI 10.1093/ije/dyl210; Gunderson EP, 2001, INT J OBESITY, V25, P853, DOI 10.1038/sj.ijo.0801631; Jensen TK, 1999, EPIDEMIOLOGY, V10, P422, DOI 10.1097/00001648-199907000-00014; Jiang JX, 2009, PUBLIC HEALTH NUTR, V12, P973, DOI 10.1017/S1368980008003509; Lamas O, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601484; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Li RW, 2003, AM J CLIN NUTR, V77, P931, DOI 10.1093/ajcn/77.4.931; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Manios Y, 2009, PUBLIC HEALTH NUTR, V12, P517, DOI 10.1017/S1368980008002838; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Rooney BL, 2005, OBSTET GYNECOL, V106, P1349, DOI 10.1097/01.AOG.0000185480.09068.4a; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Vohr BR, 1999, DIABETES CARE, V22, P1284, DOI 10.2337/diacare.22.8.1284; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; WHO, 2000, OB PREV MAN GLOB EP	42	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8444	10.1371/journal.pone.0008444	http://dx.doi.org/10.1371/journal.pone.0008444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041193	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000009
J	Glasgow, JN; Mikheeva, G; Krasnykh, V; Curiel, DT				Glasgow, Joel N.; Mikheeva, Galina; Krasnykh, Victor; Curiel, David T.			A Strategy for Adenovirus Vector Targeting with a Secreted Single Chain Antibody	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INTRACELLULAR ANTIBODIES; CAPTURE TECHNOLOGY; GENE DELIVERY; FIBER PROTEIN; REPLICATING ADENOVIRUS; LEUCINE ZIPPERS; CELLS; COXSACKIEVIRUS; GENERATION	Background: Successful gene therapy will require targeted delivery vectors capable of self-directed localization. In this regard, the use of antibodies or single chain antibody fragments (scFv) in conjunction with adenovirus (Ad) vectors remains an attractive means to achieve cell-specific targeting. However, a longstanding barrier to the development of Ad vectors with genetically incorporated scFvs has been the biosynthetic incompatibility between Ad capsid proteins and antibody-derived species. Specifically, scFv require posttranslational modifications not available to Ad capsid proteins due to their cytoplasmic routing during protein synthesis and virion assembly. Methodology/Principal Findings: We have therefore sought to develop scFv-targeted Ad vectors using a secreted scFv that undergoes the requisite posttranslational modifications and is trafficked for secretion. Formation of the scFv-targeted Ad vector is achieved via highly specific association of the Ad virion and a targeting scFv employing synthetic leucine zipper-like dimerization domains (zippers) that have been optimized for structural compatibility with the Ad capsid and for association with the secreted scFv. Our results show that zipper-containing Ad fiber molecules trimerize and incorporate into mature virions and that zippers can be genetically fused to scFv without ablating target recognition. Most importantly, we show that zipper-tagged virions and scFv provide target-specific gene transfer. Conclusions/Significance: This work describes a new approach to produce targeted Ad vectors using a secreted scFv molecule, thereby avoiding the problem of structural and biosynthetic incompatibility between Ad and a complex targeting ligand. This approach may facilitate Ad targeting using a wide variety of targeting ligands directed towards a variety of cellular receptors.	[Glasgow, Joel N.] Univ Alabama, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Mikheeva, Galina; Krasnykh, Victor] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Glasgow, JN (corresponding author), Univ Alabama, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	jng@uab.edu		Glasgow, Joel/0000-0002-2842-7917	NIH [7P01 CA104177, R01 CA116621]; U.S. Army Medical Research and Materiel Command [DAMD17-02-C-0006]; NATIONAL CANCER INSTITUTE [R01CA116621, P01CA104177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to acknowledge NIH grant award 7P01 CA104177 (D. T. C.), grant award DAMD17-02-C-0006 from the U.S. Army Medical Research and Materiel Command, and NIH award R01 CA116621 (V. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFDERMAUR A, 2002, J BIOL CHEM, V277, P45075; Belousova N, 2003, J VIROL, V77, P11367, DOI 10.1128/JVI.77.21.11367-11377.2003; Belousova N, 2002, J VIROL, V76, P8621, DOI 10.1128/JVI.76.17.8621-8631.2002; Carette JE, 2007, VIROLOGY, V361, P56, DOI 10.1016/j.virol.2006.11.011; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Davison E, 1999, J VIROL, V73, P4513, DOI 10.1128/JVI.73.5.4513-4517.1999; der Maur Adrian Auf, 2004, Methods (Amsterdam), V34, P215; Dmitriev I, 2000, J VIROL, V74, P6875, DOI 10.1128/JVI.74.15.6875-6884.2000; Everts M, 2005, GENE THER, V12, P1042, DOI 10.1038/sj.gt.3302491; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Haisma HJ, 2000, CANCER GENE THER, V7, P901, DOI 10.1038/sj.cgt.7700198; Haisma HJ, 1999, GENE THER, V6, P1469, DOI 10.1038/sj.gt.3300969; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Hemminki A, 2001, CANCER RES, V61, P6377; Hemminki A, 2003, CANCER GENE THER, V10, P583, DOI 10.1038/sj.cgt.7700606; IYER SV, 1991, MOL CELL BIOL, V11, P4863, DOI 10.1128/MCB.11.10.4863; Jakubczak JL, 2001, J VIROL, V75, P2972, DOI 10.1128/JVI.75.6.2972-2981.2001; Kashentseva EA, 2002, CANCER RES, V62, P609; Katz BZ, 1998, BIOTECHNIQUES, V25, P298, DOI 10.2144/98252rr01; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Korokhov N, 2003, J VIROL, V77, P12931, DOI 10.1128/JVI.77.24.12931-12940.2003; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Li HJ, 2007, CANCER RES, V67, P5354, DOI 10.1158/0008-5472.CAN-06-4679; Li HJ, 2009, CANCER RES, V69, P554, DOI 10.1158/0008-5472.CAN-08-3209; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Pereboev AV, 2002, GENE THER, V9, P1189, DOI 10.1038/sj.gt.3301767; Reynolds PN, 2001, NAT BIOTECHNOL, V19, P838, DOI 10.1038/nbt0901-838; Reynolds PN, 2000, MOL THER, V2, P562, DOI 10.1006/mthe.2000.0205; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Tse E, 2002, J MOL BIOL, V317, P85, DOI 10.1006/jmbi.2002.5403; van Beusechem VW, 2003, GENE THER, V10, P1982, DOI 10.1038/sj.gt.3302103; Visintin M, 2004, METHODS, V34, P200, DOI 10.1016/j.ymeth.2004.04.008; Visintin M, 2002, J MOL BIOL, V317, P73, DOI 10.1006/jmbi.2002.5392; Watkins SJ, 1997, GENE THER, V4, P1004, DOI 10.1038/sj.gt.3300511; Wirtz P, 1999, PROTEIN SCI, V8, P2245; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; 2008, J GENE MED CLIN TRIA	44	22	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8355	10.1371/journal.pone.0008355	http://dx.doi.org/10.1371/journal.pone.0008355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027223	Green Submitted, Green Published, gold			2022-12-27	WOS:000272940100003
J	Song, YQ; Selak, MA; Watson, CT; Coutts, C; Scherer, PC; Panzer, JA; Gibbs, S; Scott, MO; Willer, G; Gregg, RG; Ali, DW; Bennett, MJ; Balice-Gordon, RJ				Song, Yuanquan; Selak, Mary A.; Watson, Corey T.; Coutts, Christopher; Scherer, Paul C.; Panzer, Jessica A.; Gibbs, Sarah; Scott, Marion O.; Willer, Gregory; Gregg, Ronald G.; Ali, Declan W.; Bennett, Michael J.; Balice-Gordon, Rita J.			Mechanisms Underlying Metabolic and Neural Defects in Zebrafish and Human Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; ACIDURIA TYPE-II; ELECTRON-TRANSFER FLAVOPROTEIN; OXIDATION DISORDERS; RESPIRATORY-CHAIN; BETA-OXIDATION; PPAR-GAMMA; MITOCHONDRIA; DISEASES; ACIDS	In humans, mutations in electron transfer flavoprotein (ETF) or electron transfer flavoprotein dehydrogenase (ETFDH) lead to MADD/glutaric aciduria type II, an autosomal recessively inherited disorder characterized by a broad spectrum of devastating neurological, systemic and metabolic symptoms. We show that a zebrafish mutant in ETFDH, xavier, and fibroblast cells from MADD patients demonstrate similar mitochondrial and metabolic abnormalities, including reduced oxidative phosphorylation, increased aerobic glycolysis, and upregulation of the PPARG-ERK pathway. This metabolic dysfunction is associated with aberrant neural proliferation in xav, in addition to other neural phenotypes and paralysis. Strikingly, a PPARG antagonist attenuates aberrant neural proliferation and alleviates paralysis in xav, while PPARG agonists increase neural proliferation in wild type embryos. These results show that mitochondrial dysfunction, leading to an increase in aerobic glycolysis, affects neurogenesis through the PPARG-ERK pathway, a potential target for therapeutic intervention.	[Song, Yuanquan; Scherer, Paul C.; Panzer, Jessica A.; Gibbs, Sarah; Scott, Marion O.; Balice-Gordon, Rita J.] Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA; [Selak, Mary A.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Watson, Corey T.; Willer, Gregory; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Coutts, Christopher; Ali, Declan W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bennett, Michael J.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Louisville; University of Alberta; University of Pennsylvania	Song, YQ (corresponding author), Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA.	rbaliceg@mail.med.upenn.edu	Song, Yuanquan/E-2603-2012	Balice-Gordon, Rita/0000-0002-9950-7965; Gregg, Ronald/0000-0001-5805-224X	NIH [NS050524]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant NS050524 to R. B.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; BENNETT MJ, 1992, ANN CLIN BIOCHEM, V29, P541, DOI 10.1177/000456329202900509; BOHM N, 1982, EUR J PEDIATR, V139, P60, DOI 10.1007/BF00442082; Bonham JR, 1999, J INHERIT METAB DIS, V22, P174, DOI 10.1023/A:1005406205548; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; BROWN CW, 1992, ADV NEAR INFRARED ME, V1, P1; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Fajas L, 2001, NUTR METAB CARDIOVAS, V11, P64; Frerman F. E., 2001, METABOLIC MOL BASES, P2357, DOI DOI 10.1036/OMMBID.131; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nam DH, 2007, MOL HUM REPROD, V13, P829, DOI 10.1093/molehr/gam071; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Russell AP, 2003, J CLIN ENDOCR METAB, V88, P5921, DOI 10.1210/jc.2003-030885; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Shen JJ, 2000, J INHERIT METAB DIS, V23, P27, DOI 10.1023/A:1005694712583; SHEVELL MI, 1995, PEDIATR NEUROL, V12, P350, DOI 10.1016/0887-8994(95)00049-L; STOCKLER S, 1994, J PEDIATR-US, V124, P601, DOI 10.1016/S0022-3476(05)83142-7; Takanashi J, 1999, PEDIATR NEUROL, V20, P142, DOI 10.1016/S0887-8994(98)00118-0; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Van Hove JLK, 2003, LANCET, V361, P1433, DOI 10.1016/S0140-6736(03)13105-4; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Zannino DA, 2009, J NEUROSCI, V29, P2322, DOI 10.1523/JNEUROSCI.3755-08.2009	40	44	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8329	10.1371/journal.pone.0008329	http://dx.doi.org/10.1371/journal.pone.0008329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020044	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834200004
J	Matheson, CD; Vernon, KK; Lahti, A; Fratpietro, R; Spigelman, M; Gibson, S; Greenblatt, CL; Donoghue, HD				Matheson, Carney D.; Vernon, Kim K.; Lahti, Arlene; Fratpietro, Renee; Spigelman, Mark; Gibson, Shimon; Greenblatt, Charles L.; Donoghue, Helen D.			Molecular Exploration of the First-Century Tomb of the Shroud in Akeldama, Jerusalem	PLOS ONE			English	Article							HUMAN SKELETAL REMAINS; MYCOBACTERIUM-TUBERCULOSIS; MTDNA SEQUENCE; ANCIENT DNA; IDENTIFICATION; LEPROSY; LEPRAE; AMPLIFICATION; GENE	The Tomb of the Shroud is a first-century C. E. tomb discovered in Akeldama, Jerusalem, Israel that had been illegally entered and looted. The investigation of this tomb by an interdisciplinary team of researchers began in 2000. More than twenty stone ossuaries for collecting human bones were found, along with textiles from a burial shroud, hair and skeletal remains. The research presented here focuses on genetic analysis of the bioarchaeological remains from the tomb using mitochondrial DNA to examine familial relationships of the individuals within the tomb and molecular screening for the presence of disease. There are three mitochondrial haplotypes shared between a number of the remains analyzed suggesting a possible family tomb. There were two pathogens genetically detected within the collection of osteological samples, these were Mycobacterium tuberculosis and Mycobacterium leprae. The Tomb of the Shroud is one of very few examples of a preserved shrouded human burial and the only example of a plaster sealed loculus with remains genetically confirmed to have belonged to a shrouded male individual that suffered from tuberculosis and leprosy dating to the first-century C.E. This is the earliest case of leprosy with a confirmed date in which M. leprae DNA was detected.	[Matheson, Carney D.; Lahti, Arlene; Fratpietro, Renee] Lakehead Univ, Paleo DNA Lab, Thunder Bay, ON P7B 5E1, Canada; [Matheson, Carney D.] Lakehead Univ, Dept Anthropol, Thunder Bay, ON P7B 5E1, Canada; [Matheson, Carney D.; Vernon, Kim K.; Spigelman, Mark; Greenblatt, Charles L.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Vernon, Kim K.] Univ Queensland, Dept Zool, Dept Anthropol, St Lucia, Qld, Australia; [Lahti, Arlene] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Spigelman, Mark; Donoghue, Helen D.] UCL, Dept Infect, London, England; [Gibson, Shimon] Univ N Carolina, Charlotte, NC 28223 USA	Lakehead University; Lakehead University; Hebrew University of Jerusalem; University of Queensland; Lakehead University; University of London; University College London; University of North Carolina; University of North Carolina Charlotte	Matheson, CD (corresponding author), Lakehead Univ, Paleo DNA Lab, Thunder Bay, ON P7B 5E1, Canada.	cmatheso@lakeheadu.ca	Matheson, Carney/ABE-5699-2020; Vernon, Kim/GXW-0252-2022; Greenblatt, Chuck/ABC-8220-2021; Donoghue, Helen D./D-6805-2013	Matheson, Carney/0000-0002-3890-1838; Vernon, Kim/0000-0002-4875-5053; Donoghue, Helen D./0000-0003-3918-5252				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bini C, 2005, FORENSIC SCI INT, V152, P35, DOI 10.1016/j.forsciint.2005.03.006; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CANN RL, 1994, AM J HUM GENET, V55, P7; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Donoghue HD, 2001, J MED MICROBIOL, V50, P177, DOI 10.1099/0022-1317-50-2-177; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Gibson Shimon, 2009, FINAL DAYS JESUS ARC; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; GLAZIOU P, 1993, INT J LEPROSY, V61, P199; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Haas CJ, 2000, AM J CLIN PATHOL, V114, P428, DOI 10.1093/ajcp/114.3.428; Handt O, 1996, AM J HUM GENET, V59, P368; Hansen GA, 1895, LEPROSY ITS CLIN PAT; HANSEN JN, 1974, PREP BIOCHEM, V4, P473, DOI 10.1080/00327487408061549; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hummel S, 1996, HOMO, V47, P215; JAYALAKSHMI P, 1987, INT J LEPROSY, V55, P510; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; Kloner A., 2007, NECROPOLIS JERUSALEM; Kolman CJ, 2000, AM J PHYS ANTHROPOL, V111, P5; Koyama H, 2002, AM J FOREN MED PATH, V23, P181, DOI 10.1097/00000433-200206000-00014; Lutz S, 1996, INT J LEGAL MED, V109, P205, DOI 10.1007/BF01225519; Mark S, 2002, J HIST MED ALL SCI, V57, P285, DOI 10.1093/jhmas/57.3.285; Matheson CD, 2009, AM J PHYS ANTHROPOL, V140, P384, DOI 10.1002/ajpa.21106; MONOT M, 2009, NAT GENET; Nigam P, 1979, Lepr India, V51, P65; O'Rourke DH, 2000, ANNU REV ANTHROPOL, V29, P217, DOI 10.1146/annurev.anthro.29.1.217; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; RAFI A, 1994, LANCET, V343, P1360, DOI 10.1016/S0140-6736(94)92494-5; Rafi A, 1994, INT J OSTEOARCHAEOL, V4, P287; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rothschild BM, 2001, CLIN INFECT DIS, V33, P305, DOI 10.1086/321886; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Schultes T, 2000, Anthropol Anz, V58, P37; SCHULTES T, 1999, ANTHROPO AN IN PRESS; Spigelman M, 2001, AM J PHYS ANTHROPOL, V114, P92, DOI 10.1002/1096-8644(200101)114:1<92::AID-AJPA1008>3.0.CO;2-V; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; Taylor GM, 2007, MICROBIOL-SGM, V153, P1243, DOI 10.1099/mic.0.2006/002154-0; Taylor GM, 1996, J ARCHAEOL SCI, V23, P789; Taylor GM, 2000, J ARCHAEOL SCI, V27, P1133, DOI 10.1006/jasc.1999.0532; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012; WITT M, 1989, HUM GENET, V82, P271, DOI 10.1007/BF00291168	53	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8319	10.1371/journal.pone.0008319	http://dx.doi.org/10.1371/journal.pone.0008319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	533OP	20016819	Green Published, Green Submitted, gold			2022-12-27	WOS:000272834000012
J	Chung, E; Yamashita, H; Au, P; Tannous, BA; Fukumura, D; Jain, RK				Chung, Euiheon; Yamashita, Hiroshi; Au, Patrick; Tannous, Bakhos A.; Fukumura, Dai; Jain, Rakesh K.			Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases	PLOS ONE			English	Article							BREAST-CANCER CELLS; IN-VIVO; GENE-EXPRESSION; GROWTH; BRAIN; OUTGROWTH; CULTURE; VITRO	Background: Currently, only few techniques are available for quantifying systemic metastases in preclinical model. Thus techniques that can sensitively detect metastatic colonization and assess treatment response in real-time are urgently needed. To this end, we engineered tumor cells to express a naturally secreted Gaussia luciferase (Gluc), and investigated its use as a circulating biomarker for monitoring viable metastatic or primary tumor growth and their treatment responses. Methodology/Principal Findings: We first developed orthotopic primary and metastatic breast tumors with derivative of MDA-MB-231 cells expressing Gluc. We then correlated tumor burden with Gluc activity in the blood and urine along with bioluminescent imaging (BLI). Second, we utilized blood Gluc assay to monitor treatment response to lapatinib in an experimental model of systemic metastasis. We observed good correlation between the primary tumor volume and Gluc concentration in blood (R(2) = 0.84) and urine (R(2) = 0.55) in the breast tumor model. The correlation deviated as a primary tumor grew due to a reduction in viable tumor fraction. This was also supported by our mathematical models for tumor growth to compare the total and viable tumor burden in our model. In the experimental metastasis model, we found numerous brain metastases as well as systemic metastases including bone and lungs. Importantly, blood Gluc assay revealed early growth of metastatic tumors before BLI could visualize their presence. Using secreted Gluc, we localized systemic metastases by BLI and quantitatively monitored the total viable metastatic tumor burden by blood Gluc assay during the course of treatment with lapatinib, a dual tyrosine kinase inhibitor of EGFR and HER2. Conclusion/Significance: We demonstrated secreted Gluc assay accurately reflects the amount of viable cancer cells in primary and metastatic tumors. Blood Gluc activity not only tracks metastatic tumor progression but also serves as a longitudinal biomarker for tumor response to treatments.	[Chung, Euiheon; Yamashita, Hiroshi; Au, Patrick; Fukumura, Dai; Jain, Rakesh K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Edwin L Steele Lab,Dept Radiat Oncol, Boston, MA 02115 USA; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurogenet Unit,Dept Neurol, Boston, MA USA; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Ctr Mol Imaging Res, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chung, E (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Edwin L Steele Lab,Dept Radiat Oncol, Boston, MA 02115 USA.	btannous@hms.harvard.edu; dai@steele.mgh.harvard.edu; jain@steele.mgh.harvard.edu	Chung, Euiheon/A-1801-2009; Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548; Chung, Euiheon/0000-0002-3326-6927	National Cancer Institute [R01-CA96915, R01-CA85140, R01-CA115767, R01-CA126642, P01-CA80124]; Federal Share/National Cancer Institute Proton Beam Program Income;  [R00CA126839];  [P50CA86355-07]; NATIONAL CANCER INSTITUTE [R00CA126839, P01CA080124, T32CA073479, R01CA115767, R01CA085140, P50CA086355, R24CA085140, R01CA126642, R01CA096915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064983] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal Share/National Cancer Institute Proton Beam Program Income; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by R00CA126839 and P50CA86355-07 (BAT), National Cancer Institute grants R01-CA96915 (DF), and R01-CA85140, R01-CA115767, R01-CA126642, P01-CA80124, and Federal Share/National Cancer Institute Proton Beam Program Income grant (RKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Bao R, 2000, GYNECOL ONCOL, V78, P373, DOI 10.1006/gyno.2000.5925; Bao RD, 2002, J NATL CANCER I, V94, P522; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hiramatsu N, 2006, J IMMUNOL METHODS, V315, P202, DOI 10.1016/j.jim.2006.07.003; Kim HJ, 2008, J NUCL MED, V49, P1686, DOI 10.2967/jnumed.108.052894; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Meng YM, 2005, LAB INVEST, V85, P1429, DOI 10.1038/labinvest.3700341; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	21	68	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8316	10.1371/journal.pone.0008316	http://dx.doi.org/10.1371/journal.pone.0008316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016816	gold, Green Submitted, Green Published			2022-12-27	WOS:000272833800012
J	Ruiz, S; Santos, E; Bustelo, XR				Ruiz, Sergio; Santos, Eugenio; Bustelo, Xose R.			The Use of Knockout Mice Reveals a Synergistic Role of the Vav1 and Rasgrf2 Gene Deficiencies in Lymphomagenesis and Metastasis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; EXPRESSION SIGNATURE; RECEPTOR; ONCOGENE; RAS; OVEREXPRESSION; PROGRESSION; MOLECULES	Background: Vav1 and RasGRF2 are GDP/GTP exchange factors for Ras superfamily GTPases with roles in the development and/or effector functions of T-lymphocytes. Methodology/Principal Findings: Given that the phenotype of Vav1(-/-), Rasgrf2(-/-) and Vav1(-/-); Rasgrf2(-/-) mice has been studied so far in young animals, we decided to explore the long-term consequences of the inactivation of those loci in the immune system. Unexpectedly, our studies revealed that the inactivation of the Vav1 proto-oncogene favors the formation of lymphoblastic lymphoma-like tumors in aging mice. Those tumors, that can be found either localized exclusively inside the thymus or widely disseminated in hematopoietic and non-hematopoietic tissues, are composed of CD3(+) lymphoblasts that display heterogeneous combinations of CD4 and CD8 surface markers. Interestingly, the additional deletion of the Rasgrf2 gene induces a shortening in the latency period for the development of those tumors, an increase in the percentage of disseminated tumors outside the thymus and, as a result, higher mortality rates. Conclusions/Significance: These data reveal unexpected negative roles for Vav1 and RasGRF2 in different stages of T-cell lymphoma progression. They also suggest that the inactivation of Vav1 function may represent an inadequate strategy to treat T-cell lymphomas, especially those associated with low levels of Rasgrf2 gene expression.	Univ Salamanca, CSIC, Ctr Invest Canc, E-37008 Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Ruiz, S (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xbustelo@usal.es	Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022; Ruiz, Sergio/G-1561-2016	Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; Ruiz, Sergio/0000-0002-0177-6965	NIH [5R01-CA73735-13]; Spanish Ministry of Science and Innovation [SAF2006-01789]; Red Tematica de Investigacion Cooperativa en Cancer [RD06/0020/0001]; Castilla y Leon Autonomous Government [SA053A05, GR97]; Spanish Ministry of Science and Innovation; Ramon Areces Foundation; Foundation for Cancer Research at the University of Salamanca; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer; Castilla y Leon Autonomous Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon Areces Foundation; Foundation for Cancer Research at the University of Salamanca; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	X. R. B. work is supported by grants from the NIH (5R01-CA73735-13), the Spanish Ministry of Science and Innovation (SAF2006-01789), the Red Tematica de Investigacion Cooperativa en Cancer (RD06/0020/0001), and the Castilla y Leon Autonomous Government (SA053A05 and GR97). S. R. was supported by a Juan de la Cierva postdoctoral position funded by the Spanish Ministry of Science and Innovation. The activities of the Centro de Investigacion del Cancer are partially supported by the Ramon Areces Foundation and by the Foundation for Cancer Research at the University of Salamanca. X. R. B. lab has been recognized as a Consolidated Cancer Research Group by the Spanish Association against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhojwani D, 2008, J CLIN ONCOL, V26, P4376, DOI 10.1200/JCO.2007.14.4519; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Chen H, 2006, ONCOL REP, V15, P1281; Cleverley SC, 2000, ONCOGENE, V19, P13, DOI 10.1038/sj.onc.1203259; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; DUMONT C, 2008, BLOOD; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Lee KW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-158; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Prieto-Sanchez RM, 2006, BRIT J HAEMATOL, V133, P642, DOI 10.1111/j.1365-2141.2006.06094.x; Qiu CP, 2003, ONCOGENE, V22, P1253, DOI 10.1038/sj.onc.1206233; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Sauzeau V, 2007, MOL BIOL CELL, V18, P943, DOI 10.1091/mbc.E06-09-0877; Saveliev A, 2009, NAT IMMUNOL, V10, P361, DOI 10.1038/ni.1709; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	49	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8229	10.1371/journal.pone.0008229	http://dx.doi.org/10.1371/journal.pone.0008229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011522	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300011
J	Brooks-Pollock, E; Cohen, T; Murray, M				Brooks-Pollock, Ellen; Cohen, Ted; Murray, Megan			The Impact of Realistic Age Structure in Simple Models of Tuberculosis Transmission	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIC MODELS; RISKS; DISTRIBUTIONS; PERSISTENCE; INFECTIONS; DYNAMICS; PATTERNS; PERIOD; ERA	Background: Mathematical models of tuberculosis (TB) transmission have been used to characterize disease dynamics, investigate the potential effects of public health interventions, and prioritize control measures. While previous work has addressed the mathematical description of TB natural history, the impact of demography on the behaviour of TB models has not been assessed. Methods: A simple model of TB transmission, with alternative assumptions about survivorship, is used to explore the effect of age structure on the prevalence of infection, disease, basic reproductive ratio and the projected impact of control interventions. We focus our analytic arguments on the differences between constant and exponentially distributed lifespans and use an individual-based model to investigate the range of behaviour arising from realistic distributions of survivorship. Results: The choice of age structure and natural (non-disease related) mortality strongly affects steady-state dynamics, parameter estimation and predictions about the effectiveness of control interventions. Since most individuals infected with TB develop an asymptomatic latent infection and never progress to active disease, we find that assuming a constant mortality rate results in a larger reproductive ratio and an overestimation of the effort required for disease control in comparison to using more realistic age-specific mortality rates. Conclusions: Demographic modelling assumptions should be considered in the interpretation of models of chronic infectious diseases such as TB. For simple models, we find that assuming constant lifetimes, rather than exponential lifetimes, produces dynamics more representative of models with realistic age structure.	[Brooks-Pollock, Ellen; Cohen, Ted; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Ted; Murray, Megan] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Brooks-Pollock, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	ebrooks@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cohen, Ted/0000-0002-8091-7198; Brooks-Pollock, Ellen/0000-0002-5984-4932	National Institutes of Health (NIH) [U19 AI076217]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EBP, TC and MM are funded by National Institutes of Health (NIH) grant U19 AI076217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1988, NATURE, V332, P228, DOI 10.1038/332228a0; ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; BASU S, 2009, B MATH BIOL, P1; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hughes GR, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P459, DOI 10.1109/WSC.2006.323116; Keeling MJ, 1998, MATH BIOSCI, V147, P207, DOI 10.1016/S0025-5564(97)00101-6; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; MAY RM, 1985, MATH BIOSCI, V77, P141, DOI 10.1016/0025-5564(85)90093-8; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Promislow DEL, 1999, J EVOLUTION BIOL, V12, P314; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; *U CAL BERK US M P, HUM MORT DAT; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1998, EPIDEMIOL INFECT, V121, P309, DOI 10.1017/S0950268898001113; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; WAALER HT, 1969, B WORLD HEALTH ORGAN, V41, P75; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams JR, 2004, INT J EPIDEMIOL, V33, P566, DOI 10.1093/ije/dyh098; World Health Organization, 2009, GLOB TUB CONTR EP ST	38	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8479	10.1371/journal.pone.0008479	http://dx.doi.org/10.1371/journal.pone.0008479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062531	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000273414100002
J	Palacios, G; Hornig, M; Cisterna, D; Savji, N; Bussetti, AV; Kapoor, V; Hui, J; Tokarz, R; Briese, T; Baumeister, E; Lipkin, WI				Palacios, Gustavo; Hornig, Mady; Cisterna, Daniel; Savji, Nazir; Bussetti, Ana Valeria; Kapoor, Vishal; Hui, Jeffrey; Tokarz, Rafal; Briese, Thomas; Baumeister, Elsa; Lipkin, W. Ian			Streptococcus pneumoniae Coinfection Is Correlated with the Severity of H1N1 Pandemic Influenza	PLOS ONE			English	Article							A H1N1; BACTERIAL PNEUMONIA; UNITED-STATES; NEURAMINIDASE; PATHOGENS	Background: Initial reports in May 2009 of the novel influenza strain H1N1pdm estimated a case fatality rate (CFR) of 0.6%, similar to that of seasonal influenza. In July 2009, however, Argentina reported 3056 cases with 137 deaths, representing a CFR of 4.5%. Potential explanations for increased CFR included virus reassortment or genetic drift, or infection of a more vulnerable population. Virus genomic sequencing of 26 Argentinian samples representing both severe and mild disease indicated no evidence of reassortment, mutations associated with resistance to antiviral drugs, or genetic drift that might contribute to virulence. Furthermore, no evidence was found for increased frequency of risk factors for H1N1pdm disease. Methods/Principal Findings: We examined nasopharyngeal swab samples (NPS) from 199 cases of H1N1pdm infection from Argentina with MassTag PCR, testing for 33 additional microbial agents. The study population consisted of 199 H1N1pdm-infected subjects sampled between 23 June and 4 July 2009. Thirty-nine had severe disease defined as death (n = 20) or hospitalization (n = 19); 160 had mild disease. At least one additional agent of potential pathogenic importance was identified in 152 samples (76%), including Streptococcus pneumoniae (n = 62); Haemophilus influenzae (n = 104); human respiratory syncytial virus A (n = 11) and B (n = 1); human rhinovirus A (n = 1) and B (n = 4); human coronaviruses 229E (n = 1) and OC43 (n = 2); Klebsiella pneumoniae (n = 2); Acinetobacter baumannii (n = 2); Serratia marcescens (n = 1); and Staphylococcus aureus (n = 35) and methicillin-resistant S. aureus (MRSA, n = 6). The presence of S. pneumoniae was strongly correlated with severe disease. S. pneumoniae was present in 56.4% of severe cases versus 25% of mild cases; more than one-third of H1N1pdm NPS with S. pneumoniae were from subjects with severe disease (22 of 62 S. pneumoniae-positive NPS, p = 0.0004). In subjects 6 to 55 years of age, the adjusted odds ratio (OR) of severe disease in the presence of S. pneumoniae was 125.5 (95% confidence interval [CI], 16.95, 928.72; p < 0.0001). Conclusions/Significance: The association of S. pneumoniae with morbidity and mortality is established in the current and previous influenza pandemics. However, this study is the first to demonstrate the prognostic significance of non-invasive antemortem diagnosis of S. pneumoniae infection and may provide insights into clinical management.	[Palacios, Gustavo; Hornig, Mady; Savji, Nazir; Bussetti, Ana Valeria; Kapoor, Vishal; Hui, Jeffrey; Tokarz, Rafal; Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Cisterna, Daniel; Baumeister, Elsa] Inst Nacl Enfermedades Infecciosas, Adm Nacl Labs, Buenos Aires, DF, Argentina; [Cisterna, Daniel; Baumeister, Elsa] Inst Salud Dr Carlos G Malbran, Buenos Aires, DF, Argentina	Columbia University	Palacios, G (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	gp2050@columbia.edu; wil2001@columbia.edu	Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020; CIsterna, Daniel/ABC-4873-2021; Palacios, Gustavo/I-7773-2015	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; Palacios, Gustavo/0000-0001-5062-1938	National Institutes of Health [AI051292, U54 AI5715, R01 AI300278]; Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051292, U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health awards AI051292, U54 AI57158 (Northeast Biodefense Center - Lipkin), and R01 AI30027, and the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hackett S, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61511-7; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; *MSAL, 2009, INFL PAND H1N1 2009; Peltola VT, 2005, J INFECT DIS, V192, P249, DOI 10.1086/430954; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; VAILLANT L, 2009, EURO SURVEILL, V14; World Health Organization, 2009, CDC PROT REAL TIM RT	14	204	216	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8540	10.1371/journal.pone.0008540	http://dx.doi.org/10.1371/journal.pone.0008540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046873	Green Published, Green Submitted, gold			2022-12-27	WOS:000273180200019
J	Lin, S; Shi, YC; Yulyaningsih, E; Aljanova, A; Zhang, L; Macia, L; Nguyen, AD; Lin, EJD; During, MJ; Herzog, H; Sainsbury, A				Lin, Shu; Shi, Yan-Chuan; Yulyaningsih, Ernie; Aljanova, Aygul; Zhang, Lei; Macia, Laurence; Nguyen, Amy D.; Lin, En-Ju Deborah; During, Matthew J.; Herzog, Herbert; Sainsbury, Amanda			Critical Role of Arcuate Y4 Receptors and the Melanocortin System in Pancreatic Polypeptide-Induced Reduction in Food Intake in Mice	PLOS ONE			English	Article							SUBTYPE MESSENGER-RNAS; NEUROPEPTIDE-Y; STIMULATING HORMONE; PEPTIDE YY3-36; BODY-WEIGHT; PYY3-36; BRAIN; INHIBITION; EXPRESSION; ADIPOSITY	Background: Pancreatic polypeptide (PP) is a potent anti-obesity agent known to inhibit food intake in the absence of nausea, but the mechanism behind this process is unknown. Methodology/Principal Findings: Here we demonstrate that in response to i.p. injection of PP in wild type but not in Y4 receptor knockout mice, immunostaining for the neuronal activation marker c-Fos is induced specifically in neurons of the nucleus tractus solitarius and the area postrema in the brainstem, notably in cells also showing immunostaining for tyrosine hydroxylase. Importantly, strong c-Fos activation is also detected in the arcuate nucleus of the hypothalamus (ARC), particularly in neurons that co-express alpha melanocyte stimulating hormone (alpha-MSH), the anorexigenic product of the proopiomelanocortin (POMC) gene. Interestingly, other hypothalamic regions such as the paraventricular nucleus, the ventromedial nucleus and the lateral hypothalamic area also show c-Fos induction after PP injection. In addition to c-Fos activation, PP injection up-regulates POMC mRNA expression in the ARC as detected by in situ hybridization. These effects are a direct consequence of local Y4 signaling, since hypothalamus-specific conditional Y4 receptor knockout abolishes PP-induced ARC c-Fos activation and blocks the PP-induced increase in POMC mRNA expression. Additionally, the hypophagic effect of i.p. PP seen in wild type mice is completely absent in melanocortin 4 receptor knockout mice. Conclusions/Significance: Taken together, these findings show that PP reduces food intake predominantly via stimulation of the anorexigenic alpha-MSH signaling pathway, and that this effect is mediated by direct action on local Y4 receptors within the ARC, highlighting a potential novel avenue for the treatment of obesity.	[Lin, Shu; Shi, Yan-Chuan; Yulyaningsih, Ernie; Aljanova, Aygul; Zhang, Lei; Macia, Laurence; Nguyen, Amy D.; Herzog, Herbert; Sainsbury, Amanda] St Vincents Hosp, Garvan Inst Med Res, Neurosci Program, Sydney, NSW 2010, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Lin, En-Ju Deborah; During, Matthew J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lin, En-Ju Deborah; During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Canc Genet & Neurosci Program, Columbus, OH 43210 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lin, S (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurosci Program, Sydney, NSW 2010, Australia.	h.herzog@garvan.org.au	Macia, laurence/D-5983-2016; /A-4361-2010; Nguyen, Amy D/K-2588-2019; During, Matthew/AAC-1388-2020; Herzog, Herbert/B-8294-2008; /E-2900-2010; /A-6021-2011; Salis, Amanda/A-3187-2011; /B-6258-2012	Macia, laurence/0000-0003-0835-851X; Nguyen, Amy D/0000-0003-4603-564X; /0000-0003-2110-2017; Salis, Amanda/0000-0001-9176-1574; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council (NHMRC) of Australia [427661, 427606]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported the National Health and Medical Research Council (NHMRC) of Australia grants #427661 & #427606, and AS and HH are supported by NHMRC Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Balasubramaniam A, 2006, J MED CHEM, V49, P2661, DOI 10.1021/jm050907d; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; BERNTSON GG, 1993, PEPTIDES, V14, P497, DOI 10.1016/0196-9781(93)90138-7; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Challis BG, 2003, BIOCHEM BIOPH RES CO, V311, P915, DOI 10.1016/j.bbrc.2003.10.089; Chelikani PK, 2006, AM J PHYSIOL-REG I, V290, pR298, DOI 10.1152/ajpregu.00674.2005; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Date Y, 2006, CELL METAB, V4, P323, DOI 10.1016/j.cmet.2006.09.004; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Erondu N, 2007, OBESITY, V15, P895, DOI 10.1038/oby.2007.620; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gantz I, 2007, J CLIN ENDOCR METAB, V92, P1754, DOI 10.1210/jc.2006-1806; GETTYS TW, 1991, PANCREAS, V6, P46, DOI 10.1097/00006676-199101000-00007; GLASER B, 1988, HORM METAB RES, V20, P288, DOI 10.1055/s-2007-1010817; Halatchev IG, 2004, ENDOCRINOLOGY, V145, P2585, DOI 10.1210/en.2003-1754; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; HORVATH TL, 1992, NEUROSCIENCE, V51, P391, DOI 10.1016/0306-4522(92)90323-T; INOUE S, 1991, BRAIN RES BULL, V27, P511, DOI 10.1016/0361-9230(91)90151-9; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; JEGOU S, 1993, ANN NY ACAD SCI, V680, P260, DOI 10.1111/j.1749-6632.1993.tb19689.x; Jesudason DR, 2007, BRIT J NUTR, V97, P426, DOI 10.1017/S0007114507336799; JIA BQ, 1984, GASTROENTEROLOGY, V87, P338; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Levi R, 2007, BIOCHEM PHARMACOL, V73, P1146, DOI 10.1016/j.bcp.2007.01.001; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; McTigue DM, 1997, J PHYSIOL-LONDON, V499, P475, DOI 10.1113/jphysiol.1997.sp021942; Parker R, 2000, METH MOL B, V153, P165; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Parkinson JRC, 2009, NEUROIMAGE, V44, P1022, DOI 10.1016/j.neuroimage.2008.09.047; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pittner R, 2004, INT J OBESITY, P1; Reinehr T, 2006, INT J OBESITY, V30, P1476, DOI 10.1038/sj.ijo.0803393; Sainsbury A, 2002, GENE DEV, V16, P1077, DOI 10.1101/gad.979102; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; SMITH MS, 1993, ENDOCRINOLOGY, V133, P1258, DOI 10.1210/en.133.3.1258; TOMITA T, 1989, PANCREAS, V4, P395, DOI 10.1097/00006676-198908000-00001; Ueno N, 1999, GASTROENTEROLOGY, V117, P1427, DOI 10.1016/S0016-5085(99)70293-3; Vergoni AV, 2000, EUR J PHARMACOL, V405, P25, DOI 10.1016/S0014-2999(00)00538-0; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1037, DOI 10.1152/ajpregu.00125.2007; Wang HC, 2001, CRIT REV IMMUNOL, V21, P323	49	50	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8488	10.1371/journal.pone.0008488	http://dx.doi.org/10.1371/journal.pone.0008488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041129	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700006
J	Yang, JH; Pospisil, R; Ray, S; Milton, J; Mage, RG				Yang, Jiahui; Pospisil, Richard; Ray, Satyajit; Milton, Jacqueline; Mage, Rose G.			Investigations of a Rabbit (Oryctolagus cuniculus) Model of Systemic Lupus Erythematosus (SLE), BAFF and Its Receptors	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR BLYS; ANTI-DNA ANTIBODIES; B-CELL; EXPRESSION; TACI; AUTOIMMUNITY; SURVIVAL; DISEASE; TISSUES; CD5	B-cell activation factor belonging to the tumor necrosis factor family (BAFF) is a major contributor to survival of B lymphocytes during development and maturation. A relationship between circulating BAFF levels and disease activity has been reported in patients with the autoimmune disease Systemic Lupus Erythematosus (SLE). Clinical trials targeting BAFF or its receptors are currently in progress. In order to further characterize a rabbit (Oryctolagus cuniculus) model of SLE, we investigated the expression of BAFF and its receptors in non-inbred, pedigreed rabbits derived from breeding and selection based on autoantibody responses. We immunized rabbits related to previous groups that developed autoantibodies and inflammatory responses after immunizations with peptides synthesized on multiple antigen-branched polylysine backbones. Blood and sera collected before immunization and after boosts were used for health monitoring, analyses of serum autoantibody responses by ELISA and immunofluorescence. Peripheral blood mononuclear cells (PBMC) were studied by flow cytometry and were the source of mRNA for quantitative PCR analyses. We hypothesized that BAFF mRNA expression and serum BAFF levels measured indirectly through BAFF receptor binding might increase in autoantibody-producing rabbits. Immunized rabbits developed elevated levels of leucocyte populations, anti-nuclear, anti-dsDNA and other autoantibodies. BR3 mRNA levels in total PBMC decreased and BAFF levels remained low and unchanged in most immunized rabbits. By flow cytometry, percentages of BAFF positive cells decreased. Percentages of transmembrane activator and CAML interactor (TACI) decreased in most rabbits from all the immunized groups. The rabbit is an important model for human autoimmune and infectious diseases, and a high quality draft rabbit genome assembly was recently completed. Human disease models developed in non-inbred pedigreed animals are better able to reflect the complexities of diseases such as SLE with familial patterns of inheritance. Although no consistent pattern of elevated expression of BAFF mRNA or protein was found in the rabbits studied, the data collected and reported here build upon previous data to refine understanding of a rabbit model of SLE.	[Yang, Jiahui; Pospisil, Richard; Ray, Satyajit; Milton, Jacqueline; Mage, Rose G.] NIAID, Immunol Lab, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA)	Yang, JH (corresponding author), NIAID, Immunol Lab, NIH, Baltimore, MD USA.	rmage@niaid.nih.gov	Pospisil, Richard/B-7467-2012		NIH; NIAID; Oak Ridge Associated Universities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000036] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oak Ridge Associated Universities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the intramural research program of the NIH, NIAID (http://www3.niaid.nih.gov/) and the Oak Ridge Associated Universities (http://www.orau.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardoin SP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2488; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Carter RH, 2005, ARTHRITIS RHEUM-US, V52, P3943, DOI 10.1002/art.21489; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Ding C, 2008, BIODRUGS, V22, P239, DOI 10.2165/00063030-200822040-00003; Furie R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2506; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; Ju SQ, 2006, CLIN BIOCHEM, V39, P1131, DOI 10.1016/j.clinbiochem.2006.09.010; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Ng LG, 2006, EUR J IMMUNOL, V36, P1837, DOI 10.1002/eji.200635956; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pego-Reigosa JM, 2008, EXPERT OPIN INV DRUG, V17, P31, DOI 10.1517/13543784.17.1.31; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Pospisil R, 2005, VET IMMUNOL IMMUNOP, V103, P257, DOI 10.1016/j.vetimm.2004.09.030; Pospisil R, 2006, DEV COMP IMMUNOL, V30, P711, DOI 10.1016/j.dci.2005.10.001; Pospisil R, 2009, MOL IMMUNOL, V46, P2456, DOI 10.1016/j.molimm.2009.05.026; Puliyath N, 2008, VET IMMUNOL IMMUNOP, V125, P251, DOI 10.1016/j.vetimm.2008.05.020; Rai G, 2006, J IMMUNOL, V176, P660, DOI 10.4049/jimmunol.176.1.660; RAMAN C, 1992, J IMMUNOL, V149, P3858; Sakurai D, 2007, EUR J IMMUNOL, V37, P110, DOI 10.1002/eji.200636623; Salzer U, 2005, CURR OPIN ALLERGY CL, V5, P496, DOI 10.1097/01.all.0000191887.89773.cc; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Servais G, 2009, CLIN CHEM LAB MED, V47, P543, DOI 10.1515/CCLM.2009.122; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Treml JF, 2009, CELL BIOCHEM BIOPHYS, V53, P1, DOI 10.1007/s12013-008-9036-1; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yang JH, 2009, DEV COMP IMMUNOL, V33, P697, DOI 10.1016/j.dci.2008.12.001	36	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8494	10.1371/journal.pone.0008494	http://dx.doi.org/10.1371/journal.pone.0008494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041151	Green Submitted, gold, Green Published			2022-12-27	WOS:000278068700009
J	Christiansen, HE; Lang, MR; Pace, JM; Parichy, DM				Christiansen, Helena E.; Lang, Michael R.; Pace, James M.; Parichy, David M.			Critical Early Roles for col27a1a and col27a1b in Zebrafish Notochord Morphogenesis, Vertebral Mineralization and Post-embryonic Axial Growth	PLOS ONE			English	Article							LOW-BACK-PAIN; COLLAGEN GENE; LYSYL OXIDASE; SCOLIOSIS; EXPRESSION; MUTATIONS; GASTRULATION; KNOCKDOWN; MOVEMENTS; DEFECTS	Background: Fibrillar collagens are well known for their links to human diseases, with which all have been associated except for the two most recently identified fibrillar collagens, type XXIV collagen and type XXVII collagen. To assess functions and potential disease phenotypes of type XXVII collagen, we examined its roles in zebrafish embryonic and post-embryonic development. Methodology/Principal Findings: We identified two type XXVII collagen genes in zebrafish, col27a1a and col27a1b. Both col27a1a and col27a1b were expressed in notochord and cartilage in the embryo and early larva. To determine sites of type XXVII collagen function, col27a1a and col27a1b were knocked down using morpholino antisense oligonucleotides. Knockdown of col27a1a singly or in conjunction with col27a1b resulted in curvature of the notochord at early stages and formation of scoliotic curves as well as dysmorphic vertebrae at later stages. These defects were accompanied by abnormal distributions of cells and protein localization in the notochord, as visualized by transmission electron microscopy, as well as delayed vertebral mineralization as detected histologically. Conclusions/Significance: Together, our findings indicate a key role for type XXVII collagen in notochord morphogenesis and axial skeletogenesis and suggest a possible human disease phenotype.	[Christiansen, Helena E.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Lang, Michael R.; Parichy, David M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Pace, James M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Christiansen, HE (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	jpace@u.washington.edu; dparichy@u.washington.edu			National Institutes of Health [NIH P01 GM078195, NIH R01 GM62182, NIH R03 AR052476]; National Science Foundation Graduate Research Fellowship; National Institutes of Health NRSA Predoctoral Fellowship [1F31 AG032825-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR052476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062182, P01GM078195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the National Institutes of Health (NIH P01 GM078195 and NIH R01 GM62182 to DMP; NIH R03 AR052476 to JMP). HEC was supported by the National Science Foundation Graduate Research Fellowship and National Institutes of Health NRSA Predoctoral Fellowship (1F31 AG032825-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; Anderson C, 2007, MOL BIOSYST, V3, P51, DOI 10.1039/b613673g; Biot B, 1982, ANN MED PHYS, V25, P251; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Daffner Scott D, 2003, Am J Orthop (Belle Mead NJ), V32, P77; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Erol B, 2004, J PEDIATR ORTHOPED, V24, P674, DOI 10.1097/01241398-200411000-00015; FENQ H, 2006, J BONE JOINT SURG S2, V88, P25; Gansner JM, 2007, DEV BIOL, V307, P202, DOI 10.1016/j.ydbio.2007.04.029; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Gorman KF, 2007, SPINE, V32, P735, DOI 10.1097/01.brs.0000259081.40354.e2; Gorman KF, 2009, MED HYPOTHESES, V72, P348, DOI 10.1016/j.mehy.2008.09.052; Guiot BH, 2000, NEUROSURGERY, V47, P1034, DOI 10.1097/00006123-200011000-00003; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; KOSTUIK JP, 1981, SPINE, V6, P268, DOI 10.1097/00007632-198105000-00009; Madsen EC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000261; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parichy DM, 2000, DEVELOPMENT, V127, P3031; PERENNOU D, 1994, SPINE, V19, P123, DOI 10.1097/00007632-199401001-00001; POTTHOFF T, 1984, AM SOC ICHTHYOLOGIST, V1, P35; Reynaud C, 2008, MATRIX BIOL, V27, P547, DOI 10.1016/j.matbio.2008.03.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stemple DL, 1996, DEVELOPMENT, V123, P117; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308	37	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8481	10.1371/journal.pone.0008481	http://dx.doi.org/10.1371/journal.pone.0008481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041163	Green Published, gold, Green Submitted			2022-12-27	WOS:000273105200014
J	Hasan, Z; Cliff, JM; Dockrell, HM; Jamil, B; Irfan, M; Ashraf, M; Hussain, R				Hasan, Zahra; Cliff, Jacqueline M.; Dockrell, Hazel M.; Jamil, Bushra; Irfan, Muhammad; Ashraf, Mussarat; Hussain, Rabia			CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; TNF-ALPHA PRODUCTION; EXTRAPULMONARY TUBERCULOSIS; IFN-GAMMA; GENE-EXPRESSION; CHEMOKINE LIGAND-2; HUMAN MONOCYTES; BOVIS BCG; INFECTION; MACROPHAGES	Background: Leucocyte activating chemokines such as CCL2, CCL3, and CXCL8 together with proinflammatory IFN gamma, TNF alpha and downmodulatory IL10 play a central role in the restriction of M. tuberculosis infections, but is unclear whether these markers are indicative of tuberculosis disease severity. Methodology: We investigated live M. tuberculosis- and M. bovis BCG- induced peripheral blood mononuclear cell responses in patients with tuberculosis (TB) and healthy endemic controls (ECs, n = 36). TB patients comprised pulmonary (PTB, n = 34) and extrapulmonary groups, subdivided into those with less severe localized extrapulmonary TB (L-ETB, n = 16) or severe disseminated ETB (D-ETB, n = 16). Secretion of CCL2, IFN gamma, IL10 and CCL3, and mRNA expression of CCL2, TNF alpha, CCL3 and CXCL8 were determined. Results: M. tuberculosis- and BCG- induced CCL2 secretion was significantly increased in both PTB and D-ETB (p<0.05, p<0.01) as compared with L-ETB patients. CCL2 secretion in response to M. tuberculosis was significantly greater than to BCG in the PTB and D-ETB groups. M. tuberculosis- induced CCL2 mRNA transcription was greater in PTB than L-ETB (p = 0.023), while CCL2 was reduced in L-ETB as compared with D-ETB (p = 0.005) patients. M. tuberculosis -induced IFN gamma was greater in L-ETB than PTB (p = 0.04), while BCG- induced IFN gamma was greater in L-ETB as compared with D-ETB patients (p = 0.036). TNF alpha mRNA expression was raised in PTB as compared with L-ETB group in response to M. tuberculosis (p = 0.02) and BCG (p = 0.03). Mycobacterium-induced CCL3 and CXCL8 was comparable between TB groups. Conclusions: The increased CCL2 and TNF alpha in PTB patients may support effective leucocyte recruitment and M. tuberculosis localization. CCL2 alone is associated with severity of TB, possibly due to increased systemic inflammation found in severe disseminated TB or due to increased monocyte infiltration to lung parenchyma in pulmonary disease.	[Hasan, Zahra; Jamil, Bushra; Irfan, Muhammad; Ashraf, Mussarat; Hussain, Rabia] Aga Khan Univ, Karachi, Pakistan; [Cliff, Jacqueline M.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, London WC1, England	Aga Khan University; University of London; London School of Hygiene & Tropical Medicine	Hasan, Z (corresponding author), Aga Khan Univ, Karachi, Pakistan.	zahra.hasan@aku.edu	Hasan, Zahra/AAF-2191-2020; Hussain, Rabia/E-9982-2015; Hasan, Zahra/F-5111-2015; Irfan, Muhammad/G-2058-2015	Hasan, Zahra/0000-0001-7580-372X; Cliff, Jackie/0000-0002-5653-1818; Irfan, Muhammad/0000-0002-5796-2548; Dockrell, Hazel/0000-0003-1869-9107	United Nations Children's Fund (UNICEF); United Nations Development Programme (UNDP); World Bank; World Health Organization (WHO)	United Nations Children's Fund (UNICEF); United Nations Development Programme (UNDP); World Bank(The World Bank India); World Health Organization (WHO)(World Health Organization)	This investigation received financial support from the United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/World Health Organization (WHO) and was funded by the Special Programme for Training in Tropical Diseases Research, TDR, WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, INT J LEPROSY, V68, P156; Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; [Anonymous], 2009, GLOB TUB CONTR; Bean AGD, 1999, J IMMUNOL, V162, P3504; Cagatay AA, 2004, SCAND J INFECT DIS, V36, P799, DOI 10.1080/00365540410025339; Chaly YV, 2000, CYTOKINE, V12, P636, DOI 10.1006/cyto.1999.0664; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; *CONS CONS SOC, 2000, 3 PART EV EXP PROGR; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Ebdrup L, 2003, SCAND J INFECT DIS, V35, P244, DOI 10.1080/00365540310000274; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233; HARRIES AD, 1990, LANCET, V335, P387, DOI 10.1016/0140-6736(90)90216-R; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hasan Z, 2003, TUBERCULOSIS, V83, P299, DOI 10.1016/S1472-9792(03)00003-9; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Hasan Z, 2009, CLIN VACCINE IMMUNOL, V16, P991, DOI 10.1128/CVI.00091-09; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Hussain Rabia, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P257; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Kim DK, 2006, RESPIROLOGY, V11, P557, DOI 10.1111/j.1440-1843.2006.00896.x; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; Mastroianni CM, 1998, CLIN EXP IMMUNOL, V114, P210; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; ORME IM, 1993, CURR OPIN IMMUNOL, V5, P497, DOI 10.1016/0952-7915(93)90029-R; Park JS, 2003, SCAND J IMMUNOL, V57, P463, DOI 10.1046/j.1365-3083.2003.01201.x; Penido C, 2003, J IMMUNOL, V171, P6788, DOI 10.4049/jimmunol.171.12.6788; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Sterling TR, 2007, PEDIATRICS, V120, pE912, DOI 10.1542/peds.2006-3150; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; *WHO, 2008, COUNTR PROF PAK, P133; WHO, 2008, IMPL WHO STOP TB STR; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	58	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8459	10.1371/journal.pone.0008459	http://dx.doi.org/10.1371/journal.pone.0008459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041183	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000273105200005
J	Arazi, A; Sharabi, A; Zinger, H; Mozes, E; Neumann, AU				Arazi, Arnon; Sharabi, Amir; Zinger, Heidy; Mozes, Edna; Neumann, Avidan U.			In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4(+)CD25(-) Cells in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; COMPLEMENTARITY-DETERMINING REGION-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTI-DNA; MURINE LUPUS; TGF-BETA; PEPTIDE; AUTOANTIBODY; RESPONSES; MANIFESTATIONS	Background: Regulatory T cells (Tregs) were shown to be central in maintaining immunological homeostasis and preventing the development of autoimmune diseases. Several subsets of Tregs have been identified to date; however, the dynamics of the interactions between these subsets, and their implications on their regulatory functions are yet to be elucidated. Methodology/Principal Findings: We employed a combination of mathematical modeling and frequent in vivo measurements of several T cell subsets. Healthy BALB/c mice received a single injection of either hCDR1 - a tolerogenic peptide previously shown to induce Tregs, a control peptide or vehicle alone, and were monitored for 16 days. During this period, splenocytes from the treated mice were analyzed for the levels of CD4, CD25, CD8, CD28 and Foxp3. The collected data were then fitted to mathematical models, in order to test competing hypotheses regarding the interactions between the followed T cell subsets. In all 3 treatment groups, a significant, lasting, non-random perturbation of the immune system could be observed. Our analysis predicted the emergence of functional CD4 Tregs based on inverse oscillations of the latter and CD4(+)CD25(-) cells. Furthermore, CD4 Tregs seemed to require a sufficiently high level of CD8 Tregs in order to become functional, while conversion was unlikely to be their major source. Our results indicated in addition that Foxp3 is not a sufficient marker for regulatory activity. Conclusions/Significance: In this work, we unraveled the dynamics of the interplay between CD4, CD8 Tregs and effector T cells, using, for the first time, a mathematical-mechanistic perspective in the analysis of Treg kinetics. Furthermore, the results obtained from this interdisciplinary approach supported the notion that CD4 Tregs need to interact with CD8 Tregs in order to become functional. Finally, we generated predictions regarding the time-dependent function of Tregs, which can be further tested empirically in future work.	[Arazi, Arnon; Neumann, Avidan U.] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Sharabi, Amir; Zinger, Heidy; Mozes, Edna] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Arazi, A (corresponding author), Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel.	neumann@mail.biu.ac.il	Sharabi, Amir/I-1742-2019	Sharabi, Amir/0000-0002-6242-6774	Israeli Council for Higher Education; Bar-Ilan University	Israeli Council for Higher Education; Bar-Ilan University	AA is funded by the Converging Technologies PhD scholarship, given by the Israeli Council for Higher Education, and by the Bar-Ilan University President's PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Borghans JAM, 2007, IMMUNOL REV, V216, P35; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jiang Qi, 2006, BMC Immunol, V7, P6, DOI 10.1186/1471-2172-7-6; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lan RY, 2005, AUTOIMMUN REV, V4, P351, DOI 10.1016/j.autrev.2005.01.007; Luger D, 2004, J CLIN IMMUNOL, V24, P579, DOI 10.1007/s10875-004-6245-2; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Masteller EL, 2003, J IMMUNOL, V171, P5587, DOI 10.4049/jimmunol.171.10.5587; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nolte-'t Hoen ENM, 2008, J LEUKOCYTE BIOL, V83, P112, DOI 10.1189/jlb.0607436; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Regoes RR, 2007, IMMUNOL CELL BIOL, V85, P274, DOI 10.1038/sj.icb.7100053; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sela U, 2005, J IMMUNOL, V175, P7255, DOI 10.4049/jimmunol.175.11.7255; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Sharabi A, 2006, CLIN IMMUNOL, V119, P146, DOI 10.1016/j.clim.2006.01.007; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Sharabi A, 2007, J IMMUNOL, V179, P4979, DOI 10.4049/jimmunol.179.8.4979; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Singh RP, 2008, J IMMUNOL, V180, P2069, DOI 10.4049/jimmunol.180.4.2069; Sthoeger ZM, 2003, CLIN EXP IMMUNOL, V131, P385, DOI 10.1046/j.1365-2249.2003.02058.x; Ueha S, 2007, J LEUKOCYTE BIOL, V82, P1230, DOI 10.1189/jlb.0906574; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; WAISMAN A, 1995, INT IMMUNOL, V7, P689, DOI 10.1093/intimm/7.4.689; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zelinskyy G, 2006, EUR J IMMUNOL, V36, P2658, DOI 10.1002/eji.200636059	30	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8447	10.1371/journal.pone.0008447	http://dx.doi.org/10.1371/journal.pone.0008447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041142	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000012
J	an der Heiden, M; Buchholz, U; Krause, G; Kirchner, G; Claus, H; Haas, WH				an der Heiden, Matthias; Buchholz, Udo; Krause, Gerard; Kirchner, Goeran; Claus, Hermann; Haas, Walter H.			Breaking the Waves: Modelling the Potential Impact of Public Health Measures to Defer the Epidemic Peak of Novel Influenza A/H1N1	PLOS ONE			English	Article							MITIGATION STRATEGIES	Background: On June 11, 2009, the World Health Organization declared phase 6 of the novel influenza A/H1N1 pandemic. Although by the end of September 2009, the novel virus had been reported from all continents, the impact in most countries of the northern hemisphere has been limited. The return of the virus in a second wave would encounter populations that are still nonimmune and not vaccinated yet. We modelled the effect of control strategies to reduce the spread with the goal to defer the epidemic wave in a country where it is detected in a very early stage. Methodology/Principal Findings: We constructed a deterministic SEIR model using the age distribution and size of the population of Germany based on the observed number of imported cases and the early findings for the epidemiologic characteristics described by Fraser (Science, 2009). We propose a two-step control strategy with an initial effort to trace, quarantine, and selectively give prophylactic treatment to contacts of the first 100 to 500 cases. In the second step, the same measures are focused on the households of the next 5,000 to 10,000 cases. As a result, the peak of the epidemic could be delayed up to 7.6 weeks if up to 30% of cases are detected. However, the cumulative attack rates would not change. Necessary doses of antivirals would be less than the number of treatment courses for 0.1% of the population. In a sensitivity analysis, both case detection rate and the variation of R0 have major effects on the resulting delay. Conclusions/Significance: Control strategies that reduce the spread of the disease during the early phase of a pandemic wave may lead to a substantial delay of the epidemic. Since prophylactic treatment is only offered to the contacts of the first 10,000 cases, the amount of antivirals needed is still very limited.	[an der Heiden, Matthias; Buchholz, Udo; Krause, Gerard; Kirchner, Goeran; Claus, Hermann; Haas, Walter H.] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany	Robert Koch Institute	an der Heiden, M (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	anderHeidenM@rki.de		Claus, Hermann/0000-0002-0120-1846; an der Heiden, Matthias/0000-0001-5863-4549; Krause, Gerard/0000-0003-3328-8808				*AHO, 2009, FLU PAND AL RAIS PHA; ANDERSON R M, 1991; Bacaer N, 2009, B MATH BIOL, V71, P1954, DOI 10.1007/s11538-009-9433-7; Bitar D, 2009, EUROSURVEILLANCE, V14; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cohen J, 2009, SCIENCE, V324, P996, DOI 10.1126/science.324_996; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Davey VJ, 2008, EMERG INFECT DIS, V14, P365, DOI 10.3201/eid1403.070673; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; *ECDC, 2009, ECDC SIT REP INFL A; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FRASER C, 2009, PANDEMIC POTENTIAL S, P1557; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8356	10.1371/journal.pone.0008356	http://dx.doi.org/10.1371/journal.pone.0008356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027293	gold, Green Submitted, Green Published			2022-12-27	WOS:000272940100004
J	Kuhn, H; Hierlmeier, T; Merl, J; Jakob, S; Aguissa-Toure, AH; Milkereit, P; Tschochner, H				Kuehn, Holger; Hierlmeier, Thomas; Merl, Juliane; Jakob, Steffen; Aguissa-Toure, Almass-Houd; Milkereit, Philipp; Tschochner, Herbert			The Noc-Domain Containing C-Terminus of Noc4p Mediates Both Formation of the Noc4p-Nop14p Submodule and Its Incorporation into the SSU Processome	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; PROTEIN; SUBUNITS; COMPLEXES; BIOGENESIS; EXPRESSION; CYTOPLASM; YEAST	Noc1p, Noc3p and Noc4p are eukaryotic proteins which play essential roles in yeast ribosome biogenesis and contain a homologous stretch of about 45 aminoacids (Noc-domain) of unknown function. Yeast Noc4p is a component of the small ribosomal subunit (SSU) processome, can be isolated as a stable Noc4p-Nop14p SSU-processome submodule from yeast cells, and is required for nuclear steps of small ribosomal subunit rRNA maturation. We expressed a series of mutated alleles of NOC4 in yeast cells and analysed whether the corresponding protein variants support vegetative growth, interact with Nop14p, and are incorporated into the SSU-processome. The data reveal that the essential C-terminus of Noc4p which contains 237 aminoacids including the Noc-domain represents a protein-protein interaction module. It is required and sufficient for its association with Nop14p and several nuclear precursors of the small ribosomal subunit. The N-terminal Noc4-part seems to be targeted to pre-ribosomes via the C-terminus of Noc4p and plays there an essential role in SSU-processome function. Replacement of the Noc4p-Noc-domain by its homologues Noc1p-counterpart results in a hybrid Noc4p variant which fails to associate with Nop14p and pre-ribosomes. On the other hand, exchange of 6 amino acids in the Noc1-Noc-domain of this hybrid Noc4p protein is sufficient to restore its essential in vivo functions. These data suggest that Noc-domains of Noc1p and Noc4p share a common structural backbone in which diverging amino acids play crucial roles in mediating specific regulated interactions. Our analysis allows us to distinguish between different functions of certain domains within Noc4p and contribute to the understanding of how incorporation of Noc4p into ribosomal precursors is coupled to rRNA processing and maturation of the small ribosomal subunit.	[Kuehn, Holger; Hierlmeier, Thomas; Merl, Juliane; Jakob, Steffen; Milkereit, Philipp; Tschochner, Herbert] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Regensburg, Germany; [Aguissa-Toure, Almass-Houd] Univ Toulouse UPS, Lab Biol Mol Eucaryote, Toulouse, France	University of Regensburg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE)	Kuhn, H (corresponding author), Univ Regensburg, Inst Biochem Genet & Mikrobiol, Regensburg, Germany.	philipp.milkereit@vkl.uni-regensburg.de; herbert.tschochner@vkl.uni-regensburg.de	Merl-Pham, Juliane/N-7258-2014	Merl-Pham, Juliane/0000-0002-3422-4083	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Dez C, 2007, RNA, V13, P1516, DOI 10.1261/rna.609807; Dlakic M, 2004, RNA, V10, P351, DOI 10.1261/rna.5184704; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vos HR, 2004, EUKARYOT CELL, V3, P1504, DOI 10.1128/EC.3.6.1504-1512.2004; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018	43	19	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8370	10.1371/journal.pone.0008370	http://dx.doi.org/10.1371/journal.pone.0008370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20019888	Green Published, gold, Green Submitted			2022-12-27	WOS:000272870600010
J	Horovitz, I; Martin, T; Bloch, J; Ladeveze, S; Kurz, C; Sanchez-Villagra, MR				Horovitz, Ines; Martin, Thomas; Bloch, Jonathan; Ladeveze, Sandrine; Kurz, Cornelia; Sanchez-Villagra, Marcelo R.			Cranial Anatomy of the Earliest Marsupials and the Origin of Opossums	PLOS ONE			English	Article							FUNCTIONAL-ADAPTIVE ANATOMY; MAYULESTES-FEROX; EXTANT MARSUPIALS; INNER-EAR; PALEOBIOLOGY; SEQUENCES; HERPETOTHERIUM; PHYLOGENY	Background: The early evolution of living marsupials is poorly understood in part because the early offshoots of this group are known almost exclusively from jaws and teeth. Filling this gap is essential for a better understanding of the phylogenetic relationships among living marsupials, the biogeographic pathways that led to their current distribution as well as the successive evolutionary steps that led to their current diversity, habits and various specializations that distinguish them from placental mammals. Methodology/Principal Findings: Here we report the first skull of a 55 million year old peradectid marsupial from the early Eocene of North America and exceptionally preserved skeletons of an Oligocene herpetotheriid, both representing critical groups to understand early marsupial evolution. A comprehensive phylogenetic cladistic analysis of Marsupialia including the new findings and close relatives of marsupials show that peradectids are the sister group of living opossums and herpetotheriids are the sister group of all living marsupials. Conclusions/Significance: The results imply that North America played an important role in early Cenozoic marsupial evolutionary history and may have even been the center of origin of living marsupials and opossums. New data from the herpetotheriid postcranium support the view that the ancestral morphotype of Marsupialia was more terrestrial than opossums are. The resolution of the phylogenetic position of peradectids reveals an older calibration point for molecular estimates of divergence times among living marsupials than those currently used.	[Horovitz, Ines] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA; [Martin, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-5300 Bonn, Germany; [Bloch, Jonathan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Ladeveze, Sandrine; Sanchez-Villagra, Marcelo R.] Palaeontol Inst & Museum, Zurich, Switzerland; [Kurz, Cornelia] Nat Kundemuseum Ottoneum Kassel, Kassel, Germany	University of California System; University of California Los Angeles; University of Bonn; State University System of Florida; University of Florida	Horovitz, I (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	horovitz@ucla.edu; m.sanchez@pim.uzh.ch		Bloch, Jonathan/0000-0003-1484-6931; Sanchez-Villagra, Marcelo Ricardo/0000-0001-7587-3648	University of Zurich; Swiss National Fond [3100A0-116013]	University of Zurich; Swiss National Fond(Swiss National Science Foundation (SNSF))	University of Zurich and Swiss National Fond (3100A0-116013) gave Financial support to Marcelo R. Sanchez-Villagra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; Archibald J.D., 1987, P24; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Asher RJ, 2004, MOL PHYLOGENET EVOL, V33, P240, DOI 10.1016/j.ympev.2004.05.004; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; Beck RMD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001858; Bowen GJ, 2002, J SEDIMENT RES, V72, P46, DOI 10.1306/061901720046; BOWN T M, 1979, Contributions from the Museum of Paleontology University of Michigan, V25, P89; CASE JA, 2005, J MAMM EVOL, V12, P223; Cifelli RL, 2004, B AM MUS NAT HIST, P62; Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Clemens WA, 2006, PALAEONTOGR ABT A, V277, P19; de Muizon Christian, 2003, P43; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Forasiepi AM, 2009, J ZOOL SYST EVOL RES, V47, P391, DOI 10.1111/j.1439-0469.2008.00519.x; FOX RC, 1983, CAN J EARTH SCI, V20, P1565, DOI 10.1139/e83-146; GINGERICH P D, 1987, Contributions from the Museum of Paleontology University of Michigan, V27, P275; GINGERICH PD, 2001, U MICHIGAN PAPERS PA, V33, P37; Horovitz I, 2008, PALAEONTOGR ABT A, V284, P109; Johanson Z, 1996, J PALEONTOL, V70, P1023, DOI 10.1017/S0022336000038725; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Koenigswald W von, 1992, MESSEL INSIGHT HIST, P155; KORTH WW, 2007, EVOLUTION TERTIARY M, V2, P39; Kurz Conny, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P21; Kurz Conny, 2007, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V15, P3; Lofgren Donald L., 2004, P43; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Marshall L.G., 1990, Current Mammalogy, V2, P433; MARSHALL LG, 1988, NATL GEOGR RES, V4, P23; MENG J, 1995, ZOOL J LINN SOC-LOND, V115, P47, DOI 10.1006/zjls.1995.0033; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; OLIVEIRA EV, 2006, MARSUPIAIS BRASIL BI, P607; Phillips MJ, 2006, SYST BIOL, V55, P122, DOI 10.1080/10635150500481614; REIG OA, 1987, POSSUMS OPOSSUMS STU, V1, P1; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Sanchez-Villagra M, 2007, BIOL LETTERS, V3, P318, DOI 10.1098/rsbl.2007.0090; Sánchez-Villagra Marcelo R., 2007, Mastozool. neotrop., V14, P53; SWOFFORD D, 2002, PAUP 4 0 B10 PROGRAM; Szalay F. S., 1994, EVOLUTIONARY HIST MA; VULLO R, 2009, P NATL ACAD SCI US	44	72	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8278	10.1371/journal.pone.0008278	http://dx.doi.org/10.1371/journal.pone.0008278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016823	Green Published, gold			2022-12-27	WOS:000272834000009
J	Lu, DS; Liu, JX; Endo, T; Zhou, HW; Yao, SY; Willert, K; Schmidt-Wolf, IGH; Kipps, TJ; Carson, DA				Lu, Desheng; Liu, Jerry X.; Endo, Tomoyuki; Zhou, Haowen; Yao, Shiyin; Willert, Karl; Schmidt-Wolf, Ingo G. H.; Kipps, Thomas J.; Carson, Dennis A.			Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; SIGNALING PATHWAY; MULTIPLE-MYELOMA; WNT PROTEINS; COLON-CANCER; CYCLIN D1; EXPRESSION; APOPTOSIS; LEF-1	Background: Aberrant activation of Wnt/beta-catenin signaling promotes the development of several cancers. It has been demonstrated that the Wnt signaling pathway is activated in chronic lymphocytic leukemia (CLL) cells, and that uncontrolled Wnt/beta-catenin signaling may contribute to the defect in apoptosis that characterizes this malignancy. Thus, the Wnt signaling pathway is an attractive candidate for developing targeted therapies for CLL. Methodology/Principal Findings: The diuretic agent ethacrynic acid (EA) was identified as a Wnt inhibitor using a cell-based Wnt reporter assay. In vitro assays further confirmed the inhibitory effect of EA on Wnt/beta-catenin signaling. Cell viability assays showed that EA selectively induced cell death in primary CLL cells. Exposure of CLL cells to EA decreased the expression of Wnt/beta-catenin target genes, including LEF-1, cyclin D1 and fibronectin. Immune co-precipitation experiments demonstrated that EA could directly bind to LEF-1 protein and destabilize the LEF-1/beta-catenin complex. N-acetyl-L-cysteine (NAC), which can react with the a, beta-unsaturated ketone in EA, but not other anti-oxidants, prevented the drug's inhibition of Wnt/beta-catenin activation and its ability to induce apoptosis in CLL cells. Conclusions/Significance: Our studies indicate that EA selectively suppresses CLL survival due to inhibition of Wnt/beta-catenin signaling. Antagonizing Wnt signaling in CLL with EA or related drugs may represent an effective treatment of this disease.	[Lu, Desheng; Liu, Jerry X.; Endo, Tomoyuki; Zhou, Haowen; Yao, Shiyin; Kipps, Thomas J.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Schmidt-Wolf, Ingo G. H.] Univ Bonn, Ctr Integrated Oncol, D-5300 Bonn, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Bonn	Lu, DS (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	delu@ucsd.edu; decarson@ucsd.edu	Lu, Deheng/AAK-5216-2020; Lu, desheng/E-4822-2013	Lu, desheng/0000-0002-3616-6657; Lu, Desheng/0000-0002-0314-5649	Leukemia and Lymphoma Society SCOR [CA81534-06]; National Cancer Institute-Drug Development Group [CA113318-01]; National Institutes of Health [PO1-CA081534]; Vassiliadis Family Fellowship; NATIONAL CANCER INSTITUTE [P20CA081534, U19CA113318, P01CA081534] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); National Cancer Institute-Drug Development Group; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vassiliadis Family Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Leukemia and Lymphoma Society SCOR grant (CA81534-06), a National Cancer Institute-Drug Development Group grant (CA113318-01) and a National Institutes of Health Grant PO1-CA081534. J.X.L is the recipient of the Vassiliadis Family Fellowship for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 2003, CANCER SCI, V94, P886, DOI 10.1111/j.1349-7006.2003.tb01371.x; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Han YS, 2005, SHOCK, V23, P45, DOI 10.1097/01.shk.0000150629.53699.3f; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, P467; Horie R, 2006, LEUKEMIA, V20, P800, DOI 10.1038/sj.leu.2404167; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Howe D, 2006, LEUKEMIA RES, V30, P29, DOI 10.1016/j.leukres.2005.06.004; Jin GY, 2009, BIOORG MED CHEM LETT, V19, P606, DOI 10.1016/j.bmcl.2008.12.067; Kay Neil E, 2002, Hematology Am Soc Hematol Educ Program, P193, DOI 10.1182/asheducation-2002.1.193; Keating Michael J, 2003, Hematology Am Soc Hematol Educ Program, P153, DOI 10.1182/asheducation-2003.1.153; KIPPS TJ, 1995, WILLIAMS HEMATOLOGY, P1017; LACRETA FP, 1994, J PHARMACOL EXP THER, V270, P1186; LAMBERT E, 1992, LEUKEMIA, V6, P1063; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; ODWYER PJ, 1991, CANCER RES, V51, P6059; Polakis P, 2000, GENE DEV, V14, P1837; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Schultz M, 1997, ADV DRUG DELIVER REV, V26, P91, DOI 10.1016/S0169-409X(97)00029-X; Sercan HO, 2007, ONCOL REP, V18, P1563; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SILBER R, 1992, BLOOD, V80, P2038; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TEW KD, 1988, CANCER RES, V48, P3622; TWENTYMAN PR, 1992, LEUKEMIA, V6, P726; Wang R, 2007, CANCER RES, V67, P7856, DOI 10.1158/0008-5472.CAN-07-0151; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2	46	88	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8294	10.1371/journal.pone.0008294	http://dx.doi.org/10.1371/journal.pone.0008294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011538	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300043
J	Sachs, AJ; David, SA; Haider, NB; Nystuen, AM				Sachs, Andrew J.; David, Samuel A.; Haider, Neena B.; Nystuen, Arne M.			Patterned Neuroprotection in the Inpp4a(wbl) Mutant Mouse Cerebellum Correlates with the Expression of Eaat4	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 4-PHOSPHATASE; METABOTROPIC GLUTAMATE RECEPTORS; PURKINJE-CELL DEGENERATION; G-ALPHA-Q; ZEBRIN-II; PHOSPHOLIPASE-C-BETA-4 EXPRESSION; 1,4,5-TRISPHOSPHATE RECEPTOR; SYNAPTIC PLASTICITY; MOTOR COORDINATION; NULL MUTATION	The weeble mutant mouse has a frame shift mutation in inositol polyphosphate 4-phosphatase type I (Inpp4a). The phenotype is characterized by an early onset cerebellar ataxia and neurodegeneration, especially apparent in the Purkinje cells. Purkinje cell loss is a common pathological finding in many human and mouse ataxic disorders. Here we show that in the Inpp4a(wbl) mutant, Purkinje cells are lost in a specific temporal and spatial pattern. Loss occurs early in postnatal development; however, prior to the appearance of climbing fibers in the developing molecular layer, the mutant has a normal complement of Purkinje cells and they are properly positioned. Degeneration and reactive gliosis are present at postnatal day 5 and progress rapidly in a defined pattern of patches; however, Inpp4a is expressed uniformly across Purkinje cells. In late stage mutants, patches of surviving Purkinje cells appear remarkably normal with the exception that the climbing fibers have been excessively eliminated. Surviving Purkinje cells express Eaat4, a glutamate transporter that is differentially expressed in subsets of Purkinje cells during development and into adult stages. Prior to Purkinje cell loss, reactive gliosis and dendritic atrophy can be seen in Eaat4 negative stripes. Our data suggest that Purkinje cell loss in the Inpp4a(wbl) mutant is due to glutamate excitotoxicity initiated by the climbing fiber, and that Eaat4 may exert a protective effect.	[Sachs, Andrew J.; David, Samuel A.; Haider, Neena B.; Nystuen, Arne M.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68182 USA; [Haider, Neena B.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sachs, AJ (corresponding author), Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68182 USA.	nhaidern@unmc.edu; anystuen@unmc.edu			The Nebraska Tobacco Settlement Biomedical Research Fund	The Nebraska Tobacco Settlement Biomedical Research Fund	This work was funded by The Nebraska Tobacco Settlement Biomedical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; EDWARDS MA, 1994, ANAT EMBRYOL, V190, P417; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Marzban H, 2007, J COMP NEUROL, V502, P857, DOI 10.1002/cne.21352; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Nagao S, 1997, NEUROSCIENCE, V78, P929; Nikkuni O, 2007, NEUROSCI RES, V59, P296, DOI 10.1016/j.neures.2007.07.006; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Nystuen A, 2001, NEURON, V32, P203, DOI 10.1016/S0896-6273(01)00468-8; Nystuen AM, 2007, NEUROGENETICS, V8, P1, DOI 10.1007/s10048-006-0068-7; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; Sachs AJ, 2007, MAMM GENOME, V18, P749, DOI 10.1007/s00335-007-9064-y; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Street VA, 1997, J NEUROSCI, V17, P635; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Welsh JP, 2002, ADV NEUROL, V89, P331; Williams BL, 2007, J VIROL, V81, P2675, DOI 10.1128/JVI.02245-06; Yamada K, 1997, NEUROSCI RES, V27, P191, DOI 10.1016/S0168-0102(96)01148-0; Yamashita A, 2006, NEUROSCI RES, V55, P264, DOI 10.1016/j.neures.2006.03.007	42	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8270	10.1371/journal.pone.0008270	http://dx.doi.org/10.1371/journal.pone.0008270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011524	gold, Green Submitted, Green Published			2022-12-27	WOS:000272830300026
J	Geib, T; Hertel, KJ				Geib, Till; Hertel, Klemens J.			Restoration of Full-Length SMN Promoted by Adenoviral Vectors Expressing RNA Antisense Oligonucleotides Embedded in U7 snRNAs	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; PRE-MESSENGER-RNA; RECOMBINANT ADENOVIRUS; PROTEIN; GENE; COMPLEX; MODULATION; RESCUE; MODEL; SITE	Background: Spinal Muscular Atrophy (SMA) is an autosomal recessive disease that leads to specific loss of motor neurons. It is caused by deletions or mutations of the survival of motor neuron 1 gene (SMN1). The remaining copy of the gene, SMN2, generates only low levels of the SMN protein due to a mutation in SMN2 exon 7 that leads to exon skipping. Methodology/Principal Findings: To correct SMN2 splicing, we use Adenovirus type 5-derived vectors to express SMN2-antisense U7 snRNA oligonucleotides targeting the SMN intron 7/exon 8 junction. Infection of SMA type I-derived patient fibroblasts with these vectors resulted in increased levels of exon 7 inclusion, upregulating the expression of SMN to similar levels as in non-SMA control cells. Conclusions/Significance: These results show that Adenovirus type 5-derived vectors delivering U7 antisense oligonucleotides can efficiently restore full-length SMN protein and suggest that the viral vector-mediated oligonucleotide application may be a suitable therapeutic approach to counteract SMA.	[Geib, Till; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine	Geib, T (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Sch Med, Irvine, CA 92717 USA.	khertel@uci.edu		Hertel, Klemens/0000-0002-7560-9529	NIH [GM62287]; Muscular Dystrophy [MDA4043]; Families of SMA [HER0607]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004043] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy; Families of SMA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grant GM62287 (KJH), a Muscular Dystrophy grant MDA4043 ( KJH), and a Families of SMA grant HER0607 ( KJH). TG was supported by a fellowship from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Brun C, 2003, CELL MOL LIFE SCI, V60, P557, DOI 10.1007/s000180300047; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Driesse MJ, 1999, HUM GENE THER, V10, P2347, DOI 10.1089/10430349950016997; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fox-Walsh KL, 2009, P NATL ACAD SCI USA, V106, P1766, DOI 10.1073/pnas.0813128106; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; GRIMM C, 1993, EMBO J, V12, P1229, DOI 10.1002/j.1460-2075.1993.tb05764.x; Lai CM, 2002, DNA CELL BIOL, V21, P895, DOI 10.1089/104454902762053855; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Navarro V, 1999, GENE THER, V6, P1884, DOI 10.1038/sj.gt.3301008; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Rubinchik S, 2000, GENE THER, V7, P875, DOI 10.1038/sj.gt.3301172; Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Vacek M, 2003, CELL MOL LIFE SCI, V60, P825, DOI 10.1007/s00018-003-3042-7; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	33	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8204	10.1371/journal.pone.0008204	http://dx.doi.org/10.1371/journal.pone.0008204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997596	Green Published, gold			2022-12-27	WOS:000272829700004
J	Beurrier, C; Faideau, M; Bennouar, KE; Escartin, C; Kerkerian-Le Goff, L; Bonvento, G; Gubellini, P				Beurrier, Corinne; Faideau, Mathilde; Bennouar, Khaled-Ezaheir; Escartin, Carole; Kerkerian-Le Goff, Lydia; Bonvento, Gilles; Gubellini, Paolo			Ciliary Neurotrophic Factor Protects Striatal Neurons against Excitotoxicity by Enhancing Glial Glutamate Uptake	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUNTINGTONS-DISEASE; QUINOLINIC ACID; RAFT MICRODOMAINS; REACTIVE GLIOSIS; FACTOR-RECEPTOR; GENE-TRANSFER; RAT MODEL; IN-VIVO; CNTF	Ciliary neurotrophic factor (CNTF) is a potent neuroprotective cytokine in different animal models of glutamate-induced excitotoxicity, although its action mechanisms are still poorly characterized. We tested the hypothesis that an increased function of glial glutamate transporters (GTs) could underlie CNTF-mediated neuroprotection. We show that neuronal loss induced by in vivo striatal injection of the excitotoxin quinolinic acid (QA) was significantly reduced (by similar to 75%) in CNTF-treated animals. In striatal slices, acute QA application dramatically inhibited corticostriatal field potentials (FPs), whose recovery was significantly higher in CNTF rats compared to controls (similar to 40% vs similar to 7%), confirming an enhanced resistance to excitotoxicity. The GT inhibitor DL-threo-beta-benzyloxyaspartate greatly reduced FP recovery in CNTF rats, supporting the role of GT in CNTF-mediated neuroprotection. Whole-cell patch-clamp recordings from striatal medium spiny neurons showed no alteration of basic properties of striatal glutamatergic transmission in CNTF animals, but the increased effect of a low-affinity competitive glutamate receptor antagonist (gamma-D-glutamylglycine) also suggested an enhanced GT function. These data strongly support our hypothesis that CNTF is neuroprotective via an increased function of glial GTs, and further confirms the therapeutic potential of CNTF for the clinical treatment of progressive neurodegenerative diseases involving glutamate overflow.	[Beurrier, Corinne; Bennouar, Khaled-Ezaheir; Kerkerian-Le Goff, Lydia; Gubellini, Paolo] Univ Aix Marseille 2, IBDML, UMR6216, CNRS, Marseille, France; [Faideau, Mathilde; Escartin, Carole; Bonvento, Gilles] CEA, I2BM, Mol Imaging Res Ctr, Fontenay Aux Roses, France; [Faideau, Mathilde; Escartin, Carole; Bonvento, Gilles] CEA, CNRS, URA2210, Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Beurrier, C (corresponding author), Univ Aix Marseille 2, IBDML, UMR6216, CNRS, Marseille, France.	paolo.gubellini@ibdml.univ-mrs.fr	Bonvento, Gilles/F-6023-2013; Escartin, Carole/A-1952-2010	Bonvento, Gilles/0000-0002-2886-4228; Escartin, Carole/0000-0003-3613-4118; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite de la Mediterranee; Association Francaise contre les Myopathies; Fondation de France; Pathogenie de la maladie de Parkinson [2005-013853]; French Ministry of Education and Research [ANR-05-NEUR-013]	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation de France(Fondation de France); Pathogenie de la maladie de Parkinson; French Ministry of Education and Research	This work was supported by the Commissariat a l'Energie Atomique (CEA; http://www.cea.fr/), the Centre National de la Recherche Scientifique (CNRS; http://www.cnrs.fr/), the Universite de la Mediterranee (http://www.univmed.fr/), the Association Francaise contre les Myopathies (AFM; http://www.afm-telethon.fr/), the Fondation de France (http://www.fondationdefrance.org/) (project "Pathogenie de la maladie de Parkinson'', Engt. 2005-013853), and the French Ministry of Education and Research (http://www.agence-nationale-recherche.fr/) (project ANR-05-NEUR-013 "DYPLAGB''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberch J, 2004, PROG BRAIN RES, V146, P195, DOI 10.1016/S0079-6123(03)46014-7; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Beurrier C, 2002, J NEUROSCI, V22, P5817; Beurrier C, 2009, NEUROSCIENCE, V158, P1608, DOI 10.1016/j.neuroscience.2008.11.018; Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; CONNICK JH, 1988, BRIT J PHARMACOL, V93, P868, DOI 10.1111/j.1476-5381.1988.tb11474.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0; Emerich DF, 1996, J NEUROSCI, V16, P5168; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Kordower JH, 1997, J COMP NEUROL, V377, P365, DOI 10.1002/(SICI)1096-9861(19970120)377:3<365::AID-CNE5>3.0.CO;2-0; Levison SW, 1996, EXP NEUROL, V141, P256, DOI 10.1006/exnr.1996.0160; Lievens JC, 1997, MOL BRAIN RES, V50, P181, DOI 10.1016/S0169-328X(97)00182-4; Lisovoski F, 1997, J NEUROSCI, V17, P7228; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mallozzi C, 2007, J NEUROSCI RES, V85, P2770, DOI 10.1002/jnr.21178; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Mathern GW, 1999, NEUROLOGY, V52, P453, DOI 10.1212/WNL.52.3.453; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Mittoux V, 2002, J NEUROSCI, V22, P4478, DOI 10.1523/JNEUROSCI.22-11-04478.2002; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; Monville C, 2001, MOL CELL NEUROSCI, V17, P373, DOI 10.1006/mcne.2000.0926; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Orlando LR, 2001, EXP NEUROL, V167, P196, DOI 10.1006/exnr.2000.7542; Pintor A, 2006, NEUROPHARMACOLOGY, V51, P1004, DOI 10.1016/j.neuropharm.2006.06.013; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; SENDTNER M, 1994, J NEUROBIOL, V25, P1436, DOI 10.1002/neu.480251110; STONE TW, 1993, PHARMACOL REV, V45, P309; Tebano MT, 2002, EUR J PHARMACOL, V450, P253, DOI 10.1016/S0014-2999(02)02148-9; WINTER CG, 1995, P NATL ACAD SCI USA, V92, P5865, DOI 10.1073/pnas.92.13.5865	39	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8550	10.1371/journal.pone.0008550	http://dx.doi.org/10.1371/journal.pone.0008550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20062544	Green Published, Green Submitted, gold			2022-12-27	WOS:000273225000013
J	Li, ZJ; Wilson, KD; Smith, B; Kraft, DL; Jia, FJ; Huang, M; Xie, XY; Robbins, RC; Gambhir, SS; Weissman, IL; Wu, JC				Li, Zongjin; Wilson, Kitchener D.; Smith, Bryan; Kraft, Daniel L.; Jia, Fangjun; Huang, Mei; Xie, Xiaoyan; Robbins, Robert C.; Gambhir, Sanjiv S.; Weissman, Irving L.; Wu, Joseph C.			Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction	PLOS ONE			English	Article							PROGENITOR CELLS; EXTRACELLULAR-MATRIX; PERIPHERAL-BLOOD; CORD BLOOD; CARDIOMYOCYTES; MORPHOGENESIS; NEOVASCULARIZATION; TRANSPLANTATION; ISCHEMIA; SURVIVAL	Background: Differentiation of human embryonic stem cells into endothelial cells (hESC-ECs) has the potential to provide an unlimited source of cells for novel transplantation therapies of ischemic diseases by supporting angiogenesis and vasculogenesis. However, the endothelial differentiation efficiency of the conventional embryoid body (EB) method is low while the 2-dimensional method of co-culturing with mouse embryonic fibroblasts (MEFs) require animal product, both of which can limit the future clinical application of hESC-ECs. Moreover, to fully understand the beneficial effects of stem cell therapy, investigators must be able to track the functional biology and physiology of transplanted cells in living subjects over time. Methodology: In this study, we developed an extracellular matrix (ECM) culture system for increasing endothelial differentiation and free from contaminating animal cells. We investigated the transcriptional changes that occur during endothelial differentiation of hESCs using whole genome microarray, and compared to human umbilical vein endothelial cells (HUVECs). We also showed functional vascular formation by hESC-ECs in a mouse dorsal window model. Moreover, our study is the first so far to transplant hESC-ECs in a myocardial infarction model and monitor cell fate using molecular imaging methods. Conclusion: Taken together, we report a more efficient method for derivation of hESC-ECs that express appropriate patterns of endothelial genes, form functional vessels in vivo, and improve cardiac function. These studies suggest that hESC-ECs may provide a novel therapy for ischemic heart disease in the future.	[Li, Zongjin; Wilson, Kitchener D.; Smith, Bryan; Jia, Fangjun; Huang, Mei; Xie, Xiaoyan; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Li, Zongjin; Wilson, Kitchener D.; Smith, Bryan; Jia, Fangjun; Huang, Mei; Xie, Xiaoyan; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Weissman, Irving L.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA; [Li, Zongjin] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Nankai University	Li, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	joewu@stanford.edu	Li, Zongjin/A-1115-2014; Smith, Bryan/AAS-1108-2021; Li, Zongjin/G-3118-2010; Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Li, Zongjin/0000-0002-4603-3743; Smith, Bryan/0000-0002-5990-2901; Li, Zongjin/0000-0002-4603-3743; Wu, Joseph/0000-0002-6068-8041	BWF CAMS; CIRM [RS1-00322, R21HL091453, R21HL091453-01A1S109]; CA BCRP [14IB-0039]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091453] Funding Source: NIH RePORTER	BWF CAMS; CIRM(California Institute for Regenerative Medicine); CA BCRP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding supports are from BWF CAMS, CIRM RS1-00322, R21HL091453, R21HL091453-01A1S109, CA BCRP 14IB-0039 (JCW), and Mitzi and William Blahd, MD Pilot Research Grant (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Cao F, 2007, J TISSUE ENG REGEN M, V1, P465, DOI 10.1002/term.55; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chen SS, 2003, STEM CELLS, V21, P281, DOI 10.1634/stemcells.21-3-281; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014; Heeschen C, 2006, J AM COLL CARDIOL, V48, P2553, DOI 10.1016/j.jacc.2006.07.066; Hsiai TK, 2008, CURR CARDIOL REV, V4, P269, DOI 10.2174/157340308786349471; Huang PP, 2007, THROMB HAEMOSTASIS, V98, P1335, DOI 10.1160/TH07-02-0137; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kudo T, 2002, CIRCULATION, V106, P118, DOI 10.1161/01.CIR.0000020221.28996.78; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; LEHR HA, 1993, AM J PATHOL, V143, P1055; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Li ZJ, 2005, J CELL BIOCHEM, V95, P559, DOI 10.1002/jcb.20436; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Li ZJ, 2009, J CELL BIOCHEM, V106, P194, DOI 10.1002/jcb.22003; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Malinda KM, 2003, METH MOLEC MED, V78, P329; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Smith BR, 2008, NANO LETT, V8, P2599, DOI 10.1021/nl080141f; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Xu CH, 2006, STEM CELLS DEV, V15, P931, DOI 10.1089/scd.2006.15.931; Xu MF, 2007, J MOL CELL CARDIOL, V42, P441, DOI 10.1016/j.yjmcc.2006.10.009; Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378	42	106	113	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8443	10.1371/journal.pone.0008443	http://dx.doi.org/10.1371/journal.pone.0008443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046878	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200002
J	Andersson, T; Simonyte, K; Andrew, R; Strand, M; Buren, J; Walker, BR; Mattsson, C; Olsson, T				Andersson, Therese; Simonyte, Kotryna; Andrew, Ruth; Strand, Magnus; Buren, Jonas; Walker, Brian R.; Mattsson, Cecilia; Olsson, Tommy			Tissue-Specific Increases in 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Normal Weight Postmenopausal Women	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; BODY-FAT DISTRIBUTION; CORTISOL METABOLISM; SEXUAL-DIMORPHISM; GLUCOCORTICOID METABOLISM; VISCERAL OBESITY; GENE-EXPRESSION; GROWTH-HORMONE; AROMATASE GENE; IN-VIVO	With age and menopause there is a shift in adipose distribution from gluteo-femoral to abdominal depots in women. Associated with this redistribution of fat are increased risks of type 2 diabetes and cardiovascular disease. Glucocorticoids influence body composition, and 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1) which converts inert cortisone to active cortisol is a putative key mediator of metabolic complications in obesity. Increased 11 beta HSD1 in adipose tissue may contribute to postmenopausal central obesity. We hypothesized that tissue-specific 11 beta HSD1 gene expression and activity are up-regulated in the older, postmenopausal women compared to young, premenopausal women. Twenty-three pre- and 23 postmenopausal, healthy, normal weight women were recruited. The participants underwent a urine collection, a subcutaneous adipose tissue biopsy and the hepatic 11 beta HSD1 activity was estimated by the serum cortisol response after an oral dose of cortisone. Urinary (5 alpha-tetrahydrocortisol+5 beta-tetrahydrocortisol)/tetrahydrocortisone ratios were higher in postmenopausal women versus premenopausal women in luteal phase (P<0.05), indicating an increased whole-body 11 beta HSD1 activity. Postmenopausal women had higher 11 beta HSD1 gene expression in subcutaneous fat (P<0.05). Hepatic first pass conversion of oral cortisone to cortisol was also increased in postmenopausal women versus premenopausal women in follicular phase of the menstrual cycle (P<0.01, at 30 min post cortisone ingestion), suggesting higher hepatic 11 beta HSD1 activity. In conclusion, our results indicate that postmenopausal normal weight women have increased 11 beta HSD1 activity in adipose tissue and liver. This may contribute to metabolic dysfunctions with menopause and ageing in women.	[Andersson, Therese; Simonyte, Kotryna; Strand, Magnus; Buren, Jonas; Mattsson, Cecilia; Olsson, Tommy] Umea Univ Hosp, Div Med, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Andrew, Ruth; Walker, Brian R.] Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Umea University; University of Edinburgh	Andersson, T (corresponding author), Umea Univ Hosp, Div Med, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden.	tommy.olsson@medicin.umu.se	Simonyté Sjödin, Kotryna/CAI-1642-2022; Simonyté Sjödin, Kotryna/CAF-5168-2022; Andrew, Ruth/C-2727-2008	Simonyté Sjödin, Kotryna/0000-0002-1323-9913; Simonyté Sjödin, Kotryna/0000-0002-1323-9913; Andrew, Ruth/0000-0002-6916-2994; Buren, Jonas/0000-0001-5846-9002; Olsson, Tommy/0000-0001-7768-1076	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Diabetes Foundation; Umea University; Vasterbotten County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Foundation; Umea University; Vasterbotten County Council	This study was supported by the Swedish Research Council (http://www.vr.se), the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se), the Swedish Diabetes Foundation (http://www.diabetes.se), Umea University (http://www.umu.se), and Vasterbotten County Council (http://www.vll.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON T, 2009, OBESITY SIL IN PRESS; Andrew R, 2002, J CLIN ENDOCR METAB, V87, P277, DOI 10.1210/jc.87.1.277; Best R, 1997, J ENDOCRINOL, V153, P41, DOI 10.1677/joe.0.1530041; Bjorkelund C, 1996, INT J OBESITY, V20, P213; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Dieudonne MN, 2006, J STEROID BIOCHEM, V99, P189, DOI 10.1016/j.jsbmb.2006.01.007; DUBUC PU, 1974, ENDOCRINOLOGY, V95, P1733, DOI 10.1210/endo-95-6-1733; Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3; Finken MJJ, 1999, J CLIN ENDOCR METAB, V84, P3316, DOI 10.1210/jc.84.9.3316; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P145, DOI 10.1080/09513590600629092; Jamieson PM, 1999, J ENDOCRINOL, V160, P103, DOI 10.1677/joe.0.1600103; Johansson A, 2001, J CLIN ENDOCR METAB, V86, P4276, DOI 10.1210/jc.86.9.4276; Kalleinen N, 2008, J CLIN ENDOCR METAB, V93, P1655, DOI 10.1210/jc.2007-2677; Lee MJ, 2008, OBESITY, V16, P1178, DOI 10.1038/oby.2008.207; Li X, 2007, INT J OBESITY, V31, P820, DOI 10.1038/sj.ijo.0803470; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mattsson C, 2009, J CLIN ENDOCR METAB, V94, P1347, DOI 10.1210/jc.2008-2054; McKenzie J, 2006, CLIN ENDOCRINOL, V65, P40, DOI 10.1111/j.1365-2265.2006.02543.x; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Misso ML, 2005, MENOPAUSE, V12, P210, DOI 10.1097/00042192-200512020-00016; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Nwe KHH, 2000, STEROIDS, V65, P40, DOI 10.1016/S0039-128X(99)00078-1; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Paulsen SK, 2008, OBESITY, V16, P731, DOI 10.1038/oby.2008.2; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Simonyte K, 2009, OBESITY, V17, P1982, DOI 10.1038/oby.2009.99; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Veilleux A, 2009, J CLIN ENDOCR METAB, V94, P3550, DOI 10.1210/jc.2008-2011; Walker BR, 2006, ANN NY ACAD SCI, V1083, P165, DOI 10.1196/annals.1367.012; Walker GE, 2007, OBESITY, V15, P1933, DOI 10.1038/oby.2007.231; WALTON C, 1993, EUR J CLIN INVEST, V23, P466, DOI 10.1111/j.1365-2362.1993.tb00792.x; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8475	10.1371/journal.pone.0008475	http://dx.doi.org/10.1371/journal.pone.0008475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041117	gold, Green Published, Green Submitted			2022-12-27	WOS:000273105200011
J	Grimplet, J; Cramer, GR; Dickerson, JA; Mathiason, K; Van Hemert, J; Fennell, AY				Grimplet, Jerome; Cramer, Grant R.; Dickerson, Julie A.; Mathiason, Kathy; Van Hemert, John; Fennell, Anne Y.			VitisNet: "Omics" Integration through Grapevine Molecular Networks	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; CV CABERNET-SAUVIGNON; PROTEOMIC ANALYSIS; METABOLIC NETWORK; SEQUENCE TAGS; TRANSCRIPT; PROTEIN; REVEALS; RESPONSES; BIOSYNTHESIS	Background: Genomic data release for the grapevine has increased exponentially in the last five years. The Vitis vinifera genome has been sequenced and Vitis EST, transcriptomic, proteomic, and metabolomic tools and data sets continue to be developed. The next critical challenge is to provide biological meaning to this tremendous amount of data by annotating genes and integrating them within their biological context. We have developed and validated a system of Grapevine Molecular Networks (VitisNet). Methodology/Principal Findings: The sequences from the Vitis vinifera (cv. Pinot Noir PN40024) genome sequencing project and ESTs from the Vitis genus have been paired and the 39,424 resulting unique sequences have been manually annotated. Among these, 13,145 genes have been assigned to 219 networks. The pathway sets include 88 "Metabolic", 15 "Genetic Information Processing", 12 "Environmental Information Processing", 3 "Cellular Processes", 21 "Transport", and 80 "Transcription Factors". The quantitative data is loaded onto molecular networks, allowing the simultaneous visualization of changes in the transcriptome, proteome, and metabolome for a given experiment. Conclusions/Significance: VitisNet uses manually annotated networks in SBML or XML format, enabling the integration of large datasets, streamlining biological functional processing, and improving the understanding of dynamic processes in systems biology experiments. VitisNet is grounded in the Vitis vinifera genome (currently at 8x coverage) and can be readily updated with subsequent updates of the genome or biochemical discoveries. The molecular network files can be dynamically searched by pathway name or individual genes, proteins, or metabolites through the MetNet Pathway database and web-portal at http://metnet3.vrac.iastate.edu/. All VitisNet files including the manual annotation of the grape genome encompassing pathway names, individual genes, their genome identifier, and chromosome location can be accessed and downloaded from the VitisNet tab at http://vitis-dormancy.sdstate.org.	[Grimplet, Jerome; Mathiason, Kathy; Fennell, Anne Y.] S Dakota State Univ, Hort Forestry Landscape & Pk Dept, Brookings, SD 57007 USA; [Cramer, Grant R.] Univ Nevada, Dept Biochem, Reno, NV 89557 USA; [Dickerson, Julie A.; Van Hemert, John] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA USA; [Dickerson, Julie A.; Van Hemert, John] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA USA	South Dakota State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Iowa State University; Iowa State University	Grimplet, J (corresponding author), S Dakota State Univ, Hort Forestry Landscape & Pk Dept, Brookings, SD 57007 USA.	anne.fennell@sdstate.edu	Grimplet, Jérôme/M-4589-2019; Grimplet, Jerome/A-3422-2011; Cramer, Grant R/E-1815-2011	Grimplet, Jérôme/0000-0002-3265-4012; Grimplet, Jerome/0000-0002-3265-4012; Dickerson, Julie A/0000-0003-4973-5641	National Science Foundation Plant Genome Program [DBI-0604755]	National Science Foundation Plant Genome Program(National Science Foundation (NSF))	This work was support by a grant from the National Science Foundation Plant Genome Program (DBI-0604755) to Anne Y. Fennell, Grant R. Cramer, Julie A. Dickerson and Karen Schlauch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Bylesjo M, 2009, J PROTEOME RES, V8, P199, DOI 10.1021/pr800298s; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Castro AJ, 2005, J EXP BOT, V56, P2783, DOI 10.1093/jxb/eri271; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; da Silva FG, 2005, PLANT PHYSIOL, V139, P574, DOI 10.1104/pp.105.065748; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Doerks T, 2002, TRENDS BIOCHEM SCI, V27, P168, DOI 10.1016/S0968-0004(01)02042-4; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Funahashi A., 2004, 8 ANN INT C RES COMP; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Lund ST, 2008, PLANT MOL BIOL, V68, P301, DOI 10.1007/s11103-008-9371-z; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Mesarovic MD, 1968, SYSTEMS THEORY BIOL, P59, DOI [DOI 10.1007/978-3-642-88343-9_3, 10.1007/978-3-642-88343-9_3]; Miller JG, 1978, LIVING SYSTEMS; Moser C., 2005, Functional & Integrative Genomics, V5, P208, DOI 10.1007/s10142-005-0143-4; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oresic Matej, 2004, Appl Bioinformatics, V3, P205; Peng FY, 2007, GENE, V402, P40, DOI 10.1016/j.gene.2007.07.016; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Vincent D, 2007, J EXP BOT, V58, P1873, DOI 10.1093/jxb/erm012; Waters Daniel L. E., 2005, Functional & Integrative Genomics, V5, P40, DOI 10.1007/s10142-004-0124-z; Wise Roger P., 2007, V406, P347; Wurtele ES, 2007, CONCEPTS IN PLANT METABOLOMICS, P145, DOI 10.1007/978-1-4020-5608-6_10; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376	60	99	100	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8365	10.1371/journal.pone.0008365	http://dx.doi.org/10.1371/journal.pone.0008365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027228	Green Published, Green Submitted, gold			2022-12-27	WOS:000272940100011
J	Hirrlinger, J; Requardt, RP; Winkler, U; Wilhelm, F; Schulze, C; Hirrlinger, PG				Hirrlinger, Johannes; Requardt, Robert P.; Winkler, Ulrike; Wilhelm, Franziska; Schulze, Christine; Hirrlinger, Petra G.			Split-CreERT2: Temporal Control of DNA Recombination Mediated by Split-Cre Protein Fragment Complementation	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; TRANSGENIC MICE; SOMATIC MUTAGENESIS; NEONATAL TREATMENT; RADIAL GLIA; STEM-CELLS; MOUSE; TAMOXIFEN; EXPRESSION; GENERATION	Background: DNA recombination technologies such as the Cre/LoxP system advance modern biological research by allowing conditional gene regulation in vivo. However, the precise targeting of a particular cell type at a given time point has remained challenging since spatial specificity has so far depended exclusively on the promoter driving Cre recombinase expression. We have recently established split-Cre that allows DNA recombination to be controlled by coincidental activity of two promoters, thereby increasing spatial specificity of Cre-mediated DNA recombination. To allow temporal control of split-Cre-mediated DNA recombination we have now extended split-Cre by fusing split-Cre proteins with the tamoxifen inducible ERT2 domain derived from CreERT2. Methodology/Principal Findings: In the split-CreERT2 system, Cre-mediated DNA recombination is controlled by two expression cassettes as well as the time of tamoxifen application. By using two independent Cre-dependent reporters in cultured cells, the combination of NCre-ERT2+ERT2-CCre was identified as having the most favorable properties of all constructs tested, showing an induction ratio of about 10 and EC50-values for 4-hydroxy-tamoxifen of 10 nM to 70 nM. Conclusions/Significance: These characteristics of split-CreERT2 in vitro indicate that split-CreERT2 will be well suited for inducing DNA recombination in living mice harboring LoxP-flanked alleles. In this way, split-CreERT2 will provide a new tool of modern genetics allowing spatial and temporal precise genetic access to cell populations defined by the simultaneous activity of two promoters.	[Hirrlinger, Johannes; Requardt, Robert P.; Winkler, Ulrike; Wilhelm, Franziska; Schulze, Christine] Univ Leipzig, Interdisciplinary Ctr Clin Res, IZKF, Leipzig, Germany; [Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Hirrlinger, Petra G.] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Hirrlinger, J (corresponding author), Univ Leipzig, Interdisciplinary Ctr Clin Res, IZKF, N05 Neural Plast, Leipzig, Germany.	johannes.hirrlinger@medizin.uni-leipzig.de	Hirrlinger, Johannes/F-5984-2010		Interdisciplinary Centre for Clinical Research (IZKF) [N05]; Deutsche Forschungsgemeinschaft DFG [HI1414/1-1, RE849/10-3]	Interdisciplinary Centre for Clinical Research (IZKF); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig [N05 to JH] and the Deutsche Forschungsgemeinschaft DFG [HI1414/1-1 to JH; RE849/10-3 to A. Reichenbach, Paul-Flechsig-Institute for Brain Research, Leipzig, Germany]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Casper K. B., 2006, MOL CELL NEUROSCI; Csaba G, 2001, PHARMACOL RES, V43, P531, DOI 10.1006/phrs.2001.0818; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Vancutsem PM, 1997, TERATOLOGY, V56, P220, DOI 10.1002/(SICI)1096-9926(199709)56:3<220::AID-TERA5>3.3.CO;2-D; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhu HZ, 2003, WORLD J GASTROENTERO, V9, P1844, DOI 10.3748/wjg.v9.i8.1844	35	42	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8354	10.1371/journal.pone.0008354	http://dx.doi.org/10.1371/journal.pone.0008354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016782	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834000025
J	Jerke, U; Tkachuk, S; Kiyan, J; Stepanova, V; Kusch, A; Hinz, M; Dietz, R; Haller, H; Fuhrman, B; Dumler, I				Jerke, Uwe; Tkachuk, Sergey; Kiyan, Julia; Stepanova, Victoria; Kusch, Angelika; Hinz, Michael; Dietz, Rainer; Haller, Hermann; Fuhrman, Bianca; Dumler, Inna			Stat1 Nuclear Translocation by Nucleolin upon Monocyte Differentiation	PLOS ONE			English	Article							FAMILY TRANSCRIPTION FACTORS; SMOOTH-MUSCLE-CELLS; HEMATOPOIETIC-CELLS; SIGNAL TRANSDUCER; BINDING-PROTEIN; GENE-EXPRESSION; LEUKEMIA-CELLS; FACTOR PU.1; IMPORT; PHOSPHORYLATION	Background: Members of the signal transducer and activator of transcription (Stat) family of transcription factors traverse the nuclear membrane through a specialized structure, called the nuclear pore complex (NPC), which represents a selective filter for the import of proteins. Karyophilic molecules can bind directly to a subset of proteins of the NPC, collectively called nucleoporins. Alternatively, the transport is mediated via a carrier molecule belonging to the importin/karyopherin superfamily, which transmits the import into the nucleus through the NPC. Methodology/Principal Findings: In this study, we provide evidence for an alternative Stat1 nuclear import mechanism, which is mediated by the shuttle protein nucleolin. We observed Stat1-nucleolin association, nuclear translocation and specific binding to the regulatory DNA element GAS. Using expression of nucleolin transgenes, we found that the nuclear localization signal (NLS) of nucleolin is responsible for Stat1 nuclear translocation. We show that this mechanism is utilized upon differentiation of myeloid cells and is specific for the differentiation step from monocytes to macrophages. Conclusions/Significance: Our data add the nucleolin-Stat1 complex as a novel functional partner for the cell differentiation program, which is uniquely poised to regulate the transcription machinery via Stat1 and nuclear metabolism via nucleolin.	[Jerke, Uwe; Tkachuk, Sergey; Kiyan, Julia; Haller, Hermann; Dumler, Inna] Hannover Med Sch, D-3000 Hannover, Germany; [Jerke, Uwe; Kusch, Angelika; Dietz, Rainer; Dumler, Inna] Max Delbruck Ctr, ECRC, Berlin, Germany; [Stepanova, Victoria] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fuhrman, Bianca] Technion Israel Inst Technol, Fac Med, Lipid Res Lab, Rappaport Inst Med Sci, Haifa, Israel; [Fuhrman, Bianca] Rambam Med Ctr, Haifa, Israel	Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Pennsylvania; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Jerke, U (corresponding author), Hannover Med Sch, D-3000 Hannover, Germany.	uwe.jerke@charite.de	Hinz, Michael/HCI-0550-2022; Kiyan, Yulia/D-7284-2011	Kiyan, Yulia/0000-0002-2063-6327; Hinz, Michael/0000-0003-2611-4121; Jerke, Uwe/0000-0001-6887-8010	Deutsche Forschungsgemeinschaft [Du 344/2-4]; North Atlantic Treaty Organization [CLG.978262]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); North Atlantic Treaty Organization(NATO (North Atlantic Treaty Organisation))	This work was supported by grant Du 344/2-4 from the Deutsche Forschungsgemeinschaft and in part by grant CLG.978262 from the North Atlantic Treaty Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Barahmandpour F, 1996, CURR TOP MICROBIOL, V211, P121; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; CAIZERGUESFERRER M, 1989, GENE DEV, V3, P324, DOI 10.1101/gad.3.3.324; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Coccia EM, 1999, INT IMMUNOL, V11, P1075, DOI 10.1093/intimm/11.7.1075; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; DEVERDUGO UR, 1995, J VIROL, V69, P6751, DOI 10.1128/JVI.69.11.6751-6757.1995; Dimberg A, 2000, BLOOD, V96, P2870; Dimberg A, 2006, SCAND J IMMUNOL, V64, P271, DOI 10.1111/j.1365-3083.2006.01827.x; Dumler I, 1999, J BIOL CHEM, V274, P24059, DOI 10.1074/jbc.274.34.24059; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; EILERS A, 1995, IMMUNOBIOLOGY, V193, P328, DOI 10.1016/S0171-2985(11)80562-0; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Galdiero M, 2006, CYTOKINE, V36, P218, DOI 10.1016/j.cyto.2006.12.003; GILLET G, 1993, ONCOGENE, V8, P565; Ginisty H, 1999, J CELL SCI, V112, P761; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669; KURATA S, 1990, EXP CELL RES, V191, P89, DOI 10.1016/0014-4827(90)90040-H; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Martinet W, 2003, BIOTECHNOL LETT, V25, P1025, DOI 10.1023/A:1024157508492; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Meyer J, 2002, MAR ENVIRON RES, V54, P621, DOI 10.1016/S0141-1136(02)00170-8; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; PASTERNACK MS, 1991, J BIOL CHEM, V266, P14703; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; SAXENA A, 2006, ONCOGENE; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; Stephanou A, 2004, J CELL MOL MED, V8, P519, DOI 10.1111/j.1582-4934.2004.tb00476.x; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Tu X, 2003, EXP CELL RES, V288, P119, DOI 10.1016/S0014-4827(03)00178-2; TUTEJA N, 1995, NUCLEIC ACIDS RES, V23, P2457, DOI 10.1093/nar/23.13.2457; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Tuyt LML, 1998, BLOOD, V92, P1364, DOI 10.1182/blood.V92.4.1364.416k34_1364_1373; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wincewicz A, 2007, EUR J INTERN MED, V18, P267, DOI 10.1016/j.ejim.2006.12.007; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	69	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8302	10.1371/journal.pone.0008302	http://dx.doi.org/10.1371/journal.pone.0008302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011528	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000272830300049
J	Wu, SW; Dal Martello, MF; Maloney, LT				Wu, Shih-Wei; Dal Martello, Maria F.; Maloney, Laurence T.			Sub-Optimal Allocation of Time in Sequential Movements	PLOS ONE			English	Article							STATISTICAL DECISION-THEORY; TRADE-OFFS; MOTOR; ACCURACY; INFORMATION; LIMITS; GAIN	The allocation of limited resources such as time or energy is a core problem that organisms face when planning complex actions. Most previous research concerning planning of movement has focused on the planning of single, isolated movements. Here we investigated the allocation of time in a pointing task where human subjects attempted to touch two targets in a specified order to earn monetary rewards. Subjects were required to complete both movements within a limited time but could freely allocate the available time between the movements. The time constraint presents an allocation problem to the subjects: the more time spent on one movement, the less time is available for the other. In different conditions we assigned different rewards to the two tokens. How the subject allocated time between movements affected their expected gain on each trial. We also varied the angle between the first and second movements and the length of the second movement. Based on our results, we developed and tested a model of speed-accuracy tradeoff for sequential movements. Using this model we could predict the time allocation that would maximize the expected gain of each subject in each experimental condition. We compared human performance with predicted optimal performance. We found that all subjects allocated time sub-optimally, spending more time than they should on the first movement even when the reward of the second target was five times larger than the first. We conclude that the movement planning system fails to maximize expected reward in planning sequences of as few as two movements and discuss possible interpretations drawn from economic theory.	[Wu, Shih-Wei; Maloney, Laurence T.] NYU, Dept Psychol, New York, NY 10003 USA; [Wu, Shih-Wei] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Dal Martello, Maria F.] Univ Padua, Dept Gen Psychol, Padua, Italy; [Maloney, Laurence T.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; California Institute of Technology; University of Padua; New York University	Wu, SW (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	shihwei@caltech.edu		DAL MARTELLO, Maria/0000-0003-0647-1332	NIH [EY08266]; NATIONAL EYE INSTITUTE [R01EY008266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH EY08266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivar MP, 2005, PSICOLOGICA, V26, P61; Baron J., 2000, THINKING DECIDING; Battaglia PW, 2007, J NEUROSCI, V27, P6984, DOI 10.1523/JNEUROSCI.1309-07.2007; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Dean M, 2007, J VISION, V7, DOI 10.1167/7.5.10; DiDonato A. R., 1961, MATH COMPUT, V15, P375, DOI [10.1090/S0025-5718-1961-0129116-8, DOI 10.1090/S0025-5718-1961-0129116-8]; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kreps D. M, 1990, COURSE MICROECONOMIC; LOEWENSTEIN GF, 1993, PSYCHOL REV, V100, P91, DOI 10.1037/0033-295X.100.1.91; Maloney L. T., 2002, PERCEPTION PHYS WORL, P145; Maloney L.T., 2007, INTEGRATED MODELS CO, P297, DOI [10.1093/acprof:oso/9780195189193.003.0021, DOI 10.1093/ACPROF:OSO/9780195189193.003.0021, https://doi.org/10.1093/acprof:oso/9780195189193.003.0021]; Mamassian P, 2008, PSYCHOL SCI, V19, P601, DOI 10.1111/j.1467-9280.2008.02129.x; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; Roy EA, 2004, MOTOR CONTROL, V8, P121, DOI 10.1123/mcj.8.2.121; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schmidt RA., 1978, INFORM PROCESSING MO, P183, DOI DOI 10.1016/B978-0-12-665960-3.50014-1; Simon, 1957, MODELS MAN SOCIAL RA; Stephens D.W., 1986, pi; STONE LD, 2007, THEORY OPTIMAL SEARC; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Trommershauser J, 2006, EXP BRAIN RES, V175, P276, DOI 10.1007/s00221-006-0546-z; Trommershauser J, 2006, PSYCHOL SCI, V17, P981, DOI 10.1111/j.1467-9280.2006.01816.x; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; WRIGHT CE, 1983, Q J EXP PSYCHOL-A, V35, P279, DOI 10.1080/14640748308402134; Wu SW, 2006, J VISION, V6, P53, DOI 10.1167/6.1.5	40	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8228	10.1371/journal.pone.0008228	http://dx.doi.org/10.1371/journal.pone.0008228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533NE	20011047	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000272829800016
J	Qian, XN; Yoon, BJ				Qian, Xiaoning; Yoon, Byung-Jun			Effective Identification of Conserved Pathways in Biological Networks Using Hidden Markov Models	PLOS ONE			English	Article							PROTEIN-INTERACTION; ALIGNMENT; TOOL; YEAST	Background: The advent of various high-throughput experimental techniques for measuring molecular interactions has enabled the systematic study of biological interactions on a global scale. Since biological processes are carried out by elaborate collaborations of numerous molecules that give rise to a complex network of molecular interactions, comparative analysis of these biological networks can bring important insights into the functional organization and regulatory mechanisms of biological systems. Methodology/Principal Findings: In this paper, we present an effective framework for identifying common interaction patterns in the biological networks of different organisms based on hidden Markov models (HMMs). Given two or more networks, our method efficiently finds the top k matching paths in the respective networks, where the matching paths may contain a flexible number of consecutive insertions and deletions. Conclusions/Significance: Based on several protein-protein interaction (PPI) networks obtained from the Database of Interacting Proteins (DIP) and other public databases, we demonstrate that our method is able to detect biologically significant pathways that are conserved across different organisms. Our algorithm has a polynomial complexity that grows linearly with the size of the aligned paths. This enables the search for very long paths with more than 10 nodes within a few minutes on a desktop computer. The software program that implements this algorithm is available upon request from the authors.	[Qian, Xiaoning] Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA; [Yoon, Byung-Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA	State University System of Florida; University of South Florida; Texas A&M University System; Texas A&M University College Station	Qian, XN (corresponding author), Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA.	bjyoon@ece.tamu.edu	Malwad, Govind V/F-4682-2010; Qian, Huiping/E-8264-2010; Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Cancer Institute [R25CA090301-06]; NATIONAL CANCER INSTITUTE [R25CA090301] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute under 2 R25CA090301-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T., 1998, P 9 ANN ACM SIAM S D, P695; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; FLANNICK J, 2008, P 10 ANN INT C RES C; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; KALAEV M, 2008, P 10 ANN INT C RES C; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Koyuturk M, 2004, BIOINFORMATICS, V20, P200, DOI 10.1093/bioinformatics/bth919; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Pagni M, 2001, Brief Bioinform, V2, P51, DOI 10.1093/bib/2.1.51; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pinter RY, 2005, BIOINFORMATICS, V21, P3401, DOI 10.1093/bioinformatics/bti554; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; SRINIVASAN B, 2006, P 10 ANN INT C RES C; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Tian WH, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P99; Uetz P, 2004, GENOME RES, V14, P2029, DOI 10.1101/gr.2583304; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yang QW, 2007, J COMPUT BIOL, V14, P56, DOI 10.1089/cmb.2006.0076; Zaslavskiy M, 2009, BIOINFORMATICS, V25, pI259, DOI 10.1093/bioinformatics/btp196; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	31	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8070	10.1371/journal.pone.0008070	http://dx.doi.org/10.1371/journal.pone.0008070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997609	Green Published, gold			2022-12-27	WOS:000272829500004
J	Becher, D; Hempel, K; Sievers, S; Zuhlke, D; Pane-Farre, J; Otto, A; Fuchs, S; Albrecht, D; Bernhardt, J; Engelmann, S; Volker, U; van Dijl, JM; Hecker, M				Becher, Doerte; Hempel, Kristina; Sievers, Susanne; Zuehlke, Daniela; Pane-Farre, Jan; Otto, Andreas; Fuchs, Stephan; Albrecht, Dirk; Bernhardt, Joerg; Engelmann, Susanne; Voelker, Uwe; van Dijl, Jan Maarten; Hecker, Michael			A Proteomic View of an Important Human Pathogen - Towards the Quantification of the Entire Staphylococcus aureus Proteome	PLOS ONE			English	Article								The genome sequence is the "blue-print of life,'' but proteomics provides the link to the actual physiology of living cells. Because of their low complexity bacteria are excellent model systems to identify the entire protein assembly of a living organism. Here we show that the majority of proteins expressed in growing and non-growing cells of the human pathogen Staphylococcus aureus can be identified and even quantified by a metabolic labeling proteomic approach. S. aureus has been selected as model for this proteomic study, because it poses a major risk to our health care system by combining high pathogenicity with an increasing frequency of multiple antibiotic resistance, thus requiring the development of new antistaphylococcal therapy strategies. Since such strategies will likely have to target extracellular and surface-exposed virulence factors as well as staphylococcal survival and adaptation capabilities, we decided to combine four subproteomic fractions: cytosolic proteins, membrane-bound proteins, cell surface-associated and extracellular proteins, to comprehensively cover the entire proteome of S. aureus. This quantitative proteomics approach integrating data ranging from gene expression to subcellular localization in growing and non-growing cells is a proof of principle for whole-cell physiological proteomics that can now be extended to address physiological questions in infection-relevant settings. Importantly, with more than 1700 identified proteins (and 1450 quantified proteins) corresponding to a coverage of about three-quarters of the expressed proteins, our model study represents the most comprehensive quantification of a bacterial proteome reported to date. It thus paves the way towards a new level in understanding of cell physiology and pathophysiology of S. aureus and related pathogenic bacteria, opening new avenues for infection-related research on this crucial pathogen.	[Becher, Doerte; Hempel, Kristina; Sievers, Susanne; Zuehlke, Daniela; Pane-Farre, Jan; Otto, Andreas; Fuchs, Stephan; Albrecht, Dirk; Bernhardt, Joerg; Engelmann, Susanne; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [van Dijl, Jan Maarten] Univ Groningen, Groningen, Netherlands	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Groningen; University of Groningen	Becher, D (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany.	hecker@uni-greifswald.de	Sievers, Susanne/Q-9261-2017; Becher, Doerte/B-4454-2015; van Dijl, Jan Maarten/G-1205-2013; Bernhardt, Jörg/AGQ-8765-2022	Sievers, Susanne/0000-0002-5457-2552; Becher, Doerte/0000-0002-9630-5735; Volker, Uwe/0000-0002-5689-3448; Fuchs, Stephan/0000-0002-1338-2699	Deutsche Forschungsgemeinschaft [SFB/TR34]; Bundesministerium fAf1/4r Bildung und Forschung [0313812C, 03ZIK011]; EU [LSHG-CT-2006-037469]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fAf1/4r Bildung und Forschung; EU(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/TR34), the Bundesministerium fAf1/4r Bildung und Forschung (0313812C and 03ZIK011) and the EU ( BaSysBio LSHG-CT-2006-037469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2008, APPL ENVIRON MICROB, V74, P594, DOI 10.1128/AEM.01921-07; Balzer M, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P49, DOI 10.1109/INFVIS.2005.1532128; BANDOW JE, 2007, PROG DRUG RES, V79, P81; Batzilla CF, 2006, PROTEOMICS, V6, P3602, DOI 10.1002/pmic.200500732; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dreisbach A, 2008, PROTEOMICS, V8, P2062, DOI 10.1002/pmic.200701081; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hecker M, 2008, PROTEOMICS, V8, P4958, DOI 10.1002/pmic.200800278; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Loevenich SN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-59; Lorenz U, 2000, ADV EXP MED BIOL, V485, P273; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Tjalsma H, 2005, PROTEOMICS, V5, P4472, DOI 10.1002/pmic.200402080; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185; Wolff S, 2008, MOL CELL PROTEOMICS, V7, P1460, DOI 10.1074/mcp.M700554-MCP200; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937	38	124	124	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8176	10.1371/journal.pone.0008176	http://dx.doi.org/10.1371/journal.pone.0008176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997597	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829200012
J	Wussow, F; Fickenscher, H; Tischer, BK				Wussow, Felix; Fickenscher, Helmut; Tischer, B. Karsten			Red-Mediated Transposition and Final Release of the Mini-F Vector of a Cloned Infectious Herpesvirus Genome	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; VARICELLA-ZOSTER-VIRUS; ESCHERICHIA-COLI; IN-VITRO; DNA; RECOMBINATION; REPLICATION; CELLS; BAC; CLONING	Bacterial artificial chromosomes ( BACs) are well-established cloning vehicles for functional genomics and for constructing targeting vectors and infectious viral DNA clones. Red-recombination-based mutagenesis techniques have enabled the manipulation of BACs in Escherichia coli without any remaining operational sequences. Here, we describe that the F-factor-derived vector sequences can be inserted into a novel position and seamlessly removed from the present location of the BAC-cloned DNA via synchronous Red-recombination in E. coli in an en passant mutagenesis-based procedure. Using this technique, the mini-F elements of a cloned infectious varicella zoster virus (VZV) genome were specifically transposed into novel positions distributed over the viral DNA to generate six different BAC variants. In comparison to the other constructs, a BAC variant with mini-F sequences directly inserted into the junction of the genomic termini resulted in highly efficient viral DNA replication-mediated spontaneous vector excision upon virus reconstitution in transfected VZV-permissive eukaryotic cells. Moreover, the derived vector-free recombinant progeny exhibited virtually indistinguishable genome properties and replication kinetics to the wild-type virus. Thus, a sequence-independent, efficient, and easy-to-apply mini-F vector transposition procedure eliminates the last hurdle to perform virtually any kind of imaginable targeted BAC modifications in E. coli. The herpesviral terminal genomic junction was identified as an optimal mini-F vector integration site for the construction of an infectious BAC, which allows the rapid generation of mutant virus without any unwanted secondary genome alterations. The novel mini-F transposition technique can be a valuable tool to optimize, repair or restructure other established BACs as well and may facilitate the development of gene therapy or vaccine vectors.	[Wussow, Felix; Fickenscher, Helmut; Tischer, B. Karsten] Univ Kiel, Inst Infect Med, Kiel, Germany; [Wussow, Felix; Fickenscher, Helmut; Tischer, B. Karsten] Univ Med Ctr Schleswig Holstein, Kiel, Germany; [Tischer, B. Karsten] Free Univ Berlin, Inst Virol, D-1000 Berlin, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin	Wussow, F (corresponding author), Univ Kiel, Inst Infect Med, Kiel, Germany.	fickenscher@infmed.uni-kiel.de; k.tischer@fu-berlin.de	Fickenscher, Helmut/J-9655-2019; Fickenscher, Helmut/A-3004-2010	Fickenscher, Helmut/0000-0003-0043-1153; 	Varicella Zoster Virus Foundation ( New York); Medical Faculty of the Christian-Albrechts University of Kiel ( Research Center Integrative Neurobiology); Excellence Cluster Inflammation at Interfaces	Varicella Zoster Virus Foundation ( New York); Medical Faculty of the Christian-Albrechts University of Kiel ( Research Center Integrative Neurobiology); Excellence Cluster Inflammation at Interfaces	This work was supported by an award grant from the Varicella Zoster Virus Foundation ( New York) and by an intramural grant from the Medical Faculty of the Christian-Albrechts University of Kiel ( Research Center Integrative Neurobiology), as well as by the Excellence Cluster Inflammation at Interfaces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Ben Wang J, 2008, J VIROL, V82, P2394, DOI 10.1128/JVI.00063-07; BENPORAT T, 1977, VIROLOGY, V79, P292, DOI 10.1016/0042-6822(77)90356-7; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Brune W, 2000, TRENDS GENET, V16, P254, DOI 10.1016/S0168-9525(00)02015-1; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Cohen J. I., 2007, VIROLOGY, P2773; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; GARBER DA, 1993, VIROLOGY, V197, P459, DOI 10.1006/viro.1993.1612; Horsburgh BC, 1999, METHOD ENZYMOL, V306, P337; Kress M, 2001, FASEB J, V15, P1037, DOI 10.1096/fj.00-0440com; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Loparev VN, 2004, J VIROL, V78, P8349, DOI 10.1128/jvi.78.15.8349-8358.2004; McVoy MA, 2000, J VIROL, V74, P4882, DOI 10.1128/JVI.74.10.4882-4887.2000; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Patel AH, 1996, VIROLOGY, V217, P111, DOI 10.1006/viro.1996.0098; Ristevski S, 2005, MOL BIOTECHNOL, V29, P153, DOI 10.1385/MB:29:2:153; Sato B, 2003, J VIROL, V77, P5607, DOI 10.1128/JVI.77.10.5607-5620.2003; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Schmidt Michaela, 2003, Journal of Medical Virology, V70, pS82, DOI 10.1002/jmv.10327; Schynts F, 2003, VIROLOGY, V314, P326, DOI 10.1016/S0042-6822(03)00437-9; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Shizuya Hiroaki, 2001, Keio Journal of Medicine, V50, P26, DOI 10.2302/kjm.50.26; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Stavropoulos TA, 1998, J VIROL, V72, P7137, DOI 10.1128/JVI.72.9.7137-7143.1998; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Tischer BK, 2007, J VIROL, V81, P13200, DOI 10.1128/JVI.01148-07; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; TISCHER BK, 2009, IN VITRO MU IN PRESS; Umene K, 1999, REV MED VIROL, V9, P171, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;171::AID-RMV243&gt;3.0.CO;2-A; VARMUZA SL, 1985, CELL, V41, P793, DOI 10.1016/S0092-8674(85)80060-X; Wagner M, 2002, TRENDS MICROBIOL, V10, P318, DOI 10.1016/S0966-842X(02)02394-6; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WELLER TH, 1953, P SOC EXP BIOL MED, V83, P340, DOI 10.3181/00379727-83-20354; Yamagishi Y, 2008, J VIROL, V82, P795, DOI 10.1128/JVI.01722-07; Yang XW, 2005, CURR PROTOC NEUROSCI, DOI [DOI 10.1002/0471142301.NS0520S31.CHAPTER, 10.1002/0471142301.ns0520s31, DOI 10.1002/0471142301.NS0520S31]; Zhou FC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn890	47	13	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8178	10.1371/journal.pone.0008178	http://dx.doi.org/10.1371/journal.pone.0008178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997639	gold, Green Submitted, Green Published			2022-12-27	WOS:000272829200013
J	Chen, WY; Bergsman, JB; Wang, XH; Gilkey, G; Pierpoint, CR; Daniel, EA; Awumey, EM; Dauban, P; Dodd, RH; Ruat, M; Smith, SM				Chen, Wenyan; Bergsman, Jeremy B.; Wang, Xiaohua; Gilkey, Gawain; Pierpoint, Carol-Renee; Daniel, Erin A.; Awumey, Emmanuel M.; Dauban, Philippe; Dodd, Robert H.; Ruat, Martial; Smith, Stephen M.			Presynaptic External Calcium Signaling Involves the Calcium-Sensing Receptor in Neocortical Nerve Terminals	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; CELL-SURFACE EXPRESSION; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; GLUTAMATE RELEASE; CATION CHANNEL; PROTEIN-KINASE; ACID RECEPTOR; CA2+; RAT	Background: Nerve terminal invasion by an axonal spike activates voltage-gated channels, triggering calcium entry, vesicle fusion, and release of neurotransmitter. Ion channels activated at the terminal shape the presynaptic spike and so regulate the magnitude and duration of calcium entry. Consequently characterization of the functional properties of ion channels at nerve terminals is crucial to understand the regulation of transmitter release. Direct recordings from small neocortical nerve terminals have revealed that external [Ca2+] ([Ca2+](o)) indirectly regulates a non- selective cation channel (NSCC) in neocortical nerve terminals via an unknown [Ca2+](o) sensor. Here, we identify the first component in a presynaptic calcium signaling pathway. Methodology/Principal Findings: By combining genetic and pharmacological approaches with direct patch-clamp recordings from small acutely isolated neocortical nerve terminals we identify the extracellular calcium sensor. Our results show that the calcium-sensing receptor (CaSR), a previously identified G-protein coupled receptor that is the mainstay in serum calcium homeostasis, is the extracellular calcium sensor in these acutely dissociated nerve terminals. The NSCC currents from reduced function mutant CaSR mice were less sensitive to changes in [Ca2+](o) than wild-type. Calindol, an allosteric CaSR agonist, reduced NSCC currents in direct terminal recordings in a dose-dependent and reversible manner. In contrast, glutamate and GABA did not affect the NSCC currents. Conclusions/Significance: Our experiments identify CaSR as the first component in the [Ca2+](o) sensor-NSCC signaling pathway in neocortical terminals. Decreases in [Ca2+](o) will depress synaptic transmission because of the exquisite sensitivity of transmitter release to [Ca2+](o) following its entry via voltage-activated Ca2+ channels. CaSR may detects such falls in [Ca2+](o) and increase action potential duration by increasing NSCC activity, thereby attenuating the impact of decreases in [Ca2+](o) on release probability. CaSR is positioned to detect the dynamic changes of [Ca2+](o) and provide presynaptic feedback that will alter brain excitability.	[Chen, Wenyan; Bergsman, Jeremy B.; Wang, Xiaohua; Gilkey, Gawain; Pierpoint, Carol-Renee; Daniel, Erin A.; Smith, Stephen M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Awumey, Emmanuel M.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC USA; [Dauban, Philippe; Dodd, Robert H.] CNRS, Inst Chim Subst Nat, Gif Sur Yvette, France; [Ruat, Martial] CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France	Oregon Health & Science University; University of North Carolina; North Carolina Central University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Chen, WY (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	smisteph@ohsu.edu	Ruat, Martial/E-5544-2016; Chen, Wenyan/V-7000-2019	Smith, Stephen/0000-0002-0331-7615	OHSU-HHMI Biomedical Support Program; NINDS [R01-NS 43444]; OHSU President's Fund; French Agence Nationale de la Recherche [07-physio-027-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL099139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043444] Funding Source: NIH RePORTER	OHSU-HHMI Biomedical Support Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OHSU President's Fund; French Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the OHSU-HHMI Biomedical Support Program, NINDS (R01-NS 43444), and OHSU President's Fund. M. R. is supported by a grant from the French Agence Nationale de la Recherche (07-physio-027-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1991, P NATL ACAD SCI USA, V88, P6528, DOI 10.1073/pnas.88.15.6528; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Awumey EM, 2007, AM J PHYSIOL-CELL PH, V292, pC1895, DOI 10.1152/ajpcell.00404.2006; Azkue JJ, 2001, J COMP NEUROL, V430, P448, DOI 10.1002/1096-9861(20010219)430:4<448::AID-CNE1042>3.0.CO;2-O; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bailey TW, 2006, J NEUROSCI, V26, P6131, DOI 10.1523/JNEUROSCI.5176-05.2006; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1998, RECENT PROG HORM RES, V53, P257; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Chattopadhyay N, 1998, GLIA, V24, P449, DOI 10.1002/(SICI)1098-1136(199812)24:4<449::AID-GLIA10>3.3.CO;2-0; Chen WY, 2007, CHANNELS, V1, P281, DOI 10.4161/chan.4988; Cheng ZQ, 2007, ENDOCRINOLOGY, V148, P4984, DOI 10.1210/en.2007-0653; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; CONLEY YP, 2008, AM J MED GENET B; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; GARRETT JE, 1995, ENDOCRINOLOGY, V136, P5202, DOI 10.1210/en.136.11.5202; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HARNETT MT, 2009, NEUROPHARMACOLOGY; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Ikeda K, 2008, J NEUROSCI, V28, P13563, DOI 10.1523/JNEUROSCI.3350-08.2008; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Kapoor A, 2008, ANN NEUROL, V64, P158, DOI 10.1002/ana.21428; Kessler A, 2004, BIOORG MED CHEM LETT, V14, P3345, DOI 10.1016/j.bmcl.2004.03.056; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; LI PA, 1995, EXP BRAIN RES, V105, P363; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2918, DOI 10.1073/pnas.73.8.2918; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Nearing J, 2002, P NATL ACAD SCI USA, V99, P9231, DOI 10.1073/pnas.152294399; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Oda Y, 2000, J BIOL CHEM, V275, P1183, DOI 10.1074/jbc.275.2.1183; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ray K, 2005, J BIOL CHEM, V280, P37013, DOI 10.1074/jbc.M506681200; Ruat M, 1996, J BIOL CHEM, V271, P5972, DOI 10.1074/jbc.271.11.5972; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Saunders R, 1998, NEUROPHARMACOLOGY, V37, P273, DOI 10.1016/S0028-3908(98)00027-6; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Vyleta NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003155; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Wittmann M, 2001, J NEUROPHYSIOL, V85, P1960, DOI 10.1152/jn.2001.85.5.1960; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	77	32	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8563	10.1371/journal.pone.0008563	http://dx.doi.org/10.1371/journal.pone.0008563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052292	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500008
J	Musazzi, L; Milanese, M; Farisello, P; Zappettini, S; Tardito, D; Barbiero, VS; Bonifacino, T; Mallei, A; Baldelli, P; Racagni, G; Raiteri, M; Benfenati, F; Bonanno, G; Popoli, M				Musazzi, Laura; Milanese, Marco; Farisello, Pasqualina; Zappettini, Simona; Tardito, Daniela; Barbiero, Valentina S.; Bonifacino, Tiziana; Mallei, Alessandra; Baldelli, Pietro; Racagni, Giorgio; Raiteri, Maurizio; Benfenati, Fabio; Bonanno, Giambattista; Popoli, Maurizio			Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTORS; MAJOR DEPRESSION; MEMBRANE-FUSION; FRONTAL-CORTEX; MESSENGER-RNA; SNARE COMPLEX; HIPPOCAMPUS; SYNAPTOSOMES; BRAIN; CORTICOSTERONE	Background: Behavioral stress is recognized as a main risk factor for neuropsychiatric diseases. Converging evidence suggested that acute stress is associated with increase of excitatory transmission in certain forebrain areas. Aim of this work was to investigate the mechanism whereby acute stress increases glutamate release, and if therapeutic drugs prevent the effect of stress on glutamate release. Methodology/Findings: Rats were chronically treated with vehicle or drugs employed for therapy of mood/anxiety disorders (fluoxetine, desipramine, venlafaxine, agomelatine) and then subjected to unpredictable footshock stress. Acute stress induced marked increase in depolarization-evoked release of glutamate from synaptosomes of prefrontal/frontal cortex in superfusion, and the chronic drug treatments prevented the increase of glutamate release. Stress induced rapid increase in the circulating levels of corticosterone in all rats (both vehicle- and drug-treated), and glutamate release increase was blocked by previous administration of selective antagonist of glucocorticoid receptor (RU 486). On the molecular level, stress induced accumulation of presynaptic SNARE complexes in synaptic membranes (both in vehicle- and drug-treated rats). Patch-clamp recordings of pyramidal neurons in the prefrontal cortex revealed that stress increased glutamatergic transmission through both pre- and postsynaptic mechanisms, and that antidepressants may normalize it by reducing release probability. Conclusions/Significance: Acute footshock stress up-regulated depolarization-evoked release of glutamate from synaptosomes of prefrontal/frontal cortex. Stress-induced increase of glutamate release was dependent on stimulation of glucocorticoid receptor by corticosterone. Because all drugs employed did not block either elevation of corticosterone or accumulation of SNARE complexes, the dampening action of the drugs on glutamate release must be downstream of these processes. This novel effect of antidepressants on the response to stress, shown here for the first time, could be related to the therapeutic action of these drugs.	[Musazzi, Laura; Tardito, Daniela; Barbiero, Valentina S.; Mallei, Alessandra; Racagni, Giorgio; Popoli, Maurizio] Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, Milan, Italy; [Musazzi, Laura; Tardito, Daniela; Barbiero, Valentina S.; Mallei, Alessandra; Racagni, Giorgio; Popoli, Maurizio] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy; [Milanese, Marco; Zappettini, Simona; Bonifacino, Tiziana; Racagni, Giorgio; Raiteri, Maurizio; Bonanno, Giambattista] Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy; [Farisello, Pasqualina; Baldelli, Pietro; Racagni, Giorgio; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Racagni, Giorgio] Ist Ricovero & Cura Carattere Sci San Giovanni di, Brescia, Italy; [Milanese, Marco; Zappettini, Simona; Bonifacino, Tiziana; Racagni, Giorgio; Raiteri, Maurizio; Bonanno, Giambattista] Ctr Excellence Biomed Res, Genoa, Italy; [Milanese, Marco; Farisello, Pasqualina; Zappettini, Simona; Bonifacino, Tiziana; Baldelli, Pietro; Racagni, Giorgio; Raiteri, Maurizio; Benfenati, Fabio; Bonanno, Giambattista] Natl Inst Neurosci, Genoa, Italy; [Farisello, Pasqualina; Baldelli, Pietro; Racagni, Giorgio; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Physiol Sect, Genoa, Italy	University of Milan; University of Milan; University of Genoa; Istituto Italiano di Tecnologia - IIT; University of Genoa	Musazzi, L (corresponding author), Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, Milan, Italy.	maurizio.popoli@unimi.it	Bonanno, Giambattista/C-5856-2008; Milanese, Marco/C-4444-2013; Racagni, Giorgio A./B-5826-2011; Baldelli, Pietro/AAH-2493-2021; Tardito, Daniela/J-8076-2015; Baldelli, Pietro/AAA-6298-2020; Milanese, Marco/AAB-2238-2021; Bonifacino, Tiziana/AAA-5471-2019	Milanese, Marco/0000-0003-3384-0666; Tardito, Daniela/0000-0001-5585-1054; Milanese, Marco/0000-0003-3384-0666; Bonifacino, Tiziana/0000-0002-3966-9874; Mallei, Alessandra/0000-0001-6955-4755; Bonanno, Giambattista/0000-0003-3744-5786; Baldelli, Pietro/0000-0001-9599-3436	Italian Ministry of University and Research; PRIN [2003053993, 2005054953, 2008T4ZCNL, 2008JRRXCN]; Italian Ministry of Health Progetto Giovani; Compagnia di San Paolo, Telethon - Italy; Servier	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health Progetto Giovani(Ministry of Health, Italy); Compagnia di San Paolo, Telethon - Italy(Compagnia di San PaoloFondazione Telethon); Servier(Servier)	This study was supported by grants from the Italian Ministry of University and Research, PRIN no. 2003053993 and 2005054953, 2008T4ZCNL and 2008JRRXCN; Italian Ministry of Health Progetto Giovani, Compagnia di San Paolo, Telethon - Italy and a research grant from Servier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 2008, EXPERT OPIN EMERG DR, V13, P479, DOI [10.1517/14728214.13.3.479, 10.1517/14728214.13.3.479 ]; Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Azpiroz A, 1999, PSYCHONEUROENDOCRINO, V24, P345, DOI 10.1016/S0306-4530(98)00084-5; Bagley J, 1997, NEUROSCIENCE, V77, P65, DOI 10.1016/S0306-4522(96)00435-6; Barbiero VS, 2007, NEUROPSYCHOPHARMACOL, V32, P2511, DOI 10.1038/sj.npp.1301378; Bianchi R, 2009, J NEUROSCI, V29, P3497, DOI 10.1523/JNEUROSCI.5447-08.2009; Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Conti AC, 2004, J NEUROSCI, V24, P1967, DOI 10.1523/JNEUROSCI.4804-03.2004; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Du Jing, 2006, Drug Discov Today Ther Strateg, V3, P519, DOI 10.1016/j.ddstr.2006.11.012; Duncan GE, 1998, J PHARMACOL EXP THER, V285, P579; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Holden C, 2003, SCIENCE, V300, P1866, DOI 10.1126/science.300.5627.1866; Honer WG, 2002, CEREB CORTEX, V12, P349, DOI 10.1093/cercor/12.4.349; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lonart G, 2000, J BIOL CHEM, V275, P27703; LOWY MT, 1995, J NEUROCHEM, V65, P268; Matar MA, 2009, EUR NEUROPSYCHOPHARM, V19, P283, DOI 10.1016/j.euroneuro.2008.12.004; Matveeva EA, 2003, J NEUROCHEM, V84, P621, DOI 10.1046/j.1471-4159.2003.01589.x; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Michael-Titus AT, 2000, NEUROSCIENCE, V100, P681, DOI 10.1016/S0306-4522(00)00390-0; Millan MJ, 2003, J PHARMACOL EXP THER, V306, P954, DOI 10.1124/jpet.103.051797; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Moulder KL, 2006, MOL NEUROBIOL, V33, P133, DOI 10.1385/MN:33:2:133; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pittaluga A, 2007, NEUROPHARMACOLOGY, V53, P27, DOI 10.1016/j.neuropharm.2007.04.006; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; RAITERI M, 1983, EUR J PHARMACOL, V91, P141, DOI 10.1016/0014-2999(83)90377-1; RAITERI M, 1974, EUR J PHARMACOL, V25, P411, DOI 10.1016/0014-2999(74)90272-6; Raiteri M, 2000, J NEUROCHEM, V74, P423, DOI 10.1046/j.1471-4159.2000.0740423.x; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; STEINBEHRENS BA, 1994, J NEUROCHEM, V63, P596; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TARDITO D, 2009, INT J NEUROPSYCHOPHA; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; Tokarski K, 2008, NEUROSCIENCE, V153, P789, DOI 10.1016/j.neuroscience.2008.03.007; Venero C, 1999, EUR J NEUROSCI, V11, P2465, DOI 10.1046/j.1460-9568.1999.00668.x; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	54	206	213	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8566	10.1371/journal.pone.0008566	http://dx.doi.org/10.1371/journal.pone.0008566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052403	gold, Green Published, Green Submitted			2022-12-27	WOS:000273338500010
J	Chalopin, M; Tesse, A; Martinez, MC; Rognan, D; Arnal, JF; Andriantsitohaina, R				Chalopin, Matthieu; Tesse, Angela; Martinez, Maria Carmen; Rognan, Didier; Arnal, Jean-Francois; Andriantsitohaina, Ramaroson			Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the Endothelium	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; CARDIOVASCULAR ALTERATIONS; DEPENDENT VASORELAXATION; VASCULAR FUNCTION; CELLS; HYPERTENSION; RESVERATROL; SYNTHASE; RATS; MICROPARTICLES	Background: A greater reduction in cardiovascular risk and vascular protection associated with diet rich in polyphenols are generally accepted; however, the molecular targets for polyphenols effects remain unknown. Meanwhile evidences in the literature have enlightened, not only structural similarities between estrogens and polyphenols known as phytoestrogens, but also in their vascular effects. We hypothesized that alpha isoform of estrogen receptor (ER alpha) could be involved in the transduction of the vascular benefits of polyphenols. Methodology/Principal Findings: Here, we used ER alpha deficient mice to show that endothelium-dependent vasorelaxation induced either by red wine polyphenol extract, Provinols (TM), or delphinidin, an anthocyanin that possesses similar pharmacological profile, is mediated by ER alpha. Indeed, Provinols (TM), delphinidin and ER alpha agonists, 17-beta-estradiol and PPT, are able to induce endothelial vasodilatation in aorta from ER alpha Wild-Type but not from Knock-Out mice, by activation of nitric oxide (NO) pathway in endothelial cells. Besides, silencing the effects of ER alpha completely prevented the effects of Provinols (TM) and delphinidin to activate NO pathway (Src, ERK 1/2, eNOS, caveolin-1) leading to NO production. Furthermore, direct interaction between delphinidin and ER alpha activator site is demonstrated using both binding assay and docking. Most interestingly, the ability of short term oral administration of Provinols (TM) to decrease response to serotonin and to enhance sensitivity of the endothelium-dependent relaxation to acetylcholine, associated with concomitant increased NO production and decreased superoxide anions, was completely blunted in ER alpha deficient mice. Conclusions/Significance: This study provides evidence that red wine polyphenols, especially delphinidin, exert their endothelial benefits via ER alpha activation. It is a major breakthrough bringing new insights of the potential therapeutic of polyphenols against cardiovascular pathologies.	[Chalopin, Matthieu; Tesse, Angela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] Univ Angers, INSERM, U771, CNRS UMR 6214, Angers, France; [Rognan, Didier] Univ Louis Pasteur Strasbourg 1, UMR 7175, CNRS, Illkirch Graffenstaden, France; [Arnal, Jean-Francois] Univ Toulouse 3, INSERM, U858, CHU, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chalopin, M (corresponding author), Univ Angers, INSERM, U771, CNRS UMR 6214, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	Tesse, Angela/D-4803-2015; ARNAL, Jean Francois/K-7004-2014; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; Rognan, Didier/B-9939-2014	Tesse, Angela/0000-0002-2153-4357; Martinez, M Carmen/0000-0003-3897-7397; ARNAL, Jean Francois/0000-0003-2229-6300; chalopin, matthieu/0000-0002-9285-8869; andriantsitohaina, ramaroson/0000-0002-4770-3585	Fonds Europeen pour le Developpement Regional [8891]; INSERM; Universite d'Angers	Fonds Europeen pour le Developpement Regional; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Angers	Supported by institutional grants from the Fonds Europeen pour le Developpement Regional (no. 8891), INSERM, and Universite d'Angers. R. A. was supported by a Contrat d'Interface INSERM. M. C. is recipient of a doctoral fellowship from French Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Andriambeloson E, 1998, J NUTR, V128, P2324, DOI 10.1093/jn/128.12.2324; Arnal JF, 2007, CURR OPIN LIPIDOL, V18, P554, DOI 10.1097/MOL.0b013e3282ef3bca; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bernatova I, 2002, AM J PHYSIOL-HEART C, V282, pH942, DOI 10.1152/ajpheart.00724.2001; Kim KH, 2008, STEROIDS, V73, P864, DOI 10.1016/j.steroids.2008.01.008; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Martin S, 2003, BRIT J PHARMACOL, V139, P1095, DOI 10.1038/sj.bjp.0705347; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Pechanova O, 2006, PHYSIOL RES, V55, pS17, DOI 10.33549/physiolres.930000.55.S1.17; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Rathel TR, 2005, BRIT J PHARMACOL, V144, P394, DOI 10.1038/sj.bjp.0706075; Renaud SC, 2004, AM J CLIN NUTR, V80, P621; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Sakamoto K, 2008, CELL METAB, V7, P3, DOI 10.1016/j.cmet.2007.12.005; Vera R, 2007, CLIN SCI, V112, P183, DOI 10.1042/CS20060185; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Walker HA, 2001, CIRCULATION, V103, P258, DOI 10.1161/01.CIR.103.2.258; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200	28	92	98	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8554	10.1371/journal.pone.0008554	http://dx.doi.org/10.1371/journal.pone.0008554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049322	Green Published, gold			2022-12-27	WOS:000273225000017
J	Camats, M; Kokolo, M; Heesom, KJ; Ladomery, M; Bach-Elias, M				Camats, Maria; Kokolo, Mariette; Heesom, Kate J.; Ladomery, Michael; Bach-Elias, Montse			P19 H-Ras Induces G1/S Phase Delay Maintaining Cells in a Reversible Quiescence State	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3A; C-JUN; PROTEIN; EXPRESSION; PATHWAY; PROLIFERATION; PROTOONCOGENE; PROGRESSION; ACTIVATION; GROWTH	Background:Three functional c-ras genes, known as c-H-ras, c-K-ras, and c-N-ras, have been largely studied in mammalian cells with important insights into normal and tumorigenic cellular signal transduction events. Two K-Ras mRNAs are obtained from the same pre-mRNA by alternative splicing. H-Ras pre-mRNA can also be alternatively spliced in the IDX and 4A terminal exons, yielding the p19 and p21 proteins, respectively. However, despite the Ras gene family's established role in tumorigenic cellular signal transduction events, little is known about p19 function. Previous results showed that p19 did not interact with two known p21 effectors, Raf1 and Rini, but was shown to interact with RACK1, a scaffolding protein that promotes multi-protein complexes in different signaling pathways (Cancer Res 2003, 63 p5178). This observation suggests that p19 and p21 play differential and complementary roles in the cell. Principal Findings: We found that p19 regulates telomerase activity through its interaction with p73a./I3 proteins. We also found that p19 overexpression induces G1/S phase delay; an observation that correlates with hypophosphorylation of both Akt and p7OSK6. Similarly, we also observed that FOX01 is upregulated when p19 is overexpressed. The three observations of (1) hypophosphorylation of Akt, (2) G1/S phase delay and (3) upregulation of FOX01 lead us to conclude that p19 induces G1/S phase delay, thereby maintaining cells in a reversible quiescence state and preventing entry into apoptosis. We then assessed the effect of p19 RNAi on HeLa cell growth and found that p19 RNAi increases cell growth, thereby having the opposite effect of arrest of the G1/S phase or producing a cellular quiescence state. Significance:Interestingly, p19 induces FOX01 that in combination with the G1/S phase delay and hypophosphorylation of both Akt and p7OSK6 leads to maintenance of a reversible cellular quiescence state, thereby preventing entry into apoptosis.	[Camats, Maria; Kokolo, Mariette; Bach-Elias, Montse] CSIC, Inst Invest Biomed Barcelona, Unidad Splicing, Barcelona, Spain; [Heesom, Kate J.] Univ Bristol, Prote Facil, Bristol, Avon, England; [Ladomery, Michael] Univ W England, Fac Hlth & Life Sci, Ctr Res Biomed, Bristol BS16 1QY, Avon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; University of Bristol; University of West England	Camats, M (corresponding author), CSIC, Inst Invest Biomed Barcelona, Unidad Splicing, Barcelona, Spain.	mbebmc@cid.csic.es			Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC) [51U200500701]; Fundacion Eugenio Rodriguez Pascual	Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC)(Spanish Government); Fundacion Eugenio Rodriguez Pascual	This work was supported by Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA), the Plan Nacional (MEC) 51U200500701 and the Fundacion Eugenio Rodriguez Pascual. M.C. was a recipient of a Fmed MMA fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Cai DC, 2004, BRAIN RES, V1014, P14, DOI 10.1016/j.brainres.2004.04.008; COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; Dereure O, 2006, ANN DERMATOL VENER, V133, P731, DOI 10.1016/S0151-9638(06)71003-1; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Gripp KW, 2006, AM J MED GENET A, V140A, P2163, DOI 10.1002/ajmg.a.31456; Guil S, 2003, CANCER RES, V63, P5178; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jeong MH, 2006, J BIOL CHEM, V281, P8707, DOI 10.1074/jbc.M513853200; Kim JW, 2008, BIOCHEM BIOPH RES CO, V373, P146, DOI 10.1016/j.bbrc.2008.06.010; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Marabese M, 2007, EUR J CANCER, V43, P1361, DOI 10.1016/j.ejca.2007.01.042; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Pells S, 1997, ONCOGENE, V15, P1781, DOI 10.1038/sj.onc.1201354; Rahman-Roblick R, 2007, P NATL ACAD SCI USA, V104, P5401, DOI 10.1073/pnas.0700794104; Rangatia J, 2003, ONCOGENE, V22, P4760, DOI 10.1038/sj.onc.1206664; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Taub J, 2003, NATURE, V421, P764, DOI 10.1038/nature01425; Toh WH, 2005, J BIOL CHEM, V280, P17329, DOI 10.1074/jbc.M500044200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8513	10.1371/journal.pone.0008513	http://dx.doi.org/10.1371/journal.pone.0008513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20046837	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700024
J	Mithani, SK; Shao, C; Tan, M; Smith, IM; Califano, JA; El-Naggar, AK; Ha, PK				Mithani, Suhail K.; Shao, Chunbo; Tan, Marietta; Smith, Ian M.; Califano, Joseph A.; El-Naggar, Adel K.; Ha, Patrick K.			Mitochondrial Mutations in Adenoid Cystic Carcinoma of the Salivary Glands	PLOS ONE			English	Article							DNA G10398A POLYMORPHISM; AFRICAN-AMERICAN WOMEN; INVASIVE BREAST-CANCER; ESOPHAGEAL CANCER; MTDNA MUTATIONS; GENOME INSTABILITY; DISTANT METASTASIS; KIT PROTEIN; TUMORS; EXPRESSION	Background: The Mito Chip v2.0 resequencing array is an array-based technique allowing for accurate and complete sequencing of the mitochondrial genome. No studies have investigated mitochondrial mutation in salivary gland adenoid cystic carcinomas. Methodology:The entire mitochondrial genome of 22 salivary gland adenoid cystic carcinomas (ACC) of salivary glands and matched leukocyte DNA was sequenced to determine the frequency and distribution of mitochondrial mutations in ACC tumors. Principal Findings: Seventeen of 22 ACCs (77%) carried mitochondrial mutations, ranging in number from 1 to 37 mutations. A disproportionate number of mutations occurred in the D-loop. Twelve of 17 tumors (70.6%) carried mutations resulting in amino acid changes of translated proteins. Nine of 17 tumors (52.9%) with a mutation carried an amino acid changing mutation in the nicotinamide adenine dinucleotide dehydrogenase (NADH) complex. Conclusions/Significance: Mitochondrial mutation is frequent in salivary ACCs. The high incidence of amino acid changing mutations implicates alterations in aerobic respiration in ACC carcinogenesis. D-loop mutations are of unclear significance, but may be associated with alterations in transcription or replication.	[Mithani, Suhail K.] Johns Hopkins Med Inst, Dept Surg, Div Plast & Reconstruct Surg, Baltimore, MD 21205 USA; [Shao, Chunbo; Tan, Marietta; Smith, Ian M.; Califano, Joseph A.; Ha, Patrick K.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Califano, Joseph A.; Ha, Patrick K.] Milton J Dance Head & Neck Ctr, Greater Baltimore Med Ctr, Baltimore, MD USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center; University of Texas System; UTMD Anderson Cancer Center	Mithani, SK (corresponding author), Johns Hopkins Med Inst, Dept Surg, Div Plast & Reconstruct Surg, Baltimore, MD 21205 USA.	pha1@jhmi.edu	Shao, Chunbo/C-5412-2011	Mithani, Suhail/0000-0002-3762-0831	Flight Attendant Medical Research Institute; NIDCR [1R01DE015939, 9P50DE019032]; NCI [5P20CA118782]; Johns Hopkins Clinician Scientist Award; NIDCR Head and Neck SPORE [9P50DE019032]; NATIONAL CANCER INSTITUTE [P20CA118782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE018463, R01DE015939] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins Clinician Scientist Award; NIDCR Head and Neck SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the NIDCR 1R01DE015939, and NIDCR Head and Neck SPORE 9P50DE019032, and NCI 5P20CA118782 to JC and also by the NIDCR K08DE018463, the Johns Hopkins Clinician Scientist Award, and the NIDCR Head and Neck SPORE 9P50DE019032 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Allalunis-Turner J, 2006, CANCER LETT, V243, P193, DOI 10.1016/j.canlet.2005.11.035; BROWN MD, 1992, GENETICS, V130, P163; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Daa T, 2004, MODERN PATHOL, V17, P1475, DOI 10.1038/modpathol.3800209; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; DeHaan C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-19; Dodd RL, 2006, ORAL ONCOL, V42, P759, DOI 10.1016/j.oraloncology.2006.01.001; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Franchi A, 1999, AM J CLIN PATHOL, V111, P43; Hibi K, 2001, INT J CANCER, V94, P429, DOI 10.1002/ijc.1480; Hibi K, 2001, INT J CANCER, V92, P319, DOI 10.1002/ijc.1204; Holst VA, 1999, MODERN PATHOL, V12, P956; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ishikawa Y, 1997, J ORAL MAXIL SURG, V55, P1460, DOI 10.1016/S0278-2391(97)90651-0; Jeng YM, 2000, CANCER LETT, V154, P107, DOI 10.1016/S0304-3835(00)00387-6; Johns MM, 1996, CANCER RES, V56, P1151; Khan AJ, 2001, INT J CANCER, V96, P149, DOI 10.1002/ijc.1013; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Liu VWS, 2003, BRIT J CANCER, V89, P697, DOI 10.1038/sj.bjc.6601110; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mims MP, 2006, CANCER RES, V66, P1880, DOI 10.1158/0008-5472.CAN-05-3774; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Setiawan VW, 2008, CANCER GENET CYTOGEN, V181, P16, DOI 10.1016/j.cancergencyto.2007.10.019; Shahsavari Fatemeh, 2005, Asian Pac J Cancer Prev, V6, P527; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shintani S, 2000, ANTICANCER RES, V20, P2169; Spiro RH, 1997, AM J SURG, V174, P495; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Takata T, 1999, CANCER, V86, P928, DOI 10.1002/(SICI)1097-0142(19990915)86:6<928::AID-CNCR6>3.3.CO;2-O; Tamura G, 1999, EUR J CANCER, V35, P316, DOI 10.1016/S0959-8049(98)00360-8; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Tan DJ, 2002, CANCER RES, V62, P972; Tan DJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-93; Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269; Teymoortash A, 2006, J CANCER RES CLIN, V132, P51, DOI 10.1007/s00432-005-0040-1; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vered M, 2002, HEAD NECK-J SCI SPEC, V24, P632, DOI 10.1002/hed.10104; Voo KS, 2006, CANCER RES, V66, P5919, DOI 10.1158/0008-5472.CAN-05-4574; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537; Zhao YB, 2005, WORLD J GASTROENTERO, V11, P3304, DOI 10.3748/wjg.v11.i21.3304; Zhidkov I, 2009, GENOME RES, V19, P576, DOI 10.1101/gr.086462.108; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008	51	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8493	10.1371/journal.pone.0008493	http://dx.doi.org/10.1371/journal.pone.0008493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041111	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700008
J	Bansal, D; Herbert, F; Lim, P; Deshpande, P; Becavin, C; Guiyedi, V; de Maria, I; Rousselle, JC; Namane, A; Jain, R; Cazenave, PA; Mishra, GC; Ferlini, C; Fesel, C; Benecke, A; Pied, S				Bansal, Devendra; Herbert, Fabien; Lim, Pharath; Deshpande, Prakash; Becavin, Christophe; Guiyedi, Vincent; de Maria, Ilaria; Rousselle, Jean Claude; Namane, Abdelkader; Jain, Rajendra; Cazenave, Pierre-Andre; Mishra, Gyan Chandra; Ferlini, Cristiano; Fesel, Constantin; Benecke, Arndt; Pied, Sylviane			IgG Autoantibody to Brain Beta Tubulin III Associated with Cytokine Cluster-II Discriminate Cerebral Malaria in Central India	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTICARDIOLIPIN ANTIBODIES; INFECTED PATIENTS; GLOBAL ANALYSIS; T-CELLS; PATHOGENESIS; REPERTOIRES; SPECIFICITY; RESPONSES; CORRELATE	Background: The main processes in the pathogenesis of cerebral malaria caused by Plasmodium falciparum involved sequestration of parasitized red blood cells and immunopathological responses. Among immune factors, IgG autoantibodies to brain antigens are increased in P. falciparum infected patients and correlate with disease severity in African children. Nevertheless, their role in the pathophysiology of cerebral malaria (CM) is not fully defined. We extended our analysis to an Indian population with genetic backgrounds and endemic and environmental status different from Africa to determine if these autoantibodies could be either a biomarker or a risk factor of developing CM. Methods/Principal Findings: We investigated the significance of these self-reactive antibodies in clinically well-defined groups of P. falciparum infected patients manifesting mild malaria (MM), severe non-cerebral malaria (SM), or cerebral malaria (CM) and in control subjects from Gondia, a malaria epidemic site in central India using quantitative immunoprinting and multivariate statistical analyses. A two-fold complete-linkage hierarchical clustering allows classifying the different patient groups and to distinguish the CM from the others on the basis of their profile of IgG reactivity to brain proteins defined by PANAMA Blot. We identified beta tubulin III (TBB3) as a novel discriminant brain antigen in the prevalence of CM. In addition, circulating IgG from CM patients highly react with recombinant TBB3. Overall, correspondence analyses based on singular value decomposition show a strong correlation between IgG anti-TBB3 and elevated concentration of cluster-II cytokine (IFN gamma, IL1 beta, TNF alpha, TGF beta) previously demonstrated to be a predictor of CM in the same population. Conclusions/Significance: Collectively, these findings validate the relationship between antibody response to brain induced by P. falciparum infection and plasma cytokine patterns with clinical outcome of malaria. They also provide significant insight into the immune mechanisms associated to CM by the identification of TBB3 as a new disease-specific marker and potential therapeutic target.	[Bansal, Devendra; Herbert, Fabien; Lim, Pharath; Guiyedi, Vincent; Cazenave, Pierre-Andre; Pied, Sylviane] Pole Univ Nord, Inst Pasteur Lille, INSERM, Equipe PIME,CNRS,U547, Lille, France; [Deshpande, Prakash; Mishra, Gyan Chandra] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Becavin, Christophe; Benecke, Arndt] Univ Lille 1, CNRS, USR3078, Inst Rech Interdisciplinaire, Bures Sur Yvette, France; [Becavin, Christophe; Benecke, Arndt] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [de Maria, Ilaria; Ferlini, Cristiano] Univ Cattolica Sacro Cuore, Lab Antineoplast Pharmacol, Rome, Italy; [Rousselle, Jean Claude; Namane, Abdelkader] Inst Pasteur, CNRS, URA 2185, Paris, France; [Cazenave, Pierre-Andre] Univ Paris 06, CNRS, U7087, Paris, France; [Fesel, Constantin] Inst Gulbenkian Ciencias, Oeiras, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Saclay; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Instituto Gulbenkian de Ciencia	Bansal, D (corresponding author), Pole Univ Nord, Inst Pasteur Lille, INSERM, Equipe PIME,CNRS,U547, Lille, France.	sylviane.pied@pasteur-lille.fr	Ferlini, Cristiano/K-1339-2013; Namane, Abdelkader/O-1857-2013; Lim, Pharath/AAF-6699-2020; Benecke, Arndt G./T-1079-2019; Bécavin, Christophe/AAA-2046-2020; HERBERT, Fabien/I-3069-2018	Ferlini, Cristiano/0000-0003-3886-9134; Namane, Abdelkader/0000-0001-7180-7619; Bécavin, Christophe/0000-0003-1555-3153; Lim, Pharath/0000-0002-1012-2461; Bansal, Devendra/0000-0002-1387-4335; Cazenave, Pierre-Andre/0000-0002-1345-8526; Fesel, Constantin/0000-0003-3537-5243; Pied, Sylviane/0000-0003-0642-1423; HERBERT, Fabien/0000-0001-7988-3819	Indo-French Centre for Promotion of Advanced Research [2103-3, 3703-2]; Institut Pasteur and Pasteur-Genopole-Ile-de-France; "Fondation des Treilles''; Genopole Evry; Agence Nationale pour la Recherche (ANR); Agence Nationale de Recherches sur le SIDA (ANRS) et les hepatites virales; Fundation para a Ciencia e Tecnologia (Portugal)	Indo-French Centre for Promotion of Advanced Research(French National Research Agency (ANR)); Institut Pasteur and Pasteur-Genopole-Ile-de-France; "Fondation des Treilles''; Genopole Evry; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Agence Nationale de Recherches sur le SIDA (ANRS) et les hepatites virales(ANRS); Fundation para a Ciencia e Tecnologia (Portugal)	This work was part of the Centre National de la Recherche Scientifique (CNRS)-Programme d'Incitation a la Mobilite d'Equipe (PIME): Malaria Immunopathophysiology. It was supported by the Indo-French Centre for Promotion of Advanced Research (grant 2103-3 and 3703-2). This work was also supported by grants from the Institut Pasteur and Pasteur-Genopole-Ile-de-France and "Fondation des Treilles''. Work in the Benecke group is funded by grants from the Genopole Evry, the Agence Nationale pour la Recherche (ANR), and the Agence Nationale de Recherches sur le SIDA (ANRS) et les hepatites virales. CB is recipient of a Ph. D. fellowship from the ANRS. CF received a post-doctoral fellowship from the Fundation para a Ciencia e Tecnologia (Portugal).	Adams S, 2002, TRENDS PARASITOL, V18, P360, DOI 10.1016/S1471-4922(02)02353-X; ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Consigny PH, 2002, CLIN EXP IMMUNOL, V127, P158, DOI 10.1046/j.1365-2249.2002.01722.x; DANIELRIBEIRO C, 1983, T ROY SOC TROP MED H, V77, P185, DOI 10.1016/0035-9203(83)90064-0; Duarte J, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-1; FREEMAN RR, 1978, CLIN EXP IMMUNOL, V32, P41; GALLIEN S, 2007, J INFECTION, V54, P1; GENDREL D, 1992, PRESSE MED, V21, P1805; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Greenwood BM, 1997, ANN TROP MED PARASIT, V91, P763, DOI 10.1080/00034989760518; GREENWOOD BM, 1974, LANCET, V1, P435; Guiyedi V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000389; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; HOWARD MK, 1987, CLIN EXP IMMUNOL, V68, P78; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; JAKOBSEN PH, 1993, IMMUNOLOGY, V79, P653; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; KORENROMP E, 2004, WORLD MALARIA REPORT; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lang B, 2005, J INFECT DIS, V191, P117, DOI 10.1086/426512; Lima MRD, 1996, SCAND J IMMUNOL, V43, P263; Mazier D, 2000, PARASITE IMMUNOL, V22, P613, DOI 10.1046/j.1365-3024.2000.00342.x; Medana IM, 2007, J INFECT DIS, V195, P921, DOI 10.1086/512089; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Minoprio P, 2001, INT J PARASITOL, V31, P588, DOI 10.1016/S0020-7519(01)00171-0; NOBREGA A, 1993, EUR J IMMUNOL, V23, P2851, DOI 10.1002/eji.1830231119; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; SHAPER AG, 1968, LANCET, V1, P1342; SONI PN, 1993, S AFR MED J, V83, P660; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; TRIPATHI AK, 2009, BLOOD           0827; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004	41	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8245	10.1371/journal.pone.0008245	http://dx.doi.org/10.1371/journal.pone.0008245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011600	gold, Green Published			2022-12-27	WOS:000272830300017
J	Jones, HE; Harris, KA; Azizia, M; Bank, L; Carpenter, B; Hartley, JC; Klein, N; Peebles, D				Jones, Hannah E.; Harris, Kathryn A.; Azizia, Malika; Bank, Lindsay; Carpenter, Bernadette; Hartley, John C.; Klein, Nigel; Peebles, Donald			Differing Prevalence and Diversity of Bacterial Species in Fetal Membranes from Very Preterm and Term Labor	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; TOLL-LIKE RECEPTORS; UREAPLASMA-UREALYTICUM; INTRAUTERINE INFECTION; MONOCYTE DEACTIVATION; PREMATURE RUPTURE; AMNIOTIC-FLUID; COLONIZATION; INFLAMMATION; ASSOCIATION	Background: Intrauterine infection may play a role in preterm delivery due to spontaneous preterm labor (PTL) and preterm prolonged rupture of membranes (PPROM). Because bacteria previously associated with preterm delivery are often difficult to culture, a molecular biology approach was used to identify bacterial DNA in placenta and fetal membranes. Methodology/Principal findings: We used broad-range 16S rDNA PCR and species-specific, real-time assays to amplify bacterial DNA from fetal membranes and placenta. 74 women were recruited to the following groups: PPROM,32 weeks (n = 26; 11 caesarean); PTL with intact membranes,32 weeks ( n = 19; all vaginal birth); indicated preterm delivery,32 weeks ( n = 8; all caesarean); term ( n = 21; 11 caesarean). 50% (5/10) of term vaginal deliveries were positive for bacterial DNA. However, little spread was observed through tissues and species diversity was restricted. Minimal bacteria were detected in term elective section or indicated preterm deliveries. Bacterial prevalence was significantly increased in samples from PTL with intact membranes [89% (17/19) versus 50% (5/10) in term vaginal delivery p = 0.03] and PPROM ( CS) [55% (6/11) versus 0% (0/11) in term elective CS, p = 0.01]. In addition, bacterial spread and diversity was greater in the preterm groups with 68% (13/19) PTL group having 3 or more positive samples and over 60% (12/19) showing two or more bacterial species ( versus 20% (2/10) in term vaginal deliveries). Blood monocytes from women with PTL with intact membranes and PPROM who were 16S bacterial positive showed greater level of immune paresis ( p = 0.03). A positive PCR result was associated with histological chorioamnionitis in preterm deliveries. Conclusion/Significance: Bacteria are found in both preterm and term fetal membranes. A greater spread and diversity of bacterial species were found in tissues of women who had very preterm births. It is unclear to what extent the greater bacterial prevalence observed in all vaginal delivery groups reflects bacterial contamination or colonization of membranes during labor. Bacteria positive preterm tissues are associated with histological chorioamnionitis and a pronounced maternal immune paresis.	[Jones, Hannah E.; Bank, Lindsay; Carpenter, Bernadette; Klein, Nigel] Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Jones, Hannah E.; Azizia, Malika; Peebles, Donald] UCL, Dept Obstet & Gynecol, Inst Womens Hlth, London, England; [Harris, Kathryn A.; Hartley, John C.] Great Ormond St Hosp Sick Children, Dept Microbiol, Camelia Botner Labs, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Jones, HE (corresponding author), Inst Child Hlth, Infect Dis & Microbiol Unit, London, England.	h.jones@ich.ucl.ac.uk		Harris, Kathryn/0000-0003-3807-9749; Klein, Nigel/0000-0003-3925-9258	SPARKS [06UCL01]; University College London Hospital/University College London; Great Ormond Street Hospital Microbiology Department; Department of Health NIHR Biomedical Research Centres	SPARKS; University College London Hospital/University College London; Great Ormond Street Hospital Microbiology Department; Department of Health NIHR Biomedical Research Centres(National Institute for Health Research (NIHR))	This work was funded by project grant 06UCL01 from SPARKS ( Sport Aiding medical Research for Kids, www.SPARKS.org.UK) charity. The study was undertaken at University College London Hospital/University College London and Great Ormond Street Hospital Microbiology Department. University College London Hospital/University College London received a proportion of funding from the Department of Health NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2002, CRIT CARE MED, V30, P1140, DOI 10.1097/00003246-200205000-00031; Alvarez-de-la-Rosa M, 2000, EUR J OBSTET GYN R B, V88, P57, DOI 10.1016/S0301-2115(99)00129-3; Bergseng H, 2007, J MED MICROBIOL, V56, P223, DOI 10.1099/jmm.0.46731-0; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Boutaga K, 2005, FEMS IMMUNOL MED MIC, V45, P191, DOI 10.1016/j.femsim.2005.03.011; Cahill RJ, 2005, MOL HUM REPROD, V11, P761, DOI 10.1093/molehr/gah234; Cao X, 2007, DIAGN MICR INFEC DIS, V57, P373, DOI 10.1016/j.diagmicrobio.2006.09.006; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dubicke A, 2008, MOL HUM REPROD, V14, P641, DOI 10.1093/molehr/gan060; Feikin DR, 2001, AM J OBSTET GYNECOL, V184, P427, DOI 10.1067/mob.2001.109936; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gomez R, 2007, J MATERN-FETAL NEO M, V20, P167, DOI 10.1080/14767050601135485; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Greig PC, 1997, OBSTET GYNECOL, V90, P465, DOI 10.1016/S0029-7844(97)00294-9; Guaschino S, 2006, BJOG-INT J OBSTET GY, V113, P46, DOI 10.1111/j.1471-0528.2006.01122.x; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Hobel CJ, 1999, ANN NY ACAD SCI, V897, P54, DOI 10.1111/j.1749-6632.1999.tb07878.x; Hutzal CE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.008; Kataoka S, 2006, J CLIN MICROBIOL, V44, P51, DOI 10.1128/JCM.44.1.51-55.2006; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; King J, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000246; Lloyd J, 2007, OBSTET GYNECOL, V110, P1335, DOI 10.1097/01.AOG.0000289226.08442.e1; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Nguyen DP, 2004, J PERINAT MED, V32, P323, DOI 10.1515/JPM.2004.060; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.044; Patni S, 2007, BJOG-INT J OBSTET GY, V114, P1326, DOI 10.1111/j.1471-0528.2007.01488.x; Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252; Pretorius C, 2007, J PERINAT MED, V35, P93, DOI 10.1515/JPM.2007.039; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Shobokshi A, 2002, INT J GYNECOL OBSTET, V79, P209, DOI 10.1016/S0020-7292(02)00238-2; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Steinborn A, 1996, J PERINAT MED, V24, P381, DOI 10.1515/jpme.1996.24.4.381; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Witt A, 2005, AM J OBSTET GYNECOL, V193, P1663, DOI 10.1016/j.ajog.2005.03.067; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036	45	105	109	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8205	10.1371/journal.pone.0008205	http://dx.doi.org/10.1371/journal.pone.0008205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997613	gold, Green Submitted, Green Published			2022-12-27	WOS:000272829700005
J	Lock, FE; Hotchin, NA				Lock, Frances E.; Hotchin, Neil A.			Distinct Roles for ROCK1 and ROCK2 in the Regulation of Keratinocyte Differentiation	PLOS ONE			English	Article							VENTRAL BODY-WALL; RHO-KINASE-II; MYOSIN PHOSPHATASE; TERMINAL DIFFERENTIATION; IN-VIVO; ADHESION; PROTEIN; PHOSPHORYLATION; EXPRESSION; MECHANISM	Background: The human epidermis is comprised of several layers of specialized epithelial cells called keratinocytes. Normal homoeostasis of the epidermis requires that the balance between keratinocyte proliferation and terminal differentiation be tightly regulated. The mammalian serine/threonine kinases (ROCK1 and ROCK2) are well-characterised downstream effectors of the small GTPase RhoA. We have previously demonstrated that the RhoA/ROCK signalling pathway plays an important role in regulation of human keratinocyte proliferation and terminal differentiation. In this paper we addressed the question of which ROCK isoform was involved in regulation of keratinocyte differentiation. Methodology and Principal Findings: We used RNAi to specifically knockdown ROCK1 or ROCK2 expression in cultured human keratinocytes. ROCK1 depletion results in decreased keratinocyte adhesion to fibronectin and an increase in terminal differentiation. Conversely, ROCK2 depletion results in increased keratinocyte adhesion to fibronectin and inhibits terminal differentiation. Conclusion: These data suggest that ROCK1 and ROCK2 play distinct roles in regulating keratinocyte adhesion and terminal differentiation.	[Lock, Frances E.; Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Lock, FE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	n.a.hotchin@bham.ac.uk		Hotchin, Neil/0000-0002-1844-7607	Cancer Research UK project [C20692]	Cancer Research UK project(Cancer Research UK)	This work was funded by a Cancer Research UK project grant (C20692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Leung T, 1996, MOL CELL BIOL, V16, P5313; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684	30	72	80	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8190	10.1371/journal.pone.0008190	http://dx.doi.org/10.1371/journal.pone.0008190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997641	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829200019
J	Little, MP; Heidenreich, WF; Li, GQ				Little, Mark P.; Heidenreich, Wolfgang F.; Li, Guangquan			Parameter Identifiability and Redundancy in a General Class of Stochastic Carcinogenesis Models	PLOS ONE			English	Article							CLONAL EXPANSION MODEL; COLON-CANCER DATA; GENOMIC INSTABILITY; REPARAMETERISATIONS; IDENTIFICATION; SYSTEMS	Background: Heidenreich et al. ( Risk Anal 1997 17 391-399) considered parameter identifiability in the context of the two-mutation cancer model and demonstrated that combinations of all but two of the model parameters are identifiable. We consider the problem of identifiability in the recently developed carcinogenesis models of Little and Wright ( Math Biosci 2003 183 111-134) and Little et al. (J Theoret Biol 2008 254 229-238). These models, which incorporate genomic instability, generalize a large number of other quasi-biological cancer models, in particular those of Armitage and Doll (Br J Cancer 1954 8 1-12), the two-mutation model (Moolgavkar et al. Math Biosci 1979 47 55-77), the generalized multistage model of Little ( Biometrics 1995 51 1278-1291), and a recently developed cancer model of Nowak et al. (PNAS 2002 99 16226-16231). Methodology/Principal Findings: We show that in the simpler model proposed by Little and Wright ( Math Biosci 2003 183 111-134) the number of identifiable combinations of parameters is at most two less than the number of biological parameters, thereby generalizing previous results of Heidenreich et al. ( Risk Anal 1997 17 391-399) for the two-mutation model. For the more general model of Little et al. ( J Theoret Biol 2008 254 229-238) the number of identifiable combinations of parameters is at most r + 1 less than the number of biological parameters, where r is the number of destabilization types, thereby also generalizing all these results. Numerical evaluations suggest that these bounds are sharp. We also identify particular combinations of identifiable parameters. Conclusions/Significance: We have shown that the previous results on parameter identifiability can be generalized to much larger classes of quasi-biological carcinogenesis model, and also identify particular combinations of identifiable parameters. These results are of theoretical interest, but also of practical significance to anyone attempting to estimate parameters for this large class of cancer models.	[Little, Mark P.; Li, Guangquan] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Heidenreich, Wolfgang F.] Helmholtz Zentrum Munchen, Inst Strahlenschutz, Neuherberg, Germany	Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Little, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England.	mark.little@imperial.ac.uk	Li, Guangquan/AAW-6920-2021	Li, Guangquan/0000-0002-8736-5349; Little, Mark/0000-0003-0980-7567	European Commission [FI6R-CT-2003-508842, FP6-036465]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded partially by the European Commission under contract FI6R-CT-2003-508842 (RISC-RAD) and FP6-036465 ( NOTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Catchpole EA, 1997, BIOMETRIKA, V84, P187, DOI 10.1093/biomet/84.1.187; Chappell MJ, 1998, MATH BIOSCI, V148, P21, DOI 10.1016/S0025-5564(97)10004-9; COLE D, 2009, DETERMINING PARAMETR; Evans ND, 2000, MATH BIOSCI, V168, P137, DOI 10.1016/S0025-5564(00)00047-X; Golub GH., 2013, MATRIX COMPUTATIONS; Hanin LG, 1996, RISK ANAL, V16, P711, DOI 10.1111/j.1539-6924.1996.tb00819.x; Hanin LG, 2002, DISCRETE DYN NAT SOC, V7, P177, DOI 10.1080/1026022021000001454; Heidenreich WF, 1996, RADIAT ENVIRON BIOPH, V35, P127, DOI 10.1007/s004110050020; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; JACQUEZ JA, 1990, AM J PHYSIOL, V258, pE727, DOI 10.1152/ajpendo.1990.258.4.E727; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; LITTLE MP, 2009, PLOS ONE UNPUB; McCullagh P, 1989, GEN LINEAR MODELS; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; *NUM ALG GROUP, 2006, NAG LIB MARK 21; Press W., 1992, NUMERICAL RECIPES FO; ROTHENBERG TJ, 1971, ECONOMETRICA, V39, P577, DOI 10.2307/1913267; Silvey S.D., 1975, REPRINTING MONOGRAPH	23	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8520	10.1371/journal.pone.0008520	http://dx.doi.org/10.1371/journal.pone.0008520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	538JK	20046831	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000273180200008
J	Ji, Z; Tian, B				Ji, Zhe; Tian, Bin			Reprogramming of 3 ' Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types	PLOS ONE			English	Article							MICRORNA TARGETS; SITE SELECTION; MOUSE TESTIS; GENES; ELEMENTS; 3'-END; REPRESSION; MECHANISM; EVOLUTION; REVEALS	Background: The 3' untranslated regions (3'UTRs) of mRNAs contain cis elements involved in post-transcriptional regulation of gene expression. Over half of all mammalian genes contain multiple polyadenylation sites that lead to different 3'UTRs for a gene. Studies have shown that the alternative polyadenylation (APA) pattern varies across tissues, and is dynamically regulated in proliferating or differentiating cells. Generation of induced pluripotent stem (iPS) cells, in which differentiated cells are reprogrammed to an embryonic stem (ES) cell-like state, has been intensively studied in recent years. However, it is not known how 3'UTRs are regulated during cell reprogramming. Methods/Main Findings: Using a computational method that robustly examines APA across DNA microarray data sets, we analyzed 3'UTR dynamics in generation of iPS cells from different cell types. We found that 3'UTRs shorten during reprogramming of somatic cells, the extent of which depends on the type of source cell. By contrast, reprogramming of spermatogonial cells involves 3'UTR lengthening. The alternative polyadenylation sites that are highly responsive to change of cell state in generation of iPS cells are also highly regulated during embryonic development in opposite directions. Compared with other sites, they are more conserved, can lead to longer alternative 3'UTRs, and are associated with more cis elements for polyadenylation. Consistently, reprogramming of somatic cells and germ cells involves significant upregulation and downregulation, respectively, of mRNAs encoding polyadenylation factors, and RNA processing is one of the most significantly regulated biological processes during cell reprogramming. Furthermore, genes containing target sites of ES cell-specific microRNAs (miRNAs) in different portions of 3'UTR are distinctively regulated during cell reprogramming, suggesting impact of APA on miRNA targeting. Conclusions/Significance: Taken together, these findings indicate that reprogramming of 3'UTRs by APA, which result from regulation of both general polyadenylation activity and cell type-specific factors and can reset post-transcriptional gene regulatory programs in the cell, is an integral part of iPS cell generation, and the APA pattern can be a good biomarker for cell type and state, useful for sample classification. The results also suggest that perturbation of the mRNA polyadenylation machinery or RNA processing activity may facilitate generation of iPS cells.	[Ji, Zhe] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ji, Z (corresponding author), Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	btian@umdnj.edu	Ji, Zhe/P-7094-2018; Ji, Zhe/U-8320-2018	Ji, Zhe/0000-0002-1809-8099; Tian, Bin/0000-0001-8903-8256	NIH [R01 GM084089]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from NIH (R01 GM084089) to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lowry WE, 2008, NAT BIOTECHNOL, V26, P1246, DOI 10.1038/nbt1108-1246; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Venables WN., 2002, MODERN APPL STAT S 4; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	56	192	202	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8419	10.1371/journal.pone.0008419	http://dx.doi.org/10.1371/journal.pone.0008419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037631	Green Submitted, Green Published, gold			2022-12-27	WOS:000272998100010
J	Nasrin, N; Kaushik, VK; Fortier, E; Wall, D; Pearson, KJ; de Cabo, R; Bordone, L				Nasrin, Nargis; Kaushik, Virendar K.; Fortier, Eric; Wall, Daniel; Pearson, Kevin J.; de Cabo, Rafael; Bordone, Laura			JNK1 Phosphorylates SIRT1 and Promotes Its Enzymatic Activity	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; OXIDATIVE STRESS; CALORIE RESTRICTION; CAENORHABDITIS-ELEGANS; HISTONE DEACETYLASE; CELL APOPTOSIS; LONGEVITY; TRANSCRIPTION; PATHWAYS; SURVIVAL	SIRT1 is a NAD-dependent deacetylase that regulates a variety of pathways including the stress protection pathway. SIRT1 deacetylates a number of protein substrates, including histones, FOXOs, PGC-1 alpha, and p53, leading to cellular protection. We identified a functional interaction between cJUN N-terminal kinase (JNK1) and SIRT1 by coimmunoprecipitation of endogenous proteins. The interaction between JNK1 and SIRT1 was identified under conditions of oxidative stress and required activation of JNK1 via phosphorylation. Modulation of SIRT1 activity or protein levels using nicotinamide or RNAi did not modify JNK1 activity as measured by its ability to phosphorylate cJUN. In contrast, human SIRT1 was phosphorylated by JNK1 on three sites: Ser27, Ser47, and Thr530 and this phosphorylation of SIRT1 increased its nuclear localization and enzymatic activity. Surprisingly, JNK1 phosphorylation of SIRT1 showed substrate specificity resulting in deacetylation of histone H3, but not p53. These findings identify a mechanism for regulation of SIRT1 enzymatic activity in response to oxidative stress and shed new light on its role in the stress protection pathway.	[Nasrin, Nargis; Kaushik, Virendar K.; Fortier, Eric; Bordone, Laura] Novartis Inst BioMed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA USA; [Kaushik, Virendar K.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Pearson, Kevin J.; de Cabo, Rafael] NIA, NIH, Bethesda, MD 20892 USA	Novartis; Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Nasrin, N (corresponding author), Novartis Inst BioMed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA USA.	laura.bordone@novartis.com	de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442	National Institutes of Health (NIH); National Institute on Aging (NIA); Novartis Institutes for Biomedical Research; NATIONAL INSTITUTE ON AGING [ZIAAG000363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novartis Institutes for Biomedical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging (NIA), and by internal funding from Novartis Institutes for Biomedical Research. Employees of the entities sponsoring the work were involved in conception, experimental design, analysis, and preparation of the paper.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Berthiaume M, 2006, DNA CELL BIOL, V25, P124, DOI 10.1089/dna.2006.25.124; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	24	191	205	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8414	10.1371/journal.pone.0008414	http://dx.doi.org/10.1371/journal.pone.0008414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027304	gold, Green Submitted, Green Published			2022-12-27	WOS:000272998000018
J	Strunnikova, NV; Barb, J; Sergeev, YV; Thiagarajasubramanian, A; Silvin, C; Munson, PJ; MacDonald, IM				Strunnikova, Natalia V.; Barb, Jennifer; Sergeev, Yuri V.; Thiagarajasubramanian, Ashwin; Silvin, Christopher; Munson, Peter J.; MacDonald, Ian M.			Loss-of-Function Mutations in Rab Escort Protein 1 (REP-1) Affect Intracellular Transport in Fibroblasts and Monocytes of Choroideremia Patients	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; DRUSEN FORMATION; GENE-EXPRESSION; MOLECULAR-BASIS; CELLS; RPE; DYSFUNCTION; EXOCYTOSIS; EFFECTORS; DEGENERATION	Background: Choroideremia (CHM) is a progressive X-linked retinopathy caused by mutations in the CHM gene, which encodes Rab escort protein-1 (REP-1), an escort protein involved in the prenylation of Rabs. Under-prenylation of certain Rabs, as a result of loss of function mutations in REP-1, could affect vesicular trafficking, exocytosis and secretion in peripheral cells of CHM patients. Methodology/Principal Findings: To evaluate this hypothesis, intracellular vesicle transport, lysosomal acidification and rates of proteolytic degradation were studied in monocytes (CD14+ fraction) and primary skin fibroblasts from the nine age-matched controls and thirteen CHM patients carrying 10 different loss-of-function mutations. With the use of pHrodo (TM) BioParticles (R) conjugated with E. coli, collagen I coated FluoSpheres beads and fluorescent DQ (TM) ovalbumin with BODYPY FL dye, we demonstrated for the first time that lysosomal pH was increased in monocytes of CHM patients and, as a consequence, the rates of proteolytic degradation were slowed. Microarray analysis of gene expression revealed that some genes involved in the immune response, small GTPase regulation, transcription, cell adhesion and the regulation of exocytosis were significantly up and down regulated in cells from CHM patients compared to controls. Finally, CHM fibroblasts secreted significantly lower levels of cytokine/growth factors such as macrophage chemoattractant protein-1 (MCP-1), pigment epithelial derived factor (PEDF), tumor necrosis factor (TNF) alpha, fibroblast growth factor (FGF) beta and interleukin (IL)-8. Conclusions/Significance: We demonstrated for the first time that peripheral cells of CHM patients had increased pH levels in lysosomes, reduced rates of proteolytic degradation and altered secretion of cytokines. Peripheral cells from CHM patients expose characteristics that were not previously recognized and could used as an alternative models to study the effects of different mutations in the REP-1 gene on mechanism of CHM development in human population.	[Strunnikova, Natalia V.; Sergeev, Yuri V.; Thiagarajasubramanian, Ashwin] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Barb, Jennifer; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Silvin, Christopher] NIH, Genet & Mol Biol Branch, NHGRI, Bethesda, MD 20892 USA; [MacDonald, Ian M.] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alberta	Strunnikova, NV (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	Strunnikovan@nei.nih.gov		Barb, Jennifer/0000-0003-3022-0154; MacDonald, Ian/0000-0001-7472-8385	National Institutes of Health (NIH); CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Intramural NIH research program. The sponsor had no role in the design, data analysis, interpretation, or writing of the report. The manuscript was reviewed and cleared for publication by the Division of Intramural Research, National Institutes of Health prior to submission.	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Alory C, 2000, J CELL BIOL, V150, P89, DOI 10.1083/jcb.150.1.89; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Andersson LIM, 2007, SCAND J IMMUNOL, V66, P52, DOI 10.1111/j.1365-3083.2007.01948.x; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; BOK D, 1993, J CELL SCI, P189; Bonilha VL, 2008, OPHTHALMIC GENET, V29, P99, DOI 10.1080/13816810802206499; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850; Corbeel L, 2008, EUR J PEDIATR, V167, P723, DOI 10.1007/s00431-008-0740-z; CREMERS FPM, 1990, HUM GENET, V86, P61, DOI 10.1007/BF00205174; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; GORDIYENKO NV, 2009, INVEST OPHTHALMOL VI; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Kaemmerer E, 2007, INVEST OPHTH VIS SCI, V48, P1342, DOI 10.1167/iovs.06-0549; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Krock BL, 2007, P NATL ACAD SCI USA, V104, P4600, DOI 10.1073/pnas.0605818104; Larijani B, 2003, J BIOL CHEM, V278, P46798, DOI 10.1074/jbc.M307799200; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; MacDonald IM, 2004, EXPERT REV MOL DIAGN, V4, P478, DOI 10.1586/14737159.4.4.478; MacDonald IM, 1998, OPHTHALMOLOGY, V105, P1637, DOI 10.1016/S0161-6420(98)99031-5; Mahon GJ, 2004, CURR EYE RES, V28, P277, DOI 10.1076/ceyr.28.4.277.27835; MARMOR M F, 1975, International Ophthalmology Clinics, V15, P115, DOI 10.1097/00004397-197501510-00010; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Nabavi N, 2008, J BIOL CHEM, V283, P19678, DOI 10.1074/jbc.M802517200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Peters S, 2006, OPHTHAL RES, V38, P83, DOI 10.1159/000090268; Preising Markus, 2004, Ophthalmic Genet, V25, P101, DOI 10.1080/13816810490514333; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; RODRIGUES MM, 1984, OPHTHALMOLOGY, V91, P873; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Sergeev YV, 2009, MUTAT RES-FUND MOL M, V665, P44, DOI 10.1016/j.mrfmmm.2009.02.015; Shi W, 2004, DEV BIOL, V272, P53, DOI 10.1016/j.ydbio.2004.04.016; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sundelin SP, 2002, APMIS, V110, P481, DOI 10.1034/j.1600-0463.2002.100606.x; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tanaka D, 2008, GENES CELLS, V13, P1141, DOI 10.1111/j.1365-2443.2008.01232.x; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; vandenHurk JAJM, 1997, HUM MUTAT, V9, P110, DOI 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.3.CO;2-9; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Zarbin MA, 2008, AM J OPHTHALMOL, V146, P151, DOI 10.1016/j.ajo.2008.05.027	61	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8402	10.1371/journal.pone.0008402	http://dx.doi.org/10.1371/journal.pone.0008402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027300	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998000009
J	Gushiken, FC; Han, HJ; Pradhan, S; Langlois, KW; Alrehani, N; Cruz, MA; Rumbaut, RE; Vijayan, KV				Gushiken, Francisca C.; Han Hyojeong; Pradhan, Subhashree; Langlois, Kimberly W.; Alrehani, Nawaf; Cruz, Miguel A.; Rumbaut, Rolando E.; Vijayan, K. Vinod			The Catalytic Subunit of Protein Phosphatase 1 Gamma Regulates Thrombin-Induced Murine Platelet alpha(IIb)beta(3) Function	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INTEGRIN ALPHA(IIB)BETA(3); OKADAIC ACID; P-SELECTIN; ACTIVATION; PHOSPHORYLATION; AGGREGATION; SECRETION; MICE; INHIBITORS	Background: Hemostasis and thrombosis are regulated by agonist-induced activation of platelet integrin alpha(IIb)beta(3). Integrin activation, in turn is mediated by cellular signaling via protein kinases and protein phosphatases. Although the catalytic subunit of protein phosphatase 1 (PP1c) interacts with alpha(IIb)beta(3), the role of PP1c in platelet reactivity is unclear. Methodology/Principal Findings: Using c isoform of PP1c deficient mice (PP1c gamma(-/-)), we show that the platelets have moderately decreased soluble fibrinogen binding and aggregation to low concentrations of thrombin or protease-activated receptor 4 (PAR4)-activating peptide but not to adenosine diphosphate (ADP), collagen or collagen-related peptide (CRP). Thrombin-stimulated PP1c gamma(-/-) platelets showed decreased alpha(IIb)beta(3) activation despite comparable levels of alpha(IIb)beta(3), PAR3, PAR4 expression and normal granule secretion. Functions regulated by outside-in integrin alpha(IIb)beta(3) signaling like adhesion to immobilized fibrinogen and clot retraction were not altered in PP1c gamma(-/-) platelets. Thrombus formation induced by a light/dye injury in the cremaster muscle venules was significantly delayed in PP1c gamma(-/-) mice. Phosphorylation of glycogen synthase kinase (GSK3) beta-serine 9 that promotes platelet function, was reduced in thrombin-stimulated PP1c gamma(-/-) platelets by an AKT independent mechanism. Inhibition of GSK3 beta partially abolished the difference in fibrinogen binding between thrombin-stimulated wild type and PP1c gamma(-/-) platelets. Conclusions/Significance: These studies illustrate a role for PP1c gamma in maintaining GSK3 beta-serine9 phosphorylation downstream of thrombin signaling and promoting thrombus formation via fibrinogen binding and platelet aggregation.	[Gushiken, Francisca C.; Han Hyojeong; Pradhan, Subhashree; Alrehani, Nawaf; Cruz, Miguel A.; Rumbaut, Rolando E.; Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Langlois, Kimberly W.; Rumbaut, Rolando E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Gushiken, FC (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	vvijayan@bcm.tmc.edu		Rumbaut, Rolando/0000-0002-8486-1013	National Institutes of Health (NIH) [HL081613, HL079368, T-32HL072754]; American Heart Association (AHA) [09GRNT2260224, 060180N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, T32HL072754, R01HL079368] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health (NIH) HL081613 (K. V. V), HL079368 (R. E. R) and a Grant-In Aid 09GRNT2260224 from the American Heart Association (AHA) to K. V. V. F. C. G. is supported by the Scientist Development Grant 060180N from the AHA. S. P. was supported in part by NIH grant T-32HL072754. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bynagari YS, 2009, J BIOL CHEM, V284, P13413, DOI 10.1074/jbc.M808970200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cohen PTW, 2002, J CELL SCI, V115, P241; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DE ML, 1991, J BIOL CHEM, V266, P23776; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; LASNE D, 1995, THROMB HAEMOSTASIS, V74, P1323; LAU LF, 1994, BIOCHEM J, V303, P391, DOI 10.1042/bj3030391; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li ZY, 2006, BLOOD, V107, P965, DOI 10.1182/blood-2005-03-1308; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2004, J BIOL CHEM, V279, P42469, DOI 10.1074/jbc.M401532200; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Rumbaut RE, 2004, MICROCIRCULATION, V11, P239, DOI 10.1080/10739680490425949; Satoh K, 1996, BIOCHEM BIOPH RES CO, V225, P1084, DOI 10.1006/bbrc.1996.1299; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Watanabe Y, 2001, BLOOD, V97, P3798, DOI 10.1182/blood.V97.12.3798; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8304	10.1371/journal.pone.0008304	http://dx.doi.org/10.1371/journal.pone.0008304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016849	Green Published, gold, Green Submitted			2022-12-27	WOS:000272833800006
J	Crameri, G; Todd, S; Grimley, S; McEachern, JA; Marsh, GA; Smith, C; Tachedjian, M; De Jong, C; Virtue, ER; Yu, M; Bulach, D; Liu, JP; Michalski, WP; Middleton, D; Field, HE; Wang, LF				Crameri, Gary; Todd, Shawn; Grimley, Samantha; McEachern, Jennifer A.; Marsh, Glenn A.; Smith, Craig; Tachedjian, Mary; De Jong, Carol; Virtue, Elena R.; Yu, Meng; Bulach, Dieter; Liu, Jun-Ping; Michalski, Wojtek P.; Middleton, Deborah; Field, Hume E.; Wang, Lin-Fa			Establishment, Immortalisation and Characterisation of Pteropid Bat Cell Lines	PLOS ONE			English	Article							HUMAN TELOMERASE; HUMAN-FIBROBLASTS; GENE-TRANSFER; NIPAH VIRUS; FRUIT BATS; T-ANTIGENS; SIMIAN-VIRUS-40; TRANSFORMATION; MORBILLIVIRUS; TRANSMISSION	Background: Bats are the suspected natural reservoir hosts for a number of new and emerging zoonotic viruses including Nipah virus, Hendra virus, severe acute respiratory syndrome coronavirus and Ebola virus. Since the discovery of SARS-like coronaviruses in Chinese horseshoe bats, attempts to isolate a SL-CoV from bats have failed and attempts to isolate other bat-borne viruses in various mammalian cell lines have been similarly unsuccessful. New stable bat cell lines are needed to help with these investigations and as tools to assist in the study of bat immunology and virus-host interactions. Methodology/Findings: Black flying foxes (Pteropus alecto) were captured from the wild and transported live to the laboratory for primary cell culture preparation using a variety of different methods and culture media. Primary cells were successfully cultured from 20 different organs. Cell immortalisation can occur spontaneously, however we used a retroviral system to immortalise cells via the transfer and stable production of the Simian virus 40 Large T antigen and the human telomerase reverse transcriptase protein. Initial infection experiments with both cloned and uncloned cell lines using Hendra and Nipah viruses demonstrated varying degrees of infection efficiency between the different cell lines, although it was possible to infect cells in all tissue types. Conclusions/Significance: The approaches developed and optimised in this study should be applicable to bats of other species. We are in the process of generating further cell lines from a number of different bat species using the methodology established in this study.	[Crameri, Gary; Todd, Shawn; Grimley, Samantha; McEachern, Jennifer A.; Marsh, Glenn A.; Tachedjian, Mary; Yu, Meng; Bulach, Dieter; Michalski, Wojtek P.; Middleton, Deborah; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Crameri, Gary; McEachern, Jennifer A.; Smith, Craig; Tachedjian, Mary; De Jong, Carol; Virtue, Elena R.; Yu, Meng; Bulach, Dieter; Field, Hume E.; Wang, Lin-Fa] Australian Biosecur Cooperat Res Ctr Emerging Inf, Brisbane, Qld, Australia; [Grimley, Samantha; Michalski, Wojtek P.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3004, Australia; [Smith, Craig; De Jong, Carol; Field, Hume E.] Queensland Primary Ind & Fisheries, Brisbane, Qld, Australia; [Virtue, Elena R.; Wang, Lin-Fa] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Liu, Jun-Ping] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; University of Melbourne; Monash University	Crameri, G (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	linfa.wang@csiro.au	Crameri, Gary/H-8441-2013; Marsh, Glenn A/A-5418-2013; Barr, Jennifer A/H-9254-2013; Bulach, Dieter M/D-5793-2011; Michalski, Wojtek/H-3544-2013; wang, lin/GSE-3040-2022; Tachedjian, Mary/H-4572-2013	Marsh, Glenn A/0000-0002-3469-1837; Bulach, Dieter M/0000-0001-9823-6078; Barr, Jennifer/0000-0001-5266-9142; Wang, Lin-Fa/0000-0003-2752-0535; Liu, Jun-Ping/0000-0001-7442-2116; Tachedjian, Mary/0000-0002-8936-6564	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; Commonwealth Science and Industry Research Organisation (CSIRO) Chief Executive Officer (CEO) Science Leader Award	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Commonwealth Science and Industry Research Organisation (CSIRO) Chief Executive Officer (CEO) Science Leader Award(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The work conducted in this study is funded in part by grants from the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases (to H. F. and L.-F.W.) and the Commonwealth Science and Industry Research Organisation (CSIRO) Chief Executive Officer (CEO) Science Leader Award (to L.-F.W.). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bossart KN, 2008, VIROLOGY, V372, P357, DOI 10.1016/j.virol.2007.11.011; Buser R, 2006, J CELL BIOCHEM, V98, P267, DOI 10.1002/jcb.20715; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FRESHNEY IR, 2005, TRANSFORMATION IMMOR, P291; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; He YL, 2009, THERIOGENOLOGY, V71, P1417, DOI 10.1016/j.theriogenology.2009.01.012; Julius MA, 2000, BIOTECHNIQUES, V28, P702, DOI 10.2144/00284st06; KASAHARA S, 1983, ANN GENET-PARIS, V26, P197; Kwak S, 2006, ANIM BIOTECHNOL, V17, P51, DOI 10.1080/10495390500461070; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; LECHARDEUR D, 1995, EXP CELL RES, V220, P161, DOI 10.1006/excr.1995.1302; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Meyerson M, 1998, TOXICOL LETT, V103, P41, DOI 10.1016/S0378-4274(98)00278-1; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Namba M, 1996, CRIT REV ONCOGENESIS, V7, P19, DOI 10.1615/CritRevOncog.v7.i1-2.20; SCOTT DM, 1986, EXP CELL RES, V166, P391, DOI 10.1016/0014-4827(86)90485-4; Soloff MS, 2004, MOL HUM REPROD, V10, P685, DOI 10.1093/molehr/gah086; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Stacey G, 2001, CELL BIOL TOXICOL, V17, P231, DOI 10.1023/A:1012525014791; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Takeuchi O, 2004, J ENDOTOXIN RES, V10, P252, DOI 10.1179/096805104225005896; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x	32	110	119	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8266	10.1371/journal.pone.0008266	http://dx.doi.org/10.1371/journal.pone.0008266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011515	gold, Green Published, Green Accepted			2022-12-27	WOS:000272830200010
J	Nasby-Lucas, N; Dewar, H; Lam, CH; Goldman, KJ; Domeier, ML				Nasby-Lucas, Nicole; Dewar, Heidi; Lam, Chi H.; Goldman, Kenneth J.; Domeier, Michael L.			White Shark Offshore Habitat: A Behavioral and Environmental Characterization of the Eastern Pacific Shared Offshore Foraging Area	PLOS ONE			English	Article							SOUTH-FARALLON-ISLANDS; TUNA THUNNUS-OBESUS; CARCHARODON-CARCHARIAS; BLUEFIN TUNA; VERTICAL MOVEMENTS; SWIMMING BEHAVIOR; TEMPERATURE; PERFORMANCE; MIGRATION; TRACKING	Background: Although much is known about the behavior of white sharks in coastal regions, very little is known about their vertical movements offshore in the eastern Pacific where they spend up to five months. We provide the first detailed description of the offshore habitat use of white sharks in the eastern North Pacific. Methodology/Principal Findings: This study uses 2-min data from four recovered pop-up satellite archival tags deployed at Guadalupe Island (2002 and 2005). Deployments ranged from 5.4 to 8.2 months. Two predominant vertical patterns were described. The first was a bimodal vertical pattern with time spent at the surface and at depth, which was observed while traveling. The second was a repetitive oscillatory diving mode displayed by sharks in the Shared Offshore Foraging Area (SOFA). For all four datasets the average maximum daily dive depths ranged from 442.5 to 492.8 m and were typically associated with dissolved oxygen concentrations of above 1.7 ml L-1. Although infrequent, occasional dives to near 1000 m with a minimum temperature of 3.9 degrees C and a minimum O-2 level of 0.3 ml L-1 were observed. Conclusions/Significance: Recovered pop-up satellite tags from Guadalupe Island white sharks advance our understanding of the vertical habitat use of white sharks while offshore. The bimodal vertical pattern during traveling is most likely related to geolocation. The oscillatory dive pattern is likely associated with foraging. While feeding is not documented, foraging is likely occurring in association with the deep scattering layer. Diving depths were not limited by temperature but were constrained by O-2 levels below approximately 1.5 ml L-1. While oxygen may limit the extent of sharks' vertical movements, it will also impact prey distribution. Consequently, the shallow oxygen minimum zone in the SOFA may act to concentrate prey, thus enhancing foraging opportunities in these oligotrophic waters.	[Nasby-Lucas, Nicole; Domeier, Michael L.] Marine Conservat Sci Inst, Fallbrook, CA USA; [Dewar, Heidi] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA; [Lam, Chi H.] Univ So Calif, Los Angeles, CA USA; [Goldman, Kenneth J.] Alaska Dept Fish & Game, Homer, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Southern California; Alaska Department of Fish & Game	Nasby-Lucas, N (corresponding author), Marine Conservat Sci Inst, Fallbrook, CA USA.	nicole@marinecsi.org			George T. Pfleger foundation; Offield family Foundation	George T. Pfleger foundation; Offield family Foundation	This work was funded by the George T. Pfleger foundation and the Offield family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P109; Anderson SD, 2003, CALIF FISH GAME, V89, P96; [Anonymous], 2004, MARINE FISHERIES REV; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bernal D, 2003, J EXP BIOL, V206, P2831, DOI 10.1242/jeb.00481; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; BLOCK BA, 1985, J COMP PHYSIOL B, V156, P229, DOI 10.1007/BF00695777; Block BA, 1997, MAR BIOL, V130, P119, DOI 10.1007/s002270050231; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; BRILL RW, 2001, TUNA PHYSL ECOLOGY E, P00079; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Carey F.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P92; CAREY FG, 1981, FISH B-NOAA, V79, P277; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; CAREY FG, 1982, COPEIA, P254; Compagno LJV., 1984, FAO FISH SYNOP, P20; Deutschlander ME, 1999, J EXP BIOL, V202, P891; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dickson KA, 1996, COMP BIOCHEM PHYS A, V113, P39, DOI 10.1016/0300-9629(95)02056-X; DICKSON RR, 1972, J CONSEIL, V34, P416; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Domeier ML, 2005, FISH B-NOAA, V103, P292; Emery S.H., 1985, Memoirs of the Southern California Academy of Sciences, V9, P73; EMERY SH, 1986, COPEIA, P700, DOI 10.2307/1444952; Ferreira CA, 1996, GREAT WHITE SHARKS, P381, DOI 10.1016/B978-012415031-7/50036-7; Garcia-Castellano JM, 2005, EJC SUPPL, V3, P63; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Graham J.B., 1983, P248; Hanamoto E., 1987, B JPN SOC FISH OCEAN, V51, P203; HOLLAND KN, 1990, FISH B-NOAA, V88, P493; HOLLAND KN, 1992, NATURE, V358, P410, DOI 10.1038/358410a0; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Linkowski TB, 1996, MAR BIOL, V124, P495, DOI 10.1007/BF00351031; Lowe TE, 2000, MAR BIOL, V136, P1087, DOI 10.1007/s002270000255; Matciak M., 1997, OCEANOLOGICAL STUDIE, V26, P3540; MCCOSKER JE, 1987, COPEIA, P195; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; MUSYL MK, 2004, PFRP NEWSLETTER  OCT, P1; NEILL W H, 1976, Environmental Biology of Fishes, V1, P61, DOI 10.1007/BF00761729; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Okamoto Hiroaki, 2003, Inter-American Tropical Tuna Commission Bulletin, V22, P221; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Strong WR, 1996, GREAT WHITE SHARKS, P229, DOI 10.1016/B978-012415031-7/50022-7; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; TONT SA, 1976, REP CALIF COOP OCEAN, V18, P112; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; WEIHS D, 1973, J MAR RES, V31, P194; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003	68	61	62	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8163	10.1371/journal.pone.0008163	http://dx.doi.org/10.1371/journal.pone.0008163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011032	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800002
J	Jawara, M; Smallegange, RC; Jeffries, D; Nwakanma, DC; Awolola, TS; Knols, BGJ; Takken, W; Conway, DJ				Jawara, Musa; Smallegange, Renate C.; Jeffries, David; Nwakanma, Davis C.; Awolola, Taiwo Samson; Knols, Bart G. J.; Takken, Willem; Conway, David J.			Optimizing Odor-Baited Trap Methods for Collecting Mosquitoes during the Malaria Season in The Gambia	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; VECTOR ANOPHELES-GAMBIAE; MM-X TRAPS; CARBON-DIOXIDE; HUMAN SKIN; SEMIFIELD CONDITIONS; MOLECULAR-FORMS; COMPLEX; DIPTERA; ATTRACTIVENESS	Background: Baited traps are potential tools for removal or surveillance of disease vectors. To optimize the use of counter-flow traps baited with human odor ( nylon socks that had been worn for a single day) to capture wild mosquitoes in the Gambia, investigations were conducted at a field experimental site. Methodology/Principal Findings: Experiments employing Latin square design were conducted with a set of six huts to investigate the effects of the following on overnight mosquito trap catches: (1) placement of traps indoors or immediately outdoors, CO2 supply, and presence of a human subject in the hut; (2) trap height for collecting mosquitoes immediately outdoors; (3) height and distance from hut; (4) interaction between multiple traps around a single hut and entry of mosquitoes into huts. A total of 106,600 adult mosquitoes (9.1% Anopheles gambiae s.l., 4.0% other Anopheles species) were collected over 42 nights. The high numbers of An. gambiae s.l. and other mosquitoes collected by odor-baited traps required CO2 but were largely independent of the presence of a person sleeping in the hut or of trap placement indoors or outdoors. For outdoor collection that is considered less intrusive, traps opening 15 cm above the floor of the hut veranda were more highly effective than traps at other heights or further from the hut. There was no significant evidence of saturation or competition by the traps, with multiple traps around a hut each collecting almost as many mosquitoes as single traps and no effect on the numbers of mosquitoes entering the huts. Conclusions/Significance: The outdoor trapping protocol is convenient to compare attractiveness of different odors or synthetic chemicals to malaria vectors and other wild mosquitoes. The finding that such traps are reliably attractive in the presence or absence of a human volunteer encourages their potential development as standardised surveillance tools.	[Jawara, Musa; Jeffries, David; Nwakanma, Davis C.; Awolola, Taiwo Samson; Conway, David J.] MRC Labs, Banjul, Gambia; [Smallegange, Renate C.; Knols, Bart G. J.; Takken, Willem] Wageningen Univ, Entomol Lab, Wageningen, Netherlands	MRC Laboratory Molecular Biology; Wageningen University & Research	Jawara, M (corresponding author), MRC Labs, Banjul, Gambia.	dconway@mrc.gm	Smallegange, Renate C./L-1566-2019	Smallegange, Renate C./0000-0002-6946-9777; Conway, David/0000-0002-8711-3037; Nwakanma, Davis/0000-0002-6706-6069	Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative [121]; Medical Research Council of the United Kingdom	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative(Bill & Melinda Gates Foundation); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded as part of a grant from the Foundation for the National Institutes of Health and the Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative ( GCGH# 121 grant co-ordinated by Dr. Larry Zwiebel), and by the Medical Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cooper RD, 2004, J AM MOSQUITO CONTR, V20, P239; Cork A, 1996, CIBA F SYMP, V200, P71; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GILLIES MT, 1969, B ENTOMOL RES, V59, P441, DOI 10.1017/S0007485300003412; Healy TP, 2000, MED VET ENTOMOL, V14, P195, DOI 10.1046/j.1365-2915.2000.00238.x; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Seyoum A, 2002, AM J TROP MED HYG, V67, P191, DOI 10.4269/ajtmh.2002.67.191; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52	26	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8167	10.1371/journal.pone.0008167	http://dx.doi.org/10.1371/journal.pone.0008167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997640	Green Published, gold, Green Accepted			2022-12-27	WOS:000272829200007
J	Crawford, AC; Riggins, RB; Shajahan, AN; Zwart, A; Clarke, R				Crawford, Anatasha C.; Riggins, Rebecca B.; Shajahan, Ayesha N.; Zwart, Alan; Clarke, Robert			Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY FACTOR-I; FACTOR-KAPPA-B; POSTMENOPAUSAL WOMEN; ACQUIRED-RESISTANCE; INDEPENDENT GROWTH; ENDOCRINE THERAPY; MCF-7 CELLS; APOPTOSIS; DEATH	BCL2 family members affect cell fate decisions in breast cancer but the role of BCL-W (BCL2L2) is unknown. We now show the integrated roles of the antiapoptotic BCL-W and BCL2 in affecting responsiveness to the antiestrogen ICI 182,780 (ICI; Fulvestrant Faslodex), using both molecular (siRNA; shRNA) and pharmacologic (YC137) approaches in three breast cancer variants; MCF-7/LCC1 (ICI sensitive), MCF-7/LCC9 (ICI resistant), and LY2 (ICI resistant). YC137 inhibits BCL-W and BCL2 and restores ICI sensitivity in resistant cells. Co-inhibition of BCL-W and BCL2 is both necessary and sufficient to restore sensitivity to ICI, and explains mechanistically the action of YC137. These data implicate functional cooperation and/or redundancy in signaling between BCL-W and BCL2, and suggest that broad BCL2 family member inhibitors will have greater therapeutic value than targeting only individual proteins. Whereas ICI sensitive MCF-7/LCC1 cells undergo increased apoptosis in response to ICI following BCL-W +/- BCL2 co-inhibition, the consequent resensitization of resistant MCF-7/LCC9 and LY2 cells reflects increases in autophagy (LC3 cleavage; p62/SQSTM1 expression) and necrosis but not apoptosis or cell cycle arrest. Thus, de novo sensitive cells and resensitized resistant cells die through different mechanisms. Following BCL-W+BCL2 co-inhibition, suppression of functional autophagy by 3-methyladenine or BECN1 shRNA reduces ICI-induced necrosis but restores the ability of resistant cells to die through apoptosis. These data demonstrate the plasticity of cell fate mechanisms in breast cancer cells in the context of antiestrogen responsiveness. Restoration of ICI sensitivity in resistant cells appears to occur through an increase in autophagy-associated necrosis. BCL-W, BCL2, and BECN1 integrate important functions in determining antiestrogen responsiveness, and the presence of functional autophagy may influence the balance between apoptosis and necrosis.	[Crawford, Anatasha C.] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA; Georgetown Univ, Sch Med, Dept Oncol, Washington, DC USA	Georgetown University; Georgetown University	Crawford, AC (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA.	clarker@georgetown.edu	Clarke, Robert/A-6485-2008; Riggins, Rebecca/GQH-4466-2022	Clarke, Robert/0000-0002-9278-0854; Shajahan-Haq, Ayesha/0000-0001-7616-320X; Riggins, Rebecca/0000-0002-1555-4431; Zwart, Alan/0000-0001-6834-9290	Department of Defense Breast Cancer Research Program [BC050389]; U.S. Department of Health and Human Services [R01-CA131465]; Department of Defense [BC073977]; Flow Cytometry, Microscopy and Imaging, and Tissue Culture Shared Resources [P30-CA-51008-16]; NATIONAL CANCER INSTITUTE [R01CA131465, P30CA051008] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); U.S. Department of Health and Human Services; Department of Defense(United States Department of Defense); Flow Cytometry, Microscopy and Imaging, and Tissue Culture Shared Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by awards from the Department of Defense Breast Cancer Research Program (BC050389) to Dr. Anatasha Crawford, and from the U.S. Department of Health and Human Services (R01-CA131465) and Department of Defense (BC073977) to Dr. R. Clarke. Flow Cytometry, Microscopy and Imaging, and Tissue Culture Shared Resources are supported by P30-CA-51008-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cameron DA, 2000, EUR J CANCER, V36, P845, DOI 10.1016/S0959-8049(00)00013-7; CLARKE R, 1989, J ENDOCRINOL, V122, P331, DOI 10.1677/joe.0.1220331; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, PHARMACOL REV, V53, P25; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Ellis PA, 1998, BREAST CANCER RES TR, V48, P107, DOI 10.1023/A:1005933815809; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; GEE JMW, 1994, INT J CANCER, V59, P619, DOI 10.1002/ijc.2910590508; Gjertsen BT, 2007, CURR PHARM BIOTECHNO, V8, P373, DOI 10.2174/138920107783018381; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Gu ZP, 2002, CANCER RES, V62, P3428; Heckman CA, 2000, J BIOL CHEM, V275, P6499, DOI 10.1074/jbc.275.9.6499; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Huang ZW, 2000, ONCOGENE, V19, P6627, DOI 10.1038/sj.onc.1204087; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kessel D, 2007, CANCER LETT, V249, P294, DOI 10.1016/j.canlet.2006.09.009; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2491, DOI 10.1002/cncr.20696; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; O'Reilly LA, 2001, CELL DEATH DIFFER, V8, P486, DOI 10.1038/sj.cdd.4400835; Osborne CK, 2002, J CLIN ONCOL, V20, P3386, DOI 10.1200/JCO.2002.10.058; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Real PJ, 2004, CANCER RES, V64, P7947, DOI 10.1158/0008-5472.CAN-04-0945; Riggins RB, 2005, MOL CANCER THER, V4, P33; Romanelli S, 1998, CANCER CHEMOTH PHARM, V41, P385, DOI 10.1007/s002800050755; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Samara C, 2008, CURR PHARM DESIGN, V14, P97, DOI 10.2174/138161208783378770; Sung KF, 2009, EXP CELL RES, V315, P1975, DOI 10.1016/j.yexcr.2009.01.009; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yao MZ, 2007, J NEUROSCI, V27, P1422, DOI 10.1523/JNEUROSCI.2382-06.2007; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	47	52	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8604	10.1371/journal.pone.0008604	http://dx.doi.org/10.1371/journal.pone.0008604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062536	Green Submitted, gold, Green Published			2022-12-27	WOS:000273338600022
J	Teramitsu, I; Poopatanapong, A; Torrisi, S; White, SA				Teramitsu, Ikuko; Poopatanapong, Amy; Torrisi, Salvatore; White, Stephanie A.			Striatal FoxP2 Is Actively Regulated during Songbird Sensorimotor Learning	PLOS ONE			English	Article							ZEBRA FINCH SONG; BASAL GANGLIA; FOREBRAIN NUCLEUS; LANGUAGE DISORDER; AUDITORY-FEEDBACK; INHERITED SPEECH; GENE-EXPRESSION; HUMAN BRAIN; BIRDSONG; LESIONS	Background: Mutations in the FOXP2 transcription factor lead to language disorders with developmental onset. Accompanying structural abnormalities in cortico-striatal circuitry indicate that at least a portion of the behavioral phenotype is due to organizational deficits. We previously found parallel FoxP2 expression patterns in human and songbird cortico/pallio-striatal circuits important for learned vocalizations, suggesting that FoxP2's function in birdsong may generalize to speech. Methodology/Principal Findings: We used zebra finches to address the question of whether FoxP2 is additionally important in the post-organizational function of these circuits. In both humans and songbirds, vocal learning depends on auditory guidance to achieve and maintain optimal vocal output. We tested whether deafening prior to or during the sensorimotor phase of song learning disrupted FoxP2 expression in song circuitry. As expected, the songs of deafened juveniles were abnormal, however basal FoxP2 levels were unaffected. In contrast, when hearing or deaf juveniles sang for two hours in the morning, FoxP2 was acutely down-regulated in the striatal song nucleus, area X. The extent of down-regulation was similar between hearing and deaf birds. Interestingly, levels of FoxP2 and singing were correlated only in hearing birds. Conclusions/Significance: Hearing appears to link FoxP2 levels to the amount of vocal practice. As juvenile birds spent more time practicing than did adults, their FoxP2 levels are likely to be low more often. Behaviorally-driven reductions in the mRNA encoding this transcription factor could ultimately affect downstream molecules that function in vocal exploration, especially during sensorimotor learning.	[Teramitsu, Ikuko; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Mol Cellular & Integrat, Los Angeles, CA USA; [Torrisi, Salvatore; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [Poopatanapong, Amy; White, Stephanie A.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teramitsu, I (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	sawhite@ucla.edu	Torrisi, Salvatore/L-8603-2019; White, Stephanie Ann/AAE-7683-2019	White, Stephanie Ann/0000-0002-3490-2294	University of California Los Angeles Edith Hyde; UCLA Tennenbaum Family Creativity Initiative and Center [RO1 MH070712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070712] Funding Source: NIH RePORTER	University of California Los Angeles Edith Hyde; UCLA Tennenbaum Family Creativity Initiative and Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the University of California Los Angeles Edith Hyde and dissertation year fellowships (IT), UCLA Tennenbaum Family Creativity Initiative and Center for Autism Research and Treatment awards and by RO1 MH070712 (SAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Brainard MS, 2001, J NEUROSCI, V21, P2501, DOI 10.1523/JNEUROSCI.21-07-02501.2001; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Brenowitz EA, 1997, J NEUROBIOL, V33, P495, DOI 10.1002/(SICI)1097-4695(19971105)33:5<495::AID-NEU1>3.3.CO;2-D; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Immelmann K., 1969, P61; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M., 1969, BIRD VOCALIZATIONS; Kurt S, 2009, BRAIN RES, V1289, P30, DOI 10.1016/j.brainres.2009.06.092; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Miller JE, 2008, J NEUROPHYSIOL, V100, P2015, DOI 10.1152/jn.90415.2008; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Perkel DJ, 2002, BRAIN RES BULL, V57, P529, DOI 10.1016/S0361-9230(01)00690-6; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Rochefort C, 2007, DEV NEUROBIOL, V67, P809, DOI 10.1002/dneu.20393; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; WILD JM, 1993, BRAIN RES, V606, P319, DOI 10.1016/0006-8993(93)91001-9	49	57	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8548	10.1371/journal.pone.0008548	http://dx.doi.org/10.1371/journal.pone.0008548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062527	gold, Green Published			2022-12-27	WOS:000273338600007
J	Nagao, K; Zhu, JJ; Heneghan, MB; Hanson, JC; Morasso, MI; Tessarollo, L; Mackem, S; Udey, MC				Nagao, Keisuke; Zhu, Jianjian; Heneghan, Mallorie B.; Hanson, Jeffrey C.; Morasso, Maria I.; Tessarollo, Lino; Mackem, Susan; Udey, Mark C.			Abnormal Placental Development and Early Embryonic Lethality in EpCAM-Null Mice	PLOS ONE			English	Article							CELL ADHESION MOLECULE; CD44 VARIANT ISOFORMS; EP-CAM; E-CADHERIN; EPITHELIAL GLYCOPROTEIN; INSERTIONAL MUTATIONS; MURINE HOMOLOG; EXPRESSION; GENE; ANTIGEN	Background: EpCAM (CD326) is encoded by the tacstd1 gene and expressed by a variety of normal and malignant epithelial cells and some leukocytes. Results of previous in vitro experiments suggested that EpCAM is an intercellular adhesion molecule. EpCAM has been extensively studied as a potential tumor marker and immunotherapy target, and more recent studies suggest that EpCAM expression may be characteristic of cancer stem cells. Methodology/Principal Findings: To gain insights into EpCAM function in vivo, we generated EpCAM -/- mice utilizing an embryonic stem cell line with a tacstd1 allele that had been disrupted. Gene trapping resulted in a protein comprised of the N-terminus of EpCAM encoded by 2 exons of the tacstd1 gene fused in frame to beta geo. EpCAM +/- mice were viable and fertile and exhibited no obvious abnormalities. Examination of EpCAM +/- embryos revealed that bgeo was expressed in several epithelial structures including developing ears (otocysts), eyes, branchial arches, gut, apical ectodermal ridges, lungs, pancreas, hair follicles and others. All EpCAM -/- mice died in utero by E12.5, and were small, developmentally delayed, and displayed prominent placental abnormalities. In developing placentas, EpCAM was expressed throughout the labyrinthine layer and by spongiotrophoblasts as well. Placentas of EpCAM -/- embryos were compact, with thin labyrinthine layers lacking prominent vascularity. Parietal trophoblast giant cells were also dramatically reduced in EpCAM -/- placentas. Conclusion: EpCAM was required for differentiation or survival of parietal trophoblast giant cells, normal development of the placental labyrinth and establishment of a competent maternal-fetal circulation. The findings in EpCAM-reporter mice suggest involvement of this molecule in development of vital organs including the gut, kidneys, pancreas, lungs, eyes, and limbs.	[Nagao, Keisuke; Heneghan, Mallorie B.; Udey, Mark C.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nagao, Keisuke; Heneghan, Mallorie B.; Udey, Mark C.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Zhu, Jianjian; Hanson, Jeffrey C.; Mackem, Susan] NCI, Pathol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Zhu, Jianjian; Hanson, Jeffrey C.; Mackem, Susan] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Morasso, Maria I.] NIAMSD, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Zhu, Jianjian; Mackem, Susan] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhu, Jianjian; Mackem, Susan] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nagao, K (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	udeym@mail.nih.gov	Nagao, Keisuke/J-5116-2013; Nagao, Keisuke/P-3837-2018	Nagao, Keisuke/0000-0002-7005-3138; Nagao, Keisuke/0000-0002-7005-3138	NIH; Center for Cancer Research of the NCI; NIAMS; NATIONAL CANCER INSTITUTE [ZIABC010956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported the Intramural Program of the NIH, specifically the Center for Cancer Research of the NCI and the Intramural Program of NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Bany BM, 2006, DEV BIOL, V294, P445, DOI 10.1016/j.ydbio.2006.03.006; BERGSAGEL PL, 1992, J IMMUNOL, V148, P590; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Bonin A, 2000, METH MOL B, V158, P121; Borkowski TA, 1996, EUR J IMMUNOL, V26, P110, DOI 10.1002/eji.1830260117; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; EDWARDS DP, 1986, CANCER RES, V46, P1306; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HERLYN M, 1979, P NATL ACAD SCI USA, V76, P1438, DOI 10.1073/pnas.76.3.1438; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nelson AJ, 1996, EUR J IMMUNOL, V26, P401, DOI 10.1002/eji.1830260220; Pizard Anne, 2004, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1409s66; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; ROSS AH, 1986, BIOCHEM BIOPH RES CO, V135, P297, DOI 10.1016/0006-291X(86)90976-9; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Stephan JP, 1999, ENDOCRINOLOGY, V140, P5841, DOI 10.1210/en.140.12.5841; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908	42	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8543	10.1371/journal.pone.0008543	http://dx.doi.org/10.1371/journal.pone.0008543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046825	gold, Green Submitted, Green Published			2022-12-27	WOS:000273180200020
J	Rawlinson, SCF; Mckay, IJ; Ghuman, M; Wellmann, C; Ryan, P; Prajaneh, S; Zaman, G; Hughes, FJ; Kingsmill, VJ				Rawlinson, Simon C. F.; Mckay, Ian J.; Ghuman, Mandeep; Wellmann, Claudia; Ryan, Paul; Prajaneh, Saengsome; Zaman, Gul; Hughes, Francis J.; Kingsmill, Virginia J.			Adult Rat Bones Maintain Distinct Regionalized Expression of Markers Associated with Their Development	PLOS ONE			English	Article							SPINAL-CORD-INJURY; GENE-EXPRESSION; MINERAL DENSITY; OSTEOCYTE DENSITY; ENDOCHONDRAL BONE; MECHANICAL STRAIN; EMBRYONIC ORIGIN; EARLY RESPONSES; CALVARIAL BONE; LONG-BONE	The incidence of limb bone fracture and subsequent morbidity and mortality due to excessive bone loss is increasing in the progressively ageing populations of both men and women. In contrast to bone loss in the weight-bearing limb, bone mass in the protective skull vault is maintained. One explanation for this could be anatomically diverse bone matrix characteristics generated by heterogeneous osteoblast populations. We have tested the hypothesis that adult bones demonstrate site-specific characteristics, and report differences at the organ, cell and transcriptome levels. Limb bones contain greater amounts of polysulphated glycosaminoglycan stained with Alcian Blue and have significantly higher osteocyte densities than skull bone. Site-specific patterns persist in cultured adult bone-derived cells both phenotypically (proliferation rate, response to estrogen and cell volumes), and at the level of specific gene expression (collagen triple helix repeat containing 1, reelin and ras-like and estrogen-regulated growth inhibitor). Based on genome-wide mRNA expression and cluster analysis, we demonstrate that bones and cultured adult bone-derived cells segregate according to site of derivation. We also find the differential expression of genes associated with embryological development (Skull: Zic, Dlx, Irx, Twist1 and Cart1; Limb: Hox, Shox2, and Tbx genes) in both adult bones and isolated adult bone-derived cells. Together, these site-specific differences support the view that, analogous to different muscle types (cardiac, smooth and skeletal), skull and limb bones represent separate classes of bone. We assign these differences, not to mode of primary ossification, but to the embryological cell lineage; the basis and implications of this division are discussed.	[Rawlinson, Simon C. F.; Mckay, Ian J.; Wellmann, Claudia; Ryan, Paul; Kingsmill, Virginia J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England; [Ghuman, Mandeep; Prajaneh, Saengsome; Hughes, Francis J.] Kings Coll London, Guys Hosp, Inst Dent, London WC2R 2LS, England; [Zaman, Gul] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University of London Royal Veterinary College	Rawlinson, SCF (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	s.c.f.rawlinson@qmul.ac.uk		Rawlinson, Simon/0000-0003-2367-7391; Ghuman, Mandeep/0000-0001-8927-0741; Hughes, Francis/0000-0001-9073-8962; Ryan, Paul/0000-0002-7091-9974	NIHR Clinician Scientist Fellowship; MRC Clinical Research Training Fellow; MRC [G0601408] Funding Source: UKRI; Medical Research Council [G0601408] Funding Source: researchfish	NIHR Clinician Scientist Fellowship; MRC Clinical Research Training Fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a NIHR Clinician Scientist Fellowship awarded to VJK. MG is a MRC Clinical Research Training Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2004, AM J MED GENET B, V127B, P51, DOI 10.1002/ajmg.b.20142; Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Acampora D, 1999, DEVELOPMENT, V126, P3795; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Boonen S, 2007, BONE, V40, pS26, DOI 10.1016/j.bone.2007.03.003; CHAYEN J, 1973, PRACTICAL HISTOCHEMI; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Everts V, 1999, FASEB J, V13, P1219, DOI 10.1096/fasebj.13.10.1219; Everts V, 2009, BBA-MOL BASIS DIS, V1792, P757, DOI 10.1016/j.bbadis.2009.05.004; FINKELMAN RD, 1994, PLAST RECONSTR SURG, V93, P732; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Gersch RP, 2005, J ORTHOP RES, V23, P882, DOI 10.1016/j.orthres.2005.02.005; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; HARDESTY RA, 1990, PLAST RECONSTR SURG, V85, P5, DOI 10.1097/00006534-199001000-00002; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hatton DC, 2002, J APPL PHYSIOL, V92, P3, DOI 10.1152/jappl.2002.92.1.3; Hillam R, 1996, BONE, V19, P686, DOI DOI 10.1016/S8756-3282(97)84305-0; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Jansen I.D., 2009, FASEB J; Kimura H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003174; Kingsmill VJ, 1999, OSTEOPOROSIS INT, V9, P260, DOI 10.1007/s001980050146; LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; LANYON LE, 1993, CALCIF TISSUE INT S1, V53, pS106; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Lee JY, 2006, MOL CELLS, V22, P182; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Li QY, 1997, NAT GENET, V15, P21; Ma YL, 2008, J BIOMECH, V41, P1324, DOI 10.1016/j.jbiomech.2008.01.017; Maimoun L, 2002, METABOLISM, V51, P958, DOI [10.1053/meta.2002.34013, 10.1053/meta2002.34013]; MANI P, 2009, DEV DYNAM, DOI DOI 10.1002/DVDY.22072; Mason D. J., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P406; Mason DJ, 1997, BONE, V20, P199, DOI 10.1016/S8756-3282(96)00386-9; McGonnell IM, 2001, DEV BIOL, V236, P354, DOI 10.1006/dbio.2001.0330; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Osborn MJ, 1998, BON PHYSL STRAT RES, P80; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Power J, 2002, BONE, V30, P859, DOI 10.1016/S8756-3282(02)00731-7; RAGO R, 1990, ANAL BIOCHEM, V191, P31; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; RAWLINSON SCF, 1995, J BONE MINER RES, V10, P1225; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; RUBIN CT, 1982, J EXP BIOL, V101, P187; Schrauwen I, 2009, AM J HUM GENET, V84, P328, DOI 10.1016/j.ajhg.2009.01.023; SCOTT CK, 1991, CALCIFIED TISSUE INT, V49, P349, DOI 10.1007/BF02556258; Skerry TM, 1999, J BONE MINER METAB, V17, P66, DOI 10.1007/s007740050067; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Turner AS, 1997, CALCIFIED TISSUE INT, V61, P110, DOI 10.1007/s002239900305; TURNER CH, 1991, BONE, V12, P203, DOI 10.1016/8756-3282(91)90043-I; Turner CH, 2002, CALCIFIED TISSUE INT, V70, P435, DOI 10.1007/s00223-001-1024-z; van den Bos T, 2008, BONE, V43, P459, DOI 10.1016/j.bone.2008.05.009; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; VICO L, 1995, J APPL PHYSIOL, V79, P1426, DOI 10.1152/jappl.1995.79.5.1426; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; ZHAO GQ, 1993, P NATL ACAD SCI USA, V90, P8633, DOI 10.1073/pnas.90.18.8633; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275; ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005	71	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8358	10.1371/journal.pone.0008358	http://dx.doi.org/10.1371/journal.pone.0008358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027296	Green Published, Green Submitted, gold			2022-12-27	WOS:000272940100006
J	Thomas, BE; Dewan, PK; Vijay, S; Thomas, A; Chauhan, LS; Vedachalam, C; Vaidyanathan, P; Swaminathan, S				Thomas, Beena E.; Dewan, Puneet K.; Vijay, Sophia; Thomas, Aleyamma; Chauhan, Lakhdir Singh; Vedachalam, Chandrasekaran; Vaidyanathan, Preetish; Swaminathan, Soumya			Perceptions of Tuberculosis Patients on Provider-Initiated HIV Testing and Counseling - A Study from South India	PLOS ONE			English	Article							ROUTINE; MORTALITY; ADULTS; RISK	Background: The acceptability and feasibility of provider-initiated HIV testing and counseling (PITC) in many settings across Asia with concentrated HIV epidemics is not known. A pilot study of the PITC policy undertaken within the public health care systems in two districts in India offered the opportunity to understand patient's perspectives on the process of referral for HIV testing and linking to HIV treatment and care. Methods: We conducted a cross-sectional study of randomly selected TB patients registered by the TB control program between July and November 2007 in two districts in south India. Trained interviewers met patients shortly after TB diagnosis and administered a structured questionnaire. Patients were assessed regarding their experience with HIV status assessment, referral for counseling and testing, and for HIV-infected patients the counseling itself and subsequent referral for HIV treatment and care. Results: Of the 568 interviewed TB patients, 455 (80%) reported being referred for HIV testing after they presented to the health facility for investigations or treatment for TB. Over half the respondents reported having to travel long distances and incurred financial difficulties in reaching the Integrated Counselling and Testing Centre (ICTC) and two-thirds had to make more than two visits. Only 48% reported having been counseled before the test. Of the 110 HIV-infected patients interviewed, (including 43 with previously-known positive HIV status and 67 detected by PITC), 89 (81%) reported being referred for anti-retroviral treatment (ART); 82 patients reached the ART centre but only 44 had been initiated on ART. Conclusions: This study provides the first evidence from India that routine, provider-initiated voluntary HIV testing of TB patients is acceptable, feasible and can be achieved with very high efficiency under programmatic conditions. While PITC is useful in identifying new HIV-infected patients so that they can be successfully linked to ART, the convenience and proximity of testing centres, quality of HIV counseling, and efficiency of ART services need attention.	[Thomas, Beena E.; Thomas, Aleyamma; Vedachalam, Chandrasekaran; Swaminathan, Soumya] TB Res Ctr, Madras, Tamil Nadu, India; [Dewan, Puneet K.] Reg Off SE Asia, WHO, New Delhi, India; [Vijay, Sophia; Vaidyanathan, Preetish] Natl TB Inst, Bangalore, Karnataka, India; [Chauhan, Lakhdir Singh] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Thomas, BE (corresponding author), TB Res Ctr, Madras, Tamil Nadu, India.	beenaelli@hotmail.com			Central Tuberculosis Division, Ministry of Health, Government of India	Central Tuberculosis Division, Ministry of Health, Government of India	This study was funded by the Central Tuberculosis Division, Ministry of Health, Government of India. http://www.tbcindia.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckwith CG, 2005, CLIN INFECT DIS, V40, P1037, DOI 10.1086/428620; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; DEGU J, 2007, BMC INT HEALTH HUM R, V7, P4; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Gasana M, 2008, INT J TUBERC LUNG D, V12, pS39; Girardi E, 2000, AIDS, V14, pS47; Harries AD, 2004, INT J TUBERC LUNG D, V8, P384; *JOINT UN PROGR HI, 2002, UNAIDS CAS STUD; *KAIS FAM FDN, 2006, KAIS FAM FND SURV AM; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lopez-Quintero C, 2005, AIDS PATIENT CARE ST, V19, P672, DOI 10.1089/apc.2005.19.672; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mugisha B, 2006, INT J TUBERC LUNG D, V10, P761; *NACO, 2007, EST HIV INF IND; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; SOPHIA V, 2009, PROVIDER INITI UNPUB; Thomas BE, 2007, INT J TUBERC LUNG D, V11, P1296; Wandwalo Eliud, 2004, Afr Health Sci, V4, P109; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; *WHO, 2004, WHOHTMTB2004342; *WHO UNAIDS, 2004, UNAIDS WHO POL STAT; World Health Organization (WHO), 2003, RIGHT KNOW NEW APPR; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2004, INT J TUBERC LUNG D, V8, P1058	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8389	10.1371/journal.pone.0008389	http://dx.doi.org/10.1371/journal.pone.0008389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20041167	Green Published, Green Accepted, gold			2022-12-27	WOS:000272940100022
J	Wang, Y; Zhang, GP; Zhou, HW; Barakat, A; Querfurth, H				Wang, Yun; Zhang, Guangping; Zhou, Hongwei; Barakat, Amey; Querfurth, Henry			Opposite Effects of Low and High Doses of A beta 42 on Electrical Network and Neuronal Excitability in the Rat Prefrontal Cortex	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; CA1 PYRAMIDAL NEURONS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; FREQUENCY OSCILLATIONS; INTERSTITIAL FLUID; MEMORY; PEPTIDE; SYNCHRONIZATION	Changes in neuronal synchronization have been found in patients and animal models of Alzheimer's disease (AD). Synchronized behaviors within neuronal networks are important to such complex cognitive processes as working memory. The mechanisms behind these changes are not understood but may involve the action of soluble beta-amyloid (A beta) on electrical networks. In order to determine if A beta can induce changes in neuronal synchronization, the activities of pyramidal neurons were recorded in rat prefrontal cortical (PFC) slices under calcium-free conditions using multi-neuron patch clamp technique. Electrical network activities and synchronization among neurons were significantly inhibited by low dose A beta 42 (1 nM) and initially by high dose A beta 42 (500 nM). However, prolonged application of high dose A beta 42 resulted in network activation and tonic firing. Underlying these observations, we discovered that prolonged application of low and high doses of A beta 42 induced opposite changes in action potential (AP)-threshold and after-hyperpolarization (AHP) of neurons. Accordingly, low dose A beta 42 significantly increased the AP-threshold and deepened the AHP, making neurons less excitable. In contrast, high dose A beta 42 significantly reduced the AP-threshold and shallowed the AHP, making neurons more excitable. These results support a model that low dose A beta 42 released into the interstitium has a physiologic feedback role to dampen electrical network activity by reducing neuronal excitability. Higher concentrations of A beta 42 over time promote supra-synchronization between individual neurons by increasing their excitability. The latter may disrupt frontal-based cognitive processing and in some cases lead to epileptiform discharges.	[Wang, Yun; Zhang, Guangping; Zhou, Hongwei; Barakat, Amey; Querfurth, Henry] Tufts Med Sch, Caritas St Elizabeths Med Ctr, Boston, MA USA	St. Elizabeth's Medical Center; Tufts Medical Center; Tufts University	Wang, Y (corresponding author), Tufts Med Sch, Caritas St Elizabeths Med Ctr, Boston, MA USA.	yun.wang@tufts.edu	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221	Caritas St. Elizabeth's Medical Center	Caritas St. Elizabeth's Medical Center	This study was supported by the starting grant from Caritas St. Elizabeth's Medical Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZLEEFMANS FJ, 1979, J PHYSIOL-LONDON, V294, P387, DOI 10.1113/jphysiol.1979.sp012936; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Good TA, 1996, P NATL ACAD SCI USA, V93, P15130, DOI 10.1073/pnas.93.26.15130; HAAS HL, 1984, J PHYSIOL-LONDON, V354, P185, DOI 10.1113/jphysiol.1984.sp015371; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hormuzdi SG, 2004, BBA-BIOMEMBRANES, V1662, P113, DOI 10.1016/j.bbamem.2003.10.023; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Jedlicka P, 2006, PHYSIOL RES, V55, P139, DOI 10.33549/physiolres.930764; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Jin Hong-wei, 2002, Yaoxue Xuebao, V37, P598; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lima PA, 2007, BRAIN RES, V1150, P74, DOI 10.1016/j.brainres.2007.02.067; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mercer A, 2006, BRAIN CELL BIOL, V35, P13, DOI 10.1007/s11068-006-9005-9; MILLER C, 2000, GENOME BIOL, V1, P4; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Missonnier P, 2006, DEMENT GERIATR COGN, V22, P250, DOI 10.1159/000094974; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Reid W, 1996, ARCH NEUROL-CHICAGO, V53, P1056, DOI 10.1001/archneur.1996.00550100142023; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; Rowan MJ, 2004, EXP GERONTOL, V39, P1661, DOI 10.1016/j.exger.2004.06.020; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wang Y, 2004, P NATL ACAD SCI USA, V101, P5093, DOI 10.1073/pnas.0400954101; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; WANG Y, 2009, FRONTIERS N IN PRESS; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Zhuo JM, 2008, CURR ALZHEIMER RES, V5, P385, DOI 10.2174/156720508785132280; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	63	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8366	10.1371/journal.pone.0008366	http://dx.doi.org/10.1371/journal.pone.0008366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027222	Green Published, Green Submitted, gold			2022-12-27	WOS:000272940100012
J	Naresh, R; Song, Y; Hampson, DJ				Naresh, Ram; Song, Yong; Hampson, David J.			The Intestinal Spirochete Brachyspira pilosicoli Attaches to Cultured Caco-2 Cells and Induces Pathological Changes	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; SERPULINA-PILOSICOLI; EXPERIMENTAL-INFECTION; ESCHERICHIA-COLI; PREVALENCE; PORCINE; HUMANS; PIGS; PATHOGENICITY; ASSOCIATION	Background: Brachyspira pilosicoli is an anaerobic spirochete that has received relatively little study, partly due to its specialized culture requirements and slow growth. This bacterium colonizes the large intestine of various species, including humans; typically, a dense layer of spirochete cells may be found intimately attached by one cell end to the surface of colonic enterocytes. Colonized individuals may develop colitis, but the mechanisms involved are not understood. The current study aimed to develop an in vitro model to investigate this process. Methodology/Principal Findings: Four strains of B. pilosicoli were incubated at a high multiplicity of infection with monolayers of a human colonic adenocarcinoma cell line (Caco-2 cells). One strain isolated from a pig (95/1000) and one from a human (WesB) attached to the monolayers. Colonization increased with time, with the Caco-2 cell junctions being the initial targets of attachment. By electron microscopy, individual spirochete cells could be seen to have one cell end invaginated into the Caco-2 cell membranes, with the rest of the spirochete draped over the Caco-2 cell surface. After 6 h incubation, the monolayer was covered with a layer of spirochetes. Colonized monolayers demonstrated a time-dependent series of changes: staining with labelled phalloidin identified accumulation of actin at the cell junctions; ZO-1 staining revealed a loss of Caco-2 tight junction integrity; and Hoechst staining showed condensation and fragmentation of nuclear material consistent with apoptosis. Using quantitative reverse transcription PCR, the colonized monolayers demonstrated a significant up-regulation of interleukin-1 beta (IL-1 beta) and IL-8 expression. B. pilosicoli sonicates caused significant up-regulation of IL-1 beta, TNF-alpha, and IL-6, but culture supernatants and non-pathogenic Brachyspira innocens did not alter cytokine expression. Conclusions/Significance: The changes induced in the Caco-2 cells provide evidence that B. pilosicoli has pathogenic potential, and give insights into the likely in vivo pathogenesis.	[Naresh, Ram; Song, Yong; Hampson, David J.] Murdoch Univ, Anim Res Inst, Murdoch, WA 6150, Australia	Murdoch University	Naresh, R (corresponding author), Murdoch Univ, Anim Res Inst, Murdoch, WA 6150, Australia.	d.hampson@murdoch.edu.au	Hampson, David J/A-9464-2008; Song, Yong/C-2407-2013; Hampson, David/AAE-3666-2019	Hampson, David J/0000-0002-7729-0427; Song, Yong/0000-0002-8178-5641	Murdoch University; Australian Research Council; Novartis Animal Vaccines through Linkage [LP0348441]	Murdoch University; Australian Research Council(Australian Research Council); Novartis Animal Vaccines through Linkage	Ram Naresh was in receipt of a postgraduate scholarship from Murdoch University. This study was supported by the Australian Research Council and Novartis Animal Vaccines through Linkage grant number LP0348441. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Dassanayake RP, 2004, J MED MICROBIOL, V53, P319, DOI 10.1099/jmm.0.45549-0; Duhamel Gerald E., 2001, Animal Health Research Reviews, V2, P3; Goosney DL, 1999, EMERG INFECT DIS, V5, P216, DOI 10.3201/eid0502.990205; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; HAMPSON DJ, 2006, DIS SWINE, P755; HARLAND WA, 1967, BRIT MED J, V3, P718, DOI 10.1136/bmj.3.5567.718; Hartland EL, 1998, FEMS MICROBIOL LETT, V165, P59, DOI 10.1111/j.1574-6968.1998.tb13127.x; HOVINDHOUGEN K, 1982, J CLIN MICROBIOL, V16, P1127, DOI 10.1128/JCM.16.6.1127-1136.1982; Jensen TK, 2000, VET PATHOL, V37, P22, DOI 10.1354/vp.37-1-22; KUNKLE RA, 1986, J CLIN MICROBIOL, V24, P669, DOI 10.1128/JCM.24.4.669-671.1986; LAW CLH, 1994, GENITOURIN MED, V70, P26; LEE JI, 1994, J MED MICROBIOL, V40, P365, DOI 10.1099/00222615-40-5-365; LEE JI, 1993, J CLIN MICROBIOL, V31, P16, DOI 10.1128/JCM.31.1.16-21.1993; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margawani KR, 2004, J MED MICROBIOL, V53, P325, DOI 10.1099/jmm.0.05415-0; MIKOSZA ASJ, 2001, ANIM HLTH RES REV, V2, P83; Muniappa N, 1996, VET PATHOL, V33, P542, DOI 10.1177/030098589603300509; Muniappa N, 1998, J SPIROCHETAL TICK B, V5, P44; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; Nelson EJ, 2009, EMERG INFECT DIS, V15, P571, DOI 10.3201/eid1504.081214; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Obiso RJ, 1997, INFECT IMMUN, V65, P1431, DOI 10.1128/IAI.65.4.1431-1439.1997; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Sacco RE, 1997, INFECT IMMUN, V65, P5349, DOI 10.1128/IAI.65.12.5349-5353.1997; SARAK M, 2004, MICROBES INFECT, V6, P676; Song Y, 2009, VET MICROBIOL, V137, P129, DOI 10.1016/j.vetmic.2008.12.020; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Stephens C. P., 2001, Animal Health Research Reviews, V2, P83; TAYLOR DJ, 1980, VET REC, V106, P326, DOI 10.1136/vr.106.15.326; Thomson JR, 1997, INFECT IMMUN, V65, P3693, DOI 10.1128/IAI.65.9.3693-3700.1997; Trivett-Moore NL, 1998, J CLIN MICROBIOL, V36, P261, DOI 10.1128/JCM.36.1.261-265.1998; Trott Darren J., 2001, Animal Health Research Reviews, V2, P19; Trott DJ, 1997, J CLIN MICROBIOL, V35, P482, DOI 10.1128/JCM.35.2.482-485.1997; TROTT DJ, 1995, INFECT IMMUN, V63, P3705, DOI 10.1128/IAI.63.9.3705-3710.1995; Trott DJ, 1997, EPIDEMIOL INFECT, V119, P369, DOI 10.1017/S0950268897008194; Trott DJ, 1996, INFECT IMMUN, V64, P4648, DOI 10.1128/IAI.64.11.4648-4654.1996; Varon C, 2009, GUT, V58, P629, DOI 10.1136/gut.2007.144501; Vernal R, 2008, ARCH ORAL BIOL, V53, P910, DOI 10.1016/j.archoralbio.2008.04.004	42	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8352	10.1371/journal.pone.0008352	http://dx.doi.org/10.1371/journal.pone.0008352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020053	Green Published, gold			2022-12-27	WOS:000272834200016
J	Li, XF; Kinsey-Jones, JS; Cheng, YS; Knox, AMI; Lin, YS; Petrou, NA; Roseweir, A; Lightman, SL; Milligan, SR; Millar, RP; O'Byrne, KT				Li, Xiao-Feng; Kinsey-Jones, James S.; Cheng, Yewsong; Knox, Alice M. I.; Lin, Yuanshao; Petrou, Nikoletta A.; Roseweir, Antonia; Lightman, Stafford L.; Milligan, Stuart R.; Millar, Robert P.; O'Byrne, Kevin T.			Kisspeptin Signalling in the Hypothalamic Arcuate Nucleus Regulates GnRH Pulse Generator Frequency in the Rat	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MONKEY MACACA-MULATTA; PITUITARY-GONADAL AXIS; PULSATILE LH-RELEASE; LUTEINIZING-HORMONE; RHESUS-MONKEY; MEDIAN-EMINENCE; HYPOGONADOTROPIC HYPOGONADISM; OVARIECTOMIZED RATS; ELECTRICAL-ACTIVITY	Background: Kisspeptin and its G protein-coupled receptor (GPR) 54 are essential for activation of the hypothalamo-pituitary-gonadal axis. In the rat, the kisspeptin neurons critical for gonadotropin secretion are located in the hypothalamic arcuate (ARC) and anteroventral periventricular (AVPV) nuclei. As the ARC is known to be the site of the gonadotropin-releasing hormone (GnRH) pulse generator we explored whether kisspeptin-GPR54 signalling in the ARC regulates GnRH pulses. Methodology/Principal Findings: We examined the effects of kisspeptin-10 or a selective kisspeptin antagonist administration intra-ARC or intra-medial preoptic area (mPOA), (which includes the AVPV), on pulsatile luteinizing hormone (LH) secretion in the rat. Ovariectomized rats with subcutaneous 17 beta-estradiol capsules were chronically implanted with bilateral intra-ARC or intra-mPOA cannulae, or intra-cerebroventricular (icv) cannulae and intravenous catheters. Blood samples were collected every 5 min for 5-8 h for LH measurement. After 2 h of control blood sampling, kisspeptin-10 or kisspeptin antagonist was administered via pre-implanted cannulae. Intranuclear administration of kisspeptin-10 resulted in a dose-dependent increase in circulating levels of LH lasting approximately 1 h, before recovering to a normal pulsatile pattern of circulating LH. Both icv and intra-ARC administration of kisspeptin antagonist suppressed LH pulse frequency profoundly. However, intra-mPOA administration of kisspeptin antagonist did not affect pulsatile LH secretion. Conclusions/Significance: These data are the first to identify the arcuate nucleus as a key site for kisspeptin modulation of LH pulse frequency, supporting the notion that kisspeptin-GPR54 signalling in this region of the mediobasal hypothalamus is a critical neural component of the hypothalamic GnRH pulse generator.	[Li, Xiao-Feng; Kinsey-Jones, James S.; Cheng, Yewsong; Knox, Alice M. I.; Lin, Yuanshao; Petrou, Nikoletta A.; Milligan, Stuart R.; O'Byrne, Kevin T.] Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England; [Roseweir, Antonia; Millar, Robert P.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Lightman, Stafford L.] Univ Bristol, Henry Wellcome Lab Integrat Neurosci & Endocrinol, Bristol, Avon, England; [Millar, Robert P.] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa	University of London; King's College London; University of Edinburgh; University of Bristol; University of Cape Town	Li, XF (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England.	r.millar@hrsu.mrc.ac.uk	Millar, Robert P/A-4853-2012	Petrou, Nikoletta/0000-0001-6295-2451; Roseweir, Antonia K./0000-0001-6158-1564; Lightman, Stafford/0000-0002-8546-9646; Millar, Robert P/0000-0003-3606-2708	Wellcome Trust; Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC); Society for Reproduction and Fertility (UK); MRC [MC_EX_G0701682] Funding Source: UKRI; Medical Research Council [MC_EX_G0701682] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for Reproduction and Fertility (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust, Medical Research Council (MRC) and Biotechnology and Biological Sciences Research Council (BBSRC) UK. YSC is a Vacation Scholar funded by the Society for Reproduction and Fertility (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE CA, 1974, ENDOCRINOLOGY, V94, P730, DOI 10.1210/endo-94-3-730; CAGAMPANG FRA, 1991, J ENDOCRINOL, V129, P321, DOI 10.1677/joe.0.1290321; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Tassigny XD, 2008, ENDOCRINOLOGY, V149, P3926, DOI 10.1210/en.2007-1487; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; HALASZ B, 1965, ENDOCRINOLOGY, V77, P553, DOI 10.1210/endo-77-3-553; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kinsey-Jones JS, 2009, J NEUROENDOCRINOL, V21, P20, DOI 10.1111/j.1365-2826.2008.01807.x; Kinsey-Jones JS, 2008, ENDOCRINOLOGY, V149, P1004, DOI 10.1210/en.2007-1505; KIRILOV MJ, 2009, ANN M SOC NEUR CHIC; Maeda KI, 2007, REV ENDOCR METAB DIS, V8, P21, DOI 10.1007/s11154-007-9032-6; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; NISHIHARA M, 1994, NEUROENDOCRINOLOGY, V59, P513, DOI 10.1159/000126700; O'Byrne KT, 1994, METHODS NEUROSCIENCE, P100; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Patterson M, 2006, J NEUROENDOCRINOL, V18, P349, DOI 10.1111/j.1365-2826.2006.01420.x; PELLETIER G, 1975, CELL TISSUE RES, V156, P521; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; PLANT TM, 1978, ENDOCRINOLOGY, V102, P52, DOI 10.1210/endo-102-1-52; Plant TM, 2009, PEPTIDES, V30, P67, DOI 10.1016/j.peptides.2008.06.029; Pompolo S, 2006, ENDOCRINOLOGY, V147, P804, DOI 10.1210/en.2005-1123; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; RASMUSSEN DD, 1993, NEUROENDOCRINOLOGY, V58, P511, DOI 10.1159/000126584; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; SILVERMAN AJ, 1986, NEUROENDOCRINOLOGY, V44, P168, DOI 10.1159/000124641; Smith JT, 2006, REPRODUCTION, V131, P623, DOI 10.1530/rep.1.00368; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Suter KJ, 2000, ENDOCRINOLOGY, V141, P3731, DOI 10.1210/en.141.10.3731; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tenenbaum-Rakover Y, 2007, J CLIN ENDOCR METAB, V92, P1137, DOI 10.1210/jc.2006-2147; Terasawa E, 1999, J NEUROSCI, V19, P5898, DOI 10.1523/JNEUROSCI.19-14-05898.1999; Thompson JS, 2004, BIOL BLOOD MARROW TR, V10, P858, DOI 10.1016/j.bbmt.2004.09.006; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; Yamada S, 2007, ENDOCRINOLOGY, V148, P2226, DOI 10.1210/en.2006-1529	46	151	155	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8334	10.1371/journal.pone.0008334	http://dx.doi.org/10.1371/journal.pone.0008334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016824	Green Published, Green Submitted, gold			2022-12-27	WOS:000272834000020
J	Payne, RJH; Grierson, CS				Payne, Robert J. H.; Grierson, Claire Suzanne			A Theoretical Model for ROP Localisation by Auxin in Arabidopsis Root Hair Cells	PLOS ONE			English	Article							PLANAR POLARITY; ETHYLENE; GROWTH; BIOSYNTHESIS; TRANSPORT; MECHANISM; PATTERN; GTPASES; INITIATION; EPIDERMIS	Background: Local activation of Rho GTPases is important for many functions including cell polarity, morphology, movement, and growth. Although a number of molecules affecting Rho-of-Plants small GTPase (ROP) signalling are known, it remains unclear how ROP activity becomes spatially organised. Arabidopsis root hair cells produce patches of ROP at consistent and predictable subcellular locations, where root hair growth subsequently occurs. Methodology/Principal Findings: We present a mathematical model to show how interaction of the plant hormone auxin with ROPs could spontaneously lead to localised patches of active ROP via a Turing or Turing-like mechanism. Our results suggest that correct positioning of the ROP patch depends on the cell length, low diffusion of active ROP, a gradient in auxin concentration, and ROP levels. Our theory provides a unique explanation linking the molecular biology to the root hair phenotypes of multiple mutants and transgenic lines, including OX-ROP, CA-rop, aux1, axr3, tip1, eto1, etr1, and the triple mutant aux1 ein2 gnom(eb). Conclusions/Significance: We show how interactions between Rho GTPases (in this case ROPs) and regulatory molecules (in this case auxin) could produce characteristic subcellular patterning that subsequently affects cell shape. This has important implications for research on the morphogenesis of plants and other eukaryotes. Our results also illustrate how gradient-regulated Turing systems provide a particularly robust and flexible mechanism for pattern formation.	[Payne, Robert J. H.; Grierson, Claire Suzanne] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Payne, RJH (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	robert.payne@bristol.ac.uk; claire.grierson@bristol.ac.uk			Royal Society; Biotechnology and Biological Sciences Research Council [BB/F011709/1] Funding Source: researchfish; BBSRC [BB/F011709/1] Funding Source: UKRI	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RJHP is funded by the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Benson DL, 1998, J MATH BIOL, V37, P381, DOI 10.1007/s002850050135; Bouyer D, 2008, PLOS BIOL, V6, P1166, DOI 10.1371/journal.pbio.0060141; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Crampin E.J., 2001, Comments on Theoretical Biology, V6, P229; De Cnodder T, 2005, NEW PHYTOL, V168, P541, DOI 10.1111/j.1469-8137.2005.01540.x; Digiuni S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.54; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jilkine A, 2007, B MATH BIOL, V69, P1943, DOI 10.1007/s11538-007-9200-6; Jones AR, 2009, NAT CELL BIOL, V11, P78, DOI 10.1038/ncb1815; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; LACALLI TC, 1988, DEVELOPMENT, V104, P105; Le J, 2001, PLANT PHYSIOL, V125, P519, DOI 10.1104/pp.125.2.519; LEAVITT RG, 2004, P BOSTON SOC NAT HIS, P274; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Masucci JD, 1996, PLANT CELL, V8, P1505, DOI 10.1105/tpc.8.9.1505; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; MURRAY JD, 1982, J THEOR BIOL, V98, P143, DOI 10.1016/0022-5193(82)90063-7; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Page KM, 2005, PHYSICA D, V202, P95, DOI 10.1016/j.physd.2005.01.022; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Passey S, 2004, BIOCHEM SOC T, V32, P1115, DOI 10.1042/BST0321115; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; Savage NS, 2008, PLOS BIOL, V6, P1899, DOI 10.1371/journal.pbio.0060235; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Singh SK, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-57; Sorek N, 2007, MOL CELL BIOL, V27, P2144, DOI 10.1128/MCB.02347-06; Strier DE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001053; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Yalovsky S, 2008, PLANT PHYSIOL, V147, P1527, DOI 10.1104/pp.108.122150; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005	51	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8337	10.1371/journal.pone.0008337	http://dx.doi.org/10.1371/journal.pone.0008337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016781	Green Published, Green Submitted, gold			2022-12-27	WOS:000272834000023
J	Franklin, DC; Whelan, PI				Franklin, Donald C.; Whelan, Peter I.			Tropical Mosquito Assemblages Demonstrate 'Textbook' Annual Cycles	PLOS ONE			English	Article							COMMUNITY STRUCTURE; AUSTRALIA; CULICIDAE; ESTUARY; DIPTERA; SURVIVAL; DURATION; SEASON; DARWIN	Background: Annual biological rhythms are often depicted as predictably cyclic, but quantitative evaluations are few and rarely both cyclic and constant among years. In the monsoon tropics, the intense seasonality of rainfall frequently drives fluctuations in the populations of short-lived aquatic organisms. However, it is unclear how predictably assemblage composition will fluctuate because the intensity, onset and cessation of the wet season varies greatly among years. Methodology/Principal Findings: Adult mosquitoes were sampled using EVS suction traps baited with carbon dioxide around swamplands adjacent to the city of Darwin in northern Australia. Eleven sites were sampled weekly for five years, and one site weekly for 24 years, the sample of c. 1.4 million mosquitoes yielding 63 species. Mosquito abundance, species richness and diversity fluctuated seasonally, species richness being highly predictable. Ordination of assemblage composition demonstrated striking annual cycles that varied little from year to year. The mosquito assemblage was temporally structured by a succession of species peaks in abundance. Conclusion/Significance: Ordination provided strong visual representation of annual rhythms in assemblage composition and the means to evaluate variability among years. Because most mosquitoes breed in shallow freshwater which fluctuates with rainfall, we did not anticipate such repeatability; we conclude that mosquito assemblage composition appears adapted to predictable elements of the rainfall.	[Franklin, Donald C.] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia; [Whelan, Peter I.] Ctr Dis Control, NT Dept Hlth & Families, Darwin, NT, Australia	Charles Darwin University	Franklin, DC (corresponding author), Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia.	don.franklin@cdu.edu.au	Franklin, Don/F-1171-2014	Franklin, Don/0000-0002-9813-0959	Australian Research Council [LP0667619]; government of the Northern Territory	Australian Research Council(Australian Research Council); government of the Northern Territory	The study was funded by an Australian Research Council grant (LP0667619) and the government of the Northern Territory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat, 2008, STUDENTS APPEAL RULI; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Bisevac L, 2009, J AM MOSQUITO CONTR, V25, P58, DOI 10.2987/08-5814.1; Bowman D. M. J. S., 2002, AUSTR GEOGRAPHICAL S, V40, P261, DOI DOI 10.1111/1467-8470.00179; Campos RE, 2006, MEM I OSWALDO CRUZ, V101, P47, DOI 10.1590/S0074-02762006000100009; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cook GD, 2001, INT J CLIMATOL, V21, P1723, DOI 10.1002/joc.704; Cuesta JA, 2006, HYDROBIOLOGIA, V557, P85, DOI 10.1007/s10750-005-1311-1; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; Heckman CW, 1997, GLOBAL ECOL BIOGEOGR, V6, P97, DOI 10.2307/2997567; Jacups SP, 2008, TROP MED INT HEALTH, V13, P943, DOI 10.1111/j.1365-3156.2008.02095.x; Jeffery JAL, 2005, AUST J ENTOMOL, V44, P226, DOI 10.1111/j.1440-6055.2005.00479.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Legendre P., 2012, NUMERICAL ECOLOGY; Maes J, 2005, J APPL ICHTHYOL, V21, P86, DOI 10.1111/j.1439-0426.2004.00628.x; MCCOWN RL, 1981, AGR SYST, V7, P163, DOI 10.1016/0308-521X(81)90044-5; McCune B, 1999, MULTIVARIATE ANAL EC; McDonald N.S., 1991, MONSOONAL AUSTR, P19; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021; Morisette JT, 2009, FRONT ECOL ENVIRON, V7, P253, DOI 10.1890/070217; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Ruane AC, 2007, EARTH INTERACT, V11, DOI 10.1175/EI225.1; RUSSELL RC, 1986, AUST J ECOL, V11, P99, DOI 10.1111/j.1442-9993.1986.tb01381.x; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Tsou TS, 2002, ESTUARIES, V25, P1372, DOI 10.1007/BF02692231; White G.C., 1990, ANAL WILDLIFE RADIO; Winemiller Kirk O., 1996, P99, DOI 10.1016/B978-012178075-3/50006-4; Yang GJ, 2008, POPUL ECOL, V50, P293, DOI 10.1007/s10144-008-0082-8; Zhang SP, 2008, INT J CLIMATOL, V28, P1563, DOI 10.1002/joc.1659	33	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8296	10.1371/journal.pone.0008296	http://dx.doi.org/10.1371/journal.pone.0008296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011531	Green Published, gold			2022-12-27	WOS:000272830300044
J	Lin, YH; Chang, CC; Wong, CW; Teng, SC				Lin, Yi-Hsuan; Chang, Chia-Ching; Wong, Chui-Wei; Teng, Shu-Chun			Recruitment of Rad51 and Rad52 to Short Telomeres Triggers a Mec1-Mediated Hypersensitivity to Double-Stranded DNA Breaks in Senescent Budding Yeast	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; MAINTENANCE; PATHWAY; DYSFUNCTION; EFFICIENT; INVOLVEMENT; RESCUES; ARREST; REPAIR	Telomere maintenance is required for chromosome stability, and telomeres are typically replicated by the action of telomerase. In both mammalian tumor and yeast cells that lack telomerase, telomeres are maintained by an alternative recombination mechanism. Here we demonstrated that the budding yeast Saccharomyces cerevisiae type I survivors derived from telomerase-deficient cells were hypersensitive to DNA damaging agents. Assays to track telomere lengths and drug sensitivity of telomerase-deficient cells from spore colonies to survivors suggested a correlation between telomere shortening and bleomycin sensitivity. Our genetic studies demonstrated that this sensitivity depends on Mec1, which signals checkpoint activation, leading to prolonged cell-cycle arrest in senescent budding yeasts. Moreover, we also observed that when cells equipped with short telomeres, recruitments of homologous recombination proteins, Rad51 and Rad52, were reduced at an HO-endonuclease-catalyzed double-strand break (DSB), while their associations were increased at chromosome ends. These results suggested that the sensitive phenotype may be attributed to the sequestration of repair proteins to compromised telomeres, thus limiting the repair capacity at bona fide DSB sites.	[Lin, Yi-Hsuan; Chang, Chia-Ching; Wong, Chui-Wei; Teng, Shu-Chun] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan	National Taiwan University	Lin, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	shuchunteng@ntu.edu.tw		TENG, SHU-CHUN/0000-0002-6492-2560	National Science Council [NRPGM-98-3112-B-002-039]; National Health Research Institute of Taiwan [NHRI-EX98-9727BI]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the National Science Council (NRPGM-98-3112-B-002-039) and National Health Research Institute of Taiwan (NHRI-EX98-9727BI) to SCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; HAYFLICK L, 1974, J AM GERIATR SOC, V22, P1; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Huang CF, 2002, J CELL SCI, V115, P275; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; JPMA I, 2003, MOL BIOL CELL, V14, P987, DOI DOI 10.1091/MBC.02-04-0057; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lin CY, 2005, EUKARYOT CELL, V4, P327, DOI 10.1128/EC.4.2.327-336.2005; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Meyer DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003318; NAUK DA, 1971, SSSR, V201, P1496; Nautiyal S, 2002, P NATL ACAD SCI USA, V99, P9316, DOI 10.1073/pnas.142162499; Olovnikov A, 2005, ANN NY ACAD SCI, V1057, P112, DOI 10.1196/annals.1356.006; OLOVNIKOV AM, 1971, SOKL AN SSSR, V201, P1496; Pike BL, 2007, MOL CELL BIOL, V27, P6532, DOI 10.1128/MCB.00471-07; Rose MD., 1990, METHODS YEAST GENETI; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teng SC, 2002, BIOCHEM BIOPH RES CO, V291, P714, DOI 10.1006/bbrc.2002.6509; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; Tsai YL, 2002, MOL CELL BIOL, V22, P5679, DOI 10.1128/MCB.22.16.5679-5687.2002; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8224	10.1371/journal.pone.0008224	http://dx.doi.org/10.1371/journal.pone.0008224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011546	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300010
J	Sobrino, A; Mata, M; Laguna-Fernandez, A; Novella, S; Oviedo, PJ; Garcia-Perez, MA; Tarin, JJ; Cano, A; Hermenegildo, C				Sobrino, Agua; Mata, Manuel; Laguna-Fernandez, Andres; Novella, Susana; Oviedo, Pilar J.; Angel Garcia-Perez, Miguel; Tarin, Juan J.; Cano, Antonio; Hermenegildo, Carlos			Estradiol Stimulates Vasodilatory and Metabolic Pathways in Cultured Human Endothelial Cells	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; BREAST-CANCER CELLS; GENE-EXPRESSION; ASYMMETRIC DIMETHYLARGININE; HEART-DISEASE; REPLACEMENT; CYCLOOXYGENASES; INHIBITION; MECHANISMS; PREVENTION	Vascular effects of estradiol are being investigated because there are controversies among clinical and experimental studies. DNA microarrays were used to investigate global gene expression patterns in cultured human umbilical vein endothelial cells (HUVEC) exposed to 1 nmol/L estradiol for 24 hours. When compared to control, 187 genes were identified as differentially expressed with 1.9-fold change threshold. Supervised principal component analysis and hierarchical cluster analysis revealed the differences between control and estradiol-treated samples. Physiological concentrations of estradiol are sufficient to elicit significant changes in HUVEC gene expression. Notch signaling, actin cytoskeleton signaling, pentose phosphate pathway, axonal guidance signaling and integrin signaling were the top-five canonical pathways significantly regulated by estrogen. A total of 26 regulatory networks were identified as estrogen responsive. Microarray data were confirmed by quantitative RT-PCR in cardiovascular meaning genes; cyclooxigenase (COX) 1, dimethylarginine dimethylaminohydrolase (DDAH) 2, phospholipase A2 group IV (PLA2G4) B, and 7-dehydrocholesterol reductase were up-regulated by estradiol in a dose-dependent and estrogen receptor-dependent way, whereas COX2, DDAH1 and PLA2G4A remained unaltered. Moreover, estradiol-induced COX1 gene expression resulted in increased COX1 protein content and enhanced prostacyclin production. DDAH2 protein content was also increased, which in turn decreased asymmetric dimethylarginine concentration and increased NO release. All stimulated effects of estradiol on gene and protein expression were estrogen receptor-dependent, since were abolished in the presence of the estrogen receptor antagonist ICI 182780. This study identifies new vascular mechanisms of action by which estradiol may contribute to a wide range of biological processes.	[Sobrino, Agua; Laguna-Fernandez, Andres; Novella, Susana; Oviedo, Pilar J.; Angel Garcia-Perez, Miguel; Hermenegildo, Carlos] Univ Valencia, Res Fdn, Hosp Clin Univ, Valencia, Spain; [Mata, Manuel] Univ Valencia, Res Fdn, Hosp Gen Univ, Valencia, Spain; [Novella, Susana; Hermenegildo, Carlos] Univ Valencia, Dept Physiol, Valencia, Spain; [Tarin, Juan J.] Univ Valencia, Dept Funct Biol & Phys Anthropol, Valencia, Spain; [Cano, Antonio] Univ Valencia, Dept Pediat Obstet & Gynecol, Valencia, Spain	Hospital Clinic Universitari de Valencia; University of Valencia; Hospital Clinic Universitari de Valencia; University of Valencia; University of Valencia; University of Valencia; University of Valencia	Sobrino, A (corresponding author), Univ Valencia, Res Fdn, Hosp Clin Univ, Valencia, Spain.	carlos.hermenegildo@uv.es	Garcia Perez, Miguel Angel/S-8090-2018; Novella, Susana/A-7406-2017; Morcillo, Esteban/I-1552-2015; Fernandez, Andres Laguna/G-1262-2015; Roig, Manuel Mata/G-4338-2015; Hermenegildo, Carlos/C-5995-2008	Garcia Perez, Miguel Angel/0000-0002-0626-7502; Novella, Susana/0000-0001-8303-7252; Morcillo, Esteban/0000-0003-4373-9457; Fernandez, Andres Laguna/0000-0002-0066-7222; Roig, Manuel Mata/0000-0002-1506-7983; Tarin, Juan/0000-0002-4436-5162; Hermenegildo, Carlos/0000-0002-4015-2645	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Madrid, Spain [06/0589, RD06/0009/0005]; Conselleri-a de Educacion, Generalitat Valenciana, Spain [BFPI 06/145]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleri-a de Educacion, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants FIS 06/0589 and Red HERACLES RD06/0009/0005 from the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Madrid, Spain. Pilar J Oviedo holds a post-doc position and Agua Sobrino is a fellowship recipient from the FPI program (BFPI 06/145), both from Conselleri-a de Educacion, Generalitat Valenciana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archacki Stephen R., 2006, V129, P1; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Cid M C, 1999, Angiogenesis, V3, P271, DOI 10.1023/A:1009023329294; Djurovic S, 2000, J INTERN MED, V247, P279, DOI 10.1046/j.1365-2796.2000.00648.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farina MG, 2007, REPRODUCTION, V134, P355, DOI 10.1530/REP-07-0078; Forbes NS, 2006, METAB ENG, V8, P639, DOI 10.1016/j.ymben.2006.06.005; Gourdy P, 2007, ARTERIOSCL THROM VAS, V27, P2214, DOI 10.1161/ATVBAHA.107.150300; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Graham D, 2007, HYPERTENSION, V50, P1134, DOI 10.1161/HYPERTENSIONAHA.107.095349; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hermenegildo C, 2006, CURR PHARM DESIGN, V12, P205, DOI 10.2174/138161206775193136; Hermenegildo C, 2005, J PHARMACOL EXP THER, V315, P722, DOI 10.1124/jpet.105.090456; Hermenegildo C, 2002, AM J PHYSIOL-HEART C, V283, pH2644, DOI 10.1152/ajpheart.00369.2002; Hiltunen MO, 2002, ATHEROSCLEROSIS, V165, P23, DOI 10.1016/S0021-9150(02)00187-9; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jun SS, 1998, J CLIN INVEST, V102, P176, DOI 10.1172/JCI2034; KolfClauw M, 1996, TERATOLOGY, V54, P115, DOI 10.1002/(SICI)1096-9926(199609)54:3<115::AID-TERA1>3.0.CO;2-2; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Mendelsohn ME, 2000, J STEROID BIOCHEM, V74, P337, DOI 10.1016/S0960-0760(00)00110-2; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Monsalve E, 2007, CARDIOVASC RES, V73, P66, DOI 10.1016/j.cardiores.2006.09.020; Oviedo PJ, 2007, FERTIL STERIL, V88, P326, DOI 10.1016/j.fertnstert.2006.11.185; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rupnow HL, 2002, BIOL REPROD, V66, P468, DOI 10.1095/biolreprod66.2.468; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; Stevenson JC, 2007, MATURITAS, V57, P31, DOI 10.1016/j.maturitas.2007.02.007; THOMAS M, 1990, CANCER RES, V50, P1195; Toth B, 2009, ACTA HISTOCHEM, V111, P508, DOI 10.1016/j.acthis.2008.05.006; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com; Witsch-Baumgartner M, 2001, HUM MUTAT, V17, P172, DOI 10.1002/humu.2	45	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8242	10.1371/journal.pone.0008242	http://dx.doi.org/10.1371/journal.pone.0008242			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011585	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300016
J	Weber, AL; Zhao, Q; McMullen, MD; Doebley, JF				Weber, Allison L.; Zhao, Qiong; McMullen, Michael D.; Doebley, John F.			Using Association Mapping in Teosinte to Investigate the Function of Maize Selection-Candidate Genes	PLOS ONE			English	Article							MAYS SSP PARVIGLUMIS; ARTIFICIAL SELECTION; CROP IMPROVEMENT; DOMESTICATION; ARCHITECTURE; ARABIDOPSIS; EXPRESSION; EVOLUTION; PLANT; INHIBITION	Background: Large-scale screens of the maize genome identified 48 genes that show the putative signature of artificial selection during maize domestication or improvement. These selection-candidate genes may act as quantitative trait loci (QTL) that control the phenotypic differences between maize and its progenitor, teosinte. The selection-candidate genes appear to be located closer in the genome to domestication QTL than expected by chance. Methods and Findings: As a step toward defining the traits controlled by these genes, we performed phenotype-genotype association mapping in teosinte for 32 of the 48 plus three other selection-candidate genes. Our analyses assayed 32 phenotypic traits, many of which were altered during maize domestication or improvement. We observed several significant associations between SNPs in the selection-candidate genes and trait variation in teosinte. These included two associations that surpassed the Bonferroni correction and five instances where a gene significantly associated with the same trait in both of our association mapping panels. Despite these significant associations, when compared as a group the selection-candidate genes performed no better than randomly chosen genes. Conclusions: Our results suggest association analyses can be helpful for identifying traits under the control of selection-candidate genes. Indeed, we present evidence for new functions for several selection-candidate genes. However, with the current set of selection-candidate genes and our association mapping strategy, we found very few significant associations overall and no more than we would have found with randomly chosen genes. We discuss possible reasons that a large number of significant genotype-phenotype associations were not discovered.	[Weber, Allison L.; Zhao, Qiong; Doebley, John F.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [McMullen, Michael D.] Univ Missouri, Plant Genet Res Unit, ARS, USDA, Columbia, MO USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Weber, AL (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	alweber@ncsu.edu			National Science Foundation [DBI-0321467]; National Institutes of Health [GM-58816]; US Department of Agriculture [WIS04772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058816] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation (www.nsf.gov) grant DBI-0321467, National Institutes of Health (www.nih.gov) grant GM-58816, and US Department of Agriculture (www.usda.gov) Hatch grant WIS04772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; HUDSON RR, 1987, GENETICS, V116, P153; Hufford KM, 2007, PLANT PHYSIOL, V144, P1642, DOI 10.1104/pp.107.098988; KING RW, 1973, PLANT PHYSIOL, V51, P727, DOI 10.1104/pp.51.4.727; LANG A, 1977, P NATL ACAD SCI USA, V74, P2412, DOI 10.1073/pnas.74.6.2412; LEDGER SE, 1994, PLANT MOL BIOL, V25, P877, DOI 10.1007/BF00028882; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; RISCH N, 1996, SCIENCE, V273, P1517; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TAJIMA F, 1983, GENETICS, V105, P437; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wirdnam C, 2004, PLANT MOL BIOL, V56, P717, DOI 10.1007/s11103-004-4679-9; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; YAMASAKI M, 2008, PLANT GENOME, V1; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHANG H, 1992, PLANT CELL, V4, P1575, DOI 10.1105/tpc.4.12.1575; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	32	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8227	10.1371/journal.pone.0008227	http://dx.doi.org/10.1371/journal.pone.0008227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011044	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800015
J	Perron, JC; Dodd, J				Perron, Jeanette C.; Dodd, Jane			ActRIIA and BMPRII Type II BMP Receptor Subunits Selectively Required for Smad4-Independent BMP7-Evoked Chemotaxis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; GROWTH-FACTOR-BETA; ACTIN CYTOSKELETON REORGANIZATION; MESSENGER-RNA EXPRESSION; GUIDANCE MOLECULE RGMA; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; DORSAL SPINAL-CORD; TGF-BETA; SIGNALING PATHWAYS	Bone morphogenetic protein (BMP)-evoked reorientation and chemotaxis of cells occurs with rapid onset and involves events local to the cell membrane. The signaling pathways underlying these rapid processes likely diverge from those mediating classical transcriptional responses to BMPs but it remains unclear how BMP receptors are utilized to generate distinct intracellular mechanisms. We show that BMP7-evoked chemotaxis of monocytic cells depends on the activity of canonical type II BMP receptors. Although the three canonical type II BMP receptors are expressed in monocytic cells, inhibition of receptor subunit expression by RNAi reveals that ActRIIA and BMPRII, but not ActRIIB, are each essential for BMP7-evoked chemotaxis but not required individually for BMP-mediated induction. Furthermore, the chemotactic response to BMP7 does not involve canonical Smad4-dependent signaling but acts through PI3K-dependent signaling, illustrating selective activation of distinct intracellular events through differential engagement of receptors. We suggest a model of a BMP receptor complex in which the coordinated activity of ActRIIA and BMPRII receptor subunits selectively mediates the chemotactic response to BMP7.	[Perron, Jeanette C.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA; Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University	Perron, JC (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	jd18@columbia.edu		Perron, Jeanette C./0000-0002-6942-6320	National Institutes of Health (NIH) [NS 27113]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027113] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by National Institutes of Health (NIH) NS 27113 to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740; DAVID L, 2006, BLOOD; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Lee DH, 2006, TISSUE ENG, V12, P1577, DOI 10.1089/ten.2006.12.1577; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Liu J, 2003, DEV BIOL, V256, P34, DOI 10.1016/S0012-1606(02)00115-X; Machida H, 2000, EUR J ENDOCRINOL, V143, P705, DOI 10.1530/eje.0.1430705; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Newfeld SJ, 1999, GENETICS, V152, P783; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POSTLETHWAITE AE, 1994, J CELL PHYSIOL, V161, P562, DOI 10.1002/jcp.1041610320; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sanchez-Camacho C, 2005, BRAIN RES REV, V49, P242, DOI 10.1016/j.brainresrev.2004.10.004; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shah PK, 2001, PROTEINS, V45, P408, DOI 10.1002/prot.10010; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shoba LNN, 2003, J CELL BIOCHEM, V88, P1247, DOI 10.1002/jcb.10474; Steuerwald N, 1999, MOL HUM REPROD, V5, P1034, DOI 10.1093/molehr/5.11.1034; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	59	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8198	10.1371/journal.pone.0008198	http://dx.doi.org/10.1371/journal.pone.0008198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	20011660	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829700003
J	Marucci, L; Barton, DAW; Cantone, I; Ricci, MA; Cosma, MP; Santini, S; di Bernardo, D; di Bernardo, M				Marucci, Lucia; Barton, David A. W.; Cantone, Irene; Ricci, Maria Aurelia; Cosma, Maria Pia; Santini, Stefania; di Bernardo, Diego; di Bernardo, Mario			How to Turn a Genetic Circuit into a Synthetic Tunable Oscillator, or a Bistable Switch	PLOS ONE			English	Article							TOGGLE SWITCH; CONSTRUCTION; NETWORKS; BIOLOGY; DESIGN	Systems and Synthetic Biology use computational models of biological pathways in order to study in silico the behaviour of biological pathways. Mathematical models allow to verify biological hypotheses and to predict new possible dynamical behaviours. Here we use the tools of non-linear analysis to understand how to change the dynamics of the genes composing a novel synthetic network recently constructed in the yeast Saccharomyces cerevisiae for In-vivo Reverse-engineering and Modelling Assessment (IRMA). Guided by previous theoretical results that make the dynamics of a biological network depend on its topological properties, through the use of simulation and continuation techniques, we found that the network can be easily turned into a robust and tunable synthetic oscillator or a bistable switch. Our results provide guidelines to properly re-engineering in vivo the network in order to tune its dynamics.	[Marucci, Lucia; Ricci, Maria Aurelia; Cosma, Maria Pia; di Bernardo, Diego] TIGEM, Naples, Italy; [Marucci, Lucia; Santini, Stefania; di Bernardo, Diego; di Bernardo, Mario] Univ Naples Federico II, Dept Comp & Syst Engn, Naples, Italy; [Barton, David A. W.; di Bernardo, Mario] Univ Bristol, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England; [Cantone, Irene] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Bristol; Imperial College London	Marucci, L (corresponding author), TIGEM, Naples, Italy.	dibernardo@tigem.it; mario.dibernardo@unina.it	di Bernardo, Mario/I-2805-2012; Barton, David/R-9896-2019; Barton, David AW/A-2438-2009; Cantone, Irene/AAB-1071-2020; di Bernardo, Diego/I-9440-2012; di Bernardo, Mario/AAL-9311-2021; di Bernardo, Diego/AAF-5881-2021; Marucci, Lucia/P-1582-2016; Cosma, Maria Pia/E-8731-2015	Barton, David/0000-0002-0595-4239; Barton, David AW/0000-0002-0595-4239; Cantone, Irene/0000-0002-8156-7126; di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Mario/0000-0002-2171-4745; di Bernardo, Diego/0000-0002-1911-7407; Marucci, Lucia/0000-0002-7553-6358; Cosma, Maria Pia/0000-0003-4207-5097	EU; SEMM (European School of Molecular Medicine); United Kingdom Engineering and Physical Sciences Research Council (EPSRC); Fondazione Telethon Funding Source: Custom	EU(European Commission); SEMM (European School of Molecular Medicine); United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fondazione Telethon(Fondazione Telethon)	This work was supported by EU-STREP FP6 grant (COBIOS) to L. M., M. P. C., D. d. B. and M. d. B.; I. C. PhD fellowship was provided by SEMM (European School of Molecular Medicine). L. M. acknowledges support from the United Kingdom Engineering and Physical Sciences Research Council (EPSRC) platform grant "Making it Real" during her visit to the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; BOGACKI P, 1989, APPL MATH LETT, V2, P1; Calzone L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100171; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18; DELVECCHIO D, 2007, AM CONTR C 2007 ACC; EISWIRTH M, 1991, J PHYS CHEM-US, V95, P1294, DOI 10.1021/j100156a048; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endler L, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0035.focus; Engelborghs K, 2000, SIAM J SCI COMPUT, V22, P1593, DOI 10.1137/S1064827599363381; ENGELBORGHS K, 2001, VD330 TW KU LEUV DEP; Fall CP., 2002, COMPUTATIONAL CELL B; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Horsthemke W., 1984, NOISE INDUCED TRANSI; KOVACECH B, 2003, NUCLEIC ACIDS RES, V31, P5831; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kuras L, 1997, EMBO J, V16, P2441, DOI 10.1093/emboj/16.9.2441; LUBISCHER JL, 2007, CELL CYCLE; Luzyanina T, 1996, J COMPUT APPL MATH, V72, P379, DOI 10.1016/0377-0427(96)00008-8; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; MURRAY JD, 2008, MATH BIOL, V1; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; PENGCHENG F, 2009, SYSTEMS BIOL SYNTHET; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SERTIL O, 1996, MOL CELL BIO, V16, P3264; Seydel R., 2009, PRACTICAL BIFURCATIO, V5; Shampine LF, 2001, APPL NUMER MATH, V37, P441, DOI 10.1016/S0168-9274(00)00055-6; STRICKER J, 2008, NATURE; THOMAS R, 1981, SPRINGER SERIES SYNE; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Widder S, 2007, J THEOR BIOL, V246, P395, DOI 10.1016/j.jtbi.2007.01.004	39	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8083	10.1371/journal.pone.0008083	http://dx.doi.org/10.1371/journal.pone.0008083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997611	gold, Green Published, Green Submitted			2022-12-27	WOS:000272829500005
J	Sarantseva, S; Timoshenko, S; Bolshakova, O; Karaseva, E; Rodin, D; Schwarzman, AL; Vitek, MP				Sarantseva, Svetlana; Timoshenko, Svetlana; Bolshakova, Olga; Karaseva, Eugenia; Rodin, Dmitry; Schwarzman, Alexander L.; Vitek, Michael P.			Apolipoprotein E-Mimetics Inhibit Neurodegeneration and Restore Cognitive Functions in a Transgenic Drosophila Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BLOOD-BRAIN-BARRIER; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT; MOLECULAR-BASIS; A-BETA; PEPTIDE; AGGREGATION; HYPOTHESIS; EXPRESSION	Background: Mutations of the amyloid precursor protein gene (APP) are found in familial forms of Alzheimer's disease (AD) and some lead to the elevated production of amyloid-beta-protein (A beta). While A beta has been implicated in the causation of AD, the exact role played by A beta and its APP precursor are still unclear. Principal Findings: In our study, Drosophila melanogaster transgenics were established as a model to analyze AD-like pathology caused by APP overexpression. We demonstrated that age related changes in the levels and pattern of synaptic proteins accompanied progressive neurodegeneration and impairment of cognitive functions in APP transgenic flies, but that these changes may be independent from the generation of A beta. Using novel peptide mimetics of Apolipoprotein-E, COG112 or COG133 proved to be neuroprotective and significantly improved the learning and memory of APP transgenic flies. Conclusions: The development of neurodegeneration and cognitive deficits was corrected by injections of COG112 or COG133, novel mimetics of apolipoprotein-E (apoE) with neuroprotective activities.	[Sarantseva, Svetlana; Timoshenko, Svetlana; Bolshakova, Olga; Karaseva, Eugenia; Rodin, Dmitry; Schwarzman, Alexander L.] Russian Acad Sci, Petersburg Inst Nucl Phys, Gatchina, Russia; [Schwarzman, Alexander L.] Russian Acad Med Sci, Inst Expt Med, St Petersburg, Russia; [Vitek, Michael P.] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC USA	Russian Academy of Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Duke University	Sarantseva, S (corresponding author), Russian Acad Sci, Petersburg Inst Nucl Phys, Gatchina, Russia.	Michael.Vitek@Duke.edu	Bolshakova, Olga/S-8262-2018; Latypova, Evgeniya/O-7363-2014	Bolshakova, Olga/0000-0003-3761-3014; Vitek, Michael/0000-0001-8140-8048	Russian Foundation for Basic Research [07-04-00128, 09-04-00647]; Russian Academy of Sciences; Alzheimer's Association [IIRG-07-59655]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Alzheimer's Association(Alzheimer's Association)	This study is supported by the Russian Foundation for Basic Research (grants: 07-04-00128 to A. L. S. and 09-04-00647 to S. S.) and by the Program of the Presidium of the Russian Academy of Sciences "Fundamental Sciences for Medicine" (to A. L. S.) and an Alzheimer's Association grant IIRG-07-59655 to M. P. V. These funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Ashe KH, 2000, ANN NY ACAD SCI, V924, P39; Bolton SJ, 2000, EUR J NEUROSCI, V12, P2847, DOI 10.1046/j.1460-9568.2000.00171.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; Chiang HC, 2009, FASEB J, V23, P1969, DOI 10.1096/fj.08-121152; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Isacson O, 2004, NEURON, V43, P165, DOI 10.1016/j.neuron.2004.07.007; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Peng T, 2004, ACTA BIOCH BIOPH SIN, V36, P629, DOI 10.1093/abbs/36.9.629; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Samuels SC, 1998, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P267; Sarantseva S V, 2009, Genetika, V45, P119; Sarantseva SV, 2009, BIOCHEM MOSC-SUPPL S, V3, P149, DOI 10.1134/S199075080902005X; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHWARZMAN AL, 2005, AMYLOID, V12, P1; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senechal Y, 2006, NEURODEGENER DIS, V3, P134, DOI 10.1159/000094772; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; TAN L, 2008, PLOS ONE, V3, P1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Torroja L, 1999, J NEUROSCI, V19, P7793; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4	56	51	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8191	10.1371/journal.pone.0008191	http://dx.doi.org/10.1371/journal.pone.0008191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997607	gold, Green Published, Green Submitted			2022-12-27	WOS:000272829500015
J	Wain, LV; Pedroso, I; Landers, JE; Breen, G; Shaw, CE; Leigh, PN; Brown, RH; Tobin, MD; Al-Chalabi, A				Wain, Louise V.; Pedroso, Inti; Landers, John E.; Breen, Gerome; Shaw, Christopher E.; Leigh, P. Nigel; Brown, Robert H.; Tobin, Martin D.; Al-Chalabi, Ammar			The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; HEAVY NEUROFILAMENT SUBUNIT; GENE-MUTATIONS; PROTEIN; VARIANTS; EXPRESSION; LINKAGE; FORM	Background: The genetic contribution to sporadic amyotrophic lateral sclerosis (ALS) has not been fully elucidated. There are increasing efforts to characterise the role of copy number variants (CNVs) in human diseases; two previous studies concluded that CNVs may influence risk of sporadic ALS, with multiple rare CNVs more important than common CNVs. A little-explored issue surrounding genome-wide CNV association studies is that of post-calling filtering and merging of raw CNV calls. We undertook simulations to define filter thresholds and considered optimal ways of merging overlapping CNV calls for association testing, taking into consideration possibly overlapping or nested, but distinct, CNVs and boundary estimation uncertainty. Methodology and Principal Findings: In this study we screened Illumina 300K SNP genotyping data from 730 ALS cases and 789 controls for copy number variation. Following quality control filters using thresholds defined by simulation, a total of 11321 CNV calls were made across 575 cases and 621 controls. Using region-based and gene-based association analyses, we identified several loci showing nominally significant association. However, the choice of criteria for combining calls for association testing has an impact on the ranking of the results by their significance. Several loci which were previously reported as being associated with ALS were identified here. However, of another 15 genes previously reported as exhibiting ALS-specific copy number variation, only four exhibited copy number variation in this study. Potentially interesting novel loci, including EEF1D, a translation elongation factor involved in the delivery of aminoacyl tRNAs to the ribosome ( a process which has previously been implicated in genetic studies of spinal muscular atrophy) were identified but must be treated with caution due to concerns surrounding genomic location and platform suitability. Conclusions and Significance: Interpretation of CNV association findings must take into account the effects of filtering and combining CNV calls when based on early genome-wide genotyping platforms and modest study sizes.	[Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Shaw, Christopher E.; Leigh, P. Nigel; Al-Chalabi, Ammar] Kings Coll London, MRC, Ctr Neurodegenerat Res, Inst Psychiat, London WC2R 2LS, England; [Landers, John E.; Brown, Robert H.] Univ Massachusetts, Sch Med, Dept Neurol, Day Neuromuscular Res Lab, Worcester, MA USA; [Pedroso, Inti; Breen, Gerome] Kings Coll London, MRC, Ctr Social Genet & Dev Psychiat, Inst Psychiat, London WC2R 2LS, England; [Pedroso, Inti; Breen, Gerome] Kings Coll London, NIHR Biomed Res Ctr Mental Hlth, S London & Maudsley NHS Fdn Trust, London WC2R 2LS, England; [Pedroso, Inti; Breen, Gerome] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Leicester; University of Leicester; University of London; King's College London; University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London	Wain, LV (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	mt47@le.ac.uk; ammar.al-chalabi@kcl.ac.uk	Leigh, Peter/AAD-5638-2019; Breen, Gerome/Y-2706-2019; pedroso, inti/B-4989-2010; Al-Chalabi, Ammar/E-5361-2010	Breen, Gerome/0000-0003-2053-1792; pedroso, inti/0000-0002-5947-4556; Al-Chalabi, Ammar/0000-0002-4924-7712; Wain, Louise/0000-0003-4951-1867; Shaw, Christopher/0000-0003-0251-0146; Landers, John/0000-0001-8084-5043; Tobin, Martin/0000-0002-3596-7874	Motor Neurone Disease Association; Medical Research Council; National Institute of Health Research; Biomedical Research Centre for Mental Health; ALS Therapy Alliance, Project ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; ALS Association; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; NINDS; Medical Research Council Clinician Scientist Fellowship [G0501942]; Medical Research Council [G9817803B, G0500289B, G90/106, G0501942, G0701003, G0900688, G0500289, G0701420, G0600974] Funding Source: researchfish; MRC [G90/106, G0900688, G0701003, G0501942, G0701420, G0600974, G0500289] Funding Source: UKRI	Motor Neurone Disease Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Biomedical Research Centre for Mental Health; ALS Therapy Alliance, Project ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; ALS Association; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Motor Neurone Disease Association and Medical Research Council for support. IP and GB thank the National Institute of Health Research, Biomedical Research Centre for Mental Health for funding support. Generous support was provided by the ALS Therapy Alliance, Project ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the ALS Association, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation and the NINDS. MDT holds a Medical Research Council Clinician Scientist Fellowship (G0501942). This work was performed using the University of Leicester Mathematical Modelling Centre's supercomputer which was purchased through the HEFCE Science Research Investment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Beleza-Meireles A, 2009, AMYOTROPH LATERAL SC, V10, P1, DOI 10.1080/17482960802585469; BLAUW HM, 2008, LANCET NEUROL, V28, P28; CHEN HS, 1997, J DESERT RES, V17, P63; Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Corcia P, 2002, ANN NEUROL, V51, P243, DOI 10.1002/ana.10104; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; CRONIN S, 2008, HUM MOL GENET, V7, P7; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; GAO X, 2009, GENET EPIDEMIOL, V11, P11; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Hand CK, 2003, ARCH NEUROL-CHICAGO, V60, P1768, DOI 10.1001/archneur.60.12.1768; Hayward C, 1999, NEUROLOGY, V52, P1899, DOI 10.1212/WNL.52.9.1899; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; MCCARROLL SA, 2008, NAT GENET, V24, P24; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McDermott CJ, 2003, AMYOTROPH LATERAL SC, V4, P96; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomkins J, 1998, NEUROREPORT, V9, P3967, DOI 10.1097/00001756-199812010-00036; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; WANG K, 2007, GENOME RES, V5, P5; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; XU B, 2008, NAT GENET, V30, P30; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	53	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8175	10.1371/journal.pone.0008175	http://dx.doi.org/10.1371/journal.pone.0008175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997636	Green Accepted, gold, Green Published			2022-12-27	WOS:000272829200011
J	Kelly, RP; Palumbi, SR				Kelly, Ryan P.; Palumbi, Stephen R.			Genetic Structure Among 50 Species of the Northeastern Pacific Rocky Intertidal Community	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPARATIVE PHYLOGEOGRAPHY; MARINE POPULATIONS; LOTTIA-DIGITALIS; ALLELE FREQUENCY; SPATIAL SCALE; FLOW; DIFFERENTIATION; PATTERNS; BIOGEOGRAPHY	Comparing many species' population genetic patterns across the same seascape can identify species with different levels of structure, and suggest hypotheses about the processes that cause such variation for species in the same ecosystem. This comparative approach helps focus on geographic barriers and selective or demographic processes that define genetic connectivity on an ecosystem scale, the understanding of which is particularly important for large-scale management efforts. Moreover, a multispecies dataset has great statistical advantages over single-species studies, lending explanatory power in an effort to uncover the mechanisms driving population structure. Here, we analyze a 50-species dataset of Pacific nearshore invertebrates with the aim of discovering the most influential structuring factors along the Pacific coast of North America. We collected cytochrome c oxidase I (COI) mtDNA data from populations of 34 species of marine invertebrates sampled coarsely at four coastal locations in California, Oregon, and Alaska, and added published data from 16 additional species. All nine species with non-pelagic development have strong genetic structure. For the 41 species with pelagic development, 13 show significant genetic differentiation, nine of which show striking F-ST levels of 0.1-0.6. Finer scale geographic investigations show unexpected regional patterns of genetic change near Cape Mendocino in northern California for five of the six species tested. The region between Oregon and Alaska is a second focus of intraspecific genetic change, showing differentiation in half the species tested. Across regions, strong genetic subdivision occurs more often than expected in mid-to-high intertidal species, a result that may reflect reduced gene flow due to natural selection along coastal environmental gradients. Finally, the results highlight the importance of making primary research accessible to policymakers, as unexpected barriers to marine dispersal break the coast into separate demographic zones that may require their own management plans.	[Kelly, Ryan P.; Palumbi, Stephen R.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA	Stanford University	Kelly, RP (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	rpk@stanford.edu		Kelly, Ryan/0000-0001-5037-2441	Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO); Andrew W. Mellon Foundation	Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO); Andrew W. Mellon Foundation	Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO) and the Andrew W. Mellon Foundation ( to S. R. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Arndt A, 1998, MOL ECOL, V7, P1053, DOI 10.1046/j.1365-294x.1998.00429.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Avise John C., 1994, pi; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barth JA, 2000, DEEP-SEA RES PT II, V47, P783, DOI 10.1016/S0967-0645(99)00127-7; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Botsford LW, 2003, ECOL APPL, V13, pS25; Buonaccorsi VP, 2002, CAN J FISH AQUAT SCI, V59, P1374, DOI 10.1139/F02-101; Burford MO, 2008, MAR BIOL, V154, P701, DOI 10.1007/s00227-008-0963-6; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; BURTON RS, 1983, MAR BIOL LETT, V4, P193; BURTON RS, 1987, EVOLUTION, V41, P504, DOI 10.1111/j.1558-5646.1987.tb05821.x; BURTON RS, 1981, EVOLUTION, V35, P1192, DOI 10.1111/j.1558-5646.1981.tb04989.x; BURTON RS, 1982, ESTUARINE COMP, P537, DOI DOI 10.1016/B978-0-12-404070-0.50038-7; Cassone BJ, 2006, MAR BIOL, V149, P213, DOI 10.1007/s00227-005-0197-9; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Crummett LT, 2007, MAR BIOL, V152, P1, DOI 10.1007/s00227-007-0621-4; Cudaback CN, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002608; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Dawson MN, 2002, MOL ECOL, V11, P1065, DOI 10.1046/j.1365-294X.2002.01503.x; Doyle R. F, 1985, BIOGEOGRAPHICAL STUD; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARRELL TM, 1991, LIMNOL OCEANOGR, V36, P279, DOI 10.4319/lo.1991.36.2.0279; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freeland HJ, 2006, ATMOS OCEAN, V44, P321, DOI 10.3137/ao.440401; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; Hastings A, 2003, ECOL APPL, V13, pS65; HASTINGS A, 2006, PNAS, V13, P6067; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Hellberg ME, 2002, B MAR SCI, V70, P273; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; JABLONSKI D, 1985, PALEOBIOLOGY, V11, P75, DOI 10.1017/S0094837300011416; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; KELLY RP, 2008, MOL ECOLOGY IN PRESS; Kelly RP, 2007, EVOLUTION, V61, P700, DOI 10.1111/j.1558-5646.2007.00055.x; KOEHN RK, 1980, P NATL ACAD SCI-BIOL, V77, P5385, DOI 10.1073/pnas.77.9.5385; Lubchenco J, 2003, ECOL APPL, V13, pS3; MAGNELL BA, 1990, OCEANOGRAPHY     APR, P4; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; MCMILLAN WO, 1992, EVOLUTION, V46, P1299, DOI 10.1111/j.1558-5646.1992.tb01125.x; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; POWERS DA, 1978, BIOCHEM GENET, V16, P593, DOI 10.1007/BF00484222; Pringle JM, 2007, MAR ECOL PROG SER, V335, P69, DOI 10.3354/meps335069; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Rocha-Olivares A, 1999, CAN J FISH AQUAT SCI, V56, P803, DOI 10.1139/cjfas-56-5-803; ROUGHGARDEN J, 1991, ACTA OECOL, V12, P35; Schmidt PS, 2001, EVOLUTION, V55, P1336; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; Shanks AL, 1998, J EXP MAR BIOL ECOL, V222, P31, DOI 10.1016/S0022-0981(97)00135-4; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SLOCOMBE DS, 1993, BIOSCIENCE, V43, P612, DOI 10.2307/1312148; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Veliz D, 2004, J EVOLUTION BIOL, V17, P953, DOI 10.1111/j.1420-9101.2004.00753.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Wares JP, 2001, EVOLUTION, V55, P295; WATT WB, 1977, GENETICS, V87, P177	74	254	255	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8594	10.1371/journal.pone.0008594	http://dx.doi.org/10.1371/journal.pone.0008594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062807	Green Submitted, Green Published, gold			2022-12-27	WOS:000273414100004
J	Okorokov, AL; Chaban, YL; Bugreev, DV; Hodgkinson, J; Mazin, AV; Orlova, EV				Okorokov, Andrei L.; Chaban, Yuriy L.; Bugreev, Dmitry V.; Hodgkinson, Julie; Mazin, Alexander V.; Orlova, Elena V.			Structure of the hDmc1-ssDNA Filament Reveals the Principles of Its Architecture	PLOS ONE			English	Article							ESCHERICHIA-COLI RECA; N-TERMINAL DOMAIN; PROTEIN BINDS DNA; DOUBLE-STRAND BREAK; HUMAN DMC1 PROTEIN; MEIOTIC RECOMBINATION; CRYSTAL-STRUCTURE; HELICAL FILAMENTS; CHROMOSOME SYNAPSIS; SINGLE PARTICLES	In eukaryotes, meiotic recombination is a major source of genetic diversity, but its defects in humans lead to abnormalities such as Down's, Klinefelter's and other syndromes. Human Dmc1 (hDmc1), a RecA/Rad51 homologue, is a recombinase that plays a crucial role in faithful chromosome segregation during meiosis. The initial step of homologous recombination occurs when hDmc1 forms a filament on single-stranded (ss) DNA. However the structure of this presynaptic complex filament for hDmc1 remains unknown. To compare hDmc1-ssDNA complexes to those known for the RecA/Rad51 family we have obtained electron microscopy (EM) structures of hDmc1-ssDNA nucleoprotein filaments using single particle approach. The EM maps were analysed by docking crystal structures of Dmc1, Rad51, RadA, RecA and DNA. To fully characterise hDmc1-DNA complexes we have analysed their organisation in the presence of Ca(2+), Mg(2+), ATP, AMP-PNP, ssDNA and dsDNA. The 3D EM structures of the hDmc1-ssDNA filaments allowed us to elucidate the principles of their internal architecture. Similar to the RecA/Rad51 family, hDmc1 forms helical filaments on ssDNA in two states: extended (active) and compressed (inactive). However, in contrast to the RecA/Rad51 family, and the recently reported structure of hDmc1-double stranded (ds) DNA nucleoprotein filaments, the extended (active) state of the hDmc1 filament formed on ssDNA has nine protomers per helical turn, instead of the conventional six, resulting in one protomer covering two nucleotides instead of three. The control reconstruction of the hDmc1-dsDNA filament revealed 6.4 protein subunits per helical turn indicating that the filament organisation varies depending on the DNA templates. Our structural analysis has also revealed that the N-terminal domain of hDmc1 accomplishes its important role in complex formation through domain swapping between adjacent protomers, thus providing a mechanistic basis for coordinated action of hDmc1 protomers during meiotic recombination.	[Okorokov, Andrei L.] UCL, Wolfson Inst Biomed Res, London, England; [Chaban, Yuriy L.; Hodgkinson, Julie; Orlova, Elena V.] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; [Bugreev, Dmitry V.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	University of London; University College London; University of London; Birkbeck University London; Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Okorokov, AL (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London, England.	a.okorokov@ucl.ac.uk; e.orlova@mail.cryst.bbk.ac.uk	Orlova, Elena/CAF-8290-2022	Orlova, Elena/0000-0003-3371-415X; Okorokov, Andrei/0000-0003-2477-3254	the Leukemia and Lymphoma Society [1054-09]	the Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	AVM is supported by the Leukemia and Lymphoma Society Scholar Award 1054-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; BENSON FE, 1994, EMBO J, V13, P576; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bishop DK, 2006, CELL, V127, P1095, DOI 10.1016/j.cell.2006.11.029; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Chang YC, 2005, BIOCHEMISTRY-US, V44, P6052, DOI 10.1021/bi048897q; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen XG, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/01/002; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Egelman EH, 2001, J MOL BIOL, V309, P539, DOI 10.1006/jmbi.2001.4686; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kurumizaka H, 1996, J BIOL CHEM, V271, P33515, DOI 10.1074/jbc.271.52.33515; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Saxton W O, 1986, J Mol Biol, V187, P251, DOI 10.1016/0022-2836(86)90232-9; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xing X, 2004, J MOL BIOL, V342, P1471, DOI 10.1016/j.jmb.2004.07.091; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	56	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8586	10.1371/journal.pone.0008586	http://dx.doi.org/10.1371/journal.pone.0008586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062530	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000273338600010
J	Ahmed, RPH; Haider, KH; Shujia, J; Afzal, MR; Ashraf, M				Ahmed, Rafeeq P. H.; Haider, Khawaja Husnain; Shujia, Jiang; Afzal, Muhammad Rizwan; Ashraf, Muhammad			Sonic Hedgehog Gene Delivery to the Rodent Heart Promotes Angiogenesis via iNOS/Netrin-1/PKC Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; CELLS; TRANSPLANTATION; ACTIVATION; NETRIN-1; MOTILITY	Background: We hypothesized that genetic modification of mesenchymal stem cells (MSCs) with Sonic Hedgehog (Shh) transgene, a morphogen during embryonic development and embryonic and adult stem cell growth, improved their survival and angiogenic potential in the ischemic heart via iNOS/netrin/PKC pathway. Methods/Principal Findings: MSCs from young Fisher-344 rat bone marrow were purified and transfected with pCMV Shh plasmid ((MSCs)-M-Shh). Immunofluorescence, RT-PCR and Western blotting showed higher expression of Shh in (MSCs)-M-Shh which also led to increased expression of angiogenic and pro-survival growth factors in (MSCs)-M-Shh. Significantly improved migration and tube formation was seen in Shh MSCs as compared to empty vector transfected MSCs ((MSCs)-M-Emp). Significant upregulation of netrin-1 and iNOS was observed in (MSCs)-M-Shh in P13K independent but PKC dependent manner. For in vivo studies, acute myocardial infarction model was developed in Fisher-344 rats. The animals were grouped to receive 70 mu l basal DMEM without cells (group-1) or containing 1x10(6) (MSCs)-M-Emp (group-2) and (MSCs)-M-Shh (group-3). Group-4 received recombinant netrin-1 protein injection into the infarcted heart. FISH and sry-quantification revealed improved survival of (MSCs)-M-Shh post engraftment. Histological studies combined with fluorescent microspheres showed increased density of functionally competent blood vessels in group-3 and group-4. Echocardiography showed significantly preserved heart function indices post engraftment with (MSCs)-M-Shh in group-3 animals. Conclusions/Significance: Reprogramming of stem cells with Shh maximizes their survival and angiogenic potential in the heart via iNOS/netrin-1/PKC signaling.	[Ahmed, Rafeeq P. H.; Haider, Khawaja Husnain; Shujia, Jiang; Afzal, Muhammad Rizwan; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Ahmed, RPH (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA.	muhammad.ashraf@uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [R37-HL074272, HL-080686, HL087246, HL087288, HL089535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL074272, R01HL087288, R01HL089535, R01HL080686, R01HL087246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants #R37-HL074272; HL-080686; HL087246 to M.A. and HL087288; HL089535 to Kh.H.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; ANDREA JE, 1992, HYPERTENSION, V20, P585, DOI 10.1161/01.HYP.20.5.585; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Cooney R, 2006, J VASC RES, V43, P462, DOI 10.1159/000095163; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Jiang SJ, 2006, CIRC RES, V99, P776, DOI 10.1161/01.RES.0000244687.97719.4f; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Massard C, 2006, ANN ONCOL, V17, P1620, DOI 10.1093/annonc/mdl074; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Purdie KJ, 2002, CARDIOVASC RES, V54, P659, DOI 10.1016/S0008-6363(02)00255-9; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; STRAFACE G, 2008, J CELL MOL MED; Sun MH, 2005, WORLD J GASTROENTERO, V11, P5931, DOI 10.3748/wjg.v11.i38.5931; White D, 2007, J EXP BIOL, V210, P4053, DOI 10.1242/jeb.007013; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9	27	59	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8576	10.1371/journal.pone.0008576	http://dx.doi.org/10.1371/journal.pone.0008576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052412	Green Submitted, gold, Green Published			2022-12-27	WOS:000273338500019
J	Kelker, HC; Itri, VR; Valentine, FT				Kelker, Hanna C.; Itri, Vincenza R.; Valentine, Fred T.			A Strategy for Eliciting Antibodies against Cryptic, Conserved, Conformationally Dependent Epitopes of HIV Envelope Glycoprotein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; CLADE NEUTRALIZING ACTIVITY; HIV-1/SIV CHIMERIC VIRUS; CD4 BINDING-SITE; TYPE-1 GP120; GLYCOSYLATION SITES; PASSIVE TRANSFER; DISULFIDE BONDS; PEPTIDE	Background: Novel strategies are needed for the elicitation of broadly neutralizing antibodies to the HIV envelope glycoprotein, gp120. Experimental evidence suggests that combinations of antibodies that are broadly neutralizing in vitro may protect against challenge with HIV in nonhuman primates, and a small number of these antibodies have been selected by repertoire sampling of B cells and by the fractionation of antiserum from some patients with prolonged disease. Yet no additional strategies for identifying conserved epitopes, eliciting antibodies to these epitopes, and determining whether these epitopes are accessible to antibodies have been successful to date. The defining of additional conserved, accessible epitopes against which one can elicit antibodies will increase the probability that some may be the targets of broadly neutralizing antibodies. Methodology/Principal Findings: We postulate that additional cryptic epitopes of gp120 are present, against which neutralizing antibodies might be elicited even though these antibodies are not elicited by gp120, and that many of these epitopes may be accessible to antibodies should they be formed. We demonstrate a strategy for eliciting antibodies in mice against selected cryptic, conformationally dependent conserved epitopes of gp120 by immunizing with multiple identical copies of covalently linked peptides (MCPs). This has been achieved with MCPs representing 3 different domains of gp120. We show that some cryptic epitopes on gp120 are accessible to the elicited antibodies, and some epitopes in the CD4 binding region are not accessible. The antibodies bind to gp120 with relatively high affinity, and bind to oligomeric gp120 on the surface of infected cells. Conclusions/Significance: Immunization with MCPs comprised of selected peptides of HIV gp120 is able to elicit antibodies against conserved, conformationally dependent epitopes of gp120 that are not immunogenic when presented as gp120. Some of these cryptic epitopes are accessible to the elicited antibodies.	[Kelker, Hanna C.; Itri, Vincenza R.; Valentine, Fred T.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Valentine, Fred T.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Kelker, HC (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	Fred.Valentine@nyumc.org		Valentine, Fred/0000-0002-6046-5913	National Institutes of Health [RO1 AI43898]; New York University Center for AIDS Research [P30AI27742]; Robert Farber Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for AIDS Research; Robert Farber Foundation	National Institutes of Health grants: RO1 AI43898, the New York University Center for AIDS Research grant P30AI27742 and a grant from the Robert Farber Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Baba T, 2000, MOL CELL BIOCHEM, V206, P1, DOI 10.1023/A:1007007626813; Boots LJ, 1997, AIDS RES HUM RETROV, V13, P1549, DOI 10.1089/aid.1997.13.1549; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Cole KS, 2004, J VIROL, V78, P1525, DOI 10.1128/JVI.78.3.1525-1539.2004; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Graham BS, 2005, J INFECT DIS, V191, P647, DOI 10.1086/428406; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Haynes BF, 2006, EXPERT REV VACCINES, V5, P347, DOI 10.1586/14760584.5.3.347; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; KELKER HC, 1994, J IMMUNOL, V152, P4139; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kumar A, 2000, VIROLOGY, V274, P149, DOI 10.1006/viro.2000.0444; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montefiori David C., 1999, AIDS Research and Human Retroviruses, V15, P689, DOI 10.1089/088922299310773; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; POSNER MR, 1991, J IMMUNOL, V146, P4325; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Ren XP, 2005, J VIROL, V79, P5616, DOI 10.1128/JVI.79.9.5616-5624.2005; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sanders RW, 2008, MOL BIOL CELL, V19, P4707, DOI 10.1091/mbc.E08-07-0670; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; SUN NC, 1989, J VIROL, V63, P3579, DOI 10.1128/JVI.63.9.3579-3585.1989; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yuan W, 2005, VIROLOGY, V332, P369, DOI 10.1016/j.virol.2004.11.013; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zwick MB, 2001, J VIROL, V75, P6692, DOI 10.1128/JVI.75.14.6692-6699.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	68	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8555	10.1371/journal.pone.0008555	http://dx.doi.org/10.1371/journal.pone.0008555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052405	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338500005
J	Holman, RC; Belay, ED; Christensen, KY; Maddox, RA; Minino, AM; Folkema, AM; Haberling, DL; Hammett, TA; Kochanek, KD; Sejvar, JJ; Schonberger, LB				Holman, Robert C.; Belay, Ermias D.; Christensen, Krista Y.; Maddox, Ryan A.; Minino, Arialdi M.; Folkema, Arianne M.; Haberling, Dana L.; Hammett, Teresa A.; Kochanek, Kenneth D.; Sejvar, James J.; Schonberger, Lawrence B.			Human Prion Diseases in the United States	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; NATIONAL MORTALITY DATA; DEATH CERTIFICATES; PROTEIN; CLASSIFICATION; EPIDEMIOLOGY; CANADA	Background: Prion diseases are a family of rare, progressive, neurodegenerative disorders that affect humans and animals. The most common form of human prion disease, Creutzfeldt-Jakob disease (CJD), occurs worldwide. Variant CJD (vCJD), a recently emerged human prion disease, is a zoonotic foodborne disorder that occurs almost exclusively in countries with outbreaks of bovine spongiform encephalopathy. This study describes the occurrence and epidemiology of CJD and vCJD in the United States. Methodology/Principal Findings: Analysis of CJD and vCJD deaths using death certificates of US residents for 1979-2006, and those identified through other surveillance mechanisms during 1996-2008. Since CJD is invariably fatal and illness duration is usually less than one year, the CJD incidence is estimated as the death rate. During 1979 through 2006, an estimated 6,917 deaths with CJD as a cause of death were reported in the United States, an annual average of approximately 247 deaths (range 172-304 deaths). The average annual age-adjusted incidence for CJD was 0.97 per 1,000,000 persons. Most (61.8%) of the CJD deaths occurred among persons >= 65 years of age for an average annual incidence of 4.8 per 1,000,000 persons in this population. Most deaths were among whites (94.6%); the age-adjusted incidence for whites was 2.7 times higher than that for blacks (1.04 and 0.40, respectively). Three patients who died since 2004 were reported with vCJD; epidemiologic evidence indicated that their infection was acquired outside of the United States. Conclusion/Significance: Surveillance continues to show an annual CJD incidence rate of about 1 case per 1,000,000 persons and marked differences in CJD rates by age and race in the United States. Ongoing surveillance remains important for monitoring the stability of the CJD incidence rates, and detecting occurrences of vCJD and possibly other novel prion diseases in the United States.	[Holman, Robert C.; Belay, Ermias D.; Christensen, Krista Y.; Maddox, Ryan A.; Folkema, Arianne M.; Haberling, Dana L.; Hammett, Teresa A.; Sejvar, James J.; Schonberger, Lawrence B.] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, US Dept HHS, Atlanta, GA 30333 USA; [Minino, Arialdi M.; Kochanek, Kenneth D.] Ctr Dis Control & Prevent, Div Vital Stat, Natl Ctr Hlth Stat, US Dept HHS, Hyattsville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Holman, RC (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, US Dept HHS, Atlanta, GA 30333 USA.	rholman@cdc.gov	Belay, Ermias/A-8829-2013	Haberling, Dana/0000-0002-3871-8216; Christensen, Krista/0000-0003-4431-336X; Belay, Ermias/0000-0002-9837-0960				[Anonymous], 1992, INT STAT CLASS DIS R, V1-3; Belay ED, 2005, ANNU REV PUBL HEALTH, V26, P191, DOI 10.1146/annurev.publhealth.26.021304.144536; Belay ED, 2005, EMERG INFECT DIS, V11, P1351, DOI 10.3201/eid1109.050371; Belay ED, 2005, CLIN INFECT DIS, V41, P834, DOI 10.1086/432726; Belay ED, 2003, NEUROLOGY, V60, P176, DOI 10.1212/01.WNL.0000036913.87823.D6; Belay ED, 2002, CLIN LAB MED, V22, P849, DOI 10.1016/S0272-2712(02)00024-0; Belay ED, 1999, ANNU REV MICROBIOL, V53, P283, DOI 10.1146/annurev.micro.53.1.283; Brown P, 2001, EMERG INFECT DIS, V7, P6, DOI 10.3201/eid0701.010102; *BUR CENS, 2008, INT EST POP AG SEX R; *CDC, VAR C JAK DIS; *CDC, 1996, MMWR-MORBID MORTAL W, V45, P665; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; DAVANIPOUR Z, 1995, NEUROEPIDEMIOLOGY, V14, P1, DOI 10.1159/000109771; deSilva R, 1997, POSTGRAD MED J, V73, P557, DOI 10.1136/pgmj.73.863.557; *DHHS CDC NCHS, MORT DAT NAT VIT STA; ElSaadany S, 2005, NEUROEPIDEMIOLOGY, V24, P15, DOI 10.1159/000081044; GAJDUSEK DC, 1996, FIELDS VIROLOGY, V2, P2851; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghosh S, 2004, ADV DRUG DELIVER REV, V56, P915, DOI 10.1016/j.addr.2003.10.035; Gibbons RV, 2000, JAMA-J AM MED ASSOC, V284, P2322, DOI 10.1001/jama.284.18.2322; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Holman RC, 1996, EMERG INFECT DIS, V2, P333, DOI 10.3201/eid0204.960409; HOLMAN RC, 1995, NEUROEPIDEMIOLOGY, V14, P174, DOI 10.1159/000109793; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Klein RJSC., 2001, HLTH PEOPLE STAT NOT, V20; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Klug GM, 2006, COMMUN DIS INTELL, V30, P144; KOVANEN J, 1988, ACTA NEUROL SCAND, V77, P474, DOI 10.1111/j.1600-0404.1988.tb05943.x; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; MAYTENYI K, 1991, EUR J EPIDEMIOL, V7, P457, DOI 10.1007/BF00143121; Melonie Heron Ph.D, 2009, NATL VITAL STAT REPO, V57; MOORE RA, 2009, CURR OPIN STRUC 0119; *NAT CTR HLTH STAT, 1984, PUBL US DAT TAP DOC; National Center for Health Statistics, 1985, PUBL US DAT TAP DOC; *NCJDSU, C JAK DIS SURV; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; *US BUR CENS, CENS REG DIV US; *US DEP HHS, 2008, VIT STAT MORT DAT MU; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; WHO, 1977, MAN INT STAT CLASS D, V1; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Will Robert G., 2004, VVolume 41, P629; Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003; WORLD ANIMAL HLTH SI; BSE BOVINE SPONGIFOR	47	64	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8521	10.1371/journal.pone.0008521	http://dx.doi.org/10.1371/journal.pone.0008521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049325	Green Published, gold			2022-12-27	WOS:000273225000004
J	D'Orsogna, MR; Chou, T				D'Orsogna, Maria R.; Chou, Tom			Optimal Cytoplasmic Transport in Viral Infections	PLOS ONE			English	Article							TRIM5-ALPHA RESTRICTION FACTOR; PROCESSIVE RUN-LENGTH; VIRUS TYPE-1 CORE; REVERSE-TRANSCRIPTASE; NONDIVIDING CELLS; INTRACELLULAR TRAFFICKING; ENVELOPED VIRUSES; REPLICATION; MUTATIONS; HIV	For many viruses, the ability to infect eukaryotic cells depends on their transport through the cytoplasm and across the nuclear membrane of the host cell. During this journey, viral contents are biochemically processed into complexes capable of both nuclear penetration and genomic integration. We develop a stochastic model of viral entry that incorporates all relevant aspects of transport, including convection along microtubules, biochemical conversion, degradation, and nuclear entry. Analysis of the nuclear infection probabilities in terms of the transport velocity, degradation, and biochemical conversion rates shows how certain values of key parameters can maximize the nuclear entry probability of the viral material. The existence of such "optimal" infection scenarios depends on the details of the biochemical conversion process and implies potentially counterintuitive effects in viral infection, suggesting new avenues for antiviral treatment. Such optimal parameter values provide a plausible transport-based explanation of the action of restriction factors and of experimentally observed optimal capsid stability. Finally, we propose a new interpretation of how genetic mutations unrelated to the mechanism of drug action may nonetheless confer novel types of overall drug resistance.	[D'Orsogna, Maria R.] Calif State Univ Northridge, Dept Math, Los Angeles, CA USA; [Chou, Tom] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Chou, Tom] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90024 USA	California State University System; California State University Northridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	D'Orsogna, MR (corresponding author), Calif State Univ Northridge, Dept Math, Los Angeles, CA USA.	tomchou@ucla.edu			Division of Mathematical Sciences of the National Science Foundation [DMS-0719462, DMS-0349195]; National Institutes of Health [K25AI058672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI058672] Funding Source: NIH RePORTER	Division of Mathematical Sciences of the National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Mathematical Sciences of the National Science Foundation through grants DMS-0719462 (MRD) and DMS-0349195 (TC), and by the National Institutes of Health through grant K25AI058672 (TC). Part of this work was performed during the "Optimal Transport" program at the Institute for Pure and Applied Mathematics (IPAM) at University of California, Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2005, GENE THER, V12, P1667, DOI 10.1038/sj.gt.3302591; Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Baldanti F, 2003, AIDS, V17, P1568, DOI 10.1097/00002030-200307040-00021; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bukrinsky M, 2004, MOL MED, V10, P1; Cherwa JE, 2009, J VIROL, V83, P11746, DOI 10.1128/JVI.01297-09; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Chou T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2764053; Dee KU, 1997, BIOTECHNOL BIOENG, V54, P468, DOI 10.1002/(SICI)1097-0290(19970605)54:5<468::AID-BIT7>3.0.CO;2-C; Dinh AT, 2005, BIOPHYS J, V89, P1574, DOI 10.1529/biophysj.105.059477; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Fields B. N., 2007, FIELDS VIROLOGY; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gao YQ, 2006, BIOPHYS J, V90, P811, DOI 10.1529/biophysj.105.073189; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOLEMAN D, 2008, SIAM J APPL MATH, V68, P1146; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Krogstad P, 1996, AIDS RES HUM RETROV, V12, P977, DOI 10.1089/aid.1996.12.977; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; LUBYPHELPS K, 1988, CELL MOTIL CYTOSKEL, V10, P28, DOI 10.1002/cm.970100107; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Naeger LK, 2001, ANTIVIR THER, V6, P115; Nowak SA, 2009, BIOPHYS J, V96, P2624, DOI 10.1016/j.bpj.2009.01.018; Paolucci S, 2004, ANTIMICROB AGENTS CH, V48, P4611, DOI 10.1128/AAC.48.12.4611-4617.2004; PARKIN N, 2003, ANTIVIR THER, V8, pS31; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sharma PL, 1999, J VIROL, V73, P8448, DOI 10.1128/JVI.73.10.8448-8456.1999; Singh MP, 2005, P NATL ACAD SCI USA, V102, P12059, DOI 10.1073/pnas.0501570102; Smith DA, 2001, BIOPHYS J, V80, P45, DOI 10.1016/S0006-3495(01)75994-2; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Thomas JA, 2008, J VIROL, V82, P9318, DOI 10.1128/JVI.00583-08; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; Vodicka Marie A., 2001, Somatic Cell and Molecular Genetics, V26, P35, DOI 10.1023/A:1021022629126; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8165	10.1371/journal.pone.0008165	http://dx.doi.org/10.1371/journal.pone.0008165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20046829	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700001
J	Domingues, MM; Castanho, MARB; Santos, NC				Domingues, Marco M.; Castanho, Miguel A. R. B.; Santos, Nuno C.			rBPI(21) Promotes Lipopolysaccharide Aggregation and Exerts Its Antimicrobial Effects by (Hemi)fusion of PG-Containing Membranes	PLOS ONE			English	Article							BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; LPS-BINDING-PROTEIN; INTEGRAL-EQUATIONS; TERMINAL FRAGMENT; ESCHERICHIA-COLI; LIGHT-SCATTERING; HOST-DEFENSE; PEPTIDES; BACTERIAL; BPI	Antimicrobial peptides (AMPs) are important potential alternatives to conventional therapies against bacterial infections. rBPI(21) is a 21 kDa peptide based on the N-terminal region of the neutrophil bactericidal/permeability-increasing protein (BPI). This AMP possesses highly selective bactericidal effects on Gram-negative bacteria and have affinity for lipopolysaccharide (LPS) which is believed to be at the origin of its neutralizing effect of the LPS segregated into the bloodstream. We aim at understanding the molecular bases of rBPI(21) bactericidal and LPS neutralization actions, using biomembrane model systems. Using dynamic light scattering spectroscopy we demonstrate that rBPI(21) promotes aggregation of negatively charged large unilamellar vesicles (LUV), even in the absence of LPS, and LPS aggregates, while for zwitterionic phosphatidylcholine (POPC) LUV the size remains unchanged. The peptide also promotes the fusion (or hemifusion) of membranes containing phosphatidylglycerol (POPG). The aggregation and fusion of negatively charged LUV are peptide concentration-dependent until massive aggregation is reached, followed by sample flocculation/precipitation. Concomitantly, there is a progressive change in the zeta-potential of the LUV systems and LPS aggregates. LUV systems composed of phosphatidylglycerol (POPG) and lipid mixtures with POPG have higher zeta-potential variations than in the absence of POPG. The interaction of rBPI(21) with lipid vesicles is followed by leakage, with higher effect in POPG-containing membranes. LPS aggregation can be related with a decreased toxicity, possibly by facilitating its clearance by macrophage phagocytosis and/or blocking of LPS specific receptor recognition. Our data indicate that rBPI(21) mechanism of action at the molecular level involves the interaction with the LPS of the outer membrane of Gram-negative bacteria, followed by internalization and leakage induction through the (hemi) fusion of the bacterial outer and inner membranes, both enriched in phosphatidylglycerol.	[Domingues, Marco M.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	Universidade de Lisboa	Domingues, MM (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.	nsantos@fm.ul.pt	Santos, Nuno/N-7248-2013; Domingues, Marco/AAA-9690-2021	Santos, Nuno/0000-0002-0580-0475; FCCN, Bogus/0000-0003-1034-3552; Domingues, Marco/0000-0003-1502-1421; FCCN, Bogus/0000-0001-6282-8004; Castanho, Miguel/0000-0001-7891-7562	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/41750/2007]; Ministerio da Ciencia, Tecnologia e Ensino Superior (Portugal)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministerio da Ciencia, Tecnologia e Ensino Superior (Portugal)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT), from the Ministerio da Ciencia, Tecnologia e Ensino Superior (Portugal). M. M. D. acknowledges FCT PhD fellowship SFRH/BD/41750/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELMELK BJ, 1994, INFECT IMMUN, V62, P3564, DOI 10.1128/IAI.62.8.3564-3567.1994; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 1999, BIOCHEM PHARMACOL, V57, P225, DOI 10.1016/S0006-2952(98)00279-2; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; CAPODICI C, 1994, INFECT IMMUN, V62, P259, DOI 10.1128/IAI.62.1.259-265.1994; Dawson RM, 2008, CRIT REV MICROBIOL, V34, P89, DOI [10.1080/10408410802143808, 10.1080/10408410802143808 ]; DeMeulenaer B, 1997, J COLLOID INTERF SCI, V189, P254, DOI 10.1006/jcis.1997.4789; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Domingues MM, 2009, BIOPHYS J, V96, P987, DOI 10.1016/j.bpj.2008.10.044; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Garcia-Verdugo I, 2005, BIOCHEM J, V391, P115, DOI 10.1042/BJ20050529; Garcia-Verdugo I, 2007, BIOPHYS J, V93, P3529, DOI 10.1529/biophysj.107.109793; GAZZANOSANTORO H, 1992, INFECT IMMUN, V60, P4754, DOI 10.1128/IAI.60.11.4754-4761.1992; Gura T, 2001, SCIENCE, V291, P2068, DOI 10.1126/science.291.5511.2068; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Herbig ME, 2005, BBA-BIOMEMBRANES, V1712, P197, DOI 10.1016/j.bbamem.2005.04.006; Horwitz AH, 2000, PROTEIN EXPRES PURIF, V18, P77, DOI 10.1006/prep.1999.1163; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; LEEUWENBERG JFM, 1994, J IMMUNOL, V152, P5070; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Muller M, 2003, J MEMBRANE BIOL, V192, P33, DOI 10.1007/s00232-002-1062-0; Nomura K, 2008, BIOPHYS J, V95, P1226, DOI 10.1529/biophysj.108.131706; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; SCHUMANN RR, 1992, RES IMMUNOL, V143, P11, DOI 10.1016/0923-2494(92)80074-U; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; van Balen GP, 2004, MED RES REV, V24, P299, DOI 10.1002/med.10063; WEISS J, 1978, J BIOL CHEM, V253, P2664; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10311, DOI 10.1021/bi970177e; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10301, DOI 10.1021/bi970176m	41	65	66	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8385	10.1371/journal.pone.0008385	http://dx.doi.org/10.1371/journal.pone.0008385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027298	gold, Green Published, Green Submitted			2022-12-27	WOS:000272998000002
J	Hamm, CA; Xie, HH; Costa, FF; Vanin, EF; Seftor, EA; Sredni, ST; Bischof, J; Wang, DL; Bonaldo, MF; Hendrix, MJC; Soares, MB				Hamm, Christopher A.; Xie, Hehuang; Costa, Fabricio F.; Vanin, Elio F.; Seftor, Elisabeth A.; Sredni, Simone T.; Bischof, Jared; Wang, Deli; Bonaldo, Maria F.; Hendrix, Mary J. C.; Soares, Marcelo B.			Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2 '-Deoxycytidine Results in Increased Tumorigenicity	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; DNA METHYLATION; GENE-EXPRESSION; BREAST-CANCER; SILENCED GENES; MESSENGER-RNA; HUMAN GENOME; STEM-CELLS; MIDKINE; METHYLTRANSFERASE	Abnormal patterns of DNA methylation are observed in several types of human cancer. While localized DNA methylation of CpG islands has been associated with gene silencing, the effect that genome-wide loss of methylation has on tumorigenesis is not completely known. To examine its effect on tumorigenesis, we induced DNA demethylation in a rat model of human chondrosarcoma using 5-aza-2-deoxycytidine. Rat specific pyrosequencing assays were utilized to assess the methylation levels in both LINEs and satellite DNA sequences following 5-aza-2-deoxycytidine treatment. Loss of DNA methylation was accompanied by an increase in invasiveness of the rat chondrosarcoma cells, in vitro, as well as by an increase in tumor growth in vivo. Subsequent microarray analysis provided insight into the gene expression changes that result from 5-aza-2-deoxycytidine induced DNA demethylation. In particular, two genes that may function in tumorigenesis, sox-2 and midkine, were expressed at low levels in control cells but upon 5-aza-2-deoxycytidine treatment these genes became overexpressed. Promoter region DNA analysis revealed that these genes were methylated in control cells but became demethylated following 5-aza-2-deoxycytidine treatment. Following withdrawal of 5-aza-2-deoxycytidine, the rat chondrosarcoma cells reestablished global DNA methylation levels that were comparable to that of control cells. Concurrently, invasiveness of the rat chondrosarcoma cells, in vitro, decreased to a level indistinguishable to that of control cells. Taken together these experiments demonstrate that global DNA hypomethylation induced by 5-aza-2-deoxycytidine may promote specific aspects of tumorigenesis in rat chondrosarcoma cells.	[Hamm, Christopher A.] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA; [Hamm, Christopher A.; Xie, Hehuang; Costa, Fabricio F.; Vanin, Elio F.; Seftor, Elisabeth A.; Sredni, Simone T.; Bischof, Jared; Bonaldo, Maria F.; Hendrix, Mary J. C.; Soares, Marcelo B.] Childrens Mem Res Ctr, Falk Brain Tumor Ctr, Canc Biol & Epigenom Program, Chicago, IL USA; [Xie, Hehuang; Bonaldo, Maria F.; Hendrix, Mary J. C.; Soares, Marcelo B.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Deli] Northwestern Univ, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	University of Iowa; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Hamm, CA (corresponding author), Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA.	mbsoares@childrensmemorial.org	Costa, Fabricio/M-5309-2017	Sredni, Simone/0000-0002-1715-3885	The Everett/O'Connor Charitable Trust; Dr. Ralph and Marian C. Falk Medical Research Trust; Gus Foundation; The Maeve McNicholas Memorial Foundation; Medical Research Institute Council	The Everett/O'Connor Charitable Trust; Dr. Ralph and Marian C. Falk Medical Research Trust; Gus Foundation; The Maeve McNicholas Memorial Foundation; Medical Research Institute Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Everett/O'Connor Charitable Trust; Dr. Ralph and Marian C. Falk Medical Research Trust; Gus Foundation; The Maeve McNicholas Memorial Foundation; Medical Research Institute Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2002, VIRCHOWS ARCH, V441, P219, DOI 10.1007/s00428-002-0641-X; Asp J, 2001, J ORTHOPAED RES, V19, P149, DOI 10.1016/S0736-0266(00)00022-X; Asp J, 2000, INT J CANCER, V85, P782, DOI 10.1002/(SICI)1097-0215(20000315)85:6<782::AID-IJC7>3.0.CO;2-O; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Cayre A, 2003, BREAST CANCER RES, V5, pR223, DOI 10.1186/bcr652; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHOI HU, 1971, P NATL ACAD SCI USA, V68, P877, DOI 10.1073/pnas.68.5.877; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Costa FF, 2006, CANCER GENET CYTOGEN, V165, P135, DOI 10.1016/j.cancergencyto.2005.07.023; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Ijichi N, 2004, J BIOCHEM, V135, P413, DOI 10.1093/jb/mvh049; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Kato M, 2000, MODERN PATHOL, V13, P1060, DOI 10.1038/modpathol.3880195; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Lee FY, 1999, J BONE JOINT SURG AM, V81A, P326, DOI 10.2106/00004623-199903000-00004; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; MAIBENCO HC, 1967, CANCER RES, V27, P362; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Morcuende Jose A, 2002, Iowa Orthop J, V22, P28; Mund C, 2005, CANCER RES, V65, P7086, DOI 10.1158/0008-5472.CAN-05-0695; Mund C, 2006, EPIGENETICS-US, V1, P7; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Ropke M, 2003, PATHOL RES PRACT, V199, P437, DOI 10.1078/0344-0338-00443; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Sanada Y, 2006, ONCOL REP, V15, P1157; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Soderstrom M, 2001, MATRIX BIOL, V19, P717, DOI 10.1016/S0945-053X(00)00124-4; Soderstrom M, 2001, APMIS, V109, P305, DOI 10.1034/j.1600-0463.2001.d01-125.x; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Stevens Jeff W, 2005, Iowa Orthop J, V25, P135; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Stuart JJ, 2000, BIOCHEM BIOPH RES CO, V274, P641, DOI 10.1006/bbrc.2000.3189; Takai Daiya, 2003, In Silico Biology, V3, P235; Tanabe K, 2008, CANCER SCI, V99, P1125, DOI 10.1111/j.1349-7006.2008.00796.x; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028; Zou P, 2006, J NEUROCHEM, V99, P1470, DOI 10.1111/j.1471-4159.2006.04138.x	55	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8340	10.1371/journal.pone.0008340	http://dx.doi.org/10.1371/journal.pone.0008340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019818	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834200007
J	Salas, A; Fachal, L; Marcos-Alonso, S; Vega, A; Martinon-Torres, F				Salas, Antonio; Fachal, Laura; Marcos-Alonso, Sonia; Vega, Ana; Martinon-Torres, Federico		Grp Invest ESIGEM	Investigating the Role of Mitochondrial Haplogroups in Genetic Predisposition to Meningococcal Disease	PLOS ONE			English	Article							SPORADIC BREAST-CANCER; NEISSERIA-MENINGITIDIS; POPULATION-STRUCTURE; HUMAN MTDNA; DNA; PHYLOGENY; ANCESTRY; EVOLUTIONARY; MUTATIONS; SURVIVAL	Background and Aims: Meningococcal disease remains one of the most important infectious causes of death in industrialized countries. The highly diverse clinical presentation and prognosis of Neisseria meningitidis infections are the result of complex host genetics and environmental interactions. We investigated whether mitochondrial genetic background contributes to meningococcal disease (MD) susceptibility. Methodology/Principal Findings: Prospective controlled study was performed through a national research network on MD that includes 41 Spanish hospitals. Cases were 307 paediatric patients with confirmed MD, representing the largest series of MD patients analysed to date. Two independent sets of ethnicity-matched control samples (CG1 [N = 917]), and CG2 [N = 616]) were used for comparison. Cases and controls underwent mtDNA haplotyping of a selected set of 25 mtDNA SNPs (mtSNPs), some of them defining major European branches of the mtDNA phylogeny. In addition, 34 ancestry informative markers (AIMs) were genotyped in cases and CG2 in order to monitor potential hidden population stratification. Samples of known African, Native American and European ancestry (N = 711) were used as classification sets for the determination of ancestral membership of our MD patients. A total of 39 individuals were eliminated from the main statistical analyses (including fourteen gypsies) on the basis of either non-Spanish self-reported ancestry or the results of AIMs indicating a European membership lower than 95%. Association analysis of the remaining 268 cases against CG1 suggested an overrepresentation of the synonym mtSNP G11719A variant (Pearson's chi-square test; adjusted P-value = 0.0188; OR [95% CI] = 1.63 [1.22-2.18]). When cases were compared with CG2, the positive association could not be replicated. No positive association has been observed between haplogroup (hg) status of cases and CG1/CG2 and hg status of cases and several clinical variants. Conclusions: We did not find evidence of association between mtSNPs and mtDNA hgs with MD after carefully monitoring the confounding effect of population sub-structure. MtDNA variability is particularly stratified in human populations owing to its low effective population size in comparison with autosomal markers and therefore, special care should be taken in the interpretation of seeming signals of positive associations in mtDNA case-control association studies.	[Salas, Antonio; Fachal, Laura] Univ Santiago de Compostela, Unidad Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain; [Salas, Antonio; Fachal, Laura] Univ Santiago de Compostela, Inst Med Legal, Santiago De Compostela, Galicia, Spain; [Fachal, Laura; Vega, Ana] Hosp Clin Univ Santiago, Fdn Publ Galega Med Xenom, Santiago De Compostela, Galicia, Spain; [Marcos-Alonso, Sonia] Hosp Univ A Coruna, Serv Pediat, La Coruna, Galicia, Spain; [Martinon-Torres, Federico] Hosp Clin Univ Santiago, Serv Crit Intermedios & Urgencias Pediat, Santiago De Compostela, Galicia, Spain; [Martinon-Torres, Federico] Inst Invest Sanitaria Santiago, Grp Gallego Genet Vacunas & Invest Pediat, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complejo Hospitalario Universitario A Coruna; Complexo Hospitalario Universitario de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Unidad Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Fachal, Laura/N-5560-2014; Vega, Ana/R-4758-2019; Salas, Antonio/E-3977-2012; Miguel, Ana Mosquera/ABG-9735-2020; Martinon-Torres, Federico/E-4982-2016; Salas, Antonio/U-2029-2019	Fachal, Laura/0000-0002-7256-9752; Salas, Antonio/0000-0002-2336-702X; Miguel, Ana Mosquera/0000-0003-3939-8338; Martinon-Torres, Federico/0000-0002-9023-581X; Salas, Antonio/0000-0002-2336-702X; Esteban, Elisabeth/0000-0003-0159-0375; Concha-Torre, Andres/0000-0002-0698-1570; Munoz-Bonet, Juan Ignacio/0000-0003-4392-6834	Xunta de Galicia [PGIDIT06PXIB208079PR, Grupos Emerxentes: 2008/037]; Fundacion de Investigacion Medica Mutua Madrilena [2008/CL444]; Ministerio de Ciencia e Innovacion [SAF2008-02971]; Instituto Carlos III (Intensificacion de la actividad investigadora); Conselleria de Sanidade [RHI07/2-intensificacion actividad investigadora]; Instituto Carlos III; Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS); Fondo de Investigacion Sanitaria [PI070069]; 'fondos FEDER'	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); Conselleria de Sanidade; Instituto Carlos III(Instituto de Salud Carlos III); Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); 'fondos FEDER'(European Commission)	The present project and the ESIGEM research group were supported by grants from Xunta de Galicia (PGIDIT06PXIB208079PR and Grupos Emerxentes: 2008/037), Fundacion de Investigacion Medica Mutua Madrilena (2008/CL444) and Ministerio de Ciencia e Innovacion (SAF2008-02971) given to AS; Instituto Carlos III (Intensificacion de la actividad investigadora) given to AVG; Conselleria de Sanidade (Xunta de Galicia, RHI07/2-intensificacion actividad investigadora), Instituto Carlos III (Intensificacion de la actividad investigadora), and Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS), Fondo de Investigacion Sanitaria (FIS; PI070069) del plan nacional de I+D+I and 'fondos FEDER' given to FMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Amigo J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S3-S5; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chinnery PF, 1999, LANCET, V354, pSI17; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Hodgetts TJ, 1998, J ACCID EMERG MED, V15, P72; Houshmand M, 2007, RESPIROLOGY, V12, P823, DOI 10.1111/j.1440-1843.2007.01163.x; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Ioannidis JPA, 2007, PLOS MED, V4, P1132, DOI 10.1371/journal.pmed.0040215; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2007, REV CLIN ESP, V207, P563, DOI 10.1157/13111575; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vega A, 2009, GYNECOL ONCOL, V112, P210, DOI 10.1016/j.ygyno.2008.09.012; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343	55	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8347	10.1371/journal.pone.0008347	http://dx.doi.org/10.1371/journal.pone.0008347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019817	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834200013
J	Feng, WG; Leach, SM; Tipney, H; Phang, T; Geraci, M; Spritz, RA; Hunter, LE; Williams, T				Feng, Weiguo; Leach, Sonia M.; Tipney, Hannah; Phang, Tzulip; Geraci, Mark; Spritz, Richard A.; Hunter, Lawrence E.; Williams, Trevor			Spatial and Temporal Analysis of Gene Expression during Growth and Fusion of the Mouse Facial Prominences	PLOS ONE			English	Article							CRANIOFACIAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; TRANSCRIPTIONAL CONTROL; MICROARRAY ANALYSIS; CLEFT LIP/PALATE; BRANCHIAL ARCH; NEURAL CREST; CELLS; DIFFERENTIATION; MICE	Orofacial malformations resulting from genetic and/or environmental causes are frequent human birth defects yet their etiology is often unclear because of insufficient information concerning the molecular, cellular and morphogenetic processes responsible for normal facial development. We have, therefore, derived a comprehensive expression dataset for mouse orofacial development, interrogating three distinct regions - the mandibular, maxillary and frontonasal prominences. To capture the dynamic changes in the transcriptome during face formation, we sampled five time points between E10.5-E12.5, spanning the developmental period from establishment of the prominences to their fusion to form the mature facial platform. Seven independent biological replicates were used for each sample ensuring robustness and quality of the dataset. Here, we provide a general overview of the dataset, characterizing aspects of gene expression changes at both the spatial and temporal level. Considerable coordinate regulation occurs across the three prominences during this period of facial growth and morphogenesis, with a switch from expression of genes involved in cell proliferation to those associated with differentiation. An accompanying shift in the expression of polycomb and trithorax genes presumably maintains appropriate patterns of gene expression in precursor or differentiated cells, respectively. Superimposed on the many coordinated changes are prominence-specific differences in the expression of genes encoding transcription factors, extracellular matrix components, and signaling molecules. Thus, the elaboration of each prominence will be driven by particular combinations of transcription factors coupled with specific cell: cell and cell: matrix interactions. The dataset also reveals several prominence-specific genes not previously associated with orofacial development, a subset of which we externally validate. Several of these latter genes are components of bidirectional transcription units that likely share cis-acting sequences with well-characterized genes. Overall, our studies provide a valuable resource for probing orofacial development and a robust dataset for bioinformatic analysis of spatial and temporal gene expression changes during embryogenesis.	[Feng, Weiguo; Williams, Trevor] Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO USA; [Williams, Trevor] Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO USA; [Leach, Sonia M.; Tipney, Hannah; Phang, Tzulip; Hunter, Lawrence E.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Geraci, Mark] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Spritz, Richard A.] Univ Colorado Denver, Human Med Genet Program, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Feng, WG (corresponding author), Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO USA.	trevor.williams@ucdenver.edu	wang, edwin/G-5372-2010	Hunter, Lawrence/0000-0003-1455-3370	National Institutes of Health [DE15191 (R.A.S.), LM008111 (L.E.H.), GM083649 (L.E.H.), DE12728 (T.W.)]; An institutional training [T15LM009451]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083649] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008111, T15LM009451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); An institutional training; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by National Institutes of Health Grants DE15191 (R.A.S.), LM008111 (L.E.H.), GM083649 (L.E.H.) and DE12728 (T.W.). An institutional training grant T15LM009451 supported S.M.L. and an AstraZeneca-Fulbright Scholarship supported H.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avila JR, 2006, AM J MED GENET A, V140A, P2562, DOI 10.1002/ajmg.a.31367; Awakura Y, 2008, INT J ONCOL, V33, P893, DOI 10.3892/ijo_00000078; Benayahu D, 2007, CRIT REV EUKAR GENE, V17, P103, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.20; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X; Creuzet S, 2002, DEVELOPMENT, V129, P4301; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Handrigan GR, 2007, CLIN GENET, V71, P109, DOI 10.1111/j.1399-0004.2007.00761.x; Harder JL, 2008, CELL, V133, DOI 10.1016/j.cell.2008.06.002; Herwig R, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e117; Hunter L, 2001, Bioinformatics, V17 Suppl 1, pS115; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Jeong J, 2008, DEVELOPMENT, V135, P2905, DOI 10.1242/dev.019778; Jheon AH, 2009, J DENT RES, V88, P12, DOI 10.1177/0022034508327757; JIANG R, 2006, DEV DYNAM, P235; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kaufmann U, 1999, CELL TISSUE RES, V296, P191, DOI 10.1007/s004410051280; Kholodnyuk ID, 2006, INT J CANCER, V119, P99, DOI 10.1002/ijc.21794; Kielty C. M., 2003, CONNECTIVE TISSUE IT, P159; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792; Koval M, 2006, CELL COMMUN ADHES, V13, P127, DOI 10.1080/15419060600726209; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Leach SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000215; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Meunier D, 2003, ANAT EMBRYOL, V207, P109, DOI 10.1007/s00429-003-0330-9; Miyake T, 1996, J CRAN GENET DEV BIO, V16, P1; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagai Y, 2005, GENESIS, V43, P12, DOI 10.1002/gene.20146; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Northcutt RG, 2005, J EXP ZOOL PART B, V304B, P274, DOI 10.1002/jez.b.21063; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Phang T L, 2003, Pac Symp Biocomput, P351; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, pR19; ROSSANT J, 2002, MOUSE DEV PATTERNING, pR18; Salbaum JM, 1998, MECH DEVELOP, V71, P201, DOI 10.1016/S0925-4773(98)00005-7; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Suri M, 2005, SEMIN FETAL NEONAT M, V10, P243, DOI 10.1016/j.siny.2004.12.002; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tipney HJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S12; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Yang W, 2001, MOL CELL BIOL, V21, P6031, DOI 10.1128/MCB.21.17.6031-6043.2001; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	76	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8066	10.1371/journal.pone.0008066	http://dx.doi.org/10.1371/journal.pone.0008066			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016822	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834000001
J	Guthrie, BL; Kiarie, JN; Morrison, S; John-Stewart, GC; Kinuthia, J; Whittington, WLH; Farquhar, C				Guthrie, Brandon L.; Kiarie, James N.; Morrison, Susan; John-Stewart, Grace C.; Kinuthia, John; Whittington, William L. H.; Farquhar, Carey			Sexually Transmitted Infections among HIV-1-Discordant Couples	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TRICHOMONAS-VAGINALIS; HIV-INFECTION; RISK-FACTORS; GENITAL HERPES; RURAL UGANDA; TRANSMISSION; WOMEN; PREVENTION; DISEASES	Introduction: More new HIV-1 infections occur within stable HIV-1-discordant couples than in any other group in Africa, and sexually transmitted infections (STIs) may increase transmission risk among discordant couples, accounting for a large proportion of new HIV-1 infections. Understanding correlates of STIs among discordant couples will aid in optimizing interventions to prevent HIV-1 transmission in these couples. Methods: HIV-1-discordant couples in which HIV-1-infected partners were HSV-2-seropositive were tested for syphilis, chlamydia, gonorrhea, and trichomoniasis, and HIV-1-uninfected partners were tested for HSV-2. We assessed sociodemographic, behavioral, and biological correlates of a current STI. Results: Of 416 couples enrolled, 16% were affected by a treatable STI, and among these both partners were infected in 17% of couples. A treatable STI was found in 46 (11%) females and 30 (7%) males. The most prevalent infections were trichomoniasis (5.9%) and syphilis (2.6%). Participants were 5.9-fold more likely to have an STI if their partner had an STI (P<0.01), and STIs were more common among those reporting any unprotected sex (OR = 2.43; P<0.01) and those with low education (OR = 3.00; P<0.01). Among HIV-1-uninfected participants with an HSV-2-seropositive partner, females were significantly more likely to be HSV-2-seropositive than males (78% versus 50%, P<0.01). Conclusions: Treatable STIs were common among HIV-1-discordant couples and the majority of couples affected by an STI were discordant for the STI, with relatively high HSV-2 discordance. Awareness of STI correlates and treatment of both partners may reduce HIV-1 transmission.	[Guthrie, Brandon L.; John-Stewart, Grace C.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Morrison, Susan; John-Stewart, Grace C.; Whittington, William L. H.; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Morrison, Susan; John-Stewart, Grace C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Kiarie, James N.; Kinuthia, John] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi	Guthrie, BL (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	brguth@u.washington.edu	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	Kinuthia, John/0000-0001-6571-8927; kiarie, james/0000-0003-4180-7858	Bill and Melinda Gates Foundation [26469]; NIH [T32 AI07140]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, P30AI027757] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Bill and Melinda Gates Foundation (grant ID # 26469). NIH funded training grant (T32 AI07140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; [Anonymous], AIDS EP UPD DEC 2007; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Baryarama F, 2007, JAIDS-J ACQ IMM DEF, V44, P99, DOI 10.1097/01.qai.0000245879.36015.54; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Butler DA, 2008, AIDS, V22, P1667, DOI 10.1097/QAD.0b013e32830bfed8; Buve A, 2001, AIDS, V15, pS89, DOI 10.1097/00002030-200108004-00010; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hira SK, 1997, INT J STD AIDS, V8, P243, DOI 10.1258/0956462971919994; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Kissinger P, 2008, CLIN INFECT DIS, V46, P994, DOI 10.1086/529149; Klinger EV, 2006, SEX TRANSM DIS, V33, P712, DOI 10.1097/01.olq.0000222667.42207.08; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Mason PR, 2005, EPIDEMIOL INFECT, V133, P315, DOI 10.1017/S0950268804003127; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; Sangani P, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001220.PUB2, 10.1002/14651858.CD001220.pub2]; *UNAIDS, 2005, AIDS EP UPD DEC 2005; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; World Health Organization, 2005, SEX TRANSM OTH REPR	53	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8276	10.1371/journal.pone.0008276	http://dx.doi.org/10.1371/journal.pone.0008276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011596	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300030
J	Schloss, PD				Schloss, Patrick D.			A High-Throughput DNA Sequence Aligner for Microbial Ecology Studies	PLOS ONE			English	Article							ESTIMATING SPECIES RICHNESS; GUT MICROBIOTA; DIVERSITY; ALIGNMENT; PROGRAMS; DATABASE; ARB; BIOSPHERE; SEARCH	As the scope of microbial surveys expands with the parallel growth in sequencing capacity, a significant bottleneck in data analysis is the ability to generate a biologically meaningful multiple sequence alignment. The most commonly used aligners have varying alignment quality and speed, tend to depend on a specific reference alignment, or lack a complete description of the underlying algorithm. The purpose of this study was to create and validate an aligner with the goal of quickly generating a high quality alignment and having the flexibility to use any reference alignment. Using the simple nearest alignment space termination algorithm, the resulting aligner operates in linear time, requires a small memory footprint, and generates a high quality alignment. In addition, the alignments generated for variable regions were of as high a quality as the alignment of full-length sequences. As implemented, the method was able to align 18 full-length 16S rRNA gene sequences and 58 V2 region sequences per second to the 50,000-column SILVA reference alignment. Most importantly, the resulting alignments were of a quality equal to SILVA-generated alignments. The aligner described in this study will enable scientists to rapidly generate robust multiple sequences alignments that are implicitly based upon the predicted secondary structure of the 16S rRNA molecule. Furthermore, because the implementation is not connected to a specific database it is easy to generalize the method to reference alignments for any DNA sequence.	[Schloss, Patrick D.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Michigan System; University of Michigan	Schloss, PD (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	pschloss@umich.edu		Schloss, Patrick/0000-0002-6935-4275	College of Natural Resources and the Environment at the University of Massachusetts; School of Medicine at the University of Michigan; Sloan Foundation; National Science Foundation [0743432]	College of Natural Resources and the Environment at the University of Massachusetts; School of Medicine at the University of Michigan; Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF))	This project was funded by the College of Natural Resources and the Environment at the University of Massachusetts, the School of Medicine at the University of Michigan, a grant from the Sloan Foundation, and a grant from the National Science Foundation ( award #0743432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; GUSFIELD D, 1997, ALGORITHMS STRINGS T, P228; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; TICHY WF, 1984, ACM T COMPUT SYST, V2, P309, DOI 10.1145/357401.357404; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540	35	224	229	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8230	10.1371/journal.pone.0008230	http://dx.doi.org/10.1371/journal.pone.0008230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011594	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300012
J	Shafer, OT; Taghert, PH				Shafer, Orie T.; Taghert, Paul H.			RNA-Interference Knockdown of Drosophila Pigment Dispersing Factor in Neuronal Subsets: The Anatomical Basis of a Neuropeptide's Circadian Functions	PLOS ONE			English	Article							HORMONE-IMMUNOREACTIVE NEURONS; PERIOD CLOCK GENE; PACEMAKER NEURONS; LATERAL NEURONS; NERVOUS-SYSTEM; PDF CELLS; MELANOGASTER; EXPRESSION; RECEPTOR; RHYTHMS	Background: In animals, neuropeptide signaling is an important component of circadian timekeeping. The neuropeptide pigment dispersing factor (PDF) is required for several aspects of circadian activity rhythms in Drosophila. Methodology/Principal Findings: Here we investigate the anatomical basis for PDF's various circadian functions by targeted PDF RNA-interference in specific classes of Drosophila neuron. We demonstrate that PDF is required in the ventrolateral neurons (vLNs) of the central brain and not in the abdominal ganglion for normal activity rhythms. Differential knockdown of PDF in the large or small vLNs indicates that PDF from the small vLNs is likely responsible for the maintenance of free-running activity rhythms and that PDF is not required in the large vLNs for normal behavior. PDF's role in setting the period of free-running activity rhythms and the proper timing of evening activity under light: dark cycles emanates from both subtypes of vLN, since PDF in either class of vLN was sufficient for these aspects of behavior. Conclusions/Significance: These results reveal the neuroanatomical basis PDF's various circadian functions and refine our understanding of the clock neuron circuitry of Drosophila.	[Shafer, Orie T.; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shafer, OT (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	oshafer@umich.edu			NINDS [1K99NS062953-01]; NIMH [MH067122]; NIH [NS057105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS062953, P30NS057105] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the NINDS (1K99NS062953-01) to OTS, by a grant from the NIMH (#MH067122) to PHT, and by an NIH Neuroscience Blueprint Core Grant (#NS057105) to Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EWER J, 1992, J NEUROSCI, V12, P3321; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hamblen MJ, 1998, GENETICS, V149, P165; Harmar AJ, 2003, J NEUROENDOCRINOL, V15, P335, DOI 10.1046/j.1365-2826.2003.01005.x; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2007, COLD SPRING HARB SYM, V72, P517, DOI 10.1101/sqb.2007.72.063; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Hewes RS, 2000, GENETICS, V155, P1711; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kimbrell DA, 2002, GENESIS, V34, P23, DOI 10.1002/gene.10134; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shafer OT, 2002, J NEUROSCI, V22, P5946; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STENGL M, 1994, J COMP PHYSIOL A, V175, P203, DOI 10.1007/BF00215116; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009	50	76	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8298	10.1371/journal.pone.0008298	http://dx.doi.org/10.1371/journal.pone.0008298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011537	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300046
J	Sherman, CDH; Wapstra, E; Olsson, M				Sherman, Craig D. H.; Wapstra, Erik; Olsson, Mats			Consistent Paternity Skew through Ontogeny in Peron's Tree Frog (Litoria peronii)	PLOS ONE			English	Article							FITNESS CONSEQUENCES; POLYANDROUS FEMALES; SPERM COMPETITION; CRINIA-GEORGIANA; FERTILIZATION; BENEFITS; SELECTION; SUCCESS; MICE; MHC	Background: A large number of studies in postcopulatory sexual selection use paternity success as a proxy for fertilization success. However, selective mortality during embryonic development can lead to skews in paternity in situations of polyandry and sperm competition. Thus, when assessment of paternity fails to incorporate mortality skews during early ontogeny, this may interfere with correct interpretation of results and subsequent evolutionary inference. In a previous series of in vitro sperm competition experiments with amphibians (Litoria peronii), we showed skewed paternity patterns towards males more genetically similar to the female. Methodology/Principal Findings: Here we use in vitro fertilizations and sperm competition trials to test if this pattern of paternity of fully developed tadpoles reflects patterns of paternity at fertilization and if paternity skews changes during embryonic development. We show that there is no selective mortality through ontogeny and that patterns of paternity of hatched tadpoles reflects success of competing males in sperm competition at fertilization. Conclusions/Significance: While this study shows that previous inferences of fertilization success from paternity data are valid for this species, rigorous testing of these assumptions is required to ensure that differential embryonic mortality does not confound estimations of true fertilization success.	[Sherman, Craig D. H.] Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic, Australia; [Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Olsson, Mats] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	Deakin University; University of Tasmania; University of Wollongong	Sherman, CDH (corresponding author), Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic, Australia.	csherman@deakin.edu.au	Sherman, Craig/A-2484-2010; Wapstra, Erik/J-7482-2014; Olsson, Mats/AAK-5565-2021	Sherman, Craig/0000-0003-2099-0462; Wapstra, Erik/0000-0002-2050-8026; Olsson, Mats/0000-0002-4130-1323	Australian Research Council [DP0559867]	Australian Research Council(Australian Research Council)	This study was funded by the Australian Research Council ( Discovery grant DP0559867) to MO and EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne RK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-34; Dziminski MA, 2006, J EVOLUTION BIOL, V19, P144, DOI 10.1111/j.1420-9101.2005.00978.x; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Firman RC, 2008, EVOLUTION, V62, P603, DOI 10.1111/j.1558-5646.2007.00307.x; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Garcia-Gonzalez F, 2008, EVOLUTION, V62, P1653, DOI 10.1111/j.1558-5646.2008.00362.x; Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054; Gosner K. L., 1960, Herpetologica, V16, P183; Griffiths K, 2006, FROGS REPTILES SYDNE; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P735, DOI 10.1111/j.1420-9101.2004.00873.x; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Rulicke T, 1998, P ROY SOC B-BIOL SCI, V265, P711, DOI 10.1098/rspb.1998.0351; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; SHERMAN CDH, 2009, HEREDITY IN PRESS; Sherman CDH, 2007, CONSERV GENET, V8, P999, DOI 10.1007/s10592-006-9218-6; Sherman CDH, 2009, BIOL LETTERS, V5, P232, DOI 10.1098/rsbl.2008.0796; Stockley P, 1997, P ROY SOC B-BIOL SCI, V264, P1497, DOI 10.1098/rspb.1997.0207; Wedekind C, 1996, HEREDITY, V77, P400, DOI 10.1038/hdy.1996.160; YAMAZAKI K, 1983, SCIENCE, V221, P186, DOI 10.1126/science.6857281	22	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8252	10.1371/journal.pone.0008252	http://dx.doi.org/10.1371/journal.pone.0008252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011595	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300020
J	Liu, QZ; Sung, AH; Chen, ZX; Liu, JZ; Huang, XD; Deng, YP				Liu, Qingzhong; Sung, Andrew H.; Chen, Zhongxue; Liu, Jianzhong; Huang, Xudong; Deng, Youping			Feature Selection and Classification of MAQC-II Breast Cancer and Multiple Myeloma Microarray Gene Expression Data	PLOS ONE			English	Article							STATISTICAL-INFERENCE; ALGORITHMS; REGRESSION	Microarray data has a high dimension of variables but available datasets usually have only a small number of samples, thereby making the study of such datasets interesting and challenging. In the task of analyzing microarray data for the purpose of, e. g., predicting gene-disease association, feature selection is very important because it provides a way to handle the high dimensionality by exploiting information redundancy induced by associations among genetic markers. Judicious feature selection in microarray data analysis can result in significant reduction of cost while maintaining or improving the classification or prediction accuracy of learning machines that are employed to sort out the datasets. In this paper, we propose a gene selection method called Recursive Feature Addition (RFA), which combines supervised learning and statistical similarity measures. We compare our method with the following gene selection methods: Support Vector Machine Recursive Feature Elimination (SVMRFE) Leave-One-Out Calculation Sequential Forward Selection (LOOCSFS) Gradient based Leave-one-out Gene Selection (GLGS) To evaluate the performance of these gene selection methods, we employ several popular learning classifiers on the MicroArray Quality Control phase II on predictive modeling (MAQC-II) breast cancer dataset and the MAQC-II multiple myeloma dataset. Experimental results show that gene selection is strictly paired with learning classifier. Overall, our approach outperforms other compared methods. The biological functional analysis based on the MAQC-II breast cancer dataset convinced us to apply our method for phenotype prediction. Additionally, learning classifiers also play important roles in the classification of microarray data and our experimental results indicate that the Nearest Mean Scale Classifier (NMSC) is a good choice due to its prediction reliability and its stability across the three performance measurements: Testing accuracy, MCC values, and AUC errors.	[Liu, Qingzhong; Sung, Andrew H.] New Mexico Inst Min & Technol, Dept Comp Sci, Socorro, NM 87801 USA; [Liu, Qingzhong; Sung, Andrew H.] New Mexico Inst Min & Technol, Inst Complex Addit Syst Anal, Socorro, NM USA; [Chen, Zhongxue] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol & Biostat, Miami, FL 33199 USA; [Liu, Jianzhong] QuantumBio Inc, State Coll, PA USA; [Huang, Xudong] Brigham & Womens Hosp, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA; [Huang, Xudong] Brigham & Womens Hosp, Dept Radiol, Ctr Adv Med Imaging, Boston, MA 02115 USA; [Huang, Xudong] Harvard Univ, Sch Med, Boston, MA USA; [Deng, Youping] SpecPro, Vicksburg, MS USA; [Deng, Youping] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	New Mexico Institute of Mining Technology; New Mexico Institute of Mining Technology; State University System of Florida; Florida International University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Southern Mississippi	Liu, QZ (corresponding author), New Mexico Inst Min & Technol, Dept Comp Sci, Socorro, NM 87801 USA.	sung@cs.nmt.edu; youping.deng@usm.edu	Chen, Zhongxue/K-1372-2013; Huang, Xudong/D-9711-2018	Chen, Zhongxue/0000-0003-2537-7843; Huang, Xudong/0000-0002-4811-1901; Liu, Qingzhong/0000-0002-2006-5413	NIH/NCMHD/RIMI [P20MD002725]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD002725] Funding Source: NIH RePORTER	NIH/NCMHD/RIMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The first two authors gratefully appreciate the support for this study from the Institute for Complex Additive Systems Analysis, a research division of New Mexico Tech. The last author highly appreciate the support under the grant of NIH/NCMHD/RIMI, P20MD002725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bo TH, 2002, GENOME BIOL, V3; Brazma A, 2006, NAT REV GENET, V7, P593, DOI 10.1038/nrg1922; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hand DJ, 2005, J BIOMED BIOTECHNOL, P215, DOI 10.1155/JBB.2005.215; HEIJDEN FVD, 2004, CLASSIFICATION PARAM; Inza I, 2002, J INTELL FUZZY SYST, V12, P25; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Liang Yulan, 2005, Int J Bioinform Res Appl, V1, P399, DOI 10.1504/IJBRA.2005.008443; Liu QZ, 2008, PATTERN RECOGN, V41, P56, DOI 10.1016/j.patcog.2007.06.005; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Monari G, 2000, NEUROCOMPUTING, V35, P195, DOI 10.1016/S0925-2312(00)00325-8; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Rivals I., 2003, Journal of Machine Learning Research, V3, P1383, DOI 10.1162/153244303322753724; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; SHI L, NATURE BIOT IN PRESS; Tan P, 2005, INTRO DATA MINING, P76; Tang EK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-95; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torrente A, 2005, BIOINFORMATICS, V21, P3993, DOI 10.1093/bioinformatics/bti644; Yu JS, 2005, BIOINFORMATICS, V21, pI487, DOI 10.1093/bioinformatics/bti1030; Zhou X, 2005, BIOINFORMATICS, V21, P1559, DOI 10.1093/bioinformatics/bti216	30	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8250	10.1371/journal.pone.0008250	http://dx.doi.org/10.1371/journal.pone.0008250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011240	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830200005
J	Hag, AMF; Kristoffersen, US; Pedersen, SF; Gutte, H; Lebech, AM; Kjaer, A				Hag, Anne Mette Fisker; Kristoffersen, Ulrik Sloth; Pedersen, Sune Folke; Gutte, Henrik; Lebech, Anne-Mette; Kjaer, Andreas			Regional Gene Expression of LOX-1, VCAM-1, and ICAM-1 in Aorta of HIV-1 Transgenic Rats	PLOS ONE			English	Article							ADHESION MOLECULES; DISTURBED FLOW; ATHEROSCLEROSIS; MODEL; ENDOTHELIUM; MECHANISMS; PROFILES; THERAPY; DISEASE	Background: Increased prevalence of atherosclerotic cardiovascular disease in HIV-infected patients has been observed. The cause of this accelerated atherosclerosis is a matter of controversy. As clinical studies are complicated by a multiplicity of risk-factors and a low incidence of hard endpoints, studies in animal models could be attractive alternatives. Methodology/Principal Findings: We evaluated gene expression of lectin-like oxidized-low-density-lipoprotein receptor-1 (LOX-1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 ( ICAM- 1) in HIV-1 transgenic (HIV-1Tg) rats; these genes are all thought to play important roles in early atherogenesis. Furthermore, the plasma level of sICAM-1 was measured. We found that gene expressions of LOX-1 and VCAM- 1 were higher in the aortic arch of HIV-1Tg rats compared to controls. Also, the level of sICAM-1 was elevated in the HIV-1Tg rats compared to controls, but the ICAM- 1 gene expression profile did not show any differences between the groups. Conclusions/Significance: HIV-1Tg rats have gene expression patterns indicating endothelial dysfunction and accelerated atherosclerosis in aorta, suggesting that HIV-infection per se may cause atherosclerosis. This transgenic rat model may be a very promising model for further studies of the pathophysiology behind HIV-associated cardiovascular disease.	[Hag, Anne Mette Fisker; Kristoffersen, Ulrik Sloth; Pedersen, Sune Folke; Gutte, Henrik; Kjaer, Andreas] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Hag, Anne Mette Fisker; Kristoffersen, Ulrik Sloth; Pedersen, Sune Folke; Gutte, Henrik; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Lebech, Anne-Mette] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Hag, AMF (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark.	annemette@mfi.ku.dk	Kjaer, Andreas/E-8932-2015	Kjaer, Andreas/0000-0002-2706-5547; Gutte, Henrik/0000-0001-5494-5323; Lebech, Anne-Mette/0000-0002-0943-3289; Hag, Anne Mette F/0000-0001-9492-3663	Novo Nordisk Foundation; Lundbeck Foundation; A. P. Moller Foundation; The Danish Heart Foundation [09-04-R72-A2356-22560]; Danish Medical Research Council [959592772]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); A. P. Moller Foundation; The Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The financial support from Novo Nordisk Foundation (www.novonordiskfonden.dk), Lundbeck Foundation (www.lundbeckfonden.dk), A. P. Moller Foundation (www.apmollerfonde.dk), The Danish Heart Foundation ( grant no. 09-04-R72-A2356-22560; www.hjerteforeningen.dk), and Danish Medical Research Council ( grant no. 959592772; www.fi.dk) is gratefully acknowledged. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brooks AR, 2004, ENDOTHELIUM-J ENDOTH, V11, P45, DOI 10.1080/10623320490432470; Brooks AR, 2002, PHYSIOL GENOMICS, V9, P27, DOI 10.1152/physiolgenomics.00075.2001; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; DE JW, 2003, CLIN DIAGN LAB IMMUN, V10, P133; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Hag AMF, 2008, BIOCHEM BIOPH RES CO, V377, P689, DOI 10.1016/j.bbrc.2008.10.037; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; Kotler DP, 2008, JAIDS-J ACQ IMM DEF, V49, pS79, DOI 10.1097/QAI.0b013e318186519c; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroianni CM, 2000, CLIN IMMUNOL, V95, P212, DOI 10.1006/clim.2000.4865; Mazzucchelli R, 2004, MOL IMMUNOL, V41, P979, DOI 10.1016/j.molimm.2004.06.023; Moghadasian MH, 2002, LIFE SCI, V70, P855, DOI 10.1016/S0024-3205(01)01479-5; Mu H, 2007, WORLD J SURG, V31, P632, DOI 10.1007/s00268-006-0730-0; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; OGURA S, 2009, CIRC J; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Ray PE, 2003, KIDNEY INT, V63, P2242, DOI 10.1046/j.1523-1755.2003.00028.x; Reid W, 2004, VIROLOGY, V321, P111, DOI 10.1016/j.virol.2003.12.010; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8170	10.1371/journal.pone.0008170	http://dx.doi.org/10.1371/journal.pone.0008170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997643	gold, Green Published, Green Submitted			2022-12-27	WOS:000272829200009
J	Mukai, M; Replogle, K; Drnevich, J; Wang, G; Wacker, D; Band, M; Clayton, DF; Wingfield, JC				Mukai, Motoko; Replogle, Kirstin; Drnevich, Jenny; Wang, Gang; Wacker, Douglas; Band, Mark; Clayton, David F.; Wingfield, John C.			Seasonal Differences of Gene Expression Profiles in Song Sparrow (Melospiza melodia) Hypothalamus in Relation to Territorial Aggression	PLOS ONE			English	Article							HYPOPHYSEAL PARS TUBERALIS; WHITE-CROWNED SPARROW; CHALLENGE HYPOTHESIS; THYROID-HORMONE; PLASMA-LEVELS; ENDOTHELIAL INTERACTIONS; MEDIAN-EMINENCE; NERVE-TERMINALS; MICROARRAY DATA; JAPANESE-QUAIL	Background: Male song sparrows (Melospiza melodia) are territorial year-round; however, neuroendocrine responses to simulated territorial intrusion (STI) differ between breeding ( spring) and non-breeding seasons ( autumn). In spring, exposure to STI leads to increases in luteinizing hormone and testosterone, but not in autumn. These observations suggest that there are fundamental differences in the mechanisms driving neuroendocrine responses to STI between seasons. Microarrays, spotted with EST cDNA clones of zebra finch, were used to explore gene expression profiles in the hypothalamus after territorial aggression in two different seasons. Methodology/Principal Findings: Free-living territorial male song sparrows were exposed to either conspecific or heterospecific ( control) males in an STI in spring and autumn. Behavioral data were recorded, whole hypothalami were collected, and microarray hybridizations were performed. Quantitative PCR was performed for validation. Our results show 262 cDNAs were differentially expressed between spring and autumn in the control birds. There were 173 cDNAs significantly affected by STI in autumn; however, only 67 were significantly affected by STI in spring. There were 88 cDNAs that showed significant interactions in both season and STI. Conclusions/Significance: Results suggest that STI drives differential genomic responses in the hypothalamus in the spring vs. autumn. The number of cDNAs differentially expressed in relation to season was greater than in relation to social interactions, suggesting major underlying seasonal effects in the hypothalamus which may determine the differential response upon social interaction. Functional pathway analyses implicated genes that regulate thyroid hormone action and neuroplasticity as targets of this neuroendocrine regulation.	[Mukai, Motoko; Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mukai, Motoko] Univ Illinois, Dept Vet Biosci, Champaign, IL 61820 USA; [Replogle, Kirstin; Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Champaign, IL 61820 USA; [Replogle, Kirstin; Clayton, David F.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Clayton, David F.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Drnevich, Jenny; Band, Mark] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Wang, Gang; Wacker, Douglas; Wingfield, John C.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle	Mukai, M (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	momukai@ucdavis.edu	Mukai, Motoko/L-9910-2014; Clayton, David/B-2190-2008	Mukai, Motoko/0000-0002-5695-3826; Clayton, David/0000-0002-6395-3488	National Science Foundation [IBN-0317141, IOS-0712882, IOS-0750540]; Endowment in Physiology, University of California, Davis; SoNG Initiative [NS045264]; Eli Lilly postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Endowment in Physiology, University of California, Davis(University of California System); SoNG Initiative; Eli Lilly postdoctoral fellowship(Eli Lilly); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Science Foundation grants # IBN-0317141, IOS-0712882, IOS-0750540 and Endowment in Physiology, University of California, Davis ( to JCW), SoNG Initiative # NS045264 (to DFC), and MM was supported by Eli Lilly postdoctoral fellowship ( Eli Lilly Co., Indianapolis, Indiana) during part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Benvenga S, 1998, ENDOCRINOLOGY, V139, P4311, DOI 10.1210/en.139.10.4311; Bockmann J, 1996, ENDOCRINOLOGY, V137, P1804, DOI 10.1210/en.137.5.1804; Bockmann J, 1997, ACTA ANAT, V160, P189; Brouillette J, 2008, NEUROBIOL AGING, V29, P1721, DOI 10.1016/j.neurobiolaging.2007.04.007; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; CALDWELL GS, 1984, P NATL ACAD SCI-BIOL, V81, P5255, DOI 10.1073/pnas.81.16.5255; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Cavigelli SA, 2000, HORM BEHAV, V37, P246, DOI 10.1006/hbeh.2000.1585; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Demas GE, 1999, PHYSIOL BEHAV, V66, P59, DOI 10.1016/S0031-9384(98)00268-6; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Draghici S, 2002, DRUG DISCOV TODAY, V7, pS55, DOI 10.1016/S1359-6446(02)02292-4; ESTIENNE MJ, 1990, BIOL REPROD, V42, P126, DOI 10.1095/biolreprod42.1.126; FOLLETT BK, 1985, J ENDOCRINOL, V107, P211, DOI 10.1677/joe.0.1070211; Gibbons IR, 1996, CELL STRUCT FUNCT, V21, P331, DOI 10.1247/csf.21.331; GROSS DS, 1984, GEN COMP ENDOCR, V56, P283, DOI 10.1016/0016-6480(84)90043-1; Hirschenhauser K, 2003, HORM BEHAV, V43, P508, DOI 10.1016/S0018-506X(03)00027-8; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Jones S, 2008, BRAIN RES BULL, V76, P536, DOI 10.1016/j.brainresbull.2008.03.008; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kameda Y, 2000, CELL TISSUE RES, V299, P71, DOI 10.1007/s004419900131; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Klukowski M, 1998, HORM BEHAV, V33, P197, DOI 10.1006/hbeh.1998.1449; Kouchi Z, 1999, BIOCHEM BIOPH RES CO, V254, P804, DOI 10.1006/bbrc.1998.9977; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; London SE, 2009, DEV NEUROBIOL, V69, P437, DOI 10.1002/dneu.20719; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; MIKAMI S, 1975, CELL TISSUE RES, V162, P419; Nakao N, 2008, REPRODUCTION, V136, P1, DOI 10.1530/REP-08-0041; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; PANKHURST NW, 1993, GEN COMP ENDOCR, V90, P168, DOI 10.1006/gcen.1993.1071; PARKINSON TJ, 1995, P ROY SOC B-BIOL SCI, V259, P1, DOI 10.1098/rspb.1995.0001; PELLETIER J, 1992, CELL TISSUE RES, V267, P301, DOI 10.1007/BF00302968; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; Prevot V, 1999, NEUROSCIENCE, V94, P809, DOI 10.1016/S0306-4522(99)00383-8; Prevot V, 2007, PSYCHONEUROENDOCRINO, V32, pS46, DOI 10.1016/j.psyneuen.2007.03.018; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rubenstein DR, 2005, HORM BEHAV, V48, P329, DOI 10.1016/j.yhbeh.2005.04.006; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; Smith LC, 2005, HORM BEHAV, V47, P76, DOI 10.1016/j.yhbeh.2004.08.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soma KK, 2002, HORM BEHAV, V41, P203, DOI 10.1006/hbeh.2001.1750; Soma KK, 2003, J NEUROBIOL, V56, P209, DOI 10.1002/neu.10225; Suzuki H, 2007, NEUROSCI LETT, V421, P152, DOI 10.1016/j.neulet.2007.03.077; Suzuki S, 2007, MOL ENDOCRINOL, V21, P885, DOI 10.1210/me.2006-0403; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Tsuzuki K, 2000, NEUROSCI LETT, V281, P171, DOI 10.1016/S0304-3940(00)00834-X; URBANSKI HF, 1990, ENDOCRINOLOGY, V127, P2223, DOI 10.1210/endo-127-5-2223; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728; WILSON RC, 1982, BRAIN RES, V248, P177, DOI 10.1016/0006-8993(82)91160-X; WINGFIELD JC, 1985, HORM BEHAV, V19, P174, DOI 10.1016/0018-506X(85)90017-0; WINGFIELD JC, 1994, HORM BEHAV, V28, P1, DOI 10.1006/hbeh.1994.1001; WINGFIELD JC, 1994, ANIM BEHAV, V47, P77, DOI 10.1006/anbe.1994.1009; Wingfield JC, 2005, HORM BEHAV, V48, P253, DOI 10.1016/j.yhbeh.2005.05.009; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1989, J COMP PHYSIOL A, V166, P189; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; YAMAMOTO Y, 1993, J PHYS IV, V3, P39, DOI 10.1051/jp4:1993507; Yamamura T, 2006, CELL TISSUE RES, V324, P175, DOI 10.1007/s00441-005-0126-8; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233	78	70	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8182	10.1371/journal.pone.0008182	http://dx.doi.org/10.1371/journal.pone.0008182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997634	Green Submitted, gold, Green Published			2022-12-27	WOS:000272829200015
J	Sun, T; Adra, S; Smallwood, R; Holcombe, M; MacNeil, S				Sun, Tao; Adra, Salem; Smallwood, Rod; Holcombe, Mike; MacNeil, Sheila			Exploring Hypotheses of the Actions of TGF-beta 1 in Epidermal Wound Healing Using a 3D Computational Multiscale Model of the Human Epidermis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BASEMENT-MEMBRANE FORMATION; TRANSFORMING GROWTH-FACTOR-BETA-1; HUMAN KERATINOCYTES; IN-VITRO; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; GENE-EXPRESSION; ACTIVATION; REEPITHILIALIZATION	In vivo and in vitro studies give a paradoxical picture of the actions of the key regulatory factor TGF-beta 1 in epidermal wound healing with it stimulating migration of keratinocytes but also inhibiting their proliferation. To try to reconcile these into an easily visualized 3D model of wound healing amenable for experimentation by cell biologists, a multiscale model of the formation of a 3D skin epithelium was established with TGF-beta 1 literature-derived rule sets and equations embedded within it. At the cellular level, an agent-based bottom-up model that focuses on individual interacting units ( keratinocytes) was used. This was based on literature-derived rules governing keratinocyte behavior and keratinocyte/ECM interactions. The selection of these rule sets is described in detail in this paper. The agent-based model was then linked with a subcellular model of TGF-beta 1 production and its action on keratinocytes simulated with a complex pathway simulator. This multiscale model can be run at a cellular level only or at a combined cellular/subcellular level. It was then initially challenged ( by wounding) to investigate the behavior of keratinocytes in wound healing at the cellular level. To investigate the possible actions of TGF-beta 1, several hypotheses were then explored by deliberately manipulating some of these rule sets at subcellular levels. This exercise readily eliminated some hypotheses and identified a sequence of spatial-temporal actions of TGF-beta 1 for normal successful wound healing in an easy-to-follow 3D model. We suggest this multiscale model offers a valuable, easy-to-visualize aid to our understanding of the actions of this key regulator in wound healing, and provides a model that can now be used to explore pathologies of wound healing.	[Sun, Tao] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland; [Adra, Salem; Smallwood, Rod; Holcombe, Mike] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield S10 2TN, S Yorkshire, England	University of Glasgow; University of Sheffield; University of Sheffield	Sun, T (corresponding author), Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland.	t.sun@bio.gla.ac.uk; s.macneil@sheffield.ac.uk	Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632	Engineering and Physical Sciences Research Council (EPSRC) [GR/S62321/01]; University of York [GR/S62338/01]; Engineering and Physical Sciences Research Council [GR/S62321/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of York(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is part of the Epitheliome Project, which is funded by the Engineering and Physical Sciences Research Council (EPSRC) through two grants: one to the University of Sheffield (GR/S62321/01), and the other to the University of York (GR/S62338/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt C, 2002, J CELL SCI, V115, P2189; Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x; Baker CTH, 1998, J MATH BIOL, V37, P341, DOI 10.1007/s002850050133; Barcellos-Hoff MH, 1996, J MAMMARY GLAND BIOL, V1, P353, DOI 10.1007/BF02017391; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Fleischmajer R, 2000, MATRIX BIOL, V19, P637, DOI 10.1016/S0945-053X(00)00092-5; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GARLICK JA, 1994, LAB INVEST, V70, P916; GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847; GRINNELL F, 1992, J CELL SCI, V101, P1; Hakkinen L, 2004, AM J PATHOL, V164, P229, DOI 10.1016/S0002-9440(10)63113-6; HEBDA PA, 1988, J INVEST DERMATOL, V91, P440, DOI 10.1111/1523-1747.ep12476480; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Krampert M, 2004, MOL BIOL CELL, V15, P5242, DOI 10.1091/mbc.E04-02-0109; Kutz SM, 2001, J CELL SCI, V114, P3905; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MATOLTSY AG, 1970, J INVEST DERMATOL, V55, P20, DOI 10.1111/1523-1747.ep12290488; Mazzieri R, 2005, J CELL SCI, V118, P2177, DOI 10.1242/jcs.02352; Morel D, 2001, ACTA BIOTHEOR, V49, P219, DOI 10.1023/A:1014201805222; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nodder S, 1997, ANAT EMBRYOL, V195, P215, DOI 10.1007/s004290050041; Olofsson A, 1995, J BIOL CHEM, V270, P31294, DOI 10.1074/jbc.270.52.31294; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Rashbass J, 1996, TRENDS CELL BIOL, V6, P280, DOI 10.1016/0962-8924(96)60028-2; SELLHEYER K, 1993, P NATL ACAD SCI USA, V90, P5237, DOI 10.1073/pnas.90.11.5237; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Wang XJ, 1997, P NATL ACAD SCI USA, V94, P2386, DOI 10.1073/pnas.94.6.2386; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Woolley K, 2000, BIOESSAYS, V22, P911; Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC; Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X; Yang LJ, 2001, AM J PATHOL, V159, P2147, DOI 10.1016/S0002-9440(10)63066-0; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	66	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8515	10.1371/journal.pone.0008515	http://dx.doi.org/10.1371/journal.pone.0008515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046881	Green Published, Green Accepted, gold			2022-12-27	WOS:000273180200006
J	Cordeiro, JV; Guerra, S; Arakawa, Y; Dodding, MP; Esteban, M; Way, M				Cordeiro, Joao V.; Guerra, Susana; Arakawa, Yoshiki; Dodding, Mark P.; Esteban, Mariano; Way, Michael			F11-Mediated Inhibition of RhoA Signalling Enhances the Spread of Vaccinia Virus In Vitro and In Vivo in an Intranasal Mouse Model of Infection	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; EXTRACELLULAR ENVELOPED VIRUS; N-WASP; F11L-MEDIATED INHIBITION; INTRACELLULAR MOVEMENT; PROTEIN; MICROTUBULES; VIRIONS; KINASES; COMPLEX	The cortical actin cytoskeleton beneath the plasma membrane represents a physical barrier that vaccinia virus has to overcome during its exit from an infected cell. Previous observations using overexpression and pharmacological approaches suggest that vaccinia enhances its release by modulating the cortical actin cytoskeleton by inhibiting RhoA signalling using the viral protein F11. We have now examined the role of El 1 and its ability to interact with RhoA to inhibit its downstream signalling in the spread of vaccinia infection both in vitro and in vivo. Live cell imaging over 48 hours reveals that loss of Eli or its ability to bind RhoA dramatically reduces the rate of cell-to-cell spread of the virus in a cell monolayer. Cells infected with the AF11L virus also maintained their cell-to-cell contacts, and did not undergo virus-induced motility as observed during wild-type infections. The AF11L virus is also attenuated in intranasal mouse models of infection, as it is impaired in its ability to spread from the initial sites of infection to the lungs and spleen. Loss of the ability of F11 to bind RhoA also reduces viral spread in vivo. Our results clearly establish that viral-mediated inibition of RhoA signalling can enhance the spread of infection not only in cell monolayers, but also in vivo.	[Cordeiro, Joao V.; Arakawa, Yoshiki; Dodding, Mark P.; Way, Michael] London Res Inst, Cell Motil Lab, London, England; [Guerra, Susana; Esteban, Mariano] Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Arakawa, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Kyoto University	Cordeiro, JV (corresponding author), London Res Inst, Cell Motil Lab, London, England.	Michael.Way@cancer.org.uk	guerra, susana/K-5972-2014; Cordeiro, Joao V/M-6122-2013; Arakawa, Yoshiki/H-6067-2017; Esteban, Mariano/ABG-5375-2020	guerra, susana/0000-0001-9067-2991; Cordeiro, Joao V/0000-0003-4605-1615; Arakawa, Yoshiki/0000-0003-4626-4645; Esteban, Mariano/0000-0003-0846-2827; Way, Michael/0000-0001-7207-2722; Dodding, Mark/0000-0001-8091-6534	Cancer Research UK; European Union [CT-2006-03954]; Foundation Botin; Ramon y Cajal of Spain	Cancer Research UK(Cancer Research UK); European Union(European Commission); Foundation Botin; Ramon y Cajal of Spain	This investigation was supported by Cancer Research UK (to MW, JVC, VA, and MPD), and in part by the European Union (CT-2006-03954) and Foundation Botin (to ME). SG holds a research contract from the program Ramon y Cajal of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Boulter E A, 1973, Prog Med Virol, V16, P86; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cudmore S, 1996, J CELL SCI, V109, P1739; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Dodding MP, 2009, CELL MICROBIOL, V11, P808, DOI 10.1111/j.1462-5822.2009.01296.x; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Guerra S, 2005, J VIROL, V79, P2133, DOI 10.1128/JVI.79.4.2133-2140.2005; HILLER G, 1985, J VIROL, V55, P651, DOI 10.1128/JVI.55.3.651-659.1985; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kato SEM, 2004, J VIROL METHODS, V115, P31, DOI 10.1016/j.jviromet.2003.09.011; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Morales I, 2008, TRAFFIC, V9, P1283, DOI 10.1111/j.1600-0854.2008.00762.x; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Moss B, 2007, FIELDS VIROLOGY; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; RODRIGUEZ JF, 1985, J VIROL, V56, P482, DOI 10.1128/JVI.56.2.482-488.1985; Rottger S, 1999, J VIROL, V73, P2863; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x; Schramm B, 2005, TRAFFIC, V6, P839, DOI 10.1111/j.1600-0854.2005.00324.x; Schramm B, 2006, TRAFFIC, V7, P1352, DOI 10.1111/j.1600-0854.2006.00470.x; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Smith GL, 1998, ADV EXP MED BIOL, V440, P395; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Thorne SH, 2005, CURR OPIN MOL THER, V7, P359; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000	54	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8506	10.1371/journal.pone.0008506	http://dx.doi.org/10.1371/journal.pone.0008506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041165	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700020
J	Feng, JN; Zhang, ZF; Li, WY; Shen, XM; Song, WJ; Yang, CM; Chang, F; Longmate, J; Marek, C; St Amand, RP; Krontiris, TG; Shively, JE; Sommer, SS				Feng, Jinong; Zhang, Zhifang; Li, Wenyan; Shen, Xiaoming; Song, Wenjia; Yang, Chunmei; Chang, Frances; Longmate, Jeffrey; Marek, Claudia; St Amand, R. Paul; Krontiris, Theodore G.; Shively, John E.; Sommer, Steve S.			Missense Mutations in the MEFV Gene Are Associated with Fibromyalgia Syndrome and Correlate with Elevated IL-1 beta Plasma Levels	PLOS ONE			English	Article							FAMILIAL MEDITERRANEAN FEVER; IRRITABLE-BOWEL-SYNDROME; NOD-LIKE RECEPTORS; CIAS1 MUTATIONS; T102C POLYMORPHISM; MOLECULAR-BASIS; DISEASE; CRYOPYRIN; DOMAIN; PYRIN	Background: Fibromyalgia syndrome (FMS), a common, chronic, widespread musculoskeletal pain disorder found in 2% of the general population and with a preponderance of 85% in females, has both genetic and environmental contributions. Patients and their parents have high plasma levels of the chemokines MCP-1 and eotaxin, providing evidence for both a genetic and an immunological/inflammatory origin for the syndrome (Zhang et al., 2008, Exp. Biol. Med. 233: 1171-1180). Methods and Findings: In a search for a candidate gene affecting inflammatory pathways, among five screened in our patient samples (100 probands with FMS and their parents), we found 10 rare and one common alleles for MEFV, a gene in which various compound heterozygous mutations lead to Familial Mediterranean Fever (FMF). A total of 2.63 megabases of genomic sequence of the MEFV gene were scanned by direct sequencing. The collection of rare missense mutations (all heterozygotes and tested in the aggregate) had a significant elevated frequency of transmission to affecteds (p = 0.0085, one-sided, exact binomial test). Our data provide evidence that rare missense variants of the MEFV gene are, collectively, associated with risk of FMS and are present in a subset of 15% of FMS patients. This subset had, on average, high levels of plasma IL-1 beta (p = 0.019) compared to FMS patients without rare variants, unaffected family members with or without rare variants, and unrelated controls of unknown genotype. IL-1 beta is a cytokine associated with the function of the MEFV gene and thought to be responsible for its symptoms of fever and muscle aches. Conclusions: Since misregulation of IL-1 beta expression has been predicted for patients with mutations in the MEFV gene, we conclude that patients heterozygous for rare missense variants of this gene may be predisposed to FMS, possibly triggered by environmental factors.	[Feng, Jinong; Li, Wenyan; Shen, Xiaoming; Song, Wenjia; Yang, Chunmei; Sommer, Steve S.] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Genet, Duarte, CA 91010 USA; [Feng, Jinong; Zhang, Zhifang; Chang, Frances; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [Longmate, Jeffrey] City Hope Natl Med Ctr, Beckman Res Inst, Dept Biostat, Duarte, CA USA; [Marek, Claudia; St Amand, R. Paul] Fibromyalgia Treatment Ctr, Los Angeles, CA USA; [Krontiris, Theodore G.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Genet, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Feng, JN (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Genet, Duarte, CA 91010 USA.	jshively@coh.org; ssommer@medomics.com		Longmate, Jeffrey/0000-0002-0869-7928	Los Angeles Fibromyalgia Foundation; National Institutes of Health General Clinical Research Center [M01 RR00043]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	Los Angeles Fibromyalgia Foundation; National Institutes of Health General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a grant from the Los Angeles Fibromyalgia Foundation and in part by an National Institutes of Health General Clinical Research Center Grant, M01 RR00043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin J, 2008, JOINT BONE SPINE, V75, P273, DOI 10.1016/j.jbspin.2007.09.010; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Arnold LM, 2007, PAIN MED, V8, pS63, DOI 10.1111/j.1526-4637.2006.00178.x; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Baio P, 2008, CLIN EXP RHEUMATOL, V26, pS74; Berkun Y, 2007, CLIN EXP RHEUMATOL, V25, pS6; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bondy B, 1999, NEUROBIOL DIS, V6, P433, DOI 10.1006/nbdi.1999.0262; Buskila D, 1997, J RHEUMATOL, V24, P941; Buskila D, 1996, SEMIN ARTHRITIS RHEU, V26, P605, DOI 10.1016/S0049-0172(96)80011-4; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Chen G., 2008, ANN REV PATHOL; Cohen H, 2002, ARTHRITIS RHEUM, V46, P845, DOI 10.1002/art.10103; Crofford LJ, 2008, CURR OPIN RHEUMATOL, V20, P246, DOI 10.1097/BOR.0b013e3282fb0268; Dan B, 2004, MOL PSYCHIATR, V9, P730, DOI 10.1038/sj.mp.4001506; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gavrilin MA, 2000, BIOCHEM BIOPH RES CO, V277, P37, DOI 10.1006/bbrc.2000.3619; Giaglis S, 2007, CLIN GENET, V71, P458, DOI 10.1111/j.1399-0004.2007.00789.x; Gursoy S, 2001, RHEUMATOL INT, V21, P58, DOI 10.1007/s002960100130; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Mathews RJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2525; MCCARTHY MI, 2009, EXPLORING UNKNOWN A; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Onen F, 2006, RHEUMATOL INT, V26, P489, DOI 10.1007/s00296-005-0074-3; Pace F, 2006, WORLD J GASTROENTERO, V12, P3874, DOI 10.3748/wjg.v12.i24.3874; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ritis K, 2004, ANN RHEUM DIS, V63, P438, DOI 10.1136/ard.2003.009258; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Samuels J, 2006, CURR OPIN RHEUMATOL, V18, P108, DOI 10.1097/01.bor.0000198006.65697.5b; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schwarz MJ, 2003, ADV EXP MED BIOL, V527, P265; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shinkai K, 2005, ARCH DERMATOL, V141, P242, DOI 10.1001/archderm.141.2.242; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Sperber AD, 1999, AM J GASTROENTEROL, V94, P3541, DOI 10.1111/j.1572-0241.1999.01643.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sprott H, 2004, ANN RHEUM DIS, V63, P245, DOI 10.1136/ard.2002.004762; Stehlik C, 2007, CURR PROTEIN PEPT SC, V8, P293, DOI 10.2174/138920307780831857; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; WOLFE F, 1990, ARCH INTERN MED, V150, P460, DOI 10.1001/archinte.150.2.460; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	58	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8480	10.1371/journal.pone.0008480	http://dx.doi.org/10.1371/journal.pone.0008480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041150	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700005
J	Love, HD; Booton, SE; Boone, BE; Breyer, JP; Koyama, T; Revelo, MP; Shappell, SB; Smith, JR; Hayward, SW				Love, Harold D.; Booton, S. Erin; Boone, Braden E.; Breyer, Joan P.; Koyama, Tatsuki; Revelo, Monica P.; Shappell, Scott B.; Smith, Jeffrey R.; Hayward, Simon W.			Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer	PLOS ONE			English	Article							UROGENITAL SINUS MESENCHYME; PROTEASE-ACTIVATED RECEPTOR-1; MESSENGER-RNA EXPRESSION; FIBROBLAST GROWTH-FACTOR; BINDING PROTEIN; CARCINOMA-CELLS; TISSUE FACTOR; IN-VIVO; INHIBITS PROLIFERATION; ENDOTHELIAL LIPASE	Benign prostatic hyperplasia (BPH) and prostate carcinoma (CaP) are linked to aging and the presence of androgens, suggesting that androgen regulated genes play a major role in these common diseases. Androgen regulation of prostate growth and development depends on the presence of intact epithelial-stromal interactions. Further, the prostatic stroma is implicated in BPH. This suggests that epithelial cell lines are inadequate to identify androgen regulated genes that could contribute to BPH and CaP and which could serve as potential clinical biomarkers. In this study, we used a human prostate xenograft model to define a profile of genes regulated in vivo by androgens, with an emphasis on identifying candidate biomarkers. Benign transition zone (TZ) human prostate tissue from radical prostatectomies was grafted to the sub-renal capsule site of intact or castrated male immunodeficient mice, followed by the removal or addition of androgens, respectively. Microarray analysis of RNA from these tissues was used to identify genes that were; 1) highly expressed in prostate, 2) had significant expression changes in response to androgens, and, 3) encode extracellular proteins. A total of 95 genes meeting these criteria were selected for analysis and validation of expression in patient prostate tissues using quantitative real-time PCR. Expression levels of these genes were measured in pooled RNAs from human prostate tissues with varying severity of BPH pathologic changes and CaP of varying Gleason score. A number of androgen regulated genes were identified. Additionally, a subset of these genes were over-expressed in RNA from clinical BPH tissues, and the levels of many were found to correlate with disease status. Our results demonstrate the feasibility, and some of the problems, of using a mouse xenograft model to characterize the androgen regulated expression profiles of intact human prostate tissues.	[Love, Harold D.; Shappell, Scott B.; Hayward, Simon W.] Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA; [Booton, S. Erin] Vanderbilt Univ, Sch Med, Div Dermatol, Nashville, TN 37212 USA; [Breyer, Joan P.; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Koyama, Tatsuki; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Shappell, Scott B.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Koyama, Tatsuki; Hayward, Simon W.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Smith, Jeffrey R.; Hayward, Simon W.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Smith, Jeffrey R.] VA Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN USA; [Revelo, Monica P.] Univ Utah, Dept Pathol & Lab Med, Lake City, UT USA; [Shappell, Scott B.] Avero Diagnost, Dallas, TX USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Utah System of Higher Education; University of Utah	Love, HD (corresponding author), Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA.	Simon.Hayward@vanderbilt.edu	Smith, Jeff/C-3484-2012	Smith, Jeffrey/0000-0001-8424-910X; Hayward, Simon/0000-0002-6059-6550	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) MPSA Consortium [UO1-DK63587]; National Institutes of Health (NIH) [DK067049]; Vanderbilt Microarray Shared Resource; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Center [P30 DK58404]; Vanderbilt Vision Center [P30 EY08126]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK067049, U01DK063587, P30DK058404, R01DK067049] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) MPSA Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Microarray Shared Resource; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Center; Vanderbilt Vision Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) MPSA Consortium grant UO1-DK63587, National Institutes of Health (NIH) grant DK067049 and The Vanderbilt Microarray Shared Resource, supported by the Vanderbilt Ingram Cancer Center, grant P30 CA68485, and the Vanderbilt Digestive Disease Center, grant P30 DK58404, and the Vanderbilt Vision Center, grant P30 EY08126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Aigner A, 2002, ONCOGENE, V21, P5733, DOI 10.1038/sj.onc.1205560; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Begley LA, 2008, NEOPLASIA, V10, P244, DOI 10.1593/neo.07976; Bhattacharjee G, 2008, CIRC RES, V102, P457, DOI 10.1161/CIRCRESAHA.107.167759; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Cardillo M, 1997, J UROLOGY, V158, P212, DOI 10.1097/00005392-199707000-00073; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Chokkalingam AP, 2002, PROSTATE, V52, P98, DOI 10.1002/pros.10096; CUNHA GR, 1983, J CELL BIOL, V96, P1662, DOI 10.1083/jcb.96.6.1662; CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1; Cunha GR, 1996, PROSTATE, P22; DEHARO MSL, 1988, BIOCHEM J, V250, P647, DOI 10.1042/bj2500647; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Djonov V, 1997, PROSTATE, V31, P103; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gale AJ, 2001, ACTA HAEMATOL-BASEL, V106, P25, DOI 10.1159/000046586; GRIGNON D, 1985, PROSTATE, V7, P195, DOI 10.1002/pros.2990070209; Grossklaus DJ, 2001, J UROLOGY, V165, P455, DOI 10.1097/00005392-200102000-00024; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hayward SW, 1996, ANN NY ACAD SCI, V784, P50, DOI 10.1111/j.1749-6632.1996.tb16227.x; Imasato Y, 2000, J UROLOGY, V164, P1819, DOI 10.1016/S0022-5347(05)67113-3; ISAACS JT, 1989, PROSTATE, P33; Jack GS, 2000, HUM PATHOL, V31, P1146, DOI 10.1053/hupa.2000.16670; Jack GS, 2002, J UROLOGY, V168, P519, DOI 10.1016/S0022-5347(05)64671-X; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Kramer G, 2006, CURR OPIN UROL, V16, P25; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; LEE C, 1995, UROL CLIN N AM, V22, P237; Lein M, 1998, UROLOGE A, V37, P377, DOI 10.1007/s001200050194; Luo J, 2001, CANCER RES, V61, P4683; Luo J, 2002, PROSTATE, V51, P189, DOI 10.1002/pros.10087; Macoska JA, 2008, PROSTATE, V68, P442, DOI 10.1002/pros.20717; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McNeal J E, 1984, Prog Clin Biol Res, V145, P27; McNeal J. E., 1983, BENIGN PROSTATIC HYP, P152; McNeal JE., 1985, REGULATION ANDROGEN, P191; Mishra VC, 2007, BJU INT, V100, P327, DOI 10.1111/j.1464-410X.2007.06910.x; MORI H, 1990, PROSTATE, V16, P71, DOI 10.1002/pros.2990160108; MYDLO JH, 1988, PROSTATE, V13, P241, DOI 10.1002/pros.2990130306; Nakamura T, 2003, CANCER RES, V63, P6543; Nakamura T, 2003, UROLOGY, V61, P1042, DOI 10.1016/S0090-4295(02)02443-3; Paradis ME, 2006, J LIPID RES, V47, P2808, DOI 10.1194/jlr.P600002-JLR200; PARTIN AW, 1991, J UROLOGY, V145, P405, DOI 10.1016/S0022-5347(17)38353-2; Qi H, 2002, CANCER RES, V62, P721; Rafii MS, 2006, J CELL PHYSIOL, V209, P439, DOI 10.1002/jcp.20740; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Roehrborn Claus G, 2005, Rev Urol, V7 Suppl 9, pS3; Ropiquet F, 1999, J UROLOGY, V162, P595, DOI 10.1016/S0022-5347(05)68632-6; Rosini P, 2002, PROSTATE, V53, P310, DOI 10.1002/pros.10164; Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04; SCHULZ P, 1985, BIOL CHEM H-S, V366, P1033, DOI 10.1515/bchm3.1985.366.2.1033; SCIARRA A, 2007, J STEROID BIOCH MOL; Scorilas A, 2006, BIOL CHEM, V387, P789, DOI 10.1515/BC.2006.099; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Shappell SB, 2001, NEOPLASIA, V3, P287, DOI 10.1038/sj.neo.7900166; Shappell SB, 2001, CANCER RES, V61, P497; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Sinowatz F, 2000, HISTOL HISTOPATHOL, V15, P475, DOI 10.14670/HH-15.475; Smitherman AB, 2004, J UROLOGY, V171, P916, DOI 10.1097/01.ju.0000104674.70170.cd; Soulitzis N, 2006, INT J ONCOL, V29, P305; Staack A, 2003, PROSTATE, V54, P212, DOI 10.1002/pros.10179; Trojan L, 2006, EUR UROL, V49, P286, DOI 10.1016/j.eururo.2005.08.022; Vaarala MH, 2000, LAB INVEST, V80, P1259, DOI 10.1038/labinvest.3780134; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe; Williams K, 2005, PROSTATE, V63, P369, DOI 10.1002/pros.20200; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhao HJ, 2007, J CELL PHYSIOL, V210, P111, DOI 10.1002/jcp.20828	76	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8384	10.1371/journal.pone.0008384	http://dx.doi.org/10.1371/journal.pone.0008384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027305	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100019
J	Andreani, G; Celentano, AM; Solana, ME; Cazorla, SI; Malchiodi, EL; Peralta, LAM; Dolcini, GL				Andreani, Guadalupe; Celentano, Ana M.; Solana, Maria E.; Cazorla, Silvia I.; Malchiodi, Emilio L.; Martinez Peralta, Liliana A.; Dolcini, Guillermina L.			Inhibition of HIV-1 Replication in Human Monocyte-Derived Macrophages by Parasite Trypanosoma cruzi	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TROPICAL INFECTIOUS-DISEASES; CHRONIC CHAGAS-DISEASE; MONONUCLEAR PHAGOCYTES; TRANS-SIALIDASE; LYMPHOID-TISSUE; MEASLES-VIRUS; EX-VIVO; EXPRESSION; PATHOGENESIS	Background: Cells of monocyte/macrophage lineage are one of the major targets of HIV-1 infection and serve as reservoirs for viral persistence in vivo. These cells are also the target of the protozoa Trypanosoma cruzi, the causative agent of Chagas disease, being one of the most important endemic protozoonoses in Latin America. It has been demonstrated in vitro that co-infection with other pathogens can modulate HIV replication. However, no studies at cellular level have suggested an interaction between T. cruzi and HIV-1 to date. Methodology/Principal Findings: By using a fully replicative wild-type virus, our study showed that T. cruzi inhibits HIV-1 antigen production by nearly 100% (p<0.001) in monocyte-derived macrophages (MDM). In different infection schemes with luciferase-reporter VSV-G or BaL pseudotyped HIV-1 and trypomastigotes, T. cruzi induced a significant reduction of luciferase level for both pseudotypes in all the infection schemes (p<0.001), T. cruzi-HIV (>99%) being stronger than HIV-T. cruzi (similar to 90% for BaL and similar to 85% for VSV-G) infection. In MDM with established HIV-1 infection, T. cruzi significantly inhibited luciferate activity (p<0.01). By quantifying R-U5 and U5-gag transcripts by real time PCR, our study showed the expression of both transcripts significantly diminished in the presence of trypomastigotes (p<0.05). Thus, T. cruzi inhibits viral post-integration steps, early post-entry steps and entry into MDM. Trypomastigotes also caused a similar to 60-70% decrease of surface CCR5 expression on MDM. Multiplication of T. cruzi inside the MDM does not seem to be required for inhibiting HIV-1 replication since soluble factors secreted by trypomastigotes have shown similar effects. Moreover, the major parasite antigen cruzipain, which is secreted by the trypomastigote form, was able to inhibit viral production in MDM over 90% (p<0.01). Conclusions/Significance: Our study showed that T. cruzi inhibits HIV-1 replication at several replication stages in macrophages, a major cell target for both pathogens.	[Andreani, Guadalupe; Martinez Peralta, Liliana A.; Dolcini, Guillermina L.] Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina; [Celentano, Ana M.; Solana, Maria E.; Cazorla, Silvia I.; Malchiodi, Emilio L.] Univ Buenos Aires, Sch Med, Dept Microbiol, Parasitol Lab, Buenos Aires, DF, Argentina; [Cazorla, Silvia I.; Malchiodi, Emilio L.] Univ Buenos Aires, Sch Pharm & Biochem, CONICET, IDEHU Inst Studies Humoral Immun, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Andreani, G (corresponding author), Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina.	gdolcini@fmed.uba.ar	Cazorla, Silvia/AAA-7958-2022; Dolcini, Guillermina Laura/AAC-2546-2022	Dolcini, Guillermina Laura/0000-0002-1496-0083; Malchiodi, Emilio/0000-0001-7501-3330; Cazorla, Silvia/0000-0002-6811-2207	Argentina's National Agency for Promotion of Science and Technology [PICT 05-33947, PICT 05-34123, PICT 06-608]; National Council for Technology and Scientific Research [PIP 6119]	Argentina's National Agency for Promotion of Science and Technology(ANPCyT); National Council for Technology and Scientific Research	This work was partly supported by grants from Argentina's National Agency for Promotion of Science and Technology (www.agencia.gov.ar) (PICT 05-33947 to LMP, PICT 05-34123 to GLD and PICT 06-608 to ELM) and the National Council for Technology and Scientific Research (www.conicet.gov.ar)( PIP 6119 to GLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Alfano M, 2005, CURR PHARM DESIGN, V11, P2909, DOI 10.2174/1381612054546725; Aquaro S, 1997, J BIOL REG HOMEOS AG, V11, P69; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brodskyn C, 2002, INFECT IMMUN, V70, P3736, DOI 10.1128/IAI.70.7.3736-3743.2002; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Cazorla SI, 2008, VACCINE, V26, P1999, DOI 10.1016/j.vaccine.2008.02.011; Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07; CELENTANO AM, 1992, PARASITE IMMUNOL, V14, P155, DOI 10.1111/j.1365-3024.1992.tb00458.x; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; David A, 2006, J IMMUNOL, V177, P6291, DOI 10.4049/jimmunol.177.9.6291; de Diego J, 1997, J IMMUNOL, V159, P4983; Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; Dolcini GL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-53; Ferreira MS, 2002, MEM I OSWALDO CRUZ, V97, P443, DOI 10.1590/S0074-02762002000400001; Frank FM, 2003, VACCINE, V22, P77, DOI 10.1016/S0264-410X(03)00541-3; Garcia M, 2008, J GEN VIROL, V89, P984, DOI 10.1099/vir.0.83601-0; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; Golding H, 2005, J BIOL CHEM, V280, P29570, DOI 10.1074/jbc.M500236200; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Gruppi A, 1997, ACTA TROP, V63, P141, DOI 10.1016/S0001-706X(96)00616-X; Guarner J, 2001, AM J TROP MED HYG, V65, P152, DOI 10.4269/ajtmh.2001.65.152; Gurer C, 2005, J VIROL, V79, P5557, DOI 10.1128/JVI.79.9.5557-5567.2005; Harms G, 2002, TROP MED INT HEALTH, V7, P479, DOI 10.1046/j.1365-3156.2002.00893.x; Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180; Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181; Kedzierska K, 2003, REV MED VIROL, V13, P39, DOI 10.1002/rmv.369; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Morel CM, 2003, NAT REV MICROBIOL, V1, P14, DOI 10.1038/nrmicro735; *PAHO, 2003, EP B PAHO; Perez-Ramirez L, 1999, AM J TROP MED HYG, V61, P198; Risso MG, 2004, J INFECT DIS, V189, P2250, DOI 10.1086/420831; Rosestolato CTF, 2002, CELL STRUCT FUNCT, V27, P91, DOI 10.1247/csf.27.91; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Sartori AMC, 1998, CLIN INFECT DIS, V26, P177, DOI 10.1086/516257; Sartori AMC, 2002, AM J TROP MED HYG, V67, P521, DOI 10.4269/ajtmh.2002.67.521; SARTORI AMC, 1995, CLIN INFECT DIS, V21, P1297, DOI 10.1093/clinids/21.5.1297; SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sorice M, 2001, FEBS LETT, V506, P55, DOI 10.1016/S0014-5793(01)02830-7; SOUTOPADRON T, 1990, J CELL SCI, V96, P485; STEVENSON M, 1994, J LEUKOCYTE BIOL, V56, P278, DOI 10.1002/jlb.56.3.278; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Vaidian Anil K, 2004, Kinetoplastid Biol Dis, V3, P2, DOI 10.1186/1475-9292-3-2; Warrilow D, 2007, CURR HIV RES, V5, P293, DOI 10.2174/157016207780636579; Woolsey AM, 2004, CELL MICROBIOL, V6, P829, DOI 10.1111/j.1462-5822.2004.00405.x; Xiang JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002580; Xiang WS, 2006, PESTIC BIOCHEM PHYS, V85, P1, DOI 10.1016/j.pestbp.2005.09.001; Zhao CQ, 2004, J IMMUNOL, V172, P3086, DOI 10.4049/jimmunol.172.5.3086; Zhao CQ, 2004, CLIN IMMUNOL, V113, P81, DOI 10.1016/j.clim.2004.06.003	63	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8246	10.1371/journal.pone.0008246	http://dx.doi.org/10.1371/journal.pone.0008246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011521	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300018
J	Facente, SN; Dowling, T; Vittinghoff, E; Sykes, DL; Colfax, GN				Facente, Shelley N.; Dowling, Teri; Vittinghoff, Eric; Sykes, Deanna L.; Colfax, Grant N.			False Positive Rate of Rapid Oral Fluid HIV Tests Increases as Kits Near Expiration Date	PLOS ONE			English	Article								Background: Because a recent cluster of false positive results on the OraQuick ADVANCE(R) Rapid HIV-1/2 Antibody Test occurred in San Francisco on test kits close to their expiration date, we decided to assess the relationship between time to expiration and rate of false positive results from tests used with oral fluid. Methodology/Principal Findings: We analyzed results of 20,904 tests with either an initial HIV-negative result (n = 20,828) or a preliminary positive result that was then negative on confirmatory tests (n = 76). We computed specificity for kits with time to expiration from <= 1 to >= 6 months, with exact binomial confidence intervals, then used logistic regression to estimate the independent association of time to expiration with false positive results, adjusting for site and technician effects. For 1,108 kits used in the last month before expiration, specificity was 98.83% (95% exact binomial confidence interval (CI) 98.00%-99.37%); the upper bound is below the claimed specificity of 99.60%. After adjustment using regression standardization for the effects of site, test lot, and technician factors, adjusted specificity in the last month before expiration was 99.18% (95% bootstrap confidence interval 98.60-99.57%). Conclusions/Significance: We found that specificity of the OraQuick ADVANCE(R) with oral fluid declined significantly with <= 1 month remaining to expiration, leaving little margin for error from other sources.	[Facente, Shelley N.; Dowling, Teri; Colfax, Grant N.] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA USA; [Vittinghoff, Eric] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Sykes, Deanna L.] Calif Dept Publ Hlth, Ctr Infect Dis, Off AIDS, Sacramento, CA USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; California Department of Public Health	Facente, SN (corresponding author), Facente Consulting, Richmond, CA USA.	shelley@facenteconsulting.com	Facente, Shelley/M-1147-2019	Facente, Shelley N./0000-0002-7266-352X				[Anonymous], 2006, BUSINESS WIRE; *CDC, 2003, QUAL ASS GUID US ORA; *CDC, 2008, QUEST ANSW FALS POS; CDC, 2004, MMWR-MORBID MORTAL W, V53, P221; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1287; *CLIA, 2008, BP010047 CLIA FOOD D; *COUNS TEST LINK U, 2006, CTL DAT QA GUID; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; MacKellar D. A., 2006, Morbidity and Mortality Weekly Report, V55, P673; *OFF AIDS, 2003, ORAQUICK RAP HIV TES; *ORASURE TECHN INC, 2009, US FDA APPR ORAQUICK; OraSure Technologies Inc, 2004, ORAQUICK ADVANCE RAP; *SAN FRANC DEP PUB, 2007, HIV COUNS TEST LINK; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; 2004, BUSINESS WIRE	18	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8217	10.1371/journal.pone.0008217	http://dx.doi.org/10.1371/journal.pone.0008217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011584	Green Published, gold			2022-12-27	WOS:000272830300008
J	Lee, W; Zhang, Y; Mukhyala, K; Lazarus, RA; Zhang, ZM				Lee, William; Zhang, Yan; Mukhyala, Kiran; Lazarus, Robert A.; Zhang, Zemin			Bi-Directional SIFT Predicts a Subset of Activating Mutations	PLOS ONE			English	Article							HUMAN DNASE I; UBIQUITIN-PROTEIN LIGASE; ONCOGENIC MUTATIONS; SOMATIC MUTATIONS; LAC REPRESSOR; HUMAN BREAST; CANCER; PATHWAYS; PIK3CA; POLYMORPHISMS	Advancements in sequencing technologies have empowered recent efforts to identify polymorphisms and mutations on a global scale. The large number of variations and mutations found in these projects requires high-throughput tools to identify those that are most likely to have an impact on function. Numerous computational tools exist for predicting which mutations are likely to be functional, but none that specifically attempt to identify mutations that result in hyperactivation or gain-of-function. Here we present a modified version of the SIFT (Sorting Intolerant from Tolerant) algorithm that utilizes protein sequence alignments with homologous sequences to identify functional mutations based on evolutionary fitness. We show that this bi-directional SIFT (B-SIFT) is capable of identifying experimentally verified activating mutants from multiple datasets. B-SIFT analysis of large-scale cancer genotyping data identified potential activating mutations, some of which we have provided detailed structural evidence to support. B-SIFT could prove to be a valuable tool for efforts in protein engineering as well as in identification of functional mutations in cancer.	[Lee, William; Zhang, Yan; Mukhyala, Kiran; Zhang, Zemin] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Lazarus, Robert A.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Lee, W (corresponding author), Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA.	zemin@gene.com			Genentech Research fund	Genentech Research fund	The authors were funded by the general Genentech Research fund. The funders did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; HART RK, 2009, PACIFIC S BIOCOMPUTI, V14, P403; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MANKOO PK, 2008, PROTEINS STRUCTURE F, V9999; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Pan CQ, 1998, J BIOL CHEM, V273, P11701, DOI 10.1074/jbc.273.19.11701; Pan CQ, 2000, METH MOL B, V160, P309; Pan CQ, 1997, BIOCHEMISTRY-US, V36, P6624, DOI 10.1021/bi962960x; Pan CQ, 1998, PROTEIN SCI, V7, P628, DOI 10.1002/pro.5560070312; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SINICROPI D, 1994, ANAL BIOCHEM, V222, P351, DOI 10.1006/abio.1994.1502; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8311	10.1371/journal.pone.0008311	http://dx.doi.org/10.1371/journal.pone.0008311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011534	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300054
J	Bate, C; Tayebi, M; Diomede, L; Salmona, M; Williams, A				Bate, Clive; Tayebi, Mourad; Diomede, Luisa; Salmona, Mario; Williams, Alun			Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE; INFECTED NEUROBLASTOMA-CELLS; DISEASE AMYLOID PROTEIN; RAT ADIPOCYTES; PROSTAGLANDIN E-2; INSULIN-RECEPTOR; DIABETES-MELLITUS; CULTURED-CELLS; A(2) ACTIVITY; SCRAPIE	Background: A hallmark of the prion diseases is the conversion of the host-encoded cellular prion protein (PrPC) into a disease related, alternatively folded isoform (PrPSc). The accumulation of PrPSc within the brain is associated with synapse loss and ultimately neuronal death. Novel therapeutics are desperately required to treat neurodegenerative diseases including the prion diseases. Principal Findings: Treatment with glimepiride, a sulphonylurea approved for the treatment of diabetes mellitus, induced the release of PrPC from the surface of prion-infected neuronal cells. The cell surface is a site where PrPC molecules may be converted to PrPSc and glimepiride treatment reduced PrPSc formation in three prion infected neuronal cell lines (ScN2a, SMB and ScGT1 cells). Glimepiride also protected cortical and hippocampal neurones against the toxic effects of the prion-derived peptide PrP82-146. Glimepiride treatment significantly reduce both the amount of PrP82-146 that bound to neurones and PrP82-146 induced activation of cytoplasmic phospholipase A(2) (cPLA(2)) and the production of prostaglandin E-2 that is associated with neuronal injury in prion diseases. Our results are consistent with reports that glimepiride activates an endogenous glycosylphosphatidylinositol (GPI)-phospholipase C which reduced PrPC expression at the surface of neuronal cells. The effects of glimepiride were reproduced by treatment of cells with phosphatidylinositol-phospholipase C (PI-PLC) and were reversed by co-incubation with p-chloromercuriphenylsulphonate, an inhibitor of endogenous GPI-PLC. Conclusions: Collectively, these results indicate that glimepiride may be a novel treatment to reduce PrPSc formation and neuronal damage in prion diseases.	[Bate, Clive; Tayebi, Mourad; Williams, Alun] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms, England; [Diomede, Luisa; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy	University of London; University of London Royal Veterinary College; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bate, C (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms, England.	cbate@rvc.ac.uk	Diomede, Luisa/P-3417-2014; TAYEBI, MOURAD/F-7404-2010; salmona, mario/ABI-4066-2020; salmona, mario/AAA-7116-2020	Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; TAYEBI, MOURAD/0000-0001-8664-6918	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission FP6 NeuroPrion Network of Excellence (http://www.neuroprion.org/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bate C, 2004, NEUROREPORT, V15, P509, DOI 10.1097/00001756-200403010-00025; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2007, NEUROPHARMACOLOGY, V53, P222, DOI 10.1016/j.neuropharm.2007.05.003; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Becker ML, 2008, CLIN PHARMACOL THER, V83, P288, DOI 10.1038/sj.clpt.6100273; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fioriti L, 2007, J NEUROSCI, V27, P1576, DOI 10.1523/JNEUROSCI.5145-06.2007; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Godsave SF, 2008, J NEUROSCI, V28, P12489, DOI 10.1523/JNEUROSCI.4474-08.2008; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Minghetti L, 2002, NEUROLOGY, V58, P127, DOI 10.1212/WNL.58.1.127; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; Movahedi S, 1997, BIOCHEM J, V326, P531, DOI 10.1042/bj3260531; Mueller G, 2008, MOL PHARMACOL, V73, P1513, DOI 10.1124/mol.107.043935; Muller G, 2008, BIOCHEMISTRY-US, V47, P1259, DOI 10.1021/bi701413t; Muller G, 2009, CELL SIGNAL, V21, P324, DOI 10.1016/j.cellsig.2008.10.021; MULLER G, 1993, BIOCHEM J, V289, P509; Muller G, 2005, BIOCHEM PHARMACOL, V69, P761, DOI 10.1016/j.bcp.2004.11.014; MULLER G, 1994, J CELL BIOL, V126, P1267, DOI 10.1083/jcb.126.5.1267; Muller G, 2002, MOL MED, V8, P120, DOI 10.1007/BF03402005; Nielsen D, 2004, BIOCHEM J, V380, P571, DOI 10.1042/BJ20040010; Ostlund P, 2001, J BIOL CHEM, V276, P36110, DOI 10.1074/jbc.M105710200; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PARKIN ET, 2004, DUAL MECH SHEDDING C; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Salmona M, 2003, J BIOL CHEM, V278, P48146, DOI 10.1074/jbc.M307295200; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schatzl HM, 1997, J VIROL, V71, P8821; SRINIVASAPPA J, 1989, MICROB PATHOGENESIS, V7, P189, DOI 10.1016/0882-4010(89)90054-5; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stanton JD, 2002, BIOCHEM J, V366, P281, DOI 10.1042/bj20020367; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Williams A, 1997, BRAIN RES, V754, P171, DOI 10.1016/S0006-8993(97)00067-X; WILLIAMS AE, 1994, BRAIN RES, V654, P200, DOI 10.1016/0006-8993(94)90480-4	70	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8221	10.1371/journal.pone.0008221	http://dx.doi.org/10.1371/journal.pone.0008221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011040	gold, Green Published			2022-12-27	WOS:000272829800010
J	Moyer, BD; Hevezi, P; Gao, N; Lu, M; Kalabat, D; Soto, H; Echeverri, F; Laita, B; Yeh, SA; Zoller, M; Zlotnik, A				Moyer, Bryan D.; Hevezi, Peter; Gao, Na; Lu, Min; Kalabat, Dalia; Soto, Hortensia; Echeverri, Fernando; Laita, Bianca; Yeh, Shaoyang Anthony; Zoller, Mark; Zlotnik, Albert			Expression of Genes Encoding Multi-Transmembrane Proteins in Specific Primate Taste Cell Populations	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; BOTULINUM NEUROTOXIN-A; RECEPTOR-CELLS; MAMMALIAN TASTE; TRANSIENT RECEPTOR; MEMBRANE-PROTEIN; PROSTATE-CANCER; FAMILY-MEMBERS; BUDS; CALCIUM	Background: Using fungiform (FG) and circumvallate (CV) taste buds isolated by laser capture microdissection and analyzed using gene arrays, we previously constructed a comprehensive database of gene expression in primates, which revealed over 2,300 taste bud-associated genes. Bioinformatics analyses identified hundreds of genes predicted to encode multi-transmembrane domain proteins with no previous association with taste function. A first step in elucidating the roles these gene products play in gustation is to identify the specific taste cell types in which they are expressed. Methodology/Principal Findings: Using double label in situ hybridization analyses, we identified seven new genes expressed in specific taste cell types, including sweet, bitter, and umami cells (TRPM5-positive), sour cells (PKD2L1-positive), as well as other taste cell populations. Transmembrane protein 44 (TMEM44), a protein with seven predicted transmembrane domains with no homology to GPCRs, is expressed in a TRPM5-negative and PKD2L1-negative population that is enriched in the bottom portion of taste buds and may represent developmentally immature taste cells. Calcium homeostasis modulator 1 (CALHM1), a component of a novel calcium channel, along with family members CALHM2 and CALHM3; multiple C2 domains; transmembrane 1 (MCTP1), a calcium-binding transmembrane protein; and anoctamin 7 (ANO7), a member of the recently identified calcium-gated chloride channel family, are all expressed in TRPM5 cells. These proteins may modulate and effect calcium signalling stemming from sweet, bitter, and umami receptor activation. Synaptic vesicle glycoprotein 2B (SV2B), a regulator of synaptic vesicle exocytosis, is expressed in PKD2L1 cells, suggesting that this taste cell population transmits tastant information to gustatory afferent nerve fibers via exocytic neurotransmitter release. Conclusions/Significance: Identification of genes encoding multi-transmembrane domain proteins expressed in primate taste buds provides new insights into the processes of taste cell development, signal transduction, and information coding. Discrete taste cell populations exhibit highly specific gene expression patterns, supporting a model whereby each mature taste receptor cell is responsible for sensing, transmitting, and coding a specific taste quality.	[Moyer, Bryan D.; Hevezi, Peter; Gao, Na; Lu, Min; Kalabat, Dalia; Soto, Hortensia; Echeverri, Fernando; Laita, Bianca; Yeh, Shaoyang Anthony; Zoller, Mark; Zlotnik, Albert] Senomyx Inc, San Diego, CA USA		Moyer, BD (corresponding author), Senomyx Inc, San Diego, CA USA.	bryan.moyer@senomyx.com			Senomyx, Inc.	Senomyx, Inc.	This study was supported by Senomyx, Inc. (http://www.senomyx.com) and did not use any public funds. Senomyx supported the research (purchased equipment, reagents, and supplies) and approved publication of the manuscript. Senomyx employees were involved in study design, data collection and analysis, and preparation of the manuscript. The authors were all employed by Senomyx, Inc. during the described experiments. P. Hevezi and A. Zlotnik are now in the Department of Physiology and Biophysics as The University of California, Irvine, California, USA. H. Soto is currently at BioLegend, 11080 Roselle Street, San Diego, CA 92121, USA. All authors are aware of and will adhere to the PLoS ONE policies on sharing data and materials, as detailed on the PLoS ONE website.	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Braissant O, 1998, BIOCHEMICA, V1, P10; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Das S, 2007, CANCER RES, V67, P1594, DOI 10.1158/0008-5472.CAN-06-2673; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Herness MS, 1999, J NEUROPHYSIOL, V82, P260, DOI 10.1152/jn.1999.82.1.260; Hever A, 2007, P NATL ACAD SCI USA, V104, P12451, DOI 10.1073/pnas.0703451104; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kiessling A, 2005, PROSTATE, V64, P387, DOI 10.1002/pros.20250; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Medler KF, 2003, J NEUROSCI, V23, P2608; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Nakayama A, 2008, J COMP NEUROL, V509, P211, DOI 10.1002/cne.21738; PARAN N, 1975, CELL TISSUE RES, V161, P1; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Romanov RA, 2008, J GEN PHYSIOL, V132, P731, DOI 10.1085/jgp.200810108; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; TAYLOR R, 1994, J NEUROPHYSIOL, V72, P475, DOI 10.1152/jn.1994.72.1.475; WONG L, 1994, CHEM SENSES, V19, P251, DOI 10.1093/chemse/19.3.251; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yoshida R, 2006, ARCH HISTOL CYTOL, V69, P233, DOI 10.1679/aohc.69.233; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007	60	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e7682	10.1371/journal.pone.0007682	http://dx.doi.org/10.1371/journal.pone.0007682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997627	Green Published, gold			2022-12-27	WOS:000272829200001
J	Carr, AJ; Vugler, AA; Hikita, ST; Lawrence, JM; Gias, C; Chen, LL; Buchholz, DE; Ahmado, A; Semo, M; Smart, MJK; Hasan, S; da Cruz, L; Johnson, LV; Clegg, DO; Coffey, PJ				Carr, Amanda-Jayne; Vugler, Anthony A.; Hikita, Sherry T.; Lawrence, Jean M.; Gias, Carlos; Chen, Li Li; Buchholz, David E.; Ahmado, Ahmad; Semo, Ma'ayan; Smart, Matthew J. K.; Hasan, Shazeen; da Cruz, Lyndon; Johnson, Lincoln V.; Clegg, Dennis O.; Coffey, Pete J.			Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RCS RAT; SUBRETINAL TRANSPLANTATION; AUTOLOGOUS TRANSPLANTATION; PHOTORECEPTOR DEGENERATION; MACULAR TRANSLOCATION; HUMAN FIBROBLASTS; PROGENITOR CELLS; VISUAL FUNCTION; RPE	Transformation of somatic cells with a set of embryonic transcription factors produces cells with the pluripotent properties of embryonic stem cells (ESCs). These induced pluripotent stem (iPS) cells have the potential to differentiate into any cell type, making them a potential source from which to produce cells as a therapeutic platform for the treatment of a wide range of diseases. In many forms of human retinal disease, including age-related macular degeneration (AMD), the underlying pathogenesis resides within the support cells of the retina, the retinal pigment epithelium (RPE). As a monolayer of cells critical to photoreceptor function and survival, the RPE is an ideally accessible target for cellular therapy. Here we report the differentiation of human iPS cells into RPE. We found that differentiated iPS-RPE cells were morphologically similar to, and expressed numerous markers of developing and mature RPE cells. iPS-RPE are capable of phagocytosing photoreceptor material, in vitro and in vivo following transplantation into the Royal College of Surgeons (RCS) dystrophic rat. Our results demonstrate that iPS cells can be differentiated into functional iPS-RPE and that transplantation of these cells can facilitate the short-term maintenance of photoreceptors through phagocytosis of photoreceptor outer segments. Longterm visual function is maintained in this model of retinal disease even though the xenografted cells are eventually lost, suggesting a secondary protective host cellular response. These findings have identified an alternative source of replacement tissue for use in human retinal cellular therapies, and provide a new in vitro cellular model system in which to study RPE diseases affecting human patients.	[Carr, Amanda-Jayne; Vugler, Anthony A.; Lawrence, Jean M.; Gias, Carlos; Chen, Li Li; Ahmado, Ahmad; Semo, Ma'ayan; Smart, Matthew J. K.; Hasan, Shazeen; Coffey, Pete J.] UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Hikita, Sherry T.; Buchholz, David E.; Johnson, Lincoln V.; Clegg, Dennis O.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Johnson, Lincoln V.; Clegg, Dennis O.] Univ Calif Santa Barbara, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA; [da Cruz, Lyndon] Moorfields Eye Hosp, Dept Vitreoretinal Surg, London, England	University of London; University College London; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Carr, AJ (corresponding author), UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.	a.carr@ucl.ac.uk	Ahmado, Ahmad/R-5537-2019; Carr, Amanda/ABG-6282-2020	Carr, Amanda/0000-0002-5469-0030; Semo, Ma'ayan/0000-0002-3890-721X; Coffey, Peter/0000-0002-5427-2939	London Project to Cure Blindness; The California Institute for Regenerative Medicine	London Project to Cure Blindness; The California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by funding from the London Project to Cure Blindness and The California Institute for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aisenbrey S, 2002, ARCH OPHTHALMOL-CHIC, V120, P451; BALASUBRAMANIAN S, 2009, STEM CELLS; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Carr AJ, 2009, MOL VIS, V15, P283; Carwile ME, 1998, EXP EYE RES, V66, P791, DOI 10.1006/exer.1998.0488; Chen FK, 2008, INVEST OPHTH VIS SCI, V49, P3143, DOI 10.1167/iovs.07-1648; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P1848, DOI 10.1167/iovs.08-2845; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Del Priore LV, 2003, INVEST OPHTH VIS SCI, V44, P4044, DOI 10.1167/iovs.02-1175; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Falk T, 2009, NEUROSCI LETT, V458, P49, DOI 10.1016/j.neulet.2009.04.018; Francis PJ, 2009, INVEST OPHTH VIS SCI, V50, P3425, DOI 10.1167/iovs.08-2908; Gabrielian K, 1999, GRAEF ARCH CLIN EXP, V237, P326, DOI 10.1007/s004170050240; Gias C, 2007, EUR J NEUROSCI, V25, P1940, DOI 10.1111/j.1460-9568.2007.05459.x; Grisanti S, 2002, JPN J OPHTHALMOL, V46, P36, DOI 10.1016/S0021-5155(01)00464-6; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Grozdanic SD, 2006, EXP EYE RES, V82, P597, DOI 10.1016/j.exer.2005.08.020; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ho TC, 1997, EXP EYE RES, V64, P133, DOI 10.1006/exer.1996.0199; Huerta JJ, 1997, NEUROSCI LETT, V232, P143, DOI 10.1016/S0304-3940(97)00595-8; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Joussen AM, 2006, AM J OPHTHALMOL, V142, P17, DOI 10.1016/j.ajo.2006.01.090; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Lawrence JM, 2000, INVEST OPHTH VIS SCI, V41, P518; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; LI W, 2009, STEM CELLS; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Luhmann U. F., 2009, INVEST OPHTHALMOL VI; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Ma ZZ, 2009, INVEST OPHTH VIS SCI, V50, P2975, DOI 10.1167/iovs.08-2573; MACHEMER R, 1993, GRAEF ARCH CLIN EXP, V231, P635, DOI 10.1007/BF00921957; MacLaren RE, 2007, OPHTHALMOLOGY, V114, P561, DOI 10.1016/j.ophtha.2006.06.049; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Ming M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-53; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P934, DOI 10.1016/0006-291X(87)90340-8; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; SILVERMAN MS, 1990, CURR EYE RES, V9, P183, DOI 10.3109/02713689008995205; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tezel TH, 2007, AM J OPHTHALMOL, V143, P584, DOI 10.1016/j.ajo.2006.12.007; Thumann G, 2009, GRAEF ARCH CLIN EXP, V247, P363, DOI 10.1007/s00417-008-0998-x; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; West EL, 2009, PROG BRAIN RES, V175, P3, DOI 10.1016/S0079-6123(09)17501-5; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang D, 2009, CELL RES, V52, P615; Zhang Hou-Liang, 2007, Neurosci Bull, V23, P137, DOI 10.1007/s12264-007-0020-3; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	78	332	354	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8152	10.1371/journal.pone.0008152	http://dx.doi.org/10.1371/journal.pone.0008152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997644	gold, Green Published			2022-12-27	WOS:000272829000010
J	Betapudi, V				Betapudi, Venkaiah			Myosin II Motor Proteins with Different Functions Determine the Fate of Lamellipodia Extension during Cell Spreading	PLOS ONE			English	Article							RAT SYMPATHETIC NEURONS; INTERFERING RNAS; MESSENGER-RNA; LEADING-EDGE; ACTIN; ISOFORMS; LOCALIZATION; CYTOKINESIS; EXPRESSION; MOTILITY	Non-muscle cells express multiple myosin-II motor proteins myosin IIA, myosin IIB and myosin IIC transcribed from different loci in the human genome. Due to a significant homology in their sequences, these ubiquitously expressed myosin II motor proteins are believed to have overlapping cellular functions, but the mechanistic details are not elucidated. The present study uncovered a mechanism that coordinates the distinctly localized myosin IIA and myosin IIB with unexpected opposite mechanical roles in maneuvering lamellipodia extension, a critical step in the initiation of cell invasion, spreading, and migration. Myosin IIB motor protein by localizing at the front drives lamellipodia extension during cell spreading. On the other hand, myosin IIA localizes next to myosin IIB and attenuates or retracts lamellipodia extension. Myosin IIA and IIB increase cell adhesion by regulating focal contacts formation in the spreading margins and central part of the spreading cell, respectively. Spreading cells expressing both myosin IIA and myosin IIB motor proteins display an organized actin network consisting of retrograde filaments, arcs and central filaments attached to focal contacts. This organized actin network especially arcs and focal contacts formation in the spreading margins were lost in myosin II (A) over bar cells. Surprisingly, myosin II (B) over bar cells displayed long parallel actin filaments connected to focal contacts in the spreading margins. Thus, with different roles in the regulation of the actin network and focal contacts formation, both myosin IIA and IIB determine the fate of lamellipodia extension during cell spreading.	[Betapudi, Venkaiah] Case Western Reserve Univ, Dept Cell Biol, Lerner Coll Med, Cleveland, OH 44106 USA; [Betapudi, Venkaiah] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Betapudi, V (corresponding author), Case Western Reserve Univ, Dept Cell Biol, Lerner Coll Med, Cleveland, OH 44106 USA.	betapuv@ccf.org			U.S. National Institutes of Health [GM077224]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077224] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the U.S. National Institutes of Health to TTE (grant GM077224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Kolega J, 1998, J CELL SCI, V111, P2085; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19; Lord M, 2005, MOL BIOL CELL, V16, P5346, DOI 10.1091/mbc.E05-07-0601; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Saitoh T, 2001, FEBS LETT, V509, P365, DOI 10.1016/S0014-5793(01)03186-6; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Semizarov D, 2004, NUCLEIC ACIDS RES, V32, P3836, DOI 10.1093/nar/gkh714; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Takagishi Y, 2005, J PHYSIOL-LONDON, V569, P195, DOI 10.1113/jphysiol.2005.095943; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WANG YL, 2007, SCI STKE, pE10; Wei Q, 2002, MOL BIOL CELL, V13, P683, DOI 10.1091/mbc.01-07-0358; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783; Zimerman B, 2004, IEE Proc Nanobiotechnol, V151, P62, DOI 10.1049/ip-nbt:20040474	65	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8560	10.1371/journal.pone.0008560	http://dx.doi.org/10.1371/journal.pone.0008560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052411	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338500007
J	Caschera, F; Gazzola, G; Bedau, MA; Moreno, CB; Buchanan, A; Cawse, J; Packard, N; Hanczyc, MM				Caschera, Filippo; Gazzola, Gianluca; Bedau, Mark A.; Moreno, Carolina Bosch; Buchanan, Andrew; Cawse, James; Packard, Norman; Hanczyc, Martin M.			Automated Discovery of Novel Drug Formulations Using Predictive Iterated High Throughput Experimentation	PLOS ONE			English	Article							AMPHOTERICIN-B; PROTEIN CRYSTALLIZATION; OPTIMIZATION; GLUCOSIDE; AMBISOME; BILAYERS	Background: We consider the problem of optimizing a liposomal drug formulation: a complex chemical system with many components (e. g., elements of a lipid library) that interact nonlinearly and synergistically in ways that cannot be predicted from first principles. Methodology/Principal Findings: The optimization criterion in our experiments was the percent encapsulation of a target drug, Amphotericin B, detected experimentally via spectrophotometric assay. Optimization of such a complex system requires strategies that efficiently discover solutions in extremely large volumes of potential experimental space. We have designed and implemented a new strategy of evolutionary design of experiments (Evo-DoE), that efficiently explores high-dimensional spaces by coupling the power of computer and statistical modeling with experimentally measured responses in an iterative loop. Conclusions: We demonstrate how iterative looping of modeling and experimentation can quickly produce new discoveries with significantly better experimental response, and how such looping can discover the chemical landscape underlying complex chemical systems.	[Caschera, Filippo; Gazzola, Gianluca; Bedau, Mark A.; Moreno, Carolina Bosch; Buchanan, Andrew; Cawse, James; Packard, Norman; Hanczyc, Martin M.] ProtoLife Inc, San Francisco, CA USA; [Caschera, Filippo; Hanczyc, Martin M.] Univ So Denmark, Inst Chem & Phys, Odense, Denmark; [Packard, Norman] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bedau, Mark A.; Packard, Norman] European Ctr Living Technol, Venice, Italy; [Bedau, Mark A.] Reed Coll, Portland, OR 97202 USA; [Bedau, Mark A.] Univ So Denmark, Initiat Sci Soc & Policy, Odense, Denmark; [Cawse, James] Cawse & Effect, Pittsfield, MA USA	University of Southern Denmark; The Santa Fe Institute; Reed College - Oregon; University of Southern Denmark	Caschera, F (corresponding author), ProtoLife Inc, San Francisco, CA USA.	martin@ifk.sdu.dk	CASCHERA, FILIPPO/ABF-7941-2021; Gazzola, Gianluca/AAD-3204-2020	CASCHERA, FILIPPO/0000-0001-9884-775X; Gazzola, Gianluca/0000-0002-8306-1225; Hanczyc, Martin/0000-0002-5453-2139	ProtoLife Srl	ProtoLife Srl	This work was funded internally by ProtoLife Srl. All research was conducted at ProtoLife's laboratories in Venice, Italy. At that time, all of the authors were employed by ProtoLife Srl. The authors and therefore ProtoLife Srl designed and executed the study. The role of the funders was to supply the funds.	Adler-Moore J, 2002, J ANTIMICROB CHEMOTH, V49, P21, DOI 10.1093/jac/49.suppl_1.21; [Anonymous], 1998, NEURAL NETWORKS COMP; Boswell GW, 1998, J CLIN PHARMACOL, V38, P583, DOI 10.1002/j.1552-4604.1998.tb04464.x; CARTER CW, 1979, J BIOL CHEM, V254, P2219; Cawse J. N., 2002, 2002GRC253, P25; CAWSE JN, 2007, COMBINATORIAL MAT SC, P21; Davison AC, 1997, BOOTSTRAP METHODS TH; DeLucas LJ, 2003, J STRUCT BIOL, V142, P188, DOI 10.1016/S1047-8477(03)00050-9; DEVARIAS DP, 2005, ADV NEURAL INFORM PR, P1; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Fujii G, 1997, BIOCHEMISTRY-US, V36, P4959, DOI 10.1021/bi962894z; Gagos M, 2001, BBA-BIOMEMBRANES, V1511, P90, DOI 10.1016/S0005-2736(00)00386-2; He LZ, 2000, J MOL LIQ, V89, P239, DOI 10.1016/S0167-7322(00)90017-5; Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; NIST/SEMATECH, NIST SEMATECH E HDB; PROFFITT RT, 2004, Patent No. 6770290; Selassie C.D., 2003, BURGERS MED CHEM DRU, P1, DOI DOI 10.1002/0471266949.BMC001; Singh J, 1996, J AM CHEM SOC, V118, P1669, DOI 10.1021/ja953172i; THEIS M, 2006, ECCS06 ONL P OXF; WEBER L, 1995, ANGEW CHEM INT EDIT, V34, P2280, DOI 10.1002/anie.199522801; WOLF D, 2002, EXPT DESIGN COMBINAT, P147	22	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8546	10.1371/journal.pone.0008546	http://dx.doi.org/10.1371/journal.pone.0008546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049327	Green Submitted, Green Published, gold			2022-12-27	WOS:000273225000011
J	Sahar, S; Zocchi, L; Kinoshita, C; Borrelli, E; Sassone-Corsi, P				Sahar, Saurabh; Zocchi, Loredana; Kinoshita, Chisato; Borrelli, Emiliana; Sassone-Corsi, Paolo			Regulation of BMAL1 Protein Stability and Circadian Function by GSK3 beta-Mediated Phosphorylation	PLOS ONE			English	Article							CLOCK; COMPONENT; TRANSCRIPTION; INHIBITION; ACTIVATION; REVEALS; GSK-3; AGE	Background: Circadian rhythms govern a large array of physiological and metabolic functions. To achieve plasticity in circadian regulation, proteins constituting the molecular clock machinery undergo various post-translational modifications (PTMs), which influence their activity and intracellular localization. The core clock protein BMAL1 undergoes several PTMs. Here we report that the Akt-GSK3 beta signaling pathway regulates BMAL1 protein stability and activity. Principal Findings: GSK3 beta phosphorylates BMAL1 specifically on Ser 17 and Thr 21 and primes it for ubiquitylation. In the absence of GSK3 beta-mediated phosphorylation, BMAL1 becomes stabilized and BMAL1 dependent circadian gene expression is dampened. Dopamine D2 receptor mediated signaling, known to control the Akt-GSK3 beta pathway, influences BMAL1 stability and in vivo circadian gene expression in striatal neurons. Conclusions: These findings uncover a previously unknown mechanism of circadian clock control. The GSK3 beta kinase phosphorylates BMAL1, an event that controls the stability of the protein and the amplitude of circadian oscillation. BMAL1 phosphorylation appears to be an important regulatory step in maintaining the robustness of the circadian clock.	[Sahar, Saurabh; Zocchi, Loredana; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Kinoshita, Chisato; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Sahar, Saurabh; Borrelli, Emiliana; Sassone-Corsi, Paolo] Univ Calif Irvine, Unite 904, INSERM Epigenet & Neuronal Plast, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sahar, S (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	psc@uci.edu	Borrelli, Emiliana/M-8994-2018; Kinoshita, Chisato/AAW-5116-2020; Sassone-Corsi, Paolo/H-6182-2011	Kinoshita, Chisato/0000-0001-5877-0196; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024689] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA024689, R01-DA024689] Funding Source: Medline; NIGMS NIH HHS [R01 GM081634, R01-GM081634-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; MacAulay K, 2008, EXPERT OPIN THER TAR, V12, P1265, DOI 10.1517/14728222.12.10.1265 ; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; WOODGETT JR, 2001, SCI STKE, pRE12; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	45	200	211	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8561	10.1371/journal.pone.0008561	http://dx.doi.org/10.1371/journal.pone.0008561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049328	Green Published, gold			2022-12-27	WOS:000273225000020
J	Raffegerst, SH; Hoelzlwimmer, G; Kunder, S; Mysliwietz, J; Quintanilla-Martinez, L; Schendel, DJ				Raffegerst, Silke H.; Hoelzlwimmer, Gabriele; Kunder, Sandra; Mysliwietz, Josef; Quintanilla-Martinez, Leticia; Schendel, Dolores J.			Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice	PLOS ONE			English	Article							COMBINED IMMUNODEFICIENT MICE; REED-STERNBERG CELLS; RECEPTOR BETA-CHAINS; CENTER B-CELLS; HEMATOPOIETIC NEOPLASMS; REARRANGEMENT ANALYSIS; BETHESDA PROPOSALS; DEFICIENT MICE; DISEASE; MODELS	A chimeric HLA-DR4-H2-E (DR4) homozygous transgenic mouse line spontaneously develops diverse hematological malignancies with high frequency (70%). The majority of malignancies were distributed equally between T and B cell neoplasms and included lymphoblastic T cell lymphoma (LTCL), lymphoblastic B cell lymphoma (LBCL), diffuse large B cell lymphoma (DLBCL), the histiocyte/T cell rich variant of DLBCL (DLBCL-HA/T cell rich DLBCL), splenic marginal zone lymphoma (SMZL), follicular B cell lymphoma (FBL) and plasmacytoma (PCT). Most of these neoplasms were highly similar to human diseases. Also, some non-lymphoid malignancies such as acute myeloid leukemia (AML) and histiocytic sarcoma were found. Interestingly, composite lymphomas, including Hodgkin-like lymphomas, were also detected that had CD30(+) Hodgkin/Reed-Sternberg (H/RS)-like cells, representing a tumor type not previously described in mice. Analysis of microdissected H/RS-like cells revealed their origin as germinal center B cells bearing somatic hypermutations and, in some instances, crippled mutations, as described for human Hodgkin lymphoma (HL). Transgene integration in an oncogene was excluded as an exclusive driving force of tumorigenesis and age-related lymphoma development suggests a multi-step process. Thus, this DR4 line is a useful model to investigate common molecular mechanisms that may contribute to important neoplastic diseases in man.	[Raffegerst, Silke H.; Mysliwietz, Josef; Schendel, Dolores J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Raffegerst, Silke H.; Schendel, Dolores J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, Munich, Germany; [Hoelzlwimmer, Gabriele; Kunder, Sandra; Quintanilla-Martinez, Leticia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Raffegerst, SH (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany.	silke.raffegerst@helmholtz-muenchen.de	Mysliwietz, Josef/B-8941-2015	Mysliwietz, Josef/0000-0003-4418-5345	Federal Ministry of Education and Research [NGFN2]; Helmholtz Society [HA-202]; German Research Foundation [SFB-TR36]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Society(Helmholtz Association); German Research Foundation(German Research Foundation (DFG))	This work was partially supported by the Federal Ministry of Education and Research (NGFN2), the Helmholtz Society (Alliance for Immunotherapy of Cancer, HA-202) and the German Research Foundation (SFB-TR36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARD DA, 1989, METHOD CELL BIOL, V30, P353; AKESON EC, 2001, CURR PROTOC HUM GENE, pCH4; BARGOU RC, 1993, J EXP MED, V177, P1257, DOI 10.1084/jem.177.5.1257; Bellan C, 2002, DIAGN MOL PATHOL, V11, P2, DOI 10.1097/00019606-200203000-00002; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Brunning RD., 2001, PATHOLOGY GENETICS T; Caleo A, 2003, AM J SURG PATHOL, V27, P1577, DOI 10.1097/00000478-200312000-00012; Deshpande AJ, 2007, CELL CYCLE, V6, P543, DOI 10.4161/cc.6.5.3968; Eriksson B, 1999, EXP HEMATOL, V27, P682, DOI 10.1016/S0301-472X(99)00003-X; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Hoogervorst EM, 2005, MUTAT RES-FUND MOL M, V574, P3, DOI 10.1016/j.mrfmmm.2005.01.018; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; KAPP U, 1993, BLOOD, V82, P1247; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kunder S, 2007, TOXICOL PATHOL, V35, P366, DOI 10.1080/01926230701230296; Kuppers R, 1996, ANN ONCOL, V7, P27; Largaespada DA, 2000, LEUKEMIA, V14, P1174, DOI 10.1038/sj.leu.2401852; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lim MS, 2002, AM J SURG PATHOL, V26, P1458, DOI 10.1097/00000478-200211000-00008; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Mikkers H, 2002, ONCOGENE, V21, P6559, DOI 10.1038/sj.onc.1205930; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; SIMPSON E, 1995, EUR J IMMUNOL, V25, P2813, DOI 10.1002/eji.1830251015; Sonderstrup G, 1999, IMMUNOL REV, V172, P335, DOI 10.1111/j.1600-065X.1999.tb01377.x; VONKALLE C, 1992, INT J CANCER, V52, P887, DOI 10.1002/ijc.2910520610; Ward JM, 2006, EXP TOXICOL PATHOL, V57, P377, DOI 10.1016/j.etp.2006.01.007; Zettl A, 2005, HISTOPATHOLOGY, V46, P217, DOI 10.1111/j.1365-2559.2005.02046.x	36	6	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8539	10.1371/journal.pone.0008539	http://dx.doi.org/10.1371/journal.pone.0008539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046882	Green Submitted, Green Published, gold			2022-12-27	WOS:000273180200018
J	Abiola, M; Favier, M; Christodoulou-Vafeiadou, E; Pichard, AL; Martelly, I; Guillet-Deniau, I				Abiola, Mounira; Favier, Maryline; Christodoulou-Vafeiadou, Eleni; Pichard, Anne-Lise; Martelly, Isabelle; Guillet-Deniau, Isabelle			Activation of Wnt/beta-Catenin Signaling Increases Insulin Sensitivity through a Reciprocal Regulation of Wnt10b and SREBP-1c in Skeletal Muscle Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; GLUCOSE-TRANSPORT; GENE-EXPRESSION; MYOGENIC CELLS; FATTY-ACIDS; RAT MUSCLES; KINASE; DIFFERENTIATION; PHOSPHORYLATION; ADIPOGENESIS	Background: Intramyocellular lipid accumulation is strongly related to insulin resistance in humans, and we have shown that high glucose concentration induced de novo lipogenesis and insulin resistance in murin muscle cells. Alterations in Wnt signaling impact the balance between myogenic and adipogenic programs in myoblasts, partly due to the decrease of Wnt10b protein. As recent studies point towards a role for Wnt signaling in the pathogenesis of type 2 diabetes, we hypothesized that activation of Wnt signaling could play a crucial role in muscle insulin sensitivity. Methodology/Principal Findings: Here we demonstrate that SREBP-1c and Wnt10b display inverse expression patterns during muscle ontogenesis and regeneration, as well as during satellite cells differentiation. The Wnt/beta-catenin pathway was reactivated in contracting myotubes using siRNA mediated SREBP-1 knockdown, Wnt10b over-expression or inhibition of GSK-3 beta, whereas Wnt signaling was inhibited in myoblasts through silencing of Wnt10b. SREBP-1 knockdown was sufficient to induce Wnt10b protein expression in contracting myotubes and to activate the Wnt/beta-catenin pathway. Conversely, silencing Wnt10b in myoblasts induced SREBP-1c protein expression, suggesting a reciprocal regulation. Stimulation of the Wnt/beta-catenin pathway i) drastically decreased SREBP-1 c protein and intramyocellular lipid deposition in myotubes; ii) increased basal glucose transport in both insulin-sensitive and insulin-resistant myotubes through a differential activation of Akt and AMPK pathways; iii) restored insulin sensitivity in insulin-resistant myotubes. Conclusions/Significance:We conclude that activation of Wnt/beta-catenin signaling in skeletal muscle cells improved insulin sensitivity by i) decreasing intramyocellular lipid deposition through downregulation of SREBP-1c; ii) increasing insulin effects through a differential activation of the Akt/PKB and AMPK pathways; iii) inhibiting the MAPK pathway. A crosstalk between these pathways and Wnt/beta-catenin signaling in skeletal muscle opens the exciting possibility that organ-selective modulation of Wnt signaling might become an attractive therapeutic target in regenerative medicine and to treat obese and diabetic populations.	[Abiola, Mounira; Favier, Maryline; Christodoulou-Vafeiadou, Eleni; Pichard, Anne-Lise; Guillet-Deniau, Isabelle] Univ Paris 05, CNRS, UMR 8104, Genet & Dev Dept,Inst Cochin, Paris, France; [Abiola, Mounira; Favier, Maryline; Christodoulou-Vafeiadou, Eleni; Pichard, Anne-Lise; Guillet-Deniau, Isabelle] INSERM, U567, Paris, France; [Martelly, Isabelle] Univ Paris 12, CNRS, UMR 7149, CRRET, Creteil, France; [Guillet-Deniau, Isabelle] UPMC Paris 6, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Sorbonne Universite	Abiola, M (corresponding author), Univ Paris 05, CNRS, UMR 8104, Genet & Dev Dept,Inst Cochin, Paris, France.	isabelle.guillet-deniau@inserm.fr						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bizeau ME, 2003, J NUTR, V133, P1787, DOI 10.1093/jn/133.6.1787; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Etgen GJ, 1997, DIABETES, V46, P1915, DOI 10.2337/diabetes.46.11.1915; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Grimaldi PA, 1997, PROSTAG LEUKOTR ESS, V57, P71, DOI 10.1016/S0952-3278(97)90495-6; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; GUILLETDENIAU I, 1994, J CELL SCI, V107, P487; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Millar JBA, 2002, GENOME BIOL, V3; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Takata H, 2007, DEV DYNAM, V236, P2800, DOI 10.1002/dvdy.21327; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Zahler S, 2007, CHEM BIOL, V14, P1207, DOI 10.1016/j.chembiol.2007.10.010	46	90	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8509	10.1371/journal.pone.0008509	http://dx.doi.org/10.1371/journal.pone.0008509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041157	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700022
J	Guittot, SM; Bouchard, MF; Robert-Grenon, JP; Robert, C; Goodyer, CG; Silversides, DW; Viger, RS				Guittot, Severine Mazaud; Bouchard, Marie France; Robert-Grenon, Jean-Philippe; Robert, Claude; Goodyer, Cynthia G.; Silversides, David W.; Viger, Robert S.			Conserved Usage of Alternative 5 ' Untranslated Exons of the GATA4 Gene	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; MOUSE GONADAL DEVELOPMENT; HEART TUBE FORMATION; VENTRAL MORPHOGENESIS; REGULATORY ELEMENTS; EXPRESSION; PROMOTERS; FAMILY; TISSUE; FETAL	Background: GATA4 is an essential transcription factor required for the development and function of multiple organs. Despite this important role, our knowledge of how the GATA4 gene is regulated remains limited. To better understand this regulation, we characterized the 59 region of the mouse, rat, and human GATA4 genes. Methodology/Principal Findings: Using 59 RACE, we identified novel transcription start sites in all three species. GATA4 is expressed as multiple transcripts with varying 59 ends encoded by alternative untranslated first exons. Two of these non-coding first exons are conserved between species: exon 1a located 3.5 kb upstream of the GATA4 ATG site in exon 2, and a second first exon (exon 1b) located 28 kb further upstream. Expression of both mRNA variants was found in all GATA4-expressing organs but with a preference for the exon 1a-containing transcript. The exception was the testis where exon 1a- and 1b-containing transcripts were similarly expressed. In some tissues such as the intestine, alternative transcript expression appears to be regionally regulated. Polysome analysis suggests that both mRNA variants contribute to GATA4 protein synthesis. Conclusions/Significance: Taken together, our results indicate that the GATA4 gene closely resembles the other GATA family members in terms of gene structure where alternative first exon usage appears to be an important mechanism for regulating its tissue- and cell-specific expression.	[Guittot, Severine Mazaud; Bouchard, Marie France; Viger, Robert S.] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Guittot, Severine Mazaud; Bouchard, Marie France; Robert-Grenon, Jean-Philippe; Robert, Claude; Viger, Robert S.] Univ Laval, CRBR, Quebec City, PQ, Canada; [Robert-Grenon, Jean-Philippe; Robert, Claude] Univ Laval, Dept Anim Sci, Quebec City, PQ, Canada; [Goodyer, Cynthia G.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3H 1P3, Canada; [Silversides, David W.] Univ Montreal, Fac Vet Med, St Hyacinthe, PQ J2S 7C6, Canada; [Viger, Robert S.] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; McGill University; Universite de Montreal; Laval University	Guittot, SM (corresponding author), Univ Rennes 1, INSERM, GERHM, Rennes, France.	robert.viger@crchul.ulaval.ca	Mazaud-Guittot, Severine/I-4694-2015	Mazaud-Guittot, Severine/0000-0003-0566-4124; Robert, Claude/0000-0001-9690-8088	Canadian Institutes of Health Research (CIHR) [MOP-14796]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	To SMG, a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR) Institute of Gender and Health: www.cihr.ca/e/8673. html. To RSV, a Canada Research Chair in Reproduction and Sex Development: www.chairs-chaires.gc.ca, and CIHR operating grant MOP-14796: www.cihr.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bouchard MF, 2009, J MOL ENDOCRINOL, V42, P149, DOI 10.1677/JME-08-0089; Bouma GJ, 2007, P NATL ACAD SCI USA, V104, P14994, DOI 10.1073/pnas.0701677104; Brewer A, 1999, J BIOL CHEM, V274, P38004, DOI 10.1074/jbc.274.53.38004; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Dusing MR, 2005, J MOL HISTOL, V36, P15, DOI 10.1007/s10735-004-2908-9; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Guigon CJ, 2005, ENDOCRINOLOGY, V146, P2992, DOI 10.1210/en.2005-0045; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Jacobsen CM, 2005, DEV DYNAM, V234, P355, DOI 10.1002/dvdy.20552; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007; Kiiveri S, 2002, ENDOCRINOLOGY, V143, P3136, DOI 10.1210/endo.143.8.8939; Kimura R, 2000, BIOCHEM BIOPH RES CO, V278, P63, DOI 10.1006/bbrc.2000.3774; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; MacNeill C, 1997, J BIOL CHEM, V272, P8396, DOI 10.1074/jbc.272.13.8396; Manuylov NL, 2007, DEV BIOL, V307, P356, DOI 10.1016/j.ydbio.2007.04.040; Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247; Mazaud S, 2002, ENDOCRINOLOGY, V143, P4775, DOI 10.1210/en.2002-220464; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; MUNSICK RA, 1984, AM J OBSTET GYNECOL, V149, P883, DOI 10.1016/0002-9378(84)90609-4; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Nony P, 1998, J BIOL CHEM, V273, P32910, DOI 10.1074/jbc.273.49.32910; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Onodera K, 1997, J BIOCHEM, V121, P251; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shil Pratip, 2006, In Silico Biology, V6, P373; TAMURA S, 1993, P NATL ACAD SCI USA, V90, P10876, DOI 10.1073/pnas.90.22.10876; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Tremblay JJ, 2003, J STEROID BIOCHEM, V85, P291, DOI 10.1016/S0960-0760(03)00211-5; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Viger RS, 2004, J ANDROL, V25, P441; Viger RS, 1998, DEVELOPMENT, V125, P2665; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	52	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8454	10.1371/journal.pone.0008454	http://dx.doi.org/10.1371/journal.pone.0008454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041118	Green Submitted, Green Published, gold			2022-12-27	WOS:000273104000016
J	Wang, YG; Mukhopadhyay, D; Mathew, S; Hasebe, T; Heimeier, RA; Azuma, Y; Kolli, N; Shi, YB; Wilkinson, KD; Dasso, M				Wang, Yonggang; Mukhopadhyay, Debaditya; Mathew, Smita; Hasebe, Takashi; Heimeier, Rachel A.; Azuma, Yoshiaki; Kolli, Nagamalleswari; Shi, Yun-Bo; Wilkinson, Keith D.; Dasso, Mary			Identification and Developmental Expression of Xenopus laevis SUMO Proteases	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEINS; SMAD TRANSCRIPTIONAL ACTIVITY; CAENORHABDITIS-ELEGANS; STRUCTURAL BASIS; DOWN-REGULATION; GENE-REGULATION; SUMOYLATION; PATHWAY; YEAST; VERTEBRATE	SUMO proteins are small ubiquitin-related modifiers. All SUMOs are synthesized as propeptides that are post-translationally cleaved prior to conjugation. After processing, SUMOs become covalently conjugated to cellular targets through a pathway that is similar to ubiquitination. Ubiquitin like protein proteases/Sentrin specific proteases (Ulp/SENPs) mediate both processing and deconjugation of SUMOs. The action of Ulp/SENPs makes SUMOylation a highly dynamic post-translational modification. To investigate how Ulp/SENPs are regulated in a developmental context, we isolated and characterized all Ulp/SENPs in Xenopus laevis. Xenopus possess homologues of mammalian SENP3, 5, 6 and 7. All of these enzymes reacted with HA-tagged vinyl sulfone derivatives of SUMO-2 (HA-SU2-VS) but not SUMO-1 ( HA-SU1-VS), suggesting that they act primarily on SUMO-2 and -3. In contrast, Xenopus possess a single member of the SENP1/SENP2 subfamily of Ulp/SENPs, most closely related to mammalian SENP1. Xenopus SENP1 reacted with HA-SU1-VS and HA-SU2-VS, suggesting that it acts on all SUMO paralogues. We analyzed the mRNA and protein levels for each of the Ulp/SENPs through development; we found that they show distinct patterns of expression that may involve both transcriptional and post-transcriptional regulation. Finally, we have characterized the developmental function of the most abundant Ulp/SENP found within Xenopus eggs, SENP3. Depletion of SENP3 using morpholino antisense oligonucleotides (morpholinos) caused accumulation of high molecular weight SUMO-2/3 conjugated species, defects in developing embryos and changes in the expression of some genes regulated by the transforming growth factor beta (TGF-beta) pathway. These findings collectively indicate that SUMO proteases are both highly regulated and essential for normal development.	[Wang, Yonggang; Mukhopadhyay, Debaditya; Mathew, Smita; Hasebe, Takashi; Heimeier, Rachel A.; Azuma, Yoshiaki; Shi, Yun-Bo; Dasso, Mary] NICHHD, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA; [Kolli, Nagamalleswari; Wilkinson, Keith D.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University	Wang, YG (corresponding author), NICHHD, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA.	mdasso@helix.nih.gov		Dasso, Mary/0000-0002-5410-1371; Hasebe, Takashi/0000-0001-7200-8173; Shi, Yun-Bo/0000-0002-6330-0639	National Institute of Child Health and Human Development; National Institutes of Health [5R01GM066355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901, ZIAHD001902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066355] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Child Health and Human Development intramural funds ( to Y. Wang, D. Mukhopadhyay, S. Mathew, T. Hasebe, R. Heimeier, Y. Azuma, Y.- B. Shi and M. Dasso) and by National Institutes of Health grant # 5R01GM066355 ( to N. Kolli and K. D. Wilkinson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Broday L, 2004, GENE DEV, V18, P2380, DOI 10.1101/gad.1227104; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Daniels M, 2004, DEVELOPMENT, V131, P5613, DOI 10.1242/dev.01449; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; DUVAL C, 1990, MOL CELL BIOL, V10, P4123, DOI 10.1128/MCB.10.8.4123; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Hay RT, 2006, E SCHERING RES FDN W, V57, P173; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heimeier RA, 2009, ENDOCRINOLOGY, V150, P2964, DOI 10.1210/en.2008-1503; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hocking JC, 2007, INT J DEV BIOL, V51, P161, DOI 10.1387/ijdb.062185jh; Imoto S, 2004, BIOCHEM BIOPH RES CO, V319, P275, DOI 10.1016/j.bbrc.2004.04.161; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kadoya T, 2002, MOL CELL BIOL, V22, P3803, DOI 10.1128/MCB.22.11.3803-3819.2002; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KORNBLUTH S, 2001, CURRENT PROTOCOLS CE; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; LIMA CD, 2008, J BIOL CHEM; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nowak M, 2006, MOL BIOL CELL, V17, P5324, DOI 10.1091/mbc.E06-05-0413; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pollet N, 2006, GENOME DYN, V2, P138, DOI 10.1159/000095101; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Talamillo A, 2008, BIOCHEM SOC T, V36, P868, DOI 10.1042/BST0360868; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Xu Z, 2005, BIOCHEM J, V386, P325, DOI 10.1042/BJ20041210; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yukita A, 2004, GENES CELLS, V9, P723, DOI 10.1111/j.1356-9597.2004.00757.x; Yukita A, 2007, DEV DYNAM, V236, P2757, DOI 10.1002/dvdy.21297; YUN C, 2008, J CELL BIOL IN PRESS; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185; Zhang H, 2004, NAT GENET, V36, P507, DOI 10.1038/ng1336	54	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8462	10.1371/journal.pone.0008462	http://dx.doi.org/10.1371/journal.pone.0008462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041154	Green Submitted, Green Published, gold			2022-12-27	WOS:000273104000022
J	Wong, ACN; Palmeri, TJ; Rogers, BP; Gore, JC; Gauthier, I				Wong, Alan C. -N.; Palmeri, Thomas J.; Rogers, Baxter P.; Gore, John C.; Gauthier, Isabel			Beyond Shape: How You Learn about Objects Affects How They Are Represented in Visual Cortex	PLOS ONE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; INFERIOR TEMPORAL CORTEX; PERCEPTUAL EXPERTISE; SINGLE LETTERS; FMRI DATA; RECOGNITION; CATEGORIZATION; ORGANIZATION; SELECTIVITY	Background: Experience can alter how objects are represented in the visual cortex. But experience can take different forms. It is unknown whether the kind of visual experience systematically alters the nature of visual cortical object representations. Methodology/Principal Findings: We take advantage of different training regimens found to produce qualitatively different types of perceptual expertise behaviorally in order to contrast the neural changes that follow different kinds of visual experience with the same objects. Two groups of participants went through training regimens that required either subordinate-level individuation or basic-level categorization of a set of novel, artificial objects, called "Ziggerins''. fMRI activity of a region in the right fusiform gyrus increased after individuation training and was correlated with the magnitude of configural processing of the Ziggerins observed behaviorally. In contrast, categorization training caused distributed changes, with increased activity in the medial portion of the ventral occipito-temporal cortex relative to more lateral areas. Conclusions/Significance: Our results demonstrate that the kind of experience with a category of objects can systematically influence how those objects are represented in visual cortex. The demands of prior learning experience therefore appear to be one factor determining the organization of activity patterns in visual cortex.	[Wong, Alan C. -N.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Palmeri, Thomas J.; Gauthier, Isabel] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37240 USA	Chinese University of Hong Kong; Vanderbilt University; Vanderbilt University	Wong, ACN (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	alanwong@psy.cuhk.edu.hk	Wong, Alan C.-N./H-3414-2019	Wong, Alan C.-N./0000-0002-2129-3485; Rogers, Baxter/0000-0002-5666-2797; Gauthier, Isabel/0000-0002-6249-4769; Palmeri, Thomas/0000-0001-7617-9797; Lauwereyns, Jan/0000-0003-0551-2550	James S. McDonnell Foundation; Temporal Dynamics of Learning Center [SBE-0542013]; NSF Science of Learning Center; National Institutes of Health; National Eye Institute [EY13441]; NATIONAL EYE INSTITUTE [R01EY013441] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Temporal Dynamics of Learning Center; NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a grant from the James S. McDonnell Foundation and the Temporal Dynamics of Learning Center (SBE-0542013), and the NSF Science of Learning Center, to I. G. and T.J.P, and the National Institutes of Health and the National Eye Institute (EY13441) to I. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; ENGEL SA, 2009, P SPIE, V7263; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; James KH, 2009, COGN NEUROPSYCHOL, V26, P91, DOI 10.1080/02643290802425914; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Op de Beeck H, 2000, NEUROIMAGE, V12, P28, DOI 10.1006/nimg.2000.0598; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Scott LS, 2008, BRAIN RES, V1210, P204, DOI 10.1016/j.brainres.2008.02.054; Scott LS, 2006, J COGNITIVE NEUROSCI, V18, P1453, DOI 10.1162/jocn.2006.18.9.1453; Tanaka JW, 2005, PSYCHOL SCI, V16, P145, DOI 10.1111/j.0956-7976.2005.00795.x; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Wong ACN, 2007, VIS COGN, V15, P854, DOI 10.1080/13506280600948350; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Wong ACN, 2009, COGN NEUROPSYCHOL, V26, P111, DOI 10.1080/02643290802340972; WONG YK, J COGNITIVE IN PRESS; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006; Xue G, 2007, J COGNITIVE NEUROSCI, V19, P1643, DOI 10.1162/jocn.2007.19.10.1643; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	45	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8405	10.1371/journal.pone.0008405	http://dx.doi.org/10.1371/journal.pone.0008405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	535US	20027229	gold, Green Published, Green Submitted			2022-12-27	WOS:000272998000010
J	Witwer, KW; Gama, L; Li, M; Bartizal, CM; Queen, SE; Varrone, JJ; Brice, AK; Graham, DR; Tarwater, PM; Mankowski, JL; Zink, MC; Clements, JE				Witwer, Kenneth W.; Gama, Lucio; Li, Ming; Bartizal, Christopher M.; Queen, Suzanne E.; Varrone, John J.; Brice, Angela K.; Graham, David R.; Tarwater, Patrick M.; Mankowski, Joseph L.; Zink, M. Christine; Clements, Janice E.			Coordinated Regulation of SIV Replication and Immune Responses in the CNS	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; BINDING-PROTEIN-BETA; TRANSCRIPTIONAL ACTIVATOR PROTEIN; TUMOR-NECROSIS-FACTOR; LONG TERMINAL REPEAT; BLOOD-BRAIN-BARRIER; CD4(+) T-CELLS; CEREBROSPINAL-FLUID; HIV-1 REPLICATION	Central nervous system (CNS) invasion during acute-stage HIV-infection has been demonstrated in a small number of individuals, but there is no evidence of neurological impairment at this stage and virus infection in brain appears to be controlled until late-stage disease. Using our reproducible SIV macaque model to examine the earliest stages of infection in the CNS, we identified immune responses that differentially regulate inflammation and virus replication in the brain compared to the peripheral blood and lymphoid tissues. SIV replication in brain macrophages and in brain of SIV-infected macaques was detected at 4 days post-inoculation (p.i.). This was accompanied by upregulation of innate immune responses, including IFN beta, IFN beta-induced gene MxA mRNA, and TNF alpha. Additionally, IL-10, the chemokine CCL2, and activation markers in macrophages, endothelial cells, and astrocytes were all increased in the brain at four days p.i. We observed synchronous control of virus replication, cytokine mRNA levels and inflammatory markers (MHC Class II, CD68 and GFAP) by 14 days p.i.; however, control failure was followed by development of CNS lesions in the brain. SIV infection was accompanied by induction of the dominant-negative isoform of C/EBP beta, which regulates SIV, CCL2, and IL6 transcription, as well as inflammatory responses in macrophages and astrocytes. This synchronous response in the CNS is in part due to the effect of the C/EBP beta on virus replication and cytokine expression in macrophage-lineage cells in contrast to CD4+ lymphocytes in peripheral blood and lymphoid tissues. Thus, we have identified a crucial period in the brain when virus replication and inflammation are controlled. As in HIV-infected individuals, though, this control is not sustained in the brain. Our results suggest that intervention with antiretroviral drugs or anti-inflammatory therapeutics with CNS penetration would sustain early control. These studies further suggest that interventions should target HIV-infected individuals with increased CCL2 levels or HIV RNA in the CNS.	[Witwer, Kenneth W.; Gama, Lucio; Li, Ming; Bartizal, Christopher M.; Queen, Suzanne E.; Varrone, John J.; Brice, Angela K.; Graham, David R.; Mankowski, Joseph L.; Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Mankowski, Joseph L.; Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Mankowski, Joseph L.; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Graham, David R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tarwater, Patrick M.] Texas Tech Univ, Dept Biomed Sci, Hlth Sci Ctr, El Paso, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Texas Tech University System; Texas Tech University	Witwer, KW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	jclements@jhmi.edu	Witwer, Kenneth W./G-1626-2013	Witwer, Kenneth W./0000-0003-1664-4233; Gama, Lucio/0000-0001-9511-012X	National Institutes of Health [MH070306, NS47984, NS050028, NS055648, MH68116, MH061189, NS055651]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061189, P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055651, R01NS050028, R01NS047984, R01NS055648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health Grants MH070306, NS47984, NS050028, NS055648 (to J. E. C.); MH68116, MH061189 (to M. C. Z.); and NS055651 (to J. L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Ances BM, 2008, CURR NEUROL NEUROSCI, V8, P455, DOI 10.1007/s11910-008-0073-3; Babas T, 2003, J VIROL, V77, P208, DOI 10.1128/JVI.77.1.208-216.2003; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Bartee E, 2008, CURR OPIN MICROBIOL, V11, P378, DOI 10.1016/j.mib.2008.05.015; Bartee E, 2009, J VIROL, V83, P498, DOI 10.1128/JVI.01376-08; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Byrnes AA, 2008, J LEUKOCYTE BIOL, V84, P1447, DOI 10.1189/jlb.0708438; Carruth LM, 2005, J MED PRIMATOL, V34, P109, DOI 10.1111/j.1600-0684.2005.00103.x; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Czub S, 1996, ACTA NEUROPATHOL, V92, P487, DOI 10.1007/s004010050551; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; de Almeida SN, 2005, J NEUROIMMUNOL, V169, P144, DOI 10.1016/j.jneuroim.2005.07.012; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Fischer-Smith T, 2004, AM J PATHOL, V164, P2089, DOI 10.1016/S0002-9440(10)63767-4; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Gupta S, 2008, IMMUNOLOGY, V124, P553, DOI 10.1111/j.1365-2567.2008.02809.x; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Marcondes MCG, 2008, J INFECT DIS, V197, P1567, DOI 10.1086/588002; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Orandle MS, 2002, J VIROL, V76, P5797, DOI 10.1128/JVI.76.11.5797-5802.2002; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Pope R, 2000, CYTOKINE, V12, P1171, DOI 10.1006/cyto.2000.0691; Raber J, 1998, BRAIN RES REV, V26, P320, DOI 10.1016/S0165-0173(97)00041-6; Roberts ES, 2004, J NEUROIMMUNOL, V157, P81, DOI 10.1016/j.jneuroim.2004.08.030; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; SINCLAIR E, 1992, J NEUROL, V239, P469, DOI 10.1007/BF00856814; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; Tanaka N, 2005, J ORTHOP SCI, V10, P3, DOI 10.1007/s00776-004-0859-3; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Wright EK, 2006, J NEUROVIROL, V12, P411, DOI 10.1080/13550280601009538; Zink MC, 2006, CURR HIV RES, V4, P293; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	72	86	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8129	10.1371/journal.pone.0008129	http://dx.doi.org/10.1371/journal.pone.0008129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019816	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834200001
J	Deyts, C; Galan-Rodriguez, B; Martin, E; Bouveyron, N; Roze, E; Charvin, D; Caboche, J; Betuing, S				Deyts, Carole; Galan-Rodriguez, Beatriz; Martin, Elodie; Bouveyron, Nicolas; Roze, Emmanuel; Charvin, Delphine; Caboche, Jocelyne; Betuing, Sandrine			Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation	PLOS ONE			English	Article							BINDING PROTEIN-PHOSPHORYLATION; RHO-ASSOCIATED KINASE; PROJECTION NEURONS; POLYGLUTAMINE AGGREGATION; INTRANUCLEAR INCLUSIONS; LYSOPHOSPHATIDIC ACID; NEURITE RETRACTION; SIGNALING PATHWAY; MUTANT HUNTINGTIN; PREFERENTIAL LOSS	Background: Huntington's disease (HD) is a polyglutamine-expanded related neurodegenerative disease. Despite the ubiquitous expression of expanded, polyQ-Huntingtin (ExpHtt) in the brain, striatal neurons present a higher susceptibility to the mutation. A commonly admitted hypothesis is that Dopaminergic inputs participate to this vulnerability. We previously showed that D2 receptor stimulation increased aggregate formation and neuronal death induced by ExpHtt in primary striatal neurons in culture, and chronic D2 antagonist treatment protects striatal dysfunctions induced by ExpHtt in a lentiviral-induced model system in vivo. The present work was designed to elucidate the signalling pathways involved, downstream D2 receptor (D2R) stimulation, in striatal vulnerability to ExpHtt. Methodology/Principal Findings: Using primary striatal neurons in culture, transfected with a tagged-GFP version of human exon 1 ExpHtt, and siRNAs against D2R or D1R, we confirm that DA potentiates neuronal dysfunctions via D2R but not D1R stimulation. We demonstrate that D2 agonist treatment induces neuritic retraction and growth cone collapse in Htt-and ExpHtt expressing neurons. We then tested a possible involvement of the Rho/ROCK signalling pathway, which plays a key role in the dynamic of the cytoskeleton, in these processes. The pharmacological inhibitors of ROCK (Y27632 and Hydroxyfasudil), as well as siRNAs against ROCK-II, reversed D2-related effects on neuritic retraction and growth cone collapse. We show a coupling between D2 receptor stimulation and Rho activation, as well as hyperphosphorylation of Cofilin, a downstream effector of ROCK-II pathway. Importantly, D2 agonist-mediated potentiation of aggregate formation and neuronal death induced by ExpHtt, was totally reversed by Y27632 and Hydroxyfasudil and ROCK-II siRNAs. Conclusions/Significance: Our data provide the first demonstration that D2R-induced vulnerability in HD is critically linked to the activation of the Rho/ROCK signalling pathway. The inclusion of Rho/ROCK inhibitors could be an interesting therapeutic option aimed at forestalling the onset of the disease.	[Deyts, Carole; Galan-Rodriguez, Beatriz; Martin, Elodie; Bouveyron, Nicolas; Roze, Emmanuel; Charvin, Delphine; Caboche, Jocelyne; Betuing, Sandrine] Univ Paris 06, CNRS, UMR 7102, Paris, France; [Deyts, Carole; Galan-Rodriguez, Beatriz; Martin, Elodie; Bouveyron, Nicolas; Roze, Emmanuel; Charvin, Delphine; Caboche, Jocelyne; Betuing, Sandrine] Univ Paris 06, CNRS, INSERM, UMRS 952,UMR 7224, Paris, France; [Deyts, Carole] Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA; [Roze, Emmanuel] Hop La Pitie Salpetriere, AP HP, Serv Neurol, Paris, France; [Betuing, Sandrine] Univ Evry Val dEssonne, Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Chicago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Betuing, S (corresponding author), Univ Paris 06, CNRS, UMR 7102, Paris, France.	sandrine.betuing@snv.jussieu.fr	Betuing, Sandrine/X-2179-2018; Betuing, Sandrine/F-2967-2013; Betuing, Sandrine/X-1957-2019; IBIS, SINAPTICA/C-2547-2016	Martin, Elodie/0000-0001-5668-7516; Charvin, Delphine/0000-0002-4801-7800	Centre National de la Recherche Scientifique (CNRS); Universite Pierre et Marie Curie-Paris 6; High Q Foundation for Jocelyne Caboche and Sandrine Betuing	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie-Paris 6; High Q Foundation for Jocelyne Caboche and Sandrine Betuing	This work was supported by Centre National de la Recherche Scientifique (CNRS), Universite Pierre et Marie Curie-Paris 6 and High Q Foundation for Jocelyne Caboche and Sandrine Betuing. Carole Deyts and Beatriz Galan-Rodriguez were grant recipients from the High Q foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam OR, 2008, NEUROTHERAPEUTICS, V5, P181, DOI 10.1016/j.nurt.2008.01.008; ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; BAUER PO, 2009, J BIOL CHEM; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bowyer JF, 1996, BRAIN RES, V712, P221, DOI 10.1016/0006-8993(95)01417-9; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Cass WA, 1997, J PHARMACOL EXP THER, V280, P105; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Charvin D, 2008, NEUROBIOL DIS, V29, P22, DOI 10.1016/j.nbd.2007.07.028; Correll CU, 2007, CNS SPECTRUMS, V12, P10, DOI 10.1017/S1092852900015959; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Cyr M, 2006, FASEB J, V20, P2541, DOI 10.1096/fj.06-6533fje; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Paoletti P, 2008, J NEUROSCI, V28, P10090, DOI 10.1523/JNEUROSCI.3237-08.2008; Parish CL, 2002, EUR J NEUROSCI, V16, P787, DOI 10.1046/j.1460-9568.2002.02132.x; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; RICAURTE GA, 1982, BRAIN RES, V235, P93, DOI 10.1016/0006-8993(82)90198-6; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Robinson P, 2008, NEUROSCIENCE, V153, P762, DOI 10.1016/j.neuroscience.2008.02.052; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; SAPP E, 1995, NEUROSCIENCE, V64, P397, DOI 10.1016/0306-4522(94)00427-7; Senogles SE, 2000, MOL PHARMACOL, V58, P455, DOI 10.1124/mol.58.2.455; SHAO J, 2008, MOL CELL BIOL; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Tallaksen-Greene SJ, 2005, NEUROSCIENCE, V131, P843, DOI 10.1016/j.neuroscience.2004.10.037; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yohrling GJ, 2003, MOL BRAIN RES, V119, P28, DOI 10.1016/j.molbrainres.2003.08.009; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	56	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8287	10.1371/journal.pone.0008287	http://dx.doi.org/10.1371/journal.pone.0008287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016831	gold, Green Published, Green Submitted			2022-12-27	WOS:000272833800004
J	Diaz-Sylvester, PL; Copello, JA				Diaz-Sylvester, Paula L.; Copello, Julio A.			Voltage-Dependent Modulation of Cardiac Ryanodine Receptors (RyR2) by Protamine	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA2+ RELEASE; DIHYDROPYRIDINE RECEPTOR; K+ CHANNELS; SURFACE-CHARGE; MECHANISMS; POLYAMINES; BLOCK	It has been reported that protamine (> 10 mg/ml) blocks single skeletal RyR1 channels and inhibits RyR1-mediated Ca(2+) release from sarcoplasmic reticulum microsomes. We extended these studies to cardiac RyR2 reconstituted into planar lipid bilayers. We found that protamine (0.02-20 mg/ml) added to the cytosolic surface of fully activated RyR2 affected channel activity in a voltage-dependent manner. At membrane voltage (V(m); SR lumen - cytosol) = 0 mV, protamine induced conductance transitions to several intermediate states (substates) as well as full block of RyR2. At V(m) > 10 mV, the substate with the highest level of conductance was predominant. Increasing V(m) from 0 to +80 mV, decreased the number of transitions and residence of the channel in this substate. The drop in current amplitude (full opening to substate) had the same magnitude at 0 and +80 mV despite the similar to 3-fold increase in amplitude of the full opening. This is more similar to rectification of channel conductance induced by other polycations than to the action of selective conductance modifiers (ryanoids, imperatoxin). A distinctive effect of protamine (which might be shared with polylysines and histones but not with non-peptidic polycations) is the activation of RyR2 in the presence of nanomolar cytosolic Ca(2+) and millimolar Mg(2+) levels. Our results suggest that RyRs would be subject to dual modulation (activation and block) by polycationic domains of neighboring proteins via electrostatic interactions. Understanding these interactions could be important as such anomalies may be associated with the increased RyR2-mediated Ca(2+) leak observed in cardiac diseases.	[Diaz-Sylvester, Paula L.; Copello, Julio A.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Diaz-Sylvester, PL (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	jcopello@siumed.edu		Diaz-Sylvester, Paula/0000-0002-1531-1958	National Institutes of Health [R01 GM078665]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 GM078665 to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1969, INT J PROT RES, V1, P221; Balke CW, 2003, J GEN PHYSIOL, V121, P349, DOI 10.1085/jgp.200308841; Bers DM, 2001, EXCITATION CONTRACTI; BRUNDER DG, 1992, J PHYSIOL-LONDON, V445, P759, DOI 10.1113/jphysiol.1992.sp018949; Byun Y, 1999, THROMB RES, V94, P53, DOI 10.1016/S0049-3848(98)00201-1; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; COPELLO JA, 2003, BIOPHYS J, V84; Copello JA, 2006, CIRCULATION, V114, P57; Copello JA, 2007, AM J PHYSIOL-CELL PH, V292, pC2129, DOI 10.1152/ajpcell.00437.2006; David JS, 2001, ANESTH ANALG, V92, P817; DESLONGCHAMPS P, 1990, CAN J CHEM, V68, P115, DOI 10.1139/v90-021; DEUTSCH N, 1994, J GEN PHYSIOL, V104, P773, DOI 10.1085/jgp.104.4.773; Diaz-Sylvester PL, 2009, BIOPHYS J, V96, p113A, DOI 10.1016/j.bpj.2008.12.493; DIAZSYLVESTER P, 2006, BIOPHYS J, V89; EBERT G, 1990, PROG COLL POL SCI S, V83, P181; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j; Gonzalez A, 2000, P NATL ACAD SCI USA, V97, P4380, DOI 10.1073/pnas.070056497; Green D, 2003, BIOCHEM J, V370, P517, DOI 10.1042/BJ20021488; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOBBHAHN J, 1991, J APPL PHYSIOL, V71, P1415, DOI 10.1152/jappl.1991.71.4.1415; Kobayashi S, 2004, BIOCHEM J, V380, P561, DOI 10.1042/BJ20040112; Koulen P, 2000, MOL BIOL CELL, V11, P2213, DOI 10.1091/mbc.11.7.2213; Li LH, 2005, J GEN PHYSIOL, V126, P285, DOI 10.1085/jgp.200509289; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU XY, 1994, J BIOL CHEM, V269, P6511; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Mead F, 2002, BIOPHYS J, V82, P1953, DOI 10.1016/S0006-3495(02)75544-6; Mead FC, 2004, BIOPHYS J, V87, P3814, DOI 10.1529/biophysj.104.049338; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; OHKUSA T, 1991, J BIOCHEM-TOKYO, V109, P609, DOI 10.1093/oxfordjournals.jbchem.a123428; PALADE P, 1987, J BIOL CHEM, V262, P6149; PARK WK, 1994, CARDIOVASC RES, V28, P505, DOI 10.1093/cvr/28.4.505; Porta M, 2004, BIOPHYS J, V86, p241A; Porta M, 2004, BIOPHYS J, V86, p62A; Porta M, 2008, BBA-BIOMEMBRANES, V1778, P2469, DOI 10.1016/j.bbamem.2008.07.024; Pugsley MK, 2002, LIFE SCI, V72, P293, DOI 10.1016/S0024-3205(02)02245-2; Ranatunga KM, 2007, MOL MEMBR BIOL, V24, P185, DOI 10.1080/09687860601076522; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; Samso M, 1999, J CELL BIOL, V146, P493, DOI 10.1083/jcb.146.2.493; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Sitsapesan R, 1998, STRUCTURE FUNCTION R; Stern MD, 2004, CELL CALCIUM, V35, P591, DOI 10.1016/j.ceca.2004.01.013; Stern MD, 1999, J GEN PHYSIOL, V113, P469, DOI 10.1085/jgp.113.3.469; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Tanna B, 2000, J GEN PHYSIOL, V116, P1, DOI 10.1085/jgp.116.1.1; Terentyev D, 2002, CIRC RES, V91, P414, DOI 10.1161/01.RES.0000032490.04207.BD; Tinker A, 1996, BIOPHYS J, V70, P2110, DOI 10.1016/S0006-3495(96)79777-1; Tripathy A, 1998, J GEN PHYSIOL, V111, P679, DOI 10.1085/jgp.111.5.679; TU Q, 1994, J GEN PHYSIOL, V103, P853, DOI 10.1085/jgp.103.5.853; Uehara A, 1996, BIOPHYS J, V71, P769, DOI 10.1016/S0006-3495(96)79276-7; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; XU L, 1993, J GEN PHYSIOL, V101, P207, DOI 10.1085/jgp.101.2.207; Yamamoto T, 1999, CARDIOVASC RES, V44, P146, DOI 10.1016/S0008-6363(99)00200-X; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V291, P1102, DOI 10.1006/bbrc.2002.6569; Yano M, 1998, J CARDIOVASC PHARM, V32, P96, DOI 10.1097/00005344-199807000-00015	66	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8315	10.1371/journal.pone.0008315	http://dx.doi.org/10.1371/journal.pone.0008315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016815	gold, Green Submitted, Green Published			2022-12-27	WOS:000272833800011
J	Horzinski, L; Huyghe, A; Cardoso, MC; Gonthier, C; Ouchchane, L; Schiffmann, R; Blanc, P; Boespflug-Tanguy, O; Fogli, A				Horzinski, Laetitia; Huyghe, Aurelia; Cardoso, Marie-Celeste; Gonthier, Celine; Ouchchane, Lemlih; Schiffmann, Raphael; Blanc, Pierre; Boespflug-Tanguy, Odile; Fogli, Anne			Eukaryotic Initiation Factor 2B (eIF2B) GEF Activity as a Diagnostic Tool for EIF2B-Related Disorders	PLOS ONE			English	Article							VANISHING WHITE-MATTER; NATURAL-HISTORY; LEUKOENCEPHALOPATHY; ASIALOTRANSFERRIN; MUTATIONS; SUBUNITS; DISEASE; ATAXIA	Background: In recent years, the phenotypes of leukodystrophies linked to mutations in the eukaryotic initiation factor 2B genes have been extended, classically called CACH/VWM (Childhood ataxia with cntral hypomyelination/vanishing white matter disorder). The large clinical spectrum observed from the more severe antenatal forms responsible for fetal death to milder adult forms with an onset after 16 years old and restricted to slow cognitive impairment have lead to the concept of eIF2B-related disorders. The typical MRI pattern with a diffuse CSF-like aspect of the cerebral white matter can lack particularly in the adult forms whereas an increasing number of patients with clinical and MRI criteria for CACH/VWM disease but without eIF2B mutations are found. Then we propose the use of biochemical markers to help in this difficult diagnosis. The biochemical diagnosis of eIF2B-related disorder is difficult as no marker, except the recently described asialotransferrin/transferrin ratio measured in cerebrospinal fluid, has been proposed and validated until now. Decreased eIF2B GEF activity has been previously reported in lymphoblastoid cell lines from 30 eIF2B-mutated patients. Our objective was to evaluate further the utility of this marker and to validate eIF2B GEF activity in a larger cohort as a specific diagnostic test for eIF2B-related disorders. Methodology/Principal Findings: We performed eIF2B GEF activity assays in cells from 63 patients presenting with different clinical forms and eIF2B mutations in comparison to controls but also to patients with defined leukodystrophies or CACH/VWM-like diseases without eIF2B mutations. We found a significant decrease of GEF activity in cells from eIF2B-mutated patients with 100% specificity and 89% sensitivity when the activity threshold was set at <= 77.5%. Conclusion: These results validate the measurement of eIF2B GEF activity in patients' transformed-lymphocytes as an important tool for the diagnosis of eIF2B-related disorders.	[Horzinski, Laetitia; Huyghe, Aurelia; Cardoso, Marie-Celeste; Gonthier, Celine; Blanc, Pierre; Boespflug-Tanguy, Odile; Fogli, Anne] Univ Clermont, INSERM, U931, GReD,CNRS 6247, Clermont Ferrand, France; [Horzinski, Laetitia; Huyghe, Aurelia; Cardoso, Marie-Celeste; Boespflug-Tanguy, Odile; Fogli, Anne] Univ Clermont 1, UFR Med, Clermont Ferrand, France; [Cardoso, Marie-Celeste; Blanc, Pierre; Fogli, Anne] CHU Clermont Ferrand, Serv Biochim Med & Biol Mol, Clermont Ferrand, France; [Ouchchane, Lemlih] Univ Clermont, UFR Med, EA3295, Equipe Rech Signal & Imagerie Med, Clermont Ferrand, France; [Ouchchane, Lemlih] Hop Gabriel Montpied, CHU Clermont Ferrand, Lab Biostat Telemat & Traitement Images, Clermont Ferrand, France; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Boespflug-Tanguy, Odile] Hop Hotel Dieu, CHU Clermont Ferrand, Serv Genet Med, Ctr Reference Leucodystrophies, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand; Baylor Scott & White Health; Baylor University Medical Center; CHU Clermont Ferrand	Horzinski, L (corresponding author), Univ Clermont, INSERM, U931, GReD,CNRS 6247, Clermont Ferrand, France.	anne.fogli@inserm.u-clermont1.fr	Fogli, Anne/AAL-6640-2020; Huyghe, Aurélia/AAA-5203-2020	Fogli, Anne/0000-0002-2651-7441; GONTHIER-GUERET, Celine/0000-0002-4449-559X; BLANC, Pierre/0000-0003-3802-0923	ELA Foundation	ELA Foundation	This work was supported by grants from the ELA Foundation (2006-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; van der Heide M, 2003, TOP CURR GENET, V2, P207; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vanderver A, 2008, NEUROLOGY, V70, P2226, DOI 10.1212/01.wnl.0000313857.54398.0e; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053	15	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8318	10.1371/journal.pone.0008318	http://dx.doi.org/10.1371/journal.pone.0008318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016818	Green Published, Green Submitted, gold			2022-12-27	WOS:000272833800014
J	Wang, PG; Kudelko, M; Lo, J; Siu, LYL; Kwok, KTH; Sachse, M; Nicholls, JM; Bruzzone, R; Altmeyer, RM; Nal, B				Wang, Pei-Gang; Kudelko, Mateusz; Lo, Joanne; Siu, Lewis Yu Lam; Kwok, Kevin Tsz Hin; Sachse, Martin; Nicholls, John M.; Bruzzone, Roberto; Altmeyer, Ralf M.; Nal, Beatrice			Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; VIRUS-LIKE PARTICLES; YELLOW-FEVER VIRUS; ENVELOPE GLYCOPROTEIN; ENDOPLASMIC-RETICULUM; MODEL SYSTEM; FLAVIVIRUS; MATURATION; TYPE-2; INFECTION	Background: Flavivirus infected cells produce infectious virions and subviral particles, both of which are formed by the assembly of prM and E envelope proteins and are believed to undergo the same maturation process. Dengue recombinant subviral particles have been produced in cell cultures with either modified or chimeric proteins but not using the native forms of prM and E. Methodology/Principal Findings: We have used a codon optimization strategy to obtain an efficient expression of native viral proteins and production of recombinant subviral particles (RSPs) for all four dengue virus (DV) serotypes. A stable HeLa cell line expressing DV1 prME was established (HeLa-prME) and RSPs were analyzed by immunofluorescence and transmission electron microscopy. We found that E protein is mainly present in the endoplasmic reticulum (ER) where assembly of RSPs could be observed. Biochemical characterization of DV1 RSPs secretion revealed both prM protein cleavage and homodimerization of E proteins before their release into the supernatant, indicating that RSPs undergo a similar maturation process as dengue virus. Pulse chase experiment showed that 8 hours are required for the secretion of DV1 RSPs. We have used HeLa-prME to develop a semi-quantitative assay and screened a human siRNA library targeting genes involved in membrane trafficking. Knockdown of 23 genes resulted in a significant reduction in DV RSP secretion, whereas for 22 others we observed an increase of RSP levels in cell supernatant. Conclusions/Significance: Our data describe the efficient production of RSPs containing native prM and E envelope proteins for all dengue serotypes. Dengue RSPs and corresponding producing cell lines are safe and novel tools that can be used in the study of viral egress as well as in the development of vaccine and drugs against dengue virus.	[Wang, Pei-Gang; Kudelko, Mateusz; Siu, Lewis Yu Lam; Kwok, Kevin Tsz Hin; Bruzzone, Roberto; Altmeyer, Ralf M.; Nal, Beatrice] Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Lo, Joanne; Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Nal, Beatrice] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Lo, Joanne; Sachse, Martin] Inst Pasteur, Paris, France	University of Hong Kong; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wang, PG (corresponding author), Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China.	pgwang@hkucc.hku.hk	Bruzzone, Roberto/G-9355-2017; NAL, Beatrice/GYU-8888-2022; Sachse, Martin/W-7403-2019; Bruzzone, Roberto/C-4719-2009; Nicholls, John Malcolm/C-4375-2009	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Nicholls, John Malcolm/0000-0001-7217-7444; Wang, Peigang/0000-0001-6045-2007; Nal, Beatrice/0000-0003-3452-7524; Sachse, Martin/0000-0001-5981-9166	6th European Framework programme DENFRAME; Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID) [08070952]; University of Hong Kong; Consulate General of France in Hong Kong	6th European Framework programme DENFRAME(European Commission); Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID); University of Hong Kong(University of Hong Kong); Consulate General of France in Hong Kong	This work was supported by the 6th European Framework programme DENFRAME and by the Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID#08070952). MK is a PhD student supported by the University of Hong Kong. JL is an MPhil student supported by the University of Hong Kong, and by the "Alexandre Yersin Excellence Scholarship" awarded by the Consulate General of France in Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003; ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Barreto DF, 2007, MEM I OSWALDO CRUZ, V102, P175, DOI 10.1590/S0074-02762007005000007; Barth O. M., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P407; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DEUBEL V, 1981, AM J TROP MED HYG, V30, P1071, DOI 10.4269/ajtmh.1981.30.1071; dos Santos CND, 2000, VIROLOGY, V274, P292, DOI 10.1006/viro.2000.0457; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pryor MJ, 2004, J GEN VIROL, V85, P3627, DOI 10.1099/vir.0.80283-0; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; YU IM, 2009, J VIROL; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t	46	56	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8325	10.1371/journal.pone.0008325	http://dx.doi.org/10.1371/journal.pone.0008325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016834	Green Published, gold			2022-12-27	WOS:000272833800018
J	Ballif, M; Ledergerber, B; Battegay, M; Cavassini, M; Bernasconi, E; Schmid, P; Hirschel, B; Furrer, H; Rickenbach, M; Opravil, M; Weber, R				Ballif, Marie; Ledergerber, Bruno; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Schmid, Patrick; Hirschel, Bernard; Furrer, Hansjakob; Rickenbach, Martin; Opravil, Milos; Weber, Rainer		Swiss HIV Cohort Study	Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007	PLOS ONE			English	Article							SWISS HIV COHORT; SELF-REPORTED NONADHERENCE; INFECTED PATIENTS; COMBINATION; PROGRESSION; PREDICTORS; RISK; TIME	Background: Combination antiretroviral treatment (cART) has been very successful, especially among selected patients in clinical trials. The aim of this study was to describe outcomes of cART on the population level in a large national cohort. Methods: Characteristics of participants of the Swiss HIV Cohort Study on stable cART at two semiannual visits in 2007 were analyzed with respect to era of treatment initiation, number of previous virologically failed regimens and self reported adherence. Starting ART in the mono/dual era before HIV-1 RNA assays became available was counted as one failed regimen. Logistic regression was used to identify risk factors for virological failure between the two consecutive visits. Results: Of 4541 patients 31.2% and 68.8% had initiated therapy in the mono/dual and cART era, respectively, and been on treatment for a median of 11.7 vs. 5.7 years. At visit 1 in 2007, the mean number of previous failed regimens was 3.2 vs. 0.5 and the viral load was undetectable (<50 copies/ml) in 84.6% vs. 89.1% of the participants, respectively. Adjusted odds ratios of a detectable viral load at visit 2 for participants from the mono/dual era with a history of 2 and 3, 4, >4 previous failures compared to 1 were 0.9 (95% CI 0.4-1.7), 0.8 (0.4-1.6), 1.6 (0.8-3.2), 3.3 (1.7-6.6) respectively, and 2.3 (1.1-4.8) for >2 missed cART doses during the last month, compared to perfect adherence. From the cART era, odds ratios with a history of 1, 2 and >2 previous failures compared to none were 1.8 (95% CI 1.3-2.5), 2.8 (1.7-4.5) and 7.8 (4.5-13.5), respectively, and 2.8 (1.6-4.8) for >2 missed cART doses during the last month, compared to perfect adherence. Conclusions: A higher number of previous virologically failed regimens, and imperfect adherence to therapy were independent predictors of imminent virological failure.	[Ballif, Marie; Ledergerber, Bruno; Opravil, Milos; Weber, Rainer] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Battegay, Manuel] Univ Basel, Univ Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Cavassini, Matthias] Univ Hosp, Div Infect Dis & Hosp Epidemiol, Lausanne, Switzerland; [Bernasconi, Enos] Cantonal Hosp, Div Infect Dis & Hosp Epidemiol, Lugano, Switzerland; [Schmid, Patrick] Cantonal Hosp, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Hirschel, Bernard] Univ Hosp, Div Infect Dis & Hosp Epidemiol, Geneva, Switzerland; [Furrer, Hansjakob] Univ Hosp Bern, Div Infect Dis, Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Rickenbach, Martin] CHU Vaudois, Swiss HIV Cohort Study, Lausanne, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital St. Gallen; University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ballif, M (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	infled@usz.uzh.ch	Ledergerber, Bruno/B-5656-2009; Pantaleo, Giuseppe/K-6163-2016; VALLET, Yannick/F-9979-2011; Weber, Rainer/D-5175-2012; SHCS, social sciences/G-4093-2011; Furrer, Hansjakob/G-6768-2013; cavassini, matthias/F-8987-2017	Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; cavassini, matthias/0000-0003-0933-7833	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JA, 2007, HIV CLIN TRIALS, V8, P221, DOI 10.1310/hct0804-221; Benzie AA, 2007, AIDS, V21, P1423, DOI 10.1097/QAD.0b013e3281532ca7; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; COOPER D, 2008, 15 C RETR OPP INF FE; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Dray-Spira R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000255079.39352.9b; Eron J, 2006, LANCET, V368, P1238, DOI 10.1016/S0140-6736(06)69155-1; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Glass TR, 2008, ANTIVIR THER, V13, P77; Hatano H, 2006, CLIN INFECT DIS, V43, P1329, DOI 10.1086/508655; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Opravil M, 2002, J INFECT DIS, V185, P1251, DOI 10.1086/340312; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Sabin CA, 2008, AIDS, V22, P1463; Staehelin C, 2003, AIDS, V17, P2237, DOI 10.1097/00002030-200310170-00012; Temesgen Z, 2006, LANCET INFECT DIS, V6, P496, DOI 10.1016/S1473-3099(06)70550-3; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141	22	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8275	10.1371/journal.pone.0008275	http://dx.doi.org/10.1371/journal.pone.0008275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011544	Green Published, gold			2022-12-27	WOS:000272830300029
J	Figueroa, KP; Farooqi, S; Harrup, K; Frank, J; O'Rahilly, S; Pulst, SM				Figueroa, Karla P.; Farooqi, Sadaf; Harrup, Kristopher; Frank, Johnathan; O'Rahilly, Stephen; Pulst, Stefan M.			Genetic Variance in the Spinocerebellar Ataxia Type 2 (ATXN2) Gene in Children with Severe Early Onset Obesity	PLOS ONE			English	Article							GENOME-WIDE SCAN; LOCALIZATION; EXPRESSION; EXPANSION; INTERACTS; RECEPTOR; PROTEIN; REPEAT; REGION; MOUSE	Background: Expansion of a CAG repeat in the coding region of exon 1 in the ATXN2 gene located in human chromosome 12q24.1 causes the neurodegenerative disease spinocerebellar ataxia type 2 (SCA2). In contrast to other polyglutamine (polyQ) disorders, the SCA2 repeat is not highly polymorphic in central European (CEU) controls with Q22 representing 90% of alleles, and Q23 contributing between 5-7% of alleles. Recently, the ATXN2 CAG repeat has been identified as a target of adaptive selection in the CEU population. Mouse lines deficient for atxn2 develop marked hyperphagia and obesity raising the possibility that loss-of-function mutations in the ATXN2 gene may be related to energy balance in humans. Some linkage studies of obesity related phenotypes such as antipsychotic induced weight gain have reported significant lod scores on chromosome 12q24. We tested the hypothesis that rare loss-of-function ATXN2 variants cause obesity analogous to rare mutations in the leptin, leptin receptor and MC4R genes. Methodology/Principal Findings: We sequenced the coding region of ATXN2 including intron-exon boundaries in 92 severely obese children with a body mass index (BMI).3.2 standard deviations above age-and gender-adjusted means. We confirmed five previously identified single nucleotide polymorphisms (SNPs) and three new SNPs resulting in two synonymous substitutions and one intronic polymorphism. Alleles encoding. Q22 were overrepresented in our sample of obese children and contributed 15% of alleles in children identified by their parents as white. SNP rs695872 closely flanking the CAG repeat showed a greatly increased frequency of C/C homozygotes and G/C heterozygotes compared with reported frequencies in the CEU population. Conclusions/Significance: Although we did not identify variants leading to novel amino acid substitutions, nonsense or frameshift mutations, this study warrants further examination of variation in the ATXN2 gene in obesity and related phenotypes in a larger case-control study with emphasis on rs695872 and CAG repeat structure.	[Figueroa, Karla P.; Harrup, Kristopher; Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Farooqi, Sadaf; O'Rahilly, Stephen] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Frank, Johnathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pulst, Stefan M.] Univ Utah, Program Neurosci, Salt Lake City, UT USA; [Pulst, Stefan M.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Figueroa, KP (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	stefan.pulst@hsc.utah.edu	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504	The National Institute of Health [R01 NS33123]; Wellcome Trust; Medical Research Council; NIHR Cambridge Biomedical Research Centre; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033123] Funding Source: NIH RePORTER; Medical Research Council [G0900554] Funding Source: researchfish; MRC [G0900554] Funding Source: UKRI	The National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The National Institute of Health R01 NS33123. ISF and SOR are supported by the Wellcome Trust, Medical Research Council and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chagnon YC, 2004, MOL PSYCHIATR, V9, P1067, DOI 10.1038/sj.mp.4001537; Dai F, 2007, INT J OBESITY, V31, P1832, DOI 10.1038/sj.ijo.0803675; Dong CH, 2005, AM J HUM GENET, V76, P427, DOI 10.1086/428438; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Huynh DP, 2003, HUM MOL GENET, V12, P1485, DOI 10.1093/hmg/ddg175; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Kiehl TR, 2006, BIOCHEM BIOPH RES CO, V339, P17, DOI 10.1016/j.bbrc.2005.10.186; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Li WD, 2004, DIABETES, V53, P812, DOI 10.2337/diabetes.53.3.812; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Nechiporuk T, 1997, GENOMICS, V44, P321, DOI 10.1006/geno.1997.4886; Nechiporuk T, 1998, HUM MOL GENET, V7, P1301, DOI 10.1093/hmg/7.8.1301; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Perusse L, 2001, DIABETES, V50, P614, DOI 10.2337/diabetes.50.3.614; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Sahba S, 1998, GENOMICS, V47, P359, DOI 10.1006/geno.1997.5131; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041	23	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8280	10.1371/journal.pone.0008280	http://dx.doi.org/10.1371/journal.pone.0008280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20016785	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300032
J	Hay, E; Nouraud, A; Marie, PJ				Hay, Eric; Nouraud, Alexandra; Marie, Pierre J.			N-Cadherin Negatively Regulates Osteoblast Proliferation and Survival by Antagonizing Wnt, ERK and PI3K/Akt Signalling	PLOS ONE			English	Article							BETA-CATENIN; BONE MASS; PATHWAY; LRP5; EXPRESSION; APOPTOSIS; CELLS; GENE; DIFFERENTIATION; ADHESION	Background: Osteoblasts are bone forming cells that play an essential role in osteogenesis. The elucidation of the mechanisms that control osteoblast number is of major interest for the treatment of skeletal disorders characterized by abnormal bone formation. Canonical Wnt signalling plays an important role in the control of osteoblast proliferation, differentiation and survival. Recent studies indicate that the cell-cell adhesion molecule N-cadherin interacts with the Wnt co-receptors LRP5/6 to regulate osteoblast differentiation and bone accrual. The role of N-cadherin in the control of osteoblast proliferation and survival remains unknown. Methods and Principal Findings: Using murine MC3T3-E1 osteoblastic cells and N-cadherin transgenic mice, we demonstrate that N-cadherin overexpression inhibits cell proliferation in vitro and in vivo. The negative effect of N-cadherin on cell proliferation results from decreased Wnt, ERK and PI3K/Akt signalling and is restored by N-cadherin neutralizing antibody that antagonizes N-cadherin-LRP5 interaction. Inhibition of Wnt signalling using DKK1 or Sfrp1 abolishes the ability of N-cadherin blockade to restore ERK and PI3K signalling and cell proliferation, indicating that the altered cell growth in Ncadherin overexpressing cells is in part secondary to alterations in Wnt signalling. Consistently, we found that N-cadherin overexpression inhibits the expression of Wnt3a ligand and its downstream targets c-myc and cyclin D1, an effect that is partially reversed by N-cadherin blockade. We also show that N-cadherin overexpression decreases osteoblast survival in vitro and in vivo. This negative effect on cell survival results from inhibition of PI3K/Akt signalling and increased Bax/Bcl-2, a mechanism that is rescued by Wnt3a. Conclusion: The data show that N-cadherin negatively controls osteoblast proliferation and survival via inhibition of autocrine/paracrine Wnt3a ligand expression and attenuation of Wnt, ERK and PI3K/Akt signalling, which provides novel mechanisms by which N-cadherin regulates osteoblast number.	[Hay, Eric] INSERM, UMR 606, Lab Osteoblast Biol & Pathol, Paris, France; Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hay, E (corresponding author), INSERM, UMR 606, Lab Osteoblast Biol & Pathol, Paris, France.	pierre.marie@inserm.fr		Hay, Eric/0000-0002-0131-9983	Inserm; EC [LSHM-CT-2003-503020, HEALTH-F2-2008-201099]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from Inserm, the 6th Framework programme Anabonos (EC Contract No: LSHM-CT-2003-503020) and the 7th Framework programme Talos (EC Contract No: HEALTH-F2-2008-201099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; BRADBURY JM, 1994, ONCOGENE, V9, P2597; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Erez N, 2005, EUR J CELL BIOL, V84, P235, DOI 10.1016/j.ejcb.2004.12.007; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Johnson ML, 2005, CRIT REV EUKAR GENE, V15, P229, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.50; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lai CF, 2006, J BONE MINER RES, V21, P1897, DOI 10.1359/JBMR.060906; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; Mbalaviele G, 2006, J BONE MINER RES, V21, P1821, DOI 10.1359/JBMR.060811; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARDEN SJ, 2009, BONE; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	53	49	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8284	10.1371/journal.pone.0008284	http://dx.doi.org/10.1371/journal.pone.0008284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011526	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300036
J	Nesterovitch, AB; Hogarth, KD; Adarichev, VA; Vinokour, EI; Schwartz, DE; Solway, J; Danilov, SM				Nesterovitch, Andrew B.; Hogarth, Kyle D.; Adarichev, Vyacheslav A.; Vinokour, Elena I.; Schwartz, David E.; Solway, Julian; Danilov, Sergei M.			Angiotensin I-Converting Enzyme Mutation (Trp1197Stop) Causes a Dramatic Increase in Blood ACE	PLOS ONE			English	Article							RENAL TUBULAR DYSGENESIS; ACUTE SEVERE ASTHMA; MONOCLONAL-ANTIBODIES; N-DOMAIN; MOLECULAR-CLONING; POINT MUTATION; HUMAN AIRWAY; HUMAN TESTIS; SERUM; SARCOIDOSIS	Background: Angiotensin-converting enzyme (ACE) metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling. Elevated ACE levels may be associated with an increased risk for different cardiovascular or respiratory diseases, including asthma. Previously, a molecular mechanism underlying a 5-fold familial increase of blood ACE was discovered: Pro1199Leu substitution enhanced the cleavage-secretion process. Carriers of this mutation were Caucasians from Europe (mostly Dutch) or had European roots. Methodology/Principal Findings: We have found a family of African-American descent whose affected members' blood ACE level was increased 13-fold over normal. In affected family members, codon TGG coding for Trp1197 was substituted in one allele by TGA (stop codon). As a result, half of ACE expressed in these individuals had a length of 1196 amino acids and lacked a transmembrane anchor. This ACE mutant is not trafficked to the cell membrane and is directly secreted out of cells; this mechanism apparently accounts for the high serum ACE level seen in affected individuals. A haplotype of the mutant ACE allele was determined based on 12 polymorphisms, which may help to identify other carriers of this mutation. Some but not all carriers of this mutation demonstrated airflow obstruction, and some but not all have hypertension. Conclusions/Significance: We have identified a novel Trp1197Stop mutation that results in dramatic elevation of serum ACE. Since blood ACE elevation is often taken as a marker of disease activity (sarcoidosis and Gaucher diseases), it is important for clinicians and medical scientists to be aware of alternative genetic causes of elevated blood ACE that are not apparently linked to disease.	[Nesterovitch, Andrew B.; Vinokour, Elena I.; Schwartz, David E.; Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA; [Hogarth, Kyle D.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Adarichev, Vyacheslav A.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Danilov, Sergei M.] Natl Cardiol Res Ctr, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; National Medical Research Center of Cardiology	Nesterovitch, AB (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA.	danilov@uic.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	Departmental funds	Departmental funds	The work was supported from Departmental funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE GM, 1985, Q J MED, V55, P253; Alfalah M, 2001, J BIOL CHEM, V276, P21105, DOI 10.1074/jbc.M100339200; ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; BARNES PJ, 1997, ASTHMA, P577; BARR M, 1991, TERATOLOGY, V44, P485, DOI 10.1002/tera.1420440503; BELDENT V, 1995, J BIOL CHEM, V270, P28962, DOI 10.1074/jbc.270.48.28962; BENETEAUBURNAT B, 1991, CRIT REV CL LAB SCI, V28, P337, DOI 10.3109/10408369109106868; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; GRIFFIN SA, 1991, HYPERTENSION, V17, P626, DOI 10.1161/01.HYP.17.5.626; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Kishimoto, 1997, LEUCOCYTE TYPING, P746; Kramers C, 2003, Ned Tijdschr Geneeskd, V147, P473; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Lacoste M, 2006, J AM SOC NEPHROL, V17, P2253, DOI 10.1681/ASN.2005121303; LATTION AL, 1989, FEBS LETT, V252, P99, DOI 10.1016/0014-5793(89)80897-X; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1989, CLIN LAB MED, V9, P745, DOI 10.1016/S0272-2712(18)30602-4; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Lue KH, 2006, PEDIAT ALLERG IMM-UK, V17, P508, DOI 10.1111/j.1399-3038.2006.00452.x; McKay S, 1998, AM J RESP CELL MOL, V18, P823, DOI 10.1165/ajrcmb.18.6.2924; MILLAR E, 1995, EUR RESPIR J, V8, P1838, DOI 10.1183/09031936.95.08111838; MILLAR EA, 1994, THORAX, V49, P492, DOI 10.1136/thx.49.5.492; NAFTILAN AJ, 1992, J CARDIOVASC PHARM, V20, pS37, DOI 10.1097/00005344-199206201-00008; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Pauls K, 2003, ANDROLOGIA, V35, P32, DOI 10.1046/j.1439-0272.2003.00535.x; Pierre C, 2008, CLIN EXP PHARMACOL P, V35, P431, DOI 10.1111/j.1440-1681.2008.04891.x; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; Ramsay SG, 1997, EUR RESPIR J, V10, P2766, DOI 10.1183/09031936.97.10122766; Ricciardolo FLM, 2003, THORAX, V58, P840, DOI 10.1136/thorax.58.10.840; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; Shen XZ, 2008, INT IMMUNOPHARMACOL, V8, P171, DOI 10.1016/j.intimp.2007.08.010; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SILVERSTEIN E, 1976, ANN NY ACAD SCI, V278, P498, DOI 10.1111/j.1749-6632.1976.tb47062.x; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Soubrier F, 2002, EUR J HUM GENET, V10, P553, DOI 10.1038/sj.ejhg.5200847; STUDDY P, 1978, LANCET, V2, P1331; Veerappan A, 2008, P NATL ACAD SCI USA, V105, P1315, DOI 10.1073/pnas.0709739105; Villard E, 1996, AM J HUM GENET, V58, P1268; WEI L, 1991, J BIOL CHEM, V266, P5540; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711	74	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8282	10.1371/journal.pone.0008282	http://dx.doi.org/10.1371/journal.pone.0008282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011602	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300034
J	Garbin, U; Fratta Pasini, A; Stranieri, C; Cominacini, M; Pasini, A; Manfro, S; Lugoboni, F; Mozzini, C; Guidi, G; Faccini, G; Cominacini, L				Garbin, Ulisse; Fratta Pasini, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Manfro, Stefania; Lugoboni, Fabio; Mozzini, Chiara; Guidi, GianCesare; Faccini, Giovanni; Cominacini, Luciano			Cigarette Smoking Blocks the Protective Expression of Nrf2/ARE Pathway in Peripheral Mononuclear Cells of Young Heavy Smokers Favouring Inflammation	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OBSTRUCTIVE PULMONARY-DISEASE; ELECTRON-SPIN-RESONANCE; NF-E2-RELATED FACTOR-2; OXIDIZED PHOSPHOLIPIDS; ENDOTHELIAL-CELLS; UNSTABLE ANGINA; FREE-RADICALS; IN-VIVO; KAPPA-B	Cigarette smoking is an important risk factor for atherosclerosis, a chronic inflammatory disease. However the underlying factors of this effect are unclear. It has been hypothesized that water-soluble components of cigarette smoke can directly promote oxidative stress in vasculature and blood cells. Aim of this study was to study the relationship between oxidative stress and inflammation in a group of young smokers. To do this we evaluated: 1) the oxidation products of phospholipids (oxPAPC) in peripheral blood mononuclear cells (PBMC); 2) their role in causing PBMC reactive oxygen species (ROS) generation and changes in GSH; 3) the expression of the transcription factor NF-E2-related factor 2 (Nrf2) and of related antioxidant genes ( ARE); 4) the activation of NF-kB and C-reactive protein (CRP) values. We studied 90 healthy volunteers: 32 non-smokers, 32 moderate smokers (5-10 cigarettes/day) and 26 heavy smokers (25-40 cigarettes/day). OxPAPC and p47phox expression, that reasonably reflects NADPH oxidase activity, were higher in moderate smokers and heavy smokers than in non-smokers (p<0.01), the highest values being in heavy smokers (p<0.01). In in vitro studies oxPAPC increased ROS generation via NADPH oxidase activation. GSH in PBMC and plasma was lower in moderate smokers and heavy smokers than in non-smokers (p<0.01), the lowest values being in heavy smokers (p<0.01). Nrf2 expression in PBMC was higher in moderate smokers than in non-smokers (p<0.01), but not in heavy smokers, who had the highest levels of NF-kB and CRP (p<0.01). In in vitro studies oxPAPC dose-dependently increased NF-kB activation, whereas at the highest concentrations Nrf2 expression was repressed. The small interference (si) RNA-mediated knockdown of NF-kappa B/p65 increased about three times the expression of Nrf2 stimulated with oxPAPC. Cigarette smoke promotes oxPAPC formation and oxidative stress in PBMC. This may cause the activation of NF-kB that in turn may participate in the negative regulation of Nrf2/ARE pathway favouring inflammation.	[Garbin, Ulisse; Fratta Pasini, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Manfro, Stefania; Mozzini, Chiara; Cominacini, Luciano] Univ Verona, Sect Internal Med, Dept Biomed & Surg Sci, I-37100 Verona, Italy; [Lugoboni, Fabio] Univ Hosp GB Rossi, Med Serv Addict Disorders, Verona, Italy; [Guidi, GianCesare; Faccini, Giovanni] Univ Verona, Dept Morphol & Biomed Sci, Sect Chem & Clin Microscopy, I-37100 Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Garbin, U (corresponding author), Univ Verona, Sect Internal Med, Dept Biomed & Surg Sci, I-37100 Verona, Italy.	luciano.cominacini@univr.it	mozzini, chiara/AAW-3028-2021; cominacini, luciano/B-2775-2011; Stranieri, Chiara/GWV-1749-2022	Guidi, Gian Cesare/0000-0002-4682-7834	Fondazione Cariverona, Verona, Italy; Ministry of University and Scientific Research of Italy	Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); Ministry of University and Scientific Research of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione Cariverona, Verona, Italy and by grants from the Ministry of University and Scientific Research of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Cominacini L, 2005, J AM COLL CARDIOL, V46, P799, DOI 10.1016/j.jacc.2005.05.063; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Garbin U, 2007, PHARMACOL RES, V56, P515, DOI 10.1016/j.phrs.2007.09.015; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V316, P969, DOI 10.1016/j.bbrc.2004.02.162; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; PRYOR WA, 1983, ENVIRON HEALTH PERSP, V47, P345, DOI 10.1289/ehp.8347345; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Rahman I, 1996, FREE RADICAL BIO MED, V21, P669, DOI 10.1016/0891-5849(96)00155-4; Rattazzi M, 2003, J HYPERTENS, V21, P1787, DOI 10.1097/00004872-200310000-00002; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rouhanizadeh M, 2005, FREE RADICAL BIO MED, V39, P1512, DOI 10.1016/j.freeradbiomed.2005.07.013; Stadler N, 2007, ARTERIOSCL THROM VAS, V27, P120, DOI 10.1161/01.ATV.0000250614.97896.4c; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; ZANG LY, 1995, FREE RADICAL BIO MED, V19, P161, DOI 10.1016/0891-5849(94)00236-D	36	71	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8225	10.1371/journal.pone.0008225	http://dx.doi.org/10.1371/journal.pone.0008225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011043	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829800013
J	Glazer, CA; Smith, IM; Ochs, MF; Begum, S; Westra, W; Chang, SS; Sun, WY; Bhan, S; Khan, Z; Ahrendt, S; Califano, JA				Glazer, Chad A.; Smith, Ian M.; Ochs, Michael F.; Begum, Shahnaz; Westra, William; Chang, Steven S.; Sun, Wenyue; Bhan, Sheetal; Khan, Zubair; Ahrendt, Steven; Califano, Joseph A.			Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC	PLOS ONE			English	Article							DNA METHYLATION; CANCER/TESTIS ANTIGENS; EXPRESSION; GENES; CTCF; BORIS; 5-AZA-2'-DEOXYCYTIDINE; HYPOMETHYLATION; DEMETHYLATION; TRANSCRIPTION	Background: Cancer/testis antigens (CTAs) were first discovered as immunogenic targets normally expressed in germline cells, but differentially expressed in a variety of human cancers. In this study, we used an integrative epigenetic screening approach to identify coordinately expressed genes in human non-small cell lung cancer ( NSCLC) whose transcription is driven by promoter demethylation. Methodology/Principal Findings: Our screening approach found 290 significant genes from the over 47,000 transcripts incorporated in the Affymetrix Human Genome U133 Plus 2.0 expression array. Of the top 55 candidates, 10 showed both differential overexpression and promoter region hypomethylation in NSCLC. Surprisingly, 6 of the 10 genes discovered by this approach were CTAs. Using a separate cohort of primary tumor and normal tissue, we validated NSCLC promoter hypomethylation and increased expression by quantitative RT-PCR for all 10 genes. We noted significant, coordinated coexpression of multiple target genes, as well as coordinated promoter demethylation, in a large set of individual tumors that was associated with the SCC subtype of NSCLC. In addition, we identified 2 novel target genes that exhibited growth-promoting effects in multiple cell lines. Conclusions/Significance: Coordinated promoter demethylation in NSCLC is associated with aberrant expression of CTAs and potential, novel candidate protooncogenes that can be identified using integrative discovery techniques. These findings have significant implications for discovery of novel CTAs and CT antigen directed immunotherapy.	[Glazer, Chad A.; Smith, Ian M.; Chang, Steven S.; Sun, Wenyue; Bhan, Sheetal; Khan, Zubair; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Begum, Shahnaz; Westra, William] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ahrendt, Steven] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Greater Baltimore Medical Center	Glazer, CA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Sun, Wenyue/0000-0003-1673-0895; Ahrendt, Steven/0000-0002-3029-2126	Flight Attendant Medical Research Institute; National Cancer Institute SPORE [5P50CA096784-05]; EDRN [U01CA084986]; NIH [T32]; NATIONAL CANCER INSTITUTE [U01CA084986, P50CA096784] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EDRN; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Califano is supported by a Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the National Cancer Institute SPORE (5P50CA096784-05) and EDRN U01CA084986. Dr. Glazer is funded in part by an NIH T32 Research Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin AJ, 2002, ANTI-CANCER DRUG, V13, P869, DOI 10.1097/00001813-200209000-00013; Bolli M, 2005, INT J CANCER, V115, P960, DOI 10.1002/ijc.20953; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteller M, 2002, SCIENCE, V297, P1807; Grunwald C, 2006, INT J CANCER, V118, P2522, DOI 10.1002/ijc.21669; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hirschowitz EA, 2006, J THORAC ONCOL, V1, P93, DOI 10.1097/01243894-200601000-00019; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hu LH, 2007, ANTI-CANCER DRUG, V18, P427, DOI 10.1097/CAD.0b013e328013d99e; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jungbluth AA, 2000, INT J CANCER, V85, P460, DOI 10.1002/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kang Y, 2007, ONCOGENE, V26, P4394, DOI 10.1038/sj.onc.1210218; Karanikas V, 2008, CANCER BIOL THER, V7, P345, DOI 10.4161/cbt.7.3.5424; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Raez Luis E, 2006, Expert Opin Emerg Drugs, V11, P445, DOI 10.1517/14728214.11.3.445; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Sugita M, 2002, CANCER RES, V62, P3971; Tajima K, 2003, LUNG CANCER-J IASLC, V42, P23, DOI 10.1016/S0169-5002(03)00244-7; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsai JR, 2007, LUNG CANCER, V56, P185, DOI 10.1016/j.lungcan.2006.12.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; WEBER J, 1994, CANCER RES, V54, P1766; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5	43	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8189	10.1371/journal.pone.0008189	http://dx.doi.org/10.1371/journal.pone.0008189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997593	Green Published, Green Accepted, gold			2022-12-27	WOS:000272829200018
J	London, R; Schwedock, J; Sage, A; Valley, H; Meadows, J; Waddington, M; Straus, D				London, Roanna; Schwedock, Julie; Sage, Andrew; Valley, Heather; Meadows, Jamie; Waddington, Michael; Straus, Don			An Automated System for Rapid Non-Destructive Enumeration of Growing Microbes	PLOS ONE			English	Article							AUTOFLUORESCENCE; FLUORESCENCE; STATE	Background: The power and simplicity of visual colony counting have made it the mainstay of microbiological analysis for more than 130 years. A disadvantage of the method is the long time required to generate visible colonies from cells in a sample. New rapid testing technologies generally have failed to maintain one or more of the major advantages of culture-based methods. Principal Findings: We present a new technology and platform that uses digital imaging of cellular autofluorescence to detect and enumerate growing microcolonies many generations before they become visible to the eye. The data presented demonstrate that the method preserves the viability of the microcolonies it detects, thus enabling generation of pure cultures for microbial identification. While visual colony counting detects Escherichia coli colonies containing about 5 x 10(6) cells, the new imaging method detects E. coli microcolonies when they contain about 120 cells and microcolonies of the yeast Candida albicans when they contain only about 12 cells. We demonstrate that digital imaging of microcolony autofluorescence detects a broad spectrum of prokaryotic and eukaryotic microbes and present a model for predicting the time to detection for individual strains. Results from the analysis of environmental samples from pharmaceutical manufacturing plants containing a mixture of unidentified microbes demonstrate the method's improved test turnaround times. Conclusion: This work demonstrates a new technology and automated platform that substantially shortens test times while maintaining key advantages of the current methods.	[London, Roanna; Schwedock, Julie; Sage, Andrew; Valley, Heather; Meadows, Jamie; Straus, Don] Rapid Micro Biosyst Inc, Bedford, MA USA; [Waddington, Michael] Accugenix Inc, Newark, DE USA		London, R (corresponding author), Rapid Micro Biosyst Inc, Bedford, MA USA.	don@firstlightbio.com			Rapid Micro Biosystems	Rapid Micro Biosystems	The work was funded by Rapid Micro Biosystems which is a privately financed company. All of the authors ( except for Michael Waddington of Accugenix) are employees of Rapid Micro Biosystems. The project concept, study design, data collection, data analysis, interpretation of the data, manuscript writing, and decision to submit took place at Rapid Micro Biosystems. The one exception is the 16S rDNA sequencing work which was carried out at Accugenix.	AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; CHANCE B, 1959, J BIOL CHEM, V234, P3044; DALTERIO RA, 1987, APPL SPECTROSC, V41, P234, DOI 10.1366/000370287774986804; DAWES CJ, 1979, BIOL TECHNIQUES TRAN, P241; ENWEMEKA CS, 2009, PHOTOMED LASER SURG, P1; Estes C, 2003, BIOSENS BIOELECTRON, V18, P511, DOI 10.1016/S0956-5663(03)00008-3; *EUR PHARM, 2006, EUR DIR QUAL MED; FDA, 2004, FOOD DRUG ADM, P32; Finney D.J., 1971, PROBIT ANAL; FROST WD, 1920, AGR BACTERIOLOGY LAB, P176; JONES DL, 1999, SOLID PHASE LASER SC, P7626; Kielbassa C, 2000, METHOD ENZYMOL, V319, P436; Limentani GB, 2005, ANAL CHEM, V77, p221A, DOI 10.1021/ac053390m; Metcalf R. L., 1943, ARCH BIOCHEM, V2, P55; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; Oliver JD, 2005, J MICROBIOL, V43, P93; *PAR DRUG ASS, 2000, J PHARM SCI TECHNO S, P1; Shapiro HM., 2003, PRACTICAL FLOW CYTOM, P681; STEGER A, 2005, ENCY RAPID MICROBIOL, P379; U.S. Food and Drug Administration, 2004, GUID IND STER DRUG P; *US PHARM CONV, 2008, US PHARM, P681; *US PHARM TNF, 2008, PDA J PHARM SCI TECH; VOGT RF, 1989, CYTOMETRY, V10, P294, DOI 10.1002/cyto.990100308; WADDINGTON MG, 2003, RAPID ANAL MICROBIOL, P59; WANG L, 2002, J RES NATL INST STAN, P339; WESCHLER T, 2004, IND MICROBIOLOGY MAR	28	24	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8609	10.1371/journal.pone.0008609	http://dx.doi.org/10.1371/journal.pone.0008609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062794	Green Submitted, gold, Green Published			2022-12-27	WOS:000273414100006
J	Wang, LP; Li, F; Shen, XM; Tsien, JZ				Wang, Lei Phillip; Li, Fei; Shen, Xiaoming; Tsien, Joe Z.			Conditional Knockout of NMDA Receptors in Dopamine Neurons Prevents Nicotine-Conditioned Place Preference	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; GENETIC ENHANCEMENT; NUCLEUS-ACCUMBENS; MEMORY; ACTIVATION; DEPRESSION; SUBTYPES; SUBUNIT; BRAIN	Nicotine from smoking tobacco produces one of the most common forms of addictive behavior and has major societal and health consequences. It is known that nicotine triggers tobacco addiction by activating nicotine acetylcholine receptors (nAChRs) in the midbrain dopaminergic reward system, primarily via the ventral tegmental area. Heterogeneity of cell populations in the region has made it difficult for pharmacology-based analyses to precisely assess the functional significance of glutamatergic inputs to dopamine neurons in nicotine addiction. By generating dopamine neuron-specific NR1 knockout mice using cre/loxP-mediated method, we demonstrate that genetic inactivation of the NMDA receptors in ventral tegmental area dopamine neurons selectively prevents nicotine-conditioned place preference. Interestingly, the mutant mice exhibit normal performances in the conditioned place aversion induced by aversive air puffs. Therefore, this selective effect on addictive drug-induced reinforcement behavior suggests that NMDA receptors in the dopamine neurons are critical for the development of nicotine addiction.	[Wang, Lei Phillip; Li, Fei; Tsien, Joe Z.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Wang, Lei Phillip; Li, Fei; Tsien, Joe Z.] Med Coll Georgia, Dept Neurol, Sch Med, Augusta, GA 30912 USA; [Wang, Lei Phillip] Yunnan Xishuang Banna Primate Model Res Ctr, Xishuang Banna, Yunnan, Peoples R China; [Li, Fei; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Shanghai Jiao Tong University	Wang, LP (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	jtsien@mcg.edu			NIMH; NIA; ECNU; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ECNU; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from NIMH, NIA, ECNU Award, and Georgia Research Alliance ( all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; Tang JR, 2009, NEURON, V63, P673, DOI 10.1016/j.neuron.2009.07.025; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	25	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8616	10.1371/journal.pone.0008616	http://dx.doi.org/10.1371/journal.pone.0008616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062537	Green Published, gold, Green Submitted			2022-12-27	WOS:000273414100010
J	Adeghate, E; Fernandez-Cabezudo, M; Hameed, R; El-Hasasna, H; El Wasila, M; Abbas, T; al-Ramadi, B				Adeghate, Ernest; Fernandez-Cabezudo, Maria; Hameed, Rashed; El-Hasasna, Hussain; El Wasila, Mohamed; Abbas, Tariq; al-Ramadi, Basel			Orexin-1 Receptor Co-Localizes with Pancreatic Hormones in Islet Cells and Modulates the Outcome of Streptozotocin-Induced Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-SECRETION; B-CELL; RAT; POLYPEPTIDE; INHIBITION; EXPRESSION; PEPTIDE; BRAIN	Recent studies have shown that orexins play a critical role in the regulation of sleep/wake states, feeding behaviour, and reward processes. The exocrine and endocrine pancreas are involved in the regulation of food metabolism and energy balance. This function is deranged in diabetes mellitus. This study examined the pattern of distribution of orexin-1 receptor (OX1R) in the endocrine cells of the pancreas of normal and diabetic Wistar (a model of type 1 diabetes), Goto-Kakizaki (GK, a model of type 2 diabetes) rats and in orexin-deficient (OX-/-) and wild type mice. Diabetes mellitus (DM) was induced in Wistar rats and mice by streptozotocin (STZ). At different time points (12 h, 24 h, 4 weeks, 8 months and 15 months) after the induction of DM, pancreatic fragments of normal and diabetic rats were processed for immunohistochemistry and Western blotting. OX1R-immunoreactive nerves were observed in the pancreas of normal and diabetic Wistar rats. OX1R was also discernible in the pancreatic islets of normal and diabetic Wistar and GK rats, and wild type mice. OX1R co-localized with insulin (INS) and glucagon (GLU) in the pancreas of Wistar and GK rats. The number of OX1R-positive cells in the islets increased markedly (p < 0.0001) after the onset of DM. The increase in the number of OX1R-positive cells is associated with a high degree of co-localization with GLU. The number of GLU-positive cells expressing OX1R was significantly (p < 0.0001) higher after the onset of DM. The tissue level of OX1R protein increased with the duration of DM especially in type 1 diabetes where it co-localized with cleaved caspase 3 in islet cells. In comparison to STZ-treated wild type mice, STZ-treated OX-/- animals exhibited reduced hyperglycemia and handled glucose more efficiently in glucose tolerance test. The findings suggest an important role for the OX-OX1R pathway in STZ-induced experimental diabetes.	[Adeghate, Ernest; Hameed, Rashed] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Anat, Al Ain, U Arab Emirates; [Fernandez-Cabezudo, Maria] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [El-Hasasna, Hussain; al-Ramadi, Basel] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Med Microbiol, Al Ain, U Arab Emirates; [El Wasila, Mohamed] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Abbas, Tariq] Dept Agr, Vet Lab, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Adeghate, E (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Anat, Al Ain, U Arab Emirates.	eadeghate@uaeu.ac.ae	Adeghate, Ernest A/A-9939-2012	Adeghate, Ernest/0000-0002-1439-1562	United Arab Emirates University, Al Ain, UAE	United Arab Emirates University, Al Ain, UAE	This study was supported by a research grant from the United Arab Emirates University, Al Ain, UAE. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E., 2005, Biogenic Amines, V19, P347, DOI 10.1163/156939105774647402; Adeghate E, 2004, PANCREAS, V29, P311, DOI 10.1097/00006676-200411000-00011; Adeghate E, 2004, MOL CELL BIOCHEM, V261, P187, DOI 10.1023/B:MCBI.0000028755.86521.11; Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; Adeghate E, 2000, TISSUE CELL, V32, P266, DOI 10.1054/tice.2000.0107; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Bingham S, 2001, PAIN, V92, P81, DOI 10.1016/S0304-3959(00)00470-X; BRAY GA, 1984, INT J OBESITY, V8, P119; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; Ehrstrom M, 2003, AM J PHYSIOL-GASTR L, V285, pG688, DOI 10.1152/ajpgi.00061.2003; El Firar A, 2009, FASEB J, V23, P4069, DOI 10.1096/fj.09-131367; GIROIX MH, 1993, ENDOCRINOLOGY, V132, P815, DOI 10.1210/en.132.2.815; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harrold Joanne A, 2006, Recent Pat CNS Drug Discov, V1, P305, DOI 10.2174/157488906778773616; Johren O, 2001, ENDOCRINOLOGY, V142, P3324, DOI 10.1210/en.142.8.3324; KAMBOJ SS, 2009, J NEUROCHEM; Katsuura G, 2002, PEPTIDES, V23, P323, DOI 10.1016/S0196-9781(01)00604-0; Kirchgessner AL, 1999, NEURON, V24, P941, DOI 10.1016/S0896-6273(00)81041-7; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; LABURTHE M, 2009, ACTA PHYSL OXF; LAMBERT DG, 1989, J ENDOCRINOL, V121, P479, DOI 10.1677/joe.0.1210479; Lu XY, 2000, HORM BEHAV, V37, P335, DOI 10.1006/hbeh.2000.1584; Madsen OD, 1996, EUR J BIOCHEM, V242, P435, DOI 10.1111/j.1432-1033.1996.435rr.x; Marciano C. R., 2001, Revista Brasileira de Ciencia do Solo, V25, P1, DOI 10.1590/S0100-06832001000100001; Matsuki Taizo, 2008, V46, P27, DOI 10.1007/400_2007_047; Miyasaka K, 2002, PANCREAS, V25, P400, DOI 10.1097/00006676-200211000-00013; Mondal MS, 1999, BIOCHEM BIOPH RES CO, V256, P495, DOI 10.1006/bbrc.1999.0362; Naslund E, 2002, AM J PHYSIOL-GASTR L, V282, pG470, DOI 10.1152/ajpgi.00219.2001; Nowak KW, 1999, LIFE SCI, V66, P449; Ouedraogo R, 2003, DIABETES, V52, P111, DOI 10.2337/diabetes.52.1.111; Randeva HS, 2001, J CLIN ENDOCR METAB, V86, P4808, DOI 10.1210/jc.86.10.4808; Russo F, 2008, ANAT REC, V291, P169, DOI 10.1002/ar.20641; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sinton CM, 2004, SEMIN NEUROL, V24, P211, DOI 10.1055/s-2004-835067; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Voisin T, 2008, FASEB J, V22, P1993, DOI 10.1096/fj.07-098723; Yamada H, 2000, BIOCHEM BIOPH RES CO, V267, P527, DOI 10.1006/bbrc.1999.1998; ZAMBONI L, 1967, J CELL BIOL, V35, pA148; Zhang X. F., 2000, SMJ, V41, P9	41	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8587	10.1371/journal.pone.0008587	http://dx.doi.org/10.1371/journal.pone.0008587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062799	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338600011
J	Desfrancois, J; Moreau-Aubry, A; Vignard, V; Godet, Y; Khammari, A; Dreno, B; Jotereau, F; Gervois, N				Desfrancois, Juliette; Moreau-Aubry, Agnes; Vignard, Virginie; Godet, Yann; Khammari, Amir; Dreno, Brigitte; Jotereau, Francine; Gervois, Nadine			Double Positive CD4CD8 alpha beta T Cells: A New Tumor-Reactive Population in Human Melanomas	PLOS ONE			English	Article							INVARIANT NKT CELLS; DENDRITIC CELLS; STANDARD PROTEASOME; PERIPHERAL-BLOOD; MEMORY CELLS; IN-VIVO; LYMPHOCYTES; IMMUNOTHERAPY; EXPRESSION; EXPANSION	Background: Double positive (DP) CD4CD8 T alpha beta cells have been reported in normal individuals as well as in different pathological conditions including inflammatory diseases, viral infections and cancer, but their function remains to be elucidated. We recently reported the increased frequency of DP T alpha beta cells in human breast pleural effusions. This manuscript addresses the question of the existence and above all the role of this non-conventional DP sub-population among tumor associated lymphocytes in melanomas. Methodology/Principal Findings: We analyzed the intratumoral cell infiltrate in solid metastasis (n = 6) and tumor invaded lymph nodes (n = 26) samples from melanomas patients by multiparametric cytometry. Here we documented for the first time significant increased frequency of DP T cells in about 60% of melanoma tumors compared to blood samples. Interestingly, a high proportion of these cells produced TNF-alpha in response to autologous melanoma cell lines. Besides, they are characterized by a unique cytokine profile corresponding to higher secretion of IL-13, IL-4 and IL-5 than simple positive T cells. In deep analysis, we derived a representative tumor-reactive DP T cell clone from a melanoma patient's invaded lymph node. This clone was restricted by HLA-A*2402 and recognized both autologous and allogeneic tumor cells of various origins as well as normal cells, suggesting that the target antigen was a ubiquitous self antigen. However, this DP T cell clone failed to kill HLA-A*2402 EBV-transformed B cells, probably due to the constitutive expression of immunoproteasome by these cells. Conclusions/Significance: In conclusion, we can postulate that, according to their broad tumor reactivity and to their original cytokine profile, the tumor associated DP T cells could participate in immune responses to tumors in vivo. Therefore, the presence of these cells and their role will be crucial to address in cancer patients, especially in the context of immunotherapies.	[Desfrancois, Juliette; Moreau-Aubry, Agnes; Vignard, Virginie; Godet, Yann; Khammari, Amir; Dreno, Brigitte; Jotereau, Francine; Gervois, Nadine] INSERM, U892, UMR, Nantes, France; [Moreau-Aubry, Agnes; Jotereau, Francine; Gervois, Nadine] Univ Nantes, Fac Sci, Nantes, France; [Khammari, Amir; Dreno, Brigitte] CHU Nantes, Unit Skin Canc, F-44035 Nantes 01, France; [Dreno, Brigitte] CHU Nantes, GMP Unit Cellular Therapy, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Desfrancois, J (corresponding author), INSERM, U892, UMR, Nantes, France.	ngervois@nantes.inserm.fr	Aubry, Agnes/K-8771-2015; Gervois, Nadine/K-6658-2015; Jotereau, Francine/AAU-1735-2020; Jotereau, Francine/L-8668-2015; Vignard, Virginie/K-7540-2015	Gervois, Nadine/0000-0002-0092-3919; Jotereau, Francine/0000-0002-2508-4875; Vignard, Virginie/0000-0002-6702-2824; Godet, Yann/0000-0003-4017-6070; MOREAU-AUBRY, Agnes/0000-0001-5540-3374	Ligue Nationale contre le Cancer; Institut National du Cancer; Association de Recherche contre le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants awarded by the "Ligue Nationale contre le Cancer" (labellisation 2005). Juliette Desfrancois was recipient of fellowship awarded by the "Institut National du Cancer" and by the "Association de Recherche contre le Cancer''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1733, DOI 10.1002/1521-4141(200006)30:6<1733::AID-IMMU1733>3.0.CO;2-E; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Bagot M, 1998, BLOOD, V91, P4331, DOI 10.1182/blood.V91.11.4331.411k12_4331_4341; Berzofsky JA, 2008, J IMMUNOL, V180, P3627, DOI 10.4049/jimmunol.180.6.3627; Chen JC, 2003, J IMMUNOL METHODS, V279, P123, DOI 10.1016/S0022-1759(03)00236-9; DEMARIA A, 1987, EUR J IMMUNOL, V17, P1815, DOI 10.1002/eji.1830171221; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Frisan T, 1998, J IMMUNOL, V160, P3281; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gervois N, 2000, CLIN CANCER RES, V6, P1459; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Hirao J, 1998, CLIN EXP IMMUNOL, V111, P397; JOTEREAU F, 1991, J IMMUNOTHER, V10, P405, DOI 10.1097/00002371-199112000-00003; KHAMMARI A, 2009, J INVEST DERMATOL; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; Martinez-Gallo M, 2008, EUR RESPIR J, V31, P1368, DOI 10.1183/09031936.00061907; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Osada T, 2005, INT IMMUNOL, V17, P1143, DOI 10.1093/intimm/dxh292; Pahar B, 2006, EUR J IMMUNOL, V36, P583, DOI 10.1002/eji.200535520; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; Pandolfino MC, 2001, CANCER IMMUNOL IMMUN, V50, P134, DOI 10.1007/PL00006683; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Pawelec G, 2004, FEBS LETT, V567, P63, DOI 10.1016/j.febslet.2004.02.091; Rahemtullah A, 2006, AM J CLIN PATHOL, V126, P805, DOI 10.1309/Y8KD32QGRYFN1XQX; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Sullivan YB, 2001, IMMUNOLOGY, V103, P270, DOI 10.1046/j.1365-2567.2001.01243.x; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; Weiss L, 1998, J INFECT DIS, V178, P1158, DOI 10.1086/515674; ZANELLI E, 1993, IMMUNOGENETICS, V38, P400, DOI 10.1007/BF00184520; Zloza A, 2003, BLOOD, V102, P2156, DOI 10.1182/blood-2002-07-1972; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	45	51	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8437	10.1371/journal.pone.0008437	http://dx.doi.org/10.1371/journal.pone.0008437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052413	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500002
J	Villar, AV; Cobo, M; Llano, M; Montalvo, C; Gonzalez-Vilchez, F; Martin-Duran, R; Hurle, MA; Nistal, JF				Villar, Ana V.; Cobo, Manuel; Llano, Miguel; Montalvo, Cecilia; Gonzalez-Vilchez, Francisco; Martin-Duran, Rafael; Hurle, Maria A.; Nistal, J. Francisco			Plasma Levels of Transforming Growth Factor-beta 1 Reflect Left Ventricular Remodeling in Aortic Stenosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CARDIAC FIBROBLASTS; GENDER-DIFFERENCES; VALVE-REPLACEMENT; ANGIOTENSIN-II; TGF-BETA; HYPERTROPHY; EXPRESSION; FIBROSIS; DISEASE	Background:TGF-beta 1 is involved in cardiac remodeling through an auto/paracrine mechanism. The contribution of TGF-beta 1 from plasmatic source to pressure overload myocardial remodeling has not been analyzed. We investigated, in patients with valvular aortic stenosis (AS), and in mice subjected to transverse aortic arch constriction (TAC), whether plasma TGF-beta 1 relates with myocardial remodeling, reflected by LV transcriptional adaptations of genes linked to myocardial hypertrophy and fibrosis, and by heart morphology and function. Methodology/Principal Findings: The subjects of the study were: 39 patients operated of AS; 27 healthy volunteers; 12 mice subjected to TAC; and 6 mice sham-operated. Myocardial samples were subjected to quantitative PCR. Plasma TGF-beta 1 was determined by ELISA. Under pressure overload, TGF-beta 1 plasma levels were significantly increased both in AS patients and TAC mice. In AS patients, plasma TGF-beta 1 correlated directly with aortic transvalvular gradients and LV mass surrogate variables, both preoperatively and 1 year after surgery. Plasma TGF-beta 1 correlated positively with the myocardial expression of genes encoding extracellular matrix (collagens I and III, fibronectin) and sarcomeric (myosin light chain-2, beta-myosin heavy chain) remodelling targets of TGF-beta 1, in TAC mice and in AS patients. Conclusions/Significance: A circulating TGF-beta 1-mediated mechanism is involved, in both mice and humans, in the excessive deposition of ECM elements and hypertrophic growth of cardiomyocytes under pressure overload. The possible value of plasma TGF-beta 1 as a marker reflecting preoperative myocardial remodeling status in AS patients deserves further analysis in larger patient cohorts.	[Villar, Ana V.; Hurle, Maria A.] Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, Fac Med, Div Farmacol, E-39005 Santander, Cantabria, Spain; [Cobo, Manuel; Llano, Miguel; Gonzalez-Vilchez, Francisco; Martin-Duran, Rafael] Hosp Univ Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Serv Cardiol, Santander, Cantabria, Spain; [Montalvo, Cecilia; Nistal, J. Francisco] Hosp Univ Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Serv Cirugia Cardiovasc, Santander, Cantabria, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Villar, AV (corresponding author), Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, Fac Med, Div Farmacol, E-39005 Santander, Cantabria, Spain.	hurlem@unican.es; jfnistal@gmail.com	Villar, Ana/I-5190-2015	Villar, Ana/0000-0003-4588-9598; Hurle, Maria Amor/0000-0002-7710-1358	Instituto de Salud Carlos III [PI060240]; Ministerio de Ciencia e Innovacion [SAF2007-65451]; Comunidad Autonoma de Cantabria	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Cantabria	This study was supported by grants from the Instituto de Salud Carlos III (PI060240) to JFN. and Ministerio de Ciencia e Innovacion (SAF2007-65451) to MAH. Dr. Nistal is in the Scientist Stabilization and Research Activity Intensification Program of the National Health System, funded by the Instituto de Salud Carlos III and Comunidad Autonoma de Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Christakis GT, 1996, ANN THORAC SURG, V62, P1084, DOI 10.1016/0003-4975(96)00533-4; Derhaschnig U, 2002, AM J HYPERTENS, V15, P207, DOI 10.1016/S0895-7061(01)02327-5; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Diehl P, 2008, THROMB HAEMOSTASIS, V99, P711, DOI 10.1160/TH07-05-0334; Fielitz J, 2001, J AM COLL CARDIOL, V37, P1443, DOI 10.1016/S0735-1097(01)01170-6; Grainger DJ, 2000, CYTOKINE GROWTH F R, V11, P133, DOI 10.1016/S1359-6101(99)00037-4; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kuruvilla L, 2007, CELL BIOCHEM BIOPHYS, V47, P65, DOI 10.1385/CBB:47:1:65; LAVIADAS C, 2000, HYPERTENSION, V36, P547; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; MONRAD ES, 1988, CIRCULATION, V77, P1345, DOI 10.1161/01.CIR.77.6.1345; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sciarretta S, 2007, AM J HYPERTENS, V20, P784, DOI 10.1016/j.amjhyper.2007.01.023; TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485; Villar AV, 2009, J MOL CELL CARDIOL, V46, P526, DOI 10.1016/j.yjmcc.2008.12.024; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1831; Wasywich CA, 2006, AM J CARDIOL, V97, P1068, DOI 10.1016/j.amjcard.2005.10.048; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	26	51	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8476	10.1371/journal.pone.0008476	http://dx.doi.org/10.1371/journal.pone.0008476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041033	Green Published, gold			2022-12-27	WOS:000278068700004
J	de Chiara, C; Menon, RP; Strom, M; Gibson, TJ; Pastore, A				de Chiara, Cesira; Menon, Rajesh P.; Strom, Molly; Gibson, Toby J.; Pastore, Annalisa			Phosphorylation of S776 and 14-3-3 Binding Modulate Ataxin-1 Interaction with Splicing Factors	PLOS ONE			English	Article							POLYGLUTAMINE-INDUCED DISEASE; AXH DOMAIN; MEDIATES NEURODEGENERATION; STRUCTURAL BASIS; PROTEIN; RECOGNITION; SPLICEOSOME; U2AF; IDENTIFICATION; ASSOCIATION	Ataxin-1 (Atx1), a member of the polyglutamine (polyQ) expanded protein family, is responsible for spinocerebellar ataxia type 1. Requirements for developing the disease are polyQ expansion, nuclear localization and phosphorylation of S776. Using a combination of bioinformatics, cell and structural biology approaches, we have identified a UHM ligand motif (ULM), present in proteins associated with splicing, in the C-terminus of Atx1 and shown that Atx1 interacts with and influences the function of the splicing factor U2AF65 via this motif. ULM comprises S776 of Atx1 and overlaps with a nuclear localization signal and a 14-3-3 binding motif. We demonstrate that phosphorylation of S776 provides the molecular switch which discriminates between 14-3-3 and components of the spliceosome. We also show that an S776D Atx1 mutant previously designed to mimic phosphorylation is unsuitable for this aim because of the different chemical properties of the two groups. Our results indicate that Atx1 is part of a complex network of interactions with splicing factors and suggest that development of the pathology is the consequence of a competition of aggregation with native interactions. Studies of the interactions formed by non-expanded Atx1 thus provide valuable hints for understanding both the function of the non-pathologic protein and the causes of the disease.	[de Chiara, Cesira; Menon, Rajesh P.; Strom, Molly; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Gibson, Toby J.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	MRC National Institute for Medical Research; European Molecular Biology Laboratory (EMBL)	de Chiara, C (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk		Gibson, Toby James/0000-0003-0657-5166; de Chiara, Cesira/0000-0002-9766-2515	Medical Research Council; National Institutes of Health (NIH) [U24NS050606]; Dept of Pharmacology, School of Medicine, University of California Davis; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept of Pharmacology, School of Medicine, University of California Davis; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Medical Research Council. The monoclonal antibody 11NQ was obtained from the UC/Davis/NINDS/NIMH NeuroMab Facility, supported by National Institutes of Health (NIH) grant U24NS050606 and maintained by the Dept of Pharmacology, School of Medicine, University of California Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Goold R, 2007, HUM MOL GENET, V16, P2122, DOI 10.1093/hmg/ddm162; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Heintz N, 2003, SCIENCE, V301, P59, DOI 10.1126/science.1086311; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; JODICE C, 1994, AM J HUM GENET, V54, P959; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu N, 2006, CELL, V127, P1299, DOI 10.1016/j.cell.2006.12.012; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Orr HT, 2001, HUM MOL GENET, V10, P2307, DOI 10.1093/hmg/10.20.2307; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Paulson H, 2003, NAT MED, V9, P825, DOI 10.1038/nm0703-825; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rino J, 2008, MOL CELL BIOL, V28, P3045, DOI 10.1128/MCB.02015-07; Sampath J, 2003, AM J PATHOL, V163, P1781, DOI 10.1016/S0002-9440(10)63538-9; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Spector DL, 1993, CURR OPIN CELL BIOL, V5, P442, DOI 10.1016/0955-0674(93)90009-F; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Umahara T, 2007, NEUROSCI LETT, V414, P130, DOI 10.1016/j.neulet.2006.12.026; Valadkhan S, 2007, CURR OPIN STRUC BIOL, V17, P310, DOI 10.1016/j.sbi.2007.05.001; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	51	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8372	10.1371/journal.pone.0008372	http://dx.doi.org/10.1371/journal.pone.0008372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037628	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998100006
J	Rajendran, L; Beckmann, J; Magenau, A; Boneberg, EM; Gaus, K; Viola, A; Giebel, B; Illges, H				Rajendran, Lawrence; Beckmann, Julia; Magenau, Astrid; Boneberg, Eva-Maria; Gaus, Katharina; Viola, Antonella; Giebel, Bernd; Illges, Harald			Flotillins Are Involved in the Polarization of Primitive and Mature Hematopoietic Cells	PLOS ONE			English	Article							LEUKEMIC STEM-CELLS; LIPID RAFTS; T-LYMPHOCYTES; EPITHELIAL-CELLS; PROGENITOR CELLS; PLASMA-MEMBRANE; HYALURONIC-ACID; LEADING-EDGE; POLARITY; PROTEINS	Background: Migration of mature and immature leukocytes in response to chemokines is not only essential during inflammation and host defense, but also during development of the hematopoietic system. Many molecules implicated in migratory polarity show uniform cellular distribution under non-activated conditions, but acquire a polarized localization upon exposure to migratory cues. Methodology/Principal Findings: Here, we present evidence that raft-associated endocytic proteins (flotillins) are pre-assembled in lymphoid, myeloid and primitive hematopoietic cells and accumulate in the uropod during migration. Furthermore, flotillins display a polarized distribution during immunological synapse formation. Employing the membrane lipid-order sensitive probe Laurdan, we show that flotillin accumulation in the immunological synapse is concomittant with membrane ordering in these regions. Conclusions: Together with the observation that flotillin polarization does not occur in other polarized cell types such as polarized epithelial cells, our results suggest a specific role for flotillins in hematopoietic cell polarization. Based on our results, we propose that in hematopoietic cells, flotillins provide intrinsic cues that govern segregation of certain microdomain-associated molecules during immune cell polarization.	[Rajendran, Lawrence] Univ Zurich, Dept Psychiat Res, Zurich, Switzerland; [Rajendran, Lawrence; Illges, Harald] Univ Konstanz, Constance, Germany; [Rajendran, Lawrence] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Beckmann, Julia; Giebel, Bernd] Univ Dusseldorf, Inst Transplantat Diagnost & Cellular Therapeut, Dusseldorf, Germany; [Beckmann, Julia; Giebel, Bernd] Univ Klinikum Essen, Inst Transfus Med, Essen, Germany; [Magenau, Astrid; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Magenau, Astrid; Gaus, Katharina] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia; [Boneberg, Eva-Maria; Illges, Harald] Biotechnol Inst Thurgau, Taegerwilen, Switzerland; [Viola, Antonella] Univ Padua, Dept Biomed Sci, Padua, Italy; [Illges, Harald] Univ Appl Sci, Rheinbach, Germany	University of Zurich; University of Konstanz; Max Planck Society; Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of New South Wales Sydney; University of Padua	Rajendran, L (corresponding author), Univ Zurich, Dept Psychiat Res, Zurich, Switzerland.	rajendran@bli.uzh.ch; bernd.giebel@uk-essen.de; harald.illges@fh-brs.de	Agatea, Lisa/L-8267-2016; Giebel, Bernd/AAH-1083-2021; Viola, Antonella/A-4321-2015	Giebel, Bernd/0000-0003-2446-948X; Gaus, Katharina/0000-0002-8009-9658; Rajendran, Lawrence/0000-0002-6390-1821; Viola, Antonella/0000-0002-0125-9271	BBW, Bern, Switzerland [MRTN-CT-2004-005693, QLG1-CT-2001-01536, QLG1-CT-2001-0140]; Deutsche Forschungsgemeinschaft [SPP1109 GI 336/1-4]; Forschungskommission of the HHU-Duesseldorf; Leukamieliga e. V.; Swiss National Science Foundation	BBW, Bern, Switzerland; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the HHU-Duesseldorf; Leukamieliga e. V.; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the BBW, Bern, Switzerland through grants MRTN-CT-2004-005693, QLG1-CT-2001-01536 and QLG1-CT-2001-01407 to H. I. as well as by grants from the Deutsche Forschungsgemeinschaft (SPP1109 GI 336/1-4), from the Forschungskommission of the HHU-Duesseldorf and the Leukamieliga e. V. to B. G. Part of this research is supported by the NCCR Neural Plasticity and Repair of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONCIC B, 2000, J DEV ENTREPRENEURSH, V5, P21; Ariel A, 2000, IMMUNOLOGY, V100, P345, DOI 10.1046/j.1365-2567.2000.00059.x; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; BABUKE T, 2009, CELL SIGNAL; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BORNENS M, 1991, NEW BIOL, V3, P627; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; delPozo MA, 1997, J CELL BIOL, V137, P493; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; GERISCH G, 1993, SYM SOC EXP BIOL, V47, P297; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Gubina E, 2002, BLOOD, V99, P2518, DOI 10.1182/blood.V99.7.2518; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Iida S, 2005, J LEUKOCYTE BIOL, V78, P481, DOI 10.1189/jlb.0904515; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Khaldoyanidi S, 1996, J LEUKOCYTE BIOL, V60, P579, DOI 10.1002/jlb.60.5.579; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lopez-Casas PP, 2003, FEBS LETT, V555, P223, DOI 10.1016/S0014-5793(03)01239-0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Millan J, 2002, BLOOD, V99, P978, DOI 10.1182/blood.V99.3.978; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pierini LM, 2001, P NATL ACAD SCI USA, V98, P9471, DOI 10.1073/pnas.181353098; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Salzer U, 2002, BLOOD, V99, P2569, DOI 10.1182/blood.V99.7.2569; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Samaniego R, 2007, J CELL SCI, V120, P3534, DOI 10.1242/jcs.006296; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Savage NDL, 2002, J IMMUNOL, V168, P3740, DOI 10.4049/jimmunol.168.8.3740; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; Solomon S, 2002, IMMUNOBIOLOGY, V205, P108, DOI 10.1078/0171-2985-00114; Sotsios Y, 1999, J IMMUNOL, V163, P5954; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; WANG JM, 1987, IMMUNOLOGY, V60, P439; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	68	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8290	10.1371/journal.pone.0008290	http://dx.doi.org/10.1371/journal.pone.0008290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027317	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998000001
J	Rhyne, A; Rotjan, R; Bruckner, A; Tlusty, M				Rhyne, Andrew; Rotjan, Randi; Bruckner, Andrew; Tlusty, Michael			Crawling to Collapse: Ecologically Unsound Ornamental Invertebrate Fisheries	PLOS ONE			English	Article							FISH TRADE; SERVICES; ECOSYSTEMS; ECOLOGY; GOODS	Background: Fishery management has historically been an inexact and reactionary discipline, often taking action only after a critical stock suffers overfishing or collapse. The invertebrate ornamental fishery in the State of Florida, with increasing catches over a more diverse array of species, is poised for collapse. Current management is static and the lack of an adaptive strategy will not allow for adequate responses associated with managing this multi-species fishery. The last decade has seen aquarium hobbyists shift their display preference from fish-only tanks to miniature reef ecosystems that include many invertebrate species, creating increased demand without proper oversight. The once small ornamental fishery has become an invertebrate-dominated major industry supplying five continents. Methodology/Principal Findings: Here, we analyzed the Florida Marine Life Fishery (FLML) landing data from 1994 to 2007 for all invertebrate species. The data were organized to reflect both ecosystem purpose (in the wild) and ecosystem services (commodities) for each reported species to address the following question: Are ornamental invertebrates being exploited for their fundamental ecosystem services and economic value at the expense of reef resilience? We found that 9 million individuals were collected in 2007, 6 million of which were grazers. Conclusions/Significance: The number of grazers now exceeds, by two-fold, the number of specimens collected for curio and ornamental purposes altogether, representing a major categorical shift. In general, landings have increased 10-fold since 1994, though the number of licenses has been dramatically reduced. Thus, despite current management strategies, the FLML Fishery appears to be crawling to collapse.	[Rhyne, Andrew; Rotjan, Randi; Tlusty, Michael] Edgerton Res Lab, Boston, MA USA; [Rhyne, Andrew] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA; [Rotjan, Randi] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Bruckner, Andrew] Khaled Bin Sultan Living Oceans Fdn, Landover, MD USA	Harvard University	Rhyne, A (corresponding author), Edgerton Res Lab, Boston, MA USA.	arhyne@rwu.edu	Tlusty, Michael/C-5349-2012; Rotjan, Randi D/T-7575-2019; Tlusty, Michael/AAF-9635-2021	Rotjan, Randi D/0000-0002-3401-9784; Tlusty, Michael/0000-0002-7493-2025; Rhyne, Andrew/0000-0001-7252-3431				ANDREWS C, 1990, J FISH BIOL, V37, P53, DOI 10.1111/j.1095-8649.1990.tb05020.x; Brown TC, 2007, NAT RESOUR J, V47, P329; Bruckner AW, 2005, REV BIOL TROP, V53, P127; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2002, REEFS RISK SE ASIA; Calado R, 2003, J CRUSTACEAN BIOL, V23, P963, DOI 10.1651/C-2409; Calado R, 2008, AQUAT CONSERV, V18, P335, DOI 10.1002/aqc.852; Ceballos G., 2010, ISSUES ECOL, V8, P1821; Chiappone M, 2001, REEF ENCOUNTERS, V30, P29; CITES, 2000, C PART GIG 11 M KEN; Daily G.C., 1997, NATURES SERVICES SOC, P1; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Gasparini JL, 2005, BIODIVERS CONSERV, V14, P2883, DOI 10.1007/s10531-004-0222-1; HINGCO TG, 1991, ICLARM C P, V22, P249; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; HUGHES TP, 1994, SCIENCE, V256, P1574; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Larkin S.L., 2003, MAR FISH REV, V65, P21; LARKIN SL, 2001, EC PROFILE FLORIDAS; Leslie H. M., 2009, ECOSYSTEM BASED MANA, P55; MORGAN GR, 2001, CORPORATE DOCUMENT R; Morison AK, 2004, FISHERIES MANAG ECOL, V11, P411, DOI 10.1111/j.1365-2400.2004.00414.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Rhyne AL, 2004, J SHELLFISH RES, V23, P227; Sall J, 2007, JMP START STAT GUIDE; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V65, P83, DOI 10.1016/0022-0981(82)90177-0; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Sutinen JG, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P291, DOI 10.1079/9780851996332.0291; Talbot F., 2001, CORAL REEFS MANGROVE; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA	32	71	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8413	10.1371/journal.pone.0008413	http://dx.doi.org/10.1371/journal.pone.0008413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027312	Green Submitted, gold, Green Published			2022-12-27	WOS:000272998000017
J	Shriner, D; Adeyemo, A; Gerry, NP; Herbert, A; Chen, GJ; Doumatey, A; Huang, HX; Zhou, J; Christman, MF; Rotimi, CN				Shriner, Daniel; Adeyemo, Adebowale; Gerry, Norman P.; Herbert, Alan; Chen, Guanjie; Doumatey, Ayo; Huang, Hanxia; Zhou, Jie; Christman, Michael F.; Rotimi, Charles N.			Transferability and Fine-Mapping of Genome-Wide Associated Loci for Adult Height across Human Populations	PLOS ONE			English	Article							BODY-MASS INDEX; LINKAGE DISEQUILIBRIUM; AFRICAN-AMERICAN; COMMON VARIANTS; FLIP-FLOP; STATURE; HERITABILITY; SCAN; GENE; REGIONS	Human height is the prototypical polygenic quantitative trait. Recently, several genetic variants influencing adult height were identified, primarily in individuals of East Asian (Chinese Han or Korean) or European ancestry. Here, we examined 152 genetic variants representing 107 independent loci previously associated with adult height for transferability in a well-powered sample of 1,016 unrelated African Americans. When we tested just the reported variants originally identified as associated with adult height in individuals of East Asian or European ancestry, only 8.3% of these loci transferred (p-values <= 0.05 under an additive genetic model with directionally consistent effects) to our African American sample. However, when we comprehensively evaluated all HapMap variants in linkage disequilibrium (r(2) >= 0.3) with the reported variants, the transferability rate increased to 54.1%. The transferability rate was 70.8% for associations originally reported as genome-wide significant and 38.0% for associations originally reported as suggestive. An additional 23 loci were significantly associated but failed to transfer because of directionally inconsistent effects. Six loci were associated with adult height in all three groups. Using differences in linkage disequilibrium patterns between HapMap CEU or CHB reference data and our African American sample, we fine-mapped these six loci, improving both the localization and the annotation of these transferable associations.	[Shriner, Daniel; Adeyemo, Adebowale; Chen, Guanjie; Doumatey, Ayo; Huang, Hanxia; Zhou, Jie; Rotimi, Charles N.] NIH, Ctr Res Gen & Global Hlth, NHGRI, Bethesda, MD 20892 USA; [Gerry, Norman P.; Christman, Michael F.] Coriell Inst Med Res, Camden, NJ USA; [Herbert, Alan] Boston Univ, Sch Med, Dept Genet & Gen, Boston, MA 02118 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Coriell Institute for Medical Research; Boston University	Shriner, D (corresponding author), NIH, Ctr Res Gen & Global Hlth, NHGRI, Bldg 10, Bethesda, MD 20892 USA.	shrinerda@mail.nih.gov; rotimic@mail.nih.gov	Herbert, Alan/AAY-4286-2020	Adeyemo, Adebowale/0000-0002-3105-3231; Herbert, Alan/0000-0002-0093-1572; Shriner, Daniel/0000-0003-1928-5520	National Institutes of Health [S06GM008016-320107, S06GM008016-380111, 2M01RR010284]; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health [Z01HG200362]; Coriell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Coriell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Howard University Family Study was supported by National Institutes of Health grants S06GM008016-320107 to CNR and S06GM008016-380111 to AA. Enrollment was carried out at the Howard University General Clinical Research Center, supported by National Institutes of Health grant 2M01RR010284. This research was supported in part by the Intramural Research Program of the Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health (Z01HG200362). Genotyping support was provided by the Coriell Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEYEMO A, 2009, PUBLIC HLTH IN PRESS; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; Deng HW, 2002, AM J MED GENET, V113, P29, DOI 10.1002/ajmg.10742; Falush D, 2003, GENETICS, V164, P1567; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-77; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lei SF, 2009, HUM GENET, V125, P1, DOI 10.1007/s00439-008-0590-9; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li MX, 2004, J HUM GENET, V49, P148, DOI 10.1007/s10038-004-0125-8; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Luke A, 2001, INT J OBESITY, V25, P1034, DOI 10.1038/sj.ijo.0801650; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Moskvina V, 2007, HUM HERED, V64, P63, DOI 10.1159/000101424; MUELLER WH, 1976, AM J PHYS ANTHROPOL, V45, P269, DOI 10.1002/ajpa.1330450212; Mukhopadhyay N, 2003, HUM HERED, V55, P191, DOI 10.1159/000073203; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price RA, 2000, OBES RES, V8, P360, DOI 10.1038/oby.2000.43; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROBERTS DF, 1978, ANN HUM GENET, V42, P15, DOI 10.1111/j.1469-1809.1978.tb00928.x; Sale MM, 2005, ANN HUM GENET, V69, P517, DOI 10.1046/j.1529-8817.2005.00176.x; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wiltshire S, 2002, AM J HUM GENET, V70, P543, DOI 10.1086/338760; Wu XD, 2003, EUR J HUM GENET, V11, P271, DOI 10.1038/sj.ejhg.5200952; Xu JF, 2002, AM J HUM GENET, V71, P646, DOI 10.1086/342216; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001	39	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8398	10.1371/journal.pone.0008398	http://dx.doi.org/10.1371/journal.pone.0008398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027299	Green Submitted, Green Published, gold			2022-12-27	WOS:000272998000006
J	Pallotta, I; Lovett, M; Rice, W; Kaplan, DL; Balduini, A				Pallotta, Isabella; Lovett, Michael; Rice, William; Kaplan, David L.; Balduini, Alessandra			Bone Marrow Osteoblastic Niche: A New Model to Study Physiological Regulation of Megakaryopoiesis	PLOS ONE			English	Article							PROPLATELET FORMATION; STEM-CELLS; OXYGEN-TENSION; MEGAKARYOCYTES; EXPRESSION; PROTEIN; DIFFERENTIATION; HEMATOPOIESIS; LOCALIZATION; MATURATION	Background: The mechanism by which megakaryocytes (Mks) proliferate, differentiate, and release platelets into circulation are not well understood. Growing evidence indicates that a complex regulatory mechanism, involving cellular interactions, composition of the extracellular matrix and physical parameters such as oxygen tension, may contribute to the quiescent or permissive microenvironment related to Mk differentiation and maturation within the bone marrow. Methodology/Principal Findings: Differentiating human mesenchymal stem cells (hMSCs) into osteoblasts (hOSTs), we established an in vitro model for the osteoblastic niche. We demonstrated for the first time that the combination of HSCs, Mks and hypoxia sustain and promote bone formation by increasing type I collagen release from hOSTs and enhancing its fibrillar organization, as revealed by second harmonic generation microscopy. Through co-culture, we demonstrated that direct cell-cell contact modulates Mk maturation and differentiation. In particular we showed that low oxygen tension and direct interaction of hematopoietic stem cells (HSCs) with hOSTs inhibits Mk maturation and proplatelet formation (PPF). This regulatory mechanism was dependent on the fibrillar structure of type I collagen released by hOSTs and on the resulting engagement of the alpha2beta1 integrin. In contrast, normoxic conditions and the direct interaction of HSCs with undifferentiated hMSCs promoted Mk maturation and PPF, through a mechanism involving the VCAM-1 pathway. Conclusions/Significance: By combining cellular, physical and biochemical parameters, we mimicked an in vitro model of the osteoblastic niche that provides a physiological quiescent microenvironment where Mk differentiation and PPF are prevented. These findings serve as an important step in developing suitable in vitro systems to use for the study and manipulation of Mk differentiation and maturation in both normal and diseased states.	[Pallotta, Isabella; Lovett, Michael; Rice, William; Kaplan, David L.; Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Pallotta, Isabella; Balduini, Alessandra] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy	Tufts University; University of Pavia	Pallotta, I (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu; alessandra.balduini@tufts.edu	Balduini, Alessandra/K-6802-2016; BALDUINI, ALESSANDRA/AAC-3363-2022; Pallotta, Isabella/J-5759-2019	Balduini, Alessandra/0000-0003-3145-1245; BALDUINI, ALESSANDRA/0000-0003-3145-1245; 	Cariplo Foundation [2006.0596/10.8485]; Banca del Monte di Lombardia Foundation; U.S. National Institutes of Health [NIH P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	Cariplo Foundation(Fondazione Cariplo); Banca del Monte di Lombardia Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from Cariplo Foundation (2006.0596/10.8485); Banca del Monte di Lombardia Foundation and the U.S. National Institutes of Health (NIH P41 EB002520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2004, EXP CELL RES, V300, P84, DOI 10.1016/j.yexcr.2004.07.011; Balduini A, 2009, J THROMB HAEMOST, V7, P478, DOI 10.1111/j.1538-7836.2008.03255.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Cheng LZ, 2000, J CELL PHYSIOL, V184, P58, DOI 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kacena MA, 2006, BONE, V39, P978, DOI 10.1016/j.bone.2006.05.019; Larson MK, 2006, PLATELETS, V17, P435, DOI 10.1080/09537100600772637; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; LEVEN RM, 1992, EXP HEMATOL, V20, P1316; Liu F, 2008, J BONE MINER METAB, V26, P312, DOI 10.1007/s00774-007-0842-0; LORD BI, 1990, INT J CELL CLONING, V8, P317, DOI 10.1002/stem.5530080501; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mostafa SS, 2000, BRIT J HAEMATOL, V111, P879, DOI 10.1046/j.1365-2141.2000.02457.x; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nurden P, 2006, BLOOD, V108, P2587, DOI 10.1182/blood-2006-03-009449; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Pecci A, 2009, THROMB HAEMOSTASIS, V102, P90, DOI 10.1160/TH09-01-0068; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Rajashekhar G, 2005, J SOC GYNECOL INVEST, V12, P310, DOI 10.1016/j.jsgi.2005.02.010; REDDI AH, 1977, P NATL ACAD SCI USA, V74, P5589, DOI 10.1073/pnas.74.12.5589; Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Schulze H, 2005, J THROMB HAEMOST, V3, P1717, DOI 10.1111/j.1538-7836.2005.01426.x; SEIB FB, 2009, TISSUE EN A IN PRESS; Seri M, 2000, NAT GENET, V26, P103; Takizawa H, 2008, EXP HEMATOL, V36, P897, DOI 10.1016/j.exphem.2008.02.004; Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022; Warren SM, 2001, J SURG RES, V99, P147, DOI 10.1006/jsre.2001.6128; Willam C, 1999, AM J PHYSIOL-HEART C, V276, pH2044, DOI 10.1152/ajpheart.1999.276.6.H2044; WILLIAMS N, 1982, BRIT J HAEMATOL, V52, P173, DOI 10.1111/j.1365-2141.1982.tb03878.x; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; ZOU Z, 2009, BLOOD IN PRESS	46	62	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8359	10.1371/journal.pone.0008359	http://dx.doi.org/10.1371/journal.pone.0008359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027303	Green Submitted, Green Published, gold			2022-12-27	WOS:000272940100007
J	Svensson, K; Granberg, M; Karlsson, L; Neubauerova, V; Forsman, M; Johansson, A				Svensson, Kerstin; Granberg, Malin; Karlsson, Linda; Neubauerova, Vera; Forsman, Mats; Johansson, Anders			A Real-Time PCR Array for Hierarchical Identification of Francisella Isolates	PLOS ONE			English	Article							TULARENSIS SUBSP TULARENSIS; POPULATION-STRUCTURE; MOLECULAR ANALYSIS; TULAREMIA VACCINE; EVOLUTION; ASSAY	A robust, rapid and flexible real-time PCR assay for hierarchical genetic typing of clinical and environmental isolates of Francisella is presented. Typing markers were found by multiple genome and gene comparisons, from which 23 canonical single nucleotide polymorphisms (canSNPs) and 11 canonical insertion-deletion mutations (canINDELs) were selected to provide phylogenetic guidelines for classification from genus to isolate level. The specificity of the developed assay, which uses 68 wells of a 96-well real-time PCR format with a detection limit of 100 pg DNA, was assessed using 62 Francisella isolates of diverse genetic and geographical origins. It was then successfully used for typing 14 F. tularensis subsp. holarctica isolates obtained from tularemia patients in Sweden in 2008 and five more genetically diverse Francisella isolates of global origins. When applied to human ulcer specimens for direct pathogen detection the results were incomplete due to scarcity of DNA, but sufficient markers were identified to detect fine-resolution differences among F. tularensis subsp. holarctica isolates causing infection in the patients. In contrast to other real-time PCR assays for Francisella, which are typically designed for specific detection of a species, subspecies, or strain, this type of assay can be easily tailored to provide appropriate phylogenetic and/or geographical resolution to meet the objectives of the analysis.	[Svensson, Kerstin; Granberg, Malin; Karlsson, Linda; Forsman, Mats; Johansson, Anders] Swedish Def Res Agcy, Div CBRN Def & Secur, Umea, Sweden; [Svensson, Kerstin; Johansson, Anders] Umea Univ, Dept Clin Microbiol Infect Dis & Bacteriol, Umea, Sweden; [Neubauerova, Vera] Cent Mil Hlth Inst, Prague, Czech Republic	Saab Group; Umea University	Svensson, K (corresponding author), Swedish Def Res Agcy, Div CBRN Def & Secur, Umea, Sweden.	kerstin.svensson@foi.se	Forsman, Mats/A-1426-2016; Johansson, Anders/D-2928-2012; Johansson, Anders/H-9362-2017	Forsman, Mats/0000-0002-4466-5325; Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943	Swedish Ministry of Foreign Affairs [A4942, A4952]; Medical Faculty, Umea University, Umea; European biodefence laboratory network [EDAB-0060-ESM4-GC]	Swedish Ministry of Foreign Affairs; Medical Faculty, Umea University, Umea; European biodefence laboratory network	This study was supported by the Swedish Ministry of Foreign Affairs (FOI project No. A4942 and A4952) www.ud.se and the Medical Faculty, Umea University, Umea, www.umu.se/medfak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was part of the European biodefence laboratory network (EDAB-0060-ESM4-GC) coordination work on dangerous pathogens.	Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; *CDCP, BIOT; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Fey PD, 2007, AM J CLIN PATHOL, V128, P926, DOI 10.1309/JN3NTHK4VVWKJT4A; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Fujita O, 2006, JPN J INFECT DIS, V59, P46; Fulop M, 1996, AM J TROP MED HYG, V54, P364, DOI 10.4269/ajtmh.1996.54.364; Germer Soren, 2003, Methods Mol Biol, V212, P197; Higgins JA, 2000, AM J TROP MED HYG, V62, P310, DOI 10.4269/ajtmh.2000.62.310; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P22; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2006, EMERG INFECT DIS, V12, P1799, DOI 10.3201/eid1211.060629; KUGELER KJ, 2009, CLIN INFECT DIS; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; LONG GW, 1993, J CLIN MICROBIOL, V31, P152, DOI 10.1128/JCM.31.1.152-154.1993; Molins CR, 2009, DIAGN MICR INFEC DIS, V64, P6, DOI 10.1016/j.diagmicrobio.2009.01.006; NEWSOM G, 2005, SAN FRANCISCO COMMUN; Nubel U, 2006, J BACTERIOL, V188, P5319, DOI 10.1128/JB.01662-05; Pavkova I, 2006, J PROTEOME RES, V5, P3125, DOI 10.1021/pr0601887; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Rozen S, 2000, Methods Mol Biol, V132, P365; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Sjostedt A, 1997, J CLIN MICROBIOL, V35, P1045; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Tomaso H, 2007, MOL CELL PROBE, V21, P12, DOI 10.1016/j.mcp.2006.06.001; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; VOGLER AJ, 2009, J BACTERIOL; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Zhai JH, 1996, J MED MICROBIOL, V45, P477, DOI 10.1099/00222615-45-6-477	35	66	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8360	10.1371/journal.pone.0008360	http://dx.doi.org/10.1371/journal.pone.0008360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027310	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100008
J	Cooksey, AM; Momen, N; Stocker, R; Burgess, SC				Cooksey, Amanda M.; Momen, Nausheen; Stocker, Russell; Burgess, Shane C.			Identifying Blood Biomarkers and Physiological Processes That Distinguish Humans with Superior Performance under Psychological Stress	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; TRANSGENIC MICE; SERUM RETINOL-BINDING-PROTEIN-4; PLASMA; PROTEOMICS; PROTEIN; HYPERLIPIDEMIA; ASSOCIATION; COAGULATION; INHIBITION	Background: Attrition of students from aviation training is a serious financial and operational concern for the U. S. Navy. Each late stage navy aviator training failure costs the taxpayer over $1,000,000 and ultimately results in decreased operational readiness of the fleet. Currently, potential aviators are selected based on the Aviation Selection Test Battery (ASTB), which is a series of multiple-choice tests that evaluate basic and aviation-related knowledge and ability. However, the ASTB does not evaluate a person's response to stress. This is important because operating sophisticated aircraft demands exceptional performance and causes high psychological stress. Some people are more resistant to this type of stress, and consequently better able to cope with the demands of naval aviation, than others. Methodology/Principal Findings: Although many psychological studies have examined psychological stress resistance none have taken advantage of the human genome sequence. Here we use high-throughput -omic biology methods and a novel statistical data normalization method to identify plasma proteins associated with human performance under psychological stress. We identified proteins involved in four basic physiological processes: innate immunity, cardiac function, coagulation and plasma lipid physiology. Conclusions/Significance: The proteins identified here further elucidate the physiological response to psychological stress and suggest a hypothesis that stress-susceptible pilots may be more prone to shock. This work also provides potential biomarkers for screening humans for capability of superior performance under stress.	[Cooksey, Amanda M.; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Cooksey, Amanda M.; Burgess, Shane C.] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Cooksey, Amanda M.; Burgess, Shane C.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA; [Momen, Nausheen] Naval Aerosp Med Res Lab, Pensacola, FL USA; [Momen, Nausheen] Navy Recruiting Dist, Boston, MA USA; [Stocker, Russell] Mississippi State Univ, Dept Math & Stat, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Cooksey, AM (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	acooksey@mafes.msstate.edu			USDA [2003-34506-13768]	USDA(United States Department of Agriculture (USDA))	This work was supported by USDA grant number 2003-34506-13768 (http://www.csrees.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Bierhaus A, 2006, ANESTHESIOL CLIN N A, V24, P325, DOI 10.1016/j.atc.2006.01.001; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; ENDRESEN IM, 1991, BEHAV MED, V17, P167, DOI 10.1080/08964289.1991.9935168; Erikstrup C, 2006, NEW ENGL J MED, V355, P1393; FRANK LH, 1993, P 35 ANN C MIL TEST, V35, P14; Fujita Y, 2004, J HUM GENET, V49, P24, DOI 10.1007/s10038-003-0101-8; HORACKOVA M, 1995, AM J PHYSIOL-CELL PH, V269, pC504, DOI 10.1152/ajpcell.1995.269.2.C504; Hortin GL, 2006, CLIN CHEM, V52, P1218, DOI 10.1373/clinchem.2006.067280; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Jong MC, 1999, BIOCHEM J, V338, P281, DOI 10.1042/0264-6021:3380281; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; KUSHWAHA RS, 1993, J LIPID RES, V34, P1285; Lee DC, 2007, METABOLISM, V56, P327, DOI 10.1016/j.metabol.2006.10.011; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936; Hermsdorff HHM, 2009, NUTRITION, V25, P392, DOI 10.1016/j.nut.2008.09.015; Nanduri B, 2008, PROTEOMICS, V8, P2104, DOI 10.1002/pmic.200701048; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SCHEDLOWSKI M, 1992, LIFE SCI, V50, P1201, DOI 10.1016/0024-3205(92)90319-K; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Soutar A K, 1978, Scand J Clin Lab Invest Suppl, V150, P53; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stoney CM, 1999, HEALTH PSYCHOL, V18, P251, DOI 10.1037/0278-6133.18.3.251; Swarnakar S, 2001, J BIOL CHEM, V276, P21121, DOI 10.1074/jbc.M101691200; TAKAHASHI H, 1990, AM J HEMATOL, V33, P90, DOI 10.1002/ajh.2830330204; Takashima N, 2006, NEW ENGL J MED, V355, P1392; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Wirtz PH, 2006, PSYCHOSOM MED, V68, P851, DOI 10.1097/01.psy.0000245866.03456.aa; Yoshida A, 2006, J ATHEROSCLER THROMB, V13, P209, DOI 10.5551/jat.13.209	35	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8371	10.1371/journal.pone.0008371	http://dx.doi.org/10.1371/journal.pone.0008371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020041	Green Submitted, Green Published, gold			2022-12-27	WOS:000272870600011
J	Singh, RK; Lau, D; Noviello, CM; Ghosh, P; Guatelli, JC				Singh, Rajendra Kumar; Lau, David; Noviello, Colleen M.; Ghosh, Partho; Guatelli, John C.			An MHC-I Cytoplasmic Domain/HIV-1 Nef Fusion Protein Binds Directly to the mu Subunit of the AP-1 Endosomal Coat Complex	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; CELL-SURFACE CD4; HIV-1 NEF; DOWN-REGULATION; STRUCTURAL EXPLANATION; RECOGNITION; MOTIF	Background: The down-regulation of the major histocompatibility complex class I (MHC-I) from the surface of infected cells by the Nef proteins of primate immunodeficiency viruses likely contributes to pathogenesis by providing evasion of cell-mediated immunity. HIV-1 Nef-induced down-regulation involves endosomal trafficking and a cooperative interaction between the cytoplasmic domain (CD) of MHC-I, Nef, and the clathrin adaptor protein complex-1 (AP-1). The CD of MHC-I contains a key tyrosine within the sequence YSQA that is required for down-regulation by Nef, but this sequence does not conform to the canonical AP-binding tyrosine-based motif Yxx phi, which mediates binding to the medium (mu) subunits of AP complexes. We previously proposed that Nef allows the MHC-I CD to bind the mu subunit of AP-1 (mu 1) as if it contained a Yxx phi motif. Methods and Findings: Here, we show that a direct interaction between the MHC-I CD/Nef and mu 1 plays a primary role in the down-regulation of MHC-I: GST pulldown assays using recombinant proteins indicated that most of the MHC-I CD and Nef residues that are required for the down-regulation in human cells contribute to direct interactions with a truncated version of mu 1. Specifically, the tyrosine residue of the YSQA sequence in the MHC-I CD as well as Nef residues E62-65 and P78 each contributed to the interaction between MHC-I CD/Nef and mu 1 in vitro, whereas Nef M20 had little to no role. Conversely, residues F172/D174 and V392/L395 of the binding pocket on mu 1 for Yxx phi motifs were required for a robust interaction. Conclusions: These data indicate that the MHC-I cytoplasmic domain, Nef, and the C-terminal two thirds of the mu subunit of AP-1 are sufficient to constitute a biologically relevant interaction. The data also reveal an unexpected role for a hydrophobic pocket in mu 1 for interaction with MHC-I CD/Nef.	[Singh, Rajendra Kumar; Lau, David; Noviello, Colleen M.; Guatelli, John C.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Guatelli, John C.] San Diego Vet Affair Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Singh, RK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	rajendra84@hotmail.com			National Institutes of Health [AI 076040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health AI 076040 to JCG and a post doctoral research fellowship award from the California HIV/AIDS Research Program (http://www.californiaaidsresearch.org) to RKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; KAMINCHIK J, 1991, J VIROL, V65, P583, DOI 10.1128/JVI.65.2.583-588.1991; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Riggs NL, 1999, VIROLOGY, V258, P203, DOI 10.1006/viro.1999.9736; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200	22	29	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8364	10.1371/journal.pone.0008364	http://dx.doi.org/10.1371/journal.pone.0008364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020046	Green Published, Green Submitted, gold			2022-12-27	WOS:000272870600007
J	Dang, TMH; Nguyen, TNL; Wolbers, M; Tran, ND; Nguyen, DQ; Tran, TVT; Le, THN; Nguyen, TNA; Tran, VQ; Nguyen, TBT; Vo, TH; Day, J; Hoang, TTH; Vo, SK; Nguyen, TN; Dai, VH; Nguyen, HD; Nguyen, HL; Farrar, J; Caws, M				Dang Thi Minh Ha; Nguyen Thi Ngoc Lan; Wolbers, Marcel; Tran Ngoc Duong; Nguyen Dang Quang; Tran Thi Van Thinh; Le Thi Hong Ngoc; Nguyen Thi Ngoc Anh; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Day, Jeremy; Hoang Thi Thanh Hang; Vo Sy Kiet; Nguyen Thi Nho; Dai Viet Hoa; Nguyen Huy Dung; Nguyen Huu Lan; Farrar, Jeremy; Caws, Maxine			Microscopic Observation Drug Susceptibility Assay (MODS) for Early Diagnosis of Tuberculosis in Children	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS	MODS is a novel liquid culture based technique that has been shown to be effective and rapid for early diagnosis of tuberculosis (TB). We evaluated the MODS assay for diagnosis of TB in children in Viet Nam. 217 consecutive samples including sputum (n = 132), gastric fluid (n = 50), CSF (n = 32) and pleural fluid (n = 3) collected from 96 children with suspected TB, were tested by smear, MODS and MGIT. When test results were aggregated by patient, the sensitivity and specificity of smear, MGIT and MODS against "clinical diagnosis'' (confirmed and probable groups) as the gold standard were 28.2% and 100%, 42.3% and 100%, 39.7% and 94.4%, respectively. The sensitivity of MGIT and MODS was not significantly different in this analysis (P = 0.5), but MGIT was more sensitive than MODS when analysed on the sample level using a marginal model (P = 0.03). The median time to detection of MODS and MGIT were 8 days and 13 days, respectively, and the time to detection was significantly shorter for MODS in samples where both tests were positive (P<0.001). An analysis of time-dependent sensitivity showed that the detection rates were significantly higher for MODS than for MGIT by day 7 or day 14 (P<0.001 and P = 0.04), respectively. MODS is a rapid and sensitive alternative method for the isolation of M. tuberculosis from children.	[Dang Thi Minh Ha; Nguyen Thi Ngoc Lan; Tran Ngoc Duong; Nguyen Dang Quang; Tran Thi Van Thinh; Le Thi Hong Ngoc; Nguyen Thi Ngoc Anh; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Nguyen Thi Nho; Dai Viet Hoa; Nguyen Huy Dung; Nguyen Huu Lan] Pham Ngoc Thach Hosp, TB Dept, Ho Chi Minh City, Vietnam; [Dang Thi Minh Ha; Wolbers, Marcel; Day, Jeremy; Hoang Thi Thanh Hang; Vo Sy Kiet; Farrar, Jeremy; Caws, Maxine] Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Dang Thi Minh Ha; Wolbers, Marcel; Day, Jeremy; Hoang Thi Thanh Hang; Vo Sy Kiet; Farrar, Jeremy; Caws, Maxine] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford	Dang, TMH (corresponding author), Pham Ngoc Thach Hosp, TB Dept, Ho Chi Minh City, Vietnam.	hadtm@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Caws, Maxine/0000-0002-9109-350X; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain	Wellcome Trust of Great Britain(Wellcome Trust)	This study was supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinza Nicoleta, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P65; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Caws M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001173; Gray JW, 2004, CLIN BIOCHEM, V37, P450, DOI 10.1016/j.clinbiochem.2004.03.003; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; PEPE, 2004, STAT EVALUATION MED; Raqib R, 2009, CLIN VACCINE IMMUNOL, V16, P521, DOI 10.1128/CVI.00391-08; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; STOP TB, 2006, WHOHTMTB2006371; Stop TB Partnership Childhood TB Subgroup World Health Organization, 2006, Int J Tuberc Lung Dis, V10, P1091; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; *WHO, 2009, GLOB TUB CONTR EP ST, P161; *WHO GLOB TUB PROG, WHOTB98258 GLOB TUB	18	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8341	10.1371/journal.pone.0008341	http://dx.doi.org/10.1371/journal.pone.0008341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020056	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834200008
J	Demina, GR; Makarov, VA; Nikitushkin, VD; Ryabova, OB; Vostroknutova, GN; Salina, EG; Shleeva, MO; Goncharenko, AV; Kaprelyants, AS				Demina, Galina R.; Makarov, Vadim A.; Nikitushkin, Vadim D.; Ryabova, Olga B.; Vostroknutova, Galina N.; Salina, Elena G.; Shleeva, Margarita O.; Goncharenko, Anna V.; Kaprelyants, Arseny S.			Finding of the Low Molecular Weight Inhibitors of Resuscitation Promoting Factor Enzymatic and Resuscitation Activity	PLOS ONE			English	Article							NON-CULTURABLE CELLS; MYCOBACTERIUM-TUBERCULOSIS; STATIONARY-PHASE; IN-VITRO; GROWTH; RPF; FAMILY; DOMAIN; REACTIVATION; PROTEINS	Background: Resuscitation promoting factors (RPF) are secreted proteins involved in reactivation of dormant actinobacteria, including Mycobacterium tuberculosis. They have been considered as prospective targets for the development of new antituberculosis drugs preventing reactivation of dormant tubercle bacilli, generally associated with latent tuberculosis. However, no inhibitors of Rpf activity have been reported so far. The goal of this study was to find low molecular weight compounds inhibiting the enzymatic and biological activities of Rpfs. Methodology/Principal Findings: Here we describe a novel class of 2-nitrophenylthiocyanates (NPT) compounds that inhibit muralytic activity of Rpfs with IC(50) 1-7 mu g/ml. Fluorescence studies revealed interaction of active NPTs with the internal regions of the Rpf molecule. Candidate inhibitors of Rpf enzymatic activity showed a bacteriostatic effect on growth of Micrococcus luteus (in which Rpf is essential for growth protein) at concentrations close to IC50. The candidate compounds suppressed resuscitation of dormant ("non-culturable'') cells of M. smegmatis at 1 mu g/ml or delayed resuscitation of dormant M. tuberculosis obtained in laboratory conditions at 10 mg/ml. However, they did not inhibit growth of active mycobacteria under these concentrations. Conclusions/Significance: NPT are the first example of low molecular weight compounds that inhibit the enzymatic and biological activities of Rpf proteins.	[Demina, Galina R.; Makarov, Vadim A.; Nikitushkin, Vadim D.; Ryabova, Olga B.; Vostroknutova, Galina N.; Salina, Elena G.; Shleeva, Margarita O.; Goncharenko, Anna V.; Kaprelyants, Arseny S.] RAS, AN Bach Inst Biochem, Moscow 117901, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Demina, GR (corresponding author), RAS, AN Bach Inst Biochem, Moscow 117901, Russia.	arseny@inbi.ras.ru	Makarov, Vadim/HGB-7756-2022; Makarov, Vadim/AAE-5483-2021; Nikitushkin, Vadim D./N-6426-2016; Shleeva, Margarita/ADL-9159-2022; Riabova, Olga/K-6030-2015	Makarov, Vadim/0000-0001-8746-2694; Makarov, Vadim/0000-0001-8746-2694; Riabova, Olga/0000-0002-3794-6495	Molecular and Cellular Biology; Russian Academy of Sciences; EU	Molecular and Cellular Biology; Russian Academy of Sciences(Russian Academy of Sciences); EU(European Commission)	This study has received funding from the Programme Molecular and Cellular Biology, Russian Academy of Sciences and "New Medicine for TB'' EU project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrih A, 1999, ANTON LEEUW INT J G, V75, P299, DOI 10.1023/A:1001800507443; Biketov S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-146; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; Cohen-Gonsaud M, 2004, TRENDS BIOCHEM SCI, V29, P7, DOI 10.1016/j.tibs.2003.10.009; Connell ND, 1995, METHOD CELL BIOL, V45, P107, DOI DOI 10.1016/S0091-679X(08)61848-8; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Finan C.L., 2003, THESIS U WALES ABERY; HURST DT, 1995, J HETEROCYCLIC CHEM, V32, P697, DOI 10.1002/jhet.5570320254; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, DOI DOI 10.1007/978-0-387-46312-4; Makarov V, 2006, J ANTIMICROB CHEMOTH, V57, P1134, DOI 10.1093/jac/dkl095; Man J. C. de, 1975, European Journal of Applied Microbiology, V1, P67; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Mukamolova G, 2008, INFECT DIS-SER, P83, DOI 10.1007/978-1-59745-569-5_10; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; QAZI SS, 2008, ARCH MICROBIOL, V189, P6; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; Ruggiero A, 2007, ACTA CRYSTALLOGR F, V63, P870, DOI 10.1107/S1744309107043217; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Russell-Goldman E, 2008, INFECT IMMUN, V76, P4269, DOI 10.1128/IAI.01735-07; Salina E G, 2006, Mikrobiologiia, V75, P502; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; SUMMERS LA, 1965, AUST J CHEM, V18, P1695, DOI 10.1071/CH9651695; Telkov MV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P414, DOI 10.1134/S0006297906040092; TEMPLIN MF, 1992, J BIOL CHEM, V267, P20039; WALLIS RS, 1994, J LEUKOCYTE BIOL, V55, P676, DOI 10.1002/jlb.55.5.676; Zhu WM, 2003, TUBERCULOSIS, V83, P261, DOI 10.1016/S1472-9792(03)00052-0	33	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8174	10.1371/journal.pone.0008174	http://dx.doi.org/10.1371/journal.pone.0008174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016836	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834000003
J	Jawaid, S; Seidle, H; Zhou, WD; Abdirahman, H; Abadeer, M; Hix, JH; van Hoek, ML; Couch, RD				Jawaid, Safdar; Seidle, Heather; Zhou, Weidong; Abdirahman, Hafsa; Abadeer, Maher; Hix, Joseph H.; van Hoek, Monique L.; Couch, Robin D.			Kinetic Characterization and Phosphoregulation of the Francisella tularensis 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (MEP Synthase)	PLOS ONE			English	Article							2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE PATHWAY; MEVALONATE-INDEPENDENT PATHWAY; HIGHER-PLANT CHLOROPLASTS; SYNECHOCYSTIS SP PCC6803; ISOPRENOID BIOSYNTHESIS; ESCHERICHIA-COLI; NONMEVALONATE PATHWAY; TERPENOID BIOSYNTHESIS; 4-(CYTIDINE 5'-DIPHOSPHO)-2-C-METHYL-D-ERYTHRITOL; MYCOBACTERIUM-TUBERCULOSIS	Deliberate and natural outbreaks of infectious disease underscore the necessity of effective vaccines and antimicrobial/antiviral therapeutics. The prevalence of antibiotic resistant strains and the ease by which antibiotic resistant bacteria can be intentionally engineered further highlights the need for continued development of novel antibiotics against new bacterial targets. Isoprenes are a class of molecules fundamentally involved in a variety of crucial biological functions. Mammalian cells utilize the mevalonic acid pathway for isoprene biosynthesis, whereas many bacteria utilize the methylerythritol phosphate (MEP) pathway, making the latter an attractive target for antibiotic development. In this report we describe the cloning and characterization of Francisella tularensis MEP synthase, a MEP pathway enzyme and potential target for antibiotic development. In vitro growth-inhibition assays using fosmidomycin, an inhibitor of MEP synthase, illustrates the effectiveness of MEP pathway inhibition with F. tularensis. To facilitate drug development, F. tularensis MEP synthase was cloned, expressed, purified, and characterized. Enzyme assays produced apparent kinetic constants (K(M)(DXP) = 104 mu M, K(M)(NADPH) = 13 mu M, k(cat)(DXP) = 2 s(-1), k(cat)(NADPH) = 1.3 s(-1)), an IC(50) for fosmidomycin of 247 nM, and a K(i) for fosmidomycin of 99 nM. The enzyme exhibits a preference for Mg(+2) as a divalent cation. Titanium dioxide chromatography-tandem mass spectrometry identified Ser177 as a site of phosphorylation. S177D and S177E site-directed mutants are inactive, suggesting a mechanism for post-translational control of metabolic flux through the F. tularensis MEP pathway. Overall, our study suggests that MEP synthase is an excellent target for the development of novel antibiotics against F. tularensis.	[Jawaid, Safdar; Seidle, Heather; Abdirahman, Hafsa; Abadeer, Maher; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA; [Zhou, Weidong; Hix, Joseph H.; van Hoek, Monique L.] George Mason Univ, Dept Mol & Microbiol, Manassas, VA USA; [Jawaid, Safdar; Seidle, Heather; Abdirahman, Hafsa; Abadeer, Maher; Hix, Joseph H.; van Hoek, Monique L.; Couch, Robin D.] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA; [Zhou, Weidong] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA	George Mason University; George Mason University; George Mason University; George Mason University	Jawaid, S (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA USA.	rcouch@gmu.edu	JAWAID, SAFDAR/C-1444-2013; van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899; Abadeer, Maher/0000-0001-5479-8255	George Mason University	George Mason University	This work was supported by startup funds provided by George Mason University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; AGRANOFF BW, 1959, J AM CHEM SOC, V81, P1254, DOI 10.1021/ja01514a059; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; AMDUR BH, 1957, J AM CHEM SOC, V79, P2647; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Campisi S, 2001, POPTRONICS, V2, P4; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Henriksson LM, 2006, ACTA CRYSTALLOGR D, V62, P807, DOI 10.1107/S0907444906019196; Herzberg G, 2000, Tech Hand Up Extrem Surg, V4, P2, DOI 10.1097/00130911-200003000-00002; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; HILL RE, 1989, J AM CHEM SOC, V117, P1661; JORDAN PM, 1983, BIOCHEM J, V213, P153, DOI 10.1042/bj2130153; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; JULLIARD JH, 1992, CR ACAD SCI III-VIE, V314, P285; Kollas AK, 2002, FEBS LETT, V532, P432, DOI 10.1016/S0014-5793(02)03725-0; Koppisch AT, 2002, BIOCHEMISTRY-US, V41, P236, DOI 10.1021/bi0118207; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P2925, DOI 10.1016/S0040-4039(00)00295-1; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P703, DOI 10.1016/S0040-4039(99)02143-7; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; McAteer S, 2001, J BACTERIOL, V183, P7403, DOI 10.1128/JB.183.24.7403-7407.2001; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; Ortmann R, 2007, ARCH PHARM, V340, P483, DOI 10.1002/ardp.200700149; Putra SR, 1998, TETRAHEDRON LETT, V39, P23, DOI 10.1016/S0040-4039(97)10458-0; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 2008, LIPIDS, V43, P1095, DOI 10.1007/s11745-008-3261-7; Singh P, 2007, INT J GREENH GAS CON, V1, P5, DOI 10.1016/S1750-5836(07)00015-1; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Walker JR, 2005, J ORG CHEM, V70, P9955, DOI 10.1021/jo0516786; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Woo YH, 2006, BIOORGAN MED CHEM, V14, P2375, DOI 10.1016/j.bmc.2005.11.012; Yajima S, 2004, J AM CHEM SOC, V126, P10824, DOI 10.1021/ja040126m; Yin XH, 2003, BBA-PROTEINS PROTEOM, V1652, P75, DOI 10.1016/j.bbapap.2003.08.005; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	24	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8288	10.1371/journal.pone.0008288	http://dx.doi.org/10.1371/journal.pone.0008288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011597	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300039
J	Jung, B; Gomez, J; Chau, E; Cabral, J; Lee, JK; Anselm, A; Slowik, P; Ream-Robinson, D; Messer, K; Sporn, J; Shin, SK; Boland, CR; Goel, A; Carethers, JM				Jung, Barbara; Gomez, Jessica; Chau, Eddy; Cabral, Jennifer; Lee, Jeffrey K.; Anselm, Aimee; Slowik, Przemyslaw; Ream-Robinson, Deena; Messer, Karen; Sporn, Judith; Shin, Sung K.; Boland, C. Richard; Goel, Ajay; Carethers, John M.			Activin Signaling in Microsatellite Stable Colon Cancers Is Disrupted by a Combination of Genetic and Epigenetic Mechanisms	PLOS ONE			English	Article							FACTOR-BETA RECEPTOR; DPC4 GENE; GROWTH; PROTEIN; INACTIVATION; MUTATION; CELLS; TRANSFORMATION; RESTORATION; METHYLATION	Background: Activin receptor 2 (ACVR2) is commonly mutated in microsatellite unstable (MSI) colon cancers, leading to protein loss, signaling disruption, and larger tumors. Here, we examined activin signaling disruption in microsatellite stable (MSS) colon cancers. Methods: Fifty-one population-based MSS colon cancers were assessed for ACVR1, ACVR2 and pSMAD2 protein. Consensus mutation-prone portions of ACVR2 were sequenced in primary cancers and all exons in colon cancer cell lines. Loss of heterozygosity (LOH) was evaluated for ACVR2 and ACVR1, and ACVR2 promoter methylation by methylation-specific PCR and bisulfite sequencing and chromosomal instability (CIN) phenotype via fluorescent LOH analysis of 3 duplicate markers. ACVR2 promoter methylation and ACVR2 expression were assessed in colon cancer cell lines via qPCR and IP-Western blots. Re-expression of ACVR2 after demethylation with 5-aza-29-deoxycytidine (5-Aza) was determined. An additional 26 MSS colon cancers were assessed for ACVR2 loss and its mechanism, and ACVR2 loss in all tested cancers correlated with clinicopathological criteria. Results: Of 51 MSS colon tumors, 7(14%) lost ACVR2, 2 (4%) ACVR1, and 5(10%) pSMAD2 expression. No somatic ACVR2 mutations were detected. Loss of ACVR2 expression was associated with LOH at ACVR2 (p<0.001) and ACVR2 promoter hypermethylation (p<0.05). ACVR2 LOH, but not promoter hypermethylation, correlated with CIN status. In colon cancer cell lines with fully methylated ACVR2 promoter, loss of ACVR2 mRNA and protein expression was restored with 5-Aza treatment. Loss of ACVR2 was associated with an increase in primary colon cancer volume (p<0.05). Conclusions: Only a small percentage of MSS colon cancers lose expression of activin signaling members. ACVR2 loss occurs through LOH and ACVR2 promoter hypermethylation, revealing distinct mechanisms for ACVR2 inactivation in both MSI and MSS subtypes of colon cancer.	[Jung, Barbara; Chau, Eddy; Cabral, Jennifer; Lee, Jeffrey K.; Anselm, Aimee; Slowik, Przemyslaw; Ream-Robinson, Deena; Sporn, Judith; Carethers, John M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jung, Barbara; Gomez, Jessica; Messer, Karen; Carethers, John M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Jung, Barbara; Carethers, John M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Shin, Sung K.; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Dept Med, Dallas, TX USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Baylor University; Baylor University Medical Center	Jung, B (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	bjung@ucsd.edu		Goel, Ajay/0000-0003-1396-6341; Shin, Sung Kwan/0000-0001-5466-1400	UCSD Academic Senate; U.S. Public Health Service [DK074019, DK067287]; VA Research Service; American Cancer Society Institutional Research [70-002]; UCSD Digestive Diseases Research Development Center [DK080506]; NCI Cancer Center [2 P30 CA023100-23]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA072851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287, R24DK080506, K08DK074019] Funding Source: NIH RePORTER	UCSD Academic Senate; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); VA Research Service(US Department of Veterans Affairs); American Cancer Society Institutional Research(American Cancer Society); UCSD Digestive Diseases Research Development Center; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the UCSD Academic Senate to B. J., the U.S. Public Health Service DK074019 to B. J.; DK067287, the VA Research Service, and the American Cancer Society Institutional Research Grant # 70-002 to J. M. C., and the UCSD Digestive Diseases Research Development Center (DK080506). DNA sequencing was performed by the DNA Sequencing Shared Resource, UCSD Cancer Center, which is funded in part by NCI Cancer Center Support Grant # 2 P30 CA023100-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Carethers JM, 1998, GASTROENTEROLOGY, V114, P1188, DOI 10.1016/S0016-5085(98)70424-X; CARETHERS JM, 2003, GASTROINTESTINAL CAN, P407; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Deacu E, 2004, CANCER RES, V64, P7690, DOI 10.1158/0008-5472.CAN-04-2082; Deng GR, 1999, CANCER RES, V59, P2029; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Gong JG, 2003, CANCER RES, V63, P3340; Grady WM, 1998, CANCER RES, V58, P3101; Grady WM, 1999, CANCER RES, V59, P320; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hempen PM, 2003, CANCER RES, V63, P994; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; Lee YJ, 2006, GENESIS, V44, P487, DOI 10.1002/dvg.20238; Mori Y, 2001, CANCER RES, V61, P6046; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Olaru A, 2003, LAB INVEST, V83, P1867, DOI 10.1097/01.LAB.0000106723.75567.72; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Schutte M, 1996, CANCER RES, V56, P2527; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Takagi Y, 1996, GASTROENTEROLOGY, V111, P1369, DOI 10.1053/gast.1996.v111.pm8898652	25	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8308	10.1371/journal.pone.0008308	http://dx.doi.org/10.1371/journal.pone.0008308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011542	Green Submitted, Green Published, gold			2022-12-27	WOS:000272830300053
J	Ould-yahoui, A; Tremblay, E; Sbai, O; Ferhat, L; Bernard, A; Charrat, E; Gueye, Y; Lim, NH; Brew, K; Risso, JJ; Dive, V; Khrestchatisky, M; Rivera, S				Ould-yahoui, Adlane; Tremblay, Evelyne; Sbai, Oualid; Ferhat, Lotfi; Bernard, Anne; Charrat, Eliane; Gueye, Yatma; Lim, Ngee Han; Brew, Keith; Risso, Jean-Jacques; Dive, Vincent; Khrestchatisky, Michel; Rivera, Santiago			A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; HIPPOCAMPAL-NEURONS; ACTIN CYTOSKELETON; TERMINAL DOMAIN; DEFICIENT MICE; AXONAL GROWTH; MESSENGER-RNA; GELATINASE-B	Background: Tissue inhibitor of metalloproteinases-1 (TIMP-1) displays pleiotropic activities, both dependent and independent of its inhibitory activity on matrix metalloproteinases (MMPs). In the central nervous system (CNS), TIMP-1 is strongly upregulated in reactive astrocytes and cortical neurons following excitotoxic/inflammatory stimuli, but no information exists on its effects on growth and morphology of cortical neurons. Principal Findings: We found that 24 h incubation with recombinant TIMP-1 induced a 35% reduction in neurite length and significantly increased growth cones size and the number of F-actin rich microprocesses. TIMP-1 mediated reduction in neurite length affected both dendrites and axons after 48 h treatment. The effects on neurite length and morphology were not elicited by a mutated form of TIMP-1 inactive against MMP-1, -2 and -3, and still inhibitory for MMP-9, but were mimicked by a broad spectrum MMP inhibitor. MMP-9 was poorly expressed in developing cortical neurons, unlike MMP-2 which was present in growth cones and whose selective inhibition caused neurite length reductions similar to those induced by TIMP-1. Moreover, TIMP-1 mediated changes in cytoskeleton reorganisation were not accompanied by modifications in the expression levels of actin, beta III-tubulin, or microtubule assembly regulatory protein MAP2c. Transfection-mediated overexpression of TIMP-1 dramatically reduced neuritic arbour extension in the absence of detectable levels of released extracellular TIMP-1. Conclusions: Altogether, TIMP-1 emerges as a modulator of neuronal outgrowth and morphology in a paracrine and autrocrine manner through the inhibition, at least in part, of MMP-2 and not MMP-9. These findings may help us understand the role of the MMP/TIMP system in post-lesion pre-scarring conditions.	[Ould-yahoui, Adlane; Tremblay, Evelyne; Sbai, Oualid; Ferhat, Lotfi; Bernard, Anne; Charrat, Eliane; Gueye, Yatma; Khrestchatisky, Michel; Rivera, Santiago] Univ Mediterranee, CNRS, UMR 6184, NICN, Marseille, France; [Lim, Ngee Han] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London, England; [Brew, Keith] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL USA; [Risso, Jean-Jacques] Univ Mediterranee, IMNSSA, UMR PPCOE MD2, Dept Rech Marine & Subaquat, Toulon Armees, France; [Dive, Vincent] CEA, DIEP, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; University of Oxford; State University System of Florida; Florida Atlantic University; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ould-yahoui, A (corresponding author), Univ Mediterranee, CNRS, UMR 6184, NICN, Marseille, France.	santiago.rivera@univmed.fr	Ferhat, Lotfi/D-8207-2017; Lim, Ngee Han/B-4226-2011; Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019; ferhat, lotfi/S-3017-2019	Brew, Keith/0000-0003-1306-1032; ferhat, lotfi/0000-0003-2763-9472; Lim, Ngee Han/0000-0002-8520-7857	CNRS; Universite de la Mediterranee; Letten Foundation; Institut de Recherche sur la Moelle Epiniere (IRME); Association Francaise contre les Myopathies (AFM); Direction Generale de l'Armement (DGA); French Ministry of Research; Association Bir el Bey (Tunisia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; Letten Foundation; Institut de Recherche sur la Moelle Epiniere (IRME); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Direction Generale de l'Armement (DGA)(General Electric); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Bir el Bey (Tunisia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding to the UMR 6184 laboratory from the CNRS and the Universite de la Mediterranee, and by grants to MK and SR from the Letten Foundation, from the Institut de Recherche sur la Moelle Epiniere (IRME), from the Association Francaise contre les Myopathies (AFM) and from the Direction Generale de l'Armement (DGA). AO-Y is recipient of a doctoral fellowship from the French Ministry of Research and the AFM. OS is recipient of a doctoral fellowship from the Association Bir el Bey (Tunisia) and from the AFM. YG is recipient of a fellowship from the Letten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Bugno M, 1999, FEBS LETT, V448, P9, DOI 10.1016/S0014-5793(99)00323-3; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chaillan FA, 2006, BEHAV BRAIN RES, V173, P191, DOI 10.1016/j.bbr.2006.06.020; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Cursio R, 2001, FASEB J, V15, P93, DOI 10.1096/fj.01-0279fje; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Dive V, 2005, INT J CANCER, V113, P775, DOI 10.1002/ijc.20459; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Gonthier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005099; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Jourquin J, 2005, EUR J NEUROSCI, V22, P2569, DOI 10.1111/j.1460-9568.2005.04426.x; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676; Khuth ST, 2001, J VIROL, V75, P8268, DOI 10.1128/JVI.75.17.8268-8282.2001; Lorenzl S, 2003, J NEUROL SCI, V207, P71, DOI 10.1016/S0022-510X(02)00398-2; McFarlane S, 2003, NEURON, V37, P559, DOI 10.1016/S0896-6273(03)00089-8; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Oliver GW, 1997, ANAL BIOCHEM, V244, P161, DOI 10.1006/abio.1996.9895; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; RIVERA OC, 2002, EUR J NEUROSCI; Rivera S, 1997, J NEUROSCI, V17, P4223; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; RIVERA S, 1999, ADV SYNAPTIC PLASTIC, P53; SBAI O, IN PRESS; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Vaillant C, 1999, J NEUROSCI, V19, P4994; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	48	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8289	10.1371/journal.pone.0008289	http://dx.doi.org/10.1371/journal.pone.0008289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011518	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300040
J	Khanim, FL; Hayden, RE; Birtwistle, J; Lodi, A; Tiziani, S; Davies, NJ; Ride, JP; Viant, MR; Gunther, UL; Mountford, JC; Schrewe, H; Green, RM; Murray, JA; Drayson, MT; Bunce, CM				Khanim, Farhat L.; Hayden, Rachel E.; Birtwistle, Jane; Lodi, Alessia; Tiziani, Stefano; Davies, Nicholas J.; Ride, Jon P.; Viant, Mark R.; Gunther, Ulrich L.; Mountford, Joanne C.; Schrewe, Heinrich; Green, Richard M.; Murray, Jim A.; Drayson, Mark T.; Bunce, Chris M.			Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INHIBITS CELL-GROWTH; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDIN; OLDER PATIENTS; MYELODYSPLASTIC-SYNDROME; PROMYELOCYTIC LEUKEMIA; OXIDATIVE STRESS; INDUCE APOPTOSIS; DOWN-REGULATION	Background: The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also those younger patients who relapse, remain dismal and novel therapies are urgently required. In particular, therapies that have anti-leukaemic activity but that, unlike conventional chemotherapy, do not impair normal haemopoiesis. Principal Findings: Here we demonstrate the potent anti-leukaemic activity of the combination of the lipid-regulating drug bezafibrate (BEZ) and the sex hormone medroxyprogesterone acetate (MPA) against AML cell lines and primary AML cells. The combined activity of BEZ and MPA (B/M) converged upon the increased synthesis and reduced metabolism of prostaglandin D-2 (PGD(2)) resulting in elevated levels of the downstream highly bioactive, anti-neoplastic prostaglandin 15-deoxy Delta(12,14) PGJ(2) (15d-PGJ(2)). BEZ increased PGD(2) synthesis via the generation of reactive oxygen species (ROS) and activation of the lipid peroxidation pathway. MPA directed prostaglandin synthesis towards 15d-PGJ(2) by inhibiting the PGD(2) 11 beta-ketoreductase activity of the aldo-keto reductase AKR1C3, which metabolises PGD(2) to 9 alpha 11 beta-PGF(2 alpha). B/M treatment resulted in growth arrest, apoptosis and cell differentiation in both AML cell lines and primary AML cells and these actions were recapitulated by treatment with 15d-PGJ(2). Importantly, the actions of B/M had little effect on the survival of normal adult myeloid progenitors. Significance: Collectively our data demonstrate that B/M treatment of AML cells elevated ROS and delivered the antineoplastic actions of 15d-PGJ(2). These observations provide the mechanistic rationale for the redeployment of B/M in elderly and relapsed AML.	[Khanim, Farhat L.; Hayden, Rachel E.; Birtwistle, Jane; Davies, Nicholas J.; Ride, Jon P.; Viant, Mark R.; Green, Richard M.; Bunce, Chris M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lodi, Alessia; Tiziani, Stefano; Gunther, Ulrich L.] Univ Birmingham, Henry Wellcome Bldg Biomol NMR Spect, CRUK Inst Canc Studies, Birmingham, W Midlands, England; [Mountford, Joanne C.] Univ Glasgow, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland; [Schrewe, Heinrich] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Schrewe, Heinrich] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Murray, Jim A.] Queen Elizabeth Hosp, Ctr Clin Haematol, Birmingham B15 2TH, W Midlands, England; [Drayson, Mark T.] Univ Birmingham, Div Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Glasgow; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Birmingham; University of Birmingham	Khanim, FL (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	C.M.Bunce@bham.ac.uk	Viant, Mark R/B-6339-2009; mountford, joanne c/H-1010-2012	Viant, Mark R/0000-0001-5898-4119; mountford, joanne c/0000-0003-2142-6572; Bunce, Chris/0000-0003-4084-8973; Drayson, Mark/0000-0002-1528-7564	Leukaemia Research UK; Marie Curie Transfer of Knowledge (ToK) (MOTET)	Leukaemia Research UK; Marie Curie Transfer of Knowledge (ToK) (MOTET)(European Commission)	Funding was recieved from Leukaemia Research UK and Marie Curie Transfer of Knowledge (ToK) (MOTET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Birtwistle L, 2009, MUTAT RES-FUND MOL M, V662, P67, DOI 10.1016/j.mrfmmm.2008.12.010; Breitkreutz I, 2008, EXPERT OPIN DRUG MET, V4, P973, DOI [10.1517/17425255.4.7.973, 10.1517/17425255.4.7.973 ]; Brunoldi EA, 2007, CHEM RES TOXICOL, V20, P1528, DOI 10.1021/tx700231a; Bunce CM, 1996, BBA-MOL CELL RES, V1311, P189, DOI 10.1016/0167-4889(96)00005-5; Burnett AK, 2006, SEMIN HEMATOL, V43, P96, DOI 10.1053/j.seminhematol.2006.01.003; Burnett AK, 2009, BRIT J HAEMATOL, V145, P318, DOI 10.1111/j.1365-2141.2009.07604.x; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cox B, 2002, BBA-MOL CELL BIOL L, V1584, P37, DOI 10.1016/S1388-1981(02)00267-6; Craig CM, 2008, BLOOD REV, V22, P221, DOI 10.1016/j.blre.2008.03.002; Date M, 2003, LIVER INT, V23, P460, DOI 10.1111/j.1478-3231.2003.00877.x; Deschler B, 2006, HAEMATOLOGICA, V91, P1513; Desmond JC, 2003, CANCER RES, V63, P505; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Estey E, 2007, J CLIN ONCOL, V25, P1908, DOI 10.1200/JCO.2006.10.2731; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Fenton SL, 1999, BRIT J HAEMATOL, V105, P448, DOI 10.1111/j.1365-2141.1999.01355.x; Fenton SL, 2003, LEUKEMIA, V17, P568, DOI 10.1038/sj.leu.2402843; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; GILES H, 1988, PROSTAGLANDINS, V35, P277, DOI 10.1016/0090-6980(88)90093-7; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Grant S, 2008, BEST PRACT RES CL HA, V21, P629, DOI 10.1016/j.beha.2008.08.003; Hasegawa H, 2007, BLOOD, V110, P1664, DOI 10.1182/blood-2007-01-068981; Hayashi N, 2004, INT J ONCOL, V24, P89; Hayden RE, 2009, LEUKEMIA, V23, P292, DOI 10.1038/leu.2008.283; Hodges NJ, 2007, MUTAGENESIS, V22, P189, DOI 10.1093/mutage/gem001; KALANTARI P, 2009, FASEB J; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1933, DOI 10.1002/cncr.23655; Kim HS, 1996, PROSTAGLANDINS, V51, P413, DOI 10.1016/0090-6980(96)00047-0; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kohrt Holbrook E, 2008, J Natl Compr Canc Netw, V6, P1003; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kuendgen A, 2007, CANCER-AM CANCER SOC, V110, P943, DOI 10.1002/cncr.22891; Landar A, 2006, BIOCHEM J, V394, P185, DOI 10.1042/BJ20051259; Lin MS, 2007, J DIGEST DIS, V8, P82, DOI 10.1111/j.1443-9573.2007.00290.x; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mills KI, 1998, FEBS LETT, V440, P158, DOI 10.1016/S0014-5793(98)01435-5; Milne GL, 2005, ANTIOXID REDOX SIGN, V7, P210, DOI 10.1089/ars.2005.7.210; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Moriai M, 2009, INT J ONCOL, V34, P1363, DOI 10.3892/ijo_00000263; Morosetti R, 2004, INT J ONCOL, V25, P493; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Nikitakis NG, 2002, BRIT J CANCER, V87, P1396, DOI 10.1038/sj.bjc.6600618; NILSSON A, 1995, EUR J CELL BIOL, V67, P379; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Paumi CM, 2003, BIOCHEMISTRY-US, V42, P5429, DOI 10.1021/bi027347u; PENNING TM, 1985, J BIOL CHEM, V260, P5266; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez-Gomez FJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P150, DOI 10.1016/j.abb.2006.10.032; Scatena R, 2004, BIOCHEM BIOPH RES CO, V319, P967, DOI 10.1016/j.bbrc.2004.05.072; Scatena R, 2003, CHEM RES TOXICOL, V16, P1440, DOI 10.1021/tx0341052; Scatena R, 1999, CELL DEATH DIFFER, V6, P781, DOI 10.1038/sj.cdd.4400551; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Tallman MS, 2008, SEMIN HEMATOL, V45, pS25, DOI 10.1053/j.seminhematol.2008.07.008; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tallman MS, 2004, SEMIN HEMATOL, V41, P27, DOI 10.1053/j.seminhematol.2004.02.004; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251	69	53	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8147	10.1371/journal.pone.0008147	http://dx.doi.org/10.1371/journal.pone.0008147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997560	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000272829500009
J	Cogen, AL; Yamasaki, K; Muto, J; Sanchez, KM; Alexander, LC; Tanios, J; Lai, YP; Kim, JE; Nizet, V; Gallo, RL				Cogen, Anna L.; Yamasaki, Kenshi; Muto, Jun; Sanchez, Katheryn M.; Alexander, Laura Crotty; Tanios, Jackelyn; Lai, Yuping; Kim, Judy E.; Nizet, Victor; Gallo, Richard L.			Staphylococcus epidermidis Antimicrobial delta-Toxin (Phenol-Soluble Modulin-gamma) Cooperates with Host Antimicrobial Peptides to Kill Group A Streptococcus	PLOS ONE			English	Article							INVASIVE BACTERIAL-INFECTION; HUMAN SKIN; NEUTROPHILS; PROTECTS; ANALOGS; AUREUS; LL-37	Antimicrobial peptides play an important role in host defense against pathogens. Recently, phenol-soluble modulins (PSMs) from Staphylococcus epidermidis (S. epidermidis) were shown to interact with lipid membranes, form complexes, and exert antimicrobial activity. Based on the abundance and innocuity of the cutaneous resident S. epidermidis, we hypothesized that their PSMs contribute to host defense. Here we show that S. epidermidis delta-toxin (PSM gamma) is normally present in the epidermis and sparsely in the dermis of human skin using immunohistochemistry. Synthetic delta-toxin interacted with neutrophil extracellular traps (NETs) and colocalized with cathelicidin while also inducing NET formation in human neutrophils. In antimicrobial assays against Group A Streptococcus (GAS), delta-toxin cooperated with CRAMP, hBD2, and hBD3. In whole blood, addition of delta-toxin exerted a bacteriostatic effect on GAS, and in NETs, delta-toxin increased their killing capacity against this pathogen. Coimmunoprecipitation and tryptophan spectroscopy demonstrated direct binding of delta-toxin to host antimicrobial peptides LL-37, CRAMP, hBD2, and hBD3. Finally, in a mouse wound model, GAS survival was reduced (along with Mip-2 cytokine levels) when the wounds were pretreated with delta-toxin. Thus, these data suggest that S. epidermidis-derived delta-toxin cooperates with the host-derived antimicrobial peptides in the innate immune system to reduce survival of an important human bacterial pathogen.	[Cogen, Anna L.; Yamasaki, Kenshi; Muto, Jun; Tanios, Jackelyn; Lai, Yuping; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Cogen, Anna L.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Sanchez, Katheryn M.; Kim, Judy E.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Alexander, Laura Crotty; Nizet, Victor; Gallo, Richard L.] Univ Calif San Diego, Dept Pediat, Sch Med, San Diego, CA 92103 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cogen, AL (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Yamasaki, Kenshi/C-8905-2018; Alexander, Laura Crotty/AIC-1001-2022; Nizet, Victor/AAF-3190-2019; Gallo, Richard L/A-8931-2009	Yamasaki, Kenshi/0000-0002-5495-4956; Alexander, Laura Crotty/0000-0002-5091-2660; Gallo, Richard L/0000-0002-1401-7861; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [P01HL057345, R56AI083358, R01AR45676]; VA Merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083358, R56AI083358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067547, R01AR045676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants P01HL057345, R56AI083358, and R01AR45676, and a VA Merit award (RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2006, INFECT IMMUN, V74, P6982, DOI 10.1128/IAI.01043-06; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; CORGEN AL, 2009, J INVEST DERMATOL; Dhople VM, 2005, PEPTIDES, V26, P217, DOI 10.1016/j.peptides.2004.09.013; DHOPLE VM, 1993, BIOSCIENCE REP, V13, P245, DOI 10.1007/BF01123506; DHOPLE VM, 1995, PROTEIN ENG, V8, P315, DOI 10.1093/protein/8.3.315; Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7; Ermert David, 2009, V470, P293, DOI 10.1007/978-1-59745-204-5_21; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Liles WC, 2001, J LEUKOCYTE BIOL, V70, P96; Luders T, 2003, APPL ENVIRON MICROB, V69, P1797, DOI 10.1128/AEM.69.3.1797-1799.2003; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001	26	140	146	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8557	10.1371/journal.pone.0008557	http://dx.doi.org/10.1371/journal.pone.0008557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052280	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000273338500006
J	Ishimaru, N; Nitta, T; Arakaki, R; Yamada, A; Lipp, M; Takahama, Y; Hayashi, Y				Ishimaru, Naozumi; Nitta, Takeshi; Arakaki, Rieko; Yamada, Akiko; Lipp, Martin; Takahama, Yousuke; Hayashi, Yoshio			In Situ Patrolling of Regulatory T Cells Is Essential for Protecting Autoimmune Exocrinopathy	PLOS ONE			English	Article							LYMPHOCYTE EGRESS; TREG; RECEPTORS; DISEASE; FOXP3; CCR7; INHIBITION; EXPRESSION; RETENTION; MIGRATION	Background: Migration of T cells, including regulatory T (Treg) cells, into the secondary lymph organs is critically controlled by chemokines and adhesion molecules. However, the mechanisms by which Treg cells regulate organ-specific autoimmunity via these molecules remain unclear. Although we previously reported autoimmune exocrinopathy resembling Sjogren's syndrome (SS) in the lacrimal and salivary glands from C-C chemokine receptor 7 (CCR7)-deficient mice, it is still unclear whether CCR7 signaling might specifically affect the dynamics and functions of Treg cells in vivo. We therefore investigated the cellular mechanism for suppressive function of Treg cells via CCR7 in autoimmunity using mouse models and human samples. Methods and Findings: Patrolling Treg cells were detected in the exocrine organs such as lacrimal and salivary glands from normal mice that tend to be targets for autoimmunity while the Treg cells were almost undetectable in the exocrine glands of CCR7(-/-) mice. In addition, we found the significantly increased retention of CD4(+)CD25(+)Foxp(3+) Treg cells in the lymph nodes of CCR7(-/-) mice with aging. Although Treg cell egress requires sphingosine 1-phosphate (S1P), chemotactic function to S1P of CCR7-/- Treg cells was impaired compared with that of WT Treg cells. Moreover, the in vivo suppression activity was remarkably diminished in CCR7(-/-)Treg cells in the model where Treg cells were co-transferred with CCR7(-/-) CD25(-)CD4(+) T cells into Rag2(-/-) mice. Finally, confocal analysis showed that CCR7(+)Treg cells were detectable in normal salivary glands while the number of CCR7(+)Treg cells was extremely decreased in the tissues from patients with Sjogren's syndrome. Conclusions: These results indicate that CCR7 essentially governs the patrolling functions of Treg cells by controlling the traffic to the exocrine organs for protecting autoimmunity. Characterization of this cellular mechanism could have clinical implications by supporting development of new diagnosis or treatments for the organ-specific autoimmune diseases such as Sjogren's syndrome and clarifying how the local immune system regulates autoimmunity.	[Ishimaru, Naozumi; Arakaki, Rieko; Yamada, Akiko; Hayashi, Yoshio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Nitta, Takeshi; Takahama, Yousuke] Univ Tokushima, Grad Sch, Inst Genome Res, Dept Expt Immunol, Tokushima 770, Japan; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, Berlin, Germany	Tokushima University; Tokushima University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ishimaru, N (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan.	hayashi@dent.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010; Lipp, Martin/G-2235-2010	Takahama, Yousuke/0000-0002-4992-9174; Lipp, Martin/0000-0002-0087-2672	Ministry of Education, Science, Sport, and Culture of Japan [17109016, 17689049]; Uehara Memorial Foundation; Takeda Science Foundation	Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant-in-Aid for Scientific Research (nos. 17109016 and 17689049) from the Ministry of Education, Science, Sport, and Culture of Japan, from the Uehara Memorial Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Ishimaru N, 2008, J IMMUNOL, V180, P6997, DOI 10.4049/jimmunol.180.10.6997; JIN Y, 2009, INVEST OPHTHALMOL VI; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li XM, 2007, J RHEUMATOL, V34, P2438; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; VANDRIEL IR, 2002, AUTOIMMUN REV, V5, P290; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177	49	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8588	10.1371/journal.pone.0008588	http://dx.doi.org/10.1371/journal.pone.0008588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052419	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500028
J	Palanisamy, V; Sharma, S; Deshpande, A; Zhou, H; Gimzewski, J; Wong, DT				Palanisamy, Viswanathan; Sharma, Shivani; Deshpande, Amit; Zhou, Hui; Gimzewski, James; Wong, David T.			Nanostructural and Transcriptomic Analyses of Human Saliva Derived Exosome	PLOS ONE			English	Article							MESSENGER-RNA; MULTIVESICULAR BODY; HORIZONTAL TRANSFER; CELL; PROTEINS; MICROVESICLES; VESICLES; IDENTIFICATION; ROLES; DIAGNOSTICS	Background: Exosomes, derived from endocytic membrane vesicles are thought to participate in cell-cell communication and protein and RNA delivery. They are ubiquitous in most body fluids (breast milk, saliva, blood, urine, malignant ascites, amniotic, bronchoalveolar lavage, and synovial fluids). In particular, exosomes secreted in human saliva contain proteins and nucleic acids that could be exploited for diagnostic purposes. To investigate this potential use, we isolated exosomes from human saliva and characterized their structural and transcriptome contents. Methodology: Exosomes were purified by differential ultracentrifugation and identified by immunoelectron microscopy (EM), flow cytometry, and Western blot with CD63 and Alix antibodies. We then described the morphology, shape, size distribution, and density using atomic force microscopy (AFM). Microarray analysis revealed that 509 mRNA core transcripts are relatively stable and present in the exosomes. Exosomal mRNA stability was determined by detergent lysis with RNase A treatment. In vitro, fluorescently labeled saliva exosomes could communicate with human keratinocytes, transferring their genetic information to human oral keratinocytes to alter gene expression at a new location. Conclusion: Our findings are consistent with the hypothesis that exosomes shuttle RNA between cells and that the RNAs present in the exosomes may be a possible resource for disease diagnostics.	[Palanisamy, Viswanathan] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Sharma, Shivani; Zhou, Hui; Gimzewski, James; Wong, David T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Sharma, Shivani; Zhou, Hui; Gimzewski, James; Wong, David T.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90024 USA; [Deshpande, Amit] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Deshpande, Amit] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA; [Gimzewski, James] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton Satellite MANA, Tsukuba, Ibaraki, Japan; [Wong, David T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Div Head & Neck Surg Otolaryngol, Sch Med, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Henry Samuel Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Medical University of South Carolina; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institute for Materials Science; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Palanisamy, V (corresponding author), Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA.	visu@musc.edu; dtww@ucla.edu		Palanisamy, Viswanathan/0000-0001-5128-2878; gimzewski, james/0000-0003-4333-6957	National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR) [R01DE017170, U01DE16275, P20RR017696, R00DE018165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017170, U01DE016275, R00DE018165] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	R01DE017170 and U01DE16275 from National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR) for David T. Wong, and P20RR017696 and R00DE018165 from NIH-NIDCR for Viswanathan Palanisamy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chavez-Munoz C, 2008, J CELL BIOCHEM, V104, P2165, DOI 10.1002/jcb.21774; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Delcayre A, 2005, BLOOD CELL MOL DIS, V35, P158, DOI 10.1016/j.bcmd.2005.07.003; Delporte C, 2006, BBA-BIOMEMBRANES, V1758, P1061, DOI 10.1016/j.bbamem.2006.01.022; Denzer K, 2000, J CELL SCI, V113, P3365; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; GONZALEZBEGNE M, 2009, J PROTEOME RES; Gruenberg Jean, 1993, Trends in Cell Biology, V3, P224, DOI 10.1016/0962-8924(93)90116-I; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; McManaman JL, 2006, J MAMMARY GLAND BIOL, V11, P249, DOI 10.1007/s10911-006-9031-3; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Prado N, 2008, J IMMUNOL, V181, P1519, DOI 10.4049/jimmunol.181.2.1519; Raab A, 1999, NAT BIOTECHNOL, V17, P902, DOI 10.1038/12898; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	49	224	233	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8577	10.1371/journal.pone.0008577	http://dx.doi.org/10.1371/journal.pone.0008577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052414	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338500020
J	McClendon, AK; Dean, JL; Ertel, A; Knudsen, ES				McClendon, A. Kathleen; Dean, Jeffry L.; Ertel, Adam; Knudsen, Erik S.			Differential Impact of Tumor Suppressor Pathways on DNA Damage Response and Therapy-Induced Transformation in a Mouse Primary Cell Model	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; LONG-TERM SURVIVORS; RETINOBLASTOMA SURVIVORS; P53-DEFICIENT MICE; PROSTATE-CANCER; BREAST-CANCER; CYCLE CONTROL; P53; RB; GENE	The RB and p53 tumor suppressors are mediators of DNA damage response, and compound inactivation of RB and p53 is a common occurrence in human cancers. Surprisingly, their cooperation in DNA damage signaling in relation to tumorigenesis and therapeutic response remains enigmatic. In the context of individuals with heritable retinoblastoma, there is a predilection for secondary tumor development, which has been associated with the use of radiation-therapy to treat the primary tumor. Furthermore, while germline mutations of the p53 gene are critical drivers for cancer predisposition syndromes, it is postulated that extrinsic stresses play a major role in promoting varying tumor spectrums and disease severities. In light of these studies, we examined the tumor suppressor functions of these proteins when challenged by exposure to therapeutic stress. To examine the cooperation of RB and p53 in tumorigenesis, and in response to therapy-induced DNA damage, a combination of genetic deletion and dominant negative strategies was employed. Results indicate that loss/inactivation of RB and p53 is not sufficient for cellular transformation. However, these proteins played distinct roles in response to therapy-induced DNA damage and subsequent tumorigenesis. Specifically, RB status was critical for cellular response to damage and senescence, irrespective of p53 function. Loss of RB resulted in a dramatic evolution of gene expression as a result of alterations in epigenetic programming. Critically, the observed changes in gene expression have been specifically associated with tumorigenesis, and RB-deficient, recurred cells displayed oncogenic characteristics, as well as increased resistance to subsequent challenge with discrete therapeutic agents. Taken together, these findings indicate that tumor suppressor functions of RB and p53 are particularly manifest when challenged by cellular stress. In the face of such challenge, RB is a critical suppressor of tumorigenesis beyond p53, and RB-deficiency could promote significant cellular evolution, ultimately contributing to a more aggressive disease.	[McClendon, A. Kathleen; Dean, Jeffry L.; Ertel, Adam; Knudsen, Erik S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	McClendon, AK (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org			NCI NIH HHS [R01 CA106471, CA106471] Funding Source: Medline; NIEHS NIH HHS [T32 ES07250-16, T32 ES007250] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ajioka I, 2008, CELL CYCLE, V7, P735, DOI 10.4161/cc.7.6.5612; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bettuzzi Saverio, 2003, Acta Biomed, V74, P101; Bosco EE, 2005, NUCLEIC ACIDS RES, V33, P1581, DOI 10.1093/nar/gki283; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Burke L, 2005, CLIN CANCER RES, V11, P232; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fletcher O, 2004, JNCI-J NATL CANCER I, V96, P357, DOI 10.1093/jnci/djh058; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaye FJ, 2004, J NATL CANCER I, V96, P342, DOI 10.1093/jnci/djh080; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Khan SH, 1998, CANCER RES, V58, P396; Kleinerman RA, 2005, J CLIN ONCOL, V23, P2272, DOI 10.1200/JCO.2005.05.054; KNUDSEN ES, 2008, TAILORING RB TUMOUR; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Limacher JM, 2001, INT J CANCER, V96, P238, DOI 10.1002/ijc.1021; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mammas IN, 2008, PATHOL ONCOL RES, V14, P345, DOI 10.1007/s12253-008-9056-6; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Markey MP, 2002, CANCER RES, V62, P6587; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew Christopher N, 2004, Methods Mol Biol, V281, P3; MAYHEW CN, 2005, CANC RES IN PRESS; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Miyamoto H, 1996, CANCER GENET CYTOGEN, V88, P181, DOI 10.1016/0165-4608(95)00292-8; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Sheard MA, 2003, CANCER RES, V63, P7176; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Siddiqui H, 2007, J CELL PHYSIOL, V211, P131, DOI 10.1002/jcp.20913; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Tabori U, 2008, CANCER RES, V68, P2053, DOI 10.1158/0008-5472.CAN-07-2091; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	61	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8558	10.1371/journal.pone.0008558	http://dx.doi.org/10.1371/journal.pone.0008558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049321	gold, Green Published, Green Submitted			2022-12-27	WOS:000273225000019
J	Sinha, S; Schwartz, MD; Qin, AG; Ross, JS				Sinha, Sanjai; Schwartz, Mark D.; Qin, Angie; Ross, Joseph S.			Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors	PLOS ONE			English	Article							MEDICATION UNDERUSE; PRIMARY-CARE; MANAGEMENT; DIAGNOSIS; OUTCOMES; ASTHMA; CARVEDILOL; GUIDELINES; MORBIDITY; MORTALITY	Background: Beta-blockers reduce mortality among patients with systolic heart failure (HF), yet primary care provider prescription rates remain low. Objective: To examine the association between primary care physician characteristics and both self-reported and actual prescription of beta-blockers among patients with systolic HF. Design: Cross-sectional survey with supplementary retrospective chart review. Participants: Primary care providers at three New York City Veterans Affairs medical centers. Measurements: Main outcomes were: 1) self-reported prescribing of beta-blockers, and 2) actual prescribing of beta-blockers among HF patients. Physician HF practice patterns and confidence levels, as well as socio-demographic and clinical characteristics, were also assessed. Results: Sixty-nine of 101 physicians (68%) completed the survey examining self-reported prescribing of beta-blockers. Physicians who served as inpatient ward attendings self-reported significantly higher rates of beta-blocker prescribing among their HF patients when compared with physicians who did not attend (78% vs. 58%; p = 0.002), as did physicians who were very confident in managing HF patients when compared with physicians who were not (82% vs. 68%; p = 0.009). Fifty-one of these 69 surveyed physicians (74%) were successfully matched to 287 HF patients for whom beta-blocker prescribing data was available. Physicians with greater self-reported rates of prescribing beta-blockers were significantly more likely to actually prescribe beta-blockers ( p = 0.02); however, no other physician characteristics were significantly associated with actual prescribing of beta-blockers among HF patients. Conclusions: Physician teaching responsibilities and confidence levels were associated with self-reported beta-blocker prescribing among their HF patients. Educational efforts focused on improving confidence levels in HF care and increasing exposure to teaching may improve beta-blocker presciption in HF patients managed in primary care.	[Sinha, Sanjai; Ross, Joseph S.] James J Peters VA Med Ctr, Dept Med, Bronx, NY USA; [Sinha, Sanjai] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Schwartz, Mark D.; Qin, Angie] VA New York Harbor Healthcare Syst, Dept Med, New York, NY USA; [Schwartz, Mark D.; Qin, Angie] NYU, Sch Med, Dept Med, New York, NY USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai	Sinha, S (corresponding author), James J Peters VA Med Ctr, Dept Med, Bronx, NY USA.	Sanjai.Sinha@med.va.gov		Schwartz, Mark/0000-0002-7123-0060; Ross, Joseph/0000-0002-9218-3320	New Researcher Seed Grant, Dept. of Veterans Affairs, Veterans Integrated Service Network 3 Award; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	New Researcher Seed Grant, Dept. of Veterans Affairs, Veterans Integrated Service Network 3 Award(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding source: New Researcher Seed Grant, Dept. of Veterans Affairs, Veterans Integrated Service Network 3 Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2003, J AM COLL CARDIOL, V41, P62, DOI 10.1016/S0735-1097(02)02493-2; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Blanc PD, 2003, AM J MED, V114, P581, DOI 10.1016/S0002-9343(03)00053-6; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CHARAP MH, 1985, AM J MED, V79, P461, DOI 10.1016/0002-9343(85)90033-6; Fehrenbach SN, 2001, AM J MANAG CARE, V7, P717; Fuat A, 2003, BRIT MED J, V326, P196, DOI 10.1136/bmj.326.7382.196; Gupta R, 2004, AM HEART J, V147, P79, DOI 10.1016/j.ahj.2003.07.022; Haagen EC, 2005, HUM REPROD, V20, P3301, DOI 10.1093/humrep/dei220; Hjalmarson A, 1999, LANCET, V353, P2001; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Hulsmann M, 2005, EUR J HEART FAIL, V7, P657, DOI 10.1016/j.ejheart.2004.11.011; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kasje Willeke N, 2005, BMC Fam Pract, V6, P19, DOI 10.1186/1471-2296-6-19; Khunti K, 2002, EUR J HEART FAIL, V4, P771, DOI 10.1016/S1388-9842(02)00119-8; Lechat P, 1999, LANCET, V353, P9; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Levy AR, 2002, ANN EPIDEMIOL, V12, P86, DOI 10.1016/S1047-2797(01)00251-4; Levy ML, 2008, EUR RESPIR J, V31, P229, DOI 10.1183/09031936.00157507; Lloyd-Jones D., 2009, HEART DIS STROKE STA; Maggioni AP, 2003, HEART, V89, P299, DOI 10.1136/heart.89.3.299; McKinlay JB, 2007, J GEN INTERN MED, V22, P289, DOI 10.1007/s11606-006-0075-2; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Rutten FH, 2003, EUR J HEART FAIL, V5, P337, DOI 10.1016/S1388-9842(03)00050-3; Sinha S, 2006, J GEN INTERN MED, V21, P1306, DOI 10.1111/j.1525-1497.2006.00601.x; Tseng CW, 2008, DIABETES CARE, V31, P261, DOI 10.2337/dc07-1341; Vollmer WM, 1997, ARCH INTERN MED, V157, P1201, DOI 10.1001/archinte.157.11.1201	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8522	10.1371/journal.pone.0008522	http://dx.doi.org/10.1371/journal.pone.0008522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046824	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200009
J	Zhong, SF; Israel, S; Xue, H; Ebstein, RP; Chew, SH				Zhong, Songfa; Israel, Salomon; Xue, Hong; Ebstein, Richard P.; Chew, Soo Hong			Monoamine Oxidase A Gene (MAOA) Associated with Attitude Towards Longshot Risks	PLOS ONE			English	Article							PROSPECT-THEORY; FINANCIAL RISK; NEUROECONOMICS; DECISION; BEHAVIOR	Decision making often entails longshot risks involving a small chance of receiving a substantial outcome. People tend to be risk preferring ( averse) when facing longshot risks involving significant gains ( losses). This differentiation towards longshot risks underpins the markets for lottery as well as for insurance. Both lottery and insurance have emerged since ancient times and continue to play a useful role in the modern economy. In this study, we observe subjects' incentivized choices in a controlled laboratory setting, and investigate their association with a widely studied, promoter-region repeat functional polymorphism in monoamine oxidase A gene (MAOA). We find that subjects with the high activity (4-repeat) allele are characterized by a preference for the longshot lottery and also less insurance purchasing than subjects with the low activity (3-repeat) allele. This is the first result to link attitude towards longshot risks to a specific gene. It complements recent findings on the neurobiological basis of economic risk taking.	[Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Ctr Expt Business Res, Kowloon, Hong Kong, Peoples R China; [Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Dept Econ, Kowloon, Hong Kong, Peoples R China; [Israel, Salomon; Ebstein, Richard P.] Hebrew Univ Jerusalem, Scheinfeld Ctr Human Genet Social Sci, Jerusalem, Israel; [Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Lab, Kowloon, Hong Kong, Peoples R China; [Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Ebstein, Richard P.] Herzog Mem Hosp, Jerusalem, Israel; [Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Chew, Soo Hong] Natl Univ Singapore, Dept Finance, Singapore 117548, Singapore	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hebrew University of Jerusalem; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hebrew University of Jerusalem; Herzog Medical Center; National University of Singapore; National University of Singapore	Zhong, SF (corresponding author), Hong Kong Univ Sci & Technol, Ctr Expt Business Res, Kowloon, Hong Kong, Peoples R China.	chew.soohong@gmail.com	Zhong, Songfa Z/I-4718-2016	Xue, Hong/0000-0002-8133-9828; Ebstein, Richard/0000-0002-3626-541X; Chew, Soo Hong/0000-0003-1245-0909; Israel, Salomon/0000-0003-3629-2466	Hong University of Science and Technology [AOE-MG/H-03/06]	Hong University of Science and Technology	Financial support is from the Hong University of Science and Technology ( grant number: AOE-MG/H-03/06; www.ust.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Benjamin D., 2007, BIOSOCIAL SURVEYS, P304; BOOIJ AS, 2009, THEORY DECI IN PRESS; Bossaerts P, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P353, DOI 10.1016/B978-0-12-374176-9.00023-3; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chew SH, 2005, REV ECON STUD, V72, P1009, DOI 10.1111/0034-6527.00359; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fehr-Duda H, 2006, THEOR DECIS, V60, P283, DOI 10.1007/s11238-005-4590-0; Friedman M, 1948, J POLIT ECON, V56, P279, DOI 10.1086/256692; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Savage L.J., 1954, FDN STAT; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; SHIH JC, 1993, J PSYCHIATR NEUROSCI, V18, P25; SLOVIC P, 1974, BEHAV SCI, V19, P368, DOI 10.1002/bs.3830190603; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; WILLIAMS LV, 1997, ECON J, P150; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312; Zhong SF, 2009, TWIN RES HUM GENET, V12, P103, DOI 10.1375/twin.12.1.103	31	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8516	10.1371/journal.pone.0008516	http://dx.doi.org/10.1371/journal.pone.0008516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046877	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200007
J	Paauw, A; Leverstein-van Hall, MA; van Kessel, KPM; Verhoef, J; Fluit, AC				Paauw, Armand; Leverstein-van Hall, Maurine A.; van Kessel, Kok P. M.; Verhoef, Jan; Fluit, Ad C.			Yersiniabactin Reduces the Respiratory Oxidative Stress Response of Innate Immune Cells	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; HYDROXYL-RADICAL PRODUCTION; SPIN-TRAPPING TECHNIQUES; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; NONRIBOSOMAL PEPTIDE; IRON CHELATORS; LIVER-ABSCESS; IRP2 GENE; ENTEROCOLITICA	Enterobacteriaceae that contain the High Pathogenicity Island (HPI), which encodes the siderophore yersiniabactin, display increased virulence. This increased virulence may be explained by the increased iron scavenging of the bacteria, which would both enhance bacterial growth and limit the availability of iron to cells of the innate immune system, which require iron to catalyze the Haber-Weiss reaction that produces hydroxyl radicals. In this study, we show that yersiniabactin increases bacterial growth when iron-saturated lactoferrin is the main iron source. This suggests that yersiniabactin provides bacteria with additional iron from saturated lactoferrin during infection. Furthermore, the production of ROS by polymorphonuclear leukocytes, monocytes, and a mouse macrophage cell line is blocked by yersiniabactin, as yersiniabactin reduces iron availability to the cells. Importantly, iron functions as a catalyst during the Haber-Weiss reaction, which generates hydroxyl radicals. While the physiologic role of the Haber-Weiss reaction in the production of hydroxyl radicals has been controversial, the siderophores yersiniabactin, aerobactin, and deferoxamine and the iron-chelator deferiprone also reduce ROS production in activated innate immune cells. This suggests that this reaction takes place under physiological conditions. Of the tested iron chelators, yersiniabactin was the most effective in reducing the ROS production in the tested innate immune cells. The likely decreased bacterial killing by innate immune cells resulting from the reduced production of hydroxyl radicals may explain why the HPI-containing Enterobacteriaceae are more virulent. This model centered on the reduced killing capacity of innate immune cells, which is indirectly caused by yersiniabactin, is in agreement with the observation that the highly pathogenic group of Yersinia is more lethal than the weakly pathogenic and the non-pathogenic group.	[Paauw, Armand; Leverstein-van Hall, Maurine A.; van Kessel, Kok P. M.; Verhoef, Jan; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Paauw, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	A.Paauw@umcutrecht.nl			Microbiology Department of the University Medical Centre Utrecht	Microbiology Department of the University Medical Centre Utrecht	The study was funded by the Microbiology Department of the University Medical Centre Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBRUSO DR, 1981, J CLIN INVEST, V67, P352, DOI 10.1172/JCI110042; AUTENRIETH I, 1991, MED MICROBIOL IMMUN, V180, P135; Bach S, 2000, FEMS MICROBIOL LETT, V183, P289, DOI 10.1016/S0378-1097(00)00005-7; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; BRITIGAN BE, 1988, J EXP MED, V168, P2367, DOI 10.1084/jem.168.6.2367; BRITIGAN BE, 1989, BIOCHEM J, V264, P447, DOI 10.1042/bj2640447; CARNIEL E, 1989, INFECT IMMUN, V57, P540, DOI 10.1128/IAI.57.2.540-545.1989; CARNIEL E, 1992, MOL MICROBIOL, V6, P379, DOI 10.1111/j.1365-2958.1992.tb01481.x; Chambers CE, 1996, BIOMETALS, V9, P157; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143, DOI 10.1007/BF00231175; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DEALMEIDA AMP, 1993, MICROB PATHOGENESIS, V14, P9, DOI 10.1006/mpat.1993.1002; EWALD JH, 1994, J INFECT DIS, V170, P140, DOI 10.1093/infdis/170.1.140; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORMAN HJ, 1986, ANNU REV PHYSIOL, V48, P669; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; GUILVOUT I, 1993, J BACTERIOL, V175, P5488, DOI 10.1128/JB.175.17.5488-5504.1993; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hu J, 2005, WORLD J GASTROENTERO, V11, P5816, DOI 10.3748/wjg.v11.i37.5816; Koczura R, 2003, MICROB PATHOGENESIS, V35, P197, DOI 10.1016/S0882-4010(03)00125-6; KONTOGHIORGHES GJ, 1985, LANCET, V1, P817; Lamb RE, 2008, INT J CLIN PRACT, V62, P1087, DOI 10.1111/j.1742-1241.2008.01789.x; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Lesic B, 2002, ANTIMICROB AGENTS CH, V46, P1741, DOI 10.1128/AAC.46.6.1741-1745.2002; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Maczurek A, 2008, ADV DRUG DELIVER REV, V60, P1463, DOI 10.1016/j.addr.2008.04.015; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mokracka J, 2004, FEMS IMMUNOL MED MIC, V40, P51, DOI 10.1016/S0928-8244(03)00276-1; Neupane GP, 2009, TRANSFUSION, V49, P1762, DOI 10.1111/j.1537-2995.2009.02186.x; PAAUW A, 2009, MICROBIOL, V155, P1558; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Pelludat C, 1998, J BACTERIOL, V180, P538, DOI 10.1128/JB.180.3.538-546.1998; Perry RD, 1999, MICROBIOL-UK, V145, P1181, DOI 10.1099/13500872-145-5-1181; Pfeifer BA, 2003, APPL ENVIRON MICROB, V69, P6698, DOI 10.1128/AEM.69.11.6698-6702.2003; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Rahman Irfan, 2002, Current Drug Targets - Inflammation and Allergy, V1, P291, DOI 10.2174/1568010023344607; Rakin A, 1999, INFECT IMMUN, V67, P5265, DOI 10.1128/IAI.67.10.5265-5274.1999; RALPH P, 1977, CANCER RES, V37, P546; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Schubert S, 2000, J INFECT DIS, V182, P1268, DOI 10.1086/315831; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Senior K, 2008, LANCET INFECT DIS, V8, P746, DOI 10.1016/S1473-3099(08)70273-1; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wang GP, 2006, J VIROL METHODS, V135, P118, DOI 10.1016/j.jviromet.2006.02.008; WESTLIN WF, 1971, CLIN TOXICOL, V4, P597, DOI 10.3109/15563657108990982	59	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8240	10.1371/journal.pone.0008240	http://dx.doi.org/10.1371/journal.pone.0008240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041108	Green Published, gold, Green Submitted			2022-12-27	WOS:000273105200001
J	Jeffs, AR; Glover, AC; Slobbe, LJ; Wang, L; He, SJ; Hazlett, JA; Awasthi, A; Woolley, AG; Marshall, ES; Joseph, WR; Print, CG; Baguley, BC; Eccles, MR				Jeffs, Aaron R.; Glover, Amy C.; Slobbe, Lynn J.; Wang, Li; He, Shujie; Hazlett, Jody A.; Awasthi, Anshul; Woolley, Adele G.; Marshall, Elaine S.; Joseph, Wayne R.; Print, Cristin G.; Baguley, Bruce C.; Eccles, Michael R.			A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MITF; BREAST-CANCER; MALIGNANT-MELANOMA; COLON-CANCER; SURVIVAL; MICROENVIRONMENT; PROLIFERATION; PROGRESSION; INHIBITOR; CARCINOMA	Background: We are investigating the molecular basis of melanoma by defining genomic characteristics that correlate with tumour phenotype in a novel panel of metastatic melanoma cell lines. The aim of this study is to identify new prognostic markers and therapeutic targets that might aid clinical cancer diagnosis and management. Principal Findings: Global transcript profiling identified a signature featuring decreased expression of developmental and lineage specification genes including MITF, EDNRB, DCT, and TYR, and increased expression of genes involved in interaction with the extracellular environment, such as PLAUR, VCAN, and HIF1a. Migration assays showed that the gene signature correlated with the invasive potential of the cell lines, and external validation by using publicly available data indicated that tumours with the invasive gene signature were less melanocytic and may be more aggressive. The invasion signature could be detected in both primary and metastatic tumours suggesting that gene expression conferring increased invasive potential in melanoma may occur independently of tumour stage. Conclusions: Our data supports the hypothesis that differential developmental gene expression may drive invasive potential in metastatic melanoma, and that melanoma heterogeneity may be explained by the differing capacity of melanoma cells to both withstand decreased expression of lineage specification genes and to respond to the tumour microenvironment. The invasion signature may provide new possibilities for predicting which primary tumours are more likely to metastasize, and which metastatic tumours might show a more aggressive clinical course.	[Jeffs, Aaron R.; Slobbe, Lynn J.; He, Shujie; Hazlett, Jody A.; Woolley, Adele G.; Eccles, Michael R.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand; [Glover, Amy C.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Wang, Li; Print, Cristin G.] Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Awasthi, Anshul] Univ Otago, Natl Sch Pharm, Dunedin, New Zealand; [Marshall, Elaine S.; Joseph, Wayne R.; Baguley, Bruce C.] Univ Auckland, Res Ctr, Auckland Canc Soc, Auckland 1, New Zealand	University of Otago; University of York - UK; University of Auckland; University of Otago; University of Auckland	Jeffs, AR (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand.	aaron.jeffs@otago.ac.nz		Print, Cristin/0000-0001-8345-7812	Health Research Council of New Zealand [04/284, 07/284]; New Zealand Lottery [AP 102395]; Otago Medical Research Foundation; Auckland Cancer Society; Hepburn Cancer Research and Mary Manning Memorial Fellowship; Health Research Council of New Zealand International Investment Opportunities Fund; University of Auckland International Doctoral Scholarship	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Lottery; Otago Medical Research Foundation; Auckland Cancer Society; Hepburn Cancer Research and Mary Manning Memorial Fellowship; Health Research Council of New Zealand International Investment Opportunities Fund; University of Auckland International Doctoral Scholarship	This research was supported by grants from the Health Research Council of New Zealand (04/284 and 07/284; BB, ME); the New Zealand Lottery Grants Board (AP 102395; AJ); the Otago Medical Research Foundation ( AA, AJ); the Auckland Cancer Society ( BB, WJ, EM); the Hepburn Cancer Research and Mary Manning Memorial Fellowship ( WJ, EM); the Health Research Council of New Zealand International Investment Opportunities Fund (CP, LW), and a University of Auckland International Doctoral Scholarship ( LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bishop JN, 2007, CLIN MED, V7, P283, DOI 10.7861/clinmedicine.7-3-283; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bjornland K, 1999, CANCER RES, V59, P4702; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; DOMENZAINREYNA C, 2009, J BIOL CHEM; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; Francken AB, 2008, ANN SURG ONCOL, V15, P1476, DOI 10.1245/s10434-007-9717-9; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Ivanov SV, 2008, BIOCHEM BIOPH RES CO, V370, P536, DOI 10.1016/j.bbrc.2008.03.066; Jacobs LK, 2008, ANN SURG ONCOL, V15, P1280, DOI 10.1245/s10434-008-9823-3; Lekmine F, 2007, BIOCHEM BIOPH RES CO, V354, P830, DOI 10.1016/j.bbrc.2007.01.075; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; MARSHALL ES, 1994, EUR J CANCER, V30A, P1370, DOI 10.1016/0959-8049(94)90188-0; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; *NZ HLTH INF SERV, 2007, CANC NEW REG DEATHS; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Rasband W., 2006, IMAGEJ; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ren FH, 2008, J UNIV SCI TECHNOL B, V15, P215, DOI 10.1016/S1005-8850(08)60041-9; Richardson A, 2008, NEW ZEAL MED J, V121, P18; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rofstad EK, 2002, CANCER RES, V62, P1847; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schon M, 2008, JNCI-J NATL CANCER I, V100, P862, DOI 10.1093/jnci/djn174; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Trudel D, 2008, HUM PATHOL, V39, P731, DOI 10.1016/j.humpath.2007.09.021; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Wong FH, 2009, INT J ONCOL, V34, P117, DOI 10.3892/ijo_00000135	50	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8461	10.1371/journal.pone.0008461	http://dx.doi.org/10.1371/journal.pone.0008461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041153	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000021
J	Das, B; Saini, D; Seshadri, M				Das, Birajalaxmi; Saini, Divyalakshmi; Seshadri, M.			Telomere Length in Human Adults and High Level Natural Background Radiation	PLOS ONE			English	Article							SOUTHWEST COAST; CHROMOSOMAL-ABERRATIONS; OXIDATIVE STRESS; HUMAN-POPULATION; SHORTER TELOMERES; PULSE PRESSURE; KERALA; AREAS; ASSOCIATION; DAMAGE	Background: Telomere length is considered as a biomarker of aging, stress, cancer. It has been associated with many chronic diseases such as hypertension and diabetes. Although, telomere shortening due to ionizing radiation has been reported in vitro, no in vivo data is available on natural background radiation and its effect on telomere length. Methodology/Principal Findings: The present investigation is an attempt to determine the telomere length among human adults residing in high level natural radiation areas (HLNRA) and the adjacent normal level radiation areas (NLNRA) of Kerala coast in Southwest India. Genomic DNA was isolated from the peripheral blood mononuclear cells of 310 individuals (HLNRA: N = 233 and NLNRA: N = 77). Telomere length was determined using real time q-PCR. Both telomere (T) and single copy gene (S) specific primers were used to calculate the relative T/S and expressed as the relative telomere length. The telomere length was determined to be 1.22+/-0.15, 1.12+/-0.15, 1.08+/-0.08, 1.12+/-0.11, respectively, among the four dose groups (<= 1.50, 1.51-3.00, 3.01-5.00 and >5.00 mGy per year), which did not show any dose response. The results suggested that the high level natural chronic radiation did not have significant effect on telomere length among young adult population living in HLNRA, which is indicative of better repair of telomeric ends. No significant difference in telomere length was observed between male and female individuals. In the present investigation, although the determination of telomere length was studied among the adults with an age group between 18 to 40 years (mean maternal age: 26.10+/-4.49), a negative correlation was observed with respect to age. However, inter-individual variation was (0.81-1.68) was clearly observed. Conclusions/Significance: In this preliminary investigation, we conclude that elevated level of natural background radiation has no significant effect on telomere length among the adult population residing in HLNRAs of Kerala coast. To our knowledge, this is the first report from HLNRAs of the world where telomere length was determined on human adults. However, more samples from each background dose group and samples from older population need to be studied to derive firm conclusions.	[Das, Birajalaxmi; Saini, Divyalakshmi; Seshadri, M.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Das, B (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Mumbai 400085, Maharashtra, India.	birajalaxmi@yahoo.co.in						Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; [Anonymous], 2006, SIGMASTAT SOFTWARE V; Aviv A, 1997, HYPERTENSION, V29, P1067, DOI 10.1161/01.HYP.29.5.1067; Aviv A, 2002, HYPERTENSION, V40, P229, DOI 10.1161/01.HYP.0000027280.91984.1B; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BHARATWAL D. S., 1958, PROC SECOND INTERNATL CONF PEACEFUL USES ATOMIC ENERGY, V23, P156; Boei JJWA, 2000, INT J RADIAT BIOL, V76, P163, DOI 10.1080/095530000138817; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheriyan VD, 1999, RADIAT RES, V152, pS154, DOI 10.2307/3580136; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; Das B, 2009, INT J RADIAT BIOL, V85, P272, DOI 10.1080/09553000902751462; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; GEORGE KP, 1976, SM202703325329 IAEA, V2; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; Hande MP, 1998, MUTAT RES-FUND MOL M, V404, P205, DOI 10.1016/S0027-5107(98)00115-8; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hayata I, 2005, INT CONGR SER, V1276, P17, DOI 10.1016/j.ics.2004.11.022; Hendry JH, 2009, J RADIOL PROT, V29, pA29, DOI 10.1088/0952-4746/29/2A/S03; Hewakapuge Sudinna, 2008, Legal Medicine, V10, P236, DOI 10.1016/j.legalmed.2008.01.007; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Jennings BJ, 2000, MOL GENET METAB, V71, P32, DOI 10.1006/mgme.2000.3077; Karlsson AO, 2008, FORENS SCI INT-GEN S, V1, P569, DOI 10.1016/j.fsigss.2007.10.153; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LLOYD DC, 1988, INT J RADIAT BIOL, V53, P49, DOI 10.1080/09553008814550411; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Raynaud CM, 2008, ANN ONCOL, V19, P1875, DOI 10.1093/annonc/mdn405; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Sgura A, 2007, RADIAT PROT DOSIM, V122, P176; Sharma GG, 2003, ONCOL REP, V10, P1733; Slijepcevic P, 1998, MUTAGENESIS, V13, P45; Starr JM, 2008, MECH AGEING DEV, V129, P745, DOI 10.1016/j.mad.2008.09.020; *STAT INC, 1995, STATISTICA WIND; SUNTA CM, 1993, P INT C HIGH LEV NAT; Thampi MV, 2005, INT CONGR SER, V1276, P8, DOI 10.1016/j.ics.2004.11.152; THAMPI MV, 2002, CYTOGENETIC STUDIES, P207; UNSCEAR, 2000, SOURC EFF ION RAD AN; VANDERHARST P, 2009, J AM COLL CARDIOL, V49, P1460; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	54	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8440	10.1371/journal.pone.0008440	http://dx.doi.org/10.1371/journal.pone.0008440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037654	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100020
J	Greub, G; Kebbi-Beghdadi, C; Bertelli, C; Collyn, F; Riederer, BM; Yersin, C; Croxatto, A; Raoult, D				Greub, Gilbert; Kebbi-Beghdadi, Carole; Bertelli, Claire; Collyn, Francois; Riederer, Beat M.; Yersin, Camille; Croxatto, Antony; Raoult, Didier			High Throughput Sequencing and Proteomics to Identify Immunogenic Proteins of a New Pathogen: The Dirty Genome Approach	PLOS ONE			English	Article							HUMAN-ANTIBODY RESPONSES; REAL-TIME PCR; PARACHLAMYDIA-ACANTHAMOEBAE; CHLAMYDIA-TRACHOMATIS; ANTIGEN DISCOVERY; RNA GENES; DNA; PNEUMONIA; AGENTS; ENDOSYMBIONT	Background: With the availability of new generation sequencing technologies, bacterial genome projects have undergone a major boost. Still, chromosome completion needs a costly and time-consuming gap closure, especially when containing highly repetitive elements. However, incomplete genome data may be sufficiently informative to derive the pursued information. For emerging pathogens, i.e. newly identified pathogens, lack of release of genome data during gap closure stage is clearly medically counterproductive. Methods/Principal Findings: We thus investigated the feasibility of a dirty genome approach, i.e. the release of unfinished genome sequences to develop serological diagnostic tools. We showed that almost the whole genome sequence of the emerging pathogen Parachlamydia acanthamoebae was retrieved even with relatively short reads from Genome Sequencer 20 and Solexa. The bacterial proteome was analyzed to select immunogenic proteins, which were then expressed and used to elaborate the first steps of an ELISA. Conclusions/Significance: This work constitutes the proof of principle for a dirty genome approach, i.e. the use of unfinished genome sequences of pathogenic bacteria, coupled with proteomics to rapidly identify new immunogenic proteins useful to develop in the future specific diagnostic tests such as ELISA, immunohistochemistry and direct antigen detection. Although applied here to an emerging pathogen, this combined dirty genome sequencing/proteomic approach may be used for any pathogen for which better diagnostics are needed. These genome sequences may also be very useful to develop DNA based diagnostic tests. All these diagnostic tools will allow further evaluations of the pathogenic potential of this obligate intracellular bacterium.	[Greub, Gilbert; Kebbi-Beghdadi, Carole; Bertelli, Claire; Collyn, Francois; Yersin, Camille; Croxatto, Antony] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland; [Riederer, Beat M.] Univ Lausanne, Dept Cellular Biol & Morphol, Lausanne, Switzerland; [Riederer, Beat M.] Cery, Dept Psychiat Neurosci, Prote Unit, Prilly, Switzerland; [Raoult, Didier] Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France	University of Lausanne; University of Lausanne; UDICE-French Research Universities; Aix-Marseille Universite	Greub, G (corresponding author), Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland.	gilbert.greub@chuv.ch	RAOULT, Didier/A-8434-2008; Greub, Gilbert/K-5804-2017; Bertelli, Claire/H-9609-2015	RAOULT, Didier/0000-0002-0633-5974; Greub, Gilbert/0000-0001-9529-3317; Kebbi Beghdadi, Carole/0000-0003-1158-6361; Bertelli, Claire/0000-0003-0550-8981	Swiss National Science Foundation [3200BO-116445]; Infectigen Foundation [In010]; CNRS [UPRESA 6020]; Leenards Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); Leenards Foundation	This project was mainly funded by a grant from the Swiss National Science Foundation no. 3200BO-116445. This project was also partially supported by a grant from the Infectigen Foundation (In010) and by the CNRS (UPRESA 6020). Gilbert Greub is supported by the Leenards Foundation through a career award entitled "Bourse Leenards pour la releve academique en medecine clinique a Lausanne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Araoz R, 2006, INFECT IMMUN, V74, P175, DOI 10.1128/IAI.74.1.175-182.2006; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Casson N, 2008, J CLIN MICROBIOL, V46, P1491, DOI 10.1128/JCM.02302-07; Casson N, 2008, MICROB PATHOGENESIS, V45, P92, DOI 10.1016/j.micpath.2008.04.003; CASSON NS, 2008, P ANN M SWISS SOC IN, P17; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Francois P, 2008, J MICROBIOL METH, V72, P296, DOI 10.1016/j.mimet.2007.12.007; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2005, CELL MICROBIOL, V7, P581, DOI 10.1111/j.1462-5822.2004.00488.x; Greub G, 2003, ANN NY ACAD SCI, V990, P311, DOI 10.1111/j.1749-6632.2003.tb07381.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2003, EMERG INFECT DIS, V9, P755; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Jarvie Thomas, 2008, Biotechniques, V44, P829, DOI 10.2144/000112894; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marrie TJ, 2001, EMERG INFECT DIS, V7, P1026, DOI 10.3201/eid0706.010619; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Naidu BR, 1998, IMMUNOL LETT, V62, P111, DOI 10.1016/S0165-2478(98)00029-7; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Rolain JM, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-1; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Senn L, 2008, CLIN INFECT DIS, V46, P1931, DOI 10.1086/588562; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004; Srivastava N, 2000, HYBRIDOMA, V19, P23, DOI 10.1089/027245700315761; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016	46	55	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8423	10.1371/journal.pone.0008423	http://dx.doi.org/10.1371/journal.pone.0008423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037647	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998100011
J	Felsheim, RF; Kurtti, TJ; Munderloh, UG				Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Genome Sequence of the Endosymbiont Rickettsia peacockii and Comparison with Virulent Rickettsia rickettsii: Identification of Virulence Factors	PLOS ONE			English	Article							MOUNTAIN WOOD TICK; DERMACENTOR-ANDERSONI; PSEUDOMONAS-AERUGINOSA; ANAPLASMA-PHAGOCYTOPHILUM; INTRACELLULAR BACTERIA; DSBA; PROTEIN; GENE; FAMILY; PHOSPHOETHANOLAMINE	Rickettsia peacockii, also known as the East Side Agent, is a non-pathogenic obligate intracellular bacterium found as an endosymbiont in Dermacentor andersoni ticks in the western USA and Canada. Its presence in ticks is correlated with reduced prevalence of Rickettsia rickettsii, the agent of Rocky Mountain Spotted Fever. It has been proposed that a virulent SFG rickettsia underwent changes to become the East Side Agent. We determined the genome sequence of R. peacockii and provide a comparison to a closely related virulent R. rickettsii. The presence of 42 chromosomal copies of the ISRpe1 transposon in the genome of R. peacockii is associated with a lack of synteny with the genome of R. rickettsii and numerous deletions via recombination between transposon copies. The plasmid contains a number of genes from distantly related organisms, such as part of the glycosylation island of Pseudomonas aeruginosa. Genes deleted or mutated in R. peacockii which may relate to loss of virulence include those coding for an ankyrin repeat containing protein, DsbA, RickA, protease II, OmpA, ScaI, and a putative phosphoethanolamine transferase. The gene coding for the ankyrin repeat containing protein is especially implicated as it is mutated in R. rickettsii strain Iowa, which has attenuated virulence. Presence of numerous copies of the ISRpe1 transposon, likely acquired by lateral transfer from a Cardinium species, are associated with extensive genomic reorganization and deletions. The deletion and mutation of genes possibly involved in loss of virulence have been identified by this genomic comparison. It also illustrates that the introduction of a transposon into the genome can have varied effects; either correlating with an increase in pathogenicity as in Francisella tularensis or a loss of pathogenicity as in R. peacockii and the recombination enabled by multiple transposon copies can cause significant deletions in some genomes while not in others.	[Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Felsheim, RF (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	munde001@umn.edu			National Institutes of Health (NIH) [2RO1 AI49424-06A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049424] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (NIH) grant 2RO1 AI49424-06A2 to UGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Chang J, 2008, FEMS IMMUNOL MED MIC, V53, P26, DOI 10.1111/j.1574-695X.2008.00394.x; Chao TC, 2005, APPL ENVIRON MICROB, V71, P5969, DOI 10.1128/AEM.71.10.5969-5982.2005; Coulthurst SJ, 2008, J BIOL CHEM, V283, P23739, DOI 10.1074/jbc.M801829200; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DERGOUSOFF SJ, 2009, APPL ENV MICROBIOL; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; GARCIAGARCIA JC, 2009, INFECT IMMUN; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; HAYES SF, 1982, INFECT IMMUN, V37, P779, DOI 10.1128/IAI.37.2.779-785.1982; HEIER K, 2008, J BACTERIOL, V190, P2488; Horn M, 2001, ENVIRON MICROBIOL, V3, P440, DOI 10.1046/j.1462-2920.2001.00210.x; Ijdo JW, 2007, CELL MICROBIOL, V9, P1284, DOI 10.1111/j.1462-5822.2006.00871.x; Isabella VM, 2009, MOL MICROBIOL, V71, P227, DOI 10.1111/j.1365-2958.2008.06522.x; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; Lee Y, 2008, FEMS MICROBIOL LETT, V278, P213, DOI 10.1111/j.1574-6968.2007.00993.x; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Munderloh UG, 2005, TICK-BORNE DISEASES OF HUMANS, P37; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; NGOKNGAM P, 2009, J BACTERIOL; Ngwamidiba M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-12; Niebylski ML, 1997, INT J SYST BACTERIOL, V47, P446, DOI 10.1099/00207713-47-2-446; Niebylski ML, 1999, APPL ENVIRON MICROB, V65, P773; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; PHILIP RN, 1981, AM J TROP MED HYG, V30, P230, DOI 10.4269/ajtmh.1981.30.230; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Rosadini CV, 2008, INFECT IMMUN, V76, P1498, DOI 10.1128/IAI.01378-07; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santhanagopalan V, 2006, GENE, V369, P119, DOI 10.1016/j.gene.2005.10.030; Simser JA, 2005, MOL MICROBIOL, V58, P71, DOI 10.1111/j.1365-2958.2005.04806.x; Simser JA, 2001, APPL ENVIRON MICROB, V67, P546, DOI 10.1128/AEM.67.2.546-552.2001; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998; Yu J, 2001, FEMS MICROBIOL LETT, V204, P81, DOI 10.1016/S0378-1097(01)00381-0; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x	61	89	296	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8361	10.1371/journal.pone.0008361	http://dx.doi.org/10.1371/journal.pone.0008361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027221	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100009
J	Steiner, T; Jin, YC; Sendhoff, B				Steiner, Till; Jin, Yaochu; Sendhoff, Bernhard			Vector Field Embryogeny	PLOS ONE			English	Article							HETEROCHRONY; FEEDBACK	We present a novel approach toward evolving artificial embryogenies, which omits the graph representation of gene regulatory networks and directly shapes the dynamics of a system, i.e., its phase space. We show the feasibility of the approach by evolving cellular differentiation, a basic feature of both biological and artificial development. We demonstrate how a spatial hierarchy formulation can be integrated into the framework and investigate the evolution of a hierarchical system. Finally, we show how the framework allows the investigation of allometry, a biological phenomenon, and its role for evolution. We find that direct evolution of allometric change, i.e., the evolutionary adaptation of the speed of system states on transient trajectories in phase space, is advantageous for a cellular differentiation task.	[Steiner, Till; Jin, Yaochu; Sendhoff, Bernhard] Honda Res Inst Europe GmbH, Offenbach, Germany	Honda Motor Company	Steiner, T (corresponding author), Honda Res Inst Europe GmbH, Offenbach, Germany.	till.steiner@honda-ri.de	Jin, Yaochu/GRY-7004-2022; Sendhoff, Bernhard/AAW-6486-2020; Jin, Yaochu/B-3776-2012	Jin, Yaochu/0000-0003-1100-0631; Sendhoff, Bernhard/0000-0002-1233-9584; Jin, Yaochu/0000-0003-1100-0631				Alon U., 2006, INTRO SYSTEMS BIOL D; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Bentley P, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P35; Bongard JC, 2003, MORPHO-FUNCTIONAL MACHINES: THE NEW SPECIES, P237; Chen G., 2007, IEEE T VISUALIZATION, V13, P1077; Chu D, 2007, IEEE C EVOL COMPUTAT, P875, DOI 10.1109/CEC.2007.4424562; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; CUSSATBLANC S, 2008, P ALIFE, V11, P134; DOURSAT R, 2008, P ALIFE, V11, P181; DOURSAT R, 2009, GECCO 09, P683; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eggenberger P, 1997, FROM ANIM ANIMAT, P205; Federici D, 2006, ARTIF LIFE, V12, P381, DOI 10.1162/artl.2006.12.3.381; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gayon J, 2000, AM ZOOL, V40, P748, DOI 10.1668/0003-1569(2000)040[0748:HOTCOA]2.0.CO;2; GEARD N, 2006, P ALIFE, V11, P56; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Gould SJ, 2000, EVOL DEV, V2, P241, DOI 10.1046/j.1525-142x.2000.00067.x; Haddow PC, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1013; Haken H, 1988, INFORM SELF ORG; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Harding S., 2008, ORGANIC COMPUTING, P201; Huang JF, 2006, LIVER INT, V26, P54; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Jeffery JE, 2002, EVOL DEV, V4, P292, DOI 10.1046/j.1525-142X.2002.02018.x; Jin YC, 2009, IEEE SYMP ART LIFE, P61, DOI 10.1109/ALIFE.2009.4937695; Khalil H. K., 2002, NONLINEAR SYSTEMS 3, V3rd; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kowaliw T, 2004, LECT NOTES COMPUT SC, V3102, P93; Leloup JC, 1999, J THEOR BIOL, V198, P445, DOI 10.1006/jtbi.1999.0924; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Miller JF, 2003, LECT NOTES ARTIF INT, V2801, P256; Nicolis G., 1995, INTRO NONLINEAR SCI; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Praun E, 2001, COMP GRAPH, P581, DOI 10.1145/383259.383328; Roggen D, 2007, GENET PROGRAM EVOL M, V8, P61, DOI 10.1007/s10710-006-9019-1; Schwefel H. -P., 1995, EVOLUTION OPTIMUM SE; Stanley K. O., 2004, EFFICIENT EVOLUTION; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Steiner T, 2007, IEEE C EVOL COMPUTAT, P867, DOI 10.1109/CEC.2007.4424561; STEINER T, 2008, P 10 ANN C GEN EV CO, P851, DOI DOI 10.1145/1389095.1389260; STEINER T, 2006, P ALIFE, V10, P70; Steiner T, 2009, IEEE C EVOL COMPUTAT, P2225, DOI 10.1109/CEC.2009.4983217; Tufte G, 2006, AHS 2006: FIRST NASA/ESA CONFERENCE ON ADAPTIVE HARDWARE AND SYSTEMS, PROCEEDINGS, P137; WOLPERT L, 1983, DEV EVOLUTION, P47; Yogev O, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1064; Zhang E, 2006, ACM T GRAPHIC, V25, P1294, DOI 10.1145/1183287.1183290	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8177	10.1371/journal.pone.0008177	http://dx.doi.org/10.1371/journal.pone.0008177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020063	gold, Green Published			2022-12-27	WOS:000272834200002
J	de Graaf, TA; Jacobs, C; Roebroeck, A; Sack, AT				de Graaf, Tom A.; Jacobs, Christianne; Roebroeck, Alard; Sack, Alexander T.			FMRI Effective Connectivity and TMS Chronometry: Complementary Accounts of Causality in the Visuospatial Judgment Network	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR THRESHOLD; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; VISUAL-CORTEX; BRAIN; PARIETAL; DISTANCE; AREAS; IMAGERY	Background: While traditionally quite distinct, functional neuroimaging (e.g. functional magnetic resonance imaging: fMRI) and functional interference techniques (e.g. transcranial magnetic stimulation: TMS) increasingly address similar questions of functional brain organization, including connectivity, interactions, and causality in the brain. Time-resolved TMS over multiple brain network nodes can elucidate the relative timings of functional relevance for behavior ("TMS chronometry''), while fMRI functional or effective connectivity (fMRI EC) can map task-specific interactions between brain regions based on the interrelation of measured signals. The current study empirically assessed the relation between these different methods. Methodology/Principal Findings: One group of 15 participants took part in two experiments: one fMRI EC study, and one TMS chronometry study, both of which used an established cognitive paradigm involving one visuospatial judgment task and one color judgment control task. Granger causality mapping (GCM), a data-driven variant of fMRI EC analysis, revealed a frontal-to-parietal flow of information, from inferior/middle frontal gyrus (MFG) to posterior parietal cortex (PPC). FMRI EC-guided Neuronavigated TMS had behavioral effects when applied to both PPC and to MFG, but the temporal pattern of these effects was similar for both stimulation sites. At first glance, this would seem in contradiction to the fMRI EC results. However, we discuss how TMS chronometry and fMRI EC are conceptually different and show how they can be complementary and mutually constraining, rather than contradictory, on the basis of our data. Conclusions/Significance: The findings that fMRI EC could successfully localize functionally relevant TMS target regions on the single subject level, and conversely, that TMS confirmed an fMRI EC identified functional network to be behaviorally relevant, have important methodological and theoretical implications. Our results, in combination with data from earlier studies by our group (Sack et al., 2007, Cerebral Cortex), lead to informed speculations on complex brain mechanisms, and TMS disruption thereof, underlying visuospatial judgment. This first in-depth empirical and conceptual comparison of fMRI EC and TMS chronometry thereby shows the complementary insights offered by the two methods.	[de Graaf, Tom A.; Jacobs, Christianne; Roebroeck, Alard; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [de Graaf, Tom A.; Jacobs, Christianne; Roebroeck, Alard; Sack, Alexander T.] Maastricht Brain Imaging Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University	de Graaf, TA (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	tom.degraaf@maastrichtuniversity.nl		Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (NWO) [021-002-087, 452-06-003, 400-07-048]; Deutsche Forschungsgemeinschaft; Netherlands Organization for Scientific Research [DN 55-19]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	T. A. G. was supported by a Grant from the Netherlands Organization for Scientific Research (NWO; Grant number 021-002-087), A. T. S. was also supported by NWO (Grant number 452-06-003), as was C. J. (Grant number 400-07-048). Furthermore, this work was supported by a cooperation Grant from the Deutsche Forschungsgemeinschaft and the Netherlands Organization for Scientific Research (DN 55-19). Website NWO: www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Edelman G.M., 2000, UNIVERSE CONSCIOUSNE, V1st Edn; Edin Fredrik, 2007, Journal of Integrative Neuroscience, V6, P567, DOI 10.1142/S0219635207001702; Ellison A, 2007, NEUROPSYCHOLOGIA, V45, P3335, DOI 10.1016/j.neuropsychologia.2007.06.014; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; Mottaghy FM, 2003, NEUROIMAGE, V18, P565, DOI 10.1016/S1053-8119(03)00010-7; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Sack AT, 2008, J NEUROSCI, V28, P8417, DOI 10.1523/JNEUROSCI.2656-08.2008; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Sack AT, 2006, CURR OPIN NEUROBIOL, V16, P593, DOI 10.1016/j.conb.2006.06.016; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Sack AT, 2006, NEUROIMAGE, V29, P1326, DOI 10.1016/j.neuroimage.2005.08.027; Sack AT, 2002, COGNITIVE BRAIN RES, V13, P85, DOI 10.1016/S0926-6410(01)00087-8; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Talairach J., 1988, COPLANAR STEREOTAXIC; Wassermann E., 2008, OXFORD HDB TRANSCRAN; [No title captured]; [No title captured]; [No title captured]	40	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8307	10.1371/journal.pone.0008307	http://dx.doi.org/10.1371/journal.pone.0008307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011541	Green Submitted, gold, Green Published			2022-12-27	WOS:000272830300052
J	Hodel, EM; Kabanywanyi, AM; Malila, A; Zanolari, B; Mercier, T; Beck, HP; Buclin, T; Olliaro, P; Decosterd, LA; Genton, B				Hodel, Eva Maria; Kabanywanyi, Abdunoor Mulokozi; Malila, Aggrey; Zanolari, Boris; Mercier, Thomas; Beck, Hans-Peter; Buclin, Thierry; Olliaro, Piero; Decosterd, Laurent Arthur; Genton, Blaise			Residual Antimalarials in Malaria Patients from Tanzania - Implications on Drug Efficacy Assessment and Spread of Parasite Resistance	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; POPULATION PHARMACOKINETICS; SULFADOXINE-PYRIMETHAMINE; CONGENITAL TOXOPLASMOSIS; ARTEMETHER-LUMEFANTRINE; SELF-MEDICATION; CHLOROQUINE; CHILDREN; BLOOD; DETERMINANTS	Background: Repeated antimalarial treatment for febrile episodes and self-treatment are common in malaria-endemic areas. The intake of antimalarials prior to participating in an in vivo study may alter treatment outcome and affect the interpretation of both efficacy and safety outcomes. We report the findings from baseline plasma sampling of malaria patients prior to inclusion into an in vivo study in Tanzania and discuss the implications of residual concentrations of antimalarials in this setting. Methods and Findings: In an in vivo study conducted in a rural area of Tanzania in 2008, baseline plasma samples from patients reporting no antimalarial intake within the last 28 days were screened for the presence of 14 antimalarials (parent drugs or metabolites) using liquid chromatography-tandem mass spectrometry. Among the 148 patients enrolled, 110 (74.3%) had at least one antimalarial in their plasma: 80 (54.1%) had lumefantrine above the lower limit of calibration (LLC = 4 ng/mL), 7 (4.7%) desbutyl-lumefantrine (4 ng/mL), 77 (52.0%) sulfadoxine (0.5 ng/mL), 15 (10.1%) pyrimethamine (0.5 ng/mL), 16 (10.8%) quinine (2.5 ng/mL) and none chloroquine (2.5 ng/mL). Conclusions: The proportion of patients with detectable antimalarial drug levels prior to enrollment into the study is worrying. Indeed artemether-lumefantrine was supposed to be available only at government health facilities. Although sulfadoxine-pyrimethamine is only recommended for intermittent preventive treatment in pregnancy (IPTp), it was still widely used in public and private health facilities and sold in drug shops. Self-reporting of previous drug intake is unreliable and thus screening for the presence of antimalarial drug levels should be considered in future in vivo studies to allow for accurate assessment of treatment outcome. Furthermore, persisting sub-therapeutic drug levels of antimalarials in a population could promote the spread of drug resistance. The knowledge on drug pressure in a given population is important to monitor standard treatment policy implementation.	[Hodel, Eva Maria; Beck, Hans-Peter; Genton, Blaise] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Kabanywanyi, Abdunoor Mulokozi; Malila, Aggrey] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kabanywanyi, Abdunoor Mulokozi; Malila, Aggrey] Ifakara Hlth Inst, Ifakara, Tanzania; [Zanolari, Boris; Mercier, Thomas; Buclin, Thierry; Decosterd, Laurent Arthur] Univ Lausanne Hosp, Dept Med, Div Clin Pharmacol, Lausanne, Switzerland; [Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Olliaro, Piero] UNICEF, UNDP, World Bank, WHO Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; Ifakara Health Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; The World Bank; World Health Organization	Hodel, EM (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	blaise.genton@unibas.ch	Hodel, Eva Maria/E-1258-2014; Decosterd, Laurent/E-8494-2019; Buclin, Thierry/P-1640-2014	Hodel, Eva Maria/0000-0001-5821-1685; Decosterd, Laurent/0000-0002-9840-1325; Buclin, Thierry/0000-0003-0639-5536; Beck, Hans-Peter/0000-0001-8326-4834; Mercier, Thomas/0000-0003-1921-4837	Swiss National Science Foundation [320000-112479, 326000-121314/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Support for this work was provided by grant No. 320000-112479 from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). LAD received a REQUIP Grant N 326000-121314/1 from the Swiss National Science Foundation for the acquisition of a new LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ASS MON ANT DRUG EFF; Babalola CP, 1998, PHARM WORLD SCI, V20, P118, DOI 10.1023/A:1008699022244; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Ben Quashie N, 2005, J TROP PEDIATRICS, V51, P149, DOI 10.1093/tropej/fmh104; Corvaisier S, 2004, ANTIMICROB AGENTS CH, V48, P3794, DOI 10.1128/AAC.48.10.3794-3800.2004; EDSTEIN MD, 1987, CHEMOTHERAPY, V33, P229, DOI 10.1159/000238499; EHRHARDT S, T R SOC TROP MED HYG, V97, P697; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; Green MD, 2007, J INFECT DIS, V196, P1403, DOI 10.1086/522632; HELLGREN U, 1994, TROP MED PARASITOL, V45, P293; Hetzel MW, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-83; Hetzel MW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-7; Hodel EM, 2009, J CHROMATOGR B, V877, P867, DOI 10.1016/j.jchromb.2009.02.006; JACKSON PR, 1991, BRIT J CLIN PHARMACO, V31, P55, DOI 10.1111/j.1365-2125.1991.tb03857.x; Mahomva A. I., 1996, Central African Journal of Medicine, V42, P345; MANSOR SM, 1989, BRIT J CLIN PHARMACO, V27, P381, DOI 10.1111/j.1365-2125.1989.tb05381.x; Mockenhaupt FP, 2000, ANTIMICROB AGENTS CH, V44, P835, DOI 10.1128/AAC.44.4.835-839.2000; Newton PN, 2002, ANTIMICROB AGENTS CH, V46, P1125, DOI 10.1128/AAC.46.4.1125-1127.2002; Nsimba SED, 2005, J CLIN PHARM THER, V30, P515, DOI 10.1111/j.1365-2710.2005.00645.x; NWANYANWU O, T R SOC TROP MED HYG, V90, P66; Obua C, 2006, Afr Health Sci, V6, P86; Obua C, 2008, BRIT J CLIN PHARMACO, V65, P493, DOI 10.1111/j.1365-2125.2007.03050.x; OFORIADJEI D, 1984, LANCET, V1, P1246; Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Rahman MM, 2008, T ROY SOC TROP MED H, V102, P861, DOI 10.1016/j.trstmh.2008.05.022; ROMBO L, 1986, TROP MED PARASITOL, V37, P237; Schwick P, 1998, TROP MED INT HEALTH, V3, P828, DOI 10.1046/j.1365-3156.1998.00307.x; Stepniewska K, 2008, ANTIMICROB AGENTS CH, V52, P1589, DOI 10.1128/AAC.00903-07; TALISUNA A, T R SOC TROP MED HYG, V96, P310; Tippawangkosol Pongsri, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P220; Trenque T, 2004, BRIT J CLIN PHARMACO, V57, P735, DOI 10.1111/j.1365-2125.2004.02077.x; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Verhoef H, 1999, AM J TROP MED HYG, V61, P770, DOI 10.4269/ajtmh.1999.61.770; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; WHITE NJ, 1982, AM J MED, V73, P564, DOI 10.1016/0002-9343(82)90337-0; Wichmann O, 2007, T ROY SOC TROP MED H, V101, P637, DOI 10.1016/j.trstmh.2007.03.004	39	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8184	10.1371/journal.pone.0008184	http://dx.doi.org/10.1371/journal.pone.0008184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011529	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300002
J	Horton, RE; Kaefer, N; Songok, E; Guijon, FB; Kettaf, N; Boucher, G; Sekaly, RP; Ball, TB; Plummer, FA				Horton, Rachel E.; Kaefer, Nadine; Songok, Elijah; Guijon, Fernando B.; Kettaf, Nadia; Boucher, Genevieve; Sekaly, Rafick-Pierre; Ball, T. Blake; Plummer, Frank A.			A Comparative Analysis of Gene Expression Patterns and Cell Phenotypes between Cervical and Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; HIV-1 INFECTION; GENITAL-TRACT; ACTIVATION; RECEPTOR; INNATE; PROTEIN	Studies of the immunological environment in the female genital tract (FGT) are critical for the development of vaccines or microbicides to halt the spread of sexually transmitted infections. Challenges arise due to the difficulties of sampling from this site, and the majority of studies have been conducted utilising peripheral blood mononuclear cells. Identifying functional differences between immune cells of the FGT and peripheral blood would aid in our understanding of mucosal immunology. We compared the gene expression profile of mononuclear cells at these two sites. Messenger RNA expression analysis was performed using gene expression arrays on matched cervical mononuclear cells and peripheral blood mononuclear cells. Further cellular phenotyping was done by 10 colour flow cytometry. Of the 22,185 genes expressed by these samples, 5345 genes were significantly differentially expressed between the cell populations. Most differences can be explained by significantly lower levels of T and B cells and higher levels of macrophages and dendritic cells in the FGT compared with peripheral blood. Several immunologically relevant pathways such as apoptosis and innate immune signalling, and a variety of cytokines and cytokine receptors were differentially expressed. This study highlights the importance of the unique immunological environment of the FGT and identifies important differences between systemic and mucosal immune compartments.	[Horton, Rachel E.; Kaefer, Nadine; Songok, Elijah; Ball, T. Blake; Plummer, Frank A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Songok, Elijah] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Guijon, Fernando B.] Univ Manitoba, Dept Obstet Gynaecol & Reprod Sci, Winnipeg, MB, Canada; [Kettaf, Nadia; Boucher, Genevieve; Sekaly, Rafick-Pierre] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Ball, T. Blake] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Lab, Winnipeg, MB, Canada; [Plummer, Frank A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; Kenya Medical Research Institute; University of Manitoba; Universite de Montreal; Public Health Agency of Canada; Public Health Agency of Canada	Horton, RE (corresponding author), Griffith Univ Gold Coast, Inst Glyc, Gold Coast, Qld, Australia.	tball@cc.umanitoba.ca	Wilkinson, Peter/AAK-6426-2020	Wilkinson, Peter/0000-0002-1365-0470; Songok, Elijah/0000-0001-7790-7063; Boucher, Genevieve/0000-0001-6389-9007	Bill and Melinda Gates Foundation; Canadian Institutes of Health Research; National Institute of Allergy and Infectious Diseases [R01-A1056980-01A1]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by a grant from the Bill and Melinda Gates Foundation and the Canadian Institutes of Health Research through the Grand Challenges in Global Health initiative and the National Institute of Allergy and Infectious Diseases (R01-A1056980-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; CHECK E, 2007, NATURE, V446, P12; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; Honey K, 2007, J CLIN INVEST, V117, P1116, DOI 10.1172/JCI32291; Horton R.E., 2008, AIDS RES HUM RETROVI; Huang YM, 1999, SCAND J IMMUNOL, V49, P177; Iqbal SM, 2005, J INFECT DIS, V192, P728, DOI 10.1086/432482; Johansson EL, 1999, IMMUNOLOGY, V96, P272; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Mestecky J, 2006, J REPROD IMMUNOL, V72, P1, DOI 10.1016/j.jri.2006.05.006; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS26, DOI 10.1016/j.jadohealth.2008.07.010; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pate MS, 2001, INFECT IMMUN, V69, P7178, DOI 10.1128/IAI.69.11.7178-7181.2001; Prakash M, 2001, J IMMUNOL METHODS, V258, P37, DOI 10.1016/S0022-1759(01)00464-1; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Ramjee G, 2007, PLOS MED, V4, P1167, DOI 10.1371/journal.pmed.0040235; Rottman JB, 1997, AM J PATHOL, V151, P1341; Russell MW, 2002, MICROBES INFECT, V4, P667, DOI 10.1016/S1286-4579(02)01585-X; SHANNON K, 2009, AM J PUBLIC HLTH; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570	38	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8293	10.1371/journal.pone.0008293	http://dx.doi.org/10.1371/journal.pone.0008293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011545	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300042
J	Sebastiani, P; Montano, M; Puca, A; Solovieff, N; Kojima, T; Wang, MC; Melista, E; Meltzer, M; Fischer, SEJ; Andersen, S; Hartley, SH; Sedgewick, A; Arai, Y; Bergman, A; Barzilai, N; Terry, DF; Riva, A; Anselmi, CV; Malovini, A; Kitamoto, A; Sawabe, M; Arai, T; Gondo, Y; Steinberg, MH; Hirose, N; Atzmon, G; Ruvkun, G; Baldwin, CT; Perls, TT				Sebastiani, Paola; Montano, Monty; Puca, Annibale; Solovieff, Nadia; Kojima, Toshio; Wang, Meng C.; Melista, Efthymia; Meltzer, Micah; Fischer, Sylvia E. J.; Andersen, Stacy; Hartley, Stephen H.; Sedgewick, Amanda; Arai, Yasumichi; Bergman, Aviv; Barzilai, Nir; Terry, Dellara F.; Riva, Alberto; Anselmi, Chiara Viviani; Malovini, Alberto; Kitamoto, Aya; Sawabe, Motoji; Arai, Tomio; Gondo, Yasuyuki; Steinberg, Martin H.; Hirose, Nobuyoshi; Atzmon, Gil; Ruvkun, Gary; Baldwin, Clinton T.; Perls, Thomas T.			RNA Editing Genes Associated with Extreme Old Age in Humans and with Lifespan in C-elegans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN LONGEVITY; EXCEPTIONAL LONGEVITY; MESSENGER-RNA; INSULIN; CENTENARIANS; POPULATION; MORTALITY; GENOTYPE; GENETICS	Background: The strong familiality of living to extreme ages suggests that human longevity is genetically regulated. The majority of genes found thus far to be associated with longevity primarily function in lipoprotein metabolism and insulin/IGF-1 signaling. There are likely many more genetic modifiers of human longevity that remain to be discovered. Methodology/Principal Findings: Here, we first show that 18 single nucleotide polymorphisms (SNPs) in the RNA editing genes ADARB1 and ADARB2 are associated with extreme old age in a U. S. based study of centenarians, the New England Centenarian Study. We describe replications of these findings in three independently conducted centenarian studies with different genetic backgrounds (Italian, Ashkenazi Jewish and Japanese) that collectively support an association of ADARB1 and ADARB2 with longevity. Some SNPs in ADARB2 replicate consistently in the four populations and suggest a strong effect that is independent of the different genetic backgrounds and environments. To evaluate the functional association of these genes with lifespan, we demonstrate that inactivation of their orthologues adr-1 and adr-2 in C. elegans reduces median survival by 50%. We further demonstrate that inactivation of the argonaute gene, rde-1, a critical regulator of RNA interference, completely restores lifespan to normal levels in the context of adr-1 and adr-2 loss of function. Conclusions/Significance: Our results suggest that RNA editors may be an important regulator of aging in humans and that, when evaluated in C. elegans, this pathway may interact with the RNA interference machinery to regulate lifespan.	[Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen H.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Montano, Monty; Meltzer, Micah] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Puca, Annibale; Anselmi, Chiara Viviani; Malovini, Alberto] IRCCS Multimed, Dept Genet, Milan, Italy; [Kojima, Toshio; Kitamoto, Aya] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Kanagawa, Japan; [Wang, Meng C.; Fischer, Sylvia E. J.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Genet, Boston, MA 02114 USA; [Wang, Meng C.; Fischer, Sylvia E. J.; Ruvkun, Gary] Harvard Univ, Sch Med, Boston, MA USA; [Melista, Efthymia; Steinberg, Martin H.; Baldwin, Clinton T.] Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; [Andersen, Stacy; Terry, Dellara F.; Perls, Thomas T.] Boston Univ, Sch Med, Dept Med, Geriatr Sect, Boston, MA 02118 USA; [Sedgewick, Amanda] Boston Univ, Sch Engn, Dept Bioengn, Boston, MA 02215 USA; [Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Dept Internal Med, Div Geriatr Med, Tokyo, Japan; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Diabet Res Ctr, Bronx, NY 10467 USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Riva, Alberto] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sawabe, Motoji; Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Gondo, Yasuyuki] Osaka Univ, Grad Sch Human Sci, Osaka, Japan	Boston University; Boston University; IRCCS Multimedica; RIKEN; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Keio University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; University of Florida; Tokyo Metropolitan Institute of Gerontology; Osaka University	Sebastiani, P (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	sebas@bu.edu; mmontano@bu.edu	Malovini, Alberto/I-8727-2018; Sedgewick, Amanda/AAU-5217-2020; Wang, Meng/F-2951-2019; Puca, Annibale Alessandro/K-2099-2018	Malovini, Alberto/0000-0003-2857-5773; Wang, Meng/0000-0002-5898-6007; Riva, Alberto/0000-0001-9150-8333; sebastiani, paola/0000-0001-6419-1545; Baldwin, Clinton/0000-0002-3275-9463; Kitamoto, Aya/0000-0002-0223-3874; Steinberg, Martin/0000-0001-8800-8020; Perls, Thomas/0000-0002-2492-4334; Andersen, Stacy/0000-0002-2442-6386; Montano, Monty/0000-0002-1473-887X; Terry, Dellara/0000-0002-1538-0216	National Institutes of Health [R01 HL087681, K24 AG025727, R01 AR055115, RO1 AG027216]; Italian Ministry of Research and University; Glenn Foundation [AG-027734, AG-18728, RR-12248, DK-20541, M01-RR12248]; Life Sciences Research Foundation; MGH ECOR Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR012248] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027216, K24AG025727, R01AG018728, P01AG027734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR)); Glenn Foundation; Life Sciences Research Foundation; MGH ECOR Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: R01 HL087681 (to M. H. S), K24 AG025727 (to T. T. P), R01 AR055115 (to M. M.), RO1 AG027216 (to C. B.), the Italian Ministry of Research and University (to A. P. and A. M), and the following grants to G. A, A. B. and N. B.: AG-027734, AG-18728, RR-12248, DK-20541, and M01-RR12248 and a grant from the Glenn Foundation. M. C. W. is supported by a Life Sciences Research Foundation fellowship. S. E. J. F. is supported by the MGH ECOR Fund for Medical Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Maas Stefan, 2006, RNA Biol, V3, P1; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2002, CURR OPIN GENET DEV, V12, P362, DOI 10.1016/S0959-437X(02)00310-6; Perls T, 2001, J GERONTOL A-BIOL, V56, pM67, DOI 10.1093/gerona/56.2.M67; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Salvioli S, 2006, FREE RADICAL RES, V40, P1303, DOI 10.1080/10715760600917136; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenhofen EA, 2006, J AM GERIATR SOC, V54, P1237, DOI 10.1111/j.1532-5415.2006.00826.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sebastiani P, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-6; Sorkin J, 2005, MECH AGEING DEV, V126, P347, DOI 10.1016/j.mad.2004.08.027; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; WANG D, 2004, COLD SPRING HARB SYM, V69, P429; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	51	60	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8210	10.1371/journal.pone.0008210	http://dx.doi.org/10.1371/journal.pone.0008210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011587	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300005
J	Giraud, G; Ramqvist, T; Pastrana, DV; Pavot, V; Lindau, C; Kogner, P; Orrego, A; Buck, CB; Allander, T; Holm, S; Gustavsson, B; Dalianis, T				Giraud, Geraldine; Ramqvist, Torbjorn; Pastrana, Diana V.; Pavot, Vincent; Lindau, Cecilia; Kogner, Per; Orrego, Abiel; Buck, Christopher B.; Allander, Tobias; Holm, Stefan; Gustavsson, Bengt; Dalianis, Tina			DNA from KI, WU and Merkel Cell Polyomaviruses Is Not Detected in Childhood Central Nervous System Tumours or Neuroblastomas	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; JC VIRUS; BK VIRUS; HUMAN BRAIN; EXPRESSION; INFECTION; CARCINOMA; CHILDREN; ANTIGEN; IDENTIFICATION	Background: BK and JC polyomaviruses (BKV and JCV) are potentially oncogenic and have in the past inconclusively been associated with tumours of the central nervous system (CNS), while BKV has been hinted, but not confirmed to be associated with neuroblastomas. Recently three new polyomaviruses (KIPyV, WUPyV and MCPyV) were identified in humans. So far KIPyV and WUPyV have not been associated to human diseases, while MCPyV was discovered in Merkel Cell carcinomas and may have neuroepithelial cell tropism. However, all three viruses can be potentially oncogenic and this compelled us to investigate for their presence in childhood CNS and neuroblastomas. Methodology: The presence of KI, WU and MCPyV DNA was analysed, by a joint WU and KI specific PCR (covering part of VP1) and by a MCPyV specific regular and real time quantitative PCR (covering part of Large T) in 25 CNS tumour biopsies and 31 neuroblastoma biopsies from the Karolinska University Hospital, Sweden. None of the three new human polyomaviruses were found to be associated with any of the tumours, despite the presence of PCR amplifiable DNA assayed by a S14 housekeeping gene PCR. Conclusion: In this pilot study, the presence of MCPyV, KI and WU was not observed in childhood CNS tumours and neuroblastomas. Nonetheless, we suggest that additional data are warranted in tumours of the central and peripheral nervous systems and we do not exclude that other still not yet detected polyomaviruses could be present in these tumours.	[Giraud, Geraldine; Ramqvist, Torbjorn; Pavot, Vincent; Orrego, Abiel; Dalianis, Tina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Pastrana, Diana V.; Buck, Christopher B.] NCI, Cellular Oncol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Lindau, Cecilia; Allander, Tobias] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kogner, Per; Holm, Stefan] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Gustavsson, Bengt] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Dalianis, Tina] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control	Giraud, G (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	geraldine.giraud@ki.se	Buck, Christopher/G-8358-2017; Pastrana, Diana/ABD-6830-2020	Buck, Christopher/0000-0003-3165-8094; Pavot, Vincent/0000-0002-7362-643X; Kogner, Per/0000-0002-2202-9694; Dalianis, Tina/0000-0001-7022-2424; Pastrana, Diana V./0000-0002-8084-5665	Swedish Children's Cancer Foundation [PROJ07/004]; Swedish Cancer Foundation [08 0278]; Swedish Research Council [K2008-57X-15282-04-3]; Stockholm City Council [75034]; Karolinska Institutet; Stockholm Cancer Society [081041]; King Gustav V's Jubilee Foundation [084052]; NATIONAL CANCER INSTITUTE [ZIABC011090] Funding Source: NIH RePORTER	Swedish Children's Cancer Foundation; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council; Karolinska Institutet(Karolinska Institutet); Stockholm Cancer Society; King Gustav V's Jubilee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported financially by: the Swedish Children's Cancer Foundation (project number PROJ07/004) http://www.barncancerfonden.se/, the Swedish Cancer Foundation (project number 08 0278) http://www.cancerfonden.se/, the Swedish Research Council (VR) (project number K2008-57X-15282-04-3) http://www.vr.se/, The Stockholm City Council (project number 75034) http://international.stockholm.se/Politics-and-organisation/Organisation/The-City-Council/, Karolinska Institutet http://ki.se/, the Stockholm Cancer Society (project number 081041) http://www.radiumhemmetsforskningsfonder.com/, and the King Gustav V's Jubilee Foundation (project number 084052) http://www.radiumhemmetsforskningsfonder.com/. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abed Y, 2007, EMERG INFECT DIS, V13, P1939, DOI 10.3201/eid1312.070909; Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; ALLISON AC, 1980, VIRAL ONCOLOGY, P481; Andres C, 2009, J DTSCH DERMATOL GES, V7, P843; Barbanti-Brodano G, 2006, ADV EXP MED BIOL, V577, P319; BARZON L, 2009, J INFECT DIS    1027; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; Bluemn EG, 2009, J CLIN VIROL, V44, P164, DOI 10.1016/j.jcv.2008.11.008; BOGDANOVIC G, 1995, CLIN DIAGN VIROL, V4, P223, DOI 10.1016/0928-0197(95)00013-X; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; CHUA KL, 1995, ANAL QUANT CYTOL, V17, P221; Dalianis T, 1990, Adv Cancer Res, V55, P57, DOI 10.1016/S0065-230X(08)60468-6; Dalianis T, 2009, SEMIN CANCER BIOL, V19, P270, DOI 10.1016/j.semcancer.2009.04.001; Del Valle L., 2002, HUMAN POLYOMAVIRUSES, P409; DWORKIN A, 2009, J INVEST DERMATOL; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Flaegstad T, 1999, CANCER RES, V59, P1160; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Giraud G, 2008, J CLIN MICROBIOL, V46, P3595, DOI 10.1128/JCM.01635-08; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Han TH, 2007, EMERG INFECT DIS, V13, P1766, DOI 10.3201/eid1311.070872; Heck JE, 2009, PAEDIATR PERINAT EP, V23, P125, DOI 10.1111/j.1365-3016.2008.00983.x; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Kantola K, 2009, J CLIN VIROL, V45, P292, DOI 10.1016/j.jcv.2009.04.008; Kassem A, 2009, INT J CANCER, V125, P356, DOI 10.1002/ijc.24323; Khalili K, 2006, ADV EXP MED BIOL, V577, P274; Krona C, 2008, INT J ONCOL, V32, P575; Krynska B, 1999, P NATL ACAD SCI USA, V96, P11519, DOI 10.1073/pnas.96.20.11519; LANNERING B, 2009, ACTA PAEDIAT; Lee W, 2006, ADV EXP MED BIOL, V577, P310; LOYO M, 2009, INT J CANC; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008; PADGETT BL, 1971, LANCET, V1, P1257; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Rencic A, 1996, P NATL ACAD SCI USA, V93, P7352, DOI 10.1073/pnas.93.14.7352; RHOADS DD, 1986, MOL CELL BIOL, V6, P2774, DOI 10.1128/MCB.6.8.2774; Ridd K, 2009, J INVEST DERMATOL, V129, P250, DOI 10.1038/jid.2008.215; Rollison DEM, 2005, INT J CANCER, V113, P769, DOI 10.1002/ijc.20641; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Sharp CP, 2009, J INFECT DIS, V199, P398, DOI 10.1086/596062; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Stolt A, 2005, INT J CANCER, V113, P393, DOI 10.1002/ijc.20573; White MK, 2005, BRAIN RES REV, V50, P69, DOI 10.1016/j.brainresrev.2005.04.007; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	50	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8239	10.1371/journal.pone.0008239	http://dx.doi.org/10.1371/journal.pone.0008239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011509	Green Submitted, Green Published, gold			2022-12-27	WOS:000272830200001
J	Jubault, T; Brambati, SM; Degroot, C; Kullmann, B; Strafella, AP; Lafontaine, AL; Chouinard, S; Monchi, O				Jubault, Thomas; Brambati, Simona M.; Degroot, Clotilde; Kullmann, Benoit; Strafella, Antonio P.; Lafontaine, Anne-Louise; Chouinard, Sylvain; Monchi, Oury			Regional Brain Stem Atrophy in Idiopathic Parkinson's Disease Detected by Anatomical MRI	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CORE ASSESSMENT PROGRAM; COGNITIVE IMPAIRMENT; CEREBRAL ATROPHY; DIAGNOSIS; PATHOLOGY; DEMENTIA; ACCURACY	Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder characterized by the dysfunction of dopaminergic dependent cortico-basal ganglia loops and diagnosed on the basis of motor symptoms (tremors and/or rigidity and bradykinesia). Post-mortem studies tend to show that the destruction of dopaminergic neurons in the substantia nigra constitutes an intermediate step in a broader neurodegenerative process rather than a unique feature of Parkinson's disease, as a consistent pattern of progression would exist, originating from the medulla oblongata/pontine tegmentum. To date, neuroimaging techniques have been unable to characterize the pre-symptomatic stages of PD. However, if such a regular neurodegenerative pattern were to exist, consistent damages would be found in the brain stem, even at early stages of the disease. We recruited 23 PD patients at Hoenn and Yahr stages I to II of the disease and 18 healthy controls (HC) matched for age. T1-weighted anatomical scans were acquired (MPRAGE, 1 mm3 resolution) and analyzed using an optimized VBM protocol to detect white and grey matter volume reduction without spatial a priori. When the HC group was compared to the PD group, a single cluster exhibited statistical difference (p < 0.05 corrected for false detection rate, 4287 mm3) in the brain stem, between the pons and the medulla oblongata. The present study provides in-vivo evidence that brain stem damage may be the first identifiable stage of PD neuropathology, and that the identification of this consistent damage along with other factors could help with earlier diagnosis in the future. This damage could also explain some non-motor symptoms in PD that often precede diagnosis, such as autonomic dysfunction and sleep disorders.	[Jubault, Thomas; Brambati, Simona M.; Degroot, Clotilde; Kullmann, Benoit; Monchi, Oury] Inst Univ Geriatrie Montreal, Unite Neuroimagerie Fonctionelle, Montreal, PQ, Canada; [Jubault, Thomas; Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; [Strafella, Antonio P.] Univ Toronto, CAMH PET Imaging Ctr, Toronto, ON, Canada; [Lafontaine, Anne-Louise] McGill Univ, Ctr Hlth, Movement Disorders Unit, Montreal, PQ, Canada; [Chouinard, Sylvain] Ctr Hosp Univ Montreal, Unite Desordres Mouvement, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; McGill University; Universite de Montreal	Jubault, T (corresponding author), Inst Univ Geriatrie Montreal, Unite Neuroimagerie Fonctionelle, Montreal, PQ, Canada.	thomas.jubault@umontreal.ca	Brambati, Simona Maria/GRO-4583-2022; Monchi, Oury/N-8417-2019	Brambati, Simona Maria/0000-0002-9227-1443; 	Canadian Institutes for Health Research [MOP-81114]; Fond de la Recherche du Quebec; Parkinson Society of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fond de la Recherche du Quebec; Parkinson Society of Canada	This work was supported by an operating grant from the Canadian Institutes for Health Research to OM (MOP-81114). OM receives a faculty salary award from the Fond de la Recherche du Quebec and TJ a postdoctoral fellowship from the Parkinson Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chaudhuri KR, 2001, CURR OPIN NEUROL, V14, P505, DOI 10.1097/00019052-200108000-00012; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; DUYCKAERTS C, 2003, REV NEUROL PARIS, V159; ESCOUROLLE R, 1970, REV PRATICIEN, V20, P5175; FRISTON KJ, 1995, HUM BRAIN MAPP; Gagnon JF, 2002, NEUROLOGY, V59, P585, DOI 10.1212/WNL.59.4.585; Ghorayeb I, 2005, REV NEUROL-FRANCE, V161, P907, DOI 10.1016/S0035-3787(05)85154-9; GOOD CD, 2001, VOXEL BASED MORPHOME; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; Meara J, 1999, AGE AGEING, V28, P99, DOI 10.1093/ageing/28.2.99; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Price S, 2004, NEUROIMAGE, V23, P663, DOI 10.1016/j.neuroimage.2004.06.013; Ramirez-Ruiz B, 2005, J NEUROL, V252, P1345, DOI 10.1007/s00415-005-0864-2; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Seppi K, 2005, CURR OPIN NEUROL, V18, P370, DOI 10.1097/01.wco.0000173141.74137.63; Sohn YH, 1998, YONSEI MED J, V39, P50, DOI 10.3349/ymj.1998.39.1.50; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943	31	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2009	4	12							e8247	10.1371/journal.pone.0008247	http://dx.doi.org/10.1371/journal.pone.0008247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NG	20011063	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830000001
J	Abadie, V; Bonduelle, O; Duffy, D; Parizot, C; Verrier, B; Combadiere, B				Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Verrier, Bernard; Combadiere, Behazine			Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice	PLOS ONE			English	Article							MODIFIED VACCINIA VIRUS; CD8-ALPHA(+) DENDRITIC CELLS; CD8(+) T-CELLS; SMALLPOX VACCINE; LYMPH-NODE; IN-VIVO; ATTENUATED MVA; LANGERHANS CELLS; ANKARA MVA; MEMORY	Background: Obtaining a certain multi-functionality of cellular immunity for the control of infectious diseases is a burning question in immunology and in vaccine design. Early events, including antigen shuttling to secondary lymphoid organs and recruitment of innate immune cells for adaptive immune response, determine host responsiveness to antigens. However, the sequence of these events and their impact on the quality of the immune response remain to be elucidated. Here, we chose to study Modified Vaccinia virus Ankara (MVA) which is now replacing live Smallpox vaccines and is proposed as an attenuated vector for vaccination strategies against infectious diseases. Methodology/Principal findings: We analyzed in vivo mechanisms triggered following intradermal (i.d.) and intramuscular (i.m.) Modified Vaccinia virus Ankara (MVA) administration. We demonstrated significant differences in the antigen shuttling to lymphoid organs by macrophages (M Phi s), myeloid dendritic cells (DCs), and neutrophils (PMNs). MVA i.d. administration resulted in better antigen distribution and more sustained antigen-presenting cells (APCs) recruitment into draining lymph nodes than with i.m. administration. These APCs, which comprise both DCs and M Phi s, were differentially involved in T cell priming and shaped remarkably the quality of cytokine-producing virus-specific T cells according to the entry route of MVA. Conclusions/Significance: This study improves our understanding of the mechanisms of antigen delivery and their consequences on the quality of immune responses and provides new insights for vaccine development.	[Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Combadiere, Behazine] INSERM, U945, Paris, France; [Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Combadiere, Behazine] Univ Paris 06, Paris, France; [Abadie, Valerie; Bonduelle, Olivia; Duffy, Darragh; Parizot, Christophe; Combadiere, Behazine] AP HP, Paris, France; [Verrier, Bernard] CNRS UCBL, Inst Biol & Chim Prot, UMR 5086, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Abadie, V (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	behazine.combadiere@upmc.fr	Combadiere, Behazine/S-8054-2019; Combadiere, Behazine/G-3881-2013; verrier, bernard/J-4094-2017	Combadiere, Behazine/0000-0002-2353-4406; verrier, bernard/0000-0002-8478-7095; PARIZOT, Christophe/0000-0001-5723-4471	Fondation pour la Recherche Medicale (FRM); MuNanoVac (EU-FP6); Agence Nationale de Recherche; ANRS	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MuNanoVac (EU-FP6)(European Commission); Agence Nationale de Recherche(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by a grant from Fondation pour la Recherche Medicale (FRM), MuNanoVac (EU-FP6), and Young Investigator Awards of the Agence Nationale de Recherche. B. Combadiere is a recipient of INSERM-Interface program. D. Duffy is a recipient of ANRS fellowship. V. Abadie is a recipient of the FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Bontkes HJ, 2005, CELL ONCOL, V27, P175; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Cosma A, 2004, CLIN DIAGN LAB IMMUN, V11, P406, DOI 10.1128/CDLI.11.2.406-410.2004; Drexler I, 2003, P NATL ACAD SCI USA, V100, P217, DOI 10.1073/pnas.262668999; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iga M, 2007, VACCINE, V25, P4554, DOI 10.1016/j.vaccine.2007.04.028; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Phelps AL, 2007, VACCINE, V25, P34, DOI 10.1016/j.vaccine.2006.07.022; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Puissant B, 2006, CELL MOL LIFE SCI, V63, P2249, DOI 10.1007/s00018-006-6313-2; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	48	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8159	10.1371/journal.pone.0008159	http://dx.doi.org/10.1371/journal.pone.0008159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997562	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829500012
J	Hellquist, A; Zucchelli, M; Lindgren, CM; Saarialho-Kere, U; Jarvinen, TM; Koskenmies, S; Julkunen, H; Onkamo, P; Skoog, T; Panelius, J; Raisanen-Sokolowski, A; Hasan, T; Widen, E; Gunnarson, I; Svenungsson, E; Padyukov, L; Assadi, G; Berglind, L; Makela, VV; Kivinen, K; Wong, A; Graham, DSC; Vyse, TJ; D'Amato, M; Kere, J				Hellquist, Anna; Zucchelli, Marco; Lindgren, Cecilia M.; Saarialho-Kere, Ulpu; Jarvinen, Tiina M.; Koskenmies, Sari; Julkunen, Heikki; Onkamo, Paivi; Skoog, Tiina; Panelius, Jaana; Raisanen-Sokolowski, Anne; Hasan, Taina; Widen, Elisabeth; Gunnarson, Iva; Svenungsson, Elisabet; Padyukov, Leonid; Assadi, Ghazaleh; Berglind, Linda; Makela, Ville-Veikko; Kivinen, Katja; Wong, Andrew; Graham, Deborah S. Cunningham; Vyse, Timothy J.; D'Amato, Mauro; Kere, Juha			Identification of MAMDC1 as a Candidate Susceptibility Gene for Systemic Lupus Erythematosus (SLE)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULES; TUMOR-NECROSIS-FACTOR; AUTOIMMUNE-DISEASE; IMMUNOGLOBULIN SUPERFAMILY; LINKAGE DISEQUILIBRIUM; UP-REGULATION; TNF-ALPHA; NEUROTICISM; EXPRESSION	Background: Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with multiple susceptibility genes. We have previously reported suggestive linkage to the chromosomal region 14q21-q23 in Finnish SLE families. Principal Findings: Genetic fine mapping of this region in the same family material, together with a large collection of parent affected trios from UK and two independent case-control cohorts from Finland and Sweden, indicated that a novel uncharacterized gene, MAMDC1 (MAM domain containing glycosylphosphatidylinositol anchor 2, also known as MDGA2, MIM 611128), represents a putative susceptibility gene for SLE. In a combined analysis of the whole dataset, significant evidence of association was detected for the MAMDC1 intronic single nucleotide polymorphisms (SNP) rs961616 (P - value = 0.001, Odds Ratio (OR) = 1.292, 95% CI 1.103-1.513) and rs2297926 (P - value = 0.003, OR = 1.349, 95% CI 1.109-1.640). By Northern blot, real-time PCR (qRT-PCR) and immunohistochemical (IHC) analyses, we show that MAMDC1 is expressed in several tissues and cell types, and that the corresponding mRNA is up-regulated by the pro-inflammatory cytokines tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) in THP-1 monocytes. Based on its homology to known proteins with similar structure, MAMDC1 appears to be a novel member of the adhesion molecules of the immunoglobulin superfamily (IgCAM), which is involved in cell adhesion, migration, and recruitment to inflammatory sites. Remarkably, some IgCAMs have been shown to interact with ITGAM, the product of another SLE susceptibility gene recently discovered in two independent genome wide association (GWA) scans. Significance: Further studies focused on MAMDC1 and other molecules involved in these pathways might thus provide new insight into the pathogenesis of SLE.	[Hellquist, Anna; Zucchelli, Marco; Skoog, Tiina; Assadi, Ghazaleh; D'Amato, Mauro; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Med, Oxford, England; [Saarialho-Kere, Ulpu; Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana] Univ Helsinki, Cent Hosp, Dept Dermatol, FIN-00170 Helsinki, Finland; [Saarialho-Kere, Ulpu; Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana] Skin & Allergy Hosp, Helsinki, Finland; [Saarialho-Kere, Ulpu; Skoog, Tiina] Stockholm Soder Hosp, Karolinska Inst, Dermatol Sect, Stockholm, Sweden; [Saarialho-Kere, Ulpu; Skoog, Tiina] Stockholm Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Jarvinen, Tiina M.; Koskenmies, Sari; Widen, Elisabeth; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Widen, Elisabeth; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Julkunen, Heikki] Peijas Hosp, Vantaa, Finland; [Julkunen, Heikki] Helsinki Univ Hosp, Dept Med, Vantaa, Finland; [Onkamo, Paivi] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Raisanen-Sokolowski, Anne] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Raisanen-Sokolowski, Anne] Univ Helsinki, Cent Hosp, Transplantat Lab, Helsinki, Finland; [Hasan, Taina] Univ Tampere, FIN-33101 Tampere, Finland; [Hasan, Taina] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland; [Gunnarson, Iva; Svenungsson, Elisabet; Padyukov, Leonid] Karolinska Univ Hosp, Karolinska Inst, Rheumatol Unit, Dept Med, Stockholm, Sweden; [Berglind, Linda; Makela, Ville-Veikko; Kere, Juha] Karolinska Univ Hosp, Clin Res Ctr, Huddinge, Sweden; [Kivinen, Katja] Wellcome Trust Sanger Inst, Cambridge, England; [Wong, Andrew; Graham, Deborah S. Cunningham] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Rheumatol Sect, London, England; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Mol Genet & Rheumatol Sect, London, England	Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Wellcome Trust Sanger Institute; Imperial College London; Imperial College London	Hellquist, A (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	juha.kere@ki.se	Wong, Andrew/M-8899-2016; D'Amato, Mauro/F-2450-2010; Räisänen-Sokolowski, Anne/AAD-7005-2021; D'Amato, Mauro/B-5050-2019; Kere, Juha/AAX-9117-2021; Wong, Andrew/AAE-6995-2019; Kere, Juha/A-9179-2008; Skoog, Tiina/B-8598-2014; Skoog, Tiina/N-3525-2019; Padyukov, Leonid/A-4890-2009	Wong, Andrew/0000-0003-2079-4779; D'Amato, Mauro/0000-0003-2743-5197; Räisänen-Sokolowski, Anne/0000-0002-2154-7377; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; Wong, Andrew/0000-0003-2079-4779; Kere, Juha/0000-0003-1974-0271; Skoog, Tiina/0000-0002-0148-0654; Padyukov, Leonid/0000-0003-2950-5670; Kivinen, Katja/0000-0002-1135-7625; Svenungsson, Elisabet/0000-0003-3396-3244; Lindgren, Cecilia/0000-0002-4903-9374; Assadi, Ghazaleh/0000-0002-3723-9141	Academy of Finland; Sigrid Juselius Foundation; Finska Lakarsallskapet, Finland; Swedish Research Council; Helsinki University Central Hospital Research Fund [TYH5241]; Welander-Finsen Foundation, Sweden; Helsinki Biomedical Graduate School; University of Helsinki Research Foundation; Biomedicum Helsinki Foundation; Swedish Heart-Lung Foundation; Royal Physiographic Society in Lund; The King Gustaf V 80th Birthday Fund; Ake Wiberg Foundation; Stockholm County Council	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakarsallskapet, Finland; Swedish Research Council(Swedish Research CouncilEuropean Commission); Helsinki University Central Hospital Research Fund; Welander-Finsen Foundation, Sweden; Helsinki Biomedical Graduate School; University of Helsinki Research Foundation; Biomedicum Helsinki Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Royal Physiographic Society in Lund; The King Gustaf V 80th Birthday Fund; Ake Wiberg Foundation; Stockholm County Council(Stockholm County Council)	This study was supported by the Academy of Finland, Sigrid Juselius Foundation and Finska Lakarsallskapet, Finland and Swedish Research Council (to JK and US-K), the Helsinki University Central Hospital Research Fund (TYH5241), the Welander-Finsen Foundation, Sweden (to TS), the Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine (to TMJ), and by personal grants from the University of Helsinki Research Foundation and the Biomedicum Helsinki Foundation (TMJ). Further support came from the Swedish Heart-Lung Foundation, The Royal Physiographic Society in Lund, The King Gustaf V 80th Birthday Fund, The Ake Wiberg Foundation and ALF funding from Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aringer M, 2003, ARTHRITIS RES THER, V5, P172, DOI 10.1186/ar770; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELMONT HM, 1994, ARTHRITIS RHEUM, V37, P376, DOI 10.1002/art.1780370311; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Criswell LA, 2008, BULL HOSP JT DIS, V66, P176; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; De Juan C, 2002, ONCOGENE, V21, P3089, DOI 10.1038/sj.onc.1205383; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Diaz-Lopez A, 2005, EXP CELL RES, V307, P91, DOI 10.1016/j.yexcr.2005.02.016; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Fairhurst AM, 2006, ADV IMMUNOL, V92, P1, DOI 10.1016/S0065-2776(06)92001-X; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harley JB, 2006, SPRINGER SEMIN IMMUN, V28, P119, DOI 10.1007/s00281-006-0040-5; Hettema JM, 2009, PSYCHIAT GENET, V19, P213, DOI 10.1097/YPG.0b013e32832cec22; HOCHBERG MC, 1987, J RHEUMATOL, V14, P867; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Koskenmies S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009977; Koskenmies S, 2008, LUPUS, V17, P337, DOI 10.1177/0961203307087403; Koskenmies S, 2004, EUR J HUM GENET, V12, P489, DOI 10.1038/sj.ejhg.5201125; Koskenmies S, 2001, J RHEUMATOL, V28, P758; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Litwack ED, 2004, MOL CELL NEUROSCI, V25, P263, DOI 10.1016/j.mcn.2003.10.016; McHale JF, 1999, J IMMUNOL, V163, P3993; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Molina V, 2005, AUTOIMMUNITY, V38, P235, DOI 10.1080/08916930500050277; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; Norman MU, 2005, TISSUE ANTIGENS, V66, P163, DOI 10.1111/j.1399-0039.2005.00434.x; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PALLIS M, 1993, ANN RHEUM DIS, V52, P667, DOI 10.1136/ard.52.9.667; Rhodes B, 2008, RHEUMATOLOGY, V47, P1603, DOI 10.1093/rheumatology/ken247; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P317, DOI 10.1007/s100670050109; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Svenungsson E, 2008, SCAND J RHEUMATOL, V37, P352, DOI 10.1080/03009740802007514; Svenungsson E, 2003, ARTHRITIS RHEUM-US, V48, P2533, DOI 10.1002/art.11264; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Tsao BP, 2004, CURR OPIN RHEUMATOL, V16, P513, DOI 10.1097/01.bor.0000132648.62680.81; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; WIDIGER TA, 1992, J PERS, V60, P363, DOI 10.1111/j.1467-6494.1992.tb00977.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou XD, 2003, ARTHRITIS RHEUM-US, V48, P2585, DOI 10.1002/art.11220	60	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8037	10.1371/journal.pone.0008037	http://dx.doi.org/10.1371/journal.pone.0008037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997561	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829500003
J	Salzler, HR; Davidson, JM; Montgomery, ND; Duronio, RJ				Salzler, Harmony R.; Davidson, Jean M.; Montgomery, Nathan D.; Duronio, Robert J.			Loss of the Histone Pre-mRNA Processing Factor Stem-Loop Binding Protein in Drosophila Causes Genomic Instability and Impaired Cellular Proliferation	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; DNA-SYNTHESIS; S-PHASE; 3' END; CYCLE PROGRESSION; IN-VIVO; REPLICATION; MELANOGASTER; CHROMATIN; CELLS	Background: Metazoan replication-dependent histone mRNAs terminate in a conserved stem-loop structure rather than a polyA tail. Formation of this unique mRNA 3' end requires Stem-loop Binding Protein ( SLBP), which directly binds histone pre-mRNA and stimulates 3' end processing. The 3' end stem-loop is necessary for all aspects of histone mRNA metabolism, including replication coupling, but its importance to organism fitness and genome maintenance in vivo have not been characterized. Methodology/Principal Findings: In Drosophila, disruption of the Slbp gene prevents normal histone pre-mRNA processing and causes histone pre-mRNAs to utilize the canonical 3' end processing pathway, resulting in polyadenylated histone mRNAs that are no longer properly regulated. Here we show that Slbp mutants display genomic instability, including loss of heterozygosity (LOH), increased presence of chromosome breaks, tetraploidy, and changes in position effect variegation (PEV). During imaginal disc growth, Slbp mutant cells show defects in S phase and proliferate more slowly than control cells. Conclusions/Significance: These data are consistent with a model in which changing the 3' end of histone mRNA disrupts normal replication-coupled histone mRNA biosynthesis and alters chromatin assembly, resulting in genomic instability, inhibition of cell proliferation, and impaired development.	[Salzler, Harmony R.; Montgomery, Nathan D.; Duronio, Robert J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Davidson, Jean M.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Duronio, Robert J.] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Salzler, HR (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	duronio@med.unc.edu	Davidson, Jean/G-7558-2012	Davidson, Jean/0000-0001-5951-5955; Salzler, Harmony/0000-0002-1544-8700; Duronio, Robert/0000-0001-6469-6965; Montgomery, Nathan/0000-0003-1765-6623	National Science Foundation [MCB-9984068]; National Institutes of Health [GM57859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057859] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation (MCB-9984068) and the National Institutes of Health ( GM57859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADESNIK M, 1972, J MOL BIOL, V67, P397, DOI 10.1016/0022-2836(72)90458-5; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BIRNSTIEL ML, 1998, STRUCTURE FUNCTION M, P155; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; de la Cruz Aida Flor A., 2008, V420, P373, DOI 10.1007/978-1-59745-583-1_24; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2005, RNA, V11, P1835, DOI 10.1261/rna.2179305; Dominski Z, 1995, RNA, V1, P915; Dominski Z, 2003, P NATL ACAD SCI USA, V100, P9422, DOI 10.1073/pnas.1533509100; DOMINSKI Z, 2007, GENE; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Ephrussi B, 1944, GENETICS, V29, P148; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GATTI M, 1974, GENETICS, V77, P701; Godfrey AC, 2006, RNA, V12, P396, DOI 10.1261/rna.2270406; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hanlon SE, 2003, GENETICS, V164, P1333; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Konev AY, 2003, GENETICS, V165, P2039; Lanzotti DJ, 2002, MOL CELL BIOL, V22, P2267, DOI 10.1128/MCB.22.7.2267-2282.2002; LEVINE BJ, 1987, P NATL ACAD SCI USA, V84, P6189, DOI 10.1073/pnas.84.17.6189; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; MOORE GD, 1979, NATURE, V282, P312, DOI 10.1038/282312a0; MOORE GD, 1983, GENETICS, V105, P327; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PARKER DR, 1965, MUTAT RES, V2, P523, DOI 10.1016/0027-5107(65)90017-5; Paro R, 2000, DROSOPHILA PROTOCOLS; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez R, 2002, MOL CELL BIOL, V22, P7093, DOI 10.1128/MCB.22.20.7093-7104.2002; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tsui KC, 1997, GENETICS, V145, P647; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Wagner EJ, 2006, MOL CELL BIOL, V26, P6702, DOI 10.1128/MCB.00391-06; XU T, 1993, DEVELOPMENT, V117, P1223; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Ye XF, 2003, CELL CYCLE, V2, P185, DOI 10.4161/cc.2.3.389; ZHANG P, 1994, P NATL ACAD SCI USA, V91, P3539, DOI 10.1073/pnas.91.9.3539; Zhao XJ, 2004, J CELL SCI, V117, P6043, DOI 10.1242/jcs.01523	66	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8168	10.1371/journal.pone.0008168	http://dx.doi.org/10.1371/journal.pone.0008168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997601	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829200008
J	Bechah, Y; Paddock, CD; Capo, C; Mege, JL; Raoult, D				Bechah, Yassina; Paddock, Christopher D.; Capo, Christian; Mege, Jean-Louis; Raoult, Didier			Adipose Tissue Serves as a Reservoir for Recrudescent Rickettsia prowazekii Infection in a Mouse Model	PLOS ONE			English	Article							BRILL-ZINSSER-DISEASE; EPIDEMIC TYPHUS; TRENCH FEVER; BODY LOUSE; DEXAMETHASONE; ADIPOCYTE; OUTBREAK; VECTOR; GLUCOCORTICOIDS; TUBERCULOSIS	Brill-Zinsser disease, the relapsing form of epidemic typhus, typically occurs in a susceptible host years or decades after the primary infection; however, the mechanisms of reactivation and the cellular reservoir during latency are poorly understood. Herein we describe a murine model for Brill-Zinsser disease, and use PCR and cell culture to show transient rickettsemia in mice treated with dexamethasone >3 months after clinical recovery from the primary infection. Treatment of similarly infected mice with cyclosporine failed to produce recrudescent bacteremia. Therapy with doxycycline for the primary infection prevented recrudescent bacteremia in most of these mice following treatment with dexamethasone. Rickettsia prowazekii (the etiologic agent of epidemic typhus) was detected by PCR, cell culture, and immunostaining methods in murine adipose tissue, but not in liver, spleen, lung, or central nervous system tissues of mice 4 months after recovery from the primary infection. The lungs of dexamethasone-treated mice showed impaired expression of beta-defensin transcripts that may be involved in the pathogenesis of pulmonary lesions. In vitro, R. prowazekii rickettsiae infected and replicated in the murine adipocyte cell line 3T3-L1. Collectively these data suggest a role for adipose tissue as a potential reservoir for dormant infections with R. prowazekii.	[Bechah, Yassina; Capo, Christian; Mege, Jean-Louis; Raoult, Didier] Univ Mediterranean, Unit Res Emergent & Trop Infect Dis URMITE, CNRS IRD UMR 6236, Fac Med, Marseille, France; [Paddock, Christopher D.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div Viral & Rickettsial Dis, Atlanta, GA USA	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centers for Disease Control & Prevention - USA	Bechah, Y (corresponding author), Univ Mediterranean, Unit Res Emergent & Trop Infect Dis URMITE, CNRS IRD UMR 6236, Fac Med, Marseille, France.	didier.raoult@medecine.univ-mrs.fr	MEGE, JEAN-LOUIS/O-6063-2016; RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974	French Centre National de la Recherche Scientifique (CNRS)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study was founded by the French Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Andersson JO, 2000, RES MICROBIOL, V151, P143, DOI 10.1016/S0923-2508(00)00116-9; Avitsur R, 2005, BRAIN BEHAV IMMUN, V19, P311, DOI 10.1016/j.bbi.2004.09.005; Bechah Y, 2007, MICROBES INFECT, V9, P898, DOI 10.1016/j.micinf.2007.03.008; Birg ML, 1999, J CLIN MICROBIOL, V37, P3722, DOI 10.1128/JCM.37.11.3722-3724.1999; Bise G, 1997, T ROY SOC TROP MED H, V91, P133, DOI 10.1016/S0035-9203(97)90198-X; Brili NE, 1911, AM J MED SCI, V142, P196, DOI 10.1097/00000441-191108000-00004; Brill NE, 1910, AM J MED SCI, V139, P484; Brouqui P, 2005, MEDICINE, V84, P61, DOI 10.1097/01.md.0000152373.07500.6e; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Freylikhman O, 2003, ANN NY ACAD SCI, V990, P496, DOI 10.1111/j.1749-6632.2003.tb07417.x; GREEN CR, 1990, JAMA-J AM MED ASSOC, V264, P1811, DOI 10.1001/jama.1990.03450140031026; Hans Z, 1934, AM J HYG, V20, P513, DOI 10.1093/oxfordjournals.aje.a118091; Hart PD, 1996, INFECT IMMUN, V64, P1491, DOI 10.1128/IAI.64.4.1491-1493.1996; Hashimoto A, 2007, BIOMED PHARMACOTHER, V61, P81, DOI 10.1016/j.biopha.2006.06.023; Houhamdi L, 2006, J INFECT DIS, V194, P1589, DOI 10.1086/508995; KROTKIEWSKI M, 1975, ACTA ENDOCRINOL-COP, V80, P667, DOI 10.1530/acta.0.0800667; Lutwick LI, 2001, LANCET, V357, P1198, DOI 10.1016/S0140-6736(00)04339-7; Massung RF, 2001, CLIN INFECT DIS, V32, P979, DOI 10.1086/319351; Mitchell GB, 2007, INFECT IMMUN, V75, P1325, DOI 10.1128/IAI.00686-06; Mokrani K, 2004, J CLIN MICROBIOL, V42, P3898, DOI 10.1128/JCM.42.8.3898-3900.2004; MURRAY ES, 1950, JAMA-J AM MED ASSOC, V142, P1059, DOI 10.1001/jama.1950.02910320021006; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Niang M, 1999, EMERG INFECT DIS, V5, P716, DOI 10.3201/eid0505.990515; ONG JM, 1992, ENDOCRINOLOGY, V130, P2310, DOI 10.1210/en.130.4.2310; PARKER RT, 1954, J IMMUNOL, V73, P383; PORTNOY J, 1974, CAN MED ASSOC J, V111, P166; PRICE WINSTON H., 1955, JOUR BACT, V69, P106; Raoult D, 1997, EMERG INFECT DIS, V3, P357, DOI 10.3201/eid0303.970313; Raoult D, 1999, CLIN INFECT DIS, V29, P434, DOI 10.1086/520229; Raoult D, 1998, LANCET, V352, P353, DOI 10.1016/S0140-6736(97)12433-3; RAOULT D, 1987, J INFECT DIS, V155, P1059, DOI 10.1093/infdis/155.5.1059; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; REILLY PJ, 1980, WESTERN J MED, V133, P338; Renes J, 2005, CELL MOL LIFE SCI, V62, P492, DOI 10.1007/s00018-004-4498-9; ROTH JA, 1982, J AM VET MED ASSOC, V180, P894; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; SLATER GG, 1962, ENDOCRINOLOGY, V70, P18, DOI 10.1210/endo-70-1-18; SMADEL JE, 1952, AM J HYG, V56, P294, DOI 10.1093/oxfordjournals.aje.a119553; Stein A, 1999, LANCET, V353, P1936, DOI 10.1016/S0140-6736(99)01995-9; Tarasevich I, 1998, LANCET, V352, P1151, DOI 10.1016/S0140-6736(05)79799-3	43	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8547	10.1371/journal.pone.0008547	http://dx.doi.org/10.1371/journal.pone.0008547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049326	Green Submitted, Green Published, gold			2022-12-27	WOS:000273225000012
J	Codina, M; Li, JL; Gutierrez, J; Kao, JPY; Du, SJ				Codina, Marta; Li, Junling; Gutierrez, Joaquim; Kao, Joseph P. Y.; Du, Shao Jun			Loss of Smyhc1 or Hsp90 alpha 1 Function Results in Different Effects on Myofibril Organization in Skeletal Muscles of Zebrafish Embryos	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; CAENORHABDITIS-ELEGANS; SELECTIVE REMOVAL; ELASTIC FILAMENTS; ACTIN INTERACTION; STRIATED-MUSCLE; THICK FILAMENTS; IN-VIVO; CELLS; SLOW	Background: Myofibrillogenesis requires the correct folding and assembly of sarcomeric proteins into highly organized sarcomeres. Heat shock protein 90 alpha 1 (Hsp90 alpha 1) has been implicated as a myosin chaperone that plays a key role in myofibrillogenesis. Knockdown or mutation of hsp90 alpha 1 resulted in complete disorganization of thick and thin filaments and M-and Z-line structures. It is not clear whether the disorganization of these sarcomeric structures is due to a direct effect from loss of Hsp90 alpha 1 function or indirectly through the disorganization of myosin thick filaments. Methodology/Principal Findings: In this study, we carried out a loss-of-function analysis of myosin thick filaments via gene-specific knockdown or using a myosin ATPase inhibitor BTS (N-benzyl-p-toluene sulphonamide) in zebrafish embryos. We demonstrated that knockdown of myosin heavy chain 1 (myhc1) resulted in sarcomeric defects in the thick and thin filaments and defective alignment of Z-lines. Similarly, treating zebrafish embryos with BTS disrupted thick and thin filament organization, with little effect on the M-and Z-lines. In contrast, loss of Hsp90 alpha 1 function completely disrupted all sarcomeric structures including both thick and thin filaments as well as the M-and Z-lines. Conclusion/Significance: Together, these studies indicate that the hsp90 alpha 1 mutant phenotype is not simply due to disruption of myosin folding and assembly, suggesting that Hsp90 alpha 1 may play a role in the assembly and organization of other sarcomeric structures.	[Codina, Marta; Li, Junling; Du, Shao Jun] Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; [Codina, Marta; Gutierrez, Joaquim] Univ Barcelona, Dept Physiol, Barcelona, Spain; [Kao, Joseph P. Y.] Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Du, Shao Jun] Univ Maryland, Sch Med, Interdisciplinary Training Program Muscle Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Barcelona; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Codina, M (corresponding author), Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, 600 E Lombard St, Baltimore, MD 21202 USA.	dus@umbi.umd.edu	Gutierrez, Joaquim/H-2836-2015	Gutierrez, Joaquim/0000-0002-3126-2236; du, Jim/0000-0001-9227-4153; Kao, Joseph/0000-0002-8875-2180	BARD, the United States-Israel Binational Agricultural Research and Development Fund [IS-3703-05]; University of Maryland Biotechnology Institute	BARD, the United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); University of Maryland Biotechnology Institute	This research was supported by research grant No IS-3703-05 from BARD, the United States-Israel Binational Agricultural Research and Development Fund, and an intercenter collaboration grant (Kao-Du) from University of Maryland Biotechnology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; BEJSOVEC A, 1988, GENE DEV, V2, P1307, DOI 10.1101/gad.2.10.1307; Boateng SY, 2008, CARDIOVASC RES, V77, P667, DOI 10.1093/cvr/cvm048; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; CHUN MY, 1988, J CELL BIOL, V107, P2613, DOI 10.1083/jcb.107.6.2613; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cripps RM, 1999, EMBO J, V18, P1793, DOI 10.1093/emboj/18.7.1793; Devoto SH, 1996, DEVELOPMENT, V122, P3371; DIBB NJ, 1985, J MOL BIOL, V183, P543, DOI 10.1016/0022-2836(85)90170-6; Dou Y, 2008, J GEN PHYSIOL, V131, P445, DOI 10.1085/jgp.200809982; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; EPSTEIN HF, 1991, SCIENCE, V251, P1039, DOI 10.1126/science.1998120; EPSTEIN HF, 1992, DEV BIOL, V154, P231, DOI 10.1016/0012-1606(92)90064-N; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; FUNATSU T, 1993, J CELL BIOL, V120, P711, DOI 10.1083/jcb.120.3.711; FUNATSU T, 1990, J CELL BIOL, V110, P53, DOI 10.1083/jcb.110.1.53; Granato M, 1996, DEVELOPMENT, V123, P399; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; HAYASHI T, 1977, J MOL BIOL, V111, P159; Kagawa M, 2006, ZOOL SCI, V23, P969, DOI 10.2108/zsj.23.969; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Landsverk ML, 2005, CELL MOL LIFE SCI, V62, P2270, DOI 10.1007/s00018-005-5176-2; Li HQ, 2009, FASEB J, V23, P1988, DOI 10.1096/fj.08-125542; LOWEY S, 1969, J MOL BIOL, V42, P1, DOI 10.1016/0022-2836(69)90483-5; McGuigan K, 2004, MOL BIOL EVOL, V21, P1042, DOI 10.1093/molbev/msh103; Moerman DG, 2006, SARCOMERE ASSEMBLY C, P1; Ramachandran I, 2003, CELL MOTIL CYTOSKEL, V55, P61, DOI 10.1002/cm.10113; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Sass JB, 1999, INT J DEV BIOL, V43, P835; Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f; Soeno Y, 1999, CELL TISSUE RES, V295, P307, DOI 10.1007/s004410051237; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Squire JM, 1997, CURR OPIN STRUC BIOL, V7, P247, DOI 10.1016/S0959-440X(97)80033-4; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; van der Ven PFM, 2000, J CELL SCI, V113, P1405; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	46	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8416	10.1371/journal.pone.0008416	http://dx.doi.org/10.1371/journal.pone.0008416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049323	Green Published, gold, Green Submitted			2022-12-27	WOS:000273225000002
J	Subramanya, S; Mensa-Wilmot, K				Subramanya, Sandesh; Mensa-Wilmot, Kojo			Diacylglycerol-Stimulated Endocytosis of Transferrin in Trypanosomatids Is Dependent on Tyrosine Kinase Activity	PLOS ONE			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-PHOSPHOLIPASE-C; HEMOGLOBIN ENDOCYTOSIS; AFRICAN TRYPANOSOME; LEISHMANIA-DONOVANI; FLAGELLAR POCKET; PHORBOL ESTERS; BRUCEI-BRUCEI; RECEPTOR; MEMBRANE; DOMAINS	Small molecule regulation of cell function is an understudied area of trypanosomatid biology. In Trypanosoma brucei diacylglycerol (DAG) stimulates endocytosis of transferrin (Tf). However, it is not known whether other trypanosomatidae respond similarly to the lipid. Further, the biochemical pathways involved in DAG signaling to the endocytic system in T. brucei are unknown, as the parasite genome does not encode canonical DAG receptors (e. g. C1-domains). We established that DAG stimulates endocytosis of Tf in Leishmania major, and we evaluated possible effector enzymes in the pathway with multiple approaches. First, a heterologously expressed glycosylphosphatidylinositol phospholipase C (GPI-PLC) activated endocytosis of Tf 300% in L. major. Second, exogenous phorbol ester and DAGs promoted Tf endocytosis in L. major. In search of possible effectors of DAG signaling, we discovered a novel C1-like domain (i.e. C1_5) in trypanosomatids, and we identified protein Tyr kinases (PTKs) linked with C1_5 domains in T. brucei, T. cruzi, and L. major. Consequently, we hypothesized that trypanosome PTKs might be effector enzymes for DAG signaling. General uptake of Tf was reduced by inhibitors of either Ser/Thr or Tyr kinases. However, DAG-stimulated endocytosis of Tf was blocked only by an inhibitor of PTKs, in both T. brucei and L. major. We conclude that (i) DAG activates Tf endocytosis in L. major, and that (ii) PTKs are effectors of DAG-stimulated endocytosis of Tf in trypanosomatids. DAG-stimulated endocytosis of Tf may be a T. brucei adaptation to compete effectively with host cells for vertebrate Tf in blood, since DAG does not enhance endocytosis of Tf in human cells.	[Subramanya, Sandesh; Mensa-Wilmot, Kojo] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Subramanya, S (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, El Paso, TX USA.	mensawil@uga.edu			National Institutes of Health [AI070141]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health grant number AI070141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; Britigan BE, 1998, ADV EXP MED BIOL, V443, P135; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Chopra LC, 1997, AM J RESP CELL MOL, V16, P372, DOI 10.1165/ajrcmb.16.4.9115747; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; EICHHOLTZ T, 1992, J BIOL CHEM, V267, P22490; Eltayeb R, 2000, J INFECT DIS, V181, P400, DOI 10.1086/315189; FOX JA, 1986, J BIOL CHEM, V261, P5767; Gruszynski AE, 2006, MOL BIOCHEM PARASIT, V147, P211, DOI 10.1016/j.molbiopara.2006.02.013; HERELD D, 1986, J BIOL CHEM, V261, P3813; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Hurley JH, 1997, PROTEIN SCI, V6, P477; Jonassen I, 1997, COMPUT APPL BIOSCI, V13, P509; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; KOHNO H, 1986, CELL STRUCT FUNCT, V11, P181, DOI 10.1247/csf.11.181; Kotsonis P, 1996, BRIT J PHARMACOL, V119, P115, DOI 10.1111/j.1476-5381.1996.tb15684.x; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; LIBERALI P, 2008, ANN REV CELL DEV BIO; Maier A, 1996, FEBS LETT, V396, P87, DOI 10.1016/0014-5793(96)01073-3; MENSAWILMOT K, 1994, J CELL BIOL, V124, P935, DOI 10.1083/jcb.124.6.935; Merschjohann Karin, 2006, Kinetoplastid Biol Dis, V5, P3, DOI 10.1186/1475-9292-5-3; MORARU II, 1990, FEBS LETT, V274, P93, DOI 10.1016/0014-5793(90)81337-N; MORRIS JC, 1995, J BIOL CHEM, V270, P2517, DOI 10.1074/jbc.270.6.2853; Mustafa E, 1997, J INFECT DIS, V175, P669, DOI 10.1093/infdis/175.3.669; Parsons M, 2000, PARASITOL TODAY, V16, P56, DOI 10.1016/S0169-4758(99)01590-2; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Rambaratsingh RA, 2003, J BIOL CHEM, V278, P52792, DOI 10.1074/jbc.M308240200; Rashid MB, 1999, EUR J BIOCHEM, V264, P914, DOI 10.1046/j.1432-1327.1999.00690.x; Reinhardt J, 2002, AM J PHYSIOL-RENAL, V283, pF335, DOI 10.1152/ajprenal.00226.2001; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; SCHELL D, 1991, PARASITOL RES, V77, P558, DOI 10.1007/BF00931012; Seebeck T, 2004, CURR MOL MED, V4, P585, DOI 10.2174/1566524043360113; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Steverding D, 1998, PARASITOL RES, V84, P59, DOI 10.1007/s004360050357; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Subramanya S, 2006, FEBS J, V273, P2110, DOI 10.1111/j.1742-4658.2006.05225.x; Subramanya S, 2009, BIOCHEM J, V417, P685, DOI 10.1042/BJ20080167; VOYIATZAKI CS, 1992, J BIOL CHEM, V267, P9112; WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wilson ME, 2002, EXP PARASITOL, V100, P196, DOI 10.1016/S0014-4894(02)00018-8; WILSON ME, 1994, INFECT IMMUN, V62, P3262, DOI 10.1128/IAI.62.8.3262-3269.1994; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; ZHENG Z, 2004, J BIOL CHEM; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200	55	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8538	10.1371/journal.pone.0008538	http://dx.doi.org/10.1371/journal.pone.0008538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049089	Green Published, Green Submitted, gold			2022-12-27	WOS:000273225000007
J	Clark-Knowles, KV; Senterman, MK; Collins, O; Vanderhyden, BC				Clark-Knowles, Katherine V.; Senterman, Mary K.; Collins, Olga; Vanderhyden, Barbara C.			Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; SURFACE EPITHELIUM; TUMOR-FORMATION; BREAST-CANCER; MICE LACKING; DNA-DAMAGE; CYCLE; MUTATIONS; PROTEIN; EXPRESSION	Epithelial ovarian cancer (EOC) is thought to arise in part from the ovarian surface epithelium (OSE); however, the molecular events underlying this transformation are poorly understood. Germline mutations in the BRCA1 tumor suppressor gene result in a significantly increased risk of developing EOC and a large proportion of sporadic EOCs display some sort of BRCA1 dysfunction. To generate a model in which Brca1-mediated transformation can be studied, we previously inactivated Brca1 alone in murine OSE, which resulted in an increased accumulation of premalignant changes, but no tumor formation. In this study, we examined tumor formation in mice with conditionally expressed alleles of Brca1, p53 and Rb, alone or in combination. Intrabursal injection of adenovirus expressing Cre recombinase to inactivate p53 resulted in tumors in 100% of mice. Tumor progression was accelerated in mice with concomitant inactivation of Brca1 and p53, but not Rb and p53. Immunohistologic analyses classified the tumors as leiomyosarcomas that may be arising from the ovarian bursa. Brca1 inactivation in primary cultures of murine OSE cells led to a suppression of proliferation that could be rescued by concomitant inactivation of p53 and/or Rb. Brca1-deficient OSE cells displayed an increased sensitivity to the DNA damaging agent cisplatin, and this effect could be modulated by inactivation of p53 and/or Rb. These results indicate that Brca1 deficiency can accelerate tumor development and alter the sensitivity of OSE cells to chemotherapeutic agents. Intrabursal delivery of adenovirus intended to alter gene expression in the ovarian surface epithelium may, in some strains of mice, result in more rapid transformation of adjacent cells, resulting in leiomyosarcomas.	[Clark-Knowles, Katherine V.; Vanderhyden, Barbara C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Senterman, Mary K.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Vanderhyden, Barbara C.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Clark-Knowles, Katherine V.; Collins, Olga; Vanderhyden, Barbara C.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Clark-Knowles, KV (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	bvanderhyden@ohri.ca			National Cancer Institute of Canada; Canadian Institutes of Health Research; Ontario Graduate Scholarships; Ontario Graduate Scholarship in Science and Technology	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships(Ontario Graduate Scholarship); Ontario Graduate Scholarship in Science and Technology	This research was supported by funds from the National Cancer Institute of Canada and the Canadian Institutes of Health Research (BCV) and by Ontario Graduate Scholarships and an Ontario Graduate Scholarship in Science and Technology (KVC-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Auersperg N, 1998, SEMIN ONCOL, V25, P281; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Aunoble B, 2000, INT J ONCOL, V16, P567; Berchuck A, 1998, CLIN CANCER RES, V4, P2433; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chan KYK, 2002, CANCER RES, V62, P4151; Chen JJ, 1999, CANCER RES, V59, p1752S; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; Cressman VL, 1999, CELL GROWTH DIFFER, V10, P1; Deng CX, 2001, MUTAT RES-FUND MOL M, V477, P183, DOI 10.1016/S0027-5107(01)00119-1; DEVOS S, 1994, GYNECOL ONCOL, V54, P205, DOI 10.1006/gyno.1994.1194; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; FINCH A, 2005, GYNECOL ONCOL; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Heller DS, 2003, INT J GYNECOL CANCER, V13, P303, DOI 10.1046/j.1525-1438.2003.13201.x; Hirst JE, 2009, INT J GYNECOL CANCER, V19, P826, DOI 10.1111/IGC.0b013e3181a1b5dc; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lanzi C, 1998, BIOCHEM PHARMACOL, V55, P1247, DOI 10.1016/S0006-2952(97)00599-6; Larson JS, 1997, CANCER RES, V57, P3351; LAVIOLETTE L, 2009, ENDOCRINOLO IN PRESS; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Leiser AL, 2006, GYNECOL ONCOL, V101, P86, DOI 10.1016/j.ygyno.2005.09.055; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Pal T., 2005, CANCER; Perego P, 1998, ANN ONCOL, V9, P423, DOI 10.1023/A:1008265012435; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Roh MH, 2009, AM J SURG PATHOL, V33, P376, DOI 10.1097/PAS.0b013e3181868904; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; Salazar H, 1996, JNCI-J NATL CANCER I, V88, P1810, DOI 10.1093/jnci/88.24.1810; Schlosshauer PW, 2003, CANCER, V98, P2599, DOI 10.1002/cncr.11848; Sgagias MK, 2004, CELL CYCLE, V3, P1451, DOI 10.4161/cc.3.11.1211; Shao NS, 1996, ONCOGENE, V13, P1; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Simpson KJ, 2004, INT J DEV BIOL, V48, P675, DOI 10.1387/ijdb.041849ks; Sood AK, 1998, CANCER, V82, P1731, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.3.CO;2-0; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Tos APD, 1996, AM J PATHOL, V148, P1037; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Werness BA, 1999, HUM PATHOL, V30, P151, DOI 10.1016/S0046-8177(99)90269-1; Woodworth CD, 2004, CARCINOGENESIS, V25, P1771, DOI 10.1093/carcin/bgh170; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yu V, 2000, BREAST CANCER RES, V2, P82, DOI 10.1186/bcr37; Zweemer RP, 1999, J CLIN PATHOL, V52, P372, DOI 10.1136/jcp.52.5.372	58	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8534	10.1371/journal.pone.0008534	http://dx.doi.org/10.1371/journal.pone.0008534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046869	Green Published, Green Submitted, gold			2022-12-27	WOS:000273180200015
J	Lavelin, I; Beer, A; Kam, Z; Boner, V; Oren, M; Navon, A; Geiger, B				Lavelin, Irena; Beer, Avital; Kam, Zvi; Boner, Varda; Oren, Moshe; Navon, Ami; Geiger, Benjamin			Discovery of Novel Proteasome Inhibitors Using a High-Content Cell-Based Screening System	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; MULTIPLE-MYELOMA; BETA-CATENIN; ANTITUMOR ACTIVITIES; 20S PROTEASOME; CANCER-CELLS; P53; APOPTOSIS; PROTEIN; RESOLUTION	The regulated degradation of damaged or misfolded proteins, as well as down-regulation of key signaling proteins, within eukaryotic and bacterial cells is catalyzed primarily by large, ATP-dependent multimeric proteolytic complexes, termed proteasomes. Inhibition of proteasomal activity affects a wide variety of physiological and pathological processes, and was found to be particularly effective for cancer therapy. We report here on the development of a novel high throughput assay for proteasome inhibition using a unique, highly sensitive live-cell screening, based on the cytoplasm-to-nucleus translocation of a fluorescent proteasome inhibition reporter (PIR) protein, consisting of nuclear localization signal-deficient p53 derivative. We further show here that mdm2, a key negative regulator of p53 plays a key role in the accumulation of PIR in the nucleus upon proteasome inhibition. Using this assay, we have screened the NCI Diversity Set library, containing 1,992 low molecular weight synthetic compounds, and identified four proteasome inhibitors. The special features of the current screen, compared to those of other approaches are discussed.	[Lavelin, Irena; Kam, Zvi; Boner, Varda; Oren, Moshe; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Beer, Avital; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Lavelin, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il		Oren, Moshe/0000-0003-4311-7172	Israel Science Foundation; Minerva Foundation; German-Israeli Foundation for Scientific Research and Development; Jeanne and Joseph Nissim Foundation for Life Sciences Research; Rolando Uziel	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Jeanne and Joseph Nissim Foundation for Life Sciences Research; Rolando Uziel	This study was supported by grants from the Israel Science Foundation (BG and AN), the Minerva Foundation (AN), the German-Israeli Foundation for Scientific Research and Development (AN), the Jeanne and Joseph Nissim Foundation for Life Sciences Research (BG), and a special gift from Rolando Uziel (AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Andreatta C, 2001, BIOTECHNIQUES, V30, P656, DOI 10.2144/01303dd03; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bonvini P, 2000, BBA-MOL CELL RES, V1495, P308, DOI 10.1016/S0167-4889(99)00162-7; Cavo M, 2006, LEUKEMIA, V20, P1341, DOI 10.1038/sj.leu.2404278; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Daniel KG, 2004, BIOCHEM PHARMACOL, V67, P1139, DOI 10.1016/j.bcp.2003.10.031; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Dobbelstein M, 1999, ONCOGENE, V18, P2101, DOI 10.1038/sj.onc.1202512; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Klibanov SA, 2001, J CELL SCI, V114, P1867; Latonen L, 2003, CELL SIGNAL, V15, P95, DOI 10.1016/S0898-6568(02)00044-X; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Liron Y, 2006, J MICROSC-OXFORD, V221, P145, DOI 10.1111/j.1365-2818.2006.01550.x; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Orlowski RZ, 1998, CANCER RES, V58, P4342; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; Richardson Paul G, 2003, Clin Adv Hematol Oncol, V1, P596; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tsukamoto S, 2009, EXPERT OPIN THER TAR, V13, P605, DOI [10.1517/14728220902866851 , 10.1517/14728220902866851]; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485	44	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8503	10.1371/journal.pone.0008503	http://dx.doi.org/10.1371/journal.pone.0008503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041034	gold, Green Published, Green Submitted			2022-12-27	WOS:000278068700017
J	Corcione, A; Ferretti, E; Bertolotto, M; Fais, F; Raffaghello, L; Gregorio, A; Tenca, C; Ottonello, L; Gambini, C; Furtado, G; Lira, S; Pistoia, V				Corcione, Anna; Ferretti, Elisa; Bertolotto, Maria; Fais, Franco; Raffaghello, Lizzia; Gregorio, Andrea; Tenca, Claudya; Ottonello, Luciano; Gambini, Claudio; Furtado, Glaucia; Lira, Sergio; Pistoia, Vito			CX(3)CR1 Is Expressed by Human B Lymphocytes and Meditates CX(3)CL1 Driven Chemotaxis of Tonsil Centrocytes	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; MEMBRANE-BOUND CHEMOKINE; PROTEIN-KINASE CASCADE; GERMINAL-CENTERS; SOMATIC MUTATION; CELL-ADHESION; TNF-ALPHA; ACTIVATION; MIGRATION; GENES	Background: Fractalkine/CX(3)CL1, a surface chemokine, binds to CX(3)CR1 expressed by different lymphocyte subsets. Since CX(3)CL1 has been detected in the germinal centres of secondary lymphoid tissue, in this study we have investigated CX(3)CR1 expression and function in human naive, germinal centre and memory B cells isolated from tonsil or peripheral blood. Methodology/Principal Findings: We demonstrate unambiguously that highly purified human B cells from tonsil and peripheral blood expressed CX(3)CR1 at mRNA and protein levels as assessed by quantitative PCR, flow cytometry and competition binding assays. In particular, naive, germinal centre and memory B cells expressed CX(3)CR1 but only germinal centre B cells were attracted by soluble CX(3)CL1 in a transwell assay. CX(3)CL1 signalling in germinal centre B cells involved PI3K, Erk1/2, p38, and Src phosphorylation, as assessed by Western blot experiments. CX(3)CR1(+) germinal centre B cells were devoid of centroblasts and enriched for centrocytes that migrated to soluble CX(3)CL1. ELISA assay showed that soluble CX(3)CL1 was secreted constitutively by follicular dendritic cells and T follicular helper cells, two cell populations homing in the germinal centre light zone as centrocytes. At variance with that observed in humans, soluble CX(3)CL1 did not attract spleen B cells from wild type mice. OVA immunized CX(3)CR1-/- or CX(3)CL1-/- mice showed significantly decreased specific IgG production compared to wild type mice. Conclusion/Significance: We propose a model whereby human follicular dendritic cells and T follicular helper cells release in the light zone of germinal centre soluble CX(3)CL1 that attracts centrocytes. The functional implications of these results warrant further investigation.	[Corcione, Anna; Ferretti, Elisa; Raffaghello, Lizzia; Pistoia, Vito] IRCCS G Gaslini, Lab Oncol, Genoa, Italy; [Bertolotto, Maria; Ottonello, Luciano] Univ Genoa, Dept Internal Med, Lab Phagocyte Physiopathol & Inflammat, I-16126 Genoa, Italy; [Fais, Franco; Tenca, Claudya] Univ Genoa, Dept Expt Med, Human Anat Sect, Genoa, Italy; [Gregorio, Andrea; Gambini, Claudio] IRCCS G Gaslini, Human Pathol Sect, Genoa, Italy; [Furtado, Glaucia; Lira, Sergio] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Icahn School of Medicine at Mount Sinai	Corcione, A (corresponding author), IRCCS G Gaslini, Lab Oncol, Genoa, Italy.	annacorcione@ospedale-gaslini.ge.it	Gregorio, Anna A/J-1632-2012; FAIS, FRANCO/AAG-3069-2021; Ottonello, Luciano/I-3250-2018; Corcione, Anna/AAA-7370-2020; Fais, Franco/K-1096-2016	FAIS, FRANCO/0000-0002-6643-7083; Ottonello, Luciano/0000-0001-7431-3841; Corcione, Anna/0000-0003-2439-1221; Fais, Franco/0000-0002-6643-7083; Bertolotto, Maria Bianca/0000-0002-4889-8046; Raffaghello, Lizzia/0000-0003-2357-0607	Fondazione Italiana Lotta al Neuroblastoma; Fondazione Italiana Ricerca sul Cancro (F. I. R. C.); Compagnia di S. Paolo [4824 SD/CV-2007.2880]; Fondazione Carige; Associazione Italiana Ricerca sul Cancro (A. I. R. C.); Progetti Strategici Oncologia, Ministero della Salute 2006	Fondazione Italiana Lotta al Neuroblastoma; Fondazione Italiana Ricerca sul Cancro (F. I. R. C.)(Fondazione AIRC per la ricerca sul cancro); Compagnia di S. Paolo(Compagnia di San Paolo); Fondazione Carige(Fondazione Carige); Associazione Italiana Ricerca sul Cancro (A. I. R. C.)(Fondazione AIRC per la ricerca sul cancro); Progetti Strategici Oncologia, Ministero della Salute 2006	LR and AG were supported by Fondazione Italiana Lotta al Neuroblastoma, EF by Fondazione Italiana Ricerca sul Cancro (F. I. R. C.), CT by Compagnia di S. Paolo (4824 SD/CV-2007.2880), MB by Fondazione Carige. Funding: i) Associazione Italiana Ricerca sul Cancro (A. I. R. C.) to VP, and ii) Progetti Strategici Oncologia, Ministero della Salute 2006 to AC and VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ANDERSSON J, 1994, IMMUNOLOGY, V83, P16; Andreasson U, 2008, CANCER LETT, V259, P138, DOI 10.1016/j.canlet.2007.10.031; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Casamayor-Palleja M, 2002, BLOOD, V99, P1913, DOI 10.1182/blood.V99.6.1913; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; CORCIONE A, 1994, J IMMUNOL, V153, P2868; Corcione A, 2000, J NATL CANCER I, V92, P628, DOI 10.1093/jnci/92.8.628; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; Dono M, 1996, EUR J IMMUNOL, V26, P2035, DOI 10.1002/eji.1830260911; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kansra V, 2001, J BIOL CHEM, V276, P31831, DOI 10.1074/jbc.M009374200; KIM HS, 1994, J IMMUNOL, V153, P2951; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KomaiKoma M, 1997, IMMUNOLOGY, V90, P23, DOI 10.1046/j.1365-2567.1997.d01-2131.x; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Liao F, 2002, J IMMUNOL, V168, P4871, DOI 10.4049/jimmunol.168.10.4871; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shang XZ, 2004, CELL IMMUNOL, V229, P106, DOI 10.1016/j.cellimm.2004.06.007; Umehara H, 2001, TRENDS IMMUNOL, V22, P602, DOI 10.1016/S1471-4906(01)02051-8; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; WANG JM, 1993, J IMMUNOL, V150, P3022	48	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8485	10.1371/journal.pone.0008485	http://dx.doi.org/10.1371/journal.pone.0008485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041188	Green Published, Green Submitted, gold			2022-12-27	WOS:000273105200017
J	Rebetz, J; Na, ML; Su, CQ; Holmqvist, B; Edqvist, A; Nyberg, C; Widegren, B; Salford, LG; Sjogren, HO; Arnberg, N; Qian, QJ; Fan, XL				Rebetz, Johan; Na, Manli; Su, Changqing; Holmqvist, Bo; Edqvist, Anna; Nyberg, Cecilia; Widegren, Bengt; Salford, Leif G.; Sjogren, Hans Olov; Arnberg, Niklas; Qian, Qijun; Fan, Xiaolong			Fiber Mediated Receptor Masking in Non-Infected Bystander Cells Restricts Adenovirus Cell Killing Effect but Promotes Adenovirus Host Co-Existence	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; WILD-TYPE ADENOVIRUS; GENE-TRANSFER; B ADENOVIRUSES; SIALIC-ACID; VECTORS; CD46; INFECTIONS; COXSACKIE; REPLICATION	The basic concept of conditionally replicating adenoviruses (CRAD) as oncolytic agents is that progenies generated from each round of infection will disperse, infect and kill new cancer cells. However, CRAD has only inhibited, but not eradicated tumor growth in xenograft tumor therapy, and CRAD therapy has had only marginal clinical benefit to cancer patients. Here, we found that CRAD propagation and cancer cell survival co-existed for long periods of time when infection was initiated at low multiplicity of infection (MOI), and cancer cell killing was inefficient and slow compared to the assumed cell killing effect upon infection at high MOI. Excessive production of fiber molecules from initial CRAD infection of only 1 to 2% cancer cells and their release prior to the viral particle itself caused a tropism-specific receptor masking in both infected and noninfected bystander cells. Consequently, the non-infected bystander cells were inefficiently bound and infected by CRAD progenies. Further, fiber overproduction with concomitant restriction of adenovirus spread was observed in xenograft cancer therapy models. Besides the CAR-binding Ad4, Ad5, and Ad37, infection with CD46-binding Ad35 and Ad11 also caused receptor masking. Fiber overproduction and its resulting receptor masking thus play a key role in limiting CRAD functionality, but potentially promote adenovirus and host cell co-existence. These findings also give important clues for understanding mechanisms underlying the natural infection course of various adenoviruses.	[Rebetz, Johan; Na, Manli; Edqvist, Anna; Widegren, Bengt; Salford, Leif G.; Sjogren, Hans Olov; Fan, Xiaolong] Lund Univ, Rausing Lab, Lund, Sweden; [Rebetz, Johan; Edqvist, Anna; Widegren, Bengt] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Holmqvist, Bo] Lund Univ, Dept Oncol, Lund, Sweden; [Holmqvist, Bo] Lund Univ, LBIC Opt Imaging Unit, Lund, Sweden; [Nyberg, Cecilia; Arnberg, Niklas] Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden; [Na, Manli; Su, Changqing; Qian, Qijun] Second Mil Med Univ, Lab Gene & Viral Therapy, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Fan, Xiaolong] Beijing Normal Univ, Dept Physiol, Life Sci Coll, Beijing 100875, Peoples R China	Lund University; Lund University; Lund University; Lund University; Umea University; Naval Medical University; Beijing Normal University	Rebetz, J (corresponding author), Lund Univ, Rausing Lab, Lund, Sweden.	Xiaolong.Fan@med.lu.se	Na, Manli/AAM-9864-2020; Arnberg, Niklas/G-2663-2012; Rebetz, Johan/AAK-9569-2021; Arnberg, Niklas/K-5878-2019	Rebetz, Johan/0000-0003-1673-0684; Arnberg, Niklas/0000-0002-7069-6678; Su, Changqing/0000-0002-3396-7248; Na, Manli/0000-0002-7306-8941	Swedish Cancer Society; Swedish Pediatric Cancer Foundation; Swedish Research Council; Lund University Medical Faculty; Hans and Marit Rausing Charitable Foundation; Gunnar Nilsson Cancer Foundation; Erik Philip-Sorensens Foundation; Crafoord Foundation; Lund University Hospital Donation Fund; Royal Physiographic Society in Lund	Swedish Cancer Society(Swedish Cancer Society); Swedish Pediatric Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Medical Faculty; Hans and Marit Rausing Charitable Foundation; Gunnar Nilsson Cancer Foundation; Erik Philip-Sorensens Foundation; Crafoord Foundation; Lund University Hospital Donation Fund; Royal Physiographic Society in Lund	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by Swedish Cancer Society, Swedish Pediatric Cancer Foundation, Swedish Research Council, Lund University Medical Faculty, Hans and Marit Rausing Charitable Foundation, Gunnar Nilsson Cancer Foundation, Erik Philip-Sorensens Foundation, Crafoord Foundation, Lund University Hospital Donation Fund, and the Royal Physiographic Society in Lund. Xiaolong Fan is a Li Ka Shing Scholar.	Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Edqvist A, 2006, MOL THER, V14, P139, DOI 10.1016/j.ymthe.2005.12.018; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Greber UF, 2007, CELL HOST MICROBE, V2, P143, DOI 10.1016/j.chom.2007.08.004; Harrison D, 2001, HUM GENE THER, V12, P1323, DOI 10.1089/104303401750270977; Heise C, 2000, J CLIN INVEST, V105, P847, DOI 10.1172/JCI9762; HONG JS, 1991, VIROLOGY, V185, P758; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; Kaye SB, 2005, J MED VIROL, V77, P227, DOI 10.1002/jmv.20440; Krasnykh V, 2000, CANCER RES, V60, P6784; Lichtenstein DL, 2004, CANCER GENE THER, V11, P819, DOI 10.1038/sj.cgt.7700765; Marttila M, 2005, J VIROL, V79, P14429, DOI 10.1128/JVI.79.22.14429-14436.2005; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; NORRBY E, 1969, J GEN VIROL, V5, P221, DOI 10.1099/0022-1317-5-2-221; NUMAZAKI Y, 1968, NEW ENGL J MED, V278, P700, DOI 10.1056/NEJM196803282781303; Pring-Akerblom P, 1998, J VIROL, V72, P2297; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Sauthoff H, 2003, HUM GENE THER, V14, P425, DOI 10.1089/104303403321467199; Schaack J, 2005, VIRAL IMMUNOL, V18, P79, DOI 10.1089/vim.2005.18.79; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; SHIELDS AF, 1985, NEW ENGL J MED, V312, P529, DOI 10.1056/NEJM198502283120901; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang Y, 2006, J MOL HISTOL, V37, P153, DOI 10.1007/s10735-006-9055-4; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Wirth T, 2003, CANCER RES, V63, P3181; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Zhang Q, 2006, CLIN CANCER RES, V12, P6523, DOI 10.1158/1078-0432.CCR-06-1491; Zhang YM, 2005, J VIROL, V79, P12125, DOI 10.1128/JVI.79.19.12125-12131.2005	43	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8484	10.1371/journal.pone.0008484	http://dx.doi.org/10.1371/journal.pone.0008484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041185	Green Published, Green Submitted, gold			2022-12-27	WOS:000273105200016
J	Kim, W; Silby, MW; Purvine, SO; Nicoll, JS; Hixson, KK; Monroe, M; Nicora, CD; Lipton, MS; Levy, SB				Kim, Wook; Silby, Mark W.; Purvine, Sam O.; Nicoll, Julie S.; Hixson, Kim K.; Monroe, Matt; Nicora, Carrie D.; Lipton, Mary S.; Levy, Stuart B.			Proteomic Detection of Non-Annotated Protein-Coding Genes in Pseudomonas fluorescens Pf0-1	PLOS ONE			English	Article							OVERLAPPING GENES; ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; IN-VIVO; EXPRESSION; INITIATION; DISCOVERY; SEQUENCES; SURVIVAL; BACTERIA	Genome sequences are annotated by computational prediction of coding sequences, followed by similarity searches such as BLAST, which provide a layer of possible functional information. While the existence of processes such as alternative splicing complicates matters for eukaryote genomes, the view of bacterial genomes as a linear series of closely spaced genes leads to the assumption that computational annotations that predict such arrangements completely describe the coding capacity of bacterial genomes. We undertook a proteomic study to identify proteins expressed by Pseudomonas fluorescens Pf0-1 from genes that were not predicted during the genome annotation. Mapping peptides to the Pf0-1 genome sequence identified sixteen non-annotated protein-coding regions, of which nine were antisense to predicted genes, six were intergenic, and one read in the same direction as an annotated gene but in a different frame. The expression of all but one of the newly discovered genes was verified by RT-PCR. Few clues as to the function of the new genes were gleaned from informatic analyses, but potential orthologs in other Pseudomonas genomes were identified for eight of the new genes. The 16 newly identified genes improve the quality of the Pf0-1 genome annotation, and the detection of antisense protein-coding genes indicates the under-appreciated complexity of bacterial genome organization.	[Kim, Wook; Silby, Mark W.; Nicoll, Julie S.; Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA; [Kim, Wook; Silby, Mark W.; Nicoll, Julie S.; Levy, Stuart B.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Purvine, Sam O.; Hixson, Kim K.; Monroe, Matt; Nicora, Carrie D.; Lipton, Mary S.] Pacific NW Natl Lab, Richland, WA 99352 USA	Tufts University; Tufts University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Kim, W (corresponding author), Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA.	Stuart.Levy@tufts.edu	Lipton, Mary S/H-3913-2012; Purvine, Samuel O/O-3358-2017; Hixson, Kim/AAW-2332-2020; Hixson, Kim/AAJ-7714-2020	Purvine, Samuel O/0000-0002-2257-2400; Hixson, Kim/0000-0003-3915-7040; Hixson, Kim/0000-0003-3716-0326; Silby, Mark/0000-0002-3092-8008	US Department of Energy, Office of Biological and Environmental Research [43488, DE-AC05-76RL01830]; United States Department of Agriculture [2006-35604-16673]; Natural Sciences and Engineering Research Council of Canada	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Portions of this research were conducted at the Environmental Molecular Sciences Laboratory (EMSL), U. S. Department of Energy ( DOE) national scientific user facility located at the Pacific Northwest National Laboratory in Richland, Washington. This work was supported by the US Department of Energy, Office of Biological and Environmental Research ( project 43488), and the United States Department of Agriculture ( grant 2006-35604-16673 to SBL). PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the DOE under Contract DE-AC05-76RL01830. W.K. was supported in part by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; BARRICK D, 1994, NUCLEIC ACIDS RES, V22, P1287, DOI 10.1093/nar/22.7.1287; Behrens M, 2002, INFECT IMMUN, V70, P2915, DOI 10.1128/IAI.70.6.2915-2925.2002; BEREMAND MN, 1979, CELL, V18, P257, DOI 10.1016/0092-8674(79)90045-X; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Delaye L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-31; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; DREYFUS M, 1988, J MOL BIOL, V204, P79, DOI 10.1016/0022-2836(88)90601-8; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; GODSON GN, 1978, NATURE, V276, P236, DOI 10.1038/276236a0; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim W, 2008, APPL ENVIRON MICROB, V74, P3644, DOI 10.1128/AEM.00429-08; KING EO, 1954, J LAB CLIN MED, V44, P301; Kirner S, 1996, MICROBIOL-UK, V142, P2129, DOI 10.1099/13500872-142-8-2129; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Ochman H, 2002, TRENDS GENET, V18, P335, DOI 10.1016/S0168-9525(02)02668-9; RAK B, 1982, NATURE, V297, P124, DOI 10.1038/297124a0; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakharkar KR, 2005, INT J SYST EVOL MICR, V55, P1205, DOI 10.1099/ijs.0.63446-0; Silby MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000094; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Silby MW, 2004, J BACTERIOL, V186, P7411, DOI 10.1128/JB.186.21.7411-7419.2004; Silby MW, 2004, MICROBIOL-SGM, V150, P518, DOI 10.1099/mic.0.26871-0; Veloso F, 2005, OMICS, V9, P91, DOI 10.1089/omi.2005.9.91; Wang LF, 1999, J BACTERIOL, V181, P353, DOI 10.1128/JB.181.1.353-356.1999; Wong RSY, 2000, MOL MICROBIOL, V37, P364, DOI 10.1046/j.1365-2958.2000.01998.x	42	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8455	10.1371/journal.pone.0008455	http://dx.doi.org/10.1371/journal.pone.0008455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041161	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000017
J	Mwacharo, J; Dunachie, SJ; Kai, O; Hill, AVS; Bejon, P; Fletcher, HA				Mwacharo, Jedidah; Dunachie, Susanna J.; Kai, Oscar; Hill, Adrian V. S.; Bejon, Philip; Fletcher, Helen A.			Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine	PLOS ONE			English	Article							T-CELLS; GLOBAL DISTRIBUTION; ME-TRAP; PROTECTION; IMMUNIZATION; ANTIGENS; IMMUNOGENICITY; SPOROZOITES; INFECTION; HUMANS	Background: The T-cell mediated immune response plays a central role in the control of malaria after natural infection or vaccination. There is increasing evidence that T-cell responses are heterogeneous and that both the quality of the immune response and the balance between pro-inflammatory and regulatory T-cells determines the outcome of an infection. As Malaria parasites have been shown to induce immunosuppressive responses to the parasite and non-related antigens this study examined T-cell mediated pro-inflammatory and regulatory immune responses induced by malaria vaccination in children in an endemic area to determine if these responses were associated with vaccine immunogenicity. Methods: Using real-time RT-PCR we profiled the expression of a panel of key markers of immunogenecity at different time points after vaccination with two viral vector vaccines expressing the malaria TRAP antigen (FP9-TRAP and MVA-TRAP) or following rabies vaccination as a control. Principal Findings: The vaccine induced modest levels of IFN-gamma mRNA one week after vaccination. There was also an increase in FoxP3 mRNA expression in both TRAP stimulated and media stimulated cells in the FFM ME-TRAP vaccine group; however, this may have been driven by natural exposure to parasite rather than by vaccination. Conclusion: Quantitative PCR is a useful method for evaluating vaccine induced cell mediated immune responses in frozen PBMC from children in a malaria endemic country. Future studies should seek to use vaccine vectors that increase the magnitude and quality of the IFN-gamma immune response in naturally exposed populations and should monitor the induction of a regulatory T cell response.	[Mwacharo, Jedidah; Kai, Oscar; Bejon, Philip] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya; [Dunachie, Susanna J.; Hill, Adrian V. S.; Bejon, Philip; Fletcher, Helen A.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Jenner Inst, Oxford, England	Kenya Medical Research Institute; University of Oxford; Jenner Institute	Mwacharo, J (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya.	JMwacharo@kilifi.kemri-wellcome.org	Fletcher, Helen/D-1470-2011	Fletcher, Helen/0000-0002-0435-1006; Dunachie, Susanna/0000-0001-5665-6293	Gates Malaria Programme; Wellcome Trust; Oxford Biomedical Research Centre; MRC; European Commission; MRC [G84/6323] Funding Source: UKRI; Medical Research Council [G84/6323] Funding Source: researchfish	Gates Malaria Programme; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	J.M was funded by the Gates Malaria Programme and the Wellcome Trust; P. B. is supported by the Oxford Biomedical Research Centre; S.J.D. held an MRC Training Fellowship; K. M. is funded by the Wellcome Trust; A. V. S. H. is a Wellcome Trust Principal Research Fellow; H.A.F. was funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Doolan DL, 1997, PHILOS T R SOC B, V352, P1361, DOI 10.1098/rstb.1997.0121; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Flanagan KL, 2006, AM J TROP MED HYG, V74, P367, DOI 10.4269/ajtmh.2006.74.367; GREENWOOD BM, 1972, LANCET, V1, P169; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Malkin E, 2006, TRENDS PARASITOL, V22, P292, DOI 10.1016/j.pt.2006.05.002; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; WEISS WR, 1993, J IMMUNOL, V151, P2690; White N, 2004, LANCET, V363, P1160, DOI 10.1016/S0140-6736(04)15904-7; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8434	10.1371/journal.pone.0008434	http://dx.doi.org/10.1371/journal.pone.0008434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037644	gold, Green Published, Green Accepted			2022-12-27	WOS:000272998100018
J	Dharajiya, N; Vaidya, S; Sinha, M; Luxon, B; Boldogh, I; Sur, S				Dharajiya, Nilesh; Vaidya, Swapnil; Sinha, Mala; Luxon, Bruce; Boldogh, Istvan; Sur, Sanjiv			Allergen Challenge Induces Ifng Dependent GTPases in the Lungs as Part of a Th1 Transcriptome Response in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							INTERFERON-INDUCED GTPASES; T-CELLS; AIRWAY INFLAMMATION; CYTOKINE PRODUCTION; GENE-EXPRESSION; DEFICIENT MICE; P47 GTPASES; MOUSE MODEL; GAMMA; IMMUNITY	According to the current paradigm, allergic airway inflammation is mediated by Th2 cytokines and pro-inflammatory chemokines. Since allergic inflammation is self-limited, we hypothesized that allergen challenge simultaneously induces anti-inflammatory genes to counter-balance the effects of Th2 cytokines and chemokines. To identify these putative anti-inflammatory genes, we compared the gene expression profile in the lungs of ragweed-sensitized mice four hours after challenge with either PBS or ragweed extract (RWE) using a micro-array platform. Consistent with our hypothesis, RWE challenge concurrently upregulated Th1-associated early target genes of the Il12/Stat4 pathway, such as p47 and p65 GTPases (Iigp, Tgtp and Gbp1), Socs1, Cxcl9, Cxcl10 and Gadd45g with the Th2 genes Il4, Il5, Ccl2 and Ccl7. These Th1-associated genes remain upregulated longer than the Th2 genes. Augmentation of the local Th1 milieu by administration of Il12 or CpG prior to RWE challenge further upregulated these Th1 genes. Abolition of the Th1 response by disrupting the Ifng gene increased allergic airway inflammation and abrogated RWE challenge-induced upregulation of GTPases, Cxcl9, Cxcl10 and Socs1, but not Gadd45g. Our data demonstrate that allergen challenge induces two sets of Th1-associated genes in the lungs: 1) Ifng-dependent genes such as p47 and p65 GTPases, Socs1, Cxcl9 and Cxcl10 and 2) Ifng-independent Th1-inducing genes like Gadd45g. We propose that allergen-induced airway inflammation is regulated by simultaneous upregulation of Th1 and Th2 genes, and that persistent unopposed upregulation of Th1 genes resolves allergic inflammation.	[Dharajiya, Nilesh; Vaidya, Swapnil; Sur, Sanjiv] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dharajiya, N (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	sasur@utmb.edu	Luxon, Bruce A/C-9140-2012		National Institutes of Health [1R01 HL071163]; NIAID Program Project [1P01 AI062885]; National Heart, Lung and Blood Institute Proteomics Initiative [N01-HV28184]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung and Blood Institute Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from National Institutes of Health (#1R01 HL071163 S. Sur), NIAID Program Project Grant (# 1P01 AI062885 S. Sur, PI on Project 4), National Heart, Lung and Blood Institute Proteomics Initiative (# N01-HV28184) to S. Sur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloebaum RM, 2004, CURR OPIN ALLERGY CL, V4, P63, DOI 10.1097/01.all.0000113681.18759.5e; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Carlow DA, 1998, J IMMUNOL, V161, P2348; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Choudhury BK, 2002, J IMMUNOL, V169, P5955, DOI 10.4049/jimmunol.169.10.5955; Chtanova T, 2001, J IMMUNOL, V167, P3057, DOI 10.4049/jimmunol.167.6.3057; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Hiroi M, 2003, BIOCHEM J, V376, P393, DOI 10.1042/BJ20030842; HUNT LW, 1994, AM J RESP CRIT CARE, V149, P1471, DOI 10.1164/ajrccm.149.6.8004300; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Leonard P, 2003, BIODRUGS, V17, P1, DOI 10.2165/00063030-200317010-00001; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Lund RJ, 2004, J IMMUNOL, V172, P6775, DOI 10.4049/jimmunol.172.11.6775; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Michalec L, 2002, J IMMUNOL, V168, P846, DOI 10.4049/jimmunol.168.2.846; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; SHAPIRA SK, 1991, P NATL ACAD SCI USA, V88, P7528, DOI 10.1073/pnas.88.17.7528; Sur S, 2000, EXP LUNG RES, V26, P457; Sur S, 1996, J IMMUNOL, V157, P4173; Sur S, 1999, J IMMUNOL, V162, P6284; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vestal DJ, 1998, J INTERF CYTOK RES, V18, P977, DOI 10.1089/jir.1998.18.977; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Walker PS, 1999, P NATL ACAD SCI USA, V96, P6970, DOI 10.1073/pnas.96.12.6970; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8172	10.1371/journal.pone.0008172	http://dx.doi.org/10.1371/journal.pone.0008172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027288	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100001
J	Hwang-Verslues, WW; Kuo, WH; Chang, PH; Pan, CC; Wang, HH; Tsai, ST; Jeng, YM; Shew, JY; Kung, JT; Chen, CH; Lee, EYHP; Chang, KJ; Lee, WH				Hwang-Verslues, Wendy W.; Kuo, Wen-Hung; Chang, Po-Hao; Pan, Chi-Chun; Wang, Hsing-Hui; Tsai, Sheng-Ta; Jeng, Yung-Ming; Shew, Jin-Yu; Kung, John T.; Chen, Chung-Hsuan; Lee, Eva Y. -H. P.; Chang, King-Jen; Lee, Wen-Hwa			Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers	PLOS ONE			English	Article							EXPRESSION; TUMORS; PROGENITORS; CD44(+)/CD24(-); TRANSPORTER; METASTASIS; PHENOTYPE; DISORDER; DIVISION; SUBTYPES	Heterogeneity of cancer stem/progenitor cells that give rise to different forms of cancer has been well demonstrated for leukemia. However, this fundamental concept has yet to be established for solid tumors including breast cancer. In this communication, we analyzed solid tumor cancer stem cell markers in human breast cancer cell lines and primary specimens using flow cytometry. The stem/progenitor cell properties of different marker expressing-cell populations were further assessed by in vitro soft agar colony formation assay and the ability to form tumors in NOD/SCID mice. We found that the expression of stem cell markers varied greatly among breast cancer cell lines. In MDA-MB-231 cells, PROCR and ESA, instead of the widely used breast cancer stem cell markers CD44(+)/CD24(-/low) and ALDH, could be used to highly enrich cancer stem/progenitor cell populations which exhibited the ability to self renew and divide asymmetrically. Furthermore, the PROCR(+)/ESA(+) cells expressed epithelial-mesenchymal transition markers. PROCR could also be used to enrich cells with colony forming ability from MB-361 cells. Moreover, consistent with the marker profiling using cell lines, the expression of stem cell markers differed greatly among primary tumors. There was an association between metastasis status and a high prevalence of certain markers including CD44(+)/CD24(-/low), ESA(+), CD133(+), CXCR4(+) and PROCR(+) in primary tumor cells. Taken together, these results suggest that similar to leukemia, several stem/progenitor cell-like subpopulations can exist in breast cancer.	[Hwang-Verslues, Wendy W.; Chang, Po-Hao; Pan, Chi-Chun; Wang, Hsing-Hui; Tsai, Sheng-Ta; Shew, Jin-Yu; Chen, Chung-Hsuan; Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Kung, John T.] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; University of California System; University of California Irvine; University of California System; University of California Irvine	Hwang-Verslues, WW (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	elee@uci.edu; kingjen@ntu.edu.tw; whlee@uci.edu	Kung, John T/AAZ-8354-2021; Chen, Chung-Hsuan/F-7940-2012; Lee, Wen-Hwa/C-2519-2014	Kung, John T/0000-0001-9052-1392; Wang, Hsing-Hui/0000-0003-3283-9583; JENG, YUNG-MING/0000-0002-3878-4491; Chang, King jen/0000-0001-9811-3422; KUO, WEN-HUNG/0000-0002-9881-4605; Hwang-Verslues, Wendy/0000-0002-0383-1710	Academia Sinica Peak Project [2371, 4012]; Academia Sinica Distinguished Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	Academia Sinica Peak Project(Academia Sinica - Taiwan); Academia Sinica Distinguished Postdoctoral Fellowship(Academia Sinica - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Academia Sinica Peak Project (grant number 2371, 4012, http://www.sinica.edu.tw) and an Academia Sinica Distinguished Postdoctoral Fellowship (http://aao.sinica.edu.tw/pfjob-e.html) to WWHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dittmer A, 2008, CANCER LETT, V260, P56, DOI 10.1016/j.canlet.2007.10.020; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hwang-Verslues WW, 2008, J FORMOS MED ASSOC, V107, P751, DOI 10.1016/S0929-6646(08)60188-6; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Korkaya H, 2008, ONCOGENE; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Vercauteren SM, 2001, CYTOTHERAPY, V3, P449, DOI 10.1080/146532401317248054; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	44	171	191	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8377	10.1371/journal.pone.0008377	http://dx.doi.org/10.1371/journal.pone.0008377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027313	Green Published, Green Submitted, gold			2022-12-27	WOS:000272940100013
J	Yang, S; Bourne, PE				Yang, Song; Bourne, Philip E.			The Evolutionary History of Protein Domains Viewed by Species Phylogeny	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MULTIDOMAIN PROTEINS; GENOME EVOLUTION; QUANTIFICATION; DUPLICATION; LIFE; REARRANGEMENTS; ARCHITECTURES; COMBINATIONS; DIVERGENCE	Background: Protein structural domains are evolutionary units whose relationships can be detected over long evolutionary distances. The evolutionary history of protein domains, including the origin of protein domains, the identification of domain loss, transfer, duplication and combination with other domains to form new proteins, and the formation of the entire protein domain repertoire, are of great interest. Methodology/Principal Findings: A methodology is presented for providing a parsimonious domain history based on gain, loss, vertical and horizontal transfer derived from the complete genomic domain assignments of 1015 organisms across the tree of life. When mapped to species trees the evolutionary history of domains and domain combinations is revealed, and the general evolutionary trend of domain and combination is analyzed. Conclusions/Significance: We show that this approach provides a powerful tool to study how new proteins and functions emerged and to study such processes as horizontal gene transfer among more distant species.	[Yang, Song; Bourne, Philip E.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego	Yang, S (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.	pbourne@ucsd.edu	Bourne, Philip E/C-2073-2008		National Institutes of Health (NIH) [GM 078596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078596] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grant GM 078596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Ekman D, 2007, J MOL BIOL, V372, P1337, DOI 10.1016/j.jmb.2007.06.022; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; Gough J, 2005, BIOINFORMATICS, V21, P1464, DOI 10.1093/bioinformatics/bti204; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Itoh M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r121; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Lee D, 2003, CURR OPIN STRUC BIOL, V13, P359, DOI 10.1016/S0959-440X(03)00079-4; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [10.1005667/978-3-642-86659-3.567, 10.1007/978-3-642-86659-3, DOI 10.1007/978-3-642-86659-3, 10. 1007/978-3-642-86659-3]; Padyana AK, 2001, BIOCHEM BIOPH RES CO, V282, P893, DOI 10.1006/bbrc.2001.4663; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wolf YI, 1999, GENOME RES, V9, P17; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	43	58	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8378	10.1371/journal.pone.0008378	http://dx.doi.org/10.1371/journal.pone.0008378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20041107	Green Published, gold			2022-12-27	WOS:000272940100014
J	Le Gouar, PJ; Vallet, D; David, L; Bermejo, M; Gatti, S; Levrero, F; Petit, EJ; Menard, N				Le Gouar, Pascaline J.; Vallet, Dominique; David, Laetitia; Bermejo, Magdalena; Gatti, Sylvain; Levrero, Florence; Petit, Eric J.; Menard, Nelly			How Ebola Impacts Genetics of Western Lowland Gorilla Populations	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EMERGING INFECTIOUS-DISEASES; NATURAL-POPULATION; GENOTYPING ERRORS; COMPUTER-PROGRAM; BARBARY MACAQUES; BOTTLENECK; VIRUS; SIZE; CONSERVATION	Background: Emerging infectious diseases in wildlife are major threats for both human health and biodiversity conservation. Infectious diseases can have serious consequences for the genetic diversity of populations, which could enhance the species' extinction probability. The Ebola epizootic in western and central Africa induced more than 90% mortality in Western lowland gorilla population. Although mortality rates are very high, the impacts of Ebola on genetic diversity of Western lowland gorilla have never been assessed. Methodology/Principal Findings: We carried out long term studies of three populations of Western lowland gorilla in the Republic of the Congo (Odzala-Kokoua National Park, Lossi gorilla sanctuary both affected by Ebola and Lossi's periphery not affected). Using 17 microsatellite loci, we compared genetic diversity and structure of the populations and estimate their effective size before and after Ebola outbreaks. Despite the effective size decline in both populations, we did not detect loss in genetic diversity after the epizootic. We revealed temporal changes in allele frequencies in the smallest population. Conclusions/Significance: Immigration and short time elapsed since outbreaks could explain the conservation of genetic diversity after the demographic crash. Temporal changes in allele frequencies could not be explained by genetic drift or random sampling. Immigration from genetically differentiated populations and a non random mortality induced by Ebola, i.e., selective pressure and cost of sociality, are alternative hypotheses. Understanding the influence of Ebola on gorilla genetic dynamics is of paramount importance for human health, primate evolution and conservation biology.	[Le Gouar, Pascaline J.; Vallet, Dominique; David, Laetitia; Gatti, Sylvain; Levrero, Florence; Petit, Eric J.; Menard, Nelly] Univ Rennes 1, UMR Ecobio 6553, CNRS, Paimpont, France; [Bermejo, Magdalena] Univ Barcelona, Dept Biol Anim, ECOFAC, Barcelona, Spain; [Levrero, Florence] Univ St Etienne, Lab Ecol & Neuroethol Sensorielles, EA 3988, St Etienne, France; [Petit, Eric J.] Univ Rennes 1, UMR BiO3P 1099, INRA, Le Rheu, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of Barcelona; Universite Jean Monnet; INRAE; Universite de Rennes	Le Gouar, PJ (corresponding author), Univ Rennes 1, UMR Ecobio 6553, CNRS, Paimpont, France.	pascalinelegouar@free.fr	Petit, Eric J/C-1091-2011; Le Gouar, Pascaline/A-6209-2010; VALLET, Dominique/L-2309-2018; MENARD, Nelly/L-2214-2018	Petit, Eric J/0000-0001-5058-5826; VALLET, Dominique/0000-0002-8551-6019; Levrero, Florence/0000-0002-6904-1375; MENARD, Nelly/0000-0003-4122-9330; Le Gouar, Pascaline/0000-0001-5309-3667	Ministere de l'Ecologie et du Developpement Durable, France; DG Environnement, UE	Ministere de l'Ecologie et du Developpement Durable, France; DG Environnement, UE	This research is funded by the ECOFOR program (Ministere de l'Ecologie et du Developpement Durable, France) and the Especes-Phares program (DG Environnement, UE, carried out by RAPAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; BAKER CS, 1994, J HERED, V85, P52; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; BELKHIR K, 1996, GENETIX LOGICIEL WIN; Bermejo M, 2004, AM J PRIMATOL, V64, P223, DOI 10.1002/ajp.20073; Bermejo M, 1999, ORYX, V33, P323, DOI 10.1017/S0030605300030726; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Bradley Brenda J., 2000, Conservation Genetics, V1, P289, DOI 10.1023/A:1011514007741; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Clifford SL, 1999, MOL ECOL, V8, P1556, DOI 10.1046/j.1365-294X.1999.07184.x; Clifford SL, 2003, CAM S BIO EVOL ANTHR, V35, P269; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garrigan D, 2003, EVOLUTION, V57, P1707; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Gerber LR, 2005, ECOL APPL, V15, P1402, DOI 10.1890/04-0880; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GROSS L, 2005, PLOS BIOL, V3, pE403; Gulland F. M. D., 1995, P20, DOI 10.1017/CBO9780511629396.002; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Harcourt A H, 1980, J Reprod Fertil Suppl, VSuppl 28, P59; Harcourt AH, 1996, BIOL CONSERV, V75, P165, DOI 10.1016/0006-3207(95)00059-3; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARTL GB, 1994, BIODIVERS CONSERV, V3, P546, DOI 10.1007/BF00115160; Hawley DM, 2006, MOL ECOL, V15, P263, DOI 10.1111/j.1365-294X.2005.02767.x; Hedrick PW, 1998, GENETICA, V104, P207, DOI 10.1023/A:1026494212540; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hopkin M, 2007, NATURE, V449, P127, DOI 10.1038/449127a; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; HUO CH, 2003, MOL ECOL NOTES, V3, P669; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lathuilliere M, 2001, AM J PRIMATOL, V55, P151, DOI 10.1002/ajp.1048; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Levrero F, 2006, AM J PRIMATOL, V68, P275, DOI 10.1002/ajp.20223; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Lukas D, 2004, MOL ECOL, V13, P3389, DOI 10.1111/j.1365-294X.2004.02353.x; Magliocca F, 1999, AM J PRIMATOL, V48, P1, DOI 10.1002/(SICI)1098-2345(1999)48:1<1::AID-AJP1>3.0.CO;2-2; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Morvan JM, 1999, MICROBES INFECT, V1, P1193, DOI 10.1016/S1286-4579(99)00242-7; Murphy M.F., 1982, International Zoo Yearbook, V22, P180, DOI 10.1111/j.1748-1090.1982.tb02031.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nunn CL, 2008, EVOL ECOL, V22, P519, DOI 10.1007/s10682-007-9180-x; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; Queney G, 2000, MOL ECOL, V9, P1253, DOI 10.1046/j.1365-294x.2000.01003.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rizkalla C, 2007, ECOHEALTH, V4, P151, DOI 10.1007/s10393-007-0096-2; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; SLATKIN M, 1995, MOL BIOL EVOL, V12, P473; Smith DG, 2000, AM J PRIMATOL, V50, P1; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Sullivan N, 2003, J VIROL, V77, P9733, DOI 10.1128/JVI.77.18.9733-9737.2003; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Valsecchi E, 2004, ANIM CONSERV, V7, P139, DOI 10.1017/S1367943004001325; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogel G, 2007, SCIENCE, V317, P1484, DOI 10.1126/science.317.5844.1484; Vogel TU, 1999, IMMUNOL REV, V167, P327, DOI 10.1111/j.1600-065X.1999.tb01402.x; Waldick RC, 2002, MOL ECOL, V11, P2241, DOI 10.1046/j.1365-294X.2002.01605.x; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; WATTERSON GA, 1978, GENETICS, V88, P171; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilberg MJ, 2004, MOL ECOL NOTES, V4, P783, DOI 10.1111/j.1471-8286.2004.00797.x; Wisely SM, 2008, J WILDLIFE DIS, V44, P53, DOI 10.7589/0090-3558-44.1.53	108	25	25	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8375	10.1371/journal.pone.0008375	http://dx.doi.org/10.1371/journal.pone.0008375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020045	Green Published, gold, Green Submitted			2022-12-27	WOS:000272870600014
J	Ganzhorn, JU; Arrigo-Nelson, S; Boinski, S; Bollen, A; Carrai, V; Derby, A; Donati, G; Koenig, A; Kowalewski, M; Lahann, P; Norscia, I; Polowinsky, SY; Schwitzer, C; Stevenson, PR; Talebi, MG; Tan, C; Vogel, ER; Wright, PC				Ganzhorn, Joerg U.; Arrigo-Nelson, Summer; Boinski, Sue; Bollen, An; Carrai, Valentina; Derby, Abigail; Donati, Giuseppe; Koenig, Andreas; Kowalewski, Martin; Lahann, Petra; Norscia, Ivan; Polowinsky, Sandra Y.; Schwitzer, Christoph; Stevenson, Pablo R.; Talebi, Mauricio G.; Tan, Chia; Vogel, Erin R.; Wright, Patricia C.			Possible Fruit Protein Effects on Primate Communities in Madagascar and the Neotropics	PLOS ONE			English	Article							NUTRITIONAL QUALITY; SEASONAL-VARIATION; DIETARY-RESPONSE; FOLIVOROUS LEMUR; SEED DISPERSAL; LEAF CHEMISTRY; HOWLER MONKEYS; NATIONAL-PARK; RAIN-FOREST; FOOD	Background: The ecological factors contributing to the evolution of tropical vertebrate communities are still poorly understood. Primate communities of the tropical Americas have fewer folivorous but more frugivorous genera than tropical regions of the Old World and especially many more frugivorous genera than Madagascar. Reasons for this phenomenon are largely unexplored. We developed the hypothesis that Neotropical fruits have higher protein concentrations than fruits from Madagascar and that the higher representation of frugivorous genera in the Neotropics is linked to high protein concentrations in fruits. Low fruit protein concentrations in Madagascar would restrict the evolution of frugivores in Malagasy communities. Methodology/Principal Findings: We reviewed the literature for nitrogen concentrations in fruits from the Neotropics and from Madagascar, and analyzed fruits from an additional six sites in the Neotropics and six sites in Madagascar. Fruits from the Neotropical sites contain significantly more nitrogen than fruits from the Madagascar sites. Nitrogen concentrations in New World fruits are above the concentrations to satisfy nitrogen requirements of primates, while they are at the lower end or below the concentrations to cover primate protein needs in Madagascar. Conclusions/Significance: Fruits at most sites in the Neotropics contain enough protein to satisfy the protein needs of primates. Thus, selection pressure to develop new adaptations for foods that are difficult to digest (such as leaves) may have been lower in the Neotropics than in Madagascar. The low nitrogen concentrations in fruits from Madagascar may contribute to the almost complete absence of frugivorous primate species on this island.	[Ganzhorn, Joerg U.; Lahann, Petra] Univ Hamburg, Biozentrum Grindel, Hamburg, Germany; [Arrigo-Nelson, Summer; Derby, Abigail; Kowalewski, Martin; Stevenson, Pablo R.; Tan, Chia; Vogel, Erin R.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci Ecol & E, Stony Brook, NY 11794 USA; [Boinski, Sue] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Bollen, An] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Bollen, An] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Carrai, Valentina; Donati, Giuseppe; Norscia, Ivan] Univ Pisa, Dept Biol, Pisa, Italy; [Koenig, Andreas; Wright, Patricia C.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Lahann, Petra] Forschungsinstitut Biol Landwirtschaftlicher Nutz, Dummerstorf, Germany; [Polowinsky, Sandra Y.; Schwitzer, Christoph] Bristol Conservat & Sci Fdn, Bristol, Avon, England; [Talebi, Mauricio G.] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England	University of Hamburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida; University of Antwerp; University of Pisa; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Forschungsinstitut fur Nutztierbiologie (FBN); University of Cambridge	Ganzhorn, JU (corresponding author), Univ Hamburg, Biozentrum Grindel, Hamburg, Germany.	ganzhorn@zoologie.uni-hamburg.de	Ganzhorn, Joerg/AAO-6955-2020; Koenig, Andreas/G-6705-2013; Koenig, Andreas/AAE-6492-2020; Norscia, Ivan/J-3321-2015; Talebi, Mauricio/J-9376-2014	Ganzhorn, Joerg/0000-0003-1395-9758; Koenig, Andreas/0000-0003-1494-9156; Koenig, Andreas/0000-0003-1494-9156; Norscia, Ivan/0000-0002-1618-7717; Donati, Giuseppe/0000-0002-4803-0642; Talebi, Mauricio/0000-0001-6783-2715	Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Belgian Fund for Scientific Research; Flanders; Conservation International's Primate Action Fund; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; Earthwatch Institute; German Primate Center; Italian Ministry for Scientific Research (MURST); J. William Fulbright Foundation; Margot Marsh Biodiversity Foundation; National Science Foundation; National Geographic; St. Louis Zoo	Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Flanders; Conservation International's Primate Action Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Earthwatch Institute; German Primate Center; Italian Ministry for Scientific Research (MURST)(Ministry of Education, Universities and Research (MIUR)); J. William Fulbright Foundation; Margot Marsh Biodiversity Foundation; National Science Foundation(National Science Foundation (NSF)); National Geographic(National Geographic Society); St. Louis Zoo	Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL), the Belgian Fund for Scientific Research, Flanders, Conservation International's Primate Action Fund, the Deutsche Forschungsgemeinschaft, the Deutscher Akademischer Austauschdienst, Earthwatch Institute, the German Primate Center, the Italian Ministry for Scientific Research (MURST), the J. William Fulbright Foundation, the Margot Marsh Biodiversity Foundation, the National Science Foundation, National Geographic, and St. Louis Zoo. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsalis S, 1999, INT J PRIMATOL, V20, P193, DOI 10.1023/A:1020518419038; ATSALIS S, 2007, NATURAL HIST BROWN M; Bollen A, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P93, DOI 10.1007/1-4020-3833-X_6; Bollen A, 2004, OECOLOGIA, V139, P604, DOI 10.1007/s00442-004-1544-0; Bollen An, 2007, P127; Brockman D.K., 2005, PRIMATE SEASONALITY; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; Conklin-Brittain NL, 1999, J CHEM ECOL, V25, P2601, DOI 10.1023/A:1020835120701; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Curtis DJ, 2004, AM J PHYS ANTHROPOL, V124, P234, DOI 10.1002/ajpa.10268; DAUSMANN K, LEAPING AHE IN PRESS; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Emmons Louise H., 1999, P171, DOI 10.1017/CBO9780511542381.011; ESTRADA A, 1984, AM J PRIMATOL, V6, P77, DOI 10.1002/ajp.1350060202; Estrada A, 1986, FRUGIVORES SEED DISP, P93; *FAO, 1991, GUID LAND EV EXT GRA; Faulkner AL, 2006, FOLIA PRIMATOL, V77, P218, DOI 10.1159/000091231; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Fleagle John G., 1999, P92, DOI 10.1017/CBO9780511542381.007; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Foster R. B., 1982, ECOLOGY TROPICAL FOR, P201; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Ganzhorn Jorg U., 1999, P75, DOI 10.1017/CBO9780511542381.005; Ganzhorn JU, 2004, J ZOOL, V263, P393, DOI 10.1017/S0952836904005394; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Ganzhorn JU, 2002, OECOLOGIA, V131, P427, DOI 10.1007/s00442-002-0891-y; GAUTIERHION A, 1989, ECOLOGY, V70, P1826, DOI 10.2307/1938115; GENIN FGS, EVOLUTION E IN PRESS; Godfrey LR, 2004, J HUM EVOL, V47, P145, DOI 10.1016/j.jhevol.2004.06.003; Goodman SM, 1997, REV ECOL-TERRE VIE, V52, P321; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Heiduck S, 1997, INT J PRIMATOL, V18, P487, DOI 10.1023/A:1026355004744; Heymann EW, 2001, AM J PRIMATOL, V55, P171, DOI 10.1002/ajp.1050; HLADIK CM, 1971, FOLIA PRIMATOL, V16, P85, DOI 10.1159/000155393; JANSON C, 2005, TROPICAL FRUITS FRUG, P307; JANSON CH, 1986, FRUGIVORES SEED DISP, P00083, DOI DOI 10.1007/978-94-009-4812-9_9; Kappeler PM, 1996, BIOL J LINN SOC, V59, P297; Kay R.F., 1984, P21; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Lahann P, 2007, J ZOOL, V271, P88, DOI 10.1111/j.1469-7998.2006.00222.x; Lambert J.E., 2007, PRIMATES PERSPECTIVE, P482, DOI DOI 10.1146/ANNUREV-ANTHRO-102313-025928; Langrand O., 1990, GUIDE BIRDS MADAGASC; Levey DJ, 2000, J CHEM ECOL, V26, P1749, DOI 10.1023/A:1005503316406; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; MILTON K, 1981, BIOTROPICA, V13, P177, DOI 10.2307/2388122; MILTON K, 1990, J TROP ECOL, V6, P493, DOI 10.1017/S0266467400004909; Mutschler T, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P221; Norconk MA, 2004, INT J PRIMATOL, V25, P1, DOI 10.1023/B:IJOP.0000014642.68751.ed; O'Brien TG, 1998, NATURE, V392, P668, DOI 10.1038/33580; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; OFTEDAL OT, 1991, PHILOS T R SOC B, V334, P161, DOI 10.1098/rstb.1991.0105; Powzyk JA, 2003, INT J PRIMATOL, V24, P1143, DOI 10.1023/B:IJOP.0000005984.36518.94; RASAMIMANANA B, 2004, DOMINANCE FEMELLES M; Richard AF, 2000, J HUM EVOL, V39, P381, DOI 10.1006/jhev.2000.0427; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Silver SC, 2000, ZOO BIOL, V19, P95, DOI 10.1002/1098-2361(2000)19:2<95::AID-ZOO1>3.0.CO;2-D; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Simmen B, 2007, INT J PRIMATOL, V28, P1253, DOI 10.1007/s10764-007-9217-6; SPSS, 1999, SPSS BAS 9 0 US GUID; Stevenson P, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P37, DOI 10.1007/1-4020-3833-X_3; Stevenson PR, 2004, INT J PRIMATOL, V25, P367, DOI 10.1023/B:IJOP.0000019157.35464.a0; Strier K.B., 2007, PRIMATE BEHAV ECOLOG, V3rd ed.; Terborgh J., 1987, P205; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Terborgh J., 1986, CONSERVATION BIOL SC, P330; van Schaik CP, 2005, CAM S BIO EVOL ANTHR, V44, P445, DOI 10.1017/CBO9780511542343.016; White T. C. R., 1993, INADEQUATE ENV NITRO; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Wright Patricia C., 1997, P127; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7; ZUNINO GE, 1989, B PRIMATOLOGICO LATI, V1, P75	80	66	67	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8253	10.1371/journal.pone.0008253	http://dx.doi.org/10.1371/journal.pone.0008253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016841	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834000006
J	Cohen, JM; Hutcheon, JA; Julien, SG; Tremblay, ML; Fuhrer, R				Cohen, Jacqueline M.; Hutcheon, Jennifer A.; Julien, Sofi G.; Tremblay, Michel L.; Fuhrer, Rebecca			Insufficient Milk Supply and Breast Cancer Risk: A Systematic Review	PLOS ONE			English	Article							LACTATION HISTORY; ASSOCIATION; WOMEN	Background: An association between insufficient milk supply, the inability of a mother's breast milk to provide sufficiently for her infant, and breast cancer has been suggested by observations in animal models. To determine if an association has been reported in epidemiological studies of human breast cancer, a systematic review of the literature has been conducted. We also sought to identify the methodological limitations of existing studies to guide the design of any future prospective studies in this field. Methodology/Principal Findings: PubMed, EMBASE, Web of Science, BIOSIS, and CAB abstracts were searched. We selected any study that (1) assessed breast cancer in association with breastfeeding history and (2) examined the relationship between insufficient milk supply with breast cancer. Seven relevant studies were identified that met both criteria. There was statistically significant heterogeneity among the results which likely reflects clinically significant differences in definitions of insufficient milk supply and reference groups that were used. Among premenopausal women who had experienced insufficient milk supply, odds ratios (ORs) for breast cancer risk ranged from 0.9 to 16.3. Among postmenopausal women, ORs ranged from 0.6 to 6.7. Based on the range of odds ratios obtained in the studies reported in this review, it remains unclear if there is a true association between insufficient milk supply and breast cancer. Conclusions/Significance: Although some studies have shown a strong positive association, there is no consistent evidence for an effect of insufficient milk supply on breast cancer risk. Exposure definitions are in need of improvement in order to focus on primary insufficient milk supply. Reference groups consisting of women who have successfully breastfed may also introduce positive bias (inflation of the odds ratio) into study results because of the protective effect of prolonged breastfeeding in the control group.	[Cohen, Jacqueline M.; Hutcheon, Jennifer A.; Fuhrer, Rebecca] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Julien, Sofi G.; Tremblay, Michel L.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Cohen, JM (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	rebecca.fuhrer@mcgill.ca	Cohen, Jacqueline M./H-6517-2019	Cohen, Jacqueline M./0000-0002-7300-0488; Hutcheon, Jennifer/0000-0002-6618-6018; Julien, Sophie/0000-0003-2694-7211	Canadian Institutes of Health Research [MOP-62887]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research operating grant (MOP-62887) to MLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINTON LA, 1995, CANCER CAUSE CONTROL, V6, P199, DOI 10.1007/BF00051791; BYERS T, 1985, AM J EPIDEMIOL, V121, P664, DOI 10.1093/aje/121.5.664; *CAN CANC SOC NAT, 2008, CAN CANC STAT 2008; Dennis CL, 2002, JOGNN-J OBST GYN NEO, V31, P12, DOI 10.1111/j.1552-6909.2002.tb00019.x; Dodds L, 2008, OBSTET GYNECOL, V111, P1167, DOI 10.1097/AOG.0b013e31816fd778; Freudenheim JL, 1997, AM J EPIDEMIOL, V146, P932, DOI 10.1093/oxfordjournals.aje.a009219; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILLMAN H, 1989, PHYSIOL CHEM PHYS ME, V21, P145; Hutchinson JN, 2000, ONCOGENE, V19, P6130, DOI 10.1038/sj.onc.1203970; JULIEN SG, COMMUNICATION; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Katsouyanni K, 1996, BRIT J CANCER, V73, P814, DOI 10.1038/bjc.1996.143; Kim Y, 2007, EUR J CANCER PREV, V16, P124, DOI 10.1097/01.cej.0000228400.07364.52; Lipworth L, 2000, JNCI-J NATL CANCER I, V92, P302, DOI 10.1093/jnci/92.4.302; NEIFERT M, 1990, BIRTH-ISS PERINAT C, V17, P31, DOI 10.1111/j.1523-536X.1990.tb00007.x; Neifert MR, 2004, CLIN OBSTET GYNECOL, V47, P656, DOI 10.1097/01.grf.0000136183.12304.96; Newcomb PA, 1999, AM J EPIDEMIOL, V150, P174, DOI 10.1093/oxfordjournals.aje.a009977; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; Newcomb PA, 1997, J MAMMARY GLAND BIOL, V2, P311, DOI 10.1023/A:1026344707161; Romieu I, 1996, AM J EPIDEMIOL, V143, P543, DOI 10.1093/oxfordjournals.aje.a008784; Sakai T, 2001, MCN Am J Matern Child Nurs, V26, P42, DOI 10.1097/00005721-200101000-00011; *SEER, 2008, SEER STAT FACT SHEET; Shema L, 2007, J CANCER RES CLIN, V133, P539, DOI 10.1007/s00432-007-0199-8; SISKIND V, 1989, AM J EPIDEMIOL, V130, P229; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; YANG CP, 1993, AM J EPIDEMIOL, V138, P1050, DOI 10.1093/oxfordjournals.aje.a116823	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8237	10.1371/journal.pone.0008237	http://dx.doi.org/10.1371/journal.pone.0008237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011591	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300015
J	Mancini, N; Diotti, RA; Perotti, M; Sautto, G; Clementi, N; Nitti, G; Patel, AH; Ball, JK; Clementi, M; Burioni, R				Mancini, Nicasio; Diotti, Roberta A.; Perotti, Mario; Sautto, Giuseppe; Clementi, Nicola; Nitti, Giovanni; Patel, Arvind H.; Ball, Jonathan K.; Clementi, Massimo; Burioni, Roberto			Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; E2 ENVELOPE GLYCOPROTEIN; HYPERVARIABLE REGION 1; SYNERGISTIC NEUTRALIZATION; CONFORMATIONAL EPITOPES; REPERTOIRE CLONING; CD4-BINDING SITE; MAJOR GENOTYPES; CELL-CULTURE; V3 LOOP	Anti-hepatitis C virus (HCV) cross-neutralizing human monoclonal antibodies, directed against conserved epitopes on surface E2 glycoprotein, are central tools for understanding virus-host interplay, and for planning strategies for prevention and treatment of this infection. Recently, we developed a research aimed at identifying these antibody specificities. The characteristics of one of these antibodies (Fab e20) were addressed in this study. Firstly, using immunofluorescence and FACS analysis of cells expressing envelope HCV glycoproteins, Fab e20 was able to recognize all HCV genotypes. Secondly, competition assays with a panel of mouse and rat monoclonals, and alanine scanning mutagenesis analyses located the e20 epitope within the CD81 binding site, documenting that three highly conserved HCV/E2 residues (W529, G530 and D535) are critical for e20 binding. Finally, a strong neutralizing activity against HCV pseudoparticles (HCVpp) incorporating envelope glycoproteins of genotypes 1a, 1b, 2a, 2b and 4, and against the cell culture-grown (HCVcc) JFH1 strain, was observed. The data highlight that neutralizing antibodies against HCV epitopes present in all HCV genotypes are elicited during natural infection. Their availability may open new avenues to the understanding of HCV persistence and to the development of strategies for the immune control of this infection.	[Mancini, Nicasio; Diotti, Roberta A.; Perotti, Mario; Sautto, Giuseppe; Clementi, Nicola; Nitti, Giovanni; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Patel, Arvind H.] Univ Glasgow, Inst Virol, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Ball, Jonathan K.] Univ Nottingham, Inst Infect Immun & Inflammat, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2RD, England	Vita-Salute San Raffaele University; University of Glasgow; University of Nottingham	Mancini, N (corresponding author), Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy.	mancini.nicasio@hsr.it	Burioni, Roberto/F-2396-2012; Clementi, Massimo/F-6646-2013; Clementi, Nicola/G-8545-2014; Ball, Jonathan/HGU-3130-2022; Mancini, Nicasio/AAN-6203-2020; Sautto, Giuseppe Andrea/A-8588-2015	Clementi, Nicola/0000-0002-1822-9861; Sautto, Giuseppe Andrea/0000-0002-0273-2235; Clementi, Massimo/0000-0002-7461-5898; MANCINI, Nicasio/0000-0003-0637-0910; ball, jonathan/0000-0001-5773-8733	Medical Research Council [G0801169, MC_U130184144] Funding Source: Medline; MRC [MC_U130184144, G0801169] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allander T, 2000, J GEN VIROL, V81, P2451, DOI 10.1099/0022-1317-81-10-2451; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bowen DG, 2005, J HEPATOL, V42, P408, DOI 10.1016/j.jhep.2004.12.013; BUCHBINDER A, 1992, AIDS RES HUM RETROV, V8, P425, DOI 10.1089/aid.1992.8.425; BUGLI F, 2001, J VIROL, V83; Burioni R, 1998, HEPATOLOGY, V28, P810, DOI 10.1002/hep.510280331; Burioni R, 2004, VIROLOGY, V327, P242, DOI 10.1016/j.virol.2004.06.042; Burioni R, 2002, J VIROL, V76, P11775, DOI 10.1128/JVI.76.22.11775-11779.2002; Burioni R, 2001, VIROLOGY, V288, P29, DOI 10.1006/viro.2001.1014; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Esumi M, 2002, VACCINE, V20, P3095, DOI 10.1016/S0264-410X(02)00271-2; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Iacob RE, 2008, BBA-PROTEINS PROTEOM, V1784, P530, DOI 10.1016/j.bbapap.2007.12.015; Ishii K, 1998, HEPATOLOGY, V28, P1117, DOI 10.1002/hep.510280429; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; LAAL S, 1994, J VIROL, V68, P4001, DOI 10.1128/JVI.68.6.4001-4008.1994; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Manzin A, 2000, J VIROL, V74, P4327, DOI 10.1128/JVI.74.9.4327-4334.2000; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Piazza M, 1997, ARCH INTERN MED, V157, P1537, DOI 10.1001/archinte.157.14.1537; Plaisant P, 1997, RES VIROLOGY, V148, P165, DOI 10.1016/S0923-2516(97)89904-9; Prabhu R, 2004, AM J PATHOL, V165, P1163, DOI 10.1016/S0002-9440(10)63377-9; Puntoriero G, 1998, EMBO J, V17, P3521, DOI 10.1093/emboj/17.13.3521; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; TILLEY SA, 1992, AIDS RES HUM RETROV, V8, P461, DOI 10.1089/aid.1992.8.461; Timm J, 2007, WORLD J GASTROENTERO, V13, P4808, DOI 10.3748/wjg.v13.i36.4808; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; ZHANG P, 2009, P NATL ACAD SCI US	51	54	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8254	10.1371/journal.pone.0008254	http://dx.doi.org/10.1371/journal.pone.0008254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011511	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000272830200007
J	Souza-e-Silva, H; Savino, W; Feijoo, RA; Vasconcelos, ATR				Souza-e-Silva, Hallan; Savino, Wilson; Feijoo, Raul A.; Ribeiro Vasconcelos, Ana Tereza			A Cellular Automata-Based Mathematical Model for Thymocyte Development	PLOS ONE			English	Article							BONE-MARROW-CELLS; MEDULLA MIGRATION; DIFFERENTIATION; THYMUS; DURATION; MICROENVIRONMENTS; POPULATION; CHEMOKINES; DYNAMICS; GROWTH	Intrathymic T cell development is an important process necessary for the normal formation of cell-mediated immune responses. Importantly, such a process depends on interactions of developing thymocytes with cellular and extracellular elements of the thymic microenvironment. Additionally, it includes a series of oriented and tunely regulated migration events, ultimately allowing mature cells to cross endothelial barriers and leave the organ. Herein we built a cellular automata-based mathematical model for thymocyte migration and development. The rules comprised in this model take into account the main stages of thymocyte development, two-dimensional sections of the normal thymic microenvironmental network, as well as the chemokines involved in intrathymic cell migration. Parameters of our computer simulations with further adjusted to results derived from previous experimental data using sub-lethally irradiated mice, in which thymus recovery can be evaluated. The model fitted with the increasing numbers of each CD4/CD8-defined thymocyte subset. It was further validated since it fitted with the times of permanence experimentally ascertained in each CD4/CD8-defined differentiation stage. Importantly, correlations using the whole mean volume of young normal adult mice revealed that the numbers of cells generated in silico with the mathematical model fall within the range of total thymocyte numbers seen in these animals. Furthermore, simulations made with a human thymic epithelial network using the same mathematical model generated similar profiles for temporal evolution of thymocyte developmental stages. Lastly, we provided in silico evidence that the thymus architecture is important in the thymocyte development, since changes in the epithelial network result in different theoretical profiles for T cell development/migration. This model likely can be used to predict thymocyte evolution following therapeutic strategies designed for recovery of the thymus in diseases coursing with thymus involution, such as some primary immunodeficiencies, acute infections, and malnutrition.	[Souza-e-Silva, Hallan; Ribeiro Vasconcelos, Ana Tereza] LNCC MCT, Bioinformat Lab, Petropolis, Brazil; [Savino, Wilson] Inst Oswaldo Cruz, Lab Thymus Res, BR-20001 Rio De Janeiro, Brazil; [Feijoo, Raul A.] INCT MACC, Natl Inst Sci & Technol Med Assisted Sci Comp, Petropolis, Brazil; [Feijoo, Raul A.] LNCC MCT, Comp Sci Coordinat, Petropolis, Brazil	Laboratorio Nacional de Computacao Cientifica (LNCC); Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC)	Souza-e-Silva, H (corresponding author), Univ Fed Vicosa, Dept Phys, Vicosa, MG, Brazil.	savino@fiocruz.br	Vasconcelos, Ana Tereza R/I-1011-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; 	Brazilian Ministries of Science (PCI-LNCC - www.lncc.br, and CNPq-www.cnpq.br), Education (CAPES-www.capes.gov.br), and Health (Fiocruz - www.fiocruz.br)	Brazilian Ministries of Science (PCI-LNCC - www.lncc.br, and CNPq-www.cnpq.br), Education (CAPES-www.capes.gov.br), and Health (Fiocruz - www.fiocruz.br)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been funded with grants from the Brazilian Ministries of Science (PCI-LNCC - www.lncc.br, and CNPq-www.cnpq.br), Education (CAPES-www.capes.gov.br), and Health (Fiocruz - www.fiocruz.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990; Efroni S, 2005, COMPUTER, V38, P38, DOI 10.1109/MC.2005.31; Efroni S, 2003, GENOME RES, V13, P2485, DOI 10.1101/gr.1215303; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; EREN R, 1988, CELL IMMUNOL, V112, P449, DOI 10.1016/0008-8749(88)90315-2; Geankoplis Christie J, 1993, TRANSPORT PROCESS UN, V3rd; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Lewin R, 1993, COMPLEXITY LIFE EDGE; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; MEHR R, 1993, MECH AGEING DEV, V67, P159, DOI 10.1016/0047-6374(93)90120-G; Mehr R, 1996, J THEOR BIOL, V181, P157, DOI 10.1006/jtbi.1996.0122; MEHR R, 1995, J THEOR BIOL, V175, P103, DOI 10.1006/jtbi.1995.0124; MENDESDACRUZ DA, 2008, J IMMUNOL, V180, P8; MENDESDACRUZ DA, 2008, J IMMUNOL, V180, P11; Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; SALINAS FA, 1972, J CELL PHYSIOL, V80, P339, DOI 10.1002/jcp.1040800304; Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Savino W, 2007, EXP PHYSIOL, V92, P813, DOI 10.1113/expphysiol.2007.038422; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Shi HJ, 2006, MATH BIOSCI ENG, V3, P237; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Suzuki G, 1999, J IMMUNOL, V162, P5981; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; WOLFRAM S, 1986, THEORY APLLICATIONS; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zhou R, 2004, J MOL ENDOCRINOL, V32, P349, DOI 10.1677/jme.0.0320349	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8233	10.1371/journal.pone.0008233	http://dx.doi.org/10.1371/journal.pone.0008233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011042	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800017
J	Tan, CE; Li, HJ; Zhang, XG; Zhang, H; Han, PY; An, Q; Ding, WJ; Wang, MQ				Tan, Cong E.; Li, Hong Jun; Zhang, Xian Geng; Zhang, Hui; Han, Pei Yu; An, Qu; Ding, Wei Jun; Wang, Mi Qu			The Impact of the Wenchuan Earthquake on Birth Outcomes	PLOS ONE			English	Article							SEX-RATIO; STRESS; TWIN; PREGNANCY; PROVINCE; DECLINE; AREA	Background: Earthquakes and other catastrophic events frequently occurring worldwide can be considered as outliers and cause a growing and urgent need to improve our understanding of the negative effects imposed by such disasters. Earthquakes can intensively impact the birth outcomes upon psychological and morphological development of the unborn children, albeit detailed characteristics remain obscure. Methods and Findings: We utilized the birth records at Du Jiang Yan and Peng Zhou counties to investigate the birth outcomes as a consequence of a major earthquake occurred in Wenchuan, China on May 12, 2008. Totally 13,003 of neonates were recorded, with 6638 and 6365 for pre- and post-earthquake, respectively. Significant low birthweight, high ratio of low birthweight, and low Apgar scores of post-earthquake group were observed. In contrast, the sex ratio at birth, birth length and length of gestation did not show statistical differences. The overall ratio of birth-defect in the post-earthquake (1.18%) is statistically high than that of pre- earthquake (0.99%), especially for those in the first trimester on earthquake day (1.47%). The birth-defect spectrum was dramatically altered after earthquake, with the markedly increased occurrences of ear malformations. The ratio of preterm birth post-earthquake (7.41%) is significant increased than that of pre- earthquake (5.63%). For the birth outcomes of twins, significant differences of the ratio of twins, birth weight, ratio of low birthweight and birth-defect rate were observed after earthquake. Conclusion: A hospital-based study of birth outcomes impacted by the Wenchuan earthquake shows that the earthquake was associated with significant effects on birth outcomes, indicating it is a major monitor for long-term pregnant outcomes.	[Tan, Cong E.; Li, Hong Jun; Zhang, Xian Geng; Zhang, Hui; Han, Pei Yu; An, Qu; Ding, Wei Jun; Wang, Mi Qu] Chengdu Univ Tradit Chinese Med, Inst Basic Med, Chengdu, Peoples R China; [Tan, Cong E.] Shaanxi Univ Chinese Med, Xian, Peoples R China	Chengdu University of Traditional Chinese Medicine; Shaanxi University of Chinese Medicine	Tan, CE (corresponding author), Chengdu Univ Tradit Chinese Med, Inst Basic Med, Chengdu, Peoples R China.	Ding2004wj@yahoo.com.cn; wangmiqu@yahoo.com.cn		Ding, Wei-Jun/0000-0002-0419-0900	National Science Funds of China [30873316, 90709053]	National Science Funds of China	This work is supported by National Science Funds of China (NO. 30873316, and NO. 90709053)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein E, 2009, Minerva Ginecol, V61, P113; CASTILLA EE, 1986, INT J EPIDEMIOL, V15, P364, DOI 10.1093/ije/15.3.364; Catalano R, 2006, HUM REPROD, V21, P3127, DOI 10.1093/humrep/del283; Chang HL, 2002, PSYCHIAT CLIN NEUROS, V56, P139, DOI 10.1046/j.1440-1819.2002.00948.x; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Hibino Y, 2009, PSYCHIAT CLIN NEUROS, V63, P107, DOI 10.1111/j.1440-1819.2008.01911.x; King S, 2000, Sante Ment Que, V25, P163; Li S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004964; Liu Shi-an, 2009, Zhonghua Yufang Yixue Zazhi, V43, P380, DOI 10.3760/cma.j.issn.0253-9624.2009.05.010; MONTENEGRO MA, 1995, ARCH ORAL BIOL, V40, P33; Parsons T, 2008, NATURE, V454, P509, DOI 10.1038/nature07177; Saadat M, 2008, J BIOSOC SCI, V40, P935, DOI 10.1017/S0021932008002745; Siribaddana SH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-49; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Stone R, 2009, SCIENCE, V324, P713, DOI 10.1126/science.324_713; Wadhawan R, 2009, PEDIATRICS, V123, pE220, DOI 10.1542/peds.2008-1126; Young NM, 2007, ANAT REC, V290, P123, DOI 10.1002/ar.20415; Zhu J, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P62	20	67	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8200	10.1371/journal.pone.0008200	http://dx.doi.org/10.1371/journal.pone.0008200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997649	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829500018
J	Wang, XL; Gou, DM; Xu, SY				Wang, Xiaolong; Gou, Deming; Xu, Shuang-yong			Polymerase-Endonuclease Amplification Reaction (PEAR) for Large-Scale Enzymatic Production of Antisense Oligonucleotides	PLOS ONE			English	Article							ISOTHERMAL DNA AMPLIFICATION; CIRCLE AMPLIFICATION; RESTRICTION ENZYME; MICRORNA; CHROMATOGRAPHY; PURIFICATION; INHIBITION; DUPLEXES; DISEASE; SYSTEM	Antisense oligonucleotides targeting microRNAs or their mRNA targets prove to be powerful tools for molecular biology research and may eventually emerge as new therapeutic agents. Synthetic oligonucleotides are often contaminated with highly homologous failure sequences. Synthesis of a certain oligonucleotide is difficult to scale up because it requires expensive equipment, hazardous chemicals and a tedious purification process. Here we report a novel thermocyclic reaction, polymerase-endonuclease amplification reaction (PEAR), for the amplification of oligonucleotides. A target oligonucleotide and a tandem repeated antisense probe are subjected to repeated cycles of denaturing, annealing, elongation and cleaving, in which thermostable DNA polymerase elongation and strand slipping generate duplex tandem repeats, and thermostable endonuclease (PspGI) cleavage releases monomeric duplex oligonucleotides. Each round of PEAR achieves over 100-fold amplification. The product can be used in one more round of PEAR directly, and the process can be further repeated. In addition to avoiding dangerous materials and improved product purity, this reaction is easy to scale up and amenable to full automation. PEAR has the potential to be a useful tool for large-scale production of antisense oligonucleotide drugs.	[Wang, Xiaolong] Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China; [Gou, Deming] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Xu, Shuang-yong] New England Biolabs Inc, Ipswich, MA USA	Ocean University of China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; New England Biolabs	Wang, XL (corresponding author), Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China.	xiaolong@ouc.edu.cn	Wang, Xiaolong/F-3704-2010		National Science Foundation of China [30500379]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China through grant 30500379. SYX is employed at NEB. Thus, although NEB did not provide direct financial support, it can be considered as an indirect funder for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Astriab-Fisher A, 2004, BIOCHEM PHARMACOL, V68, P403, DOI 10.1016/j.bcp.2004.03.040; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; BALOTTA C, 1993, J VIROL, V67, P4409, DOI 10.1128/JVI.67.7.4409-4414.1993; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Brown E L, 1979, Methods Enzymol, V68, P109; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; CASTLEBERRY CM, 2008, ELECTROSPRAY IONIZAT, V35; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Gilar M, 2001, ANAL BIOCHEM, V298, P196, DOI 10.1006/abio.2001.5386; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krotz AH, 2000, ORG PROCESS RES DEV, V4, P190, DOI 10.1021/op990183d; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lohmann JS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-49; Lu YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1053; Masud MM, 2003, CHEMBIOCHEM, V4, P584, DOI 10.1002/cbic.200200539; Morgan R, 1998, APPL ENVIRON MICROB, V64, P3669; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pingoud V, 2003, J MOL BIOL, V329, P913, DOI 10.1016/S0022-2836(03)00523-0; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shanagar J, 2005, J BIOCHEM BIOPH METH, V64, P216, DOI 10.1016/j.jbbm.2005.08.004; Tan E, 2008, BIOCHEMISTRY-US, V47, P9987, DOI 10.1021/bi800746p; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, NUCLEOS NUCLEOT NUCL, V26, P1207, DOI 10.1080/15257770701527844; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; WALKER GT, 1992, P NATL ACAD SCI USA, V89, P392, DOI 10.1073/pnas.89.1.392; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654	36	7	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8430	10.1371/journal.pone.0008430	http://dx.doi.org/10.1371/journal.pone.0008430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20062528	Green Published, Green Submitted, gold			2022-12-27	WOS:000273225000003
J	Ong, AK; Chen, MI; Lin, L; Tan, AS; Nwe, NW; Barkham, T; Tay, SY; Leo, YS				Ong, Adrian K.; Chen, Mark I.; Lin, Li; Tan, Adriana S.; Nwe, Ni Win; Barkham, Timothy; Tay, Seow Yian; Leo, Yee Sin			Improving the Clinical Diagnosis of Influenza-a Comparative Analysis of New Influenza A (H1N1) Cases	PLOS ONE			English	Article							VIRUS; TESTS; CHILDREN; SENSITIVITY; SYMPTOMS	Background: The presentation of new influenza A(H1N1) is broad and evolving as it continues to affect different geographic locations and populations. To improve the accuracy of predicting influenza infection in an outpatient setting, we undertook a comparative analysis of H1N1(2009), seasonal influenza, and persons with acute respiratory illness (ARI) in an outpatient setting. Methodology/Principal Findings: Comparative analyses of one hundred non-matched cases each of PCR confirmed H1N1(2009), seasonal influenza, and ARI cases. Multivariate analysis was performed to look for predictors of influenza infection. Receiver operating characteristic curves were constructed for various combinations of clinical and laboratory case definitions. The initial clinical and laboratory features of H1N1(2009) and seasonal influenza were similar. Among ARI cases, fever, cough, headache, rhinorrhea, the absence of leukocytosis, and a normal chest radiograph positively predict for both PCR-confirmed H1N1-2009 and seasonal influenza infection. The sensitivity and specificity of current WHO and CDC influenza-like illness (ILI) criteria were modest in predicting influenza infection. However, the combination of WHO ILI criteria with the absence of leukocytosis greatly improved the accuracy of diagnosing H1N1(2009) and seasonal influenza (positive LR of 7.8 (95% CI 3.5-17.5) and 9.2 (95% CI 4.1-20.3) respectively). Conclusions/Significance: The clinical presentation of H1N1(2009) infection is largely indistinguishable from that of seasonal influenza. Among patients with acute respiratory illness, features such as a temperature greater than 38 degrees C, rhinorrhea, a normal chest radiograph, and the absence of leukocytosis or significant gastrointestinal symptoms were all positively associated with H1N1(2009) and seasonal influenza infection. An enhanced ILI criteria that combines both a symptom complex with the absence of leukocytosis on testing can improve the accuracy of predicting both seasonal and H1N1-2009 influenza infection.	[Ong, Adrian K.; Chen, Mark I.; Lin, Li; Tan, Adriana S.; Nwe, Ni Win; Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Tay, Seow Yian] Tan Tock Seng Hosp, Dept Emergency Med, Singapore, Singapore; [Barkham, Timothy] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital	Ong, AK (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	Adrian_Ong@ttsh.com.sg	Chen, Mark/AGC-5338-2022; Chen, Mark/CAG-2949-2022	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830	National Medical Research Council [NMRC/H1N1/002/2009]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a grant from the National Medical Research Council (NMRC/H1N1/002/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Chan KH, 2007, J CLIN VIROL, V38, P169, DOI 10.1016/j.jcv.2006.11.010; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x; KERR AA, 1975, LANCET, V1, P291; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; *MIN HLTH, 2009, 342009 MOH; *MIN HLTH, 2009, 792009 MOH; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Ong AK, 2007, J INFECT DIS, V196, P181, DOI 10.1086/518939; Sugaya N, 1996, J MED VIROL, V50, P120, DOI 10.1002/(SICI)1096-9071(199610)50:2&lt;120::AID-JMV4&gt;3.0.CO;2-C; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P237	23	60	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8453	10.1371/journal.pone.0008453	http://dx.doi.org/10.1371/journal.pone.0008453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041115	Green Published, Green Submitted			2022-12-27	WOS:000273105200004
J	Solis, CF; Santi-Rocca, J; Perdomo, D; Weber, C; Guillen, N				Solis, Carlos F.; Santi-Rocca, Julien; Perdomo, Doranda; Weber, Christian; Guillen, Nancy			Use of Bacterially Expressed dsRNA to Downregulate Entamoeba histolytica Gene Expression	PLOS ONE			English	Article							AMEBIC LIVER-ABSCESS; ACID-RICH PROTEIN; RNA INTERFERENCE; MOUSE MODEL; ANTISENSE INHIBITION; CYSTEINE PROTEINASES; ESCHERICHIA-COLI; LYSINE-RICH; PARASITE; SUSCEPTIBILITY	Background: Modern RNA interference (RNAi) methodologies using small interfering RNA (siRNA) oligonucleotide duplexes or episomally synthesized hairpin RNA are valuable tools for the analysis of gene function in the protozoan parasite Entamoeba histolytica. However, these approaches still require time-consuming procedures including transfection and drug selection, or costly synthetic molecules. Principal Findings: Here we report an efficient and handy alternative for E. histolytica gene down-regulation mediated by bacterial double-stranded RNA (dsRNA) targeting parasite genes. The Escherichia coli strain HT115 which is unable to degrade dsRNA, was genetically engineered to produce high quantities of long dsRNA segments targeting the genes that encode E. histolytica beta-tubulin and virulence factor KERP1. Trophozoites cultured in vitro were directly fed with dsRNA-expressing bacteria or soaked with purified dsRNA. Both dsRNA delivery methods resulted in significant reduction of protein expression. In vitro host cell-parasite assays showed that efficient downregulation of kerp1 gene expression mediated by bacterial dsRNA resulted in significant reduction of parasite adhesion and lytic capabilities, thus supporting a major role for KERP1 in the pathogenic process. Furthermore, treatment of trophozoites cultured in microtiter plates, with a repertoire of eighty-five distinct bacterial dsRNA segments targeting E. histolytica genes with unknown function, led to the identification of three genes potentially involved in the growth of the parasite. Conclusions: Our results showed that the use of bacterial dsRNA is a powerful method for the study of gene function in E. histolytica. This dsRNA delivery method is also technically suitable for the study of a large number of genes, thus opening interesting perspectives for the identification of novel drug and vaccine targets.	[Solis, Carlos F.; Santi-Rocca, Julien; Perdomo, Doranda; Weber, Christian; Guillen, Nancy] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Solis, Carlos F.; Santi-Rocca, Julien; Perdomo, Doranda; Weber, Christian; Guillen, Nancy] INSERM, U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Solis, CF (corresponding author), Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France.	nguillen@pasteur.fr	Santi-Rocca, Julien/AAD-2448-2020; Weber, Christian/AAW-2153-2020	Santi-Rocca, Julien/0000-0002-9791-3521; Weber, Christian/0000-0003-4610-8714; Perdomo, Doranda/0000-0001-9949-751X	Fondation pour la Recherche Medicale in France; Pasteur-Weizmann Council; European Union; Pasteur-Weizmann Research Council and Genopole Pasteur Ile de France	Fondation pour la Recherche Medicale in France(Institut National du Cancer (INCA) France); Pasteur-Weizmann Council; European Union(European Commission); Pasteur-Weizmann Research Council and Genopole Pasteur Ile de France	This work has been supported by postdoctoral fellowships from the Fondation pour la Recherche Medicale in France to CFS and to JSR as well as a postdoctoral fellowship from the Pasteur-Weizmann Council and a PhD fellowship from the "Regime Social des Independants" in France to JSR and grants to NG from INCO-DEV in the Fifth Framework Program of the European Union, Pasteur-Weizmann Research Council and Genopole Pasteur Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2005, EXP PARASITOL, V110, P265, DOI 10.1016/j.exppara.2005.02.023; Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Ankri S, 1998, MOL MICROBIOL, V28, P777, DOI 10.1046/j.1365-2958.1998.00837.x; Bansal D, 2006, INDIAN J MED RES, V123, P115; Blazquez S, 2007, INT J PARASITOL, V37, P425, DOI 10.1016/j.ijpara.2006.10.008; CEDENO JR, 1983, J INFECT DIS, V148, P1090, DOI 10.1093/infdis/148.6.1090; CIESLAK PR, 1992, J EXP MED, V176, P1605, DOI 10.1084/jem.176.6.1605; Cottrell TR, 2003, TRENDS MICROBIOL, V11, P37, DOI 10.1016/S0966-842X(02)00004-5; Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9; De S, 2006, EXP PARASITOL, V113, P239, DOI 10.1016/j.exppara.2006.01.009; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Issa Z, 2005, INT J PARASITOL, V35, P935, DOI 10.1016/j.ijpara.2005.06.001; Joshua-Tor L, 2006, COLD SPRING HARB SYM, V71, P67, DOI 10.1101/sqb.2006.71.048; Kaur G, 2004, BIOCHEM BIOPH RES CO, V320, P1118, DOI 10.1016/j.bbrc.2004.06.064; KOLBER MA, 1988, J IMMUNOL METHODS, V108, P255, DOI 10.1016/0022-1759(88)90427-9; Leitsch D, 2007, PLOS BIOL, V5, P1820, DOI 10.1371/journal.pbio.0050211; Linford AS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-38; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Mahmood-Ur-Rahman, 2008, BIOTECHNOL ADV, V26, P202, DOI 10.1016/j.biotechadv.2007.12.002; Marinets A, 1997, J EXP MED, V186, P1557, DOI 10.1084/jem.186.9.1557; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Padilla-Vaca F, 1999, INFECT IMMUN, V67, P2096, DOI 10.1128/IAI.67.5.2096-2102.1999; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Rigothier MC, 2002, INFECT IMMUN, V70, P3208, DOI 10.1128/IAI.70.6.3208-3215.2002; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Seigneur M, 2005, CELL MICROBIOL, V7, P569, DOI 10.1111/j.1462-5822.2005.00487.x; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; TAKIFF HE, 1989, J BACTERIOL, V171, P2581, DOI 10.1128/jb.171.5.2581-2590.1989; Tavares P, 2005, INFECT IMMUN, V73, P1771, DOI 10.1128/IAI.73.3.1771-1778.2005; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vayssie L, 2004, MOL BIOCHEM PARASIT, V138, P21, DOI 10.1016/j.molbiopara.2004.07.005; Weber C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000165; Zhang Z, 2003, INFECT IMMUN, V71, P5355, DOI 10.1128/IAI.71.9.5355-5359.2003	38	51	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8424	10.1371/journal.pone.0008424	http://dx.doi.org/10.1371/journal.pone.0008424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037645	gold, Green Submitted, Green Published			2022-12-27	WOS:000272998100012
J	Voynov, V; Chennamsetty, N; Kayser, V; Helk, B; Forrer, K; Zhang, H; Fritsch, C; Heine, H; Trout, BL				Voynov, Vladimir; Chennamsetty, Naresh; Kayser, Veysel; Helk, Bernhard; Forrer, Kurt; Zhang, Heidi; Fritsch, Cornelius; Heine, Holger; Trout, Bernhardt L.			Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation	PLOS ONE			English	Article							FUCOSE-CONTAINING OLIGOSACCHARIDES; FC-GAMMA RECEPTOR; HUMAN BLOOD-GROUP; THERAPEUTIC PROTEINS; FORCE-FIELD; GLYCOSYLATION; BINDING; IGG; RECOGNITION; STABILITY	Protein-carbohydrate interactions are important for glycoprotein structure and function. Antibodies of the IgG class, with increasing significance as therapeutics, are glycosylated at a conserved site in the constant Fc region. We hypothesized that disruption of protein-carbohydrate interactions in the glycosylated domain of antibodies leads to the exposure of aggregation-prone motifs. Aggregation is one of the main problems in protein-based therapeutics because of immunogenicity concerns and decreased efficacy. To explore the significance of intramolecular interactions between aromatic amino acids and carbohydrates in the IgG glycosylated domain, we utilized computer simulations, fluorescence analysis, and site-directed mutagenesis. We find that the surface exposure of one aromatic amino acid increases due to dynamic fluctuations. Moreover, protein-carbohydrate interactions decrease upon stress, while protein-protein and carbohydrate-carbohydrate interactions increase. Substitution of the carbohydrate-interacting aromatic amino acids with non-aromatic residues leads to a significantly lower stability than wild type, and to compromised binding to Fc receptors. Our results support a mechanism for antibody aggregation via decreased protein-carbohydrate interactions, leading to the exposure of aggregation-prone regions, and to aggregation.	[Voynov, Vladimir; Chennamsetty, Naresh; Kayser, Veysel; Trout, Bernhardt L.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Helk, Bernhard; Forrer, Kurt; Zhang, Heidi; Fritsch, Cornelius; Heine, Holger] Novartis Pharma AG, Basel, Switzerland	Massachusetts Institute of Technology (MIT); Novartis	Voynov, V (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	trout@mit.edu	Kayser, Veysel/L-4432-2019	Kayser, Veysel/0000-0003-1310-9534; Chennamsetty, Naresh/0000-0003-4641-7840	Novartis Pharma AG	Novartis Pharma AG	This work was supported by Novartis Pharma AG. Employees of Novartis participated in study design, data collection and analysis, and preparation of the manuscript.	Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bucior I, 2004, J CELL BIOL, V165, P529, DOI 10.1083/jcb.200309005; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chennamsetty N, 2009, J MOL BIOL, V391, P404, DOI 10.1016/j.jmb.2009.06.028; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Cordoba-Rodriguez RV, 2008, BIOPHARM INT, V21, P44; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Ionescu RM, 2008, J PHARM SCI-US, V97, P1414, DOI 10.1002/jps.21104; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAYSER V, 2009, MECH THERAPEUT UNPUB; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kuttel M, 2002, J COMPUT CHEM, V23, P1236, DOI 10.1002/jcc.10119; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; LLOYD KO, 1966, BIOCHEMISTRY-US, V5, P1489, DOI 10.1021/bi00869a007; Lund J, 1996, J IMMUNOL, V157, P4963; MACKERELL J, 1998, J PHYS CHEM B, V102; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; PAINTER TJ, 1965, NATURE, V206, P594, DOI 10.1038/206594a0; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; REGE VP, 1964, NATURE, V203, P360, DOI 10.1038/203360a0; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Spiwok V, 2005, J COMPUT AID MOL DES, V19, P887, DOI 10.1007/s10822-005-9033-z; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89; TAVES CJ, 1984, BIOCHEM BIOPH RES CO, V124, P605; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; VOYNOV V, 2009, DESIGN APPL AN UNPUB; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wei W, 1999, INT J PHARMACEUT, V185, P129, DOI 10.1016/S0378-5173(99)00152-0; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472	39	36	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8425	10.1371/journal.pone.0008425	http://dx.doi.org/10.1371/journal.pone.0008425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037630	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100013
J	Ribas, L; Li, MS; Doddington, BJ; Robert, J; Seidel, JA; Kroll, JS; Zimmerman, LB; Grassly, NC; Garner, TWJ; Fisher, MC				Ribas, Laia; Li, Ming-Shi; Doddington, Benjamin J.; Robert, Jacques; Seidel, Judith A.; Kroll, J. Simon; Zimmerman, Lyle B.; Grassly, Nicholas C.; Garner, Trenton W. J.; Fisher, Matthew C.			Expression Profiling the Temperature-Dependent Amphibian Response to Infection by Batrachochytrium dendrobatidis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; XENOPUS-TROPICALIS; ACTIVE PEPTIDES; RANA-ESCULENTA; SKIN; CHYTRIDIOMYCOSIS; PATHOGEN; DECLINES; DISEASE; FROG	Amphibians are experiencing a panzootic of unprecedented proportions caused by the emergence of Batrachochytrium dendrobatidis (Bd). However, all species are not equally at risk of infection, and risk is further modified by environmental variables, specifically temperature. In order to understand how, and when, hosts mount a response to Bd we analysed infection dynamics and patterns of gene expression in the model amphibian species Silurana (Xenopus) tropicalis. Mathematical modelling of infection dynamics demonstrate the existence of a temperature-dependent protective response that is largely independent of the intrinsic growth-rate of Bd. Using temporal expression-profiling by microarrays and qRT-PCR, we characterise this response in the main amphibian lymphoid tissue, the spleen. We demonstrate that clearance of Bd at the host-optimal temperature is not clearly associated with an adaptive immune response, but rather is correlated with the induction of components of host innate immunity including the expression of genes that are associated with the production of the antimicrobial skin peptide preprocareulein (PPCP) as well as inflammatory responses. We find that adaptive immunity appears to be lacking at host-optimal temperatures. This suggests that either Bd does not stimulate, or suppresses, adaptive immunity, or that trade-offs exist between innate and adaptive limbs of the amphibian immune system. At cold temperatures, S. tropicalis loses the ability to mount a PPCP-based innate response, and instead manifests a more pronounced inflammatory reaction that is characterised by the production of proteases and higher pathogen burdens. This study demonstrates the temperature-dependency of the amphibian response to infection by Bd and indicates the influence that changing climates may exert on the ectothermic host response to pathogens.	[Ribas, Laia; Doddington, Benjamin J.; Seidel, Judith A.; Grassly, Nicholas C.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; [Li, Ming-Shi; Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; [Robert, Jacques] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Zimmerman, Lyle B.] Natl Inst Med Res, London NW7 1AA, England; [Garner, Trenton W. J.] Zool Soc London, Inst Zool, London NW1 4RY, England	Imperial College London; Imperial College London; University of Rochester; MRC National Institute for Medical Research; Zoological Society of London	Ribas, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England.	matthew.fisher@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008; Garner, Trenton WJ/D-6873-2011; Fisher, Matthew/B-9094-2011; Ribas, Laia/E-1466-2013; Robert, Jacques/B-2179-2008	Grassly, Nicholas C/0000-0001-6067-4507; Garner, Trenton WJ/0000-0002-0336-9706; Fisher, Matthew/0000-0002-1862-6402; Ribas, Laia/0000-0001-5538-6236; Robert, Jacques/0000-0003-4380-1476; Seidel, Judith/0000-0001-6116-9246	United Kingdom Biotechnology and Biological Research Council (BBSRC) [BB/E0232071]; United Kingdom Natural Environmental Research Council (NERC) [NE/E006701/1]; Royal Society; George John and Sheilah Livanos Charitable Trust; National Institutes of Health (NIH) [R24-AI-059830]; Biotechnology and Biological Sciences Research Council [BB/E023207/1] Funding Source: researchfish; Medical Research Council [MC_U117560482] Funding Source: researchfish; Natural Environment Research Council [NE/E006701/1, NER/A/S/2002/00832] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI059830] Funding Source: NIH RePORTER; BBSRC [BB/E023207/1] Funding Source: UKRI; MRC [MC_U117560482] Funding Source: UKRI; NERC [NE/E006701/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); George John and Sheilah Livanos Charitable Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by United Kingdom Biotechnology and Biological Research Council (BBSRC) grant BB/E0232071 and United Kingdom Natural Environmental Research Council (NERC) grant NE/E006701/1 to MCF and TWJG, a Royal Society grant to MCF, a George John and Sheilah Livanos Charitable Trust grant to MSL, and National Institutes of Health (NIH) grant R24-AI-059830 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2001, BBA-PROTEIN STRUCT M, V1550, P81, DOI 10.1016/S0167-4838(01)00272-2; Arron JR., 2002, CURR PROTOC IMMUNOL, P11119, DOI [10.1002/0471142735.im1109ds87, DOI 10.1002/0471142735.IM1109DS51, 10.1002/0471142735.im1109ds51]; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; BREVINS CL, 1990, ANNU REV BIOCHEM, V59, P395; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; COOPER EL, 1992, CRYOBIOLOGY, V29, P616, DOI 10.1016/0011-2240(92)90066-B; ERSPAMER V, 1984, COMP BIOCHEM PHYS C, V77, P99, DOI 10.1016/0742-8413(84)90137-3; ERSPAMER V, 1984, COMP BIOCHEM PHYS C, V79, P1, DOI 10.1016/0742-8413(84)90153-1; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Fisher P, 2007, IEEE COMPUT INTELL M, V2, P9, DOI 10.1109/MCI.2007.357188; Fujita T, 2004, MOL IMMUNOL, V41, P103, DOI 10.1016/j.molimm.2004.03.026; Gewin V, 2008, PLOS BIOL, V6, P18, DOI 10.1371/journal.pbio.0060024; Graindorge A, 2006, NUCLEIC ACIDS RES, V34, P986, DOI 10.1093/nar/gkj492; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Maniero GD, 1997, J COMP PHYSIOL B, V167, P256, DOI 10.1007/s003600050072; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Park PJ, 2004, J BIOTECHNOL, V112, P225, DOI 10.1016/j.jbiotec.2004.05.006; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Rauter I, 2008, J ALLERGY CLIN IMMUN, V121, P197, DOI 10.1016/j.jaci.2007.08.015; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2006, DEV COMP IMMUNOL, V30, P831, DOI 10.1016/j.dci.2005.10.005; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; SEKI T, 1989, CELL TISSUE RES, V258, P483; Simmaco M, 1998, SCAND J IMMUNOL, V48, P357; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; TYLER MJ, 1992, J PHARMACOL TOXICOL, V28, P199, DOI 10.1016/1056-8719(92)90004-K; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	51	108	110	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8408	10.1371/journal.pone.0008408	http://dx.doi.org/10.1371/journal.pone.0008408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027316	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998000013
J	Yang, J; Zhang, WQ; Jiang, W; Sun, XN; Han, YH; Ding, MX; Shi, Y; Deng, HK				Yang, Jie; Zhang, Weiqi; Jiang, Wei; Sun, Xiaoning; Han, Yuhua; Ding, Mingxiao; Shi, Yan; Deng, Hongkui			P21(cip)-Overexpression in the Mouse beta Cells Leads to the Improved Recovery from Streptozotocin-Induced Diabetes	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; PARTIAL-PANCREATECTOMY; ISLET TRANSPLANTATION; TRANSGENIC MICE; INSULIN GENE; CYCLE ARREST; IN-VIVO; REGENERATION; PANCREAS; MODEL	Under normal conditions, the regeneration of mouse beta cells is mainly dependent on their own duplication. Although there is evidence that pancreatic progenitor cells exist around duct, whether non-beta cells in the islet could also potentially contribute to beta cell regeneration in vivo is still controversial. Here, we developed a novel transgenic mouse model to study the pancreatic beta cell regeneration, which could specifically inhibit beta cell proliferation by overexpressing p21(cip) in beta cells via regulation of the Tet-on system. We discovered that p21 overexpression could inhibit beta-cell duplication in the transgenic mice and these mice would gradually suffer from hyperglycemia. Importantly, the recovery efficiency of the p21-overexpressing mice from streptozotocin-induced diabetes was significantly higher than control mice, which is embodied by better physiological quality and earlier emergence of insulin expressing cells. Furthermore, in the islets of these streptozotocin-treated transgenic mice, we found a large population of proliferating cells which expressed pancreatic duodenal homeobox 1 (PDX1) but not markers of terminally differentiated cells. Transcription factors characteristic of early pancreatic development, such as Nkx2.2 and NeuroD1, and pancreatic progenitor markers, such as Ngn3 and c-Met, could also be detected in these islets. Thus, our work showed for the first time that when b cell self-duplication is repressed by p21 overexpression, the markers for embryonic pancreatic progenitor cells could be detected in islets, which might contribute to the recovery of these transgenic mice from streptozotocin-induced diabetes. These discoveries could be important for exploring new diabetes therapies that directly promote the regeneration of pancreatic progenitors to differentiate into islet beta cells in vivo.	[Yang, Jie; Zhang, Weiqi; Jiang, Wei; Ding, Mingxiao; Deng, Hongkui] Peking Univ, MOE Key Lab Cell Proliferat & Differentiat, Coll Life Sci, Beijing 100871, Peoples R China; [Sun, Xiaoning; Shi, Yan; Deng, Hongkui] Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Han, Yuhua] Beijing Vitalstar Biotech Co Ltd, Beijing, Peoples R China; [Deng, Hongkui] Anim Res Ctr, Beijing Lab, Beijing, Peoples R China	Peking University; Peking University; University Town of Shenzhen	Yang, J (corresponding author), Peking Univ, MOE Key Lab Cell Proliferat & Differentiat, Coll Life Sci, Beijing 100871, Peoples R China.	hongkui_deng@pku.edu	Jiang, Wei/J-7993-2012	Jiang, Wei/0000-0002-6463-7356; Zhang, Weiqi/0000-0002-8885-5104	Ministry of Science and Technology [2006AA02A113]; Science and Technology Plan of Beijing Municipal Government [D07050701350705]; Gongjian project of Beijing Municipal Education Commission; National Basic Research Program for China (973 Program) [2007CB947900, 2009CB941200]; National Natural Science Foundation of China [30830061, 30421004]; 111 Project	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Science and Technology Plan of Beijing Municipal Government; Gongjian project of Beijing Municipal Education Commission; National Basic Research Program for China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This research was supported by Ministry of Science and Technology grant (2006AA02A113), Science and Technology Plan of Beijing Municipal Government (D07050701350705), Gongjian project of Beijing Municipal Education Commission, National Basic Research Program for China (973 Program 2007CB947900, 2009CB941200), National Natural Science Foundation of China (30830061, 30421004) and a 111 Project to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; Beattie GM, 1999, DIABETES, V48, P1013, DOI 10.2337/diabetes.48.5.1013; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Cozar-Castellano I, 2006, DIABETES, V55, P70, DOI 10.2337/diabetes.55.01.06.db05-0632; Cozar-Castellano I, 2006, DIABETES, V55, P3271, DOI 10.2337/db06-0627; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Garcia-Ocana A, 2001, DIABETES, V50, P2752, DOI 10.2337/diabetes.50.12.2752; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; HUME WJ, 1979, J ORAL PATHOL MED, V8, P3, DOI 10.1111/j.1600-0714.1979.tb01618.x; Kodama S, 2005, BIOCHEM BIOPH RES CO, V327, P1170, DOI 10.1016/j.bbrc.2004.12.120; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lee CS, 2006, DIABETES, V55, P269; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; RILEY WJ, 1981, DIABETES, V30, P718, DOI 10.2337/diabetes.30.9.718; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Whitson JM, 2009, INT J CANCER, V125, P446, DOI 10.1002/ijc.24370; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	36	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8344	10.1371/journal.pone.0008344	http://dx.doi.org/10.1371/journal.pone.0008344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020058	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834200011
J	Cakir, I; Perello, M; Lansari, O; Messier, NJ; Vaslet, CA; Nillni, EA				Cakir, Isin; Perello, Mario; Lansari, Omar; Messier, Norma J.; Vaslet, Charles A.; Nillni, Eduardo A.			Hypothalamic Sirt1 Regulates Food Intake in a Rodent Model System	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROTHYROTROPIN-RELEASING HORMONE; HIGH-FAT DIET; CALORIE RESTRICTION; GENE-EXPRESSION; ENERGY HOMEOSTASIS; SIRNA DELIVERY; CELL-SURVIVAL; IN-VIVO; TRANSCRIPTION	Sirt1 is an evolutionarily conserved NAD+ dependent deacetylase involved in a wide range of processes including cellular differentiation, apoptosis, as well as metabolism, and aging. In this study, we investigated the role of hypothalamic Sirt1 in energy balance. Pharmacological inhibition or siRNA mediated knock down of hypothalamic Sirt1 showed to decrease food intake and body weight gain. Central administration of a specific melanocortin antagonist, SHU9119, reversed the anorectic effect of hypothalamic Sirt1 inhibition, suggesting that Sirt1 regulates food intake through the central melanocortin signaling. We also showed that fasting increases hypothalamic Sirt1 expression and decreases FoxO1 (Forkhead transcription factor) acetylation suggesting that Sirt1 regulates the central melanocortin system in a FoxO1 dependent manner. In addition, hypothalamic Sirt1 showed to regulate S6K signaling such that inhibition of the fasting induced Sirt1 activity results in up-regulation of the S6K pathway. Thus, this is the first study providing a novel role for the hypothalamic Sirt1 in the regulation of food intake and body weight. Given the role of Sirt1 in several peripheral tissues and hypothalamus, potential therapies centered on Sirt1 regulation might provide promising therapies in the treatment of metabolic diseases including obesity.	[Cakir, Isin; Perello, Mario; Lansari, Omar; Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Div Endocrinol, Dept Med,Warren Alpert Med Sch, Providence, RI 02903 USA; [Cakir, Isin; Lansari, Omar; Nillni, Eduardo A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Messier, Norma J.; Vaslet, Charles A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Cakir, I (corresponding author), Brown Univ, Rhode Isl Hosp, Div Endocrinol, Dept Med,Warren Alpert Med Sch, Providence, RI 02903 USA.	Eduardo_Nillni@brown.edu		Perello, Mario/0000-0003-2114-6765; cakir, isin/0000-0003-4293-7267	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIH) [R01 DK58148]; National Institute of Neurological Disorders and Stroke/NIH [R01 NS045231]; Center for Cancer Signaling Networks COBRE [5PR20RR015578-09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Cancer Signaling Networks COBRE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIH) Grant R01 DK58148 and National Institute of Neurological Disorders and Stroke/NIH Grant R01 NS045231 to E.A.N. Gene expression studies were supported by the Center for Cancer Signaling Networks COBRE Grant 5PR20RR015578-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Guissouma H, 2006, NEUROSCI LETT, V406, P240, DOI 10.1016/j.neulet.2006.07.041; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hassani Z, 2005, J GENE MED, V7, P198, DOI 10.1002/jgm.659; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Niedemhofer LJ, 2008, INT J BIOCHEM CELL B, V40, P176, DOI 10.1016/j.biocel.2007.10.008; Nillni EA, 2000, J BIOL CHEM, V275, P36124, DOI 10.1074/jbc.M003549200; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Perello M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1348, DOI 10.1152/ajpendo.00466.2006; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; RAMADORI G, 2009, ENDOCRINOLOGY; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	50	155	159	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8322	10.1371/journal.pone.0008322	http://dx.doi.org/10.1371/journal.pone.0008322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20020036	Green Published, gold, Green Submitted			2022-12-27	WOS:000272833800016
J	Robbins, ML; Wang, PH; Sekhon, RS; Chopra, S				Robbins, Michael L.; Wang, PoHao; Sekhon, Rajandeep S.; Chopra, Surinder			Gene Structure Induced Epigenetic Modifications of pericarp color1 Alleles of Maize Result in Tissue-Specific Mosaicism	PLOS ONE			English	Article							CHROMATIN; METHYLATION; PARAMUTATION; INHERITANCE; SEQUENCES; RECOMBINATION; ARABIDOPSIS; EXPRESSION; DIVERSITY; INSERTION	Background: The pericarp color1 (p1) gene encodes for a myb-homologous protein that regulates the biosynthesis of brick-red flavonoid pigments called phlobahpenes. The pattern of pigmentation on the pericarp and cob glumes depends upon the allelic constitution at the p1 locus. p1 alleles have unique gene structure and copy number which have been proposed to influence the epigenetic regulation of tissue-specific gene expression. For example, the presence of tandem-repeats has been correlated with the suppression of pericarp pigmentation though a mechanism associated with increased DNA methylation. Methodology/Principal Findings: Herein, we extensively characterize a p1 allele called P1-mosaic (P1-mm) that has mosaic pericarp and light pink or colorless cob glumes pigmentation. Relative to the P1-wr (white pericarp and red cob glumes), we show that the tandem repeats of P1-mm have a modified gene structure containing a reduced number of repeats. The P1-mm has reduced DNA methylation at a distal enhancer and elevated DNA methylation downstream of the transcription start site. Conclusions/Significance: Mosaic gene expression occurs in many eukaryotes. Herein we use maize p1 gene as model system to provide further insight about the mechanisms that govern expression mosaicism. We suggest that the gene structure of P1-mm is modified in some of its tandem gene repeats. It is known that repeated genes are susceptible to chromatin-mediated regulation of gene expression. We discuss how the modification to the tandem repeats of P1-mm may have disrupted the epigenetic mechanisms that stably confer tissue-specific expression.	[Robbins, Michael L.; Wang, PoHao; Sekhon, Rajandeep S.; Chopra, Surinder] Penn State Univ, Dept Crop & Soil Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Robbins, ML (corresponding author), Penn State Univ, Dept Crop & Soil Sci, University Pk, PA 16802 USA.	sic3@psu.edu			NSF [MCB-0619330]; Hatch [4154]; Department of Crop and Soil Sciences; Plant Biology Graduate Program	NSF(National Science Foundation (NSF)); Hatch(United States Department of Agriculture (USDA)); Department of Crop and Soil Sciences; Plant Biology Graduate Program	This work was supported by an NSF award MCB-0619330, a Hatch 4154 award to SC, and dissertation award from the College of Agricultural Sciences and Research Assistantships from the Department of Crop and Soil Sciences and Plant Biology Graduate Program to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EG, 1924, GENETICS, V9, P442; ANDERSON EG, 1929, MICH ACAD SCI ARTS, V9, P5; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; ATHMA P, 1992, GENETICS, V131, P199; ATHMA P, 1991, GENETICS, V128, P163; BARCLAY PC, 1954, P NATL ACAD SCI USA, V40, P1118, DOI 10.1073/pnas.40.12.1118; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bender J, 1998, TRENDS BIOCHEM SCI, V23, P252, DOI 10.1016/S0968-0004(98)01225-0; BRAWN RI, 1966, MAIZE GENETICS COOPE, V40, P92; BRINK RA, 1966, MAIZE GENET COOP NEW, V40, P149; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Chandler VL, 2004, COLD SPRING HARB SYM, V69, P355, DOI 10.1101/sqb.2004.69.355; Chopra S, 1998, MOL GEN GENET, V260, P372, DOI 10.1007/s004380050906; Chopra S, 2003, GENETICS, V163, P1135; Cocciolone SM, 2001, PLANT J, V27, P467, DOI 10.1046/j.1365-313X.2001.01124.x; Coe EH, 2001, NAT REV GENET, V2, P898, DOI 10.1038/35098524; Correns C. J., 1900, BERICHTE DTSCH BOT G, V18, P158, DOI DOI 10.1111/J.1438-8677.1900.TB04893.X; Emerson RA, 1939, GENETICS, V24, P368; Emerson RA, 1914, AM NAT, V48, P87, DOI 10.1086/279393; Emerson RA, 1917, GENETICS, V2, P1; EMERSON RA, 1911, ANN REPT NEBRASKA AG, V24, P59; Eyster WH, 1925, GENETICS, V10, P179; Fedoroff N, 1998, GENETICS, V150, P957; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Goettel W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000516; Grant-Downton RT, 2004, TRENDS GENET, V20, P188, DOI 10.1016/j.tig.2004.02.005; GROTEWOLD E, 1991, MOL GEN GENET, V230, P329, DOI 10.1007/BF00290684; Hayes HK, 1917, GENETICS, V2, P261; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; LECHELT C, 1989, MOL GEN GENET, V219, P225, DOI 10.1007/BF00261181; Li GF, 2002, BIOESSAYS, V24, P234, DOI 10.1002/bies.10055; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Matzke M, 2001, GENETICS, V158, P451; NELSON OE, 1991, MAIZE GENETICS COOPE, V65, P85; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Robbins ML, 2008, GENETICS, V178, P1859, DOI 10.1534/genetics.107.082503; ROBBINS ML, 2008, MAIZE GENET COOP NEW, V82, P28; Sabl JF, 1996, GENETICS, V142, P447; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; SCHWARTZ D, 1982, P NATL ACAD SCI-BIOL, V79, P5991, DOI 10.1073/pnas.79.19.5991; Sekhon RS, 2007, GENETICS, V175, P1059, DOI 10.1534/genetics.106.066134; Sekhon RS, 2009, GENETICS, V181, P81, DOI 10.1534/genetics.108.097170; Sidorenko LV, 2000, PLANT J, V22, P471, DOI 10.1046/j.1365-313x.2000.00750.x; Sidorenko LV, 2001, PLANT CELL, V13, P319, DOI 10.1105/tpc.13.2.319; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Slotkin RK, 2003, GENETICS, V165, P781; SUTO T, 1952, J FAS HOKKAIDO U, V6, P68; Watanabe K, 2005, PLANT J, V44, P531, DOI 10.1111/j.1365-313X.2005.02546.x; Ye F, 1996, P NATL ACAD SCI USA, V93, P10881, DOI 10.1073/pnas.93.20.10881; Zhang F, 2005, PLANT CELL, V17, P903, DOI 10.1105/tpc.104.029660; Zhang F, 2006, GENETICS, V174, P753, DOI 10.1534/genetics.105.053942; Zhang PF, 2000, PLANT CELL, V12, P2311, DOI 10.1105/tpc.12.12.2311	54	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8231	10.1371/journal.pone.0008231	http://dx.doi.org/10.1371/journal.pone.0008231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011605	Green Submitted, gold, Green Published			2022-12-27	WOS:000272830300013
J	Tinahones, F; Salas, J; Mayas, MD; Ruiz-Villalba, A; Macias-Gonzalez, M; Garrido-Sanchez, L; DeMora, M; Moreno-Santos, I; Bernal, R; Cardona, F; El Bekay, R				Tinahones, Francisco; Salas, Julian; Dolores Mayas, Maria; Ruiz-Villalba, Adrian; Macias-Gonzalez, Manuel; Garrido-Sanchez, Lourdes; DeMora, Manuel; Moreno-Santos, Inmaculada; Bernal, Rosa; Cardona, Fernando; El Bekay, Rajaa			VEGF Gene Expression in Adult Human Thymus Fat: A Correlative Study with Hypoxic Induced Factor and Cyclooxigenase-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ARTERY GRAFT; PPAR-GAMMA; IN-VITRO; ANGIOGENESIS; CANCER; CYCLOOXYGENASE-2; DIFFERENTIATION; ADIPOCYTES; INDUCTION	It is well known that the adult human thymus degenerates into fat tissue; however, it has never been considered as a potential source of angiogenic factors. Recently, we have described that this fat (TAT) produces angiogenic factors and induces human endothelial cell proliferation and migration, indicating its potential angiogenic properties. Design: Adult thymus fat and subcutaneous adipose tissue specimens were obtained from 28 patients undergoing cardiac surgery, making this tissue readily available as a prime source of adipose tissue. We focused our investigation on determining VEGF gene expression and characterizing the different genes, mediators of inflammation and adipogenesis, and which are known to play a relevant role in angiogenesis regulation. Results: We found that VEGF-A was the isoform most expressed in TAT. This expression was accompanied by an upregulation of HIF-1 alpha, COX-2 and HO-1 proteins, and by increased HIF-1 DNA binding activity, compared to SAT. Furthermore, we observed that TAT contains a high percentage of mature adipocytes, 0.25% of macrophage cells, 15% of endothelial cells and a very low percentage of thymocyte cells, suggesting the cellular variability of TAT, which could explain the differences in gene expression observed in TAT. Subsequently, we showed that the expression of genes known as adipogenic mediators, including PPAR gamma 1/gamma 2, FABP-4 and adiponectin was similar in both TAT and SAT. Moreover the expression of these latter genes presented a significantly positive correlation with VEGF, suggesting the potential association between VEGF and the generation of adipose tissue in adult thymus. Conclusion: Here we suggest that this fat has a potential angiogenic function related to ongoing adipogenesis, which substitutes immune functions within the adult thymus. The expression of VEGF seems to be associated with COX-2, HO-1 and adipogenesis related genes, suggesting the importance that this new fat has acquired in research in relation to adipogenesis and angiogenesis.	[Tinahones, Francisco; Dolores Mayas, Maria; Macias-Gonzalez, Manuel; Garrido-Sanchez, Lourdes; Moreno-Santos, Inmaculada; Bernal, Rosa; Cardona, Fernando; El Bekay, Rajaa] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Tinahones, Francisco] Hosp Virgen de la Victoria, Serv Endocrinol, Malaga, Spain; [Salas, Julian] Hosp Carlos Haya, Dept Cirugia Cardiovasc, Malaga, Spain; [Ruiz-Villalba, Adrian; El Bekay, Rajaa] Hosp Virgen de la Victoria, Lab Invest Biomed, Fdn Inst Mediterraneo Avance Biotecnol & Invest S, Malaga, Spain; [DeMora, Manuel] Hosp Carlos Haya, Dept Enfermedades Cardiovasc, Malaga, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Virgen de la Victoria; Hospital Carlos Haya; Hospital Virgen de la Victoria; Hospital Carlos Haya	Tinahones, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.	elbekay@gmail.com	Bekay, Rajaa El/AAZ-3959-2020; Bernal-Lopez, Rosa/F-3548-2011; Cardona, Fernando/AAG-7835-2019; Tinahones, Francisco José/AAB-2882-2020; Cardona, Fernando/H-6022-2015; El Bekay, RAJAA/AGN-6069-2022; Ruiz-Villalba, Adrián/AAP-6130-2020; MACIAS-GONZALEZ, MANUEL/E-7584-2016	Cardona, Fernando/0000-0003-4460-6824; Cardona, Fernando/0000-0003-4460-6824; El Bekay, RAJAA/0000-0003-3332-3431; , Adrian/0000-0001-8063-0317; MACIAS-GONZALEZ, MANUEL/0000-0002-6475-4704; Tinahones, Francisco J/0000-0001-6871-4403	Andalusian Health Service [SAS PI-0251]; Spanish Ministry of Health [CP07/00288, CP04/00039, CP07/0095, PI070953]	Andalusian Health Service; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by grants from Andalusian Health Service [SAS PI-0251]; R. El Bekay, M. Macias and F. Cardona are recipients of a post doctoral grant 'Miguel Servet' (FIS-2007) [CP07/00288, CP04/00039, CP07/0095] from the Spanish Ministry of Health; and part of this project was supported by grant from Spanish Ministry of Health (FIS) [PI070953]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano A, 2001, MOL CELL ENDOCRINOL, V174, P71, DOI 10.1016/S0303-7207(00)00450-0; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Chinen J, 2006, J ALLERGY CLIN IMMUN, V118, P489, DOI 10.1016/j.jaci.2006.05.021; Csiki I, 2006, CANCER RES, V66, P143, DOI 10.1158/0008-5472.CAN-05-1357; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Fernandez M, 2003, BRIT J PHARMACOL, V139, P634, DOI 10.1038/sj.bjp.0705272; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Fukuda R, 2003, CANCER RES, V63, P2330; Hale Laura P, 2004, Ann Diagn Pathol, V8, P50, DOI 10.1016/j.anndiagpath.2003.11.006; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Mukherjee D, 1999, AM J CARDIOL, V84, P598, DOI 10.1016/S0002-9149(99)00387-2; PACIFICO AD, 1986, ANN THORAC SURG, V42, P708, DOI 10.1016/S0003-4975(10)64618-8; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rathore KS, 2009, TEX HEART I J, V36, P131; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Saiki A, 2006, INT J OBESITY, V30, P1676, DOI 10.1038/sj.ijo.0803316; SALAS J, 2009, CELL TISSUE RES; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Solban N, 2006, CANCER RES, V66, P5633, DOI 10.1158/0008-5472.CAN-06-0604; Sosman JA, 2003, NAT MED, V9, P649, DOI 10.1038/nm0603-649; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TRAYHURN P, 2008, BR J NUTR, V100, P236; Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8213	10.1371/journal.pone.0008213	http://dx.doi.org/10.1371/journal.pone.0008213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011601	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300006
J	Veitia, RA; Bottani, S				Veitia, Reiner A.; Bottani, Samuel			Whole Genome Duplications and a 'Function' for Junk DNA? Facts and Hypotheses	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; EUKARYOTIC GENOME; NUCLEAR-DNA; GENES; EVOLUTION; RETROTRANSPOSITION; TETRAPLOIDY; COEVOLUTION; DYNAMICS; SIZE	Background: The lack of correlation between genome size and organismal complexity is understood in terms of the massive presence of repetitive and non-coding DNA. This non-coding subgenome has long been called "junk'' DNA. However, it might have important functions. Generation of junk DNA depends on proliferation of selfish DNA elements and on local or global DNA duplication followed by genic non-fonctionalization. Methodology/Principal Findings: Evidence from genomic analyses and experimental data indicates that Whole Genome Duplications (WGD) are often followed by a return to the diploid state, through DNA deletions and intra/interchromosomal rearrangements. We use simple theoretical models and simulations to explore how a WGD accompanied by sequence deletions might affect the dosage balance often required among several gene products involved in regulatory processes. We find that potential genomic deletions leading to changes in nuclear and cell volume might potentially perturb gene dosage balance. Conclusions/Significance: The potentially negative impact of DNA deletions can be buffered if deleted genic DNA is, at least temporarily, replaced by repetitive DNA so that the nuclear/cell volume remains compatible with normal living. Thus, we speculate that retention of non-functionalized non-coding DNA, and replacement of deleted DNA through proliferation of selfish elements, might help avoid dosage imbalances in cycles of polyploidization and diploidization, which are particularly frequent in plants.	[Veitia, Reiner A.] CNRS, Inst Jacques Monod, UMR 7592, Paris, France; [Bottani, Samuel] CNRS, Lab Mat & Syst Complexes MSC, UMR 7057, Paris, France; [Veitia, Reiner A.; Bottani, Samuel] Univ Paris 07, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Veitia, RA (corresponding author), CNRS, Inst Jacques Monod, UMR 7592, Paris, France.	reiner.veitia@inserm.fr			Universite Paris Diderot/Paris 7; Institut Universitaire de France	Universite Paris Diderot/Paris 7; Institut Universitaire de France	The research was funded by the Universite Paris Diderot/Paris 7. RAV is also funded by the Institut Universitaire de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; BENNETT M D, 1971, Proceedings of the Royal Society of London Series B Biological Sciences, V178, P277; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Cavalier-Smith T, 1999, GENETICA, V106, P3, DOI 10.1023/A:1003701925110; CAVALIERSMITH T, 1982, ANNU REV BIOPHYS BIO, V11, P273, DOI 10.1146/annurev.bb.11.060182.001421; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; MIRSKY AE, 1951, J GEN PHYSIOL, V34, P451, DOI 10.1085/jgp.34.4.451; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Patrushev LI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1519, DOI 10.1134/S0006297908130117; Patrushev LI, 1997, BIOCHEM MOL BIOL INT, V41, P851; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Sharma A, 2008, P NATL ACAD SCI USA, V105, P15470, DOI 10.1073/pnas.0805694105; SWIFT H, 1950, P NATL ACAD SCI USA, V36, P643, DOI 10.1073/pnas.36.11.643; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Veitia RA, 2004, GENETICS, V168, P569, DOI 10.1534/genetics.104.029785; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Vinogradov AE, 1998, J THEOR BIOL, V193, P197, DOI 10.1006/jtbi.1997.0629; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; VONSTERNBERG RM, 1992, GENETICA, V86, P215, DOI 10.1007/BF00133722; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100	36	9	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8201	10.1371/journal.pone.0008201	http://dx.doi.org/10.1371/journal.pone.0008201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011530	Green Submitted, Green Published, gold			2022-12-27	WOS:000272830300004
J	Poll, G; Braun, T; Jakovljevic, J; Neueder, A; Jakob, S; Woolford, JL; Tschochner, H; Milkereit, P				Poell, Gisela; Braun, Tobias; Jakovljevic, Jelena; Neueder, Andreas; Jakob, Steffen; Woolford, John L., Jr.; Tschochner, Herbert; Milkereit, Philipp			rRNA Maturation in Yeast Cells Depleted of Large Ribosomal Subunit Proteins	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE VIABILITY; FUNCTIONAL-ANALYSIS; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; NUCLEAR EXPORT; 80S RIBOSOME; FINAL STEP; GENES; BIOGENESIS; 5.8S	The structural constituents of the large eukaryotic ribosomal subunit are 3 ribosomal RNAs, namely the 25S, 5.8S and 5S rRNA and about 46 ribosomal proteins (r-proteins). They assemble and mature in a highly dynamic process that involves more than 150 proteins and 70 small RNAs. Ribosome biogenesis starts in the nucleolus, continues in the nucleoplasm and is completed after nucleo-cytoplasmic translocation of the subunits in the cytoplasm. In this work we created 26 yeast strains, each of which conditionally expresses one of the large ribosomal subunit (LSU) proteins. In vivo depletion of the analysed LSU r-proteins was lethal and led to destabilisation and degradation of the LSU and/or its precursors. Detailed steady state and metabolic pulse labelling analyses of rRNA precursors in these mutant strains showed that LSU r-proteins can be grouped according to their requirement for efficient progression of different steps of large ribosomal subunit maturation. Comparative analyses of the observed phenotypes and the nature of r-protein - rRNA interactions as predicted by current atomic LSU structure models led us to discuss working hypotheses on i) how individual r-proteins control the productive processing of the major 59 end of 5.8S rRNA precursors by exonucleases Rat1p and Xrn1p, and ii) the nature of structural characteristics of nascent LSUs that are required for cytoplasmic accumulation of nascent subunits but are nonessential for most of the nuclear LSU pre-rRNA processing events.	[Poell, Gisela; Braun, Tobias; Neueder, Andreas; Jakob, Steffen; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Inst Biochem 3, Regensburg, Germany; [Jakovljevic, Jelena; Woolford, John L., Jr.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	University of Regensburg; Carnegie Mellon University	Poll, G (corresponding author), Univ Regensburg, Inst Biochem 3, Regensburg, Germany.	jw17@andrew.cmu.edu; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Neueder, Andreas/K-4319-2015	Neueder, Andreas/0000-0002-2389-5236; Woolford, John/0000-0002-7553-7043	Deutsche Forschungsgemeinschaft [FOR-1068]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, in the research unit FOR-1068 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023, DOI 10.1128/MCB.17.9.5023; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; Burke D., 2000, METHODS YEAST GENETI; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; DeLabre ML, 2002, BBA-GENE STRUCT EXPR, V1574, P255, DOI 10.1016/S0167-4781(01)00372-4; DESHMUKH M, 1993, MOL CELL BIOL, V13, P2835, DOI 10.1128/MCB.13.5.2835; DONOVAN DM, 1990, MOL CELL BIOL, V10, P6097, DOI 10.1128/MCB.10.11.6097; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Faber AW, 2006, BIOCHEM BIOPH RES CO, V345, P796, DOI 10.1016/j.bbrc.2006.04.166; Faber AW, 2002, RNA, V8, P1095, DOI 10.1017/S1355838202021027; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FRIED HM, 1985, MOL CELL BIOL, V5, P99, DOI 10.1128/MCB.5.1.99; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Geerlings TH, 2000, RNA, V6, P1698, DOI 10.1017/S1355838200001540; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Hofer A, 2007, J BIOL CHEM, V282, P32630, DOI 10.1074/jbc.M705057200; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koller HT, 1996, YEAST, V12, P53, DOI 10.1002/(SICI)1097-0061(199601)12:1<53::AID-YEA886>3.0.CO;2-M; Kufel J, 1999, RNA, V5, P909, DOI 10.1017/S135583829999026X; LIANG X, 2009, RNA; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; LINDAHL L, 1992, NUCLEIC ACIDS RES, V20, P295, DOI 10.1093/nar/20.2.295; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUCIOLI A, 1988, MOL CELL BIOL, V8, P4792, DOI 10.1128/MCB.8.11.4792; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; MOORE JBT, 2009, HAEMATOLOGICA; Moore Peter B, 2009, J Biol, V8, P8, DOI 10.1186/jbiol103; OHTAKE Y, 1995, GENETICS, V140, P129; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Rivlin AA, 1999, J MOL BIOL, V294, P909, DOI 10.1006/jmbi.1999.3309; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; ROHL R, 1982, P NATL ACAD SCI-BIOL, V79, P729, DOI 10.1073/pnas.79.3.729; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; RUTGERS CA, 1990, BIOCHIM BIOPHYS ACTA, V1050, P74, DOI 10.1016/0167-4781(90)90144-Q; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; Sambrook J., 2002, MOL CLONING LAB MANU; SANTOS C, 1994, J BIOL CHEM, V269, P15689; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; SHUAI K, 1991, NUCLEIC ACIDS RES, V19, P5059, DOI 10.1093/nar/19.18.5059; SMITT WWS, 1972, EXP CELL RES, V71, P33, DOI 10.1016/0014-4827(72)90259-5; Song JR, 1996, CURR GENET, V30, P273, DOI 10.1007/s002940050132; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Timsit Y, 2009, INT J MOL SCI, V10, P817, DOI 10.3390/ijms10030817; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P275, DOI 10.1016/0005-2787(76)90302-6; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P265, DOI 10.1016/0005-2787(76)90301-4; van Beekvelt CA, 2001, NUCLEIC ACIDS RES, V29, P5001, DOI 10.1093/nar/29.24.5001; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Venema J, 1998, METH MOL B, V77, P257; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S; YON J, 1991, MOL GEN GENET, V227, P72, DOI 10.1007/BF00260709; Yu X, 2001, J BIOL CHEM, V276, P33821, DOI 10.1074/jbc.M103772200; Zengel JM, 2003, RNA, V9, P1188, DOI 10.1261/rna.5400703; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	72	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8249	10.1371/journal.pone.0008249	http://dx.doi.org/10.1371/journal.pone.0008249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011513	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830200004
J	McKernan, DP; Nolan, A; Brint, EK; O'Mahony, SM; Hyland, NP; Cryan, JF; Dinan, TG				McKernan, Declan P.; Nolan, Aoife; Brint, Elizabeth K.; O'Mahony, Siobhain M.; Hyland, Niall P.; Cryan, John F.; Dinan, Timothy G.			Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome	PLOS ONE			English	Article							WISTAR-KYOTO RATS; FUNCTIONAL GASTROINTESTINAL DISORDERS; IMPAIRED GASTRIC ACCOMMODATION; VISCERAL HYPERSENSITIVITY; NEGATIVE REGULATION; IMMUNE DYSFUNCTION; EPITHELIAL-CELLS; NERVE INJURY; MAP KINASE; GUT AXIS	Background: Irritable bowel syndrome (IBS) is largely viewed as a stress-related disorder caused by aberrant brain-gut-immune communication and altered gastrointestinal (GI) homeostasis. Accumulating evidence demonstrates that stress modulates innate immune responses; however, very little is known on the immunological effects of stress on the GI tract. Toll-like receptors (TLRs) are critical pattern recognition molecules of the innate immune system. Activation of TLRs by bacterial and viral molecules leads to activation of NF-kB and an increase in inflammatory cytokine expression. It was our hypothesis that innate immune receptor expression may be changed in the gastrointestinal tract of animals with stress-induced IBS-like symptoms. Methodology/Principal Findings: In this study, our objective was to evaluate the TLR expression profile in the colonic mucosa of two rat strains that display colonic visceral hypersensivity; the stress-sensitive Wistar-Kyoto (WKY) rat and the maternally separated (MS) rat. Quantitative PCR of TLR2-10 mRNA in both the proximal and distal colonic mucosae was carried out in adulthood. Significant increases are seen in the mRNA levels of TLR3, 4 & 5 in both the distal and proximal colonic mucosa of MS rats compared with controls. No significant differences were noted for TLR 2, 7, 9 & 10 while TLR 6 could not be detected in any samples in both rat strains. The WKY strain have increased levels of mRNA expression of TLR3, 4, 5, 7, 8, 9 & 10 in both the distal and proximal colonic mucosa compared to the control Sprague-Dawley strain. No significant differences in expression were found for TLR2 while as before TLR6 could not be detected in all samples in both strains. Conclusions: These data suggest that both early life stress (MS) and a genetic predisposition (WKY) to stress affect the expression of key sentinels of the innate immune system which may have direct relevance for the molecular pathophysiology of IBS.	[McKernan, Declan P.; Nolan, Aoife; Brint, Elizabeth K.; O'Mahony, Siobhain M.; Hyland, Niall P.; Cryan, John F.; Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Lab Neurogastroenterol, Cork, Ireland; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Hyland, Niall P.; Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [O'Mahony, Siobhain M.] Natl Univ Ireland Univ Coll Cork, Dept Anat, Cork, Ireland; [Brint, Elizabeth K.] Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	McKernan, DP (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Lab Neurogastroenterol, Cork, Ireland.	j.cryan@ucc.ie; t.dinan@ucc.ie	O'Mahony, Siobhain M./AAE-9167-2021; Dinan, Timothy/ABA-8284-2020; McKernan, Declan P/AEK-0857-2022; Cryan, John F./A-6950-2013	O'Mahony, Siobhain M./0000-0002-9597-9391; McKernan, Declan P/0000-0002-9691-1671; Cryan, John F./0000-0001-5887-2723; Dinan, Timothy/0000-0002-2316-7220; Hyland, Niall/0000-0003-0060-7390; Brint, Elizabeth/0000-0001-9214-149X	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan; SFI; GlaxoSmithKline	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); SFI(Science Foundation Ireland); GlaxoSmithKline(GlaxoSmithKline)	The Alimentary Pharmabiotic Centre is a Centre for Science and Technology (CSET) funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan. The authors and their work were supported by SFI and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Arebi N, 2008, ALIMENT PHARM THER, V28, P830, DOI 10.1111/j.1365-2036.2008.03801.x; Bailey MT, 2007, AM J PHYSIOL-REG I, V293, pR1180, DOI 10.1152/ajpregu.00307.2007; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Brades S, 2009, GASTROENTEROLOGY, V136, P1339, DOI 10.1053/j.gastro.2008.12.044; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Clarke G, 2009, TRENDS MOL MED, V15, P478, DOI 10.1016/j.molmed.2009.08.001; De La Garza R, 2004, BRAIN RES, V1021, P209, DOI 10.1016/j.brainres.2004.06.052; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Dinan TG, 2008, AM J GASTROENTEROL, V103, P2570, DOI 10.1111/j.1572-0241.2008.01871.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gopal R, 2008, PARASITE IMMUNOL, V30, P563, DOI 10.1111/j.1365-3024.2008.01055.x; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Gunter WD, 2000, PHYSIOL BEHAV, V69, P379, DOI 10.1016/S0031-9384(99)00254-1; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hutchinson MR, 2009, BRAIN BEHAV IMMUN; Hyland NP, 2009, GUT, V58, P1029, DOI 10.1136/gut.2008.167882; Hyland NP, 2008, GASTROENTEROLOGY, V134, pA552; John CD, 2003, CURR OPIN PHARMACOL, V3, P78, DOI 10.1016/S1471-4892(02)00009-7; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P389, DOI 10.1111/j.1365-2982.2008.01220.x; Lahmame A, 1997, EUR J PHARMACOL, V337, P115, DOI 10.1016/S0014-2999(97)01276-4; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macsharry J, 2008, SCAND J GASTROENTERO, V43, P1467, DOI 10.1080/00365520802276127; Malkesman O, 2006, BIOL PSYCHIAT, V59, P17, DOI 10.1016/j.biopsych.2005.05.039; MALKESMAN O, 2009, PROGR NEURO IN PRESS; Martinez V, 2007, N-S ARCH PHARMACOL, V376, P205, DOI 10.1007/s00210-007-0195-1; Mayer EA, 2008, GUT, V57, DOI 10.1136/gut.2006.101675; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nielsen MA, 2006, SCAND J GASTROENTERO, V41, P773, DOI 10.1080/00365520500483215; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; O'Malley D, 2010, NEUROGASTROENT MOTIL, V22, P301, DOI 10.1111/j.1365-2982.2009.01412.x; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; OBATA K, 2008, J NEUROCHEM; OHMAN L, 2009, NEUROGASTROENTEROL M; Ohman L, 2009, AM J GASTROENTEROL, V104, P1205, DOI 10.1038/ajg.2009.116; OMALLEY D, 2009, STRESS IN PRESS; PARE WP, 1993, J PHYSIOL-PARIS, V87, P229, DOI 10.1016/0928-4257(93)90010-Q; Park JH, 2005, DIGEST DIS SCI, V50, P1454, DOI 10.1007/s10620-005-2860-x; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Quigley EMM, 2003, SCAND J GASTROENTERO, V38, P1, DOI 10.1080/00855910310001403; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Thomas R. R., 1999, FLUOROPOLYMERS, P47; Zhang Y, 2008, J NEUROIMMUNOL, V194, P115, DOI 10.1016/j.jneuroim.2007.12.002; Zhang Y, 2008, J NEUROIMMUNOL, V204, P13, DOI 10.1016/j.jneuroim.2008.08.011	67	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8226	10.1371/journal.pone.0008226	http://dx.doi.org/10.1371/journal.pone.0008226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011045	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829800014
J	Chevaliez, S; Bouvier-Alias, M; Brillet, R; Pawlotsky, JM				Chevaliez, Stephane; Bouvier-Alias, Magali; Brillet, Rozenn; Pawlotsky, Jean-Michel			Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice	PLOS ONE			English	Article							POLYMERASE INHIBITOR; PLUS RIBAVIRIN; PEGINTERFERON; TELAPREVIR; PROTEASE; ASSAY; CLASSIFICATION; SYSTEM	Background: With the development of new specific inhibitors of hepatitis C virus (HCV) enzymes and functions that may yield different antiviral responses and resistance profiles according to the HCV subtype, correct HCV genotype 1 subtype identification is mandatory in clinical trials for stratification and interpretation purposes and will likely become necessary in future clinical practice. The goal of this study was to identify the appropriate molecular tool(s) for accurate HCV genotype 1 subtype determination. Methodology/Principal Findings: A large cohort of 500 treatment-naive patients eligible for HCV drug trials and infected with either subtype 1a or 1b was studied. Methods based on the sole analysis of the 5' non-coding region (5'NCR) by sequence analysis or reverse hybridization failed to correctly identify HCV subtype 1a in 22.8%-29.5% of cases, and HCV subtype 1b in 9.5%-8.7% of cases. Natural polymorphisms at positions 107, 204 and/or 243 were responsible for mis-subtyping with these methods. A real-time PCR method using genotype- and subtype-specific primers and probes located in both the 5'NCR and the NS5B-coding region failed to correctly identify HCV genotype 1 subtype in approximately 10% of cases. The second-generation line probe assay, a reverse hybridization assay that uses probes targeting both the 5'NCR and core-coding region, correctly identified HCV subtypes 1a and 1b in more than 99% of cases. Conclusions/Significance: In the context of new HCV drug development, HCV genotyping methods based on the exclusive analysis of the 5'NCR should be avoided. The second-generation line probe assay is currently the best commercial assay for determination of HCV genotype 1 subtypes 1a and 1b in clinical trials and practice.	[Chevaliez, Stephane; Bouvier-Alias, Magali; Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, French Natl Reference Ctr Viral Hepatitis B C & D, Dept Virol, F-94010 Creteil, France; [Chevaliez, Stephane; Bouvier-Alias, Magali; Brillet, Rozenn; Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chevaliez, S (corresponding author), Univ Paris 12, Hop Henri Mondor, French Natl Reference Ctr Viral Hepatitis B C & D, Dept Virol, F-94010 Creteil, France.	jean-michel.pawlotsky@hmn.aphp.fr	Pawlotsky, Jean-Michel/R-8159-2018; Bouvier-Alias, Magali/S-5631-2018	Bouvier-Alias, Magali/0000-0003-1590-5980; Pawlotsky, Jean-Michel/0000-0003-0745-7559	VIRGIL European Network of Excellence on Antiviral Drug Resistance [LSHM-CT-2004-503359]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health''; 6th Framework Program of the European Union	VIRGIL European Network of Excellence on Antiviral Drug Resistance; Priority 1 "Life Sciences, Genomics and Biotechnology for Health''; 6th Framework Program of the European Union(European Commission)	The Trugene HCV 5'NC Genotyping kits and the INNO-LiPA HCV kits were kindly provided by Siemens Medical Solutions Diagnostics. The Abbott RealTime HCV Genotype II kits were kindly provided by Abbott Molecular. This work is part of the activity of the VIRGIL European Network of Excellence on Antiviral Drug Resistance supported by a grant (LSHM-CT-2004-503359) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health'' program in the 6th Framework Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Bouchardeau F, 2007, J CLIN MICROBIOL, V45, P1140, DOI 10.1128/JCM.01982-06; Bronowicki JP, 2006, GASTROENTEROLOGY, V131, P1040, DOI 10.1053/j.gastro.2006.07.022; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Chevaliez S, 2008, BEST PRACT RES CL GA, V22, P1031, DOI 10.1016/j.bpg.2008.11.004; Erhardt A, 2009, ANTIVIR THER, V14, P23; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang LJ, 2009, J HEPATOL, V50, pS6, DOI 10.1016/S0168-8278(09)60010-6; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kwo P, 2009, J HEPATOL, V50, pS4, DOI 10.1016/S0168-8278(09)60006-4; Liang YQ, 2008, GASTROENTEROLOGY, V135, P1710, DOI 10.1053/j.gastro.2008.07.023; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martro E, 2008, J CLIN MICROBIOL, V46, P192, DOI 10.1128/JCM.01623-07; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Meffre C, 2007, HEPATOLOGY, V46, p625A; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Nettles R, 2008, HEPATOLOGY, V48, p1025A; Nolte FS, 2003, J CLIN MICROBIOL, V41, P1558, DOI 10.1128/JCM.41.4.1558-1564.2003; Nolte FS, 2001, MOL DIAGN, V6, P265, DOI 10.1054/modi.2001.29157; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pawlotsky Jean-Michel, 2009, Therap Adv Gastroenterol, V2, P205, DOI 10.1177/1756283X09336045; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Qiu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-62; Ross RS, 2007, J VIROL METHODS, V143, P153, DOI 10.1016/j.jviromet.2007.03.006; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson P, 2009, J HEPATOL, V50, pS37, DOI 10.1016/S0168-8278(09)60092-1; Verbeeck J, 2008, J CLIN MICROBIOL, V46, P1901, DOI 10.1128/JCM.02390-07; Villano S, 2006, HEPATOLOGY, V44, p607A; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506	39	105	115	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8209	10.1371/journal.pone.0008209	http://dx.doi.org/10.1371/journal.pone.0008209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997618	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829700007
J	Kooij, G; Backer, R; Koning, JJ; Reijerkerk, A; van Horssen, J; van der Pol, SMA; Drexhage, J; Schinkel, A; Dijkstra, CD; den Haan, JMM; Geijtenbeek, TBH; de Vries, HE				Kooij, Gijs; Backer, Ronald; Koning, Jasper J.; Reijerkerk, Arie; van Horssen, Jack; van der Pol, Susanne M. A.; Drexhage, Joost; Schinkel, Alfred; Dijkstra, Christine D.; den Haan, Joke M. M.; Geijtenbeek, Teunis B. H.; de Vries, Helga E.			P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; BLOOD-BRAIN-BARRIER; T-CELL-ACTIVATION; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; PATHOGENESIS; TRANSPORT; DRUG; MICE	Background: Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system in which autoreactive myelin-specific T cells cause extensive tissue damage, resulting in neurological deficits. In the disease process, T cells are primed in the periphery by antigen presenting dendritic cells (DCs). DCs are considered to be crucial regulators of specific immune responses and molecules or proteins that regulate DC function are therefore under extensive investigation. We here investigated the potential immunomodulatory capacity of the ATP binding cassette transporter P-glycoprotein (Pgp). P-gp generally drives cellular efflux of a variety of compounds and is thought to be involved in excretion of inflammatory agents from immune cells, like DCs. So far, the immunomodulatory role of these ABC transporters is unknown. Methods and Findings: Here we demonstrate that P-gp acts as a key modulator of adaptive immunity during an in vivo model for neuroinflammation. The function of the DC is severely impaired in P-gp knockout mice (Mdr1a/1b-/-), since both DC maturation and T cell stimulatory capacity is significantly decreased. Consequently, Mdr1a/1b-/- mice develop decreased clinical signs of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. Reduced clinical signs coincided with impaired T cell responses and T cell-specific brain inflammation. We here describe the underlying molecular mechanism and demonstrate that P-gp is crucial for the secretion of pro-inflammatory cytokines such as TNF-alpha and IFN-gamma. Importantly, the defect in DC function can be restored by exogenous addition of these cytokines. Conclusions: Our data demonstrate that P-gp downmodulates DC function through the regulation of pro-inflammatory cytokine secretion, resulting in an impaired immune response. Taken together, our work highlights a new physiological role for P-gp as an immunomodulatory molecule and reveals a possible new target for immunotherapy.	[Kooij, Gijs; Backer, Ronald; Koning, Jasper J.; Reijerkerk, Arie; van Horssen, Jack; van der Pol, Susanne M. A.; Drexhage, Joost; Dijkstra, Christine D.; den Haan, Joke M. M.; de Vries, Helga E.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Schinkel, Alfred] Netherlands Canc Inst NKI, Dept Mol Biol, Amsterdam, Netherlands; [Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Kooij, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	He.devries@vumc.nl	den Haan, Joke MM/A-4281-2010; Kooij, Gijs/AAA-4268-2020; Backer, Ronald/F-5437-2013	den Haan, Joke MM/0000-0002-4421-6917; Backer, Ronald/0000-0003-1464-3755; de Vries, Helga/0000-0001-7904-7124; Kooij, Gijs/0000-0002-9488-2918; van Horssen, Jack/0000-0003-4078-7402	Netherlands Organization of Scientific Research [016.046.314, 917.46.311]; VICI [918.56.612]; Dutch foundation of MS Research; Netherlands [MS 05-567]; J. van Horssen and J. Drexhage [MS 05-358c]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); VICI(Netherlands Organization for Scientific Research (NWO)); Dutch foundation of MS Research; Netherlands(Netherlands Government); J. van Horssen and J. Drexhage	This work was supported by grants from the Netherlands Organization of Scientific Research (grant 016.046.314, G. Kooij, A. Reijerkerk; grant 917.46.311, J. den Haan, R. Backer), a VICI grant (918.56.612, J. Koning) and grants from the Dutch foundation of MS Research, The Netherlands ( grant MS 05-567, J. van Horssen and J. Drexhage; grant MS 05-358c, J. van Horssen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Backer R, 2008, EUR J IMMUNOL, V38, P370, DOI 10.1002/eji.200737647; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnes KM, 1996, BIOCHEMISTRY-US, V35, P4820, DOI 10.1021/bi952380k; Bauer B, 2005, EXP BIOL MED, V230, P118; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Eisenbraun MD, 1999, J IMMUNOL, V163, P2621; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Ewing C, 1998, IMMUNOL CELL BIOL, V76, P47, DOI 10.1046/j.1440-1711.1998.00718.x; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Frank MH, 2001, J IMMUNOL, V166, P2451, DOI 10.4049/jimmunol.166.4.2451; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Hussien Y, 2001, J NEUROIMMUNOL, V121, P102, DOI 10.1016/S0165-5728(01)00432-5; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Koubeissi A, 2006, BIOORG MED CHEM LETT, V16, P5700, DOI 10.1016/j.bmcl.2006.07.059; Lagas JS, 2008, ANTIMICROB AGENTS CH, V52, P1034, DOI 10.1128/AAC.01041-07; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lucchinetti C, 2001, CURR OPIN NEUROL, V14, P259, DOI 10.1097/00019052-200106000-00002; Meijer OC, 1998, ENDOCRINOLOGY, V139, P1789, DOI 10.1210/en.139.4.1789; Pendse SS, 2006, AM J TRANSPLANT, V6, P2884, DOI 10.1111/j.1600-6143.2006.01561.x; Quah BJC, 2005, J CELL MOL MED, V9, P643, DOI 10.1111/j.1582-4934.2005.tb00494.x; Raggers RJ, 2001, BIOCHEM J, V357, P859, DOI 10.1042/0264-6021:3570859; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Schroeijers AB, 2002, J IMMUNOL, V168, P1572, DOI 10.4049/jimmunol.168.4.1572; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159, DOI 10.1177/37.2.2463300; Vieira PL, 2003, J IMMUNOL, V170, P4483, DOI 10.4049/jimmunol.170.9.4483; Weiss HA, 2007, J NEUROIMMUNOL, V191, P79, DOI 10.1016/j.jneuroim.2007.09.011	39	55	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8212	10.1371/journal.pone.0008212	http://dx.doi.org/10.1371/journal.pone.0008212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997559	Green Published, gold			2022-12-27	WOS:000272829700009
J	Yamada, K; Matsuzaki, S; Hattori, T; Kuwahara, R; Taniguchi, M; Hashimoto, H; Shintani, N; Baba, A; Kumamoto, N; Yamada, K; Yoshikawa, T; Katayama, T; Tohyama, M				Yamada, Kohei; Matsuzaki, Shinsuke; Hattori, Tsuyoshi; Kuwahara, Ryusuke; Taniguchi, Manabu; Hashimoto, Hitoshi; Shintani, Norihito; Baba, Akemichi; Kumamoto, Natsuko; Yamada, Kazuo; Yoshikawa, Takeo; Katayama, Taiichi; Tohyama, Masaya			Increased Stathmin1 Expression in the Dentate Gyrus of Mice Causes Abnormal Axonal Arborizations	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; IN-SITU HYBRIDIZATION; MICROTUBULE DESTABILIZER; NEURITE OUTGROWTH; DEFICIENT MICE; GENE FAMILY; SCHIZOPHRENIA; PACAP; CELLS; RECEPTOR	Pituitary adenylate cyclase-activating polypeptide (PACAP) is involved in multiple brain functions. To clarify the cause of abnormal behavior in PACAP deficient-mice, we attempted the identification of genes whose expression was altered in the dentate gyrus of PACAP-deficient mice using the differential display method. Expression of stathmin1 was up-regulated in the dentate gyrus at both the mRNA and protein levels. PACAP stimulation inhibited stathmin1 expression in PC12 cells, while increased stathmin1expression in neurons of the subgranular zone and in primary cultured hippocampal neurons induced abnormal arborization of axons. We also investigated the pathways involved in PACAP deficiency. Ascl1 binds to E10 box of the stathmin1 promoter and increases stathmin1 expression. Inhibitory bHLH proteins (Hes1 and Id3) were rapidly up-regulated by PACAP stimulation, and Hes1 could suppress Ascl1 expression and Id3 could inhibit Ascl1 signaling. We also detected an increase of stathmin1 expression in the brains of schizophrenic patients. These results suggest that up-regulation of stathmin1 in the dentate gyrus, secondary to PACAP deficiency, may create abnormal neuronal circuits that cause abnormal behavior.	[Yamada, Kohei; Kuwahara, Ryusuke; Taniguchi, Manabu; Kumamoto, Natsuko; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Matsuzaki, Shinsuke; Hashimoto, Hitoshi; Katayama, Taiichi; Tohyama, Masaya] Osaka Univ, United Grad Sch Child Dev, Osaka, Japan; [Matsuzaki, Shinsuke; Hashimoto, Hitoshi; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka, Japan; [Matsuzaki, Shinsuke; Hashimoto, Hitoshi; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan; [Hattori, Tsuyoshi; Shintani, Norihito] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka, Japan; [Hashimoto, Hitoshi; Shintani, Norihito; Baba, Akemichi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Osaka, Japan; [Yamada, Kazuo; Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan	Osaka University; Osaka University; Kanazawa University; Hamamatsu University School of Medicine; Osaka University; Osaka University; RIKEN	Yamada, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	katayama@ugscd.osaka-u.ac.jp	Shintani, Norihito/N-1600-2019; Shintani, Norihito/D-5860-2014; Hashimoto, Hitoshi/D-1209-2010; Yoshikawa, Takeo/F-9599-2019	Shintani, Norihito/0000-0002-7850-9064; Shintani, Norihito/0000-0002-7850-9064; Hashimoto, Hitoshi/0000-0001-6548-4016; 	Osaka University	Osaka University	This work was supported in part by Osaka University operating budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKE B, 2009, AM J MED GE IN PRESS; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Clark D, 2006, MOL PSYCHIATR, V11, P459, DOI 10.1038/sj.mp.4001806; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; Ghzili H, 2006, REGUL PEPTIDES, V137, P89, DOI 10.1016/j.regpep.2006.06.015; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS152; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Liu AX, 2005, J NEUROSCI, V25, P737, DOI 10.1523/JNEUROSCI.4174-04.2005; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millsap RE, 2001, STRUCT EQU MODELING, V8, P1, DOI 10.1207/S15328007SEM0801_1; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Nicot A, 2004, J NEUROSCI, V24, P8786, DOI 10.1523/JNEUROSCI.1910-04.2004; Ohkawa N, 2007, NEUROSCI RES, V59, P93, DOI 10.1016/j.neures.2007.06.1464; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; Polzin RG, 2004, GENE, V341, P209, DOI 10.1016/j.gene.2004.06.052; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; ROWLANDS DC, 1995, LAB INVEST, V72, P100; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Shintani N, 2002, REGUL PEPTIDES, V109, P45, DOI 10.1016/S0167-0115(02)00169-6; Shintani N, 2006, ANN NY ACAD SCI, V1070, P545, DOI 10.1196/annals.1317.079; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; VONVISGER JR, 1994, EXP NEUROL, V128, P34, DOI 10.1006/exnr.1994.1110; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Yamanaka H, 2005, NEUROSCIENCE, V132, P183, DOI 10.1016/j.neuroscience.2004.12.003	47	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8596	10.1371/journal.pone.0008596	http://dx.doi.org/10.1371/journal.pone.0008596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062533	Green Published, gold			2022-12-27	WOS:000273338600016
J	Soshi, T; Kuriyama, K; Aritake, S; Enomoto, M; Hida, A; Tamura, M; Kim, Y; Mishima, K				Soshi, Takahiro; Kuriyama, Kenichi; Aritake, Sayaka; Enomoto, Minori; Hida, Akiko; Tamura, Miyuki; Kim, Yoshiharu; Mishima, Kazuo			Sleep Deprivation Influences Diurnal Variation of Human Time Perception with Prefrontal Activity Change: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							BRAIN ACTIVATION; WORKING-MEMORY; DIVIDED ATTENTION; DURATION; CORTEX; LONG; DISCRIMINATION; REPRESENTATION; FLUCTUATION; NETWORKS	Human short-time perception shows diurnal variation. In general, short-time perception fluctuates in parallel with circadian clock parameters, while diurnal variation seems to be modulated by sleep deprivation per se. Functional imaging studies have reported that short-time perception recruits a neural network that includes subcortical structures, as well as cortical areas involving the prefrontal cortex (PFC). It has also been reported that the PFC is vulnerable to sleep deprivation, which has an influence on various cognitive functions. The present study is aimed at elucidating the influence of PFC vulnerability to sleep deprivation on short-time perception, using the optical imaging technique of functional near-infrared spectroscopy. Eighteen participants performed 10-s time production tasks before (at 21: 00) and after (at 09: 00) experimental nights both in sleep-controlled and sleep-deprived conditions in a 4-day laboratory-based crossover study. Compared to the sleep-controlled condition, one-night sleep deprivation induced a significant reduction in the produced time simultaneous with an increased hemodynamic response in the left PFC at 09:00. These results suggest that activation of the left PFC, which possibly reflects functional compensation under a sleep-deprived condition, is associated with alteration of short-time perception.	[Soshi, Takahiro; Kuriyama, Kenichi; Aritake, Sayaka; Enomoto, Minori; Hida, Akiko; Tamura, Miyuki; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Natl Inst Mental Hlth, Tokyo, Japan; [Soshi, Takahiro; Kuriyama, Kenichi; Kim, Yoshiharu] Natl Ctr Neurol & Psychiat, Dept Adult Mental Hlth, Natl Inst Mental Hlth, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Soshi, T (corresponding author), Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Natl Inst Mental Hlth, Tokyo, Japan.	kenichik@ncnp.go.jp		MISHIMA, KAZUO/0000-0003-1182-1181; Soshi, Takahiro/0000-0003-1924-936X	Ministry of Education, Culture, Sports, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Grants-in-Aid for Scientific Research [22791161, 21390335] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Special Coordination Funds of the Ministry of Education, Culture, Sports, and Technology of Japan and by a Grant-in-Aid for Cooperative Research from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Aschoff J, 1997, CHRONOBIOL INT, V14, P585, DOI 10.3109/07420529709001449; ASCHOFF J, 1985, HUM NEUROBIOL, V4, P41; Aschoff J, 1998, J BIOL RHYTHM, V13, P437, DOI 10.1177/074873098129000264; ASCHOFF J, 1988, ANN NY ACAD SCI, V423, P442; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOYAR RM, 1979, J CLIN ENDOCR METAB, V48, P760, DOI 10.1210/jcem-48-5-760; Bschor T, 2004, ACTA PSYCHIAT SCAND, V109, P222, DOI 10.1046/j.0001-690X.2003.00244.x; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; FEVRE M, 1978, J CLIN ENDOCR METAB, V47, P1383, DOI 10.1210/jcem-47-6-1383; GIBBON J, 1981, J EXP PSYCHOL ANIM B, V7, P87, DOI 10.1037/0097-7403.7.2.87; Harrington DL, 1998, J NEUROSCI, V18, P1085; HOAGLAND HUDSON, 1933, JOUR GEN PSYCHOL, V9, P267; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; HOSHI Y, 1993, J APPL PHYSIOL, V75, P1842, DOI 10.1152/jappl.1993.75.4.1842; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; JASPER HH, 1958, ELECTROENCEPHALOGR C, V86, P7; Jindal SL, 2002, J ASTHMA, V39, P363, DOI 10.1081/JAS-120004029; KLEBER RJ, 1963, J COMP PHYSIOL PSYCH, V56, P362, DOI 10.1037/h0049227; KRAFT M, 1995, DIS MON, V41, P501; Kuriyama K, 2005, NEUROSCI RES, V53, P123, DOI 10.1016/j.neures.2005.06.006; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Kuriyama K, 2003, NEUROSCI RES, V46, P23, DOI 10.1016/S0168-0102(03)00025-7; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2002, NEUROREPORT, V13, P1731, DOI 10.1097/00001756-200210070-00008; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; MATTEL MS, 2004, COGNITIVE BRAIN RES, V58, P119; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miro E, 2003, HUM FACTORS, V45, P148, DOI 10.1518/hfes.45.1.148.27227; Moore RY, 1998, CHRONOBIOL INT, V15, P475, DOI 10.3109/07420529808998703; MOOREEDE MC, 1983, NEW ENGL J MED, V309, P469, DOI 10.1056/NEJM198308253090806; Morell V, 1996, SCIENCE, V271, P905, DOI 10.1126/science.271.5251.905; Mu QW, 2005, SLEEP, V28, P55, DOI 10.1093/sleep/28.1.55; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; POPPEL E, 1970, PSYCHOL FORSCH, V34, P182, DOI 10.1007/BF00424544; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Rammsayer T, 2005, ACTA PSYCHOL, V120, P141, DOI 10.1016/j.actpsy.2005.03.005; Rammsayer TH, 2006, BRAIN RES, V1073, P407, DOI 10.1016/j.brainres.2005.12.019; RAMMSAYER TH, 1992, NEUROPSYCHOBIOLOGY, V26, P71, DOI 10.1159/000118899; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TYSK L, 1984, PERCEPT MOTOR SKILL, V58, P455, DOI 10.2466/pms.1984.58.2.455; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Volkow ND, 2008, J NEUROSCI, V28, P8454, DOI 10.1523/JNEUROSCI.1443-08.2008; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319	67	23	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8395	10.1371/journal.pone.0008395	http://dx.doi.org/10.1371/journal.pone.0008395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049334	Green Published, Green Submitted, gold			2022-12-27	WOS:000273225000001
J	Chan, RCK; Wang, Y; Wang, L; Chen, EYH; Manschreck, TC; Li, ZJ; Yu, X; Gong, QY				Chan, Raymond C. K.; Wang, Ya; Wang, Li; Chen, Eric Y. H.; Manschreck, Theo C.; Li, Zhan-jiang; Yu, Xin; Gong, Qi-yong			Neurological Soft Signs and Their Relationships to Neurocognitive Functions: A Re-Visit with the Structural Equation Modeling Design	PLOS ONE			English	Article							SCHIZOPHRENIC-PATIENTS; NEUROPSYCHOLOGICAL PERFORMANCE; SUSTAINED ATTENTION; ABNORMALITIES; DYSFUNCTION; INSTRUMENT; ACTIVATION; INVENTORY; SYMPTOMS; CHILDREN	Background: Neurological soft signs and neurocognitive impairments have long been considered important features of schizophrenia. Previous correlational studies have suggested that there is a significant relationship between neurological soft signs and neurocognitive functions. The purpose of the current study was to examine the underlying relationships between these two distinct constructs with structural equation modeling (SEM). Methods: 118 patients with schizophrenia and 160 healthy controls were recruited for the current study. The abridged version of the Cambridge Neurological Inventory (CNI) and a set of neurocognitive function tests were administered to all participants. SEM was then conducted independently in these two samples to examine the relationships between neurological soft signs and neurocognitive functions. Results: Both the measurement and structural models showed that the models fit well to the data in both patients and healthy controls. The structural equations also showed that there were modest to moderate associations among neurological soft signs, executive attention, verbal memory, and visual memory, while the healthy controls showed more limited associations. Conclusions: The current findings indicate that motor coordination, sensory integration, and disinhibition contribute to the latent construct of neurological soft signs, whereas the subset of neurocognitive function tests contribute to the latent constructs of executive attention, verbal memory, and visual memory in the present sample. Greater evidence of neurological soft signs is associated with more severe impairment of executive attention and memory functions. Clinical and theoretical implications of the model findings are discussed.	[Chan, Raymond C. K.; Wang, Ya] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Chan, Raymond C. K.; Wang, Ya; Wang, Li] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Chan, Raymond C. K.; Chen, Eric Y. H.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Manschreck, Theo C.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Li, Zhan-jiang] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Yu, Xin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Gong, Qi-yong] Sichuan Univ, Huaxi MR Res Ctr, Dept Radiol, W China Hosp,W China Sch Med, Chengdu 610064, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Hong Kong; Harvard University; Harvard Medical School; Capital Medical University; Peking University; Sichuan University	Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009; Gong, Qiyong/W-3052-2019; Wang, Ya/C-7374-2009	Chan, Raymond CK/0000-0002-3414-450X; Gong, Qiyong/0000-0002-5912-4871; Wang, Ya/0000-0001-5764-6740; Chen, Eric/0000-0002-5247-3593; wang, li/0000-0002-1459-3412	Project-Oriented Hundred Talents Programme [O7CX031003]; Chinese Academy of Sciences [KSCX2-YW-R-131]; National Science Foundation of China [30770723]; National Basic Research Programme of China [2007CB512302/5]	Project-Oriented Hundred Talents Programme; Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China(National Basic Research Program of China)	This study was supported partially by the Project-Oriented Hundred Talents Programme (O7CX031003), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-R-131), a grant from National Science Foundation of China (30770723) and National Basic Research Programme of China (973 Program) (2007CB512302/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Arango C, 1999, AM J PSYCHIAT, V156, P1349; Black J.T, 1992, MULTIVARIATE DATA AN; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; BUCHANAN RW, 1989, PSYCHIAT RES, V27, P335, DOI 10.1016/0165-1781(89)90148-0; Candela SF, 2003, PSYCHIAT ANN, V33, P157, DOI 10.3928/0048-5713-20030301-05; Chan RCK, 2008, NEUROSCI BIOBEHAV R, V32, P957, DOI 10.1016/j.neubiorev.2008.01.005; Chan RCK, 2006, NEUROSCI LETT, V398, P189, DOI 10.1016/j.neulet.2006.01.014; Chan RCK, 2007, BEHAV NEUROL, V18, P171, DOI 10.1155/2007/451703; Chan RCK, 2006, SCHIZOPHR RES, V82, P51, DOI 10.1016/j.schres.2005.09.020; Chan RCK, 2006, SCHIZOPHR RES, V81, P173, DOI 10.1016/j.schres.2005.08.011; Chan RCK, 2004, J NERV MENT DIS, V192, P781, DOI 10.1097/01.nmd.0000144697.48042.eb; Chan RCK, 2004, EUR ARCH PSY CLIN N, V254, P256, DOI 10.1007/s00406-00-0492-3; Chan RCK, 2004, CLIN NEUROPSYCHOL, V18, P114, DOI 10.1080/13854040490507208; CHAN RCK, 2006, SCHIZOPHRENIC PSYCHO, P1; Chen E. Y. H., 1996, British Journal of Psychiatry, V168, P227, DOI 10.1192/bjp.168.2.227; Chen EYH, 2003, PSYCHIAT ANN, V33, P202, DOI 10.3928/0048-5713-20030301-09; Chen EYH, 2001, EUR ARCH PSY CLIN N, V251, P1, DOI 10.1007/s004060170059; CHEN EYH, 1995, PSYCHIAT RES, V56, P183, DOI 10.1016/0165-1781(95)02535-2; Dazzan P, 2004, BRAIN, V127, P143, DOI 10.1093/brain/awh015; Dazzan P, 2006, CEREB CORTEX, V16, P1225, DOI 10.1093/cercor/bhj063; FISH B, 1977, ARCH GEN PSYCHIAT, V34, P1297; Flashman LA, 1996, AM J PSYCHIAT, V153, P526; FOX G, 2001, BRAIN IMPAIR, V2, P140; Gong Y., 1989, MANUAL WECHSLER MEMO; Gong Y.X., 1992, MANUAL WECHSLER ADUL; GOTTESMAN II, 1973, BRIT J PSYCHIAT, V122, P15, DOI 10.1192/bjp.122.1.15; Griffiths TD, 1998, BRAIN, V121, P191, DOI 10.1093/brain/121.2.191; GUNTHER W, 1991, BIOL PSYCHIAT, V29, P535, DOI 10.1016/0006-3223(91)90090-9; GUPTA S, 1995, AM J PSYCHIAT, V152, P191; GUREJE O, 1988, ACTA PSYCHIAT SCAND, V78, P505, DOI 10.1111/j.1600-0447.1988.tb06374.x; Heaton R.K., 1993, WISCONSIN CARD SORTI; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Heinrichs RW, 2005, AM PSYCHOL, V60, P229, DOI 10.1037/0003-066X.60.3.229; HU LT, 1999, STRUCTURAL EQUATION, V1, P55; Kaufman A. S., 1983, ASSESSMENT BATTERY C; KENNARD MA, 1960, NEUROLOGY, V10, P753, DOI 10.1212/WNL.10.8.753; KINNEY DK, 1986, ARCH GEN PSYCHIAT, V43, P665; Korkman M, 1999, NEUROPSYCHOL REV, V9, P89, DOI 10.1023/A:1025659808004; Lawrie SM, 2001, BRIT J PSYCHIAT, V178, P524, DOI 10.1192/bjp.178.6.524; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Marcus P., 1985, PSYCHOANALYTIC INQUI, V5, P85; Mohr F, 1996, EUR ARCH PSY CLIN N, V246, P240, DOI 10.1007/BF02190275; Mohr F, 2003, PSYCHIAT RES, V121, P21, DOI 10.1016/S0165-1781(03)00203-8; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Niethammer R, 2000, AM J PSYCHIAT, V157, P272, DOI 10.1176/appi.ajp.157.2.272; Rao H, 2008, NEUROIMAGE, V41, P1345, DOI 10.1016/j.neuroimage.2008.04.026; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROSSI A, 1990, BRIT J PSYCHIAT, V157, P735, DOI 10.1192/bjp.157.5.735; Schroder J, 1999, NEUROIMAGE, V9, P81, DOI 10.1006/nimg.1998.0387; *SCI SOFTW INT, 2005, LISREL 8 53; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Tsuang MT, 1999, ACTA PSYCHIAT SCAND, V99, P2, DOI 10.1111/j.1600-0447.1999.tb05977.x; TSUANG MT, 1991, SCHIZOPHR RES, V4, P157, DOI 10.1016/0920-9964(91)90031-L; Wong AHC, 1997, SCHIZOPHR RES, V23, P139, DOI 10.1016/S0920-9964(96)00095-3; Yazici AH, 2002, SCHIZOPHR RES, V58, P241, DOI 10.1016/S0920-9964(01)00338-3	58	55	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8469	10.1371/journal.pone.0008469	http://dx.doi.org/10.1371/journal.pone.0008469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	537HN	20041110	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000026
J	MacKellar, J; Cushman, SW; Periwal, V				MacKellar, Jennifer; Cushman, Samuel W.; Periwal, Vipul			Differential Effects of Thiazolidinediones on Adipocyte Growth and Recruitment in Zucker Fatty Rats	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-GAMMA; PIOGLITAZONE	Background: Adipose tissue grows by two mechanisms: hyperplasia ( cell number increase) and hypertrophy ( cell size increase). Thiazolidinediones are insulin-sensitizing peroxisome proliferator-activated receptor gamma agonists that are known to affect the morphology of adipose tissue. Methodology: In this study, adipose cell-size probability distributions were measured in six Zucker fa/fa rats over a period of 24 days, from four weeks of age, using micro-biopsies to obtain subcutaneous ( inguinal) fat tissue from the animals. Three of the rats were gavaged daily with rosiglitazone, a thiazolidinedione, and three served as controls. These longitudinal probability distributions were analyzed to obtain the rate of increase in cell-size diameter in rosiglitazone-treated animals, and the hyperplasia induced by treatment quantitatively. Conclusions: We found that treatment leads to hypertrophy that leads to an approximately linear rate of cell diameter increase ( 2 mu m/day), and that the hyperplasia evident in treated animals occurs largely within the first eight days of treatment. The availability of additional lipid storage due to treatment may alleviate lipotoxicity and thereby promote insulin sensitivity. The hypothesis that a TZD regimen involving repeated treatments of limited duration may suffice for improvements in insulin sensitivity merits further investigation.	[MacKellar, Jennifer; Cushman, Samuel W.] NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; [Periwal, Vipul] NIDDKD, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	MacKellar, J (corresponding author), NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA.	vipulp@mail.nih.gov	Periwal, Vipul/I-1728-2012	MacKellar, Jennifer/0000-0003-0162-7430	Intramural Research Program of the National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075014, ZIADK013035] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Boden G, 2003, METABOLISM, V52, P753, DOI 10.1016/S0026-0495(03)00055-6; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Gregory P., 2005, BAYESIAN LOGICAL DAT; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; HIRSCH J, 1968, J LIPID RES, V9, P110; Jiang GQ, 2002, DIABETES, V51, P2412, DOI 10.2337/diabetes.51.8.2412; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; MCLAUGHLIN T, 2009, OBESITY IN PRESS; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Smith SR, 2006, ADIPOCYTES, V2, P11; Tierney L., 1990, LISP STAT OBJECT ORI; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829	14	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8196	10.1371/journal.pone.0008196	http://dx.doi.org/10.1371/journal.pone.0008196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041138	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000001
J	Ouedraogo, AL; Bousema, T; Schneider, P; de Vlas, SJ; Ilboudo-Sanogo, E; Cuzin-Ouattara, N; Nebie, I; Roeffen, W; Verhave, JP; Luty, AJF; Sauerwein, R				Ouedraogo, Andre Lin; Bousema, Teun; Schneider, Petra; de Vlas, Sake J.; Ilboudo-Sanogo, Edith; Cuzin-Ouattara, Nadine; Nebie, Issa; Roeffen, Will; Verhave, Jan Peter; Luty, Adrian J. F.; Sauerwein, Robert			Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission	PLOS ONE			English	Article							MALARIA TRANSMISSION; BURKINA-FASO; BLOCKING VACCINES; ANOPHELES-GAMBIAE; WESTERN KENYA; MOSQUITOS; COMBINATION; POPULATIONS; CHILDREN; THAILAND	Background: Man to mosquito transmission of malaria depends on the presence of the sexual stage parasites, gametocytes, that often circulate at low densities. Gametocyte densities below the microscopical threshold of detection may be sufficient to infect mosquitoes but the importance of submicroscopical gametocyte carriage in different transmission settings is unknown. Methodology/Principal Findings: Membrane feeding experiments were carried out on 80 children below 14 years of age at the end of the wet season in an area of seasonal malaria transmission in Burkina Faso. Gametocytes were quantified by microscopy and by Pfs25-based quantitative nucleic acid sequence-based amplification assay (QT-NASBA). The children's infectiousness was determined by membrane feeding experiments in which a venous blood sample was offered to locally reared Anopheles mosquitoes. Gametocytes were detected in 30.0% (24/80) of the children by microscopy compared to 91.6% (65/71) by QT-NASBA (p < 0.001). We observed a strong association between QT-NASBA gametocyte density and infection rates (p = 0.007). Children with microscopically detectable gametocytes were more likely to be infectious (68.2% compared to 31.7% of carriers of submicroscopical gametocytes, p = 0.001), and on average infected more mosquitoes (13.2% compared to 2.3%, p < 0.001). However, because of the high prevalence of submicroscopical gametocyte carriage in the study population, carriers of sub-microscopical gametocytes were responsible for 24.2% of the malaria transmission in this population. Conclusions/Significance: Submicroscopical gametocyte carriage is common in an area of seasonal transmission in Burkina Faso and contributes substantially to the human infectious reservoir. Submicroscopical gametocyte carriage should therefore be considered when implementing interventions that aim to reduce malaria transmission.	[Ouedraogo, Andre Lin; Ilboudo-Sanogo, Edith; Cuzin-Ouattara, Nadine; Nebie, Issa] Ctr Natl Rech & Format le Paludisme, Dept Biomed Sci, Ouagadougou, Burkina Faso; [Ouedraogo, Andre Lin; Roeffen, Will; Verhave, Jan Peter; Luty, Adrian J. F.; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Bousema, Teun] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Schneider, Petra] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC	Ouedraogo, AL (corresponding author), Ctr Natl Rech & Format le Paludisme, Dept Biomed Sci, Ouagadougou, Burkina Faso.	andrelin.cnrfp@fasonet.bf	Roeffen, W.F.G./L-4607-2015; Luty, Adrian/CAH-2547-2022; Sauerwein, Robert/C-8519-2013; Bousema, Teun/N-3574-2014	Bousema, Teun/0000-0003-2666-094X; Verhave, Jan Peter/0000-0002-5149-8772; Schneider, Petra/0000-0002-2616-237X; Nebie, Issa/0000-0003-3051-3600; de Vlas, Sake J./0000-0002-1830-5668; Luty, Adrian John Frederick/0000-0001-8830-3425	Netherlands Foundation for the Advancement of Tropical Research (WOTRO) [WM 93-350]; Netherlands Organization for Scientific Research (NWO) [825.08.025]; Wellcome Trust	Netherlands Foundation for the Advancement of Tropical Research (WOTRO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Netherlands Foundation for the Advancement of Tropical Research (WOTRO WM 93-350). Teun Bousema is supported by a Rubicon fellowship of the Netherlands Organization for Scientific Research (NWO; Rubicon 825.08.025). Petra Schneider is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2006, CURR MOL MED, V6, P223, DOI 10.2174/156652406776055140; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P479, DOI 10.4269/ajtmh.1991.45.479; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; MUIRHEADTHOMSON RC, 1954, T ROY SOC TROP MED H, V48, P208, DOI 10.1016/0035-9203(54)90067-X; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Ouedraogo AL, 2008, ACTA TROP, V105, P28, DOI 10.1016/j.actatropica.2007.09.003; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Pethleart A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-34; Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Sauerwein RW, 2007, MICROBES INFECT, V9, P792, DOI 10.1016/j.micinf.2007.02.011; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; YOUNG MD, 1948, AM J TROP MED, V28, P303	29	137	138	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8410	10.1371/journal.pone.0008410	http://dx.doi.org/10.1371/journal.pone.0008410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027314	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000272998000015
J	Goh, JO; Tan, JC; Park, DC				Goh, Joshua O.; Tan, Jiat Chow; Park, Denise C.			Culture Modulates Eye-Movements to Visual Novelty	PLOS ONE			English	Article							OBJECT; ATTENTION; DISTRACTORS; CAPTURE; BINDING; CONTEXT; TASKS; AGE	Background: When viewing complex scenes, East Asians attend more to contexts whereas Westerners attend more to objects, reflecting cultural differences in holistic and analytic visual processing styles respectively. This eye-tracking study investigated more specific mechanisms and the robustness of these cultural biases in visual processing when salient changes in the objects and backgrounds occur in complex pictures. Methodology/Principal Findings: Chinese Singaporean (East Asian) and Caucasian US (Western) participants passively viewed pictures containing selectively changing objects and background scenes that strongly captured participants' attention in a data-driven manner. We found that although participants from both groups responded to object changes in the pictures, there was still evidence for cultural divergence in eye-movements. The number of object fixations in the US participants was more affected by object change than in the Singapore participants. Additionally, despite the picture manipulations, US participants consistently maintained longer durations for both object and background fixations, with eye-movements that generally remained within the focal objects. In contrast, Singapore participants had shorter fixation durations with eye-movements that alternated more between objects and backgrounds. Conclusions/Significance: The results demonstrate a robust cultural bias in visual processing even when external stimuli draw attention in an opposite manner to the cultural bias. These findings also extend previous studies by revealing more specific, but consistent, effects of culture on the different aspects of visual attention as measured by fixation duration, number of fixations, and saccades between objects and backgrounds.	[Goh, Joshua O.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Tan, Jiat Chow] Duke NUS Grad Med Sch, Cognit Neurosci Lab, Singapore, Singapore; [Park, Denise C.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA	University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; University of Texas System; University of Texas Dallas	Goh, JO (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	jogoh2@uiuc.edu	GOH, JOSHUA/C-8063-2016	GOH, JOSHUA/0000-0001-7808-5452	NIH [R-37-AG006265-26, R-01-AG015047-09]; NATIONAL INSTITUTE ON AGING [R37AG006265, R01AG015047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant numbers R-37-AG006265-26 and R-01-AG015047-09 awarded to Denise Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2005, J EXP PSYCHOL GEN, V134, P207, DOI 10.1037/0096-3445.134.2.207; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Chee MWL, 2006, J COGNITIVE NEUROSCI, V18, P495, DOI 10.1162/jocn.2006.18.4.495; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Duchowski A.T., 2003, EYE TRACKING METHODO; Forster S, 2008, J EXP PSYCHOL-APPL, V14, P73, DOI 10.1037/1076-898X.14.1.73; Godijn R, 2008, VIS COGN, V16, P279, DOI 10.1080/13506280701437295; GOH JO, 2009, CULTURE SCULPTS PERC; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Gronau N, 2006, PSYCHON B REV, V13, P570, DOI 10.3758/BF03193964; Gutchess AH, 2006, COGN AFFECT BEHAV NE, V6, P102, DOI 10.3758/CABN.6.2.102; Hedden T, 2008, PSYCHOL SCI, V19, P12, DOI 10.1111/j.1467-9280.2008.02038.x; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JENKINS LJ, 2009, SOC COGN AF IN PRESS; Ji LJ, 2004, J PERS SOC PSYCHOL, V87, P57, DOI 10.1037/0022-3514.87.1.57; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; MULLER HJ, 1991, J EXP PSYCHOL HUMAN, V17, P107, DOI 10.1037/0096-1523.17.1.107; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Neo G, 2006, PERCEPT PSYCHOPHYS, V68, P1286, DOI 10.3758/BF03193728; Nisbett R.E, 2003, GEOGRAPHY THOUGHT AS; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Potter MC, 2009, J EXP PSYCHOL HUMAN, V35, P28, DOI 10.1037/a0013624; Prinzmetal W, 2005, J EXP PSYCHOL GEN, V134, P73, DOI 10.1037/0096-3445.134.1.73; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Schwarz W, 2008, J EXP PSYCHOL HUMAN, V34, P1337, DOI 10.1037/a0011060; Shomstein S, 2004, PSYCHON B REV, V11, P247, DOI 10.3758/BF03196566; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yi DJ, 2006, BRAIN RES, V1080, P53, DOI 10.1016/j.brainres.2006.01.090	40	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8238	10.1371/journal.pone.0008238	http://dx.doi.org/10.1371/journal.pone.0008238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533OP	20016829	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834000005
J	Sinclair, BJ; Gibbs, AG; Lee, WK; Rajamohan, A; Roberts, SP; Socha, JJ				Sinclair, Brent J.; Gibbs, Allen G.; Lee, Wah-Keat; Rajamohan, Arun; Roberts, Stephen P.; Socha, John J.			Synchrotron X-Ray Visualisation of Ice Formation in Insects during Lethal and Non-Lethal Freezing	PLOS ONE			English	Article							COLD ADAPTATION; TOLERANCE; LARVAE; DESICCATION; PHYSIOLOGY; SURVIVAL; DIPTERA; FLY	Although the biochemical correlates of freeze tolerance in insects are becoming well-known, the process of ice formation in vivo is subject to speculation. We used synchrotron x-rays to directly visualise real-time ice formation at 3.3 Hz in intact insects. We observed freezing in diapausing 3(rd) instar larvae of Chymomyza amoena (Diptera: Drosophilidae), which survive freezing if it occurs above -14 degrees C, and non-diapausing 3(rd) instar larvae of C. amoena and Drosophila melanogaster (Diptera: Drosophilidae), neither of which survive freezing. Freezing was readily observed in all larvae, and on one occasion the gut was seen to freeze separately from the haemocoel. There were no apparent qualitative differences in ice formation between freeze tolerant and non-freeze tolerant larvae. The time to complete freezing was positively related to temperature of nucleation (supercooling point, SCP), and SCP declined with decreasing body size, although this relationship was less strong in diapausing C. amoena. Nucleation generally occurred at a contact point with the thermocouple or chamber wall in non-diapausing larvae, but at random in diapausing larvae, suggesting that the latter have some control over ice nucleation. There were no apparent differences between freeze tolerant and non-freeze tolerant larvae in tracheal displacement or distension of the body during freezing, although there was markedly more distension in D. melanogaster than in C. amoena regardless of diapause state. We conclude that although control of ice nucleation appears to be important in freeze tolerant individuals, the physical ice formation process itself does not differ among larvae that can and cannot survive freezing. This suggests that a focus on cellular and biochemical mechanisms is appropriate and may reveal the primary adaptations allowing freeze tolerance in insects.	[Sinclair, Brent J.; Rajamohan, Arun] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gibbs, Allen G.; Roberts, Stephen P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Lee, Wah-Keat] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Socha, John J.] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA	Western University (University of Western Ontario); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; United States Department of Energy (DOE); Argonne National Laboratory; Virginia Polytechnic Institute & State University	Sinclair, BJ (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	bsincla7@uwo.ca	Gibbs, Allen/D-6968-2011; Lee, Wah-Keat/GRR-9734-2022; Gibbs, Allen G/G-6939-2014	Gibbs, Allen G/0000-0001-5233-2056; Rajamohan, Arun/0000-0003-1587-2891; Sinclair, Brent/0000-0002-8191-9910	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Center for Research Resources (NCRR) [RR022885]; NSERC; Canada Foundation for Innovation; Ontario Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR022885] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. This work was supported by grant number RR022885 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); an NSERC Discovery Grant and grants from the Canada Foundation for Innovation and the Ontario Research Fund to BJS. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funding bodies or Argonne National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atici O, 2003, PHYTOCHEMISTRY, V64, P1187, DOI 10.1016/S0031-9422(03)00420-5; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; BAND HT, 1982, EXPERIENTIA, V38, P1448, DOI 10.1007/BF01955762; BLOCK W, 1994, ACTA OECOL, V15, P13; Bundy JG, 2003, CRYOLETTERS, V24, P347; Colinet H, 2007, J THERM BIOL, V32, P374, DOI 10.1016/j.jtherbio.2007.03.005; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Izumi Y, 2006, J INSECT PHYSIOL, V52, P215, DOI 10.1016/j.jinsphys.2005.11.001; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Lee Wah-Keat, 2009, BMC Physiology, V9, P2, DOI 10.1186/1472-6793-9-2; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mietchen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003826; Palmer CM, 2004, BIOTECHNIQUES, V37, P212, DOI 10.2144/04372BI01; Philip BN, 2008, J EXP BIOL, V211, P1114, DOI 10.1242/jeb.016758; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; RING RA, 1982, COMP BIOCHEM PHYS A, V73, P605, DOI 10.1016/0300-9629(82)90267-5; ROJAS RR, 1992, CRYO-LETT, V13, P355; SALT R. W., 1963, CANADIAN ENTOMOL, V95, P1190; SALT RW, 1962, NATURE, V193, P1207, DOI 10.1038/1931207a0; SHIMADA K, 1988, CRYO-LETT, V9, P5; Sinclair BJ, 1997, J INSECT PHYSIOL, V43, P621, DOI 10.1016/S0022-1910(97)00018-8; Sinclair BJ, 2004, J EXP BIOL, V207, P1287, DOI 10.1242/jeb.00880; Sinclair BJ, 2003, BIOL REV, V78, P181, DOI 10.1017/S1464793102006024; Socha JJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-6; Somme L, 2000, CRYOLETTERS, V21, P289; Storey K.B., 2008, HYPOMETABOLISM ANIMA, P101; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; STRACHAN LA, 2009, THESIS U W ONTARIO L; Takahashi H, 2008, CRYOBIOLOGY, V57, P75, DOI 10.1016/j.cryobiol.2008.04.004; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Worland MR, 2004, J INSECT PHYSIOL, V50, P225, DOI 10.1016/j.jinsphys.2003.12.001; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	37	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8259	10.1371/journal.pone.0008259	http://dx.doi.org/10.1371/journal.pone.0008259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011523	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300023
J	Kolaczkowski, B; Thornton, JW				Kolaczkowski, Bryan; Thornton, Joseph W.			Long-Branch Attraction Bias and Inconsistency in Bayesian Phylogenetics	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SUBSTITUTION RATES VARY; POSTERIOR PROBABILITIES; PARSIMONY; BOOTSTRAP; INFERENCE; MODEL; EVOLUTION; SUPPORT; TREES	Bayesian inference (BI) of phylogenetic relationships uses the same probabilistic models of evolution as its precursor maximum likelihood (ML), so BI has generally been assumed to share ML's desirable statistical properties, such as largely unbiased inference of topology given an accurate model and increasingly reliable inferences as the amount of data increases. Here we show that BI, unlike ML, is biased in favor of topologies that group long branches together, even when the true model and prior distributions of evolutionary parameters over a group of phylogenies are known. Using experimental simulation studies and numerical and mathematical analyses, we show that this bias becomes more severe as more data are analyzed, causing BI to infer an incorrect tree as the maximum a posteriori phylogeny with asymptotically high support as sequence length approaches infinity. BI's long branch attraction bias is relatively weak when the true model is simple but becomes pronounced when sequence sites evolve heterogeneously, even when this complexity is incorporated in the model. This bias-which is apparent under both controlled simulation conditions and in analyses of empirical sequence data-also makes BI less efficient and less robust to the use of an incorrect evolutionary model than ML. Surprisingly, BI's bias is caused by one of the method's stated advantages-that it incorporates uncertainty about branch lengths by integrating over a distribution of possible values instead of estimating them from the data, as ML does. Our findings suggest that trees inferred using BI should be interpreted with caution and that ML may be a more reliable framework for modern phylogenetic analysis.	[Kolaczkowski, Bryan; Thornton, Joseph W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon	Kolaczkowski, B (corresponding author), Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022		Howard Hughes Medical Institute; National Science Foundation [DEB-0516530, IGERT DGE-9972830]; National Institutes of Health [NIH R01-GM62351]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062351] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Howard Hughes Medical Institute, National Science Foundation (DEB-0516530, IGERT DGE-9972830), National Institutes of Health (NIH R01-GM62351), and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2004, SUBJECTIVE PROBABILI; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Bruno WJ, 1999, MOL BIOL EVOL, V16, P564, DOI 10.1093/oxfordjournals.molbev.a026137; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Chang JT, 1996, MATH BIOSCI, V134, P189, DOI 10.1016/0025-5564(95)00172-7; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Edwards AWF, 1992, LIKELIHOOD; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HILLIS DM, 1994, NATURE, V369, P363, DOI 10.1038/369363a0; Hillis DM, 1997, SCIENCE, V276, P218, DOI 10.1126/science.276.5310.218; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; HUELSENBECK JP, 1995, SYST BIOL, V17, P48; Inagaki Y, 2004, MOL BIOL EVOL, V21, P1340, DOI 10.1093/molbev/msh130; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kolaczkowski B, 2008, MOL BIOL EVOL, V25, P1054, DOI 10.1093/molbev/msn042; Kolaczkowski B, 2007, MOL BIOL EVOL, V24, P2108, DOI 10.1093/molbev/msm141; Kolaczkowski B, 2006, MOL BIOL EVOL, V23, P1819, DOI 10.1093/molbev/msl059; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Lewis PO, 2001, TRENDS ECOL EVOL, V16, P30, DOI 10.1016/S0169-5347(00)02025-5; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Misawa K, 2003, J MOL EVOL, V57, pS290, DOI 10.1007/s00239-003-0039-7; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; PENNY D, 1992, TRENDS ECOL EVOL, V7, P73, DOI 10.1016/0169-5347(92)90244-6; Rogers JS, 1997, SYST BIOL, V46, P354, DOI 10.2307/2413629; Rogers JS, 2001, SYST BIOL, V50, P713, DOI 10.1080/106351501753328839; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmons MP, 2004, MOL BIOL EVOL, V21, P188, DOI 10.1093/molbev/msh014; Spencer M, 2005, MOL BIOL EVOL, V22, P1161, DOI 10.1093/molbev/msi123; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Susko E, 2008, SYST BIOL, V57, P602, DOI 10.1080/10635150802302468; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Taylor DJ, 2004, MOL BIOL EVOL, V21, P1534, DOI 10.1093/molbev/msh156; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yang ZZ, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P63	58	65	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e7891	10.1371/journal.pone.0007891	http://dx.doi.org/10.1371/journal.pone.0007891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011052	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800001
J	Szafran, AT; Hartig, S; Sun, HY; Uray, IP; Szwarc, M; Shen, YQ; Mediwala, SN; Bell, J; McPhaul, MJ; Mancini, MA; Marcelli, M				Szafran, Adam T.; Hartig, Sean; Sun, Huiying; Uray, Ivan P.; Szwarc, Maria; Shen, Yuqing; Mediwala, Sanjay N.; Bell, Jennifer; McPhaul, Michael J.; Mancini, Michael A.; Marcelli, Marco			Androgen Receptor Mutations Associated with Androgen Insensitivity Syndrome: A High Content Analysis Approach Leading to Personalized Medicine	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; QUALITATIVE ABNORMALITY; ESTROGEN-RECEPTOR; SKIN FIBROBLASTS; GENE-EXPRESSION; RESISTANCE; COACTIVATOR; TRANSCRIPTION; SPECIFICITY; STABILITY	Androgen insensitivity syndrome (AIS) is a rare disease associated with inactivating mutations of AR that disrupt male sexual differentiation, and cause a spectrum of phenotypic abnormalities having as a common denominator loss of reproductive viability. No established treatment exists for these conditions, however there are sporadic reports of patients (or recapitulated mutations in cell lines) that respond to administration of supraphysiologic doses (or pulses) of testosterone or synthetic ligands. Here, we utilize a novel high content analysis (HCA) approach to study AR function at the single cell level in genital skin fibroblasts (GSF). We discuss in detail findings in GSF from three historical patients with AIS, which include identification of novel mechanisms of AR malfunction, and the potential ability to utilize HCA for personalized treatment of patients affected by this condition.	[Szafran, Adam T.; Hartig, Sean; Uray, Ivan P.; Szwarc, Maria; Mancini, Michael A.; Marcelli, Marco] Baylor Coll Med, Dept Mol & Cellular Biol & Med, Houston, TX 77030 USA; [Sun, Huiying; Shen, Yuqing; Mediwala, Sanjay N.; Marcelli, Marco] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Sun, Huiying; Shen, Yuqing; Mediwala, Sanjay N.; Marcelli, Marco] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bell, Jennifer] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [McPhaul, Michael J.] Univ Texas Southwestern Med Sch, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Szafran, AT (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol & Med, Houston, TX 77030 USA.	mancini@bcm.edu; marcelli@bcm.edu	McPhaul, Michael/AAC-7124-2020; marcelli, marco/AGR-6853-2022		Gilson-Logenbaugh Foundation; VA; Solvay Clinical Research; Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics;  [R01 DK-55622];  [U54 HD-07495];  [P30 CA125123];  [P30 DK56338]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK055622] Funding Source: NIH RePORTER	Gilson-Logenbaugh Foundation; VA(US Department of Veterans Affairs); Solvay Clinical Research(Solvay SA); Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Gilson-Logenbaugh Foundation (MAM and MM), VA Merit Award (MM), R01 DK-55622 (MAM), and the Solvay Clinical Research Award (SNM). Imaging resources were supported by U54 HD-07495 (O'Malley), P30 CA125123 (Osborne), P30 DK56338 (Estes), the Dan L. Duncan Cancer Center and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2000, J CLIN ENDOCR METAB, V85, P658, DOI 10.1210/jc.85.2.658; Amazit L, 2007, MOL CELL BIOL, V27, P6913, DOI 10.1128/MCB.01695-06; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; BEITEL LK, 1994, J CLIN INVEST, V94, P546, DOI 10.1172/JCI117368; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; Berno V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002286; Bevan CL, 1996, HUM MOL GENET, V5, P265, DOI 10.1093/hmg/5.2.265; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; BROWN TR, 1982, J CLIN ENDOCR METAB, V55, P61, DOI 10.1210/jcem-55-1-61; DEBELLIS A, 1994, J CLIN ENDOCR METAB, V78, P513, DOI 10.1210/jc.78.3.513; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Georget V, 1998, J CLIN ENDOCR METAB, V83, P3597, DOI 10.1210/jc.83.10.3597; GRIFFIN JE, 1979, J CLIN INVEST, V64, P1624, DOI 10.1172/JCI109624; GRINO PB, 1989, J CLIN ENDOCR METAB, V68, P578, DOI 10.1210/jcem-68-3-578; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Holterhus PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r37; KEENAN BS, 1974, J CLIN ENDOCR METAB, V38, P1143, DOI 10.1210/jcem-38-6-1143; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Ledig S, 2005, HORM RES, V63, P263, DOI 10.1159/000086018; MARCELLI M, 1994, J CLIN INVEST, V94, P1642, DOI 10.1172/JCI117507; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Mazur T, 2005, ARCH SEX BEHAV, V34, P411, DOI 10.1007/s10508-005-4341-x; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MCPHAUL MJ, 1992, J CLIN INVEST, V90, P2097, DOI 10.1172/JCI116093; Nazareth LV, 1999, MOL ENDOCRINOL, V13, P2065, DOI 10.1210/me.13.12.2065; PINSKY L, 1989, AM J MED GENET, V32, P100, DOI 10.1002/ajmg.1320320121; PINSKY L, 1992, CLIN INVEST MED, V15, P456; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Radmayr C, 1998, EUR UROL, V33, P222, DOI 10.1159/000019540; RISSTALPERS C, 1994, PEDIATR RES, V36, P227, DOI 10.1203/00006450-199408000-00015; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; SZAFRAN AT, 2008, P INT S BIOMED IMAGI, P320; VILLEGAS J, 2005, CURR PROTOC MOL BIOL, pCH28, DOI DOI 10.1002/0471142727.MB2803S71; Wang MH, 2005, BIOCHEM BIOPH RES CO, V335, P335, DOI 10.1016/j.bbrc.2005.07.077; Weidemann W, 1998, J CLIN ENDOCR METAB, V83, P1173, DOI 10.1210/jc.83.4.1173; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; [No title captured]	41	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8179	10.1371/journal.pone.0008179	http://dx.doi.org/10.1371/journal.pone.0008179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011049	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800003
J	Teves, ME; Guidobaldi, HA; Unates, DR; Sanchez, R; Miska, W; Publicover, SJ; Garcia, AAM; Giojalas, LC				Teves, Maria E.; Guidobaldi, Hector A.; Unates, Diego R.; Sanchez, Raul; Miska, Werner; Publicover, Stephen J.; Garcia, Aduen A. Morales; Giojalas, Laura C.			Molecular Mechanism for Human Sperm Chemotaxis Mediated by Progesterone	PLOS ONE			English	Article							ADENYLYL-CYCLASE; HUMAN SPERMATOZOA; SIGNALING PATHWAY; PLASMA-MEMBRANE; CA2+ ENTRY; CHANNELS; CALCIUM; PHOSPHORYLATION; EXPRESSION; KINASE	Sperm chemotaxis is a chemical guiding mechanism that may orient spermatozoa to the egg surface. A picomolar concentration gradient of Progesterone ( P), the main steroidal component secreted by the cumulus cells that surround the egg, attracts human spermatozoa. In order to elucidate the molecular mechanism of sperm chemotaxis mediated by P, we combine the application of different strategies: pharmacological inhibition of signaling molecules, measurements of the concentrations of second messengers and activation of the chemotactic signaling. Our data implicate a number of classic signal transduction pathways in the response and provide a model for the sequence of events, where the tmAC-cAMP-PKA pathway is activated first, followed by protein tyrosine phosphorylation ( equatorial band and flagellum) and calcium mobilization (through IP3R and SOC channels), whereas the sGC-cGMP-PKG cascade, is activated later. These events lead to sperm orientation towards the source of the chemoattractant. The finding proposes a molecular mechanism which contributes to the understanding of the signal transduction pathway that takes place in a physiological process as chemotaxis.	[Teves, Maria E.; Guidobaldi, Hector A.; Unates, Diego R.; Giojalas, Laura C.] Univ Nacl Cordoba, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina; [Sanchez, Raul] Univ La Frontera, Dept Ciencias Preclin, Ctr Biotecnol Reprod, Temuco, Chile; [Miska, Werner] Univ Giessen, Ctr Dermatol & Androl, Giessen, Germany; [Publicover, Stephen J.; Garcia, Aduen A. Morales] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	National University of Cordoba; Universidad de La Frontera; Justus Liebig University Giessen; University of Birmingham	Teves, ME (corresponding author), Univ Nacl Cordoba, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina.	lcgiojalas@com.uncor.edu	Guidobaldi, Héctor Alejandro/K-6724-2017; Teves, Maria/AAJ-9523-2020; Sanchez, Raul/ABH-3868-2020; Publicover, Steve J/E-7970-2018; Sanchez, Raul/L-1224-2016	Guidobaldi, Héctor Alejandro/0000-0002-5033-2981; Teves, Maria/0000-0001-7035-2202; Sanchez, Raul/0000-0003-4853-4282; Giojalas, Laura/0000-0002-1036-1251	SECYT-UNC; CONICET; FONCYT (Argentina); MINCYT (Argentina); BMBF (Germany); Royal Society (UK)	SECYT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT (Argentina)(FONCyT); MINCYT (Argentina); BMBF (Germany)(Federal Ministry of Education & Research (BMBF)); Royal Society (UK)(Royal Society of London)	This work was supported by the following science promotion agencies: SECYT-UNC, CONICET and FONCYT (Argentina); MINCYT (Argentina); BMBF (Germany) and Royal Society (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Guidobaldi HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003040; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baxendale RW, 2003, MOL REPROD DEV, V66, P181, DOI 10.1002/mrd.10344; Bedu-Addo K, 2005, MOL HUM REPROD, V11, P683, DOI 10.1093/molehr/gah226; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; Beltran C, 2007, BIOCHEM BIOPH RES CO, V358, P1128, DOI 10.1016/j.bbrc.2007.05.061; BRANHAM MT, 2009, J BIOL CHEM; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2004, HUM REPROD, V19, P139, DOI 10.1093/humrep/deh040; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Felix R, 2005, REPRODUCTION, V129, P251, DOI 10.1530/rep.1.00478; Fellner SK, 2008, AM J PHYSIOL-RENAL, V294, pF212, DOI 10.1152/ajprenal.00244.2007; Fodor AA, 1997, J GEN PHYSIOL, V110, P591, DOI 10.1085/jgp.110.5.591; Furlong LI, 2000, BIOL REPROD, V62, P606, DOI 10.1095/biolreprod62.3.606; FURUYA S, 1992, J ASSIST REPROD GEN, V9, P391, DOI 10.1007/BF01203965; GO KJ, 1985, BIOL REPROD, V32, P145, DOI 10.1095/biolreprod32.1.145; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Harrison RAP, 2003, REPROD DOMEST ANIM, V38, P102, DOI 10.1046/j.1439-0531.2003.00400.x; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Khorasani AM, 2000, J ANDROL, V21, P586; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Kirkman-Brown JC, 2003, DEV BIOL, V259, P71, DOI 10.1016/S0012-1606(03)00137-4; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Machado-Oliveira G, 2008, DEVELOPMENT, V135, P3677, DOI 10.1242/dev.024521; Miraglia E, 2007, FERTIL STERIL, V87, P1059, DOI 10.1016/j.fertnstert.2006.07.1540; Munck S, 2004, EUR J NEUROSCI, V19, P791, DOI 10.1111/j.0953-816X.2004.03118.x; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parinaud J, 1996, J CLIN ENDOCR METAB, V81, P1357, DOI 10.1210/jc.81.4.1357; PETERSON RN, 1980, J CELL SCI, V43, P93; Petrunkina AM, 2003, J ANDROL, V24, P423; Poutrain P, 2009, J EXP BOT, V60, P1387, DOI 10.1093/jxb/erp017; Revelli A, 2002, ENDOCR REV, V23, P484, DOI 10.1210/er.2001-0020; Revelli A, 2001, BIOL REPROD, V64, P1708, DOI 10.1095/biolreprod64.6.1708; Sakkas D, 2003, BIOL REPROD, V68, P1463, DOI 10.1095/biolreprod.102.011023; Shiba K, 2008, P NATL ACAD SCI USA, V105, P19312, DOI 10.1073/pnas.0808580105; Shimizu H, 2008, P NATL ACAD SCI USA, V105, P11998, DOI 10.1073/pnas.0802175105; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Tubbs C, 2008, STEROIDS, V73, P935, DOI 10.1016/j.steroids.2007.12.022; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHO, 1999, WHO LAB MAN EX HUM S, P1; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Yoshida M, 2003, P NATL ACAD SCI USA, V100, P149, DOI 10.1073/pnas.0135565100	61	113	118	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8211	10.1371/journal.pone.0008211	http://dx.doi.org/10.1371/journal.pone.0008211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997608	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829700008
J	Chen, SH; Su, SY; Lo, CZ; Chen, KH; Huang, TJ; Kuo, BH; Lin, CY				Chen, Shu-Hwa; Su, Sheng-Yao; Lo, Chen-Zen; Chen, Kuei-Hsien; Huang, Teng-Jay; Kuo, Bo-Han; Lin, Chung-Yen			PALM: A Paralleled and Integrated Framework for Phylogenetic Inference with Automatic Likelihood Model Selectors	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; PROTEIN EVOLUTION; RECONSTRUCTION; PROGRAM; DIALIGN; SPACE; DNA	Background: Selecting an appropriate substitution model and deriving a tree topology for a given sequence set are essential in phylogenetic analysis. However, such time consuming, computationally intensive tasks rely on knowledge of substitution model theories and related expertise to run through all possible combinations of several separate programs. To ensure a thorough and efficient analysis and avert tedious manipulations of various programs, this work presents an intuitive framework, the phylogenetic reconstruction with automatic likelihood model selectors (PALM), with convincing, updated algorithms and a best-fit model selection mechanism for seamless phylogenetic analysis. Methodology: As an integrated framework of ClustalW, PhyML, MODELTEST, ProtTest, and several in-house programs, PALM evaluates the fitness of 56 substitution models for nucleotide sequences and 112 substitution models for protein sequences with scores in various criteria. The input for PALM can be either sequences in FASTA format or a sequence alignment file in PHYLIP format. To accelerate the computing of maximum likelihood and bootstrapping, this work integrates MPICH2/PhyML, PalmMonitor and Palm job controller across several machines with multiple processors and adopts the task parallelism approach. Moreover, an intuitive and interactive web component, PalmTree, is developed for displaying and operating the output tree with options of tree rooting, branches swapping, viewing the branch length values, and viewing bootstrapping score, as well as removing nodes to restart analysis iteratively. Significance: The workflow of PALM is straightforward and coherent. Via a succinct, user-friendly interface, researchers unfamiliar with phylogenetic analysis can easily use this server to submit sequences, retrieve the output, and re-submit a job based on a previous result if some sequences are to be deleted or added for phylogenetic reconstruction. PALM results in an inference of phylogenetic relationship not only by vanquishing the computation difficulty of ML methods but also providing statistic methods for model selection and bootstrapping. The proposed approach can reduce calculation time, which is particularly relevant when querying a large data set. PALM can be accessed online at http://palm.iis.sinica.edu.tw.	[Chen, Shu-Hwa; Su, Sheng-Yao; Lo, Chen-Zen; Chen, Kuei-Hsien; Huang, Teng-Jay; Kuo, Bo-Han; Lin, Chung-Yen] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Lin, Chung-Yen] Natl Hlth Res Inst, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan; [Lin, Chung-Yen] Natl Taiwan Univ, Coll Life Sci, Inst Fishery Sci, Taipei 10764, Taiwan; [Lin, Chung-Yen] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chen, SH (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	cylin@iis.sinica.edu.tw	Lin, Chung-Yen/AAQ-3833-2021	Lin, Chung-Yen/0000-0002-4733-9488	National Science Council (NSC)/National Research Program of Genomic Medicine (NRPGM), Taiwan [NSC 98-3112-B-400-010, NSC 98-2221-E-001-018, NSC 98-2811-001-014]	National Science Council (NSC)/National Research Program of Genomic Medicine (NRPGM), Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC)/National Research Program of Genomic Medicine (NRPGM), Taiwan, for financially supporting this research under Contract No. NSC 98-3112-B-400-010, NSC 98-2221-E-001-018 and NSC 98-2811-001-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Brauer MJ, 2002, MOL BIOL EVOL, V19, P1717, DOI 10.1093/oxfordjournals.molbev.a003994; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Essoussi N, 2008, BIOINFORMATION, V2, P452; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Felsenstein J, 2001, SYST BIOL, V50, P465, DOI 10.1080/106351501750435022; GILBERTD R, READSEQ; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keane TM, 2007, NUCLEIC ACIDS RES, V35, pW33, DOI 10.1093/nar/gkm359; Keane TM, 2005, BIOINFORMATICS, V21, P969, DOI 10.1093/bioinformatics/bti100; Lin CY, 2005, NUCLEIC ACIDS RES, V33, pW553, DOI 10.1093/nar/gki494; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; MOUNT DW, 2008, CHOOSING METHOD PHYL; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Robinson DM, 2003, MOL BIOL EVOL, V20, P1692, DOI 10.1093/molbev/msg184; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Tao N, 2005, FINDMODEL TOOL SELEC; Tarraga J, 2007, NUCLEIC ACIDS RES, V35, pW38, DOI 10.1093/nar/gkm224; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; Thorne JL, 2007, CURR OPIN STRUC BIOL, V17, P337, DOI 10.1016/j.sbi.2007.05.006; Vinh LS, 2004, MOL BIOL EVOL, V21, P1565, DOI 10.1093/molbev/msh176; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	37	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8116	10.1371/journal.pone.0008116	http://dx.doi.org/10.1371/journal.pone.0008116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997614	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829500007
J	Wells, JV; Robertson, B; Rosenberg, KV; Mehlman, DW				Wells, Jeffrey V.; Robertson, Bruce; Rosenberg, Kenneth V.; Mehlman, David W.			Global versus Local Conservation Focus of US State Agency Endangered Bird Species Lists	PLOS ONE			English	Article							PRIORITIES; PARTNERS; PAROCHIALISM; POPULATIONS; LANDBIRDS; SYSTEMS; RARE	The development of species priorities for conservation at local or regional scales (for example, within a state or province) poses an interesting paradox. One the one hand, locally or regionally-derived species priorities may lead to greater interest in and resources directed to biodiversity conservation by local or regional institutions. On the other hand, locally or regionally-derived species priorities could overlook national or global priorities. We assessed U. S. state government agency endangered-threatened bird lists to determine the comparative representation of species of global versus local conservation significance on them. State lists tended to be represented primarily by species of low global risk-low global responsibility (range: 15-100%; mean 51%) and high global risk-high global responsibility (range: 0-73%; mean 35%). In 25 states, more than half of the species on the state lists were in the low global risk-low global responsibility category. Most U.S. state agency lists represent a combined strategy of highlighting species of both local and global conservation significance. Even with this combined local-global strategy, most state lists were predominated by species that represent local but not global conservation significance. Such a strategy could have profound negative consequences for many species that are not formally recognized under national endangered species protections but that are also left off of state-level endangered species lists.	[Wells, Jeffrey V.] Boreal Songbird Initiat, Seattle, WA USA; [Robertson, Bruce] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Rosenberg, Kenneth V.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Mehlman, David W.] Nature Conservancy, Albuquerque, NM USA	Michigan State University; Cornell University	Wells, JV (corresponding author), Boreal Songbird Initiat, Seattle, WA USA.	jeffwells@borealbirds.org						Andelman SJ, 2004, ACTA OECOL, V26, P75, DOI 10.1016/j.actao.2004.04.005; Atwood Jonathan L., 1994, Studies in Avian Biology, V15, P328; Beissinger SR, 2000, AUK, V117, P549, DOI 10.1642/0004-8038(2000)117[0549:ROTACC]2.0.CO;2; Belanger D., 1988, MANAGING AM WILDLIFE; Bunnell FL, 2004, CAN J FOREST RES, V34, P2240, DOI [10.1139/x04-102, 10.1139/X04-102]; Carter MF, 2000, AUK, V117, P541, DOI 10.1642/0004-8038(2000)117[0541:SCPFLI]2.0.CO;2; CARTER MF, 1993, STATUS MANAGEMENT NE; CRAIG RJ, 2006, AVIAN CONSERVATION E; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; DUDLEY JP, 1995, CONSERV BIOL, V9, P1332, DOI 10.1046/j.1523-1739.1995.9051329.x-i1; Dunn EH, 1999, CONSERV BIOL, V13, P1404, DOI 10.1046/j.1523-1739.1999.98400.x; Gardenfors U, 2001, TRENDS ECOL EVOL, V16, P511, DOI 10.1016/S0169-5347(01)02214-5; Gardenfors U, 2001, CONSERV BIOL, V15, P1206, DOI 10.1046/j.1523-1739.2001.00112.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; GEORGE S, 1998, STATE ENDANGERED SPE; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; HUNTER WC, 1993, STATUS MANAGEMENT NE; IUCN, 2003, IUCN SPEC SURV COMM; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Mehlman DW, 2004, BIOL CONSERV, V120, P383, DOI 10.1016/j.biocon.2004.03.013; MILLSAP BA, 1990, WILDLIFE MONOGR, P1; Nuttle T, 2003, AUK, V120, P541, DOI 10.1642/0004-8038(2003)120[0541:ACVOBC]2.0.CO;2; Panjabi A., 2001, PARTNERS FLIGHT HDB; RICHIE D, 1998, STATE WILDLIFE DIVER; Rodrigues ASL, 2002, CONSERV BIOL, V16, P674, DOI 10.1046/j.1523-1739.2002.00455.x; Rosenberg K. V., 2005, BIRD CONSERVATION IM, V1, P57; ROSENBERG KV, 2000, GLOBAL PERSPECTIVES; Sagarin RD, 2006, OIKOS, V115, P386, DOI 10.1111/j.2006.0030-1299.14438.x; VICKERY PD, 1992, T NE SECT WILDL SOC, V48, P1; Wells J. V., 2007, BIRDERS CONSERVATION; WELLS JV, 1995, WILDLIFE SOC B, V23, P458; Wells JV, 1999, STUD AVIAN BIOL-SER, P72; Wild M, 2006, DIVERS DISTRIB, V12, P749, DOI [10.1111/j.1472-4642.2006.00287.x, 10.1111/j.1366-9516.2006.00287.x]; [No title captured]; 2005, STATE WILDLIFE ACTIO	35	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8608	10.1371/journal.pone.0008608	http://dx.doi.org/10.1371/journal.pone.0008608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062538	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338600026
J	Zamudio, S; Torricos, T; Fik, E; Oyala, M; Echalar, L; Pullockaran, J; Tutino, E; Martin, B; Belliappa, S; Balanza, E; Illsley, NP				Zamudio, Stacy; Torricos, Tatiana; Fik, Ewa; Oyala, Maria; Echalar, Lourdes; Pullockaran, Janet; Tutino, Emily; Martin, Brittney; Belliappa, Sonia; Balanza, Elfride; Illsley, Nicholas P.			Hypoglycemia and the Origin of Hypoxia-Induced Reduction in Human Fetal Growth	PLOS ONE			English	Article							VEIN BLOOD-FLOW; HIGH-ALTITUDE; GESTATIONAL-AGE; HUMAN-FETUS; INSULIN-SECRETION; GLUCOSE-TRANSPORT; PLACENTAL HYPOXIA; OXYGEN DELIVERY; PLASMA-GLUCOSE; VENOUS-BLOOD	Background: The most well known reproductive consequence of residence at high altitude (HA 2700 m) is reduction in fetal growth. Reduced fetoplacental oxygenation is an underlying cause of pregnancy pathologies, including intrauterine growth restriction and preeclampsia, which are more common at HA. Therefore, altitude is a natural experimental model to study the etiology of pregnancy pathophysiologies. We have shown that the proximate cause of decreased fetal growth is not reduced oxygen availability, delivery, or consumption. We therefore asked whether glucose, the primary substrate for fetal growth, might be decreased and/or whether altered fetoplacental glucose metabolism might account for reduced fetal growth at HA. Methods: Doppler and ultrasound were used to measure maternal uterine and fetal umbilical blood flows in 69 and 58 residents of 400 vs 3600 m. Arterial and venous blood samples from mother and fetus were collected at elective cesarean delivery and analyzed for glucose, lactate and insulin. Maternal delivery and fetal uptakes for oxygen and glucose were calculated. Principal Findings: The maternal arterial-venous glucose concentration difference was greater at HA. However, umbilical venous and arterial glucose concentrations were markedly decreased, resulting in lower glucose delivery at 3600 m. Fetal glucose consumption was reduced by >28%, but strongly correlated with glucose delivery, highlighting the relevance of glucose concentration to fetal uptake. At altitude, fetal lactate levels were increased, insulin concentrations decreased, and the expression of GLUT1 glucose transporter protein in the placental basal membrane was reduced. Conclusion/Significance: Our results support that preferential anaerobic consumption of glucose by the placenta at high altitude spares oxygen for fetal use, but limits glucose availability for fetal growth. Thus reduced fetal growth at high altitude is associated with fetal hypoglycemia, hypoinsulinemia and a trend towards lactacidemia. Our data support that placentally-mediated reduction in glucose transport is an initiating factor for reduced fetal growth under conditions of chronic hypoxemia.	[Zamudio, Stacy] Univ Med & Dent New Jersey, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA; [Fik, Ewa; Oyala, Maria; Pullockaran, Janet; Tutino, Emily; Martin, Brittney; Belliappa, Sonia; Illsley, Nicholas P.] Univ Med & Dent New Jersey, Dept Obstet Gynecol & Womens Hlth, Newark, NJ 07103 USA; [Torricos, Tatiana] Hosp Hernandez Vera, Villa Primer De Mayo, Santa Cruz, Bolivia; [Torricos, Tatiana; Echalar, Lourdes; Balanza, Elfride] Univ San Andreas Mayor, Inst Boliviano Biol Altura, La Paz, Bolivia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad Mayor de San Andres	Zamudio, S (corresponding author), Univ Med & Dent New Jersey, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA.	Stacy.Zamudio@gmail.com		Illsley, Nicholas/0000-0002-4336-2832	National Institutes of Health [HD042737, TW007444, HD046982]; National Science Foundation [BCS-0309142]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042737, R01HD046982] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW007444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors would like to acknowledge the support of the National Institutes of Health (HD042737, TW007444, SZ; HD046982, NI) and the National Science Foundation (BCS-0309142, SZ) for the conduct of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, PRENATAL DIAG, V25, P99, DOI 10.1002/pd.1091; Acharya G, 2009, ACTA OBSTET GYN SCAN, V88, P104, DOI 10.1080/00016340802460339; Alkalay AL, 2006, AM J PERINAT, V23, P115, DOI 10.1055/s-2006-931912; [Anonymous], 1987, TROPHOBLAST RES; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bernstein IM, 2002, OBSTET GYNECOL, V99, P620, DOI 10.1016/S0029-7844(01)01787-2; BOZZETTI P, 1988, METABOLISM, V37, P358, DOI 10.1016/0026-0495(88)90136-9; Brahimi-Horn Christiane, 2006, Bull Cancer, V93, pE73; CARTER AM, 1989, J DEV PHYSIOL, V12, P305; Carver TD, 1997, AM J PHYSIOL-ENDOC M, V272, pE107, DOI 10.1152/ajpendo.1997.272.1.E107; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; DESANTO JT, 1993, EARLY HUM DEV, V33, P1, DOI 10.1016/0378-3782(93)90168-T; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V160, P385, DOI 10.1016/0002-9378(89)90453-5; ENGEL PC, 1978, ANAL BIOCHEM, V88, P475, DOI 10.1016/0003-2697(78)90447-5; Esterman A, 1997, PLACENTA, V18, P129, DOI 10.1016/S0143-4004(97)90084-9; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Galan HL, 1999, AM J OBSTET GYNECOL, V181, P1149, DOI 10.1016/S0002-9378(99)70098-0; GILFILLAN CA, 1985, BIOL NEONATE, V47, P141, DOI 10.1159/000242105; Giussani DA, 2007, J PHYSIOL-LONDON, V585, P911, DOI 10.1113/jphysiol.2007.141572; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GRUPPUSO PA, 1981, BIOL NEONATE, V40, P113, DOI 10.1159/000241479; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; Hay WW, 2006, J PHYSIOL-LONDON, V572, P17, DOI 10.1113/jphysiol.2006.105072; HUBINONT C, 1991, OBSTET GYNECOL, V77, P541; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Kamei Y, 1999, ENDOCRINOLOGY, V140, P4236, DOI 10.1210/en.140.9.4236; KHOUZAMI VA, 1981, AM J OBSTET GYNECOL, V139, P423, DOI 10.1016/0002-9378(81)90319-7; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348, DOI 10.1152/ajpregu.1989.256.6.R1348; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; Konje JC, 2003, BJOG-INT J OBSTET GY, V110, P301, DOI 10.1016/S1470-0328(02)02963-4; Krampl E, 2001, BRIT J OBSTET GYNAEC, V108, P254, DOI 10.1016/S0306-5456(00)00072-3; Krampl E, 2001, DIABETES CARE, V24, P817, DOI 10.2337/diacare.24.5.817; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lackman F, 2001, AM J OBSTET GYNECOL, V185, P674, DOI 10.1067/mob.2001.116686; Lackman F, 2001, AM J OBSTET GYNECOL, V184, P946, DOI 10.1067/mob.2001.111719; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; LUEDER FL, 1992, PEDIATR RES, V32, P436, DOI 10.1203/00006450-199210000-00013; Marconi AM, 2006, PEDIATR RES, V59, P570, DOI 10.1203/01.pdr.0000205477.70391.3e; Marconi AM, 1996, OBSTET GYNECOL, V87, P937, DOI 10.1016/0029-7844(96)00048-8; MARCONI AM, 1993, METABOLISM, V42, P860, DOI 10.1016/0026-0495(93)90060-2; Mason SD, 2007, AM J PHYSIOL-REG I, V293, pR2059, DOI 10.1152/ajpregu.00335.2007; MCLOUGHLIN P, 1992, J APPL PHYSIOL, V73, P937, DOI 10.1152/jappl.1992.73.3.937; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Mongelli M, 2000, CURR OPIN OBSTET GYN, V12, P111, DOI 10.1097/00001703-200004000-00009; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; NICOLINI U, 1989, AM J OBSTET GYNECOL, V161, P924, DOI 10.1016/0002-9378(89)90753-9; PALMER SK, 1992, OBSTET GYNECOL, V80, P1000; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Ronzoni S, 2002, AM J OBSTET GYNECOL, V187, P741, DOI 10.1067/mob.2002.124291; Rosenn B M, 2000, J Matern Fetal Med, V9, P29, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<29::AID-MFM7>3.0.CO;2-Z; Rozance PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1256, DOI 10.1152/ajpendo.00265.2006; Rozance PJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE404, DOI 10.1152/ajpendo.00643.2005; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; SONNENBERG GE, 1982, METABOLISM, V31, P1; SUTTON MS, 1990, PEDIATR RES, V28, P383, DOI 10.1203/00006450-199010000-00016; Takaya J, 2007, PEDIATR RES, V62, P700, DOI 10.1203/PDR.0b013e318157d219; VANASSCHE EA, 1983, AM J OBSTET GYNECOL, V146, P349, DOI 10.1016/0002-9378(83)90775-5; Vardhana PA, 2002, PLACENTA, V23, P653, DOI 10.1053/plac.2002.0857; Wilson MJ, 2007, AM J PHYSIOL-REG I, V293, pR1313, DOI 10.1152/ajpregu.00806.2006; Zamudio S, 2006, PLACENTA, V27, P49, DOI 10.1016/j.placenta.2004.12.010; Zamudio S, 2007, J PHYSIOL-LONDON, V582, P883, DOI 10.1113/jphysiol.2007.130708; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185; Zamudio S, 2007, FRONT BIOSCI-LANDMRK, V12, P2967, DOI 10.2741/2286	70	93	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8551	10.1371/journal.pone.0008551	http://dx.doi.org/10.1371/journal.pone.0008551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049329	gold, Green Submitted, Green Published			2022-12-27	WOS:000273225000014
J	Lamikanra, AA; Theron, M; Kooij, TWA; Roberts, DJ				Lamikanra, Abigail A.; Theron, Michel; Kooij, Taco W. A.; Roberts, David J.			Hemozoin (Malarial Pigment) Directly Promotes Apoptosis of Erythroid Precursors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; INFECTED ERYTHROCYTES; BONE-MARROW; TNF-ALPHA; IN-VITRO; CASPASE ACTIVATION; OXIDATIVE STRESS; PROGENITOR CELLS; INEFFECTIVE ERYTHROPOIESIS	Severe malarial anemia is the most common syndrome of severe malaria in endemic areas. The pathophysiology of chronic malaria is characterised by a striking degree of abnormal development of erythroid precursors (dyserythropoiesis) and an inadequate erythropoietic response in spite of elevated levels of erythropoietin. The cause of dyserythropoiesis is unclear although it has been suggested that bone-marrow macrophages release cytokines, chemokines or lipo-peroxides after exposure to hemozoin, a crystalloid form of undigested heme moieties from malarial infected erythrocytes, and so inhibit erythropoiesis. However, we have previously shown that hemozoin may directly inhibit erythroid development in vitro and the levels of hemozoin in plasma from patients with malarial anemia and hemozoin within the bone marrow was associated with reduced reticulocyte response. We hypothesized that macrophages may reduce, not enhance, the inhibitory effect of hemozoin on erythropoiesis. In an in vitro model of erythropoiesis, we now show that inhibition of erythroid cell development by hemozoin isolated from P. falciparum is characterised by delayed expression of the erythroid markers and increased apoptosis of progenitor cells. Crucially, macrophages appear to protect erythroid cells from hemozoin, consistent with a direct contribution of hemozoin to the depression of reticulocyte output from the bone marrow in children with malarial anemia. Moreover, hemozoin isolated from P. falciparum in vitro inhibits erythroid development independently of inflammatory mediators by inducing apoptotic pathways that not only involve activation of caspase 8 and cleavage of caspase 3 but also loss of mitochondrial potential. Taken together these data are consistent with a direct effect of hemozoin in inducing apoptosis in developing erythroid cells in malarial anemia. Accumulation of hemozoin in the bone marrow could therefore result in inadequate reticulocytosis in children that have adequate levels of circulating erythropoietin.	[Lamikanra, Abigail A.; Roberts, David J.] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Lamikanra, Abigail A.; Roberts, David J.] John Radcliffe Hosp, Natl Blood Serv, Oxford Ctr, Oxford OX3 9DU, England; [Theron, Michel] Wellcome Trust Genome Ctr, Wellcome Trust Sanger Inst, Cambridge, England; [Kooij, Taco W. A.] Max Planck Inst Infect Biol, Dept Parasitol, Berlin, Germany	University of Oxford; University of Oxford; Wellcome Trust Sanger Institute; Max Planck Society	Lamikanra, AA (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	david.roberts@ndcls.ox.ac.uk	Theron, Michel/E-2067-2012; Kooij, Taco W.A./L-5623-2015; Lamikanra, Abigail/AAD-9603-2019	Kooij, Taco W.A./0000-0002-8547-7523; Theron, Michel/0000-0002-5781-1985	NHS Blood and Transplant (NHSBT); Howard Hughes Medical Institute; EU BioMalPar NoE; NHS Research and Development; National Institute for Health Research (NIHR)	NHS Blood and Transplant (NHSBT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EU BioMalPar NoE; NHS Research and Development; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was supported by the NHS Blood and Transplant (NHSBT), the Howard Hughes Medical Institute and the EU BioMalPar NoE. The research benefits from NHS Research and Development funding and the National Institute for Health Research (NIHR) Biomedical Research Centre Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; ABDALLA SH, 1984, T ROY SOC TROP MED H, V78, P60, DOI 10.1016/0035-9203(84)90173-1; ABDALLA SH, 1988, CLIN LAB HAEMATOL, V10, P33; Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Angus BJ, 1997, BLOOD, V90, P2037, DOI 10.1182/blood.V90.5.2037; Arese P, 1997, ANN TROP MED PARASIT, V91, P501, DOI 10.1080/00034989760879; Awandare GA, 2007, INFECT IMMUN, V75, P201, DOI 10.1128/IAI.01327-06; Baliga B, 2003, CELL DEATH DIFFER, V10, P16, DOI 10.1038/sj.cdd.4401166; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Biemba G, 2000, TROP MED INT HEALTH, V5, P256, DOI 10.1046/j.1365-3156.2000.00545.x; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Casals-Pascual C, 2006, BLOOD; Cashman JD, 1999, BLOOD, V94, P3722, DOI 10.1182/blood.V94.11.3722.423k20_3722_3729; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; Claessens YE, 2006, AM J RESP CRIT CARE, V174, P51, DOI 10.1164/rccm.200504-561OC; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; DORMER P, 1983, BLUT, V46, P279, DOI 10.1007/BF00319868; Douki JBL, 2003, BLOOD, V101, P5025, DOI 10.1182/blood-2002-12-3710; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Fariss MW, 2001, FREE RADICAL BIO MED, V31, P530, DOI 10.1016/S0891-5849(01)00615-3; FIBACH E, 1989, BLOOD, V73, P100; Giribaldi G, 2004, HAEMATOLOGICA, V89, P492; GOGU SR, 1991, EXP HEMATOL, V19, P649; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; Hanscheid T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-109; Hemmer CJ, 2008, CRIT CARE MED, V36, P2562, DOI 10.1097/CCM.0b013e31818441ee; Hristoskova S, 2007, EXP CELL RES, V313, P1024, DOI 10.1016/j.yexcr.2006.12.018; Inger L, 2004, METHODS MALARIA RES; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Leimberg JM, 2005, HEMATOLOGY, V10, P73, DOI 10.1080/10245330412331269876; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MAGGIOPRICE L, 1985, BLOOD, V66, P1080; MAYANI H, 1995, EXP HEMATOL, V23, P422; MAZUR EM, 1986, J INTERFERON RES, V6, P199, DOI 10.1089/jir.1986.6.199; McDevitt Michael A, 2004, Curr Hematol Rep, V3, P97; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Pouvelle B, 2000, NAT MED, V6, P1264, DOI 10.1038/81374; Prato M, 2005, J IMMUNOL, V175, P6436, DOI 10.4049/jimmunol.175.10.6436; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rudin W, 1997, PARASITOLOGY, V115, P467, DOI 10.1017/S0031182097001583; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; SHAFFER N, 1991, J INFECT DIS, V163, P96, DOI 10.1093/infdis/163.1.96; SHERRY BA, 1995, J INFLAMM, V45, P85; Silvestris F, 2002, BLOOD, V99, P1305, DOI 10.1182/blood.V99.4.1305; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Taramelli D, 2000, LAB INVEST, V80, P1781, DOI 10.1038/labinvest.3780189; TARUMI T, 1995, EXP HEMATOL, V23, P1310; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; WEISS L, 1990, IMMUNOL LETT, V25, P165, DOI 10.1016/0165-2478(90)90109-4; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Wilson NO, 2008, MOL BIOCHEM PARASIT, V162, P172, DOI 10.1016/j.molbiopara.2008.09.003; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	76	59	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8446	10.1371/journal.pone.0008446	http://dx.doi.org/10.1371/journal.pone.0008446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041181	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000011
J	Napthine, S; Lever, RA; Powell, ML; Jackson, RJ; Brown, TDK; Brierley, I				Napthine, Sawsan; Lever, Robert A.; Powell, Michael L.; Jackson, Richard J.; Brown, T. David K.; Brierley, Ian			Expression of the VP2 Protein of Murine Norovirus by a Translation Termination-Reinitiation Strategy	PLOS ONE			English	Article							MESSENGER-RNA; COUPLED TRANSLATION; MUTATIONAL ANALYSIS; RIBOSOMAL-SUBUNITS; CALICIVIRUS; INITIATION; MIGRATION; COMPONENT; SIGNAL; GENE	Background: Expression of the minor virion structural protein VP2 of the calicivirus murine norovirus (MNV) is believed to occur by the unusual mechanism of termination codon-dependent reinitiation of translation. In this process, following translation of an upstream open reading frame (ORF) and termination at the stop codon, a proportion of 40S subunits remain associated with the mRNA and reinitiate at the AUG of a downstream ORF, which is typically in close proximity. Consistent with this, the VP2 start codon (AUG) of MNV overlaps the stop codon of the upstream VP1 ORF (UAA) in the pentanucleotide UAAUG. Principal Findings: Here, we confirm that MNV VP2 expression is regulated by termination-reinitiation and define the mRNA sequence requirements. Efficient reintiation is dependent upon 43 nt of RNA immediately upstream of the UAAUG site. Chemical and enzymatic probing revealed that the RNA in this region is not highly structured and includes an essential stretch of bases complementary to 18S rRNA helix 26 (Motif 1). The relative position of Motif 1 with respect to the UAAUG site impacts upon the efficiency of the process. Termination-reinitiation in MNV was also found to be relatively insensitive to the initiation inhibitor edeine. Conclusions: The termination-reinitiation signal of MNV most closely resembles that of influenza BM2. Similar to other viruses that use this strategy, base-pairing between mRNA and rRNA is likely to play a role in tethering the 40S subunit to the mRNA following termination at the VP1 stop codon. Our data also indicate that accurate recognition of the VP2 ORF AUG is not a pre-requisite for efficient reinitiation of translation in this system.	[Napthine, Sawsan; Lever, Robert A.; Powell, Michael L.; Brown, T. David K.; Brierley, Ian] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Jackson, Richard J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge	Napthine, S (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	ib103@mole.bio.cam.ac.uk			Biotechnology and Biological Sciences Research Council UK [RG41021]; BBSRC [BB/D008190/1, BB/C007034/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C007034/1, BB/D008190/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK (www.bbsrc.ac.uk), grant number RG41021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; BRIERLEY I, 1991, J MOL BIOL, V220, P889, DOI 10.1016/0022-2836(91)90361-9; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Girnary R, 2007, J GEN VIROL, V88, P226, DOI 10.1099/vir.0.82064-0; Gould PS, 2007, J VIROL, V81, P8488, DOI 10.1128/JVI.00457-07; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; Grentzmann G, 1998, RNA, V4, P479; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1979, J BIOL CHEM, V254, P4731; KOZAK M, 1983, CELL, V34, P971, DOI 10.1016/0092-8674(83)90554-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; PASSMORE LA, 2007, MOL CELL, P2641; PAVLAKIS G N, 1990, New Biologist, V2, P20; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Powell ML, 2008, BIOCHEM SOC T, V36, P717, DOI 10.1042/BST0360717; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x	33	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8390	10.1371/journal.pone.0008390	http://dx.doi.org/10.1371/journal.pone.0008390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027307	Green Submitted, Green Published, gold			2022-12-27	WOS:000272998000003
J	Siddiqui, MR; Velidi, NR; Pati, S; Rath, N; Kanungo, AK; Bhanjadeo, AK; Rao, BB; Ojha, BM; Moorthy, KK; Soutar, D; Porter, JDH; Rao, PVR				Siddiqui, M. Ruby; Velidi, Nageswara Rao; Pati, Surendra; Rath, Nilambar; Kanungo, Akshay K.; Bhanjadeo, Amiya K.; Rao, Bandaru Bhaskar; Ojha, Bijaya M.; Moorthy, Kodyur Krishna; Soutar, Douglas; Porter, John D. H.; Rao, Pemmaraju V. Ranganadha			Integration of Leprosy Elimination into Primary Health Care in Orissa, India	PLOS ONE			English	Article								Background: Leprosy was eliminated as a public health problem (, 1 case per 10,000) in India by December 2005. With this target in sight the need for a separate vertical programme was diminished. The second phase of the National Leprosy Eradication Programme was therefore initiated: decentralisation of the vertical programme, integration of leprosy services into the primary health care (PHC) system and development of a surveillance system to monitor programme performance. Methodology/Principal Findings: To study the process of integration a qualitative analysis of issues and perceptions of patients and providers, and a review of leprosy records and registers to evaluate programme performance was carried out in the state of Orissa, India. Program performance indicators such as a low mean defaulter rate of 3.83% and a low-misdiagnosis rate of 4.45% demonstrated no detrimental effect of integration on program success. PHC staff were generally found to be highly knowledgeable of diagnosis and management of leprosy cases due to frequent training and a support network of leprosy experts. However in urban hospitals district-level leprosy experts had assumed leprosy activities. The aim was to aid busy PHC staff but it also compromised their leprosy knowledge and management capacity. Inadequate monitoring of a policy of 'new case validation,' in which MDT was not initiated until primary diagnosis had been verified by a leprosy expert, may have led to approximately 26% of suspect cases awaiting confirmation of diagnosis 1-8 months after their initial PHC visit. Conclusions/Significance: This study highlights the need for effective monitoring and evaluation of the integration process. Inadequate monitoring could lead to a reduction in early diagnosis, a delay in initiation of MDT and an increase in disability rates. This in turn could reverse some of the programme's achievements. These findings may help Andhra Pradesh and other states in India to improve their integration process and may also have implications for other disease elimination programmes such as polio and guinea worm (dracunculiasis) as they move closer to their elimination goals.	[Siddiqui, M. Ruby; Porter, John D. H.] London Sch Hyg & Trop Med, London WC1, England; [Velidi, Nageswara Rao; Rath, Nilambar; Kanungo, Akshay K.; Bhanjadeo, Amiya K.; Rao, Bandaru Bhaskar; Ojha, Bijaya M.] LEPRA Hlth Act, Bargarh, Orissa, India; [Pati, Surendra] LEPRA Hlth Act, Bhubaneswar, Orissa, India; [Moorthy, Kodyur Krishna] LEPRA Hlth Act, Hyderabad, Andhra Pradesh, India; [Soutar, Douglas] LEPRA Hlth Act, Colchester, Essex, England; [Rao, Pemmaraju V. Ranganadha] LEPRA Hlth Act, W Marredpally, Secunderabad, India	University of London; London School of Hygiene & Tropical Medicine	Siddiqui, MR (corresponding author), Med Sans Frontieres, London, England.	ruby.siddiqui@london.msf.org		Siddiqui, Ruby/0000-0002-9638-594X	LEPRA UK (Leprosy Relief Association)	LEPRA UK (Leprosy Relief Association)	This study was funded by LEPRA UK (Leprosy Relief Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, RES ACT SOCIOLOGY TH; *CENTR LEPR DIV, 2003, NAT LEPR ER PROGR GU; *DIR GEN HLTH SERV, 2006, NAT ACT PLAN YEAR 20; Glaser B.G., 1968, DISCOV GROUNDED THEO; *GOV IND, 2005, NLEP NEW CAS DET CON; *GOV IND ILEP DIR, 2005, LEARN MAT LEPR CAP B; Green J., 2004, QUALITATIVE METHODS, V2nd; *MIN HLTH FAM WELF, 2004, VAL LEPR DIAGN IND	8	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8351	10.1371/journal.pone.0008351	http://dx.doi.org/10.1371/journal.pone.0008351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020051	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000272870600005
J	Farioli-Vecchioli, S; Saraulli, D; Costanzi, M; Leonardi, L; Cina, I; Micheli, L; Nutini, M; Longone, P; Oh, SP; Cestari, V; Tirone, F				Farioli-Vecchioli, Stefano; Saraulli, Daniele; Costanzi, Marco; Leonardi, Luca; Cina, Irene; Micheli, Laura; Nutini, Michele; Longone, Patrizia; Oh, S. Paul; Cestari, Vincenzo; Tirone, Felice			Impaired Terminal Differentiation of Hippocampal Granule Neurons and Defective Contextual Memory in PC3/Tis21 Knockout Mice	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; NERVE GROWTH-FACTOR; CELL-CYCLE; ADULT NEUROGENESIS; SYNAPTIC PLASTICITY; PROGENITOR CELLS; MESSENGER-RNA; PC3; INHIBITION; EXPRESSION	Neurogenesis in the dentate gyrus of the adult hippocampus has been implicated in neural plasticity and memory, but the molecular mechanisms controlling the proliferation and differentiation of newborn neurons and their integration into the synaptic circuitry are still largely unknown. To investigate this issue, we have analyzed the adult hippocampal neurogenesis in a PC3/Tis21-null mouse model. PC3/Tis21 is a transcriptional co-factor endowed with antiproliferative and prodifferentiative properties; indeed, its upregulation in neural progenitors has been shown to induce exit from cell cycle and differentiation. We demonstrate here that the deletion of PC3/Tis21 causes an increased proliferation of progenitor cells in the adult dentate gyrus and an arrest of their terminal differentiation. In fact, in the PC3/Tis21-null hippocampus postmitotic undifferentiated neurons accumulated, while the number of terminally differentiated neurons decreased of 40%. As a result, PC3/Tis21-null mice displayed a deficit of contextual memory. Notably, we observed that PC3/Tis21 can associate to the promoter of Id3, an inhibitor of proneural gene activity, and negatively regulates its expression, indicating that PC3/Tis21 acts upstream of Id3. Our results identify PC3/Tis21 as a gene required in the control of proliferation and terminal differentiation of newborn neurons during adult hippocampal neurogenesis and suggest its involvement in the formation of contextual memories.	[Farioli-Vecchioli, Stefano; Leonardi, Luca; Cina, Irene; Micheli, Laura; Tirone, Felice] Fondaz S Lucia, Inst Neurobiol & Mol Med, CNR, Rome, Italy; [Saraulli, Daniele; Costanzi, Marco; Cestari, Vincenzo] CNR, Inst Neurosci, Rome, Italy; [Saraulli, Daniele; Costanzi, Marco; Cestari, Vincenzo] LUMSA Univ, Fac Educ Sci, Rome, Italy; [Nutini, Michele; Longone, Patrizia] Fondaz S Lucia, Mol Neurobiol Unit, Rome, Italy; [Oh, S. Paul] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Universita LUMSA; State University System of Florida; University of Florida	Farioli-Vecchioli, S (corresponding author), Fondaz S Lucia, Inst Neurobiol & Mol Med, CNR, Rome, Italy.	vincenzo.cestari@ipsifar.rm.cnr.it; tirone@inmm.cnr.it	Longone, Patrizia/G-8428-2016; vecchioli, stefano farioli/ABE-2288-2020; Micheli, Laura/AAY-1641-2020; Tirone, Felice/P-6745-2014	Longone, Patrizia/0000-0001-8964-1637; MICHELI, LAURA/0000-0001-8647-7261; farioli vecchioli, stefano/0000-0001-7059-7779; Tirone, Felice/0000-0002-0980-4377; Cestari, Vincenzo/0000-0002-9623-157X	FIRB (Fondo Investimenti Ricerca di Base) [RBIN04P4ET]; Italian Ministry of Research; PRIN (Progettidi Ricerca di Interesse Nazionale) [20074Z3H3N_003]; FILAS	FIRB (Fondo Investimenti Ricerca di Base); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); PRIN (Progettidi Ricerca di Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FILAS	This research was supported by FIRB (Fondo Investimenti Ricerca di Base) project RBIN04P4ET (to F. T.; by the Italian Ministry of Research; http://www.miur.it/DefaultDesktop.aspx) and by PRIN (Progettidi Ricerca di Interesse Nazionale) project 20074Z3H3N_003 (to F. T.; by Italian Ministry of Research; http://www.miur.it/DefaultDesktop.aspx). LM and MC were supported by FILAS (Finanziaria Laziale di Sviluppo; Regione Lazio; http://www. filas. it/Page. aspx? IDPage = 156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; ATTARDO A, 2009, CEREB CORTEX    0529; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Corrente G, 2002, NEUROREPORT, V13, P417, DOI 10.1097/00001756-200203250-00011; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; DISALVO CV, 1995, CELL PROLIFERAT, V28, P511, DOI 10.1111/j.1365-2184.1995.tb00089.x; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fukuda S, 2003, J NEUROSCI, V23, P9357; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kitajima K, 2006, BRAIN RES, V1073, P93, DOI 10.1016/j.brainres.2005.12.048; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Malin EL, 2006, P NATL ACAD SCI USA, V103, P1959, DOI 10.1073/pnas.0510890103; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; MCGAUGH JL, 1970, PHYSIOL BEHAV, V5, P1109, DOI 10.1016/0031-9384(70)90197-6; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2000, J CELL SCI, V113, P1101; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; ONEILL LP, 1995, EMBO J, V14, P3946, DOI 10.1002/j.1460-2075.1995.tb00066.x; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Passeri D, 2006, MOL CELL BIOL, V26, P5023, DOI 10.1128/MCB.01360-05; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WILSON RC, 1976, BEHAV BIOL, V17, P495, DOI 10.1016/S0091-6773(76)90901-9; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	82	66	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8339	10.1371/journal.pone.0008339	http://dx.doi.org/10.1371/journal.pone.0008339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020054	gold, Green Published			2022-12-27	WOS:000272834200006
J	Alexandrov, LB; Alexandrova, S; Usheva, A				Alexandrov, Ludmil B.; Alexandrova, Stoyana; Usheva, Anny			Computer Modeling Describes Gravity-Related Adaptation in Cell Cultures	PLOS ONE			English	Article							ESCHERICHIA-COLI; SURVIVAL; STARVATION; EVOLUTION; STRESS; RPOS	Questions about the changes of biological systems in response to hostile environmental factors are important but not easy to answer. Often, the traditional description with differential equations is difficult due to the overwhelming complexity of the living systems. Another way to describe complex systems is by simulating them with phenomenological models such as the well-known evolutionary agent-based model (EABM). Here we developed an EABM to simulate cell colonies as a multi-agent system that adapts to hyper-gravity in starvation conditions. In the model, the cell's heritable characteristics are generated and transferred randomly to offspring cells. After a qualitative validation of the model at normal gravity, we simulate cellular growth in hyper-gravity conditions. The obtained data are consistent with previously confirmed theoretical and experimental findings for bacterial behavior in environmental changes, including the experimental data from the microgravity Atlantis and the Hypergravity 3000 experiments. Our results demonstrate that it is possible to utilize an EABM with realistic qualitative description to examine the effects of hypergravity and starvation on complex cellular entities.	[Alexandrov, Ludmil B.; Alexandrova, Stoyana; Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Alexandrov, Ludmil B.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Alexandrova, Stoyana] Bryn Mawr Coll, Dept Phys, Bryn Mawr, PA 19010 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Cambridge; Bryn Mawr College	Alexandrov, LB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu	Alexandrov, Ludmil/B-6582-2014; Alexandrov, Ludmil/AAS-1454-2021	Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Ludmil/0000-0003-3596-4515	National Institutes of Health (NIH) [R01 GM073911]; Howard Hughes Medical Institute's Science Horizons Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute's Science Horizons Research(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health (NIH) grant R01 GM073911. SA was financed by Howard Hughes Medical Institute's Science Horizons Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; COOPER T, 2003, ESCHERICHIA COLI, P1072; Figge MT, 2006, PLOS COMPUT BIOL, V2, P1377, DOI 10.1371/journal.pcbi.0020171; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; GAC M, 2008, ESCHERICHIA COLI, V178, P1049; Ingber D, 1999, FASEB J, V13, pS3; JOHNSON BC, 2006, GRAVITATIONAL SPACE, V19; Kim PS, 2008, B MATH BIOL, V70, P728, DOI 10.1007/s11538-007-9276-z; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; Mitchell S. D., 2003, BIOL COMPLEXITY INTE; ONEAL CR, 1994, J BACTERIOL, V176, P4610, DOI 10.1128/JB.176.15.4610-4616.1994; Prescott L., 1996, MICROBIOLOGY, V3rd ed; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Schaechter M, 2001, MICROBIOL MOL BIOL R, V65, P119, DOI 10.1128/MMBR.65.1.119-130.2001; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; SIEGELE DA, 1992, J BACTERIOL, V174, P345, DOI 10.1128/jb.174.2.345-348.1992; Spector MP, 1998, ADV MICROB PHYSIOL, V40, P233, DOI 10.1016/S0065-2911(08)60133-2; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Zinser ER, 2000, J BACTERIOL, V182, P4361, DOI 10.1128/JB.182.15.4361-4365.2000	25	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8332	10.1371/journal.pone.0008332	http://dx.doi.org/10.1371/journal.pone.0008332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016778	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834000018
J	Perlin, MW; Sinelnikov, A				Perlin, Mark W.; Sinelnikov, Alexander			An Information Gap in DNA Evidence Interpretation	PLOS ONE			English	Article							MICROSATELLITE MARKERS; TANDEM REPEATS; STR MIXTURES; PEAK AREAS; PROFILES; IDENTIFICATION; DECONVOLUTION; SIMULATION; GENETICS; MODEL	Forensic DNA evidence often contains mixtures of multiple contributors, or is present in low template amounts. The resulting data signals may appear to be relatively uninformative when interpreted using qualitative inclusion-based methods. However, these same data can yield greater identification information when interpreted by computer using quantitative data-modeling methods. This study applies both qualitative and quantitative interpretation methods to a well-characterized DNA mixture and dilution data set, and compares the inferred match information. The results show that qualitative interpretation loses identification power at low culprit DNA quantities (below 100 pg), but that quantitative methods produce useful information down into the 10 pg range. Thus there is a ten-fold information gap that separates the qualitative and quantitative DNA mixture interpretation approaches. With low quantities of culprit DNA (10 pg to 100 pg), computer-based quantitative interpretation provides greater match sensitivity.	[Perlin, Mark W.] Cybergenetics, Pittsburgh, PA USA; [Sinelnikov, Alexander] Genetica, Cincinnati, OH USA		Perlin, MW (corresponding author), Cybergenetics, Pittsburgh, PA USA.	perlin@cybgen.com			Office of Justice Programs [2001-IJ-CX-K003]; National Institute of Justice; Department of Justice	Office of Justice Programs; National Institute of Justice(US National Institute of Justice); Department of Justice	This research was supported in part under Award number 2001-IJ-CX-K003 from the Office of Justice Programs, National Institute of Justice, Department of Justice (www.ojp.usdoj.gov/nij/). Cybergenetics (www.cybgen.com) provided salary support for Drs. Perlin and Sinelnikov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken C., 2004, STAT EVALUATION EVID; [Anonymous], 1950, PROBABILITY WEIGHING; BALDING DJ, 2009, INTERPRETING LOW TEM; Bill M, 2005, FORENSIC SCI INT, V148, P181, DOI 10.1016/j.forsciint.2004.06.037; BLUMSTEIN A, 1988, J QUANTITATIVE CRIMI, V0004; Buckleton J.S., 2004, FORENSIC DNA EVIDENC; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Budowle B, 2009, CROAT MED J, V50, P207, DOI 10.3325/cmj.2009.50.207; Butler J., 2005, PROM 16 INT S HUM ID; Butler JM, 2005, FORENSIC DNA TYPING; Clayton TM, 1998, FORENSIC SCI INT, V91, P55, DOI 10.1016/S0379-0738(97)00175-8; Cook R, 1998, SCI JUSTICE, V38, P151, DOI 10.1016/S1355-0306(98)72099-4; Cowell RG, 2007, BAYESIAN ANAL, V2, P333, DOI 10.1214/07-BA214; Cowell RG, 2007, FORENSIC SCI INT, V166, P28, DOI 10.1016/j.forsciint.2006.03.021; Cowell RG, 2008, FORENS SCI INT-GEN S, V1, P640, DOI 10.1016/j.fsigss.2007.10.087; Cupples CM, 2009, J FORENSIC SCI, V54, P103, DOI 10.1111/j.1556-4029.2008.00914.x; Curran JM, 2008, SCI JUSTICE, V48, P168, DOI 10.1016/j.scijus.2007.09.014; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Evett IW, 1998, J FORENSIC SCI, V43, P62; Feller W., 1968, INTRO PROBABILITY TH, V1; FREGEAU CJ, 1993, BIOTECHNIQUES, V15, P100; Gelman A., 1995, BAYESIAN DATA ANAL; Gilder JR, 2007, J FORENSIC SCI, V52, P97, DOI 10.1111/j.1556-4029.2006.00318.x; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Gill P, 1998, FORENSIC SCI INT, V91, P41, DOI 10.1016/S0379-0738(97)00174-6; Gill P, 2000, FORENSIC SCI INT, V112, P17, DOI 10.1016/S0379-0738(00)00158-4; Gill P, 2006, FORENSIC SCI INT, V160, P90, DOI 10.1016/j.forsciint.2006.04.009; Gill P, 2005, NUCLEIC ACIDS RES, V33, P632, DOI 10.1093/nar/gki205; GILL P, 2009, GENETICS, V3, P104; *ILL STAT POL, 2008, PCR INT PROT 6 02 DN; KING G, 1989, AM J POLIT SCI, V33, P762, DOI 10.2307/2111071; Koehler JJ, 2001, LAW HUMAN BEHAV, V25, P493, DOI 10.1023/A:1012892815916; Kullback S., 1968, INFORM THEORY STAT; Ladd C, 2001, CROAT MED J, V42, P244; Lancia G, 1998, DISCRETE APPL MATH, V88, P291, DOI 10.1016/S0166-218X(98)80006-1; Lindley D.V., 2006, UNDERSTANDING UNCERT; Michaelis R C, 2008, LITIGATORS GUIDE DNA; Mortera J, 2003, THEOR POPUL BIOL, V63, P191, DOI 10.1016/S0040-5809(03)00006-6; *NAT RES COUNC, 1996, EV FOR DNA EV UPD EV; National Academy of Sciences, 2009, STRENGTHENING FORENS; NIEZGODA SJ, 1995, 6 INT S HUM ID SCOTT; O'Hagan A., 2004, BAYESIAN INFERENCE; Perlin MW, 2001, J FORENSIC SCI, V46, P1372; PERLIN MW, 1995, AM J HUM GENET, V57, P1199; PERLIN MW, 2009, MATCH LIKEL IN PRESS; PERLIN MW, 2006, PROM 17 INT S HUM ID; Perlin MW, 2003, PROM 14 INT S HUM ID; Savage L.J., 1954, FDN STAT; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2000, FORENSIC SCI COMMUN, V2; Sisson SA, 2007, AM STAT, V61, P112, DOI 10.1198/000313007X169965; Stenman J, 2001, NAT BIOTECHNOL, V19, P1011, DOI 10.1038/nbt1101-1011b; Stolovitzky G, 1996, P NATL ACAD SCI USA, V93, P12947, DOI 10.1073/pnas.93.23.12947; THOMAS DC, 1995, MARKOV CHAIN MONTE C, P419; TOBIN WA, 2006, CHAMPION, V30, P12; Wang TW, 2006, J FORENSIC SCI, V51, P1284, DOI 10.1111/j.1556-4029.2006.00268.x; WICKENHEISER R, 2004, J BIOLAW BUS, V7; Zedlewski Edwin, 2006, NIJ J, V253, P2	57	44	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8327	10.1371/journal.pone.0008327	http://dx.doi.org/10.1371/journal.pone.0008327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20020039	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834000014
J	Kozera, L; White, E; Calaghan, S				Kozera, Lukasz; White, Ed; Calaghan, Sarah			Caveolae Act as Membrane Reserves Which Limit Mechanosensitive I-Cl,I-swell Channel Activation during Swelling in the Rat Ventricular Myocyte	PLOS ONE			English	Article							CARDIAC MYOCYTES; TYROSINE KINASES; CHLORIDE CHANNEL; APICAL MEMBRANE; VOLUME; SRC; INCREASES; VESICLES; PROTEIN; STRETCH	Background: Many ion channels are preferentially located in caveolae where compartmentalisation/scaffolding with signal transduction components regulates their activity. Channels that are mechanosensitive may be additionally dependent on caveolar control of the mechanical state of the membrane. Here we test which mechanism underlies caveolar-regulation of the mechanosensitive I-Cl,I-swell channel in the adult cardiac myocyte. Methodology/Principal Findings: Rat ventricular myocytes were exposed to solution of 0.02 tonicity (T; until lysis), 0.64T for 10-15 min (swelling), and/or methyl-beta-cyclodextrin (MBCD; to disrupt caveolae). MBCD and 0.64T swelling reduced the number of caveolae visualised by electron microscopy by 75 and 50% respectively. MBCD stimulated translocation of caveolin 3 from caveolae-enriched buoyant membrane fractions, but both caveolin 1 and 3 remained in buoyant fractions after swelling. I-Cl,I-swell inhibition in control cells decreased time to half-maximal volume (t(0.5,vol); 0.64T), consistent with a role for I-Cl,I-swell in volume regulation. MBCD-treated cells showed reduced time to lysis (0.02T) and t(0.5,vol) (0.64T) compared with controls. The negative inotropic response to swelling (an index of I-Cl,I-swell activation) was enhanced by MBCD. Conclusions/Significance: These data show that disrupting caveolae removes essential membrane reserves, which speeds swelling in hyposmotic conditions, and thereby promotes activation of I-Cl,I-swell. They illustrate a general principle whereby caveolae as a membrane reserve limit increases in membrane tension during stretch/swelling thereby restricting mechanosensitive channel activation.	[Kozera, Lukasz; White, Ed; Calaghan, Sarah] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	University of Leeds	Kozera, L (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England.	s.c.calaghan@leeds.ac.uk		Calaghan, Sarah/0000-0002-9145-2576	Cardiovascular Institute at Leeds (CRISTAL); British Heart Foundation [PG/06/047]	Cardiovascular Institute at Leeds (CRISTAL); British Heart Foundation(British Heart Foundation)	This work was supported by a Cardiovascular Institute at Leeds (CRISTAL) Ph. D. studentship to L. K. and the British Heart Foundation (grant number PG/06/047 to S. C, E. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; BOYETT MR, 1991, EXP PHYSIOL, V76, P259, DOI 10.1113/expphysiol.1991.sp003492; Brette F, 2000, AM J PHYSIOL-HEART C, V279, pH1963, DOI 10.1152/ajpheart.2000.279.4.H1963; Browe DM, 2003, J GEN PHYSIOL, V122, P689, DOI 10.1085/jgp.200308899; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Calaghan SC, 1998, PFLUG ARCH EUR J PHY, V436, P948, DOI 10.1007/s004240050728; Dick GM, 1999, BRIT J PHARMACOL, V127, P1819, DOI 10.1038/sj.bjp.0702730; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; GABELLA G, 1978, J ULTRA MOL STRUCT R, V65, P135, DOI 10.1016/S0022-5320(78)90051-5; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Kawabe J, 2004, AM J PHYSIOL-HEART C, V286, pH1845, DOI 10.1152/ajpheart.00593.2003; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kohl P, 2003, PROG BIOPHYS MOL BIO, V82, P221, DOI 10.1016/S0079-6107(03)00024-5; KORDYLEWSKI L, 1993, CIRC RES, V73, P135, DOI 10.1161/01.RES.73.1.135; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; Li GR, 2002, AM J PHYSIOL-HEART C, V282, pH1270, DOI 10.1152/ajpheart.00946.2001; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; MARTINEZPALOMO A, 1973, J CELL BIOL, V58, P1, DOI 10.1083/jcb.58.1.1; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Okada Yasunobu, 1999, Journal of Physiology (Cambridge), V520, P2, DOI 10.1111/j.1469-7793.1999.00002.x; PAGE E, 1978, AM J PHYSIOL, V235, pC147, DOI 10.1152/ajpcell.1978.235.5.C147; Patel HH, 2007, FASEB J, V21, P1565, DOI 10.1096/fj.06-7719com; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Ren ZJ, 2005, AM J PHYSIOL-HEART C, V288, pH2628, DOI 10.1152/ajpheart.00992.2004; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Sens P, 2007, LIPID RAFTS CAVEOLAE, P25; SEVERS NJ, 1988, J CELL SCI, V90, P341; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Trouet D, 1999, J PHYSIOL-LONDON, V520, P113, DOI 10.1111/j.1469-7793.1999.t01-1-00113.x; TSENG GN, 1992, AM J PHYSIOL, V262, pC1056, DOI 10.1152/ajpcell.1992.262.4.C1056; VANDENBERG JI, 1994, J GEN PHYSIOL, V104, P997, DOI 10.1085/jgp.104.6.997; Vandenberg JI, 1997, AM J PHYSIOL-CELL PH, V273, pC541, DOI 10.1152/ajpcell.1997.273.2.C541; Walsh KB, 2005, AM J PHYSIOL-HEART C, V289, pH2566, DOI 10.1152/ajpheart.00292.2005	39	83	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8312	10.1371/journal.pone.0008312	http://dx.doi.org/10.1371/journal.pone.0008312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011535	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300055
J	Imai, N; Samejima, H; Langner, A; Ong, RC; Kita, S; Titin, J; Chung, AYC; Lagan, P; Lee, YF; Kitayama, K				Imai, Nobuo; Samejima, Hiromitsu; Langner, Andreas; Ong, Robert C.; Kita, Satoshi; Titin, Jupiri; Chung, Arthur Y. C.; Lagan, Peter; Lee, Ying Fah; Kitayama, Kanehiro			Co-Benefits of Sustainable Forest Management in Biodiversity Conservation and Carbon Sequestration	PLOS ONE			English	Article							REDUCED-IMPACT; TROPICAL FORESTS; MALAYSIA; SABAH; INDONESIA	Background: Sustainable forest management (SFM), which has been recently introduced to tropical natural production forests, is beneficial in maintaining timber resources, but information about the co-benefits for biodiversity conservation and carbon sequestration is currently lacking. Methodology/Principal Findings: We estimated the diversity of medium to large-bodied forest-dwelling vertebrates using a heat-sensor camera trapping system and the amount of above-ground, fine-roots, and soil organic carbon by a combination of ground surveys and aerial-imagery interpretations. This research was undertaken both in SFM applied as well as conventionally logged production forests in Sabah, Malaysian Borneo. Our carbon estimation revealed that the application of SFM resulted in a net gain of 54 Mg C ha(-1) on a landscape scale. Overall vertebrate diversity was greater in the SFM applied forest than in the conventionally logged forest. Specifically, several vertebrate species (6 out of recorded 36 species) showed higher frequency in the SFM applied forest than in the conventionally logged forest. Conclusions/Significance: The application of SFM to degraded natural production forests could result in greater diversity and abundance of vertebrate species as well as increasing carbon storage in the tropical rain forest ecosystems.	[Imai, Nobuo; Samejima, Hiromitsu; Langner, Andreas; Kita, Satoshi; Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Ong, Robert C.; Titin, Jupiri; Chung, Arthur Y. C.; Lee, Ying Fah] Forest Res Ctr, Sabah Forestry Dept, Sandakan, Sabah, Malaysia; [Lagan, Peter] Deramakot Forest Off, Sabah Forestry Dept, Sandakan, Sabah, Malaysia	Kyoto University; Pusat Penyelidikan Hutan; Pusat Penyelidikan Hutan	Imai, N (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan.	inobuo@kais.kyoto-u.ac.jp	Langner, Andreas/J-9746-2019; Imai, Nobuo/AAR-7008-2020	Langner, Andreas/0000-0002-8083-3779; Imai, Nobuo/0000-0002-8435-7693	Ministry of the Environment, Japan [F-071]; JSPS	Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Global Environment Research Fund (F-071) of the Ministry of the Environment, Japan, to KK and in part by the JSPS AA Science Platform Program to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Bertault JG, 1997, FOREST ECOL MANAG, V94, P209, DOI 10.1016/S0378-1127(96)03974-6; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brown S, 1997, 134 FAO; Gitelson AA, 2004, J PLANT PHYSIOL, V161, P165, DOI 10.1078/0176-1617-01176; *INT TROP TIMB ORG, 2006, STAT TROP FOR MAN 20; IUCN, 2014, IUCN RED LIST THREAT; KLEINE M, 1993, FOREST ECOL MANAG, V61, P277, DOI 10.1016/0378-1127(93)90207-4; Kollert W, 2007, FOREST POLICY ECON, V9, P862, DOI 10.1016/j.forpol.2006.03.005; Lagan P, 2007, ECOL RES, V22, P414, DOI 10.1007/s11284-007-0362-3; LEE YF, 2006, P 2 WORKSH SYN CARB; ONG RC, 1996, DIPTEROCARP FOREST E, P274; ONG RC, 1995, 2 FRC SAB FOR DEP; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Putz FE, 2008, PLOS BIOL, V6, P1368, DOI 10.1371/journal.pbio.0060166; *SAB FOR DEP, 2005, FOR MAN PLANT, V2; Sist P, 1998, FOREST ECOL MANAG, V108, P251, DOI 10.1016/S0378-1127(98)00228-X; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; World Resources Institute, 2005, MILL EC ASS EC HUM W	20	51	53	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8267	10.1371/journal.pone.0008267	http://dx.doi.org/10.1371/journal.pone.0008267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011516	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830200011
J	Guenther, FH; Brumberg, JS; Wright, EJ; Nieto-Castanon, A; Tourville, JA; Panko, M; Law, R; Siebert, SA; Bartels, JL; Andreasen, DS; Ehirim, P; Mao, H; Kennedy, PR				Guenther, Frank H.; Brumberg, Jonathan S.; Wright, E. Joseph; Nieto-Castanon, Alfonso; Tourville, Jason A.; Panko, Mikhail; Law, Robert; Siebert, Steven A.; Bartels, Jess L.; Andreasen, Dinal S.; Ehirim, Princewill; Mao, Hui; Kennedy, Philip R.			A Wireless Brain-Machine Interface for Real-Time Speech Synthesis	PLOS ONE			English	Article							THOUGHT-TRANSLATION DEVICE; COMPUTER INTERFACE; CORTICAL CONTROL; CONE ELECTRODE; ARM MOVEMENTS; MOTOR CORTEX; BCI; COMMUNICATION; PERCEPTION; TTD	Background: Brain-machine interfaces (BMIs) involving electrodes implanted into the human cerebral cortex have recently been developed in an attempt to restore function to profoundly paralyzed individuals. Current BMIs for restoring communication can provide important capabilities via a typing process, but unfortunately they are only capable of slow communication rates. In the current study we use a novel approach to speech restoration in which we decode continuous auditory parameters for a real-time speech synthesizer from neuronal activity in motor cortex during attempted speech. Methodology/Principal Findings: Neural signals recorded by a Neurotrophic Electrode implanted in a speech-related region of the left precentral gyrus of a human volunteer suffering from locked-in syndrome, characterized by near-total paralysis with spared cognition, were transmitted wirelessly across the scalp and used to drive a speech synthesizer. A Kalman filter-based decoder translated the neural signals generated during attempted speech into continuous parameters for controlling a synthesizer that provided immediate (within 50 ms) auditory feedback of the decoded sound. Accuracy of the volunteer's vowel productions with the synthesizer improved quickly with practice, with a 25% improvement in average hit rate (from 45% to 70%) and 46% decrease in average endpoint error from the first to the last block of a three-vowel task. Conclusions/Significance: Our results support the feasibility of neural prostheses that may have the potential to provide near-conversational synthetic speech output for individuals with severely impaired speech motor control. They also provide an initial glimpse into the functional properties of neurons in speech motor cortical areas.	[Guenther, Frank H.; Brumberg, Jonathan S.; Tourville, Jason A.; Panko, Mikhail; Law, Robert] Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Guenther, Frank H.; Brumberg, Jonathan S.; Tourville, Jason A.; Panko, Mikhail; Law, Robert] Boston Univ, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; [Guenther, Frank H.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Brumberg, Jonathan S.; Wright, E. Joseph; Siebert, Steven A.; Bartels, Jess L.; Andreasen, Dinal S.; Kennedy, Philip R.] Neural Signals Inc, Duluth, GA USA; [Nieto-Castanon, Alfonso] StatsANC LLC, Buenos Aires, DF, Argentina; [Andreasen, Dinal S.] Georgia Tech Res Inst, Marietta, GA USA; [Ehirim, Princewill] Gwinnett Med Ctr, Lawrenceville, GA USA; [Mao, Hui] Emory Univ Hosp, Emory Ctr Syst Imaging, Atlanta, GA 30322 USA	Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology; Emory University	Guenther, FH (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.	guenther@cns.bu.edu		Tourville, Jason/0000-0002-7197-2427; Brumberg, Jonathan/0000-0001-5739-968X; Panko, Mikhail/0000-0003-3927-1265; Nieto-Castanon, Alfonso/0000-0002-3451-3475	National Institute on Deafness and other Communication Disorders [R44-DC007050, R01-DC007683, R01-DC002852]; CELEST; NSF [SBE-0354378]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R44DC007050, R01DC002852, R01DC007683] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CELEST(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research supported by National Institute on Deafness and other Communication Disorders grants R44-DC007050, R01-DC007683, and R01-DC002852 and by CELEST, an NSF Science of Learning Center (SBE-0354378). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Employees EJW, SAS, JLB, DSA, and PRK of Neural Signals, Inc (the recipient of Grant R44-DC007050; http://www.neuralsignals.com) played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Bartels J, 2008, J NEUROSCI METH, V174, P168, DOI 10.1016/j.jneumeth.2008.06.030; Birbaumer N, 2003, IEEE T NEUR SYS REH, V11, P120, DOI 10.1109/TNSRE.2003.814439; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2000, IEEE T REHABIL ENG, V8, P190, DOI 10.1109/86.847812; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Cox D. R., 1962, RENEWAL THEORY; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FANT G, 1959, ERICSSON TECHNICS, V1, P106; FLANAGAN JL, 1963, 15 ANN M AUD ENG SOC; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Hinterberger T, 2003, CLIN NEUROPHYSIOL, V114, P416, DOI 10.1016/S1388-2457(02)00411-X; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; KENNEDY PR, 1989, J NEUROSCI METH, V29, P181, DOI 10.1016/0165-0270(89)90142-8; KENNEDY PR, 1992, NEUROSCI LETT, V142, P89, DOI 10.1016/0304-3940(92)90627-J; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Kim S-P, 2007, 3 INT IEEE EMBS C NE; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 1999, EXP BRAIN RES, V124, P223, DOI 10.1007/s002210050617; Lawrence W., 1953, COMMUN THEOR, P460; MAEDA S, 1990, NATO ADV SCI I D-BEH, V55, P131; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Rabiner L., 1993, FUNDAMENTALS SPEECH; RABINER LR, 1968, J ACOUST SOC AM, V43, P822, DOI 10.1121/1.1910901; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P222, DOI 10.1109/86.847823; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Zemlin W., 1998, SPEECH HEARING SCI A	48	164	171	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8218	10.1371/journal.pone.0008218	http://dx.doi.org/10.1371/journal.pone.0008218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011034	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800009
J	Crawford, DC; Moulder, KL; Gereau, RW; Story, GM; Mennerick, S				Crawford, Devon C.; Moulder, Krista L.; Gereau, Robert W.; Story, Gina M., IV; Mennerick, Steven			Comparative Effects of Heterologous TRPV1 and TRPM8 Expression in Rat Hippocampal Neurons	PLOS ONE			English	Article							REMOTE-CONTROL; ION CHANNELS; HOMEOSTATIC REGULATION; OPTOGENETIC CONTROL; GLUTAMATE-RECEPTOR; CAPSAICIN RECEPTOR; NEURAL CIRCUITRY; MENTHOL; CALCIUM; DEPOLARIZATION	Heterologous channel expression can be used to control activity in select neuronal populations, thus expanding the tools available to modern neuroscience. However, the secondary effects of exogenous channel expression are often left unexplored. We expressed two transient receptor potential (TRP) channel family members, TRPV1 and TRPM8, in cultured hippocampal neurons. We compared functional expression levels and secondary effects of channel expression and activation on neuronal survival and signaling. We found that activation of both channels with appropriate agonist caused large depolarizing currents in voltage-clamped hippocampal neurons, exceeding the amplitude responses to a calibrating 30 mM KCl stimulation. Both TRPV1 and TRPM8 currents were reduced but not eliminated by 4 hr incubation in saturating agonist concentration. In the case of TRPV1, but not TRPM8, prolonged agonist exposure caused strong calcium-dependent toxicity. In addition, TRPV1 expression depressed synaptic transmission dramatically without overt signs of toxicity, possibly due to low-level TRPV1 activation in the absence of exogenous agonist application. Despite evidence of expression at presynaptic sites, in addition to somatodendritic sites, TRPM8 expression alone exhibited no effects on synaptic transmission. Therefore, by a number of criteria, TRPM8 proved the superior choice for control over neuronal membrane potential. This study also highlights the need to explore potential secondary effects of long-term expression and activation of heterologously introduced channels.	[Crawford, Devon C.] Washington Univ, Grad Program Neurosci, St Louis, MO 63130 USA; [Crawford, Devon C.; Moulder, Krista L.; Mennerick, Steven] Washington Univ, Dept Psychiat, St Louis, MO USA; [Gereau, Robert W.; Story, Gina M., IV] Washington Univ, Dept Anesthesiol, St Louis, MO USA; [Gereau, Robert W.; Story, Gina M., IV; Mennerick, Steven] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, DC (corresponding author), Washington Univ, Grad Program Neurosci, St Louis, MO 63130 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Crawford, Devon/0000-0002-9354-4976	U. S. National Institutes of Health (NIH) [T32GM08151, F31NS066611, DA018109, NS42595, NS48602, MH78823, NS54174, P30NS057105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048602, P30NS057105, F31NS066611, R01NS042595, R01NS054174, R56NS048602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA018109] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U. S. National Institutes of Health (NIH) grants T32GM08151 ( D. C. C.), F31NS066611 ( D. C. C.), DA018109 ( K. L. M.), NS42595 ( R. W. G), NS48602 ( R. W. G), MH78823 ( S. M.), NS54174 ( S. M.), and an NIH Neuroscience Blueprint Core Grant P30NS057105 to Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; CHOI DW, 1987, J NEUROSCI, V7, P369; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P319, DOI 10.1113/jphysiol.1947.sp004215; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Meyers JR, 2003, J NEUROSCI, V23, P4054; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Moulder KL, 2006, MOL NEUROBIOL, V33, P133, DOI 10.1385/MN:33:2:133; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Okada M, 2008, NEUROSCIENCE, V156, P289, DOI 10.1016/j.neuroscience.2008.07.038; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3; Zhang XB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003386; Zimmermann G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005100; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	54	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8166	10.1371/journal.pone.0008166	http://dx.doi.org/10.1371/journal.pone.0008166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997638	Green Published, gold			2022-12-27	WOS:000272829200006
J	Santilli, G; Lamorte, G; Carlessi, L; Ferrari, D; Nodari, LR; Binda, E; Delia, D; Vescovi, AL; De Filippis, L				Santilli, Guido; Lamorte, Giuseppe; Carlessi, Luigi; Ferrari, Daniela; Nodari, Laura Rota; Binda, Elena; Delia, Domenico; Vescovi, Angelo L.; De Filippis, Lidia			Mild Hypoxia Enhances Proliferation and Multipotency of Human Neural Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HUMAN CNS; IN-VITRO; DOPAMINERGIC DIFFERENTIATION; PRECURSOR CELLS; OXYGEN-TENSION; HIF-1; PATHOPHYSIOLOGY	Background: Neural stem cells (NSCs) represent an optimal tool for studies and therapy of neurodegenerative diseases. We recently established a v-myc immortalized human NSC (IhNSC) line, which retains stem properties comparable to parental cells. Oxygen concentration is one of the most crucial environmental conditions for cell proliferation and differentiation both in vitro and in vivo. In the central nervous system, physiological concentrations of oxygen range from 0.55 to 8% oxygen. In particular, in the in the subventricular zone niche area, it's estimated to be 2.5 to 3%. Methodology/Principal Findings: We investigated in vitro the effects of 1, 2.5, 5, and 20% oxygen concentrations on IhNSCs both during proliferation and differentiation. The highest proliferation rate, evaluated through neurosphere formation assay, was obtained at 2.5 and 5% oxygen, while 1% oxygen was most noxious for cell survival. The differentiation assays showed that the percentages of beta-tubIII+ or MAP2+ neuronal cells and of GalC+ oligodendrocytes were significantly higher at 2.5% compared with 1, 5, or 20% oxygen at 17 days in vitro. Mild hypoxia (2.5 to 5% oxygen) promoted differentiation into neuro-oligodendroglial progenitors as revealed by the higher percentage of MAP2+/Ki67+ and GalC+/Ki67+ residual proliferating progenitors, and enhanced the yield of GABAergic and slightly of glutamatergic neurons compared to 1% and 20% oxygen where a significant percentage of GFAP+/nestin+ cells were still present at 17 days of differentiation. Conclusions/Significance: These findings raise the possibility that reduced oxygen levels occurring in neuronal disorders like cerebral ischemia transiently lead to NSC remaining in a state of quiescence. Conversely, mild hypoxia favors NSC proliferation and neuronal and oligodendroglial differentiation, thus providing an important advance and a useful tool for NSC-mediated therapy of ischemic stroke and neurodegenerative diseases like Parkinson's disease, multiple sclerosis, and Alzheimer's disease.	[Santilli, Guido; Lamorte, Giuseppe; Ferrari, Daniela; Nodari, Laura Rota; Binda, Elena; Vescovi, Angelo L.; De Filippis, Lidia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Carlessi, Luigi; Delia, Domenico] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, Milan, Italy	University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan	Santilli, G (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	vescovi@tin.it; lidia.defilippis@unimib.it	Ferrari, Daniela/AHE-7647-2022; Carlessi, Luigi/D-5802-2017; Vescovi, Angelo Luigi/A-4919-2015; Binda, Elena/B-2650-2017; De Filippis, Lidia/H-3098-2017	Ferrari, Daniela/0000-0001-7251-9854; Carlessi, Luigi/0000-0002-7395-8872; Vescovi, Angelo Luigi/0000-0002-1742-4112; Binda, Elena/0000-0002-8750-2905; Lamorte, Giuseppe/0000-0001-9377-7537; De Filippis, Lidia/0000-0002-2196-9430	Cariplo (Cassa di Risparmio delle Provincie Lombarde) Foundation; Neurothon ONLUS (Organizzazione non lucrativa di utilita sociale) Foundation; Italian Association for Cancer Research; Stemgen Spa	Cariplo (Cassa di Risparmio delle Provincie Lombarde) Foundation(Fondazione Cariplo); Neurothon ONLUS (Organizzazione non lucrativa di utilita sociale) Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Stemgen Spa	This work was financially supported by grants from Cariplo (Cassa di Risparmio delle Provincie Lombarde) Foundation, Neurothon ONLUS (Organizzazione non lucrativa di utilita sociale) Foundation (a nonprofit organization), the Italian Association for Cancer Research, and Stemgen Spa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgers HF, 2008, EXP BRAIN RES, V188, P33, DOI 10.1007/s00221-008-1336-6; Carlessi L, 2009, CELL DEATH DIFFER, V16, P795, DOI 10.1038/cdd.2009.10; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Erba E, 2001, EUR J CANCER, V37, P97, DOI 10.1016/S0959-8049(00)00357-9; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Freyer JP, 1998, J CELL PHYSIOL, V176, P138, DOI 10.1002/(SICI)1097-4652(199807)176:1<138::AID-JCP16>3.3.CO;2-7; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GRITTI A, 1995, NEUROSCI LETT, V185, P151, DOI 10.1016/0304-3940(95)11247-T; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Ohta K, 2003, ACT NEUR S, V86, P187; Panchision D, 1998, CURR OPIN CELL BIOL, V10, P727, DOI 10.1016/S0955-0674(98)80114-2; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Radley JM, 1999, EXP HEMATOL, V27, P365, DOI 10.1016/S0301-472X(98)00017-4; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	44	148	174	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8575	10.1371/journal.pone.0008575	http://dx.doi.org/10.1371/journal.pone.0008575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052410	gold, Green Published, Green Submitted			2022-12-27	WOS:000273338500018
J	Simon, GG; Hu, YL; Khan, AM; Zhou, JS; Salmon, J; Chikhlikar, PR; Jung, KO; Marques, ETA; August, JT				Simon, Gregory G.; Hu, Yongli; Khan, Asif M.; Zhou, Jingshi; Salmon, Jerome; Chikhlikar, Priya R.; Jung, Keun-Ok; Marques, Ernesto T. A.; August, J. Thomas			Dendritic Cell Mediated Delivery of Plasmid DNA Encoding LAMP/HIV-1 Gag Fusion Immunogen Enhances T Cell Epitope Responses in HLA DR4 Transgenic Mice	PLOS ONE			English	Article							MEMBRANE-PROTEIN; RHESUS MACAQUES; VACCINE CHIMERA; II COMPARTMENT; GENE-TRANSFER; IN-VITRO; RNA; ANTIGEN; EXPRESSION; TRANSFECTION	This report describes the identification and bioinformatics analysis of HLA-DR4-restricted HIV-1 Gag epitope peptides, and the application of dendritic cell mediated immunization of DNA plasmid constructs. BALB/c (H-2d) and HLA-DR4 (DRA1*0101, DRB1*0401) transgenic mice were immunized with immature dendritic cells transfected by a recombinant DNA plasmid encoding the lysosome-associated membrane protein-1/HIV-1 Gag (pLAMP/gag) chimera antigen. Three immunization protocols were compared: 1) primary subcutaneous immunization with 1x10(5) immature dendritic cells transfected by electroporation with the pLAMP/gag DNA plasmid, and a second subcutaneous immunization with the naked pLAMP/gag DNA plasmid; 2) primary immunization as above, and a second subcutaneous immunization with a pool of overlapping peptides spanning the HIV-1 Gag sequence; and 3) immunization twice by subcutaneous injection of the pLAMP/gag DNA plasmid. Primary immunization with pLAMP/gag-transfected dendritic cells elicited the greatest number of peptide specific T-cell responses, as measured by ex vivo IFN-gamma ELISpot assay, both in BALB/c and HLA-DR4 transgenic mice. The pLAMP/gag-transfected dendritic cells prime and naked DNA boost immunization protocol also resulted in an increased apparent avidity of peptide in the ELISpot assay. Strikingly, 20 of 25 peptide-specific T-cell responses in the HLA-DR4 transgenic mice contained sequences that corresponded, entirely or partially to 18 of the 19 human HLA-DR4 epitopes listed in the HIV molecular immunology database. Selection of the most conserved epitope peptides as vaccine targets was facilitated by analysis of their representation and variability in all reported sequences. These data provide a model system that demonstrates a) the superiority of immunization with dendritic cells transfected with LAMP/gag plasmid DNA, as compared to naked DNA, b) the value of HLA transgenic mice as a model system for the identification and evaluation of epitope-based vaccine strategies, and c) the application of variability analysis across reported sequences in public databases for selection of historically conserved HIV epitopes as vaccine targets.	[Simon, Gregory G.; Zhou, Jingshi; Salmon, Jerome; Chikhlikar, Priya R.; Jung, Keun-Ok; Marques, Ernesto T. A.; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hu, Yongli; Khan, Asif M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Marques, Ernesto T. A.; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; National University of Singapore; Johns Hopkins University	Simon, GG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	gsimon2@jhmi.edu	Khan, Mohammad Asif/F-4663-2010; Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Khan, M. Asif/ABE-7839-2021; Publica, Inct Saude/J-9544-2013	Khan, Mohammad Asif/0000-0001-9202-279X; Marques, Ernesto T. A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358; Khan, M. Asif/0000-0001-9202-279X; Jung, Keunok/0000-0003-2967-8432	National Institute of Allergy and Infectious Diseases [R37-AI41908]; National Cancer Institute [T32 CA9009243]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041908] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Grants R37-AI41908 from the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute training grant T32 CA9009243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Artusio E, 2006, CANCER BIOL THER, V5, P1624, DOI 10.4161/cbt.5.12.3353; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bedoui S, 2009, IMMUNOL CELL BIOL, V87, P255, DOI 10.1038/icb.2008.105; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bonehill A, 2004, J IMMUNOL, V172, P6649, DOI 10.4049/jimmunol.172.11.6649; Bontkes HJ, 2007, GENE THER, V14, P366, DOI 10.1038/sj.gt.3302874; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Casares S, 1997, J EXP MED, V186, P1481, DOI 10.1084/jem.186.9.1481; Chikhlikar P, 2004, VIROLOGY, V323, P220, DOI 10.1016/j.virol.2004.02.025; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Cope AP, 1999, ARTHRITIS RHEUM, V42, P1497, DOI 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO;2-#; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Dell K, 2008, ANTIVIR THER, V13, P495; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FUGGER L, 1994, P NATL ACAD SCI USA, V91, P6151, DOI 10.1073/pnas.91.13.6151; GIESE NA, 1994, J VIROL, V68, P5819, DOI 10.1128/JVI.68.9.5819-5824.1994; Gross DA, 2004, J CLIN INVEST, V113, P425, DOI 10.1172/JCI200419418; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kalergis AM, 2000, J IMMUNOL, V165, P280, DOI 10.4049/jimmunol.165.1.280; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Landi A, 2007, J LEUKOCYTE BIOL, V82, P849, DOI 10.1189/jlb.0906561; Lenz P, 2003, FEBS LETT, V538, P149, DOI 10.1016/S0014-5793(03)00169-8; Liao XS, 2004, MOL THER, V9, P757, DOI 10.1016/j.ymthe.2004.02.011; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Melhem NM, 2007, EUR J IMMUNOL, V37, P2164, DOI 10.1002/eji.200636782; Mitchell DA, 2000, J CLIN INVEST, V106, P1065, DOI 10.1172/JCI11405; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Nair SK, 1998, NAT BIOTECHNOL, V16, P364, DOI 10.1038/nbt0498-364; Nishimura Y, 2004, MOL IMMUNOL, V40, P1089, DOI 10.1016/j.molimm.2003.11.009; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; ROWELL JF, 1995, J IMMUNOL, V155, P1818; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103	43	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8574	10.1371/journal.pone.0008574	http://dx.doi.org/10.1371/journal.pone.0008574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052293	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338500017
J	Tang, YZ; Wu, HJ; Ugai, H; Matthews, QL; Curiel, DT				Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.			Derivation of a Triple Mosaic Adenovirus for Cancer Gene Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLINICAL-TRIALS WORLDWIDE; PROTEIN-IX; THYMIDINE KINASE; FUNCTIONAL DISPLAY; IN-VIVO; TRANSCYTOSIS; VECTORS; POLYPEPTIDES; APHTHOVIRUS	A safe and efficacious cancer medicine is necessary due to the increasing population of cancer patients whose particular diseases cannot be cured by the currently available treatment. Adenoviral ( Ad) vectors represent a promising therapeutic medicine for human cancer therapy. However, several improvements are needed in order for Ad vectors to be effective cancer therapeutics, which include, but are not limited to, improvement of cellular uptake, enhanced cancer cell killing activity, and the capability of vector visualization and tracking once injected into the patients. To this end, we attempted to develop an Ad as a multifunctional platform incorporating targeting, imaging, and therapeutic motifs. In this study, we explored the utility of this proposed platform by generating an Ad vector containing the poly-lysine (pK), the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK), and the monomeric red fluorescent protein (mRFP1) as targeting, tumor cell killing, and imaging motifs, respectively. Our study herein demonstrates the generation of the triple mosaic Ad vector with pK, HSV-1 TK, and mRFP1 at the carboxyl termini of Ad minor capsid protein IX (pIX). In addition, the functionalities of pK, HSV-1 TK, and mRFP1 proteins on the Ad vector were retained as confirmed by corresponding functional assays, indicating the potential multifunctional application of this new Ad vector for cancer gene therapy. The validation of the triple mosaic Ad vectors also argues for the ability of pIX modification as a base for the development of multifunctional Ad vectors.	[Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Tang, Yizhe] Univ Alabama Birmingham, Vis Sci Grad Program, Birmingham, AL 35294 USA; [Matthews, Qiana L.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tang, YZ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA.	curiel@uab.edu	Matthews, Qiana/P-9624-2019; Tang, Yizhe/A-8682-2014; Ugai, Hideyo/K-4920-2017	Tang, Yizhe/0000-0001-5354-478X; Ugai, Hideyo/0000-0002-9121-8480	NIH [5R01CA111569]; Juvenile Diabetes Research Foundation [1-2005-71]; NATIONAL CANCER INSTITUTE [R01CA111569] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant 5R01CA111569 (Dr. D. T. Curiel) and Juvenile Diabetes Research Foundation grant 1-2005-71 ( Dr. H. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalu A, 1999, J VIROL, V73, P6182, DOI 10.1128/JVI.73.7.6182-6187.1999; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Edelstein ML, 2004, J GENE MED, V6, P597, DOI 10.1002/jgm.619; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Le LP, 2005, J GEN VIROL, V86, P3201, DOI 10.1099/vir.0.80968-0; Le LP, 2006, JNCI-J NATL CANCER I, V98, P203, DOI 10.1093/jnci/djj022; Li J, 2005, VIROLOGY, V338, P247, DOI 10.1016/j.virol.2005.04.005; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mathis JM, 2006, J GENE MED, V8, P1105, DOI 10.1002/jgm.935; Matthews QL, 2006, MOL IMAGING, V5, P510, DOI 10.2310/7290.2006.00029; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Mocanu JD, 2007, MOL THER, V15, P921, DOI 10.1038/mt.sj.6300119; Pereboeva L, 2004, VIRUS RES, V105, P35, DOI 10.1016/j.virusres.2004.04.012; Saban SD, 2005, J MOL BIOL, V349, P526, DOI 10.1016/j.jmb.2005.04.034; SHENK T, 1996, ADENOVIRIDAE VIRUSES, P2111; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takayama K, 2003, VIROLOGY, V309, P282, DOI 10.1016/S0042-6822(03)00067-9; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Tang YZ, 2008, VIROLOGY, V377, P391, DOI 10.1016/j.virol.2008.04.023; Tsuruta Y, 2007, CLIN CANCER RES, V13, P2777, DOI 10.1158/1078-0432.CCR-06-2706; UGAI H, 2009, J MOL BIOL; Vellinga J, 2004, J VIROL, V78, P3470, DOI 10.1128/JVI.78.7.3470-3479.2004; Wadhwa PD, 2002, ANNU REV MED, V53, P437, DOI 10.1146/annurev.med.53.082901.104039; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Zhu ZB, 2004, VIROLOGY, V325, P116, DOI 10.1016/j.virol.2004.04.021	36	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8526	10.1371/journal.pone.0008526	http://dx.doi.org/10.1371/journal.pone.0008526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046872	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200010
J	Hemming, ML; Elias, JE; Gygi, SP; Selkoe, DJ				Hemming, Matthew L.; Elias, Joshua E.; Gygi, Steven P.; Selkoe, Dennis J.			Identification of beta-Secretase (BACE1) Substrates Using Quantitative Proteomics	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN-CONVERTING ENZYME; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; NERVOUS-SYSTEM; ECTODOMAIN PHOSPHORYLATION; TRANSMEMBRANE SEMAPHORIN; REGULATED CLEAVAGE; ASPARTYL PROTEASE; GROWTH	beta-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease with a lumenal active site that sheds the ectodomains of membrane proteins through juxtamembrane proteolysis. BACE1 has been studied principally for its role in Alzheimer's disease as the beta-secretase responsible for generating the amyloid-beta protein. Emerging evidence from mouse models has identified the importance of BACE1 in myelination and cognitive performance. However, the substrates that BACE1 processes to regulate these functions are unknown, and to date only a few beta-secretase substrates have been identified through candidate-based studies. Using an unbiased approach to substrate identification, we performed quantitative proteomic analysis of two human epithelial cell lines stably expressing BACE1 and identified 68 putative beta-secretase substrates, a number of which we validated in a cell culture system. The vast majority were of type I transmembrane topology, although one was type II and three were GPI-linked proteins. Intriguingly, a preponderance of these proteins are involved in contact-dependent intercellular communication or serve as receptors and have recognized roles in the nervous system and other organs. No consistent sequence motif predicting BACE1 cleavage was identified in substrates versus non-substrates. These findings expand our understanding of the proteins and cellular processes that BACE1 may regulate, and suggest possible mechanisms of toxicity arising from chronic BACE1 inhibition.	[Hemming, Matthew L.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Elias, Joshua E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hemming, ML (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu		Hemming, Mathew/0000-0003-4674-7778	National Institutes of Health [AG06173, AG12749, HG3456, GM67945]; Harvard-MIT Division of Health Sciences and Technology London Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006173, R01AG012749, R37AG006173, RF1AG006173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-MIT Division of Health Sciences and Technology London Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG06173, AG12749 (DJS), HG3456, GM67945 (SPG, JEE), and the Harvard-MIT Division of Health Sciences and Technology London Fellowship (MLH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chang MH, 2008, J MOL ENDOCRINOL, V41, P65, DOI 10.1677/JME-08-0051; Citron M, 2002, J NEUROSCI RES, V70, P373, DOI 10.1002/jnr.10393; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; El-Shewy HM, 2007, J BIOL CHEM, V282, P26150, DOI 10.1074/jbc.M703276200; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert E, 2006, BIOSCIENCE REP, V26, P7, DOI 10.1007/s10540-006-9002-3; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Ko JA, 2005, FEBS LETT, V579, P2236, DOI 10.1016/j.febslet.2005.03.022; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Natarajan R, 2004, MOL BIOL CELL, V15, P4798, DOI 10.1091/mbc.E04-05-0366; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Sauder JM, 2000, J MOL BIOL, V300, P241, DOI 10.1006/jmbi.2000.3860; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Starr T, 2007, TRAFFIC, V8, P1265, DOI 10.1111/j.1600-0854.2007.00607.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zaina S, 1998, J BIOL CHEM, V273, P28610, DOI 10.1074/jbc.273.44.28610	58	138	150	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8477	10.1371/journal.pone.0008477	http://dx.doi.org/10.1371/journal.pone.0008477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041192	gold, Green Published, Green Submitted			2022-12-27	WOS:000273105200012
J	Enzi, B; de Greck, M; Prosch, U; Tempelmann, C; Northoff, G				Enzi, Bjoern; de Greck, Moritz; Proesch, Ulrike; Tempelmann, Claus; Northoff, Georg			Is Our Self Nothing but Reward? Neuronal Overlap and Distinction between Reward and Personal Relevance and Its Relation to Human Personality	PLOS ONE			English	Article							NEURAL ACTIVITY; PHYSIOLOGICAL CONDITION; PREFRONTAL CORTEX; SOCIAL COGNITION; ANTERIOR INSULA; DEFAULT MODE; BRAIN; ACTIVATION; FMRI; EMOTION	Background: The attribution of personal relevance, i.e. relating internal and external stimuli to establish a sense of belonging, is a common phenomenon in daily life. Although previous research demonstrated a relationship between reward and personal relevance, their exact neuronal relationship including the impact of personality traits remains unclear. Methodology/Principal Findings: Using functional magnetic resonance imaging, we applied an experimental paradigm that allowed us to explore the neural response evoked by reward and the attribution of personal relevance separately. We observed different brain regions previously reported to be active during reward and personal relevance, including the bilateral caudate nucleus and the pregenual anterior cingulate cortex (PACC). Additional analysis revealed activations in the right and left insula specific for the attribution of personal relevance. Furthermore, our results demonstrate a negative correlation between signal changes in both the PACC and the left anterior insula during the attribution of low personal relevance and the personality dimension novelty seeking. Conclusion/Significance: While a set of subcortical and cortical regions including the PACC is commonly involved in reward and personal relevance, other regions like the bilateral anterior insula were recruited specifically during personal relevance. Based on our correlation between novelty seeking and signal changes in both regions during personal relevance, we assume that the neuronal response to personally relevant stimuli is dependent on the personality trait novelty seeking.	[Enzi, Bjoern; Northoff, Georg] Otto VonGuericke Univ Magdegurg, Dept Psychiat, D-39016 Magdeburg, Germany; [de Greck, Moritz] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Tempelmann, Claus] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39016 Magdeburg, Germany; [Proesch, Ulrike] Clin Psychosomat Med & Addict Disorders, Lubstorf, Germany; [Northoff, Georg] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	Otto von Guericke University; Peking University; Otto von Guericke University; University of Ottawa	Enzi, B (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Psychiat, D-39016 Magdeburg, Germany.	georg.northoff@rohcg.on.ca		Tempelmann, Claus/0000-0001-8570-4960; de Greck, Moritz/0000-0002-4937-1262	Salus Stiftung; Deutsche Forschungsgesellschaft (DFG) [304/4-1]; Sonderforschungsbereich 779 of the Deutsche Forschungsgesellschaft (SFB) [779-A6]; Hope of Depression Research Foundation (HDRF); Schweizer Nationalfonds zur Foerderung der wissenschaftlichen Forschung (FNSNF) [3100A0-100830]; Wissenschaftsrat der Allgemeinen Hospital Gesellschaft (AHG); European Union [STF-25]	Salus Stiftung; Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Sonderforschungsbereich 779 of the Deutsche Forschungsgesellschaft (SFB)(German Research Foundation (DFG)); Hope of Depression Research Foundation (HDRF); Schweizer Nationalfonds zur Foerderung der wissenschaftlichen Forschung (FNSNF)(Austrian Science Fund (FWF)); Wissenschaftsrat der Allgemeinen Hospital Gesellschaft (AHG); European Union(European Commission)	The study was supported by a Heisenberg grant from the Salus Stiftung, the Deutsche Forschungsgesellschaft (DFG, 304/4-1 to G.N.), the Sonderforschungsbereich 779 of the Deutsche Forschungsgesellschaft (SFB 779-A6 to G.N. and B.E.), the Hope of Depression Research Foundation (HDRF, to G.N), the Schweizer Nationalfonds zur Foerderung der wissenschaftlichen Forschung (FNSNF 3100A0-100830, to G.N.), the Wissenschaftsrat der Allgemeinen Hospital Gesellschaft (AHG Wissenschaftsrat, to U. P) and a fellowship grant of the European Union (STF-25, to M. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bermpohl F, 2008, PSYCHIAT RES-NEUROIM, V164, P81, DOI 10.1016/j.pscychresns.2007.12.019; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Cloninger C. R., 1999, TEMPERAMENT UND CHAR; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; de Greck M, 2008, NEUROIMAGE, V39, P2066, DOI 10.1016/j.neuroimage.2007.11.006; de Greck M, 2009, HUM BRAIN MAPP, V30, P1691, DOI 10.1002/hbm.20634; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gallinat J, 2007, NEUROIMAGE, V34, P671, DOI 10.1016/j.neuroimage.2006.10.004; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Goodwin GM, 1997, BRIT J PSYCHIAT, V170, P426, DOI 10.1192/bjp.170.5.426; Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006; Hautzinger M., 1995, BECK DEPRESSIONS INV; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; MONTAGUE P, 2006, ANN REV NEUROSCI, V29; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2008, TRENDS COGN SCI, V12, P259, DOI 10.1016/j.tics.2008.04.007; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2009, HUM BRAIN MAPP, V30, P369, DOI 10.1002/hbm.20510; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Oatley K., 1996, UNDERSTANDING EMOTIO; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Pollard D, 2007, AM BOOK REV, V28, P18, DOI 10.1353/abr.2007.0103; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; STRAKOWSKI SM, 1993, PSYCHIAT RES, V48, P1, DOI 10.1016/0165-1781(93)90107-R; Sugiura M, 2000, NEUROIMAGE, V11, P541, DOI 10.1006/nimg.2000.0564; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; WITTMANN B, 2008, NEURON, V58	77	95	97	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8429	10.1371/journal.pone.0008429	http://dx.doi.org/10.1371/journal.pone.0008429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	537HN	20041155	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000004
J	Nakamura, K; Radhakrishnan, K; Wong, YM; Rockson, SG				Nakamura, Kenta; Radhakrishnan, Kavita; Wong, Yat Man; Rockson, Stanley G.			Anti-Inflammatory Pharmacotherapy with Ketoprofen Ameliorates Experimental Lymphatic Vascular Insufficiency in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-C; NECROSIS-FACTOR-ALPHA; STNF-RI; LYMPHANGIOGENESIS; EXPRESSION; TNF; THERAPY; CELLS; ANGIOGENESIS; MACROPHAGES	Background: Disruption of the lymphatic vasculature causes edema, inflammation, and end-tissue destruction. To assess the therapeutic efficacy of systemic anti-inflammatory therapy in this disease, we examined the impact of a nonsteroidal anti-inflammatory drug (NSAID), ketoprofen, and of a soluble TNF-alpha receptor (sTNF-R1) upon tumor necrosis factor (TNF)-alpha activity in a mouse model of acquired lymphedema. Methods and Findings: Lymphedema was induced by microsurgical ablation of major lymphatic conduits in the murine tail. Untreated control mice with lymphedema developed significant edema and extensive histopathological inflammation compared to sham surgical controls. Short-term ketoprofen treatment reduced tail edema and normalized the histopathology while paradoxically increasing TNF-alpha gene expression and cytokine levels. Conversely, sTNF-R1 treatment increased tail volume, exacerbated the histopathology, and decreased TNF-alpha gene expression. Expression of vascular endothelial growth factor-C (VEGF-C), which stimulates lymphangiogenesis, closely correlated with TNF-alpha expression. Conclusions: Ketoprofen therapy reduces experimental post-surgical lymphedema, yet direct TNF-alpha inhibition does not. Reducing inflammation while preserving TNF-alpha activity appears to optimize the repair response. It is possible that the observed favorable responses, at least in part, are mediated through enhanced VEGF-C signaling.	[Nakamura, Kenta; Radhakrishnan, Kavita; Wong, Yat Man; Rockson, Stanley G.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Nakamura, K (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	srockson@cvmed.stanford.edu		rockson, stanley/0000-0003-1253-474X	Susan G. Komen Breast Cancer Foundation; Western States Affiliate of the American Heart Association; Society of Vascular Medicine	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Western States Affiliate of the American Heart Association(American Heart Association); Society of Vascular Medicine	This study was supported by the Susan G. Komen Breast Cancer Foundation (to SGR) and the Western States Affiliate of the American Heart Association (to KN). Portions of this work were awarded the Jay D. Coffman Young Investigator Award by the Society of Vascular Medicine in May 2008 (to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton EL, 1996, DATAMATION, V42, P48; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Bush KA, 2002, SCAND J RHEUMATOL, V31, P198, DOI 10.1080/030097402320318378; Cha HS, 2007, J RHEUMATOL, V34, P16; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Cheung L, 2006, BIODRUGS, V20, P363, DOI 10.2165/00063030-200620060-00007; Edwards CK, 1999, ANN RHEUM DIS, V58, P73; Ghezzi P, 1998, J PHARMACOL EXP THER, V287, P969; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hub E, 1998, AM J PATHOL, V152, P749; Jin Da Pan, 2009, Lymphatic Research and Biology, V7, P47, DOI 10.1089/lrb.2009.0002; Jorres A, 1997, CYTOKINE, V9, P119, DOI 10.1006/cyto.1996.0145; Kunkel S L, 1988, Methods Achiev Exp Pathol, V13, P240; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Meyer AM, 2006, DIGEST DIS SCI, V51, P168, DOI 10.1007/s10620-006-3103-5; Mouta Carla, 2003, Lymphat Res Biol, V1, P201, DOI 10.1089/153968503768330247; Nakamura K, 2008, INT J CARDIOL; NAKAMURA K, 2008, LYMPHAT RES IN PRESS; Nakaniura K, 2007, MOL DIAGN THER, V11, P227, DOI 10.1007/BF03256244; OLSZEWSKI WL, 1990, LYMPHOLOGY, V23, P23; Paavonen K, 2002, J RHEUMATOL, V29, P39; Pan Da, 2006, Lymphatic Research and Biology, V4, P211, DOI 10.1089/lrb.2006.4405; Pan Da, 2006, Lymphatic Research and Biology, V4, P153, DOI 10.1089/lrb.2006.4.153; RENZ H, 1988, J IMMUNOL, V141, P2388; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Rockson SG, 2008, J AM COLL CARDIOL, V52, P799, DOI 10.1016/j.jacc.2008.06.005; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Sanders JE, 1999, COMPUT METH PROG BIO, V59, P167, DOI 10.1016/S0169-2607(99)00003-6; SANTUCCI L, 1994, GUT, V35, P909, DOI 10.1136/gut.35.7.909; Scavelli C, 2004, J ANAT, V204, P433, DOI 10.1111/j.0021-8782.2004.00293.x; Schneider M, 2006, PLOS MED, V3, P970, DOI 10.1371/journal.pmed.0030264; SIRONI M, 1992, INT J IMMUNOPHARMACO, V14, P1045, DOI 10.1016/0192-0561(92)90149-F; Sitzia J, 1995, Eur J Cancer Care (Engl), V4, P11; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; TANNENBAUM CS, 1989, J IMMUNOL, V142, P1274; TSUBOI I, 1995, CYTOKINE, V7, P372, DOI 10.1006/cyto.1995.0047; Ulfgren AK, 2000, ARTHRITIS RHEUM, V43, P2391, DOI 10.1002/1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F; Wauke K, 2002, J RHEUMATOL, V29, P34; Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830	45	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8380	10.1371/journal.pone.0008380	http://dx.doi.org/10.1371/journal.pone.0008380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027220	Green Published, Green Submitted, gold			2022-12-27	WOS:000272940100016
J	Verner-Jeffreys, DW; Welch, TJ; Schwarz, T; Pond, MJ; Woodward, MJ; Haig, SJ; Rimmer, GSE; Roberts, E; Morrison, V; Baker-Austin, C				Verner-Jeffreys, David W.; Welch, Timothy J.; Schwarz, Tamar; Pond, Michelle J.; Woodward, Martin J.; Haig, Sarah J.; Rimmer, Georgina S. E.; Roberts, Edward; Morrison, Victoria; Baker-Austin, Craig			High Prevalence of Multidrug-Tolerant Bacteria and Associated Antimicrobial Resistance Genes Isolated from Ornamental Fish and Their Carriage Water	PLOS ONE			English	Article							QUINOLONE RESISTANCE; AEROMONAS-SALMONICIDA; ANTIBIOTIC-RESISTANCE; DRUG-RESISTANCE; INTEGRONS; ENVIRONMENT; AQUACULTURE; PLASMIDS; IDENTIFICATION; DETERMINANTS	Background: Antimicrobials are used to directly control bacterial infections in pet (ornamental) fish and are routinely added to the water these fish are shipped in to suppress the growth of potential pathogens during transport. Methodology/Principal Findings: To assess the potential effects of this sustained selection pressure, 127 Aeromonas spp. isolated from warm and cold water ornamental fish species were screened for tolerance to 34 antimicrobials. Representative isolates were also examined for the presence of 54 resistance genes by a combination of miniaturized microarray and conventional PCR. Forty-seven of 94 Aeromonas spp. isolates recovered from tropical ornamental fish and their carriage water were tolerant to >= 15 antibiotics, representing seven or more different classes of antimicrobial. The quinolone and fluoroquinolone resistance gene, qnrS2, was detected at high frequency (37% tested recent isolates were positive by PCR). Class 1 integrons, IncA/C broad host range plasmids and a range of other antibiotic resistance genes, including floR, blaTEM21, tet(A), tet(D), tet(E), qacE2, sul1, and a number of different dihydrofolate reductase and aminoglycoside transferase coding genes were also detected in carriage water samples and bacterial isolates. Conclusions: These data suggest that ornamental fish and their carriage water act as a reservoir for both multi-resistant bacteria and resistance genes.	[Verner-Jeffreys, David W.; Schwarz, Tamar; Pond, Michelle J.; Haig, Sarah J.; Rimmer, Georgina S. E.; Roberts, Edward; Baker-Austin, Craig] Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England; [Welch, Timothy J.] ARS, USDA, Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV USA; [Schwarz, Tamar; Haig, Sarah J.] Univ Glasgow, Div Infect & Immun, Glasgow, Lanark, Scotland; [Woodward, Martin J.; Morrison, Victoria] Vet Labs Agcy, Addlestone, Surrey, England	Centre for Environment Fisheries & Aquaculture Science; United States Department of Agriculture (USDA); University of Glasgow; Veterinary Laboratories Agency	Verner-Jeffreys, DW (corresponding author), Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England.	david.verner-jeffreys@cefas.co.uk	Woodward, Martin J/E-8955-2010; Haig, Sarah/H-5986-2019	Haig, Sarah/0000-0002-0004-8894; Welch, Tim/0000-0003-1096-3006	UK government's Department for Environment Food and Rural Affairs [FC1178, FB001, FC1172]	UK government's Department for Environment Food and Rural Affairs	This study was funded by The UK government's Department for Environment Food and Rural Affairs through projects FC1178, FB001 and a sandwich placement studentship for T.S. (Project FC1172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Chang YC, 2007, DIAGN MICR INFEC DIS, V59, P191, DOI 10.1016/j.diagmicrobio.2007.04.007; *CLIN LAB STAND I, 2004, M49P CLSI; COLE B, 1999, PUBLICATION CTR TROP, V131; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DIXON B A, 1990, Journal of Aquatic Animal Health, V2, P295, DOI 10.1577/1548-8667(1990)002&lt;0295:AROASI&gt;2.3.CO;2; Dixon Beverly A., 1993, Journal of the World Aquaculture Society, V24, P102, DOI 10.1111/j.1749-7345.1993.tb00155.x; Egorova S, 2008, EMERG INFECT DIS, V14, P954, DOI 10.3201/eid1406.071168; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Furushita M, 2003, APPL ENVIRON MICROB, V69, P5336, DOI 10.1128/AEM.69.9.5336-5342.2003; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Gillings MR, 2008, FEMS MICROBIOL LETT, V287, P56, DOI 10.1111/j.1574-6968.2008.01291.x; Giraud E, 2004, J MED MICROBIOL, V53, P895, DOI 10.1099/jmm.0.45579-0; Goni-Urriza M, 2002, ANTIMICROB AGENTS CH, V46, P350, DOI 10.1128/AAC.46.2.350-359.2002; Hall RM, 1999, ANN NY ACAD SCI, V870, P68, DOI 10.1111/j.1749-6632.1999.tb08866.x; Izumi S, 2004, APPL ENVIRON MICROB, V70, P3968, DOI 10.1128/AEM.70.7.3968-3972.2004; Jacobs L, 2007, INT J FOOD MICROBIOL, V114, P295, DOI 10.1016/j.ijfoodmicro.2006.09.030; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Moura A, 2007, J ANTIMICROB CHEMOTH, V60, P1243, DOI 10.1093/jac/dkm340; Musto J, 2006, COMMUN DIS INTELL, V30, P222; O'Brien TF, 2002, CLIN INFECT DIS, V34, pS78, DOI 10.1086/340244; Pan JC, 2008, ANTIMICROB AGENTS CH, V52, P3829, DOI 10.1128/AAC.00375-08; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rosser SJ, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.1.11; Rossolini GM, 1996, MICROB DRUG RESIST, V2, P245, DOI 10.1089/mdr.1996.2.245; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Schmidt AS, 2001, APPL ENVIRON MICROB, V67, P5675, DOI 10.1128/AEM.67.12.5675-5682.2001; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Smith P, 2008, EMERG INFECT DIS, V14, P1327, DOI 10.3201/eid1408.080329; Sorum H, 2003, ANTIMICROB AGENTS CH, V47, P1285, DOI 10.1128/AAC.47.4.1285-1290.2003; TRUST TJ, 1976, ANTIMICROB AGENTS CH, V10, P598, DOI 10.1128/AAC.10.4.598; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welch TJ, 2009, ANTIMICROB AGENTS CH, V53, P845, DOI 10.1128/AAC.01312-08; Whittington RJ, 2007, PREV VET MED, V81, P92, DOI 10.1016/j.prevetmed.2007.04.007; 1999, REPORT MICROBIAL RES	42	90	98	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8388	10.1371/journal.pone.0008388	http://dx.doi.org/10.1371/journal.pone.0008388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027306	Green Published, Green Submitted, gold			2022-12-27	WOS:000272940100021
J	Volkmann, G; Liu, XQ				Volkmann, Gerrit; Liu, Xiang-Qin			Protein C-Terminal Labeling and Biotinylation Using Synthetic Peptide and Split-Intein	PLOS ONE			English	Article							CELL-SURFACE PROTEINS; LIVE CELLS; TRANSFERRIN RECEPTOR; MEMBRANE-PROTEINS; SMALL MOLECULES; DNAB INTEIN; IN-VIVO; LIGATION; PCC6803; TAG	Background: Site-specific protein labeling or modification can facilitate the characterization of proteins with respect to their structure, folding, and interaction with other proteins. However, current methods of site-specific protein labeling are few and with limitations, therefore new methods are needed to satisfy the increasing need and sophistications of protein labeling. Methodology: A method of protein C-terminal labeling was developed using a non-canonical split-intein, through an intein-catalyzed trans-splicing reaction between a protein and a small synthetic peptide carrying the desired labeling groups. As demonstrations of this method, three different proteins were efficiently labeled at their C-termini with two different labels (fluorescein and biotin) either in solution or on a solid surface, and a transferrin receptor protein was labeled on the membrane surface of live mammalian cells. Protein biotinylation and immobilization on a streptavidin-coated surface were also achieved in a cell lysate without prior purification of the target protein. Conclusions: We have produced a method of site-specific labeling or modification at the C-termini of recombinant proteins. This method compares favorably with previous protein labeling methods and has several unique advantages. It is expected to have many potential applications in protein engineering and research, which include fluorescent labeling for monitoring protein folding, location, and trafficking in cells, and biotinylation for protein immobilization on streptavidin-coated surfaces including protein microchips. The types of chemical labeling may be limited only by the ability of chemical synthesis to produce the small C-intein peptide containing the desired chemical groups.	[Volkmann, Gerrit; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University	Volkmann, G (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	paul.liu@dal.ca			National Science and Engineering Research Council (NSERC) of Canada	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the National Science and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Appleby JH, 2009, J BIOL CHEM, V284, P6194, DOI 10.1074/jbc.M805474200; Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; EVANS TC, 1998, SEMISYNTHESIS CYTOTO, V7, P2256; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; Gong HS, 2008, BBA-PROTEINS PROTEOM, V1784, P1835, DOI 10.1016/j.bbapap.2008.07.017; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; Guy J, 2007, J AM CHEM SOC, V129, P11969, DOI 10.1021/ja0738125; Kalia J, 2006, CHEMBIOCHEM, V7, P1375, DOI 10.1002/cbic.200600150; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kurpiers T, 2008, CHEMBIOCHEM, V9, P2317, DOI 10.1002/cbic.200800319; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Kwon Y, 2006, ANGEW CHEM INT EDIT, V45, P1726, DOI 10.1002/anie.200503475; Lesaicherre ML, 2002, J AM CHEM SOC, V124, P8768, DOI 10.1021/ja0265963; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Ludwig C, 2008, J BIOL CHEM, V283, P25264, DOI 10.1074/jbc.M802972200; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Lue RYP, 2004, J AM CHEM SOC, V126, P1055, DOI 10.1021/ja037914g; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; McCann CM, 2005, BIOTECHNIQUES, V38, P945, DOI 10.2144/05386IT02; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Wood RJ, 2004, BIOCONJUGATE CHEM, V15, P366, DOI 10.1021/bc0341728; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Yin J, 2004, J AM CHEM SOC, V126, P7754, DOI 10.1021/ja047749k	40	30	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8381	10.1371/journal.pone.0008381	http://dx.doi.org/10.1371/journal.pone.0008381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027230	Green Submitted, Green Published, gold			2022-12-27	WOS:000272940100017
J	Andrews, G; Kemp, A; Sunderland, M; Von Korff, M; Ustun, TB				Andrews, Gavin; Kemp, Alice; Sunderland, Matthew; Von Korff, Michael; Ustun, Tevik Bedirhan			Normative Data for the 12 Item WHO Disability Assessment Schedule 2.0	PLOS ONE			English	Article							HEALTH	Background: The World Health Organization Disability Assessment Schedule (WHODAS 2.0) measures disability due to health conditions including diseases, illnesses, injuries, mental or emotional problems, and problems with alcohol or drugs. Method: The 12 Item WHODAS 2.0 was used in the second Australian Survey of Mental Health and Well-being. We report the overall factor structure and the distribution of scores and normative data (means and SDs) for people with any physical disorder, any mental disorder and for people with neither. Findings: A single second order factor justifies the use of the scale as a measure of global disability. People with mental disorders had high scores (mean 6.3, SD 7.1), people with physical disorders had lower scores (mean 4.3, SD 6.1). People with no disorder covered by the survey had low scores (mean 1.4, SD 3.6). Interpretation: The provision of normative data from a population sample of adults will facilitate use of the WHODAS 2.0 12 item scale in clinical and epidemiological research.	[Andrews, Gavin; Kemp, Alice; Sunderland, Matthew] UNSW, Clin Res Unit Anxiety & Depress, Sch Psychiat, St Vincents Hosp, Sydney, NSW, Australia; [Von Korff, Michael] Grp Hlth Cooperat Puget Sound, Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [Ustun, Tevik Bedirhan] WHO, Classificat Terminol & Stand, CH-1211 Geneva, Switzerland	St Vincents Hospital Sydney; University of New South Wales Sydney; Group Health Cooperative; World Health Organization	Andrews, G (corresponding author), UNSW, Clin Res Unit Anxiety & Depress, Sch Psychiat, St Vincents Hosp, Sydney, NSW, Australia.	gavina@unsw.edu.au	Sunderland, Matthew/AAF-3035-2021; Andrews, Gavin/J-6537-2012	Sunderland, Matthew/0000-0001-8452-364X; Andrews, Gavin/0000-0002-4315-2173; VonKorff, Michael/0000-0001-5386-8477	Australian National Health and Medical Research Council [510137]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Australian National Health and Medical Research Council (Project Grant No. 510137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ferrie JE, 2005, OCCUP ENVIRON MED, V62, P74, DOI 10.1136/oem.2004.013896; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Rehm J., 1999, INT J METH PSYCH RES, V8, P110, DOI DOI 10.1002/MPR.61; REVICKI DA, 1994, MED CARE, V32, P401, DOI 10.1097/00005650-199404000-00008; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; Stewart WF, 1999, PAIN, V79, P291, DOI 10.1016/S0304-3959(98)00181-X; Tabachnick B. G., 2001, USING MULTIVARIATE S; [No title captured]	10	273	274	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8343	10.1371/journal.pone.0008343	http://dx.doi.org/10.1371/journal.pone.0008343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533OR	20020047	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834200010
J	Girvetz, EH; Zganjar, C; Raber, GT; Maurer, EP; Kareiva, P; Lawler, JJ				Girvetz, Evan H.; Zganjar, Chris; Raber, George T.; Maurer, Edwin P.; Kareiva, Peter; Lawler, Joshua J.			Applied Climate-Change Analysis: The Climate Wizard Tool	PLOS ONE			English	Article							FOOD SECURITY; WINTER CHILL; PRECIPITATION; TEMPERATURE; IMPACTS; MODEL; VARIABILITY; SNOWPACK; FRUIT	Background: Although the message of "global climate change'' is catalyzing international action, it is local and regional changes that directly affect people and ecosystems and are of immediate concern to scientists, managers, and policy makers. A major barrier preventing informed climate-change adaptation planning is the difficulty accessing, analyzing, and interpreting climate-change information. To address this problem, we developed a powerful, yet easy to use, web-based tool called Climate Wizard (http://ClimateWizard.org) that provides non-climate specialists with simple analyses and innovative graphical depictions for conveying how climate has and is projected to change within specific geographic areas throughout the world. Methodology/Principal Findings: To demonstrate the Climate Wizard, we explored historic trends and future departures (anomalies) in temperature and precipitation globally, and within specific latitudinal zones and countries. We found the greatest temperature increases during 1951-2002 occurred in northern hemisphere countries (especially during January-April), but the latitude of greatest temperature change varied throughout the year, sinusoidally ranging from approximately 50 degrees N during February-March to 10 degrees N during August-September. Precipitation decreases occurred most commonly in countries between 0-20 degrees N, and increases mostly occurred outside of this latitudinal region. Similarly, a quantile ensemble analysis based on projections from 16 General Circulation Models (GCMs) for 2070-2099 identified the median projected change within countries, which showed both latitudinal and regional patterns in projected temperature and precipitation change. Conclusions/Significance: The results of these analyses are consistent with those reported by the Intergovernmental Panel on Climate Change, but at the same time, they provide examples of how Climate Wizard can be used to explore regionally- and temporally-specific analyses of climate change. Moreover, Climate Wizard is not a static product, but rather a data analysis framework designed to be used for climate change impact and adaption planning, which can be expanded to include other information, such as downscaled future projections of hydrology, soil moisture, wildfire, vegetation, marine conditions, disease, and agricultural productivity.	[Girvetz, Evan H.; Lawler, Joshua J.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA; [Girvetz, Evan H.; Zganjar, Chris] Nature Conservancy, Global Climate Change Program, Arlington, VA USA; [Raber, George T.] Univ So Mississippi, Dept Geog & Geol, Hattiesburg, MS 39406 USA; [Maurer, Edwin P.] Santa Clara Univ, Dept Civil Engn, Santa Clara, CA 95053 USA; [Kareiva, Peter] Nature Conservancy, Worldwide Off, Seattle, WA USA	University of Washington; University of Washington Seattle; Nature Conservancy; University of Southern Mississippi; Santa Clara University; Nature Conservancy	Girvetz, EH (corresponding author), Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA.	girvetz@u.washington.edu	Maurer, Edwin P/C-7190-2009; Girvetz, Evan/B-3533-2010	Maurer, Edwin P/0000-0001-7134-487X; 	Nature Conservancy Climate Change Program	Nature Conservancy Climate Change Program	E. Girvetz was supported by a generous donation to The Nature Conservancy. G. Raber and C. Zganjar were supported by The Nature Conservancy Climate Change Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002499; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bachelet D, 2001, ECOSYSTEMS, V4, P164, DOI 10.1007/s10021-001-0002-7; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Bissonette JA, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P3; Brekke LD, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006941; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Climate Change Science Program CCSP, 2008, PREL REV AD OPT CLIM; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Daly C, 2000, ECOL APPL, V10, P449, DOI 10.1890/1051-0761(2000)010[0449:DSOTGI]2.0.CO;2; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Fried JS, 2008, CLIMATIC CHANGE, V87, pS251, DOI 10.1007/s10584-007-9360-2; Giorgi F, 2005, CLIMATIC CHANGE, V73, P239, DOI 10.1007/a10584-005-6857-4; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Hamlet AF, 2005, J HYDROMETEOROL, V6, P330, DOI 10.1175/JHM420.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Manabe S, 2004, HYDROLOG SCI J, V49, P625, DOI 10.1623/hysj.49.4.625.54429; Maurer EP, 2009, HYDROL EARTH SYST SC, V13, P183, DOI 10.5194/hess-13-183-2009; Maurer E. P., 2007, EOS T AM GEOPHYS UN, V88, P504, DOI DOI 10.1029/2007EO470006; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MITCHELL TD, 2004, COMPR SET HIGH RES G; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Parry ML, 2007, CLIMATE CHANGE 2007; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; PIERCE D, 2006, NCDF INTERFACE UNIDA; Pierce DW, 2009, P NATL ACAD SCI USA, V106, P8441, DOI 10.1073/pnas.0900094106; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Poulter B, 2008, INT J GEOGR INF SCI, V22, P167, DOI 10.1080/13658810701371858; R Core Team, 2021, R LANGUAGE ENV STAT; Randall DA., 2007, CLIMATE CHANGE 2007; Reading CJ, 1998, OECOLOGIA, V117, P469, DOI 10.1007/s004420050682; REICHLER T, 2008, J GEOPHYS RES ATMOSP, V113; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tebaldi C, 2005, J CLIMATE, V18, P1524, DOI 10.1175/JCLI3363.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WHITE D, 2009, MAPTREE MAPPING PRUN; WIGLEY TML, 2006, REPORT CLIMATE CHANG; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e	54	114	119	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8320	10.1371/journal.pone.0008320	http://dx.doi.org/10.1371/journal.pone.0008320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016827	Green Published, gold			2022-12-27	WOS:000272833800015
J	Hawn, TR; Scholes, D; Wang, HW; Li, SS; Stapleton, AE; Janer, M; Aderem, A; Stamm, WE; Zhao, LP; Hooton, TM				Hawn, Thomas R.; Scholes, Delia; Wang, Hongwei; Li, Sue S.; Stapleton, Ann E.; Janer, Marta; Aderem, Alan; Stamm, Walter E.; Zhao, Lue Ping; Hooton, Thomas M.			Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women	PLOS ONE			English	Article							P-BLOOD-GROUP; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; RISK-FACTORS; ARG753GLN POLYMORPHISM; RECEPTOR POLYMORPHISMS; LEGIONNAIRES-DISEASE; SEXUAL-ACTIVITY; CUTTING EDGE; YOUNG-WOMEN	Background: Although several studies suggest that genetic factors are associated with human UTI susceptibility, the role of DNA variation in regulating early in vivo urine inflammatory responses has not been fully examined. We examined whether candidate gene polymorphisms were associated with altered urine inflammatory profiles in asymptomatic women with or without bacteriuria. Methodology: We conducted a cross-sectional analysis of asymptomatic bacteriuria (ASB) in 1,261 asymptomatic women ages 18-49 years originally enrolled as participants in a population-based case-control study of recurrent UTI and pyelonephritis. We genotyped polymorphisms in CXCR1, CXCR2, TLR1, TLR2, TLR4, TLR5, and TIRAP in women with and without ASB. We collected urine samples and measured levels of uropathogenic bacteria, neutrophils, and chemokines. Principal Findings: Polymorphism TLR2_G2258A, a variant associated with decreased lipopeptide-induced signaling, was associated with increased ASB risk (odds ratio 3.44, 95% CI; 1.65-7.17). Three CXCR1 polymorphisms were associated with ASB caused by gram-positive organisms. ASB was associated with urinary CXCL-8 levels, but not CXCL-5, CXCL-6, or sICAM-1 (P <= 0.0001). Urinary levels of CXCL-8 and CXCL-6, but not ICAM-1, were associated with higher neutrophil levels (P <= 0.0001). In addition, polymorphism CXCR1_G827C was associated with increased CXCL-8 levels in women with ASB (P=0.004). Conclusions: TLR2 and CXCR1 polymorphisms were associated with ASB and a CXCR1 variant was associated with urine CXCL-8 levels. These results suggest that genetic factors are associated with early in vivo human bladder immune responses prior to the development of symptomatic UTIs.	[Hawn, Thomas R.; Stapleton, Ann E.; Stamm, Walter E.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Scholes, Delia] Univ Washington, Grp Hlth Ctr Hlth Studies, Seattle, WA 98195 USA; [Scholes, Delia] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wang, Hongwei; Li, Sue S.; Zhao, Lue Ping] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Janer, Marta; Aderem, Alan] Inst Syst Biol, Seattle, WA USA; [Hooton, Thomas M.] Univ Miami, Dept Med, Miami, FL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Institute for Systems Biology (ISB); University of Miami	Hawn, TR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	thawn@u.washington.edu	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [2 PO1 DK53369-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053369, R01DK062863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases ( NIDDK) grant #2 PO1 DK53369-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Bengtsson C, 1998, SCAND J UROL NEPHROL, V32, P284; Benson M, 1996, J INFECT DIS, V174, P1080, DOI 10.1093/infdis/174.5.1080; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; GAYMANS R, 1976, LANCET, V2, P674; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; HEDGES S, 1992, J INFECT DIS, V166, P653, DOI 10.1093/infdis/166.3.653; HOOTEN TM, 1994, CLIN INFECT DIS, V19, P274, DOI 10.1093/clinids/19.2.274; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; Hopkins WJ, 1999, AM J MED GENET, V83, P422, DOI 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1; Ishitoya S, 2002, BJU INT, V89, P851, DOI 10.1046/j.1464-410X.2002.02782.x; JACOBSON SH, 1994, NEPHRON, V67, P172, DOI 10.1159/000187923; Jantausch BA, 2000, PEDIATR NEPHROL, V15, P236, DOI 10.1007/s004670000456; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; Kassir K, 2001, CLIN DIAGN LAB IMMUN, V8, P1060, DOI 10.1128/CDLI.8.6.1060-1063.2001; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7; KO YC, 1993, INFECT IMMUN, V61, P1307, DOI 10.1128/IAI.61.4.1307-1314.1993; KUNIN CM, 1970, NEW ENGL J MED, V282, P1443, DOI 10.1056/NEJM197006252822601; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Marple CD, 1941, ANN INTERN MED, V14, P2220, DOI 10.7326/0003-4819-14-12-2220; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647, DOI 10.1016/S0891-5520(05)70378-0; NORDEN CW, 1968, ANNU REV MED, V19, P431, DOI 10.1146/annurev.me.19.020168.002243; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Olszyna DP, 2001, J INFECT DIS, V184, P301, DOI 10.1086/322030; Olszyna DP, 2000, J INFECT DIS, V182, P1731, DOI 10.1086/317603; Otto G, 2005, KIDNEY INT, V68, P62, DOI 10.1111/j.1523-1755.2005.00381.x; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Storm Niels, 2003, Methods Mol Biol, V212, P241; STROM BL, 1987, ANN INTERN MED, V107, P816, DOI 10.7326/0003-4819-107-6-816; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Tabel Y, 2007, INT J IMMUNOGENET, V34, P399, DOI 10.1111/j.1744-313X.2007.00709.x; TOMISAWA S, 1989, SCAND J INFECT DIS, V21, P403, DOI 10.3109/00365548909167444; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	69	42	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8300	10.1371/journal.pone.0008300	http://dx.doi.org/10.1371/journal.pone.0008300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016852	gold, Green Submitted, Green Published			2022-12-27	WOS:000272833800005
J	Hedges, D; Burges, D; Powell, E; Almonte, C; Huang, J; Young, S; Boese, B; Schmidt, M; Pericak-Vance, MA; Martin, E; Zhang, X; Harkins, TT; Zuchner, S				Hedges, Dale; Burges, Dan; Powell, Eric; Almonte, Cherylyn; Huang, Jia; Young, Stuart; Boese, Benjamin; Schmidt, Mike; Pericak-Vance, Margaret A.; Martin, Eden; Zhang, Xinmin; Harkins, Timothy T.; Zuechner, Stephan			Exome Sequencing of a Multigenerational Human Pedigree	PLOS ONE			English	Article							GENOMIC SELECTION; HYBRID SELECTION; CAPTURE; EXONS; GENE	Over the next few years, the efficient use of next-generation sequencing (NGS) in human genetics research will depend heavily upon the effective mechanisms for the selective enrichment of genomic regions of interest. Recently, comprehensive exome capture arrays have become available for targeting approximately 33 Mb or similar to 180,000 coding exons across the human genome. Selective genomic enrichment of the human exome offers an attractive option for new experimental designs aiming to quickly identify potential disease-associated genetic variants, especially in family-based studies. We have evaluated a 2.1 M feature human exome capture array on eight individuals from a three-generation family pedigree. We were able to cover up to 98% of the targeted bases at a long-read sequence read depth of >= 3, 86% at a read depth of >= 10, and over 50% of all targets were covered with >= 20 reads. We identified up to 14,284 SNPs and small indels per individual exome, with up to 1,679 of these representing putative novel polymorphisms. Applying the conservative genotype calling approach HCDiff, the average rate of detection of a variant allele based on Illumina 1 M BeadChips genotypes was 95.2% at >= 10x sequence. Further, we propose an advantageous genotype calling strategy for low covered targets that empirically determines cut-off thresholds at a given coverage depth based on existing genotype data. Application of this method was able to detect >99% of SNPs covered >= 8x. Our results offer guidance for "real-world'' applications in human genetics and provide further evidence that microarray-based exome capture is an efficient and reliable method to enrich for chromosomal regions of interest in next-generation sequencing experiments.	[Hedges, Dale; Powell, Eric; Almonte, Cherylyn; Huang, Jia; Schmidt, Mike; Pericak-Vance, Margaret A.; Martin, Eden; Zuechner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Burges, Dan; Boese, Benjamin; Zhang, Xinmin; Harkins, Timothy T.] Roche Diagnost Corp Inc, Indianapolis, IN USA; [Young, Stuart] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA	University of Miami; Roche Holding; University of Miami	Hedges, D (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	szuchner@med.miami.edu			National Institute for Neurology and Stroke [NS065712, NS026630]; National Human Genome Research Institute [RC2HG005605]; Roche Inc; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, U54NS065712] Funding Source: NIH RePORTER	National Institute for Neurology and Stroke; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Roche Inc(Roche Holding); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the National Institute for Neurology and Stroke ( NS065712 to S. Z. and NS026630 to M. A. P-V), the National Human Genome Research Institute ( RC2HG005605 to E. M), and Roche Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hegde MR, 2008, HUM MUTAT, V29, P1091, DOI 10.1002/humu.20831; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Nachman MW, 2000, GENETICS, V156, P297; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Okou DT, 2009, ANN HUM GENET, V73, P502, DOI 10.1111/j.1469-1809.2009.00530.x; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SEXTON DP, 2007, 57 ANN M AM SOC HUM, pA2168; Taly V, 2007, CHEMBIOCHEM, V8, P263, DOI 10.1002/cbic.200600425; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	29	58	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8232	10.1371/journal.pone.0008232	http://dx.doi.org/10.1371/journal.pone.0008232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011588	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300014
J	Alexa, K; Choe, SK; Hirsch, N; Etheridge, L; Laver, E; Sagerstrom, CG				Alexa, Kristen; Choe, Seong-Kyu; Hirsch, Nicolas; Etheridge, Letitiah; Laver, Elizabeth; Sagerstroem, Charles G.			Maternal and Zygotic aldh1a2 Activity Is Required for Pancreas Development in Zebrafish	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; CENTRAL-NERVOUS-SYSTEM; VITAMIN-A-DEFICIENCY; ALDEHYDE DEHYDROGENASE; EMBRYONIC-DEVELOPMENT; MESODERMAL SIGNALS; ENDODERM FORMATION; ORGAN DEVELOPMENT; CAUDAL HINDBRAIN; XENOPUS EMBRYOS	We have isolated and characterized a novel zebrafish pancreas mutant. Mutant embryos lack expression of isl1 and sst in the endocrine pancreas, but retain isl1 expression in the CNS. Non-endocrine endodermal gene expression is less affected in the mutant, with varying degrees of residual expression observed for pdx1, carbA, hhex, prox1, sid4, transferrin and ifabp. In addition, mutant embryos display a swollen pericardium and lack fin buds. Genetic mapping revealed a mutation resulting in a glycine to arginine change in the catalytic domain of the aldh1a2 gene, which is required for the production of retinoic acid from vitamin A. Comparison of our mutant (aldh1a2(um22)) to neckless (aldh1a2(i26)), a previously identified aldh1a2 mutant, revealed similarities in residual endodermal gene expression. In contrast, treatment with DEAB (diethylamino-benzaldehyde), a competitive reversible inhibitor of Aldh enzymes, produces a more severe phenotype with complete loss of endodermal gene expression, indicating that a source of Aldh activity persists in both mutants. We find that mRNA from the aldh1a2(um22) mutant allele is inactive, indicating that it represents a null allele. Instead, the residual Aldh activity is likely due to maternal aldh1a2, since we find that translation-blocking, but not splice-blocking, aldh1a2 morpholinos produce a phenotype similar to DEAB treatment. We conclude that Aldh1a2 is the primary Aldh acting during pancreas development and that maternal Aldh1a2 activity persists in aldh1a2(um22) and aldh1a2(i26) mutant embryos.	[Alexa, Kristen; Choe, Seong-Kyu; Hirsch, Nicolas; Etheridge, Letitiah; Laver, Elizabeth; Sagerstroem, Charles G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Alexa, K (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	charles.sagerstrom@umassmed.edu			JDRF [1-2007-753]; NIDDK [5 P30 DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by JDRF grant 1-2007-753 (http://www.jdrf.org), as well as by DERC grant 5 P30 DK32520 from the NIDDK (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HL, 1996, J BIOL CHEM, V271, P9526, DOI 10.1074/jbc.271.16.9526; Ang HL, 1999, EUR J BIOCHEM, V260, P227, DOI 10.1046/j.1432-1327.1999.00139.x; Aoki TO, 2002, DEVELOPMENT, V129, P275; Begemann G, 2001, DEVELOPMENT, V128, P3081; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Blumberg B, 1997, DEVELOPMENT, V124, P373; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Chen YL, 2001, MECH DEVELOP, V101, P91, DOI 10.1016/S0925-4773(00)00558-X; Costaridis P, 1996, DEV DYNAM, V205, P41; David NB, 2001, DEVELOPMENT, V128, P3937; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dickman ED, 1997, DEVELOPMENT, V124, P3111; diIorio PJ, 2005, DEV BIOL, V282, P55, DOI 10.1016/j.ydbio.2005.02.036; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dupe V, 1999, DEVELOPMENT, V126, P5051; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Gale E, 1999, MECH DEVELOP, V89, P43, DOI 10.1016/S0925-4773(99)00202-6; Grandel H, 2002, DEVELOPMENT, V129, P2851; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkel MD, 2009, P NATL ACAD SCI USA, V106, P7864, DOI 10.1073/pnas.0813108106; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; Kopinke D, 2006, DEV DYNAM, V235, P2695, DOI 10.1002/dvdy.20905; KRAFT JC, 1994, BIOCHEM J, V301, P111, DOI 10.1042/bj3010111; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Malpel S, 2000, DEVELOPMENT, V127, P3057; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mic FA, 2002, DEVELOPMENT, V129, P2271; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Pittlik S, 2008, GENE EXPR PATTERNS, V8, P141, DOI 10.1016/j.gep.2007.11.003; PLATEROTI M, 1993, EXP CELL RES, V208, P137, DOI 10.1006/excr.1993.1231; Reiter JF, 2001, DEVELOPMENT, V128, P125; Roman BL, 2002, DEVELOPMENT, V129, P3009; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sagerstrom CG, 1996, DEVELOPMENT, V122, P1873; Sagerstrom GC, 2001, DEV DYNAM, V220, P402, DOI 10.1002/dvdy.1119; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Song JB, 2007, DEV BIOL, V303, P561, DOI 10.1016/j.ydbio.2006.11.040; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; van der Wees J, 1998, DEVELOPMENT, V125, P545; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wells JM, 2000, DEVELOPMENT, V127, P1563; White JC, 1998, P NATL ACAD SCI USA, V95, P13459, DOI 10.1073/pnas.95.23.13459; White JC, 2000, DEV BIOL, V220, P263, DOI 10.1006/dbio.2000.9635; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	68	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8261	10.1371/journal.pone.0008261	http://dx.doi.org/10.1371/journal.pone.0008261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011517	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830200008
J	Zhang, JY; Vankova, R; Malbeck, J; Dobrev, PI; Xu, YY; Chong, K; Neff, MM				Zhang, Jingyu; Vankova, Radomira; Malbeck, Jiri; Dobrev, Petre I.; Xu, Yunyuan; Chong, Kang; Neff, Michael M.			AtSOFL1 and AtSOFL2 Act Redundantly as Positive Modulators of the Endogenous Content of Specific Cytokinins in Arabidopsis	PLOS ONE			English	Article							TRANSGENIC TOBACCO PLANTS; OXIDASE/DEHYDROGENASE GENES; ISOPENTENYL TRANSFERASE; MERISTEM ACTIVITY; BIOSYNTHESIS; EXPRESSION; THALIANA; OXIDASE; MAIZE; IDENTIFICATION	Background: Although cytokinins have been known for decades to play important roles in the regulation of plant growth and development, our knowledge of the regulatory mechanism of endogenous content of specific cytokinins remains limited. Methodology/Principal Findings: Here, we characterized two SOB five-like (SOFL) genes, AtSOFL1 and AtSOFL2, in Arabidopsis (Arabidopsis thaliana) and showed that they acted redundantly in regulating specific cytokinin levels. Analysis of the translational fusion AtSOFL1: AtSOFL1-GUS and AtSOFL2: AtSOFL2-GUS indicated that AtSOFL1 and AtSOFL2 exhibited similar expression patterns. Both proteins were predominantly expressed in the vascular tissues of developing leaves, flowers and siliques, but barely detectable in roots and stems. Overexpression of either AtSOFL1 or AtSOFL2 led to increased cytokinin content and obvious corresponding mutant phenotypes for both transgenic seedlings and adult plants. In addition, overexpression and site-directed mutagenesis experiments demonstrated that the SOFL domains are necessary for AtSOFL2's overexpression phenotypes. Silencing or disrupting either AtSOFL1 or AtSOFL2 caused no obvious developmental defects. Endogenous cytokinin analysis, however, revealed that compared to the wild type control, the SOFL1-RNAi62 sofl2-1 double mutant accumulated lower levels of trans-zeatin riboside monophosphate (tZRMP) and N-6-(Delta(2)-isopentenyl) adenosine monophosphate (iPRMP), which are biosynthetic intermediates of bioactive cytokinins. The double mutant also displayed decreased response to exogenous cytokinin in both callus-formation and inhibition-of-hypocotyl-elongation assays. Conclusions/Significance: Taken together, our data suggest that in plants AtSOFL1 and AtSOFL2 work redundantly as positive modulators in the fine-tuning of specific cytokinin levels as well as responsiveness.	[Zhang, Jingyu; Xu, Yunyuan; Chong, Kang] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China; [Vankova, Radomira; Malbeck, Jiri; Dobrev, Petre I.] Inst Expt Bot, Lab Hormonal Regulat Plants, Prague, Czech Republic; [Neff, Michael M.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Washington State University	Zhang, JY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China.	mmneff@wsu.edu	Zhang, Jingyu/AAL-4934-2021; Dobrev, Petre I./H-2391-2014; Vanková, Radomíra/G-6808-2014; Malbeck, Jiří/F-7358-2014	Malbeck, Jiří/0000-0001-6796-2608	Monsanto Corporation - Washington University Biology Research Agreement [46011J]; United States National Science Foundation [0758411]; United States Department of Energy [DE-FG02-08ER15927]; Grant Agency of the Czech Republic [206/06/1306]	Monsanto Corporation - Washington University Biology Research Agreement; United States National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was initially supported by the Monsanto Corporation - Washington University Biology Research Agreement (grant number 46011J to Michael M. Neff). Work was also supported by the United States National Science Foundation (Division of Integrative Organismal Systems, Grant Number 0758411 to Michael M. Neff), the United States Department of Energy (Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, Grant Number DE-FG02-08ER15927 to Michael M. Neff) and the Grant Agency of the Czech Republic (grant number 206/06/1306 to Radomira Vankova). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYOSHI DE, 1984, P NATL ACAD SCI-BIOL, V81, P5994, DOI 10.1073/pnas.81.19.5994; Armstrong DJ, 1994, CYTOKININS CHEM ACTI, P139; Astot C, 2000, P NATL ACAD SCI USA, V97, P14778, DOI 10.1073/pnas.260504097; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; HEWELT A, 1994, PLANT J, V6, P879, DOI 10.1046/j.1365-313X.1994.6060879.x; Houba-Herin N, 1999, PLANT J, V17, P615, DOI 10.1046/j.1365-313X.1999.00408.x; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; LI Y, 1992, DEV BIOL, V153, P386, DOI 10.1016/0012-1606(92)90123-X; *MC M, 1994, CYTOK CHEM ACT FUNCT, P155; McGaw Brian A., 1995, P98; MEDFORD JI, 1989, PLANT CELL, V1, P403, DOI 10.1105/tpc.1.4.403; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Morris RO, 1999, BIOCHEM BIOPH RES CO, V255, P328, DOI 10.1006/bbrc.1999.0199; MOYTKA V, 2003, PHYSIOL PLANTARUM, V117, P11; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Sun JQ, 2003, PLANT PHYSIOL, V131, P167, DOI 10.1104/pp.011494; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; Turk EM, 2003, PLANT PHYSIOL, V133, P1643, DOI 10.1104/pp.103.030882; VONSCHWARTZENBE.K, 2007, PLANT PHYSIOL, P786; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Yang SH, 2003, PLANT MOL BIOL, V51, P237, DOI 10.1023/A:1021115816540; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176; Zhang J, 2006, PLANT J, V46, P834, DOI 10.1111/j.1365-313X.2006.02745.x; Zubko E, 2002, PLANT J, V29, P797, DOI 10.1046/j.1365-313X.2002.01256.x	47	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8236	10.1371/journal.pone.0008236	http://dx.doi.org/10.1371/journal.pone.0008236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011053	Green Submitted, gold, Green Published			2022-12-27	WOS:000272829800020
J	Edelstein, SJ; Stefan, MI; Le Novere, N				Edelstein, Stuart J.; Stefan, Melanie I.; Le Novere, Nicolas			Ligand Depletion in vivo Modulates the Dynamic Range and Cooperativity of Signal Transduction	PLOS ONE			English	Article							ASPARTATE-TRANSCARBAMYLASE; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; SYSTEMS BIOLOGY; ALLOSTERIC INTERACTIONS; CONFORMATIONAL SPREAD; HUMAN GLUCOKINASE; STRUCTURAL BASIS; PLAUSIBLE MODEL; BINDING	Biological signal transduction commonly involves cooperative interactions in the binding of ligands to their receptors. In many cases, ligand concentrations in vivo are close to the value of the dissociation constant of their receptors, resulting in the phenomenon of ligand depletion. Using examples based on rotational bias of bacterial flagellar motors and calcium binding to mammalian calmodulin, we show that ligand depletion diminishes cooperativity and broadens the dynamic range of sensitivity to the signaling ligand. As a result, the same signal transducer responds to different ranges of signal with various degrees of cooperativity according to its effective cellular concentration. Hence, results from in vitro dose-response analyses cannot be applied directly to understand signaling in vivo. Moreover, the receptor concentration is revealed to be a key element in controlling signal transduction and we propose that its modulation constitutes a new way of controlling sensitivity to signals. In addition, through an analysis of the allosteric enzyme aspartate transcarbamylase, we demonstrate that the classical Hill coefficient is not appropriate for characterizing the change in conformational state upon ligand binding to an oligomeric protein (equivalent to a dose-response curve), because it ignores the cooperativity of the conformational change for the corresponding equivalent monomers, which are generally characterized by a Hill coefficient << 1. Therefore, we propose a new index of cooperativity based on the comparison of the properties of oligomers and their equivalent monomers.	[Edelstein, Stuart J.; Stefan, Melanie I.; Le Novere, Nicolas] European Bioinformat Inst, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Edelstein, SJ (corresponding author), European Bioinformat Inst, Hinxton, England.	lenov@ebi.ac.uk	Le Novère, Nicolas/F-9973-2010	Le Novère, Nicolas/0000-0002-6309-7327; Stefan, Melanie/0000-0002-6086-7357	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	S.E. acknowledges support from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Belas R, 2008, J BACTERIOL, V190, P1849, DOI 10.1128/JB.01943-07; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHANGEUX JP, 1968, BIOCHEMISTRY-US, V7, P553, DOI 10.1021/bi00842a601; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; FERDINAND W, 1966, BIOCHEM J, V98, P278, DOI 10.1042/bj0980278; Fetler L, 2007, P NATL ACAD SCI USA, V104, P495, DOI 10.1073/pnas.0607641104; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GERHART JC, 1968, BIOCHEMISTRY-US, V7, P538, DOI 10.1021/bi00842a600; GERHART JC, 1967, J BIOL CHEM, V242, P2886; GERHART JC, 1962, J BIOL CHEM, V237, P891; Giegling I, 2008, PHARMACOPSYCHIATRY, V41, pS32, DOI 10.1055/s-2008-1081200; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; GOLDSTEIN A, 1987, MOL PHARMACOL, V31, P603; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; Henkin RI, 1997, J DENT RES, V76, P1430, DOI 10.1177/00220345970760080201; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; KISTER J, 1987, J BIOL CHEM, V262, P12085; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Le Novere N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-28; Legewie S, 2005, FEBS J, V272, P4071, DOI 10.1111/j.1742-4658.2005.04818.x; LIPSCOMB WN, 1994, ADV ENZYMOL RAMB, V68, P67; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martinez KL, 2000, BIOCHEMISTRY-US, V39, P6979, DOI 10.1021/bi992811p; McEvoy MM, 1999, J MOL BIOL, V289, P1423, DOI 10.1006/jmbi.1999.2830; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PORUMB T, 1994, ANAL BIOCHEM, V220, P227, DOI 10.1006/abio.1994.1332; Qian H, 2008, BIOPHYS J, V95, P10, DOI 10.1529/biophysj.108.131771; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0; SCHACHMAN HK, 1988, J BIOL CHEM, V263, P18583; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Stefan MI, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-68; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; WEBER K, 1968, NATURE, V218, P1116, DOI 10.1038/2181116a0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WHITEHEAD EP, 1978, BIOCHEM J, V171, P501, DOI 10.1042/bj1710501; WILEY DC, 1968, NATURE, V218, P1119, DOI 10.1038/2181119a0; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	62	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8449	10.1371/journal.pone.0008449	http://dx.doi.org/10.1371/journal.pone.0008449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052284	Green Published, gold			2022-12-27	WOS:000273338500003
J	Yu, SW; Khor, TO; Cheung, KL; Li, WG; Wu, TY; Huang, Y; Foster, BA; Kan, YW; Kong, AN				Yu, Siwang; Khor, Tin Oo; Cheung, Ka-Lung; Li, Wenge; Wu, Tien-Yuan; Huang, Ying; Foster, Barbara A.; Kan, Yuet Wai; Kong, Ah-Ng			Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GSTP1 CPG ISLAND; DNA METHYLATION; TRANSGENIC ADENOCARCINOMA; OXIDATIVE STRESS; CELL-LINES; INTRAEPITHELIAL NEOPLASIA; INCREASED SUSCEPTIBILITY; CHEMOPREVENTIVE AGENTS; ANTIOXIDANT RESPONSE	Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a transcription factor which regulates the expression of many cytoprotective genes. In the present study, we found that the expression of Nrf2 was suppressed in prostate tumor of the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice. Similarly, the expression of Nrf2 and the induction of NQO1 were also substantially suppressed in tumorigenic TRAMP C1 cells but not in non-tumorigenic TRAMP C3 cells. Examination of the promoter region of the mouse Nrf2 gene identified a CpG island, which was methylated at specific CpG sites in prostate TRAMP tumor and in TRAMP C1 cells but not in normal prostate or TRAMP C3 cells, as shown by bisulfite genomic sequencing. Reporter assays indicated that methylation of these CpG sites dramatically inhibited the transcriptional activity of the Nrf2 promoter. Chromatin immunopreceipitation (ChIP) assays revealed increased binding of the methyl-CpG-binding protein 2 (MBD2) and trimethyl-histone H3 (Lys9) proteins to these CpG sites in the TRAMP C1 cells as compared to TRAMP C3 cells. In contrast, the binding of RNA Pol II and acetylated histone H3 to the Nrf2 promoter was decreased. Furthermore, treatment of TRAMP C1 cells with DNA methyltransferase (DNMT) inhibitor 5-aza-2'-deoxycytidine (5-aza) and histone deacetylase (HDAC) inhibitor trichostatin A (TSA) restored the expression of Nrf2 as well as the induction of NQO1 in TRAMP C1 cells. Taken together, these results indicate that the expression of Nrf2 is suppressed epigenetically by promoter methylation associated with MBD2 and histone modifications in the prostate tumor of TRAMP mice. Our present findings reveal a novel mechanism by which Nrf2 expression is suppressed in TRAMP prostate tumor, shed new light on the role of Nrf2 in carcinogenesis and provide potential new directions for the detection and prevention of prostate cancer.	[Yu, Siwang; Khor, Tin Oo; Cheung, Ka-Lung; Li, Wenge; Wu, Tien-Yuan; Huang, Ying; Kong, Ah-Ng] Rutgers State Univ, Dept Pharmaceut, Ernest Mario Sch Pharm, Piscataway, NJ USA; [Foster, Barbara A.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Rutgers State University New Brunswick; Roswell Park Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yu, SW (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Beijing 100871, Peoples R China.	KongT@rci.rutgers.edu	Wu, Tien-Yuan/AAV-6964-2020; Kong, Ah-Ng Tony/AAX-2828-2020	Wu, Tien-Yuan/0000-0002-5205-4567; Yu, Siwang/0000-0002-3336-202X	National Institutes of Health [R01-CA118947, R01-094828]; NATIONAL CANCER INSTITUTE [R01CA118947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by the National Institutes of Health grants R01-CA118947 and R01-094828 to A.-N.T. Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Barve A, 2009, INT J CANCER, V124, P1693, DOI 10.1002/ijc.24106; Berger J, 2005, BIOCHEM SOC T, V33, P1537, DOI 10.1042/BST0331537; Bostwick DG, 2007, HUM PATHOL, V38, P1394, DOI 10.1016/j.humpath.2007.02.008; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Camoriano M, 2008, CANCER RES, V68, P4173, DOI 10.1158/0008-5472.CAN-07-6715; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen C, 2005, TRENDS PHARMACOL SCI, V26, P318, DOI 10.1016/j.tips.2005.04.004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Costa VL, 2007, DIS MARKERS, V23, P31, DOI 10.1155/2007/356742; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Foster BA, 1997, CANCER RES, V57, P3325; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Khor TO, 2008, PLANTA MED, V74, P1540, DOI 10.1055/s-0028-1088303; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Kotrikadze N., 2008, Experimental Oncology, V30, P244; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lin XH, 2003, CANCER RES, V63, P498; Mavis CK, 2009, PROSTATE, V69, P1312, DOI 10.1002/pros.20976; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Minelli A, 2009, BBA-REV CANCER, V1795, P83, DOI 10.1016/j.bbcan.2008.11.001; Morey SR, 2006, CANCER RES, V66, P11659, DOI 10.1158/0008-5472.CAN-06-1937; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2007, FRONT BIOSCI-LANDMRK, V12, P4254, DOI 10.2741/2385; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Rauhala HE, 2008, INT J CANCER, V123, P1601, DOI 10.1002/ijc.23658; Schulz WA, 2006, J CELL MOL MED, V10, P100, DOI 10.1111/j.1582-4934.2006.tb00293.x; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Yossepowitch O, 2007, J UROLOGY, V178, P1238, DOI 10.1016/j.juro.2007.05.145; Yu SW, 2007, CURR CANCER DRUG TAR, V7, P416; Zorn CS, 2007, CLIN CANCER RES, V13, P2136, DOI 10.1158/1078-0432.CCR-06-2381	40	164	174	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8579	10.1371/journal.pone.0008579	http://dx.doi.org/10.1371/journal.pone.0008579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20062804	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338500022
J	Creanza, N; Schwarz, JS; Cohen, JE				Creanza, Nicole; Schwarz, Jason S.; Cohen, Joel E.			Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza	PLOS ONE			English	Article							EVOLUTION; VIRUS; REVEALS	Long-term influenza evolution has been well studied, but the patterns of sequence diversity within seasons are less clear. H3N2 influenza genomes sampled from New York State over ten years indicated intraseasonal changes in evolutionary dynamics. Using the mean Hamming distance of a set of amino acid or nucleotide sequences as an indicator of its diversity, we found that influenza sequence diversity was significantly higher during the early epidemic period than later in the influenza season. Diversity was lowest during the peak of the epidemic, most likely due to the high prevalence of a single dominant amino acid sequence or very few dominant sequences during the peak epidemic period, corresponding with rapid expansion of the viral population. The frequency and duration of dominant sequences varied by influenza protein, but all proteins had an abundance of one distinct sequence during the peak epidemic period. In New York State from 1995 to 2005, high sequence diversity during the early epidemic suggested that seasonal antigenic drift could have occurred primarily in this period, followed by a clonal expansion of typically one clade during the peak of the epidemic, possibly indicating a shift to neutral drift or purifying selection.	[Creanza, Nicole; Schwarz, Jason S.; Cohen, Joel E.] Rockefeller Univ, Lab Populat, New York, NY 10021 USA; [Cohen, Joel E.] Columbia Univ, Earth Inst, New York, NY USA	Rockefeller University; Columbia University	Creanza, N (corresponding author), Rockefeller Univ, Lab Populat, 1230 York Ave, New York, NY 10021 USA.	jschwarz@rockefeller.edu		Creanza, Nicole/0000-0001-8821-7383	U.S. National Science Foundation Graduate Fellowship [DMS-0443803]; U.S. National Institutes of Health [GM66699]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER	U.S. National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NC was supported in part by a U.S. National Science Foundation Graduate Fellowship (nsf. gov). JSS was supported in part by a U.S. National Institutes of Health institutional training grant GM66699 (nih. gov). JEC was supported by US National Science Foundation grant DMS-0443803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gog JR, 2008, VACCINE, V26, pC15, DOI 10.1016/j.vaccine.2008.04.008; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lavenu A, 2006, EPIDEMIOL INFECT, V134, P514, DOI 10.1017/S0950268805005686; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *WHO, 211 WHO	15	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8544	10.1371/journal.pone.0008544	http://dx.doi.org/10.1371/journal.pone.0008544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049091	Green Submitted, gold, Green Published			2022-12-27	WOS:000273225000009
J	Whelan, AO; Coad, M; Cockle, PJ; Hewinson, G; Vordermeier, M; Gordon, SV				Whelan, Adam O.; Coad, Michael; Cockle, Paul J.; Hewinson, Glyn; Vordermeier, Martin; Gordon, Stephen V.			Revisiting Host Preference in the Mycobacterium tuberculosis Complex: Experimental Infection Shows M. tuberculosis H37Rv to Be Avirulent in Cattle	PLOS ONE			English	Article							BOVIS BCG VACCINATION; DIAGNOSTIC REAGENTS; EXPRESSION; IDENTIFICATION; ANTIGENS; MPB83	Experiments in the late 19th century sought to define the host specificity of the causative agents of tuberculosis in mammals. Mycobacterium tuberculosis, the human tubercle bacillus, was independently shown by Smith, Koch, and von Behring to be avirulent in cattle. This finding was erroneously used by Koch to argue the converse, namely that Mycobacterium bovis, the agent of bovine tuberculosis, was avirulent for man, a view that was subsequently discredited. However, reports in the literature of M. tuberculosis isolation from cattle with tuberculoid lesions suggests that the virulence of M. tuberculosis for cattle needs to be readdressed. We used an experimental bovine infection model to test the virulence of well-characterized strains of M. tuberculosis and M. bovis in cattle, choosing the genome-sequenced strains M. tuberculosis H37Rv and M. bovis 2122/97. Cattle were infected with approximately 10(6) CFU of M. tuberculosis H37Rv or M. bovis 2122/97, and sacrificed 17 weeks post-infection. IFN-gamma and tuberculin skin tests indicated that both M. bovis 2122 and M. tuberculosis H37Rv were equally infective and triggered strong cell-mediated immune responses, albeit with some indication of differential antigen-specific responses. Postmortem examination revealed that while M. bovis 2122/97-infected animals all showed clear pathology indicative of bovine tuberculosis, the M. tuberculosis-infected animals showed no pathology. Culturing of infected tissues revealed that M. tuberculosis was able to persist in the majority of animals, albeit at relatively low bacillary loads. In revisiting the early work on host preference across the M. tuberculosis complex, we have shown M. tuberculosis H37Rv is avirulent for cattle, and propose that the immune status of the animal, or genotype of the infecting bacillus, may have significant bearing on the virulence of a strain for cattle. This work will serve as a baseline for future studies into the genetic basis of host preference, and in particular the molecular basis of virulence in M. bovis.	[Whelan, Adam O.; Coad, Michael; Cockle, Paul J.; Hewinson, Glyn; Vordermeier, Martin; Gordon, Stephen V.] Vet Labs Agcy Weybridge, TB Res Grp, New Haw, England; [Gordon, Stephen V.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Coll Life Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	Veterinary Laboratories Agency; University College Dublin; University College Dublin; University College Dublin; University College Dublin	Whelan, AO (corresponding author), Vet Labs Agcy Weybridge, TB Res Grp, New Haw, England.	stephen.gordon@ucd.ie	Hewinson, Glyn/AAA-2364-2019; Coad, Mick/D-8093-2011; Vordermeier, H Martin/C-6936-2011; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/F-7077-2010; Whelan, Adam O/C-9497-2011	Gordon, Stephen/0000-0002-4833-5542; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food, and Rural Affairs (Defra), United Kingdom	Department for Environment, Food, and Rural Affairs (Defra), United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This study was funded by the Department for Environment, Food, and Rural Affairs (Defra), United Kingdom. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was cleared for publication by Defra.	Bean AGD, 1999, J IMMUNOL, V162, P3504; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; BUDDLE BM, 1995, RES VET SCI, V59, P10, DOI 10.1016/0034-5288(95)90023-3; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; CHATTERJEE D, 1989, INFECT IMMUN, V57, P322, DOI 10.1128/IAI.57.2.322-330.1989; Chen YY, 2009, TUBERCULOSIS, V89, P95, DOI 10.1016/j.tube.2008.07.003; Cockle PJ, 2002, INFECT IMMUN, V70, P6996, DOI 10.1128/IAI.70.12.6996-7003.2002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Inwald J, 2003, TUBERCULOSIS, V83, P387, DOI 10.1016/j.tube.2003.08.018; JARNAGIN JL, 1983, AM J VET RES, V44, P1920; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koch R, 1901, Br Med J, V2, P189; Littel-van den Hurk SV, 1998, J GEN VIROL, V79, P831; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; SMITH T, 1896, T ASSOC AM PHYSICIAN, V11, P75; Srivastava K, 2008, INDIAN J MED RES, V128, P26; VONBEHRING E, 1901, NOBEL LECT PHYSL MED; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Wiker HG, 1996, SCAND J IMMUNOL, V43, P374, DOI 10.1046/j.1365-3083.1996.d01-61.x	27	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8527	10.1371/journal.pone.0008527	http://dx.doi.org/10.1371/journal.pone.0008527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049086	gold, Green Published, Green Submitted			2022-12-27	WOS:000273225000006
J	Karrlander, M; Lindberg, N; Olofsson, T; Kastemar, M; Olsson, AK; Uhrbom, L				Karrlander, Maria; Lindberg, Nanna; Olofsson, Tommie; Kastemar, Marianne; Olsson, Anna-Karin; Uhrbom, Lene			Histidine-Rich Glycoprotein Can Prevent Development of Mouse Experimental Glioblastoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BEVACIZUMAB PLUS IRINOTECAN; IN-VIVO; ANTIANGIOGENIC THERAPY; TUMOR ANGIOGENESIS; POTENT INHIBITOR; CELL; CANCER; GLIOMA; PROGRESSION	Extensive angiogenesis, formation of new capillaries from pre-existing blood vessels, is an important feature of malignant glioma. Several antiangiogenic drugs targeting vascular endothelial growth factor (VEGF) or its receptors are currently in clinical trials as therapy for high-grade glioma and bevacizumab was recently approved by the FDA for treatment of recurrent glioblastoma. However, the modest efficacy of these drugs and emerging problems with anti-VEGF treatment resistance welcome the development of alternative antiangiogenic therapies. One potential candidate is histidine-rich glycoprotein (HRG), a plasma protein with antiangiogenic properties that can inhibit endothelial cell adhesion and migration. We have used the RCAS/TV-A mouse model for gliomas to investigate the effect of HRG on brain tumor development. Tumors were induced with platelet-derived growth factor-B (PDGF-B), in the presence or absence of HRG. We found that HRG had little effect on tumor incidence but could significantly inhibit the development of malignant glioma and completely prevent the occurrence of grade IV tumors (glioblastoma).	[Karrlander, Maria; Lindberg, Nanna; Kastemar, Marianne; Uhrbom, Lene] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Olofsson, Tommie] Natl Board Forens Med, Dept Forens Med, Uppsala, Sweden; [Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University; Swedish National Board of Forensic Medicine; Uppsala University	Karrlander, M (corresponding author), Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden.	lene.uhrbom@genpat.uu.se			Swedish Cancer Society; Swedish Research Council; Association for International Cancer Research; Swedish Childhood Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Association for International Cancer Research; Swedish Childhood Cancer Foundation(European Commission)	This work was supported by grants to LU from the Swedish Cancer Society, the Swedish Research Council, the Association for International Cancer Research, and the Swedish Childhood Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joshua C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000768; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Borza DB, 1996, BIOCHEMISTRY-US, V35, P1925, DOI 10.1021/bi952061t; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dixelius J, 2006, CANCER RES, V66, P2089, DOI 10.1158/0008-5472.CAN-05-2217; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Gorgani NN, 1997, BIOCHEMISTRY-US, V36, P6653, DOI 10.1021/bi962573n; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Juarez JC, 2002, CANCER RES, V62, P5344; KOIDE T, 1987, FEBS LETT, V216, P17, DOI 10.1016/0014-5793(87)80748-2; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; LAMBWHARTON RJ, 1993, CELL IMMUNOL, V152, P544, DOI 10.1006/cimm.1993.1311; Lee C, 2006, EXP CELL RES, V312, P2547, DOI 10.1016/j.yexcr.2006.04.022; LIJNEN HR, 1983, J BIOL CHEM, V258, P3803; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Olsson AK, 2004, CANCER RES, V64, P599, DOI 10.1158/0008-5472.CAN-03-1941; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PETROPOULOS CJ, 1992, J VIROL, V66, P3391, DOI 10.1128/JVI.66.6.3391-3397.1992; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; SAIGO K, 1989, J BIOL CHEM, V264, P8249; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Simantov R, 2001, J CLIN INVEST, V107, P45, DOI 10.1172/JCI9061; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Vanwildemeersch M, 2006, J BIOL CHEM, V281, P10298, DOI 10.1074/jbc.M508483200; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8536	10.1371/journal.pone.0008536	http://dx.doi.org/10.1371/journal.pone.0008536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046875	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200017
J	Li, Q; Kluz, T; Sun, H; Costa, M				Li, Qin; Kluz, Thomas; Sun, Hong; Costa, Max			Mechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia	PLOS ONE			English	Article							PROTEIN STABILITY; MITOCHONDRIAL BIOGENESIS; DNA-DAMAGE; HISTONE H3; FACTOR-I; CELL; TRANSFORMATION; TRANSCRIPTION; GENES; USP28	Nickel (Ni) compounds have been found to cause cancer in humans and animal models and to transform cells in culture. At least part of this effect is mediated by stabilization of hypoxia inducible factor (HIF1a) and activating its downstream signaling. Recent studies reported that hypoxia signaling might either antagonize or enhance c-myc activity depending on cell context. We investigated the effect of nickel on c-myc levels, and demonstrated that nickel, hypoxia, and other hypoxia mimetics degraded c-myc protein in a number of cancer cells (A549, MCF-7, MDA-453, and BT-474). The degradation of the c-Myc protein was mediated by the 26S proteosome. Interestingly, knockdown of both HIF-1 alpha and HIF-2 alpha attenuated c-Myc degradation induced by Nickel and hypoxia, suggesting the functional HIF-1 alpha and HIF-2 alpha was required for c-myc degradation. Further studies revealed two potential pathways mediated nickel and hypoxia induced c-myc degradation. Phosphorylation of c-myc at T58 was significantly increased in cells exposed to nickel or hypoxia, leading to increased ubiquitination through Fbw7 ubiquitin ligase. In addition, nickel and hypoxia exposure decreased USP28, a c-myc de-ubiquitinating enzyme, contributing to a higher steady state level of c-myc ubiquitination and promoting c-myc degradation. Furthermore, the reduction of USP28 protein by hypoxia signaling is due to both protein degradation and transcriptional repression. Nickel and hypoxia exposure significantly increased the levels of dimethylated H3 lysine 9 at the USP28 promoter and repressed its expression. Our study demonstrated that Nickel and hypoxia exposure increased c-myc T58 phosphorylation and decreased USP28 protein levels in cancer cells, which both lead to enhanced c-myc ubiquitination and proteasomal degradation.	[Li, Qin; Kluz, Thomas; Sun, Hong; Costa, Max] New York Univ, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10016 USA	New York University	Li, Q (corresponding author), New York Univ, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10016 USA.	max.costa@nyumc.org	costa, max/H-1754-2012		National Institutes of Environmental Health Sciences [ES000260, ES014454, ES005512, T32-ES07324]; National Cancer Institute [CA16087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014454, T32ES007324, P30ES000260, R01ES005512] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants ES000260, ES014454, ES005512, and T32-ES07324 from the National Institutes of Environmental Health Sciences, and grant CA16087 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartholomeusz G, 2007, CANCER RES, V67, P3912, DOI 10.1158/0008-5472.CAN-06-4464; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chen H, 2009, BIOMETALS, V22, P191, DOI 10.1007/s10534-008-9190-3; CHEN WC, 2006, PLATAX, V3, P9; DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Ke QD, 2008, TOXICOL APPL PHARM, V228, P190, DOI 10.1016/j.taap.2007.12.015; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Kerckaert GA, 1996, FUND APPL TOXICOL, V34, P67, DOI 10.1006/faat.1996.0176; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kuper CF, 1997, MUTAT RES-FUND MOL M, V380, P19, DOI 10.1016/S0027-5107(97)00123-1; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Q, 2006, TOXICOL APPL PHARM, V213, P245, DOI 10.1016/j.taap.2005.11.006; Lusher B, 2007, EMBO REP, V8, P1110, DOI 10.1038/sj.embor.7401121; Miller AC, 2001, CARCINOGENESIS, V22, P115, DOI 10.1093/carcin/22.1.115; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; PULVERER BJ, 1994, ONCOGENE, V9, P59; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	36	42	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8531	10.1371/journal.pone.0008531	http://dx.doi.org/10.1371/journal.pone.0008531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046830	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200012
J	Almenberg, J; Kittlitz, K; Pfeiffer, T				Almenberg, Johan; Kittlitz, Ken; Pfeiffer, Thomas			An Experiment on Prediction Markets in Science	PLOS ONE			English	Article							EXPERIMENTAL ASSET MARKETS; INFORMATION AGGREGATION; RATIONAL-EXPECTATIONS; PRICE MANIPULATION; SECURITY MARKETS; TRADERS; EFFICIENCY; BUBBLES; DESIGN; BIASES	Prediction markets are powerful forecasting tools. They have the potential to aggregate private information, to generate and disseminate a consensus among the market participants, and to provide incentives for information acquisition. These market functionalities can be very valuable for scientific research. Here, we report an experiment that examines the compatibility of prediction markets with the current practice of scientific publication. We investigated three settings. In the first setting, different pieces of information were disclosed to the public during the experiment. In the second setting, participants received private information. In the third setting, each piece of information was private at first, but was subsequently disclosed to the public. An automated, subsidizing market maker provided additional incentives for trading and mitigated liquidity problems. We find that the third setting combines the advantages of the first and second settings. Market performance was as good as in the setting with public information, and better than in the setting with private information. In contrast to the first setting, participants could benefit from information advantages. Thus the publication of information does not detract from the functionality of prediction markets. We conclude that for integrating prediction markets into the practice of scientific research it is of advantage to use subsidizing market makers, and to keep markets aligned with current publication practice.	[Almenberg, Johan] Stockholm Sch Econ, S-11383 Stockholm, Sweden; [Kittlitz, Ken] Consensus Point, Nashville, TN USA; [Pfeiffer, Thomas] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Stockholm School of Economics; Harvard University	Almenberg, J (corresponding author), Stockholm Sch Econ, S-11383 Stockholm, Sweden.	pfeiffer@fas.harvard.edu	Pfeiffer, Thomas/R-1339-2019; Chanelian, Serena/ABE-4873-2021	Pfeiffer, Thomas/0000-0002-0592-577X; Chanelian, Serena/0000-0001-5727-6137	Society in Science/The Branco Weiss Fellowship; Jan Wallander and Tom Hedelius Foundation; Torsten and Ragnar Soderberg Foundations	Society in Science/The Branco Weiss Fellowship; Jan Wallander and Tom Hedelius Foundation; Torsten and Ragnar Soderberg Foundations	TP gratefully acknowledges financial support from Society in Science/The Branco Weiss Fellowship. JA gratefully acknowledges support from the Jan Wallander and Tom Hedelius Foundation and the Torsten and Ragnar Soderberg Foundations. Consensus Point provided the software interface used in the experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert LF, 1997, J ECON BEHAV ORGAN, V33, P61, DOI 10.1016/S0167-2681(97)00021-8; ALLEN F, 1992, REV FINANC STUD, V5, P503, DOI 10.1093/rfs/5.3.503; ANDERSON MJ, 1995, ORGAN BEHAV HUM DEC, V64, P185, DOI 10.1006/obhd.1995.1099; Arrow KJ, 2008, SCIENCE, V320, P877, DOI 10.1126/science.1157679; Axelrod BS, 2009, J ECON BEHAV ORGAN, V69, P170, DOI 10.1016/j.jebo.2007.09.010; CAMERER C, 1991, J BUS, V64, P463, DOI 10.1086/296548; CAMERER CF, 1987, AM ECON REV, V77, P981; Camerer CF, 1998, J POLIT ECON, V106, P457, DOI 10.1086/250018; CHAKRABORTY A, 2008, AM EC REV PAPERS P, V90, P280; CHEN KY, 2002, INFORM AGGREGATION M; CHEN Y, 2007, P INT WORKSH INT NET; COPELAND TE, 1987, J FINANC, V42, P763, DOI 10.2307/2328387; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; FORSYTHE R, 1982, ECONOMETRICA, V50, P537, DOI 10.2307/1912600; FORSYTHE R, 1990, ECONOMETRICA, V58, P309, DOI 10.2307/2938206; Ganguly AR, 2000, J RISK UNCERTAINTY, V20, P219, DOI 10.1023/A:1007848013750; GODE DK, 1993, J POLIT ECON, V101, P119, DOI 10.1086/261868; Hanson R, 2003, INFORM SYST FRONT, V5, P107, DOI 10.1023/A:1022058209073; Hanson R., 1995, SOC EPISTEMOL, V9, P3, DOI [10.1080/02691729508578768, DOI 10.1080/02691729508578768]; Hanson RD, 1999, IEEE INTELL SYST APP, V14, P16; Hanson RD, 2002, LOGARITHMIC MARKET S; Hanson R, 2006, J ECON BEHAV ORGAN, V60, P449, DOI 10.1016/j.jebo.2004.09.011; Hommes C, 2008, J ECON BEHAV ORGAN, V67, P116, DOI 10.1016/j.jebo.2007.06.006; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jamal K, 1996, J ECON BEHAV ORGAN, V31, P273, DOI 10.1016/S0167-2681(96)00892-X; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Manski CF, 2006, ECON LETT, V91, P425, DOI 10.1016/j.econlet.2006.01.004; Meloso D, 2009, SCIENCE, V323, P1335, DOI 10.1126/science.1158624; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; PETERSON SP, 1993, J ECON BEHAV ORGAN, V22, P269, DOI 10.1016/0167-2681(93)90002-7; Pfeiffer T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004607; PLOTT CR, 1982, J POLIT ECON, V90, P663, DOI 10.1086/261084; PLOTT CR, 1988, ECONOMETRICA, V56, P1085, DOI 10.2307/1911360; Plott CR, 2003, ECON THEOR, V22, P311, DOI 10.1007/s00199-002-0306-7; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; SMITH VL, 1988, ECONOMETRICA, V56, P1119, DOI 10.2307/1911361; Tom W.Bell, 2006, GEO MASON L REV, V14, P46; Veiga H, 2009, EUR ECON REV, V53, P327, DOI 10.1016/j.euroecorev.2008.05.004; Wolfers J, 2004, J ECON PERSPECT, V18, P107, DOI 10.1257/0895330041371321; Wolfers J, 2006, INTERPRETING PREDICT	40	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8500	10.1371/journal.pone.0008500	http://dx.doi.org/10.1371/journal.pone.0008500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041139	Green Submitted, gold, Green Published			2022-12-27	WOS:000278068700015
J	Cremer, TJ; Ravneberg, DH; Clay, CD; Piper-Hunter, MG; Marsh, CB; Elton, TS; Gunns, JS; Amer, A; Kanneganti, TD; Schlesinger, LS; Butchar, JP; Tridandapani, S				Cremer, Thomas J.; Ravneberg, David H.; Clay, Corey D.; Piper-Hunter, Melissa G.; Marsh, Clay B.; Elton, Terry S.; Gunns, John S.; Amer, Amal; Kanneganti, Thirumala-Devi; Schlesinger, Larry S.; Butchar, Jonathan P.; Tridandapani, Susheela			M1R-155 Induction by F. novicida but Not the Virulent F. tularensis Results in SHIP Down-Regulation and Enhanced Pro-Inflammatory Cytokine Response	PLOS ONE			English	Article							VIRUS-INDUCED LYMPHOMAS; FRANCISELLA-TULARENSIS; MONONUCLEAR PHAGOCYTES; SURVIVAL ADVANTAGE; MURINE MACROPHAGES; ACTIVATION; MICRORNA-155; INFECTION; RECEPTOR; MIR-155	The intracellular Gram-negative bacterium Francisella tularensis causes the disease tularemia and is known for its ability to subvert host immune responses. Previous work from our laboratory identified the PI3K/Akt pathway and SHIP as critical modulators of host resistance to Francisella. Here, we show that SHIP expression is strongly down-regulated in monocytes and macrophages following infection with F. tularensis novicida (F.n.). To account for this negative regulation we explored the possibility that microRNAs (miRs) that target SHIP may be induced during infection. There is one miR that is predicted to target SHIP, miR-155. We tested for induction and found that F.n. induced miR-155 both in primary monocytes/ macrophages and in vivo. Using luciferase reporter assays we confirmed that miR-155 led to down-regulation of SHIP, showing that it specifically targets the SHIP 3'UTR. Further experiments showed that miR-155 and BIC, the gene that encodes miR-155, were induced as early as four hours post-infection in primary human monocytes. This expression was dependent on TLR2/MyD88 and did not require inflammasome activation. Importantly, miR-155 positively regulated proinflammatory cytokine release in human monocytes infected with Francisella. In sharp contrast, we found that the highly virulent type A SCHU 54 strain of Francisella tularensis (Ft.) led to a significantly lower miR-155 response than the less virulent F.n. Hence, F.n. induces miR-155 expression and leads to down-regulation of SHIP, resulting in enhanced proinflammatory responses. However, impaired miR-155 induction by SCHU S4 may help explain the lack of both SHIP downregulation and pro-inflammatory response and may account for the virulence of Type A Francisella.	[Cremer, Thomas J.; Tridandapani, Susheela] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Ravneberg, David H.; Clay, Corey D.; Amer, Amal; Schlesinger, Larry S.; Tridandapani, Susheela] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Piper-Hunter, Melissa G.; Marsh, Clay B.; Amer, Amal; Schlesinger, Larry S.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Elton, Terry S.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Gunns, John S.; Amer, Amal; Schlesinger, Larry S.; Tridandapani, Susheela] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; St Jude Children's Research Hospital	Cremer, TJ (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Kanneganti, Thirumala-Devi/M-9435-2018; Tridandapani, Susheela/E-4209-2011; Amer, Amal/E-2643-2011; Kanneganti, Thirumala-Devi/Y-2503-2019; Butchar, Jonathan/E-2825-2011	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Ravneberg, David/0000-0002-0107-5683	NIH [1-U54-AI-057153]; American Cancer Society Ohio [ROI A1059406, P01 CA095426]; NIH/NIAID [1-T32-AI-065411]; Center for Microbial Interface Biology (CMIB); Ohio State University; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, T32AI065411, R01AI059406, R21AI083871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Ohio(American Cancer Society); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Microbial Interface Biology (CMIB); Ohio State University(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). This work was also supported by ROI A1059406 and P01 CA095426. J.P.B. is supported by the American Cancer Society Ohio Division Postdoctoral Fellowship. T.J.C. is sponsored by NIH/NIAID award # 1-T32-AI-065411, a National Research Service Award (NRSA) training grant administered by the Center for Microbial Interface Biology (CMIB), at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CHASE JC, 2009, INFECT IMMU IN PRESS; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Helgason CD, 1998, EXP HEMATOL, V26, P815; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; LOFGREN S, 1983, INFECT IMMUN, V39, P715; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; MEHTA P, 2009, CURR ENZYME IN PRESS; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; SANTIC M, 2009, CELL MICROB IN PRESS; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Strassheim D, 2005, J IMMUNOL, V174, P8064, DOI 10.4049/jimmunol.174.12.8064; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Teng G, 2009, PHILOS T R SOC B, V364, P631, DOI 10.1098/rstb.2008.0209; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	53	126	131	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8508	10.1371/journal.pone.0008508	http://dx.doi.org/10.1371/journal.pone.0008508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041145	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700021
J	Wisdom, A; Kutkowska, AE; Leitch, ECM; Gaunt, E; Templeton, K; Harvala, H; Simmonds, P				Wisdom, Anne; Kutkowska, Aldona E.; Leitch, E. Carol McWilliam; Gaunt, Eleanor; Templeton, Kate; Harvala, Heli; Simmonds, Peter			Genetics, Recombination and Clinical Features of Human Rhinovirus Species C (HRV-C) Infections; Interactions of HRV-C with Other Respiratory Viruses	PLOS ONE			English	Article							CHILDREN; ILLNESS; INFANTS	To estimate the frequency, molecular epidemiological and clinical associations of infection with the newly described species C variants of human rhinoviruses (HRV), 3243 diagnostic respiratory samples referred for diagnostic testing in Edinburgh were screened using a VP4-encoding region-based selective polymerase chain reaction (PCR) for HRV-C along with parallel PCR testing for 13 other respiratory viruses. HRV-C was the third most frequently detected behind respiratory syncytial virus (RSV) and adenovirus, with 141 infection episodes detected among 1885 subjects over 13 months (7.5%). Infections predominantly targeted the very young (median age 6-12 months; 80% of infections in those <2 years), occurred throughout the year but with peak incidence in early winter months. HRV-C was detected significantly more frequently among subjects with lower (LRT) and upper respiratory tract (URT) disease than controls without respiratory symptoms; HRV-C mono-infections were the second most frequently detected virus (behind RSV) in both disease presentations (6.9% and 7.8% of all cases respectively). HRV variants were classified by VP4/VP2 sequencing into 39 genotypically defined types, increasing the current total worldwide to 60. Through sequence comparisons of the 5'untranslated region (5'UTR), the majority grouped with species A (n = 96; 68%, described as HRV-Ca), the remainder forming a phylogenetically distinct 5'UTR group (HRV-Cc). Multiple and bidirectional recombination events between HRV-Ca and HRV-Cc variants and with HRV species A represents the most parsimonious explanation for their interspersed phylogeny relationships in the VP4/VP2-encoding region. No difference in age distribution, seasonality or disease associations was identified between HRV-Ca and HRV-Cc variants. HRV-C-infected subjects showed markedly reduced detection frequencies of RSV and other respiratory viruses, providing evidence for a major interfering effect of HRV-C on susceptibility to other respiratory virus infections. HRV-C's disease associations, its prevalence and evidence for interfering effects on other respiratory viruses mandates incorporation of rhinoviruses into future diagnostic virology screening.	[Wisdom, Anne; Kutkowska, Aldona E.; Leitch, E. Carol McWilliam; Gaunt, Eleanor; Simmonds, Peter] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Templeton, Kate; Harvala, Heli] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Simmonds, P (corresponding author), Univ Edinburgh, Ctr Infect Dis, Summerhall, Edinburgh, Midlothian, Scotland.	Peter.Simmonds@ed.ac.uk		Chmielewska, Aldona/0000-0003-3411-6776; Simmonds, Peter/0000-0002-7964-4700; Leitch, Carol/0000-0002-0910-9593; Templeton, Kate/0000-0001-7414-1277; Harvala, Heli/0000-0001-9154-4190				ANDEN KE, 2006, J MED VIROL, V78, P1232; Arruda E, 1997, J CLIN MICROBIOL, V35, P2864, DOI 10.1128/JCM.35.11.2864-2868.1997; Calvo C, 2009, EMERG INFECT DIS, V15, P1506, DOI 10.3201/eid1509.090453; FUCAPHER CR, 1991, VIROLOGY, V180, P814; GALVA C, 2007, PEDIATR INFECT DIS J, V26, P904; GANNT L, 2009, J CLIN VIROL    1009; Gerna G, 2009, J MED VIROL, V81, P1498, DOI 10.1002/jmv.21548; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; HAN TH, 2009, ARCH VIROL; HARMAN ZG, 2007, J VIROL, V81, P1796; HARVADA H, 2008, J CLIN MICROBIOL, V16, P3116; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; JARTI T, 2009, PEDIATR INFECT DIS J, V27, P1193; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; LATT SK, 2009, J INFECT DIS, V200, P1096; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; LIUSUWANON P, 2009, J INFECTION, V59, P115; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Monto AS, 2002, CLIN THER, V24, P1987, DOI 10.1016/S0149-2918(02)80093-5; Peltola V, 2008, J CLIN VIROL, V43, P411, DOI 10.1016/j.jcv.2008.08.014; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Peltola V, 2009, J MED VIROL, V81, P1831, DOI 10.1002/jmv.21590; PIRADLA A, 2009, J CLIN VIROL, V15, P311; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Savolainen-Kopra C, 2009, PEDIATR INFECT DIS J, V28, P59, DOI 10.1097/INF.0b013e318182c90a; Savolainen-Kopra C, 2009, J CLIN MICROBIOL, V47, P1278, DOI 10.1128/JCM.02130-08; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stanway G, 2005, VIRUS TAXONOMY, P757; TAMMA K, 2007, MOL BIOL EXD, V21, P1396; TEMPLETON KE, 2001, J CLIN MICROBIOL, V12, P1564; Vesa S, 2001, PEDIATR INFECT DIS J, V20, P574, DOI 10.1097/00006454-200106000-00006; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; WISDOM A, 2009, J CLIN MICROBIO 1014	47	53	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8518	10.1371/journal.pone.0008518	http://dx.doi.org/10.1371/journal.pone.0008518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041158	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000278068700027
J	Dias-Neto, E; Nunes, DN; Giordano, RJ; Sun, J; Botz, GH; Yang, K; Setubal, JC; Pasqualini, R; Arap, W				Dias-Neto, Emmanuel; Nunes, Diana N.; Giordano, Ricardo J.; Sun, Jessica; Botz, Gregory H.; Yang, Kuan; Setubal, Joao C.; Pasqualini, Renata; Arap, Wadih			Next-Generation Phage Display: Integrating and Comparing Available Molecular Tools to Enable Cost-Effective High-Throughput Analysis	PLOS ONE			English	Article							PEPTIDES; TARGET; IDENTIFICATION; VASCULATURE; EXPRESSION; GUIDELINES; LIBRARIES; SELECTION; VECTOR; ALPHA	Background: Combinatorial phage display has been used in the last 20 years in the identification of protein-ligands and protein-protein interactions, uncovering relevant molecular recognition events. Rate-limiting steps of combinatorial phage display library selection are (i) the counting of transducing units and (ii) the sequencing of the encoded displayed ligands. Here, we adapted emerging genomic technologies to minimize such challenges. Methodology/Principal Findings: We gained efficiency by applying in tandem real-time PCR for rapid quantification to enable bacteria-free phage display library screening, and added phage DNA next-generation sequencing for large-scale ligand analysis, reporting a fully integrated set of high-throughput quantitative and analytical tools. The approach is far less labor-intensive and allows rigorous quantification; for medical applications, including selections in patients, it also represents an advance for quantitative distribution analysis and ligand identification of hundreds of thousands of targeted particles from patient-derived biopsy or autopsy in a longer timeframe post library administration. Additional advantages over current methods include increased sensitivity, less variability, enhanced linearity, scalability, and accuracy at much lower cost. Sequences obtained by qPhage plus pyrosequencing were similar to a dataset produced from conventional Sanger-sequenced transducing-units (TU), with no biases due to GC content, codon usage, and amino acid or peptide frequency. These tools allow phage display selection and ligand analysis at >1,000-fold faster rate, and reduce costs similar to 250-fold for generating 10(6) ligand sequences. Conclusions/Significance: Our analyses demonstrates that whereas this approach correlates with the traditional colony-counting, it is also capable of a much larger sampling, allowing a faster, less expensive, more accurate and consistent analysis of phage enrichment. Overall, qPhage plus pyrosequencing is superior to TU-counting plus Sanger sequencing and is proposed as the method of choice over a broad range of phage display applications in vitro, in cells, and in vivo.	[Dias-Neto, Emmanuel; Nunes, Diana N.; Giordano, Ricardo J.; Sun, Jessica; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Botz, Gregory H.] Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA; [Yang, Kuan; Setubal, Joao C.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Setubal, Joao C.] Virginia Polytech Inst & State Univ, Dept Comp Sci, Blacksburg, VA 24061 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Dias-Neto, E (corresponding author), Hosp AC Camargo Fund Antonio Prudente, Ctr Pesquisas, Sao Paulo, Brazil.	rpasqual@mdanderson.org; warap@mdanderson.org	Setubal, Joao Carlos/C-7305-2012; Dias-Neto, Emmanuel/A-5869-2008; Dias-Neto, Emmanuel/AAE-9147-2020; Giordano, Ricardo/A-2074-2010; Dias-Neto, Emmanuel/AAA-6701-2019; Nunes, Diana N/A-7867-2010	Setubal, Joao Carlos/0000-0001-9174-2816; Dias-Neto, Emmanuel/0000-0001-5670-8559; Giordano, Ricardo/0000-0001-8116-6771; 	National Institutes of Health; U.S. Department of Defense; AngelWorks; Gillson-Longenbaugh Foundation; Marcus Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); AngelWorks; Gillson-Longenbaugh Foundation; Marcus Foundation	This work was funded by grants from the National Institutes of Health and the U.S. Department of Defense, and by awards from AngelWorks, the Gillson-Longenbaugh Foundation, and the Marcus Foundation (all to RP and WA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Ballard VLT, 2006, PHYSIOL GENOMICS, V26, P202, DOI 10.1152/physiolgenomics.00025.2006; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarkson T., 2004, PHAGE DISPLAY PRACTI; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Guerfali FZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-238; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jaye DL, 2003, AM J PATHOL, V162, P1419, DOI 10.1016/S0002-9440(10)64275-7; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Langley RR, 2003, CANCER RES, V63, P2971; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mintz PJ, 2009, P NATL ACAD SCI USA, V106, P2182, DOI 10.1073/pnas.0807543105; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Nishimura S, 2008, J BIOL CHEM, V283, P11752, DOI 10.1074/jbc.M708849200; O'Brien PM, 2002, ANTIBODY PHAGE DISPL; Ojopi EPB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-186; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145; Pentz RD, 2003, HASTINGS CENT REP, V33, P20, DOI 10.2307/3527910; Rahim Ahad A., 2007, V373, P135; Rahim M, 2003, BIOTECHNIQUES, V35, P317, DOI 10.2144/03352st04; Sidhu S. S., 2005, PHAGE DISPLAY BIOTEC, V2nd; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Walter G, 2001, COMB CHEM HIGH T SCR, V4, P193; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	35	110	114	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8338	10.1371/journal.pone.0008338	http://dx.doi.org/10.1371/journal.pone.0008338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020040	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834200005
J	del Corral, H; Paris, SC; Marin, ND; Marin, DM; Lopez, L; Henao, HM; Martinez, T; Villa, L; Barrera, LF; Ortiz, BL; Ramirez, ME; Montes, CJ; Oquendo, MC; Arango, LM; Riano, F; Aguirre, C; Bustamante, A; Belisle, JT; Dobos, K; Mejia, GI; Giraldo, MR; Brennan, PJ; Robledo, J; Arbelaez, MP; Rojas, CA; Garcia, LF				del Corral, Helena; Paris, Sara C.; Marin, Nancy D.; Marin, Diana M.; Lopez, Lucelly; Henao, Hanna M.; Martinez, Teresita; Villa, Liliana; Barrera, Luis F.; Ortiz, Blanca L.; Ramirez, Maria E.; Montes, Carlos J.; Oquendo, Maria C.; Arango, Lisandra M.; Riano, Felipe; Aguirre, Carlos; Bustamante, Alberto; Belisle, John T.; Dobos, Karen; Mejia, Gloria I.; Giraldo, Margarita R.; Brennan, Patrick J.; Robledo, Jaime; Arbelaez, Maria P.; Rojas, Carlos A.; Garcia, Luis F.			IFN gamma Response to Mycobacterium tuberculosis, Risk of Infection and Disease in Household Contacts of Tuberculosis Patients in Colombia	PLOS ONE			English	Article							T-CELL RESPONSES; LATENT TUBERCULOSIS; IMMUNE-RESPONSES; PREDICTIVE-VALUE; SKIN-TEST; ASSAYS; DIAGNOSIS; CHILDREN; ANTIGENS; ELISPOT	Objectives: Household contacts (HHCs) of pulmonary tuberculosis patients are at high risk of Mycobacterium tuberculosis infection and early disease development. Identification of individuals at risk of tuberculosis disease is a desirable goal for tuberculosis control. Interferon-gamma release assays (IGRAs) using specific M. tuberculosis antigens provide an alternative to tuberculin skin testing (TST) for infection detection. Additionally, the levels of IFN gamma produced in response to these antigens may have prognostic value. We estimated the prevalence of M. tuberculosis infection by IGRA and TST in HHCs and their source population (SP), and assessed whether IFN gamma levels in HHCs correlate with tuberculosis development. Methods: A cohort of 2060 HHCs was followed for 2-3 years after exposure to a tuberculosis case. Besides TST, IFN gamma responses to mycobacterial antigens: CFP, CFP-10, HspX and Ag85A were assessed in 7-days whole blood cultures and compared to 766 individuals from the SP in Medellin, Colombia. Isoniazid prophylaxis was not offered to child contacts because Colombian tuberculosis regulations consider it only in children under 5 years, TST positive without BCG vaccination. Results: Using TST 65.9% of HHCs and 42.7% subjects from the SP were positive (OR 2.60, p, 0.0001). IFN gamma response to CFP-10, a biomarker of M. tuberculosis infection, tested positive in 66.3% HHCs and 24.3% from the SP (OR = 6.07, p, 0.0001). Tuberculosis incidence rate was 7.0/1000 person years. Children <5 years accounted for 21.6% of incident cases. No significant difference was found between positive and negative IFN gamma responders to CFP-10 (HR 1.82 95% CI 0.79-4.20 p = 0.16). However, a significant trend for tuberculosis development amongst high HHC IFN gamma producers was observed (trend Log rank p = 0.007). Discussion: CFP-10-induced IFN gamma production is useful to establish tuberculosis infection prevalence amongst HHC and identify those at highest risk of disease. The high tuberculosis incidence amongst children supports administration of chemoprohylaxis to child contacts regardless of BCG vaccination.	[del Corral, Helena; Marin, Diana M.; Lopez, Lucelly; Martinez, Teresita; Villa, Liliana; Arbelaez, Maria P.; Rojas, Carlos A.] Univ Antioquia, Epidemiol Grp, Medellin, Colombia; [del Corral, Helena] Univ Antioquia, Escuela Microbiol, Medellin, Colombia; [Paris, Sara C.; Marin, Nancy D.; Henao, Hanna M.; Villa, Liliana; Barrera, Luis F.; Ortiz, Blanca L.; Ramirez, Maria E.; Montes, Carlos J.; Oquendo, Maria C.; Arango, Lisandra M.; Riano, Felipe; Garcia, Luis F.] Univ Antioquia, Grp Inmunol Celular & Immunogenet, Medellin, Colombia; [Aguirre, Carlos; Bustamante, Alberto] Univ Antioquia, Dept Pediat, Medellin, Colombia; [del Corral, Helena; Paris, Sara C.; Marin, Diana M.; Lopez, Lucelly; Henao, Hanna M.; Martinez, Teresita; Barrera, Luis F.; Ortiz, Blanca L.; Oquendo, Maria C.; Arango, Lisandra M.; Mejia, Gloria I.; Robledo, Jaime; Arbelaez, Maria P.; Rojas, Carlos A.; Garcia, Luis F.] Ctr Colombiano Invest TB, Medellin, Colombia; [Mejia, Gloria I.; Robledo, Jaime] Corp Invest Biol, Medellin, Colombia; [Belisle, John T.; Dobos, Karen; Brennan, Patrick J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Giraldo, Margarita R.] Direcc Secc Salud Antioquia, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Colorado State University	del Corral, H (corresponding author), Univ Antioquia, Epidemiol Grp, Medellin, Colombia.	lfgarcia@udea.edu.co	Belisle, John T/B-8944-2017; Rojas Cruz, Carlos Alberto/GZM-2307-2022; Dobos, Karen/D-1170-2017	Belisle, John T/0000-0002-2539-2798; Rojas Cruz, Carlos Alberto/0000-0003-0915-6653; Dobos, Karen/0000-0001-7115-8524; Marin Agudelo, Nancy Dora/0000-0002-2626-3349; Arbelaez Montoya, Maria Patricia/0000-0003-2435-4658; Marin Pineda, Diana/0000-0002-4715-8388; Barrera, Luis/0000-0002-6108-6747; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318	Colciencias, Bogota, Colombia [11150416335, 34261817270, 111540820482]; Direccion Seccional de Salud de Antioquia, Medellin' Colombia [2007SS162363]; NIAID [HHSN26266400091C, N01-AI-40091]	Colciencias, Bogota, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Direccion Seccional de Salud de Antioquia, Medellin' Colombia; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by Colciencias, Bogota, Colombia Grants: 11150416335, 34261817270, 111540820482; Direccion Seccional de Salud de Antioquia, Medellin' Colombia, Grant 2007SS162363; NIAID Contract No. HHSN26266400091C NIH, NIAID N01-AI-40091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, INT J TUBERC LUNG D, V11, P350; *AM THOR SOC, 1999, AM J RESP CRIT CARE, pS221; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; CARDOSOLEAO S, 2004, PRACTICAL HDB PHENOT; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Connell TG, 2006, EXPERT REV MOL DIAGN, V6, P663, DOI 10.1586/14737159.6.5.663; *DANE, 2006, CENS GEN 2005 REP CO; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dillon DC, 2000, J CLIN MICROBIOL, V38, P3285, DOI 10.1128/JCM.38.9.3285-3290.2000; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 2007, B WORLD HEALTH ORGAN, V85, P364, DOI 10.2471/BLT.06.037580; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gray A., 2001, DEFINITIONS CROWDING; Higuchi K, 2008, TUBERCULOSIS, V88, P244, DOI 10.1016/j.tube.2007.11.009; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; JOHNSON NL, 1994, CONTINUOS UNIVARIATE; KLEINBAUM D, 2005, LOGISTIC REGRESSION, P327; Lalvani A, 2005, LANCET INFECT DIS, V5, P322, DOI 10.1016/S1473-3099(05)70118-3; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; Lewinsohn DA, 2008, PEDIATR RES, V63, P115, DOI 10.1203/PDR.0b013e3181652085; Lewinsohn DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003407; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Maher D, 2007, B WORLD HEALTH ORGAN, V85, P341, DOI 10.2471/BLT.06.037820; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; *MIN SAL COL, 2000, GUIA AT TUB PULM EXT; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Richeldi L, 2007, PEDIATRICS, V119, pE1, DOI 10.1542/peds.2006-1057; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Soysal A, 2008, JPN J INFECT DIS, V61, P192; STOP TB, 2006, GUIDANCE NATL TUBERC; Styblo K, 1980, Adv Tuberc Res, V20, P1; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; WHO, 2008, IMPL WHO STOP TB STR; World Health Organization, 2008, GLOB TUB CONTR SURV; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	53	76	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8257	10.1371/journal.pone.0008257	http://dx.doi.org/10.1371/journal.pone.0008257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011589	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300022
J	Fant, X; Srsen, V; Espigat-Georger, A; Merdes, A				Fant, Xavier; Srsen, Vlastimil; Espigat-Georger, Aude; Merdes, Andreas			Nuclei of Non-Muscle Cells Bind Centrosome Proteins upon Fusion with Differentiating Myoblasts	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; MICROTUBULE NUCLEATION; GAMMA-TUBULIN; ORGANIZATION; ELONGATION; CENTRIOLES; FILAMENTS; MYOSIN	Background: In differentiating myoblasts, the microtubule network is reorganized from a centrosome-bound, radial array into parallel fibres, aligned along the long axis of the cell. Concomitantly, proteins of the centrosome relocalize from the pericentriolar material to the outer surface of the nucleus. The mechanisms that govern this relocalization are largely unknown. Methodology: In this study, we perform experiments in vitro and in cell culture indicating that microtubule nucleation at the centrosome is reduced during myoblast differentiation, while nucleation at the nuclear surface increases. We show in heterologous cell fusion experiments, between cultures of differentiating mouse myoblasts and human cells of nonmuscular origin, that nuclei from non-muscle cells recruit centrosome proteins once fused with the differentiating myoblasts. This recruitment still occurs in the presence of cycloheximide and thus appears to be independent of new protein biosynthesis. Conclusions: Altogether, our data suggest that nuclei of undifferentiated cells have the dormant potential to bind centrosome proteins, and that this potential becomes activated during myoblast differentiation.	[Fant, Xavier; Srsen, Vlastimil] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Espigat-Georger, Aude; Merdes, Andreas] Ctr Natl Rech Sci Pierre Fabre, UMR 2587, Toulouse, France	University of Edinburgh	Fant, X (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	andreas.merdes@istmt.cnrs.fr			Wellcome Trust; Association Francaise contre les Myopathies [12471]	Wellcome Trust(Wellcome TrustEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The work was supported in part by a Wellcome Trust Senior Research Fellowship to A. M., by a Wellcome Trust Prize Fellowship to X. F. (http://www.wellcome.ac.uk), and by grant 12471 from the "Association Francaise contre les Myopathies'', awarded to A. M. (http://www.afm-france.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; ANTIN PB, 1981, J CELL BIOL, V90, P300, DOI 10.1083/jcb.90.2.300; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; CONNOLLY JA, 1986, EUR J CELL BIOL, V39, P341; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; HOLTZER H, 1975, P NATL ACAD SCI USA, V72, P513, DOI 10.1073/pnas.72.2.513; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moudjou M, 1996, J CELL SCI, V109, P875; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Paoletti A, 1996, J CELL SCI, V109, P3089; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; PRZYBYLSKI RJ, 1971, J CELL BIOL, V48, P214; SAITOH O, 1988, CELL TISSUE RES, V252, P263; Schmit AC, 2002, INT REV CYTOL, V220, P257; Srsen V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-28; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; WARREN RH, 1974, J CELL BIOL, V63, P550, DOI 10.1083/jcb.63.2.550; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	22	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8303	10.1371/journal.pone.0008303	http://dx.doi.org/10.1371/journal.pone.0008303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011525	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300050
J	Zot, HG; Hasbun, JE; Van Minh, N				Zot, Henry G.; Hasbun, Javier E.; Van Minh, Nguyen			Striated Muscle Regulation of Isometric Tension by Multiple Equilibria	PLOS ONE			English	Article							THIN FILAMENT; MYOSIN SUBFRAGMENT-1; COOPERATIVE BINDING; ACTIN; TROPOMYOSIN; TROPONIN; MODEL; CONTRACTION; ACTIVATION; DIFFRACTION	Cooperative activation of striated muscle by calcium is based on the movement of tropomyosin described by the steric blocking theory of muscle contraction. Presently, the Hill model stands alone in reproducing both myosin binding data and a sigmoidal-shaped curve characteristic of calcium activation (Hill TL (1983) Two elementary models for the regulation of skeletal muscle contraction by calcium. Biophys J 44: 383-396.). However, the free myosin is assumed to be fixed by the muscle lattice and the cooperative mechanism is based on calcium-dependent interactions between nearest neighbor tropomyosin subunits, which has yet to be validated. As a result, no comprehensive model has been shown capable of fitting actual tension data from striated muscle. We show how variable free myosin is a selective advantage for activating the muscle and describe a mechanism by which a conformational change in tropomyosin propagates free myosin given constant total myosin. This mechanism requires actin, tropomyosin, and filamentous myosin but is independent of troponin. Hence, it will work equally well with striated, smooth and non-muscle contractile systems. Results of simulations with and without data are consistent with a strand of tropomyosin composed of similar to 20 subunits being moved by the concerted action of 3-5 myosin heads, which compares favorably with the predicted length of tropomyosin in the overlap region of thick and thin filaments. We demonstrate that our model fits both equilibrium myosin binding data and steady-state calcium-dependent tension data and show how both the steepness of the response and the sensitivity to calcium can be regulated by the actin-troponin interaction. The model simulates non-cooperative calcium binding both in the presence and absence of strong binding myosin as has been observed. Thus, a comprehensive model based on three well-described interactions with actin, namely, actin-troponin, actin-tropomyosin, and actin-myosin can explain the cooperative calcium activation of striated muscle.	[Zot, Henry G.] Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA; [Hasbun, Javier E.] Univ W Georgia, Dept Phys, Carrollton, GA USA; [Van Minh, Nguyen] Univ W Georgia, Dept Math, Carrollton, GA USA	University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia	Zot, HG (corresponding author), Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA.	hzot@westga.edu			National Science Foundation [MCB-0508203]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation to HGZ (MCB-0508203). The NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNIESZKA GR, 2008, J MOL BIOL, V379, P929; AKIHIRO N, 2001, J MOL BIOL, V308, P241; Bekyarova TI, 2008, P NATL ACAD SCI USA, V105, P10372, DOI 10.1073/pnas.0709877105; CORNELIUS F, 1980, J GEN PHYSIOL, V75, P709, DOI 10.1085/jgp.75.6.709; EISENBERG E, 1980, BIOPHYS J, V29, P195, DOI 10.1016/S0006-3495(80)85126-5; GEEVES MA, 1987, BIOPHYS J, V52, P215, DOI 10.1016/S0006-3495(87)83208-3; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Getz EB, 1998, BIOPHYS J, V75, P2971, DOI 10.1016/S0006-3495(98)77738-0; GOLDMAN YE, 1986, J PHYSIOL-LONDON, V378, P175, DOI 10.1113/jphysiol.1986.sp016213; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; HILL LE, 1992, J BIOL CHEM, V267, P16106; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, BIOPHYS J, V44, P383, DOI 10.1016/S0006-3495(83)84312-4; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; KAWAI M, 1987, PFLUG ARCH EUR J PHY, V408, P1, DOI 10.1007/BF00581833; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; REGNIER MA, 2002, J PHYSL, V15, P485; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; ROSENFELD SS, 1987, J BIOL CHEM, V262, P9984; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8052	10.1371/journal.pone.0008052	http://dx.doi.org/10.1371/journal.pone.0008052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997610	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829700001
J	Kitchen, SG; Bennett, M; Galic, Z; Kim, J; Xu, Q; Young, A; Lieberman, A; Joseph, A; Goldstein, H; Ng, H; Yang, O; Zack, JA				Kitchen, Scott G.; Bennett, Michael; Galic, Zoran; Kim, Joanne; Xu, Qing; Young, Alan; Lieberman, Alexis; Joseph, Aviva; Goldstein, Harris; Ng, Hwee; Yang, Otto; Zack, Jerome A.			Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice	PLOS ONE			English	Article							SCID-HU MOUSE; BLOOD MONONUCLEAR-CELLS; VIRUS TYPE-1 INFECTION; HUMAN THYMIC IMPLANTS; IN-VIVO; EFFECTOR FUNCTIONS; VIRAL-INFECTIONS; FINE SPECIFICITY; GENE-EXPRESSION; RECEPTOR GENES	There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treating persistent viral infections. We examined the potential of genetically programming human hematopoietic stem cells to generate mature CD8+ cytotoxic T lymphocytes that express a molecularly cloned, "transgenic" human anti-HIV T cell receptor (TCR). Anti-HIV TCR transduction of human hematopoietic stem cells directed the maturation of a large population of polyfunctional, HIV-specific CD8+ cells capable of recognizing and killing viral antigen-presenting cells. Thus, through this proof-of-concept we propose that genetic engineering of human hematopoietic stem cells will allow the tailoring of effector T cell responses to fight HIV infection or other diseases that are characterized by the loss of immune control.	[Kitchen, Scott G.; Galic, Zoran; Kim, Joanne; Xu, Qing; Young, Alan; Lieberman, Alexis; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Yang, Otto] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA; [Bennett, Michael; Ng, Hwee; Yang, Otto; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bennett, Michael; Ng, Hwee; Yang, Otto; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Joseph, Aviva; Goldstein, Harris] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Joseph, Aviva; Goldstein, Harris] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kitchen, SG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	skitchen@ucla.edu			California Institute for Regenerative Medicine (CIRM) [RC1-00149-1]; UCLA Center for AIDS esearch (CFAR)	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCLA Center for AIDS esearch (CFAR)	This work was funded by the California Institute for Regenerative Medicine (CIRM) Grant # RC1-00149-1 (http://www.cirm.ca.gov) and the UCLA Center for AIDS esearch (CFAR) (http://www.aidsinstitute.med.ucla.edu/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AKKINA RK, 1994, BLOOD, V84, P1393; Amado RG, 1999, J VIROL, V73, P6361, DOI 10.1128/JVI.73.8.6361-6369.1999; Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; Benito JM, 2004, AIDS REV, V6, P79; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Bollard CM, 2007, BLOOD, V110, P2838, DOI 10.1182/blood-2007-05-091280; Bollard CM, 2004, BIOL BLOOD MARROW TR, V10, P143, DOI 10.1016/j.bbmt.2003.09.017; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bristol GC, 1997, METHODS, V12, P343, DOI 10.1006/meth.1997.0488; Brodie SJ, 2000, J CLIN INVEST, V105, P1407, DOI 10.1172/JCI8707; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Clay TM, 1999, J IMMUNOL, V163, P507; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DiGiusto DL, 1996, BLOOD, V87, P1261, DOI 10.1182/blood.V87.4.1261.bloodjournal8741261; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Galic Z, 2009, STEM CELLS, V27, P100, DOI 10.1634/stemcells.2008-0813; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Huynen MA, 1996, SCIENCE, V272, P1962, DOI 10.1126/science.272.5270.1962; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Kitchen SG, 2005, P NATL ACAD SCI USA, V102, P3794, DOI 10.1073/pnas.0406603102; Kitchen SG, 2000, J VIROL, V74, P2943, DOI 10.1128/JVI.74.6.2943-2948.2000; Kitchen SG, 1998, J VIROL, V72, P9054, DOI 10.1128/JVI.72.11.9054-9060.1998; Lieberman J, 1997, BLOOD, V90, P2196, DOI 10.1182/blood.V90.6.2196.2196_2196_2206; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miles JJ, 2006, CURR MED CHEM, V13, P2725, DOI 10.2174/092986706778521959; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Sullivan YB, 2001, IMMUNOLOGY, V103, P270, DOI 10.1046/j.1365-2567.2001.01243.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; TERSTAPPEN LWMM, 1992, BLOOD, V79, P666; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; WALKER BD, 1989, P NATL ACAD SCI USA, V86, P9514, DOI 10.1073/pnas.86.23.9514; WithersWard ES, 1997, NAT MED, V3, P1102, DOI 10.1038/nm1097-1102; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Yang L, 2002, P NATL ACAD SCI USA, V99, P6204, DOI 10.1073/pnas.092154599; Yang LP, 1998, J EXP MED, V187, P1139, DOI 10.1084/jem.187.7.1139; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977	52	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8208	10.1371/journal.pone.0008208	http://dx.doi.org/10.1371/journal.pone.0008208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997617	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829500021
J	Wust, S; Tischner, D; John, M; Tuckermann, JP; Menzfeld, C; Hanisch, UK; van den Brandt, J; Luhder, F; Reichardt, HM				Wuest, Simone; Tischner, Denise; John, Michael; Tuckermann, Jan P.; Menzfeld, Christiane; Hanisch, Uwe-Karsten; van den Brandt, Jens; Luehder, Fred; Reichardt, Holger M.			Therapeutic and Adverse Effects of a Non-Steroidal Glucocorticoid Receptor Ligand in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; DNA-BINDING; IN-VIVO; T-CELLS; INFLAMMATION; REPRESSION; APOPTOSIS; METHYLPREDNISOLONE; TRANSACTIVATION	Background: Dissociating glucocorticoid receptor (GR) ligands hold great promise for treating inflammatory disorders since it is assumed that they exert beneficial activities mediated by transrepression but avoid adverse effects of GR action requiring transactivation. Here we challenged this paradigm by investigating 2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride (CpdA), a dissociating non-steroidal GR ligand, in the context of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Methodology/Principal Findings: CpdA inhibited pro-inflammatory mediators in myelin-specific T cells and fibroblasts in a GR-dependent manner while gene activation was abolished. However, it also induced massive apoptosis in various cell types even in the absence of the GR by engaging a Bcl-2- and caspase-dependent pathway. (1)H NMR spectroscopy corroborated these findings by revealing that CpdA dissolved in buffered solutions rapidly decomposes into aziridine intermediates known to act as alkylating pro-apoptotic agents. Importantly, the dichotomy of CpdA action also became evident in vivo. Administration of high-dose CpdA to mice was lethal while treatment of EAE with low to intermediate amounts of CpdA dissolved in water significantly ameliorated the disease. The beneficial effect of CpdA required expression of the GR in T cells and was achieved by down regulating LFA-1 and CD44 on peripheral Th cells and by repressing IL-17 production. Conclusions/Significance: CpdA has significant therapeutic potential although adverse effects severely compromise its application in vivo. Hence, non-steroidal GR ligands require careful analysis prior to their translation into new therapeutic concepts.	[Wuest, Simone; Luehder, Fred] Univ Gottingen & Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Gottingen, Germany; [Tischner, Denise; van den Brandt, Jens; Reichardt, Holger M.] Univ Gottingen, Sch Med, Dept Cellular & Mol Immunol, Gottingen, Germany; [John, Michael] Univ Gottingen, Inst Inorgan Chem, Gottingen, Germany; [Tuckermann, Jan P.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Menzfeld, Christiane; Hanisch, Uwe-Karsten] Univ Gottingen, Dept Neuropathol, Sch Med, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Gottingen	Wust, S (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	fred.luehder@med.uni-goettingen.de; hreichardt@med.uni-goettingen.de	John, Michael/I-5673-2019; Reichardt, Holger/AAF-3048-2020	John, Michael/0000-0002-5786-9028; Reichardt, Holger/0000-0003-4647-057X	Gemeinnutzige Hertie-Stiftung [1.01.1/06/010]; Deutsche Forschungsgemeinschaft [Re1631/1-3, Tu220/3-1]	Gemeinnutzige Hertie-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Gemeinnutzige Hertie-Stiftung (1.01.1/06/010) and the Deutsche Forschungsgemeinschaft (Re1631/1-3, Tu220/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2001, J CLIN INVEST, V107, P265, DOI 10.1172/JCI12157; BROIS SJ, 1970, TETRAHEDRON, V26, P296; CHAPMAN NB, 1963, J CHEM SOC, P1385, DOI 10.1039/jr9630001385; Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355; CRIST DR, 1980, ORG MAGN RESONANCE, V13, P45, DOI 10.1002/mrc.1270130110; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOLD R, 1995, P NATL ACAD SCI USA, V92, P5850, DOI 10.1073/pnas.92.13.5850; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; HENCH PS, 1950, ARCH INTERN MED, V85, P545, DOI 10.1001/archinte.1950.00230100002001; Herold MJ, 2006, J BIOL CHEM, V281, P13663, DOI 10.1074/jbc.M600266200; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kirwan J, 2007, CURR OPIN RHEUMATOL, V19, P233, DOI 10.1097/BOR.0b013e3280d6471a; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Louw A, 1999, ENDOCRINOLOGY, V140, P2044, DOI 10.1210/en.140.5.2044; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Luhder F, 2009, CRIT REV IMMUNOL, V29, P255, DOI 10.1615/CritRevImmunol.v29.i3.50; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Oliveri RL, 1998, NEUROLOGY, V50, P1833, DOI 10.1212/WNL.50.6.1833; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Tanner TM, 2003, MOL CELL ENDOCRINOL, V201, P155, DOI 10.1016/S0303-7207(02)00411-2; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Tuckermann JP, 2005, CRIT REV CL LAB SCI, V42, P71, DOI 10.1080/10408360590888983; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Tudor G, 2000, CELL DEATH DIFFER, V7, P574, DOI 10.1038/sj.cdd.4400688; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434	37	59	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8202	10.1371/journal.pone.0008202	http://dx.doi.org/10.1371/journal.pone.0008202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997594	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829500019
J	Chen, F; Hu, YL; Li, DQ; Chen, HD; Zhang, XL				Chen, Fang; Hu, Yilan; Li, Dongqing; Chen, Haidan; Zhang, Xiao-Lian			CS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2	PLOS ONE			English	Article							RNA APTAMERS; CD81; IDENTIFICATION; INTERFERON; TIME; GENOTYPE-6; RECEPTORS; RIBAVIRIN; SELECTION; BINDING	Currently, the development of effective diagnostic reagents as well as treatments against Hepatitis C virus (HCV) remains a high priority. In this study, we have described the development of an alive cell surface -Systematic Evolution of Ligands by Exponential Enrichment (CS-SELEX) technique and screened the functional ssDNA aptamers that specifically bound to HCV envelope surface glycoprotein E2. Through 13 rounds of selection, the CS-SELEX generated high-affinity ssDNA aptamers, and the selected ssDNA aptamer ZE2 demonstrated the highest specificity and affinity to E2-positive cells. HCV particles could be specifically captured and diagnosed using the aptamer ZE2. A good correlation was observed in HCV patients between HCV E2 antigen-aptamer assay and assays for HCV RNA quantities or HCV antibody detection. Moreover, the selected aptamers, especially ZE2, could competitively inhibit E2 protein binding to CD81, an important HCV receptor, and significantly block HCV cell culture (HCVcc) infection of human hepatocytes (Huh7.5.1) in vitro. Our data demonstrate that the newly selected ssDNA aptamers, especially aptamer ZE2, hold great promise for developing new molecular probes, as an early diagnostic reagent for HCV surface antigen, or a therapeutic drug specifically for HCV.	[Chen, Fang; Hu, Yilan; Li, Dongqing; Chen, Haidan; Zhang, Xiao-Lian] Wuhan Univ, Sch Med, Hubei Prov Key Lab Allergy & Immunol, State Key Lab Virol,Dept Immunol, Wuhan, Hubei, Peoples R China	Wuhan University	Chen, F (corresponding author), Wuhan Univ, Sch Med, Hubei Prov Key Lab Allergy & Immunol, State Key Lab Virol,Dept Immunol, Wuhan, Hubei, Peoples R China.	zhangxl65@whu.edu.cn		Chen, Haidan/0000-0002-6086-7402	National Natural Science Foundation of China [20532020, 30670098, 30870122]; 973 Program of China [2006CB504300, 2009CB522507]; Hubei Province Natural Science Foundation [2006ABD007]; National Grand Program on Key Infectious Disease [2008ZX10003-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province); National Grand Program on Key Infectious Disease	This work was supported by grants from the National Natural Science Foundation of China (20532020, 30670098, and 30870122), the 973 Program of China (2006CB504300, 2009CB522507), the Hubei Province Natural Science Foundation (2006ABD007), and National Grand Program on Key Infectious Disease (2008ZX10003-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bellecave Pantxika, 2008, Hepatology, V48, P1330, DOI 10.1002/hep.22571; Biroccio A, 2002, J VIROL, V76, P3688, DOI 10.1128/JVI.76.8.3688-3696.2002; Boyer N, 2000, J HEPATOL, V32, P98, DOI 10.1016/S0168-8278(00)80419-5; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cao J, 2003, CELL RES, V13, P473, DOI 10.1038/sj.cr.7290190; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; De LC, 2005, EUR J CLIN MICROBIOL, V24, P566, DOI 10.1007/s10096-005-1369-8; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2000, REV MED VIROL, V10, P101, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;101::AID-RMV268&gt;3.0.CO;2-W; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Hsu CS, 2008, LIVER INT, V28, P271, DOI 10.1111/j.1478-3231.2007.01626.x; Hwang B, 2004, RNA, V10, P1277, DOI 10.1261/rna.7100904; Kikuchi K, 2003, J BIOCHEM, V133, P263, DOI 10.1093/jb/mvg036; Li PF, 2007, VACCINE, V25, P1544, DOI 10.1016/j.vaccine.2006.09.091; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Memon MI, 2002, J VIRAL HEPATITIS, V9, P84, DOI 10.1046/j.1365-2893.2002.00329.x; Menegazzi P, 2008, NEW MICROBIOL, V31, P181; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Oh HB, 2008, J MED VIROL, V80, P1712, DOI 10.1002/jmv.21162; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pan Q, 2005, ANTIMICROB AGENTS CH, V49, P4052, DOI 10.1128/AAC.49.10.4052-4060.2005; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rosenberg S, 2001, J MOL BIOL, V313, P451, DOI 10.1006/jmbi.2001.5055; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smallwood GA, 2008, TRANSPLANTATION, V86, P1795, DOI 10.1097/TP.0b013e3181914188; Takahashi M, 2005, J CLIN MICROBIOL, V43, P186, DOI 10.1128/JCM.43.1.186-191.2005; Yang JH, 2002, J VIROL METHODS, V102, P119, DOI 10.1016/S0166-0934(02)00007-1	39	66	72	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8142	10.1371/journal.pone.0008142	http://dx.doi.org/10.1371/journal.pone.0008142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997645	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829000004
J	Chen, PW; Randazzo, PA; Parent, CA				Chen, Pei-Wen; Randazzo, Paul A.; Parent, Carole A.			ACAP-A/B Are ArfGAP Homologs in Dictyostelium Involved in Sporulation but Not in Chemotaxis	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; CELL-MIGRATION; ACTIN CYTOSKELETON; BINDING PROTEINS; ASAP1; LOCALIZATION; GAP; CANCER; PHOSPHORYLATION	Arfs and Arf GTPase-activating proteins (ArfGAPs) are regulators of membrane trafficking and actin dynamics in mammalian cells. In this study, we identified a primordial Arf, ArfA, and two ArfGAPs (ACAP-A/B) containing BAR, PH, ArfGAP and Ankyrin repeat domains in the eukaryote Dictyostelium discoideum. In vitro, ArfA has similar nucleotide binding properties as mammalian Arfs and, with GTP bound, is a substrate for ACAP-A and B. We also investigated the physiological functions of ACAP-A/B by characterizing cells lacking both ACAP-A and B. Although ACAP-A/B knockout cells showed no defects in cell growth, migration or chemotaxis, they exhibited abnormal actin protrusions and similar to 50% reduction in spore yield. We conclude that while ACAP-A/B have a conserved biochemical mechanism and effect on actin organization, their role in migration is not conserved. The absence of an effect on Dictyostelium migration may be due to a specific requirement for ACAPs in mesenchymal migration, which is observed in epithelial cancer cells where most studies of mammalian ArfGAPs were performed.	[Chen, Pei-Wen; Randazzo, Paul A.; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, PW (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov	Chen, Pei-Wen/B-7142-2015		National Cancer Institute, National Institutes of Health [Z01-BC-007365]; NATIONAL CANCER INSTITUTE [Z01BC007365, ZIABC010418, ZIABC007365] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the intramural program of the National Cancer Institute, National Institutes of Health, project Z01-BC-007365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLOT CH, 1987, J BIOL CHEM, V262, P3918; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gotthardt D, 2006, MOL CELL PROTEOMICS, V5, P2228, DOI 10.1074/mcp.M600113-MCP200; Gruschus JM, 2009, STRUCTURE, V17, P2, DOI 10.1016/j.str.2008.12.002; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Ha VL, 2008, ADV CANCER RES, V101, P1, DOI 10.1016/S0065-230X(08)00401-6; HAUN RS, 1993, J BIOL CHEM, V268, P7064; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Koizumi K, 2005, DEVELOPMENT, V132, P1699, DOI 10.1242/dev.01716; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; LOOMIS WF, 1969, J BACTERIOL, V99, P65, DOI 10.1128/JB.99.1.65-69.1969; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Luo R, 2009, CELL SIGNAL, V21, P1169, DOI 10.1016/j.cellsig.2009.03.006; Mahadeo DC, 2006, CURR TOP DEV BIOL, V73, P115, DOI 10.1016/S0070-2153(05)73004-0; Mondal S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-23; MURTAGH JJ, 1992, J BIOL CHEM, V267, P9654; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Naramoto S, 2009, DEVELOPMENT, V136, P1529, DOI 10.1242/dev.030098; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pilcher KE, 2007, NAT PROTOC, V2, P1325, DOI 10.1038/nprot.2007.180; Ponte E, 2000, MECH DEVELOP, V91, P153, DOI 10.1016/S0925-4773(99)00292-0; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Repass SL, 2007, J CELL SCI, V120, P3977, DOI 10.1242/jcs.011213; Srinivasan S, 2000, TRENDS CELL BIOL, V10, P215, DOI 10.1016/S0962-8924(00)01758-X; Srinivasan S, 2001, PROTEOMICS, V1, P1119, DOI 10.1002/1615-9861(200109)1:9<1119::AID-PROT1119>3.3.CO;2-O; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Zhang P, 2001, DIFFERENTIATION, V67, P72, DOI 10.1046/j.1432-0436.2001.067003072.x	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8624	10.1371/journal.pone.0008624	http://dx.doi.org/10.1371/journal.pone.0008624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062541	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414100011
J	Bruchas, MR; Land, BB; Lemos, JC; Chavkin, C				Bruchas, Michael R.; Land, Benjamin B.; Lemos, Julia C.; Chavkin, Charles			CRF1-R Activation of the Dynorphin/Kappa Opioid System in the Mouse Basolateral Amygdala Mediates Anxiety-Like Behavior	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; STRESS-INDUCED RELAPSE; ELEVATED PLUS-MAZE; COCAINE SEEKING; HIGH-AFFINITY; ANTAGONIST; INCREASES; DOPAMINE; CORTICOSTERONE; STIMULATION	Stress is a complex human experience and having both rewarding and aversive motivational properties. The adverse effects of stress are well documented, yet many of underlying mechanisms remain unclear and controversial. Here we report that the anxiogenic properties of stress are encoded by the endogenous opioid peptide dynorphin acting in the basolateral amygdala. Using pharmacological and genetic approaches, we found that the anxiogenic-like effects of Corticotropin Releasing Factor (CRF) were triggered by CRF1-R activation of the dynorphin/kappa opioid receptor (KOR) system. Central CRF administration significantly reduced the percent open-arm time in the elevated plus maze (EPM). The reduction in open-arm time was blocked by pretreatment with the KOR antagonist norbinaltorphimine (norBNI), and was not evident in mice lacking the endogenous KOR ligand dynorphin. The CRF1-R agonist stressin 1 also significantly reduced open-arm time in the EPM, and this decrease was blocked by norBNI. In contrast, the selective CRF2-R agonist urocortin III did not affect open arm time, and mice lacking CRF2-R still showed an increase in anxiety-like behavior in response to CRF injection. However, CRF2-R knockout animals did not develop CRF conditioned place aversion, suggesting that CRF1-R activation may mediate anxiety and CRF2-R may encode aversion. Using a phosphoselective antibody (KORp) to identify sites of dynorphin action, we found that CRF increased KORp-immunoreactivity in the basolateral amygdala (BLA) of wildtype, but not in mice pretreated with the selective CRF1-R antagonist, antalarmin. Consistent with the concept that acute stress or CRF injection-induced anxiety was mediated by dynorphin release in the BLA, local injection of norBNI blocked the stress or CRF-induced increase in anxiety-like behavior; whereas norBNI injection in a nearby thalamic nucleus did not. The intersection of stress-induced CRF and the dynorphin/KOR system in the BLA was surprising, and these results suggest that CRF and dynorphin/KOR systems may coordinate stress-induced anxiety behaviors and aversive behaviors via different mechanisms.	[Bruchas, Michael R.; Land, Benjamin B.; Lemos, Julia C.; Chavkin, Charles] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Land, Benjamin B.; Lemos, Julia C.; Chavkin, Charles] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bruchas, MR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	cchavkin@u.washington.edu	Chavkin, Charles/G-2797-2010; Bruchas, Michael/G-7616-2012	Lemos, Julia/0000-0002-5442-8876	US National Institutes of Health, National Institute on Drug Abuse [DA20570, DA16898, DA25182]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020570, R00DA025182, R21DA025970, K99DA025182, R01DA016898] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health, National Institute on Drug Abuse (DA20570, DA16898, DA25182) (www.nih.gov) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; BALE TL, 2001, ANN REV PHARM TOXICO, V11, P523; Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO, V33, P425, DOI 10.1016/j.psyneuen.2007.12.010; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; BRUCHAS MR, 2009, BRAIN RES; BRUELAS MR, 2007, J BIOL CHEM, V282, P29803; CADOR M, 1992, BRAIN RES, V597, P304, DOI 10.1016/0006-8993(92)91487-Y; Carey AN, 2007, EUR J PHARMACOL, V569, P84, DOI 10.1016/j.ejphar.2007.05.007; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; COSTE SC, 2000, NAT GENET, V21, P103; DESOUZA EB, 1987, J NEUROSCI, V7, P88; Erb S, 1998, J NEUROSCI, V18, P5529, DOI 10.1523/JNEUROSCI.18-14-05529.1998; Funk CK, 2007, BIOL PSYCHIAT, V61, P78, DOI 10.1016/j.biopsych.2006.03.063; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; GREIBEL G, 2002, J PHARMACOL EXP THER, V301, P333; Hammack SE, 2003, J NEUROSCI, V23, P1019; Heinrichs SC, 1995, ANN NY ACAD SCI, V771, P92, DOI 10.1111/j.1749-6632.1995.tb44673.x; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Hubbard DT, 2007, NEUROSCIENCE, V150, P818, DOI 10.1016/j.neuroscience.2007.10.001; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kudryavtseva NN, 2004, PEPTIDES, V25, P1355, DOI 10.1016/j.peptides.2004.05.005; LAND BB, 2009, P NATL ACAD SCI US; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lu L, 2003, J NEUROCHEM, V84, P1378, DOI 10.1046/j.1471-4159.2003.01635.x; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; MULLER MB, 2008, NAT NEUROSCI, V10, P1100; NIKOLARAKIS KE, 1986, BRAIN RES, V399, P152, DOI 10.1016/0006-8993(86)90610-4; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Redila VA, 2008, PSYCHOPHARMACOLOGY, V200, P59, DOI 10.1007/s00213-008-1122-y; Rivier J, 2007, J MED CHEM, V50, P1668, DOI 10.1021/jm0613875; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sandi C, 2008, EUR J NEUROSCI, V28, P1836, DOI 10.1111/j.1460-9568.2008.06451.x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1997, J NEUROSCI, V17, P2605; SHARIFI N, 2004, J NEUROSCI, V86, P707; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SONG ZH, 1992, EUR J PHARMACOL, V222, P27, DOI 10.1016/0014-2999(92)90458-G; Spina MG, 2000, NEUROPSYCHOPHARMACOL, V22, P230, DOI 10.1016/S0893-133X(99)00108-6; Ugolini A, 2008, FRONT BEHAV NEUROSCI, V2, DOI 10.3389/neuro.08.002.2008; Wall PM, 2001, NEUROSCI BIOBEHAV R, V25, P275, DOI 10.1016/S0149-7634(01)00013-6; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; WINMANN W, 2008, NEUROPSYCHOPHARMACOL, V34, P775; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	53	137	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8528	10.1371/journal.pone.0008528	http://dx.doi.org/10.1371/journal.pone.0008528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YP	20052275	Green Published, Green Submitted, gold			2022-12-27	WOS:000207567200002
J	Nguyen, LN; Trofa, D; Nosanchuk, JD				Nguyen, Long Nam; Trofa, David; Nosanchuk, Joshua D.			Fatty Acid Synthase Impacts the Pathobiology of Candida parapsilosis In Vitro and during Mammalian Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CRYPTOCOCCUS-NEOFORMANS; BIOFILM FORMATION; ALBICANS; INHIBITION; GENE; BIOSYNTHESIS; ARCHITECTURE; RESOLUTION; VIRULENCE	Cytosolic fungal fatty acid synthase is composed of two subunits alpha and beta, which are encoded by Fas1 and Fas2 genes. In this study, the Fas2 genes of the human pathogen Candida parapsilosis were deleted using a modified SAT1 flipper technique. CpFas2 was essential in media lacking exogenous fatty acids and the growth of Fas2 disruptants (Fas2 KO) was regulated by the supplementation of different long chain fatty acids, such as myristic acid (14: 0), palmitic acid (16: 0), and Tween 80, in a dose-specific manner. Lipidomic analysis revealed that Fas2 KO cells were severely restricted in production of unsaturated fatty acids. The Fas2 KO strains were unable to form normal biofilms and were more efficiently killed by murine-like macrophages, J774.16, than the wild type, heterozygous and reconstituted strains. Furthermore, Fas2 KO yeast were significantly less virulent in a systemic murine infection model. The Fas2 KO cells were also hypersensitive to human serum, and inhibition of CpFas2 in WT C. parapsilosis by cerulenin significantly decreased fungal growth in human serum. This study demonstrates that CpFas2 is essential for C. parapsilosis growth in the absence of exogenous fatty acids, is involved in unsaturated fatty acid production, influences fungal virulence, and represents a promising antifungal drug target.	[Nguyen, Long Nam; Trofa, David; Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Med, Div Infect Dis, New York, NY USA; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Yeshiva University; Yeshiva University	Nguyen, LN (corresponding author), Albert Einstein Coll Med, Dept Med, Div Infect Dis, New York, NY USA.	nosanchu@aecom.yu.edu	Nguyen, Long/AAY-6172-2021; Nosanchuk, Joshua/AAS-7801-2021	Nguyen, Long N/0000-0002-9857-2239; Trofa, David/0000-0002-1550-9534	Irma T. Hirschl/Monique Weill-Caulier Trust; IDSA Medical Scholarship	Irma T. Hirschl/Monique Weill-Caulier Trust; IDSA Medical Scholarship	JDN is supported in part by an Irma T. Hirschl/Monique Weill-Caulier Trust Research Award and DT was supported by an IDSA Medical Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chayakulkeeree M, 2007, ANTIMICROB AGENTS CH, V51, P3537, DOI 10.1128/AAC.00442-07; Gacser A, 2007, J CLIN INVEST, V117, P3049, DOI 10.1172/JCI32294; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Johansson P, 2008, P NATL ACAD SCI USA, V105, P12803, DOI 10.1073/pnas.0805827105; Krishnamurthy S, 2004, MICROBIOL-SGM, V150, P1991, DOI 10.1099/mic.0.27029-0; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Kuhn DM, 2004, EMERG INFECT DIS, V10, P1074, DOI 10.3201/eid1006.030873; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinez LR, 2006, ANTIMICROB AGENTS CH, V50, P1021, DOI 10.1128/AAC.50.3.1021-1033.2006; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Morbidoni HR, 2006, CHEM BIOL, V13, P297, DOI 10.1016/j.chembiol.2006.01.005; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; Neugnot V, 2002, EUR J BIOCHEM, V269, P1734, DOI 10.1046/j.1432-1327.2002.02828.x; Ngo SC, 2007, ANTIMICROB AGENTS CH, V51, P2430, DOI 10.1128/AAC.01458-06; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; PFALLER MA, 1995, MYCOPATHOLOGIA, V130, P3, DOI 10.1007/BF01104343; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Xu DM, 2009, J BIOL CHEM, V284, P19754, DOI 10.1074/jbc.M109.019877; Zhao XJ, 1996, MICROBIOL-UK, V142, P2509, DOI 10.1099/00221287-142-9-2509; Zhao XJ, 1997, INFECT IMMUN, V65, P829, DOI 10.1128/IAI.65.2.829-832.1997	31	32	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8421	10.1371/journal.pone.0008421	http://dx.doi.org/10.1371/journal.pone.0008421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027295	Green Submitted, Green Published, gold			2022-12-27	WOS:000272998000020
J	Hinoue, T; Weisenberger, DJ; Pan, F; Campan, M; Kim, M; Young, J; Whitehall, VL; Leggett, BA; Laird, PW				Hinoue, Toshinori; Weisenberger, Daniel J.; Pan, Fei; Campan, Mihaela; Kim, Myungjin; Young, Joanne; Whitehall, Vicki L.; Leggett, Barbara A.; Laird, Peter W.			Analysis of the Association between CIMP and BRAF(V600E) in Colorectal Cancer by DNA Methylation Profiling	PLOS ONE			English	Article							CPG ISLAND METHYLATION; ABERRANT CRYPT FOCI; SERRATED POLYPS; COLON-CANCER; BRAF MUTATION; MICROSATELLITE INSTABILITY; HYPERPLASTIC POLYPOSIS; GENE-EXPRESSION; KRAS MUTATIONS; CELL-LINES	A CpG island methylator phenotype (CIMP) is displayed by a distinct subset of colorectal cancers with a high frequency of DNA hypermethylation in a specific group of CpG islands. Recent studies have shown that an activating mutation of BRAF (BRAF(V600E)) is tightly associated with CIMP, raising the question of whether BRAF(V600E) plays a causal role in the development of CIMP or whether CIMP provides a favorable environment for the acquisition of BRAF(V600E). We employed Illumina GoldenGate DNA methylation technology, which interrogates 1,505 CpG sites in 807 different genes, to further study this association. We first examined whether expression of BRAF(V600E) causes DNA hypermethylation by stably expressing BRAF(V600E) in the CIMP-negative, BRAF wild-type COLO 320DM colorectal cancer cell line. We determined 100 CIMP-ssociated CpG sites and examined changes in DNA methylation in eight stably transfected clones over multiple passages. We found that BRAF(V600E) is not sufficient to induce CIMP in our system. Secondly, considering the alternative possibility, we identified genes whose DNA hypermethylation was closely linked to BRAF(V600E) and CIMP in 235 primary colorectal tumors. Interestingly, genes that showed the most significant link include those that mediate various signaling pathways implicated in colorectal tumorigenesis, such as BMP3 and BMP6 (BMP signaling), EPHA3, KIT, and FLT1 (receptor tyrosine kinases) and SMO (Hedgehog signaling). Furthermore, we identified CIMP-dependent DNA hypermethylation of IGFBP7, which has been shown to mediate BRAF(V600E)-induced cellular senescence and apoptosis. Promoter DNA hypermethylation of IGFBP7 was associated with silencing of the gene. CIMP-specific inactivation of BRAF(V600E)-induced senescence and apoptosis pathways by IGFBP7 DNA hypermethylation might create a favorable context for the acquisition of BRAF(V600E) in CIMP+ colorectal cancer. Our data will be useful for future investigations toward understanding CIMP in colorectal cancer and gaining insights into the role of aberrant DNA hypermethylation in colorectal tumorigenesis.	[Hinoue, Toshinori; Weisenberger, Daniel J.; Pan, Fei; Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Hinoue, Toshinori; Campan, Mihaela; Kim, Myungjin; Laird, Peter W.] Univ So Calif, Dept Surg, Los Angeles, CA 90033 USA; [Hinoue, Toshinori; Campan, Mihaela; Kim, Myungjin; Laird, Peter W.] Univ So Calif, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Young, Joanne] Queensland Inst Med Res, Familial Canc Lab, Herston, Qld 4006, Australia; [Young, Joanne] Univ Queensland, Sch Med, Herston, Qld, Australia; [Whitehall, Vicki L.; Leggett, Barbara A.] Royal Brisbane & Womens Hosp Res Fdn, Conjoint Gastroenterol Lab, Clin Res Ctr, Herston, Qld, Australia	University of Southern California; University of Southern California; University of Southern California; QIMR Berghofer Medical Research Institute; University of Queensland; Royal Brisbane & Women's Hospital	Hinoue, T (corresponding author), Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA.	plaird@usc.edu	Whitehall, Vicki L/B-6262-2013; Weisenberger, Daniel/AAA-8314-2020; Young, Joanne P/B-9981-2011; Young, Joanne P/H-7774-2014; Leggett, Barbara A/D-3579-2011; Laird, Peter W/G-8683-2012; Whitehall, Vicki/E-5414-2019	Whitehall, Vicki L/0000-0002-8285-2391; Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Young, Joanne/0000-0002-1514-1522; Leggett, Barbara/0000-0003-2062-7380	National Institutes of Health (NIH) [R01 CA118699-02, R01 CA075090-09]; NATIONAL CANCER INSTITUTE [R01CA075090, R01CA118699] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (NIH) grants R01 CA118699-02 (P. W. Laird), R01 CA075090-09 (P. W. Laird). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura S, 2009, GASTROENTEROLOGY, V137, P629, DOI 10.1053/j.gastro.2009.04.059; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bates RC, 2003, CURR BIOL, V13, P1721, DOI 10.1016/j.cub.2003.09.002; Beach R, 2005, AM J PATHOL, V166, P1069, DOI 10.1016/S0002-9440(10)62327-9; Bellone G, 2006, INT J ONCOL, V29, P851; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bibikova Marina, 2009, V507, P149, DOI 10.1007/978-1-59745-522-0_12; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cichowski K, 2008, CELL, V133, P958, DOI 10.1016/j.cell.2008.05.027; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Haigis KM, 2007, GENE DEV, V21, P361, DOI 10.1101/gad.1532107; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Kraunz KS, 2005, BRIT J CANCER, V93, P949, DOI 10.1038/sj.bjc.6602790; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lin J, 2007, J PATHOL, V212, P83, DOI 10.1002/path.2144; Loh K, 2008, GENE CHROMOSOME CANC, V47, P449, DOI 10.1002/gcc.20552; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Muthuswami R, 2000, BIOCHEMISTRY-US, V39, P4358, DOI 10.1021/bi992503r; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; O'Brien MJ, 2007, GASTROENTEROL CLIN N, V36, P947, DOI 10.1016/j.gtc.2007.08.007; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Velho S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-255; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	53	117	119	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8357	10.1371/journal.pone.0008357	http://dx.doi.org/10.1371/journal.pone.0008357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027224	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100005
J	Annan, RB; Lee, AY; Reid, ID; Sayad, A; Whiteway, M; Hallett, M; Thomas, DY				Annan, Robert B.; Lee, Anna Y.; Reid, Ian D.; Sayad, Azin; Whiteway, Malcolm; Hallett, Michael; Thomas, David Y.			A Biochemical Genomics Screen for Substrates of Ste20p Kinase Enables the In Silico Prediction of Novel Substrates	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; PROTEIN-PROTEIN INTERACTIONS; HIDDEN MARKOV-MODELS; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; ACTIN CYTOSKELETON; BUDDING YEAST; PHEROMONE RESPONSE; GLOBAL ANALYSIS; CELL POLARITY	The Ste20/PAK family is involved in many cellular processes, including the regulation of actin-based cytoskeletal dynamics and the activation of MAPK signaling pathways. Despite its numerous roles, few of its substrates have been identified. To better characterize the roles of the yeast Ste20p kinase, we developed an in vitro biochemical genomics screen to identify its substrates. When applied to 539 purified yeast proteins, the screen reported 14 targets of Ste20p phosphorylation. We used the data resulting from our screen to build an in silico predictor to identify Ste20p substrates on a proteome-wide basis. Since kinase-substrate specificity is often mediated by additional binding events at sites distal to the phosphorylation site, the predictor uses the presence/absence of multiple sequence motifs to evaluate potential substrates. Statistical validation estimates a threefold improvement in substrate recovery over random predictions, despite the lack of a single dominant motif that can characterize Ste20p phosphorylation. The set of predicted substrates significantly overrepresents elements of the genetic and physical interaction networks surrounding Ste20p, suggesting that some of the predicted substrates are in vivo targets. We validated this combined experimental and computational approach for identifying kinase substrates by confirming the in vitro phosphorylation of polarisome components Bni1p and Bud6p, thus suggesting a mechanism by which Ste20p effects polarized growth.	[Annan, Robert B.; Thomas, David Y.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Lee, Anna Y.; Reid, Ian D.; Sayad, Azin; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Whiteway, Malcolm] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ, Canada; [Lee, Anna Y.; Hallett, Michael] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Hallett, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	McGill University; McGill University; National Research Council Canada; McGill University; McGill University	Annan, RB (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	robert.annan@mail.mcgill.ca	Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X; Hallett, Michael/0000-0001-6738-6786; Reid, Ian/0000-0002-1079-3724	National Science and Engineering Research Council of Canada; National Research Council Canada; National Cancer Institute of Canada; Canadian Institutes of Health Research	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	R.B.A. and A.Y.L. were the recipients of National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) graduate student fellowships. This work was supported by the National Research Council Canada (NRC; http://www.nrc-cnrc.gc.ca) and grants to M.W. and D.Y.T. from the National Cancer Institute of Canada (http://cancer.ca/research/) and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; [Anonymous], SGD SACCHAROMYCES GE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chang EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000656; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiroli E, 2003, J CELL BIOL, V160, P857, DOI 10.1083/jcb.200209097; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Eby JJ, 1998, CURR BIOL, V8, P967, DOI 10.1016/S0960-9822(98)00398-4; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Goehring AS, 2003, MOL BIOL CELL, V14, P1501, DOI 10.1091/mbc.E02-06-0348; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Loyet KM, 2005, MOL CELL PROTEOMICS, V4, P235, DOI 10.1074/mcp.R400011-MCP200; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Payne WE, 1997, NUCLEIC ACIDS RES, V25, P57, DOI 10.1093/nar/25.1.57; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pruyne D, 2000, J CELL SCI, V113, P571; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; R Development Core Team, 2007, R LANG ENV STAT COMP; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; ROSE MD, 1990, METHODS YEAST GENETI, V5; Saunders NFW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-245; Senawongse P, 2005, J CHEM INF MODEL, V45, P1147, DOI 10.1021/ci050047+; Shah Kavita, 2003, Methods Mol Biol, V233, P253; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu C, 1997, J BIOL CHEM, V272, P30623, DOI 10.1074/jbc.272.49.30623; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu GZ, 2005, CELL CYCLE, V4, P52, DOI 10.4161/cc.4.1.1353; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	66	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8279	10.1371/journal.pone.0008279	http://dx.doi.org/10.1371/journal.pone.0008279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20020052	Green Published, gold			2022-12-27	WOS:000272834000010
J	Frank, RT; Edmiston, M; Kendall, SE; Najbauer, J; Cheung, CW; Kassa, T; Metz, MZ; Kim, SU; Glackin, CA; Wu, AM; Yazaki, PJ; Aboody, KS				Frank, Richard T.; Edmiston, Marissa; Kendall, Stephen E.; Najbauer, Joseph; Cheung, Chia-Wei; Kassa, Thewodros; Metz, Marianne Z.; Kim, Seung U.; Glackin, Carlotta A.; Wu, Anna M.; Yazaki, Paul J.; Aboody, Karen S.			Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies	PLOS ONE			English	Article							BREAST-CANCER CELLS; BRAIN METASTASES; RESISTANCE; HERCEPTIN; TROPISM; TARGET; GROWTH	Background: Recombinant monoclonal antibodies have emerged as important tools for cancer therapy. Despite the promise shown by antibody-based therapies, the large molecular size of antibodies limits their ability to efficiently penetrate solid tumors and precludes efficient crossing of the blood-brain-barrier into the central nervous system (CNS). Consequently, poorly vascularized solid tumors and CNS metastases cannot be effectively treated by intravenously-injected antibodies. The inherent tumor-tropic properties of human neural stem cells (NSCs) can potentially be harnessed to overcome these obstacles and significantly improve cancer immunotherapy. Intravenously-delivered NSCs preferentially migrate to primary and metastatic tumor sites within and outside the CNS. Therefore, we hypothesized that NSCs could serve as an ideal cellular delivery platform for targeting antibodies to malignant tumors. Methods and Findings: As proof-of-concept, we selected Herceptin(TM) (trastuzumab), a monoclonal antibody widely used to treat HER2-overexpressing breast cancer. HER2 overexpression in breast cancer is highly correlated with CNS metastases, which are inaccessible to trastuzumab therapy. Therefore, NSC-mediated delivery of trastuzumab may improve its therapeutic efficacy. Here we report, for the first time, that human NSCs can be genetically modified to secrete anti-HER2 immunoglobulin molecules. These NSC-secreted antibodies assemble properly, possess tumor cell-binding affinity and specificity, and can effectively inhibit the proliferation of HER2-overexpressing breast cancer cells in vitro. We also demonstrate that immunoglobulin-secreting NSCs exhibit preferential tropism to tumor cells in vivo, and can deliver antibodies to human breast cancer xenografts in mice. Conclusions: Taken together, these results suggest that NSCs modified to secrete HER2-targeting antibodies constitute a promising novel platform for targeted cancer immunotherapy. Specifically, this NSC-mediated antibody delivery system has the potential to significantly improve clinical outcome for patients with HER2-overexpressing breast cancer.	[Frank, Richard T.; Edmiston, Marissa; Najbauer, Joseph; Metz, Marianne Z.; Aboody, Karen S.] City Hope Natl Med Ctr, Div Hematol, Duarte, CA 91010 USA; [Frank, Richard T.; Edmiston, Marissa; Najbauer, Joseph; Metz, Marianne Z.; Aboody, Karen S.] City Hope Natl Med Ctr, Div Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Frank, Richard T.; Edmiston, Marissa; Kendall, Stephen E.; Najbauer, Joseph; Cheung, Chia-Wei; Kassa, Thewodros; Metz, Marianne Z.; Glackin, Carlotta A.; Yazaki, Paul J.; Aboody, Karen S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Kendall, Stephen E.; Glackin, Carlotta A.] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Cheung, Chia-Wei; Kassa, Thewodros; Yazaki, Paul J.] City Hope Natl Med Ctr, Dept Canc Immunotherapy & Tumor Immunol, Duarte, CA 91010 USA; [Aboody, Karen S.] City Hope Natl Med Ctr, Dept Neurosci, Duarte, CA 91010 USA; [Wu, Anna M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Gachon Univ, Gil Hosp, Inst Regenerat Med, Inchon, South Korea	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia; Gachon University	Frank, RT (corresponding author), City Hope Natl Med Ctr, Div Hematol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	rikfrank@gmail.com; kaboody@coh.org		Wu, Anna/0000-0001-8487-823X	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; Jewish Federation's Jeanne Schnitzer Reynolds Fund for Women's Health; Ziman Family Foundation; Helen and Morgan Chu Graduate Student Fellowship; Irell and Manella Graduate School of Biological Sciences; Beckman Research Institute at City of Hope	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; Jewish Federation's Jeanne Schnitzer Reynolds Fund for Women's Health; Ziman Family Foundation; Helen and Morgan Chu Graduate Student Fellowship; Irell and Manella Graduate School of Biological Sciences; Beckman Research Institute at City of Hope	This work was supported by the Rosalinde and Arthur Gilbert Foundation, STOP CANCER, The Jewish Federation's Jeanne Schnitzer Reynolds Fund for Women's Health, Ziman Family Foundation, the Helen and Morgan Chu Graduate Student Fellowship, the Irell and Manella Graduate School of Biological Sciences and the Beckman Research Institute at City of Hope. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2006, NEURO-ONCOLOGY, V8, P119, DOI 10.1215/15228517-2005-012; Adams GP, 2001, CANCER RES, V61, P4750; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Danks MK, 2007, CANCER RES, V67, P22, DOI 10.1158/0008-5472.CAN-06-3607; Dimopoulou I, 2006, ANN ONCOL, V17, P372, DOI 10.1093/annonc/mdj057; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Joo KM, 2009, MOL THER, V17, P570, DOI 10.1038/mt.2008.290; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kute T, 2004, CYTOM PART A, V57A, P86, DOI 10.1002/cyto.a.10095; Melisko ME, 2009, NAT CLIN PRACT ONCOL, V6, P25, DOI 10.1038/ncponc1243; Molina MA, 2001, CANCER RES, V61, P4744; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Nielsen DL, 2009, CANCER TREAT REV, V35, P121, DOI 10.1016/j.ctrv.2008.09.003; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; SPECTOR NL, 2009, J CLIN ONCOL; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146	22	59	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8314	10.1371/journal.pone.0008314	http://dx.doi.org/10.1371/journal.pone.0008314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016813	Green Published, gold, Green Submitted			2022-12-27	WOS:000272833800010
J	Elrefaei, M; Burke, CM; Baker, CAR; Jones, NG; Bousheri, S; Bangsberg, DR; Cao, HY				Elrefaei, Mohamed; Burke, Candace M.; Baker, Chris A. R.; Jones, Norman G.; Bousheri, Stephanie; Bangsberg, David R.; Cao, Huyen			TGF-beta and IL-10 Production by HIV-Specific CD8+T Cells Is Regulated by CTLA-4 Signaling on CD4+T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CD8(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; CYTOKINE PRODUCTION; UP-REGULATION; CUTTING EDGE; EXPRESSION; PROLIFERATION; INFECTION; INTERLEUKIN-10	Immune dysregulation in HIV-1 infection is associated with increased expression of inhibitory molecules such as CTLA-4, TGF-beta, and IL-10. In this study we examined one potential mechanism for regulating TGF-beta and IL-10 expression by HIV-specific suppressor CD8+ T cells. No overlap between TGF-beta, IL-10, and IFN-gamma cytokine production by HIV-specific CD8+ T cells was observed. TGF-beta positive and IL-10 positive cells were FOXP3 negative, CD25 negative, and displayed a heterogeneous surface expression of CD127. TGF-beta and IL-10 positive CD8+ T cells did not express CTLA-4. Nevertheless, CTLA-4 blockade resulted in a significant decrease in HIV-specific TGF-beta positive and IL-10 positive CD8+ T cell responses, and a concomitant increase in HIV-specific IFN-gamma positive CD8+ T cell responses. Depletion of CD4+ T cells abrogated the impact of CTLA-4 on HIV-specific TGF-beta positive and IL-10 positive CD8+ T cells. Our study suggests that CTLA-4 Signaling on CD4+ T cells regulates the inhibitory functions of the HIV-specific suppressor CD8+ T cells.	[Elrefaei, Mohamed; Burke, Candace M.; Baker, Chris A. R.; Jones, Norman G.; Bousheri, Stephanie; Cao, Huyen] Calif Dept Publ Hlth, Richmond, CA USA; [Bangsberg, David R.] Massachusetts Gen Hosp, Harvard Initiat Global Hlth, Cambridge, MA USA	California Department of Public Health; Harvard University; Massachusetts General Hospital	Elrefaei, M (corresponding author), Calif Dept Publ Hlth, Richmond, CA USA.	hcao@dhs.ca.gov		Baker, Chris/0000-0002-6248-654X	NIH [AI43885, MH54907, AI71772]; California Research Center for the Biology of HIV in Minorities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071772, R01AI043885, R21AI043885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Research Center for the Biology of HIV in Minorities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by NIH grants AI43885, MH54907, AI71772, and California Research Center for the Biology of HIV in Minorities grant, UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Asseman C., 2002, Autoimmunity Reviews, V1, P190, DOI 10.1016/S1568-9972(02)00054-X; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; BALASHOV KE, 1995, J CLIN INVEST, V95, P2711, DOI 10.1172/JCI117973; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Elrefaei M, 2006, J IMMUNOL, V176, P1274, DOI 10.4049/jimmunol.176.2.1274; Elrefaei M, 2008, J IMMUNOL, V180, P7757, DOI 10.4049/jimmunol.180.11.7757; Elrefaei M, 2007, J IMMUNOL, V178, P3265, DOI 10.4049/jimmunol.178.5.3265; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Filaci G, 2004, CLIN EXP MED, V4, P86, DOI 10.1007/s10238-004-0042-3; Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.humimm.2003.12.001; Filaci G, 2001, J IMMUNOL, V166, P6452, DOI 10.4049/jimmunol.166.10.6452; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Kumar V, 2004, J CLIN INVEST, V114, P1222, DOI 10.1172/JCI200423166; Leng QB, 2002, AIDS, V16, P519, DOI 10.1097/00002030-200203080-00002; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; McEvers K, 2005, VACCINE, V23, P4128, DOI 10.1016/j.vaccine.2005.03.022; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Reinhold D, 1999, IMMUNOL TODAY, V20, P384, DOI 10.1016/S0167-5699(99)01497-8; Riley JL, 2000, J EXP MED, V191, P1987, DOI 10.1084/jem.191.11.1987; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Scotto L, 2004, HUM IMMUNOL, V65, P1297, DOI 10.1016/j.humimm.2004.09.004; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; SHARMA V, 1995, BIOCHEM BIOPH RES CO, V208, P704, DOI 10.1006/bbrc.1995.1395; Sousa AE, 1999, J IMMUNOL, V162, P3718; Steiner K, 1999, CLIN EXP IMMUNOL, V115, P451; Sung JL, 2003, INT IMMUNOPHARMACOL, V3, P233, DOI 10.1016/S1567-5769(02)00276-X; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Valdez H, 1997, AIDS Clin Rev, P187; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	50	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8194	10.1371/journal.pone.0008194	http://dx.doi.org/10.1371/journal.pone.0008194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20016783	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300003
J	Lacroix-Lamande, S; Rochereau, N; Mancassola, R; Barrier, M; Clauzon, A; Laurent, F				Lacroix-Lamande, Sonia; Rochereau, Nicolas; Mancassola, Roselyne; Barrier, Mathieu; Clauzon, Amandine; Laurent, Fabrice			Neonate Intestinal Immune Response to CpG Oligodeoxynucleotide Stimulation	PLOS ONE			English	Article							CRYPTOSPORIDIUM-PARVUM INFECTION; EPITHELIAL-CELLS; VACCINE DEVELOPMENT; MUCOSAL; MICE; HOMEOSTASIS; RECEPTORS; TOLERANCE; TLR9; LIFE	Background: The development of mucosal vaccines is crucial to efficiently control infectious agents for which mucosae are the primary site of entry. Major drawbacks of these protective strategies are the lack of effective mucosal adjuvant. Synthetic oligodeoxynucleotides that contain several unmethylated cytosine-guanine dinucleotide (CpG-ODN) motifs are now recognized as promising adjuvants displaying mucosal adjuvant activity through direct activation of TLR9-expressing cells. However, little is known about the efficacy of these molecules in stimulating the intestinal immune system in neonates. Methodology/Principal Findings: First, newborn mice received CpG-ODN orally, and the intestinal cytokine and chemokine response was measured. We observed that oral administration of CpG-ODN induces CXC and CC chemokine responses and a cellular infiltration in the intestine of neonates as detected by immunohistochemistry. We next compared the efficiency of the oral route to intraperitoneal administration in stimulating the intestinal immune responses of both adults and neonates. Neonates were more responsive to TLR9-stimulation than adults whatever the CpG-ODN administration route. Their intestinal epithelial cells (IECs) indirectly responded to TLR9 stimulation and contributed to the CXC chemokine response, whereas other TLR9-bearing cells of the lamina-propria produced CC chemokines and Th1-type cytokines. Moreover, we showed that the intestine of adult exhibited a significantly higher level of IL10 at homeostasis than neonates, which might be responsible for the unresponsiveness to TLR9-stimulation, as confirmed by our findings in IL10-deficient mice. Conclusions/Significance: This is the first report that deciphers the role played by CpG-ODN in the intestine of neonates. This work clearly demonstrates that an intraperitoneal administration of CpG-ODN is more efficient in neonates than in adults to stimulate an intestinal chemokine response due to their lower IL-10 intestinal level. In addition we report the efficiency of the oral route at inducing intestinal chemokine responses in neonate that might be taken into consideration for further vaccine development against neonatal diseases.	[Lacroix-Lamande, Sonia; Rochereau, Nicolas; Mancassola, Roselyne; Barrier, Mathieu; Clauzon, Amandine; Laurent, Fabrice] INRA Tours, Lab Controle & Immunol Malad Enter Nouveau Ne, Infectiol Anim & Sante Publ UR1282, Nouzilly, France	INRAE	Lacroix-Lamande, S (corresponding author), INRA Tours, Lab Controle & Immunol Malad Enter Nouveau Ne, Infectiol Anim & Sante Publ UR1282, Nouzilly, France.	slacroix@tours.inra.fr	Laurent, fabrice/AAC-2266-2019	Laurent, fabrice/0000-0002-9687-7952; , rochereau/0000-0002-6522-895X; LAMANDE, Sonia/0000-0002-7865-4587	INRA	INRA	This research program was supported by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Auray G, 2007, MICROBES INFECT, V9, P574, DOI 10.1016/j.micinf.2007.01.026; Ballas ZK, 2007, IMMUNOL RES, V39, P15, DOI 10.1007/s12026-007-0066-3; Barrier M, 2006, J INFECT DIS, V193, P1400, DOI 10.1086/503748; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Booth JS, 2009, MUCOSAL IMMUNOL, V2, P265, DOI 10.1038/mi.2009.6; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; Fadel SA, 2002, J IMMUNOL, V169, P3293, DOI 10.4049/jimmunol.169.6.3293; Gupta K, 2008, DRUGS R&D, V9, P137, DOI 10.2165/00126839-200809030-00001; Ito S, 2005, J IMMUNOL, V174, P777, DOI 10.4049/jimmunol.174.2.777; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Lacroix-Lamande S, 2002, INFECT IMMUN, V70, P2090, DOI 10.1128/IAI.70.4.2090-2099.2002; LECCE JG, 1979, ENVIRON HEALTH PERSP, V33, P57, DOI 10.2307/3429072; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raghavan S, 2003, INFECT IMMUN, V71, P7014, DOI 10.1128/IAI.71.12.7014-7022.2003; Ramirez K, 2009, J IMMUNOL, V182, P1211, DOI 10.4049/jimmunol.182.2.1211; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; Wang DQ, 2005, VACCINE, V23, P2614, DOI 10.1016/j.vaccine.2004.11.028; Wilson C B, 1991, Adv Exp Med Biol, V310, P17	28	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8291	10.1371/journal.pone.0008291	http://dx.doi.org/10.1371/journal.pone.0008291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011519	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300041
J	Srinivasan, R; Zabuawala, T; Huang, H; Zhang, JY; Gulati, P; Fernandez, S; Karlo, JC; Landreth, GE; Leone, G; Ostrowski, MC				Srinivasan, Ruchika; Zabuawala, Tahera; Huang, Hong; Zhang, Jianying; Gulati, Parul; Fernandez, Soledad; Karlo, J. Colleen; Landreth, Gary E.; Leone, Gustavo; Ostrowski, Michael C.			Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration during Mouse Embryonic Angiogenesis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MICE LACKING; MAP KINASE; IN-VIVO; FAK; SRC; MOTILITY	Angiogenesis is a complex process orchestrated by both growth factors and cell adhesion and is initiated by focal degradation of the vascular basement membrane with subsequent migration and proliferation of endothelial cells. The Ras/Raf/MEK/ERK pathway is required for EC function during angiogenesis. Although in vitro studies implicate ERK1 and ERK2 in endothelial cell survival, their precise role in angiogenesis in vivo remains poorly defined. Cre/loxP technology was used to inactivate Erk1 and Erk2 in endothelial cells during murine development, resulting in embryonic lethality due to severely reduced angiogenesis. Deletion of Erk1 and Erk2 in primary endothelial cells resulted in decreased cell proliferation and migration, but not in increased apoptosis. Expression of key cell cycle regulators was diminished in the double knockout cells, and decreased DNA synthesis could be observed in endothelial cells during embryogenesis. Interestingly, both Paxillin and Focal Adhesion Kinase were expressed at lower levels in endothelial cells lacking Erk1 and Erk2 both in vivo and in vitro, leading to defects in the organization of the cytoskeleton and in cell motility. The regulation of Paxillin and Focal Adhesion Kinase expression occurred post-transcriptionally. These results demonstrate that ERK1 and ERK2 coordinate endothelial cell proliferation and migration during angiogenesis.	[Srinivasan, Ruchika; Zabuawala, Tahera; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Srinivasan, Ruchika; Zabuawala, Tahera; Leone, Gustavo; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Tumor Microenvironm Program, Columbus, OH 43210 USA; [Huang, Hong] Nationwide Childrens Hosp, Ctr Cardiovasc Med, Columbus, OH USA; [Zhang, Jianying; Gulati, Parul; Fernandez, Soledad] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Karlo, J. Colleen; Landreth, Gary E.] Case Western Reserve Univ, Dept Cellular & Mol Neurosci, Cleveland, OH 44106 USA; [Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Case Western Reserve University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Srinivasan, R (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu	Gulati, Parul/K-7375-2013; Ostrowski, Michael/H-3108-2011	Gulati, Parul/0000-0001-9341-9844; Ostrowski, Michael/0000-0003-2948-6297	NCI [R01-CA53271, P01-CA097189]; Evelyn Simmers Foundation; Department of Defense Breast Cancer Program; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA053271] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Evelyn Simmers Foundation; Department of Defense Breast Cancer Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NCI grants R01-CA53271, P01-CA097189 and the Evelyn Simmers Foundation (MCO). TZ was funded by a predoctoral fellowship from the Department of Defense Breast Cancer Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Houle F, 2007, J CELL SCI, V120, P3666, DOI 10.1242/jcs.003251; Huang H, 2003, IN VITRO CELL DEV-AN, V39, P43; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Liu WL, 2001, ENDOCRINOLOGY, V142, P1710, DOI 10.1210/en.142.5.1710; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Pages Gilles, 2004, Methods Mol Biol, V250, P155; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rose JL, 2007, J PHARMACOL EXP THER, V321, P318, DOI 10.1124/jpet.106.113498; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Serban D, 2008, CIRC RES, V102, P1350, DOI 10.1161/CIRCRESAHA.107.169664; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Shen TL, 2001, FEBS LETT, V499, P176, DOI 10.1016/S0014-5793(01)02545-5; Son SH, 2009, CANCER LETT, V280, P86, DOI 10.1016/j.canlet.2009.02.012; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WEI G, 2009, BLOOD; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J	51	114	118	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8283	10.1371/journal.pone.0008283	http://dx.doi.org/10.1371/journal.pone.0008283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011539	Green Published, gold			2022-12-27	WOS:000272830300035
J	Attout, T; Hoerauf, A; Denece, G; Debrah, AY; Marfo-Debrekyei, Y; Boussinesq, M; Wanji, S; Martinez, V; Mand, S; Adjei, O; Bain, O; Specht, S; Martin, C				Attout, Tarik; Hoerauf, Achim; Denece, Gaelle; Debrah, Alexander Yaw; Marfo-Debrekyei, Yeboah; Boussinesq, Michel; Wanji, Samuel; Martinez, Valerie; Mand, Sabine; Adjei, Ohene; Bain, Odile; Specht, Sabine; Martin, Coralie			Lymphatic Vascularisation and Involvement of Lyve-1(+) Macrophages in the Human Onchocerca Nodule	PLOS ONE			English	Article							SKIN-LESIONS; WOLBACHIA ENDOBACTERIA; CD11B(+) MACROPHAGES; ANGIOGENIC ACTIVITY; FILARIAL NEMATODES; LYMPHANGIOGENESIS; VOLVULUS; IVERMECTIN; CANCER; GROWTH	Onchocerciasis, caused by the filarial nematode Onchocerca volvulus, is a parasitic disease leading to debilitating skin disease and blindness, with major economic and social consequences. The pathology of onchocerciasis is principally considered to be a consequence of long-standing host inflammatory responses. In onchocerciasis a subcutaneous nodule is formed around the female worms, the core of which is a dense infiltrate of inflammatory cells in which microfilariae are released. It has been established that the formation of nodules is associated with angiogenesis. In this study, we show using specific markers of endothelium (CD31) and lymphatic endothelial cells (Lyve-1, Podoplanin) that not only angiogenesis but also lymphangiogenesis occurs within the nodule. 7% of the microfilariae could be found within the lymphatics, but none within blood vessels in these nodules, suggesting a possible route of migration for the larvae. The neovascularisation was associated with a particular pattern of angio/lymphangiogenic factors in nodules of onchocerciasis patients, characterized by the expression of CXCL12, CXCR4, VEGF-C, Angiopoietin-1 and Angiopoietin-2. Interestingly, a proportion of macrophages were found to be positive for Lyve-1 and some were integrated into the endothelium of the lymphatic vessels, revealing their plasticity in the nodular micro-environment. These results indicate that lymphatic as well as blood vascularization is induced around O. volvulus worms, either by the parasite itself, e. g. by the release of angiogenic and lymphangiogenic factors, or by consecutive host immune responses.	[Attout, Tarik; Denece, Gaelle; Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, USM Parasitol Comparee & Modeles Expt 307, F-75231 Paris, France; [Hoerauf, Achim; Mand, Sabine; Specht, Sabine] Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Debrah, Alexander Yaw; Marfo-Debrekyei, Yeboah; Adjei, Ohene] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana; [Boussinesq, Michel] IRD, UMR 1045, Montpellier, France; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon; [Wanji, Samuel] Univ Buea, Dept Biochem & Microbiol, Buea, Cameroon; [Martinez, Valerie] Hop Antoine Beclere, Serv Med Interne & Immunol Clin, Clamart, France	Museum National d'Histoire Naturelle (MNHN); University of Bonn; Kumasi Center for Collaborative Research; Institut de Recherche pour le Developpement (IRD); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Attout, T (corresponding author), Museum Natl Hist Nat, USM Parasitol Comparee & Modeles Expt 307, F-75231 Paris, France.	cmartin@mnhn.fr	martin, coralie/O-3983-2019; Boussinesq, Michel/J-7256-2016; Martin, Coralie/N-6293-2018	martin, coralie/0000-0003-3801-2595; Boussinesq, Michel/0000-0001-6312-0681; Debrah, Alexander Yaw/0000-0001-5721-0891	European Community [INCO-CT-2006-032321]; Region Ile de France	European Community(European Commission); Region Ile de France(Region Ile-de-France)	This work was supported by European Community grant INCO-CT-2006-032321. T. Attout was supported by a postdoctoral fellowship from Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; BAIN O, 1985, CR ACAD SCI III-VIE, V301, P513; BAIN O, 1994, PARASITE, V1, P241, DOI 10.1051/parasite/1994013241; BAIN O, 1976, Annales de Parasitologie Humaine et Comparee, V51, P461; BAIN O, 2003, FILARIA J, V2, P16, DOI DOI 10.1186/1475-2883-2-16; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; BEVERIDGE I, 1980, TROPENMED PARASITOL, V31, P75; BONUCCI E, 1979, TROPENMED PARASITOL, V30, P489; Brattig NW, 2004, MICROBES INFECT, V6, P113, DOI 10.1016/j.micinf.2003.11.003; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; BRUMPT E, 1904, REV MED HYG TROP, V1, P43; BURCHARD GD, 1979, TROPENMED PARASITOL, V30, P103; BUTTNER DW, 1982, TROPENMED PARASITOL, V33, P201; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; COLLINS RC, 1982, AM J TROP MED HYG, V31, P267, DOI 10.4269/ajtmh.1982.31.267; Connor D H, 1970, Hum Pathol, V1, P553, DOI 10.1016/S0046-8177(70)80057-0; CONNOR DH, 1969, ARCH PATHOL, V87, P193; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; DUKE BOL, 1970, T ROY SOC TROP MED H, V64, P791, DOI 10.1016/0035-9203(70)90030-1; EDGEWORTH JD, 1993, CLIN EXP IMMUNOL, V92, P84, DOI 10.1111/j.1365-2249.1993.tb05952.x; GEORGE GH, 1985, AM J TROP MED HYG, V34, P1144, DOI 10.4269/ajtmh.1985.34.1144; Hartmann S, 2002, PARASITE IMMUNOL, V24, P253, DOI 10.1046/j.1365-3024.2002.00459.x; Higazi TB, 2003, MOL BIOCHEM PARASIT, V129, P61, DOI 10.1016/S0166-6851(03)00094-X; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Hoerauf A, 2002, TRENDS PARASITOL, V18, P25, DOI 10.1016/S1471-4922(01)02173-0; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Jeon BH, 2008, CANCER RES, V68, P1100, DOI 10.1158/0008-5472.CAN-07-2572; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; KERSHAW WE, 1954, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.4890.724; Knab J, 1997, TROP MED INT HEALTH, V2, P1156, DOI 10.1046/j.1365-3156.1997.d01-217.x; LABADIELAGRAVE D, 1899, ARCH PARASITOL, V2, P451; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PARKHOUSE RME, 1985, CLIN EXP IMMUNOL, V62, P13; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; REBER E W, 1964, Z Tropenmed Parasitol, V15, P153; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Ruegg C, 2006, J LEUKOCYTE BIOL, V80, P682, DOI 10.1189/jlb.0606394; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; SCHULZKEY H, 1976, TROPENMED PARASITOL, V27, P229; Smith R J, 1988, Trop Med Parasitol, V39 Suppl 4, P418; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Tawe W, 2000, MOL BIOCHEM PARASIT, V109, P91, DOI 10.1016/S0166-6851(00)00231-0; Vuong P N, 1994, Rev Elev Med Vet Pays Trop, V47, P47; VUONG PN, 1988, TROP MED PARASITOL, V39, P105; VUONG PN, 1993, ANN PARASIT HUM COMP, V68, P176, DOI 10.1051/parasite/1993684176; VUONG PN, 1992, ANN PARASIT HUM COMP, V67, P194, DOI 10.1051/parasite/1992676194; VUONGNGOC P, 1986, ANN PARASIT HUM COMP, V61, P311, DOI 10.1051/parasite/1986613311; Wildenburg G, 1997, PARASITOL RES, V83, P109, DOI 10.1007/s004360050220; WILDENBURG G, 1994, TROP MED PARASITOL, V45, P87; Wildenburg G, 1998, PARASITOLOGY, V116, P257, DOI 10.1017/S0031182097002278; Wildenburg G, 1998, TROP MED INT HEALTH, V3, P918	59	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8234	10.1371/journal.pone.0008234	http://dx.doi.org/10.1371/journal.pone.0008234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011036	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829800018
J	Ronan, EO; Lee, LN; Beverley, PCL; Tchilian, EZ				Ronan, Edward O.; Lee, Lian Ni; Beverley, Peter C. L.; Tchilian, Elma Z.			Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection	PLOS ONE			English	Article							T-CELL RESPONSES; PULMONARY TUBERCULOSIS; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; BOVIS BCG; ANTIGEN 85B; IN-VIVO; MUCOSAL; CD4; LYMPHOCYTES	Background: In pulmonary Mycobacterium tuberculosis (Mtb) infection, immune responses are delayed compared to other respiratory infections, so that antigen-specific cells are not detected in the lungs earlier than day 14. Even after parenteral immunization with Bacille Calmette Guerin (BCG) or a subunit vaccine, the immune response after Mtb challenge is only slightly accelerated and the kinetics of pulmonary Mtb growth do not differ between naive and immunized animals up to day 14. Methods and Findings: Mice were immunized intranasally with a recombinant adenovirus expressing mycobacterial antigen 85A (Ad85A), challenged by aerosol with Mtb and the kinetics of Mtb growth in the lungs measured. Intranasal immunization with Ad85A inhibits Mtb growth in the early phase of infection, up to day 8. Protection is sustained for at least 7 months and correlates with the presence of antigen-specific activated effector CD8 T cells in the lungs. Antigen 85A-specific T cells respond to antigen presenting cells from the lungs of mice immunized with Ad85A 23 weeks previously, demonstrating the persistence of antigen in the lungs. Conclusions/Significance: Intranasal immunization with Ad85A can inhibit early growth of Mtb because it establishes a lung antigen depot and maintains an activated lung-resident lymphocyte population. We propose that an optimal immunization strategy for tuberculosis should aim to induce both lung and systemic immunity, targeting the early and late phases of Mtb growth.	[Ronan, Edward O.; Lee, Lian Ni; Beverley, Peter C. L.; Tchilian, Elma Z.] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Ronan, EO (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	elma.tchilian@ndm.ox.ac.uk	Tchilian, Elma Z/Q-5976-2017	Tchilian, Elma Z/0000-0002-4869-5118; Lee, Lian Ni/0000-0003-3915-3015; Beverley, Peter/0000-0003-0481-2180	UK Medical Research Council [G0701235]; Medical Research Council [G0701235] Funding Source: researchfish; MRC [G0701235] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a UK Medical Research Council (www.mrc.ac.uk) Grant No: G0701235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Beverley PCL, 2008, EXPERT REV VACCINES, V7, P1165, DOI 10.1586/14760584.7.8.1165; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mollenkopf HJ, 2004, J INFECT DIS, V190, P588, DOI 10.1086/422394; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Serbina NV, 2001, INFECT IMMUN, V69, P4320, DOI 10.1128/IAI.69.7.4320-4328.2001; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; TATSIS N, 2007, VIROLOGY, V22, P22; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Xing Z, 2009, EXPERT REV VACCINES, V8, P1465, DOI 10.1586/ERV.09.110; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856; Yu H, 2008, LAB ANIM-UK, V42, P294, DOI 10.1258/la.2007.007055	37	43	44	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8235	10.1371/journal.pone.0008235	http://dx.doi.org/10.1371/journal.pone.0008235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011050	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829800019
J	Yoshimura, T; Sonoda, KH; Sugahara, M; Mochizuki, Y; Enaida, H; Oshima, Y; Ueno, A; Hata, Y; Yoshida, H; Ishibashi, T				Yoshimura, Takeru; Sonoda, Koh-Hei; Sugahara, Mika; Mochizuki, Yasutaka; Enaida, Hiroshi; Oshima, Yuji; Ueno, Akifumi; Hata, Yasuaki; Yoshida, Hiroki; Ishibashi, Tatsuro			Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; PROLIFERATIVE DIABETIC-RETINOPATHY; RETINAL VEIN OCCLUSION; MONOCYTE CHEMOTACTIC PROTEIN-1; MULTIPLEX BEAD ANALYSIS; C-C CHEMOKINES; VITREOUS FLUID; MACULAR EDEMA; INTRAVITREAL TRIAMCINOLONE	Inflammation affects the formation and the progression of various vitreoretinal diseases. We performed a comprehensive analysis of inflammatory immune mediators in the vitreous fluids from total of 345 patients with diabetic macular edema (DME, n = 92), proliferative diabetic retinopathy (PDR, n = 147), branch retinal vein occlusion (BRVO, n = 30), central retinal vein occlusion (CRVO, n = 13) and rhegmatogenous retinal detachment (RRD, n = 63). As a control, we selected a total of 83 patients with either idiopathic macular hole (MH) or idiopathic epiretinal membrane (ERM) that were free of major pathogenic intraocular changes, such as ischemic retina and proliferative membranes. The concentrations of 20 soluble factors (nine cytokines, six chemokines, and five growth factors) were measured simultaneously by multiplex bead analysis system. Out of 20 soluble factors, three factors: interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1) were significantly elevated in all groups of vitreoretinal diseases ( DME, PDR, BRVO, CRVO, and RRD) compared with control group. According to the correlation analysis in the individual patient's level, these three factors that were simultaneously increased, did not show any independent upregulation in all the examined diseases. Vascular endothelial growth factor ( VEGF) was significantly elevated in patients with PDR and CRVO. In PDR patients, the elevation of VEGF was significantly correlated with the three factors: IL-6, IL-8, and MCP-1, while no significant correlation was observed in CRVO patients. In conclusion, multiplex bead system enabled a comprehensive soluble factor analysis in vitreous fluid derived from variety of patients. Major three factors: IL-6, IL-8, and MCP-1 were strongly correlated with each other indicating a common pathway involved in inflammation process in vitreoretinal diseases.	[Yoshimura, Takeru; Sonoda, Koh-Hei; Sugahara, Mika; Mochizuki, Yasutaka; Enaida, Hiroshi; Oshima, Yuji; Ueno, Akifumi; Hata, Yasuaki; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan; [Yoshida, Hiroki] Saga Univ, Fac Med, Dept Biomol Sci, Saga 840, Japan	Kyushu University; Saga University	Yoshimura, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan.	sonodak@med.kyushu-u.ac.jp		Yoshimura, Takeru/0000-0002-5983-7193	Ministry of Education, Science, Sports and Culture, Japan [14770962, 13470369]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture, Japan (B2 No. 14770962: K-H. Sonoda, B2 No. 13470369: T. Ishibashi) (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuElAsrar AM, 1997, AM J OPHTHALMOL, V123, P599, DOI 10.1016/S0002-9394(14)71072-4; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Arimura N, 2009, OPHTHALMOLOGY, V116, P921, DOI 10.1016/j.ophtha.2008.12.024; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Canton A, 2004, ARCH OPHTHALMOL-CHIC, V122, P743, DOI 10.1001/archopht.122.5.743; Capeans C, 1998, RETINA-J RET VIT DIS, V18, P546; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chan Chi-Chao, 2002, Curr Opin Ophthalmol, V13, P411, DOI 10.1097/00055735-200212000-00012; CHARTERIS DG, 1992, OPHTHALMOLOGY, V99, P1364; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Chong DY, 2008, INVEST OPHTH VIS SCI, V49, P3193, DOI 10.1167/iovs.07-1641; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; DEBOER JH, 1993, INVEST OPHTH VIS SCI, V34, P3376; ELASRAR AM, 1992, AM J OPHTHALMOL, V114, P731, DOI 10.1016/S0002-9394(14)74052-8; ELNER SG, 1995, CURR EYE RES, V14, P1045, DOI 10.3109/02713689508998529; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kastelan S, 2007, MED HYPOTHESES, V68, P1016, DOI 10.1016/j.mehy.2006.05.073; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Lewandowska-Furmanik Maria, 2002, Med Sci Monit, V8, pCR526; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lutty GA, 1996, ARCH OPHTHALMOL-CHIC, V114, P971, DOI 10.1001/archopht.1996.01100140179011; Maier R, 2008, MOL VIS, V14, P637; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Mitamura Y, 2002, JPN J OPHTHALMOL, V46, P218, DOI 10.1016/S0021-5155(01)00497-X; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nguyen QD, 2006, AM J OPHTHALMOL, V142, P961, DOI 10.1016/j.ajo.2006.06.068; Oppenheim JJ, 2001, INT J HEMATOL, V74, P3, DOI 10.1007/BF02982543; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Park SP, 2008, CLIN EXP OPHTHALMOL, V36, P831, DOI 10.1111/j.1442-9071.2009.01909.x; Pe'er J, 1998, OPHTHALMOLOGY, V105, P412, DOI 10.1016/S0161-6420(98)93020-2; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Siawaya JFD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002535; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Struyf S, 2003, ADV IMMUNOL, V81, P1, DOI 10.1016/S0065-2776(03)81001-5; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vilcek J, 2004, TRENDS PHARMACOL SCI, V25, P201, DOI 10.1016/j.tips.2004.02.011; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489; Yuuki T, 2001, J DIABETES COMPLICAT, V15, P257, DOI 10.1016/S1056-8727(01)00155-6	51	253	267	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8158	10.1371/journal.pone.0008158	http://dx.doi.org/10.1371/journal.pone.0008158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997642	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829200005
J	Dutta, S; Sullivan, JS; Grady, KK; Haynes, JD; Komisar, J; Batchelor, AH; Soisson, L; Diggs, CL; Heppner, DG; Lanar, DE; Collins, WE; Barnwell, JW				Dutta, Sheetij; Sullivan, JoAnn S.; Grady, Katharine K.; Haynes, J. David; Komisar, Jack; Batchelor, Adrian H.; Soisson, Lorraine; Diggs, Carter L.; Heppner, D. Gray; Lanar, David E.; Collins, William E.; Barnwell, John W.			High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model	PLOS ONE			English	Article							INSTITUTE-OF-RESEARCH; BLOOD-STAGE MALARIA; PLASMODIUM-FALCIPARUM; VACCINE CANDIDATE; MONKEYS; IMMUNOGENICITY; INVASION; SAFETY; AMA-1; CHILDREN	A Plasmodium falciparum 3D7 strain Apical Membrane Antigen-1 (AMA1) vaccine, formulated with AS02A adjuvant, slowed parasite growth in a recent Phase 1/2a trial, however sterile protection was not observed. We tested this AS02A, and a Montanide ISA720 (ISA) formulation of 3D7 AMA1 in Aotus monkeys. The 3D7 parasite does not invade Aotus erythrocytes, hence two heterologous strains, FCH/4 and FVO, were used for challenge, FCH/4 AMA1 being more homologous to 3D7 than FVO AMA1. Following three vaccinations, the monkeys were challenged with 50,000 FCH/4 or 10,000 FVO parasites. Three of the six animals in the AMA+ISA group were protected against FCH/4 challenge. One monkey did not become parasitemic, another showed only a short period of low level parasitemia that self-cured, and a third animal showed a delay before exhibiting its parasitemic phase. This is the first protection shown in primates with a recombinant P. falciparum AMA1 without formulation in Freund's complete adjuvant. No animals in the AMA+AS02(A) group were protected, but this group exhibited a trend towards reduced growth rate. A second group of monkeys vaccinated with AMA+ISA vaccine was not protected against FVO challenge, suggesting strain-specificity of AMA1-based protection. Protection against FCH/4 strain correlated with the quantity of induced antibodies, as the protected animals were the only ones to have in vitro parasite growth inhibitory activity of > 70% at 1:10 serum dilution; immuno-fluorescence titers.8,000; ELISA titers against full-length AMA1 > 300,000 and ELISA titer against AMA1 domains1+2 > 100,000. A negative correlation between log ELISA titer and day 11 cumulative parasitemia (Spearman rank r = 20.780, p value = 0.0001), further confirmed the relationship between antibody titer and protection. High titers of cross-strain inhibitory antibodies against AMA1 are therefore critical to confer solid protection, and the Aotus model can be used to down-select future AMA1 formulations, prior to advanced human trials.	[Dutta, Sheetij; Batchelor, Adrian H.] Walter Reed Army Inst Res, Dept Epitope Mapping, Silver Spring, MD USA; [Sullivan, JoAnn S.; Grady, Katharine K.; Collins, William E.; Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Atlanta, GA USA; [Soisson, Lorraine; Diggs, Carter L.] US Agcy Int Dev, Malaria Vaccine Dev Program, Washington, DC 20523 USA; [Haynes, J. David; Komisar, Jack; Heppner, D. Gray; Lanar, David E.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Dutta, S (corresponding author), Walter Reed Army Inst Res, Dept Epitope Mapping, Silver Spring, MD USA.	sheetij.dutta@us.army.mil; wzb3@cdc.gov	Lanar, David E/B-3560-2011		U.S. Agency for International Development (USAID)	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for this work was provided by U.S. Agency for International Development (USAID) Malaria Vaccine Development Program. Two of the authors on the paper, CLD and LS, are USAID representatives and were involved in the planning phase of this study.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; COLLINS WE, 1994, AM J TROP MED HYG, V51, P224, DOI 10.4269/ajtmh.1994.51.224; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Fandeur T, 1998, AM J TROP MED HYG, V58, P225, DOI 10.4269/ajtmh.1998.58.225; Hall Molly J., 2002, PTSD RES Q, V13, P1; Haynes J David, 2002, Methods Mol Med, V72, P535, DOI 10.1385/1-59259-271-6:535; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Izumiyama S, 2009, EXP PARASITOL, V121, P144, DOI 10.1016/j.exppara.2008.10.008; Kaneko O, 1999, EXP PARASITOL, V93, P116, DOI 10.1006/expr.1999.4441; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1999, INFECT IMMUN, V67, P43, DOI 10.1128/IAI.67.1.43-49.1999; Lehtoranta L, 2009, J VIROL METHODS, V159, P271, DOI 10.1016/j.jviromet.2009.04.015; Lynch MM, 2009, CLIN VACCINE IMMUNOL, V16, P293, DOI 10.1128/CVI.00230-08; Miura K, 2008, J IMMUNOL, V181, P8776, DOI 10.4049/jimmunol.181.12.8776; NAGATAKE T, 1992, AM J TROP MED HYG, V47, P614, DOI 10.4269/ajtmh.1992.47.614; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x	37	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8138	10.1371/journal.pone.0008138	http://dx.doi.org/10.1371/journal.pone.0008138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997632	gold, Green Submitted, Green Published			2022-12-27	WOS:000272829000002
J	Bronsvoort, BMD; von Wissmann, B; Fevre, EM; Handel, IG; Picozzi, K; Welburn, SC				Bronsvoort, Barend Mark de Clare; von Wissmann, Beatrix; Fevre, Eric Maurice; Handel, Ian Graham; Picozzi, Kim; Welburn, Sue Christina			No Gold Standard Estimation of the Sensitivity and Specificity of Two Molecular Diagnostic Protocols for Trypanosoma brucei spp. in Western Kenya	PLOS ONE			English	Article							SLEEPING-SICKNESS; PCR; CATTLE; TESTS; ASSAY	African animal trypanosomiasis is caused by a range of tsetse transmitted protozoan parasites including Trypanosoma vivax, Trypanosoma congolense and Trypansoma brucei. In Western Kenya and other parts of East Africa two subspecies of T. brucei, T.b. brucei and the zoonotic T.b. rhodesiense, co-circulate in livestock. A range of polymerase chain reactions (PCR) have been developed as important molecular diagnostic tools for epidemiological investigations of T. brucei s.l. in the animal reservoir and of its zoonotic potential. Quantification of the relative performance of different diagnostic PCRs is essential to ensure comparability of studies. This paper describes an evaluation of two diagnostic test systems for T. brucei using a T. brucei s.l. specific PCR [1] and a single nested PCR targeting the Internal Transcribed Spacer (ITS) regions of trypanosome ribosomal DNA [2]. A Bayesian formulation of the Hui-Walter latent class model was employed to estimate their test performance in the absence of a gold standard test for detecting T. brucei s.l. infections in ear-vein blood samples from cattle, pig, sheep and goat populations in Western Kenya, stored on Whatman FTA cards. The results indicate that the system employing the T. brucei s.l. specific PCR (Se-1 = 0.760) had a higher sensitivity than the ITS-PCR (Se-2 = 0.640); both have high specificity (Sp(1) = 0.998; Sp(2) = 0.997). The true prevalences for livestock populations were estimated (p(cattle) = 0.091, p(pigs) = 0.066, p(goats) = 0.005, p(sheep) = 0.006), taking into account the uncertainties in the specificity and sensitivity of the two test systems. Implications of test performance include the required survey sample size; due to its higher sensitivity and specificity, the T. brucei s.l. specific PCR requires a consistently smaller sample size than the ITS-PCR for the detection of T. brucei s.l. However the ITS-PCR is able to simultaneously screen samples for other pathogenic trypanosomes and may thus be, overall, a better choice of test in multi-organism studies.	[Bronsvoort, Barend Mark de Clare; Handel, Ian Graham] Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [von Wissmann, Beatrix; Picozzi, Kim; Welburn, Sue Christina] Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland; [Fevre, Eric Maurice] Univ Edinburgh, Ctr Infect Dis, Sch Biol Sci, Edinburgh EH9 1QH, Midlothian, Scotland; [Fevre, Eric Maurice] Univ Edinburgh, Ctr Infect Immun & Evolut, Sch Biol Sci, Edinburgh EH9 1QH, Midlothian, Scotland; [Bronsvoort, Barend Mark de Clare; Handel, Ian Graham] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Bronsvoort, BMD (corresponding author), Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.	Mark.Bronsvoort@ed.ac.uk		Welburn, Susan/0000-0002-9903-7086; von Wissmann, Beatrix/0000-0002-0980-4545; Fevre, Eric/0000-0001-8931-4986; Bronsvoort, Mark/0000-0002-3271-8485	United Kingdom Department for International Development Animal Health Programme (DFID-AHP); Wellcome Trust [085308]; Biotechnology and Biological Sciences Research Council (BBSRC) [338BDD RA0762]	United Kingdom Department for International Development Animal Health Programme (DFID-AHP); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the United Kingdom Department for International Development Animal Health Programme (DFID-AHP). EMF is funded by the Wellcome Trust (085308). IH is funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (338BDD RA0762). The funding agencies had no role in conducting the study and in preparing the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bronsvoort BMD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005221; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Clausen PH, 1998, ANN NY ACAD SCI, V849, P21, DOI 10.1111/j.1749-6632.1998.tb11029.x; CONNOR RJ, 1994, ONDERSTEPOORT J VET, V61, P379; Cox A, 2005, EXP PARASITOL, V111, P24, DOI 10.1016/j.exppara.2005.03.014; DENWOOD, 2009, RUNJAGS RUN BAYESIAN; EISLER MC, 2004, TRYPANOSOMIASES; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; *INCO DC, 2000, NOV APPR EP RES DRUG; Kabasa JD, 2007, TRENDS PARASITOL, V23, P191, DOI 10.1016/j.pt.2007.03.006; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Machila N, 2003, ACTA TROP, V86, P25, DOI 10.1016/S0001-706X(02)00288-7; Masake RA, 2002, VET PARASITOL, V105, P179, DOI 10.1016/S0304-4017(02)00020-1; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; MURRAY M, 1989, ANN SOC BELG MED TR, V69, P189; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Ng'ayo Musa O, 2005, Kinetoplastid Biol Dis, V4, P5, DOI 10.1186/1475-9292-4-5; *OIE, 2009, MAN DIAGN TESTS VACC; Picozzi K., 2002, African Journal of Biotechnology, V1, P39; Picozzi K, 2008, EXP PARASITOL, V118, P41, DOI 10.1016/j.exppara.2007.05.014; Pinchbeck GL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-7; Plummer M., 2003, P 3 INT WORKSH DISTR; PLUMMER M, 2009, OUTPUT ANAL DIAGNOST; R Core Team, 2020, R LANG ENV STAT COMP; Solano P, 1999, VET PARASITOL, V86, P95, DOI 10.1016/S0304-4017(99)00137-5; Taylor K., 2004, The trypanosomiases, P331, DOI 10.1079/9780851994758.0331; Thrusfield M., 2005, VET EPIDEMIOLOGY; Thumbi SM, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-46; THURANIRA CM, 2005, THESIS U EDINBURGH E; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Uilenberg G., 1998, FIELD GUIDE DIAGNOSI; Waiswa C, 2003, ANN TROP MED PARASIT, V97, P149, DOI 10.1179/000349803235001688; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Woo P. T. K., 1970, Acta trop., V27, P384; WHATMAN FTA CARDS PR	37	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8628	10.1371/journal.pone.0008628	http://dx.doi.org/10.1371/journal.pone.0008628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062795	Green Submitted, Green Published, gold			2022-12-27	WOS:000273414100013
J	Meyer-Morse, N; Robbins, JR; Rae, CS; Mochegova, SN; Swanson, MS; Zhao, ZJ; Virgin, HW; Portnoy, D				Meyer-Morse, Nicole; Robbins, Jennifer R.; Rae, Chris S.; Mochegova, Sofia N.; Swanson, Michele S.; Zhao, Zijiang; Virgin, Herbert W.; Portnoy, Daniel			Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection	PLOS ONE			English	Article							PORE-FORMING TOXIN; INTRACELLULAR GROWTH; BACILLUS-SUBTILIS; PERFRINGOLYSIN-O; VIBRIO-CHOLERAE; PATHOGENESIS; HEMOLYSIN; ACTA; GENE; DEGRADATION	Background: Recent studies have suggested that autophagy is utilized by cells as a protective mechanism against Listeria monocytogenes infection. Methodology/Principal Findings: However we find autophagy has no measurable role in vacuolar escape and intracellular growth in primary cultured bone marrow derived macrophages (BMDMs) deficient for autophagy (atg5(-/-)). Nevertheless, we provide evidence that the pore forming activity of the cholesterol-dependent cytolysin listeriolysin O (LLO) can induce autophagy subsequent to infection by L. monocytogenes. Infection of BMDMs with L. monocytogenes induced microtubule-associated protein light chain 3 (LC3) lipidation, consistent with autophagy activation, whereas a mutant lacking LLO did not. Infection of BMDMs that express LC3-GFP demonstrated that wild-type L. monocytogenes was encapsulated by LC3-GFP, consistent with autophagy activation, whereas a mutant lacking LLO was not. Bacillus subtilis expressing either LLO or a related cytolysin, perfringolysin O (PFO), induced LC3 colocalization and LC3 lipidation. Further, LLO-containing liposomes also recruited LC3-GFP, indicating that LLO was sufficient to induce targeted autophagy in the absence of infection. The role of autophagy had variable effects depending on the cell type assayed. In atg5(-/-) mouse embryonic fibroblasts, L. monocytogenes had a primary vacuole escape defect. However, the bacteria escaped and grew normally in atg5(-/-) BMDMs. Conclusions/Significance: We propose that membrane damage, such as that caused by LLO, triggers bacterial-targeted autophagy, although autophagy does not affect the fate of wild-type intracellular L. monocytogenes in primary BMDMs.	[Meyer-Morse, Nicole; Robbins, Jennifer R.; Rae, Chris S.; Mochegova, Sofia N.; Portnoy, Daniel] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Robbins, Jennifer R.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA; [Portnoy, Daniel] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Swanson, Michele S.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Zhao, Zijiang; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	University of California System; University of California Berkeley; Xavier University; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Washington University (WUSTL)	Meyer-Morse, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	portnoy@berkeley.edu		Robbins, Jennifer/0000-0002-7414-6702; Swanson, Michele/0000-0003-2542-0266; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health [P01 AI063302, AI27655, U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, P01AI063302, R01AI027655, R29AI027655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A. P. was supported by National Institutes of Health Grant P01 AI063302 and AI27655. H. W. V. was supported by National Institutes of Health Grant Project 5 of U54 AI057160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; BISHOP DK, 1987, J IMMUNOL, V139, P2005; BOHNE J, 1994, MOL MICROBIOL, V11, P1141, DOI 10.1111/j.1365-2958.1994.tb00390.x; BOLENDER RP, 1973, J CELL BIOL, V56, P746, DOI 10.1083/jcb.56.3.746; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; DABIRI GA, 1990, P NATL ACAD SCI USA, V87, P6068, DOI 10.1073/pnas.87.16.6068; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kayal S, 2006, FEMS MICROBIOL REV, V30, P514, DOI 10.1111/j.1574-6976.2006.00021.x; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lee KD, 1996, J BIOL CHEM, V271, P7249, DOI 10.1074/jbc.271.13.7249; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mandal M, 2002, BBA-BIOMEMBRANES, V1563, P7, DOI 10.1016/S0005-2736(02)00368-1; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Swanson MS, 2006, J IMMUNOL, V177, P4945, DOI 10.4049/jimmunol.177.8.4945; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; Vergne I, 2006, AUTOPHAGY, V2, P175, DOI 10.4161/auto.2830; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhao ZJ, 2007, AUTOPHAGY, V3, P581, DOI 10.4161/auto.4782	58	78	79	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8610	10.1371/journal.pone.0008610	http://dx.doi.org/10.1371/journal.pone.0008610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062534	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338600027
J	Gao, S; Chen, XY; Yi, QQ; Wang, GC; Pan, GH; Lin, AP; Peng, G				Gao, Shan; Chen, Xiaoyuan; Yi, Qianqian; Wang, Guangce; Pan, Guanghua; Lin, Apeng; Peng, Guang			A Strategy for the Proliferation of Ulva prolifera, Main Causative Species of Green Tides, with Formation of Sporangia by Fragmentation	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLOROPHYLL FLUORESCENCE; ENTEROMORPHA; EUTROPHICATION; GERMINATION; PROPAGULES; MACROALGAE; SALINITY; GROWTH; LIGHT	Ulva prolifera, a common green seaweed, is one of the causative species of green tides that occurred frequently along the shores of Qingdao in 2008 and had detrimental effects on the preparations for the 2008 Beijing Olympic Games sailing competition, since more than 30 percent of the area of the games was invaded. In view of the rapid accumulation of the vast biomass of floating U. prolifera in green tides, we investigated the formation of sporangia in disks of different diameters excised from U. prolifera, changes of the photosynthetic properties of cells during sporangia formation, and development of spores. The results suggested that disks less than 1.00 mm in diameter were optimal for the formation of sporangia, but there was a small amount of spore release in these. The highest percentage of area of spore release occurred in disks that were 2.50 mm in diameter. In contrast, sporangia were formed only at the cut edges of larger disks (3.00 mm, 3.50 mm, and 4.00 mm in diameter). Additionally, the majority of spores liberated from the disks appeared vigorous and developed successfully into new individuals. These results implied that fragments of the appropriate size from the U. prolifera thalli broken by a variety of factors via producing spores gave rise to the rapid proliferation of the seaweed under field conditions, which may be one of the most important factors to the rapid accumulation of the vast biomass of U. prolifera in the green tide that occurred in Qingdao, 2008.	[Gao, Shan; Chen, Xiaoyuan; Yi, Qianqian; Wang, Guangce; Pan, Guanghua] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China; [Wang, Guangce; Lin, Apeng; Peng, Guang] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Lin, Apeng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, S (corresponding author), Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China.	gcwang@ms.qdio.ac.cn	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	National Natural Science Foundation of China [30830015]; Project for Supporting the National Development [2008BAC49B01, 2006BAD09A04];  [2006AA10A402];  [2007AA09Z406];  [2006AA05Z112];  [2006AA10A413]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Supporting the National Development; ; ; ; 	The work was supported by the National Natural Science Foundation of China (30830015), Project for Supporting the National Development (2008BAC49B01 and 2006BAD09A04), and the 863 Project of China (2006AA10A402, 2007AA09Z406, 2006AA05Z112, and 2006AA10A413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Dan A, 2002, FISHERIES SCI, V68, P1182, DOI 10.1046/j.1444-2906.2002.00553.x; Ding LanPing, 2009, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V40, P68; Figueroa FL, 2003, PHOTOSYNTH RES, V75, P259, DOI 10.1023/A:1023936313544; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Franklin LA, 2001, J PHYCOL, V37, P756, DOI 10.1046/j.1529-8817.2001.00156.x; Gahan P. B., 2007, P3, DOI 10.1007/978-1-4020-6352-7_1; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; LI DQ, 2008, ENV PROTECTION, V402, P45; Lin A, 2008, J INTEGR PLANT BIOL, V50, P622, DOI 10.1111/j.1744-7909.2008.00647.x; Lobban CS, 1981, BIOL SEAWEEDS; Lotze HK, 2000, J PHYCOL, V36, P287, DOI 10.1046/j.1529-8817.2000.99109.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MAZE J, 1993, J APPL PHYCOL, V5, P183, DOI 10.1007/BF00004015; Merceron M, 2007, SCI TOTAL ENVIRON, V384, P293, DOI 10.1016/j.scitotenv.2007.05.007; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; Poole LJ, 1997, PROG PHYCOL RES, V12, P1; Prasady PWC, 2008, INT J ELECTRON, V95, P111, DOI 10.1080/00207210701828770; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; SANTELICES B, 1989, J PHYCOL, V25, P693, DOI 10.1111/j.0022-3646.1989.00693.x; SCHORIES D, 1993, HELGOLANDER MEERESUN, V47, P275, DOI 10.1007/BF02367169; Schramm W, 1999, J APPL PHYCOL, V11, P69, DOI 10.1023/A:1008076026792; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sousa AI, 2007, J EXP MAR BIOL ECOL, V341, P142, DOI 10.1016/j.jembe.2006.09.020; TAYLOR D, 1995, MAR ECOL PROG SER, V127, P235, DOI 10.3354/meps127235; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Van den Hoek C, 1996, ALGAE INTRO PHYCOLOG; VASIL IK, 1972, IN VITRO CELL DEV B, V8, P117; [王建伟 WANG Jianwei], 2006, [生态科学, Ecologic Science], V25, P400; Wang YZ, 2008, INT J BEHAV DEV, V32, P13, DOI 10.1177/0165025407084047	35	109	134	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8571	10.1371/journal.pone.0008571	http://dx.doi.org/10.1371/journal.pone.0008571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052408	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338500014
J	Krycer, JR; Kristiana, I; Brown, AJ				Krycer, James Robert; Kristiana, Ika; Brown, Andrew John			Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; REGULATORY ELEMENT; RECEPTOR-ACTIVITY; GENE-EXPRESSION; LDL-RECEPTOR; FEEDBACK-REGULATION; FLUOROMETRIC ASSAY; PLASMA-CHOLESTEROL; LEUKEMIC-CELLS; CULTURED-CELLS	Background: Recently, there has been renewed interest in the link between cholesterol and prostate cancer. It has been previously reported that in vitro, prostate cancer cells lack sterol-mediated feedback regulation of the major transcription factor in cholesterol homeostasis, sterol-regulatory element binding protein 2 (SREBP-2). This could explain the accumulation of cholesterol observed in clinical prostate cancers. Consequently, perturbed feedback regulation to increased sterol levels has become a pervasive concept in the prostate cancer setting. Here, we aimed to explore this in greater depth. Methodology/Principal Findings: After altering the cellular cholesterol status in LNCaP and PC-3 prostate cancer cells, we examined SREBP-2 processing, downstream effects on promoter activity and expression of SREBP-2 target genes, and functional activity (low-density lipoprotein uptake, cholesterol synthesis). In doing so, we observed that LNCaP and PC-3 cells were sensitive to increased sterol levels. In contrast, lowering cholesterol levels via statin treatment generated a greater response in LNCaP cells than PC-3 cells. This highlighted an important difference between these cell-lines: basal SREBP-2 activity appeared to be higher in PC-3 cells, reducing sensitivity to decreased cholesterol levels. Conclusion/Significance:Thus, prostate cancer cells are sensitive to changing sterol levels in vitro, but the extent of this regulation differs between prostate cancer cell-lines. These results shed new light on the regulation of cholesterol metabolism in two commonly used prostate cancer cell-lines, and emphasize the importance of establishing whether or not cholesterol homeostasis is perturbed in prostate cancer in vivo.	[Krycer, James Robert; Kristiana, Ika; Brown, Andrew John] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Krycer, JR (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270	Prostate Cancer Foundation of Australia; Petre Foundation	Prostate Cancer Foundation of Australia; Petre Foundation	AJB's research is supported by a grant from the Prostate Cancer Foundation of Australia (PR36, http://www.prostate.org.au). JRK is the recipient of the Petre Foundation scholarship (http://www.petrefoundation.org.aul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades A, 2001, GYNECOL ONCOL, V82, P84, DOI 10.1006/gyno.2001.6203; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; BROWN MS, 1981, NEW ENGL J MED, V305, P515, DOI 10.1056/NEJM198108273050909; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; CERDA SR, 1995, LIPIDS, V30, P1083, DOI 10.1007/BF02536608; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; Chung LW, 1996, UROL ONCOL-SEMIN ORI, V2, P99; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Grand-Perret T, 2001, NAT MED, V7, P1332, DOI 10.1038/nm1201-1332; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Hentosh P, 2001, MOL CARCINOGEN, V32, P154, DOI 10.1002/mc.1074; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; KAIGHN ME, 1979, INVEST UROL, V17, P16; KRUTH HS, 1979, J CELL BIOL, V83, P588, DOI 10.1083/jcb.83.3.588; Lin JQ, 1999, CANCER RES, V59, P2891; Liu JW, 1997, J LIPID RES, V38, P2035; Liu JW, 2000, J BIOL CHEM, V275, P5214, DOI 10.1074/jbc.275.7.5214; Locke JA, 2008, PROSTATE, V68, P20, DOI 10.1002/pros.20674; Masquelier M, 2006, LEUKEMIA RES, V30, P136, DOI 10.1016/j.leukres.2005.06.012; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Morris DS, 2007, CELL CYCLE, V6, P1177, DOI 10.4161/cc.6.10.4247; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Sharrard RM, 2007, CELL SIGNAL, V19, P129, DOI 10.1016/j.cellsig.2006.05.029; SIPERSTEIN MD, 1964, CANCER RES, V24, P1108; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; SPORER A, 1982, UROLOGY, V20, P244, DOI 10.1016/0090-4295(82)90631-8; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Swyer GIM, 1942, CANCER RES, V2, P372; Tatidis L, 1997, J LIPID RES, V38, P2436; Teupser D, 1996, BBA-LIPID LIPID MET, V1303, P193, DOI 10.1016/0005-2760(96)00094-X; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Warburg O. H., 1930, METABOLISM TUMOURS I; White CP, 1909, J PATHOL BACTERIOL, V13, P3, DOI 10.1002/path.1700130103; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10	51	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8496	10.1371/journal.pone.0008496	http://dx.doi.org/10.1371/journal.pone.0008496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041144	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700011
J	Tong, EHY; Guo, JJ; Xu, SX; Mak, K; Chung, SK; Chung, SSM; Huang, AL; Ko, BCB				Tong, Edith H. Y.; Guo, Jin-Jun; Xu, Song-Xiao; Mak, Keri; Chung, Sookja K.; Chung, Stephen S. M.; Huang, Ali-Long; Ko, Ben C. B.			Inducible Nucleosome Depletion at OREBP-Binding-Sites by Hypertonic Stress	PLOS ONE			English	Article							T-CELL-ACTIVATION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; OSMOTIC-STRESS; NUCLEOCYTOPLASMIC TRAFFICKING; STIMULATES TRANSCRIPTION; FACTOR TONEBP/OREBP; GENE-TRANSCRIPTION	Background: Osmotic Response Element-Binding Protein (OREBP), also known as TonEBP or NFAT5, is a unique transcription factor. It is hitherto the only known mammalian transcription factor that regulates hypertonic stress-induced gene transcription. In addition, unlike other monomeric members of the NFAT family, OREBP exists as a homodimer and it is the only transcription factor known to bind naked DNA targets by complete encirclement in vitro. Nevertheless, how OREBP interacts with target DNA, also known as ORE/TonE, and how it elicits gene transcription in vivo, remains unknown. Methodology: Using hypertonic induction of the aldose reductase (AR) gene activation as a model, we showed that OREs contained dynamic nucleosomes. Hypertonic stress induced a rapid and reversible loss of nucleosome(s) around the OREs. The loss of nucleosome(s) was found to be initiated by an OREBP-independent mechanism, but was significantly potentiated in the presence of OREBP. Furthermore, hypertonic induction of AR gene was associated with an OREBP-dependent hyperacetylation of histones that spanned the 59 upstream sequences and at least some exons of the gene. Nevertheless, nucleosome loss was not regulated by the acetylation status of histone. Significance: Our findings offer novel insights into the mechanism of OREBP-dependent transcriptional regulation and provide a basis for understanding how histone eviction and transcription factor recruitment are coupled.	[Tong, Edith H. Y.; Xu, Song-Xiao; Ko, Ben C. B.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Tong, Edith H. Y.; Xu, Song-Xiao; Ko, Ben C. B.] Chinese Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Guo, Jin-Jun; Huang, Ali-Long] Chongqing Univ Med Sci, Inst Viral Hepatitis, Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Mak, Keri; Chung, Sookja K.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tong, Edith H. Y.; Chung, Stephen S. M.] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chongqing Medical University; University of Hong Kong; University of Hong Kong	Tong, EHY (corresponding author), Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.	benko@cuhk.edu.hk	Ko, Chi-bun/ACH-7514-2022; Xu, Songxiao/L-5737-2019	Ko, Ben Chi Bun/0000-0003-2027-5899	Research Grant Council [CUHK 7327/04M, CUHK 466108]; Chinese University of Hong Kong Direct [2041317]	Research Grant Council(Hong Kong Research Grants Council); Chinese University of Hong Kong Direct(Chinese University of Hong Kong)	This work was supported by the Research Grant Council Grants CUHK 7327/04M, CUHK 466108 and by the Chinese University of Hong Kong Direct Grant for Research 2041317 ( to B. C. B. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Burg MB, 1996, KIDNEY INT, V49, P1684, DOI 10.1038/ki.1996.247; Burkhart BA, 2007, J BIOL CHEM, V282, P4400, DOI 10.1074/jbc.M609041200; Carey M, 2000, TRANSCRIPTIONAL REGU; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katsani KR, 2003, CURR TOP MICROBIOL, V274, P113; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Kosuge K, 2007, MOL PHARMACOL, V72, P826, DOI 10.1124/mol.107.034504; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; MAK KM, 2006, 2006 NEUR M PLANN AT; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; PANTAZIS P, 1984, MOL CELL BIOL, V4, P1186, DOI 10.1128/MCB.4.6.1186; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reinke H, 2004, BBA-GENE STRUCT EXPR, V1677, P24, DOI 10.1016/j.bbaexp.2003.09.014; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Waldegger S, 1998, NEPHROL DIAL TRANSPL, V13, P867, DOI 10.1093/ndt/13.4.867; Wang Y, 2005, J BIOL CHEM, V280, P19986, DOI 10.1074/jbc.M501689200; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Xu SX, 2008, J BIOL CHEM, V283, P17624, DOI 10.1074/jbc.M800281200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005	71	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8435	10.1371/journal.pone.0008435	http://dx.doi.org/10.1371/journal.pone.0008435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041176	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000005
J	Wang, YH; Ghoshal, S; Ward, M; de Villiers, W; Woodward, J; Eckhardt, E				Wang, Yuehui; Ghoshal, Sarbani; Ward, Martin; de Villiers, Willem; Woodward, Jerold; Eckhardt, Erik			Chylomicrons Promote Intestinal Absorption and Systemic Dissemination of Dietary Antigen (Ovalbumin) in Mice	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-SYSTEM; IN-VIVO; RETINOIC ACID; EMULSIFYING PROPERTIES; TOLERANCE INDUCTION; DENSITY-LIPOPROTEIN; SECRETION; MACROPHAGES; INHIBITION	Background: A small fraction of dietary protein survives enzymatic degradation and is absorbed in potentially antigenic form. This can trigger inflammatory responses in patients with celiac disease or food allergies, but typically induces systemic immunological tolerance (oral tolerance). At present it is not clear how dietary antigens are absorbed. Most food staples, including those with common antigens such as peanuts, eggs, and milk, contain long-chain triglycerides (LCT), which stimulate mesenteric lymph flux and postprandial transport of chylomicrons through mesenteric lymph nodes (MLN) and blood. Most dietary antigens, like ovalbumin (OVA), are emulsifiers, predicting affinity for chylomicrons. We hypothesized that chylomicron formation promotes intestinal absorption and systemic dissemination of dietary antigens. Methodology/Principal Findings: Absorption of OVA into MLN and blood was significantly enhanced when OVA was gavaged into fasted mice together with LCT compared with medium-chain triglycerides (MCT), which do not stimulate chylomicron formation. The effect of LCT was blocked by the addition of an inhibitor of chylomicron secretion, Pluronic L-81. Adoptively transferred OVA-specific DO11.10 T-cells proliferated more extensively in peripheral lymph nodes when OVA was gavaged with LCT than with MCT or LCT plus Pluronic L-81, suggesting that dietary OVA is systemically disseminated. Most dietary OVA in plasma was associated with chylomicrons, suggesting that these particles mediate systemic antigen dissemination. Intestinal-epithelial CaCo-2 cells secreted more cell-associated, exogenous OVA when stimulated with oleic-acid than with butyric acid, and the secreted OVA appeared to be associated with chylomicrons. Conclusions/Significance: Postprandial chylomicron formation profoundly affects absorption and systemic dissemination of dietary antigens. The fat content of a meal may affect immune responses to dietary antigens by modulating antigen absorption and transport.	[Wang, Yuehui; Ghoshal, Sarbani; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Wang, Yuehui; Ghoshal, Sarbani; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA; [Ward, Martin; Woodward, Jerold] Univ Kentucky, Dept Microbiol Immunol & Mol Med, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Wang, YH (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA.	Erik.eckhardt@uky.edu	Eckhardt, Erik/G-1567-2010; WANG, YUE/GWQ-9256-2022	Eckhardt, Erik/0000-0002-3015-5180	NIH [1P20RR021954-01A2, 1R21EY018952-01A1]; Science and Technology Facilities Council [ST/F002963/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018952] Funding Source: NIH RePORTER; STFC [ST/F002963/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by NIH grants 1P20RR021954-01A2 ( E. E.) and 1R21EY018952-01A1 (J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom-Fagerlund B, 2007, TOXICOLOGY, V237, P12, DOI 10.1016/j.tox.2007.04.014; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; Egan RM, 2000, J IMMUNOL, V164, P4543, DOI 10.4049/jimmunol.164.9.4543; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elsegood CL, 2006, ATHEROSCLEROSIS, V188, P251, DOI 10.1016/j.atherosclerosis.2005.10.043; Fatma S, 2006, J LIPID RES, V47, P2422, DOI 10.1194/jlr.M600211-JLR200; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; Harrison EH, 2001, J NUTR, V131, P1405, DOI 10.1093/jn/131.5.1405; Hathaway LJ, 2000, CELL MOL LIFE SCI, V57, P323, DOI 10.1007/PL00000693; Heyman M, 2001, P NUTR SOC, V60, P419, DOI 10.1079/PNS2001117; Hortin GL, 2006, BIOCHEM BIOPH RES CO, V340, P909, DOI 10.1016/j.bbrc.2005.12.098; Hundorfean G, 2007, AM J PHYSIOL-GASTR L, V293, pG798, DOI 10.1152/ajpgi.00135.2007; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; KARPE F, 1995, ARTERIOSCL THROM VAS, V15, P199, DOI 10.1161/01.ATV.15.2.199; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KVIETYS PR, 1991, AM J PHYSIOL, V261, pG384, DOI 10.1152/ajpgi.1991.261.3.G384; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; LUSAS EW, 1979, J AM OIL CHEM SOC, V56, P425, DOI 10.1007/BF02671530; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MADARA JL, 1990, J MEMBRANE BIOL, V116, P177, DOI 10.1007/BF01868675; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Mamo JCL, 1996, BIOCHEMISTRY-US, V35, P10210, DOI 10.1021/bi960188s; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; MINE Y, 1991, J AGR FOOD CHEM, V39, P443, DOI 10.1021/jf00003a003; MIURA S, 1993, IMMUNOLOGY, V78, P142; Miura S, 1998, J GASTROEN HEPATOL, V13, P1183, DOI 10.1046/j.1440-1746.1998.01782.x; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nayak N, 2001, J LIPID RES, V42, P272; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P6976, DOI 10.1021/bi0496900; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SHIMIZU M, 1983, J AGR FOOD CHEM, V31, P1214, DOI 10.1021/jf00120a018; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; TSO P, 1981, AM J PHYSIOL, V241, pG487, DOI 10.1152/ajpgi.1981.241.6.G487; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Van Niel G, 2003, GUT, V52, P1690, DOI 10.1136/gut.52.12.1690; Vreugdenhil ACE, 2003, J IMMUNOL, V170, P1399, DOI 10.4049/jimmunol.170.3.1399; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	40	41	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8442	10.1371/journal.pone.0008442	http://dx.doi.org/10.1371/journal.pone.0008442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041190	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000008
J	Niederstatter, H; Parson, W				Niederstaetter, Harald; Parson, Walther			Fluorescent Duplex Allele-Specific PCR and Amplicon Melting for Rapid Homogeneous mtDNA Haplogroup H Screening and Sensitive Mixture Detection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN MITOCHONDRIAL-DNA; REAL-TIME PCR; SYBR-GREEN-I; CONTROL REGION; POINT MUTATION; HIGH-FREQUENCY; GENOMIC DNA; AMPLIFICATION; HETEROPLASMY	Background: For large scale studies aiming at a better understanding of mitochondrial DNA (mtDNA), sequence variation in particular mt haplogroups (hgs) and population structure, reliable low-cost high-throughput genotyping assays are needed. Furthermore, methods facilitating sensitive mixture detection and relative quantification of allele proportions are indispensable for the study of heteroplasmy, mitochondrial sequence evolution, and mitochondrial disorders. Here the properties of a homogeneous competitive duplex allele specific PCR (ARMS) assay were scrutinized in the light of these requirements. Methodology/Principal Findings: A duplex ARMS assay amplifying either the ancestral mtDNA 2706G allele (non-hg H samples) or the derived 7028C allele (hg H samples) in the presence of SYBR Green fluorescent reporter dye was developed and characterized. Product detection, allele calling, and hg inference were based on the amplicon-characteristic melting-point temperatures obtained with on-line post-PCR fluorescent dissociation curve analysis (DCA). The analytical window of the assay covered at least 5 orders of magnitude of template DNA input with a detection limit in the low picogram range of genomic DNA. A set of forensically relevant test specimens was analyzed successfully. The presence of mtDNA mixtures was detected over a broad range of input DNA amounts and mixture ratios, and the estimation of allele proportions in samples with known total mtDNA content was feasible with limitations. A qualified DNA analyst successfully analyzed similar to 2,200 DNA extracts within three regular working days, without using robotic lab-equipment. By performing the amplification on-line, the assay also facilitated absolute mtDNA quantification. Conclusions: Although this assay was developed just for a particular purpose, the approach is general in that it is potentially suitable in a broad variety of assay-layouts for many other applications, including the analysis of mixtures. Homogeneous ARMS-DCA is a valuable tool for large-volume studies targeting small numbers of single nucleotide polymorphisms (SNPs).	[Niederstaetter, Harald; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria	Medical University of Innsbruck	Niederstatter, H (corresponding author), Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria.	harald.niederstaetter@i-med.ac.at	Parson, Walther/AAD-6845-2020	Parson, Walther/0000-0002-5692-2392				AKANE A, 1994, J FORENSIC SCI, V39, P362; AKTIPIS S, 1975, BIOCHEMISTRY-US, V14, P326, DOI 10.1021/bi00673a019; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; Bergstrom CT, 1998, GENETICS, V149, P2135; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Coble MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004838; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DEFRANCHIS R, 1988, NUCLEIC ACIDS RES, V16, P10355, DOI 10.1093/nar/16.21.10355; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Erali M, 2006, CLIN CHEM, V52, P1443, DOI 10.1373/clinchem.2006.068510; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FERRIE RM, 1992, AM J HUM GENET, V51, P251; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204; Hedman J, 2009, BIOTECHNIQUES, V47, P951, DOI 10.2144/000113246; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kline MC, 2005, J FORENSIC SCI, V50, P571; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Little S, 1995, CURRENT PROTOCOLS HU; Loreille OM, 2007, FORENSIC SCI INT-GEN, V1, P191, DOI 10.1016/j.fsigen.2007.02.006; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreau V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp661; Mulero JJ, 2008, J FORENSIC SCI, V53, P838, DOI 10.1111/j.1556-4029.2008.00760.x; Nath K, 2000, J BIOCHEM BIOPH METH, V42, P15, DOI 10.1016/S0165-022X(99)00033-0; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Niederstatter H, 2007, FORENSIC SCI INT-GEN, V1, P29, DOI 10.1016/j.fsigen.2006.10.007; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parson W, 2004, HUM MUTAT, V24, P474, DOI 10.1002/humu.20101; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Pereira L, 2006, FORENSIC SCI INT, V159, P43, DOI 10.1016/j.forsciint.2005.06.008; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Ruiz-Ponte C, 2000, CLIN CHEM, V46, P1574; Salas A, 2001, INT J LEGAL MED, V114, P186, DOI 10.1007/s004140000164; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schon EA, 2003, GENETICS MITOCHONDRI, P111; Seipp MT, 2008, CLIN CHEM, V54, P108, DOI 10.1373/clinchem.2007.097121; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; Sutlovic D, 2005, CROAT MED J, V46, P556; Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Zhidkov I, 2009, GENOME RES, V19, P576, DOI 10.1101/gr.086462.108	63	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8374	10.1371/journal.pone.0008374	http://dx.doi.org/10.1371/journal.pone.0008374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020064	gold, Green Published, Green Submitted			2022-12-27	WOS:000272870600013
J	Teschendorff, AE; Menon, U; Gentry-Maharaj, A; Ramus, SJ; Gayther, SA; Apostolidou, S; Jones, A; Lechner, M; Beck, S; Jacobs, IJ; Widschwendter, M				Teschendorff, Andrew E.; Menon, Usha; Gentry-Maharaj, Aleksandra; Ramus, Susan J.; Gayther, Simon A.; Apostolidou, Sophia; Jones, Allison; Lechner, Matthias; Beck, Stephan; Jacobs, Ian J.; Widschwendter, Martin			An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; GENE-EXPRESSION; HUMAN COLON; DNA; METHYLATION; PROFILES; CELLS; HYPERMETHYLATION; NEUTROPHILS; MARKER	Background: Recent studies have shown that DNA methylation (DNAm) markers in peripheral blood may hold promise as diagnostic or early detection/risk markers for epithelial cancers. However, to date no study has evaluated the diagnostic and predictive potential of such markers in a large case control cohort and on a genome-wide basis. Principal Findings: By performing genome-wide DNAm profiling of a large ovarian cancer case control cohort, we here demonstrate that active ovarian cancer has a significant impact on the DNAm pattern in peripheral blood. Specifically, by measuring the methylation levels of over 27,000 CpGs in blood cells from 148 healthy individuals and 113 age-matched pretreatment ovarian cancer cases, we derive a DNAm signature that can predict the presence of active ovarian cancer in blind test sets with an AUC of 0.8 (95% CI (0.74-0.87)). We further validate our findings in another independent set of 122 posttreatment cases (AUC = 0.76 (0.72-0.81)). In addition, we provide evidence for a significant number of candidate risk or early detection markers for ovarian cancer. Furthermore, by comparing the pattern of methylation with gene expression data from major blood cell types, we here demonstrate that age and cancer elicit common changes in the composition of peripheral blood, with a myeloid skewing that increases with age and which is further aggravated in the presence of ovarian cancer. Finally, we show that most cancer and age associated methylation variability is found at CpGs located outside of CpG islands. Significance: Our results underscore the potential of DNAm profiling in peripheral blood as a tool for detection or risk-prediction of epithelial cancers, and warrants further in-depth and higher CpG coverage studies to further elucidate this role.	[Teschendorff, Andrew E.; Beck, Stephan] UCL, Med Genom Grp, Inst Canc, London, England; [Menon, Usha; Gentry-Maharaj, Aleksandra; Ramus, Susan J.; Gayther, Simon A.; Apostolidou, Sophia; Jones, Allison; Lechner, Matthias; Jacobs, Ian J.; Widschwendter, Martin] UCL, Dept Gynecol Oncol, Elizabeth Garrett Anderson Inst Womens Hlth, London, England	University of London; University College London; University of London; University College London	Teschendorff, AE (corresponding author), UCL, Med Genom Grp, Inst Canc, London, England.	a.teschendorff@ucl.ac.uk; m.widschwendter@ucl.ac.uk	Menon, Usha/C-4716-2008; Jacobs, Ian J/F-1743-2013; Ramus, Susan/AAG-8352-2019	Menon, Usha/0000-0003-3708-1732; Jacobs, Ian J/0000-0002-8112-4624; Ramus, Susan/0000-0003-0005-7798; Gentry-Maharaj, Alex/0000-0001-7270-9762; Apostolidou, Sophia/0000-0003-2659-0451; Widschwendter, Martin/0000-0002-7778-8380; Jacobs, Ian/0000-0002-5005-2672	Department of Health, National Institute for Health (NIHR), Biomedical Research Centres; Heller Research Fellowship; Wellcome Trust	Department of Health, National Institute for Health (NIHR), Biomedical Research Centres(National Institute for Health Research (NIHR)); Heller Research Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Eve Appeal and undertaken at University College London Hospital (UCLH)/University College London (UCL) which received a proportion of funding from the Department of Health, National Institute for Health (NIHR), Biomedical Research Centres funding scheme. AET was supported by a Heller Research Fellowship. AET wishes to thank Michael and Morven Heller for the Heller Research Fellowship. SB was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balz V, 2002, CANCER GENET CYTOGEN, V138, P120, DOI 10.1016/S0165-4608(02)00601-5; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Christensen BC, 2009, CANCER RES, V69, P227, DOI 10.1158/0008-5472.CAN-08-2586; Cooney CA, 2007, DIS MARKERS, V23, P121, DOI 10.1155/2007/394034; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; Meng HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-457; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pauler DK, 2001, CANCER EPIDEM BIOMAR, V10, P489; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Quaye L, 2009, BRIT J CANCER, V100, P993, DOI 10.1038/sj.bjc.6604947; R Core Team, 2020, R LANG ENV STAT COMP; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; SATOMI A, 1995, ACTA ONCOL, V34, P69, DOI 10.3109/02841869509093641; Stirewalt DL, 2009, LEUKEMIA, V23, P391, DOI 10.1038/leu.2008.176; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TESCHENDORFF AE, AGE DEPENDENT UNPUB; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; WEISENBERGER D, 2008, COMPREHENSIVE DNA ME; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977	43	246	254	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8274	10.1371/journal.pone.0008274	http://dx.doi.org/10.1371/journal.pone.0008274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20019873	Green Submitted, Green Published, gold			2022-12-27	WOS:000272870600004
J	Perne, A; Muellner, MK; Steinrueck, M; Craig-Mueller, N; Mayerhofer, J; Schwarzinger, I; Sloane, M; Uras, IZ; Hoermann, G; Nijman, SMB; Mayerhofer, M				Perne, Andrea; Muellner, Markus K.; Steinrueck, Magdalena; Craig-Mueller, Nils; Mayerhofer, Julia; Schwarzinger, Ilse; Sloane, Mathew; Uras, Iris Z.; Hoermann, Gregor; Nijman, Sebastian M. B.; Mayerhofer, Matthias			Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis	PLOS ONE			English	Article							BREAST-CANCER; DIDEMNIN-B; EXPRESSION; POTASSIUM; DIGITALIS; CARCINOMA; OUABAIN; FIBROBLASTS; MECHANISMS; DIGITOXIN	Background: Cardiac glycosides are Na+/K+-pump inhibitors widely used to treat heart failure. They are also highly cytotoxic, and studies have suggested specific anti-tumor activity leading to current clinical trials in cancer patients. However, a definitive demonstration of this putative anti-cancer activity and the underlying molecular mechanism has remained elusive. Methodology/Principal Findings: Using an unbiased transcriptomics approach, we found that cardiac glycosides inhibit general protein synthesis. Protein synthesis inhibition and cytotoxicity were not specific for cancer cells as they were observed in both primary and cancer cell lines. These effects were dependent on the Na+/K+-pump as they were rescued by expression of a cardiac glycoside-resistant Na+/K+-pump. Unlike human cells, rodent cells are largely resistant to cardiac glycosides in vitro and mice were found to tolerate extremely high levels. Conclusions/Significance: The physiological difference between human and mouse explains the previously observed sensitivity of human cancer cells in mouse xenograft experiments. Thus, published mouse xenograft models used to support anti-tumor activity for these drugs require reevaluation. Our finding that cardiac glycosides inhibit protein synthesis provides a mechanism for the cytotoxicity of CGs and raises concerns about ongoing clinical trials to test CGs as anti-cancer agents in humans.	[Perne, Andrea; Steinrueck, Magdalena; Mayerhofer, Julia; Schwarzinger, Ilse; Hoermann, Gregor; Mayerhofer, Matthias] Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria; [Muellner, Markus K.; Craig-Mueller, Nils; Sloane, Mathew; Uras, Iris Z.; Nijman, Sebastian M. B.] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria	Medical University of Vienna; Austrian Academy of Sciences	Perne, A (corresponding author), Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria.	snijman@cemm.oeaw.at; matthias.mayerhofer@meduniwien.ac.at	Uras, Iris/AAH-2221-2021; Hoermann, Gregor/B-8832-2016	Hoermann, Gregor/0000-0002-7374-4380; Uras, Iris/0000-0002-2434-2756	Austrian Society of Laboratory Medicine and Clinical Chemistry	Austrian Society of Laboratory Medicine and Clinical Chemistry	Parts of this study were supported by a grant from the Austrian Society of Laboratory Medicine and Clinical Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2205; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; ANTECOL MH, 1986, CANCER RES, V46, P1867; CAHN F, 1978, J BIOL CHEM, V253, P7798; CAIN JM, 1992, INVEST NEW DRUG, V10, P23, DOI 10.1007/BF01275473; CATIMEL G, 1995, CANCER CHEMOTH PHARM, V35, P246, DOI 10.1007/BF00686555; Dresser MJ, 2000, DRUG METAB DISPOS, V28, P1135; EMANUEL JR, 1988, J BIOL CHEM, V263, P7726; ENNIS HL, 1961, BIOCHIM BIOPHYS ACTA, V50, P399, DOI 10.1016/0006-3002(61)90355-9; Ewertz M, 2001, ACTA ONCOL, V40, P467, DOI 10.1080/028418601750288181; Figlin RA, 2008, J NATL COMPR CANC S5, V6, pS21; Figlin Robert A, 2008, J Natl Compr Canc Netw, V6 Suppl 5, pS1; GOLDIN AG, 1984, LANCET, V1, P1134; Han KQ, 2007, WORLD J GASTROENTERO, V13, P3374, DOI 10.3748/wjg.v13.i24.3374; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; INADA A, 1993, BIOL PHARM BULL, V16, P930, DOI 10.1248/bpb.16.930; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lefranc F, 2008, NEOPLASIA, V10, P198, DOI 10.1593/neo.07928; LEVINE H, 1966, NATURE, V211, P1302, DOI 10.1038/2111302a0; LUBIN M, 1964, BIOCHIM BIOPHYS ACTA, V80, P614, DOI 10.1016/0926-6550(64)90306-8; LYNCH DAF, 1994, J CLIN PATHOL, V47, P122, DOI 10.1136/jcp.47.2.122; MANKOVITZ R, 1974, CELL, V3, P221, DOI 10.1016/0092-8674(74)90135-4; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Mijatovic T, 2008, NEOPLASIA, V10, P573, DOI 10.1593/neo.08290; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prassas I, 2008, CLIN CANCER RES, V14, P5778, DOI 10.1158/1078-0432.CCR-08-0706; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Stenkvist B, 1999, ONCOL REP, V6, P493; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; Svensson A, 2005, ANTICANCER RES, V25, P207; TABOULET P, 1993, J TOXICOL-CLIN TOXIC, V31, P247, DOI 10.3109/15563659309000392; TAYLOR SA, 1992, INVEST NEW DRUG, V10, P55, DOI 10.1007/BF01275484; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; WRIGHT JC, 1955, ARCH INTERN MED, V96, P61, DOI 10.1001/archinte.1955.04430010075008; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833; ZHANG H, 2008, P NATL ACAD SCI US	43	63	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8292	10.1371/journal.pone.0008292	http://dx.doi.org/10.1371/journal.pone.0008292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016840	gold, Green Submitted, Green Published			2022-12-27	WOS:000272834000011
J	Wang, SJ; Xin, FX; Liu, XY; Wang, YX; An, ZY; Qi, QS; Wang, PG				Wang, Shengjun; Xin, Fengxue; Liu, Xiaoyue; Wang, Yuxiao; An, Zhenyi; Qi, Qingsheng; Wang, Peng George			N-Terminal Deletion of Peptide: N-Glycanase Results in Enhanced Deglycosylation Activity	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTION; CYTOPLASMIC PEPTIDE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; YEAST PEPTIDE; 2-DIMENSIONAL GEL; QUALITY-CONTROL; GLYCOPROTEINS; COMPLEX; OLIGOSACCHARIDES	Peptide:N-glycanase catalyzes the detachment of N-linked glycan chains from glycopeptides or glycoproteins by hydrolyzing the beta-aspartylglucosaminyl bond. Peptide:N-glycanase in yeast binds to Rad23p through its N-terminus. In this study, the complex formed between Peptide:N-glycanase and Rad23p was found to exhibit enhanced deglycosylation activity, which suggests an important role for this enzyme in the misfolded glycoprotein degradation pathway in vivo. To investigate the role of this enzyme in this pathway, we made stepwise deletions of the N-terminal helices of peptide: N-glycanase. Enzymatic analysis of the deletion mutants showed that deletion of the N-terminal H1 helix (Png1p-Delta H1) enhanced the deglycosylation activity of N-glycanase towards denatured glycoproteins. In addition, this mutant exhibited high deglycosylation activity towards native glycoproteins. Dynamic simulations of the wild type and N-terminal H1 deletion mutant implied that Png1p-Delta H1 is more flexible than wild type Png1p. The efficient deglycosylation of Png1p-Delta H1 towards native and non-native glycoproteins offers a potential biotechnological application.	[Wang, Shengjun; Xin, Fengxue; Liu, Xiaoyue; Wang, Yuxiao; An, Zhenyi; Qi, Qingsheng; Wang, Peng George] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Qi, Qingsheng; Wang, Peng George] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Wang, SJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	qiqingsheng@sdu.edu.cn	WANG, Peng/GSN-5263-2022; Qi, Qingsheng/F-7418-2013		National Natural Science Foundation of China [30870022]; Foundation for Excellent Young Scholars in Shandong Province of China [2006BS02011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scholars in Shandong Province of China	This work was financially supported by a grant from the National Natural Science Foundation of China (30870022) and Foundation for Excellent Young Scholars in Shandong Province of China (2006BS02011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSOMIAN GD, 1990, J BIOL CHEM, V265, P6967; Biswas S, 2004, BIOCHEM BIOPH RES CO, V323, P149, DOI 10.1016/j.bbrc.2004.08.061; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Charlwood J, 2000, ANAL BIOCHEM, V284, P49, DOI 10.1006/abio.2000.4687; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; He ZC, 2006, BIOCHEM BIOPH RES CO, V343, P496, DOI 10.1016/j.bbrc.2006.03.007; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Jett M, 1971, J Biol Chem, V246, P3686; Joshi S, 2005, FEBS LETT, V579, P823, DOI 10.1016/j.febslet.2004.12.060; Kamoda S, 2006, J CHROMATOGR A, V1106, P67, DOI 10.1016/j.chroma.2005.08.052; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Su Yi-Shan, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P911; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V302, P1, DOI 10.1016/S0006-291X(03)00052-4; Suzuki T, 2001, BIOCHEM BIOPH RES CO, V287, P1083, DOI 10.1006/bbrc.2001.5688; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wang SJ, 2007, ACTA BIOCH BIOPH SIN, V39, P8, DOI 10.1111/j.1745-7270.2007.00244.x; Xin FX, 2008, BIOCHEM BIOPH RES CO, V368, P907, DOI 10.1016/j.bbrc.2008.02.017; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; ZHAO G, 2008, GLYCOBIOLOGY; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	39	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8335	10.1371/journal.pone.0008335	http://dx.doi.org/10.1371/journal.pone.0008335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016784	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834000021
J	Garcia, V; Garcia, JM; Silva, J; Martin, P; Pena, C; Dominguez, G; Diaz, R; Herrera, M; Maximiano, C; Sabin, P; Rueda, A; Cruz, MA; Rodriguez, J; Canales, MA; Bonilla, F; Provencio, M				Garcia, Vanesa; Miguel Garcia, Jose; Silva, Javier; Martin, Paloma; Pena, Cristina; Dominguez, Gemma; Diaz, Raquel; Herrera, Mercedes; Maximiano, Constanza; Sabin, Pilar; Rueda, Antonio; Angel Cruz, Miguel; Rodriguez, Jose; Angel Canales, Miguel; Bonilla, Felix; Provencio, Mariano			Extracellular Tumor-Related mRNA in Plasma of Lymphoma Patients and Survival Implications	PLOS ONE			English	Article							B-CELL LYMPHOMA; BREAST-CANCER PATIENTS; HODGKINS-LYMPHOMA; DNA; BIOMARKERS; DISEASE	Background: We studied anomalous extracellular mRNAs in plasma from patients with diffuse large B-cell lymphoma (DLBCL) and their survival implications. mRNAs studied have been reported in the literature as markers of poor (BCL2, CCND2, MYC) and favorable outcome (LMO2, BCL6, FN1) in tumors. These markers were also analyzed in lymphoma tissues to test possible associations with their presence in plasma. Methodology/Principal Findings: mRNA from 42 plasma samples and 12 tumors from patients with DLBCL was analyzed by real-time PCR. Samples post-treatment were studied. The immunohistochemistry of BCL2 and BCL6 was defined. Presence of circulating tumor cells was determined by analyzing the clonality of the immunoglobulin heavy-chain genes by PCR. In DLBCL, MYC mRNA was associated with short overall survival. mRNA targets with unfavorable outcome in tumors were associated with characteristics indicative of poor prognosis, with partial treatment response and with short progression-free survival in patients with complete response. In patients with low IPI score, unfavorable mRNA targets were related to shorter overall survival, partial response, high LDH levels and death. mRNA disappeared in post-treatment samples of patients with complete response, and persisted in those with partial response or death. No associations were found between circulating tumor cells and plasma mRNA. Absence of BCL6 protein in tumors was associated with presence of unfavorable plasma mRNA. Conclusions/Significance: Through a non-invasive procedure, tumor-derived mRNAs can be obtained in plasma. mRNA detected in plasma did not proceed from circulating tumor cells. In our study, unfavorable targets in plasma were associated with poor prognosis in B-cell lymphomas, mainly MYC mRNA. Moreover, the unfavorable targets in plasma could help us to classify patients with poor outcome within the good prognosis group according to IPI.	[Garcia, Vanesa; Miguel Garcia, Jose; Silva, Javier; Pena, Cristina; Dominguez, Gemma; Diaz, Raquel; Herrera, Mercedes; Maximiano, Constanza; Bonilla, Felix] Puerta de Hierro Univ Hosp, Dept Med Oncol, Madrid, Spain; [Martin, Paloma] Puerta de Hierro Univ Hosp, Dept Mol Pathol, Madrid, Spain; [Sabin, Pilar; Rodriguez, Jose] Gregorio Maranon Hosp, Dept Med Oncol, Madrid, Spain; [Rueda, Antonio] Virgen Victoria Hosp, Dept Med Oncol, Malaga, Spain; [Angel Cruz, Miguel] Virgen Salud Hosp, Dept Med Oncol, Toledo, Spain; [Angel Canales, Miguel] Hosp La Paz, Dept Hematol, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; General University Gregorio Maranon Hospital; Hospital Universitario La Paz	Garcia, V (corresponding author), Puerta de Hierro Univ Hosp, Dept Med Oncol, Madrid, Spain.	fbonilla.hpth@salud.madrid.org; mprovencio.hpth@salud.madrid.org	Acosta, Paloma Martin/AAF-7998-2021; Canales, Miguel Angel/GPC-7039-2022; Canales, Miguel/AAA-3647-2020; Provencio, Mariano/ABE-8586-2020; Alonso, Constanza Maximiano/AAE-9102-2021	Acosta, Paloma Martin/0000-0002-3274-4595; Canales, Miguel Angel/0000-0002-6550-2621; Provencio, Mariano/0000-0001-9053-9197; Alonso, Constanza Maximiano/0000-0002-4051-3965; Provencio Pulla, Mariano/0000-0001-6315-7919; DIAZ MARTINEZ, RAQUEL/0000-0001-9748-3464; Garcia-Barberan, Vanesa/0000-0002-2531-0203	Instituto de Salud Carlos III [(FIS)-PI04/0053, (RETIC) RD06/0020/0020]; MICINN (SAF) [2004-01002, SAF 2007-60214]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MICINN (SAF)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the following grants: Instituto de Salud Carlos III (FIS)-PI04/0053 and (RETIC) RD06/0020/0020; MICINN (SAF) 2004-01002 and SAF 2007-60214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dasi F, 2001, LAB INVEST, V81, P767, DOI 10.1038/labinvest.3780285; Frickhofen N, 1997, BLOOD, V90, P4953, DOI 10.1182/blood.V90.12.4953.4953_4953_4960; Gandhi MK, 2006, CLIN CANCER RES, V12, P460, DOI 10.1158/1078-0432.CCR-05-2008; Garcia JM, 2006, GENE CHROMOSOME CANC, V45, P692, DOI 10.1002/gcc.20334; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; Garcia V, 2008, CANCER LETT, V263, P312, DOI 10.1016/j.canlet.2008.01.008; Lossos IS, 2006, J CLIN ONCOL, V24, P995, DOI 10.1200/JCO.2005.02.4786; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Seki R, 2009, CANCER SCI, V100, P1842, DOI 10.1111/j.1349-7006.2009.01268.x; SHAPIRO B, 1983, CANCER, V51, P2116, DOI 10.1002/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tibiletti MG, 2009, HUM PATHOL, V40, P645, DOI 10.1016/j.humpath.2008.06.032; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	17	19	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8173	10.1371/journal.pone.0008173	http://dx.doi.org/10.1371/journal.pone.0008173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016842	Green Submitted, Green Published, gold			2022-12-27	WOS:000272833800002
J	Joppa, LN; Pfaff, A				Joppa, Lucas N.; Pfaff, Alexander			High and Far: Biases in the Location of Protected Areas	PLOS ONE			English	Article							TROPICAL FORESTS; GAP ANALYSIS; BIODIVERSITY; DEFORESTATION; DISTRIBUTIONS; VERTEBRATES; AMAZON; PARKS	Background: About an eighth of the earth's land surface is in protected areas (hereafter "PAs''), most created during the 20(th) century. Natural landscapes are critical for species persistence and PAs can play a major role in conservation and in climate policy. Such contributions may be harder than expected to implement if new PAs are constrained to the same kinds of locations that PAs currently occupy. Methodology/Principal Findings: Quantitatively extending the perception that PAs occupy "rock and ice'', we show that across 147 nations PA networks are biased towards places that are unlikely to face land conversion pressures even in the absence of protection. We test each country's PA network for bias in elevation, slope, distances to roads and cities, and suitability for agriculture. Further, within each country's set of PAs, we also ask if the level of protection is biased in these ways. We find that the significant majority of national PA networks are biased to higher elevations, steeper slopes and greater distances to roads and cities. Also, within a country, PAs with higher protection status are more biased than are the PAs with lower protection statuses. Conclusions/Significance: In sum, PAs are biased towards where they can least prevent land conversion (even if they offer perfect protection). These globally comprehensive results extend findings from nation-level analyses. They imply that siting rules such as the Convention on Biological Diversity's 2010 Target [to protect 10% of all ecoregions] might raise PA impacts if applied at the country level. In light of the potential for global carbon-based payments for avoided deforestation or REDD, these results suggest that attention to threat could improve outcomes from the creation and management of PAs.	[Joppa, Lucas N.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA	Duke University	Joppa, LN (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA.	joppatri@yahoo.com			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This study was funded by a National Science Foundation Graduate Research Fellowship to Lucas Joppa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Ball I., 2000, MARXAN V1 8 2 MARINE; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; CIESIN (Center for International Earth Science Information Network Columbia University); IFPRI (International Food Policy Research Institute); The World Bank and CIAT (Centro Internacional De Agricultura Tropical), 2000, GLOB RUR URB MAPP PR; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Fischer G, 2002, GLOBAL AGROECOLOGICA; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gorenflo LJ, 2006, BIOSCIENCE, V56, P723, DOI 10.1641/0006-3568(2006)56[723:KHDOGI]2.0.CO;2; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; JOPPA L, ECOLOGICAL IN PRESS; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Locke H, 2005, ENVIRON CONSERV, V32, P1, DOI 10.1017/S0376892905001852; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; *NIMA, 2000, VECT MAP LEV 0 DIG C; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Pfaff ASP, 2004, RESOUR ENERGY ECON, V26, P237, DOI 10.1016/j.reseneeco.2003.11.009; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; PRESSEY RL, 1994, AUST J ECOL, V19, P375, DOI 10.1111/j.1442-9993.1994.tb00503.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Scott JM, 2004, NAT RESOUR J, V44, P1041; SCOTT JM, 1999, CONSERVATION BIOL NE, V6, P1; USGS, 2006, SHUTTL RAD TOP MISS; 2009, LANGUAGE ENV STAT CO	40	567	589	4	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8273	10.1371/journal.pone.0008273	http://dx.doi.org/10.1371/journal.pone.0008273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011603	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300028
J	Berkemeyer, S; Schumacher, J; Thiem, U; Pientka, L				Berkemeyer, Shoma; Schumacher, Jochen; Thiem, Ulrich; Pientka, Ludger			Bone T-Scores and Functional Status: A Cross-Sectional Study on German Elderly	PLOS ONE			English	Article							HIP FRACTURE; OLDER MEN; OSTEOPOROSIS; RISK; MOBILITY; TIME	Background: We explore the association between bone T-scores, used in osteoporosis diagnosis, and functional status since we hypothesized that bone health can impact elderly functional status and indirectly independence. Methods: In a cross-sectional study (2005-2006) on community dwelling elderly (>=75 years) from Herne, Germany we measured bone T-scores with Dual-energy X-ray Absorptiometry, and functional status indexed by five geriatric tests: activities of daily living, instrumental activities of daily living, test of dementia, geriatric depression score and the timed-up-and-go test, and two pooled indexes: raw and standardized. Generalized linear regression was used to determine the relationship between T-scores and functional status. Results: From 3243 addresses, only 632 (19%) completed a clinical visit, of which only 440 (male: female, 243: 197) could be included in analysis. T-scores (20.99, 95% confidence interval [CI], 21.1-0.9) predicted activities of daily living (95.3 CI, 94.5-96.2), instrumental activities of daily living (7.3 CI, 94.5-96.2), and timed-up-and-go test (10.7 CI, 10.0-11.3) (P<= 0.05). Pooled data showed that a unit improvement in T-score improved standardized pooled functional status (15 CI, 14.7-15.3) by 0.41 and the raw (99.4 CI, 97.8-101.0) by 2.27 units. These results were limited due to pooling of different scoring directions, selection bias, and a need to follow-up with evidence testing. Conclusions: T-scores associated with lower functional status in community-dwelling elderly. Regular screening of osteoporosis as a preventive strategy might help maintain life quality with aging.	[Berkemeyer, Shoma; Thiem, Ulrich; Pientka, Ludger] Ruhr Univ Bochum, Dept Geriatr, Marienhosp Herne, D-4690 Herne, Germany; [Schumacher, Jochen] Univ Duisburg Essen, Alfried Krupp Krankenhaus Steele, Dept Internal Med, Essen, Germany	Ruhr University Bochum; University of Duisburg Essen	Berkemeyer, S (corresponding author), Ruhr Univ Bochum, Dept Geriatr, Marienhosp Herne, D-4690 Herne, Germany.	shoma.berkemeyer@ruhr-uni-bochum.de			Elsbeth-Bonhof-Stiftung, Berlin; Robert Bosch Foundation, Stuttgart	Elsbeth-Bonhof-Stiftung, Berlin; Robert Bosch Foundation, Stuttgart	This study was supported by the Elsbeth-Bonhof-Stiftung, Berlin. Drs Schumacher and Thiem were both financed by research grants from the Robert Bosch Foundation, Stuttgart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH M, 1995, SCHRIFTENREIHE GERIA; Body J J, 2008, Rev Med Brux, V29, P289; Breuil V, 2008, JOINT BONE SPINE, V75, P585, DOI 10.1016/j.jbspin.2008.01.024; Burke-Doe Annie, 2008, J Geriatr Phys Ther, V31, P11; Carpenter CR, 2009, ACAD EMERG MED, V16, P211, DOI 10.1111/j.1553-2712.2009.00351.x; del Rio L, 2008, CLIN EXP RHEUMATOL, V26, P283; Frassetto Lynda, 2009, P503; Gunter KB, 2000, J GERONTOL A-BIOL, V55, pM672, DOI 10.1093/gerona/55.11.M672; Haussler B, 2007, OSTEOPOROSIS INT, V18, P77, DOI 10.1007/s00198-006-0206-y; Joel M E, 1998, Curr Opin Rheumatol, V10, P362, DOI 10.1097/00002281-199807000-00015; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; Karagas MR, 1996, AM J EPIDEMIOL, V143, P677; Knoke JD, 2003, AM J EPIDEMIOL, V158, P1132, DOI 10.1093/aje/kwg265; Lau AN, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-151; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; MAHONEY F I, 1965, Md State Med J, V14, P61; Morris R, 2001, AGE AGEING, V30, P371, DOI 10.1093/ageing/30.5.371; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; *NIH, 2005, OST DIAGN; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raisz LG, 2000, MAYO CLIN PROC, V75, P885, DOI 10.4065/75.9.885; Russell MA, 2006, J GERONTOL A-BIOL, V61, P1090, DOI 10.1093/gerona/61.10.1090; Spangler L, 2008, J GEN INTERN MED, V23, P567, DOI 10.1007/s11606-008-0525-0; Stubbs B, 2009, INT PSYCHOGERIATR, V21, P180, DOI 10.1017/S1041610208007849; Thrane Gyrd, 2007, BMC Geriatr, V7, P1, DOI 10.1186/1471-2318-7-1; TUMULTY K, 2009, HLTH CARE UNLIKELY C, V173, P28; Waldman A, 2003, DRUGS, V63, P139, DOI 10.2165/00003495-200363020-00002; Whitson HE, 2008, AGING CLIN EXP RES, V20, P585; *WHO, 2004, ASS FRACT RISK ITS A; Wildner M, 1999, OSTEOPOROSIS INT, V9, P144, DOI 10.1007/s001980050128; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zystra RG, 2008, J AM MED DIR ASSOC, V9, P109, DOI 10.1016/j.jamda.2007.09.008; 2002, HAMBURGER EINSTUFUNG	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8216	10.1371/journal.pone.0008216	http://dx.doi.org/10.1371/journal.pone.0008216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011039	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829800008
J	Abrajano, JJ; Qureshi, IA; Gokhan, S; Zheng, DY; Bergman, A; Mehler, MF				Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Bergman, Aviv; Mehler, Mark F.			REST and CoREST Modulate Neuronal Subtype Specification, Maturation and Maintenance	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; FOREBRAIN CHOLINERGIC NEURONS; EMBRYONIC STEM-CELLS; RADIAL GLIAL-CELLS; LIM-HOMEOBOX GENE; IN-VIVO; TARGET GENES; DEVELOPMENTAL-CHANGES; GROWTH-FACTOR; TRANSCRIPTION FACTOR	Background: The repressor element-1 silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a master regulator of neuronal gene expression. REST functions as a modular scaffold for dynamic recruitment of epigenetic regulatory factors including its primary cofactor, the corepressor for element-1-silencing transcription factor (CoREST), to genomic loci that contain the repressor element-1 (RE1) binding motif. While REST was initially believed to silence RE1 containing neuronal genes in neural stem cells (NSCs) and non-neuronal cells, emerging evidence shows an increasingly complex cell type- and developmental stage-specific repertoire of REST target genes and functions that include regulation of neuronal lineage maturation and plasticity. Methodology/Principal Findings: In this study, we utilized chromatin immunoprecipitation on chip (ChIP-chip) analysis to examine REST and CoREST functions during NSC-mediated specification of cholinergic neurons (CHOLNs), GABAergic neurons (GABANs), glutamatergic neurons (GLUTNs), and medium spiny projection neurons (MSNs). We identified largely distinct but overlapping profiles of REST and CoREST target genes during neuronal subtype specification including a disproportionately high percentage that are exclusive to each neuronal subtype. Conclusions/Significance: Our findings demonstrate that the differential deployment of REST and CoREST is an important regulatory mechanism that mediates neuronal subtype specification by modulating specific gene networks responsible for inducing and maintaining neuronal subtype identity. Our observations also implicate a broad array of factors in the generation of neuronal diversity including but not limited to those that mediate homeostasis, cell cycle dynamics, cell viability, stress responses and epigenetic regulation.	[Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA; [Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Abrajano, Joseph J.; Zheng, Deyou; Bergman, Aviv; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Zheng, Deyou; Bergman, Aviv] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Mehler, Mark F.] Albert Einstein Coll Med, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Abrajano, JJ (corresponding author), Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA.	mehler@aecom.yu.edu		Zheng, Deyou/0000-0003-4354-5337	National Institutes of Health [AG028872, AG027734, NS38902, MH66290]; Roslyn and Leslie Goldstein Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028872, P01AG027734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roslyn and Leslie Goldstein Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A. B. is supported by grants from the National Institutes of Health (AG028872, AG027734) and M. F. M. is supported by grants from the National Institutes of Health (NS38902, MH66290), as well as by the F. M. Kirby, the Rosanne H. Silbermann, the Alpern Family, the Mildred and Bernard H. Kayden and the Roslyn and Leslie Goldstein Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi Fatima, 2009, Hum Genet, V125, P344; Adegbola A, 2008, AM J MED GENET A, V146A, P505, DOI 10.1002/ajmg.a.32142; Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Alvarez-Rodriguez R, 2009, J CELL SCI, V122, P595, DOI 10.1242/jcs.037556; Ando Y, 2003, NEUROCHEM RES, V28, P839, DOI 10.1023/A:1023258923002; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bonsi P, 2008, NEUROPHARMACOLOGY, V55, P392, DOI 10.1016/j.neuropharm.2008.05.020; Brivanlou AH, 1998, NAT GENET, V20, P109, DOI 10.1038/2402; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; BRUCE AW, 2009, GENOME RES; CEDAR H, 2009, NAT REV GENET; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Cohen RI, 1996, J NEUROSCI, V16, P6433; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Ferrari-Toninelli G, 2008, NEUROSCIENCE, V154, P946, DOI 10.1016/j.neuroscience.2008.04.025; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fiumelli H, 2008, CELL MOTIL CYTOSKEL, V65, P495, DOI 10.1002/cm.20278; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; Gokhan S, 2001, ANAT RECORD, V265, P142, DOI 10.1002/ar.1136; Goncalves MBCV, 2009, DEV BIOL, V326, P305, DOI 10.1016/j.ydbio.2008.11.018; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Huang YF, 2002, J NEUROSCI, V22, P8422; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Jin JZ, 2006, DEV DYNAM, V235, P547, DOI 10.1002/dvdy.20642; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; KAZANTSEVA A, 2009, J NEUROCHEM; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; KOLLER KJ, 1985, J NEUROSCI, V5, P2882; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kortazar D, 2007, EXP CELL RES, V313, P425, DOI 10.1016/j.yexcr.2006.09.002; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lakowski B, 2006, J MOL NEUROSCI, V29, P227, DOI 10.1385/JMN:29:3:227; Lein PJ, 2002, J NEUROSCI, V22, P10377; Li HD, 2007, GLIA, V55, P24, DOI 10.1002/glia.20434; Marmur R, 1998, J NEUROSCI, V18, P9800; Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099; Martorana A, 2006, SYNAPSE, V60, P371, DOI 10.1002/syn.20306; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Ohashi S, 2000, J NEUROCHEM, V75, P1781, DOI 10.1046/j.1471-4159.2000.0751781.x; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pepin D, 2007, TRENDS ENDOCRIN MET, V18, P215, DOI 10.1016/j.tem.2007.05.004; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Reilly JO, 2002, MOL CELL NEUROSCI, V19, P88, DOI 10.1006/mcne.2001.1063; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; SNYDER GL, 1994, J NEUROCHEM, V63, P1766; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Williams S, 2002, BIOCHEM BIOPH RES CO, V290, P1321, DOI 10.1006/bbrc.2002.6351; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhang HY, 2008, J NEUROSCI RES, V86, P1217, DOI 10.1002/jnr.21581; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9; Zhu G, 2000, J NEUROSCI RES, V59, P312, DOI 10.1002/(SICI)1097-4547(20000201)59:3<312::AID-JNR4>3.0.CO;2-A; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I; Zhu H, 2006, INT J DEV BIOL, V50, P71, DOI 10.1387/ijdb.052087hz	111	88	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e7936	10.1371/journal.pone.0007936	http://dx.doi.org/10.1371/journal.pone.0007936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997604	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829500002
J	Lluis, JM; Nachbur, U; Cook, WD; Gentle, IE; Moujalled, D; Moulin, M; Wong, WWL; Khan, N; Chau, D; Callus, BA; Vince, JE; Silke, J; Vaux, DL				Lluis, Josep Maria; Nachbur, Ulrich; Cook, Wendy Diane; Gentle, Ian Edward; Moujalled, Donia; Moulin, Maryline; Wong, Wendy Wei-Lynn; Khan, Nufail; Chau, Diep; Callus, Bernard Andrew; Vince, James Edward; Silke, John; Vaux, David Lawrence			TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-kappa B Dependent Induction of cFLIPL	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; C-FLIP; CANCER CELLS; CASPASE-8 ACTIVATION; SIGNALING PATHWAYS; TERMINAL KINASE; DOWN-REGULATION; EXPRESSION; DEATH; INHIBITION	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known as a "death ligand"-a member of the TNF superfamily that binds to receptors bearing death domains. As well as causing apoptosis of certain types of tumor cells, TRAIL can activate both NF-kappa B and JNK signalling pathways. To determine the role of TGF-beta-Activated Kinase-1 (TAK1) in TRAIL signalling, we analyzed the effects of adding TRAIL to mouse embryonic fibroblasts (MEFs) derived from TAK1 conditional knockout mice. TAK1-/- MEFs were significantly more sensitive to killing by TRAIL than wild-type MEFs, and failed to activate NF-kappa B or JNK. Overexpression of IKK2-EE, a constitutive activator of NF-kappa B, protected TAK1-/- MEFs against TRAIL killing, suggesting that TAK1 activation of NF-kappa B is critical for the viability of cells treated with TRAIL. Consistent with this model, TRAIL failed to induce the survival genes cIAP2 and cFlipL in the absence of TAK1, whereas activation of NF-kappa B by IKK2-EE restored the levels of both proteins. Moreover, ectopic expression of cFlipL, but not cIAP2, in TAK1-/- MEFs strongly inhibited TRAIL-induced cell death. These results indicate that cells that survive TRAIL treatment may do so by activation of a TAK1-NF-kappa B pathway that drives expression of cFlipL, and suggest that TAK1 may be a good target for overcoming TRAIL resistance.	[Lluis, Josep Maria; Nachbur, Ulrich; Cook, Wendy Diane; Gentle, Ian Edward; Moujalled, Donia; Moulin, Maryline; Wong, Wendy Wei-Lynn; Khan, Nufail; Chau, Diep; Silke, John; Vaux, David Lawrence] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [Callus, Bernard Andrew] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, Australia; [Vince, James Edward] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	La Trobe University; University of Western Australia; University of Lausanne	Lluis, JM (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia.	D.Vaux@latrobe.edu.au	Silke, John/B-7622-2008; Gentle, Ian/X-2888-2019; Wong, W. Wei-Lynn/A-6851-2015; Cook, Wendy/N-7506-2019; Vaux, David L/C-7249-2013	Silke, John/0000-0002-7611-5774; Gentle, Ian/0000-0002-6707-7809; Wong, W. Wei-Lynn/0000-0003-3155-1211; Vaux, David L/0000-0003-2703-1651; Nachbur, Ueli/0000-0001-5968-2235; Moulin, Maryline/0000-0002-1851-8727	Leukemia and Lymphoma Society; National Health and Medical Research Council [461221]	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work has been funded by the Leukemia and Lymphoma Society, and National Health and Medical Research Council grant #461221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Beraza N, 2009, J EXP MED, V206, P1727, DOI 10.1084/jem.20082152; Bullani RR, 2001, J INVEST DERMATOL, V117, P360, DOI 10.1046/j.0022-202x.2001.01418.x; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; Clarke P, 2007, APOPTOSIS, V12, P211, DOI 10.1007/s10495-006-0528-4; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Geserick P, 2008, ONCOGENE, V27, P3211, DOI 10.1038/sj.onc.1210985; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Noutomi T, 2009, ONCOL REP, V22, P1169, DOI 10.3892/or_00000551; Okano H, 2003, LAB INVEST, V83, P1033, DOI 10.1097/01.LAB.0000079328.76631.28; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Remmelink M, 2005, INT J ONCOL, V26, P247; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Ryu BK, 2001, J PATHOL, V194, P15, DOI 10.1002/path.835; Safwat N, 2005, ENDOCRINOLOGY, V146, P4814, DOI 10.1210/en.2005-0457; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang P, 2007, CELL SIGNAL, V19, P2237, DOI 10.1016/j.cellsig.2007.06.001; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585	42	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8620	10.1371/journal.pone.0008620	http://dx.doi.org/10.1371/journal.pone.0008620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062539	Green Published, Green Accepted, gold			2022-12-27	WOS:000273414200001
J	Fittipaldi, N; Takamatsu, D; Dominguez-Punaro, MD; Lecours, MP; Montpetit, D; Osaki, M; Sekizaki, T; Gottschalk, M				Fittipaldi, Nahuel; Takamatsu, Daisuke; Dominguez-Punaro, Maria de la Cruz; Lecours, Marie-Pier; Montpetit, Diane; Osaki, Makoto; Sekizaki, Tsutomu; Gottschalk, Marcelo			Mutations in the Gene Encoding the Ancillary Pilin Subunit of the Streptococcus suis srtF Cluster Result in Pili Formed by the Major Subunit Only	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; MICROVASCULAR ENDOTHELIAL-CELLS; GERM-FREE PIGS; ESCHERICHIA-COLI; CAPSULAR TYPE-2; VIRULENCE; PROTEIN; IDENTIFICATION; SEROTYPE-2; INFECTION	Pili have been shown to contribute to the virulence of different Gram-positive pathogenic species. Among other critical steps of bacterial pathogenesis, these structures participate in adherence to host cells, colonization and systemic virulence. Recently, the presence of at least four discrete gene clusters encoding putative pili has been revealed in the major swine pathogen and emerging zoonotic agent Streptococcus suis. However, pili production by this species has not yet been demonstrated. In this study, we investigated the functionality of one of these pili clusters, known as the srtF pilus cluster, by the construction of mutant strains for each of the four genes of the cluster as well as by the generation of antibodies against the putative pilin subunits. Results revealed that the S. suis serotype 2 strain P1/7, as well as several other highly virulent invasive S. suis serotype 2 isolates express pili from this cluster. However, in most cases tested, and as a result of nonsense mutations at the 59 end of the gene encoding the minor pilin subunit (a putative adhesin), pili were formed by the major pilin subunit only. We then evaluated the role these pili play in S. suis virulence. Abolishment of the expression of srtF cluster-encoded pili did not result in impaired interactions of S. suis with porcine brain microvascular endothelial cells. Furthermore, non-piliated mutants were as virulent as the wild type strain when evaluated in a murine model of S. suis sepsis. Our results show that srtF cluster-encoded, S. suis pili are atypical compared to other Gram-positive pili. In addition, since the highly virulent strains under investigation are unlikely to produce other pili, our results suggest that pili might be dispensable for critical steps of the S. suis pathogenesis of infection.	[Fittipaldi, Nahuel; Dominguez-Punaro, Maria de la Cruz; Lecours, Marie-Pier; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel; Dominguez-Punaro, Maria de la Cruz; Lecours, Marie-Pier; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Ctr Rech Infectiol Porcine, St Hyacinthe, PQ J2S 7C6, Canada; [Takamatsu, Daisuke; Osaki, Makoto] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Res Team Bacterial Parasit Dis, Tsukuba, Ibaraki, Japan; [Montpetit, Diane] Agr & Agroalimentaire Canada, Ctr Rech & Dev Aliments, St Hyacinthe, PQ, Canada; [Sekizaki, Tsutomu] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Tokyo, Japan	Universite de Montreal; Universite de Montreal; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Agriculture & Agri Food Canada; University of Tokyo	Fittipaldi, N (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada.	marcelo.gottschalk@umontreal.ca	Sekizaki, Tsutomu/AAB-1816-2021; Gottschalk, Marcelo/I-8116-2012	Sekizaki, Tsutomu/0000-0002-8899-2504; Fittipaldi, Nahuel/0000-0001-9553-3798	Natural Sciences and Engineering Research Council of Canada (NSERC) [154280, 380299]; Japan Society for the Promotion of Science (JSPS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) through grants to MG (# 154280 and Discovery Accelerator Supplement # 380299) and by the Japan Society for the Promotion of Science (JSPS) through a grant to TS. NF, MCDP and MPL are the holders of NSERC postgraduate scholarships. NF is the recipient of a JSPS Summer Program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Francois B, 1998, J CLIN MICROBIOL, V36, P2395; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Higgins R, 1990, J Vet Diagn Invest, V2, P249; Higgins R, 2006, DIS SWINE, P769; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACQUES M, 1990, J BACTERIOL, V172, P2833, DOI 10.1128/jb.172.6.2833-2838.1990; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Li YY, 2007, CLIN VACCINE IMMUNOL, V14, P937, DOI 10.1128/CVI.00046-07; Li YY, 2006, INFECT IMMUN, V74, P305, DOI 10.1128/IAI.74.1.305-312.2006; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; McNab Roderick, 1998, Methods in Cell Science, V20, P209, DOI 10.1023/A:1009763626485; MOOR CED, 1963, ANTON VAN LEE J M S, V29, P272, DOI 10.1007/BF02046069; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Rodriguez-Ortega MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-588; Roge J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-18; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Slater JD, 2003, VET MICROBIOL, V93, P197, DOI 10.1016/S0378-1135(03)00030-0; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Smith HE, 1999, INFECT IMMUN, V67, P1750; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Teifel M, 1996, EXP CELL RES, V228, P50, DOI 10.1006/excr.1996.0298; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Vanier G, 2004, INFECT IMMUN, V72, P1441, DOI 10.1128/IAI.72.3.1441-1449.2004; Vanier G, 2009, MICROB PATHOGENESIS, V46, P13, DOI 10.1016/j.micpath.2008.10.003; VECHT U, 1989, AM J VET RES, V50, P1037; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; YE C, 2008, J INFECT DIS; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	68	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8426	10.1371/journal.pone.0008426	http://dx.doi.org/10.1371/journal.pone.0008426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052283	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500001
J	Hilty, M; Burke, C; Pedro, H; Cardenas, P; Bush, A; Bossley, C; Davies, J; Ervine, A; Poulter, L; Pachter, L; Moffatt, MF; Cookson, WOC				Hilty, Markus; Burke, Conor; Pedro, Helder; Cardenas, Paul; Bush, Andy; Bossley, Cara; Davies, Jane; Ervine, Aaron; Poulter, Len; Pachter, Lior; Moffatt, Miriam F.; Cookson, William O. C.			Disordered Microbial Communities in Asthmatic Airways	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RIBOSOMAL-RNA GENES; BACTERIAL DIVERSITY; PANDEMIC INFLUENZA; ANAEROBIC-BACTERIA; INFECTION; EXACERBATIONS; SEQUENCES; EPIDEMIC; CHILDREN	Background: A rich microbial environment in infancy protects against asthma [1,2] and infections precipitate asthma exacerbations [3]. We compared the airway microbiota at three levels in adult patients with asthma, the related condition of COPD, and controls. We also studied bronchial lavage from asthmatic children and controls. Principal Findings: We identified 5,054 16S rRNA bacterial sequences from 43 subjects, detecting > 70% of species present. The bronchial tree was not sterile, and contained a mean of 2,000 bacterial genomes per cm(2) surface sampled. Pathogenic Proteobacteria, particularly Haemophilus spp., were much more frequent in bronchi of adult asthmatics or patients with COPD than controls. We found similar highly significant increases in Proteobacteria in asthmatic children. Conversely, Bacteroidetes, particularly Prevotella spp., were more frequent in controls than adult or child asthmatics or COPD patients. Significance: The results show the bronchial tree to contain a characteristic microbiota, and suggest that this microbiota is disturbed in asthmatic airways.	[Hilty, Markus; Cardenas, Paul; Bush, Andy; Bossley, Cara; Davies, Jane; Moffatt, Miriam F.; Cookson, William O. C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Burke, Conor; Ervine, Aaron; Poulter, Len] Connolly Hosp, Dept Resp Med, Dublin, Ireland; [Pedro, Helder] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Gulbenkian Ciencia, Oeiras, Portugal; [Pedro, Helder; Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA	Imperial College London; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; University of California System; University of California Berkeley	Hilty, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	w.cookson@imperial.ac.uk	Hilty, Markus/H-9560-2019; Cookson, William/HHC-1790-2022	Hilty, Markus/0000-0002-2418-6474; Pachter, Lior/0000-0002-9164-6231; Davies, Jane/0000-0003-3506-1199; Cardenas, Paul/0000-0001-9626-4489	European Commission; Wellcome Trust; Medical Research Council [G0801056B] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the GABRIEL FP6 Integrated Project of the European Commission and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Blasi F, 2007, INT J ANTIMICROB AG, V29, P485, DOI 10.1016/j.ijantimicag.2006.11.029; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cookson WOCM, 1997, SCIENCE, V275, P41, DOI 10.1126/science.275.5296.41; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Didierlaurent A, 2007, IMMUNOLOGY, V122, P457, DOI 10.1111/j.1365-2567.2007.02729.x; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Henriksson G, 2004, AM J RESP CELL MOL, V31, P657, DOI 10.1165/rcmb.2004-0207OC; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hussell T, 2009, FUTURE MICROBIOL, V4, P269, DOI 10.2217/FMB.09.3; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kittles RA, 1999, P NATL ACAD SCI USA, V96, P4204, DOI 10.1073/pnas.96.7.4204; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; MURRAY PR, 1976, J INFECT DIS, V134, P281, DOI 10.1093/infdis/134.3.281; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Payne D, 2001, ARCH DIS CHILD, V84, P423, DOI 10.1136/adc.84.5.423; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Smith NH, 1999, MOL BIOL EVOL, V16, P773, DOI 10.1093/oxfordjournals.molbev.a026162; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012	40	1077	1150	7	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8578	10.1371/journal.pone.0008578	http://dx.doi.org/10.1371/journal.pone.0008578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052417	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000273338500021
J	Smyth, DS; McDougal, LK; Gran, FW; Manoharan, A; Enright, MC; Song, JH; de Lencastre, H; Robinson, DA				Smyth, Davida S.; McDougal, Linda K.; Gran, Frode W.; Manoharan, Anand; Enright, Mark C.; Song, Jae-Hoon; de Lencastre, Herminia; Robinson, D. Ashley			Population Structure of a Hybrid Clonal Group of Methicillin-Resistant Staphylococcus aureus, ST239-MRSA-III	PLOS ONE			English	Article							RAPID IDENTIFICATION; EVOLUTIONARY HISTORY; MOLECULAR EVOLUTION; GEOGRAPHIC SPREAD; 2 HOSPITALS; MEC; CHROMOSOME; EPIDEMIC; STRAINS; EMERGENCE	The methicillin-resistant Staphylococcus aureus (MRSA) clonal group known as ST239-MRSA-III is notable for its hybrid origin and for causing sustained hospital epidemics worldwide since the late 1970s. We studied the population structure of this MRSA clonal group using a sample of 111 isolates that were collected over 34 years from 29 countries. Genetic variation was assessed using typing methods and novel ascertainment methods, resulting in approximately 15 kb of sequence from 32 loci for all isolates. A single most parsimonious tree, free of homoplasy, partitioned 28 haplotypes into geographically associated clades, including prominent European, Asian, and South American clades. The rate of evolution was estimated to be approximately 100x faster than standard estimates for bacteria, and dated the most recent common ancestor of these isolates to the mid-20th century. Associations were discovered between the ST239 phylogeny and the ccrB and dru loci of the methicillin resistance genetic element, SCCmec type III, but not with the accessory components of the element that are targeted by multiplex PCR subtyping tools. In summary, the evolutionary history of ST239 can be characterized by rapid clonal diversification that has left strong evidence of geographic and temporal population structure. SCCmec type III has remained linked to the ST239 chromosome during clonal diversification, but it has undergone homoplasious losses of accessory components. These results provide a population genetics framework for the precise identification of emerging ST239 variants, and invite a re-evaluation of the markers used for subtyping SCCmec.	[Smyth, Davida S.; Robinson, D. Ashley] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [McDougal, Linda K.] Ctr Dis Control & Prevent, Off Antimicrobial Resistance, Atlanta, GA USA; [Gran, Frode W.] Univ Trondheim Hosp, Dept Med Microbiol, Trondheim, Norway; [Manoharan, Anand] Christian Med Coll & Hosp, Dept Med Unit & Infect Dis 1, Vellore, Tamil Nadu, India; [Enright, Mark C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Song, Jae-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea; [de Lencastre, Herminia] Univ Nova Lisboa, Mol Genet Lab, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	New York Medical College; Centers for Disease Control & Prevention - USA; Norwegian University of Science & Technology (NTNU); Christian Medical College & Hospital (CMCH) Vellore; Imperial College London; Sungkyunkwan University (SKKU); Samsung Medical Center; Universidade Nova de Lisboa; Rockefeller University	Smyth, DS (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	darobinson@microbio.umsmed.edu	Song, Jae Hoon/C-9602-2011; Smyth, Davida/AAF-5326-2020	/0000-0001-6816-8932; Enright, Mark/0000-0001-5273-8750; Smyth, Davida/0000-0002-4049-0337	American Heart Association; NIH [GM080602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080602] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the American Heart Association and by NIH grant GM080602 ( to D. A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; Arakere G, 2005, J CLIN MICROBIOL, V43, P3198, DOI 10.1128/JCM.43.7.3198-3202.2005; Arakere G, 2009, FEMS MICROBIOL LETT, V292, P141, DOI 10.1111/j.1574-6968.2008.01482.x; Bartels MD, 2008, EUR J CLIN MICROBIOL, V27, P757, DOI 10.1007/s10096-008-0500-z; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Cha HY, 2005, J CLIN MICROBIOL, V43, P3610, DOI 10.1128/JCM.43.8.3610-3614.2005; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; COOKSON BD, 1988, J ANTIMICROB CHEMOTH, V21, P57, DOI 10.1093/jac/21.suppl_C.57; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; De Sousa MA, 2001, J CLIN MICROBIOL, V39, P2197, DOI 10.1128/JCM.39.6.2197-2205.2001; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; DUBIN DT, 1992, J GEN MICROBIOL, V138, P169, DOI 10.1099/00221287-138-1-169; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hsu LY, 2005, J CLIN MICROBIOL, V43, P2923, DOI 10.1128/JCM.43.6.2923-2925.2005; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lina G, 2006, CLIN MICROBIOL INFEC, V12, P1175, DOI 10.1111/j.1469-0691.2006.01548.x; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; MARPLES RR, 1985, J HOSP INFECT, V6, P342, DOI 10.1016/0195-6701(85)90040-4; Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Orth D, 2006, EUR J CLIN MICROBIOL, V25, P104, DOI 10.1007/s10096-006-0102-6; PAVILLARD R, 1982, MED J AUSTRALIA, V1, P451, DOI 10.5694/j.1326-5377.1982.tb132413.x; Perez-Losada M, 2007, INFECT GENET EVOL, V7, P271, DOI 10.1016/j.meegid.2006.11.003; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Roman RS, 1997, CLIN INFECT DIS, V25, P698, DOI 10.1086/513758; Sanches IS, 1996, MICROB DRUG RESIST, V2, P319, DOI 10.1089/mdr.1996.2.319; Sheng WH, 2009, DIAGN MICR INFEC DIS, V63, P309, DOI 10.1016/j.diagmicrobio.2008.11.014; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Simor AE, 2002, J INFECT DIS, V186, P652, DOI 10.1086/342292; SLATKIN M, 1989, GENETICS, V123, P603; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szczepanik A, 2007, EUR J CLIN MICROBIOL, V26, P29, DOI 10.1007/s10096-006-0237-5; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; Tohda S, 1997, INTERNAL MED, V36, P694, DOI 10.2169/internalmedicine.36.694; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wisplinghoff H, 2005, J CLIN MICROBIOL, V43, P5445, DOI 10.1128/JCM.43.11.5445-5451.2005; Witte W, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.suppl_1.1; Xu BL, 2009, J HOSP INFECT, V71, P245, DOI 10.1016/j.jhin.2008.10.029; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	73	61	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8582	10.1371/journal.pone.0008582	http://dx.doi.org/10.1371/journal.pone.0008582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20062529	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000273338500024
J	Song, LL; Ponomareva, L; Shen, H; Duan, X; Alimirah, F; Choubey, D				Song, Lynda Li; Ponomareva, Larissa; Shen, Hui; Duan, Xin; Alimirah, Fatouma; Choubey, Divaker			Interferon-Inducible IFI16, a Negative Regulator of Cell Growth, Down-Regulates Expression of Human Telomerase Reverse Transcriptase (hTERT) Gene	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-MYC; TUMOR-CELLS; RETINOBLASTOMA PROTEIN; GENOMIC INSTABILITY; PROSTATE-CANCER; MESSENGER-RNA; CYCLE; SENESCENCE; ALPHA	Background: Increased levels of interferon (IFN)-inducible IFI16 protein (encoded by the IFI16 gene located at 1q22) in human normal prostate epithelial cells and diploid fibroblasts (HDFs) are associated with the onset of cellular senescence. However, the molecular mechanisms by which the IFI16 protein contributes to cellular senescence-associated cell growth arrest remain to be elucidated. Here, we report that increased levels of IFI16 protein in normal HDFs and in HeLa cells negatively regulate the expression of human telomerase reverse transcriptase (hTERT) gene. Methodology/Principal Findings: We optimized conditions for real-time PCR, immunoblotting, and telomere repeat amplification protocol (TRAP) assays to detect relatively low levels of hTERT mRNA, protein, and telomerase activity that are found in HDFs. Using the optimized conditions, we report that treatment of HDFs with inhibitors of cell cycle progression, such as aphidicolin or CGK1026, which resulted in reduced steady-state levels of IFI16 mRNA and protein, was associated with increases in hTERT mRNA and protein levels and telomerase activity. In contrast, knockdown of IFI16 expression in cells increased the expression of c-Myc, a positive regulator of hTERT expression. Additionally, over-expression of IFI16 protein in cells inhibited the c-Myc-mediated stimulation of the activity of hTERT-luc-reporter and reduced the steady-state levels of c-Myc and hTERT. Conclusions/Significance: These data demonstrated that increased levels of IFI16 protein in HDFs down-regulate the expression of hTERT gene. Our observations will serve basis to understand how increased cellular levels of the IFI16 protein may contribute to certain aging-dependent diseases.	[Song, Lynda Li; Ponomareva, Larissa; Duan, Xin; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ponomareva, Larissa; Shen, Hui; Choubey, Divaker] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Alimirah, Fatouma; Choubey, Divaker] Hines VA Hosp, Hines, IL USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Song, LL (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Choubey, Divaker/A-4771-2008	Ponomareva, Larissa/0000-0003-2182-8774	National Institutes of Health [AG025036]; Merit Award from the Veterans Administration; NATIONAL INSTITUTE ON AGING [R01AG025036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Award from the Veterans Administration; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the National Institutes of Health (AG025036) and a Merit Award from the Veterans Administration (to D. C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, CANCER LETT, V142, P23, DOI 10.1016/S0304-3835(99)00109-3; Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Bellon M, 2008, BLOOD, V112, P2946, DOI 10.1182/blood-2008-01-134692; Borden EC, 2000, SEMIN CANCER BIOL, V10, P125, DOI 10.1006/scbi.2000.0315; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Casillas MA, 2003, GENE, V316, P57, DOI 10.1016/S0378-1119(03)00739-X; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; Choubey D, 1997, ONCOGENE, V15, P291, DOI 10.1038/sj.onc.1201184; Choubey D, 2002, FRONT BIOSCI-LANDMRK, V7, pE252, DOI 10.2741/choubey; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Choubey D, 2000, J BIOL REG HOMEOS AG, V14, P187; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Choubey D, 2008, FRONT BIOSCI-LANDMRK, V13, P598, DOI 10.2741/2705; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Egistelli L, 2009, J CELL BIOCHEM, V106, P666, DOI 10.1002/jcb.22053; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fridman AL, 2006, J GERONTOL A-BIOL, V61, P879, DOI 10.1093/gerona/61.9.879; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gunes C, 2000, CANCER RES, V60, P2116; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hahn WC, 2005, CURR MOL MED, V5, P227, DOI 10.2174/1566524053586572; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hiyama E, 2001, NEOPLASIA, V3, P17, DOI 10.1038/sj.neo.7900134; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Katayama T, 2007, INT J ONCOL, V31, P613; KELLY JM, 1985, EUR J BIOCHEM, V153, P367, DOI 10.1111/j.1432-1033.1985.tb09312.x; Kim EJ, 2005, J BIOL CHEM, V280, P4913, DOI 10.1074/jbc.M410542200; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594; Lee SH, 2003, ONCOGENE, V22, P381, DOI 10.1038/sj.onc.1206133; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Loayza D, 2004, CELL, V117, P279, DOI 10.1016/S0092-8674(04)00409-X; Luo Q, 2004, ONCOGENE, V23, P1088, DOI 10.1038/sj.onc.1207225; Maellaro E, 2003, BRIT J DERMATOL, V148, P1115, DOI 10.1046/j.1365-2133.2003.05301.x; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Murofushi Y, 2006, INT J ONCOL, V29, P681; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Sen GC, 2000, SEMIN CANCER BIOL, V10, P93, DOI 10.1006/scbi.2000.0312; Shiratsuchi M, 1999, LEUKEMIA LYMPHOMA, V34, P349, DOI 10.3109/10428199909050960; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Song LL, 2008, MOL CANCER RES, V6, P1732, DOI 10.1158/1541-7786.MCR-08-0208; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; TOBEY RA, 1988, EXP CELL RES, V179, P400, DOI 10.1016/0014-4827(88)90279-0; Untergasser G, 2002, CANCER RES, V62, P6255; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang H, 2000, J BIOL CHEM, V275, P27377; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Won J, 2004, P NATL ACAD SCI USA, V101, P11328, DOI 10.1073/pnas.0401801101; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Xin H, 2004, ONCOGENE, V23, P6209, DOI 10.1038/sj.onc.1207836; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446; Zhang Y, 2007, FRONT BIOSCI, V12, P4855, DOI 10.2741/2433; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011	65	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8569	10.1371/journal.pone.0008569	http://dx.doi.org/10.1371/journal.pone.0008569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052289	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338500013
J	Pecioska, S; Zillikens, MC; Henneman, P; Snijders, PJ; Oostra, BA; van Duijn, CM; Aulchenko, YS				Pecioska, Slavica; Zillikens, M. Carola; Henneman, Peter; Snijders, Pieter J.; Oostra, Ben A.; van Duijn, Cornelia M.; Aulchenko, Yurii S.			Association between Type 2 Diabetes Loci and Measures of Fatness	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; RISK LOCI; FTO GENE; OBESITY; VARIANT; SUSCEPTIBILITY; POLYMORPHISM	Background: Type 2 diabetes (T2D) is a metabolic disorder characterized by disturbances of carbohydrate, fat and protein metabolism and insulin resistance. The majority of T2D patients are obese and obesity by itself may be a cause of insulin resistance. Our aim was to evaluate whether the recently identified T2D risk alleles are associated with human measures of fatness as characterized with Dual Energy X-ray Absorptiometry (DEXA). Methodology/Principal Findings: Genotypes and phenotypes of approximately 3,000 participants from cross-sectional ERF study were analyzed. Nine single nucleotide polymorphisms (SNPs) in CDKN2AB, CDKAL1, FTO, HHEX, IGF2BP2, KCNJ11, PPARG, SLC30A8 and TCF7L2 were genotyped. We used linear regression to study association between individual SNPs and the combined allelic risk score with body mass index (BMI), fat mass index (FMI), fat percentage (FAT), waist circumference (WC) and waist to hip ratio (WHR). Significant association was observed between rs8050136 (FTO) and BMI (p = 0.003), FMI (p = 0.007) and WC (p = 0.03); fat percentage was borderline significant (p = 0.053). No other SNPs alone or combined in a risk score demonstrated significant association to the measures of fatness. Conclusions/Significance: From the recently identified T2D risk variants only the risk variant of the FTO gene (rs8050136) showed statistically significant association with BMI, FMI, and WC.	[Pecioska, Slavica; Snijders, Pieter J.; Oostra, Ben A.; van Duijn, Cornelia M.; Aulchenko, Yurii S.] Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Rotterdam, Netherlands; [Zillikens, M. Carola] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Henneman, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Aulchenko, Yurii S.] SD RAS, Inst Cytol & Genet, Novosibirsk, Russia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Pecioska, S (corresponding author), Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Rotterdam, Netherlands.	i.aoultchenko@erasmusmc.nl	Aulchenko, Yurii/M-8270-2013	Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204	Erasmus Medical Center (MC); Netherlands Organization for Scientific Research (NWO); Center of the Medical Systems Biology (CMSB)	Erasmus Medical Center (MC); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center of the Medical Systems Biology (CMSB)	This research was supported by the Erasmus Medical Center (MC), the Netherlands Organization for Scientific Research (NWO) and the Center of the Medical Systems Biology (CMSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; CAMPBELL PJ, 1993, DIABETES, V42, P405, DOI 10.2337/diabetes.42.3.405; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Ghoussaini M, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-11; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; GRANT SF, 2007, NAT GENET, V38, P320; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; ZEGGINI E, 2008, NAT GENET, V40, P683; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	20	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8541	10.1371/journal.pone.0008541	http://dx.doi.org/10.1371/journal.pone.0008541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049090	Green Published, gold, Green Submitted			2022-12-27	WOS:000273225000008
J	Spycher, BD; Silverman, M; Barben, J; Eber, E; Guinand, S; Levy, ML; Pao, C; van Aalderen, WM; van Schayck, OCP; Kuehni, CE				Spycher, Ben D.; Silverman, Michael; Barben, Juerg; Eber, Ernst; Guinand, Stephane; Levy, Mark L.; Pao, Caroline; van Aalderen, Willem M.; van Schayck, Onno C. P.; Kuehni, Claudia E.			A Disease Model for Wheezing Disorders in Preschool Children Based on Clinicians' Perceptions	PLOS ONE			English	Article							1ST 6 YEARS; LUNG-FUNCTION; EARLY-LIFE; ASTHMA; CHILDHOOD; PHENOTYPES; BIRTH; SENSITIZATION; PREDICTORS; INFANCY	Background: Wheezing disorders in childhood vary widely in clinical presentation and disease course. During the last years, several ways to classify wheezing children into different disease phenotypes have been proposed and are increasingly used for clinical guidance, but validation of these hypothetical entities is difficult. Methodology/Principal Findings: The aim of this study was to develop a testable disease model which reflects the full spectrum of wheezing illness in preschool children. We performed a qualitative study among a panel of 7 experienced clinicians from 4 European countries working in primary, secondary and tertiary paediatric care. In a series of questionnaire surveys and structured discussions, we found a general consensus that preschool wheezing disorders consist of several phenotypes, with a great heterogeneity of specific disease concepts between clinicians. Initially, 24 disease entities were described among the 7 physicians. In structured discussions, these could be narrowed down to three entities which were linked to proposed mechanisms: a) allergic wheeze, b) non-allergic wheeze due to structural airway narrowing and c) non-allergic wheeze due to increased immune response to viral infections. This disease model will serve to create an artificial dataset that allows the validation of data-driven multidimensional methods, such as cluster analysis, which have been proposed for identification of wheezing phenotypes in children. Conclusions/Significance: While there appears to be wide agreement among clinicians that wheezing disorders consist of several diseases, there is less agreement regarding their number and nature. A great diversity of disease concepts exist but a unified phenotype classification reflecting underlying disease mechanisms is lacking. We propose a disease model which may help guide future research so that proposed mechanisms are measured at the right time and their role in disease heterogeneity can be studied.	[Spycher, Ben D.; Kuehni, Claudia E.] Univ Bern, ISPM, Bern, Switzerland; [Silverman, Michael] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Barben, Juerg] Childrens Hosp St Gallen, Dept Pulmonol & Allergol, St Gallen, Switzerland; [Eber, Ernst] Med Univ Graz, Dept Paediat, Resp & Allerg Dis Div, Graz, Austria; [Guinand, Stephane] Univ Hosp Geneva, Dept Paediat, Pulmonol Unit, Geneva, Switzerland; [Levy, Mark L.] Univ Edinburgh, Allergy & Resp Res Grp, Div Community Hlth Sci, GP Sect, Edinburgh, Midlothian, Scotland; [Pao, Caroline] Barts & London Childrens Hosp, Dept Paediat, London, England; [van Aalderen, Willem M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Resp Med & Allergy, NL-1105 AZ Amsterdam, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands	University of Bern; University of Leicester; Medical University of Graz; University of Geneva; University of Edinburgh; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Spycher, BD (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	bspycher@ispm.unibe.ch	Eber, Ernst/B-6381-2012; Spycher, Ben D/B-3308-2008	Spycher, Ben D/0000-0002-1430-5695; Kuehni, Claudia E./0000-0001-8957-2002	Asthma UK [07/048]; Swiss National Science Foundation [3233-069348, 3200-069349, 823B-046481]	Asthma UK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work presented in this paper was funded by Asthma UK (Grant number 07/048) and the Swiss National Science Foundation (PROSPER grant 3233-069348, 3200-069349, and 823B-046481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2007, CLIN EXP ALLERGY, V37, P1296, DOI 10.1111/j.1365-2222.2007.02796.x; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; DeVincenzo John P, 2005, Pediatr Infect Dis J, V24, pS177, DOI 10.1097/01.inf.0000187274.48387.42; DeVincenzo JP, 2005, PEDIATR INFECT DIS J, V24, pS182; Edwards CA, 2003, CHEST, V124, P18, DOI 10.1378/chest.124.1.18; Frey U, 2001, SWISS MED WKLY, V131, P400; Gold DR, 2006, NEW ENGL J MED, V354, P2058, DOI 10.1056/NEJMe068058; Greenacre Michael, 1984, THEORY APPL CORRES A; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Henschen M, 2006, EUR RESPIR J, V27, P913, DOI 10.1183/09031936.06.00036305; Hoo AF, 2002, J PEDIATR-US, V141, P652, DOI 10.1067/mpd.2002.128114; Horak E, 2003, BRIT MED J, V326, P422, DOI 10.1136/bmj.326.7386.422; Illi S, 2001, J ALLERGY CLIN IMMUN, V108, P709, DOI 10.1067/mai.2001.118786; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Kaditis AG, 2007, PEDIATR PULM, V42, P407, DOI 10.1002/ppul.20591; Kuehni CE, 2005, SWISS MED WKLY, V135, P95; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Kurukulaaratchy RJ, 2004, THORAX, V59, P563, DOI 10.1136/thx.2003.010462; Kurukulaaratchy RJ, 2003, CLIN EXP ALLERGY, V33, P573, DOI 10.1046/j.1365-2222.2003.01657.x; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lau Susanne, 2002, Paediatr Respir Rev, V3, P265, DOI 10.1016/S1526-0542(02)00189-6; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 1998, J ALLERGY CLIN IMMUN, V102, P915, DOI 10.1016/S0091-6749(98)70328-8; Midodzi WK, 2008, RESPIROLOGY, V13, P537, DOI 10.1111/j.1440-1843.2008.01284.x; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; OSWALD H, 1994, BRIT MED J, V309, P95, DOI 10.1136/bmj.309.6947.95; Psarras Stelios, 2004, Paediatr Respir Rev, V5 Suppl A, pS179, DOI 10.1016/S1526-0542(04)90034-6; Rusconi F, 1999, AM J RESP CRIT CARE, V160, P1617, DOI 10.1164/ajrccm.160.5.9811002; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Silverman M, 2002, RESP INFECT ALLERGY, P427; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Spycher BD, 2009, STAT MED, V28, P1927, DOI 10.1002/sim.3550; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stocks J, 2003, RESPIROLOGY, V8, P266, DOI 10.1046/j.1440-1843.2003.00478.x; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; Yuan Y., 2012, ANAL RISK FACTORS CH	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8533	10.1371/journal.pone.0008533	http://dx.doi.org/10.1371/journal.pone.0008533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046874	Green Published, gold			2022-12-27	WOS:000273180200014
J	Barry, AE; Schultz, L; Buckee, CO; Reeder, JC				Barry, Alyssa E.; Schultz, Lee; Buckee, Caroline O.; Reeder, John C.			Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MULTILOCUS GENOTYPE DATA; SURFACE PROTEIN-1 MSP-1; BAY COHORT PROJECT; PAPUA-NEW-GUINEA; STAGE MALARIA; NATURAL-SELECTION; CIRCUMSPOROZOITE PROTEIN; DIVERSIFYING SELECTION; GEOGRAPHICAL STRUCTURE	The extensive diversity of Plasmodium falciporum antigens is a major obstacle to a broadly effective malaria vaccine but population genetics has rarely been used to guide vaccine design. We have completed a meta-population genetic analysis of the genes encoding ten leading P. falciparum vaccine antigens, including the pre-erythrocytic antigens csp, trap, !sal and glurp; the merozoite antigens eba175, amal, msp's 1, 3 and 4, and the gametocyte antigen pfs48/45. A total of 4553 antigen sequences were assembled from published data and we estimated the range and distribution of diversity worldwide using traditional population genetics, Bayesian clustering and network analysis. Although a large number of distinct haplotypes were identified for each antigen, they were organized into a limited number of discrete subgroups. While the nonmerozoite antigens showed geographically variable levels of diversity and geographic restriction of specific subgroups, the merozoite antigens had high levels of diversity globally, and a worldwide distribution of each subgroup. This shows that the diversity of the non-merozoite antigens is organized by physical or other location-specific barriers to gene flow and that of merozoite antigens by features intrinsic to all populations, one important possibility being the immune response of the human host. We also show that current malaria vaccine formulations are based upon low prevalence haplotypes from a single subgroup and thus may represent only a small proportion of the global parasite population. This study demonstrates significant contrasts in the population structure of P. falciparum vaccine candidates that are consistent with the merozoite antigens being under stronger balancing selection than non-merozoite antigens and suggesting that unique approaches to vaccine design will be required. The results of this study also provide a realistic framework for the diversity of these antigens to be incorporated into the design of next-generation malaria vaccines.	[Barry, Alyssa E.; Schultz, Lee; Reeder, John C.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Buckee, Caroline O.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Buckee, Caroline O.] Santa Fe Inst, Santa Fe, NM 87501 USA	Burnet Institute; University of Oxford; The Santa Fe Institute	Barry, AE (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	alyssa.barry@burnet.edu.au		Barry, Alyssa/0000-0002-1189-2310; Reeder, John/0000-0003-1395-1289	National Health and Medical Research Council of Australia (NHMRC) [488221]; Victorian Endowment for Science Knowledge and Innovation; Sir Henry Wellcome Trust	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Endowment for Science Knowledge and Innovation; Sir Henry Wellcome Trust	This project was supported by Project Grant 488221 from the National Health and Medical Research Council of Australia (NHMRC). AEB was supported by an Innovation Fellowship from the Victorian Endowment for Science Knowledge and Innovation and a NHMRC Howard Florey Centenary Fellowship. JCR is supported by an NHMRC Research Fellowship. C.O.B. is supported by a Sir Henry Wellcome Trust Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amodu OK, 2005, ACTA TROP, V95, P226, DOI 10.1016/j.actatropica.2005.06.017; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2000, MOL BIOCHEM PARASIT, V106, P321, DOI 10.1016/S0166-6851(99)00222-4; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; Baum J, 2003, GENETICS, V163, P1327; Benet A, 2004, MOL BIOCHEM PARASIT, V134, P275, DOI 10.1016/j.molbiopara.2003.12.005; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Bottius E, 1996, J IMMUNOL, V156, P2874; BUTTS CT, 2008, NETWORK CLASSES RELA; Conway DJ, 2001, MOL BIOCHEM PARASIT, V115, P145, DOI 10.1016/S0166-6851(01)00278-X; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Escalante AA, 2001, MOL BIOCHEM PARASIT, V113, P279, DOI 10.1016/S0166-6851(01)00229-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferreira MU, 2003, GENE, V304, P65, DOI 10.1016/S0378-1119(02)01180-0; Ferreira MU, 1998, MEM I OSWALDO CRUZ, V93, P631, DOI 10.1590/S0074-02761998000500013; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; FORSYTH KP, 1989, AM J TROP MED HYG, V40, P344, DOI 10.4269/ajtmh.1989.40.344; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2007, CURR OPIN INFECT DIS, V20, P467, DOI 10.1097/QCO.0b013e3282dd7a29; Gruner AC, 2001, J INFECT DIS, V184, P892, DOI 10.1086/323394; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Hartl DL, 2002, TRENDS PARASITOL, V18, P266, DOI 10.1016/S1471-4922(02)02268-7; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1992, GENETICS, V132, P583; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006; Jongwutiwes S, 2002, MOL BIOL EVOL, V19, P1585, DOI 10.1093/oxfordjournals.molbev.a004220; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; KOCKEN CHM, 1993, MOL BIOCHEM PARASIT, V61, P59, DOI 10.1016/0166-6851(93)90158-T; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Kumkhaek Chutima, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P281; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Moran M., 2007, MALARIA PRODUCT PIPE; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Polson HEJ, 2005, MOL BIOCHEM PARASIT, V142, P110, DOI 10.1016/j.molbiopara.2005.02.009; Pritchard JK, 2000, GENETICS, V155, P945; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sallenave-Sales S, 2000, PARASITOL RES, V86, P692, DOI 10.1007/PL00008554; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Team RDC, 2019, R LANG ENV STAT COMP; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang L, 2000, MOL BIOCHEM PARASIT, V109, P189, DOI 10.1016/S0166-6851(00)00248-6; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; *WHO, 2008, MAL VACC RAINB TABL; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	67	78	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8497	10.1371/journal.pone.0008497	http://dx.doi.org/10.1371/journal.pone.0008497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041125	Green Published, gold			2022-12-27	WOS:000278068700012
J	Smith, RG; Kember, RL; Mill, J; Fernandes, C; Schalkwyk, LC; Buxbaum, JD; Reichenberg, A				Smith, Rebecca G.; Kember, Rachel L.; Mill, Jonathan; Fernandes, Cathy; Schalkwyk, Leonard C.; Buxbaum, Joseph D.; Reichenberg, Abraham			Advancing Paternal Age Is Associated with Deficits in Social and Exploratory Behaviors in the Offspring: A Mouse Model	PLOS ONE			English	Article							BIPOLAR DISORDER; AUTISM; SCHIZOPHRENIA; RISK	Background: Accumulating evidence from epidemiological research has demonstrated an association between advanced paternal age and risk for several psychiatric disorders including autism, schizophrenia and early-onset bipolar disorder. In order to establish causality, this study used an animal model to investigate the effects of advanced paternal age on behavioural deficits in the offspring. Methods: C57BL/6J offspring (n = 12 per group) were bred from fathers of two different ages, 2 months (young) and 10 months (old), and mothers aged 2 months (n = 6 breeding pairs per group). Social and exploratory behaviors were examined in the offspring. Principal Findings:The offspring of older fathers were found to engage in significantly less social (p = 0.02) and exploratory (p = 0.02) behaviors than the offspring of younger fathers. There were no significant differences in measures of motor activity. Conclusions: Given the well-controlled nature of this study, this provides the strongest evidence for deleterious effects of advancing paternal age on social and exploratory behavior. De-novo chromosomal changes and/or inherited epigenetic changes are the most plausible explanatory factors.	[Smith, Rebecca G.; Kember, Rachel L.; Mill, Jonathan; Schalkwyk, Leonard C.; Reichenberg, Abraham] Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Fernandes, Cathy] Kings Coll London, Dept Psychol Med & Psychiat, London WC2R 2LS, England; [Buxbaum, Joseph D.; Reichenberg, Abraham] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Lab Mol Neuropsychiat, New York, NY USA	University of London; King's College London; University of London; King's College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Smith, RG (corresponding author), Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	cathy.fernandes@kcl.ac.uk	Schalkwyk, Leonard C/A-2150-2010; Buxbaum, Joseph D/G-6001-2010; Mill, Jonathan S/B-3276-2010; Smith, Rebecca G/C-1978-2012; Mill, Jonathan/B-5678-2014; Fernandes, Cathy/F-3422-2011; Kember, Rachel/J-3128-2012; Reichenberg, Abraham/GQB-1227-2022	Schalkwyk, Leonard C/0000-0001-7030-5756; Mill, Jonathan S/0000-0003-1115-3224; Smith, Rebecca G/0000-0001-9264-1056; Mill, Jonathan/0000-0003-1115-3224; Kember, Rachel/0000-0001-8820-2659; Buxbaum, Joseph/0000-0001-8898-8313; Fernandes, Cathy/0000-0001-7318-3352	Beatrice and Samuel A. Seaver Foundation; British Medical Association Margaret Temple Award; National Institute of Health Research (NIHR) Biomedical Research Centre (BRC); Mental Health at the South London; Maudsley National Health Service (NHS) Foundation Trust; King's College London (KCL); Medical Research Council [G9817803B] Funding Source: researchfish	Beatrice and Samuel A. Seaver Foundation; British Medical Association Margaret Temple Award; National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); Mental Health at the South London; Maudsley National Health Service (NHS) Foundation Trust; King's College London (KCL); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Beatrice and Samuel A. Seaver Foundation, by a British Medical Association Margaret Temple Award, and National Institute of Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust and Institute of Psychiatry, King's College London (KCL) Pilot Award to Drs. Jonathan Mill and Abraham (Avi) Reichenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brotman MA, 2008, J AM ACAD CHILD PSY, V47, P1455, DOI 10.1097/CHI.0b013e318188832e; Buwe A, 2005, CYTOGENET GENOME RES, V111, P213, DOI 10.1159/000086892; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Hall C. S., 1951, HDB EXPT PSYCHOL, P304; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; NOLAN NA, 1973, PSYCHOPHARMACOLOGIA, V29, P277, DOI 10.1007/BF00414043; REICHENBERG A, COGNITIVE N IN PRESS; Rothman KJ., 1997, MODERN EPIDEMIOLOGY, V2nd; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Torrey EF, 2009, SCHIZOPHR RES, V114, P1, DOI 10.1016/j.schres.2009.06.017; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22	21	64	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8456	10.1371/journal.pone.0008456	http://dx.doi.org/10.1371/journal.pone.0008456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041141	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000278068700003
J	Tokuraku, K; Marquardt, M; Ikezu, T				Tokuraku, Kiyotaka; Marquardt, Meg; Ikezu, Tsuneya			Real-Time Imaging and Quantification of Amyloid-beta Peptide Aggregates by Novel Quantum-Dot Nanoprobes	PLOS ONE			English	Article							PROTEIN-DNA COMPLEXES; ALZHEIMERS-DISEASE; IN-VIVO; EXPERIMENTAL CONSTRAINTS; FIBRILS; DEGRADATION; EXPRESSION; RECEPTORS; PATHWAYS; DYNAMICS	Background: Protein aggregation plays a major role in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease. However, direct real-time imaging of protein aggregation, including oligomerization and fibrillization, has never been achieved. Here we demonstrate the preparation of fluorescent semiconductor nanocrystal (quantum dot; QD)-labeled amyloid-beta peptide (QDA beta) and its advanced applications. Methodology/Principal Findings: The QDA beta construct retained A beta oligomer-forming ability, and the sizes of these oligomers could be estimated from the relative fluorescence intensities of the imaged spots. Both QDA beta coaggregation with intact A beta 42 and insertion into fibrils were detected by fluorescence microscopy. The coaggregation process was observed by real-time 3D imaging using slit-scanning confocal microscopy, which showed a typical sigmoid curve with 1.5 h in the lag-time and 12 h until saturation. Inhibition of coaggregation using an anti-A beta antibody can be observed as 3D images on a microscopic scale. Microglia ingested monomeric QDA beta more significantly than oligomeric QDA beta, and the ingested QDA beta was mainly accumulated in the lysosome. Conclusions/Significance: These data demonstrate that QDAP is a novel nanoprobe for studying A beta oligomerization and fibrillization in multiple modalities and may be applicable for high-throughput drug screening systems.	[Tokuraku, Kiyotaka; Marquardt, Meg; Ikezu, Tsuneya] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Tokuraku, Kiyotaka] Miyakonojo Natl Coll Technol, Dept Chem Sci & Engn, Miyakonojo, Japan	University of Nebraska System; University of Nebraska Medical Center	Tokuraku, K (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	tikezu@unmc.edu	; Tokuraku, Kiyotaka/D-4542-2014	Ikezu, Tsuneya/0000-0002-3979-8596; Tokuraku, Kiyotaka/0000-0002-7747-4808	NIH [AG032600]; Vada Kinman Oldfield Alzheimer Research Award; University of Nebraska Medical Center (UNMC); NATIONAL INSTITUTE ON AGING [R21AG032600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vada Kinman Oldfield Alzheimer Research Award; University of Nebraska Medical Center (UNMC); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is partly supported by NIH AG032600 (T.I.), Vada Kinman Oldfield Alzheimer Research Award (T.I.), University of Nebraska Medical Center (UNMC) Faculty Retention Fund (T.I.), Nanoimaging Core Facility and grants from NIH (SIG program), UNMC Program of Excellence, Nebraska Research Initiative, and Scholarship for Research Worker Abroad from Institute of National Colleges of Technology of Japan (K.T.). The hinders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Flaherty DP, 2007, J MED CHEM, V50, P4986, DOI 10.1021/jm070085f; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Ji XJ, 2006, COLLOID SURFACE B, V50, P104, DOI 10.1016/j.colsurfb.2006.02.010; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Tsay JM, 2005, CHEM BIOL, V12, P1159, DOI 10.1016/j.chembiol.2005.11.002; Vestergaard M, 2008, BIOCHEM BIOPH RES CO, V377, P725, DOI 10.1016/j.bbrc.2008.10.072; Xu G, 2008, BIOCONJUGATE CHEM, V19, P1179, DOI 10.1021/bc700477u; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang TT, 2006, NANO LETT, V6, P800, DOI 10.1021/nl0603350	40	50	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8492	10.1371/journal.pone.0008492	http://dx.doi.org/10.1371/journal.pone.0008492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041162	gold, Green Submitted, Green Published			2022-12-27	WOS:000278068700007
J	Cigana, C; Curcuru, L; Leone, MR; Ierano, T; Lore, NI; Bianconi, I; Silipo, A; Cozzolino, F; Lanzetta, R; Molinaro, A; Bernardini, ML; Bragonzi, A				Cigana, Cristina; Curcuru, Laura; Leone, Maria Rosaria; Ierano, Teresa; Lore, Nicola Ivan; Bianconi, Irene; Silipo, Alba; Cozzolino, Flora; Lanzetta, Rosa; Molinaro, Antonio; Bernardini, Maria Lina; Bragonzi, Alessandra			Pseudomonas aeruginosa Exploits Lipid A and Muropeptides Modification as a Strategy to Lower Innate Immunity during Cystic Fibrosis Lung Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; NF-KAPPA-B; PEPTIDOGLYCAN; HOST; BACTERIAL; EXPRESSION; NOD1; PATHOGEN; RECOGNITION; RECEPTORS	Pseudomonas aeruginosa can establish life-long airways chronic infection in patients with cystic fibrosis (CF) with pathogenic variants distinguished from initially acquired strain. Here, we analysed chemical and biological activity of P. aeruginosa Pathogen-Associated Molecular Patterns (PAMPs) in clonal strains, including mucoid and non-mucoid phenotypes, isolated during a period of up to 7.5 years from a CF patient. Chemical structure by MS spectrometry defined lipopolysaccharide (LPS) lipid A and peptidoglycan (PGN) muropeptides with specific structural modifications temporally associated with CF lung infection. Gene sequence analysis revealed novel mutation in pagL, which supported lipid A changes. Both LPS and PGN had different potencies when activating host innate immunity via binding TLR4 and Nod1. Significantly higher NF-kappa B activation, IL-8 expression and production were detected in HEK293hTLR4/MD2-CD14 and HEK293hNod1 after stimulation with LPS and PGN respectively, purified from early P. aeruginosa strain as compared to late strains. Similar results were obtained in macrophages-like cells THP-1, epithelial cells of CF origin IB3-1 and their isogenic cells C38, corrected by insertion of cystic fibrosis transmembrane conductance regulator (CFTR). In murine model, altered LPS structure of P. aeruginosa late strains induces lower leukocyte recruitment in bronchoalveolar lavage and MIP-2, KC and IL-1 beta cytokine levels in lung homogenates when compared with early strain. Histopathological analysis of lung tissue sections confirmed differences between LPS from early and late P. aeruginosa. Finally, in this study for the first time we unveil how P. aeruginosa has evolved the capacity to evade immune system detection, thus promoting survival and establishing favourable conditions for chronic persistence. Our findings provide relevant information with respect to chronic infections in CF.	[Cigana, Cristina; Lore, Nicola Ivan; Bianconi, Irene; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Curcuru, Laura; Bernardini, Maria Lina] Univ Roma La Sapienza, Dipartimento Biol Cellulare & Sviluppo, Rome, Italy; [Leone, Maria Rosaria; Ierano, Teresa; Silipo, Alba; Cozzolino, Flora; Lanzetta, Rosa; Molinaro, Antonio] Univ Naples Federico II, Dipartimento Chim Organ & Biochim, Naples, Italy; [Leone, Maria Rosaria; Ierano, Teresa; Silipo, Alba; Cozzolino, Flora; Lanzetta, Rosa; Molinaro, Antonio] CEINGE Biotecnol Avanzate, Naples, Italy; [Bernardini, Maria Lina] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Fondazione Cenci Bolognetti	Cigana, C (corresponding author), Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy.	bragonzi.alessandra@hsr.it	Lorè, Nicola Ivan/K-9285-2016; Silipo, Alba/L-5929-2014; Bragonzi, Alessandra/AAC-6751-2022; Cigana, Cristina/D-2883-2016; cozzolino, flora/AAA-3155-2022	Lorè, Nicola Ivan/0000-0001-9159-1632; Cigana, Cristina/0000-0003-0436-9721; Molinaro, Antonio/0000-0002-3456-7369; Bianconi, Irene/0000-0002-5923-4296; Bragonzi, Alessandra/0000-0002-5808-7669; cozzolino, flora/0000-0002-4648-8107; silipo, alba/0000-0002-5394-6532; BERNARDINI, Maria/0000-0002-4305-7694; LANZETTA, Rosa/0000-0002-1472-5825	Fondazione per la ricerca sulla Fibrosi Cistica [FFC 8/2007];  [HEALTH-F7-2009-223670]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Fondazione per la ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported to AM and MLB by Fondazione per la ricerca sulla Fibrosi Cistica (FFC# 8/2007) with the contribute of Furla Spa, Grazia Valentini Scagliarini Spa, Delegazione FFC di Bologna and to AB by HEALTH-F7-2009-223670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; CHAPUT C, 2006, PLOS PATHOG, V2; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cigana C, 2007, ANTIMICROB AGENTS CH, V51, P975, DOI 10.1128/AAC.01142-06; Cigana C, 2006, BIOCHEM BIOPH RES CO, V350, P977, DOI 10.1016/j.bbrc.2006.09.132; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; GARCIABUSTOS JF, 1987, ANTIMICROB AGENTS CH, V31, P178, DOI 10.1128/AAC.31.2.178; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Nigro G, 2008, CELL MICROBIOL, V10, P682, DOI 10.1111/j.1462-5822.2007.01075.x; POHLMAN TH, 1987, J EXP MED, V165, P1393, DOI 10.1084/jem.165.5.1393; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SORRENTINO R, 2008, BRIT J PHARMACOL, V154, P684; STGEME JW, 1991, INFECT IMMUN, V59, P1325, DOI 10.1128/IAI.59.4.1325-1333.1991; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Uehara A, 2005, CELL MICROBIOL, V7, P675, DOI 10.1111/j.1462-5822.2004.00500.x; Verma N, 2009, FEBS LETT, V583, P2968, DOI 10.1016/j.febslet.2009.08.007; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	54	87	88	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8439	10.1371/journal.pone.0008439	http://dx.doi.org/10.1371/journal.pone.0008439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037649	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100019
J	Pilbrough, W; Munro, TP; Gray, P				Pilbrough, Warren; Munro, Trent P.; Gray, Peter			Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells	PLOS ONE			English	Article							HAMSTER OVARY CELLS; STOCHASTIC GENE-EXPRESSION; ANTIBODY-PRODUCTION; ANTIGEN EXPRESSION; MOLECULAR ANALYSIS; CLONAL VARIATION; DNA INTEGRATION; STABILITY; NOISE; AMPLIFICATION	Therapeutic glycoproteins have played a major role in the commercial success of biotechnology in the post-genomic era. But isolating recombinant mammalian cell lines for large-scale production remains costly and time-consuming, due to substantial variation and unpredictable stability of expression amongst transfected cells, requiring extensive clone screening to identify suitable high producers. Streamlining this process is of considerable interest to industry yet the underlying phenomena are still not well understood. Here we examine an antibody-expressing Chinese hamster ovary (CHO) clone at single-cell resolution using flow cytometry and vectors, which couple light and heavy chain transcription to fluorescent markers. Expression variation has traditionally been attributed to genetic heterogeneity arising from random genomic integration of vector DNA. It follows that single cell cloning should yield a homogeneous cell population. We show, in fact, that expression in a clone can be surprisingly heterogeneous (standard deviation 50 to 70% of the mean), approaching the level of variation in mixed transfectant pools, and each antibody chain varies in tandem. Phenotypic variation is fully developed within just 18 days of cloning, yet is not entirely explained by measurement noise, cell size, or the cell cycle. By monitoring the dynamic response of subpopulations and subclones, we show that cells also undergo slow stochastic fluctuations in expression (half-life 2 to 11 generations). Non-genetic diversity may therefore play a greater role in clonal variation than previously thought. This also has unexpected implications for expression stability. Stochastic gene expression noise and selection bias lead to perturbations from steady state at the time of cloning. The resulting transient response as clones reestablish their expression distribution is not ordinarily accounted for but can contribute to declines in median expression over timescales of up to 50 days. Noise minimization may therefore be a novel strategy to reduce apparent expression instability and simplify cell line selection.	[Pilbrough, Warren; Munro, Trent P.; Gray, Peter] Univ Queensland, AIBN, Brisbane, Qld, Australia; [Munro, Trent P.; Gray, Peter] ACYTE Biotech Pty Ltd, Brisbane, Qld, Australia	University of Queensland	Pilbrough, W (corresponding author), Univ Queensland, AIBN, Brisbane, Qld, Australia.	t.munro@uq.edu.au	Munro, Trent/AAC-1129-2020; Munro, Trent/B-4856-2009	Munro, Trent/0000-0003-1987-2020; 	University of Queensland; Merck Co., Inc.	University of Queensland(University of Queensland); Merck Co., Inc.(Merck & Company)	TPM and PPG are supported by the University of Queensland. WP was supported by Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHLER DW, 1984, CANCER RES, V44, P3317; Bailey CG, 1999, BIOTECHNOL TECH, V13, P615, DOI 10.1023/A:1008926708028; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barnes LM, 2004, BIOTECHNOL BIOENG, V85, P115, DOI 10.1002/bit.10893; Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Barnes LM, 2001, BIOTECHNOL BIOENG, V73, P261, DOI 10.1002/bit.1059; Barnes LM, 2007, BIOTECHNOL BIOENG, V96, P337, DOI 10.1002/bit.21119; Barnes LM, 2006, BIOTECHNOL BIOENG, V94, P530, DOI 10.1002/bit.20856; Batada NN, 2007, TRENDS GENET, V23, P480, DOI 10.1016/j.tig.2007.08.003; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Borth N, 2000, BIOTECHNOL BIOENG, V71, P266, DOI 10.1002/1097-0290(2000)71:4<266::AID-BIT1016>3.0.CO;2-2; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen C, 1998, SOMAT CELL MOLEC GEN, V24, P249, DOI 10.1023/B:SCAM.0000007127.80657.10; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; COON JS, 1985, CANCER RES, V45, P3014; DeMaria CT, 2007, BIOTECHNOL PROGR, V23, P465, DOI 10.1021/bp060298i; Derouazi M, 2006, BIOCHEM BIOPH RES CO, V340, P1069, DOI 10.1016/j.bbrc.2005.12.111; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fann CH, 2000, BIOTECHNOL BIOENG, V69, P204; Fann CH, 1999, BIOTECHNOL BIOENG, V63, P464, DOI 10.1002/(SICI)1097-0290(19990520)63:4<464::AID-BIT10>3.0.CO;2-H; FENDROCK B, 1986, HISTOCHEMISTRY, V84, P121, DOI 10.1007/BF00499822; Galbete JL, 2009, MOL BIOSYST, V5, P143, DOI 10.1039/b813657b; GAMEL JW, 1991, CELL PROLIFERAT, V24, P281, DOI 10.1111/j.1365-2184.1991.tb01157.x; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GRIFFIN JE, 1981, J BIOL CHEM, V256, P3662; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Jun SC, 2006, BIOTECHNOL PROGR, V22, P770, DOI 10.1021/bp060004t; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P537, DOI 10.1016/0076-6879(90)85044-O; Kim NS, 1998, BIOTECHNOL BIOENG, V60, P679, DOI 10.1002/(SICI)1097-0290(19981220)60:6<679::AID-BIT5>3.0.CO;2-Q; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; Kim SH, 2007, J MICROBIOL BIOTECHN, V17, P712; KROMENAKER SJ, 1994, BIOTECHNOL PROGR, V10, P299, DOI 10.1021/bp00027a010; Kwaks T, 2005, J BIOTECHNOL, V115, P35, DOI 10.1016/j.jbiotec.2004.07.012; Lattenmayer C, 2006, CYTOTECHNOLOGY, V51, P171, DOI 10.1007/s10616-006-9029-0; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lloyd DR, 2000, CYTOTECHNOLOGY, V34, P59, DOI 10.1023/A:1008103730027; MCNEALL J, 1989, GENE, V76, P81, DOI 10.1016/0378-1119(89)90010-3; MEISLER MH, 1992, TRENDS GENET, V8, P341, DOI 10.1016/0168-9525(92)90278-C; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Muller K, 2001, J BIOL CHEM, V276, P14271; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PENDSE GJ, 1992, BIOTECHNOL BIOENG, V40, P119, DOI 10.1002/bit.260400117; PETERSON JA, 1983, CANCER RES, V43, P4291; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Ramunas J, 2007, MOL THER, V15, P810, DOI 10.1038/sj.mt.6300073; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RUBIN H, 1990, CANCER METAST REV, V9, P1, DOI 10.1007/BF00047585; Sato N, 2004, GENES CELLS, V9, P619, DOI 10.1111/j.1356-9597.2004.00751.x; SCHIMKE RT, 1985, BRIT J CANCER, V51, P459, DOI 10.1038/bjc.1985.66; Schirrmann T, 2008, FRONT BIOSCI-LANDMRK, V13, P4576, DOI 10.2741/3024; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Schroder M, 1997, BIOTECHNOL BIOENG, V53, P547, DOI 10.1002/(SICI)1097-0290(19970320)53:6<547::AID-BIT2>3.0.CO;2-M; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sleiman RJ, 2008, BIOTECHNOL BIOENG, V99, P578, DOI 10.1002/bit.21612; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Strutzenberger K, 1999, J BIOTECHNOL, V69, P215, DOI 10.1016/S0168-1656(99)00044-9; Subkhankulova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-268; TAUPIER MA, 1983, CANCER RES, V43, P4050; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Voliotis M, 2008, BIOPHYS J, V94, P334, DOI 10.1529/biophysj.107.105767; Voon DC, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni030; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Winnard P, 2006, CANCER GENET CYTOGEN, V164, P174, DOI 10.1016/j.cancergencyto.2005.07.021; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Wurtele H, 2003, GENE THER, V10, P1791, DOI 10.1038/sj.gt.3302074; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Yoshikawa Y, 2000, BIOTECHNOL PROGR, V16, P710, DOI 10.1021/bp000114e; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	94	144	152	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8432	10.1371/journal.pone.0008432	http://dx.doi.org/10.1371/journal.pone.0008432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037651	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100017
J	Ubuka, T; Morgan, K; Pawson, AJ; Osugi, T; Chowdhury, VS; Minakata, H; Tsutsui, K; Millar, RP; Bentley, GE				Ubuka, Takayoshi; Morgan, Kevin; Pawson, Adam J.; Osugi, Tomohiro; Chowdhury, Vishwajit S.; Minakata, Hiroyuki; Tsutsui, Kazuyoshi; Millar, Robert P.; Bentley, George E.			Identification of Human GnIH Homologs, RFRP-1 and RFRP-3, and the Cognate Receptor, GPR147 in the Human Hypothalamic Pituitary Axis	PLOS ONE			English	Article							GONADOTROPIN-INHIBITORY HORMONE; RFAMIDE-RELATED PEPTIDE-3; QUAIL COTURNIX-JAPONICA; LPXRF-AMIDE PEPTIDES; LUTEINIZING-HORMONE; HYPOPHYSIOTROPIC ROLE; LH-SECRETION; CHICKEN; BRAIN; EXPRESSION	The existence of a hypothalamic gonadotropin-inhibiting system has been elusive. A neuropeptide named gonadotropin-inhibitory hormone (GnIH, SIKPSAYLPLRF-NH(2)) which directly inhibits gonadotropin synthesis and release from the pituitary was recently identified in quail hypothalamus. Here we identify GnIH homologs in the human hypothalamus and characterize their distribution and biological activity. GnIH homologs were isolated from the human hypothalamus by immunoaffinity purification, and then identified as MPHSFANLPLRF-NH(2) (human RFRP-1) and VPNLPQRF-NH(2) (human RFRP-3) by mass spectrometry. Immunocytochemistry revealed GnIH-immunoreactive neuronal cell bodies in the dorsomedial region of the hypothalamus with axonal projections to GnRH neurons in the preoptic area as well as to the median eminence. RT-PCR and subsequent DNA sequencing of the PCR products identified human GnIH receptor (GPR147) mRNA expression in the hypothalamus as well as in the pituitary. In situ hybridization further identified the expression of GPR147 mRNA in luteinizing hormone producing cells (gonadotropes). Human RFRP-3 has recently been shown to be a potent inhibitor of gonadotropin secretion in cultured sheep pituitary cells by inhibiting Ca(2+) mobilization. It also directly modulates GnRH neuron firing. The identification of two forms of GnIH (RFRP-1 and RFRP-3) in the human hypothalamus which targets human GnRH neurons and gonadotropes and potently inhibit gonadotropin in sheep models provides a new paradigm for the regulation of hypothalamic-pituitary-gonadal axis in man and a novel means for manipulating reproductive functions.	[Ubuka, Takayoshi; Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ubuka, Takayoshi; Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Morgan, Kevin; Pawson, Adam J.; Millar, Robert P.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Ctr Reprod Biol, Edinburgh, Midlothian, Scotland; [Osugi, Tomohiro; Chowdhury, Vishwajit S.; Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Tokyo, Japan; [Minakata, Hiroyuki] Suntory Inst Bioorgan Res, Osaka 618, Japan; [Millar, Robert P.] Univ Cape Town, Dept Med Biochem, ZA-7925 Cape Town, South Africa	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Edinburgh; Waseda University; Suntory Holdings Ltd; University of Cape Town	Ubuka, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	ubukat@berkeley.edu	Pawson, Adam J/Q-5678-2016; Oka, Yoshitaka/C-9670-2010; Millar, Robert P/A-4853-2012	Pawson, Adam J/0000-0003-2280-845X; Oka, Yoshitaka/0000-0002-3482-3051; Osugi, Tomohiro/0000-0001-6987-9576; Sur Chowdhury, Vishwajit/0000-0001-6709-2788; Ubuka, Takayoshi/0000-0002-4731-8118; Millar, Robert P/0000-0003-3606-2708	Hellmann Family Foundation Fund; UC Berkeley; National Science Foundation; Ministry of Education, Science and Culture, Japan	Hellmann Family Foundation Fund; UC Berkeley; National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Hellmann Family Foundation Fund (to G. E. B.), UC Berkeley COR Junior Faculty Research Grant (to G. E. B.), National Science Foundation (to G. E. B.), Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (to K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GM, 2009, ENDOCRINOLOGY, V150, P1834, DOI 10.1210/en.2008-1359; BALEN AH, 1995, J REPROD FERTIL, V104, P285; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794, DOI 10.1046/j.1365-2826.2003.01062.x; BURGUS R, 1972, P NATL ACAD SCI USA, V69, P278, DOI 10.1073/pnas.69.1.278; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Ducret E, 2009, ENDOCRINOLOGY, V150, P2799, DOI 10.1210/en.2008-1623; EMONS G, 1994, HUM REPROD, V9, P1364, DOI 10.1093/oxfordjournals.humrep.a138714; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; HWAN JC, 1987, ENDOCRINOLOGY, V120, P483, DOI 10.1210/endo-120-2-483; Johnson MA, 2007, HORM BEHAV, V51, P171, DOI 10.1016/j.yhbeh.2006.09.009; Kadokawa H, 2009, DOMEST ANIM ENDOCRIN, V36, P219, DOI 10.1016/j.domaniend.2009.02.001; KING JA, 1982, J BIOL CHEM, V257, P729; KING JA, 1982, J BIOL CHEM, V257, P722; Kirby ED, 2009, P NATL ACAD SCI USA, V106, P11324, DOI 10.1073/pnas.0901176106; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; MCCANN SM, 1969, PHYSIOL REV, V49, P240, DOI 10.1152/physrev.1969.49.2.240; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Millar RP, 2000, BRIT MED BULL, V56, P761, DOI 10.1258/0007142001903346; MIYAMOTO K, 1982, BIOCHEM BIOPH RES CO, V107, P820, DOI 10.1016/0006-291X(82)90596-4; Murakami M, 2008, J ENDOCRINOL, V199, P105, DOI 10.1677/JOE-08-0197; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; SARI IP, 2009, ENDOCRINOLO IN PRESS; Satake H, 2001, BIOCHEM J, V354, P379, DOI 10.1042/0264-6021:3540379; Smith JT, 2008, ENDOCRINOLOGY, V149, P5770, DOI 10.1210/en.2008-0581; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Ubuka T, 2003, J ENDOCRINOL, V178, P311, DOI 10.1677/joe.0.1780311; Ubuka T, 2008, INTEGR COMP BIOL, V48, P560, DOI 10.1093/icb/icn019; Ubuka T, 2008, ENDOCRINOLOGY, V149, P4229; Ubuka T, 2008, ENDOCRINOLOGY, V149, P268, DOI 10.1210/en.2007-0983; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ukena K, 2003, CELL TISSUE RES, V312, P73, DOI 10.1007/s00441-003-0700-x; Ukena K, 2002, FEBS LETT, V512, P255, DOI 10.1016/S0014-5793(02)02275-5; Ukena K, 2005, MASS SPECTROM REV, V24, P469, DOI 10.1002/mas.20031; Ukena K, 2003, ENDOCRINOLOGY, V144, P3879, DOI 10.1210/en.2003-0359; URBANSKI HF, 1990, J REPROD FERTIL, V90, P157, DOI 10.1530/jrf.0.0900157; WU M, 2009, J PHYSL, P1401; Yin H, 2005, J ENDOCRINOL, V184, P257, DOI 10.1677/joe.1.05926	44	194	201	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8400	10.1371/journal.pone.0008400	http://dx.doi.org/10.1371/journal.pone.0008400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027225	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998000007
J	Zerbino, DR; McEwen, GK; Margulies, EH; Birney, E				Zerbino, Daniel R.; McEwen, Gayle K.; Margulies, Elliott H.; Birney, Ewan			Pebble and Rock Band: Heuristic Resolution of Repeats and Scaffolding in the Velvet Short-Read de Novo Assembler	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; GENOME; ALGORITHM; MILLIONS	Background: Despite the short length of their reads, micro-read sequencing technologies have shown their usefulness for de novo sequencing. However, especially in eukaryotic genomes, complex repeat patterns are an obstacle to large assemblies. Principal Findings: We present a novel heuristic algorithm, Pebble, which uses paired-end read information to resolve repeats and scaffold contigs to produce large-scale assemblies. In simulations, we can achieve weighted median scaffold lengths (N50) of above 1 Mbp in Bacteria and above 100 kbp in more complex organisms. Using real datasets we obtained a 96 kbp N50 in Pseudomonas syringae and a unique 147 kbp scaffold of a ferret BAC clone. We also present an efficient algorithm called Rock Band for the resolution of repeats in the case of mixed length assemblies, where different sequencing platforms are combined to obtain a cost-effective assembly. Conclusions: These algorithms extend the utility of short read only assemblies into large complex genomes. They have been implemented and made available within the open-source Velvet short-read de novo assembler.	[Zerbino, Daniel R.; Birney, Ewan] European Bioinformat Inst, Cambridge, England; [McEwen, Gayle K.; Margulies, Elliott H.] NIH, Genome Technol Branch, NHGRI, Bethesda, MD 20892 USA	European Molecular Biology Laboratory (EMBL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Zerbino, DR (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge, England.	zerbino@ebi.ac.uk		Birney, Ewan/0000-0001-8314-8497; McEwen, Gayle/0000-0001-5134-1380; Zerbino, Daniel/0000-0001-5350-3056	European Molecular Biology Laboratory; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200341] Funding Source: NIH RePORTER	European Molecular Biology Laboratory; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	D. R. Z. and E. B. are funded by European Molecular Biology Laboratory's central funds, G. K. M. and E. H. M by the Intramural Research Program of the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CHEN J, 2007, ADV GENOME SEQUENCIN; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16; Huson DH, 2002, J ACM, V49, P603, DOI 10.1145/585265.585267; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEDVEDEV P, 2008, P 12 ANN RES COMP BI; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2004, GENOME RES, V14, P149; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	142	143	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8407	10.1371/journal.pone.0008407	http://dx.doi.org/10.1371/journal.pone.0008407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027311	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998000012
J	Whetten, K; Ostermann, J; Whetten, RA; Pence, BW; O'Donnell, K; Messer, LC; Thielman, NM				Whetten, Kathryn; Ostermann, Jan; Whetten, Rachel A.; Pence, Brian W.; O'Donnell, Karen; Messer, Lynne C.; Thielman, Nathan M.		Positive Outcomes Orphans (POFO)	A Comparison of the Wellbeing of Orphans and Abandoned Children Ages 6-12 in Institutional and Community-Based Care Settings in 5 Less Wealthy Nations	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; STRENGTHS; ATTACHMENT; MODELS; ERITREA; ROMANIA; AFRICA; MALAWI; AIDS	Background: Leaders are struggling to care for the estimated 143,000,000 orphans and millions more abandoned children worldwide. Global policy makers are advocating that institution-living orphans and abandoned children (OAC) be moved as quickly as possible to a residential family setting and that institutional care be used as a last resort. This analysis tests the hypothesis that institutional care for OAC aged 6-12 is associated with worse health and wellbeing than community residential care using conservative two-tail tests. Methodology: The Positive Outcomes for Orphans (POFO) study employed two-stage random sampling survey methodology in 6 sites across 5 countries to identify 1,357 institution-living and 1,480 community-living OAC ages 6-12, 658 of whom were double-orphans or abandoned by both biological parents. Survey analytic techniques were used to compare cognitive functioning, emotion, behavior, physical health, and growth. Linear mixed-effects models were used to estimate the proportion of variability in child outcomes attributable to the study site, care setting, and child levels and institutional versus community care settings. Conservative analyses limited the community living children to double-orphans or abandoned children. Principal Findings: Health, emotional and cognitive functioning, and physical growth were no worse for institution-living than community-living OAC, and generally better than for community-living OAC cared for by persons other than a biological parent. Differences between study sites explained 2-23% of the total variability in child outcomes, while differences between care settings within sites explained 8-21%. Differences among children within care settings explained 64-87%. After adjusting for sites, age, and gender, institution vs. community-living explained only 0.3-7% of the variability in child outcomes. Conclusion: This study does not support the hypothesis that institutional care is systematically associated with poorer wellbeing than community care for OAC aged 6-12 in those countries facing the greatest OAC burden. Much greater variability among children within care settings was observed than among care settings type. Methodologically rigorous studies must be conducted in those countries facing the new OAC epidemic in order to understand which characteristics of care promote child wellbeing. Such characteristics may transcend the structural definitions of institutions or family homes.	[Whetten, Kathryn; Ostermann, Jan; Whetten, Rachel A.; Pence, Brian W.; O'Donnell, Karen; Messer, Lynne C.; Thielman, Nathan M.] Duke Univ, Ctr Hlth Policy, Duke Global Hlth Inst, Durham, NC 27710 USA; [Whetten, Kathryn] Duke Univ, Terry Sanford Inst Publ Policy, Durham, NC USA; [O'Donnell, Karen] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [O'Donnell, Karen] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [O'Donnell, Karen] Duke Univ, Ctr Child & Family Hlth, Durham, NC USA; [Whetten, Kathryn; Pence, Brian W.] Duke Univ, Dept Community & Family Med, Durham, NC USA; [Thielman, Nathan M.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Whetten, K (corresponding author), Duke Univ, Ctr Hlth Policy, Duke Global Hlth Inst, Durham, NC 27710 USA.	katewhetten@gmail.com	Thielman, Nathan/R-5142-2019; Ostermann, Jan/GQB-4743-2022; Whetten, Kathryn/C-8572-2009	Thielman, Nathan/0000-0001-8152-2879; Whetten, Kathryn/0000-0002-4841-7695; Ostermann, Jan/0000-0002-8236-9500	National Institute of Child Health and Development (NICHD) [5R01HD046345-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080916] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Child Health and Development (NICHD), grant No. 5R01HD046345-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ABTH, 2003, COND SHELT RIO JAN; Atwine B, 2005, SOC SCI MED, V61, P555, DOI 10.1016/j.socscimed.2004.12.018; BEEGLE K, 2006, AM J AGR EC, V88; *BETT CAR NETW, FAM COMM BAS CAR; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Cluver Lucie, 2006, Ann Gen Psychiatry, V5, P8, DOI 10.1186/1744-859X-5-8; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; DEBBAS A, 2008, STRATEGIC APPROACH C; Delis DC., 2000, CALIFORNIA VERBAL LE; *DEPSOS, 2008, UNICEF SOM MATT QUAL; Foster C, 2000, AIDS, V14, pS275; Foster G., 2000, PSYCHOL HEALTH MED, V5, P55, DOI DOI 10.1080/135485000106007; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; INTERNATIONAL H, 2003, FORGOTTEN FAMILIES O, P24; KAUFMAN AS, 2003, KAUFMAN ASSESSMENT B; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; McKenzie R., 1997, CHILD YOUTH CARE, V26, P87, DOI DOI 10.1007/BF02589359; McKenzie R. B., 1999, NEW DEMOCRAT    0101; Miller G. R., 1997, ANOVA BASICS APPL ST; MULLICK MSI, 2001, SOCIAL PSYCHIAT PSYC, V36, P1337; Muris P, 2004, CHILD PSYCHIAT HUM D, V34, P317; Nyambedha Erick O, 2003, J Cross Cult Gerontol, V18, P33, DOI 10.1023/A:1024826528476; Panpanich R, 1999, ANN TROP PAEDIATR, V19, P279, DOI 10.1080/02724939992374; Powell G, 2004, CHILDREN RESIDENTIAL; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; RICHARDMACKENZI, RETHINKING ORPHANAGE; Richter L., 2008, CHILDREN THRIVE FAMI; Sachs SE, 2004, LANCET, V364, P1404, DOI 10.1016/S0140-6736(04)17220-6; Sengendo J, 1997, Health Transit Rev, V7 Suppl, P105; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Smyke AT, 2007, J CHILD PSYCHOL PSYC, V48, P210, DOI 10.1111/j.1469-7610.2006.01694.x; Smyke AT, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00016; StataCorp L, 2007, STAT DAT AN STAT SOF; TIZARD B, 1978, J CHILD PSYCHOL PSYC, V19, P99, DOI 10.1111/j.1469-7610.1978.tb00453.x; TIZARD B, 1975, J CHILD PSYCHOL PSYC, V16, P61, DOI 10.1111/j.1469-7610.1975.tb01872.x; TORITSYN A, 2007, DEV INTEGRATED SOCIA; *UN, 2007, DRAFT UN GUID APPR U; *UN DEV PROGR, HUM DEV IND STAT UPD; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; *UNICEF, 2004, CHILDR BRINK JOINT R; UNICEF, FACTS CHILDR; UNICEF UNAIDS Irish AID, 2008, COMM 4 GLOB PARTN FO; van Ijzendoorn MH, 2008, MERRILL PALMER QUART, V54, P341; Wareing PW, 2001, INT J FOOD SCI TECH, V36, P1, DOI 10.1046/j.1365-2621.2001.00419.x; *WHO, 2006, WHO CLIN GROWTH STAN; Wolff PH, 2005, AM J ORTHOPSYCHIAT, V75, P475, DOI 10.1037/0002-9432.75.4.475; WOLFF PH, 1995, SOC SCI MED, V40, P1133, DOI 10.1016/0277-9536(94)00168-S; Wolff PH, 1998, AM J PSYCHIAT, V155, P1319, DOI 10.1176/ajp.155.10.1319; World Health Organization, 2007, WORLD HLTH REP 2007; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zeanah CH, 2005, CHILD DEV, V76, P1015, DOI 10.1111/j.1467-8624.2005.00894.x	54	84	84	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8169	10.1371/journal.pone.0008169	http://dx.doi.org/10.1371/journal.pone.0008169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	534BN	20020037	Green Published, Green Submitted, gold			2022-12-27	WOS:000272870600001
J	O'Leary, DA; Sharif, O; Anderson, P; Tu, B; Welch, G; Zhou, YY; Caldwell, JS; Engels, IH; Brinker, A				O'Leary, Debra A.; Sharif, Orzala; Anderson, Paul; Tu, Buu; Welch, Genevieve; Zhou, Yingyao; Caldwell, Jeremy S.; Engels, Ingo H.; Brinker, Achim			Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; RNA SPLICING FACTORS; HISTONE DEACETYLASE INHIBITOR; CELL-CYCLE ARREST; MESSENGER-RNA; NONSENSE MUTATION; FUNCTIONAL-ANALYSIS; DMD-GENE; DROSOPHILA DEVELOPMENT; VARIABLE PHENOTYPES	One therapeutic approach to Duchenne Muscular Dystrophy (DMD) recently entering clinical trials aims to convert DMD phenotypes to that of a milder disease variant, Becker Muscular Dystrophy (BMD), by employing antisense oligonucleotides (AONs) targeting splice sites, to induce exon skipping and restore partial dystrophin function. In order to search for small molecule and genetic modulators of AON-dependent and independent exon skipping, we screened similar to 10,000 known small molecule drugs, >17,000 cDNA clones, and >2,000 kinase-targeted siRNAs against a 5.6 kb luciferase minigene construct, encompassing exon 71 to exon 73 of human dystrophin. As a result, we identified several enhancers of exon skipping, acting on both the reporter construct as well as endogenous dystrophin in mdx cells. Multiple mechanisms of action were identified, including histone deacetylase inhibition, tubulin modulation and pre-mRNA processing. Among others, the nucleolar protein NOL8 and staufen RNA binding protein homolog 2 (Stau2) were found to induce endogenous exon skipping in mdx cells in an AON-dependent fashion. An unexpected but recurrent theme observed in our screening efforts was the apparent link between the inhibition of cell cycle progression and the induction of exon skipping.	[O'Leary, Debra A.; Sharif, Orzala; Anderson, Paul; Tu, Buu; Welch, Genevieve; Zhou, Yingyao; Caldwell, Jeremy S.; Engels, Ingo H.; Brinker, Achim] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis	O'Leary, DA (corresponding author), Dart Neurosci, San Diego, CA USA.	oleary.debra@gmail.com; iengels@gnf.org			Foundation to Eradicate Duchenne (FED); Novartis Research Foundation	Foundation to Eradicate Duchenne (FED); Novartis Research Foundation	This work was supported by the Foundation to Eradicate Duchenne (FED) (http://www.duchennemd.org) and the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; AHMED S, 2009, NAT GENET; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; BUSHBY KMD, 1991, LANCET, V337, P1022, DOI 10.1016/0140-6736(91)92671-N; Caceres JF, 2007, CELL, V131, P645, DOI 10.1016/j.cell.2007.11.001; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Castellano S, 2000, ARCH PHARM, V333, P373, DOI 10.1002/1521-4184(200011)333:11<373::AID-ARDP373>3.0.CO;2-6; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; CHOU TB, 1987, EMBO J, V6, P4095, DOI 10.1002/j.1460-2075.1987.tb02755.x; COLUSSI C, 2009, FASEB J; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Davis RL, 2009, HUM MUTAT, V30, P221, DOI 10.1002/humu.20839; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; DUBEL S, 1988, J CELL SCI, V91, P347; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Ginjaar IB, 2000, EUR J HUM GENET, V8, P793, DOI 10.1038/sj.ejhg.5200535; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Hanamura A, 1998, RNA, V4, P430; Havlioglu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001246; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Hodgkinson JE, 2008, INT J PARASITOL, V38, P1149, DOI 10.1016/j.ijpara.2008.02.001; HOLDEN HE, 1980, ENVIRON MUTAGEN, V2, P67, DOI 10.1002/em.2860020110; HORWITZ SB, 1977, LLOYDIA, V40, P82; Hussein MR, 2006, INT J EXP PATHOL, V87, P451, DOI 10.1111/j.1365-2613.2006.00470.x; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong JH, 2007, J NEUROCHEM, V102, P2073, DOI 10.1111/j.1471-4159.2007.04697.x; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Katzenberger RJ, 2009, J BIOL CHEM, V284, P10737, DOI 10.1074/jbc.M809506200; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kimura T, 1993, Gan To Kagaku Ryoho, V20, P816; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Labourier E, 1999, GENE DEV, V13, P740, DOI 10.1101/gad.13.6.740; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; MATSUMOTO K, 1992, CHROMOSOMA, V102, P60, DOI 10.1007/BF00352291; McAlinden A, 2005, J BIOL CHEM, V280, P32700, DOI 10.1074/jbc.M505940200; Melis MA, 1998, HUM MUTAT, pS137; MIKHAILOV M V, 1981, Molekulyarnaya Biologiya (Moscow), V15, P690; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; Nam YJ, 2008, BIOCHEM BIOPH RES CO, V372, P525, DOI 10.1016/j.bbrc.2008.05.047; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Nishiyama A, 2008, ANN HUM GENET, V72, P717, DOI 10.1111/j.1469-1809.2008.00468.x; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; Radojevic V, 2000, CELL TISSUE RES, V300, P447, DOI 10.1007/s004410000213; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; RING HJ, 1994, MOL CELL BIOL, V14, P7499, DOI 10.1128/MCB.14.11.7499; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Sazani P, 2001, NUCLEIC ACIDS RES, V29, P3965, DOI 10.1093/nar/29.19.3965; Scaife RM, 2004, MOL CANCER THER, V3, P1229; Schaider H, 1995, ANTICANCER RES, V15, P2501; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Song JD, 2008, INT J ONCOL, V33, P1299, DOI 10.3892/ijo_00000121; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Takai N, 2006, INT J MOL MED, V17, P323; Tazi J, 1997, J MOL MED, V75, P786, DOI 10.1007/s001090050168; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vandenburgh H, 2009, FASEB J, V23, P3325, DOI 10.1096/fj.09-134411; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wells DJ, 2008, GENE THER, V15, P1077, DOI 10.1038/gt.2008.97; WELSH MJ, 1979, J CELL BIOL, V81, P624, DOI 10.1083/jcb.81.3.624; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Wilton SD, 1997, MUSCLE NERVE, V20, P728; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou YY, 2007, J CHEM INF MODEL, V47, P1386, DOI 10.1021/ci700092v; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	107	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8348	10.1371/journal.pone.0008348	http://dx.doi.org/10.1371/journal.pone.0008348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020055	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834200014
J	Irles, P; Belles, X; Piulachs, MD				Irles, Paula; Belles, Xavier; Dolors Piulachs, M.			Brownie, a Gene Involved in Building Complex Respiratory Devices in Insect Eggshells	PLOS ONE			English	Article							DROSOPHILA; COCKROACH; CHORIOGENESIS; EXPRESSION	Background: Insect eggshells must combine protection for the yolk and embryo with provisions for respiration and for the entry of sperm, which are ensured by aeropyles and micropyles, respectively. Insects which oviposit the eggs in an egg-case have a double problem of respiration as gas exchange then involves two barriers. An example of this situation is found in the cockroach Blattella germanica, where the aeropyle and the micropyle are combined in a complex structure called the sponge-like body. The sponge-like body has been well described morphologically, but nothing is known about how it is built up. Methodology/Principal Findings: In a library designed to find genes expressed during late chorion formation in B. germanica, we isolated the novel sequence Bg30009 (now called Brownie), which was outstanding due to its high copy number. In the present work, we show that Brownie is expressed in the follicle cells localized in the anterior pole of the oocyte in late choriogenesis. RNA interference (RNAi) of Brownie impaired correct formation of the sponge-like body and, as a result, the egg-case was also ill-formed and the eggs were not viable. Conclusions/Significance: Results indicate that the novel gene Brownie plays a pivotal role in building up the sponge-like body. Brownie is the first reported gene involved in the construction of complex eggshell respiratory structures.	[Irles, Paula; Belles, Xavier; Dolors Piulachs, M.] UPF, CSIC, Inst Biol Evolut, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Irles, P (corresponding author), UPF, CSIC, Inst Biol Evolut, Barcelona, Spain.	mdolors.piulachs@ibe.upf-csic.es	Piulachs, Maria-Dolors/C-3992-2011; Belles, Xavier/G-2354-2015	Piulachs, Maria-Dolors/0000-0002-4500-2718; Belles, Xavier/0000-0002-1566-303X; Irles, Paula/0000-0003-1968-1902	Ministry of Science and Innovation, Spain [BFU2008-00484, CGL2008-03517/BOS]; Laboratorio Internacional de Cambio Global (LINC-Global); Consejo Superior de Investigaciones Cientificas [I3P]	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Laboratorio Internacional de Cambio Global (LINC-Global); Consejo Superior de Investigaciones Cientificas	Financial support from the Ministry of Science and Innovation, Spain (projects BFU2008-00484 to MDP and CGL2008-03517/BOS to XB) and from Laboratorio Internacional de Cambio Global (LINC-Global) (Pontificia Universidad Catolica-Consejo Superior de Investigaciones Cientificas) is gratefully acknowledged. PI is recipient of a pre-doctoral research grant (I3P) from the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1972, pUnpaginated; BELLES X, 1993, TISSUE CELL, V25, P195, DOI 10.1016/0040-8166(93)90019-H; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Fakhouri M, 2006, DEV BIOL, V293, P127, DOI 10.1016/j.ydbio.2006.01.028; Hinton HE, 1981, BIOL INSECT EGGS; Irles P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-206; LAWSON F, 1951, OHIO J SCI, V52, P296; Mullins DE, 2002, J EXP BIOL, V205, P2987; PARKS S, 1987, GENE DEV, V1, P497, DOI 10.1101/gad.1.5.497; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; WIGGLESWORTH VB, 1950, Q J MICROSC SCI, V91, P429	12	15	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8353	10.1371/journal.pone.0008353	http://dx.doi.org/10.1371/journal.pone.0008353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20020062	Green Published, gold			2022-12-27	WOS:000272834000024
J	Zhao, HB; Ru, BH; Teeling, EC; Faulkes, CG; Zhang, SY; Rossiter, SJ				Zhao, Huabin; Ru, Binghua; Teeling, Emma C.; Faulkes, Christopher G.; Zhang, Shuyi; Rossiter, Stephen J.			Rhodopsin Molecular Evolution in Mammals Inhabiting Low Light Environments	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ROD VISUAL PIGMENTS; BOVINE RHODOPSIN; COLOR-VISION; ULTRAVIOLET VISION; ADAPTIVE EVOLUTION; CICHLID FISHES; MARINE MAMMALS; VERTEBRATES; ADAPTATIONS	The ecological radiation of mammals to inhabit a variety of light environments is largely attributed to adaptive changes in their visual systems. Visual capabilities are conferred by anatomical features of the eyes as well as the combination and properties of their constituent light sensitive pigments. To test whether evolutionary switches to different niches characterized by dim-light conditions coincided with molecular adaptation of the rod pigment rhodopsin, we sequenced the rhodopsin gene in twenty-two mammals including several bats and subterranean mole-rats. We compared these to thirty-seven published mammal rhodopsin sequences, from species with divergent visual ecologies, including nocturnal, diurnal and aquatic groups. All taxa possessed an intact functional rhodopsin; however, phylogenetic tree reconstruction recovered a gene tree in which rodents were not monophyletic, and also in which echolocating bats formed a monophyletic group. These conflicts with the species tree appear to stem from accelerated evolution in these groups, both of which inhabit low light environments. Selection tests confirmed divergent selection pressures in the clades of subterranean rodents and bats, as well as in marine mammals that live in turbid conditions. We also found evidence of divergent selection pressures among groups of bats with different sensory modalities based on vision and echolocation. Sliding window analyses suggest most changes occur in transmembrane domains, particularly obvious within the pinnipeds; however, we found no obvious pattern between photopic niche and predicted spectral sensitivity based on known critical amino acids. This study indicates that the independent evolution of rhodopsin vision in ecologically specialised groups of mammals has involved molecular evolution at the sequence level, though such changes might not mediate spectral sensitivity directly.	[Zhao, Huabin; Ru, Binghua; Zhang, Shuyi] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Teeling, Emma C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Faulkes, Christopher G.; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University College Dublin; University College Dublin; University of London; Queen Mary University London	Zhao, HB (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn; s.j.rossiter@qmul.ac.uk	Zhang, Shuyi/B-5117-2011; Zhao, Huabin/D-6956-2011; Faulkes, Chris/O-8101-2019; Zhao, Huabin/AAS-7513-2020; Rossiter, Stephen J/E-2111-2011	Zhao, Huabin/0000-0002-7848-6392; Teeling, Emma/0000-0002-3309-1346; Faulkes, Christopher/0000-0002-5228-9075; Rossiter, Stephen/0000-0002-3881-4515	National "985" Project; "211" Project; Royal Society Research; Science Foundation Ireland [PIYRA [06/YI3/B932]]	National "985" Project; "211" Project(Anhui UniversityMinistry of Education, China); Royal Society Research(Royal Society of London); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a grant under the Key Construction Program of the National "985" Project and "211" Project to S.Z., a Royal Society Research Fellowship to S.J.R and a Science Foundation Ireland grant PIYRA [06/YI3/B932] to E.C.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Cott H.B., 1940, ADAPTIVE COLORATION; CRESCITELLI F, 1991, VISION RES, V31, P339, DOI 10.1016/0042-6989(91)90086-K; David-Gray ZK, 2002, EUR J NEUROSCI, V16, P1186, DOI 10.1046/j.1460-9568.2002.02161.x; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; Fasick JI, 2000, VISUAL NEUROSCI, V17, P781, DOI 10.1017/S095252380017511X; FERRARI M, 1993, COLORS SURVIVAL MIMI; Griebel U, 2006, MAR MAMMAL SCI, V22, P156, DOI 10.1111/j.1748-7692.2006.00010.x; GRIEBEL U, 1992, VISION RES, V32, P477, DOI 10.1016/0042-6989(92)90239-F; GRIEBEL U, 2002, VIENNA SCH MARINE BI; Griebel Ulrike, 2003, Aquatic Mammals, V29, P18, DOI 10.1578/016754203101024040; Henry EC, 2006, J COMP NEUROL, V495, P434, DOI 10.1002/cne.20883; HINTON HE, 1973, NATURAL DECEPTION; HULSENBECK JP, 2001, BAYESIAN INFERENCE P; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kimchi T, 2002, CURR OPIN NEUROBIOL, V12, P728, DOI 10.1016/S0959-4388(02)00381-1; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; LDOS SC, 2006, CURR BIOL, V16, pR81; Levenson DH, 2006, J COMP PHYSIOL A, V192, P833, DOI 10.1007/s00359-006-0121-x; Levenson DH, 2003, P ROY SOC B-BIOL SCI, V270, P673, DOI 10.1098/rspb.2002.2278; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Maddison WP, 2019, MESQUITE MODULAR SYS; MADSEN CJ, 1980, CETACEAN BEHAV; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; Moss CF, 2003, CURR OPIN NEUROBIOL, V13, P751, DOI 10.1016/j.conb.2003.10.016; MUNTZ WRA, 1976, VISION RES, V16, P897, DOI 10.1016/0042-6989(76)90218-2; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nei M., 2000, MOL EVOLUTION PHYLOG; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2001, EUR J NEUROSCI, V13, P1520, DOI 10.1046/j.0953-816x.2001.01533.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pride D.T., 2004, SWAPP 1 0 2 TOOL ANA; Shi YS, 2003, P NATL ACAD SCI USA, V100, P8308, DOI 10.1073/pnas.1532535100; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Southall KD, 2002, MAR MAMMAL SCI, V18, P275, DOI 10.1111/j.1748-7692.2002.tb01033.x; Sugawara T, 2002, MOL BIOL EVOL, V19, P1807, DOI 10.1093/oxfordjournals.molbev.a004004; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trumpp-Kallmeyer S, 1995, Pharm Acta Helv, V70, P255, DOI 10.1016/0031-6865(95)00029-9; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; Wickler W., 1968, MIMICRY PLANTS ANIMA; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; Yokoyama S, 2005, GENETICS, V170, P335, DOI 10.1534/genetics.104.039511; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543; Yokoyama S, 2004, MOL BIOL EVOL, V21, P2071, DOI 10.1093/molbev/msh217; Yokoyama S, 2000, FEBS LETT, V486, P167, DOI 10.1016/S0014-5793(00)02269-9; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	66	39	39	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8326	10.1371/journal.pone.0008326	http://dx.doi.org/10.1371/journal.pone.0008326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016835	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834000013
J	Gidijala, L; Kiel, JAKW; Douma, RD; Seifar, RM; van Gulik, WM; Bovenberg, RAL; Veenhuis, M; van der Klei, IJ				Gidijala, Loknath; Kiel, Jan A. K. W.; Douma, Rutger D.; Seifar, Reza M.; van Gulik, Walter M.; Bovenberg, Roel A. L.; Veenhuis, Marten; van der Klei, Ida J.			An Engineered Yeast Efficiently Secreting Penicillin	PLOS ONE			English	Article							HANSENULA-POLYMORPHA; ISOPENICILLIN-N; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; PEROXISOMAL MEMBRANE; ARXULA-ADENINIVORANS; MASS-SPECTROMETRY; MATRIX PROTEIN; CHRYSOGENUM; GENE	This study aimed at developing an alternative host for the production of penicillin ( PEN). As yet, the industrial production of this beta(-)lactam antibiotic is confined to the filamentous fungus Penicillium chrysogenum. As such, the yeast Hansenula polymorpha, a recognized producer of pharmaceuticals, represents an attractive alternative. Introduction of the P. chrysogenum gene encoding the non-ribosomal peptide synthetase (NRPS) delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase (ACVS) in H. polymorpha, resulted in the production of active ACVS enzyme, when co-expressed with the Bacillus subtilis sfp gene encoding a phosphopantetheinyl transferase that activated ACVS. This represents the first example of the functional expression of a non-ribosomal peptide synthetase in yeast. Co-expression with the P. chrysogenum genes encoding the cytosolic enzyme isopenicillin N synthase as well as the two peroxisomal enzymes isopenicillin N acyl transferase (IAT) and phenylacetyl CoA ligase (PCL) resulted in production of biologically active PEN, which was efficiently secreted. The amount of secreted PEN was similar to that produced by the original P. chrysogenum NRRL1951 strain (approx. 1 mg/L). PEN production was decreased over two-fold in a yeast strain lacking peroxisomes, indicating that the peroxisomal localization of IAT and PCL is important for efficient PEN production. The breakthroughs of this work enable exploration of new yeast-based cell factories for the production of (novel) b-lactam antibiotics as well as other natural and semi-synthetic peptides (e.g. immunosuppressive and cytostatic agents), whose production involves NRPS's.	[Gidijala, Loknath; Kiel, Jan A. K. W.; Bovenberg, Roel A. L.; Veenhuis, Marten; van der Klei, Ida J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Gidijala, Loknath; Kiel, Jan A. K. W.; Douma, Rutger D.; Seifar, Reza M.; van Gulik, Walter M.; Veenhuis, Marten; van der Klei, Ida J.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Douma, Rutger D.; Seifar, Reza M.; van Gulik, Walter M.] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Delft, Netherlands; [Bovenberg, Roel A. L.] DSM Biotechnol Ctr, Delft, Netherlands	University of Groningen; Delft University of Technology; DSM NV	Gidijala, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands.	i.j.van.der.klei@rug.nl	van der Klei, Ida J/D-1919-2012	Van der Klei, Ida J./0000-0001-7165-9679	Netherlands Ministry of Economic Affairs; B-Basic partner organizations; public-private NWO-ACTS programme; Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations; public-private NWO-ACTS programme; Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	LG, JAKWK and RD are financially supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations (www.b-basic.nl) through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability). This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerends RJS, 1997, YEAST, V13, P1437; Baerends RJS, 1996, J BIOL CHEM, V271, P8887, DOI 10.1074/jbc.271.15.8887; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; DEMAIN A, 1983, BIOSYNTHESIS BETA LA, P180; DITZELMULLER G, 1983, ARCH MICROBIOL, V135, P63, DOI 10.1007/BF00419484; Evers ME, 2004, ADV BIOCHEM ENG BIOT, V88, P111, DOI 10.1007/b99259; Gellissen G, 2005, FEMS YEAST RES, V5, P1079, DOI 10.1016/j.femsyr.2005.06.004; Gidijala L, 2007, FEMS YEAST RES, V7, P1160, DOI 10.1111/j.1567-1364.2007.00228.x; Gidijala L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-29; GLEESON MA, 1988, YEAST, V4, P293, DOI 10.1002/yea.320040407; Haan GJ, 2002, FEMS YEAST RES, V2, P17, DOI 10.1016/S1567-1356(01)00057-5; HILLENGA DJ, 1994, EUR J BIOCHEM, V224, P581, DOI 10.1111/j.1432-1033.1994.t01-1-00581.x; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kleijn RJ, 2007, METAB ENG, V9, P112, DOI 10.1016/j.ymben.2006.08.004; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kresse H, 2007, NAT REV DRUG DISCOV, V6, P19, DOI 10.1038/nrd2226; Lutz MV, 2005, FEMS YEAST RES, V5, P1063, DOI 10.1016/j.femsyr.2005.07.002; Mashego MR, 2003, BIOTECHNOL BIOENG, V83, P395, DOI 10.1002/bit.10683; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Nagotu S, 2008, BBA-MOL CELL RES, V1783, P760, DOI 10.1016/j.bbamcr.2007.10.018; RAMOS FR, 1985, ANTIMICROB AGENTS CH, V27, P380, DOI 10.1128/AAC.27.3.380; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Seifar RM, 2008, J CHROMATOGR A, V1187, P103, DOI 10.1016/j.chroma.2008.02.008; Siewers V, 2009, METAB ENG, V11, P391, DOI 10.1016/j.ymben.2009.08.002; Sprote P, 2009, EUKARYOT CELL, V8, P421, DOI 10.1128/EC.00374-08; Stockmann C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-22; van der Lende TR, 2002, FUNGAL GENET BIOL, V37, P49, DOI 10.1016/S1087-1845(02)00036-1; van Dijk R, 2000, ENZYME MICROB TECH, V26, P793, DOI 10.1016/S0141-0229(00)00173-3; VANDERKLEI IJ, 1991, ARCH MICROBIOL, V156, P15, DOI 10.1007/BF00418181; Waksman SA, 1944, P NATL ACAD SCI USA, V30, P99, DOI 10.1073/pnas.30.5.99; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; ZWART KB, 1983, A VAN LEEUW J MICROB, V49, P369	36	58	61	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8317	10.1371/journal.pone.0008317	http://dx.doi.org/10.1371/journal.pone.0008317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016817	Green Published, Green Submitted, gold			2022-12-27	WOS:000272833800013
J	Pettengill, MA; Lam, VW; Ojcius, DM				Pettengill, Matthew A.; Lam, Verissa W.; Ojcius, David M.			The Danger Signal Adenosine Induces Persistence of Chlamydial Infection through Stimulation of A2b Receptors	PLOS ONE			English	Article							EPITHELIAL-CELLS; BACTERIAL PERSISTENCE; IMMUNE-RESPONSE; HOST-CELLS; TRACHOMATIS; GRANULOMA; PARADIGM; SURVIVAL; HYPOXIA; RELEASE	Infections with intracellular bacteria such as chlamydiae affect the majority of the world population. Infected tissue inflammation and granuloma formation help contain the short-term expansion of the invading pathogen, leading also to local tissue damage and hypoxia. However, the effects of key aspects of damaged inflamed tissues and hypoxia on continued infection with intracellular bacteria remain unknown. We find that development of Chlamydia trachomatis is reversibly retarded by prolonged exposure of infected cells to extracellular adenosine, a hallmark of hypoxia and advanced inflammation. In epithelial cells, this effect was mediated by the A2b adenosine receptor, unique in the adenosine receptor family for having a hypoxia-inducible factor (HIF1-alpha) binding site at its promoter region, and was dependent on an increase in the intracellular cAMP levels, but was independent of cAMP-dependent protein kinase (PKA). Further study of adenosine receptor signaling during intracellular bacterial infection could lead to breakthroughs in our understanding of persistent infections with these ubiquitous pathogens.	[Pettengill, Matthew A.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced	Pettengill, MA (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA.	dojcius@ucmerced.edu	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Pettengill, Matthew/0000-0002-4579-0187	University of California	University of California(University of California System)	University of California funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Hoare A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-5; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Roan NR, 2008, CELL MICROBIOL, V10, P9, DOI 10.1111/j.1462-5822.2007.01069.x; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun Y, 2008, J IMMUNOL, V180, P4173, DOI 10.4049/jimmunol.180.6.4173; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; WARD ME, 1982, J GEN MICROBIOL, V128, P639; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Yang X, 1999, J IMMUNOL, V162, P1010; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026	31	28	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8299	10.1371/journal.pone.0008299	http://dx.doi.org/10.1371/journal.pone.0008299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011598	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300047
J	Bayle, DJ; Henaff, MA; Krolak-Salmon, P				Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre			Unconsciously Perceived Fear in Peripheral Vision Alerts the Limbic System: A MEG Study	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; MEDIAL PREFRONTAL CORTEX; TEMPORAL-LOBE EPILEPSY; TIME-COURSE; FACE PERCEPTION; NEURAL ACTIVITY; HUMAN AMYGDALA; MOTOR CONTROL; RECOGNITION; RESPONSES	Background: In ecological situations, threatening stimuli often come out from the peripheral vision. Such aggressive messages must trigger rapid attention to the periphery to allow a fast and adapted motor reaction. Several clues converge to hypothesize that peripheral danger presentation can trigger off a fast arousal network potentially independent of the consciousness spot. Methodology/Principal Findings: In the present MEG study, spatio-temporal dynamics of the neural processing of danger related stimuli were explored as a function of the stimuli position in the visual field. Fearful and neutral faces were briefly presented in the central or peripheral visual field, and were followed by target faces stimuli. An event-related beamformer source analysis model was applied in three time windows following the first face presentations: 80 to 130 ms, 140 to 190 ms, and 210 to 260 ms. The frontal lobe and the right internal temporal lobe part, including the amygdala, reacted as soon as 80 ms of latency to fear occurring in the peripheral vision. For central presentation, fearful faces evoked the classical neuronal activity along the occipito-temporal visual pathway between 140 and 190 ms. Conclusions: Thus, the high spatio-temporal resolution of MEG allowed disclosing a fast response of a network involving medial temporal and frontal structures in the processing of fear related stimuli occurring unconsciously in the peripheral visual field. Whereas centrally presented stimuli are precisely processed by the ventral occipito-temporal cortex, the related-to-danger stimuli appearing in the peripheral visual field are more efficient to produce a fast automatic alert response possibly conveyed by subcortical structures.	[Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre] INSERM, U821, F-69008 Lyon, France; [Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre] Univ Lyon 1, F-69365 Lyon, France; [Bayle, Dimitri J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Krolak-Salmon, Pierre] Hosp Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CHU Lyon	Bayle, DJ (corresponding author), INSERM, U821, F-69008 Lyon, France.	dimitri.bayle@inserm.fr	krolak-salmon, pierre/AAV-2152-2020	bayle, dimitri/0000-0003-1867-2721	Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The research was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; BALOTA DA, 1983, J VERB LEARN VERB BE, V22, P88, DOI 10.1016/S0022-5371(83)80008-5; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Baumgartner C, 2000, J CLIN NEUROPHYSIOL, V17, P177, DOI 10.1097/00004691-200003000-00007; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERSON DM, 1988, PROG BRAIN RES, V75, P17; Bish JP, 2004, NEUROSCI LETT, V362, P48, DOI 10.1016/j.neulet.2004.02.032; Bullier J, 1996, J PHYSIOLOGY-PARIS, V90, P217, DOI 10.1016/S0928-4257(97)81426-X; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Carrasco M, 2003, NAT NEUROSCI, V6, P699, DOI 10.1038/nn1079; Carretie L, 2005, NEUROIMAGE, V24, P615, DOI 10.1016/j.neuroimage.2004.09.009; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Cheyne D, 2007, CLIN NEUROPHYSIOL, V118, P1691, DOI 10.1016/j.clinph.2007.05.064; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Ioannides AA, 2004, NEUROIMAGE, V23, P473, DOI 10.1016/j.neuroimage.2004.06.023; KIHLSTROM JF, 1987, SCIENCE, V237, P1445, DOI 10.1126/science.3629249; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; MARCEL PM, 1983, CAN J PSYCHOL, V37, P324; Mermillod M, 2009, CONNECT SCI, V21, P75, DOI 10.1080/09540090802213974; Mikuni N, 1997, NEUROIMAGE, V5, P298, DOI 10.1006/nimg.1997.0272; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Moses SN, 2007, BRAIN RES BULL, V71, P452, DOI 10.1016/j.brainresbull.2006.08.016; MUNK MHJ, 1995, P NATL ACAD SCI USA, V92, P988, DOI 10.1073/pnas.92.4.988; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; NIEDENTHAL PM, 1990, J EXP SOC PSYCHOL, V26, P505, DOI 10.1016/0022-1031(90)90053-O; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; PARK JY, 2008, CORTEX          0629; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; POSNER J, 2008, HUM BRAIN MAPP; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Rigoulot S, 2008, BRAIN TOPOGR, V20, P216, DOI 10.1007/s10548-008-0050-9; ROBINSON SE, 2004, NEUROL CLIN NEUROPHY, P109; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; SOARES JJF, 1993, PSYCHOPHYSIOLOGY, V30, P460, DOI 10.1111/j.1469-8986.1993.tb02069.x; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Tesche CD, 1997, BRAIN RES, V749, P53, DOI 10.1016/S0006-8993(96)01286-3; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams LM, 2004, COGNITIVE BRAIN RES, V21, P114, DOI 10.1016/j.cogbrainres.2004.06.005; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Williams MA, 2004, EXP BRAIN RES, V154, P403, DOI 10.1007/s00221-003-1740-x; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3	84	49	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8207	10.1371/journal.pone.0008207	http://dx.doi.org/10.1371/journal.pone.0008207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011048	Green Published, gold			2022-12-27	WOS:000272829800006
J	Ceccato, JC; de Seze, M; Azevedo, C; Cazalets, JR				Ceccato, Jean-Charles; de Seze, Mathieu; Azevedo, Christine; Cazalets, Jean-Rene			Comparison of Trunk Activity during Gait Initiation and Walking in Humans	PLOS ONE			English	Article							MUSCLE ACTIVATION PATTERNS; HUMAN LOCOMOTION; DIFFERENT SPEEDS; SEGMENTAL MOVEMENTS; TREADMILL WALKING; SPINAL MOTION; NEWBORN RAT; KINEMATICS; CATS; ARM	To understand the role of trunk muscles in maintenance of dynamic postural equilibrium we investigate trunk movements during gait initiation and walking, performing trunk kinematics analysis, Erector spinae muscle (ES) recordings and dynamic analysis. ES muscle expressed a metachronal descending pattern of activity during walking and gait initiation. In the frontal and horizontal planes, lateroflexion and rotation occur before in the upper trunk and after in the lower trunk. Comparison of ES muscle EMGs and trunk kinematics showed that trunk muscle activity precedes corresponding kinematics activity, indicating that the ES drive trunk movement during locomotion and thereby allowing a better pelvis mobilization. EMG data showed that ES activity anticipates propulsive phases in walking with a repetitive pattern, suggesting a programmed control by a central pattern generator. Our findings also suggest that the programs for gait initiation and walking overlap with the latter beginning before the first has ended.	[Ceccato, Jean-Charles; Cazalets, Jean-Rene] Univ Bordeaux, CNRS, UMR 5227, Lab Mouvement Adaptat Cognit, Bordeaux, France; [Ceccato, Jean-Charles; Azevedo, Christine] INRIA, LIRMM, Team DEMAR, Montpellier, France; [de Seze, Mathieu] CHU Pellegrin, Pole Neurosci Clin, Serv Med Phys & Readaptat, Bordeaux, France; [de Seze, Mathieu] Univ Bordeaux 2, Lab Anat, EA Handicap & Syst Nerveux IFR8 IFR25 4136, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Inria; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Ceccato, JC (corresponding author), Univ Bordeaux, CNRS, UMR 5227, Lab Mouvement Adaptat Cognit, Bordeaux, France.	jean-rene.cazalets@u-bordeaux2.fr	Azevedo-Coste, Christine/A-1196-2010; Ceccato, Jean-Charles/GSM-6789-2022; de seze, mathieu/AAI-8002-2021; Cazalets, Jean-René/D-7851-2014	Cazalets, Jean-René/0000-0001-9047-3933	Ministere de la Recherche [032645]; Region Aquitaine; DGA [0334045]	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Region Aquitaine(Region Nouvelle-Aquitaine); DGA	This work was funded in part by the Ministere de la Recherche (ACI Neuroscience; ACI Plateformes Technologiques 032645), Region Aquitaine, and by the DGA 0334045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2007, J ELECTROMYOGR KINES, V17, P245, DOI 10.1016/j.jelekin.2006.01.002; BRENIERE Y, 1991, J MOTOR BEHAV, V23, P235, DOI 10.1080/00222895.1991.9942034; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; Breniere Y, 1998, BIOL CYBERN, V79, P337, DOI 10.1007/s004220050483; BRUNT D, 1991, AM J PHYS MED REHAB, V70, P206, DOI 10.1097/00002060-199108000-00009; Brunt D, 1999, GAIT POSTURE, V10, P121, DOI 10.1016/S0966-6362(99)00020-X; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; CAPPOZZO A, 1981, J BIOMECH, V14, P411, DOI 10.1016/0021-9290(81)90059-2; CARLSON H, 1981, ACTA PHYSIOL SCAND, V111, P221, DOI 10.1111/j.1748-1716.1981.tb06729.x; CAVAGNA GA, 1963, EXP MED SURG, V21, P117; Cazalets JR, 2005, J PHYSIOL-LONDON, V568, P583, DOI 10.1113/jphysiol.2005.086850; CHEN W, 1997, INT PROC SYST 1997 I, V1, P185; Couillandre A, 2000, NEUROSCI LETT, V285, P150, DOI 10.1016/S0304-3940(00)01015-6; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; Crosbie J, 1997, GAIT POSTURE, V5, P13, DOI 10.1016/S0966-6362(96)01068-5; Crosbie J, 1997, GAIT POSTURE, V5, P6, DOI 10.1016/S0966-6362(96)01066-1; de Seze M, 2008, EXP BRAIN RES, V185, P237, DOI 10.1007/s00221-007-1146-2; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Dietz V, 2001, EUR J NEUROSCI, V14, P1906, DOI 10.1046/j.0953-816x.2001.01813.x; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Falgairolle M, 2007, J PHYSIOL-LONDON, V580, P87, DOI 10.1113/jphysiol.2006.115709; Feipel V, 2001, EUR SPINE J, V10, P16, DOI 10.1007/s005860000199; Ferris DP, 2006, EXERC SPORT SCI REV, V34, P113, DOI 10.1249/00003677-200607000-00005; Frigo C, 2003, CLIN BIOMECH, V18, P419, DOI 10.1016/S0268-0033(03)00028-7; GRACOVETSKY S, 1988, SPINAL ENGINE; GRACOVETSKY SA, 1987, J BIOMED ENG, V9, P99, DOI 10.1016/0141-5425(87)90020-3; GREGERSEN GG, 1967, J BONE JOINT SURG AM, VA 49, P247, DOI 10.2106/00004623-196749020-00003; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; KOEHLER WJ, 1984, J PHYSIOL-LONDON, V353, P187, DOI 10.1113/jphysiol.1984.sp015331; Konz RJ, 2006, SPINE, V31, pE898, DOI 10.1097/01.brs.0000245939.97637.ae; Kumar S, 2004, ERGONOMICS, V47, P370, DOI 10.1080/0014013032000157940; Lamont EV, 2006, EXP BRAIN RES, V173, P185, DOI 10.1007/s00221-006-0586-4; Lamoth CJC, 2002, SPINE, V27, pE92, DOI 10.1097/00007632-200202150-00016; MANN RA, 1979, J BONE JOINT SURG AM, V61, P232, DOI 10.2106/00004623-197961020-00011; Mickelborough J, 2004, GAIT POSTURE, V19, P50, DOI 10.1016/S0966-6362(03)00016-X; Nieuwenhuijzen PHJA, 2007, J NEUROPHYSIOL, V98, P2266, DOI 10.1152/jn.01226.2006; PRINCE F, 1994, J KINESIOLOGIE, P20; ROSE J, 2006, HUMAN WALKING, pR13; Sartor C, 1999, HUM MOVEMENT SCI, V18, P669, DOI 10.1016/S0167-9457(99)00037-8; Saunders SW, 2005, CLIN BIOMECH, V20, P784, DOI 10.1016/j.clinbiomech.2005.04.004; Syczewska M, 1999, CLIN BIOMECH, V14, P384, DOI 10.1016/S0268-0033(99)00003-0; THORSTENSSON A, 1982, ACTA PHYSIOL SCAND, V116, P13, DOI 10.1111/j.1748-1716.1982.tb10593.x; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; vanEmmerik REA, 1996, J BIOMECH, V29, P1175, DOI 10.1016/0021-9290(95)00128-X; Wagenaar RC, 2000, J BIOMECH, V33, P853, DOI 10.1016/S0021-9290(00)00020-8; Zehr EP, 2004, CAN J PHYSIOL PHARM, V82, P556, DOI 10.1139/Y04-056; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; ZOMLEFER MR, 1984, BRAIN RES, V290, P249, DOI 10.1016/0006-8993(84)90942-9	50	59	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8193	10.1371/journal.pone.0008193	http://dx.doi.org/10.1371/journal.pone.0008193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997606	Green Published, gold			2022-12-27	WOS:000272829500016
J	Link, A; Shin, SK; Nagasaka, T; Balaguer, F; Koi, M; Jung, B; Boland, CR; Goel, A				Link, Alexander; Shin, Sung Kwan; Nagasaka, Takeshi; Balaguer, Francesc; Koi, Minoru; Jung, Barbara; Boland, C. Richard; Goel, Ajay			JC Virus Mediates Invasion and Migration in Colorectal Metastasis	PLOS ONE			English	Article							T-ANTIGEN EXPRESSION; CHROMOSOMAL INSTABILITY; COLON-CANCER; PROTEINS; POLYOMAVIRUS; CELLS; DNA; IDENTIFICATION; TRANSFORMATION; ASSOCIATION	Introduction: JC Virus (JCV), a human polyomavirus, is frequently present in colorectal cancers (CRCs). JCV large T-Ag (T-Ag) expressed in approximately half of all CRC's, however, its functional role in CRC is poorly understood. We hypothesized that JCV T-Ag may mediate metastasis in CRC cells through increased migration and invasion. Material and Methods: CRC cell lines (HCT116 and SW837) were stably transfected with JCV early transcript sequences cloned into pCR3 or empty vectors. Migration and invasion assays were performed using Boyden chambers. Global gene expression analysis was performed to identify genetic targets and pathways altered by T-Ag expression. Microarray results were validated by qRT-PCR, protein expression analyses and immunohistochemistry. Matching primary CRCs and liver metastases from 33 patients were analyzed for T-Ag expression by immunohistochemistry. Results: T-Ag expressing cell lines showed 2 to 3-fold increase in migration and invasion compared to controls. JCV T-Ag expression resulted in differential expression of several genetic targets, including genes that mediate cell migration and invasion. Pathway analysis suggested a significant involvement of these genes with AKT and MAPK signaling. Treatment with selective PI3K/AKT and MAPK pathway inhibitors resulted in reduced migration and invasion. In support of our in-vitro results, immunohistochemical staining of the advanced stage tumors revealed frequent JCV T-Ag expression in metastatic primary tumors (92%) as well as in their matching liver metastasis (73%). Conclusion: These data suggest that JCV T-Ag expression in CRC associates with a metastatic phenotype, which may partly be mediated through the AKT/MAPK signaling pathway. Frequent expression of JCV T-Ag in CRC liver metastasis provides further clues supporting a mechanistic role for JCV as a possible mediator of cellular motility and invasion in CRC.	[Link, Alexander; Shin, Sung Kwan; Balaguer, Francesc; Koi, Minoru; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Div Gastroenterol,Dept Internal Med, Dallas, TX USA; [Link, Alexander; Shin, Sung Kwan; Balaguer, Francesc; Koi, Minoru; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Nagasaka, Takeshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg & Surg Oncol, Okayama 7008530, Japan; [Jung, Barbara] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Link, Alexander] Otto von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Shin, Sung Kwan] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol,Div Gastroenterol, Seoul, South Korea; [Balaguer, Francesc] Univ Barcelona, IDIBAPS, CIBEREHD,Dept Gastroenterol, Inst Malalties Digest & Metab,Hosp Clin, Barcelona, Catalonia, Spain	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Okayama University; University of California System; University of California San Diego; Otto von Guericke University; Yonsei University; Yonsei University Health System; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Link, A (corresponding author), Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Div Gastroenterol,Dept Internal Med, Dallas, TX USA.	rick.boland@baylorhealth.edu; ajay.goel@baylorhealth.edu	Koi, Minoru/C-3489-2012; Balaguer, Francesc/GPX-7801-2022; Koi, Minoru/G-9197-2014; BALAGUER, FRANCESC/G-2389-2016	Shin, Sung Kwan/0000-0001-5466-1400; Balaguer, Francesc/0000-0002-0206-0539; Link, Alexander/0000-0002-9514-4562; Goel, Ajay/0000-0003-1396-6341; Nagasaka, Takeshi/0000-0002-4236-350X	National Cancer Institute [R01 CA72851, CA129286]; National Institutes of Health; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA098572, R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Boland CR, 2005, GUT, V54, P1321, DOI 10.1136/gut.2004.060079; BOLLAG B, 1992, VIRUS RES, V25, P223, DOI 10.1016/0168-1702(92)90136-W; Bollag B, 2000, VIROLOGY, V274, P165, DOI 10.1006/viro.2000.0451; Bollag B, 2006, J NEUROVIROL, V12, P428, DOI 10.1080/13550280601009553; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Del Valle L, 2002, J NEUROVIROL, V8, P138, DOI 10.1080/13550280290101111; Enam S, 2002, CANCER RES, V62, P7093; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FRISQUE RJ, 1980, J VIROL, V35, P265, DOI 10.1128/JVI.35.1.265-269.1980; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Goel A, 2006, GASTROENTEROLOGY, V130, P1950, DOI 10.1053/j.gastro.2006.02.061; Hausen HZ, 2008, P NATL ACAD SCI USA, V105, P16063, DOI 10.1073/pnas.0808973105; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; ISHAQ M, 1994, P NATL ACAD SCI USA, V91, P8283, DOI 10.1073/pnas.91.17.8283; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; [苟新敏 Gou Xinmin], 2003, [癌症, Chinese  Journal  of  Cancer], V22, P481; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Knecht H, 2001, ONCOLOGY-BASEL, V60, P289, DOI 10.1159/000058523; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; Morris MA, 2008, EUR J CELL BIOL, V87, P677, DOI 10.1016/j.ejcb.2008.03.005; Nosho K, 2009, NEOPLASIA, V11, P87, DOI 10.1593/neo.81188; PADGETT BL, 1976, J INFECT DIS, V133, P686, DOI 10.1093/infdis/133.6.686; PADGETT BL, 1977, CANCER RES, V37, P718; Querbes W, 2004, J VIROL, V78, P250, DOI 10.1128/JVI.78.1.250-256.2004; Ravichandran V, 2007, J VIROL, V81, P6412, DOI 10.1128/JVI.02658-06; Ricciardiello L, 2003, CANCER RES, V63, P7256; Ricciardiello L, 2001, J VIROL, V75, P1996, DOI 10.1128/JVI.75.4.1996-2001.2001; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Saglam O, 2007, CLIN COLORECTAL CANC, V6, P652, DOI 10.3816/CCC.2007.n.034; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Schmitz KJ, 2007, VIRCHOWS ARCH, V450, P151, DOI 10.1007/s00428-006-0342-y; Shaw Leslie M., 2004, V294, P97; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; TROWBRIDGE PW, 1995, J NEUROVIROL, V1, P195, DOI 10.3109/13550289509113966; VARAKIS J, 1978, CANCER RES, V38, P1718; Verma S, 2006, VIROLOGY, V345, P457, DOI 10.1016/j.virol.2005.10.012; White MK, 2005, EUR J CANCER, V41, P2537, DOI 10.1016/j.ejca.2005.08.019; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958	44	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8146	10.1371/journal.pone.0008146	http://dx.doi.org/10.1371/journal.pone.0008146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997600	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000007
J	Chen, YF; Gao, ZY; Kerris, RJ; Wang, WY; Binder, BM; Schaller, GE				Chen, Yi-Feng; Gao, Zhiyong; Kerris, Robert J., III; Wang, Wuyi; Binder, Brad M.; Schaller, G. Eric			Ethylene Receptors Function as Components of High-Molecular-Mass Protein Complexes in Arabidopsis	PLOS ONE			English	Article							HISTIDINE KINASE DOMAIN; RAF-LIKE KINASE; ENDOPLASMIC-RETICULUM; RESPONSE PATHWAY; H+-ATPASE; ETR1; GENE; BINDING; FAMILY; CTR1	Background: The gaseous plant hormone ethylene is perceived in Arabidopsis thaliana by a five-member receptor family composed of ETR1, ERS1, ETR2, ERS2, and EIN4. Methodology/Principal Findings: Gel-filtration analysis of ethylene receptors solubilized from Arabidopsis membranes demonstrates that the receptors exist as components of high-molecular-mass protein complexes. The ERS1 protein complex exhibits an ethylene-induced change in size consistent with ligand-mediated nucleation of protein-protein interactions. Deletion analysis supports the participation of multiple domains from ETR1 in formation of the protein complex, and also demonstrates that targeting to and retention of ETR1 at the endoplasmic reticulum only requires the first 147 amino acids of the receptor. A role for disulfide bonds in stabilizing the ETR1 protein complex was demonstrated by use of reducing agents and mutation of Cys4 and Cys6 of ETR1. Expression and analysis of ETR1 in a transgenic yeast system demonstrates the importance of Cys4 and Cys6 of ETR1 in stabilizing the receptor for ethylene binding. Conclusions/Significance: These data support the participation of ethylene receptors in obligate as well as ligand-dependent non-obligate protein interactions. These data also suggest that different protein complexes may allow for tailoring of the ethylene signal to specific cellular environments and responses.	[Chen, Yi-Feng; Gao, Zhiyong; Kerris, Robert J., III; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Wang, Wuyi; Binder, Brad M.] Univ Wisconsin, Dept Bot, Madison, WI USA	Dartmouth College; University of Wisconsin System; University of Wisconsin Madison	Chen, YF (corresponding author), Univ Minnesota, Algal Biofuel Grp, Dept Bioproducts & Biosyst Engn, St Paul, MN 55108 USA.	george.e.schaller@dartmouth.edu	Chen, Yi/HIR-2608-2022	Binder, Brad/0000-0002-8172-2034	Department of Energy [DE-FG02-05ER15704]; National Science Foundation [MCB-0430191]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Department of Energy grant DE-FG02-05ER15704 and National Science Foundation grant MCB-0430191 to G. E. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; [Anonymous], 2002, ARABIDOPSIS BOOK; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Bleecker AB, 1999, TRENDS PLANT SCI, V4, P269, DOI 10.1016/S1360-1385(99)01427-2; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; Chang C, 2001, BIOESSAYS, V23, P619, DOI 10.1002/bies.1087; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; Hong BM, 1999, PLANT PHYSIOL, V119, P1165, DOI 10.1104/pp.119.4.1165; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Hyodo H., 1991, PLANT HORMONE ETHYLE; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORD JM, 1987, METHOD ENZYMOL, V148, P576; LUETHY MH, 1993, PLANT PHYSIOL, V101, P931, DOI 10.1104/pp.101.3.931; MAESHIMA M, 1992, PLANT PHYSIOL, V98, P1248, DOI 10.1104/pp.98.4.1248; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Schaller GE, 2007, METHOD ENZYMOL, V422, P270, DOI 10.1016/S0076-6879(06)22013-5; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schaller GE, 2000, ADV BOT RES, V32, P109, DOI 10.1016/S0065-2296(00)32023-7; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Takahashi H, 2002, J EXP BOT, V53, P415, DOI 10.1093/jexbot/53.368.415; Van der Hoorn RAL, 2003, PLANT J, V35, P305, DOI 10.1046/j.1365-313X.2003.01803.x; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; Vondriska TM, 2004, J MOL CELL CARDIOL, V37, P391, DOI 10.1016/j.yjmcc.2004.04.021; VONHEIJNE G, 1986, J MOL BIOL, V189, P239, DOI 10.1016/0022-2836(86)90394-3; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	63	55	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8640	10.1371/journal.pone.0008640	http://dx.doi.org/10.1371/journal.pone.0008640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062808	Green Published, gold			2022-12-27	WOS:000273414200017
J	Rossi, CA; Pozzobon, M; Ditadi, A; Archacka, K; Gastaldello, A; Sanna, M; Franzin, C; Malerba, A; Milan, G; Cananzi, M; Schiaffino, S; Campanella, M; Vettor, R; De Coppi, P				Rossi, Carlo A.; Pozzobon, Michela; Ditadi, Andrea; Archacka, Karolina; Gastaldello, Annalisa; Sanna, Marta; Franzin, Chiara; Malerba, Alberto; Milan, Gabriella; Cananzi, Mara; Schiaffino, Stefano; Campanella, Michelangelo; Vettor, Roberto; De Coppi, Paolo			Clonal Characterization of Rat Muscle Satellite Cells: Proliferation, Metabolism and Differentiation Define an Intrinsic Heterogeneity	PLOS ONE			English	Article							REGENERATING SKELETAL-MUSCLE; STEM-CELL; SELF-RENEWAL; IN-VITRO; EXPRESSION; POPULATIONS; QUIESCENT; PROTEIN; GROWTH; ACTIVATION	Satellite cells (SCs) represent a distinct lineage of myogenic progenitors responsible for the postnatal growth, repair and maintenance of skeletal muscle. Distinguished on the basis of their unique position in mature skeletal muscle, SCs were considered unipotent stem cells with the ability of generating a unique specialized phenotype. Subsequently, it was demonstrated in mice that opposite differentiation towards osteogenic and adipogenic pathways was also possible. Even though the pool of SCs is accepted as the major, and possibly the only, source of myonuclei in postnatal muscle, it is likely that SCs are not all multipotent stem cells and evidences for diversities within the myogenic compartment have been described both in vitro and in vivo. Here, by isolating single fibers from rat flexor digitorum brevis (FDB) muscle we were able to identify and clonally characterize two main subpopulations of SCs: the low proliferative clones (LPC) present in major proportion (similar to 75%) and the high proliferative clones (HPC), present instead in minor amount (similar to 25%). LPC spontaneously generate myotubes whilst HPC differentiate into adipocytes even though they may skip the adipogenic program if co-cultured with LPC. LPC and HPC differ also for mitochondrial membrane potential (Delta Psi(m)), ATP balance and Reactive Oxygen Species (ROS) generation underlying diversities in metabolism that precede differentiation. Notably, SCs heterogeneity is retained in vivo. SCs may therefore be comprised of two distinct, though not irreversibly committed, populations of cells distinguishable for prominent differences in basal biological features such as proliferation, metabolism and differentiation. By these means, novel insights on SCs heterogeneity are provided and evidences for biological readouts potentially relevant for diagnostic purposes described.	[Rossi, Carlo A.; Pozzobon, Michela; Ditadi, Andrea; Archacka, Karolina; De Coppi, Paolo] Univ Padua, Dept Pediat, Stem Cell Proc Lab, Padua, Italy; [Rossi, Carlo A.; Gastaldello, Annalisa; Malerba, Alberto; Cananzi, Mara; De Coppi, Paolo] Inst Child Hlth, Surg Unit, London, England; [Rossi, Carlo A.; Gastaldello, Annalisa; Malerba, Alberto; Cananzi, Mara; De Coppi, Paolo] Great Ormond St Hosp Sick Children, Univ Coll London, London, England; [Archacka, Karolina] Univ Warsaw, Dept Cytol, Fac Biol, Warsaw, Poland; [Gastaldello, Annalisa; Campanella, Michelangelo] Univ London Royal Vet Coll, London, England; [Sanna, Marta; Franzin, Chiara; Milan, Gabriella; Vettor, Roberto] Univ Padua, Endocrine Metab Lab, Dept Med & Surg Sci, Padua, Italy; [Schiaffino, Stefano] Venetian Inst Mol Med, Padua, Italy; [Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London, England	University of Padua; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Warsaw; University of London; University of London Royal Veterinary College; University of Padua; Veneto Institute Molecular Medicine; University of London; University College London	Rossi, CA (corresponding author), Univ Padua, Dept Pediat, Stem Cell Proc Lab, Padua, Italy.	mcampanella@rvc.ac.uk; p.decoppi@ich.ucl.ac.uk	Franzin, Chiara/A-3879-2013; Malerba, Alberto/A-5915-2010; VETTOR, ROBERTO/K-7121-2016; Gastaldello, Annalisa/H-9108-2019; Ditadi, Andrea/K-3461-2016; Milan, Gabriella/AAB-6234-2022; Pozzobon, Michela/X-7504-2019; cananzi, mara/AAS-8540-2020; Gastaldello, Annalisa/AAV-1629-2021; Pozzobon, Michela/G-7974-2018; Malerba, Alberto/H-4353-2012	Gastaldello, Annalisa/0000-0002-4365-1191; Ditadi, Andrea/0000-0003-3283-8943; Milan, Gabriella/0000-0001-8987-5310; Pozzobon, Michela/0000-0001-9213-402X; Pozzobon, Michela/0000-0001-9213-402X; Schiaffino, Stefano/0000-0002-5607-6421; Vettor, Roberto/0000-0003-0625-6667; De Coppi, Paolo/0000-0002-1659-0207; FRANZIN, Chiara/0000-0002-9610-567X; Cananzi, Mara/0000-0002-7177-2847; Archacka, Karolina/0000-0002-0274-9117	Telethon [GGP07216]; FEBS Collaborative Experimental Scholarship; Fondazione Citta' della Speranza [04/02]; CRF; Great Ormond Street Hospital Childrens Charity [V1230] Funding Source: researchfish	Telethon(Fondazione Telethon); FEBS Collaborative Experimental Scholarship; Fondazione Citta' della Speranza; CRF; Great Ormond Street Hospital Childrens Charity	C. A. R. was supported by Telethon (Grant GGP07216). K. A. by FEBS Collaborative Experimental Scholarship for Central & Eastern Europe, A. G. by English Italian Cultural Association il Circolo. This work was supported by Telethon grant (GGP07216) and Fondazione Citta' della Speranza grant (04/02), CRF (University of London), RVC internal funds for supporting the research activity in the M. C. laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; APPELL HJ, 1988, INT J SPORTS MED, V9, P297, DOI 10.1055/s-2007-1025026; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cooper RN, 1999, J CELL SCI, V112, P2895; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; De Coppi P, 2006, DIABETOLOGIA, V49, P1962, DOI 10.1007/s00125-006-0304-6; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DIAMOND JM, 1982, NATURE, V300, P683, DOI 10.1038/300683a0; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Freda PU, 2008, J CLIN ENDOCR METAB, V93, P2334, DOI 10.1210/jc.2007-2780; Gallagher D, 2009, AM J CLIN NUTR, V89, P807, DOI 10.3945/ajcn.2008.26955; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; GROUNDS MD, 1987, CELL TISSUE RES, V250, P563; HALLCRAG.EC, 1974, EXP NEUROL, V43, P349, DOI 10.1016/0014-4886(74)90176-9; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Heslop L, 2000, J CELL SCI, V113, P2299; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Jahagirdar BN, 2005, STEM CELL REV, V1, P53, DOI 10.1385/SCR:1:1:053; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; Molnar G, 1996, TISSUE CELL, V28, P547, DOI 10.1016/S0040-8166(96)80057-7; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORLET K, 1989, ANAT EMBRYOL, V180, P471, DOI 10.1007/BF00305122; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RANTANEN J, 1995, LAB INVEST, V72, P341; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Rouger K, 2004, CELL TISSUE RES, V317, P319, DOI 10.1007/s00441-004-0911-9; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4; SCHULTZ E, 1985, ADV EXP MED BIOL, V182, P73; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zhivotovsky B, 2009, SEMIN CANCER BIOL, V19, P1, DOI 10.1016/j.semcancer.2008.12.003	60	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8523	10.1371/journal.pone.0008523	http://dx.doi.org/10.1371/journal.pone.0008523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049087	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000273225000005
J	Mishra, PJ; Song, B; Mishra, PJ; Wang, Y; Humeniuk, R; Banerjee, D; Merlino, G; Ju, JF; Bertino, JR				Mishra, Prasun J.; Song, Bo; Mishra, Pravin J.; Wang, Yuan; Humeniuk, Rita; Banerjee, Debabrata; Merlino, Glenn; Ju, Jingfang; Bertino, Joseph R.			MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism	PLOS ONE			English	Article							MIRNA EXPRESSION; DIHYDROFOLATE-REDUCTASE; MICRORNA POLYMORPHISMS; THYMIDYLATE SYNTHASE; CELL; GENES; PHARMACOGENOMICS; DIFFERENTIATION; IDENTIFICATION; BINDING	MicroRNAs (miRNAs) are predicted to regulate approximately 30% of all human genes; however, only a few miRNAs have been assigned their targets and specific functions. Here we demonstrate that miR-24, a ubiquitously expressed miRNA, has an anti-proliferative effect independent of p53 function. Cell lines with differential p53 status were used as a model to study the effects of miR-24 on cell proliferation, cell cycle control, gene regulation and cellular transformation. Overexpression of miR-24 in six different cell lines, independent of p53 function, inhibited cell proliferation and resulted in G2/S cell cycle arrest. MiR-24 over expression in cells with wt-p53 upregulated TP53 and p21 protein; however, in p53-null cells miR-24 still induced cell cycle arrest without the involvement of p21. We show that miR-24 regulates p53-independent cellular proliferation by regulating an S-phase enzyme, dihydrofolate reductase (DHFR) a target of the chemotherapeutic drug methotrexate (MTX). Of interest, we found that a miR-24 target site polymorphism in DHFR 3' UTR that results in loss of miR-24-function and high DHFR levels in the cell imparts a growth advantage to immortalized cells and induces neoplastic transformation. Of clinical significance, we found that miR-24 is deregulated in human colorectal cancer tumors and a subset of tumors has reduced levels of miR-24. A novel function for miR-24 as a p53-independent cell cycle inhibitory miRNA is proposed.	[Mishra, Prasun J.; Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Mishra, Prasun J.; Mishra, Pravin J.; Banerjee, Debabrata; Bertino, Joseph R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med & Pharmacol, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Song, Bo; Wang, Yuan; Ju, Jingfang] SUNY Stony Brook, Dept Pathol, Med Ctr, Translat Res Lab, Stony Brook, NY 11794 USA; [Humeniuk, Rita] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mishra, PJ (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	bertinoj@umdnj.edu		Ju, Jingfang/0000-0002-4821-7458	Center of Cancer Research, NCI [CA0810]; NIH [C5IL039280, CA114043]; NATIONAL CANCER INSTITUTE [ZIABC008756, R21CA114043] Funding Source: NIH RePORTER	Center of Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the Center of Cancer Research, NCI, NIH; in part by NCI Cancer Research Training Award C5IL039280 ( to PJM); in part by Stony-Brook Translational Research Laboratory Start-up fund and NIH CA114043 ( to JJ); and in part by NCI Grant CA0810 ( to JRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; DANGERFIELD B, 2000, P AN M AM SOC CLIN, V19, P2000; FUKUDA Y, 2005, NUCL ACIDS S SER, V49, P341, DOI DOI 10.1093/NASS/49.1.341; Gammell P, 2007, J BIOTECHNOL, V130, P213, DOI 10.1016/j.jbiotec.2007.04.020; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI Y, 1994, ONCOGENE, V9, P2261; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCKEHUHLE C, 1994, CARCINOGENESIS, V15, P695, DOI 10.1093/carcin/15.4.695; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MISHRA PJ, 2008, P AM ASS CAN RES APR, P2458; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Mishra PJ, 2009, PERS MED, V6, P119, DOI 10.2217/17410541.6.2.119; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; MOUSSEAU M, 1993, EUR J CANCER, V29A, P753, DOI 10.1016/S0959-8049(05)80361-2; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Scanlon K J, 1989, Cancer Commun, V1, P269; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; TRIMBLE JJ, 1988, SCIENCE, V239, P1145, DOI 10.1126/science.2830673; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Xi Y, 2008, ONCOL REP, V19, P257	39	94	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8445	10.1371/journal.pone.0008445	http://dx.doi.org/10.1371/journal.pone.0008445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041160	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000010
J	Chen, XJ; Koh, E; Yoder, M; Gumbiner, BM				Chen, Xuejun; Koh, Eunjin; Yoder, Michael; Gumbiner, Barry M.			A Protocadherin-Cadherin-FLRT3 Complex Controls Cell Adhesion and Morphogenesis	PLOS ONE			English	Article							E-CADHERIN; PARAXIAL PROTOCADHERIN; TISSUE RECONSTRUCTION; DISSOCIATED CELLS; MECHANISM; ENDOCYTOSIS; PROTEINS; INVOLVEMENT; NEURONS; RND1	Background: Paraxial protocadherin (PAPC) and fibronectin leucine-rich domain transmembrane protein-3 (FLRT3) are induced by TGF beta signaling in Xenopus embryos and both regulate morphogenesis by inhibiting C-cadherin mediated cell adhesion. Principal Findings: We have investigated the functional and physical relationships between PAPC, FLRT3, and C-cadherin. Although neither PAPC nor FLRT3 are required for each other to regulate C-cadherin adhesion, they do interact functionally and physically, and they form a complex with cadherins. By itself PAPC reduces cell adhesion physiologically to induce cell sorting, while FLRT3 disrupts adhesion excessively to cause cell dissociation. However, when expressed together PAPC limits the cell dissociating and tissue disrupting activity of FLRT3 to make it effective in physiological cell sorting. PAPC counteracts FLRT3 function by inhibiting the recruitment of the GTPase RND1 to the FLRT3 cytoplasmic domain. Conclusions/Significance: PAPC and FLRT3 form a functional complex with cadherins and PAPC functions as a molecular "governor'' to maintain FLRT3 activity at the optimal level for physiological regulation of C-cadherin adhesion, cell sorting, and morphogenesis.	[Chen, Xuejun; Koh, Eunjin; Yoder, Michael; Gumbiner, Barry M.] Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA USA	University of Virginia	Chen, XJ (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	gumbiner@virginia.edu		Koh, Eunjin/0000-0001-8967-6266	US National Institutes of Health [R01GM52717]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01GM52717 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Chen X, 2007, J BIOL CHEM, V282, P32128, DOI 10.1074/jbc.M705337200; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1577, DOI 10.1073/pnas.48.9.1577; STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1769, DOI 10.1073/pnas.48.10.1769; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020	27	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8411	10.1371/journal.pone.0008411	http://dx.doi.org/10.1371/journal.pone.0008411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027292	Green Submitted, Green Published, gold			2022-12-27	WOS:000272998000016
J	Namas, R; Ghuma, A; Torres, A; Polanco, P; Gomez, H; Barclay, D; Gordon, L; Zenker, S; Kim, HK; Hermus, L; Zamora, R; Rosengart, MR; Clermont, G; Peitzman, A; Billiar, TR; Ochoa, J; Pinsky, MR; Puyana, JC; Vodovotz, Y				Namas, Rajaie; Ghuma, Ali; Torres, Andres; Polanco, Patricio; Gomez, Hernando; Barclay, Derek; Gordon, Lisa; Zenker, Sven; Kim, Hyung Kook; Hermus, Linda; Zamora, Ruben; Rosengart, Matthew R.; Clermont, Gilles; Peitzman, Andrew; Billiar, Timothy R.; Ochoa, Juan; Pinsky, Michael R.; Puyana, Juan Carlos; Vodovotz, Yoram			An Adequately Robust Early TNF-alpha Response Is a Hallmark of Survival Following Trauma/Hemorrhage	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELL DYSFUNCTION; HEMORRHAGIC-SHOCK; INFLAMMATORY RESPONSE; SEVERE SEPSIS; UP-REGULATION; NITRIC-OXIDE; TRAUMA; INTERLEUKIN-10; INJURY	Background: Trauma/hemorrhagic shock (T/HS) results in cytokine-mediated acute inflammation that is generally considered detrimental. Methodology/Principal Findings: Paradoxically, plasma levels of the early inflammatory cytokine TNF-alpha (but not IL-6, IL-10, or NO2-/NO3-) were significantly elevated within 6 h post-admission in 19 human trauma survivors vs. 4 non-survivors. Moreover, plasma TNF-alpha was inversely correlated with Marshall Score, an index of organ dysfunction, both in the 23 patients taken together and in the survivor cohort. Accordingly, we hypothesized that if an early, robust pro-inflammatory response were to be a marker of an appropriate response to injury, then individuals exhibiting such a response would be predisposed to survive. We tested this hypothesis in swine subjected to various experimental paradigms of T/HS. Twenty-three anesthetized pigs were subjected to T/HS (12 HS-only and 11 HS + Thoracotomy; mean arterial pressure of 30 mmHg for 45-90 min) along with surgery-only controls. Plasma obtained at pre-surgery, baseline post-surgery, beginning of HS, and every 15 min thereafter until 75 min (in the HS only group) or 90 min (in the HS + Thoracotomy group) was assayed for TNF-alpha, IL-6, IL-10, and NO2-/NO3-. Mean post-surgery +/- HS TNF-alpha levels were significantly higher in the survivors vs. nonsurvivors, while non-survivors exhibited no measurable change in TNF-alpha levels over the same interval. Conclusions/Significance: Contrary to the current dogma, survival in the setting of severe, acute T/HS appears to be associated with an immediate increase in serum TNF-alpha. It is currently unclear if this response was the cause of this protection, a marker of survival, or both. This abstract won a Young Investigator Travel Award at the SHOCK 2008 meeting in Cologne, Germany.	[Namas, Rajaie; Ghuma, Ali; Torres, Andres; Polanco, Patricio; Gomez, Hernando; Barclay, Derek; Gordon, Lisa; Hermus, Linda; Zamora, Ruben; Rosengart, Matthew R.; Peitzman, Andrew; Billiar, Timothy R.; Ochoa, Juan; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Zenker, Sven; Kim, Hyung Kook; Clermont, Gilles; Pinsky, Michael R.; Puyana, Juan Carlos] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Zenker, Sven; Clermont, Gilles; Billiar, Timothy R.; Ochoa, Juan; Pinsky, Michael R.; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Namas, R (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Zenker, Sven/B-1222-2008; Namas, Rajaie/U-2206-2019; Gomez, Hernando/ABB-4589-2020	Zenker, Sven/0000-0003-0774-0725; Namas, Rajaie/0000-0003-0353-895X	National Institutes of Health [RO1-HL-076157, R33-HL-089082, RO1-GM-065914, P50-GM-53789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089082, R01HL076157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065914, P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants RO1-HL-076157, R33-HL-089082, R33-HL-089082, RO1-GM-065914, and P50-GM-53789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, CRIT CARE MED, V23, P1319, DOI 10.1097/00003246-199508000-00004; Angele MK, 1998, SURGERY, V124, P394, DOI 10.1016/S0039-6060(98)70146-1; AYALA A, 1991, AM J PHYSIOL, V260, pR167, DOI 10.1152/ajpregu.1991.260.1.R167; AYALA A, 1994, ARCH SURG-CHICAGO, V129, P1172; Batistaki C, 2008, VASC PHARMACOL, V48, P85, DOI 10.1016/j.vph.2007.12.003; BEMELMANS MHA, 1993, BRIT J SURG, V80, P1055, DOI 10.1002/bjs.1800800845; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Bogdan C, 2000, PROG INFLAM RES, P217; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; CHAUDRY IH, 1990, AM J PHYSIOL, V259, pR663, DOI 10.1152/ajpregu.1990.259.4.R663; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cocchi MN, 2007, EMERG MED CLIN N AM, V25, P623, DOI 10.1016/j.emc.2007.06.001; Collins J, 2001, SURG RES, P949; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; DEMARIA EJ, 1993, J TRAUMA, V35, P720, DOI 10.1097/00005373-199311000-00012; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dirriopoulou I, 2008, CYTOKINE, V41, P263, DOI 10.1016/j.cyto.2007.11.019; ENDO S, 1994, CRIT CARE MED, V22, P949, DOI 10.1097/00003246-199406000-00012; Engles RE, 1997, J SURG RES, V69, P425, DOI 10.1006/jsre.1997.5109; FOEX BA, 1993, INJURY, V24, P373, DOI 10.1016/0020-1383(93)90098-Q; Foex BA, 1999, BRIT MED BULL, V55, P726, DOI 10.1258/0007142991902745; Fruchterman TM, 1998, SHOCK, V10, P417, DOI 10.1097/00024382-199812000-00007; Gebhard F, 1998, SHOCK, V10, P237, DOI 10.1097/00024382-199810000-00002; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Godin PJ, 1996, CRIT CARE MED, V24, P1117, DOI 10.1097/00003246-199607000-00009; Huber TS, 2000, SHOCK, V13, P425, DOI 10.1097/00024382-200006000-00002; Jarrar D, 1999, INT J MOL MED, V4, P575; Karakozis S, 2000, J SURG RES, V90, P109, DOI 10.1006/jsre.2000.5860; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Marcu AC, 2007, J TRAUMA, V63, P662, DOI 10.1097/TA.0b013e31802e70d9; Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MARZI I, 1995, SHOCK, V3, P27, DOI 10.1097/00024382-199503010-00004; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; Mimasaka S, 2001, TOHOKU J EXP MED, V193, P319, DOI 10.1620/tjem.193.319; Molina PE, 2001, NEUROIMMUNOMODULAT, V9, P125, DOI 10.1159/000049016; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Pape HC, 2007, INJURY, V38, P1358, DOI 10.1016/j.injury.2007.09.026; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rivers EP, 2004, CRIT CARE MED, V32, P314, DOI 10.1097/01.CCM.0000104937.09370.53; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; ROGY MA, 1995, J EXP MED, V181, P2289, DOI 10.1084/jem.181.6.2289; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Schneider CP, 2004, BBA-MOL BASIS DIS, V1689, P22, DOI 10.1016/j.bbadis.2004.01.003; Schwacha MG, 2001, AM J PHYSIOL-CELL PH, V281, pC1180, DOI 10.1152/ajpcell.2001.281.4.C1180; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; Smith RM, 1998, J ROY SOC MED, V91, P417, DOI 10.1177/014107689809100805; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Toth B, 2004, J APPL PHYSIOL, V97, P2184, DOI 10.1152/japplphysiol.00499.2004; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Wang WY, 1998, J SURG RES, V79, P39, DOI 10.1006/jsre.1998.5385; Waxman K, 1996, New Horiz, V4, P153; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; WU HP, 2009, SERIAL CYTOKINE LEVE; YOUN YK, 1992, WORLD J SURG, V16, P30, DOI 10.1007/BF02067111; ZINGARELLI B, 1994, AM J PHYSIOL, V266, pH1512, DOI 10.1152/ajpheart.1994.266.4.H1512	80	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8406	10.1371/journal.pone.0008406	http://dx.doi.org/10.1371/journal.pone.0008406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027315	Green Published, gold, Green Accepted			2022-12-27	WOS:000272998000011
J	Steketee, RW; Eisele, TP				Steketee, Richard W.; Eisele, Thomas P.			Is the Scale Up of Malaria Intervention Coverage Also Achieving Equity?	PLOS ONE			English	Article							INSECTICIDE-TREATED BEDNETS; MEASLES VACCINATION; DELIVERY-SYSTEMS; CHILD-MORTALITY; AFRICA; NETS; MORBIDITY; BURDEN; PRINCIPLES; TANZANIA	Background and Methods: Malaria in Africa is most severe in young children and pregnant women, particularly in rural and poor households. In many countries, malaria intervention coverage rates have increased as a result of scale up; but this may mask limited coverage in these highest-risk populations. Reports were reviewed from nationally representative surveys in African malaria-endemic countries from 2006 through 2008 to understand how reported intervention coverage rates reflect access by the most at-risk populations. Results: Reports were available from 27 Demographic and Health Surveys (DHSs), Multiple Indicator Cluster Surveys (MICSs), and Malaria Indicator Surveys (MISs) during this interval with data on household intervention coverage by urban or rural setting, wealth quintile, and sex. Household ownership of insecticide-treated mosquito nets (ITNs) varied from 5% to greater than 60%, and was equitable by urban/rural and wealth quintile status among 13 (52%) of 25 countries. Malaria treatment rates for febrile children under five years of age varied from less than 10% to greater than 70%, and while equitable coverage was achieved in 8 (30%) of 27 countries, rates were generally higher in urban and richest quintile households. Use of intermittent preventive treatment in pregnant women varied from 2% to more than 60%, and again tended to be higher in urban and richest quintile households. Across all countries, there were no significant male/female inequalities seen for children sleeping under ITNs or receiving antimalarial treatment for febrile illness. Parasitemia and anemia rates from eight national surveys showed predominance in poor and rural populations. Conclusions/Significance: Recent efforts to scale up malaria intervention coverage have achieved equity in some countries (especially with ITNs), but delivery methods in other countries are not addressing the most at-risk populations. As countries seek universal malaria intervention coverage, their delivery systems must reach the rural and poor populations; this is not a small task, but it has been achieved in some countries.	[Steketee, Richard W.] MACEPA PATH, Ferney Voltaire, France; [Eisele, Thomas P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA USA	Tulane University	Steketee, RW (corresponding author), MACEPA PATH, Ferney Voltaire, France.	rsteketee@path.org	Eisele, Thom/AAE-8958-2020		Bill and Melinda Gates Foundation; Department of International Health and Development, Tulane School of Public Health and Tropical Medicine	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department of International Health and Development, Tulane School of Public Health and Tropical Medicine	RWS is funded by the Malaria Control and Evaluation Partnership in Africa program at PATH through a grant from the Bill and Melinda Gates Foundation. TPE is funded by the Department of International Health and Development, Tulane School of Public Health and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLOB MAL ACT PLAN MA; BINKA FN, 1994, T ROY SOC TROP MED H, V88, P381, DOI 10.1016/0035-9203(94)90391-3; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; ETTLING M, 1994, TROP MED PARASITOL, V45, P74; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gates B, 2007, MALARIA FORUM KEYNOT; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Monasch R, 2004, AM J TROP MED HYG, V71, P232, DOI 10.4269/ajtmh.2004.71.232; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; RBM, 2008, GUID COR POP BAS IND; RBM, 2005, ROLL BACK MAL GLOB S; Rutstein S. O., 2004, DHS WEALTH INDEX; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steketee RW, 2008, AM J TROP MED HYG, V79, P45, DOI 10.4269/ajtmh.2008.79.45; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; *UN, 2008, WORLD MAL DAY NEW GO; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN	30	36	36	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8409	10.1371/journal.pone.0008409	http://dx.doi.org/10.1371/journal.pone.0008409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027289	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998000014
J	Aronovich, A; Tchorsh, D; Shezen, E; Rosen, C; Klionsky, Y; Cohen, S; Tal, O; Martinowitz, U; Katchman, H; Eventov-Friedman, S; Amariglio, N; Jacob-Hirsch, J; Rechavi, G; Reisner, Y				Aronovich, Anna; Tchorsh, Dalit; Shezen, Elias; Rosen, Chava; Klionsky, Yael; Cohen, Sivan; Tal, Orna; Martinowitz, Uri; Katchman, Helena; Eventov-Friedman, Smadar; Amariglio, Ninette; Jacob-Hirsch, Jasmine; Rechavi, Gideon; Reisner, Yair			Enhancement of Pig Embryonic Implants in Factor VIII KO Mice: A Novel Role for the Coagulation Cascade in Organ Size Control	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; STEM-CELL NICHE; HEMATOPOIETIC STEM; THROMBIN-CLEAVAGE; OSTEOPONTIN; GROWTH; DIFFERENTIATION; ANGIOGENESIS; HEMOSTASIS; COMPONENT	Very little is known about the mechanisms that contribute to organ size differences between species. In the present study, we used a mouse model of embryonic pig tissue implantation to define the role of host Factor VIII in controlling the final size attained by the implant. We show here that pig embryonic spleen, pancreas, and liver all grow to an increased size in mice that are deficient in the Factor VIII clotting cascade. Similar results were obtained using the transplantation model after treatment with the low molecular weight heparin derivative Clexane which markedly enhanced transplant size. Likewise, enhanced size was found upon treatment with the direct thrombin inhibitor Dabigatran, suggesting that organ size regulation might be mediated by thrombin, downstream of Factor VIII. Considering that thrombin was shown to mediate various functions unrelated to blood clotting, either directly by cleavage of protease-activated receptors (PARs) or indirectly by cleaving osteopontin (OPN) on stroma cells, the role of PAR1 and PAR4 antagonists as well as treatment with cleaved form of OPN (tcOPN) were tested. While the former was not found to have an impact on overgrowth of embryonic pig spleen implants, marked reduction of size was noted upon treatment with the (tcOPN). Collectively, our surprising set of observations suggests that factors of the coagulation cascade have a novel role in organ size control.	[Aronovich, Anna; Tchorsh, Dalit; Shezen, Elias; Rosen, Chava; Klionsky, Yael; Cohen, Sivan; Tal, Orna; Katchman, Helena; Eventov-Friedman, Smadar; Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Martinowitz, Uri] Sheba Med Ctr, Israel Natl Hemophilia Ctr, Tel Hashomer, Israel; [Amariglio, Ninette; Jacob-Hirsch, Jasmine; Rechavi, Gideon] Sheba Med Ctr, Canc Res Ctr, Tel Hashomer, Israel	Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Aronovich, A (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	yair.reisner@weizmann.ac.il	Reisner, Yair/AAA-4772-2019	Reisner, Yair/0000-0002-3354-6945	Mrs. Erica Drake and the Gabriella Rich Center	Mrs. Erica Drake and the Gabriella Rich Center	This work was supported by Mrs. Erica Drake and the Gabriella Rich Center for Transplantation Biology Research. The funding supported mice and other supplies. There was no other funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Ahn HS, 2003, CURR PHARM DESIGN, V9, P2349, DOI 10.2174/1381612033453884; Aronovich A, 2006, P NATL ACAD SCI USA, V103, P19075, DOI 10.1073/pnas.0607012103; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; DITTMER JE, 1974, AM J ANAT, V141, P155, DOI 10.1002/aja.1001410112; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Eventov-Friedman S, 2005, P NATL ACAD SCI USA, V102, P2928, DOI 10.1073/pnas.0500177102; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Landis RC, 2007, HEMATOL ONCOL CLIN N, V21, P103, DOI 10.1016/j.hoc.2006.11.005; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; METCALF D, 1963, AUST J EXP BIOL MED, V41, P437, DOI 10.1038/icb.1963.64; METCALF D, 1964, TRANSPLANTATION, V2, P387, DOI 10.1097/00007890-196405000-00008; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1995, ANN NY ACAD SCI, V760, P83, DOI 10.1111/j.1749-6632.1995.tb44622.x; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Slofstra SH, 2007, BLOOD, V110, P3176, DOI 10.1182/blood-2007-02-075440; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8362	10.1371/journal.pone.0008362	http://dx.doi.org/10.1371/journal.pone.0008362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027227	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100010
J	Orozco-Barrios, CE; Battaglia-Hsu, SF; Arango-Rodriguez, ML; Ayala-Davila, J; Chery, C; Alberto, JM; Schroeder, H; Daval, JL; Martinez-Fong, D; Gueant, JL				Enrique Orozco-Barrios, Carlos; Battaglia-Hsu, Shyue-Fang; Ligia Arango-Rodriguez, Martha; Ayala-Davila, Jose; Chery, Celine; Alberto, Jean-Marc; Schroeder, Henry; Daval, Jean-Luc; Martinez-Fong, Daniel; Gueant, Jean-Louis			Vitamin B12-Impaired Metabolism Produces Apoptosis and Parkinson Phenotype in Rats Expressing the Transcobalamin-Oleosin Chimera in Substantia Nigra	PLOS ONE			English	Article							HOMOCYSTEINE METABOLISM; COGNITIVE IMPAIRMENT; NEUROTENSIN POLYPLEX; PLASMA HOMOCYSTEINE; LIPID-PEROXIDATION; GENE-TRANSFER; IN-VITRO; DEFICIENCY; LEVODOPA; DNA	Background: Vitamin B12 is indispensable for proper brain functioning and cytosolic synthesis of S-adenosylmethionine. Whether its deficiency produces effects on viability and apoptosis of neurons remains unknown. There is a particular interest in investigating these effects in Parkinson disease where Levodopa treatment is known to increase the consumption of S-adenosylmethionine. To cause deprivation of vitamin B12, we have recently developed a cell model that produces decreased synthesis of S-adenosylmethionine by anchoring transcobalamin (TCII) to the reticulum through its fusion with Oleosin (OLEO). Methodology: Gene constructs including transcobalamin-oleosin (TCII-OLEO) and control constructs, green fluorescent protein-transcobalamin-oleosin (GFP-TCII-OLEO), oleosin-transcobalamin (OLEO-TCII), TCII and OLEO were used for expression in N1E-115 cells (mouse neuroblastoma) and in substantia nigra of adult rats, using a targeted transfection with a Neurotensin polyplex system. We studied the viability and the apoptosis in the transfected cells and targeted tissue. The turning behavior was evaluated in the rats transfected with the different plasmids. Principal Findings: The transfection of N1E-115 cells by the TCII-OLEO-expressing plasmid significantly affected cell viability and increased immunoreactivity of cleaved Caspase-3. No change in propidium iodide uptake (used as a necrosis marker) was observed. The transfected rats lost neurons immunoreactive to tyrosine hydroxylase. The expression of TCII-OLEO was observed in cells immunoreactive to tyrosine hydroxylase of the substantia nigra, with a superimposed expression of cleaved Caspase-3. These cellular and tissular effects were not observed with the control plasmids. Rats transfected with TCII-OLEO expressing plasmid presented with a significantly higher number of turns, compared with those transfected with the other plasmids. Conclusions/Significance: In conclusion, the TCII-OLEO transfection was responsible for apoptosis in N1E-115 cells and rat substantia nigra and for Parkinson-like phenotype. This suggests evaluating whether vitamin B12 deficit could aggravate the PD in patients under Levodopa therapy by impairing S-adenosylmethionine synthesis in substantia nigra.	[Enrique Orozco-Barrios, Carlos; Ligia Arango-Rodriguez, Martha; Ayala-Davila, Jose; Martinez-Fong, Daniel] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico; [Enrique Orozco-Barrios, Carlos; Battaglia-Hsu, Shyue-Fang; Chery, Celine; Alberto, Jean-Marc; Daval, Jean-Luc; Gueant, Jean-Louis] Nancy Univ, Fac Med, INSERM, U954, Nancy, France; [Schroeder, Henry] Nancy Univ, INRA, URAFPA, Nancy, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; INRAE; Universite de Lorraine	Orozco-Barrios, CE (corresponding author), Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico.	jean-louis.gueant@medecine.uhp-nancy.fr	Daval, Jean-Luc/G-6502-2014; Martinez, Isabelle/K-7178-2012	Ayala-Davila, Jose/0000-0002-1865-3662; Orozco-Barrios, Carlos E./0000-0002-3989-1205	French national agency for research; CPER (contrat de projets etat-region) of region of Lorraine (France); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV, Mexico)	French national agency for research(French National Research Agency (ANR)); CPER (contrat de projets etat-region) of region of Lorraine (France); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV, Mexico)	This study was supported by the French national agency for research (ANR, France, programme de recherche en nutrition et alimentation, project "Nutrivigene"), the CPER (contrat de projets etat-region) of region of Lorraine (France) and Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Martinez V, 2006, NEUROSCIENCE, V143, P477, DOI 10.1016/j.neuroscience.2006.08.033; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Blaise S, 2005, PEDIATR RES, V57, P777, DOI 10.1203/01.PDR.0000161406.19231.98; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Brunaud L, 2003, DIGESTION, V68, P133, DOI 10.1159/000075307; Buccellato FR, 1999, FASEB J, V13, P297, DOI 10.1096/fasebj.13.2.297; Capuano F, 2007, BIOTECHNOL ADV, V25, P203, DOI 10.1016/j.biotechadv.2006.11.006; Cheng H, 1997, EXP NEUROL, V145, P580, DOI 10.1006/exnr.1997.6466; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Chumnantana R, 2005, BBA-GEN SUBJECTS, V1722, P84, DOI 10.1016/j.bbagen.2004.11.013; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; de Lau LML, 2006, NEUROLOGY, V67, P315, DOI 10.1212/01.wnl.0000225050.57553.6d; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; GHARIB A, 1983, J NEUROCHEM, V40, P1110, DOI 10.1111/j.1471-4159.1983.tb08100.x; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Ho PI, 2001, J NEUROCHEM, V78, P249, DOI 10.1046/j.1471-4159.2001.00384.x; HSUBATTAGLIA SF, 2009, P NATL ACAD IN PRESS; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; Kannan K, 2004, FREE RADICAL BIO MED, V36, P423, DOI 10.1016/j.freeradbiomed.2003.09.012; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kuhn W, 1998, EUR NEUROL, V40, P225, DOI 10.1159/000007984; Lamberti P, 2005, MOVEMENT DISORD, V20, P69, DOI 10.1002/mds.20261; Mahfouz MM, 2004, INT J BIOCHEM CELL B, V36, P1919, DOI 10.1016/j.biocel.2004.01.028; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; McLean GR, 1997, BLOOD, V89, P235, DOI 10.1182/blood.V89.1.235.235_235_242; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miller JW, 1997, CLIN NEUROPHARMACOL, V20, P55, DOI 10.1097/00002826-199702000-00007; Muller T, 1999, LANCET, V354, P126, DOI 10.1016/S0140-6736(99)01660-8; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Pons L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006325; Raffo E, 2009, EXP NEUROL, V219, P414, DOI 10.1016/j.expneurol.2009.06.014; Rogers JD, 2003, ARCH NEUROL-CHICAGO, V60, P59, DOI 10.1001/archneur.60.1.59; ROTHENBERG SP, 1995, BAILLIERE CLIN HAEM, V8, P499, DOI 10.1016/S0950-3536(05)80218-5; Rubio-Zapata HA, 2009, CANCER GENE THER, V16, P573, DOI 10.1038/cgt.2009.1; Russell JSR, 1900, BRAIN, V23, P39, DOI 10.1093/brain/23.1.39; Scalabrino G, 2004, ANN NEUROL, V56, P886, DOI 10.1002/ana.20325; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Smith AD, 2009, AM J CLIN NUTR, V89, p707S, DOI 10.3945/ajcn.2008.26947D; Spada RS, 2007, CLIN CHEM LAB MED, V45, P136, DOI 10.1515/CCLM.2007.065; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Tan EK, 2005, AM J MED GENET B, V137B, P1, DOI 10.1002/ajmg.b.30198; Todorovic Z, 2006, J NEUROL SCI, V248, P56, DOI 10.1016/j.jns.2006.05.040; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Yasui K, 2003, ACTA NEUROL SCAND, V108, P66, DOI 10.1034/j.1600-0404.2003.00135.x	46	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8268	10.1371/journal.pone.0008268	http://dx.doi.org/10.1371/journal.pone.0008268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027219	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100002
J	Peleg-Grossman, S; Golani, Y; Kaye, Y; Melamed-Book, N; Levine, A				Peleg-Grossman, Smadar; Golani, Yael; Kaye, Yuval; Melamed-Book, Naomi; Levine, Alex			NPR1 Protein Regulates Pathogenic and Symbiotic Interactions between Rhizobium and Legumes and Non-Legumes	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PLANT-DISEASE RESISTANCE; OXYGEN SPECIES PRODUCTION; SALICYLIC-ACID; MEDICAGO-TRUNCATULA; REACTIVE OXYGEN; OXIDATIVE BURST; HYPERSENSITIVE RESPONSE; CELL-DEATH; GENE	Background: Legumes are unique in their ability to establish symbiotic interaction with rhizobacteria from Rhizobium genus, which provide them with available nitrogen. Nodulation factors (NFs) produced by Rhizobium initiate legume root hair deformation and curling that entrap the bacteria, and allow it to grow inside the plant. In contrast, legumes and non-legumes activate defense responses when inoculated with pathogenic bacteria. One major defense pathway is mediated by salicylic acid (SA). SA is sensed and transduced to downstream defense components by a redox-regulated protein called NPR1. Methodology/Principal Findings: We used Arabidopsis mutants in SA defense pathway to test the role of NPR1 in symbiotic interactions. Inoculation of Sinorhizobium meliloti or purified NF on Medicago truncatula or nim1/npr1 A. thaliana mutants induced root hair deformation and transcription of early and late nodulins. Application of S. meliloti or NF on M. truncatula or A. thaliana roots also induced a strong oxidative burst that lasted much longer than in plants inoculated with pathogenic or mutualistic bacteria. Transient overexpression of NPR1 in M. truncatula suppressed root hair curling, while inhibition of NPR1 expression by RNAi accelerated curling. Conclusions/Significance: We show that, while NPR1 has a positive effect on pathogen resistance, it has a negative effect on symbiotic interactions, by inhibiting root hair deformation and nodulin expression. Our results also show that basic plant responses to Rhizobium inoculation are conserved in legumes and non-legumes.	[Peleg-Grossman, Smadar; Golani, Yael; Kaye, Yuval; Melamed-Book, Naomi; Levine, Alex] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel	Hebrew University of Jerusalem	Peleg-Grossman, S (corresponding author), Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel.	alexl@cc.huji.ac.il	Levine, Alex/A-6867-2008		Israel Science Foundation (ISF); Canadian Friends of the Hebrew University	Israel Science Foundation (ISF)(Israel Science Foundation); Canadian Friends of the Hebrew University	This work was supported in part by the Israel Science Foundation (ISF). YK and YG were supported by the Canadian Friends of the Hebrew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; Brewin NJ, 2004, CRIT REV PLANT SCI, V23, P293, DOI 10.1080/07352680490480734; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Catoira R, 2001, DEVELOPMENT, V128, P1507; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; DAZZO FB, 1984, APPL ENVIRON MICROB, V48, P1140, DOI 10.1128/AEM.48.6.1140-1150.1984; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; EGELHOFF TT, 1985, J BACTERIOL, V164, P591, DOI 10.1128/JB.164.2.591-599.1985; Esseling JJ, 2004, PLANT CELL, V16, P933, DOI 10.1105/tpc.019653; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; GODIARD L, 1994, CURR OPIN GENET DEV, V4, P662, DOI 10.1016/0959-437X(94)90132-M; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Hepworth SR, 2005, PLANT CELL, V17, P1434, DOI 10.1105/tpc.104.030536; Hirsch AM, 1997, PLANT SOIL, V194, P171, DOI 10.1023/A:1004292020902; Jamet A, 2007, J BACTERIOL, V189, P8741, DOI 10.1128/JB.01130-07; Kuppusamy KT, 2004, PLANT PHYSIOL, V136, P3682, DOI 10.1104/pp.104.045575; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levy M, 2008, MOL PLANT PATHOL, V9, P719, DOI [10.1111/j.1364-3703.2008.00483.x, 10.1111/J.1364-3703.2008.00483.X]; Limpens E, 2003, CURR OPIN PLANT BIOL, V6, P343, DOI 10.1016/S1369-5266(03)00068-2; Liu GS, 2005, PLANT J, V41, P304, DOI 10.1111/j.1365-313X.2004.02296.x; Lohar DP, 2007, NEW PHYTOL, V173, P39, DOI 10.1111/j.1469-8137.2006.01901.x; Martinez-Abarca F, 1998, MOL PLANT MICROBE IN, V11, P153, DOI 10.1094/MPMI.1998.11.2.153; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Peleg-Grossman S, 2007, J EXP BOT, V58, P1637, DOI 10.1093/jxb/erm013; Peretz Y, 2007, PLANT PHYSIOL, V145, P1251, DOI 10.1104/pp.107.108217; PICHON M, 1992, PLANT CELL, V4, P1199, DOI 10.1105/tpc.4.10.1199; Pilotti M, 2008, TREE GENET GENOMES, V4, P49, DOI 10.1007/s11295-007-0087-z; PISTOLE TG, 1981, ANNU REV MICROBIOL, V35, P85, DOI 10.1146/annurev.mi.35.100181.000505; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shapiro AD, 2001, PLANT PHYSIOL, V127, P1089, DOI 10.1104/pp.010096; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Silverstein KAT, 2006, CURR OPIN PLANT BIOL, V9, P142, DOI 10.1016/j.pbi.2006.01.002; SMIT G, 1989, J BACTERIOL, V171, P4054, DOI 10.1128/jb.171.7.4054-4062.1989; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tirajoh A, 2005, J EXP BOT, V56, P713, DOI 10.1093/jxb/eri038; van Spronsen PC, 2003, MOL PLANT MICROBE IN, V16, P83, DOI 10.1094/MPMI.2003.16.1.83; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; Vernoud V, 1999, MOL PLANT MICROBE IN, V12, P604, DOI 10.1094/MPMI.1999.12.7.604; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Wais RJ, 2002, PLANT PHYSIOL, V129, P211, DOI 10.1104/pp.010690; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523	59	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8399	10.1371/journal.pone.0008399	http://dx.doi.org/10.1371/journal.pone.0008399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027302	Green Submitted, Green Published, gold			2022-12-27	WOS:000272940100025
J	Hashem, AM; Flaman, AS; Farnsworth, A; Brown, EG; Van Domselaar, G; He, RT; Li, XG				Hashem, Anwar M.; Flaman, Anathea S.; Farnsworth, Aaron; Brown, Earl G.; Van Domselaar, Gary; He, Runtao; Li, Xuguang			Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases	PLOS ONE			English	Article							IN-VITRO; VACCINE EFFECTIVENESS; PANDEMIC INFLUENZA; EVANS BLUE; REPLICATION; ACTIVATION; INFECTION; EMERGENCE; TRANSFECTION; SENSITIVITY	Background: Influenza viruses cause serious infections that can be prevented or treated using vaccines or antiviral agents, respectively. While vaccines are effective, they have a number of limitations, and influenza strains resistant to currently available anti-influenza drugs are increasingly isolated. This necessitates the exploration of novel anti-influenza therapies. Methodology/Principal Findings: We investigated the potential of aurintricarboxylic acid (ATA), a potent inhibitor of nucleic acid processing enzymes, to protect Madin-Darby canine kidney cells from influenza infection. We found, by neutral red assay, that ATA was protective, and by RT-PCR and ELISA, respectively, confirmed that ATA reduced viral replication and release. Furthermore, while pre-treating cells with ATA failed to inhibit viral replication, pre-incubation of virus with ATA effectively reduced viral titers, suggesting that ATA may elicit its inhibitory effects by directly interacting with the virus. Electron microscopy revealed that ATA induced viral aggregation at the cell surface, prompting us to determine if ATA could inhibit neuraminidase. ATA was found to compromise the activities of virus-derived and recombinant neuraminidase. Moreover, an oseltamivir-resistant H1N1 strain with H274Y was also found to be sensitive to ATA. Finally, we observed additive protective value when infected cells were simultaneously treated with ATA and amantadine hydrochloride, an anti-influenza drug that inhibits M2-ion channels of influenza A virus. Conclusions/Significance: Collectively, these data suggest that ATA is a potent anti-influenza agent by directly inhibiting the neuraminidase and could be a more effective antiviral compound when used in combination with amantadine hydrochloride.	[Hashem, Anwar M.; Flaman, Anathea S.; Farnsworth, Aaron; Li, Xuguang] Hlth Canada, Ctr Biol Res Biol & Genet Therapies Directorate, HPFB, Ottawa, ON K1A 0L2, Canada; [Van Domselaar, Gary; He, Runtao] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hashem, Anwar M.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Hashem, Anwar M.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Emerging Pathogens Res Ctr, Ottawa, ON, Canada	Health Canada; Public Health Agency of Canada; University of Ottawa; University of Ottawa	Hashem, AM (corresponding author), Hlth Canada, Ctr Biol Res Biol & Genet Therapies Directorate, HPFB, Ottawa, ON K1A 0L2, Canada.	Sean_Li@hc-sc.gc.ca	Hashem, Anwar M/B-2301-2017; Hashem, Anwar/E-9411-2011	Hashem, Anwar M/0000-0002-8471-7011; 	Canadian Regulatory Strategy for Biotechnology; CIHR team grant for Influenza Pandemic Preparedness [TPA 90188]	Canadian Regulatory Strategy for Biotechnology; CIHR team grant for Influenza Pandemic Preparedness(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Regulatory Strategy for Biotechnology (RH and XL) and the CIHR team grant for Influenza Pandemic Preparedness number: TPA 90188 for EGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Aymard M, 2003, Dev Biol (Basel), V115, P75; BALZARINI J, 1986, BIOCHEM BIOPH RES CO, V136, P64, DOI 10.1016/0006-291X(86)90877-6; Banzhoff A, 2008, INFLUENZA OTHER RESP, V2, P243, DOI 10.1111/j.1750-2659.2008.00059.x; Beery R, 2001, ENDOCRINOLOGY, V142, P3098, DOI 10.1210/en.142.7.3098; Belshe RB, 2009, NEW ENGL J MED, V360, P2667, DOI 10.1056/NEJMe0903995; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P8; Chen CW, 2002, BRIT J PHARMACOL, V137, P1011, DOI 10.1038/sj.bjp.0704955; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; CUSHMAN M, 1991, J MED CHEM, V34, P329, DOI 10.1021/jm00105a052; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DE J, 2005, NEW ENGL J MED, V353, P2667; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Drape RJ, 2006, VACCINE, V24, P4475, DOI 10.1016/j.vaccine.2005.08.012; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Glasspool-Malone J, 1999, HUM GENE THER, V10, P1703, DOI 10.1089/10430349950017707; Glasspool-Malone J, 2002, METHOD ENZYMOL, V346, P72; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Haimsohn M, 2002, ENDOCRINOLOGY, V143, P837, DOI 10.1210/en.143.3.837; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; He RT, 2004, BIOCHEM BIOPH RES CO, V320, P1199, DOI 10.1016/j.bbrc.2004.06.076; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; HUNT DM, 1975, J VIROL, V16, P1146, DOI 10.1128/JVI.16.5.1146-1153.1975; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Matsuno H, 1998, THROMB HAEMOSTASIS, V79, P865; Myskiw C, 2007, J VIROL, V81, P3027, DOI 10.1128/JVI.02531-06; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Sidwell RW, 2005, ANTIVIR RES, V68, P10, DOI 10.1016/j.antiviral.2005.06.003; SIDWELL RW, 1995, CHEMOTHERAPY, V41, P455, DOI 10.1159/000239382; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; STEWARD DL, 1977, ANN NY ACAD SCI, V284, P638, DOI 10.1111/j.1749-6632.1977.tb21998.x; Tsi CJ, 2002, MOL PHARMACOL, V62, P90, DOI 10.1124/mol.62.1.90; Walther W, 2005, J GENE MED, V7, P477, DOI 10.1002/jgm.690; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002	50	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8350	10.1371/journal.pone.0008350	http://dx.doi.org/10.1371/journal.pone.0008350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020057	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834200015
J	Andersen, LG; Angquist, L; Gamborg, M; Byberg, L; Bengtsson, C; Canoy, D; Eriksson, JG; Eriksson, M; Jarvelin, MR; Lissner, L; Nilsen, TI; Osler, M; Overvad, K; Rasmussen, F; Salonen, MK; Schack-Nielsen, L; Tammelin, TH; Tuomainen, TP; Sorensen, TIA; Baker, JL				Andersen, Lise Geisler; Angquist, Lars; Gamborg, Michael; Byberg, Liisa; Bengtsson, Calle; Canoy, Dexter; Eriksson, Johan G.; Eriksson, Marit; Jarvelin, Marjo-Riitta; Lissner, Lauren; Nilsen, Tom I.; Osler, Merete; Overvad, Kim; Rasmussen, Finn; Salonen, Minna K.; Schack-Nielsen, Lene; Tammelin, Tuija H.; Tuomainen, Tomi-Pekka; Sorensen, Thorkild I. A.; Baker, Jennifer L.		NordNet Study Grp	Birth Weight in Relation to Leisure Time Physical Activity in Adolescence and Adulthood: Meta-Analysis of Results from 13 Nordic Cohorts	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; ALL-CAUSE MORTALITY; BODY-COMPOSITION; MUSCLE STRENGTH; BLOOD-PRESSURE; RISK-FACTORS; LATER LIFE; MEN; GROWTH; WOMEN	Background: Prenatal life exposures, potentially manifested as altered birth size, may influence the later risk of major chronic diseases through direct biologic effects on disease processes, but also by modifying adult behaviors such as physical activity that may influence later disease risk. Methods/Principal Findings: We investigated the association between birth weight and leisure time physical activity (LTPA) in 43,482 adolescents and adults from 13 Nordic cohorts. Random effects meta-analyses were performed on categorical estimates from cohort-, age-, sex- and birth weight specific analyses. Birth weight showed a reverse U-shaped association with later LTPA; within the range of normal weight the association was negligible but weights below and above this range were associated with a lower probability of undertaking LTPA. Compared with the reference category (3.26-3.75 kg), the birth weight categories of 1.26-1.75, 1.76-2.25, 2.26-2.75, and 4.76-5.25 kg, had odds ratios of 0.67 (95% confidence interval: 0.47, 0.94), 0.72 (0.59, 0.88), 0.89 (0.79, 0.99), and 0.65 (0.50, 0.86), respectively. The shape and strength of the birth weight-LTPA association was virtually independent of sex, age, gestational age, educational level, concurrent body mass index, and smoking. Conclusions/Significance: The association between birth weight and undertaking LTPA is very weak within the normal birth weight range, but both low and high birth weights are associated with a lower probability of undertaking LTPA, which hence may be a mediator between prenatal influences and later disease risk.	[Andersen, Lise Geisler; Angquist, Lars; Gamborg, Michael; Schack-Nielsen, Lene; Sorensen, Thorkild I. A.; Baker, Jennifer L.] Copenhagen Univ Hosp, Inst Prevent Med, Ctr Hlth & Soc, Copenhagen, Denmark; [Byberg, Liisa] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Byberg, Liisa] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Bengtsson, Calle; Lissner, Lauren] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Canoy, Dexter] Univ Manchester, Sch Community Based Med, NW Inst Biohlth Informat, Manchester, Lancs, England; [Canoy, Dexter; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Canoy, Dexter; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr, Oulu, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Child & Adolescent Hlth, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Marit; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Nilsen, Tom I.] Norwegian Univ Sci & Technol, Human Movement Sci Programme, N-7034 Trondheim, Norway; [Osler, Merete] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Osler, Merete] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Salonen, Minna K.] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Schack-Nielsen, Lene] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Frederiksberg, Denmark; [Tammelin, Tuija H.] Finnish Inst Occupat Hlth, Oulu, Finland; [Tammelin, Tuija H.] Res Ctr Sport & Hlth Sci, LIKES, Jyvaskyla, Finland; [Tuomainen, Tomi-Pekka] Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland	University of Copenhagen; Uppsala University; Uppsala University; University of Gothenburg; University of Manchester; University of Oulu; University of Oulu; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Folkhalsan Research Center; Karolinska Institutet; Imperial College London; Norwegian University of Science & Technology (NTNU); University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Finland National Institute for Health & Welfare; University of Copenhagen; Finnish Institute of Occupational Health; University of Eastern Finland	Andersen, LG (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Ctr Hlth & Soc, Copenhagen, Denmark.	jba@ipm.regionh.dk	Baker, Jennifer/F-1917-2010; Canoy, Dexter/L-6440-2013; Baker, Jennifer L./AAH-4693-2020; Bjerregaard, Lise Geisler/F-3818-2014; Osler, Merete/AAF-7885-2019	Baker, Jennifer/0000-0002-9649-6615; Canoy, Dexter/0000-0003-4493-9901; Baker, Jennifer L./0000-0002-9649-6615; Bjerregaard, Lise Geisler/0000-0001-8471-0832; Overvad, Kim/0000-0001-6429-7921; Rasmussen, Finn/0000-0001-7915-7809; Eriksson, Johan/0000-0002-2516-2060; Eriksson, Marit/0000-0002-1766-5899; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Angquist, Lars/0000-0002-9516-4424	NordForsk; Danish Cancer Society; Academy of Finland; Ministry of Education; University Hospital Oulu; Biocenter; University of Oulu; Medical Research Council, UK	NordForsk; Danish Cancer Society(Danish Cancer Society); Academy of Finland(Academy of Finland); Ministry of Education; University Hospital Oulu; Biocenter; University of Oulu; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Nordic longitudinal epidemiological research program, entitled "Prenatal and Childhood Growth in Relation to Cardiovascular Disease'' (The NordNet Study), is funded by NordForsk, the Nordic Research Board. The Diet, Cancer, and Nutrition survey (KKH) was provided and funded by the Danish Cancer Society. The Northern Finland Birth cohorts (NFBC) received financial support from the Academy of Finland, Ministry of Education, University Hospital Oulu, Biocenter, University of Oulu, Finland, and the Medical Research Council, UK. The Helsinki birth Cohorts study (HBCS) was supported by Academy of Finland; British Heart Foundation; Finnish Foundation for Cardiovascular Research; Finnish Diabetes Foundation; Finska L Kares Llskapets; Juho Vainio Foundation; Signe and Ane Gyllenberg Foundation and Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Bak H, 2004, INT J OBESITY, V28, P99, DOI 10.1038/sj.ijo.0802525; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; BARALDI E, 1991, EUR J PEDIATR, V150, P713, DOI 10.1007/BF01958761; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1989, LANCET, V2, P577; Boreham CA, 2001, PUBLIC HEALTH, V115, P373; Canoy D, 2007, THORAX, V62, P396, DOI 10.1136/thx.2006.066241; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Davies AA, 2006, HYPERTENSION, V48, P431, DOI 10.1161/01.HYP.0000236551.00191.61; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson M, 2008, PAEDIATR PERINAT EP, V22, P379, DOI 10.1111/j.1365-3016.2008.00944.x; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Haennel RG, 2002, CAN FAM PHYSICIAN, V48, P65; Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Holmen TL, 2000, PREV MED, V31, P682, DOI 10.1006/pmed.2000.0750; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Jensen CB, 2007, J CLIN ENDOCR METAB, V92, P1530, DOI 10.1210/jc.2006-2360; Johnsen NF, 2006, EUR J EPIDEMIOL, V21, P877, DOI 10.1007/s10654-006-9076-z; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Lissner L, 1996, AM J EPIDEMIOL, V143, P54; Loos RJF, 2001, INT J OBESITY, V25, P1537, DOI 10.1038/sj.ijo.0801743; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; Michaelsson K, 2007, PLOS MED, V4, P1094, DOI 10.1371/journal.pmed.0040199; Morley R, 2006, SEMIN FETAL NEONAT M, V11, P73, DOI 10.1016/j.siny.2005.11.001; Osler M, 2008, INT J EPIDEMIOL, V37, P1367, DOI 10.1093/ije/dyn115; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Rasmussen F, 1998, EUR J EPIDEMIOL, V14, P373, DOI 10.1023/A:1007411613576; RASMUSSEN F, 2004, PHYS ACTIVITY EATING; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; SALONEN JT, 1988, ANN CLIN RES, V20, P46; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Tammelin T, 2007, MED SCI SPORT EXER, V39, P1067, DOI 10.1249/mss.0b13e318058a603; te Velde SJ, 2004, OSTEOPOROSIS INT, V15, P382, DOI 10.1007/s00198-003-1554-5; Willumsen AL, 1970, ENV FACTORS CONGENIT; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	47	61	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8192	10.1371/journal.pone.0008192	http://dx.doi.org/10.1371/journal.pone.0008192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016780	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000272834000004
J	Nelissen, K; Joly, O; Durand, JB; Todd, JT; Vanduffel, W; Orban, GA				Nelissen, Koen; Joly, Olivier; Durand, Jean-Baptiste; Todd, James T.; Vanduffel, Wim; Orban, Guy A.			The Extraction of Depth Structure from Shading and Texture in the Macaque Brain	PLOS ONE			English	Article							SURFACE ORIENTATION; 3D SHAPE; 3-DIMENSIONAL SHAPE; CONTRAST AGENT; OBJECT SHAPE; VISUAL SHAPE; PERCEPTION; MONKEY; REPRESENTATION; MOTION	We used contrast-agent enhanced functional magnetic resonance imaging (fMRI) in the alert monkey to map the cortical regions involved in the extraction of 3D shape from the monocular static cues, texture and shading. As in the parallel human imaging study [1], we contrasted the 3D condition to several 2D control conditions. The extraction of 3D shape from texture (3D SfT) involves both ventral and parietal regions, in addition to early visual areas. Strongest activation was observed in CIP, with decreasing strength towards the anterior part of the intraparietal sulcus (IPS). In the ventral stream 3D SfT sensitivity was observed in a ventral portion of TEO. The extraction of 3D shape from shading (3D SfS) involved predominantly ventral regions, such as V4 and a dorsal potion of TEO. These results are similar to those obtained earlier in human subjects and indicate that the extraction of 3D shape from texture is performed in both ventral and dorsal regions for both species, as are the motion and disparity cues, whereas shading is mainly processed in the ventral stream.	[Nelissen, Koen; Joly, Olivier; Durand, Jean-Baptiste; Vanduffel, Wim; Orban, Guy A.] Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, Leuven, Belgium; [Todd, James T.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Nelissen, Koen; Vanduffel, Wim] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02114 USA; [Vanduffel, Wim] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	KU Leuven; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nelissen, K (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02114 USA.	koen.nelissen@med.kuleuven.be	Durand, Jean-Baptiste/ABE-9090-2020; DURAND, Jean-Baptiste/E-9252-2011	DURAND, Jean-Baptiste/0000-0003-4780-8691; Orban, Guy/0000-0002-8179-9584; Joly, Olivier/0000-0002-5818-6552	EU [GOA 2005/18]	EU(European Commission)	This work was supported by EU project Insight 2+ and Neurobotics and GOA 2005/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DHOTEL CC, 2002, P IEEE INT S BIOM IM, V7, P21; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Fize D, 2003, J NEUROSCI, V23, P7395; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fukuda M, 2005, CEREB CORTEX, V15, P823, DOI 10.1093/cercor/bhh183; GATTASS R, 1988, J NEUROSCI, V8, P1831; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Georgieva SS, 2008, CEREB CORTEX, V18, P2416, DOI 10.1093/cercor/bhn002; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Joly O, 2009, NEUROIMAGE, V47, P262, DOI 10.1016/j.neuroimage.2009.04.043; Kaas JH, 2001, PROG BRAIN RES, V134, P285; Kolster H, 2009, J NEUROSCI, V29, P7031, DOI 10.1523/JNEUROSCI.0518-09.2009; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; Moore C, 2001, NEURON, V29, P277, DOI 10.1016/S0896-6273(01)00197-0; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; NORMAN JF, 1995, PERCEPT PSYCHOPHYS, V57, P629; ORBAN GA, 2008, SENSES COMPREHENSIVE, V2, P235; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; Todd JT, 2004, PSYCHOL SCI, V15, P40, DOI 10.1111/j.0963-7214.2004.01501007.x; Todd JT, 2004, TRENDS COGN SCI, V8, P115, DOI 10.1016/j.tics.2004.01.006; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Zhang Y, 2007, VISUAL NEUROSCI, V24, P207, DOI 10.1017/S0952523807070411	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8306	10.1371/journal.pone.0008306	http://dx.doi.org/10.1371/journal.pone.0008306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011540	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300051
J	Kalantri, A; Karambelkar, M; Joshi, R; Kalantri, S; Jajoo, U				Kalantri, Ashwini; Karambelkar, Mandar; Joshi, Rajnish; Kalantri, Shriprakash; Jajoo, Ulhas			Accuracy and Reliability of Pallor for Detecting Anaemia: A Hospital-Based Diagnostic Accuracy Study	PLOS ONE			English	Article							CLINICAL SIGNS; WESTERN KENYA; CONJUNCTIVAL PALLOR; LIKELIHOOD RATIOS; PREGNANT-WOMEN; CHILDREN; RECOGNITION; MODERATE; MALARIA; ABSENCE	Background: Anaemia is a common disorder. Most health providers in resource poor settings rely on physical signs to diagnose anaemia. We aimed to determine the diagnostic accuracy of pallor for anaemia by using haemoglobin as the reference standard. Methodology/Principal Findings: In May 2007, we enrolled consecutive patients over 12 years of age, able to consent and willing to participate and who had a haemoglobin measurement taken within a day of assessment of clinical pallor from outpatient and medicine inpatient department of a teaching hospital. We did a blind and independent comparison of physical signs (examination of conjunctivae, tongue, palms and nailbed for pallor) and the reference standard (haemoglobin estimation by an electronic cell counter). Diagnostic accuracy was measured by calculating likelihood ratio values and 95% confidence intervals (CI) at different haemoglobin thresholds and area under the receiver operating characteristic curve. Two observers examined a subset of patients (n = 128) to determine the inter-observer agreement, calculated by kappa statistics. We studied 390 patients (mean age 40.1 [SD 17.08] years); of whom 48% were women. The haemoglobin was <7 g/dL in 8% (95% confidence interval, 5, 10) patients; <9 g/dL in 21% (17, 26) patients and <12 g/dL in 64% (60, 70) patients. Among patients with haemoglobin <7 g/dL, presence of severe tongue pallor yielded a LR of 9.87 (2.81, 34.6) and its absence yielded a LR of 0. The tongue pallor outperformed other pallor sites and was also the best discriminator of anaemia at haemoglobin thresholds of 7 g/dL and 9 g/dL (area under the receiver operating characteristic curves (ROC area = 0.84 [0.77, 0.90] and 0.71[0.64, 0.76]) respectively. The agreement between the two observers for detection of anaemia was poor (kappa values = 0.07 for conjunctival pallor and 0.20 for tongue pallor). Conclusions/Significance: Clinical assessment of pallor can rule out and modestly rule in severe anaemia.	[Kalantri, Ashwini; Karambelkar, Mandar; Joshi, Rajnish; Kalantri, Shriprakash; Jajoo, Ulhas] Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India	Mahatma Gandhi Institute of Medical Sciences, Sevagram	Kalantri, A (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India.	ashwinikalantri@gmail.com	Kalantri, Ashwini/E-7319-2010; Kalantri, Shriprakash/ABG-9318-2021	Kalantri, Ashwini/0000-0001-5013-4371; Kalantri, Shriprakash/0000-0002-1633-1029; Joshi, Rajnish/0000-0002-4702-0522	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This study was partly funded by the Indian Council of Medical Research, New Delhi, India. Ashwini Kalantri, a medical student, was awarded the short term studentship (2007) to conduct this study (URL:http://www.icmr.nic.in/shortr.htm). The Indian Council of Medical Research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Desai MR, 2002, TROP MED INT HEALTH, V7, P831, DOI 10.1046/j.1365-3156.2002.00942.x; Fourn L, 2004, Sante Publique, V16, P123; Gies S, 2003, TROP MED INT HEALTH, V8, P301, DOI 10.1046/j.1365-3156.2003.01037.x; GJORUP T, 1986, AM J EPIDEMIOL, V124, P657, DOI 10.1093/oxfordjournals.aje.a114438; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hung OL, 2000, ACAD EMERG MED, V7, P146, DOI 10.1111/j.1553-2712.2000.tb00518.x; *INT WORK GROUP DI, 1999, INT CONS DIAB FOOT, P60; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P103; Lindblade KA, 2006, TROP MED INT HEALTH, V11, P1679, DOI 10.1111/j.1365-3156.2006.01721.x; LUBY SP, 1995, B WORLD HEALTH ORGAN, V73, P477; McGee S, 2002, J GEN INTERN MED, V17, P646; Mogensen CB, 2006, ACTA TROP, V99, P113, DOI 10.1016/j.actatropica.2005.12.010; Mogensen CB, 2006, ACTA TROP, V99, P119, DOI 10.1016/j.actatropica.2005.12.011; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; NARDONE DA, 1990, ARCH INTERN MED, V150, P201, DOI 10.1001/archinte.150.1.201; Prakash S, 1999, J Assoc Physicians India, V47, P995; Sheth TN, 1997, J GEN INTERN MED, V12, P102, DOI 10.1007/s11606-006-5004-x; Stoltzfus RJ, 1999, J NUTR, V129, P1675, DOI 10.1093/jn/129.9.1675; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P113; WURAPA FK, 1986, J TROP MED HYG, V89, P33; Zucker JR, 1997, B WORLD HEALTH ORGAN, V75, P97	24	36	36	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8545	10.1371/journal.pone.0008545	http://dx.doi.org/10.1371/journal.pone.0008545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049324	gold, Green Published, Green Submitted			2022-12-27	WOS:000273225000010
J	Tan, CC; Walsh, MJ; Gelb, BD				Tan, Cheryl C.; Walsh, Martin J.; Gelb, Bruce D.			Fgfr3 Is a Transcriptional Target of Ap2 delta and Ash2l-Containing Histone Methyltransferase Complexes	PLOS ONE			English	Article							DEVELOPING MIDBRAIN; ACTIVE GENES; H3; METHYLATION; EXPRESSION; MOUSE; MLL; DIFFERENTIATION; RECEPTORS; HINDBRAIN	Polycomb (PcG) and trithorax (trxG) proteins play important roles in establishing lineage-specific genetic programs through induction of chromatin modifications that lead to gene silencing or activation. Previously, we described an association between the MLL/SET1 complexes and a highly restricted, gene-specific DNA-binding protein Ap2 delta that is required for recruitment of the MLL/SET1 complex to target Hoxc8 specifically. Here, we reduced levels of Ap2 delta and Ash2l in the neuroblastoma cell line, Neuro2A, and analyzed their gene expression profiles using whole-genome mouse cDNA microarrays. This analysis yielded 42 genes that are potentially co-regulated by Ap2 delta and Ash2l, and we have identified evolutionarily conserved Ap2-binding sites in 20 of them. To determine whether some of these were direct targets of the Ap2 delta-Ash2l complex, we analyzed several promoters for the presence of Ap2 delta and Ash2l by chromatin immunoprecipitation (ChIP). Among the targets we screened, we identified Fgfr3 as a direct transcriptional target of the Ap2 delta-Ash2l complex. Additionally, we found that Ap2 delta is necessary for the recruitment of Ash2l-containing complexes to this promoter and that this recruitment leads to trimethylation of lysine 4 of histone H3 (H3K4me3). Thus, we have identified several candidate targets of complexes containing Ap2 delta and Ash2l that can be used to further elucidate their roles during development and showed that Fgfr3 is a novel direct target of these complexes.	[Tan, Cheryl C.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA; [Walsh, Martin J.; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tan, CC (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA.	bruce.gelb@mssm.edu			National Institutes of Health (NIH) [HD38018]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038018] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institutes of Health (NIH) grant HD38018 to BDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Reimers D, 2001, NEUROL RES, V23, P612, DOI 10.1179/016164101101199090; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Zhao F, 2003, GENE EXPR PATTERNS, V3, P213, DOI 10.1016/S1567-133X(02)00067-4	24	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8535	10.1371/journal.pone.0008535	http://dx.doi.org/10.1371/journal.pone.0008535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046871	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200016
J	Thomas, JH; Emerson, RO; Shendure, J				Thomas, James H.; Emerson, Ryan O.; Shendure, Jay			Extraordinary Molecular Evolution in the PRDM9 Fertility Gene	PLOS ONE			English	Article							HISTONE H3 METHYLTRANSFERASE; CENTROMERE COMPLEXITY; CRYSTAL-STRUCTURE; REPRESSION; MEISETZ; DOMAIN; DNA; SPECIATION; SUBFAMILY; PROTEINS	Recent work indicates that allelic incompatibility in the mouse PRDM9 (Meisetz) gene can cause hybrid male sterility, contributing to genetic isolation and potentially speciation. The only phenotype of mouse PRDM9 knockouts is a meiosis I block that causes sterility in both sexes. The PRDM9 gene encodes a protein with histone H3(K4) trimethyltransferase activity, a KRAB domain, and a DNA-binding domain consisting of multiple tandem C2H2 zinc finger (ZF) domains. We have analyzed human coding polymorphism and interspecies evolutionary changes in the PRDM9 gene. The ZF domains of PRDM9 are evolving very rapidly, with compelling evidence of positive selection in primates. Positively selected amino acids are predominantly those known to make nucleotide specific contacts in C2H2 zinc fingers. These results suggest that PRDM9 is subject to recurrent selection to change DNA-binding specificity. The human PRDM9 protein is highly polymorphic in its ZF domains and nearly all polymorphisms affect the same nucleotide contact residues that are subject to positive selection. ZF domain nucleotide sequences are strongly homogenized within species, indicating that interfinger recombination contributes to their evolution. PRDM9 has previously been assumed to be a transcription factor required to induce meiosis specific genes, a role that is inconsistent with its molecular evolution. We suggest instead that PRDM9 is involved in some aspect of centromere segregation conflict and that rapidly evolving centromeric DNA drives changes in PRDM9 DNA-binding domains.	[Thomas, James H.; Emerson, Ryan O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Thomas, JH (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jht@u.washington.edu	Emerson, Ryan/F-4545-2010; Shendure, Jay/AAU-3684-2021	Emerson, Ryan/0000-0003-0241-3709; Shendure, Jay/0000-0002-1516-1865	NHLBI [5901HL094976-02]; NHGRI [1921HG004749-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The sequencing in the paper was supported by the following grants: NHLBI 5901HL094976-02 "SeattleSeq", http://www.genome.gov/, NHGRI 1921HG004749-01, 'Molecular Tools for Genome Partitioning", http://www.genome.gov/. The computational work had no extramural grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Cellamare A, 2009, MOL BIOL EVOL, V26, P1889, DOI 10.1093/molbev/msp101; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Malik HS, 2006, BIOCHEM SOC T, V34, P569, DOI 10.1042/BST0340569; Malik HS, 2009, PROG MOL SUBCELL BIO, V48, P33, DOI 10.1007/978-3-642-00182-6_2; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; Malik HS, 2001, GENETICS, V157, P1293; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Thomas JH, 2006, GENETICS, V172, P2269, DOI 10.1534/genetics.105.052746; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	28	61	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8505	10.1371/journal.pone.0008505	http://dx.doi.org/10.1371/journal.pone.0008505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041164	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700019
J	Loogvali, EL; Kivisild, T; Margus, T; Villems, R				Loogvaeli, Eva-Liis; Kivisild, Toomas; Margus, Tonu; Villems, Richard			Explaining the Imperfection of the Molecular Clock of Hominid Mitochondria	PLOS ONE			English	Article							TIME DEPENDENCY; ADAPTIVE SELECTION; NATURAL-SELECTION; MTDNA VARIATION; DNA-SEQUENCES; EVOLUTION; ORIGIN; POLYMORPHISM; MUTATIONS; GENES	The molecular clock of mitochondrial DNA has been extensively used to date various genetic events. However, its substitution rate among humans appears to be higher than rates inferred from human-chimpanzee comparisons, limiting the potential of interspecies clock calibrations for intraspecific dating. It is not well understood how and why the substitution rate accelerates. We have analyzed a phylogenetic tree of 3057 publicly available human mitochondrial DNA coding region sequences for changes in the ratios of mutations belonging to different functional classes. The proportion of non-synonymous and RNA genes substitutions has reduced over hundreds of thousands of years. The highest mutation ratios corresponding to fast acceleration in the apparent substitution rate of the coding sequence have occurred after the end of the Last Ice Age. We recalibrate the molecular clock of human mtDNA as 7990 years per synonymous mutation over the mitochondrial genome. However, the distribution of substitutions at synonymous sites in human data significantly departs from a model assuming a single rate parameter and implies at least 3 different subclasses of sites. Neutral model with 3 synonymous substitution rates can explain most, if not all, of the apparent molecular clock difference between the intra- and interspecies levels. Our findings imply the sluggishness of purifying selection in removing the slightly deleterious mutations from the human as well as the Neandertal and chimpanzee populations. However, for humans, the weakness of purifying selection has been further exacerbated by the population expansions associated with the out-of Africa migration and the end of the Last Ice Age.	[Loogvaeli, Eva-Liis; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Tartu, Estonia; [Loogvaeli, Eva-Liis; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Margus, Tonu] Univ Tartu, Dept Bioinformat, EE-50090 Tartu, Estonia	Estonian Biocentre; University of Tartu; University of Cambridge; University of Tartu	Loogvali, EL (corresponding author), Estonian Bioctr, Tartu, Estonia.	eva-liis.loogvali@ut.ee	Kivisild, Toomas/P-5889-2017	Kivisild, Toomas/0000-0002-6297-7808; Margus, Tonu/0000-0003-4966-1291	Estonian Science Foundation [6040]; European Union; Estonian Biocentre; Tartu University	Estonian Science Foundation; European Union(European Commission); Estonian Biocentre; Tartu University	This research has been supported by Estonian Science Foundation grant 6040 and by the European Union through the European Regional Development Fund through the Centre of Excellence in Genomics, Estonian Biocentre and Tartu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arnason U, 1996, J MOL EVOL, V42, P145, DOI 10.1007/BF02198840; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 2008, HEREDITY, V100, P1, DOI 10.1038/sj.hdy.6801054; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Flynn SMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-339; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Forster P, 1996, AM J HUM GENET, V59, P935; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Hughes AL, 2007, MOL ECOL, V16, P1369, DOI 10.1111/j.1365-294X.2007.03242.x; Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; KIVISILD T, 2002, MOL BIOL EVOL, V1720, P1162; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nachman MW, 1996, GENETICS, V142, P953; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Nielsen R, 1999, GENETICS, V153, P497; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407	66	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8260	10.1371/journal.pone.0008260	http://dx.doi.org/10.1371/journal.pone.0008260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041137	Green Submitted, gold, Green Published			2022-12-27	WOS:000273105200002
J	Kim, S; Carrillo, M; Kulkarni, V; Jagadeeswaran, P				Kim, Seongcheol; Carrillo, Maira; Kulkarni, Vrinda; Jagadeeswaran, Pudur			Evolution of Primary Hemostasis in Early Vertebrates	PLOS ONE			English	Article							MAST-CELLS; ZEBRAFISH; TRYPSIN; IDENTIFICATION; THROMBOCYTES; THROMBOSIS; RECEPTORS; PROTEASES; ENZYMES; MOUSE	Hemostasis is a defense mechanism which protects the organism in the event of injury to stop bleeding. Recently, we established that all the known major mammalian hemostatic factors are conserved in early vertebrates. However, since their highly vascularized gills experience high blood pressure and are exposed to the environment, even very small injuries could be fatal to fish. Since trypsins are forerunners for coagulation proteases and are expressed by many extrapancreatic cells such as endothelial cells and epithelial cells, we hypothesized that trypsin or trypsin-like proteases from gill epithelial cells may protect these animals from gill bleeding following injuries. In this paper we identified the release of three different trypsins from fish gills into water under stress or injury, which have tenfold greater serine protease activity compared to bovine trypsin. We found that these trypsins activate the thrombocytes and protect the fish from gill bleeding. We found 27 protease-activated receptors (PARs) by analyzing zebrafish genome and classified them into five groups, based on tethering peptides, and two families, PAR1 and PAR2, based on homologies. We also found a canonical member of PAR2 family, PAR2-21A which is activated more readily by trypsin, and PAR2-21A tethering peptide stops gill bleeding just as trypsin. This finding provides evidence that trypsin cleaves a PAR2 member on thrombocyte surface. In conclusion, we believe that the gills are evolutionarily selected to produce trypsin to activate PAR2 on thrombocyte surface and protect the gills from bleeding. We also speculate that trypsin may also protect the fish from bleeding from other body injuries due to quick contact with the thrombocytes. Thus, this finding provides evidence for the role of trypsins in primary hemostasis in early vertebrates.	[Kim, Seongcheol; Carrillo, Maira; Kulkarni, Vrinda; Jagadeeswaran, Pudur] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Kim, S (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	jag@unt.edu			National Institutes of Health [HL077910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the National Institutes of Health, HL077910 (to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 1998, BLOOD COAGUL FIBRIN, V9, P307, DOI 10.1097/00001721-199806000-00002; Ainsworth DM, 2000, J AM VET MED ASSOC, V216, P1282, DOI 10.2460/javma.2000.216.1282; ALLEN DH, 1995, J BIOL CHEM, V270, P1408, DOI 10.1074/jbc.270.3.1408; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Hanumanthaiah R, 2002, BLOOD CELL MOL DIS, V29, P57, DOI 10.1006/bcmd.2002.0534; Hortin GL, 2001, CLIN CHEM, V47, P215; Jagadeeswaran P, 2007, J THROMB HAEMOST, V5, P300, DOI 10.1111/j.1538-7836.2007.02518.x; Jagadeeswaran P, 2005, J THROMB HAEMOST, V3, P46, DOI 10.1111/j.1538-7836.2004.00999.x; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Lentink D, 2008, J EXP BIOL, V211, P267, DOI 10.1242/jeb.006155; MAHONEY WC, 1980, EUR J BIOCHEM, V105, P545, DOI 10.1111/j.1432-1033.1980.tb04531.x; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Muller UK, 2000, J EXP BIOL, V203, P193; NEURATH H, 1967, SCIENCE, V158, P1638, DOI 10.1126/science.158.3809.1638; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Thattaliyath B, 2005, BLOOD, V106, P118, DOI 10.1182/blood-2004-10-4118; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	21	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8403	10.1371/journal.pone.0008403	http://dx.doi.org/10.1371/journal.pone.0008403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037653	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100008
J	Lin, SW; Huang, YL; Lee, T				Lin, Suewei; Huang, Yaling; Lee, Tzumin			Nuclear Receptor Unfulfilled Regulates Axonal Guidance and Cell Identity of Drosophila Mushroom Body Neurons	PLOS ONE			English	Article							B ECDYSONE RECEPTOR; COUP-TFI; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS; THERAPEUTIC TARGET; TEMPORAL IDENTITY; GENE-EXPRESSION; NERVOUS-SYSTEM; DIFFERENTIATION; MEMORY	Nuclear receptors (NRs) comprise a family of ligand-regulated transcription factors that control diverse critical biological processes including various aspects of brain development. Eighteen NR genes exist in the Drosophila genome. To explore their roles in brain development, we knocked down individual NRs through the development of the mushroom bodies (MBs) by targeted RNAi. Besides recapitulating the known MB phenotypes for three NRs, we found that unfulfilled (unf), an ortholog of human photoreceptor specific nuclear receptor (PNR), regulates axonal morphogenesis and neuronal subtype identity. The adult MBs develop through remodeling of gamma neurons plus de-novo elaboration of both alpha'/beta' and alpha/beta neurons. Notably, unf is largely dispensable for the initial elaboration of gamma neurons, but plays an essential role in their re-extension of axons after pruning during early metamorphosis. The subsequently derived MB neuron types also require unf for extension of axons beyond the terminus of the pruned bundle. Tracing single axons revealed misrouting rather than simple truncation. Further, silencing unf in single-cell clones elicited misguidance of axons in otherwise unperturbed MBs. Such axon guidance defects may occur as MB neurons partially lose their subtype identity, as evidenced by suppression of various MB subtype markers in unf knockdown MBs. In sum, unf governs axonal morphogenesis of multiple MB neuron types, possibly through regulating neuronal subtype identity.	[Lin, Suewei; Lee, Tzumin] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Huang, Yaling; Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Lin, SW (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	leet@janelia.hhmi.org	Lin, Suewei/AAA-3962-2021	Lin, Suewei/0000-0001-7079-7818	National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) grants to T. L.. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; Brown HLD, 2009, DEVELOPMENT, V136, P3247, DOI 10.1242/dev.039859; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Choi YJ, 2006, DEVELOPMENT, V133, P2223, DOI 10.1242/dev.02376; Chu YP, 2006, J COMP NEUROL, V494, P495, DOI 10.1002/cne.20828; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; DEROSNY E, 2008, BIOCHEMISTRY; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; KRAMER S, 1995, DEVELOPMENT, V121, P1361; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurusu M, 2009, DEV BIOL, V326, P224, DOI 10.1016/j.ydbio.2008.11.013; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Luo GR, 2008, MOL CELL NEUROSCI, V39, P202, DOI 10.1016/j.mcn.2008.06.010; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martini SR, 2000, DEVELOPMENT, V127, P2663; Martini SR, 2005, J NEUROBIOL, V64, P133, DOI 10.1002/neu.20130; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Much JW, 2000, DEVELOPMENT, V127, P703; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Palanker L, 2006, DEVELOPMENT, V133, P3549, DOI 10.1242/dev.02512; PARDEE K, 2004, SCI AGING KNOWLEDGE, pRE8, DOI DOI 10.1126/SAGEKE.2004.47.RE8; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; Schubiger M, 2000, DEVELOPMENT, V127, P1151; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shi L, 2007, DEV NEUROBIOL, V67, P1614, DOI 10.1002/dneu.20537; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sung C, 2009, DEV DYNAM, V238, P171, DOI 10.1002/dvdy.21817; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tran PV, 2003, MOL CELL NEUROSCI, V22, P441, DOI 10.1016/S1044-7431(03)00027-7; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Truman JW, 1996, DEV NEUROSCI-BASEL, V18, P87, DOI 10.1159/000111398; Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wightman B, 2005, DEV BIOL, V287, P74, DOI 10.1016/j.ydbio.2005.08.032; Wightman B, 1997, DEVELOPMENT, V124, P2571; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YANG MY, 1995, NEURON, V15, P45; Yu HH, 2007, TRENDS NEUROSCI, V30, P520, DOI 10.1016/j.tins.2007.07.003; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	73	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8392	10.1371/journal.pone.0008392	http://dx.doi.org/10.1371/journal.pone.0008392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027309	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998000004
J	Lanting, CI; Buitendijk, SE; Crone, MR; Segaar, D; Gravenhorst, JB; van Wouwe, JP				Lanting, Caren I.; Buitendijk, Simone E.; Crone, Matty R.; Segaar, Dewi; Gravenhorst, Jack Bennebroek; van Wouwe, Jacobus P.			Clustering of Socioeconomic, Behavioural, and Neonatal Risk Factors for Infant Health in Pregnant Smokers	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; LOW-BIRTH-WEIGHT; MATERNAL SMOKING; ATTRIBUTABLE RISK; DETERMINANTS; MIDWIVES; WOMEN	Background: Tobacco smoking is a major cause of morbidity and mortality, including during pregnancy. Although effective ways of promoting smoking cessation during pregnancy exist, the impact of these interventions has not been studied at a national level. We estimated the prevalence of smoking throughout pregnancy in the Netherlands and quantified associations of maternal smoking throughout pregnancy with socioeconomic, behavioural, and neonatal risk factors for infant health and development. Methodology/Principal Findings: Data of five national surveys, containing records of 14,553 Dutch mothers and their offspring were analyzed. From 2001 to 2007, the overall rate of smoking throughout pregnancy fell by 42% (from 13.2% to 7.6%) mainly as a result of a decrease among highly educated women. In the lowest-educated group, the overall rate of smoking throughout pregnancy was six times as high as in the highest-educated group (18.7% versus 3.2%). Prenatal tobacco smoke exposure was associated with increased risk of extremely preterm (<= 28 completed weeks) (OR 7.25; 95% CI 3.40 to 15.38) and small-for-gestational age (SGA) infants (OR 3.08; 95% CI 2.66 to 3.57). Smoking-attributable risk percents in the population (based on adjusted risk ratios) were estimated at 29% for extremely preterm births and at 17% for SGA outcomes. Infants of smokers were more likely to experience significant alcohol exposure in utero (OR 2.08; 95%CI 1.25 to 3.45) and formula feeding in early life (OR 1.91; 95% CI 1.69 to 2.16). Conclusions: The rates of maternal smoking throughout pregnancy decreased significantly in the Netherlands from 2001 to 2007. If pregnant women were to cease tobacco use completely, an estimated 29% of extremely preterm births and 17% of SGA infants may be avoided annually.	[Lanting, Caren I.; Buitendijk, Simone E.; Gravenhorst, Jack Bennebroek; van Wouwe, Jacobus P.] Netherlands Org Appl Sci Res TNO Prevent & Hlth, Leiden, Netherlands; [Segaar, Dewi] STIVORO, The Hague, Netherlands; [Buitendijk, Simone E.; Crone, Matty R.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lanting, CI (corresponding author), Netherlands Org Appl Sci Res TNO Prevent & Hlth, Leiden, Netherlands.	caren.lanting@tno.nl	Crone, Mathilde/AAR-2923-2020; Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258; Crone, Mathilde/0000-0003-1243-858X; Lanting, Caren/0000-0001-9417-7074	Netherlands Organization for Health Research and Development (ZonMW) [2500.0001]; STIVORO; Stichting Zorg voor Borstvoeding	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); STIVORO; Stichting Zorg voor Borstvoeding	This work was financially supported by grants from the Netherlands Organization for Health Research and Development (ZonMW) (grant number 2500.0001), STIVORO - for a smokefree future (www.stivoro.nl), and Stichting Zorg voor Borstvoeding (www.zorgvoorborstvoeding.nl). The funders had no role in study design, data collection and analysis, interpretation of results or decision to publish.	Amir LH, 2002, BIRTH-ISS PERINAT C, V29, P112, DOI 10.1046/j.1523-536X.2002.00152.x; Amir LH, 2001, EARLY HUM DEV, V64, P45, DOI 10.1016/S0378-3782(01)00170-0; Blair PS, 1996, BRIT MED J, V313, P195, DOI 10.1136/bmj.313.7051.195; Blalock JA, 2005, ADDICT BEHAV, V30, P1195, DOI 10.1016/j.addbeh.2004.12.010; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; COLE P, 1971, BRIT J PREV SOC MED, V25, P242; Crone MR, 2000, PATIENT EDUC COUNS, V39, P149, DOI 10.1016/S0738-3991(99)00016-6; de Jonge G A, 1982, Ned Tijdschr Geneeskd, V126, P1537; de Vries H, 2006, PATIENT EDUC COUNS, V63, P177, DOI 10.1016/j.pec.2005.10.002; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Ebert Lyn Maxine, 2007, Women Birth, V20, P161, DOI 10.1016/j.wombi.2007.08.002; Euro-Peristat Project, 2008, EUR PER HLTH REP; Goedhart G, 2009, ADDICT BEHAV, V34, P403, DOI 10.1016/j.addbeh.2008.11.006; Hannigan J H, 2000, Semin Neonatol, V5, P243; Horta BL, 2001, AM J PUBLIC HEALTH, V91, P304, DOI 10.2105/AJPH.91.2.304; Horta BL, 2007, EVIDENCE LONG TERM E, P52; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lanting CI, 2005, ACTA PAEDIATR, V94, P935, DOI 10.1080/08035250510036723; Lee JEC, 2008, J HEALTH PSYCHOL, V13, P1082, DOI 10.1177/1359105308095962; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; MACARTHUR C, 1988, BRIT J OBSTET GYNAEC, V95, P551, DOI 10.1111/j.1471-0528.1988.tb09481.x; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Mortensen EL, 2005, PAEDIATR PERINAT EP, V19, P4, DOI 10.1111/j.1365-3016.2004.00622.x; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; PARK EW, 2008, COCHRANE DB SYST REV, V1; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Segaar D, 2007, HEALTH EDUC RES, V22, P14, DOI 10.1093/her/cyl046; SIMPSON WJ, 1957, AM J OBSTET GYNECOL, V73, P808, DOI 10.1016/0002-9378(57)90391-5	31	37	37	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8363	10.1371/journal.pone.0008363	http://dx.doi.org/10.1371/journal.pone.0008363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	534BN	20020042	Green Published, gold, Green Submitted			2022-12-27	WOS:000272870600006
J	Minakshi, R; Padhan, K; Rani, M; Khan, N; Ahmad, F; Jameel, S				Minakshi, Rinki; Padhan, Kartika; Rani, Manjusha; Khan, Nabab; Ahmad, Faizan; Jameel, Shahid			The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; HEPATITIS-E VIRUS; P38 MAP KINASE; UNFOLDED PROTEIN; ER STRESS; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; ALPHA RECEPTOR; MESSENGER-RNA; SIGNALING PATHWAY	The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is reported to cause apoptosis of infected cells and several of its proteins including the 3a accessory protein, are pro-apoptotic. Since the 3a protein localizes to the endoplasmic reticulum (ER)-Golgi compartment, its role in causing ER stress was investigated in transiently transfected cells. Cells expressing the 3a proteins showed ER stress based on activation of genes for the ER chaperones GRP78 and GRP94. Since ER stress can cause differential modulation of the unfolded protein response (UPR), which includes the inositol-requiring enzyme 1 (IRE-1), activating transcription factor 6 (ATF6) and PKR-like ER kinase (PERK) pathways, these were individually tested in 3a-expressing cells. Only the PERK pathway was found to be activated in 3a-expressing cells based on (1) increased phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha) and inhibitory effects of a dominant-negative form of eIF2 alpha on GRP78 promoter activity, (2) increased translation of activating transcription factor 4 (ATF4) mRNA, and (3) ATF4-dependent activation of the C/EBP homologous protein (CHOP) gene promoter. Activation of PERK affects innate immunity by suppression of type 1 interferon (IFN) signaling. The 3a protein was found to induce serine phosphorylation within the IFN alpha-receptor subunit 1 (IFNAR1) degradation motif and to increase IFNAR1 ubiquitination. Confocal microscopic analysis showed increased translocation of IFNAR1 into the lysosomal compartment and flow cytometry showed reduced levels of IFNAR1 in 3a-expressing cells. These results provide further mechanistic details of the pro-apoptotic effects of the SARS-CoV 3a protein, and suggest a potential role for it in attenuating interferon responses and innate immunity.	[Minakshi, Rinki; Padhan, Kartika; Rani, Manjusha; Khan, Nabab; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Minakshi, Rinki; Ahmad, Faizan] Ctr Interdisciplinary Res Basic Sci, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jamia Millia Islamia	Minakshi, R (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	shahid@icgeb.res.in	Ahmad, Faizan/AGH-4493-2022; Minakshi, Rinki/AGZ-8783-2022; Padhan, Kartika/O-8215-2017; khan, Nabab/Z-3970-2019	Ahmad, Faizan/0000-0001-7021-7502; khan, Nabab/0000-0002-8563-5341; Rinki, Minakshi/0000-0001-5768-4640; PADHAN, KARTIKA/0000-0001-9561-4256	Department of Biotechnology (DBT), Government of India; Council for Scientific and Industrial Research, India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology (DBT), Government of India (http://dbtindia.nic.in); KP received a Senior Research Fellowship from the Council for Scientific and Industrial Research, India. The ICGEB also receives core support from DBT and the same is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Basu L, 1998, VIROLOGY, V242, P14, DOI 10.1006/viro.1997.9002; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bechill J, 2008, J VIROL, V82, P4492, DOI 10.1128/JVI.00017-08; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Ciccaglione AR, 2007, VIRUS RES, V126, P128, DOI 10.1016/j.virusres.2007.02.006; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dimcheff DE, 2003, J VIROL, V77, P12617, DOI 10.1128/JVI.77.23.12617-12629.2003; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Lai WL, 2005, FREE RADICAL BIO MED, V38, P1585, DOI 10.1016/j.freeradbiomed.2005.02.024; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Law PTW, 2005, J GEN VIROL, V86, P1921, DOI 10.1099/vir.0.80813-0; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MORI K, 1993, CELL, V74, P743; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Padhan K, 2008, J GEN VIROL, V89, P1960, DOI 10.1099/vir.0.83665-0; Padhan K, 2007, J GEN VIROL, V88, P3067, DOI 10.1099/vir.0.82856-0; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Tan YJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-5; Tan YJ, 2004, J VIROL, V78, P6723, DOI 10.1128/JVI.78.13.6723-6734.2004; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Vilcek J, 2003, NAT IMMUNOL, V4, P8, DOI 10.1038/ni0103-8; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WATOWICH SS, 1991, J VIROL, V65, P3590, DOI 10.1128/JVI.65.7.3590-3597.1991; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yuan XL, 2007, AM J RESP CELL MOL, V37, P9, DOI 10.1165/rcmb.2005-0345RC; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997	77	156	165	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8342	10.1371/journal.pone.0008342	http://dx.doi.org/10.1371/journal.pone.0008342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020050	Green Submitted, gold, Green Published			2022-12-27	WOS:000272834200009
J	Leopold, PL; O'Mahony, MJ; Lian, XJ; Tilley, AE; Harvey, BG; Crystal, RG				Leopold, Philip L.; O'Mahony, Michael J.; Lian, X. Julie; Tilley, Ann E.; Harvey, Ben-Gary; Crystal, Ronald G.			Smoking Is Associated with Shortened Airway Cilia	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN BRONCHIAL EPITHELIUM; SURFACE LIQUID VOLUME; CIGARETTE-SMOKE; CYSTIC-FIBROSIS; ULTRASTRUCTURAL ABNORMALITIES; RESPIRATORY EPITHELIUM; MUCOCILIARY TRANSPORT; TRACHEAL EPITHELIUM; GENE-EXPRESSION	Background: Whereas cilia damage and reduced cilia beat frequency have been implicated as causative of reduced mucociliary clearance in smokers, theoretically mucociliary clearance could also be affected by cilia length. Based on models of mucociliary clearance predicting that cilia length must exceed the 6-7 mu m airway surface fluid depth to generate force in the mucus layer, we hypothesized that cilia height may be decreased in airway epithelium of normal smokers compared to nonsmokers. Methodology/Principal Findings: Cilia length in normal nonsmokers and smokers was evaluated in aldehyde-fixed, paraffin-embedded endobronchial biopsies, and air-dried and hydrated samples were brushed from human airway epithelium via fiberoptic bronchoscopy. In 28 endobronchial biopsies, healthy smoker cilia length was reduced by 15% compared to nonsmokers (p < 0.05). In 39 air-dried samples of airway epithelial cells, smoker cilia length was reduced by 13% compared to nonsmokers (p < 0.0001). Analysis of the length of individual, detached cilia in 27 samples showed that smoker cilia length was reduced by 9% compared to nonsmokers (p < 0.05). Finally, in 16 fully hydrated, unfixed samples, smoker cilia length was reduced 7% compared to nonsmokers (p < 0.05). Using genome-wide analysis of airway epithelial gene expression we identified 6 cilia-related genes whose expression levels were significantly reduced in healthy smokers compared to healthy nonsmokers. Conclusions/Significance: Models predict that a reduction in cilia length would reduce mucociliary clearance, suggesting that smoking-associated shorter airway epithelial cilia play a significant role in the pathogenesis of smoking-induced lung disease.	[Leopold, Philip L.; O'Mahony, Michael J.; Lian, X. Julie; Tilley, Ann E.; Harvey, Ben-Gary; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Leopold, Philip L.; O'Mahony, Michael J.; Tilley, Ann E.; Harvey, Ben-Gary; Crystal, Ronald G.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY USA	Cornell University; Cornell University	Leopold, PL (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	geneticmedicine@med.cornell.edu			NCRR NIH HHS [M01RR00047, M01 RR000047] Funding Source: Medline; NHLBI NIH HHS [R01 HL074326, P50 HL084936] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074326, P50HL084936] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AILSBY RL, 1973, J PATHOL, V109, P75, DOI 10.1002/path.1711090108; ALBERT RE, 1969, ARCH ENVIRON HEALTH, V18, P738, DOI 10.1080/00039896.1969.10665482; AUERBACH O, 1979, NEW ENGL J MED, V300, P381, DOI 10.1056/NEJM197902223000801; BALLENGER JJ, 1960, NEW ENGL J MED, V263, P832, DOI 10.1056/NEJM196010272631704; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Calderon-Garciduenas L, 2001, AM J RESP CELL MOL, V24, P132, DOI 10.1165/ajrcmb.24.2.4157; Calderon-Garciduenas L, 1998, TOXICOL SCI, V46, P352, DOI 10.1006/toxs.1998.2549; Calderon-Garciduenas L, 1999, CARCINOGENESIS, V20, P383, DOI 10.1093/carcin/20.3.383; CAMNER P, 1972, ARCH ENVIRON HEALTH, V25, P60, DOI 10.1080/00039896.1972.10666136; CHANG SC, 1957, CANCER-AM CANCER SOC, V10, P1246, DOI 10.1002/1097-0142(195711/12)10:6<1246::AID-CNCR2820100623>3.0.CO;2-Z; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Danel C, 1996, AM J RESP CRIT CARE, V153, P362, DOI 10.1164/ajrccm.153.1.8542144; FOX B, 1983, EUR J RESPIR DIS, V64, P11; FOX B, 1981, CHEST, V80, P796, DOI 10.1378/chest.80.6.796; FULFORD GR, 1986, J THEOR BIOL, V121, P381, DOI 10.1016/S0022-5193(86)80098-4; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; GREENSTONE M, 1985, BRIT J DIS CHEST, V79, P9, DOI 10.1016/0007-0971(85)90003-8; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hylkema MN, 2007, EUR RESPIR J, V29, P438, DOI 10.1183/09031936.00124506; IBRAHIM AL, 1979, J ENVIRON PATHOL TOX, V3, P251; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; LEE RKW, 1997, LUNG SCI FDN, P2295; Look DC, 2001, AM J PATHOL, V159, P2055, DOI 10.1016/S0002-9440(10)63057-X; LOURENCO RV, 1971, J CLIN INVEST, V50, P1411, DOI 10.1172/JCI106624; LUNGARELLA G, 1983, LUNG, V161, P147, DOI 10.1007/BF02713856; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P429; MELLICK PW, 1977, LAB INVEST, V36, P82; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; MISKOVITS G, 1974, ACTA MORPHOL HUNG, V22, P91; Murin S, 2005, CLEV CLIN J MED, V72, P916, DOI 10.3949/ccjm.72.10.916; NAGAI A, 1991, AM REV RESPIR DIS, V144, P901, DOI 10.1164/ajrccm/144.4.901; NIKULA KJ, 1988, AM J PATHOL, V131, P373; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Ortug C, 2003, ANN ANAT, V185, P207, DOI 10.1016/S0940-9602(03)80024-9; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P355; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Rajagopalan V, 2009, MOL BIOL CELL, V20, P708, DOI 10.1091/mbc.E08-07-0746; ROSS KFA, 1953, Q J MICROSC SCI, V94, P125; Salathe M, 1997, LUNG SCI FDN, P2295; SANDERSON MJ, 1981, J CELL SCI, V47, P331; SERAFINI SM, 1977, B EUR PHYSIOPATH RES, V13, P551; SISSON JH, 1994, AM J RESP CRIT CARE, V149, P205, DOI 10.1164/ajrccm.149.1.8111584; SLEIGH MA, 1981, CHEST, V80, P791; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; SMALLMAN LA, 1986, HUM PATHOL, V17, P848, DOI 10.1016/S0046-8177(86)80206-4; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; STANLEY PJ, 1986, THORAX, V41, P519, DOI 10.1136/thx.41.7.519; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; VASTAG E, 1985, EUR J RESPIR DIS, V66, P93; VERDUGO P, 1991, AM REV RESPIR DIS, V144, pS33, DOI 10.1164/ajrccm/144.3_pt_2.S33; VERRA F, 1995, AM J RESP CRIT CARE, V151, P630; WANNER A, 1977, AM REV RESPIR DIS, V116, P73; WANNER A, 1985, EUR J RESPIR DIS, V66, P49; WOLFF RK, 1986, ENVIRON HEALTH PERSP, V66, P223, DOI 10.2307/3430237; YEATES DB, 1997, LUNG SCI FDN, P2295; 2005, J CLIN ONCOL, V23, P3175	66	141	145	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8157	10.1371/journal.pone.0008157	http://dx.doi.org/10.1371/journal.pone.0008157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016779	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834000002
J	Zak, PJ; Kurzban, R; Ahmadi, S; Swerdloff, RS; Park, J; Efremidze, L; Redwine, K; Morgan, K; Matzner, W				Zak, Paul J.; Kurzban, Robert; Ahmadi, Sheila; Swerdloff, Ronald S.; Park, Jang; Efremidze, Levan; Redwine, Karen; Morgan, Karla; Matzner, William			Testosterone Administration Decreases Generosity in the Ultimatum Game	PLOS ONE			English	Article							ECONOMIC DECISION-MAKING; SALIVARY TESTOSTERONE; OXYTOCIN RELEASE; NORMAL MEN; BEHAVIOR; EMPATHY; BRAIN; NEUROECONOMICS; AGGRESSION; ANDROGENS	How do human beings decide when to be selfish or selfless? In this study, we gave testosterone to 25 men to establish its impact on prosocial behaviors in a double-blind within-subjects design. We also confirmed participants' testosterone levels before and after treatment through blood draws. Using the Ultimatum Game from behavioral economics, we find that men with artificially raised T, compared to themselves on placebo, were 27% less generous towards strangers with money they controlled (95% CI placebo: (1.70, 2.72); 95% CI T: (.98, 2.30)). This effect scales with a man's level of total-, free-, and dihydrotestosterone (DHT). Men in the lowest decile of DHT were 560% more generous than men in the highest decile of DHT. We also found that men with elevated testosterone were more likely to use their own money punish those who were ungenerous toward them. Our results continue to hold after controlling for altruism. We conclude that elevated testosterone causes men to behave antisocially.	[Zak, Paul J.; Park, Jang; Efremidze, Levan; Redwine, Karen; Matzner, William] Claremont Grad Sch, Ctr Neuroecon Studies, Claremont, CA 91711 USA; [Kurzban, Robert] Univ Penn, Philadelphia, PA 19104 USA; [Ahmadi, Sheila] Univ Calif Los Angeles, Dept Endocrinol, Los Angeles, CA USA; [Swerdloff, Ronald S.] Harbor Univ Calif Los Angeles, Med Ctr, Div Endocrinol, Torrance, CA USA; [Morgan, Karla] Whitworth Univ, Dept Econ, Spokane, WA USA	Claremont Colleges; Claremont Graduate School; University of Pennsylvania; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Whitworth University	Zak, PJ (corresponding author), Claremont Grad Sch, Ctr Neuroecon Studies, Claremont, CA 91711 USA.	paul@pauljzak.com			MacArthur Foundation Research Network; Origin of Preferences; John Templeton Foundation	MacArthur Foundation Research Network; Origin of Preferences; John Templeton Foundation	The authors thank the MacArthur Foundation Research Network on The Nature and Origin of Preferences and the John Templeton Foundation for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic Y, 1998, BRAIN RES, V785, P167, DOI 10.1016/S0006-8993(97)01429-7; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; Book AS, 2001, AGGRESS VIOLENT BEH, V6, P579, DOI 10.1016/S1359-1789(00)00032-X; Bowles S, 2002, NATURE, V415, P125, DOI 10.1038/415125a; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Churchland PS, 2008, NEURON, V60, P409, DOI 10.1016/j.neuron.2008.10.023; Czoty PW, 2009, J NEUROENDOCRINOL, V21, P68, DOI 10.1111/j.1365-2826.2008.01800.x; Dabbs JM, 2000, HEROES ROGUES LOVERS; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Evuarherhe O, 2009, J PHYSIOL-LONDON, V587, P2977, DOI 10.1113/jphysiol.2008.168393; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; Harris JA, 1996, AGGRESSIVE BEHAV, V22, P321, DOI 10.1002/(SICI)1098-2337(1996)22:5<321::AID-AB1>3.0.CO;2-M; Hermans EJ, 2006, PSYCHONEUROENDOCRINO, V31, P859, DOI 10.1016/j.psyneuen.2006.04.002; INSEL TR, 1993, J NEUROENDOCRINOL, V5, P619, DOI 10.1111/j.1365-2826.1993.tb00531.x; Knickmeyer R, 2006, HORM BEHAV, V49, P282, DOI 10.1016/j.yhbeh.2005.08.010; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; KOURI EM, 1995, DRUG ALCOHOL DEPEN, V40, P73, DOI 10.1016/0376-8716(95)01192-7; LARSEN RJ, 1986, J PERS SOC PSYCHOL, V51, P803, DOI 10.1037/0022-3514.51.4.803; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Morhenn VB, 2008, EVOL HUM BEHAV, V29, P375, DOI 10.1016/j.evolhumbehav.2008.04.004; NISHIDA T, 1983, Primates, V24, P318, DOI 10.1007/BF02381978; O'Carroll RE, 1998, BEHAV BRAIN SCI, V21, P382, DOI 10.1017/S0140525X98461223; Petrie A, 2000, MED STAT GLANCE; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; RALEIGH MJ, 1984, ARCH GEN PSYCHIAT, V41, P405; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Singer Tania, 2007, Novartis Found Symp, V278, P20; Snyder M., 1987, PUBLIC APPEARANCES P; Stonehouse JM, 1998, J APPL STAT, V25, P63, DOI 10.1080/02664769823304; SWERDLOFF RS, 1992, PSYCHONEUROENDOCRINO, V17, P375, DOI 10.1016/0306-4530(92)90042-6; Swerdloff RS, 2000, J CLIN ENDOCR METAB, V85, P4500, DOI 10.1210/jc.85.12.4500; Takahashi T., 2008, J NEUROSCI PSYCHOL E, V1, P7, DOI DOI 10.1037/H0091587; Tricker R, 1996, J CLIN ENDOCR METAB, V81, P3754, DOI 10.1210/jc.81.10.3754; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.3.CO;2-T; Yates WR, 1999, BIOL PSYCHIAT, V45, P254, DOI 10.1016/S0006-3223(98)00028-6; Zak PJ, 2008, SCI AM, V298, P88, DOI 10.1038/scientificamerican0608-88; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2005, AM ECON REV, V95, P360, DOI 10.1257/000282805774669709; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544	49	148	156	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8330	10.1371/journal.pone.0008330	http://dx.doi.org/10.1371/journal.pone.0008330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533OP	20016825	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834000016
J	Anderson, DJ; Kaye, KS; Chen, LF; Schmader, KE; Choi, Y; Sloane, R; Sexton, DJ				Anderson, Deverick J.; Kaye, Keith S.; Chen, Luke F.; Schmader, Kenneth E.; Choi, Yong; Sloane, Richard; Sexton, Daniel J.			Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study	PLOS ONE			English	Article							POSTSTERNOTOMY MEDIASTINITIS; ATTRIBUTABLE MORTALITY; NOSOCOMIAL INFECTION; WOUND-INFECTION; BACTEREMIA; IMPACT; RISK; EPIDEMIOLOGY; PREVENTION; NETWORK	Background: The clinical and financial outcomes of SSIs directly attributable to MRSA and methicillin-resistance are largely uncharacterized. Previously published data have provided conflicting conclusions. Methodology: We conducted a multi-center matched outcomes study of 659 surgical patients. Patients with SSI due to MRSA were compared with two groups: matched uninfected control patients and patients with SSI due to MSSA. Four outcomes were analyzed for the 90-day period following diagnosis of the SSI: mortality, readmission, duration of hospitalization, and hospital charges. Attributable outcomes were determined by logistic and linear regression. Principal Findings: In total, 150 patients with SSI due to MRSA were compared to 231 uninfected controls and 128 patients with SSI due to MSSA. SSI due to MRSA was independently predictive of readmission within 90 days (OR = 35.0, 95% CI 17.3-70.7), death within 90 days (OR = 7.27, 95% CI 2.83-18.7), and led to 23 days (95% CI 19.7-26.3) of additional hospitalization and $61,681 (95% 23,352-100,011) of additional charges compared with uninfected controls. Methicillin-resistance was not independently associated with increased mortality (OR = 1.72, 95% CI 0.70-4.20) nor likelihood of readmission (OR = 0.43, 95% CI 0.21-0.89) but was associated with 5.5 days (95% CI 1.97-9.11) of additional hospitalization and $24,113 (95% 4,521-43,704) of additional charges. Conclusions/Significance: The attributable impact of S. aureus and methicillin-resistance on outcomes of surgical patients is substantial. Preventing a single case of SSI due to MRSA can save hospitals as much as $60,000.	[Anderson, Deverick J.; Chen, Luke F.; Choi, Yong; Sexton, Daniel J.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis,Duke Infect Control Outreach Netwo, Durham, NC 27710 USA; [Kaye, Keith S.] Detroit Med Ctr, Dept Med, Detroit, MI USA; [Kaye, Keith S.] Wayne State Univ, Detroit, MI USA; [Schmader, Kenneth E.] Duke Univ, Med Ctr, Dept Geriatr Med, Durham, NC USA; [Schmader, Kenneth E.] Durham VA Med Ctr, GRECC, Durham, NC USA; [Sloane, Richard] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Duke Infect Control Outreach Network, Durham, NC 27710 USA	Duke University; Detroit Medical Center; Wayne State University; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Anderson, DJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis,Duke Infect Control Outreach Netwo, Durham, NC 27710 USA.	dja@duke.edu	Kaye, Keith/AAF-1048-2019	Sexton, Daniel J/0000-0001-9604-5948; Anderson, Deverick/0000-0001-6882-5496	Pfizer, Inc.; Robert Wood Johnson Foundation; Merck and Co., Inc.; National Institute of Aging [K23 AG23621-01A1]; John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING [K23AG023621] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Merck and Co., Inc.(Merck & Company); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DJA is the recipient of the Pfizer Fellowship in Infectious Diseases from Pfizer, Inc., and is funded by the Robert Wood Johnson Foundation Physician Faculty Scholars Program. He has received additional research support from Pfizer, Inc. and Merck and Co., Inc. and has previously served on the speaker's bureau for Cubist. KSK is supported by NIH grant K23 AG23621-01A1 from the National Institute of Aging and by the John A. Hartford Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Anderson DJ, 2008, INFECT CONT HOSP EP, V29, P832, DOI 10.1086/590124; Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; Ben-David D, 2009, INFECT CONT HOSP EP, V30, P453, DOI 10.1086/596731; Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; *CDCP, 2007, NAT HEALTHC SAF NETW; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Combes A, 2004, CLIN INFECT DIS, V38, P822, DOI 10.1086/381890; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; CRUSE P, 1981, REV INFECT DIS, V3, P734; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Gonzalez C, 1999, CLIN INFECT DIS, V29, P1171, DOI 10.1086/313440; Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kaye KS, 2006, INFECT CONT HOSP EP, V27, P228, DOI 10.1086/500371; Kaye KS, 2006, J AM GERIATR SOC, V54, P391, DOI 10.1111/j.1532-5415.2005.00651.x; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Landerman LR, 1997, SOCIOL METHOD RES, V26, P3, DOI 10.1177/0049124197026001001; Lodise TP, 2007, PHARMACOTHERAPY, V27, P1001, DOI 10.1592/phco.27.7.1001; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Mekontso-Dessap A, 2001, CLIN INFECT DIS, V32, P877, DOI 10.1086/319355; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Schramm GE, 2007, INFECT CONT HOSP EP, V28, P95, DOI 10.1086/509856; Scott RD, 2009, DIRECT MED COSTS HEA; Whitby M, 2001, MED J AUSTRALIA, V175, P264, DOI 10.5694/j.1326-5377.2001.tb143562.x	30	124	127	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8305	10.1371/journal.pone.0008305	http://dx.doi.org/10.1371/journal.pone.0008305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016850	Green Submitted, gold, Green Published			2022-12-27	WOS:000272833800007
J	Duffy, D; Dawoodji, A; Agger, EM; Andersen, P; Westermann, J; Bell, EB				Duffy, Darragh; Dawoodji, Amina; Agger, Else Marie; Andersen, Peter; Westermann, Juergen; Bell, Eric B.			Immunological Memory Transferred with CD4 T Cells Specific for Tuberculosis Antigens Ag85B-TB10.4: Persisting Antigen Enhances Protection	PLOS ONE			English	Article							IN-VIVO; NAIVE-PHENOTYPE; BCG VACCINATION; B-CELLS; IMMUNITY; EFFICACY; SURVIVAL; ANTIBODY; SUBSETS; TB10.4	Background: High levels of death and morbidity worldwide caused by tuberculosis has stimulated efforts to develop a new vaccine to replace BCG. A number of Mycobacterium tuberculosis (Mtb)-specific antigens have been synthesised as recombinant subunit vaccines for clinical evaluation. Recently a fusion protein of TB antigen Ag85B combined with a second immunodominant TB antigen TB10.4 was emulsified with a novel non-phospholipid-based liposomal adjuvant to produce a new subunit vaccine, investigated here. Currently, there is no consensus as to whether or not long-term T cell memory depends on a source of persisting antigen. To explore this and questions regarding lifespan, phenotype and cytokine patterns of CD4 memory T cells, we developed an animal model in which vaccine-induced CD4 memory T cells could transfer immunity to irradiated recipients. Methodology/Principal Findings: The transfer of protective immunity using Ag85B-TB10.4-specific, CD45RB(low) CD62L(low) CD4 T cells was assessed in sub-lethally irradiated recipients following challenge with live BCG, used here as a surrogate for virulent Mtb. Donor T cells also carried an allotype marker allowing us to monitor numbers of antigen-specific, cytokine-producing CD4 T cells in recipients. The results showed that both Ag85B-TB10.4 and BCG vaccination induced immunity that could be transferred with a single injection of 3 x 10(6) CD4 T cells. Ten times fewer numbers of CD4 T cells (0.3 x 10(6)) from donors immunised with Ag85B-TB10.4 vaccine alone, transferred equivalent protection. CD4 T cells from donors primed by BCG and boosted with the vaccine similarly transferred protective immunity. When BCG challenge was delayed for 1 or 2 months after transfer (a test of memory T cell survival) recipients remained protected. Importantly, recipients that contained persisting antigen, either live BCG or inert vaccine, showed significantly higher levels of protection (p<0.01). Overall the numbers of IFN-gamma-producing CD4 T cells were poorly correlated with levels of protection. Conclusions/Significance: The Ag85B-TB10.4 vaccine, with or without BCG-priming, generated TB-specific CD4 T cells that transferred protective immunity in mice challenged with BCG. The level of protection was enhanced in recipients containing a residual source of specific antigen that could be either viable or inert.	[Duffy, Darragh; Dawoodji, Amina; Bell, Eric B.] Univ Manchester, Immunol Sect, Manchester, Lancs, England; [Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Westermann, Juergen] Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany	University of Manchester; Statens Serum Institut; University of Lubeck	Duffy, D (corresponding author), Univ Paris 06, INSERM, U543, Lab Immunol Cellulaire, Paris, France.	eric.bell@manchester.ac.uk		Andersen, Peter/0000-0002-5869-2551	European Commission [LSHP-CT-2003-503367]; Dunhill Medical Trust	European Commission(European CommissionEuropean Commission Joint Research Centre); Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported with funds from the European Commission contract no. LSHP-CT-2003-503367. Additional funding was provided by the Dunhill Medical Trust (www.dunhillmedical.org.uk) to EBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; BELL EB, 1987, J IMMUNOL, V139, P1379; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; Bell EB, 2001, EUR J IMMUNOL, V31, P1685, DOI 10.1002/1521-4141(200106)31:6<1685::AID-IMMU1685>3.0.CO;2-V; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Bunce C, 1997, J EXP MED, V185, P767, DOI 10.1084/jem.185.4.767; Christensen D, 2007, BBA-BIOMEMBRANES, V1768, P2120, DOI 10.1016/j.bbamem.2007.05.009; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Duffy D, 2006, IMMUNOLOGY, V119, P376, DOI 10.1111/j.1365-2567.2006.02446.x; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Hayashi N, 2002, P NATL ACAD SCI USA, V99, P6187, DOI 10.1073/pnas.092129899; Hayden KA, 1996, J IMMUNOL, V156, P48; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Leung CC, 2001, INT J TUBERC LUNG D, V5, P717; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mustafa AS, 2000, INFECT IMMUN, V68, P3933, DOI 10.1128/IAI.68.7.3933-3940.2000; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Robertson JM, 2006, IMMUNOL REV, V211, P49, DOI 10.1111/j.0105-2896.2006.00383.x; SARAWAR SR, 1993, EUR J IMMUNOL, V23, P103, DOI 10.1002/eji.1830230117; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; SPARSHOTT SM, 1994, EUR J IMMUNOL, V24, P2573, DOI 10.1002/eji.1830241102; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TOYOHARA M, 1959, Tubercle, V40, P184, DOI 10.1016/S0041-3879(59)80039-8; Yang CP, 2006, INT IMMUNOL, V18, P515, DOI 10.1093/intimm/dxh392; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	52	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8272	10.1371/journal.pone.0008272	http://dx.doi.org/10.1371/journal.pone.0008272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011592	Green Submitted, gold, Green Published			2022-12-27	WOS:000272830300027
J	Lee, SMY; Gardy, JL; Cheung, CY; Cheung, TKW; Hui, KPY; Ip, NY; Guan, Y; Hancock, REW; Peiris, JSM				Lee, Suki M. Y.; Gardy, Jennifer L.; Cheung, C. Y.; Cheung, Timothy K. W.; Hui, Kenrie P. Y.; Ip, Nancy Y.; Guan, Y.; Hancock, Robert E. W.; Peiris, J. S. Malik			Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages	PLOS ONE			English	Article							A H5N1; CYTOKINE SIGNALING-1; KAPPA-B; INTERFERON; CELLS; TRANSCRIPTION; PATHOGENESIS; INHIBITION; ACTIVATION; SUPPRESSOR	Human disease caused by highly pathogenic avian influenza (HPAI) H5N1 can lead to a rapidly progressive viral pneumonia leading to acute respiratory distress syndrome. There is increasing evidence from clinical, animal models and in vitro data, which suggests a role for virus-induced cytokine dysregulation in contributing to the pathogenesis of human H5N1 disease. The key target cells for the virus in the lung are the alveolar epithelium and alveolar macrophages, and we have shown that, compared to seasonal human influenza viruses, equivalent infecting doses of H5N1 viruses markedly up-regulate pro-inflammatory cytokines in both primary cell types in vitro. Whether this H5N1-induced dysregulation of host responses is driven by qualitative (i.e activation of unique host pathways in response to H5N1) or quantitative differences between seasonal influenza viruses is unclear. Here we used microarrays to analyze and compare the gene expression profiles in primary human macrophages at 1, 3, and 6 h after infection with H5N1 virus or low-pathogenic seasonal influenza A (H1N1) virus. We found that host responses to both viruses are qualitatively similar with the activation of nearly identical biological processes and pathways. However, in comparison to seasonal H1N1 virus, H5N1 infection elicits a quantitatively stronger host inflammatory response including type I interferon (IFN) and tumor necrosis factor (TNF)-alpha genes. A network-based analysis suggests that the synergy between IFN-beta and TNF-alpha results in an enhanced and sustained IFN and pro-inflammatory cytokine response at the early stage of viral infection that may contribute to the viral pathogenesis and this is of relevance to the design of novel therapeutic strategies for H5N1 induced respiratory disease.	[Lee, Suki M. Y.; Cheung, C. Y.; Cheung, Timothy K. W.; Hui, Kenrie P. Y.; Guan, Y.; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Gardy, Jennifer L.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Biotechnol Res Inst, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Peiris, J. S. Malik] Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Hong Kong University of Science & Technology; University of British Columbia; University of Hong Kong	Lee, SMY (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Guan, Yi/0000-0001-6057-9243	NIAID [HHSN26620070005C]; Council of the Hong Kong Special Administrative Region [HKU1/05C]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Area of Excellence Scheme of the University Grants Committee	This work was supported by the National Institutes of Health Grant (NIAID Contract: HHSN26620070005C; http://www.niaid.nih.gov/ncn/grants/default_grants.htm), the Canadian Institutes of Health Research Grant (grant number: TPA-90195; http://www.cihr.ca/e/193.html) and grants from the Research Grants Council of the Hong Kong Special Administrative Region, the Central Allocation Grant (grant number: HKU1/05C; http://www.ugc.edu.hk/eng/rgc/crf/crf.htm) and Area of Excellence Scheme of the University Grants Committee (grant number: AoE/M-12/06; http://www.ugc.edu.hk/eng/ugc/activity/aoes/aoes.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Bartee E, 2009, CYTOKINE, V47, P199, DOI 10.1016/j.cyto.2009.06.006; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; BILLHARZ R, 2009, J VIROL; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chae M, 2008, BIOCHEM BIOPH RES CO, V370, P519, DOI 10.1016/j.bbrc.2008.03.136; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Horsch K, 2007, MOL ENDOCRINOL, V21, P2929, DOI 10.1210/me.2007-0153; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Koen J.S., 1919, AM J VET MED ASSOC, V14, P468; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; MICHAELIS M, 2009, MED MICROBIOL IMMUNO; Mok CKP, 2007, J GEN VIROL, V88, P1275, DOI 10.1099/vir.0.82423-0; MOK KP, 2009, J INFECT DIS; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Takano R, 2009, ARCH VIROL, V154, P677, DOI 10.1007/s00705-009-0353-5; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Wei Q, 2000, DEV BIOL, V228, P239, DOI 10.1006/dbio.2000.9938; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	45	91	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8072	10.1371/journal.pone.0008072	http://dx.doi.org/10.1371/journal.pone.0008072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011590	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300001
J	Maffucci, T; Raimondi, C; Abu-Hayyeh, S; Dominguez, V; Sala, G; Zachary, I; Falasca, M				Maffucci, Tania; Raimondi, Claudio; Abu-Hayyeh, Shadi; Dominguez, Veronica; Sala, Gianluca; Zachary, Ian; Falasca, Marco			A Phosphoinositide 3-Kinase/Phospholipase Cgamma1 Pathway Regulates Fibroblast Growth Factor-Induced Capillary Tube Formation	PLOS ONE			English	Article							PHOSPHOLIPASE-C-GAMMA; ENDOTHELIAL-CELL PROLIFERATION; FACTOR RECEPTOR 1; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL 3-KINASE; PLC-GAMMA; ANGIOGENESIS; ACTIVATION; KINASE; PHOSPHORYLATION	Background: The fibroblast growth factors (FGFs) are key regulators of embryonic development, tissue homeostasis and tumour angiogenesis. Binding of FGFs to their receptor(s) results in activation of several intracellular signalling cascades including phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC)gamma 1. Here we investigated the basic FGF (FGF-2)-mediated activation of these enzymes in human umbilical vein endothelial cells (HUVECs) and defined their role in FGF-2-dependent cellular functions. Methodology/Principal Findings: We show that FGF-2 activates PLC gamma 1 in HUVECs measured by analysis of total inositol phosphates production upon metabolic labelling of cells and intracellular calcium increase. We further demonstrate that FGF-2 activates PI3K, assessed by analysing accumulation of its lipid product phosphatidylinositol-3,4,5-P(3) using TLC and confocal microscopy analysis. PI3K activity is required for FGF-2-induced PLC gamma 1 activation and the PI3K/PLC gamma 1 pathway is involved in FGF-2-dependent cell migration, determined using Transwell assay, and in FGF-2-induced capillary tube formation (tubulogenesis assays in vitro). Finally we show that PI3K-dependent PLC gamma 1 activation regulates FGF-2-mediated phosphorylation of Akt at its residue Ser473, determined by Western blotting analysis. This occurs through protein kinase C (PKC)alpha activation since dowregulation of PKC alpha expression using specific siRNA or blockade of its activity using chemical inhibition affects the FGF-2-dependent Ser473 Akt phosphorylation. Furthermore inhibition of PKC alpha blocks FGF-2-dependent cell migration. Conclusion/Significance: These data elucidate the role of PLC gamma 1 in FGF-2 signalling in HUVECs demonstrating its key role in FGF-2-dependent tubulogenesis. Furthermore these data unveil a novel role for PLC gamma 1 as a mediator of PI3K-dependent Akt activation and as a novel key regulator of different Akt-dependent processes.	[Maffucci, Tania; Raimondi, Claudio; Dominguez, Veronica; Sala, Gianluca; Falasca, Marco] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Inositide Signalling Grp,Ctr Diabet, London, England; [Abu-Hayyeh, Shadi; Zachary, Ian] UCL, British Heart Fdn Labs, Ctr Cardiovasc Biol & Med, Dept Med, London, England	University of London; Queen Mary University London; University of London; University College London	Maffucci, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Inositide Signalling Grp,Ctr Diabet, London, England.	m.falasca@qmul.ac.uk	Raimondi, Claudio/AAJ-4335-2020; Sala, Gianluca/C-2056-2017; Falasca, Marco/S-4020-2016	Raimondi, Claudio/0000-0002-1419-6855; Sala, Gianluca/0000-0002-4494-915X; Falasca, Marco/0000-0002-9801-7235	British Heart Foundation [PG/04/033/16906, PG/06/022/20348]; Barts and The London Charity [430/647]; Association for International Cancer Research [05-127]; British Heart Foundation [RG/06/003/21131] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Barts and The London Charity; Association for International Cancer Research; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation (grant PG/04/033/16906 and grant PG/06/022/20348 to MF). SA-H was supported by British Heart Foundation (grant PG/04/033/16906 to MF). VD was supported by Barts and The London Charity (grant 430/647 to TM). GS was supported by Association for International Cancer Research (grant 05-127 to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Ear T, 2001, J IMMUNOL METHODS, V257, P41, DOI 10.1016/S0022-1759(01)00445-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Landgren E, 1998, ONCOGENE, V17, P283, DOI 10.1038/sj.onc.1201936; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lee H, 2002, MOL VIS, V8, P17; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Maffucci T, 2007, BIOCHEM SOC T, V35, P229, DOI 10.1042/BST0350229; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; McLaughlin AP, 2001, AM J PHYSIOL-CELL PH, V281, pC1448, DOI 10.1152/ajpcell.2001.281.5.C1448; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Mochizuki Y, 2002, ONCOGENE, V21, P7027, DOI 10.1038/sj.onc.1205736; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; NGUYEN M, 1994, J NATL CANCER I, V86, P356, DOI 10.1093/jnci/86.5.356; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Preiss S, 2007, CARDIOVASC RES, V73, P833, DOI 10.1016/j.cardiores.2006.12.019; Price JT, 1999, CANCER RES, V59, P5475; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; SOUTTER AD, 1993, CANCER RES, V53, P5297; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Thomas SM, 2003, CANCER RES, V63, P5629; Turner T, 1997, CLIN CANCER RES, V3, P2275; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096	60	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8285	10.1371/journal.pone.0008285	http://dx.doi.org/10.1371/journal.pone.0008285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011604	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300037
J	Blom, SM; Schmitt, N; Jensen, HS				Blom, Sigrid Marie; Schmitt, Nicole; Jensen, Henrik Sindal			The Acrylamide (S)-2 As a Positive and Negative Modulator of Kv7 Channels Expressed in Xenopus laevis Oocytes	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; ANTICONVULSANT RETIGABINE; MOLECULAR DETERMINANTS; DOMINANT DEAFNESS; OPENER RETIGABINE; MAMMALIAN-CELLS; ACTIVATION; SUBUNITS; FORM; PHARMACOLOGY	Background: Activation of voltage-gated potassium channels of the Kv7 (KCNQ) family reduces cellular excitability. These channels are therefore attractive targets for treatment of diseases characterized by hyperexcitability, such as epilepsy, migraine and neuropathic pain. Retigabine, which opens Kv7.2-5, is now in clinical trial phase III for the treatment of partial onset seizures. One of the main obstacles in developing Kv7 channel active drugs has been to identify compounds that can discriminate between the neuronal subtypes, a feature that could help diminish side effects and increase the potential of drugs for particular indications. Methodology/Principal Findings: In the present study we have made a thorough investigation of the Bristol-Myers Squibb compound (S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide [(S)-2] on human Kv7.1-5 channels expressed in Xenopus laevis oocytes. We found that the compound was a weak inhibitor of Kv7.1. In contrast, (S)-2 efficiently opened Kv7.2-5 by producing hyperpolarizing shifts in the voltage-dependence of activation and enhancing the maximal current amplitude. Further, it reduced inactivation, accelerated activation kinetics and slowed deactivation kinetics. The mechanisms of action varied between the subtypes. The enhancing effects of (S)-2 were critically dependent on a tryptophan residue in S5 also known to be crucial for the effects of retigabine, (S)-1 and BMS-204352. However, while (S)-2 did not at all affect a mutant Kv7.4 with a leucine in this position (Kv7.4-W242L), a Kv7.2 with the same mutation (Kv7.2-W236L) was inhibited by the compound, showing that (S)-2 displays a subtype-selective interaction with in the Kv7 family. Conclusions/Significance: These results offer further insight into pharmacological activation of Kv7 channels, add to the understanding of small molecule interactions with the channels and may contribute to the design of subtype selective modulators.	[Blom, Sigrid Marie; Jensen, Henrik Sindal] H Lundbeck & Co AS, Sect Early Target Pharmacol & Physiol, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Lundbeck Corporation; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Blom, SM (corresponding author), H Lundbeck & Co AS, Sect Early Target Pharmacol & Physiol, Copenhagen, Denmark.	HSIN@Lundbeck.com	; Schmitt, Nicole/B-8725-2012	Blom, Sigrid Marie/0000-0002-2255-3234; Schmitt, Nicole/0000-0001-9482-9749	Danish National Research Foundation Centre for Cardiac Arrhythmia	Danish National Research Foundation Centre for Cardiac Arrhythmia(Danmarks Grundforskningsfond)	Funding was provided by the Danish National Research Foundation Centre for Cardiac Arrhythmia (www.DARC.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bentzen BH, 2006, NEUROPHARMACOLOGY, V51, P1068, DOI 10.1016/j.neuropharm.2006.07.001; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Hansen HH, 2006, J PHARMACOL EXP THER, V318, P1006, DOI 10.1124/jpet.106.106757; Jensen HS, 2007, BIOPHYS J, V92, P2747, DOI 10.1529/biophysj.106.101287; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Martin V, 2007, GEOSPATIAL HEALTH, V2, P3, DOI 10.4081/gh.2007.250; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroder RL, 2001, NEUROPHARMACOLOGY, V40, P888, DOI 10.1016/S0028-3908(01)00029-6; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Tatulian L, 2003, J PHYSIOL-LONDON, V549, P57, DOI 10.1113/jphysiol.2003.039842; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Towart Rob, 2009, Journal of Pharmacological and Toxicological Methods, V60, P1, DOI 10.1016/j.vascn.2009.04.197; Wang HS, 2000, MOL PHARMACOL, V57, P1218; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wu YJ, 2004, BIOORG MED CHEM LETT, V14, P1991, DOI 10.1016/j.bmcl.2004.01.069; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874	33	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8251	10.1371/journal.pone.0008251	http://dx.doi.org/10.1371/journal.pone.0008251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011514	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830200006
J	Duncan, PI; Raymond, F; Fuerholz, A; Sprenger, N				Duncan, Peter I.; Raymond, Frederic; Fuerholz, Andreas; Sprenger, Norbert			Sialic Acid Utilisation and Synthesis in the Neonatal Rat Revisited	PLOS ONE			English	Article							HUMAN-MILK; DEVELOPMENTAL-CHANGES; BRAIN GANGLIOSIDES; GENE-EXPRESSION; OLIGOSACCHARIDES; MOUSE; METABOLISM; EXCRETION; INFANTS; CHROMATOGRAPHY	Background: Milk is the sole source of nutrients for neonatal mammals and is generally considered to have co-evolved with the developmental needs of the suckling newborn. One evolutionary conserved constituent of milk and present on many glycoconjugates is sialic acid. The brain and colon are major sites of sialic acid display and together with the liver also of synthesis. Methodology/Principal Findings: In this study we examined in rats the relationship between the sialic acid content of milk and the uptake, utilization and synthesis of sialic acid in suckling pups. In rat milk sialic acid was found primarily as 3'sialyllactose and at highest levels between 3 and 10 days postpartum and that decreased towards weaning. In the liver of suckling pups sialic acid synthesis paralleled the increase in milk sialic acid reaching and keeping maximum activity from postnatal day 5 onwards. In the colon, gene expression profiles suggested that a switch from sialic acid uptake and catabolism towards sialic acid synthesis and utilization occurred that mirrored the change of sialic acid in milk from high to low expression. In brain sialic acid related gene expression profiles did not change to any great extent during the suckling period. Conclusions/Significance: Our results support the views that (i) when milk sialic acid levels are high, in the colon this sialic acid is catabolized to GlcNAc that in turn may be used as such or used as substrate for sialic acid synthesis and (ii) when milk sialic acid levels are low the endogenous sialic acid synthetic machinery in colon is activated.	[Duncan, Peter I.; Raymond, Frederic; Fuerholz, Andreas; Sprenger, Norbert] Nestle Res Ctr, CH-1000 Lausanne, Switzerland	Nestle SA	Duncan, PI (corresponding author), Nestle Res Ctr, CH-1000 Lausanne, Switzerland.	peter.duncan@rdls.nestle.com; norbert.sprenger@rdls.nestle.com		Raymond, Frederic/0000-0002-6148-6898	Nestec Ltd	Nestec Ltd	This work was funded by Nestec Ltd. The funders had input in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; BRUNETTI P, 1962, J BIOL CHEM, V237, P2447; Chaturvedi P, 2001, ADV EXP MED BIOL, V501, P315; Coppa GV, 2001, ADV EXP MED BIOL, V501, P307; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DICKSON JJ, 1978, BIOCHEM J, V170, P407, DOI 10.1042/bj1700407; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Gal B, 1997, COMP BIOCHEM PHYS B, V118, P13, DOI 10.1016/S0305-0491(97)00016-3; HARA S, 1986, J CHROMATOGR, V377, P111, DOI 10.1016/S0378-4347(00)80766-5; Horstkorte R, 1999, EUR J BIOCHEM, V260, P923, DOI 10.1046/j.1432-1327.1999.00253.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KARIM M, 2006, PERSPECT AGR VET SCI, V1, P18; KUHN NJ, 1972, BIOCHEM J, V130, P177, DOI 10.1042/bj1300177; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Kunz C, 1996, J CHROMATOGR B, V685, P211, DOI 10.1016/S0378-4347(96)00181-8; Laule O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-311; Luchansky SJ, 2003, J BIOL CHEM, V278, P8035, DOI 10.1074/jbc.M212127200; MORGAN BLG, 1980, J NUTR, V110, P416, DOI 10.1093/jn/110.3.416; MUCHMORE EA, 1992, GLYCOBIOLOGY, V2, P337, DOI 10.1093/glycob/2.4.337; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; NOHLE U, 1984, H-S Z PHYSIOL CHEM, V365, P1457, DOI 10.1515/bchm2.1984.365.2.1457; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; SABHARWAL H, 1991, J PEDIATR GASTR NUTR, V12, P480, DOI 10.1097/00005176-199105000-00012; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; VANRINSUM J, 1983, BIOCHEM J, V210, P21, DOI 10.1042/bj2100021; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Wang B, 1998, COMP BIOCHEM PHYS A, V119, P435, DOI 10.1016/S1095-6433(97)00445-5; Wang B, 2001, AM J CLIN NUTR, V74, P510; Wang B, 2007, ASIA PAC J CLIN NUTR, V16, P110; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; WITT W, 1979, NUTR METAB, V23, P51; Yarovaya N, 2005, NEUROBIOL DIS, V19, P351, DOI 10.1016/j.nbd.2004.12.020	43	33	35	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8241	10.1371/journal.pone.0008241	http://dx.doi.org/10.1371/journal.pone.0008241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011510	gold, Green Submitted, Green Published			2022-12-27	WOS:000272830200002
J	Moyano, AJ; Smania, AM				Moyano, Alejandro J.; Smania, Andrea M.			Simple Sequence Repeats and Mucoid Conversion: Biased mucA Mutagenesis in Mismatch Repair-Deficient Pseudomonas aeruginosa	PLOS ONE			English	Article							DNA-POLYMERASE-IV; GRAM-NEGATIVE BACTERIA; ALLOW RAPID DETECTION; CYSTIC-FIBROSIS; ESCHERICHIA-COLI; GENETIC ADAPTATION; SUICIDE VECTOR; LACZ MUTATIONS; ALGINATE; REPLICATION	In Pseudomonas aeruginosa, conversion to the mucoid phenotype marks the onset of an irreversible state of the infection in Cystic Fibrosis (CF) patients. The main pathway for mucoid conversion is mutagenesis of the mucA gene, frequently due to -1 bp deletions in a simple sequence repeat (SSR) of 5 Gs (G(5)-SSR426). We have recently observed that this mucA mutation is particularly accentuated in Mismatch Repair System (MRS)-deficient cells grown in vitro. Interestingly, previous reports have shown a high prevalence of hypermutable MRS-deficient strains occurring naturally in CF chronic lung infections. Here, we used mucA as a forward mutation model to systematically evaluate the role of G(5)-SSR426 in conversion to mucoidy in a MRS-deficient background, with this being the first analysis combining SSR-dependent localized hypermutability and the acquisition of a particular virulence/persistence trait in P. aeruginosa. In this study, mucA alleles were engineered with different contents of G: C SSRs, and tested for their effect on the mucoid conversion frequency and mucA mutational spectra in a mutS-deficient strain of P. aeruginosa. Importantly, deletion of G(5)-SSR426 severely reduced the emergence frequency of mucoid variants, with no preferential site of mutagenesis within mucA. Moreover, although mutagenesis in mucA was not totally removed, this was no longer the main pathway for mucoid conversion, suggesting that G(5)-SSR426 biased mutations towards mucA. Mutagenesis in mucA was restored by the addition of a new SSR (C-6-SSR431), and even synergistically increased when G(5)-SSR426 and C-6-SSR431 were present simultaneously, with the mucA mutations being restricted to -1 bp deletions within any of both G:C SSRs. These results confirm a critical role for G(5)-SSR426 enhancing the mutagenic process of mucA in MRS-deficient cells, and shed light on another mechanism, the SSR-localized hypermutability, contributing to mucoid conversion in P. aeruginosa.	[Moyano, Alejandro J.; Smania, Andrea M.] Univ Nacl Cordoba, CONICET, Dept Quim Biol,Fac Ciencias Quim, CIQUIBIC, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Moyano, AJ (corresponding author), Univ Nacl Cordoba, CONICET, Dept Quim Biol,Fac Ciencias Quim, CIQUIBIC, RA-5000 Cordoba, Argentina.	asmania@mail.fcq.unc.edu.ar	Moyano, Alejandro/AAB-9092-2019; Smania, Andrea/AAG-1105-2022; Smania, Andrea/AFK-2800-2022	Moyano, Alejandro/0000-0002-4976-7611; Smania, Andrea/0000-0002-6527-7719	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT-2007-00687]; Secretaria de Ciencia y Tecnica (SECYT-UNC) [05/C486]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Secretaria de Ciencia y Tecnica (SECYT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) Grant PICT-2007-00687 (http://www.agencia.gov.ar/), and Secretaria de Ciencia y Tecnica (SECYT-UNC) Grant 05/C486 (http://www.secyt.unc.edu.ar/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony M, 2002, J CLIN MICROBIOL, V40, P2772, DOI 10.1128/JCM.40.8.2772-2778.2002; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Blazquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810; Blazquez J, 2006, MOL MICROBIOL, V62, P84, DOI 10.1111/j.1365-2958.2006.05366.x; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Boucher JC, 2000, MOL MICROBIOL, V36, P341, DOI 10.1046/j.1365-2958.2000.01846.x; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; Cezairliyan BO, 2009, MOL MICROBIOL, V72, P368, DOI 10.1111/j.1365-2958.2009.06654.x; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; CUPPLES CG, 1990, GENETICS, V125, P275; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gawel D, 2002, MUTAT RES-FUND MOL M, V501, P129, DOI 10.1016/S0027-5107(02)00020-9; GOVAN JRW, 1981, J GEN MICROBIOL, V125, P217; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; KRIEG DP, 1986, J CLIN MICROBIOL, V24, P986, DOI 10.1128/JCM.24.6.986-990.1986; Kuban W, 2004, J BACTERIOL, V186, P4802, DOI 10.1128/JB.186.14.4802-4807.2004; Kuban W, 2005, J BACTERIOL, V187, P6862, DOI 10.1128/JB.187.19.6862-6866.2005; Levy DD, 2001, MUTAT RES-FUND MOL M, V474, P1, DOI 10.1016/S0027-5107(00)00169-X; MAI GT, 1993, INFECT IMMUN, V61, P559, DOI 10.1128/IAI.61.2.559-564.1993; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Petrosino JF, 2002, ANTIMICROB AGENTS CH, V46, P1535, DOI 10.1128/AAC.46.5.1535-1539.2002; PIER GB, 1990, SCIENCE, V249, P537, DOI 10.1126/science.2116663; Qiu DR, 2008, MICROBIOL-SGM, V154, P2119, DOI 10.1099/mic.0.2008/017368-0; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Reiling SA, 2005, MICROBIOL-SGM, V151, P2251, DOI 10.1099/mic.0.27772-0; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; Schnider-Keel U, 2001, APPL ENVIRON MICROB, V67, P5683, DOI 10.1128/AEM.67.12.5683-5693.2001; SIMPSON JA, 1989, FREE RADICAL BIO MED, V6, P347, DOI 10.1016/0891-5849(89)90078-6; Smania AM, 2004, MICROBIOL-SGM, V150, P1327, DOI 10.1099/mic.0.26751-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tegova R, 2004, J BACTERIOL, V186, P2735, DOI 10.1128/JB.186.9.2735-2744.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Yang ZW, 2001, MUTAT RES-FUND MOL M, V484, P95, DOI 10.1016/S0027-5107(01)00257-3; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684	61	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8203	10.1371/journal.pone.0008203	http://dx.doi.org/10.1371/journal.pone.0008203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997602	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829500020
J	Carrega, P; Pezzino, G; Queirolo, P; Bonaccorsi, I; Falco, M; Vita, G; Pende, D; Misefari, A; Moretta, A; Mingari, MC; Moretta, L; Ferlazzo, G				Carrega, Paolo; Pezzino, Gaetana; Queirolo, Paola; Bonaccorsi, Irene; Falco, Michela; Vita, Giuseppe; Pende, Daniela; Misefari, Aldo; Moretta, Alessandro; Mingari, Maria Cristina; Moretta, Lorenzo; Ferlazzo, Guido			Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells	PLOS ONE			English	Article							CLASS-I MOLECULES; MHC CLASS-I; ANTIGEN ABNORMALITIES; INHIBITORY RECEPTORS; MALIGNANT-CELLS; T-CELLS; RECOGNITION; EXPRESSION; IDENTIFICATION; CYTOTOXICITY	Background: Despite Natural Killer (NK) cells were originally defined as effectors of spontaneous cytotoxicity against tumors, extremely limited information is so far available in humans on their capability of killing cancer cells in an autologous setting. Methodology/Principal Findings: We have established a series of primary melanoma cell lines from surgically resected specimens and here showed that human melanoma cells were highly susceptible to lysis by activated autologous NK cells. A variety of NK cell activating receptors were involved in killing: particularly, DNAM-1 and NKp46 were the most frequently involved. Since self HLA class I molecules normally play a protective role from NK cell-mediated attack, we analyzed HLA class I expression on melanomas in comparison to autologous lymphocytes. We found that melanoma cells presented specific allelic losses in 50% of the patients analyzed. In addition, CD107a degranulation assays applied to NK cells expressing a single inhibitory receptor, revealed that, even when expressed, specific HLA class I molecules are present on melanoma cell surface in amount often insufficient to inhibit NK cell cytotoxicity. Remarkably, upon activation, also the so called "unlicensed'' NK cells, i.e. NK cells not expressing inhibitory receptor specific for self HLA class I molecules, acquired the capability of efficiently killing autologous melanoma cells, thus additionally contributing to the lysis by a mechanism independent of HLA class I expression on melanoma cells. Conclusions/Significance: We have investigated in details the mechanisms controlling the recognition and lysis of melanoma cells by autologous NK cells. In these autologous settings, we demonstrated an efficient in vitro killing upon NK cell activation by mechanisms that may be related or not to abnormalities of HLA class I expression on melanoma cells. These findings should be taken into account in the design of novel immunotherapy approaches against melanoma.	[Carrega, Paolo; Falco, Michela; Moretta, Lorenzo] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Pezzino, Gaetana; Bonaccorsi, Irene; Ferlazzo, Guido] Univ Messina, Lab Immunol & Biotherapy, Dept Human Pathol, Messina, Italy; [Queirolo, Paola; Pende, Daniela; Mingari, Maria Cristina] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Vita, Giuseppe; Misefari, Aldo] Univ Messina, Dept Pathol & Expt Microbiol, Unit Cell Typing, Messina, Italy; [Moretta, Alessandro; Mingari, Maria Cristina; Moretta, Lorenzo] Univ Genoa, Dept Expt Med, Genoa, Italy; [Moretta, Alessandro; Moretta, Lorenzo] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Messina; University of Genoa; IRCCS AOU San Martino IST; University of Messina; University of Genoa; University of Genoa	Carrega, P (corresponding author), Ist Giannina Gaslini, I-16148 Genoa, Italy.	guido.ferlazzo@unime.it	Bonaccorsi, Irene/J-7409-2016; Queirolo, Paola/K-6778-2016; Pende, Daniela/J-7429-2016; Carrega, Paolo/G-4883-2018; Mingari, Maria Cristina/AAB-1315-2019; Falco, Michela/K-1574-2016; Moretta, Lorenzo/AAA-7239-2020	Bonaccorsi, Irene/0000-0002-2893-0117; Queirolo, Paola/0000-0002-9917-6633; Pende, Daniela/0000-0003-1565-451X; Carrega, Paolo/0000-0001-8541-9115; Falco, Michela/0000-0002-0317-9830; Moretta, Lorenzo/0000-0003-4658-1747; Ferlazzo, Guido/0000-0002-3874-8554	Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Banco di Sicilia; Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica; Regione Sicilia, Ricerca Sanitaria Regionale 2007	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Banco di Sicilia; Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica; Regione Sicilia, Ricerca Sanitaria Regionale 2007	Research in the authors' laboratories is supported by: Associazione Italiana per la Ricerca sul Cancro (AIRC) (http://www.airc.it); Fondazione Banco di Sicilia (http://www.fondazionebancodisicilia.it/it/); Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica (http://www.ministerosalute.it/); Regione Sicilia, Ricerca Sanitaria Regionale 2007 (http://www.regione.sicilia.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; LopezBotet M, 1997, IMMUNOL REV, V155, P165, DOI 10.1111/j.1600-065X.1997.tb00949.x; Lozupone F, 2004, CANCER RES, V64, P378, DOI 10.1158/0008-5472.CAN-03-1501; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Pende D, 1998, EUR J IMMUNOL, V28, P2384, DOI 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Seliger B, 2002, SEMIN CANCER BIOL, V12, P3, DOI 10.1006/scbi.2001.0404; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010	27	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8132	10.1371/journal.pone.0008132	http://dx.doi.org/10.1371/journal.pone.0008132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997637	Green Submitted, gold, Green Published			2022-12-27	WOS:000272829200002
J	Klosowska-Wardega, A; Hasumi, Y; Burmakin, M; Ahgren, A; Stuhr, L; Moen, I; Reed, RK; Rubin, K; Hellberg, C; Heldin, CH				Klosowska-Wardega, Agnieszka; Hasumi, Yoko; Burmakin, Mikhail; Ahgren, Aive; Stuhr, Linda; Moen, Ingrid; Reed, Rolf K.; Rubin, Kristofer; Hellberg, Carina; Heldin, Carl-Henrik			Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-BB; INHIBITION; CANCER; CHEMOTHERAPY; TUMORS; TRANSPORT; PERICYTES; EFFICACY; IMATINIB; VESSELS	Elevation of the interstitial fluid pressure (IFP) of carcinoma is an obstacle in treatment of tumors by chemotherapy and correlates with poor drug uptake. Previous studies have shown that treatment with inhibitors of platelet-derived growth factor ( PDGF) or vascular endothelial growth factor ( VEGF) signaling lowers the IFP of tumors and improve chemotherapy. In this study, we investigated whether the combination of PDGFR and VEGFR inhibitors could further reduce the IFP of KAT-4 human carcinoma tumors. The tumor IFP was measured using the wick-in-needle technique. The combination of STI571 and PTK/ZK gave an additive effect on the lowering of the IFP of KAT-4 tumors, but the timing of the treatment was crucial. The lowering of IFP following combination therapy was accompanied by vascular remodeling and decreased vascular leakiness. The effects of the inhibitors on the therapeutic efficiency of Taxol were investigated. Whereas the anti-PDGF and anti-VEGF treatment did not significantly inhibit tumor growth, the inhibitors enhanced the effect of chemotherapy. Despite having an additive effect in decreasing tumor IFP, the combination therapy did not further enhance the effect of chemotherapy. Simultaneous targeting of VEGFR and PDGFR kinase activity may be a useful strategy to decrease tumor IFP, but the timing of the inhibitors should be carefully determined.	[Klosowska-Wardega, Agnieszka; Hasumi, Yoko; Burmakin, Mikhail; Ahgren, Aive; Hellberg, Carina; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Uppsala, Sweden; [Stuhr, Linda; Moen, Ingrid; Reed, Rolf K.] Univ Bergen, Dept Biomed, Bergen, Norway; [Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; University of Bergen; Uppsala University	Klosowska-Wardega, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Uppsala, Sweden.	Agnieszka.Klosowska-Wardega@LICR.uu.se	Reed, Rolf K./B-9422-2017; Rubin, Kristofer/AAC-1810-2020	Reed, Rolf K./0000-0002-2633-6595; Rubin, Kristofer/0000-0003-2789-6276; Burmakin, Mikhail/0000-0002-1370-6251	Swedish Cancer Foundation; Swedish Science Council; Research Council of Norway; Norwegian Cancer Society	Swedish Cancer Foundation; Swedish Science Council; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	KR was funded by the Swedish Cancer Foundation and the Swedish Science Council. RR was funded by the Research Council of Norway, and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; AIN KB, 1994, J CLIN ENDOCR METAB, V78, P1097, DOI 10.1210/jc.78.5.1097; [Anonymous], 1988, LAB ANIM-UK, V22, P195; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hasumi Y, 2007, INT J CANCER, V121, P2606, DOI 10.1002/ijc.22999; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; JAIN RK, 1991, INT J RADIAT BIOL, V60, P85, DOI 10.1080/09553009114551621; Lee CG, 2000, CANCER RES, V60, P5565; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pietras K, 2003, CLIN CANCER RES, V9, P3779; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2001, CANCER RES, V61, P2929; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; Rubin K, 2000, INT J CANCER, V86, P636, DOI 10.1002/(SICI)1097-0215(20000601)86:5<636::AID-IJC6>3.0.CO;2-R; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Wood JM, 2000, CANCER RES, V60, P2178	27	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8149	10.1371/journal.pone.0008149	http://dx.doi.org/10.1371/journal.pone.0008149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997591	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829200003
J	Crostarosa, F; Aravantinou, M; Akpogheneta, OJ; Jasny, E; Shaw, A; Kenney, J; Piatak, M; Lifson, JD; Teitelbaum, A; Hu, LY; Chudolij, A; Zydowsky, TM; Blanchard, J; Gettie, A; Robbiani, M				Crostarosa, Federica; Aravantinou, Meropi; Akpogheneta, Onome J.; Jasny, Edith; Shaw, Andrew; Kenney, Jessica; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Thomas M.; Blanchard, James; Gettie, Agegnehu; Robbiani, Melissa			A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PLASMACYTOID DENDRITIC CELLS; LENTIVIRUS-INDUCED PROTECTION; RHESUS MACAQUES; T-CELLS; CD8(+) LYMPHOCYTES; TYPE-2 HSV-2; DEPO-PROVERA; DOUBLE-BLIND; HIV-1 LEVELS	Background: Herpes simplex virus type-2 (HSV-2) infection enhances the transmission and acquisition of human immunodeficiency virus (HIV). This occurs in symptomatic and asymptomatic stages of HSV-2 infection, suggesting that obvious herpetic lesions are not required to increase HIV spread. An animal model to investigate the underlying causes of the synergistic action of the two viruses and where preventative strategies can be tested under such complex physiological conditions is currently unavailable. Methodology/Principal Findings: We set out to establish a rhesus macaque model in which HSV-2 infection increases the susceptibility to vaginal infection with a model immunodeficiency virus (simian-human immunodeficiency virus, SHIV-RT), and to more stringently test promising microbicides. HSV-2 exposure significantly increased the frequency of vaginal SHIV-RT infection (n = 6). Although cervical lesions were detected in only similar to 10% of the animals, long term HSV-2 DNA shedding was detected (in 50% of animals followed for 2 years). Vaginal HSV-2 exposure elicited local cytokine/chemokine (n = 12) and systemic low-level HSV-2-specific adaptive responses in all animals (n = 8), involving CD4(+) and CD8(+) HSV-specific T cells (n = 5). Local cytokine/chemokine responses were lower in co-infected animals, while simian immunodeficiency virus (SIV)-specific adaptive responses were comparable in naive and HSV-2-infected animals (n = 6). Despite the increased frequency of SHIV-RT infection, a new generation microbicide gel, comprised of Carraguard (R) and a non-nucleoside reverse transcriptase inhibitor MIV-150 (PC-817), blocked vaginal SHIV-RT infection in HSV-2-exposed animals (n = 8), just as in naive animals. Conclusions/Significance: We established a unique HSV-2 macaque model that will likely facilitate research to define how HSV-2 increases HIV transmission, and enable more rigorous evaluation of candidate anti-viral approaches in vivo.	[Crostarosa, Federica; Aravantinou, Meropi; Akpogheneta, Onome J.; Jasny, Edith; Shaw, Andrew; Kenney, Jessica; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Thomas M.; Robbiani, Melissa] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick, MD 21701 USA; [Blanchard, James] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tulane University; Rockefeller University	Crostarosa, F (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org		Akpogheneta, Onome/0000-0002-5213-4903	USAID Cooperative Agreement [GPO-A-00-04-00019-00]; Swedish Ministry of Foreign Affairs; NIH [R37 AI040877, U19 AI065412, RR00164]; National Cancer Institute (NCI) [N01 CO 124000]; F.M. Kirby Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040877, U19AI065412] Funding Source: NIH RePORTER	USAID Cooperative Agreement(United States Agency for International Development (USAID)); Swedish Ministry of Foreign Affairs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); F.M. Kirby Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the USAID Cooperative Agreement GPO-A-00-04-00019-00, the Swedish Ministry of Foreign Affairs, NIH grants R37 AI040877, U19 AI065412, the NIH base grant RR00164, and in part with Federal funds from the National Cancer Institute (NCI), NIH, under contract N01 CO 124000 (JDL and MP are employed at SAIC, but are funded by NCI. SAIC provided no funds for this research. JDL and MP provided reagents and analytical support.). MR is a 2002 Elizabeth Glaser Scientist. FC and OJA were supported by the F. M. Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; AURELIAN, 1992, HERPES SIMPLEX VIRUS, P473; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Celum C.L., 2004, HERPES, V11, p36A; Cline AN, 2005, J MED PRIMATOL, V34, P303; *COMM CAR US LAB A, 1985, GUID CAR US LAB AN, P1; Corey L, 2007, J INFECT DIS, V195, P1242, DOI 10.1086/513570; CUNNINGHAM AL, 1989, J CLIN INVEST, V83, P490, DOI 10.1172/JCI113908; Cunningham Anthony L, 2004, J HIV Ther, V9, P9; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gauduin MC, 2006, METHODS, V38, P263, DOI 10.1016/j.ymeth.2005.12.004; Genesca M, 2007, J MED PRIMATOL, V36, P266, DOI 10.1111/j.1600-0684.2007.00244.x; Harandi AM, 2001, AM J REPROD IMMUNOL, V46, P420, DOI 10.1034/j.1600-0897.2001.d01-34.x; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; Huff JL, 2003, EMERG INFECT DIS, V9, P246; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; King NJC, 1998, J IMMUNOL, V160, P1173; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; KOELLE DM, 1994, J INFECT DIS, V169, P956, DOI 10.1093/infdis/169.5.956; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; MERTZ GJ, 1985, SEX TRANSM DIS, V12, P33, DOI 10.1097/00007435-198501000-00007; Mikloska Z, 1998, J INFECT DIS, V177, P827, DOI 10.1086/515236; Mikloska Z, 1996, J INFECT DIS, V173, P7, DOI 10.1093/infdis/173.1.7; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Moriuchi M, 2000, VIROLOGY, V278, P534, DOI 10.1006/viro.2000.0667; PARR MB, 1994, LAB INVEST, V70, P369; Peretti S, 2005, BLOOD, V106, P1305, DOI 10.1182/blood-2004-12-4899; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Sacks SL, 2004, ANTIVIR RES, V63, pS19, DOI 10.1016/j.antiviral.2004.06.004; Sariol CA, 2005, J MED PRIMATOL, V34, P13, DOI 10.1111/j.1600-0684.2004.00086.x; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Teleshova N, 2004, J IMMUNOL, V173, P1647, DOI 10.4049/jimmunol.173.3.1647; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	57	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8060	10.1371/journal.pone.0008060	http://dx.doi.org/10.1371/journal.pone.0008060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	20011586	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828400014
J	Quinn, BA; Brake, T; Hua, X; Baxter-Jones, K; Litwin, S; Ellenson, LH; Connolly, DC				Quinn, Bridget A.; Brake, Tiffany; Hua, Xiang; Baxter-Jones, Kimberly; Litwin, Samuel; Ellenson, Lora Hedrick; Connolly, Denise C.			Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53	PLOS ONE			English	Article							MULTIPLE GENETIC CHANGES; SEROUS CARCINOMA; MOUSE MODEL; CANDIDATE PRECURSOR; CANCER; TUMORIGENESIS; MUTATIONS; MODULATION; EXPRESSION; FREQUENCY	Background: Approximately one out of every ten cases of epithelial ovarian cancer (EOC) is inherited. The majority of inherited cases of EOC result from mutations in the breast cancer associated gene 1 (BRCA1). In addition to mutation of BRCA1, mutation of the p53 gene is often found in patients with inherited breast and ovarian cancer syndrome. Methodology/Principal Findings: We investigated the role of loss of function of BRCA1 and p53 in ovarian cancer development using mouse models with conditionally expressed alleles of Brca1 and/or p53. Our results show that ovary-specific Cre-recombinase-mediated conditional inactivation of both Brca1(LoxP/LoxP) and p53(LoxP/LoxP) resulted in ovarian or reproductive tract tumor formation in 54% of mice, whereas conditional inactivation of either allele alone infrequently resulted in tumors (<= 55% of mice). In mice with conditionally inactivated Brca1(LoxP/LoxP) and p53(LoxP/LoxP), ovarian tumors arose after long latency with the majority exhibiting histological features consistent with high grade leiomyosarcomas lacking expression of epithelial, follicular or lymphocyte markers. In addition, tumors with conditional inactivation of both Brca1(LoxP/LoxP) and p53(LoxP/LoxP) exhibited greater genomic instability compared to an ovarian tumor with inactivation of only p53(LoxP/LoxP). Conclusions/Significance: Although conditional inactivation of both Brca1 and p53 results in ovarian tumorigenesis, our results suggest that additional genetic alterations or alternative methods for targeting epithelial cells of the ovary or fallopian tube for conditional inactivation of Brca1 and p53 are required for the development of a mouse model of Brca1-associated inherited EOC.	[Quinn, Bridget A.; Brake, Tiffany; Hua, Xiang; Baxter-Jones, Kimberly; Litwin, Samuel; Connolly, Denise C.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Ellenson, Lora Hedrick] Cornell Univ, Weil Med Coll, NewYork Presbyterian Hosp, New York, NY 10021 USA	Fox Chase Cancer Center; Cornell University; NewYork-Presbyterian Hospital	Quinn, BA (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Denise.Connolly@fccc.edu			United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH-07-1-0303, W81XWH-04-1-0063]; National Cancer Institute; Fox Chase Cancer Center Ovarian Cancer SPORE [P50 CA083638]; Fox Chase Cancer Center Core Grant [P30 CA006927]; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fox Chase Cancer Center Ovarian Cancer SPORE; Fox Chase Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP [https://cdmrp.org), W81XWH-07-1-0303 and W81XWH-04-1-0063 grants to DCC), National Cancer Institute [www.nci.nih.gov] grants: Fox Chase Cancer Center Ovarian Cancer SPORE (P50 CA083638), Fox Chase Cancer Center Core Grant (P30 CA006927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Buller RE, 2001, CLIN CANCER RES, V7, P831; Chan KYK, 2002, CANCER RES, V62, P4151; Chodankar R, 2005, CURR BIOL, V15, P561, DOI 10.1016/j.cub.2005.01.052; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; Connolly DC, 2003, CANCER RES, V63, P1389; Connolly DC, 2000, AM J PATHOL, V156, P339, DOI 10.1016/S0002-9440(10)64735-9; CONNOLLY DC, 2009, NENOGRATI TRANSGENIS; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DINNER D, 1996, NAT GENET, V4, P42; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Folkins AK, 2008, GYNECOL ONCOL, V109, P168, DOI 10.1016/j.ygyno.2008.01.012; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; NAROL SA, 1991, NAT REV CANCER, V4, P665; NING D, 2006, CANCER RES, V66, P8919; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; PATOES A, 2007, NEW ENGL J MED, V157, P2543; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Rhei E, 1998, CANCER RES, V58, P3193; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schorge JO, 2000, CANCER RES, V60, P1361; SEMMEL DR, 2002, MODERN PATHOL, V22, P985; SHAW PA, 2009, MOD PATHOL; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Sood AK, 1998, CANCER, V82, P1731, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.3.CO;2-0; Tashiro H, 1997, AM J PATHOL, V150, P177; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; WOO MM, 2001, GYNECOL ONCOL, V93, P315; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	54	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8404	10.1371/journal.pone.0008404	http://dx.doi.org/10.1371/journal.pone.0008404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YP	20046879	Green Published, gold, Green Submitted			2022-12-27	WOS:000207567200001
J	Yamanaka, N; Wong, CJ; Gertsenstein, M; Casper, RF; Nagy, A; Rogers, IM				Yamanaka, Nobuko; Wong, Christine J.; Gertsenstein, Marina; Casper, Robert F.; Nagy, Andras; Rogers, Ian M.			Bone Marrow Transplantation Results in Human Donor Blood Cells Acquiring and Displaying Mouse Recipient Class I MHC and CD45 Antigens on Their Surface	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CORD-BLOOD; PURKINJE NEURONS; NOD/SCID MICE; FUSION; CARDIOMYOCYTES; PROTEINS; ENGRAFT; CAPTURE; ORIGIN	Background: Mouse models of human disease are invaluable for determining the differentiation ability and functional capacity of stem cells. The best example is bone marrow transplants for studies of hematopoietic stem cells. For organ studies, the interpretation of the data can be difficult as transdifferentiation, cell fusion or surface antigen transfer (trogocytosis) can be misinterpreted as differentiation. These events have not been investigated in hematopoietic stem cell transplant models. Methodology/Principal Findings: In this study we investigated fusion and trogocytosis involving blood cells during bone marrow transplantation using a xenograft model. We report that using a standard SCID repopulating assay almost 100% of the human donor cells appear as hybrid blood cells containing both mouse and human surface antigens. Conclusion/Significance: Hybrid cells are not the result of cell-cell fusion events but appear to be due to efficient surface antigen transfer, a process referred to as trogocytosis. Antigen transfer appears to be non-random and includes all donor cells regardless of sub-type. We also demonstrate that irradiation preconditioning enhances the frequency of hybrid cells and that trogocytosis is evident in non-blood cells in chimera mice.	[Yamanaka, Nobuko; Wong, Christine J.; Gertsenstein, Marina; Casper, Robert F.; Nagy, Andras; Rogers, Ian M.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Casper, Robert F.; Rogers, Ian M.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Yamanaka, N (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	rogers@lunenfeld.ca	Casper, Robert F./E-3775-2013; Nagy, Andras/G-6465-2013; Rogers, Ian M/D-5092-2015	Casper, Robert F./0000-0002-6249-462X; Nagy, Andras/0000-0003-4311-0413; Rogers, Ian M/0000-0001-8466-1225	Insception Biosciences, Mississauga, Canada	Insception Biosciences, Mississauga, Canada	This project was supported by Insception Biosciences, Mississauga, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Gorin NC, 2002, J HEMATOTH STEM CELL, V11, P277, DOI 10.1089/152581602753658466; Grompe Markus, 2005, V265, P20; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kalberer CP, 2003, BLOOD, V102, P127, DOI 10.1182/blood-2002-07-2024; Kidder BL, 2008, CLONING STEM CELLS, V10, P231, DOI 10.1089/clo.2007.0039; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Madlambayan GJ, 2006, BIOL BLOOD MARROW TR, V12, P1020, DOI 10.1016/j.bbmt.2006.07.005; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nagy A., 2003, MANIPULATING MOUSE E; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Ratajczak MZ, 2007, LEUKEMIA, V21, P860, DOI 10.1038/sj.leu.2404630; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Riond J, 2007, SCAND J IMMUNOL, V66, P441, DOI 10.1111/j.1365-3083.2007.01996.x; Rogers I, 2007, EXP CELL RES, V313, P1839, DOI 10.1016/j.yexcr.2007.02.029; Rogers IM, 2008, BIOL BLOOD MARROW TR, V14, P927, DOI 10.1016/j.bbmt.2008.06.002; Sabzevari H, 2001, J IMMUNOL, V166, P2505, DOI 10.4049/jimmunol.166.4.2505; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Shi DQ, 2004, BLOOD, V104, P290, DOI 10.1182/blood-2003-03-0688; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Sussman MA, 2008, J MOL CELL CARDIOL, V44, P950, DOI 10.1016/j.yjmcc.2008.03.007; Tabiasco J, 2002, EUR J IMMUNOL, V32, P1502, DOI 10.1002/1521-4141(200205)32:5<1502::AID-IMMU1502>3.0.CO;2-Y; Tanaka M, 2000, METH MOL B, V158, P135; TILL JE, 1963, RADIAT RES, V18, P96, DOI 10.2307/3571429; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; VORMOOR J, 1994, BLOOD, V83, P2489; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Yamada S, 2008, STEM CELLS, V26, P2644, DOI 10.1634/stemcells.2008-0187; Zhou P, 2009, HEPATOLOGY, V49, P1992, DOI 10.1002/hep.22862; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	43	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8489	10.1371/journal.pone.0008489	http://dx.doi.org/10.1371/journal.pone.0008489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046883	gold, Green Published, Green Submitted			2022-12-27	WOS:000273180200003
J	Cachay, ER; Sitapati, A; Caperna, J; Freeborn, K; Lonergan, JT; Jocson, E; Mathews, WC				Cachay, Edward R.; Sitapati, Amy; Caperna, Joseph; Freeborn, Kellie; Lonergan, Joseph T.; Jocson, Edward; Mathews, William C.		Owen Clinic Study Grp	Denial of Risk Behavior Does Not Exclude Asymptomatic Anorectal Sexually Transmitted Infection in HIV-Infected Men	PLOS ONE			English	Article							ACID AMPLIFICATION TESTS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; SAN-FRANCISCO; SEX; PREVALENCE; CARE; CALIFORNIA; DIAGNOSIS; ACCURACY	Background:The Centers for Disease Control recommend screening for asymptomatic sexually transmitted infection (STI) among HIV-infected men when there is self-report of unprotected anal-receptive exposure. The study goals were: (1) to estimate the validity and usefulness for screening policies of self-reported unprotected anal-receptive exposure as a risk indicator for asymptomatic anorectal infection with Neisseria gonorrhoeae (GC) and/or Chlamydia trachomatis (CT). (2) to estimate the number of infections that would be missed if anal diagnostic assays were not performed among patients who denied unprotected anorectal exposure in the preceding month. Methods and Findings: Retrospective analysis in HIV primary care and high resolution anoscopy (HRA) clinics. HIV-infected adult men were screened for self-reported exposure during the previous month at all primary care and HRA appointments. Four sub-cohorts were defined based on microbiology methodology (GC culture and CT direct fluorescent antibody vs. GC/ CT nucleic acid amplification test) and clinical setting (primary care vs. HRA). Screening question operating characteristics were estimated using contingency table methods and then pooled across subcohorts. Among 803 patients, the prevalence of anorectal GC/CT varied from 3.5-20.1% in the 4 sub-cohorts. The sensitivity of the screening question for self-reported exposure to predict anorectal STI was higher in the primary care than in the HRA clinic, 86-100% vs. 12-35%, respectively. The negative predictive value of the screening question to predict asymptomatic anorectal STI was.90% in all sub-cohorts. In sensitivity analyses, the probability of being an unidentified case among those denying exposure increased from 0.48.1% in the primary care setting, and from 0.9-18.8% in the HRA setting as the prevalence varied from 1-20%. Conclusion: As STI prevalence increases, denial of unprotected anal-receptive exposure leads to an increasingly unacceptable proportion of unidentified asymptomatic anorectal STI if used as a criterion not to obtain microbiologic assays.	[Cachay, Edward R.; Sitapati, Amy; Caperna, Joseph; Freeborn, Kellie; Lonergan, Joseph T.; Jocson, Edward; Mathews, William C.; Owen Clinic Study Grp] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	Cachay, ER (corresponding author), Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA.	cmathews@ucsd.edu	Mathews, William C/E-4451-2010	Mathews, William C/0000-0002-2352-0725	University of California at San Diego Academy of Clinician Scholars; Pacific AIDS Education and Training Center [H4A HA 00058]; University of California at San Diego, Center for AIDS Research [AI 36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	University of California at San Diego Academy of Clinician Scholars; Pacific AIDS Education and Training Center; University of California at San Diego, Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grants of the University of California at San Diego Academy of Clinician Scholars, Pacific AIDS Education and Training Center (H4A HA 00058) and University of California at San Diego, Center for AIDS Research (AI 36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BONIN P, 1984, J CLIN MICROBIOL, V19, P218, DOI 10.1128/JCM.19.2.218-220.1984; BOOR M, 1973, J CLIN PSYCHOL, V29, P238, DOI 10.1002/1097-4679(197304)29:2<238::AID-JCLP2270290225>3.0.CO;2-D; Bousman CA, 2009, J AFFECT DISORDERS, V119, P84, DOI 10.1016/j.jad.2009.04.006; Cachay E, 2004, AIDS PATIENT CARE ST, V18, P349, DOI 10.1089/1087291041444050; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; Cook RL, 2002, SEX TRANSM INFECT, V78, P190, DOI 10.1136/sti.78.3.190; Grobbee DE, 2009, CLIN EPIDEMIOLOGY PR, P58; Gunn RA, 2008, SEX TRANSM DIS, V35, P845, DOI 10.1097/OLQ.0b013e318177ec70; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOOVER K, 2008, 2008 NAT STD PREV C; Jaccard J, 2004, J HEALTH PSYCHOL, V9, P699, DOI 10.1177/1359105304045354; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Klausner J. D., 2009, Morbidity and Mortality Weekly Report, V58, P716; Lister NA, 2003, SEX TRANSM DIS, V30, P886, DOI 10.1097/01.OLQ.0000099160.26205.22; Mansergh G, 2008, SEX TRANSM INFECT, V84, P509, DOI 10.1136/sti.2008.031807; Mettey A, 2003, SEX TRANSM INFECT, V79, P466, DOI 10.1136/sti.79.6.466; Mimiaga MJ, 2009, SEX TRANSM DIS, V36, P507, DOI 10.1097/OLQ.0b013e3181a2ad98; Reisner SL, 2009, AIDS BEHAV, V13, P822, DOI 10.1007/s10461-008-9430-0; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; RENAULT CA, 2008, MLO MED LAB OBS, V38, P12; RENAULT CA, 2006, MLO MED LAB OBS, V38, P27; RENAULT CA, 2006, MLO MED LAB OBS, V38, P24; Renault CA, 2006, MLO MED LAB OBS, V38, P21; Renault Cybele A, 2006, MLO Med Lab Obs, V38, P12; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Vivancos R, 2008, INT J STD AIDS, V19, P370, DOI 10.1258/ijsa.2007.007176	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8504	10.1371/journal.pone.0008504	http://dx.doi.org/10.1371/journal.pone.0008504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041143	Green Published, gold, Green Submitted			2022-12-27	WOS:000278068700018
J	Parsons, BD; Schindler, A; Evans, DH; Foley, E				Parsons, Brendon D.; Schindler, Anja; Evans, David H.; Foley, Edan			A Direct Phenotypic Comparison of siRNA Pools and Multiple Individual Duplexes in a Functional Assay	PLOS ONE			English	Article							SCALE RNAI SCREENS; GENOMIC ANALYSIS; INTERFERENCE; GENES; CELLS	Background: RNAi is a prominent tool for the identification of novel regulatory elements within complex cellular pathways. In invertebrates, RNAi is a relatively straightforward process, where large double-stranded RNA molecules initiate sequence-specific transcript destruction in target cells. In contrast, RNAi in mammalian cell culture assays requires the delivery of short interfering RNA duplexes to target cells. Due to concerns over off-target phenotypes and extreme variability in duplex efficiency, investigators typically deliver and analyze multiple duplexes per target. Currently, duplexes are delivered and analyzed either individually or as a pool of several independent duplexes. A choice between experiments based on siRNA pools or multiple individual duplexes has considerable implications for throughput, reagent requirements and data analysis in genome-wide surveys, yet there are relatively few data that directly compare the efficiency of the two approaches. Methodology/Principal Findings: To address this critical issue, we conducted a direct comparison of siRNA pools and multiple single siRNAs that target all human phosphatases in a robust functional assay. We determined the frequency with which both approaches uncover loss-of-function phenotypes and compared the phenotypic severity for siRNA pools and the constituent individual duplexes. Conclusions/Significance: Our survey indicates that screens with siRNA pools have several significant advantages over identical screens with the corresponding individual siRNA duplexes. Of note, we frequently observed greater phenotypic penetrance for siRNA pools than for the parental individual duplexes. Thus, our data indicate that experiments with siRNA pools have a greater likelihood of generating loss-of-function phenotypes than individual siRNA duplexes.	[Parsons, Brendon D.; Schindler, Anja; Evans, David H.; Foley, Edan] Univ Alberta, Alberta Inst Viral Immunol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta	Parsons, BD (corresponding author), Univ Alberta, Alberta Inst Viral Immunol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	efoley@ualberta.ca	Schindler, Anja/ABD-8311-2020; Evans, David H/M-1912-2016	Evans, David H/0000-0001-5871-299X	Canadian Institutes of Health Research [MOP 77746, MOP 10923]; Natural Sciences and Engineering Research Council [RGPIN 36487]; Alberta Cancer Board [23178]; Canada Foundation for Innovation; Alberta Science & Research Investment Program; Alberta Heritage Foundation for Medical Research Scholar	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Cancer Board; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science & Research Investment Program; Alberta Heritage Foundation for Medical Research Scholar(Alberta Heritage Foundation for Medical Research)	This work was supported by the Canadian Institutes of Health Research [MOP 77746 to E. F., MOP 10923 to D. H. E]; the Natural Sciences and Engineering Research Council [RGPIN 36487 to D. H. E.]; and the Alberta Cancer Board [23178 to D. H. E.]. Infrastructure funds were provided by the Canada Foundation for Innovation and the Alberta Science & Research Investment Program. E. F. is an Alberta Heritage Foundation for Medical Research Scholar and holds a Canada Research Chair in Innate Immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smith C, 2006, NAT METHODS, V3, P475, DOI 10.1038/nmeth0606-475; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062	14	51	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8471	10.1371/journal.pone.0008471	http://dx.doi.org/10.1371/journal.pone.0008471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041186	gold, Green Published			2022-12-27	WOS:000273105200007
J	Kodiha, M; Tran, D; Morogan, A; Qian, C; Stochaj, U				Kodiha, Mohamed; Tran, Dan; Morogan, Andreea; Qian, Cynthia; Stochaj, Ursula			Dissecting the Signaling Events That Impact Classical Nuclear Import and Target Nuclear Transport Factors	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; NUCLEOPORINS NUP153; PROTEIN; LOCALIZATION; INHIBITION; ALPHA; PHOSPHORYLATION; EXPRESSION; KINASE	Background: Signaling through MEK -> ERK1/2 and PI3 kinases is implicated in many aspects of cell physiology, including the survival of oxidant exposure. Oxidants play a role in numerous physiological and pathophysiological processes, many of which rely on transport in and out of the nucleus. However, how oxidative stress impacts nuclear trafficking is not well defined. Methodology/Principal Findings: To better understand the effect of stress on nucleocytoplasmic trafficking, we exposed cells to the oxidant diethyl maleate. This treatment activated MEK -> ERK1/2 as well as PI3 kinase -> Akt cascades and triggered the inhibition of classical nuclear import. To define the molecular mechanisms that regulate nuclear transport, we examined whether MEK and PI3 kinase signaling affected the localization of key transport factors. Using recently developed tools for image acquisition and analysis, the subcellular distributions of importin-alpha, CAS, and nucleoporins Nup153 and Nup88 were quantified in different cellular compartments. These studies identified specific profiles for the localization of transport factors in the nucleus and cytoplasm, and at the nuclear envelope. Our results demonstrate that MEK and PI3 kinase signaling as well as oxidative stress control nuclear trafficking and the localization of transport components. Furthermore, stress not only induced changes in transport factor distribution, but also upregulated post-translational modification of transport factors. Our results are consistent with the idea that the phosphorylation of importin-alpha, CAS, Nup153, and Nup88, and the O-GlcNAc modification of Nup153 increase when cells are exposed to oxidant. Conclusions/Significance: Our studies defined the complex regulation of classical nuclear import and identified key transport factors that are targeted by stress, MEK, and PI3 kinase signaling.	[Kodiha, Mohamed; Tran, Dan; Morogan, Andreea; Qian, Cynthia; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Kodiha, M (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021		Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Quebec (HSFQ); Heart and Stroke Foundation of Canada (HFSC); McGill University	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Quebec (HSFQ); Heart and Stroke Foundation of Canada (HFSC)(Heart & Stroke Foundation of Canada); McGill University	This research was supported by grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Heart and Stroke Foundation of Quebec (HSFQ) to US. MK is a recipient of a fellowship from the Heart and Stroke Foundation of Canada (HFSC). AM and CQ were supported by research bursaries from McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; CHU A, 2001, FASEB J, DOI DOI 10.1096/FJ.00-0680JJE; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Heistad DD, 2009, CIRC J, V73, P201, DOI 10.1253/circj.CJ-08-1082; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kalas W, 2002, LEUKEMIA LYMPHOMA, V43, P1469, DOI 10.1080/1042819022386815; Kim IS, 2000, J BIOL CHEM, V275, P23139, DOI 10.1074/jbc.M909256199; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Kumar D, 2002, HERZ, V27, P662, DOI 10.1007/s00059-002-2430-3; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P1265, DOI 10.1111/j.1745-7254.2005.00192.x; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Scherf U, 1998, BIOCHEM BIOPH RES CO, V250, P623, DOI 10.1006/bbrc.1998.9367; SCHULTE D, 1995, J CELL SCI, V108, P1381; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Stochaj U, 2000, FASEB J, V14, P2130, DOI 10.1096/fj.99-0751fje; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; ZACHARA NE, 2008, NUCLEUS, V2, P227	48	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8420	10.1371/journal.pone.0008420	http://dx.doi.org/10.1371/journal.pone.0008420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041180	gold, Green Published, Green Submitted			2022-12-27	WOS:000273104000003
J	Liu, XQ; Pawlyk, BS; Adamian, M; Olshevskaya, EV; Dizhoor, AM; Makino, CL; Li, TS				Liu, Xiaoqing; Pawlyk, Basil S.; Adamian, Michael; Olshevskaya, Elena V.; Dizhoor, Alexander M.; Makino, Clint L.; Li, Tiansen			Increased Light Exposure Alleviates One Form of Photoreceptor Degeneration Marked by Elevated Calcium in the Dark	PLOS ONE			English	Article							DOMINANT CONE DEGENERATION; GUANYLATE-CYCLASE; RETINITIS-PIGMENTOSA; TRANSGENIC MICE; MOUSE MODEL; RHODOPSIN; MUTATION; DYSTROPHY; APOPTOSIS; DISEASE	Background: In one group of gene mutations that cause photoreceptor degeneration in human patients, guanylyl cyclase is overactive in the dark. The ensuing excess opening of cGMP-gated cation channels causes intracellular calcium to rise to toxic levels. The Y99C mutation in guanylate cyclase-activating protein 1 (GCAP1) has been shown to act this way. We determined whether prolonged light exposure, which lowers cGMP levels through activation of phototransduction, might protect photoreceptors in a line of transgenic mice carrying the GCAP1-Y99C. Methodology/Principal Findings: We reared cohorts of GCAP1-Y99C transgenic mice under standard cyclic, constant dark and constant light conditions. Mouse eyes were analyzed by histology and by immunofluorescence for GFAP upregulation, a non-specific marker for photoreceptor degeneration. Full-field electroretinograms (ERGs) were recorded to assess retinal function. Consistent with our hypothesis, constant darkness accelerated disease, while continuous lighting arrested photoreceptor degeneration. Conclusions/Significance: In contrast to most forms of retinal degeneration, which are exacerbated by increased exposure to ambient light, a subset with mutations that cause overly active guanylyl cyclase and high intracellular calcium benefitted from prolonged light exposure. These findings may have therapeutic implications for patients with these types of genetic defects.	[Liu, Xiaoqing; Pawlyk, Basil S.; Adamian, Michael] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02115 USA; [Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Hafter Res Labs, Elkins Pk, PA USA; [Makino, Clint L.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA USA; [Li, Tiansen] NEI, Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Liu, XQ (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02115 USA.	tiansen.li@nih.gov	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY10309, EY10581, EY11522, EY12944, EY14104]; Macular Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [ZIAEY000490, R01EY010309, R01EY010581, P30EY014104, R01EY011522, R01EY012944, R01EY004939, R29EY010581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health EY10309, EY10581 (TL), EY11522 (AD), EY12944 (CLM), EY14104 (core grant), the Macular Vision Research Foundation, and the Foundation Fighting Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W., 2007, V45, P71; Baehr W, 2009, EXP EYE RES, V89, P2, DOI 10.1016/j.exer.2008.12.016; BERSON EL, 1971, ARCH OPHTHALMOL-CHIC, V85, P521, DOI 10.1001/archopht.1971.00990050523001; Bright SR, 2005, MOL VIS, V11, P1141; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LaVail MM, 1999, INVEST OPHTH VIS SCI, V40, P1020; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Liu CM, 2005, AM J PHYSIOL-CELL PH, V289, pC187, DOI 10.1152/ajpcell.00490.2004; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; SANYAL S, 1986, VISION RES, V26, P1177, DOI 10.1016/0042-6989(86)90099-4; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8438	10.1371/journal.pone.0008438	http://dx.doi.org/10.1371/journal.pone.0008438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041177	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000007
J	Schafer, G; Guler, R; Murray, G; Brombacher, F; Brown, GD				Schaefer, Georgia; Guler, Reto; Murray, Graeme; Brombacher, Frank; Brown, Gordon D.			The Role of Scavenger Receptor B1 in Infection with Mycobacterium tuberculosis in a Murine Model	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; IMMUNE-RESPONSES; MACROPHAGES; MICE; CELLS; PHAGOCYTOSIS; EXPRESSION; CHOLESTEROL; RECOGNITION	Background: The interaction between Mycobacterium tuberculosis (Mtb) and host cells is complex and far from being understood. The role of the different receptor(s) implicated in the recognition of Mtb in particular remains poorly defined, and those that have been found to have activity in vitro were subsequently shown to be redundant in vivo. Methods and Findings: To identify novel receptors involved in the recognition of Mtb, we screened a macrophage cDNA library and identified scavenger receptor B class 1 (SR-B1) as a receptor for mycobacteria. SR-B1 has been well-described as a lipoprotein receptor which mediates both the selective uptake of cholesteryl esters and the efflux of cholesterol, and has also recently been implicated in the recognition of other pathogens. We show here that mycobacteria can bind directly to SR-B1 on transfected cells, and that this interaction could be inhibited in the presence of a specific antibody to SR-B1, serum or LDL. We define a variety of macrophage populations, including alveolar macrophages, that express this receptor, however, no differences in the recognition and response to mycobacteria were observed in macrophages isolated from SR-B1(-/-) or wild type mice in vitro. Moreover, when wild type and SR-B1(-/-) animals were infected with a low dose of Mtb (100 CFU/mouse) there were no alterations in survival, bacterial burdens, granuloma formation or cytokine production in the lung. However, significant reduction in the production of TNF, IFN gamma, and IL10 were observed in SR-B1(-/-) mice following infection with a high dose of Mtb (1000 CFU/mouse), which marginally affected the size of inflammatory foci but did not influence bacterial burdens. Deficiency of SR-B1 also had no effect on resistance to disease under conditions of varying dietary cholesterol. We did observe, however, that the presence of high levels of cholesterol in the diet significantly enhanced the bacterial burdens in the lung, but this was independent of SR-B1. Conclusion: SR-B1 is involved in mycobacterial recognition, but this receptor plays only a minor role in anti-mycobacterial immunity in vivo. Like many other receptors for these pathogens, the loss of SR-B1 can be functionally compensated for under normal conditions.	[Schaefer, Georgia; Guler, Reto; Brombacher, Frank; Brown, Gordon D.] Univ Cape Town, Div Immunol, IIDMM, ZA-7925 Cape Town, South Africa; [Guler, Reto; Brombacher, Frank] ICGEB, Cape Town, South Africa; [Murray, Graeme] Univ Aberdeen, Sect Translat Med, Div Appl Med, Sch Med & Dent, Foresterhill, Scotland; [Brown, Gordon D.] Univ Aberdeen, Sect Immunol & Infect, Div Appl Med, Inst Med Sci, Foresterhill, Scotland	University of Cape Town; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Aberdeen; University of Aberdeen	Schafer, G (corresponding author), Univ Cape Town, Div Immunol, IIDMM, ZA-7925 Cape Town, South Africa.	gordon.brown@abdn.ac.uk	brown, gordon/B-4249-2012; Guler, Reto/A-4013-2011	brown, gordon/0000-0002-0287-5383	Deutsche Forschungsgemeinschaft (DFG), Germany [SCHA 1470/1-1]; Claude Leon Foundation, South Africa; National Research Foundation (NRF), South Africa; South African Research Chair Initiative of the Department of Science and Technology (DST); Wellcome Trust	Deutsche Forschungsgemeinschaft (DFG), Germany(German Research Foundation (DFG)); Claude Leon Foundation, South Africa; National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); South African Research Chair Initiative of the Department of Science and Technology (DST); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG), Germany, to GS ( grant SCHA 1470/1-1), the Claude Leon Foundation, South Africa, to GS and RG, the National Research Foundation (NRF), South Africa, to FB, the South African Research Chair Initiative of the Department of Science and Technology (DST) to FB, and the Wellcome Trust to GDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Baranova I, 2002, INFECT IMMUN, V70, P2995, DOI 10.1128/IAI.70.6.2995-3003.2002; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Ferguson JS, 2002, J IMMUNOL, V168, P1309, DOI 10.4049/jimmunol.168.3.1309; Ferguson JS, 1999, J IMMUNOL, V163, P312; Fidge NH, 1999, J LIPID RES, V40, P187; FREEMAN AE, 1970, J NATL CANCER I, V44, P65; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hall-Stoodley L, 2006, INFECT IMMUN, V74, P3587, DOI 10.1128/IAI.01644-05; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hu CG, 2000, J IMMUNOL, V165, P2596, DOI 10.4049/jimmunol.165.5.2596; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Randhawa AK, 2005, J IMMUNOL, V175, P1805, DOI 10.4049/jimmunol.175.3.1805; Reiling N, 2001, IMMUNOBIOLOGY, V204, P558, DOI 10.1078/0171-2985-00093; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schafer G, 2009, J INNATE IMMUN, V1, P231, DOI 10.1159/000173703; Schaefer Georgia, 2009, V531, P1, DOI 10.1007/978-1-59745-396-7_1; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Stokes RW, 1998, J IMMUNOL, V160, P5514; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	51	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8448	10.1371/journal.pone.0008448	http://dx.doi.org/10.1371/journal.pone.0008448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041149	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000013
J	Li, XX; Xu, YX; Ma, L; Sun, LY; Fu, GF; Hou, YY				Li, Xiaoxi; Xu, Yixin; Ma, Ling; Sun, Lingyun; Fu, Gengfeng; Hou, Yayi			17 beta-Estradiol Enhances the Response of Plasmacytoid Dendritic Cell to CpG	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; STRANDED DNA ANTIBODIES; ALPHA-PRODUCING CELLS; TOLL-LIKE RECEPTORS; I INTERFERON; IFN-ALPHA; INFLUENZA-VIRUS; BACTERIAL-DNA; B-CELLS; ACTIVATION	Gender differences in immune capabilities suggest that sex hormones such as estrogens were involved in the regulation of the immunocompetence. Numerous studies also suggest that plasmacytoid dendritic cells (PDCs) play a pathogenic role in SLE. However, it is unclear whether estrogen can modulate the function of PDCs to influence the development of SLE. In the present study, PDCs from murine spleens were treated with 17 beta-estradiol (E2) and CpG respectively or both in vitro, then cell viability, costimulatory molecule expression, cytokine secretion of PDCs, as well as stimulatory capacity of PDCs to B cells were analyzed. Results showed that E2 and CpG increased the cell viability and costimulatory molecule expression on PDCs synergistically. Moreover, the intracellular and extracellular secretion of IFN-alpha was increased by E2 or E2 plus CpG. In addition, E2 and CpG also increased the stimulatory capacity of PDCs to B cells, and the viability of B cells was decreased after neutralizing IFN-alpha significantly. In the experiments in vivo, mice received daily s.c. injections of E2 and CpG respectively or both, then we found that the plasma concentration of IgM were elevated by E2 and CpG synergistically and the expression of IFN-alpha/beta in spleens were noticeably increased by CpG plus E2 compared with the treatment of E2 or CpG only. This study indicates that E2 could exacerbate PDCs' activation with CpG, which further activates B cells to upregulate susceptibility to autoantigens. IFN-alpha plays an important role in the stimulatory effect of PDCs on B cells. E2 stimulation of IFN-alpha production may result in female prevalence in autoimmune diseases such as SLE through activation of PDCs. This study provides novel evidence of relationship between estrogen and SLE and also sheds light on gender biases among SLE patients.	[Li, Xiaoxi; Xu, Yixin; Ma, Ling; Hou, Yayi] Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Li, Xiaoxi; Xu, Yixin; Ma, Ling; Hou, Yayi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Lingyun] Nanjing Univ, Sch Med, Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Fu, Gengfeng] Jiangsu Ctr Dis Prevent & Control, Jiangsu, Peoples R China; [Hou, Yayi] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Li, XX (corresponding author), Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	yayihou@nju.edu.cn			National Natural Science Foundation [30771959]; Natural Science Research Foundation of Jiangsu Province [BK2006119]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Research Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work supported by grants from the National Natural Science Foundation (project number: 30771959) and Natural Science Research Foundation of Jiangsu Province ( project number: BK2006119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anolik J, 2004, CURR OPIN RHEUMATOL, V16, P505, DOI 10.1097/01.bor.0000133660.52599.f6; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bave U, 2001, J AUTOIMMUN, V17, P71, DOI 10.1006/jaut.2001.0519; BEAUMONT V, 1989, CLIN PHYSIOL BIOCH, V7, P263; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dubois B, 1998, J IMMUNOL, V161, P2223; Facchetti F, 2003, VIRCHOWS ARCH, V443, P703, DOI 10.1007/s00428-003-0918-8; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; HUMAN JU, 1985, J REPROD IMMUNOL, V7, P111; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jacobi AM, 2005, J EXP MED, V202, P341, DOI 10.1084/jem.20050221; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jiang B, 2007, CELL IMMUNOL, V248, P95, DOI 10.1016/j.cellimm.2007.10.004; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; LAHITA RG, 1982, ARTHRITIS RHEUM, V25, P843, DOI 10.1002/art.1780250726; LAHITA RG, 1981, J CLIN ENDOCR METAB, V53, P174, DOI 10.1210/jcem-53-1-174; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Linnik MD, 2005, ARTHRITIS RHEUM, V52, P1129, DOI 10.1002/art.20980; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; PETRI M, 1991, ARTHRITIS RHEUM, V34, P1538; Pisetsky DS, 2006, SCAND J IMMUNOL, V64, P200, DOI 10.1111/j.1365-3083.2006.01822.x; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Renaudineau Y, 2004, AUTOIMMUN REV, V3, P516, DOI 10.1016/j.autrev.2004.07.035; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Sato Y, 1999, J RHEUMATOL, V26, P294; STRANNEGARD O, 1982, CLIN EXP IMMUNOL, V50, P246; UROWITZ MB, 1993, ARTHRITIS RHEUM, V36, P1392, DOI 10.1002/art.1780361011; Vallin H, 1999, J IMMUNOL, V163, P6306; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wizemann T. M., 2001, EXPLORING BIOL CONTR; WONG KL, 1991, PEDIAT NEPHROLOGY, V5, P573; Woods A, 2007, J VIROL, V81, P12525, DOI 10.1128/JVI.00839-07; Yang LS, 2006, MOL IMMUNOL, V43, P357, DOI 10.1016/j.molimm.2005.02.012; Yao GH, 2004, INT IMMUNOPHARMACOL, V4, P213, DOI 10.1016/j.intimp.2003.12.005	49	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8412	10.1371/journal.pone.0008412	http://dx.doi.org/10.1371/journal.pone.0008412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037646	gold, Green Published, Green Submitted			2022-12-27	WOS:000272998100009
J	van de Wetering, D; de Paus, RA; van Dissel, JT; van de Vosse, E				van de Wetering, Diederik; de Paus, Roelof A.; van Dissel, Jaap T.; van de Vosse, Esther			Salmonella Induced IL-23 and IL-1 beta Allow for IL-12 Production by Monocytes and M phi 1 through Induction of IFN-gamma in CD56(+) NK/NK-Like T Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; NATURAL-KILLER-CELLS; INTERFERON-GAMMA; TYPE-2 MACROPHAGES; INTERLEUKIN (IL)-4; MONONUCLEAR-CELLS; CYTOKINE; GENE	Background: The type-1 cytokine pathway plays a pivotal role in immunity against intracellular bacterial pathogens such as Salmonellae and Mycobacteria. Bacterial stimulation of pattern recognition receptors on monocytes, macrophages and dendritic cells initiates this pathway, and results in the production of cytokines that activate lymphocytes to produce interferon (IFN)-gamma. Interleukin (IL)-12 and IL-23 are thought to be the key cytokines required for initiating a type-1 cytokine immune response to Mycobacteria and Salmonellae. The relative contribution of IL-23 and IL-12 to this process is uncertain. Methodology/Principal Findings: We show that various TLR agonists induce the production of IL-23 but not IL-12 in freshly isolated human monocytes and cultured human macrophages. In addition, type 1 pro-inflammatory macrophages (M phi 1) differentiated in the presence of GM-CSF and infected with live Salmonella produce IL-23, IL-1 beta and IL-18, but not IL-12. Supernatants of Salmonella-infected M phi 1 contained more IL-18 and IL-1 beta as compared with supernatants of M phi 1 stimulated with isolated TLR agonists, and induced IFN-gamma production in human CD56(+) cells in an IL-23 and IL-1 beta-dependent but IL-12-independent manner. In addition, IL-23 together with IL-18 or IL-1 beta led to the production of GM-CSF in CD56(+) cells. Both IFN-gamma and GM-CSF enhanced IL-23 production by monocytes in response to TLR agonists, as well as induced IL-12 production. Conclusions/Significance: The findings implicate a positive feedback loop in which IL-23 can enhance its release via induction of IFN-gamma and GM-CSF. The IL-23 induced cytokines allow for the subsequent production of IL-12 and amplify the IFN-gamma production in the type-1 cytokine pathway.	[van de Wetering, Diederik; de Paus, Roelof A.; van Dissel, Jaap T.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van de Wetering, D (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	E.van_de_Vosse@lumc.nl	van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009	van de Vosse, Esther/0000-0001-5199-3426				Abdi K, 2006, SCAND J IMMUNOL, V64, P83, DOI 10.1111/j.1365-3083.2006.01767.x; Bouter H, 2002, CRIT CARE MED, V30, P38, DOI 10.1097/00003246-200201000-00006; BURCHETT SK, 1988, J IMMUNOL, V140, P3473; Butchar JP, 2008, FEBS LETT, V582, P1044, DOI 10.1016/j.febslet.2008.02.058; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Carryn S, 2004, J INFECT DIS, V189, P2101, DOI 10.1086/420848; CHAMPSI JH, 1994, BIOTHERAPY, V7, P187, DOI 10.1007/BF01878485; Cooper MA, 2001, EUR J IMMUNOL, V31, P792, DOI 10.1002/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Hayes MP, 1998, BLOOD, V91, P4645, DOI 10.1182/blood.V91.12.4645.412k36_4645_4651; HAYES MP, 1995, BLOOD, V86, P646, DOI 10.1182/blood.V86.2.646.bloodjournal862646; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Hunter CA, 1997, EUR J IMMUNOL, V27, P2787, DOI 10.1002/eji.1830271107; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Marshall JD, 1997, J IMMUNOL, V159, P5705; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pirbonen J, 2002, J IMMUNOL, V169, P5673, DOI 10.4049/jimmunol.169.10.5673; SUZUKI K, 1994, CLIN EXP IMMUNOL, V98, P169; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van de Vosse E, 2006, MICROBES INFECT, V8, P1167, DOI 10.1016/j.micinf.2005.10.032; van de Wetering D, 2009, INT IMMUNOL, V21, P145, DOI 10.1093/intimm/dxn132; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; WING EJ, 1989, BLOOD, V73, P643	34	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8396	10.1371/journal.pone.0008396	http://dx.doi.org/10.1371/journal.pone.0008396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027291	Green Published, gold			2022-12-27	WOS:000272940100024
J	Sexton, M; Woodruff, G; Cudaback, E; Kreitzer, FR; Xu, C; Lin, YH; Moller, T; Bai, MF; Manning, HC; Bornhop, D; Stella, N				Sexton, Michelle; Woodruff, Grace; Cudaback, Eiron; Kreitzer, Faith R.; Xu, Cong; Lin, Yi Hsing; Moeller, Thomas; Bai, Mingfeng; Manning, H. Charles; Bornhop, Darryl; Stella, Nephi			Binding of NIR-conPK and NIR-6T to Astrocytomas and Microglial Cells: Evidence for a Protein Related to TSPO	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; IN-VIVO; HIGH-AFFINITY; MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; BRAIN-TUMORS; 18 KDA; LIGAND; ACTIVATION; PET	PK 11195 and DAA1106 bind with high-affinity to the translocator protein (TSPO, formerly known as the peripheral benzodiazepine receptor). TSPO expression in glial cells increases in response to cytokines and pathological stimuli. Accordingly, [(11)C]-PK 11195 and [(11)C]-DAA1106 are recognized molecular imaging (MI) agents capable of monitoring changes in TSPO expression occurring in vivo and in response to various neuropathologies. Here we tested the pharmacological characteristics and TSPO-monitoring potential of two novel MI agents: NIR-conPK and NIR-6T. NIR-conPK is an analogue of PK 11195 conjugated to the near-infrared (NIR) emitting fluorophore: IRDye 800CW. NIR-6T is a DAA1106 analogue also conjugated to IRDye 800CW. We found that NIR-6T competed for [(3)H]-PK 11195 binding in astrocytoma cell homogenates with nanomolar affinity, but did not exhibit specific binding in intact astrocytoma cells in culture, indicating that NIR-6T is unlikely to constitute a useful MI agent for monitoring TSPO expression in intact cells. Conversely, we found that NIR-conPK did not compete for [(3)H]-PK 11195 binding in astrocytoma cell homogenate, but exhibited specific binding in intact astrocytoma cells in culture with nanomolar affinity, suggesting that NIR-conPK binds to a protein distinct, but related to, TSPO. Accordingly, treating intact astrocytoma cells and microglia in culture with cytokines led to significant changes in the amount of NIR-conPK specific binding without corresponding change in TSPO expression. Remarkably, the cytokine-induced changes in the protein targeted by NIR-conPK in intact microglia were selective, since IFN-gamma (but not TNF alpha and TGF beta) increased the amount of NIR-conPK specific binding in these cells. Together these results suggest that NIR-conPK binds to a protein that is related to TSPO, and expressed by astrocytomas and microglia. Our results also suggest that the expression of this protein is increased by specific cytokines, and thus allows for the monitoring of a particular subtype of microglia activation.	[Sexton, Michelle] Bastyr Univ, Seattle, WA 98020 USA; [Sexton, Michelle; Woodruff, Grace; Cudaback, Eiron; Kreitzer, Faith R.; Xu, Cong; Lin, Yi Hsing; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Woodruff, Grace] Univ Washington, Neurobiol Undergrad Program, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bai, Mingfeng] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Dept Biomed Engn, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Program Chem & Phys Biol, Nashville, TN USA; [Bornhop, Darryl] Vanderbilt Univ, Dept Chem, Nashville, TN USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Sexton, M (corresponding author), Bastyr Univ, Seattle, WA 98020 USA.	nstella@u.washington.edu	Bai, Mingfeng/F-9246-2010; Möller, Thomas/W-8974-2019; Sexton, Michelle/ABD-9017-2020	Sexton, Michelle/0000-0002-0443-8355; Bai, Mingfeng/0000-0003-1139-0780	National Center for Complementary and Alternative Medicine (NCCAM) [T32ATO-0815-03]; National Institute of Neurological Disorders and Stroke (NINDS); National Science Foundation (NSF) [BES-0323067]; National Institute on Drug Abuse (NIDA) [DA14486]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014486] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Center for Complementary and Alternative Medicine (NCCAM) (T32ATO-0815-03) to MS; National Institute of Neurological Disorders and Stroke (NINDS) to TM; National Science Foundation (NSF) (BES-0323067) to DJB; and National Institute on Drug Abuse (NIDA) (DA14486) to NS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLIOT F, 1984, BRAIN RES, V306, P283, DOI 10.1016/0006-8993(84)90377-9; Bai M, 2007, BIOCONJUGATE CHEM, V18, P2018, DOI 10.1021/bc700251e; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BLACK KL, 1989, J NEUROSURG, V71, P113, DOI 10.3171/jns.1989.71.1.0113; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buvall L, 2007, J MOL CELL CARDIOL, V42, P1001, DOI 10.1016/j.yjmcc.2007.02.007; BYLUND DB, 1993, AM J PHYSIOL, V265, pL421, DOI 10.1152/ajplung.1993.265.5.L421; Cagnin A, 2004, ANN NEUROL, V56, P894, DOI 10.1002/ana.20332; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; Chaki S, 1999, EUR J PHARMACOL, V371, P197, DOI 10.1016/S0014-2999(99)00118-1; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Cleary J, 2007, BIOORG MED CHEM LETT, V17, P1667, DOI 10.1016/j.bmcl.2006.12.102; Costa B, 2006, MOL PHARMACOL, V69, P37, DOI 10.1124/mol.105.015289; Deane NG, 2007, MOL CANCER RES, V5, P341, DOI 10.1158/1541-7786.MCR-06-0225; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Fuller GN, 2002, BRAIN PATHOL, V12, P108; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gee MS, 2008, RADIOLOGY, V248, P925, DOI 10.1148/radiol.2482071496; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Gibson RM, 2004, VET J, V168, P230, DOI 10.1016/j.tvjl.2003.10.016; Giusti L, 2004, CLIN BIOCHEM, V37, P61, DOI 10.1016/j.clinbiochem.2003.10.004; GIUSTI L, 1994, BIOCHEM PHARMACOL, V48, P583, DOI 10.1016/0006-2952(94)90289-5; Goerres GW, 2001, AM J ROENTGENOL, V176, P1016, DOI 10.2214/ajr.176.4.1761016; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Gulyas B, 2009, NEUROCHEM INT, V54, P28, DOI 10.1016/j.neuint.2008.10.001; Hans G, 2005, BIOCHEM PHARMACOL, V69, P819, DOI 10.1016/j.bcp.2004.11.029; Hara M, 1998, EUR J PHARMACOL, V345, P339, DOI 10.1016/S0014-2999(98)00016-8; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; KEEN EM, 1999, METHOD MOL BIOL, P89; KOENIG JA, 1999, METHODS MOL BIOL; KUMANISHI T, 1967, JPN J EXP MED, V37, P461; LIMBIRD LE, 2005, IDENTIFICATION RECEP, P56; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; Manning HC, 2006, BIOCONJUGATE CHEM, V17, P735, DOI 10.1021/bc060020b; Manning HC, 2002, ORG LETT, V4, P1075, DOI 10.1021/ol017155b; Messmer K, 1998, NEUROSCI LETT, V241, P53, DOI 10.1016/S0304-3940(97)00967-1; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Nutt CL, 2003, CANCER RES, V63, P1602; Okubo T, 2004, BIOORGAN MED CHEM, V12, P423, DOI 10.1016/j.bmc.2003.10.050; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; Probst KC, 2007, NUCL MED BIOL, V34, P439, DOI 10.1016/j.nucmedbio.2007.02.009; QIAN H, 2008, J FLUORESC; Ryu JK, 2005, NEUROBIOL DIS, V20, P550, DOI 10.1016/j.nbd.2005.04.010; TOLL L, 1995, J PHARMACOL EXP THER, V273, P721; Urano Y, 2008, ANAL SCI, V24, P51, DOI 10.2116/analsci.24.51; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Venneti S, 2004, J CLIN INVEST, V113, P981, DOI 10.1172/JCI200420227; VENNETI S, 2006, PROGR NEURO IN PRESS; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Venneti S, 2007, J NEUROCHEM, V102, P2118, DOI 10.1111/j.1471-4159.2007.04690.x; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Williams Michael, 2004, Curr Opin Investig Drugs, V5, P29; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; ZHU SJ, 1994, MOL PHARMACOL, V45, P255	61	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8271	10.1371/journal.pone.0008271	http://dx.doi.org/10.1371/journal.pone.0008271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020060	Green Published, Green Submitted, gold			2022-12-27	WOS:000272870600003
J	Spencer, JL; Raghu, S				Spencer, Joseph L.; Raghu, S.			Refuge or Reservoir? The Potential Impacts of the Biofuel Crop Miscanthus x giganteus on a Major Pest of Maize	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; DIABROTICA-VIRGIFERA-VIRGIFERA; HOST-RANGE; COLEOPTERA; CHRYSOMELIDAE; BIOENERGY; ECOLOGY; LARVAE; SURVIVAL; INVASION	Background: Interest in the cultivation of biomass crops like the C4 grass Miscanthus x giganteus (Miscanthus) is increasing as global demand for biofuel grows. In the US, Miscanthus is promoted as a crop well-suited to the Corn Belt where it could be cultivated on marginal land interposed with maize and soybean. Interactions (direct and indirect) of Miscanthus, maize, and the major Corn Belt pest of maize, the western corn rootworm, (Diabrotica virgifera virgifera LeConte, WCR) are unknown. Adding a perennial grass/biomass crop to this system is concerning since WCR is adapted to the continuous availability of its grass host, maize (Zea mays). Methodology/Principal Findings: In a greenhouse and field study, we investigated WCR development and oviposition on Miscanthus. The suitability of Miscanthus for WCR development varied across different WCR populations. Data trends indicate that WCR populations that express behavioural resistance to crop rotation performed as well on Miscanthus as on maize. Over the entire study, total adult WCR emergence from Miscanthus (212 WCR) was 29.6% of that from maize (717 WCR). Adult dry weight was 75-80% that of WCR from maize; female emergence patterns on Miscanthus were similar to females developing on maize. There was no difference in the mean no. of WCR eggs laid at the base of Miscanthus and maize in the field. Conclusions/Significance: Field oviposition and significant WCR emergence from Miscanthus raises many questions about the nature of likely interactions between Miscanthus, maize and WCR and the potential for Miscanthus to act as a refuge or reservoir for Corn Belt WCR. Responsible consideration of the benefits and risks associated with Corn Belt Miscanthus are critical to protecting an agroecosystem that we depend on for food, feed, and increasingly, fuel. Implications for European agroecosystems in which Miscanthus is being proposed are also discussed in light of the WCR's recent invasion into Europe.	[Spencer, Joseph L.; Raghu, S.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Raghu, S.] Arid Zone Res Inst, Alice Springs, NT, Australia	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Spencer, JL (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	raghu@illinois.edu	Raghu, S./A-1281-2010; Spencer, Joe/B-6876-2012	Raghu, S./0000-0001-5843-5435; Spencer, Joe/0000-0003-4757-563X	Illinois Natural History Survey	Illinois Natural History Survey	These authors have no support or funding to report. Institutional funds from the Illinois Natural History Survey (where the authors were employed at the time of undertaking of this study) were used to defray part of the operational costs of this study. The Illinois Natural History Survey had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo W. T., 1964, Journal of the Kansas Entomological Society, V37, P9; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; BRANSON TF, 1970, J ECON ENTOMOL, V63, P800, DOI 10.1093/jee/63.3.800; BRANSON TF, 1967, J ECON ENTOMOL, V60, P201, DOI 10.1093/jee/60.1.201; Breitenbach S., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P241; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clark TL, 2004, ENVIRON ENTOMOL, V33, P681, DOI 10.1603/0046-225X-33.3.681; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Forbes S.A., 1883, REPORT STATE ENTOMOL, V12, P10; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Heaton E. A., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P433, DOI 10.1023/B:MITI.0000038848.94134.be; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hibbard BE, 2004, J ECON ENTOMOL, V97, P871, DOI 10.1603/0022-0493(2004)097[0871:ROEDOE]2.0.CO;2; Khanna M, 2008, BIOMASS BIOENERG, V32, P482, DOI 10.1016/j.biombioe.2007.11.003; LATTZ DH, 2008, FARM INCOME PRODUCTI; Lefko SA, 2008, J APPL ENTOMOL, V132, P189, DOI 10.1111/j.1439-0418.2008.01279.x; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Levine Eli, 2002, American Entomologist, V48, P94; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Moeser J, 2009, AGR FOREST ENTOMOL, V11, P3, DOI 10.1111/j.1461-9563.2008.00404.x; Moeser J, 2004, ENVIRON ENTOMOL, V33, P1169, DOI 10.1603/0046-225X-33.5.1169; *NAT AGR STAT SERV, 2009, US ALL STAT DAT CORN; Onstad DW, 1999, ENVIRON ENTOMOL, V28, P188, DOI 10.1093/ee/28.2.188; Onstad DW, 2001, ENTOMOL EXP APPL, V100, P195, DOI 10.1023/A:1019289030248; Oyediran IO, 2005, J ECON ENTOMOL, V98, P1679, DOI 10.1603/0022-0493-98.5.1679; Oyediran IO, 2004, ENVIRON ENTOMOL, V33, P740, DOI 10.1603/0046-225X-33.3.740; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Rice ME., 2004, PLANT HLTH PROG, DOI [10.1094/PHP-2004-0301-01-RV, DOI 10.1094/PHP-2004-0301-01-RV]; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Schneider JE, 2008, INT J HEALTH CARE FI, V8, P13, DOI 10.1007/s10754-007-9029-4; SHAW JT, 1976, NATURAL HIST SURVEY, V96; Sivcev I, 2009, J APPL ENTOMOL, V133, P430, DOI 10.1111/j.1439-0418.2009.01402.x; Spencer J.L., 2008, INSECT RESISTANCE MA, P153, DOI [10.1016/B978-0-12-373858-5.X5001-1, DOI 10.1016/B978-0-12-373858-5.X5001-1]; Spencer JL, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P121, DOI 10.1079/9780851998176.0121; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; Stewart JR, 2009, GCB BIOENERGY, V1, P126, DOI 10.1111/j.1757-1707.2009.01010.x; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; *UN FAO, 2009, FAOSTAT PROD PRODSTA; *UN ORG EC COOP, 2008, AGR OUTL 2008 2017; *USDA, 2006, AGR CHEM PROD TECHN; *USDA, 2006, EC INFORM B; *USDA, 2008, AD GEN ENG CROPS US; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Wilson TA, 2004, ENVIRON ENTOMOL, V33, P1102, DOI 10.1603/0046-225X-33.4.1102; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303	50	35	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8336	10.1371/journal.pone.0008336	http://dx.doi.org/10.1371/journal.pone.0008336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016814	Green Published, Green Submitted, gold			2022-12-27	WOS:000272834000022
J	Nakamura, T; Hillary, FG; Biswal, BB				Nakamura, Toru; Hillary, Frank G.; Biswal, Bharat B.			Resting Network Plasticity Following Brain Injury	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; NEURONAL AVALANCHES; FMRI; REORGANIZATION; ARCHITECTURE; PERFORMANCE; ACTIVATION; CORTEX	The purpose of this study was to examine neural network properties at separate time-points during recovery from traumatic brain injury (TBI) using graph theory. Whole-brain analyses of the topological properties of the fMRI signal were conducted in 6 participants at 3 months and 6 months following severe TBI. Results revealed alterations of network properties including a change in the degree distribution, reduced overall strength in connectivity, and increased "small-worldness'' from 3 months to 6 months post injury. The findings here indicate that, during recovery from injury, the strength but not the number of network connections diminishes, so that over the course of recovery, the network begins to approximate what is observed in healthy adults. These are the first data examining functional connectivity in a disrupted neural system during recovery.	[Nakamura, Toru; Biswal, Bharat B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA; [Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Nakamura, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, 185 S Orange Ave, Newark, NJ 07103 USA.	fhillary@psu.edu; bbiswal@yahoo.com	Hillary, Frank/AAN-8622-2021; nakamura, Toru/A-4535-2010		US National Institutes of Health [5R01NS049176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The current work is supported by US National Institutes of Health grant 5R01NS049176 to B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; FITZPATRICK NM, 2008, 36 ANN M INT NEUR SO; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; HILLARY FG, BRAIN IMAGI IN PRESS; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Marchiori M, 2000, PHYSICA A, V285, P539, DOI 10.1016/S0378-4371(00)00311-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1093/neucas/8.5.345; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stanley H.E., 1971, INTRO PHASE TRANSITI; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	58	183	187	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8220	10.1371/journal.pone.0008220	http://dx.doi.org/10.1371/journal.pone.0008220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011533	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300009
J	Tompkins, DH; Besnard, V; Lange, AW; Wert, SE; Keiser, AR; Smith, AN; Lang, R; Whitsett, JA				Tompkins, David H.; Besnard, Valerie; Lange, Alexander W.; Wert, Susan E.; Keiser, Angela R.; Smith, April N.; Lang, Richard; Whitsett, Jeffrey A.			Sox2 Is Required for Maintenance and Differentiation of Bronchiolar Clara, Ciliated, and Goblet Cells	PLOS ONE			English	Article							BASAL-CELLS; EPITHELIAL-CELLS; LUNG DEVELOPMENT; STEM-CELLS; AIRWAY; TRANSCRIPTION; MULTIPOTENT; ALVEOLARIZATION; MECHANISMS; EXPRESSION	The bronchioles of the murine lung are lined by a simple columnar epithelium composed of ciliated, Clara, and goblet cells that together mediate barrier function, mucociliary clearance and innate host defense, vital for pulmonary homeostasis. In the present work, we demonstrate that expression of Sox2 in Clara cells is required for the differentiation of ciliated, Clara, and goblet cells that line the bronchioles of the postnatal lung. The gene was selectively deleted in Clara cells utilizing Scgb1a1-Cre, causing the progressive loss of Sox2 in the bronchioles during perinatal and postnatal development. The rate of bronchiolar cell proliferation was decreased and associated with the formation of an undifferentiated, cuboidal-squamous epithelium lacking the expression of markers of Clara cells (Scgb1a1), ciliated cells (FoxJ1 and alpha-tubulin), and goblet cells (Spdef and Muc5AC). By adulthood, bronchiolar cell numbers were decreased and Sox2 was absent in extensive regions of the bronchiolar epithelium, at which time residual Sox2 expression was primarily restricted to selective niches of CGRP staining neuroepithelial cells. Allergen-induced goblet cell differentiation and mucus production was absent in the respiratory epithelium lacking Sox2. In vitro, Sox2 activated promoter-luciferase reporter constructs for differentiation markers characteristic of Clara, ciliated, and goblet cells, Scgb1a1, FoxJ1, and Agr2, respectively. Sox2 physically interacted with Smad3 and inhibited TGF-beta 1/Smad3-mediated transcriptional activity in vitro, a pathway that negatively regulates proliferation. Sox2 is required for proliferation and differentiation of Clara cells that serve as the progenitor cells from which Clara, ciliated, and goblet cells are derived.	[Tompkins, David H.] Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Perinatal Inst, Cincinnati, OH USA; Cincinnati Childrens Hosp, Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Tompkins, DH (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Perinatal Inst, Cincinnati, OH USA.	jeff.whitsett@cchmc.org	Lang, Richard/E-5578-2011	Lang, Richard/0000-0002-5212-254X; Besnard, Valerie/0000-0002-2614-629X	National Institutes of Health [HL090156, HL099580]; University of Cincinnati College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090156, R01HL095580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support from the National Institutes of Health HL090156 and HL099580 (J. A. W. and S. E. W.), and partial fulfillment of the graduate thesis in the Cancer Cell Biology program of the University of Cincinnati College of Medicine (D. H. T.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHEN G, 2009, J CLIN INVE IN PRESS; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Evans E.F., 1975, HDB SENSORY PHYSL, P1; EVANS MJ, 1978, LAB INVEST, V38, P648; EVANS MJ, 1974, CHEST, V65, pS62, DOI 10.1378/chest.65.4_Supplement.62S; *GENEPAINT, ATL GEN EXPR PATT MO; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Park ET, 2008, INT J CANCER, V122, P1253, DOI 10.1002/ijc.23225; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P695, DOI 10.1513/pats.200801-011AW; STRIPP BR, 1992, J BIOL CHEM, V267, P14703; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC; Zhang LQ, 1997, BBA-GENE STRUCT EXPR, V1350, P359, DOI 10.1016/S0167-4781(96)00180-7	52	136	138	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8248	10.1371/journal.pone.0008248	http://dx.doi.org/10.1371/journal.pone.0008248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011520	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300019
J	van der Linden, M; Al-Lahham, A; Nicklas, W; Reinert, RR				van der Linden, Mark; Al-Lahham, Adnan; Nicklas, Werner; Reinert, Ralf Rene			Molecular Characterization of Pneumococcal Isolates from Pets and Laboratory Animals	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INVASIVE DISEASE; IDENTIFICATION; CLONES; RATS; MENINGITIS; INFECTIONS; RESISTANCE; OUTBREAK; GERMANY	Background: Between 1986 and 2008 Streptococcus pneumoniae was isolated from 41 pets/zoo animals (guinea pigs (n = 17), cats (n = 12), horses (n = 4), dogs (n = 3), dolphins (n = 2), rat (n = 2), gorilla (n = 1)) treated in medical veterinary laboratories and zoos, and 44 laboratory animals (mastomys (multimammate mice; n = 32), mice (n = 6), rats (n = 4), guinea pigs (n = 2)) during routine health monitoring in an animal facility. S. pneumoniae was isolated from nose, lung and respiratory tract, eye, ear and other sites. Methodology/Principal Findings: Carriage of the same isolate of S. pneumoniae over a period of up to 22 weeks was shown for four mastomys. Forty-one animals showed disease symptoms. Pneumococcal isolates were characterized by optochin sensitivity, bile solubility, DNA hybridization, pneumolysin PCR, serotyping and multilocus sequence typing. Eighteen of the 32 mastomys isolates (56%) were optochin resistant, all other isolates were optochin susceptible. All mastomys isolates were serotype 14, all guinea pig isolates serotype 19F, all horse isolates serotype 3. Rats had serotypes 14 or 19A, mice 33A or 33F. Dolphins had serotype 23F, the gorilla serotype 14. Cats and dogs had many different serotypes. Four isolates were resistant to macrolides, three isolates also to clindamycin and tetracyclin. Mastomys isolates were sequence type (ST) 15 (serotype 14), an ST/serotype combination commonly found in human isolates. Cats, dogs, pet rats, gorilla and dolphins showed various human ST/serotype combinations. Lab rats and lab mice showed single locus variants (SLV) of human STs, in human ST/serotype combinations. All guinea pig isolates showed the same completely new combination of known alleles. The horse isolates showed an unknown allele combination and three new alleles. Conclusions/Significance: The isolates found in mastomys, mice, rats, cats, dogs, gorilla and dolphins are most likely identical to human pneumococcal isolates. Isolates from guinea pigs and horses appear to be specialized clones for these animals. Our data redraw attention to the fact that pneumococci are not strictly human pathogens. Pet animals that live in close contact to humans, especially children, can be infected by human isolates and also carriage of even resistant isolates is a realistic possibility.	[van der Linden, Mark; Reinert, Ralf Rene] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany; [Al-Lahham, Adnan] German Jordanian Univ, Sch Appl Med Sci, Amman, Jordan; [Nicklas, Werner] German Canc Res Ctr, D-6900 Heidelberg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; German-Jordanian University; Helmholtz Association; German Cancer Research Center (DKFZ)	van der Linden, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009; Reinert, Ralf Rene/D-6897-2011	van der Linden, Mark/0000-0002-6574-4313; 	Robert Koch Institute [1369-235]; German Ministry of Health	Robert Koch Institute; German Ministry of Health	The work was funded, in part, by grant 1369-235 from the Robert Koch Institute and the German Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2006, MICROB DRUG RESIST, V12, P239, DOI 10.1089/mdr.2006.12.239; AMTSBERG G, 1980, HDB BAKTERIELLEN INF, V2; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Baker D. G., 2003, NATURAL PATHOGENS LA; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; CHANTER N, 1994, EQUINE VET J, V26, P5, DOI 10.1111/j.2042-3306.1994.tb04319.x; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Chiavolini D, 2008, CLIN MICROBIOL REV, V21, P666, DOI 10.1128/CMR.00012-08; *CLIN LAB STAND I, 2006, PERF STAND ANT SUSC; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Duarte RS, 2005, J CLIN MICROBIOL, V43, P4592, DOI 10.1128/JCM.43.9.4592-4601.2005; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; FALLON MT, 1988, LAB ANIM SCI, V38, P129; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; FORD TM, 1965, LAB ANIM CARE, V15, P448; Gerber J, 2001, ACTA NEUROPATHOL, V101, P499; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Higgins R, 2000, CAN VET J, V41, P105; HOMBURGER F, 1945, SCIENCE, V102, P449, DOI 10.1126/science.102.2653.449; HUBER L, 1988, CAN VET J, V29, P665; Kuusi M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-36; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Michaud S, 1996, Can J Infect Dis, V7, P329; MIRICK GS, 1950, AM J HYG, V52, P48, DOI 10.1093/oxfordjournals.aje.a119408; MITRUKA BM, 1971, YALE J BIOL MED, V44, P253; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Reinert RR, 2005, J CLIN MICROBIOL, V43, P6035, DOI 10.1128/JCM.43.12.6035-6041.2005; Reinert RR, 2004, INT J ANTIMICROB AG, V24, P43, DOI 10.1016/j.ijantimicag.2004.02.020; van der Linden M, 2007, ANTIMICROB AGENTS CH, V51, P1830, DOI 10.1128/AAC.01453-06; Van der Ven LTM, 1999, INFECT IMMUN, V67, P6098, DOI 10.1128/IAI.67.11.6098-6103.1999; WEISBROTH SH, 1969, LAB ANIM CARE, V19, P473; Whatmore AM, 2001, J CLIN MICROBIOL, V39, P4196, DOI 10.1128/JCM.39.1.4196-4199.2001; Whatmore AM, 1999, INFECT IMMUN, V67, P2776, DOI 10.1128/IAI.67.6.2776-2782.1999; Zhang SP, 2006, J VET DIAGN INVEST, V18, P221, DOI 10.1177/104063870601800217	34	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8286	10.1371/journal.pone.0008286	http://dx.doi.org/10.1371/journal.pone.0008286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011527	Green Submitted, gold, Green Published			2022-12-27	WOS:000272830300038
J	Abhyankar, A; Park, HB; Tonolo, G; Luthman, H				Abhyankar, Avinash; Park, Hee-Bok; Tonolo, Giancarlo; Luthman, Holger			Comparative Sequence Analysis of the Non-Protein-Coding Mitochondrial DNA of Inbred Rat Strains	PLOS ONE			English	Article							MOUSE L-CELLS; D-LOOP REGION; SECONDARY STRUCTURE; STATISTICAL TESTS; BINDING SITES; REPLICATION; EVOLUTION; NEUTRALITY; MECHANISM; IDENTIFICATION	The proper function of mammalian mitochondria necessitates a coordinated expression of both nuclear and mitochondrial genes, most likely due to the co-evolution of nuclear and mitochondrial genomes. The non-protein coding regions of mitochondrial DNA (mtDNA) including the D-loop, tRNA and rRNA genes form a major component of this regulated expression unit. Here we present comparative analyses of the non-protein-coding regions from 27 Rattus norvegicus mtDNA sequences. There were two variable positions in 12S rRNA, 20 in 16S rRNA, eight within the tRNA genes and 13 in the D-loop. Only one of the three neutrality tests used demonstrated statistically significant evidence for selection in 16S rRNA and tRNA-Cys. Based on our analyses of conserved sequences, we propose that some of the variable nucleotide positions identified in 16S rRNA and tRNA-Cys, and the D-loop might be important for mitochondrial function and its regulation.	[Abhyankar, Avinash; Park, Hee-Bok; Tonolo, Giancarlo; Luthman, Holger] Lund Univ, Dept Clin Sci Malmo, Med Genet Unit, Malmo, Sweden; [Tonolo, Giancarlo] Azienda USL 2 Olbia, Diabetol Unit, Olbia, Italy	Lund University	Abhyankar, A (corresponding author), Lund Univ, Dept Clin Sci Malmo, Med Genet Unit, Malmo, Sweden.	avinash.abhyankar@med.lu.se			Swedish Research Council [K2006-72X-09109-17-3]; Knut och Alice Wallenbergs Stiftelse; Malmo University Hospital Research Foundations; Medical Faculty of Lund University; Novo Nordisk Foundation; Swedish Diabetes Association; Albert Pahlsson Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Malmo University Hospital Research Foundations; Medical Faculty of Lund University; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Albert Pahlsson Research Foundation	This study was supported by grants from the Swedish Research Council (K2006-72X-09109-17-3 and Linne grant to the Lund University Diabetes Center), the Knut och Alice Wallenbergs Stiftelse, the Malmo University Hospital Research Foundations, the Medical Faculty of Lund University, the Novo Nordisk Foundation, the Swedish Diabetes Association, and Albert Pahlsson Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3; BRANLANT C, 1981, NUCLEIC ACIDS RES, V9, P293, DOI 10.1093/nar/9.2.293; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Burk Angela, 2002, Journal of Mammalian Evolution, V9, P225, DOI 10.1023/A:1022649516930; CANTATORE P, 1995, J BIOL CHEM, V270, P25020, DOI 10.1074/jbc.270.42.25020; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Kai Y, 1999, BBA-GENE STRUCT EXPR, V1446, P126, DOI 10.1016/S0167-4781(99)00015-9; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Kraft A, 1999, GENETICS, V152, P1363; Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6; Mayer C, 1998, MOL MICROBIOL, V27, P455, DOI 10.1046/j.1365-2958.1998.00693.x; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005; Patel VB, 2001, J BIOL CHEM, V276, P6739, DOI 10.1074/jbc.M005781200; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roberti M, 1998, BIOCHEM BIOPH RES CO, V243, P36, DOI 10.1006/bbrc.1997.8052; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schlick NE, 2006, AM J PHYSIOL-CELL PH, V291, pC1183, DOI 10.1152/ajpcell.00234.2006; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Springer MS, 1996, J MOL EVOL, V43, P357; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; TAJIMA F, 1989, GENETICS, V123, P585; TAPPER DP, 1981, J BIOL CHEM, V256, P5109; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8148	10.1371/journal.pone.0008148	http://dx.doi.org/10.1371/journal.pone.0008148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997590	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829500010
J	Sengupta, U; Ukil, S; Dimitrova, N; Agrawal, S				Sengupta, Urmi; Ukil, Sanchaita; Dimitrova, Nevenka; Agrawal, Shipra			Expression-Based Network Biology Identifies Alteration in Key Regulatory Pathways of Type 2 Diabetes and Associated Risk/Complications	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-INTERACTION NETWORK; JAK/STAT SIGNALING PATHWAY; HUMAN SKELETAL-MUSCLE; FACTOR RECEPTOR; INSULIN-RESISTANCE; HIGH GLUCOSE; TGF-BETA; FATTY-ACIDS; MITOCHONDRIAL FISSION	Type 2 diabetes mellitus (T2D) is a multifactorial and genetically heterogeneous disease which leads to impaired glucose homeostasis and insulin resistance. The advanced form of disease causes acute cardiovascular, renal, neurological and microvascular complications. Thus there is a constant need to discover new and efficient treatment against the disease by seeking to uncover various novel alternate signalling mechanisms that can lead to diabetes and its associated complications. The present study allows detection of molecular targets by unravelling their role in altered biological pathways during diabetes and its associated risk factors and complications. We have used an integrated functional networks concept by merging co-expression network and interaction network to detect the transcriptionally altered pathways and regulations involved in the disease. Our analysis reports four novel significant networks which could lead to the development of diabetes and other associated dysfunctions. (a) The first network illustrates the up regulation of TGFBRII facilitating oxidative stress and causing the expression of early transcription genes via MAPK pathway leading to cardiovascular and kidney related complications. (b) The second network demonstrates novel interactions between GAPDH and inflammatory and proliferation candidate genes i.e., SUMO4 and EGFR indicating a new link between obesity and diabetes. (c) The third network portrays unique interactions PTPN1 with EGFR and CAV1 which could lead to an impaired vascular function in diabetic nephropathy condition. (d) Lastly, from our fourth network we have inferred that the interaction of beta-catenin with CDH5 and TGFBR1 through Smad molecules could contribute to endothelial dysfunction. A probability of emergence of kidney complication might be suggested in T2D condition. An experimental investigation on this aspect may further provide more decisive observation in drug target identification and better understanding of the pathophysiology of T2D and its complications.	[Sengupta, Urmi; Ukil, Sanchaita; Agrawal, Shipra] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India; [Agrawal, Shipra] BioCOS Life Sci Private Ltd, Bangalore, Karnataka, India; [Dimitrova, Nevenka] Briarcliff Manor, Philips Res N Amer, New York, NY USA	Philips; Philips Research	Sengupta, U (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	shipra@ibab.ac.in			Philips Research Asia, Bangalore; India Department of Information Technology, New Delhi, India	Philips Research Asia, Bangalore; India Department of Information Technology, New Delhi, India	This work was partially funded by Philips Research Asia, Bangalore, India Department of Information Technology, New Delhi, India. One of the authors in this paper, Dr. Nevenka Dimitrova who belongs to Philips Research Asia, Bangalore, India has actively participated in planning and executing this study.	Adhikary L, 2004, DIABETOLOGIA, V47, P1210, DOI 10.1007/s00125-004-1437-0; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baudry A, 2002, EMBO REP, V3, P323, DOI 10.1093/embo-reports/kvf078; Begley TJ, 2002, MOL CANCER RES, V1, P103; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Bento JL, 2004, DIABETES, V53, P3007, DOI 10.2337/diabetes.53.11.3007; Bergholdt R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r253; Bhattacharya S, 2007, J INDIAN MED ASSOC, V105, P594; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Bouskela E, 2007, B ACAD NAT MED PARIS, V191, P475, DOI 10.1016/S0001-4079(19)33040-7; Bray GA, 2008, AM J CLIN NUTR, V87, P1212, DOI 10.1093/ajcn/87.5.1212; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cheyssac C, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-44; Chu LH, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-56; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Corton M, 2007, J CLIN ENDOCR METAB, V92, P328, DOI 10.1210/jc.2006-1665; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Friedel CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-519; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Gogg S, 2002, J BIOL CHEM, V277, P36045, DOI 10.1074/jbc.M200575200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283; Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x; Hong SW, 2001, AM J PATHOL, V158, P1653; Hong YR, 1998, BIOCHEM BIOPH RES CO, V249, P697, DOI 10.1006/bbrc.1998.9253; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Janghorbani M, 2006, ACTA NEUROL SCAND, V114, P384, DOI 10.1111/j.1600-0404.2006.00716.x; Jbour AS, 2003, SAUDI MED J, V24, P761; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Li C., 2003, ANAL GENE EXPRESSION, P120; Lin CL, 2008, AM J NEPHROL, V28, P290, DOI 10.1159/000111142; Lin HY, 2007, DIABETES, V56, P1177, DOI 10.2337/db06-1283; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Luo XP, 2004, AM J PHYSIOL-ENDOC M, V287, pE991, DOI 10.1152/ajpendo.00200.2004; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mao CP, 2005, ACTA PHARMACOL SIN, V26, P982, DOI 10.1111/j.1745-7254.2005.00133.x; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marks JB, 1998, MED CLIN N AM, V82, P877, DOI 10.1016/S0025-7125(05)70028-6; Marrero MB, 2006, AM J PHYSIOL-RENAL, V290, pF762, DOI 10.1152/ajprenal.00181.2005; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; McCole DF, 2007, J BIOL CHEM, V282, P13303, DOI 10.1074/jbc.M700424200; McKnight AJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-5; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Ng A, 2006, NUCLEIC ACIDS RES, V34, pD527, DOI 10.1093/nar/gkj044; Ng SK, 2003, BIOINFORMATICS, V19, P923, DOI 10.1093/bioinformatics/btg118; Ng SK, 2003, NUCLEIC ACIDS RES, V31, P251, DOI 10.1093/nar/gkg079; Noso S, 2007, J CLIN ENDOCR METAB, V92, P2358, DOI 10.1210/jc.2007-0031; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Okazaki Yuko, 2007, Clin Exp Nephrol, V11, P77, DOI 10.1007/s10157-006-0456-1; Oksvold MP, 2004, FEBS LETT, V569, P207, DOI 10.1016/j.febslet.2004.05.068; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Ramachandran A, 2002, CURR SCI INDIA, V83, P1471; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Sasso FC, 2005, J AM COLL CARDIOL, V46, P827, DOI 10.1016/j.jacc.2005.06.007; Sato H, 1998, AM J NEPHROL, V18, P490, DOI 10.1159/000013415; SayedAhmed N, 1996, EXP NEPHROL, V4, P330; SCARDONI G, 2008, CENTISCAPE CYTOSCAPE; Schwartz MM, 1998, NEPHROL DIAL TRANSPL, V13, P2547, DOI 10.1093/ndt/13.10.2547; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; SHANKLAND SJ, 1995, KIDNEY INT, V47, P782, DOI 10.1038/ki.1995.119; Shen W, 2006, J AM SOC NEPHROL, V17, P2414, DOI 10.1681/ASN.2005111157; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Stein A, 2005, NUCLEIC ACIDS RES, V33, pD413, DOI 10.1093/nar/gki037; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tappenden KA, 1998, DIGEST DIS SCI, V43, P1526, DOI 10.1023/A:1018819032620; Tian YC, 2002, AM J PATHOL, V160, P1619, DOI 10.1016/S0002-9440(10)61109-1; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wei WZ, 2008, BIOCHEM BIOPH RES CO, V375, P454, DOI 10.1016/j.bbrc.2008.08.028; Weisstein E.W., LEAST SQUARES FITTIN; Whorwood CB, 2002, DIABETES, V51, P1066, DOI 10.2337/diabetes.51.4.1066; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yang X, 2002, DIABETOLOGIA, V45, P1584, DOI 10.1007/s00125-002-0905-7; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhao JW, 2008, CELL PHYSIOL BIOCHEM, V21, P445, DOI 10.1159/000129637	125	53	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8100	10.1371/journal.pone.0008100	http://dx.doi.org/10.1371/journal.pone.0008100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997558	gold, Green Submitted, Green Published			2022-12-27	WOS:000272829500006
J	Bell, CE; Watson, AJ				Bell, Christine E.; Watson, Andrew J.			SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become Segregated to the TE in the Mouse Blastocyst	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NA/K-ATPASE; GENE; EMBRYO; CELL; TROPHECTODERM; EMBRYOGENESIS; PROTEINS; SLUG	SNAI1 and SNAI2 are transcription factors that initiate Epithelial-to-Mesenchymal cell transitions throughout development and in cancer metastasis. Here we show novel expression of SNAI1 and SNAI2 throughout mouse preimplantation development revealing asymmetrical localization of both SNAI1 and SNAI2 in individual blastomeres beginning at the 2-cell stage through to the 8-cell stage where SNAI1 and SNAI2 are then only detected in outer cells and not inner cells of the blastocyst. This study implicates SNAI1 and SNAI2 in the lineage segregation of the trophectoderm and inner cell mass, and provides new insight into these oncogenes.	[Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Watson, Andrew J.] Univ Western Ontario, Dept Med, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Bell, CE (corresponding author), Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada.	CEJBell@gmail.com	Watson, Andrew J/A-5636-2015	Watson, Andrew J/0000-0002-2344-3061	Canadian Institute for Health Research - Operating [MOP-49-449]	Canadian Institute for Health Research - Operating(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institute for Health Research - Operating Grant #MOP-49-449 (URL: http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chandrasekharan N, 2001, NANO LETT, V1, P67, DOI 10.1021/nl000184f; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; FLEMING TP, 1989, J CELL BIOL, V108, P1407, DOI 10.1083/jcb.108.4.1407; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; HAMMERSCHMIDT M, 1993, DEVELOPMENT, V119, P1107; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Madan P, 2007, J BIOL CHEM, V282, P12127, DOI 10.1074/jbc.M700696200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; Rukstalis JM, 2007, GENE EXPR PATTERNS, V7, P471, DOI 10.1016/j.modgep.2006.11.001; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Veltmaat JM, 2000, INT J DEV BIOL, V44, P297; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; WATSON AJ, 1988, DEV BIOL, V126, P80, DOI 10.1016/0012-1606(88)90241-2; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8530	10.1371/journal.pone.0008530	http://dx.doi.org/10.1371/journal.pone.0008530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046880	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200011
J	Pasternak, AO; Jurriaans, S; Bakker, M; Prins, JM; Berkhout, B; Lukashov, VV				Pasternak, Alexander O.; Jurriaans, Suzanne; Bakker, Margreet; Prins, Jan M.; Berkhout, Ben; Lukashov, Vladimir V.			Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; LOAD LESS-THAN-50 COPIES/ML; CD4(+) T-LYMPHOCYTES; RESIDUAL VIREMIA; LATENT RESERVOIR; VIRAL LOAD; PERIPHERAL-BLOOD; DRUG-RESISTANCE; IN-VIVO; REPLICATION	Background: Combination antiretroviral therapy (cART), the standard of care for HIV-1 infection, is considered to be successful when plasma viremia remains below the detection limit of commercial assays. Yet, cART fails in a substantial proportion of patients after the apparent success. No laboratory markers are known that are predictive of cART outcome in initial responders during the period of undetectable plasma viremia. Methodology/Principal Findings: Here, we report the results of a retrospective longitudinal study of twenty-six HIV-infected individuals who initially responded to cART by having plasma viremia suppressed to <50 copies/ml. Eleven of these patients remained virologically suppressed, whereas fifteen experienced subsequent cART failure. Using sensitive methods based on seminested real-time PCR, we measured the levels of HIV-1 proviral (pr) DNA, unspliced ( us) RNA, and multiply spliced RNA in the peripheral blood mononuclear cells (PBMC) of these patients at multiple time points during the period of undetectable plasma viremia on cART. Median under-therapy level of usRNA was significantly higher (0.43 log(10) difference, P = 0.0015) in patients who experienced subsequent cART failure than in successfully treated patients. In multivariate analysis, adjusted for baseline CD4(+) counts, prior ART experience, and particular cART regimens, the maximal usRNA level under therapy was the best independent predictor of subsequent therapy failure ( adjusted odds ratio [95% CI], 24.4 [1.5-389.5], P = 0.024). The only other factor significantly associated with cART failure was prior ART experience ( adjusted odds ratio [ 95% CI], 12.3 [1.1-138.4], P = 0.042). Levels of usRNA under cART inversely correlated with baseline CD4(+) counts ( P = 0.0003), but did not correlate with either baseline usRNA levels or levels of prDNA under therapy. Conclusion: Our data demonstrate that the level of HIV-1 usRNA in PBMC, measured in cART-treated patients with undetectable plasma viremia, is a strong predictive marker for the outcome of therapy.	[Pasternak, Alexander O.; Bakker, Margreet; Berkhout, Ben; Lukashov, Vladimir V.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pasternak, AO (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.lukashov@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Pasternak, Alexander/P-2067-2017	Pasternak, Alexander/0000-0002-4097-4251	Dutch AIDS Fonds [2004045]; The Netherlands National Institute for Public Health and the Environment	Dutch AIDS Fonds; The Netherlands National Institute for Public Health and the Environment	The study was financially supported by the Dutch AIDS Fonds (http://www.aidsfonds.nl/), grant 2004045. The Amsterdam Cohort Studies are financially supported by The Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2002, ANTIVIR THER, V7, P91; Fischer M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-107; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gallant JE, 2007, CLIN INFECT DIS, V44, P453, DOI 10.1086/510752; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hatzakis AE, 2004, AIDS, V18, P2261, DOI 10.1097/00002030-200411190-00006; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kupfer B, 2007, J MED VIROL, V79, P1440, DOI 10.1002/jmv.20993; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; Mocroft A, 2003, AIDS, V17, P1741, DOI 10.1097/00002030-200308150-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Phillips AN, 2004, AIDS, V18, P1795, DOI 10.1097/00002030-200409030-00008; Phillips AN, 2002, J INFECT DIS, V186, P1086, DOI 10.1086/343801; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Shiu C, 2009, J VIROL, V83, P9731, DOI 10.1128/JVI.00570-09; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith CJ, 2009, HIV MED, V10, P19, DOI 10.1111/j.1468-1293.2008.00650.x; Smith CJ, 2005, J INFECT DIS, V192, P1387, DOI 10.1086/466534; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Vitoria M, 2006, ANTIRETROVIRAL THERA; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003; Yerly S, 2000, AIDS, V14, P2805, DOI 10.1097/00002030-200012220-00001; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	46	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8490	10.1371/journal.pone.0008490	http://dx.doi.org/10.1371/journal.pone.0008490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046870	Green Published, Green Submitted, gold			2022-12-27	WOS:000273180200004
J	Binder, B; Goede, A; Berndt, N; Holzhutter, HG				Binder, Bernd; Goede, Andrean; Berndt, Nikolaus; Holzhuetter, Hermann-Georg			A Conceptual Mathematical Model of the Dynamic Self-Organisation of Distinct Cellular Organelles	PLOS ONE			English	Article							MEMBRANE-FUSION; COAT PROTEINS; SPECIFICITY; ACCUMULATION; AGGREGATION; TRAFFICKING; ENERGETICS; LYSOSOMES; VESICLES	Formation, degradation and renewal of cellular organelles is a dynamic process based on permanent budding, fusion and inter-organelle traffic of vesicles. These processes include many regulatory proteins such as SNAREs, Rabs and coats. Given this complex machinery, a controversially debated issue is the definition of a minimal set of generic mechanisms necessary to enable the self-organization of organelles differing in number, size and chemical composition. We present a conceptual mathematical model of dynamic organelle formation based on interacting vesicles which carry different types of fusogenic proteins (FP) playing the role of characteristic marker proteins. Our simulations (ODEs) show that a de novo formation of non-identical organelles, each accumulating a different type of FP, requires a certain degree of disproportionation of FPs during budding. More importantly however, the fusion kinetics must indispensably exhibit positive cooperativity among these FPs, particularly for the formation of larger organelles. We compared different types of cooperativity: sequential alignment of corresponding FPs on opposite vesicle/organelles during fusion and pre-formation of FP-aggregates (equivalent, e.g., to SNARE clusters) prior to fusion described by Hill kinetics. This showed that the average organelle size in the system is much more sensitive to the disproportionation strength of FPs during budding if the vesicular transport system gets along with a fusion mechanism based on sequential alignments of FPs. Therefore, pre-formation of FP aggregates within the membranes prior to fusion introduce robustness with respect to organelle size. Our findings provide a plausible explanation for the evolution of a relatively large number of molecules to confer specificity on the fusion machinery compared to the relatively small number involved in the budding process. Moreover, we could speculate that a specific cooperativity which may be described by Hill kinetics (aggregates or Rab/SNARE complex formation) is suitable if maturation/identity switching of organelles play a role (bistability).	[Binder, Bernd; Goede, Andrean; Berndt, Nikolaus; Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Binder, B (corresponding author), Charite, Inst Biochem, D-13353 Berlin, Germany.	bernd.binder@charite.de	; Goede, Andrean/A-6652-2013	Berndt, Nikolaus/0000-0001-5594-9940; Holzhutter, Hermann-Georg/0000-0002-5054-6023; Goede, Andrean/0000-0002-9044-9869	HepatoSys; German Ministry of Education and Research [0313078A]	HepatoSys; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project was funded by HepatoSys, a competence network systems biology of hepatocytes, initiated by the German Ministry of Education and Research (http://www.hepatosys.de/en/), grant number 0313078A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker R, 1935, ANN PHYS-BERLIN, V24, P719; BENTZ J, 1983, COLLOID SURFACE, V6, P333, DOI 10.1016/0166-6622(83)80026-2; Bethani I, 2007, EMBO J, V26, P3981, DOI 10.1038/sj.emboj.7601820; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Comm. Defin. Adv. Concept, 2008, ROL THEOR ADV 21 CEN; Coveney PV, 1998, J CHEM SOC FARADAY T, V94, P233, DOI 10.1039/a703483k; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; DUFOUR JF, 1992, HEPATOLOGY, V16, P997, DOI 10.1002/hep.1840160424; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; HART P, 1983, J EXP MED, V158, P177; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Hubner K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000079; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; LEIKIN S, 1993, ANNU REV PHYS CHEM, V44, P369, DOI 10.1146/annurev.pc.44.100193.002101; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Luzio JP, 2000, J CELL SCI, V113, P1515; Malinin VS, 2004, BIOPHYS J, V86, P2951, DOI 10.1016/S0006-3495(04)74346-5; Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; NIR S, 1982, BIOCHIM BIOPHYS ACTA, V688, P275, DOI 10.1016/0005-2736(82)90604-6; NIR S, 1983, PROG SURF SCI, V13, P1, DOI 10.1016/0079-6816(83)90010-2; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Paunov VN, 1996, J COLLOID INTERF SCI, V182, P239, DOI 10.1006/jcis.1996.0456; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Ravoo BJ, 1999, BIOPHYS J, V76, P374, DOI 10.1016/S0006-3495(99)77204-8; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sanderfoot AA, 1999, PLANT CELL, V11, P629, DOI 10.1105/tpc.11.4.629; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030	38	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8295	10.1371/journal.pone.0008295	http://dx.doi.org/10.1371/journal.pone.0008295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041124	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700002
J	Pereira, AHM; Clemente, CFMZ; Cardoso, AC; Theizen, TH; Rocco, SA; Judice, CC; Guido, MC; Pascoal, VDB; Lopes-Cendes, I; Souza, JRM; Franchini, KG				Pereira, Ana Helena M.; Clemente, Carolina F. M. Z.; Cardoso, Alisson C.; Theizen, Thais H.; Rocco, Silvana A.; Judice, Carla C.; Guido, Maria Carolina; Pascoal, Vinicius D. B.; Lopes-Cendes, Iscia; Souza, Jose Roberto M.; Franchini, Kleber G.			MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice	PLOS ONE			English	Article							FOCAL ADHESION KINASE; INDUCED CARDIAC-HYPERTROPHY; MYOCYTE ENHANCER FACTOR-2; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTION FACTOR; HEART-FAILURE; GENETIC PROGRAM; C-JUN; EXPRESSION; CARDIOMYOPATHY	Background: The activation of the members of the myocyte enhancer factor-2 family (MEF2A, B, C and D) of transcription factors promotes cardiac hypertrophy and failure. However, the role of its individual components in the pathogenesis of cardiac hypertrophy remains unclear. Methodology/Principal Findings: In this study, we investigated whether MEF2C plays a role in mediating the left ventricular hypertrophy by pressure overload in mice. The knockdown of myocardial MEF2C induced by specific small interfering RNA (siRNA) has been shown to attenuate hypertrophy, interstitial fibrosis and the rise of ANP levels in aortic banded mice. We detected that the depletion of MEF2C also results in lowered levels of both PGC-1 alpha and mitochondrial DNA in the overloaded left ventricle, associated with enhanced AMP:ATP ratio. Additionally, MEF2C depletion was accompanied by defective activation of S6K in response to pressure overload. Treatment with the amino acid leucine stimulated S6K and suppressed the attenuation of left ventricular hypertrophy and fibrosis in the aforementioned aortic banded mice. Conclusion/Significance: These findings represent new evidences that MEF2C depletion attenuates the hypertrophic responses to mechanical stress and highlight the potential of MEF2C to be a target for new therapies to cardiac hypertrophy and failure.	[Pereira, Ana Helena M.; Clemente, Carolina F. M. Z.; Cardoso, Alisson C.; Theizen, Thais H.; Rocco, Silvana A.; Judice, Carla C.; Guido, Maria Carolina; Souza, Jose Roberto M.; Franchini, Kleber G.] Univ Estadual Campinas, Dept Internal Med, Sch Med, Sao Paulo, Brazil; [Pascoal, Vinicius D. B.; Lopes-Cendes, Iscia] Univ Estadual Campinas, Dept Med Genet, Sch Med, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Pereira, AHM (corresponding author), Univ Estadual Campinas, Dept Internal Med, Sch Med, Sao Paulo, Brazil.	franchin@unicamp.br	Rocco, Silvana Aparecida/Q-3828-2019; Pascoal, Vinicius/V-3076-2019; Guido, Maria C/R-1331-2017; Rocco, Silvana Aparecida/H-6300-2014; Judice, Carla/P-4738-2014; Guido, Maria Carolina/I-6416-2012; Lopes-Cendes, Iscia/B-9416-2013	Rocco, Silvana Aparecida/0000-0003-4551-3443; Guido, Maria C/0000-0001-5033-869X; Rocco, Silvana Aparecida/0000-0003-4551-3443; Judice, Carla/0000-0003-1839-053X; Guido, Maria Carolina/0000-0001-5033-869X; Lopes-Cendes, Iscia/0000-0002-6221-6822; Cardoso, Alisson/0000-0002-3051-9976; Pascoal, Vinicius/0000-0002-9009-1190; Franchini, Kleber/0000-0002-0190-6635	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/54878-3, 2008/53583-5, 2008/53519-5]; Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq) [305604/2006-6, 501160/2008-6]; Laboratorio Cristalia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratorio Cristalia	Funding for this work was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2006/54878-3, 2008/53583-5, 2008/53519-5, Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq) grants 305604/2006-6, 501160/2008-6 and Laboratorio Cristalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P19512; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	38	33	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8472	10.1371/journal.pone.0008472	http://dx.doi.org/10.1371/journal.pone.0008472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041152	gold, Green Submitted, Green Published			2022-12-27	WOS:000273105200008
J	Fuentes, MA; Gerig, A; Vicente, J				Fuentes, Miguel A.; Gerig, Austin; Vicente, Javier			Universal Behavior of Extreme Price Movements in Stock Markets	PLOS ONE			English	Article							DISTRIBUTIONS; MODELS	Many studies assume stock prices follow a random process known as geometric Brownian motion. Although approximately correct, this model fails to explain the frequent occurrence of extreme price movements, such as stock market crashes. Using a large collection of data from three different stock markets, we present evidence that a modification to the random model-adding a slow, but significant, fluctuation to the standard deviation of the process-accurately explains the probability of different-sized price changes, including the relative high frequency of extreme movements. Furthermore, we show that this process is similar across stocks so that their price fluctuations can be characterized by a single curve. Because the behavior of price fluctuations is rooted in the characteristics of volatility, we expect our results to bring increased interest to stochastic volatility models, and especially to those that can produce the properties of volatility reported here.	[Fuentes, Miguel A.; Gerig, Austin; Vicente, Javier] Santa Fe Inst, Santa Fe, NM 87501 USA; [Fuentes, Miguel A.] Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [Fuentes, Miguel A.] Inst Balseiro, Stat & Interdisciplinary Phys Grp, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Fuentes, Miguel A.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Gerig, Austin] Univ Technol Sydney, Sch Finance & Econ, Sydney, NSW 2007, Australia	The Santa Fe Institute; Pontificia Universidad Catolica de Chile; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Technology Sydney	Fuentes, MA (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	gerig@santafe.edu	Fuentes, Miguel Angel/GYQ-5828-2022	Fuentes, Miguel Angel/0000-0003-0833-1245	National Science Foundation [HSD-0624351]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant HSD-0624351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T. G., 1997, J EMPIR FINANC, V2-3, P115, DOI DOI 10.1016/S0927-5398(97)00004-2; [Anonymous], 2004, HDB STOCHASTIC METHO; Bachelier L., 1900, ANN SCIENTIFIQUES LE, V3, P21; Bassler KE, 2007, P NATL ACAD SCI USA, V104, P17287, DOI 10.1073/pnas.0708664104; BLATTBERG RC, 1974, J BUS, V47, P244, DOI 10.1086/295634; Bouchand J.-P., 2001, Quantitative Finance, V1, P105, DOI 10.1088/1469-7688/1/1/307; Bouchaud J., 2003, THEORY FINANCIAL RIS; CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Farmer JD, 2004, QUANT FINANC, V4, P383, DOI 10.1080/14697680400008627; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Heath D., 2006, BENCHMARK APPROACH Q; HILL BM, 1975, ANN STAT, V3, P1163, DOI 10.1214/aos/1176343247; Lux T., 1996, APPL FINANCIAL EC, V6, P463, DOI DOI 10.1080/096031096333917; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; NELSON DB, 1990, J ECONOMETRICS, V45, P7, DOI 10.1016/0304-4076(90)90092-8; OSBORNE MFM, 1959, OPER RES, V7, P145, DOI 10.1287/opre.7.2.145; Platen E., 2001, TRENDS MATH PP, P293; PRAETZ PD, 1972, J BUS, V45, P49, DOI 10.1086/295425; PRESS SJ, 1967, J BUS, V40, P317, DOI 10.1086/294980; Shephard N., 2005, STOCHASTIC VOLATILIT; Stanley HE, 2003, PHYSICA A, V318, P279, DOI 10.1016/S0378-4371(02)01825-3; Viswanathan GM, 2003, PHYSICA A, V329, P273, DOI 10.1016/S0378-4371(03)00608-3	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8243	10.1371/journal.pone.0008243	http://dx.doi.org/10.1371/journal.pone.0008243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	535UT	20041178	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100001
J	Yu, FX; Luo, Y				Yu, Fa-Xing; Luo, Yan			Tandem ChoRE and CCAAT Motifs and Associated Factors Regulate Txnip Expression in Response to Glucose or Adenosine-Containing Molecules	PLOS ONE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; ELEMENT-BINDING PROTEIN; NF-Y; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CELL-GROWTH; VDUP1; CANCER; APOPTOSIS	Background: Thioredoxin interacting protein (Txnip) is a multifunctional protein involved in regulation of cell cycle events and cellular metabolism. The expression of Txnip is known to be induced by glucose, adenosine-containing molecules, and other physiological cues; however, the underlying regulatory mechanisms remain elusive. Methodology/Principal Findings: In this study, using promoter reporter, electrophoresis mobility shift (EMSA), and chromatin immuno-precipitation (ChIP) assays, we have identified an additional carbohydrate response element (ChoRE) on the promoter of Txnip gene, which functions cooperatively with the earlier identified ChoRE to mediate optimal Txnip expression. However, these two ChoREs are not sufficient to mediate the induction of Txnip expression by glucose or adenosine-containing molecules; and two CCAAT boxes, both of which can recruit nuclear factor Y (NF-Y) to the Txnip promoter, are also required for the induction. Accordingly, we have found that the function of ChoREs and associated factors is contingent on tandem CCAAT boxes, in that occupancy of the Txnip promoter by NF-Y is a prerequisite for efficacious recruitment of Mondo/MLX to ChoREs under glucose stimulation. Conclusions/Significance: Our findings suggest a synergy between the tandem CCAAT and ChoRE motifs and associated NF-Y and Mondo/MLX transcription factors in enhancing transcription from the Txnip promoter. This piece of information will be helpful for future dissection of molecular mechanisms governing the transcriptional regulation of Txnip, a glucose responsive gene.	[Yu, Fa-Xing] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Luo, Yan] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Yu, FX (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	yluo@imcb.a-star.edu.sg		Yu, Fa-Xing/0000-0003-4834-9335	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work has been supported by the Agency for Science, Technology and Research (A*STAR), Singapore (http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CR, 1996, J BIOL CHEM, V271, P22271, DOI 10.1074/jbc.271.36.22271; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Billiet L, 2008, J CELL PHYSIOL, V214, P183, DOI 10.1002/jcp.21179; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Dutta KK, 2005, LAB INVEST, V85, P798, DOI 10.1038/labinvest.3700280; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Huang LL, 2000, MOL MED, V6, P849, DOI 10.1007/BF03401823; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kam KY, 2005, MOL ENDOCRINOL, V19, P148, DOI 10.1210/me.2004-0025; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Lee MG, 2003, J BIOL CHEM, V278, P41047, DOI 10.1074/jbc.M307031200; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muoio DM, 2007, CELL METAB, V5, P412, DOI 10.1016/j.cmet.2007.05.011; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Pang ST, 2009, J MOL ENDOCRINOL, V42, P205, DOI 10.1677/JME-08-0033; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Song H, 2003, IMMUNOL LETT, V86, P235, DOI 10.1016/S0165-2478(03)00024-5; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Turturro F, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-96; Villard J, 2000, MOL CELL BIOL, V20, P3364, DOI 10.1128/MCB.20.10.3364-3376.2000; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yu FX, 2009, MOL ENDOCRINOL, V23, P932, DOI 10.1210/me.2008-0383; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	54	32	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8397	10.1371/journal.pone.0008397	http://dx.doi.org/10.1371/journal.pone.0008397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027290	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998000005
J	Ichikawa, T; Li, JQ; Meyer, CJ; Janicki, JS; Hannink, M; Cui, TX				Ichikawa, Tomonaga; Li, Jinqing; Meyer, Colin J.; Janicki, Joseph S.; Hannink, Mark; Cui, Taixing			Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SIGNALING PATHWAY; KEAP1; TRITERPENOIDS; CHEMOPREVENTION; UBIQUITINATION; PHARMACOLOGY; DEGRADATION; MECHANISMS; PROTECTION	Targeting Nrf2 signaling appears to be an attractive approach for the treatment of maladaptive cardiac remodeling and dysfunction; however, pharmacological modulation of the Nrf2 pathway in the cardiovascular system remains to be established. Herein, we report that a novel synthetic triterpenoid derivative, dihydro-CDDO-trifluoroethyl amide (dh404), activates Nrf2 and suppresses oxidative stress in cardiomyocytes. Dh404 interrupted the Keap1-Cul3-Rbx1 E3 ligase complex-mediated Nrf2 ubiquitination and subsequent degradation saturating the binding capacity of Keap1 to Nrf2, thereby rendering more Nrf2 to be translocated into the nuclei to activate Nrf2-driven gene transcription. A mutant Keap1 protein containing a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 was resistant to dh404-induced stabilization of Nrf2 protein. In addition, dh404 did not dissociate the interaction of Nrf2 with the Keap1-Cul3-Rbx1 E3 ligase complex. Thus, it is likely that dh404 inhibits the ability of Keap1-Cul3-Rbx1 E3 ligase complex to target Nrf2 for ubiquitination and degradation via modifying Cys-151 of Keap1 to change the conformation of the complex. Moreover, dh404 was able to stabilize Nrf2 protein, to enhance Nrf2 nuclear translocation, to activate Nrf2-driven transcription, and to suppress angiotensin II (Ang II)-induced oxidative stress in cardiomyocytes. Knockdown of Nrf2 almost blocked the anti-oxidative effect of dh404. Dh404 activated Nrf2 signaling in the heart. Taken together, dh404 appears to be a novel Nrf2 activator with a therapeutic potential for cardiac diseases via suppressing oxidative stress.	[Ichikawa, Tomonaga; Li, Jinqing; Janicki, Joseph S.; Cui, Taixing] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Meyer, Colin J.] Reata Pharmaceut Inc, Dept Pharmacol, Irving, TX USA; [Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Missouri System; University of Missouri Columbia	Ichikawa, T (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	hanninkm@missouri.edu; Taixing.Cui@uscmed.sc.edu		Li, Jinqing/0000-0003-4635-2661; Cui, Taixing/0000-0002-9528-7299	American Heart Association (AHA) [0865101E]	American Heart Association (AHA)(American Heart Association)	This work was supported by American Heart Association (AHA) Beginning Grant-in-Aid (BGIA) (0865101E). AHA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Buckley BJ, 2008, FREE RADICAL BIO MED, V44, P692, DOI 10.1016/j.freeradbiomed.2007.10.055; CALKINS MJ, 2008, ANTIOXID REDOX SIGNA; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gagnon C, 1998, FEBS LETT, V431, P107, DOI 10.1016/S0014-5793(98)00741-8; Gillis CN, 1997, BIOCHEM PHARMACOL, V54, P1, DOI 10.1016/S0006-2952(97)00193-7; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li N, 2006, ANTIOXID REDOX SIGN, V8, P88, DOI 10.1089/ars.2006.8.88; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; NITURE SK, 2009, J BIOL CHEM; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Prisant LM, 2008, AM J MED, V121, pS8, DOI 10.1016/j.amjmed.2008.05.017; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625	49	92	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8391	10.1371/journal.pone.0008391	http://dx.doi.org/10.1371/journal.pone.0008391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027226	Green Submitted, Green Published, gold			2022-12-27	WOS:000272940100023
J	Khare, G; Gupta, V; Gupta, RK; Gupta, R; Bhat, R; Tyagi, AK				Khare, Garima; Gupta, Vibha; Gupta, Rakesh K.; Gupta, Radhika; Bhat, Rajiv; Tyagi, Anil K.			Dissecting the Role of Critical Residues and Substrate Preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis	PLOS ONE			English	Article							COENZYME-A-SYNTHETASE; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; SIGNATURE MOTIF; BINDING-SITE; SWISS-MODEL; MYMA OPERON; PROTEIN; ENZYME; CELL	Newly emerging multi-drug resistant strains of Mycobacterium tuberculosis (M.tb) everely limit the treatment options for tuberculosis (TB); hence, new antitubercular drugs are urgently needed. The mymA operon is essential for the virulence and intracellular survival of M.tb and thus represents an attractive target for the development of new antitubercular drugs. This study is focused on the structure-function relationship of Fatty Acyl-CoA Synthetase (FadD13, Rv3089) belonging to the mymA operon. Eight site-directed mutants of FadD13 were designed, constructed and analyzed for the structural-functional integrity of the enzyme. The study revealed that mutation of Lys(487) resulted in similar to 95% loss of the activity thus demonstrating its crucial requirement for the enzymatic activity. Comparison of the kinetic parameters showed the residues Lys(172) and Ala(302) to be involved in the binding of ATP and Ser(404) in the binding of CoenzymeA. The influence of mutations of the residues Val(209) and Trp(377) emphasized their importance in maintaining the structural integrity of FadD13. Besides, we show a synergistic influence of fatty acid and ATP binding on the conformation and rigidity of FadD13. FadD13 represents the first Fatty Acyl-CoA Synthetase to display biphasic kinetics for fatty acids. FadD13 exhibits a distinct preference for C-26/C-24 fatty acids, which in the light of earlier reported observations further substantiates the role of the mymA operon in remodeling the cell envelope of intracellular M.tb under acidic conditions. A three-dimensional model of FadD13 was generated; the docking of ATP to the active site verified its interaction with Lys(172), Ala(302) and Lys(487) and corresponded well with the results of the mutational studies. Our study provides a significant understanding of the FadD13 protein including the identification of residues important for its activity as well as in the maintenance of structural integrity. We believe that the findings of this study will provide valuable inputs in the development of inhibitors against the mymA operon, an important target for the development of antitubercular drugs.	[Khare, Garima; Gupta, Vibha; Gupta, Rakesh K.; Gupta, Radhika; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Dept Microbiol, Ram Lal Anand Coll, New Delhi, India; [Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	University of Delhi; University of Delhi; Jawaharlal Nehru University, New Delhi	Khare, G (corresponding author), Univ Delhi, Dept Biochem, S Campus, New Delhi, India.	aniltyagi@south.du.ac.in		Gupta, Radhika/0000-0002-0445-0194	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by the Department of Biotechnology, Government of India. GK is grateful to the Council of Scientific and Industrial Research, New Delhi for research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Black PN, 2000, J BIOL CHEM, V275, P38547, DOI 10.1074/jbc.M006413200; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Calloni G, 2005, J BIOL CHEM, V280, P10607, DOI 10.1074/jbc.M412951200; Cheruvu M, 2007, TUBERCULOSIS, V87, P12, DOI 10.1016/j.tube.2006.01.021; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Delano W.L., 2002, DELANO SCI; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KNAPP HR, 1986, J INFECT DIS, V154, P84, DOI 10.1093/infdis/154.1.84; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Langer MR, 2002, J BIOL CHEM, V277, P27337, DOI 10.1074/jbc.M203251200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARRABEE AR, 1965, P NATL ACAD SCI USA, V54, P267, DOI 10.1073/pnas.54.1.267; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Matsuda D, 2008, J ANTIBIOT, V61, P318, DOI 10.1038/ja.2008.45; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Sambrook J., MOL CLONING LAB MANU; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tiganis T, 1996, ARCH BIOCHEM BIOPHYS, V325, P289, DOI 10.1006/abbi.1996.0036; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; VesLosada A, 1996, MOL CELL BIOCHEM, V159, P1; WATKINS PA, 1994, BBA-LIPID LIPID MET, V1214, P288, DOI 10.1016/0005-2760(94)90075-2; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Wu R, 2007, BIOCHEMISTRY-US, V46, P14487, DOI 10.1021/bi701609w	58	20	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8387	10.1371/journal.pone.0008387	http://dx.doi.org/10.1371/journal.pone.0008387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027301	Green Submitted, gold, Green Published			2022-12-27	WOS:000272940100020
J	Cejas, P; Lopez-Gomez, M; Aguayo, C; Madero, R; Carpeno, JD; Belda-Iniesta, C; Barriuso, J; Garcia, VM; Larrauri, J; Lopez, R; Casado, E; Gonzalez-Baron, M; Feliu, J				Cejas, Paloma; Lopez-Gomez, Miriam; Aguayo, Cristina; Madero, Rosario; de Castro Carpeno, Javier; Belda-Iniesta, Cristobal; Barriuso, Jorge; Moreno Garcia, Victor; Larrauri, Javier; Lopez, Rocio; Casado, Enrique; Gonzalez-Baron, Manuel; Feliu, Jaime			KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; K-RAS MUTATIONS; CETUXIMAB; GENES; LIVER; BRAF; ANTIBODIES; THERAPY; SITES	Background: KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status. Methodology/Principal Findings: KRAS mutations were retrospectively studied using polymerase chain reactions and subsequent sequencing of codons 12 and 13 (exon 2) in 110 patients with metastatic colorectal tumors. These studies were performed using tissue samples from both the primary tumor and their related metastases (93 liver, 84%; 17 lung, 16%). All patients received adjuvant 5-Fluorouracil-based polychemotherapy after resection of metastases. None received anti-EGFR therapy. Mutations in KRAS were observed in 37 (34%) of primary tumors and in 40 (36%) of related metastases, yielding a 94% level of concordance (kappa index 0.86). Patients with primary tumors possessing KRAS mutations had a shorter disease-free survival period after metastasis resection (12.0 vs 18.0 months; P = 0.035) than those who did not. A higher percentage of KRAS mutations was detected in primary tumors of patiens with lung metastases than in patients with liver metastases (59% vs 32%; p = 0.054). To further evaluate this finding we analyzed 120 additional patients with unresectable metastatic colorectal cancer who previously had their primary tumors evaluated for KRAS mutational status for clinical purposes. Separately, the analysis of these 120 patients showed a tendency towards a higher degree of KRAS mutations in primary tumors of patients with lung metastases, although it did not reach statistical significance. Taken together the group of 230 patients showed that KRAS was mutated significantly more often in the primary tumors of patients with lung metastases (57% vs 35%; P = 0.006). Conclusions/Significance: Our results suggest a role for KRAS mutations in the propensity of primary colorectal tumors to metastasize to the lung.	[Cejas, Paloma; Lopez-Gomez, Miriam; Aguayo, Cristina; de Castro Carpeno, Javier; Belda-Iniesta, Cristobal; Barriuso, Jorge; Moreno Garcia, Victor; Lopez, Rocio; Gonzalez-Baron, Manuel; Feliu, Jaime] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain; [Madero, Rosario] La Paz Univ Hosp, Biostat Unit, Madrid, Spain; [Larrauri, Javier] La Paz Univ Hosp, Dept Pathol, Madrid, Spain; [Casado, Enrique] Infanta Sofi Hosp, Dept Med Oncol, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Cejas, P (corresponding author), La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain.	jfeliu.hulp@salud.madrid.org		De Castro, Javier/0000-0002-3622-6306; Moreno, Victor/0000-0001-6099-4236; Belda Iniesta, Cristobal/0000-0003-3254-7492	Amgen; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06-0020-1022]; Fundacion Mutua Madrilena; Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz (FIBHULP), Madrid, Spain	Amgen(Amgen); Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz (FIBHULP), Madrid, Spain	This work received grant support from Amgen, Red Tematica de Investigacion Cooperativa en Cancer (RTICC, RD06-0020-1022), Fundacion Mutua Madrilena and from Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz (FIBHULP), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Etienne-Grimaldi MC, 2008, CLIN CANCER RES, V14, P4830, DOI 10.1158/1078-0432.CCR-07-4906; Fong YM, 1997, J CLIN ONCOL, V15, P938, DOI 10.1200/JCO.1997.15.3.938; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Jean GW, 2008, PHARMACOTHERAPY, V28, P742, DOI 10.1592/phco.28.6.742; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lockhart C, 2005, SEMIN ONCOL, V32, P52, DOI 10.1053/j.seminoncol.2004.09.036; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Penna C, 2002, SURG CLIN N AM, V82, P1075, DOI 10.1016/S0039-6109(02)00051-8; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Santini D, 2008, ONCOLOGIST, V13, P1270, DOI 10.1634/theoncologist.2008-0181; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wong R, 2008, J CLIN ONCOL, V26, P5668, DOI 10.1200/JCO.2008.19.5024	21	124	131	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8199	10.1371/journal.pone.0008199	http://dx.doi.org/10.1371/journal.pone.0008199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020061	Green Published, Green Submitted, gold			2022-12-27	WOS:000272870600002
J	Prpich, AM; Sheng, YB; Wang, W; Biswas, ME; Chen, P				Prpich, Andrew M.; Sheng, Yuebiao; Wang, Wei; Biswas, M. Elias; Chen, P.			Tension at the Surface: Which Phase Is More Important, Liquid or Vapor?	PLOS ONE			English	Article							ADSORPTION-KINETICS; WATER; INTERFACE; EXCHANGE; DYNAMICS; ALCOHOLS	Tension at the surface is a most fundamental physicochemical property of a liquid surface. The concept of surface tension has widespread implications in numerous natural, engineering and biomedical processes. Research to date has been largely focused on the liquid side; little attention has been paid to the vapor-the other side of the surface, despite over 100 years of study. However, the question remains as to whether the vapor plays any role, and to what extent it affects the surface tension of the liquid. Here we show a systematic study of the effect of vapor on the surface tension and in particular, a surprising observation that the vapor, not the liquid, plays a dominant role in determining the surface tension of a range of common volatile organic solutions. This is in stark contrast to results of common surfactants where the concentration in the liquid plays the major role. We further confirmed our results with a modified adsorption isotherm and molecular dynamics simulations, where highly structured, hydrogen bonded networks, and in particular a solute depletion layer just beneath the Gibbs dividing surface, were revealed.	[Prpich, Andrew M.; Sheng, Yuebiao; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Sheng, Yuebiao; Wang, Wei] Nanjing Univ, Natl Lab Solid State Microstruct, Inst Biophys, Nanjing 210008, Peoples R China; [Sheng, Yuebiao; Wang, Wei] Nanjing Univ, Dept Phys, Nanjing 210008, Peoples R China; [Biswas, M. Elias] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	University of Waterloo; Nanjing University; Nanjing University; Johns Hopkins University	Prpich, AM (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC); Ontario Graduate Scholarships (OGS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC)(Canada Research Chairs); Ontario Graduate Scholarships (OGS)(Ontario Graduate Scholarship)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Research Chairs (CRC), and Ontario Graduate Scholarships (OGS). The molecular dynamics simulations were made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET: www.sharcnet.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchette F, 2006, NAT PHYS, V2, P254, DOI 10.1038/nphys268; BLEYS G, 1985, J PHYS CHEM-US, V89, P1027, DOI 10.1021/j100252a028; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burki J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090601; CHANG CH, 1992, COLLOID SURFACE, V69, P189, DOI 10.1016/0166-6622(92)80230-Y; Chang TM, 2005, J PHYS CHEM B, V109, P5759, DOI 10.1021/jp045649v; Dixit S, 2002, NATURE, V416, P829, DOI 10.1038/416829a; Eastoe J, 2000, ADV COLLOID INTERFAC, V85, P103, DOI 10.1016/S0001-8686(99)00017-2; Fainerman VB, 1996, J COLLOID INTERF SCI, V178, P168, DOI 10.1006/jcis.1996.0105; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; Guo JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157401; Hommelen J. R, 1959, J COLLOID SCI, V14, P385, DOI DOI 10.1016/0095-8522(59)90003-0; Lague P, 2004, J PHYS CHEM B, V108, P363, DOI 10.1021/jp030458y; Langmuir I., 1932, NOBEL LECT CHEM 1922; Lin SY, 1997, LANGMUIR, V13, P6211, DOI 10.1021/la970614q; MACLEOD CA, 1994, J COLLOID INTERF SCI, V166, P73, DOI 10.1006/jcis.1994.1273; MATSUMOTO M, 1988, J CHEM PHYS, V88, P3233, DOI 10.1063/1.453919; MILLER R, 1986, COLLOID POLYM SCI, V264, P357, DOI 10.1007/BF01418196; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; Prpich AM, 2008, J PHYS CHEM C, V112, P2522, DOI 10.1021/jp077012s; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; Regan BC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1887827; ROTENBERG Y, 1983, J COLLOID INTERF SCI, V93, P169, DOI 10.1016/0021-9797(83)90396-X; Vyawahare S, 2006, NANO LETT, V6, P271, DOI 10.1021/nl0522678; WOLFE J, 1985, J MEMBRANE BIOL, V86, P127, DOI 10.1007/BF01870779	25	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8281	10.1371/journal.pone.0008281	http://dx.doi.org/10.1371/journal.pone.0008281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011532	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300033
J	Al-Hasani, K; Navarro-Garcia, F; Huerta, J; Sakellaris, H; Adler, B				Al-Hasani, Keith; Navarro-Garcia, Fernando; Huerta, Jazmin; Sakellaris, Harry; Adler, Ben			The Immunogenic SigA Enterotoxin of Shigella flexneri 2a Binds to HEp-2 Cells and Induces Fodrin Redistribution in Intoxicated Epithelial Cells	PLOS ONE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; SHE PATHOGENICITY ISLAND; AUTOTRANSPORTER PROTEINS; PET TOXIN; PROTEASE; DISRUPTION; SPECTRIN; PLASMID; DAMAGE; GENES	Background: We have previously shown that the enterotoxin SigA which resides on the she pathogenicity island (PAI) of S. flexneri 2a is an autonomously secreted serine protease capable of degrading casein. We have also demonstrated that SigA is cytopathic for HEp-2 cells and plays a role in the intestinal fluid accumulation associated with S. flexneri infections. Methods/Principal Findings: In this work we show that SigA binds specifically to HEp-2 cells and degrades recombinant human alpha II spectrin (alpha-fodrin) in vitro, suggesting that the cytotoxic and enterotoxic effects mediated by SigA are likely associated with the degradation of epithelial fodrin. Consistent with our data, this study also demonstrates that SigA cleaves intracellular fodrin in situ, causing its redistribution within cells. These results strongly implicate SigA in altering the cytoskeleton during the pathogenesis of shigellosis. On the basis of these findings, cleavage of fodrin is a novel mechanism of cellular intoxication for a Shigella toxin. Furthermore, information regarding immunogenicity to SigA in infected patients is lacking. We studied the immune response of SigA from day 28 post-challenge serum of one volunteer from S. flexneri 2a challenge studies. Our results demonstrate that SigA is immunogenic following infection with S. flexneri 2a. Conclusions: This work shows that SigA binds to epithelial HEp-2 cells as well as being able to induce fodrin degradation in vitro and in situ, further extending its documented role in the pathogenesis of Shigella infections.	[Al-Hasani, Keith; Adler, Ben] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia; [Sakellaris, Harry] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; [Navarro-Garcia, Fernando; Huerta, Jazmin] Inst Politecn Nacl, Dept Cell Biol, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico	Monash University; University of Western Australia; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Al-Hasani, K (corresponding author), Univ Nice, Fac Sci, Ctr Biochim, Diabet Genet Team, Nice, France.	Ben.Adler@med.monash.edu.au	Navarro-Garcia, Fernando/A-3980-2011	Al-Hasani, Keith/0000-0001-6109-5603	Australian Research Council; National Health and Medical Research Council, Canberra, Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Canberra, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was partly supported by grants from the Australian Research Council and the National Health and Medical Research Council, Canberra, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani K, 2000, INFECT IMMUN, V68, P2457, DOI 10.1128/IAI.68.5.2457-2463.2000; Al-Hasani K, 2001, MICROB PATHOGENESIS, V30, P1, DOI 10.1006/mpat.2000.0404; Bellini EM, 2005, FEMS IMMUNOL MED MIC, V43, P259, DOI 10.1016/j.femsim.2004.08.008; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; Canizalez-Roman A, 2003, MOL MICROBIOL, V48, P947, DOI 10.1046/j.1365-2958.2003.03492.x; CHAPMAN AJ, 1987, ZBL BAKT-INT J MED M, V264, P279; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Kostakioti M, 2004, INFECT IMMUN, V72, P5548, DOI 10.1128/IAI.72.10.5548-5554.2004; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; Lan RT, 2001, INFECT IMMUN, V69, P6303, DOI 10.1128/IAI.69.10.6303-6309.2001; Navarro-Garcia F, 2004, INFECT IMMUN, V72, P3609, DOI 10.1128/IAI.72.6.3609-3621.2004; SASAKAWA C, 1995, REV MED MICROBIOL, V6, P257; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000	21	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8223	10.1371/journal.pone.0008223	http://dx.doi.org/10.1371/journal.pone.0008223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011051	Green Published, gold			2022-12-27	WOS:000272829800012
J	Muller, B; Vounatsou, P; Ngandolo, BNR; Diguimbaye-Djaibe, C; Schiller, I; Marg-Haufe, B; Oesch, B; Schelling, E; Zinsstag, J				Mueller, Borna; Vounatsou, Penelope; Ngandolo, Bongo Nare Richard; Diguimbaye-Djaibe, Colette; Schiller, Irene; Marg-Haufe, Beatrice; Oesch, Bruno; Schelling, Esther; Zinsstag, Jakob			Bayesian Receiver Operating Characteristic Estimation of Multiple Tests for Diagnosis of Bovine Tuberculosis in Chadian Cattle	PLOS ONE			English	Article							FLUORESCENCE POLARIZATION ASSAY; MYCOBACTERIUM-BOVIS; CHARACTERISTIC CURVES; INFECTIOUS-DISEASES; IMMUNE-RESPONSES; LESIONS; IDENTIFICATION; ANTIBODIES; INSPECTION; ABATTOIR	Background: Bovine tuberculosis (BTB) today primarily affects developing countries. In Africa, the disease is present essentially on the whole continent; however, little accurate information on its distribution and prevalence is available. Also, attempts to evaluate diagnostic tests for BTB in naturally infected cattle are scarce and mostly complicated by the absence of knowledge of the true disease status of the tested animals. However, diagnostic test evaluation in a given setting is a prerequisite for the implementation of local surveillance schemes and control measures. Methodology/Principal Findings: We subjected a slaughterhouse population of 954 Chadian cattle to single intra-dermal comparative cervical tuberculin (SICCT) testing and two recently developed fluorescence polarization assays (FPA). Using a Bayesian modeling approach we computed the receiver operating characteristic (ROC) curve of each diagnostic test, the true disease prevalence in the sampled population and the disease status of all sampled animals in the absence of knowledge of the true disease status of the sampled animals. In our Chadian setting, SICCT performed better if the cut-off for positive test interpretation was lowered from >4 mm (OIE standard cut-off) to >2 mm. Using this cut-off, SICCT showed a sensitivity and specificity of 66% and 89%, respectively. Both FPA tests showed sensitivities below 50% but specificities above 90%. The true disease prevalence was estimated at 8%. Altogether, 11% of the sampled animals showed gross visible tuberculous lesions. However, modeling of the BTB disease status of the sampled animals indicated that 72% of the suspected tuberculosis lesions detected during standard meat inspections were due to other pathogens than Mycobacterium bovis. Conclusions/Significance: Our results have important implications for BTB diagnosis in a high incidence sub-Saharan African setting and demonstrate the practicability of our Bayesian approach for diagnostic test evaluation.	[Mueller, Borna; Schelling, Esther; Zinsstag, Jakob] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; [Vounatsou, Penelope] Swiss Trop Inst, Dept Biostat & Epidemiol, CH-4002 Basel, Switzerland; [Ngandolo, Bongo Nare Richard; Diguimbaye-Djaibe, Colette] Lab Rech Vet & Zootech Farcha, Ndjamena, Chad; [Schiller, Irene; Marg-Haufe, Beatrice; Oesch, Bruno] Prionics AG, Schlieren, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Muller, B (corresponding author), Univ Stellenbosch, Fac Hlth Sci, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res,Div Mol Biol, Cape Town, South Africa.	bmuller@sun.ac.za	Müller, Borna/AAS-9471-2020; Zinsstag, Jakob/A-8317-2008; Schelling, Esther/K-7990-2015	Zinsstag, Jakob/0000-0002-8899-6097; Schelling, Esther/0000-0001-6444-0898; Vounatsou, Penelope/0000-0002-4904-5352	Swiss National Science Foundation [107559]; Prionics AG, Schlieren-Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Prionics AG, Schlieren-Zurich, Switzerland	Our work has received financial support from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx; project no. 107559) and from Prionics AG, Schlieren-Zurich, Switzerland (www.prionics.com). The Swiss National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prionics AG had no role in study design, data collection and analysis and decision to publish but employees of Prionics AG were involved in manuscript writing.	AMENI G, 2008, CLIN VACCINE IMMUNOL; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; CANCELA MMG, 1993, J COMP PATHOL, V109, P361, DOI 10.1016/S0021-9975(08)80299-X; Choi YK, 2006, J AGR BIOL ENVIR ST, V11, P210, DOI 10.1198/108571106X110883; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; CORNER LA, 1990, AUST VET J, V67, P389, DOI 10.1111/j.1751-0813.1990.tb03020.x; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Diguimbaye-Djaibe C, 2006, SCHWEIZ ARCH TIERH, V148, P251, DOI 10.1024/0036-7281.148.5.251; Diguimbaye-Djaibe C, 2006, EMERG INFECT DIS, V12, P769; Estrada-Chavez Ciro, 2004, Veterinaria Mexico, V35, P225; Gardner IA, 2006, VET CLIN PATH, V35, P8, DOI 10.1111/j.1939-165X.2006.tb00082.x; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Herenda D, 1994, CHAP 2 GEN PATHOLOGI; Jolley ME, 2003, COMB CHEM HIGH T SCR, V6, P235, DOI 10.2174/138620703106298419; Jolley ME, 2007, VET MICROBIOL, V120, P113, DOI 10.1016/j.vetmic.2006.10.018; Lachnik J, 2002, J CLIN MICROBIOL, V40, P3364, DOI 10.1128/JCM.40.9.3364-3373.2002; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lin M, 1996, CLIN DIAGN LAB IMMUN, V3, P438, DOI 10.1128/CDLI.3.4.438-443.1996; MOORE DF, 1995, J CLIN MICROBIOL, V33, P2686, DOI 10.1128/JCM.33.10.2686-2691.1995; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Ngandolo BNR, 2009, PREV VET MED, V89, P81, DOI 10.1016/j.prevetmed.2009.02.003; OIE, 2022, NUMB NEW H5 OUTBR; Oloya J, 2006, TROP ANIM HEALTH PRO, V38, P275, DOI 10.1007/s11250-006-4322-7; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; Pollock JM, 2005, VET IMMUNOL IMMUNOP, V108, P37, DOI 10.1016/j.vetimm.2005.08.012; Quirin R, 2001, ONDERSTEPOORT J VET, V68, P231; RENWICK AR, 2006, EPIDEMIOL INFECT, P1; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Sulieman MS, 2002, J VET MED B, V49, P415, DOI 10.1046/j.1439-0450.2002.00565.x; Surujballi OP, 2002, VET MICROBIOL, V87, P149, DOI 10.1016/S0378-1135(02)00044-5; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Teklu A, 2004, REV SCI TECH OIE, V23, P957, DOI 10.20506/rst.23.3.1534; Thornton P.K., 2002, MAPPING POVERTY LIVE; Varello K, 2008, J VET DIAGN INVEST, V20, P164, DOI 10.1177/104063870802000204; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Watrelot-Virieux D, 2006, J VET MED B, V53, P321, DOI 10.1111/j.1439-0450.2006.00957.x; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; WHO, 2006, CONTR NEGL ZOON DIS; ZINSSTAG J, 2006, MYCOBACTERIUM BOVIS; 2001, NUTR HLTH DEV COUNTR	47	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8215	10.1371/journal.pone.0008215	http://dx.doi.org/10.1371/journal.pone.0008215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011046	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829800007
J	Joshi, D; Quadri, M; Gangane, N; Joshi, R; Gangane, N				Joshi, Deepti; Quadri, Munira; Gangane, Neha; Joshi, Rajnish; Gangane, Nitin			Association of Epstein Barr Virus Infection (EBV) with Breast Cancer in Rural Indian Women	PLOS ONE			English	Article							REAL-TIME PCR; MEDULLARY CARCINOMA; LYMPHOID STROMA; EXPRESSION; RISK; DISEASE; ABSENCE; GENOME; CELLS; EPIDEMIOLOGY	Introduction: Breast cancer is the most common malignancy affecting females worldwide but conventional risk factors are able to explain only a small proportion of these cases. A possible viral etiology for breast cancer has been proposed and Epstein-Barr Virus (EBV) is a widely researched candidate virus. The aim of the present study, first one of its kind from India, was to determine if there is a greater association of EBV infection with breast cancer patients as compared to patients with benign breast diseases. Methods: We looked for expression of Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1) in breast cancer tissue specimens by employing immunohistochemistry (IHC). We also measured levels of anti-EBNA-1 Immunoglobulin (IgG) antibodies in stored sera of these patients using commercial Enzyme linked Immunosorbent Assay ( ELISA) kit. Patients with benign breast diseases were used as a comparison group for both immunohistochemical and serological analysis. Results: 58 cases of malignant breast disease and 63 of benign breast disease (controls) were included in the study. Using manufacturer determined cut-off of 3 IU/ml, 50/55 tested ( 90.9%) cases and 27/33 tested (81.8%) controls were seropositive for anti-EBNA-1 IgG. Mean antibody levels were significantly higher for cases (54.22 IU/ml) as compared to controls (18.68 IU/ml). IHC for EBNA-1 was positive in 28/51 cases (54.9%). No IHC positivity was noted in the tested 30 controls. Our results show that EBNA-1 expression is seen in a significant proportion of breast cancer tissue specimens from rural India and as compared to patients with benign breast diseases these patients also have a higher immunological response against EBNA-1.	[Joshi, Deepti; Quadri, Munira; Gangane, Nitin] Mahatma Gandhi Inst Med Sci, Dept Pathol, Sevagram, Maharashtra, India; [Joshi, Rajnish] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India	Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram	Joshi, D (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Pathol, Sevagram, Maharashtra, India.	nitingangane@rediffmail.com		Joshi, Rajnish/0000-0002-4702-0522	University Grants Commission ( UGC), New Delhi, India; Indian Council of Medical research ( ICMR), New Delhi India	University Grants Commission ( UGC), New Delhi, India(University Grants Commission, India); Indian Council of Medical research ( ICMR), New Delhi India(Indian Council of Medical Research (ICMR))	This study was supported by research grants from University Grants Commission ( UGC), New Delhi, India. Neha Gangane was supported by a short term scholarship from Indian Council of Medical research ( ICMR), New Delhi India for her work in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni A, 2001, J NATL CANCER I, V93, P560, DOI 10.1093/jnci/93.7.560; [Anonymous], 2001, LANCET, V358, P1389; Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Brink AATP, 2000, J NATL CANCER I, V92, P655, DOI 10.1093/jnci/92.8.655; Chu JS, 1998, CANCER LETT, V124, P53, DOI 10.1016/S0304-3835(97)00449-7; Chu PGG, 2001, AM J PATHOL, V159, P571, DOI 10.1016/S0002-9440(10)61728-2; Dadmanesh F, 2001, HISTOPATHOLOGY, V38, P54, DOI 10.1046/j.1365-2559.2001.01055.x; Deshpande CG, 2002, LAB INVEST, V82, P1193, DOI 10.1097/01.LAB.0000029150.90532.24; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; GAFFEY MJ, 1993, MODERN PATHOL, V6, P721; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Glaser SL, 1998, INT J CANCER, V75, P555; Grinstein S, 2002, CANCER RES, V62, P4876; Hennard C, 2006, J PATHOL, V209, P430, DOI 10.1002/path.1996; Herrmann K, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr561; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HORIUCHI K, 1994, J CLIN PATHOL, V47, P538, DOI 10.1136/jcp.47.6.538; Huang J, 2003, J VIROL, V77, P13267, DOI 10.1128/JVI.77.24.13267-13274.2003; Kalkan A, 2005, MED PRIN PRACT, V14, P268, DOI 10.1159/000085748; Kijima Y, 2001, J MED VIROL, V64, P513, DOI 10.1002/jmv.1079; LABRECQUE LG, 1995, CANCER RES, V55, P39; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; LUQMANI YA, 1995, INT J ONCOL, V6, P899; Mant C, 2004, INTERVIROLOGY, V47, P2, DOI 10.1159/000076636; McCall SA, 2001, JNCI-J NATL CANCER I, V93, P148, DOI 10.1093/jnci/93.2.148; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Murray PG, 2003, CANCER RES, V63, P2338; NANDKUMAR A, 2001, NATL CANC REGISTRY P; Perkins RS, 2006, BREAST CANCER RES, V8, DOI 10.1186/BCR1627; Perrigoue JG, 2005, CANCER EPIDEM BIOMAR, V14, P809, DOI 10.1158/1055-9965.EPI-04-0763; Preciado MV, 2005, ARCH PATHOL LAB MED, V129, P377; Ribeiro-Silva A, 2004, BRAZ J MED BIOL RES, V37, P89, DOI 10.1590/S0100-879X2004000100013; Richardson AK, 2004, BRIT J CANCER, V90, P2149, DOI 10.1038/sj.bjc.6601822; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Thorne LB, 2005, DIAGN MOL PATHOL, V14, P29, DOI 10.1097/01.pas.0000144448.23464.ab; Trabelsi A, 2008, ANN BIOL CLIN-PARIS, V66, P59, DOI 10.1684/abc.2008.0191; Tsai JH, 2005, J MED VIROL, V75, P276, DOI 10.1002/jmv.20267; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Yasui Y, 2001, CANCER EPIDEM BIOMAR, V10, P9	44	53	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8180	10.1371/journal.pone.0008180	http://dx.doi.org/10.1371/journal.pone.0008180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997605	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829200014
J	Saykally, JN; Dogan, S; Cleary, MP; Sanders, MM				Saykally, Jessica N.; Dogan, Soner; Cleary, Margot P.; Sanders, Michel M.			The ZEB1 Transcription Factor Is a Novel Repressor of Adiposity in Female Mice	PLOS ONE			English	Article							CALORIC RESTRICTION; STEM-CELLS; OBESITY; EXPRESSION; DELTA-EF1; DIFFERENTIATION; GENE; FAT; FINGER; ZFH-1	Background: Four genome-wide association studies mapped an "obesity'' gene to human chromosome 10p11-12. As the zinc finger E-box binding homeobox 1 (ZEB1) transcription factor is encoded by the TCF8 gene located in that region, and as it influences the differentiation of various mesodermal lineages, we hypothesized that ZEB1 might also modulate adiposity. The goal of these studies was to test that hypothesis in mice. Methodology/Principal Findings: To ascertain whether fat accumulation affects ZEB1 expression, female C57BL/6 mice were fed a regular chow diet (RCD) ad libitum or a 25% calorie-restricted diet from 2.5 to 18.3 months of age. ZEB1 mRNA levels in parametrial fat were six to ten times higher in the obese mice. To determine directly whether ZEB1 affects adiposity, wild type (WT) mice and mice heterozygous for TCF8 (TCF8+/-) were fed an RCD or a high-fat diet (HFD) (60% calories from fat). By two months of age on an HFD and three months on an RCD, TCF8+/- mice were heavier than WT controls, which was attributed by Echo MRI to increased fat mass (at three months on an HFD: 0.517 +/- 0.081 total fat/lean mass versus 0.313 +/- 0.036; at three months on an RCD: 0.175 +/- 0.013 versus 0.124 +/- 0.012). No differences were observed in food uptake or physical activity, suggesting that the genotypes differ in some aspect of their metabolic activity. ZEB1 expression also increases during adipogenesis in cell culture. Conclusion/Significance: These results show for the first time that the ZEB1 transcription factor regulates the accumulation of adipose tissue. Furthermore, they corroborate the genome-wide association studies that mapped an "obesity'' gene at chromosome 10p11-12.	[Saykally, Jessica N.; Dogan, Soner; Sanders, Michel M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Cleary, Margot P.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System	Saykally, JN (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	sande001@umn.edu		DOGAN, SONER/0000-0002-7762-8109	National Institute of Diabetes and Digestive Diseases [DK050456]; National Cancer Institute, [CA116849, CA101858]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA101858, U54CA116849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the University of Minnesota Obesity Prevention Center Core grant DK050456 from the National Institute of Diabetes and Digestive Diseases ( M. M. S.), by grants CA116849 ( M. M. S.) and CA101858 ( M. P. C.) from the National Cancer Institute, and by the Hormel Foundation ( M. P. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Anose BM, 2005, HORMONAL CARCINOGENESIS IV, P455, DOI 10.1007/0-387-23761-5_48; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bonorden MJL, 2009, PROSTATE, V69, P317, DOI 10.1002/pros.20878; Bui T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004373; Chambron J-C, 1999, PORPHYRIN HDB, V6, P1; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cleary MP, 2007, EXP BIOL MED, V232, P70; Clement Karine, 2002, Am J Pharmacogenomics, V2, P177, DOI 10.2165/00129785-200202030-00003; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Dolinkova M, 2008, MOL CELL ENDOCRINOL, V291, P63, DOI 10.1016/j.mce.2008.05.001; Dong CH, 2005, AM J HUM GENET, V76, P427, DOI 10.1086/428438; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; HINNAI M, 2000, PAK J FOOD SCI, V10, P5; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Inuzuka T, 2009, CANCER RES, V69, P1678, DOI 10.1158/0008-5472.CAN-08-3620; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Jasik CB, 2008, ANN NY ACAD SCI, V1135, P265, DOI 10.1196/annals.1429.009; Jethanandani P, 2005, J BIOL CHEM, V280, P36037, DOI 10.1074/jbc.M508698200; Khan Unab I, 2008, Adolesc Med State Art Rev, V19, P406; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Layden MJ, 2006, DEV BIOL, V291, P253, DOI 10.1016/j.ydbio.2005.12.009; Lee HK, 2007, MOL CELL NEUROSCI, V36, P47, DOI 10.1016/j.mcn.2007.05.011; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; MURRAY E, 2000, MOD ASP IMMUNOBIOL, V1, P2; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Postigo AA, 1999, MOL CELL BIOL, V19, P7255; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Price RA, 2001, DIABETOLOGIA, V44, P363, DOI 10.1007/s001250051627; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabin MA, 2008, FRONT HORM RES, V36, P85, DOI 10.1159/000115356; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; Sooy K, 2002, ENDOCRINOLOGY, V143, P3370, DOI 10.1210/en.2001-211441; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takagi T, 1998, DEVELOPMENT, V125, P21; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wacker I, 2003, DEVELOPMENT, V130, P3795, DOI 10.1242/dev.00570; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	60	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8460	10.1371/journal.pone.0008460	http://dx.doi.org/10.1371/journal.pone.0008460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041147	gold, Green Submitted, Green Published			2022-12-27	WOS:000273104000020
J	Wallner, M; Himly, M; Neubauer, A; Erler, A; Hauser, M; Asam, C; Mutschlechner, S; Ebner, C; Briza, P; Ferreira, F				Wallner, Michael; Himly, Martin; Neubauer, Angela; Erler, Anja; Hauser, Michael; Asam, Claudia; Mutschlechner, Sonja; Ebner, Christof; Briza, Peter; Ferreira, Fatima			The Influence of Recombinant Production on the Immunologic Behavior of Birch Pollen Isoallergens	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; HIGH-LEVEL EXPRESSION; BET V 1; ESCHERICHIA-COLI; IN-VITRO; 2 PARTS; BET-V-1; ISOFORMS; PURIFICATION; REACTIVITY	Background: Allergic reactions towards the birch major pollen allergen Bet v 1 are among the most common causes of spring pollinosis in the temperate climate zone of the Northern hemisphere. Natural Bet v 1 is composed of a complex mixture of different isoforms. Detailed analysis of recombinant Bet v 1 isoforms revealed striking differences in immunologic as well as allergenic properties of the molecules, leading to a classification of Bet v 1 isoforms into high, medium, and low IgE binding proteins. Especially low IgE binding Bet v 1 isoforms have been described as ideal candidates for desensitizing allergic patients with allergen specific immunotherapy (SIT). Since diagnosis and therapy of allergic diseases are highly dependent on recombinant proteins, continuous improvement of protein production is an absolute necessity. Methodology: Therefore, two different methods for recombinant production of a low IgE binding Bet v 1 isoform were applied; one based on published protocols, the other by implementing latest innovations in protein production. Both batches of Bet v 1.0401 were extensively characterized by an array of physicochemical as well as immunological methods to compare protein primary structure, purity, quantity, folding, aggregation state, thermal stability, and antibody binding capacity. Conclusion: The experiments demonstrated that IgE antibody binding properties of recombinant isoallergens can be significantly influenced by the production method directly affecting possible clinical applications of the molecules.	[Wallner, Michael; Himly, Martin; Erler, Anja; Hauser, Michael; Asam, Claudia; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Neubauer, Angela] Biomay AG, Vienna Competence Ctr, Vienna, Austria; [Mutschlechner, Sonja] Med Univ Vienna, Christian Doppler Lab Immunemodulat, Vienna, Austria; [Ebner, Christof] Allergieambulatorium, Vienna, Austria; [Briza, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University; Medical University of Vienna; Salzburg University	Wallner, M (corresponding author), Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.	michael.wallner@sbg.ac.at	Hauser, Michael/P-6148-2017; Briza, Peter/D-7309-2012; Ferreira, Fatima/E-4889-2011; Wallner, Michael/L-5437-2015; Ferreira, Fatima/AAB-4321-2019; Himly, Martin/D-1568-2015	Hauser, Michael/0000-0001-6558-755X; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Wallner, Michael/0000-0001-6568-7892; Ferreira, Fatima/0000-0003-0989-2335; Himly, Martin/0000-0001-5416-085X	Christian Doppler Research Association; Oesterreichische Nationalbank [12533]	Christian Doppler Research Association; Oesterreichische Nationalbank	This work was supported by grants from the Christian Doppler Research Association (www.cdg.ac.at), the Oesterreichische Nationalbank ( Project No. 12533) (www.oenb.at) and Biomay AG (www.biomay.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerdaas JH, 2003, INT ARCH ALLERGY IMM, V132, P132, DOI 10.1159/000073714; Arquint O, 1999, J ALLERGY CLIN IMMUN, V104, P1239, DOI 10.1016/S0091-6749(99)70019-9; Bohle B, 2006, J ALLERGY CLIN IMMUN, V118, P242, DOI 10.1016/j.jaci.2006.03.011; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Claverol S, 2003, MOL CELL PROTEOMICS, V2, P483, DOI 10.1074/mcp.T300003-MCP200; Ferreira F, 1997, INT ARCH ALLERGY IMM, V113, P125, DOI 10.1159/000237524; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; FERREIRA FD, 1993, J BIOL CHEM, V268, P19574; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Himly M, 2009, ALLERGY; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Kahlert H, 2008, INT ARCH ALLERGY IMM, V145, P193, DOI 10.1159/000109288; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; SHIRANO Y, 1990, FEBS LETT, V271, P128, DOI 10.1016/0014-5793(90)80388-Y; SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607; Van Ree R, 2008, ALLERGY, V63, P310, DOI 10.1111/j.1398-9995.2007.01612.x; Vaz DC, 2006, PROTEIN SCI, V15, P33, DOI 10.1110/ps.051593306; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2009, ALLERGY, V64, P452, DOI 10.1111/j.1398-9995.2008.01788.x; Wallner M, 2007, CURR OPIN MOL THER, V9, P160; Weiss C, 1996, INT ARCH ALLERGY IMM, V110, P282, DOI 10.1159/000237300	27	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8457	10.1371/journal.pone.0008457	http://dx.doi.org/10.1371/journal.pone.0008457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041109	gold, Green Published, Green Submitted			2022-12-27	WOS:000273104000018
J	Yang, LJ; Zou, J; Xie, HZ; Li, LL; Wei, YQ; Yang, SY				Yang, Li-Jun; Zou, Jun; Xie, Huan-Zhang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong			Steered Molecular Dynamics Simulations Reveal the Likelier Dissociation Pathway of Imatinib from Its Targeting Kinases c-Kit and Abl	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; THYROID-HORMONE RECEPTORS; LIGAND-BINDING; CONFORMATIONAL TRANSITIONS; CANCER-TREATMENT; STRUCTURAL BASIS; PROTEIN-KINASES; INHIBITORS; DESIGN; AUTOINHIBITION	Development of small molecular kinase inhibitors has recently been the central focus in drug discovery. And type II kinase inhibitors that target inactive conformation of kinases have attracted particular attention since their potency and selectivity are thought to be easier to achieve compared with their counterpart type I inhibitors that target active conformation of kinases. Although mechanisms underlying the interactions between type II inhibitors and their targeting kinases have been widely studied, there are still some challenging problems, for example, how type II inhibitors associate with or dissociate from their targeting kinases. In this investigation, steered molecular dynamics simulations have been carried out to explore the possible dissociation pathways of typical type II inhibitor imatinib from its targeting protein kinases c-Kit and Abl. The simulation results indicate that the most favorable pathway for imatinib dissociation corresponds to the ATP-channel rather than the relatively wider allosteric-pocket-channel, which is mainly due to the different van der Waals interaction that the ligand suffers during dissociation. Nevertheless, the direct reason comes from the fact that the residues composing the ATP-channel are more flexible than that forming the allosteric-pocket-channel. The present investigation suggests that a bulky hydrophobic head is unfavorable, but a large polar tail is allowed for a potent type II inhibitor. The information obtained here can be used to direct the discovery of type II kinase inhibitors.	[Yang, Li-Jun; Zou, Jun; Xie, Huan-Zhang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong] Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, W China Med Sch, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University	Yang, LJ (corresponding author), Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, W China Med Sch, W China Hosp, Chengdu 610064, Peoples R China.	yangsy@scu.edu.cn		Zou, Jun/0000-0002-5395-6052	863 Hi-Tech Program [2006AA020400]; National Natural Science Foundation of China [30772651, 20872100]; Youth Foundation of Sichuan Province [08ZQ026-030]	863 Hi-Tech Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Sichuan Province	This work was supported by the 863 Hi-Tech Program (2006AA020400), the National Natural Science Foundation of China (30772651 and 20872100) and the Youth Foundation of Sichuan Province (08ZQ026-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dowell J, 2005, NAT REV DRUG DISCOV, V4, P13, DOI 10.1038/nrd1612; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Genest D, 2008, EUR BIOPHYS J BIOPHY, V37, P369, DOI 10.1007/s00249-007-0220-9; Giamas G, 2007, PHARMACOGENOMICS, V8, P1005, DOI 10.2217/14622416.8.8.1005; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Leech J, 1996, IEEE COMPUT SCI ENG, V3, P38, DOI 10.1109/99.556511; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Martinez L, 2006, J MED CHEM, V49, P23, DOI 10.1021/jm050805n; Martinez L, 2008, J PHYS CHEM B, V112, P10741, DOI 10.1021/jp803403c; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morgan H., 2002, CELL, V109, P275; Murphy E, 2005, EXPERT OPIN THER TAR, V9, P447, DOI 10.1517/14728222.9.3.447; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piccaluga PP, 2006, EXPERT OPIN PHARMACO, V7, P721, DOI 10.1517/14656566.7.6.721; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Sonoda MT, 2008, MOL ENDOCRINOL, V22, P1565, DOI 10.1210/me.2007-0501; Thaimattam R, 2007, CURR PHARM DESIGN, V13, P2751, DOI 10.2174/138161207781757042; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Vlahos CJ, 2003, NAT REV DRUG DISCOV, V2, P99, DOI 10.1038/nrd1009; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zou J, 2008, PROTEINS, V72, P323, DOI 10.1002/prot.21928; 1977, J COMPUT PHYS, V23, P327	50	34	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8470	10.1371/journal.pone.0008470	http://dx.doi.org/10.1371/journal.pone.0008470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041122	Green Submitted, Green Published, gold			2022-12-27	WOS:000273104000027
J	Ruskin, DN; Kawamura, M; Masino, SA				Ruskin, David N.; Kawamura, Masahito, Jr.; Masino, Susan A.			Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; CALORIE RESTRICTION; PROTEIN RESTRICTION; LOW-CARBOHYDRATE; KETONE-BODIES; ADENOSINE; METABOLISM; CHILDREN; BRAIN; EXPRESSION	The ketogenic diet is a high-fat, low-carbohydrate regimen that forces ketone-based rather than glucose-based cellular metabolism. Clinically, maintenance on a ketogenic diet has been proven effective in treating pediatric epilepsy and type II diabetes, and recent basic research provides evidence that ketogenic strategies offer promise in reducing brain injury. Cellular mechanisms hypothesized to be mobilized by ketone metabolism and underlying the success of ketogenic diet therapy, such as reduced reactive oxygen species and increased central adenosine, suggest that the ketolytic metabolism induced by the diet could reduce pain and inflammation. To test the effects of a ketone-based metabolism on pain and inflammation directly, we fed juvenile and adult rats a control diet (standard rodent chow) or ketogenic diet (79% fat) ad libitum for 3-4 weeks. We then quantified hindpaw thermal nociception as a pain measure and complete Freund's adjuvant-induced local hindpaw swelling and plasma extravasation (fluid movement from the vasculature) as inflammation measures. Independent of age, maintenance on a ketogenic diet reduced the peripheral inflammatory response significantly as measured by paw swelling and plasma extravasation. The ketogenic diet also induced significant thermal hypoalgesia independent of age, shown by increased hindpaw withdrawal latency in the hotplate nociception test. Anti-inflammatory and hypoalgesic diet effects were generally more robust in juveniles. The ketogenic diet elevated plasma ketones similarly in both age groups, but caused slowed body growth only in juveniles. These data suggest that applying a ketogenic diet or exploiting cellular mechanisms associated with ketone-based metabolism offers new therapeutic opportunities for controlling pain and peripheral inflammation, and that such a metabolic strategy may offer significant benefits for children and adults.	[Ruskin, David N.; Kawamura, Masahito, Jr.; Masino, Susan A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Ruskin, David N.; Kawamura, Masahito, Jr.; Masino, Susan A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA; [Kawamura, Masahito, Jr.] Jikei Univ, Sch Med, Dept Pharmacol, Minato Ku, Tokyo, Japan	Trinity College; Trinity College; Jikei University	Ruskin, DN (corresponding author), Trinity Coll, Dept Psychol, Hartford, CT 06106 USA.	susan.masino@trincoll.edu			National Institutes of Health [061290]; National Science Foundation [IOS-0843585]; CHDI; Trinity College; Division Of Integrative Organismal Systems [0843585] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS061290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CHDI; Trinity College; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health (061290), National Science Foundation (IOS-0843585), CHDI (www.highqfoundation.org) and Trinity College (www.trincoll.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Becker N, 1997, PAIN, V73, P393, DOI 10.1016/S0304-3959(97)00126-7; Bough KJ, 2003, EPILEPSIA, V44, P752, DOI 10.1046/j.1528-1157.2003.55502.x; Bough KJ, 1999, EPILEPSY RES, V35, P21, DOI 10.1016/S0920-1211(98)00125-9; COLLINS JE, 1985, HUM NUTR-APPL NUTR, V39A, P255; Cullingford TE, 2004, PROSTAG LEUKOTR ESS, V70, P253, DOI 10.1016/j.plefa.2003.09.008; Cullingford T, 2008, EPILEPSIA, V49, P70, DOI 10.1111/j.1528-1167.2008.01840.x; Dickenson AH, 2000, CNS DRUGS, V13, P77, DOI 10.2165/00023210-200013020-00001; EDDY AA, 1994, AM J PHYSIOL, V266, pF884, DOI 10.1152/ajprenal.1994.266.6.F884; Fragasso G, 2008, CURR PHARM DESIGN, V14, P2582, DOI 10.2174/138161208786071245; Giordano M, 2008, DIABETOLOGIA, V51, P21, DOI 10.1007/s00125-007-0874-y; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; HAAS RH, 1986, AM J MED GENET, V24, P225; Hallbook T, 2007, EPILEPSY RES, V77, P134, DOI 10.1016/j.eplepsyres.2007.09.008; Hemingway C, 2001, PEDIATRICS, V108, P898, DOI 10.1542/peds.108.4.898; Hori A, 1997, EPILEPSIA, V38, P750, DOI 10.1111/j.1528-1157.1997.tb01461.x; Iughetti L, 2007, J ENDOCRINOL INVEST, V30, P700; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee HT, 2004, AM J PHYSIOL-RENAL, V286, pF298, DOI 10.1152/ajprenal.00185.2003; Liu YMC, 2003, J AM DIET ASSOC, V103, P707, DOI 10.1053/jada.2003.50136; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Mantis JG, 2009, EPILEPSY BEHAV, V15, P133, DOI 10.1016/j.yebeh.2009.02.038; Martinez-Dominguez E, 2001, INFLAMM RES, V50, P102, DOI 10.1007/s000110050731; MASINO SA, 2009, CURR NEUROP IN PRESS; Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009; Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Poon A, 1999, EUR J PHARMACOL, V384, P123, DOI 10.1016/S0014-2999(99)00626-3; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rodriguez-Enriquez S, 2009, MOL NUTR FOOD RES, V53, P29, DOI 10.1002/mnfr.200700470; SAWYNOK J, 1982, NEUROPHARMACOLOGY, V21, P397, DOI 10.1016/0028-3908(82)90022-3; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Shibolet O, 2002, CLIN IMMUNOL, V105, P48, DOI 10.1006/clim.2002.5260; Silva MC, 2005, NUTR NEUROSCI, V8, P259, DOI 10.1080/10284150500475032; Sorkin LS, 2003, EXP NEUROL, V184, P162, DOI 10.1016/S0014-4886(03)00102-X; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Tendler D, 2007, DIGEST DIS SCI, V52, P589, DOI 10.1007/s10620-006-9433-5; Thio LL, 2006, PEDIATR RES, V60, P413, DOI 10.1203/01.pdr.0000238244.54610.27; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004; Westman EC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-36; WINYARD PG, 1999, FREE RADICALS INFLAM; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722; Ziegler DR, 2005, PHYSIOL BEHAV, V84, P421, DOI 10.1016/j.physbeh.2005.01.003	48	108	111	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8349	10.1371/journal.pone.0008349	http://dx.doi.org/10.1371/journal.pone.0008349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20041135	gold, Green Published			2022-12-27	WOS:000272998100005
J	Forgber, M; Gellrich, S; Sharav, T; Sterry, W; Walden, P				Forgber, Michael; Gellrich, Sylke; Sharav, Tumenjargal; Sterry, Wolfram; Walden, Peter			Proteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma	PLOS ONE			English	Article							T-CELL LYMPHOMA; LUNG SQUAMOUS CARCINOMA; HEPATOCELLULAR-CARCINOMA; SEREX IDENTIFICATION; BIOMARKER DISCOVERY; MYCOSIS-FUNGOIDES; CANCER IMMUNOMICS; IMMUNE-RESPONSE; HUMAN NEOPLASMS; TESTIS	Information on specificities of serological responses against tumor cells in cutaneous lymphoma patients is relatively restricted. To advance the knowledge of serological immune responses against and to assess the scope of tumor antigenicity of cutaneous lymphoma, 1- and 2-dimensional Western blot analyses with sera from patients were combined with proteomics-based protein identification. Testing sera from 87 cutaneous lymphoma patients by 1-dimensional Western blot analysis, 64 cases of seroreactivity against lymphoma cells were found. The positive responses were relatively weak, restricted to few antigens in each case, and heterogeneous. To identify the antigens, proteins of the mycosis fungoides cell line MyLa and primary tumor cells were separated by 2-dimensional gel electrophoresis, Western-blotted and probed with heterogeneous and autologous patient sera. The antigens were identified from silver-stained replica gels by MALDI-TOF mass spectrometry. 14 different antigens were assigned and identified with this proteome-serological approach. Only one, vimentin, had been reported before, the other 13 are new antigens for cutaneous lymphomas.	[Forgber, Michael; Gellrich, Sylke; Sharav, Tumenjargal; Sterry, Wolfram; Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol Venerol & Allergy, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Forgber, M (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol Venerol & Allergy, Berlin, Germany.	peter.walden@charite.de		Sharav, Tumenjargal/0000-0003-2980-1875	Volkswagen Foundation, Hannover, Germany [I/77 908]; Deutsche Krebshilfe - Mildred Scheel Stiftung; Deutsche Forschungsgemeinschaft (DFG)	Volkswagen Foundation, Hannover, Germany(Volkswagen); Deutsche Krebshilfe - Mildred Scheel Stiftung(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by a grant from the Volkswagen Foundation, Hannover, Germany, grant I/77 908, the Deutsche Krebshilfe - Mildred Scheel Stiftung, and the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacarese-Hamilton T, 2002, BIOTECHNIQUES, P24; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Chan C, 1999, ELECTROPHORESIS, V20, P3467, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3467::AID-ELPS3467>3.3.CO;2-0; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; De Monte L, 2008, J PROTEOME RES, V7, P504, DOI 10.1021/pr070360m; Eichmuller S, 2003, INT J CANCER, V104, P482, DOI 10.1002/ijc.10967; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; EICHMULLER S, ONKOLOGIE, V25, P448; FORGBER M, 2009, PLOS ONE IN PRESS; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hardouin J, 2007, ANN NY ACAD SCI, V1107, P223, DOI 10.1196/annals.1381.024; Hartmann TB, 2008, EXP DERMATOL, V17, P324, DOI 10.1111/j.1600-0625.2007.00637.x; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Hartmann TB, 2004, BRIT J DERMATOL, V150, P252, DOI 10.1111/j.1365-2133.2004.05651.x; Hassel JC, 2004, DERMATOLOGY, V209, P296, DOI 10.1159/000080852; Hishizawa M, 2005, BRIT J HAEMATOL, V130, P418, DOI 10.1111/j.1365-2141.2005.05604.x; Huang S, 2002, CANCER IMMUNOL IMMUN, V51, P655, DOI 10.1007/s00262-002-0320-4; Huguet S, 2004, PROTEOMICS, V4, P1341, DOI 10.1002/pmic.200300757; Jager D, 2000, CANCER RES, V60, P3584; Jungblut PR, 2002, METHOD ENZYMOL, V358, P307; KALTOFT K, 1992, IN VITRO CELL DEV-AN, V28A, P161; Kellner R, 2002, PROTEOMICS, V2, P1743, DOI 10.1002/1615-9861(200212)2:12<1743::AID-PROT1743>3.0.CO;2-U; Kersten C, 2004, CANCER IMMUNOL IMMUN, V53, P1119, DOI 10.1007/s00262-004-0558-0; Klemke Claus-Detlev, 2006, J Dtsch Dermatol Ges, V4, P395, DOI 10.1111/j.1610-0387.2006.05982.x; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Krah Alexander, 2004, Methods Mol Med, V94, P19; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Li C, 2005, PROTEOMICS, V5, P1125, DOI 10.1002/pmic.200401141; Lichtenfels R, 2003, BBA-PROTEINS PROTEOM, V1646, P21, DOI 10.1016/S1570-9639(02)00547-2; Liggins AP, 2005, METH MOLEC MED, V115, P109; Liggins AP, 2004, BRIT J CANCER, V91, P141, DOI 10.1038/sj.bjc.6601875; Liggins AP, 2004, INT J CANCER, V110, P563, DOI 10.1002/ijc.20170; Linnemann T, 2001, EUR J IMMUNOL, V31, P156, DOI 10.1002/1521-4141(200101)31:1<156::AID-IMMU156>3.0.CO;2-P; Looi KS, 2008, J PROTEOME RES, V7, P4004, DOI 10.1021/pr800273h; Mobley JA, 2004, J UROLOGY, V172, P331, DOI 10.1097/01.ju.0000132355.97888.50; Modarressi MH, 2001, GENE, V262, P249; Morra E, 1999, INT J BIOL MARKER, V14, P149, DOI 10.1177/172460089901400305; Neumann F, 2004, CANCER IMMUNOL IMMUN, V53, P589, DOI 10.1007/s00262-003-0492-6; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Philip R, 2007, J PROTEOME RES, V6, P2509, DOI 10.1021/pr0606777; Preuss KD, 2002, IMMUNOL REV, V188, P43, DOI 10.1034/j.1600-065X.2002.18805.x; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Shoshan Stacy H., 2007, Cancer Biomarkers, V3, P141; Tanaka R, 2004, MICROBIOL IMMUNOL, V48, P339, DOI 10.1111/j.1348-0421.2004.tb03515.x; Theinert SM, 2005, BRIT J DERMATOL, V153, P639, DOI 10.1111/j.1365-2133.2005.06669.x; Tomaino B, 2007, J PROTEOME RES, V6, P4025, DOI 10.1021/pr070281a; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Unwin RD, 2003, PROTEOMICS, V3, P45, DOI 10.1002/pmic.200390008; USENER D, J INVEST DERMATOL, V121, P198; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Yang F, 2007, J PROTEOME RES, V6, P751, DOI 10.1021/pr0602287	59	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8376	10.1371/journal.pone.0008376	http://dx.doi.org/10.1371/journal.pone.0008376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020065	Green Published, gold, Green Submitted			2022-12-27	WOS:000272870600015
J	Nierkens, S; den Brok, MH; Roelofsen, T; Wagenaars, JAL; Figdor, CG; Ruers, TJ; Adema, GJ				Nierkens, Stefan; den Brok, Martijn H.; Roelofsen, Thijs; Wagenaars, Jori A. L.; Figdor, Carl G.; Ruers, Theo J.; Adema, Gosse J.			Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice	PLOS ONE			English	Article							T-CELL IMMUNITY; DENDRITIC CELLS; ANTITUMOR IMMUNITY; RADIOFREQUENCY ABLATION; CROSS-PRESENTATION; BACTERIAL-DNA; TUMOR; OLIGODEOXYNUCLEOTIDE; ANTIGEN; INDUCTION	Background: The TLR9 agonist CpG is increasingly applied in preclinical and clinical studies as a therapeutic modality to enhance tumor immunity. The clinical application of CpG appears, however, less successful than would be predicted from animal studies. One reason might be the different administration routes applied in most mouse studies and clinical trials. We studied whether the efficacy of CpG as an adjuvant in cancer immunotherapy is dependent on the route of CpG administration, in particular when the tumor is destructed in situ. Methodology/Principal Findings: In situ tumor destruction techniques are minimally invasive therapeutic alternatives for the treatment of (nonresectable) solid tumors. In contrast to surgical resection, tumor destruction leads to the induction of weak but tumor-specific immunity that can be enhanced by coapplication of CpG. As in situ tumor destruction by cryosurgery creates an instant local release of antigens, we applied this model to study the efficacy of CpG to enhance antitumor immunity when administrated via different routes: peritumoral, intravenous, and subcutaneous but distant from the tumor. We show that peritumoral administration is superior in the activation of dendritic cells, induction of tumor-specific CTL, and long-lasting tumor protection. Although the intravenous and subcutaneous (at distant site) exposures are commonly used in clinical trials, they only provided partial protection or even failed to enhance antitumor responses as induced by cryosurgery alone. Conclusions/Significance: CpG administration greatly enhances the efficacy of in situ tumor destruction techniques, provided that CpG is administered in close proximity of the released antigens. Hence, this study helps to provide directions to fully benefit from CpG as immune stimulant in a clinical setting.	[Nierkens, Stefan; den Brok, Martijn H.; Roelofsen, Thijs; Wagenaars, Jori A. L.; Figdor, Carl G.; Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Ruers, Theo J.] Netherlands Canc Inst, Amsterdam, Netherlands	Radboud University Nijmegen; Netherlands Cancer Institute	Nierkens, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands.	g.adema@ncmls.ru.nl	Brok, Martijn H den/O-1054-2013; Nierkens, Stefan/AAQ-5564-2021; Figdor, Carl G/A-4232-2010; Adema, G.J./H-8007-2014	Nierkens, Stefan/0000-0003-3406-817X; Figdor, Carl G/0000-0002-2366-9212; Roelofsen, Thijs/0000-0003-1470-8846; den Brok, Martijn/0000-0002-2368-0411	Dutch Cancer Society [KWF-2003-2893, KWF-2004-3137, KWF-2005-3325]; Dutch Cancer Society (KWF, Amsterdam, The Netherlands)	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Cancer Society (KWF, Amsterdam, The Netherlands)(KWF KankerbestrijdingNetherlands Government)	This research was made possible by grants of the Dutch Cancer Society (KWF-2003-2893, KWF-2004-3137, KWF-2005-3325). SN is a research fellow of the Dutch Cancer Society (KWF, Amsterdam, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Baines J, 2003, CLIN CANCER RES, V9, P2693; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Davila E, 2003, CANCER RES, V63, P3281; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; den Brok MHMGM, 2005, EXPERT REV VACCINES, V4, P699, DOI 10.1586/14760584.4.5.699; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Fallarino F, 2006, EUR J IMMUNOL, V36, P8, DOI 10.1002/eji.200535667; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Heckelsmiller K, 2002, J IMMUNOL, V169, P3892, DOI 10.4049/jimmunol.169.7.3892; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hoene V, 2006, J LEUKOCYTE BIOL, V80, P1328, DOI 10.1189/jlb.0106011; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang A, 2002, BRIT J SURG, V89, P303, DOI 10.1046/j.0007-1323.2001.02004.x; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Milas L, 2004, CANCER RES, V64, P5074, DOI 10.1158/0008-5472.CAN-04-0926; Mulier S, 2008, ANN SURG ONCOL, V15, P144, DOI 10.1245/s10434-007-9478-5; Murad YM, 2007, EXPERT OPIN BIOL TH, V7, P1257, DOI 10.1517/14712598.7.8.1257; Nierkens S, 2008, CANCER RES, V68, P5390, DOI 10.1158/0008-5472.CAN-07-6023; Ninalga C, 2005, J IMMUNOTHER, V28, P20, DOI 10.1097/00002371-200501000-00003; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Schmidt C, 2007, NAT BIOTECHNOL, V25, P825, DOI 10.1038/nbt0807-825; van Maren WWC, 2008, IMMUNOLOGY, V124, P445, DOI 10.1111/j.1365-2567.2008.02871.x; von Beust BR, 2005, EUR J IMMUNOL, V35, P1869, DOI 10.1002/eji.200526124; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602	39	69	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8368	10.1371/journal.pone.0008368	http://dx.doi.org/10.1371/journal.pone.0008368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020049	Green Submitted, Green Published, gold			2022-12-27	WOS:000272870600009
J	Wallis, TSA; Williams, MA; Arnold, DH				Wallis, Thomas S. A.; Williams, Mark A.; Arnold, Derek H.			Pre-Exposure to Moving Form Enhances Static Form Sensitivity	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; HUMAN VISUAL-SYSTEM; BIOLOGICAL MOTION; PERSISTENCE; PERCEPTION; RECOGNITION; ACTIVATION; AWARENESS; DIRECTION; FIGURES	Background: Motion-defined form can seem to persist briefly after motion ceases, before seeming to gradually disappear into the background. Here we investigate if this subjective persistence reflects a signal capable of improving objective measures of sensitivity to static form. Methodology/Principal Findings: We presented a sinusoidal modulation of luminance, masked by a background noise pattern. The sinusoidal luminance modulation was usually subjectively invisible when static, but visible when moving. We found that drifting then stopping the waveform resulted in a transient subjective persistence of the waveform in the static display. Observers' objective sensitivity to the position of the static waveform was also improved after viewing moving waveforms, compared to viewing static waveforms for a matched duration. This facilitation did not occur simply because movement provided more perspectives of the waveform, since performance following pre-exposure to scrambled animations did not match that following pre-exposure to smooth motion. Observers did not simply remember waveform positions at motion offset, since removing the waveform before testing reduced performance. Conclusions/Significance: Motion processing therefore interacts with subsequent static visual inputs in a way that can improve performance in objective sensitivity measures. We suggest that the brief subjective persistence of motion-defined forms that can occur after motion offsets is a consequence of the decay of a static form signal that has been transiently enhanced by motion processing.	[Wallis, Thomas S. A.; Arnold, Derek H.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Williams, Mark A.] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	University of Queensland; Macquarie University	Wallis, TSA (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	tsawallis@gmail.com	Wallis, Thomas S. A./AFV-5562-2022; Wallis, Thomas S. A./G-3899-2010	Williams, Mark/0000-0002-3897-5167; Wallis, Thomas/0000-0001-7431-4852; Arnold, Derek/0000-0003-1027-6222	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was supported by a Discovery Project Grant and Australian Postdoctoral Fellowship awarded to DHA by the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burr D, 2004, CURR BIOL, V14, pR381, DOI 10.1016/j.cub.2004.05.011; BURR DC, 1986, VISION RES, V26, P643, DOI 10.1016/0042-6989(86)90012-X; Burr DC, 2002, J NEUROSCI, V22, P8661; Emrich SM, 2008, CONSCIOUS COGN, V17, P319, DOI 10.1016/j.concog.2006.12.001; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; Ferber S, 2007, COGN NEUROPSYCHOL, V24, P187, DOI 10.1080/02643290601046598; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; Green DM, 1966, SIGNAL DETECTION THE; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kourtzi Z, 2008, TRENDS COGN SCI, V12, P230, DOI 10.1016/j.tics.2008.02.013; MATEEFF S, 1993, VISION RES, V33, P2563, DOI 10.1016/0042-6989(93)90135-J; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Nishida S, 2004, CURR BIOL, V14, P830, DOI 10.1016/j.cub.2004.04.044; Nishida S, 2007, CURR BIOL, V17, P366, DOI 10.1016/j.cub.2006.12.041; O'Herron P, 2009, NEURON, V61, P801, DOI 10.1016/j.neuron.2009.01.014; PARKS TE, 1965, AM J PSYCHOL, V78, P145, DOI 10.2307/1421101; REGAN D, 1986, Spatial Vision, V1, P305, DOI 10.1163/156856886X00106; Risko EF, 2006, CONSCIOUS COGN, V15, P475, DOI 10.1016/j.concog.2005.11.004; ROSS J, 1977, J PHYSIOL-LONDON, V271, pP2; SHIOIRI S, 1992, VISION RES, V32, P943, DOI 10.1016/0042-6989(92)90037-J; SIEGEL RM, 1988, NATURE, V331, P259, DOI 10.1038/331259a0; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8324	10.1371/journal.pone.0008324	http://dx.doi.org/10.1371/journal.pone.0008324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533OR	20019815	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834200003
J	Carrasco, MA; Barnosky, AD; Graham, RW				Carrasco, Marc A.; Barnosky, Anthony D.; Graham, Russell W.			Quantifying the Extent of North American Mammal Extinction Relative to the Pre-Anthropogenic Baseline	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIP; DIVERSITY; FUTURE; DISTRIBUTIONS; RAREFACTION; QUATERNARY; MEGAFAUNA; RICHNESS; ECOLOGY; TRENDS	Earth has experienced five major extinction events in the past 450 million years. Many scientists suggest we are now witnessing a sixth, driven by human impacts. However, it has been difficult to quantify the real extent of the current extinction episode, either for a given taxonomic group at the continental scale or for the worldwide biota, largely because comparisons of pre-anthropogenic and anthropogenic biodiversity baselines have been unavailable. Here, we compute those baselines for mammals of temperate North America, using a sampling-standardized rich fossil record to reconstruct species-area relationships for a series of time slices ranging from 30 million to 500 years ago. We show that shortly after humans first arrived in North America, mammalian diversity dropped to become at least 15%-42% too low compared to the "normal" diversity baseline that had existed for millions of years. While the Holocene reduction in North American mammal diversity has long been recognized qualitatively, our results provide a quantitative measure that clarifies how significant the diversity reduction actually was. If mass extinctions are defined as loss of at least 75% of species on a global scale, our data suggest that North American mammals had already progressed one-fifth to more than halfway (depending on biogeographic province) towards that benchmark, even before industrialized society began to affect them. Data currently are not available to make similar quantitative estimates for other continents, but qualitative declines in Holocene mammal diversity are also widely recognized in South America, Eurasia, and Australia. Extending our methodology to mammals in these areas, as well as to other taxa where possible, would provide a reasonable way to assess the magnitude of global extinction, the biodiversity impact of extinctions of currently threatened species, and the efficacy of conservation efforts into the future.	[Carrasco, Marc A.; Barnosky, Anthony D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Carrasco, Marc A.; Barnosky, Anthony D.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Graham, Russell W.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Graham, Russell W.] Penn State Univ, Earth & Mineral Sci Museum, University Pk, PA 16802 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Carrasco, MA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	carrasco@berkeley.edu			National Science Foundation [EAR-0310221, DEB-0543641, EAR-9005144, EAR-9807499]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation Grants EAR-0310221 and DEB-0543641 (Barnosky) and EAR-9005144 and EAR-9807499 (Graham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 1998, BIODIVERSITY DYNAMICS, P232; ALROY J, 1992, PALEOBIOLOGY, V18, P326, DOI 10.1017/S0094837300010873; Alroy J, 2003, J MAMMAL, V84, P431, DOI 10.1644/1545-1542(2003)084<0431:TIABMD>2.0.CO;2; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2002, EVOL ECOL RES, V4, P811; Barnosky AD, 2001, CONSERV BIOL, V15, P658, DOI 10.1046/j.1523-1739.2001.015003658.x; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brook BW, 2007, QUATERNARY SCI REV, V26, P560, DOI 10.1016/j.quascirev.2006.10.008; Brown J. H., 1995, MACROECOLOGY; CARRASCO MA, 2005, MIOCENE MAMMAL MAPPI; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; CONDON SM, 2005, GEOLOGICAL SURVEY PR, V1706, P1; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Desmet P, 2004, ECOL SOC, V9; Escarguel G, 2004, PALAEOGEOGR PALAEOCL, V202, P181, DOI 10.1016/S0031-0182(03)00630-8; *FAUNMAP WORK GROU, 1994, ILLINOIS STATE MUSEU, V25, P690; Fortelius M., 2009, NEOGENE OLD WORLD DA; GODRON M, 1971, Oecologia Plantarum, V6, P189; GRAHAM R W, 1976, Paleobiology, V2, P343; Graham RW, 1996, SCIENCE, V272, P1601; GRAHAM RW, 1985, ACTA ZOOL FENN, V170, P181; HAGMEIER EDWIN M., 1966, SYST ZSOL, V15, P279, DOI 10.2307/2411986; HAGMEIER EM, 1964, SYST ZOOL, V13, P125, DOI 10.2307/2411486; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Janis CM., 1998, EVOLUTION TERTIARY M, V1; Johnson C., 2007, AUSTR MAMMAL EXTINCT; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Leakey R.E., 1995, 6 EXTINCTION PATTERN; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Myers N., 1979, SINKING ARK; Ostling A, 2003, OIKOS, V103, P218, DOI 10.1034/j.1600-0706.2003.12600.x; Plotkin JB, 2000, P NATL ACAD SCI USA, V97, P10850, DOI 10.1073/pnas.97.20.10850; Prothero DR, 1998, EVOLUTION TERTIARY M, VI, P9; RAUP D M, 1975, Paleobiology, V1, P333; Regan HM, 2001, AM NAT, V157, P1, DOI 10.1086/317005; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 2001, P NATL ACAD SCI USA, V98, P5404, DOI 10.1073/pnas.101092798; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; *SMITHS I, 2009, NAT MUS NAT HIST N A; STORER JE, 1989, PAPERS FOSSIL RODENT, P17; Tedford R.H., 1987, P153; Tedford Richard H., 2004, P169; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Weiher E, 1999, J ECOL, V87, P1005, DOI 10.1046/j.1365-2745.1999.00412.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	64	33	33	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8331	10.1371/journal.pone.0008331	http://dx.doi.org/10.1371/journal.pone.0008331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016820	Green Submitted, Green Published, gold			2022-12-27	WOS:000272834000017
J	Foley, JE; Nieto, NC; Barbet, A; Foley, P				Foley, Janet E.; Nieto, Nathan C.; Barbet, Anthony; Foley, Patrick			Antigen Diversity in the Parasitic Bacterium Anaplasma phagocytophilum Arises from Selectively-Represented, Spatially Clustered Functional Pseudogenes	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; RATS NEOTOMA-FUSCIPES; MULTIGENE FAMILY; SENSU-LATO; INFECTION; MARGINALE; RECOMBINATION; EXPRESSION; MSP2; DNA	Anaplasma phagocytophilum is a tick-transmitted bacterial pathogen of humans and other animals, and is an obligate intracellular parasite. Throughout the course of infection, hosts acquire temporary resistance to granulocytic anaplasmosis as they develop immunity specific for the major antigen, major surface protein 2 (Msp2). However, the bacterium then utilizes a novel recombination mechanism shuffling functional pseudogenes sequentially into an expression cassette with conserved 59 and 39 ends, bypassing host immunity. Approximately 100 pseudogenes are present in the only fully sequenced human-origin HZ genome, representing the possibility for almost unlimited antigenic diversity. In the present study, we identified a select group of 20% of the A. phagocytophilum HZ msp2 pseudogenes that have matched preferentially to human, canine, and equine expression cassettes. Pseudogenes cluster predominantly in one spatial run limited to a single genomic island in less than 50% of the genome but phylogenetically related pseudogenes are neither necessarily located in close proximity on the genome nor share similar percent identity with expression cassettes. Pseudogenes near the expression cassette (and the origin) are more likely to be expressed than those farther away. Taken together, these findings suggest that there may be natural selection pressure to retain pseudogenes in one cluster near the putative origin of replication, even though global recombination shuffles pseudogenes around the genome, separating pseudogenes that share genetic origins as well as those with similar identities.	[Foley, Janet E.; Nieto, Nathan C.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Barbet, Anthony] Univ Florida, Dept Pathobiol, Gainesville, FL USA; [Foley, Patrick] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA	University of California System; University of California Davis; State University System of Florida; University of Florida; California State University System; California State University Sacramento	Foley, JE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	jefoley@ucdavis.edu			National Institutes of General Medical Sciences Evolution of Infectious Disease program [RO1 GM081714]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081714] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences Evolution of Infectious Disease program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of General Medical Sciences Evolution of Infectious Disease program # RO1 GM081714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Barbet AF, 2006, INFECT IMMUN, V74, P6429, DOI 10.1128/IAI.00809-06; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2003, INFECT IMMUN, V71, P6627, DOI 10.1128/IAI.71.11.6627-6632.2003; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Castro MB, 2001, AM J TROP MED HYG, V65, P261, DOI 10.4269/ajtmh.2001.65.261; DONELSON JE, 1995, J BIOL CHEM, V270, P7783, DOI 10.1074/jbc.270.14.7783; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Egenvall A, 2000, VET REC, V146, P186, DOI 10.1136/vr.146.7.186; Foley J, 2008, EXP APPL ACAROL, V45, P155, DOI 10.1007/s10493-008-9173-7; Foley JE, 2002, J WILDLIFE DIS, V38, P194, DOI 10.7589/0090-3558-38.1.194; Friedberg EC, 2006, IMPLICIT GENOME, P39; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Futse JE, 2009, INFECT IMMUN, V77, P3181, DOI 10.1128/IAI.00348-09; Granquist EG, 2008, INFECT IMMUN, V76, P120, DOI 10.1128/IAI.01206-07; Ioannidis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-182; Lin Q, 2006, INFECT IMMUN, V74, P2052, DOI 10.1128/IAI.74.4.2052-2062.2006; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Morissette E, 2009, EMERG INFECT DIS, V15, P928, DOI 10.3201/eid1506.081610; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; Nicholson WL, 1999, J CLIN MICROBIOL, V37, P3323, DOI 10.1128/JCM.37.10.3323-3327.1999; NIETO N, 2009, VECTOR BORNE ZOONOTI; Nieto NC, 2008, J MED ENTOMOL, V45, P763, DOI 10.1603/0022-2585(2008)45[763:EOSRSA]2.0.CO;2; Ohashi N, 1998, INFECT IMMUN, V66, P132, DOI 10.1128/IAI.66.1.132-139.1998; PALMER G, 2009, CELLULAR MICROBIOLOG; Stuen S, 1998, VET REC, V143, P553, DOI 10.1136/vr.143.20.553; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Wang XQ, 2004, INFECT IMMUN, V72, P6852, DOI 10.1128/IAI.72.12.6852-6859.2004; Wuritu G, 2009, JPN J INFECT DIS, V62, P142; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	36	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8265	10.1371/journal.pone.0008265	http://dx.doi.org/10.1371/journal.pone.0008265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016821	Green Submitted, Green Published, gold			2022-12-27	WOS:000272833800003
J	Kumar, S; Arankalle, VA				Kumar, Satyendra; Arankalle, Vidya A.			Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis	PLOS ONE			English	Article							RNA INTERFERENCE; MAMMALIAN-CELLS; MATRIX PROTEIN; ANDHRA-PRADESH; EXPRESSION; INFECTION; INDIA; CHILDREN; BRAIN; TRANSCRIPTION	Background: In parts of India, Chandipura Virus (CHPV) has emerged as an encephalitis causing pathogen in both epidemic and sporadic forms. This pediatric disease follows rapid course leading to 55-75% mortality. In the absence of specific treatment, effectiveness of RNA interference (RNAi) was evaluated. Methods and Findings: Efficacy of synthetic short interfering RNA (siRNA) or short hairpin RNA (shRNA) in protecting mice from CHPV infection was assessed. The target genes were P and M genes primarily because important role of the former in viral replication and lethal nature of the latter. Real time one step RT-PCR and plaque assay were used for the assessment of gene silencing. Using pAcGFP1N1-CHPV-P, we showed that P-2 siRNA was most efficient in reducing the expression of P gene in-vitro. Both quantitative assays documented 2logs reduction in the virus titer when P-2, M-5 or M-6 siRNAs were transfected 2hr post infection (PI). Use of these siRNAs in combination did not result in enhanced efficiency. P-2 siRNA was found to tolerate four mismatches in the center. As compared to five different shRNAs, P-2 siRNA was most effective in inhibiting CHPV replication. An extended survival was noted when mice infected intracranially with 100 LD(50) CHPV were treated with cationic lipid complexed 5 mu g P-2 siRNA simultaneously. Infection with 10LD(50) and treatment with two doses of siRNA first, simultaneously and second 24 hr PI, resulted in 70% survival. Surviving mice showed 4logs less CHPV titers in brain without histopathological changes or antibody response. Gene expression profiles of P-2 siRNA treated mice showed no interferon response. First dose of siRNA at 2hr or 4hr PI with second dose at 24hr resulted in 40% and 20% survival respectively suggesting potential application in therapy. Conclusions: The results highlight therapeutic potential of siRNA in treating rapid and fatal Chandipura encephalitis.	[Kumar, Satyendra; Arankalle, Vidya A.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Kumar, S (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	varankalle@yahoo.com		Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Arankalle VA, 2005, EMERG INFECT DIS, V11, P123, DOI 10.3201/eid1101.040602; Barik S, 2004, VIRUS RES, V102, P27, DOI 10.1016/j.virusres.2004.01.012; Basak S, 2007, BIOSCIENCE REP, V27, P275, DOI 10.1007/s10540-007-9054-z; Bennink JR, 2004, TRENDS MOL MED, V10, P571, DOI 10.1016/j.molmed.2004.10.004; Bernstein E, 2001, RNA, V7, P1509; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chadha MS, 2005, AM J TROP MED HYG, V73, P566, DOI 10.4269/ajtmh.2005.73.566; CHATTOPADHYAY D, 1994, CELL MOL BIOL RES, V40, P693; Clarke P, 2009, J VIROL, V83, P6161, DOI 10.1128/JVI.02488-08; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fulton A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004118; Geisbert TW, 2006, J INFECT DIS, V193, P1650, DOI 10.1086/504267; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Isacson R, 2003, ACTA PHYSIOL SCAND, V179, P173, DOI 10.1046/j.1365-201X.2003.01188.x; Israsena N, 2009, ANTIVIR RES, V84, P76, DOI 10.1016/j.antiviral.2009.07.012; Koterski J, 2007, FEMS IMMUNOL MED MIC, V51, P462, DOI 10.1111/j.1574-695X.2007.00319.x; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Kumar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-168; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Licata JM, 2003, INT REV IMMUNOL, V22, P451, DOI 10.1080/08830180305217; Lingor P, 2004, BIOCHEM BIOPH RES CO, V315, P1126, DOI 10.1016/j.bbrc.2004.01.170; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nuovo GJ, 2005, MODERN PATHOL, V18, P62, DOI 10.1038/modpathol.3800274; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; REED LJ, 1938, AM J HYG, V27, P49; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Tandale BV, 2008, J MED VIROL, V80, P118, DOI 10.1002/jmv.21041; Taylor A, 1999, VIRUS GENES, V19, P223, DOI 10.1023/A:1008188730975; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tripathy A, 2005, SCAND J INFECT DIS, V37, P590, DOI 10.1080/00365540510044067; Trottier MD, 2005, VIROLOGY, V333, P215, DOI 10.1016/j.virol.2005.01.009; Venkateswarlu CH, 2009, VACCINE, V27, P2845, DOI 10.1016/j.vaccine.2009.02.089; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005709; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Zhang Y, 2003, J GENE MED, V5, P1039, DOI 10.1002/jgm.449	46	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8615	10.1371/journal.pone.0008615	http://dx.doi.org/10.1371/journal.pone.0008615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062542	gold, Green Published, Green Submitted			2022-12-27	WOS:000273414100009
J	Abisambra, JF; Fiorelli, T; Padmanabhan, J; Neame, P; Wefes, I; Potter, H				Abisambra, Jose F.; Fiorelli, Tina; Padmanabhan, Jaya; Neame, Peter; Wefes, Inge; Potter, Huntington			LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E; TRANSGENIC MICE; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ASSOCIATION; TRANSPORT PROTEIN; HUMAN FIBROBLASTS; DOWNS-SYNDROME	Background: Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common form of dementia. The major molecular risk factor for late-onset AD is expression of the epsilon-4 allele of apolipoprotein E (apoE), the major cholesterol transporter in the brain. The low-density lipoprotein receptor (LDLR) has the highest affinity for apoE and plays an important role in brain cholesterol metabolism. Methodology/Principal Findings: Using RT-PCR and western blotting techniques we found that over-expression of APP caused increases in both LDLR mRNA and protein levels in APP transfected H4 neuroglioma cells compared to H4 controls. Furthermore, immunohistochemical experiments showed aberrant localization of LDLR in H4-APP neuroglioma cells, A beta-treated primary neurons, and in the PSAPP transgenic mouse model of AD. Finally, immunofluorescent staining of LDLR and of gamma- and alpha-tubulin showed a change in LDLR localization preferentially away from the plasma membrane that was paralleled by and likely the result of a disruption of the microtubule-organizing center and associated microtubule network. Conclusions/Significance: These data suggest that increased APP expression and A beta exposure alters microtubule function, leading to reduced transport of LDLR to the plasma membrane. Consequent deleterious effects on apoE uptake and function will have implications for AD pathogenesis and/or progression.	[Abisambra, Jose F.; Fiorelli, Tina; Padmanabhan, Jaya; Neame, Peter; Wefes, Inge; Potter, Huntington] Byrd Alzheimers Inst, Tampa, FL USA; [Abisambra, Jose F.; Fiorelli, Tina; Padmanabhan, Jaya; Neame, Peter; Wefes, Inge; Potter, Huntington] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Potter, Huntington] Eric Pfeiffer Suncoast Alzheimers & Gerontol Ctr, Tampa, FL USA; [Potter, Huntington] Florida Alzheimers Dis Res Ctr NIA, Tampa, FL USA	State University System of Florida; University of South Florida	Abisambra, JF (corresponding author), Byrd Alzheimers Inst, Tampa, FL USA.	hpotter@health.usf.edu	Abisambra, Joe/AAP-3269-2020; Abisambra, Jose/V-6860-2019; Padmanabhan, Jaya/A-4226-2012	Abisambra, Jose/0000-0001-6341-679X; Padmanabhan, Jaya/0000-0003-2019-5135	Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute	Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute	Funding provided by the Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute and the Eric Pfeiffer Chair for Research on Alzheimer's Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Cheng D, 2005, J MED GENET, V42, P129, DOI 10.1136/jmg.2004.024968; Corder EH, 2006, REJUV RES, V9, P89, DOI 10.1089/rej.2006.9.89; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDSTEIN JL, 1976, CURR TOP CELL REGUL, V11, P147; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Gopalraj RK, 2005, NEUROBIOL AGING, V26, P1, DOI 10.1016/j.neurobiolaging.2004.09.001; HAVEL RJ, 1973, P NATL ACAD SCI USA, V70, P2015, DOI 10.1073/pnas.70.7.2015; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Lopez D, 2007, BBA-MOL CELL BIOL L, V1771, P1216, DOI 10.1016/j.bbalip.2007.05.001; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; NESS GC, 1986, BIOCHEM J, V233, P167, DOI 10.1042/bj2330167; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Nizzari M, 2007, ANN NY ACAD SCI, V1096, P249, DOI 10.1196/annals.1397.091; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papassotiropoulos A, 2005, J CLIN PSYCHIAT, V66, P940, DOI 10.4088/JCP.v66n0720; Potter H, 2001, NEUROBIOL AGING, V22, P923, DOI 10.1016/S0197-4580(01)00308-6; Rasband W., 2006, IMAGEJ; Retz W, 2001, PSYCHIATR GENET, V11, P115, DOI 10.1097/00041444-200109000-00002; Rodriguez E, 2006, J NEUROL, V253, P801, DOI 10.1007/s00415-005-0063-1; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scacchi R, 2001, DEMENT GERIATR COGN, V12, P63, DOI 10.1159/000051237; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SUDHOF TC, 1985, SCIENCE, V228, P893, DOI 10.1126/science.3873704; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YLAHERTTUALA S, 1989, ATHEROSCLEROSIS, V76, P269, DOI 10.1016/0021-9150(89)90110-X; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	67	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8556	10.1371/journal.pone.0008556	http://dx.doi.org/10.1371/journal.pone.0008556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049331	Green Published, Green Submitted, gold			2022-12-27	WOS:000273225000018
J	Aksglaede, L; Juul, A; Olsen, LW; Sorensen, TIA				Aksglaede, Lise; Juul, Anders; Olsen, Lina W.; Sorensen, Thorkild I. A.			Age at Puberty and the Emerging Obesity Epidemic	PLOS ONE			English	Article							BODY-MASS-INDEX; NUTRITION EXAMINATION SURVEY; SECONDARY SEXUAL CHARACTERISTICS; BLOOD-INSTITUTE GROWTH; 3RD NATIONAL-HEALTH; SECULAR TRENDS; SCHOOL-CHILDREN; AMERICAN BOYS; YOUNG GIRLS; MATURATION	Background: Recent studies have shown that puberty starts at younger ages than previously. It has been hypothesized that the increasing prevalence of childhood obesity is contributing to this trend. The purpose of this study was to analyze the association between prepubertal body mass index (BMI) and pubertal timing, as assessed by age at onset of pubertal growth spurt (OGS) and at peak height velocity (PHV), and the secular trend of pubertal timing given the prepubertal BMI. Methodology/Principal Findings: Annual measurements of height and weight were available in all children born from 1930 to 1969 who attended primary school in the Copenhagen municipality; 156,835 children fulfilled the criteria for determining age at OGS and PHV. The effect of prepubertal BMI at age seven on these markers of pubertal development within and between birth cohorts was analyzed. BMI at seven years was significantly inversely associated with age at OGS and PHV. Dividing the children into five levels of prepubertal BMI, we found a similar secular trend toward earlier maturation in all BMI groups. Conclusion/Significance: The heavier both boys and girls were at age seven, the earlier they entered puberty. Irrespective of level of BMI at age seven, there was a downward trend in the age at attaining puberty in both boys and girls, which suggests that the obesity epidemic is not solely responsible for the trend.	[Aksglaede, Lise; Juul, Anders] Univ Copenhagen, Dept Growth & Reprod, Copenhagen, Denmark; [Olsen, Lina W.; Sorensen, Thorkild I. A.] Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark	University of Copenhagen	Aksglaede, L (corresponding author), Univ Copenhagen, Dept Growth & Reprod, Copenhagen, Denmark.	lise.aksglaede@rh.regionh.dk	Aksglaede, Lise/AAI-7163-2020; Juul, Anders/F-5864-2013	Juul, Anders/0000-0002-0534-4350; Aksglaede, Lise/0000-0001-7885-7467	Danish National Science Foundation; Danish Medical Research Council [271-05-0337]; Faculty of Health Sciences of the University of Copenhagen	Danish National Science Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Health Sciences of the University of Copenhagen	The work has been supported by the Danish National Science Foundation, the Danish Medical Research Council (271-05-0337), and the Faculty of Health Sciences of the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Aksglaede L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002728; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Bau AM, 2009, EUR J ENDOCRINOL, V160, P107, DOI 10.1530/EJE-08-0594; Bini V, 2000, EUR J CLIN NUTR, V54, P214, DOI 10.1038/sj.ejcn.1600922; BIRO FM, 1995, J PEDIATR-US, V127, P100, DOI 10.1016/S0022-3476(95)70265-2; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; CLELAND WH, 1985, J CLIN ENDOCR METAB, V60, P174, DOI 10.1210/jcem-60-1-174; Davison KK, 2003, PEDIATRICS, V111, P815, DOI 10.1542/peds.111.4.815; Den H.E., 2002, ENV HLTH PERSPECT, V110, P771; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; FOSTER TA, 1977, AM J CLIN NUTR, V30, P582, DOI 10.1093/ajcn/30.4.582; FRISCH RE, 1971, ARCH DIS CHILD, V46, P695, DOI 10.1136/adc.46.249.695; FRISCH RE, 1970, SCIENCE, V169, P397, DOI 10.1126/science.169.3943.397; HARLAN WR, 1979, J PEDIATR-US, V95, P293; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; Herman-Giddens ME, 2001, ARCH PEDIAT ADOL MED, V155, P1022, DOI 10.1001/archpedi.155.9.1022; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Juul A, 2007, INT J ANDROL, V30, P537, DOI 10.1111/j.1365-2605.2007.00751.x; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Karpati AM, 2002, J ADOLESCENT HEALTH, V30, P205, DOI 10.1016/S1054-139X(01)00320-2; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Koprowski C, 2001, OBES RES, V9, P478, DOI 10.1038/oby.2001.62; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Lee JM, 2007, PEDIATRICS, V119, pE624, DOI 10.1542/peds.2006-2188; LEE P A, 1980, Journal of Adolescent Health Care, V1, P26, DOI 10.1016/S0197-0070(80)80005-2; Lee PA, 2001, APMIS, V109, P81, DOI 10.1034/j.1600-0463.2001.d01-107.x; Louis GMB, 2008, PEDIATRICS, V121, pS192, DOI 10.1542/peds.1813E; Mamun AA, 2009, INT J OBESITY, V33, P14, DOI 10.1038/ijo.2008.220; MORRISON JA, 1994, J PEDIATR-US, V124, P889, DOI 10.1016/S0022-3476(05)83176-2; Navarro VM, 2007, REV ENDOCR METAB DIS, V8, P11, DOI 10.1007/s11154-007-9028-2; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; REYNOLDS EL, 1948, AM J DIS CHILD, V75, P329; Ribeiro J, 2006, ANN HUM BIOL, V33, P55, DOI 10.1080/00207390500434135; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; Sorensen K, 2007, J CLIN ENDOCR METAB, V92, P3189, DOI 10.1210/jc.2007-0231; Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903; Wattigney Wendy A., 1999, Ethnicity and Disease, V9, P181; World Health Organization, 1999, OB PREV MAN GLOB EP; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; Ye XY, 2006, ENVIRON HEALTH PERSP, V114, P1843, DOI 10.1289/ehp.9413; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	168	174	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8450	10.1371/journal.pone.0008450	http://dx.doi.org/10.1371/journal.pone.0008450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041184	Green Submitted, gold, Green Published			2022-12-27	WOS:000273104000014
J	van Hateren, KJJ; Landman, GWD; Kleefstra, N; Logtenberg, SJJ; Groenier, KH; Kamper, AM; Houweling, ST; Bilo, HJG				van Hateren, Kornelis J. J.; Landman, Gijs W. D.; Kleefstra, Nanne; Logtenberg, Susan J. J.; Groenier, Klaas H.; Kamper, Adriaan M.; Houweling, Sebastiaan T.; Bilo, Henk J. G.			The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; TOTAL CHOLESTEROL; DISEASE; GUIDELINES; INDIVIDUALS; MELLITUS; PROGRAM; PLASMA; CARE	Background: The precise relationship between the lipid profile and mortality in elderly patients with type 2 diabetes mellitus (T2DM) remains unclear. The aim of this study was to investigate the relationship between the lipid profile over time, and mortality in elderly patients with T2DM. Methods and Findings: In 1998, 881 primary care patients with T2DM aged 60 years and older participated in the ZODIAC study, a prospective observational study. The cohort was divided into two age categories: 60-75 years and older than 75 years. Updated means of all lipid profile indices were calculated after a median follow-up time of 9.8 years. These values were used as time dependent covariates in a Cox proportional hazard model. The cholesterol-HDL ratio and LDL-cholesterol were positively related to both all-cause and cardiovascular mortality in the low age group. In contrast, except for the triglyceride level, none of the other lipid profile indices were related to all-cause mortality in patients aged over 75 years. The mortality risk decreased by 17% (95% CI: 5% to 27%) for each 1 mmol/L higher serum level of triglycerides. The relationships between the various lipid profile indices and cardiovascular mortality were not significant. However, the results were different after stratification for diabetes duration. In the subgroup of elderly patients with a diabetes duration of 8 years and longer, higher lipids were predictive of increased cardiovascular mortality. The main limitation of this study is its observational design, which prevents us drawing conclusions about causality. Conclusion: Although the lipid profile was not predictive in the overall group of elderly patients, higher lipids were related to increased cardiovascular mortality in patients with diabetes of long duration. In order to make valid recommendations concerning lipid-lowering treatment, a randomized controlled trial or a meta-analysis concerning this specific population is mandatory.	[van Hateren, Kornelis J. J.; Landman, Gijs W. D.; Kleefstra, Nanne; Logtenberg, Susan J. J.; Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Kleefstra, Nanne; Houweling, Sebastiaan T.] Langerhans Med Res Grp, Zwolle, Netherlands; [Logtenberg, Susan J. J.; Kamper, Adriaan M.; Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Houweling, Sebastiaan T.] Gen Practice Sleeuwijk, Sleeuwijk, Netherlands; [Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands	Isala Clinics; Langerhans Medical Research Group; Isala Clinics; University of Groningen; University of Groningen	van Hateren, KJJ (corresponding author), Isala Clin, Ctr Diabet, Zwolle, Netherlands.	k.j.j.van.hateren@isala.nl	Landman, Gijs/AAJ-5540-2021	Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Brescianini S, 2003, J AM GERIATR SOC, V51, P991, DOI 10.1046/j.1365-2389.2003.51313.x; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Collins R, 2003, LANCET, V361, P2005; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Durso SC, 2006, JAMA-J AM MED ASSOC, V295, P1935, DOI 10.1001/jama.295.16.1935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Iversen A, 2009, EUR J INTERN MED, V20, P139, DOI 10.1016/j.ejim.2008.06.003; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8464	10.1371/journal.pone.0008464	http://dx.doi.org/10.1371/journal.pone.0008464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041116	gold, Green Submitted, Green Published			2022-12-27	WOS:000273104000024
J	Sen, S; Dong, MM; Kumar, S				Sen, Shamik; Dong, Meimei; Kumar, Sanjay			Isoform-Specific Contributions of alpha-Actinin to Glioma Cell Mechanobiology	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; MYOSIN-II; FOCAL ADHESIONS; MOLECULAR-MECHANISMS; RHO-KINASE; MOTILITY; MIGRATION; INVASION; PROTEIN; SHAPE	Glioblastoma Multiforme (GBM) is a malignant astrocytic tumor associated with low survival rates because of aggressive infiltration of tumor cells into the brain parenchyma. Expression of the actin binding protein alpha-actinin has been strongly correlated with the invasive phenotype of GBM in vivo. To probe the cellular basis of this correlation, we have suppressed expression of the nonmuscle isoforms alpha-actinin-1 and alpha-actinin-4 and examined the contribution of each isoform to the structure, mechanics, and motility of human glioma tumor cells in culture. While subcellular localization of each isoform is distinct, suppression of either isoform yields a phenotype that includes dramatically reduced motility, compensatory upregulation and redistribution of vinculin, reduced cortical elasticity, and reduced ability to adapt to changes in the elasticity of the extracellular matrix (ECM). Mechanistic studies reveal a relationship between alpha-actinin and non-muscle myosin II in which depletion of either alpha-actinin isoform reduces myosin expression and maximal cell-ECM tractional forces. Our results demonstrate that both alpha-actinin-1 and alpha-actinin-4 make critical and distinct contributions to cytoskeletal organization, rigidity-sensing, and motility of glioma cells, thereby yielding mechanistic insight into the observed correlation between alpha-actinin expression and GBM invasiveness in vivo.	[Sen, Shamik; Dong, Meimei; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dong, Meimei] Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany	University of California System; University of California Berkeley	Sen, S (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	skumar@berkeley.edu		Sen, Shamik/0000-0002-8639-8659	University of California; Arnold and Mabel Beckman Young; National Institutes of Health (NIH) [1DP2OD004213]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004213] Funding Source: NIH RePORTER	University of California(University of California System); Arnold and Mabel Beckman Young; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. K. gratefully acknowledges the support of the University of California, the Arnold and Mabel Beckman Young Investigator Award, and the National Institutes of Health (NIH) Director's New Innovator Award (1DP2OD004213), a part of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Belot N, 2001, GLIA, V36, P375, DOI 10.1002/glia.1124; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Beningo KA, 2006, ARCH BIOCHEM BIOPHYS, V456, P224, DOI 10.1016/j.abb.2006.09.025; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Craig DH, 2007, AM J SURG, V194, P618, DOI 10.1016/j.amjsurg.2007.08.001; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gillespie GY, 1999, CANCER RES, V59, P2076; GLUCK U, 1994, J CELL SCI, V107, P1773; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Martens JC, 2008, PFLUG ARCH EUR J PHY, V456, P95, DOI 10.1007/s00424-007-0419-8; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; Omelchenko T, 2002, P NATL ACAD SCI USA, V99, P10452, DOI 10.1073/pnas.152339899; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Salhia B, 2008, CELL MOTIL CYTOSKEL, V65, P12, DOI 10.1002/cm.20240; SEN S, 2009, CELLULAR MOL BIOENGI; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018	49	67	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8427	10.1371/journal.pone.0008427	http://dx.doi.org/10.1371/journal.pone.0008427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037648	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100014
J	Baldock, PA; Lee, NJ; Driessler, F; Lin, S; Allison, S; Stehrer, B; Lin, EJD; Zhang, L; Enriquez, RF; Wong, IPL; McDonald, MM; During, M; Pierroz, DD; Slack, K; Shi, YC; Yulyaningsih, E; Aljanova, A; Little, DG; Ferrari, SL; Sainsbury, A; Eisman, JA; Herzog, H				Baldock, Paul A.; Lee, Nicola J.; Driessler, Frank; Lin, Shu; Allison, Susan; Stehrer, Bernhard; Lin, En-Ju D.; Zhang, Lei; Enriquez, Ronald F.; Wong, Iris P. L.; McDonald, Michelle M.; During, Matthew; Pierroz, Dominique D.; Slack, Katy; Shi, Yan C.; Yulyaningsih, Ernie; Aljanova, Aygul; Little, David G.; Ferrari, Serge L.; Sainsbury, Amanda; Eisman, John A.; Herzog, Herbert			Neuropeptide Y Knockout Mice Reveal a Central Role of NPY in the Coordination of Bone Mass to Body Weight	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; GENE-EXPRESSION; TRABECULAR BONE; RECEPTOR; LEPTIN; HYPERPHAGIA; HOMEOSTASIS; PATHWAYS; OBESITY; RAT	Changes in whole body energy levels are closely linked to alterations in body weight and bone mass. Here, we show that hypothalamic signals contribute to the regulation of bone mass in a manner consistent with the central perception of energy status. Mice lacking neuropeptide Y (NPY), a well-known orexigenic factor whose hypothalamic expression is increased in fasting, have significantly increased bone mass in association with enhanced osteoblast activity and elevated expression of bone osteogenic transcription factors, Runx2 and Osterix. In contrast, wild type and NPY knockout (NPY(-/-)) mice in which NPY is specifically over expressed in the hypothalamus (AAV-NPY+) show a significant reduction in bone mass despite developing an obese phenotype. The AAV-NPY+ induced loss of bone mass is consistent with models known to mimic the central effects of fasting, which also show increased hypothalamic NPY levels. Thus these data indicate that, in addition to well characterized responses to body mass, skeletal tissue also responds to the perception of nutritional status by the hypothalamus independently of body weight. In addition, the reduction in bone mass by AAV NPY+ administration does not completely correct the high bone mass phenotype of NPY(-/-) mice, indicating the possibility that peripheral NPY may also be an important regulator of bone mass. Indeed, we demonstrate the expression of NPY specifically in osteoblasts. In conclusion, these data identifies NPY as a critical integrator of bone homeostatic signals; increasing bone mass during times of obesity when hypothalamic NPY expression levels are low and reducing bone formation to conserve energy under 'starving' conditions, when hypothalamic NPY expression levels are high.	[Baldock, Paul A.; Driessler, Frank; Allison, Susan; Enriquez, Ronald F.; Wong, Iris P. L.; Eisman, John A.] St Vincents Hosp, Osteoporosis & Bone Biol Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Lee, Nicola J.; Lin, Shu; Stehrer, Bernhard; Zhang, Lei; Slack, Katy; Shi, Yan C.; Yulyaningsih, Ernie; Aljanova, Aygul; Sainsbury, Amanda; Herzog, Herbert] St Vincents Hosp, Neurosci Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Lin, En-Ju D.] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA; [McDonald, Michelle M.; Little, David G.] Childrens Hosp Westmead, Dept Orthopaed Res & Biotechnol, Sydney, NSW, Australia; [During, Matthew] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Pierroz, Dominique D.; Ferrari, Serge L.] Univ Hosp Geneva, Serv & Lab Bone Dis, Dept Rehabil & Geriatr, Fac Med, Geneva, Switzerland; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Baldock, Paul A.; Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Georgetown University; University of Sydney; University of Auckland; University of Geneva; University of New South Wales Sydney; University of New South Wales Sydney	Baldock, PA (corresponding author), St Vincents Hosp, Osteoporosis & Bone Biol Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia.	h.herzog@garvan.org.au	/B-2038-2013; During, Matthew/AAC-1388-2020; Eisman, John A/C-2886-2014; Ferrari, Serge/ABD-2730-2020; /A-4361-2010; /A-6021-2011; Herzog, Herbert/B-8294-2008; /B-6258-2012; Baldock, Paul/B-3840-2012; /E-2900-2010; Salis, Amanda/A-3187-2011; McDonald, Michelle/AAD-4760-2019	/0000-0001-7766-6095; Ferrari, Serge/0000-0002-1372-4417; /0000-0003-2110-2017; Salis, Amanda/0000-0001-9176-1574; McDonald, Michelle/0000-0002-3928-2506; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council [481 355, 427638]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by National Health and Medical Research Council Career Development Award - 481 355 to AS and 427638 to PB and a National Health and Medical Research Council Principal Research Fellowship to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2003, ENDOCRINOLOGY, V144, P3842, DOI 10.1210/en.2003-0369; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; HEILIG M, 1989, ACTA PHYSIOL SCAND, V137, P243, DOI 10.1111/j.1748-1716.1989.tb08745.x; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; IGWE JC, 2009, J CELL BIOCH; Karl T, 2008, EUR J NEUROSCI, V28, P173, DOI 10.1111/j.1460-9568.2008.06306.x; Kellenberger S, 1998, BONE, V22, P471, DOI 10.1016/S8756-3282(98)00026-X; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Reid IR, 2006, J BONE MINER RES, V21, P495, DOI 10.1359/JBMR.051105; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; STANLEY BG, 1986, PEPTIDES, V7, P1189; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8	26	124	130	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8415	10.1371/journal.pone.0008415	http://dx.doi.org/10.1371/journal.pone.0008415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027231	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998000019
J	Vincent, AL; Lager, KM; Harland, M; Lorusso, A; Zanella, E; Ciacci-Zanella, JR; Kehrli, ME; Klimov, A				Vincent, Amy L.; Lager, Kelly M.; Harland, Michelle; Lorusso, Alessio; Zanella, Eraldo; Ciacci-Zanella, Janice R.; Kehrli, Marcus E., Jr.; Klimov, Alexander			Absence of 2009 Pandemic H1N1 Influenza A Virus in Fresh Pork	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; SWINE; PIGS; PATHOGENICITY; PATHOGENESIS	The emergence of the pandemic 2009 H1N1 influenza A virus in humans and subsequent discovery that it was of swine influenza virus lineages raised concern over the safety of pork. Pigs experimentally infected with pandemic 2009 H1N1 influenza A virus developed respiratory disease; however, there was no evidence for systemic disease to suggest that pork from pigs infected with H1N1 influenza would contain infectious virus. These findings support the WHO recommendation that pork harvested from pandemic influenza A H1N1 infected swine is safe to consume when following standard meat hygiene practices.	[Vincent, Amy L.; Lager, Kelly M.; Harland, Michelle; Lorusso, Alessio; Zanella, Eraldo; Ciacci-Zanella, Janice R.; Kehrli, Marcus E., Jr.] ARS, Virus & Pr Dis Res Unit, Natl Anim Dis Ctr, USDA, Iowa City, IA USA; [Zanella, Eraldo] Univ Passo Fundo, Passo Fundo, RS, Brazil; [Ciacci-Zanella, Janice R.] EMBRAPA Brazilian Agr Res Corp, Labex USA, Brasilia, DF, Brazil; [Klimov, Alexander] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	United States Department of Agriculture (USDA); Universidade de Passo Fundo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Centers for Disease Control & Prevention - USA	Vincent, AL (corresponding author), ARS, Virus & Pr Dis Res Unit, Natl Anim Dis Ctr, USDA, Iowa City, IA USA.	amy.vincent@ars.usda.gov	Lorusso, Alessio/A-7311-2016; zanella, janice/AAV-9729-2020; Zanella, Janice R/C-3632-2014	Lorusso, Alessio/0000-0001-6156-8212; zanella, janice/0000-0002-6259-6028; Kehrli, Marcus/0000-0003-4850-5211	USDA-ARS; DHHS-CDC	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); DHHS-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by USDA-ARS and DHHS-CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes SM, 2009, VET REC, V164, P760, DOI 10.1136/vr.164.24.760; BROWN IH, 1993, VET REC, V132, P598, DOI 10.1136/vr.132.24.598; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lipatov AS, 2009, J INFECT DIS, V199, P717, DOI 10.1086/596740; ROMIJN PC, 1989, VET REC, V124, P224, DOI 10.1136/vr.124.9.224; Swayne DE, 2005, AVIAN DIS, V49, P81, DOI 10.1637/7260-081104R; Vincent AL, 2009, VET MICROBIOL, V137, P51, DOI 10.1016/j.vetmic.2009.01.003; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08	9	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8367	10.1371/journal.pone.0008367	http://dx.doi.org/10.1371/journal.pone.0008367			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020048	gold, Green Published			2022-12-27	WOS:000272870600008
J	Cornman, RS				Cornman, R. Scott			Molecular Evolution of Drosophila Cuticular Protein Genes	PLOS ONE			English	Article							CIS-REGULATORY SEQUENCES; ANOPHELES-GAMBIAE; CUTICLE GENE; R CONSENSUS; DEVELOPMENTAL EXPRESSION; CONCERTED EVOLUTION; FAMILY EVOLUTION; PUPAL CUTICLE; GENOMIC DNA; MELANOGASTER	Several multigene families have been described that together encode scores of structural cuticular proteins in Drosophila, although the functional significance of this diversity remains to be explored. Here I investigate the evolutionary histories of several multigene families (CPR, Tweedle, CPLCG, and CPF/CPFL) that vary in age, size, and sequence complexity, using sequenced Drosophila genomes and mosquito outgroups. My objective is to describe the rates and mechanisms of 'cuticleome' divergence, in order to identify conserved and rapidly evolving elements. I also investigate potential examples of interlocus gene conversion and concerted evolution within these families during Drosophila evolution. The absolute rate of change in gene number (per million years) is an order of magnitude lower for cuticular protein families within Drosophila than it is among Drosophila and the two mosquito taxa, implying that major transitions in the cuticle proteome have occurred at higher taxonomic levels. Several hotspots of intergenic conversion and/or gene turnover were identified, e. g. some gene pairs have independently undergone intergenic conversion within different lineages. Some gene conversion hotspots were characterized by conversion tracts initiating near nucleotide repeats within coding regions, and similar repeats were found within concertedly evolving cuticular protein genes in Anopheles gambiae. Rates of amino-acid substitution were generally several fold higher along the branch connecting the Sophophora and Drosophila species groups, and 13 genes have Ka/Ks significantly greater than one along this branch, indicating adaptive divergence. Insect cuticular proteins appear to be a source of adaptive evolution within genera and, at higher taxonomic levels, subject to periods of gene-family expansion and contraction followed by quiescence. However, this relative stasis is belied by hotspots of molecular evolution, particularly concerted evolution, during the diversification of Drosophila. The prominent association between interlocus gene conversion and repeats within the coding sequence of interacting genes suggests that the latter promote strand exchange.	[Cornman, R. Scott] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Cornman, RS (corresponding author), Agr Res Serv, Bee Res Lab, USDA, Beltsville, MD USA.	scott.cornman@gmail.com			National Institutes of Health (NIH) [A155624]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author was supported during the initiation of this work by National Institutes of Health (NIH) grant A155624 to Judith H. Willis, Department of Cellular Biology, University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remainder of the work was completed with no outside funding.	Andersen SO, 1997, INSECT BIOCHEM MOLEC, V27, P121, DOI 10.1016/S0965-1748(96)00076-8; APPLE RT, 1991, DEV BIOL, V146, P569, DOI 10.1016/0012-1606(91)90257-4; AWOLOLA TS, 2008, T R SOC TROP MED HYG; Benedict M.Q., 1993, Insect Molecular Biology, V2, P93, DOI 10.1111/j.1365-2583.1993.tb00130.x; Benedict MQ, 1996, INSECT MOL BIOL, V5, P73, DOI 10.1111/j.1365-2583.1996.tb00042.x; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Bruey-Sedano N, 2005, GENESIS, V43, P17, DOI 10.1002/gene.20150; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Charles JP, 1997, GENETICS, V147, P1213; Charles JP, 1998, INSECT BIOCHEM MOLEC, V28, P131, DOI 10.1016/S0965-1748(97)00107-0; CHIHARA CJ, 1982, DEV BIOL, V89, P379, DOI 10.1016/0012-1606(82)90326-8; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Claycomb JM, 2005, TRENDS GENET, V21, P149, DOI 10.1016/j.tig.2005.01.009; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Cui HY, 2009, INSECT MOL BIOL, V18, P421, DOI 10.1111/j.1365-2583.2009.00889.x; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hastings PJ, 2007, CRIT REV BIOCHEM MOL, V42, P271, DOI 10.1080/10409230701507757; Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; KOMORI N, 1992, J CELL SCI, V102, P191; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lestradet M, 2009, INSECT MOL BIOL, V18, P431, DOI 10.1111/j.1365-2583.2009.00893.x; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Neville A.C., 1975, BIOL ARTHROPOD CUTIC; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Steinemann M, 1996, J MOL EVOL, V43, P413; Togawa T, 2004, INSECT BIOCHEM MOLEC, V34, P1059, DOI 10.1016/j.ibmb.2004.06.008; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; WHITE BJ, 2009, GENETICS; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	49	36	40	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8345	10.1371/journal.pone.0008345	http://dx.doi.org/10.1371/journal.pone.0008345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20019874	gold, Green Published, Green Submitted			2022-12-27	WOS:000272834200012
J	Li, A; Zaidi, Q				Li, Andrea; Zaidi, Qasim			Release from Cross-Orientation Suppression Facilitates 3D Shape Perception	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE; SIMPLE CELLS; SELECTIVITY; INHIBITION; MECHANISMS; TEXTURE; NEURONS; LIMITATIONS; ADAPTATION; MASKING	Cross-orientation suppression (COS) in striate cortex has been implicated in the efficient encoding of visual stimuli. We show that release from COS facilitates the decoding of 3-D shape. In planar surfaces overlaid with textures, slanting the surface can increase the visibility of the component parallel to the slant. Since this component provides the orientation flows that signify 3-D shape, the enhancement of visibility facilitates 3-D slant perception. Contrast thresholds reveal that this enhancement results from a decrease in COS when 3-D slant creates a frequency mismatch between texture components. We show that coupling compressive nonlinearities in LGN neurons with expansive nonlinearities in cortical neurons can model the frequency-specific component of suppression.	[Li, Andrea] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Zaidi, Qasim] SUNY Coll Optometry, Grad Program Vis Sci, New York, NY 10010 USA	City University of New York (CUNY) System; Queens College NY (CUNY); State University of New York (SUNY) System; SUNY Optometry	Li, A (corresponding author), CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	andrea.li@qc.cuny.edu			PSC-CUNY [69450-00 38, 61681-00 39]; NIH [EY018951, EY13312, EY07556]; NATIONAL EYE INSTITUTE [R01EY007556, R29EY007556, R01EY013312, R15EY018951] Funding Source: NIH RePORTER	PSC-CUNY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded in part by PSC-CUNY Grants 69450-00 38 and 61681-00 39 to A. Li, NIH EY018951 to A. Li, and NIH EY13312 and EY07556 to Q. Zaidi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Ben-Shahar O, 2002, LECT NOTES COMPUT SC, V2525, P189; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; BURBECK CA, 1981, J OPT SOC AM, V71, P1335, DOI 10.1364/JOSA.71.001335; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Carandini M, 1997, J NEUROSCI, V17, P8621; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; FIELD DJ, 2004, J VIS, V4, pA283; Filangieri C, 2009, VISION RES, V49, P1465, DOI 10.1016/j.visres.2009.03.006; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; GEISLER WS, 1991, J NEUROPHYSIOL, V66, P334, DOI 10.1152/jn.1991.66.1.334; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hel Or Y, 1989, Spat Vis, V4, P131, DOI 10.1163/156856889X00086; Knill DC, 2001, J OPT SOC AM A, V18, P12, DOI 10.1364/JOSAA.18.000012; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2001, VISION RES, V41, P1519, DOI 10.1016/S0042-6989(01)00021-9; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Li A, 2008, VISION RES, V48, P244, DOI 10.1016/j.visres.2007.11.009; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; Meese TS, 2007, P ROY SOC B-BIOL SCI, V274, P127, DOI 10.1098/rspb.2006.3697; Meier L, 2002, J VISION, V2, DOI 10.1167/2.4.2; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Nolt MJ, 2007, J NEUROPHYSIOL, V98, P1167, DOI 10.1152/jn.01019.2006; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; PURPURA KP, 2007, SOC NEUR ABSTR, V33, P229; Roeber U, 2008, J VISION, V8, DOI 10.1167/8.3.15; ROSS J, 1991, P ROY SOC B-BIOL SCI, V246, P61, DOI 10.1098/rspb.1991.0125; ROSS J, 1993, VISION RES, V33, P2051, DOI 10.1016/0042-6989(93)90003-F; Saunders JA, 2006, J VISION, V6, P882, DOI 10.1167/6.9.3; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Zaidi Q, 2002, VISION RES, V42, P815, DOI 10.1016/S0042-6989(01)00233-4	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8333	10.1371/journal.pone.0008333	http://dx.doi.org/10.1371/journal.pone.0008333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016832	Green Published, gold			2022-12-27	WOS:000272834000019
J	Diestra, E; Cayrol, B; Arluison, V; Risco, C				Diestra, Elia; Cayrol, Bastien; Arluison, Veronique; Risco, Cristina			Cellular Electron Microscopy Imaging Reveals the Localization of the Hfq Protein Close to the Bacterial Membrane	PLOS ONE			English	Article							SMALL RNA REGULATORS; ESCHERICHIA-COLI; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; BUNYAMWERA-VIRUS; OUTER-MEMBRANE; ROLES; METALLOTHIONEIN; ORGANIZATION; ARCHITECTURE	Background: Hfq is a bacterial protein involved in several aspects of nucleic acid transactions, but one of its best-characterized functions is to affect the post-transcriptional regulation of mRNA by virtue of its interactions with stress-related small regulatory (sRNA). Methodology and Principal Finding: By using cellular imaging based on the metallothionein clonable tag for electron microscopy, we demonstrate here that in addition to its localization in the cytoplasm and in the nucleoid, a significant amount of Hfq protein is located at the cell periphery. Simultaneous immunogold detection of specific markers strongly suggests that peripheral Hfq is close to the bacterial membrane. Because sRNAs regulate the synthesis of several membrane proteins, our result implies that the sRNA- and Hfq-dependent translational regulation of these proteins takes place in the cytoplasmic region underlying the membrane. Conclusions: This finding supports the proposal that RNA processing and translational machineries dedicated to membrane protein translation may often be located in close proximity to the membrane of the bacterial cell.	[Diestra, Elia; Risco, Cristina] CSIC, Cell Struct Lab, Ctr Nacl Biotecnol, Madrid, Spain; [Cayrol, Bastien; Arluison, Veronique] CNRS Paris 6, FRE 3132, Lab Jean Perrin, Paris, France; [Cayrol, Bastien; Arluison, Veronique] CEA Saclay, CNRS UMR 12, Commissariat Energie Atom, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; [Arluison, Veronique] Univ Paris Diderot, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Diestra, E (corresponding author), CSIC, Cell Struct Lab, Ctr Nacl Biotecnol, Madrid, Spain.	Veronique.Arluison@univ-paris-diderot.fr; crisco@cnb.csic.es	Risco, Cristina/K-4308-2014; Arluison, Veronique S/F-2714-2019	Risco, Cristina/0000-0001-7501-5934; Arluison, Veronique S/0000-0003-4056-7282	Consejo Superior de Investigaciones Cientificas (CSIC) [PIF06-004/200620F0024]; Ministry of Science and Innovation of Spain [BFU2006-04584/BMC]; University Paris Diderot; CNRS; JAE-CSIC of spain	Consejo Superior de Investigaciones Cientificas (CSIC); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University Paris Diderot; CNRS(Centre National de la Recherche Scientifique (CNRS)); JAE-CSIC of spain	This work was supported by grants PIF06-004/200620F0024 from the Consejo Superior de Investigaciones Cientificas (CSIC) and BFU2006-04584/BMC from the Ministry of Science and Innovation of Spain (to C.R.) and University Paris Diderot and CNRS (to V.A.). E.D. is funded by the JAE-CSIC program of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arluison V, 2002, J MOL BIOL, V320, P705, DOI 10.1016/S0022-2836(02)00548-X; Arluison W, 2006, J MOL BIOL, V356, P86, DOI 10.1016/j.jmb.2005.11.010; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; CASTLEMAN H, 1980, NUCLEIC ACIDS RES, V8, P4485, DOI 10.1093/nar/8.19.4485; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jasiecki J, 2005, BIOCHEM BIOPH RES CO, V329, P598, DOI 10.1016/j.bbrc.2005.02.025; Johansen J., 2006, J MOL BIOL; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Kawamoto H, 2005, GENE DEV, V19, P328, DOI 10.1101/gad.1270605; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497; Mercogliano CP, 2007, J STRUCT BIOL, V160, P70, DOI 10.1016/j.jsb.2007.06.010; Mercogliano CP, 2006, J MOL BIOL, V355, P211, DOI 10.1016/j.jmb.2005.10.026; MICZAK A, 1991, MOL MICROBIOL, V5, P1801, DOI 10.1111/j.1365-2958.1991.tb01929.x; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08; PUVIONDUTILLEUL F, 1987, J HISTOCHEM CYTOCHEM, V35, P635, DOI 10.1177/35.6.3033063; PUVIONDUTILLEUL F, 1998, IN SITU HYBRIDIZATIO, P127; Quintana C, 1998, MICRON, V29, P297, DOI 10.1016/S0968-4328(98)00011-0; Quintana C, 2001, MICROSC RES TECHNIQ, V53, P147, DOI 10.1002/jemt.1079; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Taghbalout A, 2008, J BIOL CHEM, V283, P13850, DOI 10.1074/jbc.M709118200; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Zambrano N, 2009, CELL CYCLE, V8, P2470, DOI 10.4161/cc.8.15.9090; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	50	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8301	10.1371/journal.pone.0008301	http://dx.doi.org/10.1371/journal.pone.0008301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011543	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300048
J	Kayukawa, T; Ishikawa, Y				Kayukawa, Takumi; Ishikawa, Yukio			Chaperonin Contributes to Cold Hardiness of the Onion Maggot Delia antiqua through Repression of Depolymerization of Actin at Low Temperatures	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; T-COMPLEX POLYPEPTIDE-1; SINUSOIDAL ENDOTHELIAL-CELLS; IN-VIVO; FOLDING MACHINE; WINTER DIAPAUSE; THERMAL-STRESS; UP-REGULATION; EXPRESSION; CCT	Winter-diapause and cold-acclimated non-diapause pupae of the onion maggot, Delia antiqua (Diptera: Anthomyiidae), show strong cold hardiness. To obtain insights into the mechanisms involved in the enhancement of cold hardiness, we investigated the expression patterns of genes encoding subunits of chaperonin (CCT) and the morphology of actin, a substrate of CCT, at low temperatures. Quantitative real-time PCR analyses showed the mRNA levels of CCT subunits in pupal tissues to be highly correlated with the cold hardiness of the pupae. While actin in the Malpighian tubules of non-cold-hardy pupae showed extensive depolymerization after a cold treatment, actin in the same tissue of cold-hardy pupae was not depolymerized. Damage to cell membranes became apparent after the depolymerization of actin. Moreover, administration of Latrunculin B, an inhibitor of actin polymerization, to the larvae markedly decreased the cold hardiness of the pupae obtained. These findings suggest that CCT contributes to the cold hardiness of D. antiqua through the repression of depolymerization of actin at low temperatures.	[Kayukawa, Takumi; Ishikawa, Yukio] Univ Tokyo, Appl Entomol Lab, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Kayukawa, T (corresponding author), Natl Inst Agrobiol Sci, Ibaraki, Japan.	ayucky@mail.ecc.u-tokyo.ac.jp	Ishikawa, Yukio/J-5676-2019	Ishikawa, Yukio/0000-0003-3067-2513	Japan Society for the Promotion of Science [18-10873]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in- Aid for Young Scientists (No. 18-10873) to TK from the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Chen B, 2005, INSECT MOL BIOL, V14, P697, DOI 10.1111/j.1365-2583.2005.00602.x; Chen B, 2006, J BIOCHEM MOL BIOL, V39, P749; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Denholm B, 2005, DEVELOPMENT, V132, P2389, DOI 10.1242/dev.01829; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; ISHIKAWA Y, 1983, APPL ENTOMOL ZOOL, V18, P62, DOI 10.1303/aez.18.62; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Kayukawa T, 2005, CELL STRESS CHAPERON, V10, P204, DOI 10.1379/CSC-106R.1; Kayukawa T, 2005, APPL ENTOMOL ZOOL, V40, P193, DOI 10.1303/aez.2005.193; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Kubota H, 1999, FEBS LETT, V461, P125, DOI 10.1016/S0014-5793(99)01437-4; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Miyazaki S, 2006, EUR J ENTOMOL, V103, P691, DOI 10.14411/eje.2006.090; Nomura M, 2000, J INSECT PHYSIOL, V46, P373, DOI 10.1016/S0022-1910(99)00120-1; Nomura M, 2001, APPL ENTOMOL ZOOL, V36, P443, DOI 10.1303/aez.2001.443; Ouellet F, 2001, PLANT PHYSIOL, V125, P360, DOI 10.1104/pp.125.1.360; Palmedo G, 1997, EUR J BIOCHEM, V247, P877, DOI 10.1111/j.1432-1033.1997.00877.x; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pokorna J, 2004, PLANT CELL ENVIRON, V27, P641, DOI 10.1111/j.1365-3040.2004.01186.x; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Somer L, 2002, CELL STRESS CHAPERON, V7, P47, DOI 10.1379/1466-1268(2002)007<0047:TECCIA>2.0.CO;2; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Taguchi H, 2005, J BIOCHEM, V137, P543, DOI 10.1093/jb/mvi069; Upadhya GA, 2003, HEPATOLOGY, V37, P313, DOI 10.1053/jhep.2003.50069; Upadhya GA, 1999, HEPATOLOGY, V30, P169, DOI 10.1002/hep.510300130; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0	43	33	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8277	10.1371/journal.pone.0008277	http://dx.doi.org/10.1371/journal.pone.0008277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011606	gold, Green Published, Green Submitted			2022-12-27	WOS:000272830300031
J	Quillard, T; Devalliere, J; Chatelais, M; Coulon, F; Seveno, C; Romagnoli, M; Barille-Nion, S; Charreau, B				Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Seveno, Celine; Romagnoli, Mathilde; Barille-Nion, Sophie; Charreau, Beatrice			Notch2 Signaling Sensitizes Endothelial Cells to Apoptosis by Negatively Regulating the Key Protective Molecule Survivin	PLOS ONE			English	Article							ACTIVATED NOTCH4; EXPRESSION; ANGIOGENESIS; INHIBITION; REQUIRES; PROLIFERATION; NETWORKS; DEFECTS; CANCER	Background: Notch signaling pathway controls key functions in vascular and endothelial cells (ECs) where Notch4 plays a major role. However, little is known about the contribution of other Notch receptors. This study investigated regulation of Notch2 and further examined its implication in EC dysfunction. Methodology/Principal Findings: Here, we provide evidence for a novel link between Notch and TNF signaling, where Notch2 is upregulated and activated in response to TNF. Forced expression of Notch2 intracellular domain in cultured ECs promotes apoptosis and allows the significant downregulation of several cell-death-related transcripts in a dose-dependent manner. In particular, activation of Notch2 led to a rapid decrease in survivin mRNA and protein expression, while survivin upregulation was obtained by the selective knockdown of Notch2 in ECs, indicating that survivin expression is controlled at the Notch level. Moreover, Notch2 silencing and ectopic expression of survivin, but not XIAP or Bcl2, rescued ECs from TNF and Notch2-mediated apoptosis, respectively. Conclusions/Significance: In conclusion, TNF signaling activates Notch2 that sensitizes ECs to apoptosis via modulation of the key apoptosis regulator survivin. Overall, our findings also indicate that specific Notch receptors control distinct functions in vascular cells and inflammatory cytokines contribute to this specificity.	[Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Charreau, Beatrice] INSERM, UMR643, Nantes, France; [Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Charreau, Beatrice] CHU Nantes, Inst Transplantat & Rech Transplantat, ITERT, F-44035 Nantes 01, France; [Quillard, Thibaut; Devalliere, Julie; Chatelais, Mathias; Coulon, Flora; Charreau, Beatrice] Univ Nantes, Fac Med, Nantes, France; [Seveno, Celine; Romagnoli, Mathilde; Barille-Nion, Sophie] INSERM, UMR 892, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Quillard, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	Beatrice.Charreau@univ-nantes.fr	CHARREAU, Beatrice/AAK-8186-2020; Barille-Nion, sophie/K-8057-2015; Quillard, Thibaut/K-8150-2015; Barille-nion, sophie/W-8103-2019	CHARREAU, Beatrice/0000-0001-5870-4615; Quillard, Thibaut/0000-0002-8096-2597; Barille-nion, sophie/0000-0001-5171-9937	Xenome; European Commission [LSHB-CT-2006-037377]; La Societe Francophone de Transplantation; La Societede Nephrologie; La Fondation Progreffe; la Fondation pour la Recherche Medicale	Xenome; European Commission(European CommissionEuropean Commission Joint Research Centre); La Societe Francophone de Transplantation; La Societede Nephrologie; La Fondation Progreffe; la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Xenome, a European Commission-funded Integrated Project, Life Sciences, Genomics and Biotechnology for Health LSHB-CT-2006-037377, and by fellowships from La Societe Francophone de Transplantation, La Societede Nephrologie and La Fondation Progreffe. Quillard T was supported by a grant from la Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, MOL CANCER THER, V5, P478, DOI 10.1158/1535-7163.MCT-05-0436; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bach FH, 1997, IMMUNOL TODAY, V18, P483, DOI 10.1016/S0167-5699(97)01129-8; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Boulay JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000576; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Coupel S, 2004, J AM SOC NEPHROL, V15, P2429, DOI 10.1097/01.ASN.0000138237.42675.45; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; FITAU J, 2006, J BIOL CHEM; Florena AM, 2007, PATHOBIOLOGY, V74, P317, DOI 10.1159/000110024; Gridley T, 2007, NATURE, V445, P722, DOI 10.1038/445722a; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kirkiles-Smith NC, 2004, J IMMUNOL, V172, P1391, DOI 10.4049/jimmunol.172.3.1391; Krebs LT, 2000, GENE DEV, V14, P1343; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKenzie F, 2004, BLOOD, V104, P1760, DOI 10.1182/blood-2003-12-4244; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Parr C, 2004, INT J MOL MED, V14, P779; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Romagnoli M, 2007, LEUKEMIA, V21, P1070, DOI 10.1038/sj.leu.2404602; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Shawber C, 1996, DEVELOPMENT, V122, P3765; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang GJ, 2005, ARTERIOSCL THROM VAS, V25, P2081, DOI 10.1161/01.ATV.0000183885.66153.8a; Witt CM, 2003, MOL CELL BIOL, V23, P8637, DOI 10.1128/MCB.23.23.8637-8650.2003; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	43	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8244	10.1371/journal.pone.0008244	http://dx.doi.org/10.1371/journal.pone.0008244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011512	Green Submitted, Green Published, gold			2022-12-27	WOS:000272830200003
J	April, C; Klotzle, B; Royce, T; Wickham-Garcia, E; Boyaniwsky, T; Izzo, J; Cox, D; Jones, W; Rubio, R; Holton, K; Matulonis, U; Quackenbush, J; Fan, JB				April, Craig; Klotzle, Brandy; Royce, Thomas; Wickham-Garcia, Eliza; Boyaniwsky, Tanya; Izzo, John; Cox, Donald; Jones, Wendell; Rubio, Renee; Holton, Kristina; Matulonis, Ursula; Quackenbush, John; Fan, Jian-Bing			Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; MICROARRAY ANALYSIS; RNA EXTRACTION; FROZEN TISSUE; SIGNATURES; ASSAY; OLIGONUCLEOTIDE; AMPLIFICATION; OPTIMIZATION	Background: We have developed a gene expression assay (Whole-Genome DASLH), capable of generating whole-genome gene expression profiles from degraded samples such as formalin-fixed, paraffin-embedded (FFPE) specimens. Methodology/Principal Findings: We demonstrated a similar level of sensitivity in gene detection between matched fresh-frozen (FF) and FFPE samples, with the number and overlap of probes detected in the FFPE samples being approximately 88% and 95% of that in the corresponding FF samples, respectively; 74% of the differentially expressed probes overlapped between the FF and FFPE pairs. The WG-DASL assay is also able to detect 1.3-1.5 and 1.5-2-fold changes in intact and FFPE samples, respectively. The dynamic range for the assay is,3 logs. Comparing the WG-DASL assay with an in vitro transcription-based labeling method yielded fold-change correlations of R 2,0.83, while fold-change comparisons with quantitative RT-PCR assays yielded R(2)similar to 0.86 and R(2)similar to 0.55 for intact and FFPE samples, respectively. Additionally, the WG-DASL assay yielded high self-correlations (R(2)> 0.98) with low intact RNA inputs ranging from 1 ng to 100 ng; reproducible expression profiles were also obtained with 250 pg total RNA (R(2)> 0.92), with,71% of the probes detected in 100 ng total RNA also detected at the 250 pg level. When FFPE samples were assayed, 1 ng total RNA yielded self-correlations of R(2)similar to 0.80, while still maintaining a correlation of R(2)similar to 0.75 with standard FFPE inputs (200 ng). Conclusions/Significance: Taken together, these results show that WG-DASL assay provides a reliable platform for genome-wide expression profiling in archived materials. It also possesses utility within clinical settings where only limited quantities of samples may be available (e.g. microdissected material) or when minimally invasive procedures are performed (e.g. biopsied specimens).	[April, Craig; Klotzle, Brandy; Royce, Thomas; Wickham-Garcia, Eliza; Boyaniwsky, Tanya; Izzo, John; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA; [Cox, Donald; Jones, Wendell] Express Anal Inc, Durham, NC USA; [Rubio, Renee; Holton, Kristina; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Matulonis, Ursula] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Illumina; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	April, C (corresponding author), Illumina Inc, San Diego, CA USA.	jfan@illumina.com	Jones, Wendell/AAM-4831-2021	Quackenbush, John/0000-0002-2702-5879; Jones, Wendell/0000-0002-9676-5387	Madeline Franchi Ovarian Cancer Research Fund; Claudia Adams Barr Program; US National Cancer Institute [P50 CA105009]; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	Madeline Franchi Ovarian Cancer Research Fund; Claudia Adams Barr Program; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Madeline Franchi Ovarian Cancer Research Fund, the Claudia Adams Barr Program, and a grant from the US National Cancer Institute (P50 CA105009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; Bibikova M, 2004, CLIN CHEM, V50, P2384, DOI 10.1373/clinchem.2004.037432; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bouchie A, 2004, NAT BIOTECHNOL, V22, P1071, DOI 10.1038/nbt0904-1071; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fedorowicz G, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-23; Haller AC, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-9; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Karsten SL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e4; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lassmann S, 2009, J MOL MED, V87, P211, DOI 10.1007/s00109-008-0419-y; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Li HR, 2006, CANCER RES, V66, P4079, DOI 10.1158/0008-5472.CAN-05-4264; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Paik S, 2006, CLIN CANCER RES, V12, p1019S, DOI 10.1158/1078-0432.CCR-05-2296; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Ramaswamy S, 2004, NEW ENGL J MED, V350, P1814, DOI 10.1056/NEJMp048059; Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	37	95	100	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8162	10.1371/journal.pone.0008162	http://dx.doi.org/10.1371/journal.pone.0008162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997620	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000013
J	Madison, G				Madison, Guy			An Auditory Illusion of Infinite Tempo Change Based on Multiple Temporal Levels	PLOS ONE			English	Article							PHASE CORRECTION; SYNCHRONIZATION; PERFORMANCE; INTEGRATION; VOLUNTARY; FIREFLIES; LIMITS	Humans and a few select insect and reptile species synchronise inter-individual behaviour without any time lag by predicting the time of future events rather than reacting to them. This is evident in music performance, dance, and drill. Although repetition of equal time intervals (i.e. isochrony) is the central principle for such prediction, this simple information is used in a flexible and complex way that accommodates both multiples, subdivisions, and gradual changes of intervals. The scope of this flexibility remains largely uncharted, and the underlying mechanisms are a matter for speculation. Here I report an auditory illusion that highlights some aspects of this behaviour and that provides a powerful tool for its future study. A sound pattern is described that affords multiple alternative and concurrent rates of recurrence (temporal levels). An algorithm that systematically controls time intervals and the relative loudness among these levels creates an illusion that the perceived rate speeds up or slows down infinitely. Human participants synchronised hand movements with their perceived rate of events, and exhibited a change in their movement rate that was several times larger than the physical change in the sound pattern. The illusion demonstrates the duality between the external signal and the internal predictive process, such that people's tendency to follow their own subjective pulse overrides the overall properties of the stimulus pattern. Furthermore, accurate synchronisation with sounds separated by more than 8 s demonstrate that multiple temporal levels are employed for facilitating temporal organisation and integration by the human brain. A number of applications of the illusion and the stimulus pattern are suggested.	Umea Univ, Dept Psychol, S-90187 Umea, Sweden	Umea University	Madison, G (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.	Guy.Madison@psy.umu.se	Madison, Guy/I-6152-2019	Madison, Guy/0000-0001-5366-1169	The Bank of Sweden Tercentenary Foundation [P2002:0791]	The Bank of Sweden Tercentenary Foundation	Part of this research was supported by The Bank of Sweden Tercentenary Foundation (http://www.rj.se/), through grant P2002:0791; Musical pulse in human timing and coordination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attenborough D, 1995, PRIVATE LIFE PLANTS; Bolton T.L., 1894, AM J PSYCHOL, V6, P145, DOI [10.2307/1410948, DOI 10.2307/1410948]; BUCK J, 1981, J COMP PHYSIOL, V144, P277, DOI 10.1007/BF00612559; BUCK J, 1981, J COMP PHYSIOL, V144, P287, DOI 10.1007/BF00612560; BUCK J, 1978, AM NAT, V112, P471, DOI 10.1086/283291; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; DIETZE G, 1885, PHILOS STUD, V2, P362; ERMENTROUT B, 1991, J MATH BIOL, V29, P571, DOI 10.1007/BF00164052; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; Freeman W, 2000, ORIGINS OF MUSIC, P411; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; GUTTMAN N, 1963, J ACOUST SOC AM, V35, P610, DOI 10.1121/1.1918551; HARY D, 1987, BRIT J MATH STAT PSY, V40, P109, DOI 10.1111/j.2044-8317.1987.tb00872.x; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Kauranen K, 1996, PERCEPT MOTOR SKILL, V82, P515, DOI 10.2466/pms.1996.82.2.515; KONEN CS, 2007, NAT NEUROSCI, V11, P224; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2005, MUSIC PERCEPT, V22, P441, DOI 10.1525/mp.2005.22.3.441; Madison G, 2004, NEUROSCI LETT, V370, P69, DOI 10.1016/j.neulet.2004.07.094; Madison G, 2002, PSYCHOL RES-PSYCH FO, V66, P201, DOI 10.1007/s00426-001-0085-y; MADISON G, 2000, P 6 INT C MUS PERC C; Madison G, 2009, EXP BRAIN RES, V193, P519, DOI 10.1007/s00221-008-1652-x; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; McNeil W. H., 1995, KEEPING TOGETHER TIM; Merker B, 2000, ORIGINS OF MUSIC, P315; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Meumann Ernst., 1894, PHILOS STUDIEN, V10, P249; Miller G., 2000, MATING MIND; Mithen S., 2005, SINGING NEANDERTHALS; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Repp BH, 2002, HUM MOVEMENT SCI, V21, P1, DOI 10.1016/S0167-9457(02)00076-3; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P410, DOI 10.1037//0096-1523.28.2.410; RISSET JC, 1989, CURRENT DIRECTIONS C, P151; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Thaut MH, 1998, BIOL CYBERN, V79, P241, DOI 10.1007/s004220050474; Toiviainen P, 2003, MUSIC PERCEPT, V21, P43, DOI 10.1525/mp.2003.21.1.43; TUTTLE MD, 1982, BEHAV ECOL SOCIOBIOL, V11, P125, DOI 10.1007/BF00300101; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; 2001, COMPLETE MIDI 1 0 DE; 2007, AUDITORY ILLUSIONS W	45	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8151	10.1371/journal.pone.0008151	http://dx.doi.org/10.1371/journal.pone.0008151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MW	19997635	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000009
J	Su, ZD; Yuan, YM; Chen, JJ; Cao, L; Zhu, YL; Gao, L; Qiu, Y; He, C				Su, Zhida; Yuan, Yimin; Chen, Jingjing; Cao, Li; Zhu, Yanling; Gao, Liang; Qiu, Yang; He, Cheng			Reactive Astrocytes in Glial Scar Attract Olfactory Ensheathing Cells Migration by Secreted TNF-alpha in Spinal Cord Lesion of Rat	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; SCHWANN-CELLS; DELAYED TRANSPLANTATION; NERVOUS-SYSTEM; CORTICOSPINAL TRACT; AXON REGENERATION; NEUROPATHIC PAIN; EPITHELIAL-CELLS; GROWTH-FACTOR	Background: After spinal cord injury (SCI), the formation of glial scar contributes to the failure of injured adult axons to regenerate past the lesion. Increasing evidence indicates that olfactory ensheathing cells (OECs) implanted into spinal cord are found to migrate into the lesion site and induce axons regeneration beyond glial scar and resumption of functions. However, little is known about the mechanisms of OECs migrating from injection site to glial scar/lesion site. Methods and Findings: In the present study, we identified a link between OECs migration and reactive astrocytes in glial scar that was mediated by the tumor necrosis factor-alpha (TNF-alpha). Initially, the Boyden chamber migration assay showed that both glial scar tissue and reactive astrocyte-conditioned medium promoted OECs migration in vitro. Reactive astrocyte-derived TNF-alpha and its type 1 receptor TNFR1 expressed on OECs were identified to be responsible for the promoting effect on OECs migration. TNF-alpha-induced OECs migration was demonstrated depending on activation of the extracellular signal-regulated kinase (ERK) signaling cascades. Furthermore, TNF-alpha secreted by reactive astrocytes in glial scar was also showed to attract OECs migration in a spinal cord hemisection injury model of rat. Conclusions: These findings showed that TNF-alpha was released by reactive astrocytes in glial scar and attracted OECs migration by interacting with TNFR1 expressed on OECs via regulation of ERK signaling. This migration-attracting effect of reactive astrocytes on OECs may suggest a mechanism for guiding OECs migration into glial scar, which is crucial for OECs-mediated axons regrowth beyond the spinal cord lesion site.	[Su, Zhida] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Key Lab Mol Neurobiol Minister Educ, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Su, ZD (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai, Peoples R China.	chenghe@smmu.edu.cn	Su, Zhida/G-6094-2015		National Natural Science Foundation [30700209, 30530240]; National Key Basic Research Program [2006CB500702]; Ministry of Science and Technology of China [2007CB947100, 2009ZX09311-001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation (30700209, 30530240), National Key Basic Research Program (2006CB500702), Ministry of Science and Technology of China (2007CB947100, 2009ZX09311-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MR, 2007, J NEUROTRAUM, V24, P1773, DOI 10.1089/neu.2007.0353; Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.3.CO;2-P; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Broom DC, 2004, NEUROSCIENCE, V124, P891, DOI 10.1016/j.neuroscience.2004.01.003; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cao L, 2006, GLIA, V54, P536, DOI 10.1002/glia.20403; Cervos NJ, 1991, J NEUROL SCI S, V103, pS3; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Dekaris I, 1999, J IMMUNOL, V162, P4235; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Deng C, 2006, J NEUROSCI RES, V83, P1201, DOI 10.1002/jnr.20817; Falchi M, 2001, DRUG EXP CLIN RES, V27, P97; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Graf K, 1997, FEBS LETT, V400, P119, DOI 10.1016/S0014-5793(96)01371-3; HANSEN AB, 1993, VIRCHOWS ARCH B, V63, P107, DOI 10.1007/BF02899249; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2004, EXP NEUROL, V188, P300, DOI 10.1016/j.expneurol.2004.04.021; Li Y, 1998, J NEUROSCI, V18, P10514; Li Y, 2005, J NEUROCYTOL, V34, P343, DOI 10.1007/s11068-005-8361-1; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Montesano R, 2005, J CELL SCI, V118, P3487, DOI 10.1242/jcs.02467; O'Toole DA, 2007, CELL MOL LIFE SCI, V64, P1303, DOI 10.1007/s00018-007-7106-y; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Plant GW, 2003, J NEUROTRAUM, V20, P1, DOI 10.1089/08977150360517146; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Santos-Silva A, 2007, J NEUROSCI, V27, P7154, DOI 10.1523/JNEUROSCI.1184-07.2007; Schafers M, 2003, J NEUROSCI, V23, P2517; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sippy BD, 1996, INVEST OPHTH VIS SCI, V37, P597; Son DS, 2004, ENDOCRINOLOGY, V145, P1218, DOI 10.1210/en.2003-0860; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Teare KA, 2003, NEUROREPORT, V14, P2171, DOI 10.1097/00001756-200312020-00008; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Ubink R, 2003, TRENDS NEUROSCI, V26, P604, DOI 10.1016/j.tins.2003.09.003; Van den Pol AN, 2003, J COMP NEUROL, V458, P175, DOI 10.1002/cne.10577; VIETOR I, 1993, J BIOL CHEM, V268, P18994; Vincent AJ, 2007, GLIA, V55, P905, DOI 10.1002/glia.20512; Vincent AJ, 2005, GLIA, V51, P132, DOI 10.1002/glia.20195; Vouldoukis I, 1996, FEBS LETT, V380, P237, DOI 10.1016/0014-5793(96)00050-6; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	63	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8141	10.1371/journal.pone.0008141	http://dx.doi.org/10.1371/journal.pone.0008141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997621	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000003
J	Chen, EL; Kim, RJ				Chen, Enn-Ling; Kim, Raymond J.			Magnetic Resonance Water Proton Relaxation in Protein Solutions and Tissue: T-1p Dispersion Characterization	PLOS ONE			English	Article							SPIN-LATTICE-RELAXATION; PANCREATIC TRYPSIN-INHIBITOR; BOVINE SERUM-ALBUMIN; CROSS-RELAXATION; HETEROGENEOUS SYSTEMS; BIOPOLYMER SYSTEMS; AQUEOUS-SOLUTION; EXCHANGE; DYNAMICS; DEPENDENCE	Background: Image contrast in clinical MRI is often determined by differences in tissue water proton relaxation behavior. However, many aspects of water proton relaxation in complex biological media, such as protein solutions and tissue are not well understood, perhaps due to the limited empirical data. Principal Findings: Water proton T1, T2, and T-1p of protein solutions and tissue were measured systematically under multiple conditions. Crosslinking or aggregation of protein decreased T2 and T-1p, but did not change high-field T1, T-1p dispersion profiles were similar for crosslinked protein solutions, myocardial tissue, and cartilage, and exhibited power law behavior with T-1p(0) values that closely approximated T2. The T-1p dispersion of mobile protein solutions was flat above 5 kHz, but showed a steep curve below 5 kHz that was sensitive to changes in pH. The T-1p dispersion of crosslinked BSA and cartilage in DMSO solvent closely resembled that of water solvent above 5 kHz but showed decreased dispersion below 5 kHz. Conclusions: Proton exchange is a minor pathway for tissue T1 and T-1p relaxation above 5 kHz. Potential models for relaxation are discussed, however the same molecular mechanism appears to be responsible across 5 decades of frequencies from T-1p to T1.	[Chen, Enn-Ling; Kim, Raymond J.] Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC 27706 USA; [Chen, Enn-Ling; Kim, Raymond J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kim, Raymond J.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Chen, EL (corresponding author), Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC 27706 USA.	Ennling@duke.edu	Kim, Raymond J/B-1426-2008					BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; BROWN RD, 1992, MAGNET RESON MED, V28, P145, DOI 10.1002/mrm.1910280115; BRYANT RG, 1991, MAGNET RESON MED, V21, P117, DOI 10.1002/mrm.1910210114; BRYANT RG, 1980, 178 M AM CHEM SOC WA; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; DENISOV VP, 1995, BIOCHEMISTRY-US, V34, P9046, DOI 10.1021/bi00028a013; DENISOV VP, 1995, J MOL BIOL, V245, P682, DOI 10.1006/jmbi.1994.0055; EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0; ESCANYE JM, 1982, BIOCHIM BIOPHYS ACTA, V721, P305, DOI 10.1016/0167-4889(82)90083-0; FRAENKEICONRAT H, 1945, J BIOL CHEM, V161, P259; FULLERTON GD, 1980, MAGNETIC RESONANCE I, V1, P88; FULLERTON GD, 1980, MAGNETIC RESONANCE I, V2, P88; FUNG BM, 1974, BIOCHIM BIOPHYS ACTA, V362, P209, DOI 10.1016/0304-4165(74)90042-7; FUNG BM, 1974, BIOCHIM BIOPHYS ACTA, V343, P663, DOI 10.1016/0304-4165(74)90287-6; Glantz S., 1990, PRIMER APPL REGRESSI; GORE JC, 1988, NUCL MAGN RESON, V2, P1070; HALLE B, 1995, BIOPHYS J, V69, P242, DOI 10.1016/S0006-3495(95)79895-2; HILLS BP, 1992, MOL PHYS, V76, P489, DOI 10.1080/00268979200101491; HILLS BP, 1992, MOL PHYS, V76, P509, DOI 10.1080/00268979200101501; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; KIMMICH R, 1985, PROG COLL POL SCI S, V71, P66; KIMMICH R, 1986, J MAGN RESON, V68, P263, DOI 10.1016/0022-2364(86)90243-X; KNISPEL RR, 1974, J MAGN RESON, V14, P44, DOI 10.1016/0022-2364(74)90255-8; KOENIG SH, 1993, MAGNET RESON MED, V29, P77, DOI 10.1002/mrm.1910290114; KOENIG SH, 1993, MAGN RESON MED, V30, P685, DOI 10.1002/mrm.1910300606; KOENIG SH, 1993, MAGNET RESON MED, V29, P311, DOI 10.1002/mrm.1910290306; LESTER CC, 1991, MAGNET RESON MED, V22, P143, DOI 10.1002/mrm.1910220115; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; LUFT JH, 1992, J MICROSC-OXFORD, V167, P247, DOI 10.1111/j.1365-2818.1992.tb03235.x; Makela HI, 2001, BIOCHEM BIOPH RES CO, V289, P813, DOI 10.1006/bbrc.2001.6058; MENON RS, 1990, BIOPHYS J, V57, P389, DOI 10.1016/S0006-3495(90)82555-8; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; PACKER KJ, 1977, PHILOS T R SOC B, V278, P59, DOI 10.1098/rstb.1977.0031; POLNASZEK CF, 1984, J CHEM PHYS, V81, P4038, DOI 10.1063/1.448147; RORSCHACH HE, 1986, J MAGN RESON, V70, P79, DOI 10.1016/0022-2364(86)90364-1; SHIRLEY WM, 1982, J AM CHEM SOC, V104, P2910, DOI 10.1021/ja00374a034; Venu K, 1997, J AM CHEM SOC, V119, P3122, DOI 10.1021/ja963611t; Virta A, 1997, MAGNET RESON MED, V37, P53, DOI 10.1002/mrm.1910370109; ZHOU D, 1994, MAGNET RESON MED, V32, P725, DOI 10.1002/mrm.1910320607	41	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8565	10.1371/journal.pone.0008565	http://dx.doi.org/10.1371/journal.pone.0008565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052404	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500009
J	Clarke, M; Maddera, L; Engel, U; Gerisch, G				Clarke, Margaret; Maddera, Lucinda; Engel, Ulrike; Gerisch, Guenther			Retrieval of the Vacuolar H+-ATPase from Phagosomes Revealed by Live Cell Imaging	PLOS ONE			English	Article							ENDOCYTIC PATHWAY; V-ATPASE; DICTYOSTELIUM-DISCOIDEUM; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; VESICULAR TRAFFICKING; FLUORESCENT PROTEIN; DYNAMICS; MEMBRANE; PHAGOCYTOSIS; MATURATION	Background: The vacuolar H+-ATPase, or V-ATPase, is a highly-conserved multi-subunit enzyme that transports protons across membranes at the expense of ATP. The resulting proton gradient serves many essential functions, among them energizing transport of small molecules such as neurotransmitters, and acidifying organelles such as endosomes. The enzyme is not present in the plasma membrane from which a phagosome is formed, but is rapidly delivered by fusion with endosomes that already bear the V-ATPase in their membranes. Similarly, the enzyme is thought to be retrieved from phagosome membranes prior to exocytosis of indigestible material, although that process has not been directly visualized. Methodology: To monitor trafficking of the V-ATPase in the phagocytic pathway of Dictyostelium discoideum, we fed the cells yeast, large particles that maintain their shape during trafficking. To track pH changes, we conjugated the yeast with fluorescein isothiocyanate. Cells were labeled with VatM-GFP, a fluorescently-tagged transmembrane subunit of the V-ATPase, in parallel with stage-specific endosomal markers or in combination with mRFP-tagged cytoskeletal proteins. Principal Findings: We find that the V-ATPase is commonly retrieved from the phagosome membrane by vesiculation shortly before exocytosis. However, if the cells are kept in confined spaces, a bulky phagosome may be exocytosed prematurely. In this event, a large V-ATPase-rich vacuole coated with actin typically separates from the acidic phagosome shortly before exocytosis. This vacuole is propelled by an actin tail and soon acquires the properties of an early endosome, revealing an unexpected mechanism for rapid recycling of the V-ATPase. Any V-ATPase that reaches the plasma membrane is also promptly retrieved. Conclusions/Signficance: Thus, live cell microscopy has revealed both a usual route and alternative means of recycling the V-ATPase in the endocytic pathway.	[Clarke, Margaret; Maddera, Lucinda] Oklahoma Med Res Fdn, Program Genet Models Dis, Oklahoma City, OK 73104 USA; [Engel, Ulrike] Heidelberg Univ, Nikon Imaging Ctr, Heidelberg, Germany; [Gerisch, Guenther] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Oklahoma Medical Research Foundation; Nikon Corporation; Ruprecht Karls University Heidelberg; Max Planck Society	Clarke, M (corresponding author), Oklahoma Med Res Fdn, Program Genet Models Dis, 825 NE 13th St, Oklahoma City, OK 73104 USA.	clarkem@omrf.org	Engel, Ulrike/AAO-7719-2020; Engel, Ulrike/E-5456-2014	Engel, Ulrike/0000-0002-6953-6845; Maddera, Lucinda/0000-0001-7474-7164	National Science Foundation [MCB-0344541]; Max Planck Society; Deutsche Forschungsgemeinschaft [SPP 1128]	National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant MCB-0344541 from the National Science Foundation to MC, and by the Max Planck Society and grants in the SPP 1128 program of the Deutsche Forschungsgemeinschaft to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBRY L, 1993, J CELL SCI, V105, P861; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; Bozzaro S, 2008, INT REV CEL MOL BIO, V271, P253, DOI 10.1016/S1937-6448(08)01206-9; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; Charette SJ, 2006, FEBS LETT, V580, P4923, DOI 10.1016/j.febslet.2006.08.009; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Clarke M, 2002, J CELL SCI, V115, P2893; Clarke M, 2002, TRAFFIC, V3, P791, DOI 10.1034/j.1600-0854.2002.31104.x; Clarke M, 2006, MOL BIOL CELL, V17, P4866, DOI 10.1091/mbc.E06-04-0365; Clarke M, 2006, EUR J CELL BIOL, V85, P1001, DOI 10.1016/j.ejcb.2006.05.004; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dieckmann Regis, 2008, V445, P327, DOI 10.1007/978-1-59745-157-4_21; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Duhon D, 2002, J MUSCLE RES CELL M, V23, P803, DOI 10.1023/A:1024435913949; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Engel Ulrike, 2009, Biotechnology Journal, V4, P797, DOI 10.1002/biot.200900060; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Gabriel D, 1999, J CELL SCI, V112, P3995; Gauthier NC, 2009, MOL BIOL CELL, V20, P3261, DOI 10.1091/mbc.E09-01-0071; Gerisch G, 2004, EUR J CELL BIOL, V83, P297, DOI 10.1078/0171-9335-00393; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Giorgione J, 2008, CELL MOTIL CYTOSKEL, V65, P721, DOI 10.1002/cm.20293; Gotthardt D, 2002, MOL BIOL CELL, V13, P3508, DOI 10.1091/mbc.E02-04-0206; Heuser J, 2006, EUR J CELL BIOL, V85, P859, DOI 10.1016/j.ejcb.2006.05.011; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Insall R, 2001, CELL MOTIL CYTOSKEL, V50, P115, DOI 10.1002/cm.10005; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Jenne N, 1998, J CELL SCI, V111, P61; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Liu TY, 1996, J CELL SCI, V109, P1041; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Maniak M, 2003, TRAFFIC, V4, P1, DOI 10.1034/j.1600-0854.2003.40101.x; Maniak M, 2002, INT REV CYTOL, V221, P257; Maniak M, 2001, BBA-GEN SUBJECTS, V1525, P197, DOI 10.1016/S0304-4165(01)00105-2; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McNeil PL, 2002, J CELL SCI, V115, P873; Neuhaus EM, 2002, MOL BIOL CELL, V13, P1390, DOI 10.1091/mbc.01-08-0392; NOLTA KV, 1994, BBA-MOL CELL RES, V1224, P237, DOI 10.1016/0167-4889(94)90196-1; Rauchenberger R, 1997, CURR BIOL, V7, P215, DOI 10.1016/S0960-9822(97)70093-9; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rezabek BL, 1997, J EUKARYOT MICROBIOL, V44, P284, DOI 10.1111/j.1550-7408.1997.tb05668.x; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; YUMURA S, 1985, NATURE, V314, P194, DOI 10.1038/314194a0	56	39	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8585	10.1371/journal.pone.0008585	http://dx.doi.org/10.1371/journal.pone.0008585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052281	gold, Green Submitted, Green Published			2022-12-27	WOS:000273338500027
J	Haney, RA; Feder, ME				Haney, Robert A.; Feder, Martin E.			Contrasting Patterns of Transposable Element Insertions in Drosophila Heat-Shock Promoters	PLOS ONE			English	Article							HSP70 PROMOTER; GENE-EXPRESSION; TATA BOX; EVOLUTION; MELANOGASTER; IDENTIFICATION; SEQUENCES; FAMILY; THERMOTOLERANCE; TRANSPOSITION	The proximal promoter regions of heat-shock genes harbor a remarkable number of P transposable element (TE) insertions relative to both positive and negative control proximal promoter regions in natural populations of Drosophila melanogaster. We have screened the sequenced genomes of 12 species of Drosophila to test whether this pattern is unique to these populations. In the 12 species' genomes, transposable element insertions are no more abundant in promoter regions of single-copy heat-shock genes than in promoters with similar or dissimilar architecture. Also, insertions appear randomly distributed across the promoter region, whereas insertions clustered near the transcription start site in promoters of single-copy heat-shock genes in D. melanogaster natural populations. Hsp70 promoters exhibit more TE insertions per promoter than all other genesets in the 12 species, similarly to in natural populations of D. melanogaster. Insertions in the Hsp70 promoter region, however, cluster away from the transcription start site in the 12 species, but near it in natural populations of D. melanogaster. These results suggest that D. melanogaster heat-shock promoters are unique in terms of their interaction with transposable elements, and confirm that Hsp70 promoters are distinctive in TE insertions across Drosophila.	[Haney, Robert A.; Feder, Martin E.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Haney, RA (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	rhaney@uchicago.edu		Haney, Robert/0000-0002-3742-3395	NSF [IOB06-41278]	NSF(National Science Foundation (NSF))	Supported by NSF IOB06-41278 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Caspi A, 2006, GENOME RES, V16, P260, DOI 10.1101/gr.4361206; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Chen B, 2008, CELL STRESS CHAPERON, V13, P11, DOI 10.1007/s12192-007-0002-4; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; CORCES V, 1984, J BIOL CHEM, V259, P4812; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; El Amrani A, 2002, MOL GENET GENOMICS, V267, P459, DOI 10.1007/s00438-002-0675-4; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Ganko EW, 2006, J MOL EVOL, V62, P111, DOI 10.1007/s00239-004-0312-4; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; HALL T, 1999, BIOEDIT SEQUENCE ALI; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; LANSMAN RA, 1985, NATURE, V318, P561, DOI 10.1038/318561a0; Lardenois A, 2006, NUCLEIC ACIDS RES, V34, pW578, DOI 10.1093/nar/gkl193; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Lerman DN, 2005, MOL BIOL EVOL, V22, P776, DOI 10.1093/molbev/msi063; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Maside X, 2002, CURR BIOL, V12, P1686, DOI 10.1016/S0960-9822(02)01181-8; McCollum AM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-5; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Rashkovetsky E, 2006, HEREDITY, V96, P353, DOI 10.1038/sj.hdy.6800784; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schmid CD, 2004, NUCLEIC ACIDS RES, V32, pD82, DOI 10.1093/nar/gkh122; Shilova VY, 2006, GENETICS, V173, P809, DOI 10.1534/genetics.105.053959; Silva JC, 2004, GENETICS, V168, P1323, DOI 10.1534/genetics.103.025775; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; STACEY SN, 1986, MOL BIOL EVOL, V3, P522; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Walser JC, 2006, PLOS GENET, V2, P1541, DOI 10.1371/journal.pgen.0020165; Wang J, 2007, J MOL EVOL, V65, P627, DOI 10.1007/s00239-007-9028-6; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Xu L, 2007, BIOCHEM BIOPH RES CO, V364, P668, DOI 10.1016/j.bbrc.2007.10.069; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Zatsepina OG, 2001, J EXP BIOL, V204, P1869	59	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8486	10.1371/journal.pone.0008486	http://dx.doi.org/10.1371/journal.pone.0008486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041194	gold, Green Published, Green Submitted			2022-12-27	WOS:000273105200018
J	Lu, J; Zhou, YD; Lin, XJ; Jiang, YZ; Tian, RG; Zhang, YH; Wu, J; Zhang, FW; Zhang, Y; Wang, Y; Bi, SL				Lu, Jian; Zhou, Yongdong; Lin, Xiaojing; Jiang, Yongzhen; Tian, Ruiguang; Zhang, Yonghui; Wu, Jia; Zhang, Fengwei; Zhang, Yong; Wang, Yue; Bi, Shengli			General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; E VIRUS; POLYMORPHISMS; PROTEIN; CORE; HEV	Background: Viral hepatitis is a serious health burden worldwide. To date, few reports have addressed the prevalence of hepatitis A, B, C, and E in China. Therefore, the general epidemiological parameters of viral hepatitis remain unknown. Principal Findings: In this cross-sectional study, we performed a serological prevalence analysis of viral hepatitis A, B, C, and E in 8,762 randomly selected Chinese subjects, which represented six areas of China. The overall prevalence of anti-Hepatitis C virus antibody (anti-HCV) was 0.58%, which was much lower than was estimated by WHO. The prevalences of Hepatitis B virus surface antigen (HBsAg), anti-Hepatitis B virus surface protein antibody (HBsAb), and anti-Hepatitis B virus core protein antibody (HBcAb) were 5.84%, 41.31%, and 35.92%, respectively, whereas in the group of subjects less than 5 years old, these prevalences were 1.16%, 46.77%, and 8.69% respectively, which suggests that the Hepatitis B virus (HBV)-carrier population is decreasing, and the nationwide HBV vaccine program has contributed to the lowered HBV prevalence in the younger generation in China. Meanwhile, a large deficit remains in coverage provided by the national HBV immune program. In addition, our data suggested the possibility that HBsAb may not last long enough to protect people from HBV infection throughout life. The overall prevalence of anti-Hepatitis A virus antibody (anti-HAV) and anti-Hepatitis E virus antibody (anti-HEV) were as high as 72.87% and 17.66%, respectively. The indices increased with age, which suggests that a large proportion of Chinese adults are protected by latent infection. Furthermore, the pattern of HEV infection was significantly different among ethnic groups in China. Conclusions: Our study provided much important information concerning hepatitis A, B, C, and E prevalence in China and will contribute to worldwide oversight of viral hepatitis.	[Lu, Jian; Zhou, Yongdong; Lin, Xiaojing; Jiang, Yongzhen; Tian, Ruiguang; Zhang, Yonghui; Wu, Jia; Zhang, Fengwei; Zhang, Yong; Wang, Yue; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Lu, J (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	euy-tokyo@umin.ac.jp; shengli_bi@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Bi, Shengli/0000-0002-0380-5790	National Research Programs of China [2008ZX10002-001, 2009ZX10004-711]; 863 Hi-Tech Research and Development Program of China [2007AA02Z157]	National Research Programs of China; 863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Research Programs of China (2008ZX10002-001 and 2009ZX10004-711) and the 863 Hi-Tech Research and Development Program of China (2007AA02Z157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Cao JY, 2009, HEPATOL INT, V3, P356, DOI 10.1007/s12072-008-9116-8; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, pSS2; Dai Z., 1997, VIRAL HEPATITIS CHIN, P39; DAVID MM, 2008, LANCET INFECT DIS, V8, P710; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Degertekin B, 2008, CURR OPIN GASTROEN, V24, P306, DOI 10.1097/MOG.0b013e3282f70285; Deng Y, 2009, VACCINE, V27, P2085, DOI 10.1016/j.vaccine.2009.02.003; Emerson SU, 2007, PEDIATR INFECT DIS J, V26, P1147, DOI 10.1097/INF.0b013e31815dd7c2; Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Hoofnagle JH, 1998, DIGESTION, V59, P563, DOI 10.1159/000007532; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Jiang Yong-zhen, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P468; Kuiken T, 2003, CURR OPIN BIOTECH, V14, P641, DOI 10.1016/j.copbio.2003.10.010; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liao G, 2008, HEPATOLOGY, V47, P25, DOI 10.1002/hep.21992; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V385, P257, DOI 10.1016/j.bbrc.2009.05.068; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Mohanty SR, 2006, NAT CLIN PRACT GASTR, V3, P446, DOI 10.1038/ncpgasthep0550; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Raimondo G, 2008, J HEPATOL, V49, P677, DOI 10.1016/j.jhep.2008.08.003; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Wang Y, 2004, CLIN CANCER RES, V10, P2441, DOI 10.1158/1078-0432.CCR-1187-3; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; WHO, HEP A; *WHO, WHOCDSCSREDC200112; World Health Organization, HEP B; World Health Organization, HEP E; World Health Organization (WHO), HEP C; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; 2002, NIH CONSENSUS STATE, V19	38	79	95	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8467	10.1371/journal.pone.0008467	http://dx.doi.org/10.1371/journal.pone.0008467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041146	gold, Green Submitted, Green Published			2022-12-27	WOS:000273104000025
J	Bejon, P; Ogada, E; Peshu, N; Marsh, K				Bejon, Philip; Ogada, Edna; Peshu, Norbert; Marsh, Kevin			Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children	PLOS ONE			English	Article							TREATED BED NETS; PLASMODIUM-FALCIPARUM TRANSMISSION; SPATIAL-DISTRIBUTION; YOUNG-CHILDREN; WESTERN KENYA; PEDIATRIC MALARIA; CLINICAL MALARIA; MOSQUITO NETS; MORTALITY; AREA	Background: Control measures which reduce individual exposure to malaria are expected to reduce disease, but also to eventually reduce immunity. Reassuringly, long term data following community wide ITN distribution show sustained benefits at a population level. However, the more common practice in Sub-Saharan Africa is to target ITN distribution on young children. There are few data on the long term outcomes of this practice. Methodology/Principal Findings: Episodes of febrile malaria were identified by active surveillance in 383 children over 18 months of follow up. In order to compare the short and long term outcomes of ITN use, we examined interactions between ITN use and age (12-42 months of age versus 42-80 months) in determining the risk of febrile malaria. ITN use and older age protected against the first or only episode of malaria (Hazard Ratio [HR] = 0.33, 95% CI 0.17-0.65 and HR = 0.30, 95% CI 0.17-0.51, respectively). The interaction term between ITN use and older age was HR = 2.91, 95% CI 1.02-8.3, p = 0.045, indicating that ITNs did not protect older children. When multiple episodes were included in analysis, ITN use and older age were again protective against malaria episodes (Incident Rate Ratio [IRR] = 0.43 95% CI 0.27-0.7) and IRR = 0.23, 95% CI 0.13-0.42, respectively) and the interaction term indicated that ITNs did not protect older children (IRR = 2.71, 95% CI 1.3-5.7, p = 0.008). Conclusions/Significance: These data on age interactions with ITN use suggest that larger scale studies on the long term individual outcomes should be undertaken if the policy of targeted ITN use for vulnerable groups is to continue.	[Bejon, Philip; Ogada, Edna; Peshu, Norbert; Marsh, Kevin] KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Bejon, P (corresponding author), KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya.	pbejon@well.ox.ac.uk		Ogada, Edna/0000-0003-0181-2505	Biomedical Research Programme in Oxford; Wellcome Trust; Gates Malaria Partnership; London School of Hygiene & Tropical Medicine	Biomedical Research Programme in Oxford; Wellcome Trust(Wellcome TrustEuropean Commission); Gates Malaria Partnership; London School of Hygiene & Tropical Medicine	PB is funded by the Biomedical Research Programme in Oxford. The study was funded by the Wellcome Trust and by the Gates Malaria Partnership, London School of Hygiene & Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Askjaer N, 2001, CLIN DIAGN LAB IMMUN, V8, P1289, DOI 10.1128/CDLI.8.6.1289-1291.2001; BEJON P, 2009, INFECT IMMUN; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Gimnig JE, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.115; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Kariuki SK, 2003, AM J TROP MED HYG, V68, P108, DOI 10.4269/ajtmh.2003.68.108; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Leenstra T, 2003, AM J TROP MED HYG, V68, P86, DOI 10.4269/ajtmh.2003.68.86; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P100, DOI 10.4269/ajtmh.2003.68.100; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8321	10.1371/journal.pone.0008321	http://dx.doi.org/10.1371/journal.pone.0008321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037643	Green Published, gold			2022-12-27	WOS:000272998100003
J	Malla, P; Kanitz, EE; Akhtar, M; Falzon, D; Feldmann, K; Gunneberg, C; Jha, SS; Maharjan, B; Prasai, MK; Shrestha, B; Verma, SC; Zignol, M				Malla, Pushpa; Kanitz, Elisabeth Eva; Akhtar, Mohammad; Falzon, Dennis; Feldmann, Knut; Gunneberg, Christian; Jha, Shyam Sundar; Maharjan, Bhagwan; Prasai, Mohan Kumar; Shrestha, Bhabana; Verma, Sharat Chandra; Zignol, Matteo			Ambulatory-Based Standardized Therapy for Multi-Drug Resistant Tuberculosis: Experience from Nepal, 2005-2006	PLOS ONE			English	Article							PERU; COHORT; HEALTH; LIMA	Objective: The aim of this study was to describe treatment outcomes for multi-drug resistant tuberculosis (MDR-TB) outpatients on a standardized regimen in Nepal. Methodology: Data on pulmonary MDR-TB patients enrolled for treatment in the Green Light Committee-approved National Programme between 15 September 2005 and 15 September 2006 were studied. Standardized regimen was used (8Z-Km-Ofx-Eto-Cs/16Z-Ofx-Eto-Cs) for a maximum of 32 months and follow-up was by smear and culture. Drug susceptibility testing (DST) results were not used to modify the treatment regimen. MDR-TB therapy was delivered in outpatient facilities for the whole course of treatment. Multivariable analysis was used to explain bacteriological cure as a function of sex, age, initial body weight, history of previous treatment and the region of report. Principal Findings: In the first 12-months, 175 laboratory-confirmed MDR-TB cases (62% males) had outcomes reported. Most cases had failed a Category 2 first-line regimen (87%) or a Category 1 regimen (6%), 2% were previously untreated contacts of MDR-TB cases and 5% were unspecified. Cure was reported among 70% of patients (range 38%-93% by Region), 8% died, 5% failed treatment, and 17% defaulted. Unfavorable outcomes were not correlated to the number of resistant drugs at baseline DST. Cases who died had a lower mean body weight than those surviving (40.3 kg vs 47.2 kg, p, 0.05). Default was significantly higher in two regions [Eastern OR = 6.2; 95% CL2.0-18.9; Far West OR = 5.0; 95% CL1.0-24.3]. At logistic regression, cure was inversely associated with body weight,36 kg [Adj. OR = 0.1; 95% CL0.0-0.3; ref. 55-75 kg] and treatment in the Eastern region [Adj. OR = 0.1; 95% CL0.0-0.4; ref. Central region]. Conclusions: The implementation of an ambulatory-based treatment programme for MDR-TB based on a fully standardized regimen can yield high cure rates even in resource-limited settings. The determinants of unfavorable outcome should be investigated thoroughly to maximize likelihood of successful treatment.	[Malla, Pushpa; Jha, Shyam Sundar; Verma, Sharat Chandra] NTC, Minist Hlth & Populat, Kathmandu, Nepal; [Kanitz, Elisabeth Eva; Falzon, Dennis; Gunneberg, Christian; Zignol, Matteo] WHO, CH-1211 Geneva, Switzerland; [Akhtar, Mohammad] WHO, Country Off, Kathmandu, Nepal; [Feldmann, Knut] Kuratorium TB Welt, Gauting, Germany; [Maharjan, Bhagwan; Shrestha, Bhabana] German Nepal TB Project GENTUP, Kathmandu, Nepal; [Prasai, Mohan Kumar] Reg TB Ctr, Pokhara, Nepal	World Health Organization; World Health Organization	Malla, P (corresponding author), NTC, Minist Hlth & Populat, Kathmandu, Nepal.	zignolm@who.int			United States Agency for International Development; Eli Lilly MDR-TB Partnership	United States Agency for International Development(United States Agency for International Development (USAID)); Eli Lilly MDR-TB Partnership(Eli Lilly)	This study was supported by the United States Agency for International Development and Eli Lilly MDR-TB Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barn DS, 2004, INT J TUBERC LUNG S1, V8, pS47; BYRNE A, 2009, 40 UN WORLD IN PRESS; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Park SK, 2004, INT J TUBERC LUNG D, V8, P361; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; SHRESTHA KB, 2005, INT J TUBERC LUNG S1, V9, pS257; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P560; WHO, 2009, WHOHTMTB2009411; WHO, 2009, WHOHTMTB2009422; WHO, 2000, WHOCDSTB2000279; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2003, TREATM TUB GUID NAT; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	24	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8313	10.1371/journal.pone.0008313	http://dx.doi.org/10.1371/journal.pone.0008313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20041140	Green Published, gold, Green Submitted			2022-12-27	WOS:000272998100002
J	Er, F; Nia, AM; Gassanov, N; Caglayan, E; Erdmann, E; Hoppe, UC				Er, Fikret; Nia, Amir M.; Gassanov, Natig; Caglayan, Evren; Erdmann, Erland; Hoppe, Uta C.			Impact of Rescue-Thrombolysis during Cardiopulmonary Resuscitation in Patients with Pulmonary Embolism	PLOS ONE			English	Article							CARDIAC-ARREST; MANAGEMENT; GUIDELINES; ECHOCARDIOGRAPHY; DIAGNOSIS; REGISTRY	Background: Cardiac arrest in patients with pulmonary embolism (PE) is associated with high morbidity and mortality. Thrombolysis is expected to improve the outcome in these patients. However studies evaluating rescue-thrombolysis in patients with PE are missing, mainly due to the difficulties of clinical diagnosis of PE. We aimed to determine the success influencing factors of thrombolysis during resuscitation in patients with PE. Methodology/Principal Findings: We analyzed retrospectively the outcome of 104 consecutive patients with confirmed (n = 63) or highly suspected (n = 41) PE and monitored cardiac arrest. In all patients rtPA was administrated for thrombolysis during cardiopulmonary resuscitation. In 40 of the 104 patients (38.5%) a return of spontaneous circulation (ROSC) could be achieved successfully. Patients with ROSC received thrombolysis significantly earlier after CPR onset compared to patients without ROSC (13.6+/-1.2 min versus 24.6+/-0.8 min; p<0.001). 19 patients (47.5%) out of the 40 patients with initially successful resuscitation survived to hospital discharge. In patients with hospital discharge thrombolysis therapy was begun with a significantly shorter delay after cardiac arrest compared to all other patients (11.0+/-1.3 vs. 22.5+/-0.9 min; p<0.001). Conclusion: Rescue-thrombolysis should be considered and started in patients with PE and cardiac arrest, as soon as possible after cardiac arrest onset.	[Er, Fikret; Nia, Amir M.; Gassanov, Natig; Caglayan, Evren; Erdmann, Erland; Hoppe, Uta C.] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Hoppe, Uta C.] Univ Cologne, Ctr Mol Med, CMMC, Cologne, Germany	University of Cologne; University of Cologne	Er, F (corresponding author), Univ Cologne, Dept Internal Med 2, Cologne, Germany.	Fikret.Er@uk-koeln.de	Caglayan, Evren/ABB-8674-2020		Center for Molecular Medicine Cologne, Cologne, Germany	Center for Molecular Medicine Cologne, Cologne, Germany	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding source: Center for Molecular Medicine Cologne, Cologne, Germany.	Abu-Laban RB, 2002, NEW ENGL J MED, V346, P1522, DOI 10.1056/NEJMoa012885; Aklog L, 2002, CIRCULATION, V105, P1416, DOI 10.1161/01.CIR.0000012526.21603.25; Bailen MR, 2001, CRIT CARE MED, V29, P2211, DOI 10.1097/00003246-200111000-00027; Bottiger BW, 2008, NEW ENGL J MED, V359, P2651, DOI 10.1056/NEJMoa070570; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goran KP, 2008, EUR HEART J, V29, P3066, DOI 10.1093/eurheartj/ehn474; HOFFMANN B, 2009, THROMB RES; Jardin F, 1997, CHEST, V111, P209, DOI 10.1378/chest.111.1.209; JARDIN F, 1991, PRESSE MED, V20, P2085; JENNETT B, 1975, LANCET, V1, P480; Kasper W, 1997, J AM COLL CARDIOL, V30, P1165, DOI 10.1016/S0735-1097(97)00319-7; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; SOLOFF LA, 1967, AM HEART J, V74, P710, DOI 10.1016/0002-8703(67)90510-8; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; vanderWouw PA, 1997, J AM COLL CARDIOL, V30, P780, DOI 10.1016/S0735-1097(97)00218-0; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; 2000, EUR HEART J, V21, P1301	17	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8323	10.1371/journal.pone.0008323	http://dx.doi.org/10.1371/journal.pone.0008323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016808	Green Submitted, Green Published, gold			2022-12-27	WOS:000272833800017
J	Gellerich, FN; Gizatullina, Z; Arandarcikaite, O; Jerzembek, D; Vielhaber, S; Seppet, E; Striggow, F				Gellerich, Frank Norbert; Gizatullina, Zemfira; Arandarcikaite, Odeta; Jerzembek, Doreen; Vielhaber, Stefan; Seppet, Enn; Striggow, Frank			Extramitochondrial Ca2+ in the Nanomolar Range Regulates Glutamate-Dependent Oxidative Phosphorylation on Demand	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; ADENINE-NUCLEOTIDES; LIVER MITOCHONDRIA; RUTHENIUM RED; PERMEABILITY TRANSITION; INTERMEMBRANE SPACE; CREATINE-KINASE; INNER MEMBRANE; CA-2+; TRANSPORT	We present unexpected and novel results revealing that glutamate-dependent oxidative phosphorylation (OXPHOS) of brain mitochondria is exclusively and efficiently activated by extramitochondrial Ca2+ in physiological concentration ranges (S-0.5 = 360 nM Ca2+). This regulation was not affected by RR, an inhibitor of the mitochondrial Ca2+ uniporter. Active respiration is regulated by glutamate supply to mitochondria via aralar, a mitochondrial glutamate/aspartate carrier with regulatory Ca2+-binding sites in the mitochondrial intermembrane space providing full access to cytosolic Ca2+. At micromolar concentrations, Ca2+ can also enter the intramitochondrial matrix and activate specific dehydrogenases. However, the latter mechanism is less efficient than extramitochondrial Ca2+ regulation of respiration/OXPHOS via aralar. These results imply a new mode of glutamate-dependent OXPHOS regulation as a demand-driven regulation of mitochondrial function. This regulation involves the mitochondrial glutamate/aspartate carrier aralar which controls mitochondrial substrate supply according to the level of extramitochondrial Ca2+.	[Gellerich, Frank Norbert; Jerzembek, Doreen; Striggow, Frank] KeyNeurotek Pharmaceut AG, ZENIT Technol Pk, Magdeburg, Germany; [Gizatullina, Zemfira; Vielhaber, Stefan] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Arandarcikaite, Odeta] Kaunas Univ Med, Inst Biomed Res, Kaunas, Lithuania; [Seppet, Enn] Univ Tartu, Dept Pathophysiol, Ctr Mol & Clin Med, EE-50090 Tartu, Estonia	Otto von Guericke University; Lithuanian University of Health Sciences; University of Tartu	Gellerich, FN (corresponding author), KeyNeurotek Pharmaceut AG, ZENIT Technol Pk, Magdeburg, Germany.	frank.gellerich@keyneurotek.de			European Huntington network; DFG [Ge 664/11-2]; German Federal Ministry of Economics and Technology [IWO72052]; Estonian Ministry of Education and Research [SF0180114As08]; Estonian Science Foundation [7117, 7823]	European Huntington network; DFG(German Research Foundation (DFG)); German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This work was supported by the European Huntington network, the DFG (Ge 664/11-2), the German Federal Ministry of Economics and Technology, grant No. IWO72052 (MitoscreenTest), Estonian Ministry of Education and Research (SF0180114As08) and Estonian Science Foundation (grants No. 7117 and 7823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; BUNGER R, 1980, H-S Z PHYSIOL CHEM, V361, P907, DOI 10.1515/bchm2.1980.361.1.907; CHANCE B, 1955, J BIOL CHEM, V217, P409; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; Gellerich FN, 1998, EUR J BIOCHEM, V254, P172, DOI 10.1046/j.1432-1327.1998.2540172.x; GELLERICH FN, 1987, BIOCHIM BIOPHYS ACTA, V890, P117, DOI 10.1016/0005-2728(87)90012-0; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1140, P327, DOI 10.1016/0005-2728(93)90073-O; Gizatullina ZZ, 2005, BBA-BIOENERGETICS, V1706, P98, DOI 10.1016/j.bbabio.2004.09.013; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; HEINEMAN FW, 1990, J CLIN INVEST, V85, P843, DOI 10.1172/JCI114511; JOHNSTON JD, 1986, BIOCHEM SOC T, V14, P1182, DOI 10.1042/bst0141182; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; LENZEN S, 1992, BIOCHEM J, V286, P597, DOI 10.1042/bj2860597; MCCORMACK JG, 1989, BIOCHEM J, V264, P167, DOI 10.1042/bj2640167; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROSSI CS, 1973, BIOCHEM BIOPH RES CO, V50, P846, DOI 10.1016/0006-291X(73)91322-3; RUTTER GA, 1988, BIOCHEM J, V252, P181, DOI 10.1042/bj2520181; RUTTER GA, 1989, BIOCHIM BIOPHYS ACTA, V1014, P263, DOI 10.1016/0167-4889(89)90222-X; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Seppet EK, 2001, BBA-BIOENERGETICS, V1504, P379, DOI 10.1016/S0005-2728(00)00269-3; Sharma N, 2005, J PHYSIOL-LONDON, V562, P593, DOI 10.1113/jphysiol.2004.075713; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; UNITT JF, 1989, BIOCHEM J, V262, P293, DOI 10.1042/bj2620293; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1	37	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8181	10.1371/journal.pone.0008181	http://dx.doi.org/10.1371/journal.pone.0008181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011041	gold, Green Published, Green Submitted			2022-12-27	WOS:000272829800004
J	Gjedde, A; Geday, J				Gjedde, Albert; Geday, Jacob			Deep Brain Stimulation Reveals Emotional Impact Processing in Ventromedial Prefrontal Cortex	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; DOPAMINE RELEASE; 5-HT2C RECEPTORS; FUSIFORM GYRUS; MODULATION; NEURONS; ACTIVATION	We tested the hypothesis that modulation of monoaminergic tone with deep-brain stimulation (DBS) of subthalamic nucleus would reveal a site of reactivity in the ventromedial prefrontal cortex that we previously identified by modulating serotonergic and noradrenergic mechanisms by blocking serotonin-noradrenaline reuptake sites. We tested the hypothesis in patients with Parkinson's disease in whom we had measured the changes of blood flow everywhere in the brain associated with the deep brain stimulation of the subthalamic nucleus. We determined the emotional reactivity of the patients as the average impact of emotive images rated by the patients off the DBS. We then searched for sites in the brain that had significant correlation of the changes of blood flow with the emotional impact rated by the patients. The results indicate a significant link between the emotional impact when patients are not stimulated and the change of blood flow associated with the DBS. In subjects with a low emotional impact, activity measured as blood flow rose when the electrode was turned on, while in subjects of high impact, the activity at this site in the ventromedial prefrontal cortex declined when the electrode was turned on. We conclude that changes of neurotransmission in the ventromedial prefrontal cortex had an effect on the tissue that depends on changes of monoamine concentration interacting with specific combinations of inhibitory and excitatory monoamine receptors.	[Gjedde, Albert; Geday, Jacob] Aarhus Univ Hosp, Pathophysiol & Expt Tomog Ctr, DK-8000 Aarhus, Denmark; [Gjedde, Albert; Geday, Jacob] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark	Aarhus University; Aarhus University	Gjedde, A (corresponding author), Aarhus Univ Hosp, Pathophysiol & Expt Tomog Ctr, DK-8000 Aarhus, Denmark.	gjedde@sund.ku.dk	Gjedde, Albert/I-2452-2019; Gjedde, Albert/U-3751-2019	Gjedde, Albert/0000-0002-3756-7401	Denmark's National Science Foundation; Denmark's Medical Research Council	Denmark's National Science Foundation; Denmark's Medical Research Council	Supported by grants from Denmark's National Science Foundation (www.dgf.dk) and Denmark's Medical Research Council (www.fi.dk/fss). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Alex KD, 2005, SYNAPSE, V55, P242, DOI 10.1002/syn.20109; BEAN AJ, 1989, J NEUROCHEM, V53, P655, DOI 10.1111/j.1471-4159.1989.tb07384.x; Benazzouz A, 2000, NEUROLOGY, V55, pS13; Geday J, 2003, NEUROIMAGE, V18, P675, DOI 10.1016/S1053-8119(02)00038-1; Geday J, 2006, NEUROIMAGE, V33, P706, DOI 10.1016/j.neuroimage.2006.06.056; Geday J, 2009, HUM BRAIN MAPP, V30, P112, DOI 10.1002/hbm.20486; Geday J, 2009, SYNAPSE, V63, P160, DOI 10.1002/syn.20570; Hilker R, 2003, MOVEMENT DISORD, V18, P41, DOI 10.1002/mds.10297; Jahanshahi M, 2000, BRAIN, V123, P1142, DOI 10.1093/brain/123.6.1142; Lee KH, 2004, J NEUROSURG, V101, P511, DOI 10.3171/jns.2004.101.3.0511; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Meissner W, 2002, NEUROSCI LETT, V328, P105, DOI 10.1016/S0304-3940(02)00463-9; Nimura T, 2005, J NEUROSURG, V103, P968, DOI 10.3171/jns.2005.103.6.0968; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Pozzi L, 2002, J NEUROCHEM, V82, P93, DOI 10.1046/j.1471-4159.2002.00947.x; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8120	10.1371/journal.pone.0008120	http://dx.doi.org/10.1371/journal.pone.0008120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997647	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829500008
J	Murphy, DM; Buckley, PG; Bryan, K; Das, S; Alcock, L; Foley, NH; Prenter, S; Bray, I; Watters, KM; Higgins, D; Stallings, RL				Murphy, Derek M.; Buckley, Patrick G.; Bryan, Kenneth; Das, Sudipto; Alcock, Leah; Foley, Niamh H.; Prenter, Suzanne; Bray, Isabella; Watters, Karen M.; Higgins, Desmond; Stallings, Raymond L.			Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; CELL ADHESION MOLECULE; N-MYC; C-MYC; FUNCTIONAL-ANALYSIS; MCM PROTEINS; TARGET GENES; HUMAN GENOME; IN-VIVO; EXPRESSION	Background: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, is a major cause of childhood cancer related deaths. The single most important prognostic indicator of poor clinical outcome in this disease is genomic amplification of MYCN, a member of a family of oncogenic transcription factors. Methodology: We applied MYCN chromatin immunoprecipitation to microarrays (ChIP-chip) using MYCN amplified/non-amplified cell lines as well as a conditional knockdown cell line to determine the distribution of MYCN binding sites within all annotated promoter regions. Conclusion: Assessment of E-box usage within consistently positive MYCN binding sites revealed a predominance for the CATGTG motif (p < 0.0016), with significant enrichment of additional motifs CATTTG, CATCTG, CAACTG in the MYCN amplified state. For cell lines over-expressing MYCN, gene ontology analysis revealed enrichment for the binding of MYCN at promoter regions of numerous molecular functional groups including DNA helicases and mRNA transcriptional regulation. In order to evaluate MYCN binding with respect to other genomic features, we determined the methylation status of all annotated CpG islands and promoter sequences using methylated DNA immunoprecipitation (MeDIP). The integration of MYCN ChIP-chip and MeDIP data revealed a highly significant positive correlation between MYCN binding and DNA hypermethylation. This association was also detected in regions of hemizygous loss, indicating that the observed association occurs on the same homologue. In summary, these findings suggest that MYCN binding occurs more commonly at CATGTG as opposed to the classic CACGTG E-box motif, and that disease associated over expression of MYCN leads to aberrant binding to additional weaker affinity E-box motifs in neuroblastoma. The co-localization of MYCN binding and DNA hypermethylation further supports the dual role of MYCN, namely that of a classical transcription factor affecting the activity of individual genes, and that of a mediator of global chromatin structure.	[Murphy, Derek M.; Buckley, Patrick G.; Bryan, Kenneth; Das, Sudipto; Alcock, Leah; Foley, Niamh H.; Prenter, Suzanne; Bray, Isabella; Watters, Karen M.; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Murphy, Derek M.; Buckley, Patrick G.; Bryan, Kenneth; Das, Sudipto; Alcock, Leah; Foley, Niamh H.; Prenter, Suzanne; Bray, Isabella; Watters, Karen M.; Stallings, Raymond L.] Our Ladys Childrens Hosp, Childrens Res Ctr, Dublin, Ireland; [Higgins, Desmond] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University College Dublin	Murphy, DM (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Murphy, Derek/B-1285-2013; Bray, Isabella/D-6179-2012; Stallings, Raymond/A-7213-2008; Higgins, des g/J-6314-2012	Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland; Children's Medical and Research Foundation; Cancer Research Ireland; National Institutes of Health (NIH) [5R01CA127496]; Government of Ireland Postdoctoral Fellowship in Science, Engineering and Technology; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; Cancer Research Ireland; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Ireland Postdoctoral Fellowship in Science, Engineering and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from Science Foundation Ireland, Children's Medical and Research Foundation, Cancer Research Ireland, and the National Institutes of Health (NIH) (5R01CA127496). PGB is supported by a Government of Ireland Postdoctoral Fellowship in Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2003, CANCER RES, V63, P4538; ALEX R, 1992, NUCLEIC ACIDS RES, V20, P2257, DOI 10.1093/nar/20.9.2257; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chatrath P, 2003, BRIT J CANCER, V89, P1048, DOI 10.1038/sj.bjc.6601234; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Davidson EJ, 2003, BRIT J CANCER, V88, P257, DOI 10.1038/sj.bjc.6600729; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Koppen A, 2007, CANCER LETT, V256, P218, DOI 10.1016/j.canlet.2007.06.011; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LEDENT V, 2002, GENOME BIOL, V3; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li M, 2008, BIOINFORMATICS, V24, P1745, DOI 10.1093/bioinformatics/btn256; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Lutz W, 1996, ONCOGENE, V13, P803; MA A, 1993, ONCOGENE, V8, P1093; Malynn BA, 2000, GENE DEV, V14, P1390; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morii E, 2004, AM J PATHOL, V165, P491, DOI 10.1016/S0002-9440(10)63314-7; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; PROCHOWNIK EV, 1993, P NATL ACAD SCI USA, V90, P960, DOI 10.1073/pnas.90.3.960; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sirieix PS, 2003, CLIN CANCER RES, V9, P2560; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; STANTON LW, 1986, P NATL ACAD SCI USA, V83, P1772, DOI 10.1073/pnas.83.6.1772; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; You XJ, 2007, ONCOL REP, V18, P691; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	61	59	60	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8154	10.1371/journal.pone.0008154	http://dx.doi.org/10.1371/journal.pone.0008154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997598	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829200004
J	Schoenenberger, P; Gerosa, D; Oertner, TG				Schoenenberger, Philipp; Gerosa, Daniela; Oertner, Thomas G.			Temporal Control of Immediate Early Gene Induction by Light	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHANNELRHODOPSIN-2; EXPRESSION; NEURONS; PHOTOCYCLES; ACTIVATION; CHANNEL; MICE	Background: The light-gated cation channel channelrhodopsin-2 (ChR2) is a powerful tool for the optical induction of action potentials in neurons. Mutations of the cysteine 128 (C128) residue have been shown to greatly extend the lifetime of the conducting state of ChR2. However, until now, only subthreshold depolarizations have been reported from C128 mutants. Methods and Findings: Here we report the induction of long high-frequency spike trains by brief light pulses in ChR2(C128A)-transfected pyramidal cells in hippocampal slice culture. ChR2(C128A)-mediated spike bursts triggered expression of the immediate early gene c-fos in pyramidal neurons. Robust and cell-specific expression of c-Fos protein was detected after a single blue light pulse and depended on action potential firing, but not on synaptic activity. However, photocurrents diminished upon repeated stimulation and limited the number of action potential bursts that could be elicited. Conclusions: We conclude that the C128A mutant is not suitable for chronic stimulation of neurons, but very useful for light-controlled induction of immediate early genes. This property of ChR2( C128A) could be harnessed to control the expression of proteins under control of the c-fos promoter with precise timing and single cell specificity.	[Schoenenberger, Philipp; Gerosa, Daniela; Oertner, Thomas G.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Schoenenberger, P (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	thomas.oertner@fmi.ch	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528	Novartis Research Foundation; SystemsX.ch	Novartis Research Foundation; SystemsX.ch	This work was supported by the Novartis Research Foundation and SystemsX.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMANTIDIS AR, 2007, NATURE; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; BERNDT A, 2008, NAT NEUROSCI; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cambridge SB, 1997, SCIENCE, V277, P825, DOI 10.1126/science.277.5327.825; Cambridge SB, 2009, NAT METHODS, V6, P527, DOI 10.1038/nmeth.1340; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; SCHOENENBERGER P, 2008, BRAIN CELL BIOL; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	26	55	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8185	10.1371/journal.pone.0008185	http://dx.doi.org/10.1371/journal.pone.0008185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997631	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829200016
J	Davies, MN; Bayry, J; Tchilian, EZ; Vani, J; Shaila, MS; Forbes, EK; Draper, SJ; Beverley, PCL; Tough, DF; Flower, DR				Davies, Matthew N.; Bayry, Jagadeesh; Tchilian, Elma Z.; Vani, Janakiraman; Shaila, Melkote S.; Forbes, Emily K.; Draper, Simon J.; Beverley, Peter C. L.; Tough, David F.; Flower, Darren R.			Toward the Discovery of Vaccine Adjuvants: Coupling In Silico Screening and In Vitro Analysis of Antagonist Binding to Human and Mouse CCR4 Receptors	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; CONFORMATIONAL-CHANGES; CHEMOKINE RECEPTORS; CRYSTAL-STRUCTURE; HOMOLOGY MODELS; LIGAND-BINDING; DRUG DISCOVERY; SMALL-MOLECULE; PROTEIN	Background: Adjuvants enhance or modify an immune response that is made to an antigen. An antagonist of the chemokine CCR4 receptor can display adjuvant-like properties by diminishing the ability of CD4+CD25+ regulatory T cells (Tregs) to down-regulate immune responses. Methodology: Here, we have used protein modelling to create a plausible chemokine receptor model with the aim of using virtual screening to identify potential small molecule chemokine antagonists. A combination of homology modelling and molecular docking was used to create a model of the CCR4 receptor in order to investigate potential lead compounds that display antagonistic properties. Three-dimensional structure-based virtual screening of the CCR4 receptor identified 116 small molecules that were calculated to have a high affinity for the receptor; these were tested experimentally for CCR4 antagonism. Fifteen of these small molecules were shown to inhibit specifically CCR4-mediated cellmigration, including that of CCR4(+) Tregs. Significance: Our CCR4 antagonists act as adjuvants augmenting human T cell proliferation in an in vitro immune response model and compound SP50 increases T cell and antibody responses in vivo when combined with vaccine antigens of Mycobacterium tuberculosis and Plasmodium yoelii in mice.	[Davies, Matthew N.; Bayry, Jagadeesh; Tough, David F.; Flower, Darren R.] Univ Oxford, Jenner Inst, Newbury, Berks, England; [Bayry, Jagadeesh; Vani, Janakiraman] Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers,Unite Mixte Rech Sante 872,U8, Paris, France; [Shaila, Melkote S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Forbes, Emily K.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; University of Oxford; Jenner Institute	Davies, MN (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	darren.flower@jenner.ac.uk	Draper, Simon J/F-1758-2011; J, Vani/B-4882-2013; Flower, Darren/F-1263-2010; Tchilian, Elma Z/Q-5976-2017; Bayry, Jagadeesh/A-6589-2011	Draper, Simon J/0000-0002-9415-1357; Flower, Darren/0000-0002-8542-7067; Tchilian, Elma Z/0000-0002-4869-5118; Bayry, Jagadeesh/0000-0003-0498-9808; Beverley, Peter/0000-0003-0481-2180	Edward Jenner Institute for Vaccine Research; Medical Research Council; Biotechnology and Biological Sciences Research Council; Department of Health; GlaxoSmithKline; Wellcome Trust [WT079287MA]	Edward Jenner Institute for Vaccine Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Health; GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome Trust)	This work was core funded by the Edward Jenner Institute for Vaccine Research. The Edward Jenner Institute for Vaccine Research thanks its erstwhile sponsors: the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Department of Health, and GlaxoSmithKline. PCLB and DRF received salary support from Senior Jenner Fellowships, and are both Jenner Institute Investigators. DRF drew additional support from the Wellcome Trust Grant WT079287MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2004, BIOORG MED CHEM LETT, V14, P1619, DOI 10.1016/j.bmcl.2004.01.072; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bayry J, 2008, P NATL ACAD SCI USA, V105, P10221, DOI 10.1073/pnas.0803453105; Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; Bayry J, 2008, NAT REV MICROBIOL, V6, DOI 10.1038/nrmicro1681-c1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bissantz C, 2005, PROTEINS, V61, P938, DOI 10.1002/prot.20651; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Bissantz C, 2003, J RECEPT SIG TRANSD, V23, P123, DOI 10.1081/RRS-120025192; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Byrne B, 2002, CURR OPIN STRUC BIOL, V12, P239, DOI 10.1016/S0959-440X(02)00316-0; CABANIOLS JP, 1994, EUR J IMMUNOL, V24, P1743, DOI 10.1002/eji.1830240804; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chen JZ, 2007, J CHEM INF MODEL, V47, P1626, DOI 10.1021/ci7000814; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l; Flower DR, 1998, J MOL GRAPH MODEL, V16, P239, DOI 10.1016/S1093-3263(98)80008-9; Gaulton A, 2003, CURR OPIN PHARMACOL, V3, P114, DOI 10.1016/S1471-4892(03)00005-5; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hattotuwagama CK, 2006, CURR MED CHEM, V13, P1283, DOI 10.2174/092986706776873005; Homer RW, 2008, J CHEM INF MODEL, V48, P2294, DOI 10.1021/ci7004687; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Katou F, 2001, AM J PATHOL, V158, P1263, DOI 10.1016/S0002-9440(10)64077-1; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.3.CO;2-P; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu SQ, 2007, J MOL MODEL, V13, P411, DOI 10.1007/s00894-006-0158-3; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Newhouse B, 2004, BIOORG MED CHEM LETT, V14, P5537, DOI 10.1016/j.bmcl.2004.09.001; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pandit SA, 2003, BIOPHYS J, V84, P3743, DOI 10.1016/S0006-3495(03)75102-9; Paterlini MG, 2002, BIOPHYS J, V83, P3012, DOI 10.1016/S0006-3495(02)75307-1; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Sadowski J, 1997, J COMPUT AID MOL DES, V11, P53, DOI 10.1023/A:1008023427310; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	60	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8084	10.1371/journal.pone.0008084	http://dx.doi.org/10.1371/journal.pone.0008084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	20011659	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000272828400025
J	Anwari, K; Poggio, S; Perry, A; Gatsos, X; Ramarathinam, SH; Williamson, NA; Noinaj, N; Buchanan, S; Gabriel, K; Purcell, AW; Jacobs-Wagner, C; Lithgow, T				Anwari, Khatira; Poggio, Sebastian; Perry, Andrew; Gatsos, Xenia; Ramarathinam, Sri Harsha; Williamson, Nicholas A.; Noinaj, Nicholas; Buchanan, Susan; Gabriel, Kipros; Purcell, Anthony W.; Jacobs-Wagner, Christine; Lithgow, Trevor			A Modular BAM Complex in the Outer Membrane of the alpha-Proteobacterium Caulobacter crescentus	PLOS ONE			English	Article							PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; BACTERIAL FLAGELLAR MOTOR; ESCHERICHIA-COLI; CELL-ENVELOPE; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; OMP85 FAMILY; YAET COMPLEX	Mitochondria are organelles derived from an intracellular alpha-proteobacterium. The biogenesis of mitochondria relies on the assembly of beta-barrel proteins into the mitochondrial outer membrane, a process inherited from the bacterial ancestor. Caulobacter crescentus is an alpha-proteobacterium, and the BAM (beta-barrel assembly machinery) complex was purified and characterized from this model organism. Like the mitochondrial sorting and assembly machinery complex, we find the BAM complex to be modular in nature. A similar to 150 kDa core BAM complex containing BamA, BamB, BamD, and BamE associates with additional modules in the outer membrane. One of these modules, Pal, is a lipoprotein that provides a means for anchorage to the peptidoglycan layer of the cell wall. We suggest the modular design of the BAM complex facilitates access to substrates from the protein translocase in the inner membrane.	[Anwari, Khatira; Perry, Andrew; Gabriel, Kipros; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Poggio, Sebastian; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Poggio, Sebastian; Jacobs-Wagner, Christine] Yale Univ, Microbial Pathogenesis Sect, New Haven, CT USA; [Gatsos, Xenia; Ramarathinam, Sri Harsha; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Noinaj, Nicholas; Buchanan, Susan] NIDDK, NIH, Bethesda, MD USA; [Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Monash University; Yale University; Yale University; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Yale University	Anwari, K (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	trevor.lithgow@med.monash.edu.au	Ramarathinam, Sri H/G-2278-2012; Purcell, Anthony/AAH-1942-2019; Lithgow, Trevor J/H-5925-2017; Perry, Andrew/E-5607-2010; Williamson, Nicholas A/O-9812-2016	Ramarathinam, Sri H/0000-0002-2787-1282; Purcell, Anthony/0000-0003-0532-8331; Lithgow, Trevor J/0000-0002-0102-7884; Perry, Andrew/0000-0001-9256-6068; Williamson, Nicholas A/0000-0002-2173-3452; Jacobs-Wagner, Christine/0000-0003-0980-5334; Poggio, Sebastian/0000-0001-9494-3365	National Health and Medical Research Council [508911]; ARC [LE0882913]; Monash University; Pew Latin American Fellowship; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [GM065835, GM076698]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076698, R01GM065835] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Monash University(Monash University); Pew Latin American Fellowship; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories is supported by grants from the National Health and Medical Research Council (508911; to AWP and TL), and an ARC Linkage Infrastructure Equipment and Facilities grant (LE0882913). KA is supported by a Monash University Research Scholarship; AP is supported by a National Health and Medical Research Council Training Fellowship; SP is supported by a Pew Latin American Fellowship. SB and NN are supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. The CJW laboratory is supported by the National Institutes of Health (GM065835 and GM076698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Costa T, 2008, MOL MICROBIOL, V70, P634, DOI 10.1111/j.1365-2958.2008.06432.x; DeRosier DJ, 1998, CELL, V93, P17, DOI 10.1016/S0092-8674(00)81141-1; Emelyanov VV, 2003, ARCH BIOCHEM BIOPHYS, V420, P130, DOI 10.1016/j.abb.2003.09.031; Fardini Y, 2007, INFECT IMMUN, V75, P358, DOI 10.1128/IAI.00716-06; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hizukuri Y, 2009, J BIOCHEM, V146, P219, DOI 10.1093/jb/mvp061; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Jensen GJ, 2007, CURR OPIN STRUC BIOL, V17, P260, DOI 10.1016/j.sbi.2007.03.002; Judd EM, 2005, J BACTERIOL, V187, P6874, DOI 10.1128/JB.187.20.6874-6882.2005; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lewis C, 2008, MICROBIOL-SGM, V154, P979, DOI 10.1099/mic.0.2007/011999-0; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; MIZUNO T, 1981, J BIOCHEM-TOKYO, V89, P1059; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Popov-Celeketic J, 2008, J MOL BIOL, V376, P671, DOI 10.1016/j.jmb.2007.12.006; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Soo PC, 2005, INFECT IMMUN, V73, P6075, DOI 10.1128/IAI.73.9.6075-6084.2005; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	64	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8619	10.1371/journal.pone.0008619	http://dx.doi.org/10.1371/journal.pone.0008619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062535	Green Published, gold, Green Submitted			2022-12-27	WOS:000273414200010
J	Boles, NC; Peddibhotla, S; Chen, AJ; Goodell, MA; Rosen, JM				Boles, Nathan C.; Peddibhotla, Sirisha; Chen, Alice J.; Goodell, Margaret A.; Rosen, Jeffrey M.			Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; KINASE; DIFFERENTIATION; ENUCLEATION; ACTIVATION; MATURATION; INSIGHTS; GENES	Background: Erythropoiesis is a highly regulated and well-characterized developmental process responsible for providing the oxygen transport system of the body. However, few of the mechanisms involved in this process have been elucidated. Checkpoint Kinase 1 (Chk1) is best known for its role in the cell cycle and DNA damage pathways, and it has been shown to play a part in several pathways which when disrupted can lead to anemia. Methodology/Principal Findings: Here, we show that haploinsufficiency of Chk1 results in 30% of mice developing anemia within the first year of life. The anemic Chk1+/- mice exhibit distorted spleen and bone marrow architecture, and abnormal erythroid progenitors. Furthermore, Chk1+/- erythroid progenitors exhibit an increase in spontaneous DNA damage foci and improper contractile actin ring formation resulting in aberrant enucleation during erythropoiesis. A decrease in Chk1 RNA has also been observed in patients with refractory anemia with excess blasts, further supporting a role for Chk1 in clinical anemia. Conclusions/Significance: Clinical trials of Chk1 inhibitors are currently underway to treat cancer, and thus it will be important to track the effects of these drugs on red blood cell development over an extended period. Our results support a role for Chk1 in maintaining the balance between erythroid progenitors and enucleated erythroid cells during differentiation. We show disruptions in Chk1 levels can lead to anemia.	[Boles, Nathan C.; Peddibhotla, Sirisha] Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA; [Chen, Alice J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Boles, NC (corresponding author), Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA.	goodell@bcm.edu; jrosen@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	National Institutes of Health [CA16303(JMR), DK58192 (MAG), HL08100 (MAG)]; Department of Defense Biomedical Research Commercialization Program [W81XWH-06-1-0305]; Ellison foundation [AGSS178706]; NATIONAL CANCER INSTITUTE [R01CA016303, R37CA016303, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Biomedical Research Commercialization Program; Ellison foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health CA16303(JMR), DK58192 (MAG), HL08100 (MAG), Department of Defense Biomedical Research Commercialization Program W81XWH-06-1-0305 (SP), and the Ellison foundation (AGSS178706 to MAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; CHALLEN G, 2008, CYTOMETRY IN PRESS; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kruse A, 2008, CONTRIB NEPHROL, V161, P247, DOI 10.1159/000130698; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; PEDDIBHOTLA S, 2009, CELL CYCLE IN PRESS; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Peller S, 2003, ONCOGENE, V22, P4648, DOI 10.1038/sj.onc.1206541; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Shimada M, 2008, CELL CYCLE, V7, P1555, DOI 10.4161/cc.7.11.6062; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Takagaki K, 2005, GENES CELLS, V10, P97, DOI 10.1111/j.1365-2443.2005.00821.x; TakanoOhmuro H, 1996, CELL MOTIL CYTOSKEL, V34, P95, DOI 10.1002/(SICI)1097-0169(1996)34:2<95::AID-CM2>3.0.CO;2-H; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	37	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8581	10.1371/journal.pone.0008581	http://dx.doi.org/10.1371/journal.pone.0008581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052416	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338500023
J	Friswell, MK; Gika, H; Stratford, IJ; Theodoridis, G; Telfer, B; Wilson, ID; McBain, AJ				Friswell, Melissa K.; Gika, Helen; Stratford, Ian J.; Theodoridis, Georgios; Telfer, Brian; Wilson, Ian D.; McBain, Andrew J.			Site and Strain-Specific Variation in Gut Microbiota Profiles and Metabolism in Experimental Mice	PLOS ONE			English	Article							REAL-TIME PCR; ANTIBIOTIC-INDUCED ALTERATIONS; HUMAN INTESTINAL MICROBIOTA; FECAL MICROBIOTA; GASTROINTESTINAL-TRACT; HOST GENETICS; MICROFLORA; COMMENSAL; BACTERIA; DISEASE	Background: The gastrointestinal tract microbiota (GTM) of mammals is a complex microbial consortium, the composition and activities of which influences mucosal development, immunity, nutrition and drug metabolism. It remains unclear whether the composition of the dominant GTM is conserved within animals of the same strain and whether stable GTMs are selected for by host-specific factors or dictated by environmental variables. Methodology/Principal Findings: The GTM composition of six highly inbred, genetically distinct strains of mouse (C3H, C57, GFEC, CD1, CBA nu/nu and SCID) was profiled using eubacterial -specific PCR-DGGE and quantitative PCR of feces. Animals exhibited strain-specific fecal eubacterial profiles that were highly stable (c. >95% concordance over 26 months for C57). Analyses of mice that had been relocated before and after maturity indicated marked, reproducible changes in fecal consortia and that occurred only in young animals. Implantation of a female BDF1 mouse with genetically distinct (C57 and Agoutie) embryos produced highly similar GTM profiles (c. 95% concordance) between mother and offspring, regardless of offspring strain, which was also reflected in urinary metabolite profiles. Marked institution-specific GTM profiles were apparent in C3H mice raised in two different research institutions. Conclusion/Significance: Strain-specific data were suggestive of genetic determination of the composition and activities of intestinal symbiotic consortia. However, relocation studies and uterine implantation demonstrated the dominance of environmental influences on the GTM. This was manifested in large variations between isogenic adult mice reared in different research institutions.	[Friswell, Melissa K.; McBain, Andrew J.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Microbiol Res Grp, Manchester, Lancs, England; [Stratford, Ian J.; Telfer, Brian] Univ Manchester, Sch Pharm & Pharmaceut Sci, Expt Oncol Res Grp, Manchester, Lancs, England; [Gika, Helen; Theodoridis, Georgios; Wilson, Ian D.] AstraZeneca, Dept Clin Pharmacol, Macclesfield, Cheshire, England; [Gika, Helen; Theodoridis, Georgios] Aristotle Univ Thessaloniki, Dept Chem, GR-54006 Thessaloniki, Greece	University of Manchester; University of Manchester; AstraZeneca; Aristotle University of Thessaloniki	Friswell, MK (corresponding author), Univ Manchester, Sch Pharm & Pharmaceut Sci, Microbiol Res Grp, Manchester, Lancs, England.	andrew.mcbain@manchester.ac.uk	Wilson, Ian David/ABG-4451-2021; Wilson, Ian/Z-3019-2019; Theodoridis, Georgios/B-6676-2012; Gika, Helen/I-3638-2012	Theodoridis, Georgios/0000-0002-2015-108X; Gika, Helen/0000-0002-1893-937X; Wilson, Ian/0000-0002-8558-7394; Telfer, Brian/0000-0003-1857-5120; stratford, ian/0000-0002-5222-4765; McBain, Andrew/0000-0002-5255-5425	MRC programme [G0500366]; Medical Research Council [G0500366] Funding Source: researchfish; MRC [G0500366] Funding Source: UKRI	MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partially funded by an MRC programme grant (G0500366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca contributed by performing the urinary analyses.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Cash HL, 2005, ASM NEWS, V71, P77; Clayton TA, 2007, ARCH TOXICOL, V81, P201, DOI 10.1007/s00204-006-0136-7; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Fushuku S, 2008, EXP ANIM TOKYO, V57, P489, DOI 10.1538/expanim.57.489; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Jernberg C, 2005, APPL ENVIRON MICROB, V71, P501, DOI 10.1128/AEM.71.1.501-506.2005; Kelly D, 2005, MOL IMMUNOL, V42, P895, DOI 10.1016/j.molimm.2004.12.003; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Nyhlen A, 2002, SCAND J INFECT DIS, V34, P17, DOI 10.1080/00365540110076994; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Phipps AN, 1998, XENOBIOTICA, V28, P527, DOI 10.1080/004982598239443; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; SPEAR PG, 1974, J EXP MED, V139, P249, DOI 10.1084/jem.139.2.249; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VANDERWAAIJ D, 1984, A VAN LEEUW J MICROB, V50, P745, DOI 10.1007/BF02386238; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wilson ID, 2009, CURR PHARM DESIGN, V15, P1519, DOI 10.2174/138161209788168173; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	47	156	163	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8584	10.1371/journal.pone.0008584	http://dx.doi.org/10.1371/journal.pone.0008584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052418	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500026
J	Johnson, AC; Myers, B; Lazovic, J; Towner, R; Greenwood-Van Meerveld, B				Johnson, Anthony C.; Myers, Brent; Lazovic, Jelena; Towner, Rheal; Greenwood-Van Meerveld, Beverley			Brain Activation in Response to Visceral Stimulation in Rats with Amygdala Implants of Corticosterone: An fMRI Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; C-FOS EXPRESSION; THERAPEUTIC IMPLICATIONS; COLORECTAL DISTENSION; MOLECULAR-MECHANISMS; SPINAL-CORD; RECTAL PAIN; PATHOBIOLOGY; TRANSMISSION; PROJECTIONS	Background: Although visceral pain of gastrointestinal (GI) origin is the major complaint in patients with irritable bowel syndrome (IBS) it remains poorly understood. Brain imaging studies suggest a defect in brain-gut communication in IBS with a greater activation of central arousal circuits including the amygdala. Previously, we found that stereotaxic implantation of corticosterone (CORT) onto the amygdala in rats induced anxiety and colonic hypersensitivity. In the present study we used functional magnetic resonance imaging (fMRI) to identify specific brain sites activated in a rat model characterized by anxiety and colonic hypersensitivity. Methodology/Principal Findings: Anesthetized male rats received micropellets (30 mu g each) of either CORT or cholesterol (CHOL), to serve as a control, implanted stereotaxically on the dorsal margin of each amygdala. Seven days later, rats were anesthetized and placed in the fMRI magnet (7T). A series of isobaric colorectal balloon distensions (CRD - 90s 'off', 30s 'on', 8 replicates) at two pressures (40 and 60 mmHg) were performed in a standard block-design. Cross correlation statistical analysis was used to determine significant differences between distended and non-distended states in CORT and CHOL-treated animals. Analysis of the imaging data demonstrated greater overall brain activation in response to CRD in rats with CORT implants compared to CHOL controls. Additionally, CORT implants produced significant positive bilateral increases in MRI signal in response to CRD in specific nuclei known as integration sites important in anxiety and pain perception. Conclusions and Significance: These data indicate that chronic exposure of the amygdala to elevated levels of CORT enhances overall brain activation in response to CRD, and identified other specific brain regions activated in response to mechanical distension of the colon. These results demonstrate the feasibility of performing fMRI imaging in a rodent model that supports clinical observations in IBS patients with enhanced amygdala activation and symptomatology of abdominal pain and anxiety.	[Greenwood-Van Meerveld, Beverley] Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Johnson, Anthony C.; Myers, Brent; Greenwood-Van Meerveld, Beverley] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Lazovic, Jelena] CALTECH, Div Biol, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Towner, Rheal] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Oklahoma System; University of Oklahoma Health Sciences Center; California Institute of Technology; Oklahoma Medical Research Foundation	Johnson, AC (corresponding author), Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA.	Beverley-Greenwood@ouhsc.edu	Johnson, Anthony C/J-1775-2012; Lazovic Zinnanti, Jelena/HGD-8286-2022; Johnson, Anthony C./R-7175-2019	Johnson, Anthony C/0000-0002-0939-6027; Lazovic Zinnanti, Jelena/0000-0001-7646-6104; Johnson, Anthony C./0000-0002-0939-6027; Towner, Rheal/0000-0001-7368-8983	Oklahoma Center for Neuroscience at the University of Oklahoma Health Sciences Center; Veterans Affairs [I01BX002188] Funding Source: NIH RePORTER	Oklahoma Center for Neuroscience at the University of Oklahoma Health Sciences Center; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by the Oklahoma Center for Neuroscience at the University of Oklahoma Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 1998, HEPATO-GASTROENTEROL, V45, P1559; AGARWAL MK, 1993, NEUROENDOCRINOLOGY, V58, P575, DOI 10.1159/000126593; Baklavadzhyan O G, 2000, Neurosci Behav Physiol, V30, P231, DOI 10.1007/BF02463163; BEAULIEU S, 1989, NEUROENDOCRINOLOGY, V49, P255, DOI 10.1159/000125125; Bonaz B, 2002, AM J GASTROENTEROL, V97, P654; BOUGHTONSMITH NK, 1988, BRIT J PHARMACOL, V94, P65, DOI 10.1111/j.1476-5381.1988.tb11500.x; DEFIORE CH, 1983, BRAIN RES, V278, P93, DOI 10.1016/0006-8993(83)90227-5; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DIORIO D, 1993, J NEUROSCI, V13, P3839; Febo M, 2005, J NEUROSCI, V25, P11637, DOI 10.1523/JNEUROSCI.3604-05.2005; Febo M, 2008, HORM BEHAV, V54, P330, DOI 10.1016/j.yhbeh.2008.02.024; Feldman S, 1998, BRAIN RES BULL, V45, P389, DOI 10.1016/S0361-9230(97)00384-5; Ferris CF, 2006, J NEUROENDOCRINOL, V18, P307, DOI 10.1111/j.1365-2826.2006.01424.x; Forss N, 2005, NEUROIMAGE, V24, P132, DOI 10.1016/j.neuroimage.2004.09.032; Garakani Amir, 2003, Am J Ther, V10, P61, DOI 10.1097/00045391-200301000-00014; Gebhart GF, 2000, AM J PHYSIOL-GASTR L, V278, pG834, DOI 10.1152/ajpgi.2000.278.6.G834; GREENWOOD B, 1990, BRAIN RES, V520, P192, DOI 10.1016/0006-8993(90)91705-L; Greenwood-Van Meerveld B, 2001, BRAIN RES, V893, P135, DOI 10.1016/S0006-8993(00)03305-9; Grundy D, 2004, GUT, V53, P5, DOI 10.1136/gut.2003.033415; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; HOLSTEGE G, 1987, J COMP NEUROL, V260, P98, DOI 10.1002/cne.902600109; Ji YP, 2007, J PAIN, V8, P494, DOI 10.1016/j.jpain.2007.01.006; Jones MP, 2006, NEUROGASTROENT MOTIL, V18, P91, DOI 10.1111/j.1365-2982.2005.00730.x; Kern MK, 2001, AM J PHYSIOL-GASTR L, V281, pG1512, DOI 10.1152/ajpgi.2001.281.6.G1512; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; Ladabaum U, 2000, AM J PHYSIOL-GASTR L, V279, pG1, DOI 10.1152/ajpgi.2000.279.1.G1; Lazovic J, 2005, NEUROGASTROENT MOTIL, V17, P548, DOI 10.1111/j.1365-2982.2005.00655.x; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; May A, 2007, NEUROL SCI, V28, pS101, DOI 10.1007/s10072-007-0760-x; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; MAYER EA, 2000, GUT S4, V47, P869; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; Monnikes H, 2003, BRAIN RES, V966, P253, DOI 10.1016/S0006-8993(02)04197-5; Moshiree B, 2006, GUT, V55, P905, DOI 10.1136/gut.2005.078287; Myers B, 2007, AM J PHYSIOL-GASTR L, V292, pG1622, DOI 10.1152/ajpgi.00080.2007; Naliboff BD, 2003, GASTROENTEROLOGY, V124, P1738, DOI 10.1016/S0016-5085(03)00400-1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Shepard JD, 2003, BRAIN RES, V963, P203, DOI 10.1016/S0006-8993(02)03978-1; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Traub RJ, 1996, NEUROSCI LETT, V215, P165, DOI 10.1016/S0304-3940(96)12978-5; TRAUB RJ, 1992, PAIN, V49, P393, DOI 10.1016/0304-3959(92)90247-9; Travagli RA, 2001, AM J PHYSIOL-GASTR L, V281, pG595, DOI 10.1152/ajpgi.2001.281.3.G595; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Wang J, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-28; Wang Z, 2008, PAIN, V138, P233, DOI 10.1016/j.pain.2008.04.018; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P1187, DOI 10.1016/0016-5085(90)90332-U; WHITEHEAD WE, 1992, GUT, V33, P825, DOI 10.1136/gut.33.6.825; Wilder-Smith CH, 2004, GUT, V53, P1595, DOI 10.1136/gut.2003.028514; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675; Wood JD, 2007, WORLD J GASTROENTERO, V13, P1313, DOI 10.3748/wjg.v13.i9.1313; ZHUO M, 1992, J NEUROPHYSIOL, V67, P1599, DOI 10.1152/jn.1992.67.6.1599	55	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8573	10.1371/journal.pone.0008573	http://dx.doi.org/10.1371/journal.pone.0008573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052291	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000273338500016
J	Day, A; Dong, J; Funari, VA; Harry, B; Strom, SP; Cohn, DH; Nelson, SF				Day, Allen; Dong, Jun; Funari, Vincent A.; Harry, Bret; Strom, Samuel P.; Cohn, Dan H.; Nelson, Stanley F.			Disease Gene Characterization through Large-Scale Co-Expression Analysis	PLOS ONE			English	Article							JOUBERT-SYNDROME; CENTROSOMAL PROTEIN; CANDIDATE GENES; RENAL SYNDROME; HUMAN TISSUES; AHI1 GENE; MUTATIONS; EXPRESSION; PRIORITIZATION; IDENTIFICATION	Background: In the post genome era, a major goal of biology is the identification of specific roles for individual genes. We report a new genomic tool for gene characterization, the UCLA Gene Expression Tool (UGET). Results: Celsius, the largest co-normalized microarray dataset of Affymetrix based gene expression, was used to calculate the correlation between all possible gene pairs on all platforms, and generate stored indexes in a web searchable format. The size of Celsius makes UGET a powerful gene characterization tool. Using a small seed list of known cartilage-selective genes, UGET extended the list of known genes by identifying 32 new highly cartilage-selective genes. Of these, 7 of 10 tested were validated by qPCR including the novel cartilage-specific genes SDK2 and FLJ41170. In addition, we retrospectively tested UGET and other gene expression based prioritization tools to identify disease-causing genes within known linkage intervals. We first demonstrated this utility with UGET using genetically heterogeneous disorders such as Joubert syndrome, microcephaly, neuropsychiatric disorders and type 2 limb girdle muscular dystrophy (LGMD2) and then compared UGET to other gene expression based prioritization programs which use small but discrete and well annotated datasets. Finally, we observed a significantly higher gene correlation shared between genes in disease networks associated with similar complex or Mendelian disorders. Discussion: UGET is an invaluable resource for a geneticist that permits the rapid inclusion of expression criteria from one to hundreds of genes in genomic intervals linked to disease. By using thousands of arrays UGET annotates and prioritizes genes better than other tools especially with rare tissue disorders or complex multi-tissue biological processes. This information can be critical in prioritization of candidate genes for sequence analysis.	[Day, Allen; Dong, Jun; Harry, Bret; Strom, Samuel P.; Cohn, Dan H.; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Inst Mol Biol, Los Angeles, CA 90095 USA; [Funari, Vincent A.; Cohn, Dan H.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent A.; Cohn, Dan H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Day, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Inst Mol Biol, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Strom, Samuel/C-8692-2014; Nelson, Stanley F/D-4771-2009	Strom, Samuel/0000-0003-3254-7564; Nelson, Stanley F/0000-0002-2082-3114	National Institute of Neurological Disorders and Stroke (NINDS) [U24NS052108]; National Institutes of Health Neuroscience Microarray Consortium [HD22657]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS052108] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) U24NS052108 that supports the National Institutes of Health Neuroscience Microarray Consortium and HD22657 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brzustowicz Linda M, 2008, Curr Psychiatry Rep, V10, P158, DOI 10.1007/s11920-008-0027-0; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; CARROLL L, 2009, MOL PSYCHIAT; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Hans M, 1999, J NEUROSCI, V19, P1610; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Kobayashi N, 2008, BIOINFORMATICS, V24, P1002, DOI 10.1093/bioinformatics/btn054; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MAESTRINI E, 2009, MOL PSYCHIAT; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ritvo E R, 1991, J Child Psychol Psychiatry, V32, P1031, DOI 10.1111/j.1469-7610.1991.tb01928.x; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Rossi S, 2006, NUCLEIC ACIDS RES, V34, pW285, DOI 10.1093/nar/gkl340; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Spellman PT, 2002, GENOME BIOL, V3; Steinhauser D, 2004, BIOINFORMATICS, V20, P3647, DOI 10.1093/bioinformatics/bth398; Steinhauser D, 2004, BIOINFORMATICS, V20, P1928, DOI 10.1093/bioinformatics/bth182; Stopkova P, 2004, PSYCHIAT RES, V127, P157, DOI 10.1016/j.psychres.2004.03.003; STROM S, 2009, MOL PSYCHIAT; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thornblad TA, 2007, TWIN RES HUM GENET, V10, P861, DOI 10.1375/twin.10.6.861; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Wang Y, 2008, BRIT J CANCER, V98, P1023, DOI 10.1038/sj.bjc.6604207; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005; Wilson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-419; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	70	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8491	10.1371/journal.pone.0008491	http://dx.doi.org/10.1371/journal.pone.0008491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046828	Green Published, gold, Green Submitted			2022-12-27	WOS:000273180200005
J	Iijima, K; Zhao, LJ; Shenton, C; Iijima-Ando, K				Iijima, Koichi; Zhao, LiJuan; Shenton, Christopher; Iijima-Ando, Kanae			Regulation of Energy Stores and Feeding by Neuronal and Peripheral CREB Activity in Drosophila	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; MALE COURTSHIP BEHAVIOR; RESPONSE ELEMENT; GENE-EXPRESSION; FAT-BODY; ADIPOKINETIC HORMONE; CIRCADIAN-RHYTHMS; STRESS RESISTANCE; TAKEOUT GENE	The cAMP-responsive transcription factor CREB functions in adipose tissue and liver to regulate glycogen and lipid metabolism in mammals. While Drosophila has a homolog of mammalian CREB, dCREB2, its role in energy metabolism is not fully understood. Using tissue-specific expression of a dominant-negative form of CREB (DN-CREB), we have examined the effect of blocking CREB activity in neurons and in the fat body, the primary energy storage depot with functions of adipose tissue and the liver in flies, on energy balance, stress resistance and feeding behavior. We found that disruption of CREB function in neurons reduced glycogen and lipid stores and increased sensitivity to starvation. Expression of DN-CREB in the fat body also reduced glycogen levels, while it did not affect starvation sensitivity, presumably due to increased lipid levels in these flies. Interestingly, blocking CREB activity in the fat body increased food intake. These flies did not show a significant change in overall body size, suggesting that disruption of CREB activity in the fat body caused an obese-like phenotype. Using a transgenic CRE-luciferase reporter, we further demonstrated that disruption of the adipokinetic hormone receptor, which is functionally related to mammalian glucagon and p-adrenergic signaling, in the fat body reduced CRE-mediated transcription in flies. This study demonstrates that CREB activity in either neuronal or peripheral tissues regulates energy balance in Drosophila, and that the key signaling pathway regulating CREB activity in peripheral tissue is evolutionarily conserved.	[Iijima, Koichi; Zhao, LiJuan] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Lab Neurodegenerat & Metab Dis, Philadelphia, PA 19107 USA; [Shenton, Christopher; Iijima-Ando, Kanae] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iijima, K (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Lab Neurodegenerat & Metab Dis, Philadelphia, PA 19107 USA.	koichi.iijima@jefferson.edu; kanae.iijima-ando@jefferson.edu			Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association [NIRG-08-91985]; National Institutes of Health [R01AG032279]; NATIONAL INSTITUTE ON AGING [R01AG032279] Funding Source: NIH RePORTER	Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by start-up funds from the Farber Institute for Neurosciences. K. I. is supported by a pilot research grant from the Thomas Jefferson University, and grants from Gilbert Foundation/the American Federation for Aging Research (http://www.afar.org/), the Alzheimer's Association (NIRG-08-91985)(http://www.alz.org/index.asp). K. I. and K. I.-A. are supported by the National Institutes of Health (R01AG032279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cheong J, 1998, J BIOL CHEM, V273, P22714, DOI 10.1074/jbc.273.35.22714; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Iijima-Ando K, 2005, METHOD ENZYMOL, V393, P302, DOI 10.1016/S0076-6879(05)93013-9; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LEE MJ, 1995, ANAL BIOCHEM, V228, P155, DOI 10.1006/abio.1995.1327; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LONDOS C, 1985, J BIOL CHEM, V260, P5139; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lorenz MW, 2001, ARCH INSECT BIOCHEM, V47, P198, DOI 10.1002/arch.1052; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	53	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8498	10.1371/journal.pone.0008498	http://dx.doi.org/10.1371/journal.pone.0008498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041126	gold, Green Submitted, Green Published			2022-12-27	WOS:000278068700013
J	Richmond, TK; Subramanian, SV				Richmond, Tracy K.; Subramanian, S. V.			School Variation in Asthma: Compositional or Contextual?	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; SOCIOECONOMIC-STATUS; ENVIRONMENTAL ALLERGENS; CHILDHOOD ASTHMA; PREVALENCE; CHILDREN; DISPARITIES; RISK; ASSOCIATIONS; COMMUNITIES	Background:Childhood asthma prevalence and morbidity have been shown to vary by neighborhood. Less is known about between-school variation in asthma prevalence and whether it exists beyond what one might expect due to students at higher risk of asthma clustering within different schools. Our objective was to determine whether between-school variation in asthma prevalence exists and if so, if it is related to the differential distribution of individual risk factors for and correlates of asthma or to contextual influences of schools. Methods: Cross-sectional analysis of 16,640 teens in grades 7-12 in Wave 1 (data collected in 1994-5) of the National Longitudinal Study of Adolescent Health. Outcome was current diagnosis of asthma as reported by respondents' parents. Two-level random effects models were used to assess the contribution of schools to the variance in asthma prevalence before and after controlling for individual attributes. Results:The highest quartile schools had mean asthma prevalence of 21.9% compared to the lowest quartile schools with mean asthma prevalence of 7.1%. In our null model, the school contributed significantly to the variance in asthma (sigma(2)(u0) = 0.27, CI: 0.20, 0.35). Controlling for individual, school and neighborhood attributes reduced the between-school variance modestly (sigma(2)(u0) = 0.19 CI: 0.13-0.29). Conclusion: Significant between-school variation in current asthma prevalence exists even after controlling for the individual, school and neighborhood factors. This provides evidence for school level contextual influences on asthma. Further research is needed to determine potential mechanisms through which schools may influence asthma outcomes.	[Richmond, Tracy K.] Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth SVS, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Richmond, TK (corresponding author), Childrens Hosp, Div Adolescent Med, 300 Longwood Ave, Boston, MA 02115 USA.	tracy.richmond@childrens.harvard.edu			Charles H. Hood Foundation Child Health Research Award; National Institutes of Health Career Development Award [IK01HD058042-01A1, NHLBI 1 K25 HL081275]; Maternal and Child Health Leadership Education in Adolescent Health Training Program; National Institute of Child Health and Human Development [P0I-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, K01HD058042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Charles H. Hood Foundation Child Health Research Award; National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maternal and Child Health Leadership Education in Adolescent Health Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Tracy Richmond was supported by the Charles H. Hood Foundation Child Health Research Award, the National Institutes of Health Career Development Award (IK01HD058042-01A1), and the Maternal and Child Health Leadership Education in Adolescent Health Training Program. S V Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI 1 K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research uses data from the Add Health project, a program designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullen Harris, and funded by a grant P0I-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 (addhealth@unc.edu).	Abramson SL, 2006, J SCHOOL HEALTH, V76, P246, DOI 10.1111/j.1746-1561.2006.00105.x; Akinbami LJ, 2005, PEDIATRICS, V115, P1254, DOI 10.1542/peds.2004-0897; Aligne CA, 2000, AM J RESP CRIT CARE, V162, P873; Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Amr S, 2003, ANN ALLERG ASTHMA IM, V90, P34, DOI 10.1016/S1081-1206(10)63611-3; Aveyard P, 2004, SOC SCI MED, V58, P2253, DOI 10.1016/j.socscimed.2003.08.012; Basagana X, 2004, AM J EPIDEMIOL, V160, P178, DOI 10.1093/aje/kwh186; BATTISTICH V, 1995, AM EDUC RES J, V32, P627, DOI 10.3102/00028312032003627; Blakely T, 2006, METHODS SOCIAL EPIDE; BLOOM B, 2005, VITAL HLTH STAT  DEC, P1; Cagney KA, 2004, J GEN INTERN MED, V19, P229, DOI 10.1111/j.1525-1497.2004.30359.x; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chew GL, 2005, INDOOR AIR, V15, P228, DOI 10.1111/j.1600-0668.2005.00363.x; Claudio L, 2006, ANN EPIDEMIOL, V16, P332, DOI 10.1016/j.annepidem.2005.06.046; GEORGE R, 2000, HIGH, V0084; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Goodman E, 2003, J PEDIATR-US, V143, P451, DOI 10.1067/S0022-3476(03)00456-6; Juhn YJ, 2005, SOC SCI MED, V60, P2453, DOI 10.1016/j.socscimed.2004.11.034; Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; King G., 1998, ANN M AM POL SCI ASS; Kumar Revathy, 2002, Prev Sci, V3, P105, DOI 10.1023/A:1015431300471; LEE VE, 1989, SOCIOL EDUC, V62, P172, DOI 10.2307/2112866; LITONJUA AA, 1999, PEDIAT PULMONOL, V28, P294; Maes L, 2003, SOC SCI MED, V56, P517, DOI 10.1016/S0277-9536(02)00052-7; McDaniel M, 2006, PEDIATRICS, V117, pE868, DOI 10.1542/peds.2005-1721; Moore L, 2001, TOB CONTROL, V10, P117, DOI 10.1136/tc.10.2.117; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention, 1998, MMWR RECOMMENDATIONS, V47, P1; Quinn K, 2006, AM J PUBLIC HEALTH, V96, P1599, DOI 10.2105/AJPH.2005.071514; RABEHESKETH S, 2005, MULTILIVEL LONGITUDI; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Rauh VA, 2002, ENVIRON HEALTH PERSP, V110, P323, DOI 10.1289/ehp.02110s2323; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Saha C, 2005, ARCH PEDIAT ADOL MED, V159, P759, DOI 10.1001/archpedi.159.8.759; Salmond C, 1999, J EPIDEMIOL COMMUN H, V53, P476, DOI 10.1136/jech.53.8.476; Santilli J, 2003, ANN ALLERG ASTHMA IM, V90, P203, DOI 10.1016/S1081-1206(10)62142-4; Savilahti R, 2001, ALLERGY, V56, P175, DOI 10.1034/j.1398-9995.2001.056002175.x; Schwartz J, 2004, PEDIATRICS, V113, P1037; SELLSTROM E, 2005, J EPIDEMIOL COMMUNIT, V60, P139; Shanawani H, 2006, CLIN CHEST MED, V27, P17, DOI 10.1016/j.ccm.2005.11.002; Shankardass K, 2007, SOC SCI MED, V65, P1792, DOI 10.1016/j.socscimed.2007.05.048; Smedje G, 2001, INT J TUBERC LUNG D, V5, P1059; *STATACORP, STAT STAT SOFTW; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; STRUNK RC, 1985, JAMA-J AM MED ASSOC, V254, P1193; Subramanian S. V., 2003, Neighborhoods and health, P65; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Swahn MH, 2006, AM J PUBLIC HEALTH, V96, P802, DOI 10.2105/AJPH.2005.066514; Tortolero SR, 2002, J SCHOOL HEALTH, V72, P33, DOI 10.1111/j.1746-1561.2002.tb06509.x; Tranter DC, 2005, CLIN EXP ALLERGY, V35, P126, DOI 10.1111/j.1365-2222.2005.02149.x; TURYK M, 2007, PEDIAT ALLERGY IMMUN, P1; *US BUR CENS, 1995, CURR POP SURV; *US GEN ACC OFF, 1996, SCH FAC AM SCH REP; Vig RS, 2006, ANN NY ACAD SCI, V1088, P65, DOI 10.1196/annals.1366.023; Watson JP, 1996, EUR RESPIR J, V9, P2087, DOI 10.1183/09031936.96.09102087; Weil CM, 1999, PEDIATRICS, V104, P1274, DOI 10.1542/peds.104.6.1274; Wilcox P, 2001, JUSTICE Q, V18, P509, DOI 10.1080/07418820100095001; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wright RJ, 2001, ENVIRON HEALTH PERSP, V109, P1085, DOI 10.2307/3454965; Wright RJ, 2006, CLIN CHEST MED, V27, P413, DOI 10.1016/j.ccm.2006.04.003; 2003, ADD HLTH RES DESIGN, V1; 2003, ADD HLTH RES DESIGN, V3; 2003, ADD HLTH RES DESIGN, V2	65	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8512	10.1371/journal.pone.0008512	http://dx.doi.org/10.1371/journal.pone.0008512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041121	Green Published, Green Submitted, gold			2022-12-27	WOS:000278068700023
J	Su, B; Wurtzer, S; Rameix-Welti, MA; Dwyer, D; van der Werf, S; Naffakh, N; Clavel, F; Labrosse, B				Su, Bin; Wurtzer, Sebastien; Rameix-Welti, Marie-Anne; Dwyer, Dominic; van der Werf, Sylvie; Naffakh, Nadia; Clavel, Francois; Labrosse, Beatrice			Enhancement of the Influenza A Hemagglutinin (HA)Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; RECEPTOR-BINDING; SYNCYTIUM FORMATION; HOST-RANGE; SPECIFICITY; SENSITIVITY; INHIBITORS; CARBOHYDRATE; REPLICATION; DETERMINANT	Background:The major role of the neuraminidase (NA) protein of influenza A virus is related to its sialidase activity, which disrupts the interaction between the envelope hemagglutin (HA) protein and the sialic acid receptors expressed at the surface of infected cells. This enzymatic activity is known to promote the release and spread of progeny viral particles following their production by infected cells, but a potential role of NA in earlier steps of the viral life cycle has never been clearly demonstrated. In this study we have examined the impact of NA expression on influenza HA-mediated viral membrane fusion and virion infectivity. Methodology/Principal Findings:The role of NA in the early stages of influenza virus replication was examined using a cellcell fusion assay that mimics HA-mediated membrane fusion, and a virion infectivity assay using HIV-based pseudoparticles expressing influenza HA and/or NA proteins. In the cell-cell fusion assay, which bypasses the endocytocytosis step that is characteristic of influenza virus entry, we found that in proper HA maturation conditions, NA clearly enhanced fusion in a dose-dependent manner. Similarly, expression of NA at the surface of pseudoparticles significantly enhanced virion infectivity. Further experiments using exogeneous soluble NA revealed that the most likely mechanism for enhancement of fusion and infectivity by NA was related to desialylation of virion-expressed HA. Conclusion/Significance: The NA protein of influenza A virus is not only required for virion release and spread but also plays a critical role in virion infectivity and HA-mediated membrane fusion.	[Su, Bin; Wurtzer, Sebastien; Clavel, Francois; Labrosse, Beatrice] Univ Paris Diderot Paris 7, Hop St Louis, Inst Univ Hematol, INSERM,U941, Paris, France; [Rameix-Welti, Marie-Anne; van der Werf, Sylvie; Naffakh, Nadia] Univ Paris Diderot Paris 7, CNRS, URA 3015, Inst Pasteur,Unite Genet Mol Virus ARN, Paris, France; [Dwyer, Dominic] Univ Sydney, Westmead Hosp, ICPMR, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Sydney	Su, B (corresponding author), Univ Paris Diderot Paris 7, Hop St Louis, Inst Univ Hematol, INSERM,U941, Paris, France.	beatrice.labrosse@inserm.fr	LABROSSE, Béatrice/M-9920-2017; Rameix-Welti, Marie-Anne/H-7526-2019; SU, Bin/H-1236-2012	LABROSSE, Béatrice/0000-0002-0658-4903; wurtzer, sebastien/0000-0002-9628-1075; Rameix-Welti, Marie-Anne/0000-0002-5901-3856; Naffakh, Nadia/0000-0002-0424-0277; van der WERF, Sylvie/0000-0002-1148-4456	Institut de Medecine et d'Epidemiologie Applique (IMEA); Fondation Internationale Leon MBA	Institut de Medecine et d'Epidemiologie Applique (IMEA); Fondation Internationale Leon MBA	This work was supported by the Institut de Medecine et d'Epidemiologie Applique (IMEA) Fondation Internationale Leon MBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright AV, 1998, J NEUROVIROL, V4, P486, DOI 10.3109/13550289809113493; Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; DAVISPOYNTER N, 1994, J VIROL, V68, P7586, DOI 10.1128/JVI.68.11.7586-7590.1994; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; HORIMOTO T, 1994, J VIROL, V68, P604; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; KAWAOKA Y, 1989, J VIROL, V63, P3296, DOI 10.1128/JVI.63.8.3296-3300.1989; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann T, 2005, VIROLOGY, V333, P251, DOI 10.1016/j.virol.2004.12.035; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Shtyrya Y, 2009, GLYCOCONJUGATE J, V26, P99, DOI 10.1007/s10719-008-9169-x; Sun JF, 2002, J BIOL CHEM, V277, P9825, DOI 10.1074/jbc.M110764200; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; WILEY DC, 1977, VIROLOGY, V79, P446, DOI 10.1016/0042-6822(77)90371-3; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yang P, 1997, VIROLOGY, V229, P155, DOI 10.1006/viro.1996.8421	35	87	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8495	10.1371/journal.pone.0008495	http://dx.doi.org/10.1371/journal.pone.0008495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041119	Green Published, gold			2022-12-27	WOS:000278068700010
J	Vicente, D; Esnal, O; de Goicoechea, MJL; Cisterna, R; Perez-Trallero, E				Vicente, Diego; Esnal, Olatz; Jose Lopez de Goicoechea, M.; Cisterna, Ramon; Perez-Trallero, Emilio			Influence of Two Vaccination Campaigns on Genetic Diversity of Invasive Neisseria meningitidis Isolates in Northern Spain (1997-2008)	PLOS ONE			English	Article							C CONJUGATE VACCINES; POPULATION-STRUCTURE; IDENTIFICATION; CARRIAGE; DISEASE	Background: Neisseria meningitidis diversifies rapidly, due to its high recombination rates. The aim of this study was to analyze the possible impact of two vaccination campaigns (a once-off A/C polysaccharide vaccination campaign in people aged 18 months to 20 years old in 1997, and a meningococcal C conjugate vaccination campaign in children aged <= 6 years old from 2000 to 2008) on diversification of the population of invasive isolates obtained between 1997 and 2008. All of the 461 available isolates were included (2, 319, 123, 11 and 6 belonging to serogroups A, B, C, Y and W-135, respectively). Methodology/Principal Findings: The isolates were analyzed for diversity using multilocus sequence typing, eBURST and the S.T.A.R.T.2 program. One hundred and seven sequence types (ST) and 20 clonal complexes were obtained. Five different STs (ST11, ST8, ST33, 511163 and ST3496) included 56.4% of the isolates. With the exception of ST11, all other STs were associated with a specific serogroup. Epidemic circulation of serogroup C ST8 isolates was detected in 1997-1998, as well as epidemic circulation of ST11 isolates (serogroups B and C) in 2002-2004. The epidemic behavior of serogroup B ST11 (ST11_B:2a:P1.5) was similar, although with lesser intensity, to that of ST11 of serogroup C. Although clonality increased during epidemic years, the overall diversity of the meningococcal population did not increase throughout the 12 years of the study. Conclusion: The overall diversity of the meningococcal population, measured by the frequency of STs and clonal complexes, numbers of alleles, polymorphic sites, and index of association, remained relatively constant throughout the study period, contradicting previous findings by other researchers.	[Vicente, Diego; Perez-Trallero, Emilio] Hosp Donostia, Microbiol Serv, San Sebastian, Spain; [Vicente, Diego; Perez-Trallero, Emilio] Hosp Donostia, Reference Lab Meningococcal Infect Basque Country, San Sebastian, Spain; [Vicente, Diego; Esnal, Olatz; Perez-Trallero, Emilio] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Jose Lopez de Goicoechea, M.] Hosp Galdakao, Microbiol Serv, Galdakao, Bizkaia, Spain; [Cisterna, Ramon] Hosp Basurto, Microbiol Serv, Bilbao, Spain; [Perez-Trallero, Emilio] Univ Basque Country, Fac Med, Dept Prevent Med & Publ Hlth, San Sebastian, Spain	University Hospital Donostia; University Hospital Donostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; Galdakao Hospital; Basurto Hospital; University of Basque Country	Vicente, D (corresponding author), Hosp Donostia, Microbiol Serv, San Sebastian, Spain.	mikrobiol@terra.es						Achtman M, 2004, INT J MED MICROBIOL, V294, P67, DOI 10.1016/j.ijmm.2004.06.028; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Diggle MA, 2005, J CLIN MICROBIOL, V43, P4649, DOI 10.1128/JCM.43.9.4649-4653.2005; *EU MENNET, 2005, IMP MEN EP POP BIOL; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1999, LANCET, V354, P615, DOI 10.1016/S0140-6736(99)00252-4; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0; Ramsay M., 2006, INVASIVE NEISSERIA M; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Takahashi H, 2004, J MED MICROBIOL, V53, P1175, DOI 10.1099/0022-1317-53-11-1175; Takahashi H, 2004, J MED MICROBIOL, V53, P657, DOI 10.1099/jmm.0.45541-0; Vicente D, 2006, CLIN MICROBIOL INFEC, V12, P812, DOI 10.1111/j.1469-0691.2006.01451.x; Vicente D, 2005, J MED MICROBIOL, V54, P381, DOI 10.1099/jmm.0.45855-0; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	21	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8501	10.1371/journal.pone.0008501	http://dx.doi.org/10.1371/journal.pone.0008501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041148	gold, Green Published			2022-12-27	WOS:000278068700016
J	de Castro, F; Gaedke, U; Boenigk, J				de Castro, Francisco; Gaedke, Ursula; Boenigk, Jens			Reverse Evolution: Driving Forces Behind the Loss of Acquired Photosynthetic Traits	PLOS ONE			English	Article							FRESH-WATER HABITATS; OPERON COPY NUMBER; GROWTH-RATE; BACTERIA; GENOME; STRATEGIES; PREDATION; PLANKTON; DNA; SEQUENCES	Background: The loss of photosynthesis has occurred often in eukaryotic evolution, even more than its acquisition, which occurred at least nine times independently and which generated the evolution of the supergroups Archaeplastida, Rhizaria, Chromalveolata and Excavata. This secondary loss of autotrophic capability is essential to explain the evolution of eukaryotes and the high diversity of protists, which has been severely underestimated until recently. However, the ecological and evolutionary scenarios behind this evolutionary "step back'' are still largely unknown. Methodology/Principal Findings: Using a dynamic model of heterotrophic and mixotrophic flagellates and two types of prey, large bacteria and ultramicrobacteria, we examine the influence of DOC concentration, mixotroph's photosynthetic growth rate, and external limitations of photosynthesis on the coexistence of both types of flagellates. Our key premises are: large bacteria grow faster than small ones at high DOC concentrations, and vice versa; and heterotrophic flagellates are more efficient than the mixotrophs grazing small bacteria (both empirically supported). We show that differential efficiency in bacteria grazing, which strongly depends on cell size, is a key factor to explain the loss of photosynthesis in mixotrophs (which combine photosynthesis and bacterivory) leading to purely heterotrophic lineages. Further, we show in what conditions an heterotroph mutant can coexist, or even out-compete, its mixotrophic ancestor, suggesting that bacterivory and cell size reduction may have been major triggers for the diversification of eukaryotes. Conclusions/Significance: Our results suggest that, provided the mixotroph's photosynthetic advantage is not too large, the (small) heterotroph will also dominate in nutrient-poor environments and will readily invade a community of mixotrophs and bacteria, due to its higher efficiency exploiting the ultramicrobacteria. As carbon-limited conditions were presumably widespread throughout Earth history, such a scenario may explain the numerous transitions from phototrophy to mixotrophy and further to heterotrophy within virtually all major algal lineages. We challenge prevailing concepts that affiliated the evolution of phagotrophy with eutrophic or strongly light-limited environments only.	[de Castro, Francisco; Gaedke, Ursula] Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany; [Boenigk, Jens] Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria	University of Potsdam; Austrian Academy of Sciences	de Castro, F (corresponding author), Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany.	decastro.f@gmail.com	de Castro, Francisco/G-2213-2011; Boenigk, Jens/A-9377-2013	de Castro, Francisco/0000-0001-8834-3363; 	EU [MTKDCT 2006-042261]; Marie Curie Host Fellowship; FWF [18315]	EU(European Commission); Marie Curie Host Fellowship(European Commission); FWF(Austrian Science Fund (FWF))	F. de Castro was supported by the EU project FEMMES (MTKDCT 2006-042261), a Marie Curie Host Fellowship for Transfer of Knowledge. Jens Boenigk was supported in part by FWF project 18315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bodyl A, 2009, TRENDS ECOL EVOL, V24, P119, DOI 10.1016/j.tree.2008.11.003; Boenigk J, 2000, AQUAT MICROB ECOL, V22, P243, DOI 10.3354/ame022243; Boenigk J, 2005, ENVIRON MICROBIOL, V7, P685, DOI 10.1111/j.1462-2920.2005.00743.x; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; Boenigk J, 2006, AQUAT MICROB ECOL, V44, P71, DOI 10.3354/ame044071; CARON DA, 1990, LIMNOL OCEANOGR, V35, P192, DOI 10.4319/lo.1990.35.1.0192; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Fegatella F, 1998, APPL ENVIRON MICROB, V64, P4433; Fenchel T, 1998, BACTERIAL BIOGEOCHEMISTRY: THE ECOPHYSIOLOGY OF MINERAL CYCLING, 2ND EDITION, P4; FENCHEL T, 1986, ADV MICROB ECOL, V9, P57; Fenchel T., 1987, ECOLOGY OF PROTOZOA, DOI [10.1007/978-3-662-06817-5, DOI 10.1007/978-3-662-06817-5, DOI 10.1007/978-3-662-25981-8]; GAUDY AF, 1971, APPL MICROBIOL, V22, P1041, DOI 10.1128/AEM.22.6.1041-1047.1971; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gonzalez JM, 1996, MAR BIOL, V126, P785, DOI 10.1007/BF00351345; Hachtel W, 1998, ENDOCYTOBIOSIS CELL, V12, P191; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Havskum H, 1996, MAR ECOL PROG SER, V137, P251, DOI 10.3354/meps137251; Holen DA, 1999, FRESHWATER BIOL, V42, P445, DOI 10.1046/j.1365-2427.1999.00476.x; Katechakis A, 2006, OECOLOGIA, V148, P692, DOI 10.1007/s00442-006-0413-4; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lanier W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002171; Mallet MA, 2006, J EUKARYOT MICROBIOL, V53, P79, DOI 10.1111/j.1550-7408.2005.00079.x; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; NEDWELL DB, 1994, APPL ENVIRON MICROB, V60, P1984, DOI 10.1128/AEM.60.6.1984-1992.1994; NYGAARD K, 1993, LIMNOL OCEANOGR, V38, P273, DOI 10.4319/lo.1993.38.2.0273; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pernthaler J, 1997, APPL ENVIRON MICROB, V63, P4778, DOI 10.1128/AEM.63.12.4778-4783.1997; Pfandl K, 2004, J EUKARYOT MICROBIOL, V51, P626, DOI 10.1111/j.1550-7408.2004.tb00596.x; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Sanchez-Puerta MV, 2008, J PHYCOL, V44, P1097, DOI 10.1111/j.1529-8817.2008.00559.x; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Stibor H, 2003, PROTIST, V154, P91, DOI 10.1078/143446103764928512; Thingstad TF, 1996, ECOLOGY, V77, P2108, DOI 10.2307/2265705; Troost TA, 2005, AM NAT, V166, pE45, DOI 10.1086/432038; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wu QL, 2004, APPL ENVIRON MICROB, V70, P332, DOI 10.1128/AEM.70.1.332-339.2004	43	23	23	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8465	10.1371/journal.pone.0008465	http://dx.doi.org/10.1371/journal.pone.0008465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041159	gold, Green Published, Green Submitted			2022-12-27	WOS:000273105200006
J	Jorgensen, ND; Peng, Y; Ho, CCY; Rideout, HJ; Petrey, D; Liu, P; Dauer, WT				Jorgensen, Nathan D.; Peng, Yong; Ho, Cherry C. -Y.; Rideout, Hardy J.; Petrey, Donald; Liu, Peng; Dauer, William T.			The WD40 Domain Is Required for LRRK2 Neurotoxicity	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; KINASE-ACTIVITY; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; RISK-FACTOR; ROC DOMAIN; PROTEIN; REPEAT; MUTATIONS; GENE; VARIANT	Background: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD). LRRK2 contains an "enzymatic core'' composed of GTPase and kinase domains that is flanked by leucine-rich repeat (LRR) and WD40 protein-protein interaction domains. While kinase activity and GTP-binding have both been implicated in LRRK2 neurotoxicity, the potential role of other LRRK2 domains has not been as extensively explored. Principal Findings: We demonstrate that LRRK2 normally exists in a dimeric complex, and that removing the WD40 domain prevents complex formation and autophosphorylation. Moreover, loss of the WD40 domain completely blocks the neurotoxicity of multiple LRRK2 PD mutations. Conclusion: These findings suggest that LRRK2 dimerization and autophosphorylation may be required for the neurotoxicity of LRRK2 PD mutations and highlight a potential role for the WD40 domain in the mechanism of LRRK2-mediated cell death.	[Jorgensen, Nathan D.; Peng, Yong; Ho, Cherry C. -Y.; Rideout, Hardy J.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA; [Petrey, Donald; Liu, Peng] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY USA; [Dauer, William T.] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI USA; [Dauer, William T.] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI USA	Columbia University; Columbia University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jorgensen, ND (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.	dauer@umich.edu		Dauer, William/0000-0003-1775-7504	National Institutes of Health (NIH); Spitzer Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spitzer Foundation	National Institutes of Health (NIH) and Spitzer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Di Fonzo A, 2006, NEUROGENETICS, V7, P133, DOI 10.1007/s10048-006-0041-5; Farrer MJ, 2007, NEUROLOGY, V69, P1732, DOI 10.1212/01.wnl.0000279588.20391.88; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; IMAI Y, 2008, EMBO J; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jorgensen ND, 2007, J NEUROCHEM, V102, P2040, DOI 10.1111/j.1471-4159.2007.04678.x; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Muir T, 2001, ENVIRON HEALTH PERSP, V109, P885, DOI 10.2307/3454651; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tan EK, 2007, HUM GENET, V120, P857, DOI 10.1007/s00439-006-0268-0; Tang CL, 2003, J MOL BIOL, V334, P1043, DOI 10.1016/j.jmb.2003.10.025; Taylor JP, 2007, NEUROGENETICS, V8, P95, DOI 10.1007/s10048-006-0075-8; VANEGMOND WN, 2008, J BIOL CHEM; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Yu LH, 2000, PROTEIN SCI, V9, P2470, DOI 10.1110/ps.9.12.2470; Zhou HY, 2003, PROTEIN SCI, V12, P2121, DOI 10.1002/pro.122121; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	46	80	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8463	10.1371/journal.pone.0008463	http://dx.doi.org/10.1371/journal.pone.0008463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041156	Green Published, Green Submitted, gold			2022-12-27	WOS:000273104000023
J	Yan, JB; Shah, T; Warburton, ML; Buckler, ES; McMullen, MD; Crouch, J				Yan, Jianbing; Shah, Trushar; Warburton, Marilyn L.; Buckler, Edward S.; McMullen, Michael D.; Crouch, Jonathan			Genetic Characterization and Linkage Disequilibrium Estimation of a Global Maize Collection Using SNP Markers	PLOS ONE			English	Article							INBRED LINES; CIMMYT MAIZE; POPULATION-STRUCTURE; GENOME ORGANIZATION; SEQUENCE DIVERSITY; SSR MARKERS; ASSOCIATION; GERMPLASM; LOCI; SELECTION	A newly developed maize Illumina GoldenGate Assay with 1536 SNPs from 582 loci was used to genotype a highly diverse global maize collection of 632 inbred lines from temperate, tropical, and subtropical public breeding programs. A total of 1229 informative SNPs and 1749 haplotypes within 327 loci was used to estimate the genetic diversity, population structure, and familial relatedness. Population structure identified tropical and temperate subgroups, and complex familial relationships were identified within the global collection. Linkage disequilibrium (LD) was measured overall and within chromosomes, allelic frequency groups, subgroups related by geographic origin, and subgroups of different sample sizes. The LD decay distance differed among chromosomes and ranged between 1 to 10 kb. The LD distance increased with the increase of minor allelic frequency (MAF), and with smaller sample sizes, encouraging caution when using too few lines in a study. The LD decay distance was much higher in temperate than in tropical and subtropical lines, because tropical and subtropical lines are more diverse and contain more rare alleles than temperate lines. A core set of inbreds was defined based on haplotypes, and 60 lines capture 90% of the haplotype diversity of the entire panel. The defined core sets and the entire collection can be used widely for different research targets.	[Yan, Jianbing; Crouch, Jonathan] Int Maize & Wheat Improvement Ctr, Genet Resources Program, Mexico City, DF, Mexico; [Yan, Jianbing] Int Crops Res Inst Semi Arid Trop, Dept Bioinformat, Hyderabad, Andhra Pradesh, India; [Shah, Trushar] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Warburton, Marilyn L.] ARS, Corn Host Plant Resistance Res Unit, USDA, Starkville, MS USA; [Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Buckler, Edward S.] ARS, Plant Soil & Nutr Res Unit, USDA, Ithaca, NY USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [McMullen, Michael D.] ARS, Plant Genet Res Unit, USDA, Columbia, MO USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); China Agricultural University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); Cornell University; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Yan, JB (corresponding author), Int Maize & Wheat Improvement Ctr, Genet Resources Program, Mexico City, DF, Mexico.	marilyn.warburton@ars.usda.gov	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Warburton, Marilyn/J-2250-2017	Buckler, Edward/0000-0002-3100-371X; Shah, Trushar/0000-0002-0091-7981; Warburton, Marilyn/0000-0002-9542-9912	National Science Foundation [DBI0321467]; United States Department of Agriculture - Agriculture Research Service	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture - Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the Generation Challenge Program of the Consultative Group on International Agricultural Research, the National Science Foundation Plant Genome Award DBI0321467 and funds provided by the United States Department of Agriculture - Agriculture Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bernardo R, 2009, CROP SCI, V49, P419, DOI 10.2135/cropsci2008.08.0452; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Gethi JG, 2002, CROP SCI, V42, P951, DOI 10.2135/cropsci2002.0951; Global Crop Diversity Trust (GCDT), 2007, GLOB STRAT EXS CONS; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hall T.A., 2001, BIOLIGN ALIGNMENT MU; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; HEDRICK PW, 1987, GENETICS, V117, P331; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jung M, 2004, THEOR APPL GENET, V109, P681, DOI 10.1007/s00122-004-1695-8; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Laborda PR, 2005, THEOR APPL GENET, V111, P1288, DOI 10.1007/s00122-005-0055-7; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Long AD, 1999, GENOME RES, V9, P720; Lu H, 2001, THEOR APPL GENET, V103, P613, DOI 10.1007/PL00002917; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Reif JC, 2003, THEOR APPL GENET, V107, P947, DOI 10.1007/s00122-003-1333-x; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Tarter JA, 2004, THEOR APPL GENET, V109, P609, DOI 10.1007/s00122-004-1660-6; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Xia XC, 2005, CROP SCI, V45, P2573, DOI 10.2135/cropsci2005.0246; Xia XC, 2004, CROP SCI, V44, P2230, DOI 10.2135/cropsci2004.2230; Xie CX, 2008, MOL BREEDING, V21, P407, DOI 10.1007/s11032-007-9140-8; YAN J, 2009, MOL BREED UNPUB; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	51	272	294	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8451	10.1371/journal.pone.0008451	http://dx.doi.org/10.1371/journal.pone.0008451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041112	gold, Green Published, Green Accepted			2022-12-27	WOS:000273104000015
J	Nunemaker, CS; Dishinger, JF; Dula, SB; Wu, RP; Merrins, MJ; Reid, KR; Sherman, A; Kennedy, RT; Satin, LS				Nunemaker, Craig S.; Dishinger, John F.; Dula, Stacey B.; Wu, Runpei; Merrins, Matthew J.; Reid, Kendra R.; Sherman, Arthur; Kennedy, Robert T.; Satin, Leslie S.			Glucose Metabolism, Islet Architecture, and Genetic Homogeneity in Imprinting of [Ca2+](i) and Insulin Rhythms in Mouse Islets	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CYTOPLASMIC CA2+; IN-VIVO; ELECTRICAL-ACTIVITY; OXYGEN-CONSUMPTION; MICROFLUIDIC CHIP; SINGLE ISLETS; B-CELLS; OSCILLATIONS; SECRETION	We reported previously that islets isolated from individual, outbred Swiss-Webster mice displayed oscillations in intracellular calcium ([Ca2+](i)) that varied little between islets of a single mouse but considerably between mice, a phenomenon we termed "islet imprinting." We have now confirmed and extended these findings in several respects. First, imprinting occurs in both inbred (C57BL/6J) as well as outbred mouse strains (Swiss-Webster; CD1). Second, imprinting was observed in NAD(P) H oscillations, indicating a metabolic component. Further, short-term exposure to a glucose-free solution, which transiently silenced [Ca2+](i) oscillations, reset the oscillatory patterns to a higher frequency. This suggests a key role for glucose metabolism in maintaining imprinting, as transiently suppressing the oscillations with diazoxide, a KATP-channel opener that blocks [Ca2+](i) influx downstream of glucose metabolism, did not change the imprinted patterns. Third, imprinting was not as readily observed at the level of single beta cells, as the [Ca2+](i) oscillations of single cells isolated from imprinted islets exhibited highly variable, and typically slower [Ca2+](i) oscillations. Lastly, to test whether the imprinted [Ca2+](i) patterns were of functional significance, a novel microchip platform was used to monitor insulin release from multiple islets in real time. Insulin release patterns correlated closely with [Ca2+](i) oscillations and showed significant mouseto- mouse differences, indicating imprinting. These results indicate that islet imprinting is a general feature of islets and is likely to be of physiological significance. While islet imprinting did not depend on the genetic background of the mice, glucose metabolism and intact islet architecture may be important for the imprinting phenomenon.	[Nunemaker, Craig S.; Dula, Stacey B.; Wu, Runpei] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22903 USA; [Dishinger, John F.; Reid, Kendra R.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Kennedy, Robert T.; Satin, Leslie S.] Univ Michigan, Brehm Diabet Ctr, Ann Arbor, MI 48109 USA; [Sherman, Arthur] NIH, Lab Biol Modeling, Bethesda, MD 20892 USA	University of Virginia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA	Nunemaker, CS (corresponding author), Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22903 USA.	lsatin@umich.edu	Kennedy, Robert/G-9095-2016	Kennedy, Robert/0000-0003-2447-7471; Nunemaker, Craig/0000-0003-2894-3388; Merrins, Matthew J./0000-0003-1599-9227; Sherman, Arthur/0000-0002-8372-5941	NIH [RO1 DK46409, R37 DK0469690, 1K01 DK081621]; NIH-NIDDK (National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013027, K01DK081621, R01DK046409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIDDK (National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Satin's laboratory is supported by RO1 DK46409 from the NIH. Dr. Kennedy's laboratory is supported by NIH R37 Grant DK0469690. Dr. Nunemaker's laboratory is supported by NIH 1K01 DK081621. Dr. Sherman was supported by the Intramural Research Program of the NIH-NIDDK (National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Bergsten P, 2002, DIABETES, V51, pS171, DOI 10.2337/diabetes.51.2007.S171; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Brissova Marcela, 2008, P3, DOI 10.1007/978-4-431-75452-7_1; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; CARTER JD, 2009, BIOL PROCED IN PRESS; COOK DL, 1983, METABOLISM, V32, P681, DOI 10.1016/0026-0495(83)90124-5; Dishinger JF, 2009, ANAL CHEM, V81, P3119, DOI 10.1021/ac900109t; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; GILON P, 1995, ENDOCRINOLOGY, V136, P5725, DOI 10.1210/en.136.12.5725; Gilon P, 2002, DIABETES, V51, pS144, DOI 10.2337/diabetes.51.2007.S144; GILON P, 1993, J BIOL CHEM, V268, P22265; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051; HENQUIN JC, 1982, PFLUG ARCH EUR J PHY, V393, P322, DOI 10.1007/BF00581418; Jahanshahi P, 2009, ENDOCRINOLOGY, V150, P607, DOI 10.1210/en.2008-0773; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; KOMJATI M, 1986, ENDOCRINOLOGY, V118, P312, DOI 10.1210/endo-118-1-312; Krippeit-Drews P, 2000, BIOCHEM BIOPH RES CO, V267, P179, DOI 10.1006/bbrc.1999.1921; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MARTIN F, 1995, J PHYSIOL-LONDON, V486, P361, DOI 10.1113/jphysiol.1995.sp020818; MATTHEWS DR, 1983, DIABETOLOGIA, V24, P231; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Nunemaker CS, 2006, BIOPHYS J, V91, P2082, DOI 10.1529/biophysj.106.087296; Nunemaker CS, 2005, DIABETES, V54, pA407; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; Nunemaker CS, 2004, ENDOCRINE, V25, P61, DOI 10.1385/ENDO:25:1:61; PAOLISSO G, 1988, J CLIN ENDOCR METAB, V66, P1220, DOI 10.1210/jcem-66-6-1220; PEIRIS AN, 1992, J CLIN ENDOCR METAB, V75, P290, DOI 10.1210/jc.75.1.290; Porksen N, 2002, Diabetes Nutr Metab, V15, P9; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Roper MG, 2003, ANAL CHEM, V75, P4711, DOI 10.1021/ac0346813; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; SHERMAN A, 1991, BIOPHYS J, V59, P547, DOI 10.1016/S0006-3495(91)82271-8; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zimliki CL, 2004, BIOPHYS J, V87, P193, DOI 10.1529/biophysj.103.038471	53	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8428	10.1371/journal.pone.0008428	http://dx.doi.org/10.1371/journal.pone.0008428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037650	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998100015
J	Salvatore, MF; Pruett, BS; Spann, SL; Dempsey, C				Salvatore, Michael F.; Pruett, Brandon S.; Spann, Sandy L.; Dempsey, Charles			Aging Reveals a Role for Nigral Tyrosine Hydroxylase ser31 Phosphorylation in Locomotor Activity Generation	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINE SYSTEM; AGE-RELATED DECLINE; STRIATAL DOPAMINE; SUBSTANTIA-NIGRA; NEUROTROPHIC FACTOR; CATECHOLAMINE BIOSYNTHESIS; COMMUNITY POPULATION; PARKINSONIAN SIGNS; NUCLEUS-ACCUMBENS; NERVE-TERMINALS	Background: Tyrosine hydroxylase (TH) regulates dopamine (DA) bioavailability. Its product, L-DOPA, is an established treatment for Parkinson's disease (PD), suggesting that TH regulation influences locomotion. Site-specific phosphorylation of TH at ser31 and ser40 regulates activity. No direct evidence shows that ser40 phosphorylation is the dominating mechanism of regulating TH activity in vivo, and physiologically-relevant stimuli increase L-DOPA biosynthesis independent of ser40 phosphorylation. Significant loss of locomotor activity occurs in aging as in PD, despite less loss of striatal DA or TH in aging compared to the loss associated with symptomatic PD. However, in the substantia nigra (SN), there is equivalent loss of DA or TH in aging and at the onset of PD symptoms. Growth factors increase locomotor activity in both PD and aging models and increase DA bioavailability and ser31 TH phosphorylation in SN, suggesting that ser31 TH phosphorylation status in the SN, not striatum, regulates DA bioavailability necessary for locomotor activity. Methodology and Principal Findings: We longitudinally characterized locomotor activity in young and older Brown-Norway Fischer 344 F-1 hybrid rats (18 months apart in age) at two time periods, eight months apart. The aged group served as an intact and pharmacologically-naive source of deficient locomotor activity. Following locomotor testing, we analyzed DA tissue content, TH protein, and TH phosphorylation in striatum, SN, nucleus accumbens, and VTA. Levels of TH protein combined with ser31 phosphorylation alone reflected inherent differences in DA levels among the four regions. Measures strictly pertaining to locomotor activity initiation significantly correlated to DA content only in the SN. Nigral TH protein and ser31 phosphorylation together significantly correlated to test subject's maximum movement number, horizontal activity, and duration. Conclusions/Significance: Together, these results show ser31 TH phosphorylation regulates DA bioavailability in intact neuropil, its status in the SN may regulate locomotor activity generation, and it may represent an accurate target for treating locomotor deficiency. They also show that neurotransmitter regulation in cell body regions can mediate behavioral outcomes and that ser31 TH phosphorylation plays a role in behaviors dependent upon catecholamines, such as dopamine.	[Salvatore, Michael F.; Pruett, Brandon S.; Spann, Sandy L.; Dempsey, Charles] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Salvatore, MF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	msalva@lsuhsc.edu	Pruett, Brandon/ABE-4419-2020; Salvatore, Michael/ABC-8926-2021	Pruett, Brandon/0000-0001-9760-1635; 	American Federation for Aging Research	American Federation for Aging Research	This work was funded by a grant award to Michael F. Salvatore by the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DR, 2006, EUR J NEUROSCI, V24, P617, DOI 10.1111/j.1460-9568.2006.04953.x; Beeler JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1149, DOI 10.1038/npp.2008.117; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; BROWN VJ, 1991, BRAIN, V114, P513, DOI 10.1093/brain/114.1.513; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Cass WA, 2002, BRAIN RES, V938, P29, DOI 10.1016/S0006-8993(02)02481-2; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Collier TJ, 2007, NEUROBIOL DIS, V26, P56, DOI 10.1016/j.nbd.2006.11.013; Connor JR, 2009, BRAIN, V132, P2403, DOI 10.1093/brain/awp125; Cruz-Muros I, 2007, EXP NEUROL, V204, P147, DOI 10.1016/j.expneurol.2006.10.004; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Emborg ME, 1998, J COMP NEUROL, V401, P253; EMERICH DF, 1993, BRAIN RES BULL, V32, P477, DOI 10.1016/0361-9230(93)90294-L; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fleischman DA, 2007, EXP AGING RES, V33, P59, DOI 10.1080/03610730601006370; Fortin GD, 2006, J NEUROCHEM, V96, P1740, DOI 10.1111/j.1471-4159.2006.03699.x; FREED CR, 1985, SCIENCE, V229, P62, DOI 10.1126/science.4012312; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gerhardt GA, 2002, J NEUROCHEM, V80, P168, DOI 10.1046/j.0022-3042.2001.00684.x; Grondin R, 2003, J NEUROSCI, V23, P1974; Harada K, 1996, J NEUROCHEM, V67, P629; Haycock JW, 1998, J NEUROCHEM, V71, P1670; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; Hebert MA, 1998, BRAIN RES, V797, P42, DOI 10.1016/S0006-8993(98)00370-9; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; HEFTI F, 1980, BRAIN RES, V195, P123, DOI 10.1016/0006-8993(80)90871-9; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Hornykiewicz O, 1986, ADV NEUROL, V45, P19; HUANG RL, 1995, NEUROSCI LETT, V200, P61, DOI 10.1016/0304-3940(95)12084-H; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; IRWIN I, 1994, NEURODEGENERATION, V3, P251; KISH SJ, 1992, J NEUROCHEM, V58, P642, DOI 10.1111/j.1471-4159.1992.tb09766.x; Kliem MA, 2007, J NEUROPHYSIOL, V98, P1489, DOI 10.1152/jn.00171.2007; Kubis N, 2000, BRAIN, V123, P366, DOI 10.1093/brain/123.2.366; LAVICKY J, 1993, J NEUROCHEM, V60, P602, DOI 10.1111/j.1471-4159.1993.tb03191.x; MARSHALL JF, 1990, NEUROBIOL AGING, V11, P131, DOI 10.1016/0197-4580(90)90046-3; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; Murray AM, 2004, J GERONTOL A-BIOL, V59, P864; Ossowska K, 2001, BRAIN RES, V907, P71, DOI 10.1016/S0006-8993(01)02601-4; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Parkinson JA, 1999, J NEUROSCI, V19, P2401; PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1; PONZIO F, 1982, NEUROBIOL AGING, V3, P23, DOI 10.1016/0197-4580(82)90057-4; Prettyman R, 1998, AGE AGEING, V27, P557, DOI 10.1093/ageing/27.5.557; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; ROBERTSON GS, 1989, J NEUROSCI, V9, P3326; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2003, NEUROBIOL AGING, V24, P1147, DOI 10.1016/S0197-4580(03)00129-5; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Salvatore MF, 2009, EXP NEUROL, V219, P197, DOI 10.1016/j.expneurol.2009.05.013; Sanchez HL, 2008, NEUROSCIENCE, V154, P1598, DOI 10.1016/j.neuroscience.2008.04.016; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; SPANGLER EL, 1994, NEUROBIOL AGING, V15, P319, DOI 10.1016/0197-4580(94)90027-2; SPROTT RL, 1997, ILAR J, V38, P1; Thompson LH, 2009, EUR J NEUROSCI, V30, P625, DOI 10.1111/j.1460-9568.2009.06878.x; Trevitt JT, 2001, PSYCHOPHARMACOLOGY, V156, P32; WAYMIRE JC, 1991, J NEUROCHEM, V57, P1313, DOI 10.1111/j.1471-4159.1991.tb08296.x; WOLF ME, 1991, J NEUROCHEM, V56, P1191, DOI 10.1111/j.1471-4159.1991.tb11410.x; Yurek DM, 1998, BRAIN RES, V791, P246, DOI 10.1016/S0006-8993(98)00110-3	69	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8466	10.1371/journal.pone.0008466	http://dx.doi.org/10.1371/journal.pone.0008466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037632	gold, Green Published, Green Submitted			2022-12-27	WOS:000272998100021
J	Chen, GF; Wang, LP; Tsien, JZ				Chen, Guifen; Wang, L. Phillip; Tsien, Joe Z.			Neural Population-Level Memory Traces in the Mouse Hippocampus	PLOS ONE			English	Article							SLEEP SPINDLE DENSITY; LONG-TERM-MEMORY; CONDITIONING REQUIRES; DORSAL HIPPOCAMPUS; EPISODIC MEMORY; PLACE CELLS; GENETIC ENHANCEMENT; PREFRONTAL CORTEX; ENTORHINAL CORTEX; FEAR EXTINCTION	One of the fundamental goals in neurosciences is to elucidate the formation and retrieval of brain's associative memory traces in real-time. Here, we describe real-time neural ensemble transient dynamics in the mouse hippocampal CA1 region and demonstrate their relationships with behavioral performances during both learning and recall. We employed the classic trace fear conditioning paradigm involving a neutral tone followed by a mild foot-shock 20 seconds later. Our large-scale recording and decoding methods revealed that conditioned tone responses and tone-shock association patterns were not present in CA1 during the first pairing, but emerged quickly after multiple pairings. These encoding patterns showed increased immediate-replay, correlating tightly with increased immediate-freezing during learning. Moreover, during contextual recall, these patterns reappeared in tandem six-to-fourteen times per minute, again correlating tightly with behavioral recall. Upon traced tone recall, while various fear memories were retrieved, the shock traces exhibited a unique recall-peak around the 20-second trace interval, further signifying the memory of time for the expected shock. Therefore, our study has revealed various real-time associative memory traces during learning and recall in CA1, and demonstrates that real-time memory traces can be decoded on a moment-to-moment basis over any single trial.	[Chen, Guifen] Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; Med Coll Georgia, Sch Med, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, GF (corresponding author), Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	jtsien@mcg.edu	Chen, Guifen/AAQ-5044-2020	Chen, Guifen/0000-0002-5459-660X	National Institute of Mental Health (NIMH); National Institute of Aging (NIA); MCG; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCG; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), MCG fund, and Georgia Research Alliance (All to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; BERGER TW, 1978, P NATL ACAD SCI USA, V75, P1572, DOI 10.1073/pnas.75.3.1572; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; Biedenkapp JC, 2007, LEARN MEMORY, V14, P200, DOI 10.1101/lm.499407; Cho MH, 2007, P NATL ACAD SCI USA, V104, P16317, DOI 10.1073/pnas.0703344104; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clark RE, 1998, BEHAV NEUROSCI, V112, P1062, DOI 10.1037/0735-7044.112.5.1062; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS M, 1986, BEHAV NEUROSCI, V100, P814, DOI 10.1037/0735-7044.100.6.814; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; Gais S, 2002, J NEUROSCI, V22, P6830; GALLAGHER M, 2000, AMYGDALA; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; HARRISON SA, 2009, NATURE; Hasselmo ME, 2008, EUR J NEUROSCI, V28, P1301, DOI 10.1111/j.1460-9568.2008.06437.x; Hebb Donald O., 1949, ORG BEHAV; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; Kentros C, 2006, HIPPOCAMPUS, V16, P743, DOI 10.1002/hipo.20199; Kholodar-Smith DB, 2008, NEUROBIOL LEARN MEM, V90, P537, DOI 10.1016/j.nlm.2008.06.006; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Lin LN, 2006, TRENDS NEUROSCI, V29, P48, DOI 10.1016/j.tins.2005.11.004; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2007, P NATL ACAD SCI USA, V104, P6066, DOI 10.1073/pnas.0701106104; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moser EI, 2005, NEUROSCIENCE, V130, P519, DOI 10.1016/j.neuroscience.2004.09.044; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Ohno M, 2005, LEARN MEMORY, V12, P211, DOI 10.1101/lm.90205; OLDS J, 1972, J NEUROPHYSIOL, V35, P202, DOI 10.1152/jn.1972.35.2.202; Osan R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000404; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Ponomarenko AA, 2008, EUR J NEUROSCI, V27, P3035, DOI 10.1111/j.1460-9568.2008.06232.x; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shrager Y, 2008, P NATL ACAD SCI USA, V105, P12034, DOI 10.1073/pnas.0805414105; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; THOMPSON RF, 2005, REV NEUROSCI, V17, P519; Tsien JZ, 2007, SCI AM, V297, P52, DOI 10.1038/scientificamerican0707-52; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tulving E., 1972, ORG MEMORY, P381; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004	67	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8256	10.1371/journal.pone.0008256	http://dx.doi.org/10.1371/journal.pone.0008256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016843	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834000007
J	Pilyugin, M; Demmers, J; Verrijzer, CP; Karch, F; Moshkin, YM				Pilyugin, Maxim; Demmers, Jeroen; Verrijzer, C. Peter; Karch, Francois; Moshkin, Yuri M.			Phosphorylation-Mediated Control of Histone Chaperone ASF1 Levels by Tousled-Like Kinases	PLOS ONE			English	Article							DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; ASSEMBLY PATHWAY; HO PROMOTER; REPAIR; DEPOSITION; MACHINERY; COMPLEX; CAF-1	Histone chaperones are at the hub of a diverse interaction networks integrating a plethora of chromatin modifying activities. Histone H3/H4 chaperone ASF1 is a target for cell-cycle regulated Tousled-like kinases (TLKs) and both proteins cooperate during chromatin replication. However, the precise role of post-translational modification of ASF1 remained unclear. Here, we identify the TLK phosphorylation sites for both Drosophila and human ASF1 proteins. Loss of TLK-mediated phosphorylation triggers hASF1a and dASF1 degradation by proteasome-dependent and independent mechanisms respectively. Consistent with this notion, introduction of phosphorylation-mimicking mutants inhibits hASF1a and dASF1 degradation. Human hASF1b is also targeted for proteasome-dependent degradation, but its stability is not affected by phosphorylation indicating that other mechanisms are likely to be involved in control of hASF1b levels. Together, these results suggest that ASF1 cellular levels are tightly controlled by distinct pathways and provide a molecular mechanism for post-translational regulation of dASF1 and hASF1a by TLK kinases.	[Pilyugin, Maxim; Karch, Francois] Univ Geneva, Dept Zool, Geneva, Switzerland; [Pilyugin, Maxim; Karch, Francois] Univ Geneva, Natl Res Ctr Frontiers Genet, Geneva, Switzerland; [Demmers, Jeroen] Erasmus Univ, Med Ctr, Prote Ctr, Rotterdam, Netherlands; [Verrijzer, C. Peter; Moshkin, Yuri M.] Erasmus Univ, Dept Biochem, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands	University of Geneva; University of Geneva; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam	Pilyugin, M (corresponding author), Univ Geneva, Dept Zool, Geneva, Switzerland.	Francois.Karch@zoo.unige.ch; i.mochkine@erasmusmc.nl	Moshkin, Yuri M./M-3093-2016; Demmers, Jeroen AA/F-4046-2016; Moshkin, Yuri/ABA-3435-2021	Moshkin, Yuri M./0000-0003-2964-8823; Demmers, Jeroen AA/0000-0002-8757-9611; Moshkin, Yuri/0000-0003-2964-8823	Ligue Genevoise Contre Le Cancer [0511]; European Community EuTRACC [LSHG-CT-2007-037445]; EMBO Long Term	Ligue Genevoise Contre Le Cancer; European Community EuTRACC; EMBO Long Term(European Molecular Biology Organization (EMBO))	This work was supported by the grants from Ligue Genevoise Contre Le Cancer N/ref. 0511 (to M. Pilyugin and F. Karch), European Community EuTRACC, LSHG-CT-2007-037445 (to C.P. Verrijzer) and EMBO Long Term Fellowship (Y.M. Moshkin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Bajpe PK, 2008, MOL CELL BIOL, V28, P1606, DOI 10.1128/MCB.01567-07; BERCKMANS B, 2009, TRANSCRIPTIONAL CONT; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Goodfellow H, 2007, DEV CELL, V13, P593, DOI 10.1016/j.devcel.2007.08.021; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hayashi R, 2007, DNA CELL BIOL, V26, P91, DOI 10.1089/dna.2006.0515; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Moshkin YM, 2002, GENE DEV, V16, P2621, DOI 10.1101/gad.231202; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; WORBY CA, 2001, SCI STKE 2001; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	31	24	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8328	10.1371/journal.pone.0008328	http://dx.doi.org/10.1371/journal.pone.0008328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016786	Green Submitted, gold, Green Published			2022-12-27	WOS:000272834000015
J	Iijima-Ando, K; Hearn, SA; Shenton, C; Gatt, A; Zhao, LJ; Iijima, K				Iijima-Ando, Kanae; Hearn, Stephen A.; Shenton, Christopher; Gatt, Anthony; Zhao, LiJuan; Iijima, Koichi			Mitochondrial Mislocalization Underlies A beta 42-Induced Neuronal Dysfunction in a Drosophila Model of Alzheimer's Disease	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; AMYLOID-BETA; AXONAL-TRANSPORT; A-BETA; DYNAMICS; NEURODEGENERATION; PATHOGENESIS; CALCIUM; OVEREXPRESSION; FRAGMENTATION	The amyloid-beta 42 (A beta 42) is thought to play a central role in the pathogenesis of Alzheimer's disease (AD). However, the molecular mechanisms by which A beta 42 induces neuronal dysfunction and degeneration remain elusive. Mitochondrial dysfunctions are implicated in AD brains. Whether mitochondrial dysfunctions are merely a consequence of AD pathology, or are early seminal events in AD pathogenesis remains to be determined. Here, we show that A beta 42 induces mitochondrial mislocalization, which contributes to A beta 42-induced neuronal dysfunction in a transgenic Drosophila model. In the A beta 42 fly brain, mitochondria were reduced in axons and dendrites, and accumulated in the somata without severe mitochondrial damage or neurodegeneration. In contrast, organization of microtubule or global axonal transport was not significantly altered at this stage. A beta 42-induced behavioral defects were exacerbated by genetic reductions in mitochondrial transport, and were modulated by cAMP levels and PKA activity. Levels of putative PKA substrate phosphoproteins were reduced in the A beta 42 fly brains. Importantly, perturbations in mitochondrial transport in neurons were sufficient to disrupt PKA signaling and induce late-onset behavioral deficits, suggesting a mechanism whereby mitochondrial mislocalization contributes to A beta 42-induced neuronal dysfunction. These results demonstrate that mislocalization of mitochondria underlies the pathogenic effects of A beta 42 in vivo.	[Iijima-Ando, Kanae; Shenton, Christopher; Zhao, LiJuan] Thomas Jefferson Univ, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA; [Shenton, Christopher; Gatt, Anthony; Iijima, Koichi] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Hearn, Stephen A.] Cold Spring Harbor Lab, Microscopy Facil, Cold Spring Harbor, NY 11724 USA	Jefferson University; Jefferson University; Cold Spring Harbor Laboratory	Iijima-Ando, K (corresponding author), Thomas Jefferson Univ, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA.	Kanae.Iijima-Ando@jefferson.edu; Koichi.Iijima@jefferson.edu		Hearn, Stephen/0000-0002-2489-2424	Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation; American Federation for Aging Research; Alzheimer's Association [NIRG-08-91985]; National Institutes of Health [R01AG032279-A1]; NATIONAL INSTITUTE ON AGING [R01AG032279] Funding Source: NIH RePORTER	Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation; American Federation for Aging Research; Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by start-up funds from the Farber Institute for Neurosciences, a pilot research grant from the Thomas Jefferson University, and grants from The Gilbert Foundation, the American Federation for Aging Research (http://www.afar.org/), the Alzheimer's Association (http://www.alz.org/index. asp) (NIRG-08-91985) and the National Institutes of Health (R01AG032279-A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cowburn RF, 2001, BIOCHEM SOC SYMP, V67, P163; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donato AJ, 2009, FASEB J, V23; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; MASLIAH E, 1995, HISTOL HISTOPATHOL, V10, P509; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; YIN JCP, 1995, MOL CELL BIOL, V15, P5123	59	86	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8310	10.1371/journal.pone.0008310	http://dx.doi.org/10.1371/journal.pone.0008310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016833	Green Published, Green Accepted, gold			2022-12-27	WOS:000272833800009
J	Bosch, N; Morell, M; Ponsa, I; Mercader, JM; Armengol, L; Estivill, X				Bosch, Nina; Morell, Marta; Ponsa, Immaculada; Maria Mercader, Josep; Armengol, Lluis; Estivill, Xavier			Nucleotide, Cytogenetic and Expression Impact of the Human Chromosome 8p23.1 Inversion Polymorphism	PLOS ONE			English	Article							COPY-NUMBER-VARIATION; WILLIAMS-BEUREN-SYNDROME; L1 RETROTRANSPOSITION; SOMATIC MOSAICISM; HUMAN GENOME; COMMON-CAUSE; HUMAN DNA; GENE; REARRANGEMENTS; PATIENT	Background: The human chromosome 8p23.1 region contains a 3.8-4.5 Mb segment which can be found in different orientations (defined as genomic inversion) among individuals. The identification of single nucleotide polymorphisms (SNPs) tightly linked to the genomic orientation of a given region should be useful to indirectly evaluate the genotypes of large genomic orientations in the individuals. Results: We have identified 16 SNPs, which are in linkage disequilibrium (LD) with the 8p23.1 inversion as detected by fluorescent in situ hybridization (FISH). The variability of the 8p23.1 orientation in 150 HapMap samples was predicted using this set of SNPs and was verified by FISH in a subset of samples. Four genes (NEIL2, MSRA, CTSB and BLK) were found differentially expressed (p<0.0005) according to the orientation of the 8p23.1 region. Finally, we have found variable levels of mosaicism for the orientation of the 8p23.1 as determined by FISH. Conclusion: By means of dense SNP genotyping of the region, haplotype-based computational analyses and FISH experiments we could infer and verify the orientation status of alleles in the 8p23.1 region by detecting two short haplotype stretches at both ends of the inverted region, which are likely the relic of the chromosome in which the original inversion occurred. Moreover, an impact of 8p23.1 inversion on gene expression levels cannot be ruled out, since four genes from this region have statistically significant different expression levels depending on the inversion status. FISH results in lymphoblastoid cell lines suggest the presence of mosaicism regarding the 8p23.1 inversion.	[Bosch, Nina; Morell, Marta; Ponsa, Immaculada; Maria Mercader, Josep; Armengol, Lluis; Estivill, Xavier] Ctr Genom Regulat CRG UPF, Genes & Dis Programme, Genet Causes Dis Grp, Barcelona, Catalonia, Spain; [Bosch, Nina; Morell, Marta; Maria Mercader, Josep; Armengol, Lluis; Estivill, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Catalonia, Spain; [Ponsa, Immaculada] Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, E-08193 Barcelona, Catalonia, Spain; [Ponsa, Immaculada] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Catalonia, Spain; [Armengol, Lluis] Quantitat Genom Med Labs qGenom, Barcelona, Catalonia, Spain; [Estivill, Xavier] Pompeu Fabra Univ UPF, Dept Hlth & Expt Life Sci, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University	Bosch, N (corresponding author), Ctr Genom Regulat CRG UPF, Genes & Dis Programme, Genet Causes Dis Grp, Barcelona, Catalonia, Spain.	xavier.estivill@crg.cat	Estivill, Xavier/E-2957-2012; Estivill, Xavier/A-3125-2013	Estivill, Xavier/0000-0002-0723-2256; Morell, Marta/0000-0003-1469-2223; Mercader, Josep M/0000-0001-8494-3660; Ponsa, Immaculada/0000-0003-3436-1907	Department of Universities, Research and Information Society [2005SGR00008, 2009SGR1107]; e European Union [037627]; "Ministerio de Ciencia y Innovacion'' [SAF2008-00357]; "Instituto de Salud Carlos III FIS-ISCIII"; Spanish Ministry of Science and Education [SAF2002-00799]; Danone Institute (Spain)	Department of Universities, Research and Information Society; e European Union; "Ministerio de Ciencia y Innovacion''; "Instituto de Salud Carlos III FIS-ISCIII"(Instituto de Salud Carlos III); Spanish Ministry of Science and Education(Spanish Government); Danone Institute (Spain)(Danone Nutricia)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Financial support was received from the Department of Universities, Research and Information Society (2005SGR00008, 2009SGR1107) ("Generalitat de Catalunya''), from the European Union AnEUploidy project (037627) and the "Ministerio de Ciencia y Innovacion'' (SAF2008-00357). N. B. was a recipient of a BEFI fellowship from "Instituto de Salud Carlos III FIS-ISCIII''. J. M. M. was supported by the CRG under project SAF2002-00799 (Spanish Ministry of Science and Education) and by fellowship of the Danone Institute (Spain).	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; ALDRED PM, 2005, HUM MOL GENET; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Antonacci F, 2009, HUM MOL GENET; Ballantyne C, 2007, EUR J CARDIOV PREV R, V14, P3; BANCHS I, 1994, HUM MUTAT, V4, P232; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; BARBER JC, 2005, EUR J HUM GENET; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Beiraghi S, 2003, GENE, V309, P11, DOI 10.1016/S0378-1119(03)00461-x; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; Bosch N, 2008, GENE, V420, P113, DOI 10.1016/j.gene.2008.05.003; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Chen GK, 2006, AM J HUM GENET, V79, P238, DOI 10.1086/505540; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iida A, 2000, HUM GENET, V106, P277, DOI 10.1007/s004390051038; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; LINZMEIER RM, 2005, GENOMICS; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P3205, DOI 10.1073/pnas.93.8.3205; Navarro A, 2000, GENETICS, V155, P685; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; ROYLE NJ, 1993, GENOMICS, V15, P119, DOI 10.1006/geno.1993.1019; Saito-Ohara F, 2002, AM J HUM GENET, V71, P637, DOI 10.1086/342208; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Sood R, 2004, CYTOGENET GENOME RES, V106, P61, DOI 10.1159/000078563; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Tadin-Strapps M, 2004, CYTOGENET GENOME RES, V107, P68, DOI 10.1159/000079573; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; Thomas NS, 2008, HUM GENET, V123, P607, DOI 10.1007/s00439-008-0510-z; TUZUN E, 2005, NAT GENET; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	52	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8269	10.1371/journal.pone.0008269	http://dx.doi.org/10.1371/journal.pone.0008269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011547	Green Published, gold			2022-12-27	WOS:000272830300025
J	Peckys, DB; Veith, GM; Joy, DC; de Jonge, N				Peckys, Diana B.; Veith, Gabriel M.; Joy, David C.; de Jonge, Niels			Nanoscale Imaging of Whole Cells Using a Liquid Enclosure and a Scanning Transmission Electron Microscope	PLOS ONE			English	Article							TOMOGRAPHY; INTERFACE; GROWTH; STEM	Nanoscale imaging techniques are needed to investigate cellular function at the level of individual proteins and to study the interaction of nanomaterials with biological systems. We imaged whole fixed cells in liquid state with a scanning transmission electron microscope (STEM) using a micrometer-sized liquid enclosure with electron transparent windows providing a wet specimen environment. Wet-STEM images were obtained of fixed E. coli bacteria labeled with gold nanoparticles attached to surface membrane proteins. Mammalian cells (COS7) were incubated with gold-tagged epidermal growth factor and fixed. STEM imaging of these cells resulted in a resolution of 3 nm for the gold nanoparticles. The wet-STEM method has several advantages over conventional imaging techniques. Most important is the capability to image whole fixed cells in a wet environment with nanometer resolution, which can be used, e. g., to map individual protein distributions in/on whole cells. The sample preparation is compatible with that used for fluorescent microscopy on fixed cells for experiments involving nanoparticles. Thirdly, the system is rather simple and involves only minimal new equipment in an electron microscopy (EM) laboratory.	[Peckys, Diana B.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA; [Peckys, Diana B.; Veith, Gabriel M.; de Jonge, Niels] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN USA; [Joy, David C.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [de Jonge, Niels] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; Vanderbilt University	Peckys, DB (corresponding author), Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA.	niels.de.jonge@vanderbilt.edu	de Jonge, Niels/B-5677-2008; Peckys, Diana B./B-4642-2015	de Jonge, Niels/0000-0002-3969-6821; Peckys, Diana/0000-0002-2972-9714; Veith, Gabriel/0000-0002-5186-4461	Oak Ridge National Laboratory (ORNL) Center for Nanophase Materials Science; Scientific User Facilities Division, Office of Basic Energy Sciences, U. S. Department of Energy; ORNL; Vanderbilt University Medical Center; National Institutes of Health (NIH) [R01-RR018470]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018470] Funding Source: NIH RePORTER	Oak Ridge National Laboratory (ORNL) Center for Nanophase Materials Science; Scientific User Facilities Division, Office of Basic Energy Sciences, U. S. Department of Energy(United States Department of Energy (DOE)); ORNL; Vanderbilt University Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Electron microscope access was supported by the Oak Ridge National Laboratory (ORNL) Center for Nanophase Materials Science, sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U. S. Department of Energy. Research was sponsored by the Laboratory Directed Research and Development (LDRD) Program of ORNL, managed by UT-Battelle, LLC, for the U. S. Department of Energy, by Vanderbilt University Medical Center (for NJ), and by National Institutes of Health (NIH) grant R01-RR018470 (to P. Mazur for DBP and NJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanc NS, 1998, J MICROSC-OXFORD, V192, P194, DOI 10.1046/j.1365-2818.1998.00420.x; Bogner A, 2005, ULTRAMICROSCOPY, V104, P290, DOI 10.1016/j.ultramic.2005.05.005; Bozzola J. J., 1992, ELECT MICROSCOPY; CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338; Daulton TL, 2001, MICROSC MICROANAL, V7, P470; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; de Jonge N., 2007, MICROSC MICROANAL S2, V13, P242; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Glauert A.M., 1998, BIOL SPECIMEN PREPAR; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hoenger A, 2009, CURR OPIN CELL BIOL, V21, P89, DOI 10.1016/j.ceb.2008.12.003; Iancu CV, 2006, J STRUCT BIOL, V153, P231, DOI 10.1016/j.jsb.2005.12.004; Ibaraki N, 1996, EXP EYE RES, V63, P683, DOI 10.1006/exer.1996.0162; Kirk S, 2009, J MICROSC-OXFORD, V233, P205, DOI 10.1111/j.1365-2818.2009.03111.x; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Liu KL, 2008, LAB CHIP, V8, P1915, DOI 10.1039/b804986f; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Pansons D.F., 1974, Advances Biol Med Physics, V15, P161; Reimer L., 1984, TRANSMISSION ELECT M; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sousa AA, 2008, J STRUCT BIOL, V162, P14, DOI 10.1016/j.jsb.2008.01.007; Stahlberg H, 2008, ACS CHEM BIOL, V3, P268, DOI 10.1021/cb800037d; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Xiao Y, 2003, SCIENCE, V299, P1877, DOI 10.1126/science.1080664	30	69	69	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8214	10.1371/journal.pone.0008214	http://dx.doi.org/10.1371/journal.pone.0008214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20020038	Green Published, Green Submitted, gold			2022-12-27	WOS:000272830300007
J	Dard, N; Louvet-Vallee, S; Maro, B				Dard, Nicolas; Louvet-Vallee, Sophie; Maro, Bernard			Orientation of Mitotic Spindles during the 8-to 16-Cell Stage Transition in Mouse Embryos	PLOS ONE			English	Article							CELL-DIVISION; BLASTOMERES; ALLOCATION; BLASTOCYST; MORULAE; EZRIN; INNER	Background: Asymmetric cell divisions are involved in the divergence of the first two lineages of the pre-implantation mouse embryo. They first take place after cell polarization ( during compaction) at the 8-cell stage. It is thought that, in contrast to many species, spindle orientation is random, although there is no direct evidence for this. Methodology/Principal Findings: Tubulin-GFP and live imaging with a spinning disk confocal microscope were used to directly study spindle orientation in whole embryos undergoing the 8- to 16-cell stage transition. This approach allowed us to determine that there is no predetermined cleavage pattern in 8- cell compacted mouse embryos and that mitotic spindle orientation in live embryo is only modulated by the extent of cell rounding up during mitosis. Conclusions: These results clearly demonstrate that spindle orientation is not controlled at the 8- to 16-cell transition, but influenced by cell bulging during mitosis, thus reinforcing the idea that pre-implantation development is highly regulative and not pre-patterned.	[Dard, Nicolas; Louvet-Vallee, Sophie] CNRS, UMR7622, Lab Biol Cellulaire Dev, Paris, France; [Dard, Nicolas; Louvet-Vallee, Sophie] Univ Paris 06, UMR7622, Lab Biol Cellulaire Dev, Paris, France; [Maro, Bernard] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine	Dard, N (corresponding author), CNRS, UMR7622, Lab Biol Cellulaire Dev, Paris, France.	nicolas.dard@upmc.fr	Maro, Bernard/AAL-2220-2020	Louvet, Sophie/0000-0001-7577-2329; DARD, Nicolas/0000-0001-7036-2275	Association pour la Recherche contre le Cancer [ARC-3871]; Agence Nationale pour la Recherche [ANR-05-BLAN-0120-01]; Ligue Nationale Contre le Cancer	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from Association pour la Recherche contre le Cancer to SLV (ARC-3871), and from Agence Nationale pour la Recherche to BM (ANR-05-BLAN-0120-01). ND was the recipient of fellowship from the Ligue Nationale Contre le Cancer and a post-doctoral contract from Agence Nationale pour la Recherche (ANR-05-BLAN-0120-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Dard N, 2001, DEV BIOL, V233, P161, DOI 10.1006/dbio.2001.0192; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007117; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; HANDYSIDE AH, 1981, J REPROD IMMUNOL, V2, P339, DOI 10.1016/0165-0378(81)90004-8; JOHNSTON CW, 1986, J CLIN EXP NEUROPSYC, V8, P93, DOI 10.1080/01688638608401299; KELLY SJ, 1978, J EMBRYOL EXP MORPH, V48, P37; Maro B, 1991, Dev Suppl, V1, P17; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; PICKERING SJ, 1988, DEVELOPMENT, V103, P353; SPINDLE AI, 1982, J EXP ZOOL, V235, P361; SURANI MAH, 1984, DEV BIOL, V102, P335, DOI 10.1016/0012-1606(84)90198-2	15	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8171	10.1371/journal.pone.0008171	http://dx.doi.org/10.1371/journal.pone.0008171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997595	Green Published, gold			2022-12-27	WOS:000272829200010
J	Olman, CA; Davachi, L; Inati, S				Olman, Cheryl A.; Davachi, Lila; Inati, Souheil			Distortion and Signal Loss in Medial Temporal Lobe	PLOS ONE			English	Article							ECHO-PLANAR FMRI; GRADIENT-ECHO; HUMAN BRAIN; SPIN-ECHO; PHYSIOLOGICAL NOISE; SPATIAL-RESOLUTION; BOLD FMRI; 7 T; EPI; ARTIFACTS	Background: The medial temporal lobe (MTL) contains subregions that are subject to severe distortion and signal loss in functional MRI. Air/tissue and bone/tissue interfaces in the vicinity of the MTL distort the local magnetic field due to differences in magnetic susceptibility. Fast image acquisition and thin slices can reduce the amount of distortion and signal loss, but at the cost of image signal-to-noise ratio (SNR). Methodology/Principal Findings: In this paper, we quantify the severity of distortion and signal loss in MTL subregions for three different echo planar imaging (EPI) acquisitions at 3 Tesla: a conventional moderate-resolution EPI (36363 mm), a conventional high-resolution EPI (1.5x1.5x2 mm), and a zoomed high-resolution EPI. We also demonstrate the advantage of reversing the phase encode direction to control the direction of distortion and to maximize efficacy of distortion compensation during data post-processing. With the high-resolution zoomed acquisition, distortion is not significant and signal loss is present only in the most anterior regions of the parahippocampal gyrus. Furthermore, we find that the severity of signal loss is variable across subjects, with some subjects showing negligible loss and others showing more dramatic loss. Conclusions/Significance: Although both distortion and signal loss are minimized in a zoomed field of view acquisition with thin slices, this improvement in accuracy comes at the cost of reduced SNR. We quantify this trade-off between distortion and SNR in order to provide a decision tree for design of high-resolution experiments investigating the function of subregions in MTL.	[Olman, Cheryl A.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Olman, Cheryl A.] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA; [Davachi, Lila; Inati, Souheil] NYU, Dept Psychol, New York, NY 10003 USA; [Davachi, Lila; Inati, Souheil] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; New York University; New York University	Olman, CA (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	caolman@umn.edu		Olman, Cheryl/0000-0002-7324-6461; Inati, Souheil/0000-0001-5596-9554; Davachi, Lila/0000-0003-4317-0889	Seaver Foundation; McKnight Foundation; NIH National Institute of Mental Health [MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	Seaver Foundation; McKnight Foundation; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge support from the Seaver Foundation and the McKnight Foundation (http://www.mcknight.org/), as well as an NIH National Institute of Mental Health (http://www.nimh.nih.gov/index.shtml) award MH074692 to L. Davachi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Constable RT, 1995, JMRI-J MAGN RESON IM, V5, P746, DOI 10.1002/jmri.1880050622; Cordes D, 2000, MAGN RESON IMAGING, V18, P1055, DOI 10.1016/S0730-725X(00)00199-5; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; De Panfilis C, 2005, NEUROIMAGE, V25, P112, DOI 10.1016/j.neuroimage.2004.11.014; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; FLEYSHER L, 2005, P INT SOC MAGN RES M, V13, P2685; FLEYSHER R, 2005, P INT SOC MAGNETIC R, V13; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Heberlein KA, 2004, MAGN RESON MED, V51, P212, DOI 10.1002/mrm.10680; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Merboldt KD, 2000, J MAGN RESON, V145, P184, DOI 10.1006/jmre.2000.2105; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Norris DG, 2002, NEUROIMAGE, V15, P719, DOI 10.1006/nimg.2001.1005; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103; Pruessmann Klaas P, 2004, Top Magn Reson Imaging, V15, P237, DOI 10.1097/01.rmr.0000139297.66742.4e; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; PRUESSNER JC, 2002, CEREBRAL CORTEX, V12; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Schmidt CF, 2005, NEUROIMAGE, V25, P625, DOI 10.1016/j.neuroimage.2004.12.002; SEKIHARA K, 1987, MED PHYS, V14, P1087, DOI 10.1118/1.595989; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stenger VA, 2000, MAGNET RESON MED, V44, P525, DOI 10.1002/1522-2594(200010)44:4<525::AID-MRM5>3.0.CO;2-L; Thesen S, 2003, P INT SOC MAGN RESON, V11, P1025; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Van de Moortele PF, 2002, MAGNET RESON MED, V47, P888, DOI 10.1002/mrm.10145; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Weiskopf N, 2007, MAGN RESON MATER PHY, V20, P39, DOI 10.1007/s10334-006-0067-6; Weismann August, 1906, Archiv Rassenbiol Berlin, V3; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Zheng J, 1997, JMRI-J MAGN RESON IM, V7, P843, DOI 10.1002/jmri.1880070511	43	77	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8160	10.1371/journal.pone.0008160	http://dx.doi.org/10.1371/journal.pone.0008160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997633	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000012
J	Elfving, K; Olsen, B; Bergstrom, S; Waldenstrom, J; Lundkvist, A; Sjostedt, A; Mejlon, H; Nilsson, K				Elfving, Karin; Olsen, Bjorn; Bergstrom, Sven; Waldenstrom, Jonas; Lundkvist, Ake; Sjostedt, Anders; Mejlon, Hans; Nilsson, Kenneth			Dissemination of Spotted Fever Rickettsia Agents in Europe by Migrating Birds	PLOS ONE			English	Article							PASSERINE BIRDS; INFECTED TICKS; HELVETICA; AESCHLIMANNII; PREVALENCE	Migratory birds are known to play a role as long-distance vectors for many microorganisms. To investigate whether this is true of rickettsial agents as well, we characterized tick infestation and gathered ticks from 13,260 migratory passerine birds in Sweden. A total of 1127 Ixodes spp. ticks were removed from these birds and the extracted DNA from 957 of them was available for analyses. The DNA was assayed for detection of Rickettsia spp. using real-time PCR, followed by DNA sequencing for species identification. Rickettsia spp. organisms were detected in 108 (11.3%) of the ticks. Rickettsia helvetica, a spotted fever rickettsia associated with human infections, was predominant among the PCR-positive samples. In 9 (0.8%) of the ticks, the partial sequences of 17kDa and ompB genes showed the greatest similarity to Rickettsia monacensis, an etiologic agent of Mediterranean spotted fever-like illness, previously described in southern Europe as well as to the Rickettsia sp. IrITA3 strain. For 15 (1.4%) of the ticks, the 17kDa, ompB, gltA and ompA genes showed the greatest similarity to Rickettsia sp. strain Davousti, Rickettsia japonica and Rickettsia heilongjiangensis, all closely phylogenetically related, the former previously found in Amblyomma tholloni ticks in Africa and previously not detected in Ixodes spp. ticks. The infestation prevalence of ticks infected with rickettsial organisms was four times higher among ground foraging birds than among other bird species, but the two groups were equally competent in transmitting Rickettsia species. The birds did not seem to serve as reservoir hosts for Rickettsia spp., but in one case it seems likely that the bird was rickettsiemic and that the ticks had acquired the bacteria from the blood of the bird. In conclusion, migratory passerine birds host epidemiologically important vector ticks and Rickettsia species and contribute to the geographic distribution of spotted fever rickettsial agents and their diseases.	[Elfving, Karin; Waldenstrom, Jonas; Nilsson, Kenneth] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Olsen, Bjorn; Waldenstrom, Jonas] Kalmar Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Lundkvist, Ake] Swedish Inst Infect Dis Control, Solna, Sweden; [Sjostedt, Anders] Umea Univ Hosp, Dept Clin Microbiol, S-90185 Umea, Sweden; [Mejlon, Hans] Uppsala Univ, Museum Evolut, Uppsala, Sweden; [Nilsson, Kenneth] Clin Res Ctr, Dalarna, Falun, Sweden; [Elfving, Karin; Nilsson, Kenneth] Falun Cent Hosp, Dept Clin Microbiol, Falun, Sweden	Uppsala University; Uppsala University Hospital; Linnaeus University; University of Kalmar; Umea University; Swedish Institute for Infectious Disease Control; Umea University; Uppsala University; Falun Hospital	Elfving, K (corresponding author), Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden.	kenneth.nilsson@medsci.uu.se	Sjöstedt, Anders/AAC-6575-2020; Waldenström, Jonas/E-4460-2013	Sjöstedt, Anders/0000-0002-0768-8405; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council [07922]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Formas; Swedish Foundation for Strategic Research; JC Kempe Foundation; National Institutes of Health [AI37248]; Center of Clinical Research Dalarna [9028]; Uppsala Orebro-Regional Research Council [25021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037248] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Formas(Swedish Research Council Formas); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); JC Kempe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Clinical Research Dalarna; Uppsala Orebro-Regional Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the grants from the Swedish Research Council (VR-M) 07922, the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Formas), Swedish Foundation for Strategic Research, the JC Kempe Foundation, National Institutes of Health grant AI37248 and also by grants from the Center of Clinical Research Dalarna (9028) and Uppsala Orebro-Regional Research Council (25021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1986, INFECT IMMUN, V51, P394, DOI 10.1128/IAI.51.2.394-396.1986; Bjoersdorff A, 2001, EMERG INFECT DIS, V7, P877; Bown KJ, 2003, EMERG INFECT DIS, V9, P63; BURGDORFER W, 1975, ANN NY ACAD SCI, V266, P61, DOI 10.1111/j.1749-6632.1975.tb35088.x; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; BURGDORFER W, 1966, B WORLD HEALTH ORGAN, V35, P149; Choi YJ, 2005, CLIN DIAGN LAB IMMUN, V12, P759, DOI 10.1128/CDLI.12.6.759-763.2005; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; COWAN G.O., 2003, MANSONS TROPICAL DIS, V21, P891; Fournier PE, 2000, EMERG INFECT DIS, V6, P389, DOI 10.3201/eid0604.000412; Fournier PE, 2002, J CLIN MICROBIOL, V40, P2176, DOI 10.1128/JCM.40.6.2176-2181.2002; Fransson T., 2008, SWEDISH BIRD RINGING, V3; Leitner M, 2002, AM J TROP MED HYG, V67, P166, DOI 10.4269/ajtmh.2002.67.166; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; Matsumoto K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-74; Nilsson K, 1999, LANCET, V354, P1169, DOI 10.1016/S0140-6736(99)04093-3; Nilsson K, 2009, J INFECTION, V58, P79, DOI 10.1016/j.jinf.2008.06.005; Nilsson K, 1997, J CLIN MICROBIOL, V35, P243, DOI 10.1128/JCM.35.1.243-247.1997; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Olsen B, 1998, EPIDEMIOL INFECT, V121, P481, DOI 10.1017/S0950268898001320; Palmgren H, 1997, SCAND J INFECT DIS, V29, P565, DOI 10.3109/00365549709035895; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Santos-Silva MM, 2006, EXP APPL ACAROL, V39, P331, DOI 10.1007/s10493-006-9008-3; Sekeyova Z, 2000, J MED ENTOMOL, V37, P707, DOI 10.1603/0022-2585-37.5.707; Shpynov S, 2004, J CLIN MICROBIOL, V42, P2221, DOI 10.1128/JCM.42.5.2221-2223.2004; Simser JA, 2002, APPL ENVIRON MICROB, V68, P4559, DOI 10.1128/AEM.68.9.4559-4566.2002; STANCZAK J, 2009, INT JEN S TICK BORN; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416	33	105	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8572	10.1371/journal.pone.0008572	http://dx.doi.org/10.1371/journal.pone.0008572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052286	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338500015
J	Dias, JM; Losberger, C; Deruaz, M; Power, CA; Proudfoot, AEI; Shaw, JP				Dias, Joao M.; Losberger, Christophe; Deruaz, Maud; Power, Christine A.; Proudfoot, Amanda E. I.; Shaw, Jeffrey P.			Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3	PLOS ONE			English	Article							ELECTRON-DENSITY MAPS; MIP-1-ALPHA; RANTES; IDENTIFICATION; MANIPULATION; REFINEMENT; MIP-1-BETA; MIMICRY; SYSTEM	Background:Chemokines are a subset of cytokines responsible for controlling the cellular migration of inflammatory cells through interaction with seven transmembrane G protein-coupled receptors. The blocking of a chemokine-receptor interaction results in a reduced inflammatory response, and represents a possible anti-inflammatory strategy, a strategy that is already employed by some virus and parasites. Anti-chemokine activity has been described in the extracts of tick salivary glands, and we have recently described the cloning and characterization of such chemokine binding proteins from the salivary glands, which we have named Evasins. Methodology/Principal Findings: We have solved the structure of Evasin-1, a very small and highly selective chemokinebinding protein, by x-ray crystallography and report that the structure is novel, with no obvious similarity to the previously described structures of viral chemokine binding proteins. Moreover it does not possess a known fold. We have also solved the structure of the complex of Evasin-1 and its high affinity ligand, CCL3. The complex is a 1:1 heterodimer in which the Nterminal region of CCL3 forms numerous contacts with Evasin-1, including prominent it-it interactions between residues Trp89 and Phe14 of the binding protein and Phe29 and Phe13 of the chemokine. Conclusions/Significance:However, these interactions do not appear to be crucial for the selectivity of the binding protein, since these residues are found in CCL5, which is not a ligand for Evasin-1. The selectivity of the interaction would appear to lie in the N-terminal residues of the chemokine, which form the "address" whereas the hydrophobic interactions in the rest of the complex would serve primarily to stabilize the complex. A thorough understanding of the binding mode of this small protein, and its other family members, could be very informative in the design of potent neutralizing molecules of proinflammatory mediators of the immune system, such as chemokines.	[Dias, Joao M.; Losberger, Christophe; Deruaz, Maud; Power, Christine A.; Proudfoot, Amanda E. I.; Shaw, Jeffrey P.] Merck Serono SA, Merck Serono Geneva Res Ctr, Geneva, Switzerland	Merck KGaA; EMD Serono Inc.	Dias, JM (corresponding author), Scripps Res Inst, Ollmann Saphire Lab, La Jolla, CA 92037 USA.	Jeffrey.Shaw@merckserono.net			European Union [LSHB-CT-2005-518167]	European Union(European Commission)	J.M.D. was a Serono SA-funded and employed postdoctoral fellow. This research was financed by internal funding from MerckSerono SA. The funders had no role in study design, data collection and analysis, or preparation of the manuscript and approved the decision to publish. AEIP and MD were also partially supported by the European Union FP6 (INNOCHEM, grant number LSHB-CT-2005-518167).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 2003, METH MOL B, V239, P167; Alcami A, 2007, EUR J IMMUNOL, V37, P880, DOI 10.1002/eji.200737215; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Blanpain C, 2001, J LEUKOCYTE BIOL, V69, P977; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeRider ML, 2006, J BIOMOL NMR, V36, P22, DOI [10.1007/s10858-005-6276-x, 10.1007/s10858-006-9021-1]; DERUAZ M, 2008, J EXP MED; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x; Hajnicka V, 2005, PARASITOLOGY, V130, P333, DOI 10.1017/S0031182004006535; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Johnson Z, 2003, INFLAMM RES, V52, pS187, DOI 10.1007/BF03354218; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lorenzo ME, 2001, SEMIN IMMUNOL, V13, P1, DOI 10.1006/smim.2000.0290; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nuara AA, 2007, J GEN VIROL, V88, P51, DOI 10.1099/vir.0.82324-0; Nuara AA, 2006, J VIROL, V80, P10675, DOI 10.1128/JVI.01015-06; Nuttall PA, 1998, PARASITOLOGY, V116, pS65, DOI 10.1017/S003118200008495X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Proudfoot AEI, 2000, METH MOL B, V138, P75; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P215; PROUDFOOT AEI, 1995, FEBS LETT, V376, P19, DOI 10.1016/0014-5793(95)01235-X; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Roovers RC, 2007, CURR OPIN MOL THER, V9, P327; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Tasaki Y, 1999, GENOMICS, V55, P353, DOI 10.1006/geno.1998.5670; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zoffmann S, 2001, J MED CHEM, V44, P215, DOI 10.1021/jm000982i	56	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8514	10.1371/journal.pone.0008514	http://dx.doi.org/10.1371/journal.pone.0008514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041127	gold, Green Submitted, Green Published			2022-12-27	WOS:000278068700025
J	Dillon, J; Andrianakis, I; Bull, K; Glautier, S; O'Connor, V; Holden-Dye, L; James, C				Dillon, James; Andrianakis, Ioannis; Bull, Kate; Glautier, Steve; O'Connor, Vincent; Holden-Dye, Lindy; James, Christopher			AutoEPG: Software for the Analysis of Electrical Activity in the Microcircuit Underpinning Feeding Behaviour of Caenorhabditis elegans	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; C-ELEGANS; GLUTAMATERGIC NEUROTRANSMISSION; 5-HT7-LIKE RECEPTOR; PHARYNGEAL MUSCLE; MOTOR-NEURON; SYSTEM; 5-HT; CONDUCTANCE; MOVEMENT	Background: The pharyngeal microcircuit of the nematode Caenorhabditis elegans serves as a model for analysing neural network activity and is amenable to electrophysiological recording techniques. One such technique is the electropharyngeogram (EPG) which has provided insight into the genetic basis of feeding behaviour, neurotransmission and muscle excitability. However, the detailed manual analysis of the digital recordings necessary to identify subtle differences in activity that reflect modulatory changes within the underlying network is time consuming and low throughput. To address this we have developed an automated system for the high-throughput and discrete analysis of EPG recordings (AutoEPG). Methodology/Principal Findings: AutoEPG employs a tailor made signal processing algorithm that automatically detects different features of the EPG signal including those that report on the relaxation and contraction of the muscle and neuronal activity. Manual verification of the detection algorithm has demonstrated AutoEPG is capable of very high levels of accuracy. We have further validated the software by analysing existing mutant strains with known pharyngeal phenotypes detectable by the EPG. In doing so, we have more precisely defined an evolutionarily conserved role for the calcium-dependent potassium channel, SLO-1, in modulating the rhythmic activity of neural networks. Conclusions/Significance: AutoEPG enables the consistent analysis of EPG recordings, significantly increases analysis throughput and allows the robust identification of subtle changes in the electrical activity of the pharyngeal nervous system. It is anticipated that AutoEPG will further add to the experimental tractability of the C. elegans pharynx as a model neural circuit.	[Dillon, James; Bull, Kate; O'Connor, Vincent; Holden-Dye, Lindy] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Andrianakis, Ioannis; James, Christopher] Univ Southampton, Signal Proc & Control Grp, Inst Sound & Vibrat Res, Southampton, Hants, England; [Glautier, Steve] Univ Southampton, Sch Psychol, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Dillon, J (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	jcd@soton.ac.uk	James, Christopher/AAV-4770-2020; Glautier, Steven/H-5444-2011	Glautier, Steven/0000-0001-8852-3268; Holden-Dye, Lindy/0000-0002-9704-1217; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483	BBSRC [BB/E022251/1]; Biotechnology and Biological Sciences Research Council [BB/E022251/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been funded by the BBSRC (www.bbsrc.ac.uk) as part of a 'cross-council MRC/BBSRC initiative in mental health.' Grant Number BB/E022251/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BRENNER S, 1974, GENETICS, V77, P71; Buckingham Steven D., 2008, Invertebrate Neuroscience, V8, P121, DOI 10.1007/s10158-008-0077-3; Chiang JTA, 2006, J EXP BIOL, V209, P1859, DOI 10.1242/jeb.02165; Cronin Christopher J., 2006, V351, P241; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; Holden-Dye Lindy, 2007, Invertebrate Neuroscience, V7, P199, DOI 10.1007/s10158-007-0057-z; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; James CJ, 1999, CLIN NEUROPHYSIOL, V110, P2049, DOI 10.1016/S1388-2457(99)00168-6; James CJ, 2003, ARTIF INTELL MED, V28, P89, DOI 10.1016/S0933-3657(03)00037-X; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li HY, 1997, P NATL ACAD SCI USA, V94, P5912, DOI 10.1073/pnas.94.11.5912; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Restif C, 2008, LECT NOTES COMPUT SC, V5241, P35, DOI 10.1007/978-3-540-85988-8_5; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; Tsechpenakis G, 2008, IEEE T BIO-MED ENG, V55, P1539, DOI 10.1109/TBME.2008.918582; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0	35	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8482	10.1371/journal.pone.0008482	http://dx.doi.org/10.1371/journal.pone.0008482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041123	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000273105200015
J	Fenton, K; Fismen, S; Hedberg, A; Seredkina, N; Fenton, C; Mortensen, ES; Rekvig, OP				Fenton, Kristin; Fismen, Silje; Hedberg, Annica; Seredkina, Natalya; Fenton, Chris; Mortensen, Elin Synnove; Rekvig, Ole Petter			Anti-dsDNA Antibodies Promote Initiation, and Acquired Loss of Renal Dnase1 Promotes Progression of Lupus Nephritis in Autoimmune (NZBxNZW)F1 Mice	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; MATRIX-METALLOPROTEINASE ACTIVITY; MURINE LUPUS; ALPHA-ACTININ; MATRIX-METALLOPROTEINASE-9 EXPRESSION; NEPHRITOGENIC ANTIBODIES; BASEMENT-MEMBRANE; PLASMA-LEVELS; HUMAN GENOME; HUMAN SLE	Background: Lupus nephritis is characterized by deposition of chromatin fragment-IgG complexes in the mesangial matrix and glomerular basement membranes (GBM). The latter defines end-stage disease. Methodology/Principals: In the present study we determined the impact of antibodies to dsDNA, renal Dnase1 and matrix metalloprotease (MMP) mRNA levels and enzyme activities on early and late events in murine lupus nephritis. The major focus was to analyse if these factors were interrelated, and if changes in their expression explain basic processes accounting for lupus nephritis. Findings: Early phases of nephritis were associated with chromatin-IgG complex deposition in the mesangial matrix. A striking observation was that this event correlated with appearance of anti-dsDNA antibodies and mild or clinically silent nephritis. These events preceded down-regulation of renal Dnase1. Later, renal Dnase1 mRNA level and enzyme activity were reduced, while MMP2 mRNA level and enzyme activity increased. Reduced levels of renal Dnase1 were associated in time with deficient fragmentation of chromatin from dead cells. Large fragments were retained and accumulated in GBM. Also, since chromatin fragments are prone to stimulate Toll-like receptors in e. g. dendritic cells, this may in fact explain increased expression of MMPs. Significance: These scenarios may explain the basis for deposition of chromatin-IgG complexes in glomeruli in early and late stages of nephritis, loss of glomerular integrity and finally renal failure.	[Fenton, Kristin; Hedberg, Annica; Seredkina, Natalya; Rekvig, Ole Petter] Univ Tromso, Inst Med Biol, Dept Biochem, Fac Med, Tromso, Norway; [Mortensen, Elin Synnove] Univ Tromso, Inst Med Biol, Dept Pathol, Fac Med, Tromso, Norway; [Fismen, Silje; Mortensen, Elin Synnove] Univ Hosp No Norway, Dept Pathol, Tromso, Norway; [Rekvig, Ole Petter] Univ Hosp No Norway, Dept Rheumatol, Tromso, Norway; [Fenton, Chris] Univ Tromso, Fac Med, Microarray Platform, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Fenton, K (corresponding author), Univ Tromso, Inst Med Biol, Dept Biochem, Fac Med, Tromso, Norway.	olepr@fagmed.uit.no	Rekvig, Ole Petter/V-7113-2019; Fenton, Kristin/AAY-4459-2021	Fenton, Kristin/0000-0002-8356-2628	Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization [2004/2/0250]; Northern Norway Regional Health Authority Medical Research Program [SFP-100-04, SFP-101-04]; Thematic Research Support; University of Tromso	Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization; Northern Norway Regional Health Authority Medical Research Program; Thematic Research Support; University of Tromso	This work was supported by Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization (project 2004/2/0250), from Northern Norway Regional Health Authority Medical Research Program (Grants # SFP-100-04, SFP-101-04, and Thematic Research Support), and from University of Tromso, as a Milieu support given to OPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amital H, 2005, J IMMUNOL, V175, P5516, DOI 10.4049/jimmunol.175.8.5516; Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Amoura Z, 1999, ARTHRITIS RHEUM, V42, P833, DOI 10.1002/1529-0131(199905)42:5<833::AID-ANR1>3.3.CO;2-K; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; CHAN TM, 1992, CLIN EXP IMMUNOL, V88, P68; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen M, 2005, RENAL FAILURE, V27, P507, DOI 10.1080/08860220500198151; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Daikh D, 1997, J LEUKOCYTE BIOL, V62, P156, DOI 10.1002/jlb.62.2.156; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Doerfler W, 2006, CURR TOP MICROBIOL, V301, P125; Gesualdi NM, 2007, STRESS, V10, P342, DOI 10.1080/10253890701314863; Haugbro K, 2004, ANN RHEUM DIS, V63, P386, DOI 10.1136/ard.2003.016303; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, ARTHRITIS RHEUM-US, V54, P914, DOI 10.1002/art.21622; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Krieg AM, 1998, BIODRUGS, V10, P341, DOI 10.2165/00063030-199810050-00001; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Krieg AM, 2007, IMMUNITY, V27, P695, DOI 10.1016/j.immuni.2007.11.001; Licht R, 2001, ARTHRITIS RHEUM-US, V44, P1320, DOI 10.1002/1529-0131(200106)44:6<1320::AID-ART224>3.0.CO;2-X; Lim EJ, 2006, FEBS LETT, V580, P4533, DOI 10.1016/j.febslet.2006.06.100; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; Mason LJ, 2004, ARTHRITIS RHEUM-US, V50, P866, DOI 10.1002/art.20103; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Mjelle JE, 2007, ANN RHEUM DIS, V66, P1661, DOI 10.1136/ard.2007.070482; Nephritis L, 2008, AM J PATHOL, V172, P275, DOI 10.2353/ajpath.2008.070563; Mortensen ES, 2009, J AM SOC NEPHROL, V20, P696, DOI 10.1681/ASN.2008010112; Mostoslavsky G, 2001, EUR J IMMUNOL, V31, P1221, DOI 10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Napirei M, 2004, ARTHRITIS RHEUM-US, V50, P1873, DOI 10.1002/art.20267; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Qureshi F, 2000, AM J REPROD IMMUNOL, V44, P136, DOI 10.1111/j.8755-8920.2000.440302.x; RADEKE HH, 1994, J IMMUNOL, V153, P1281; Rekvig OP, 2003, ARTHRITIS RHEUM-US, V48, P300, DOI 10.1002/art.10739; Rekvig OP, 1997, J CLIN INVEST, V99, P2045, DOI 10.1172/JCI119373; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Roth R, 1996, J IMMUNOL, V157, P2924; SABBAGA J, 1989, EUR J IMMUNOL, V19, P137, DOI 10.1002/eji.1830190122; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Seredkina N, 2009, AM J PATHOL IN PRESS; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Tveita AA, 2008, ARTHR RES T IN PRESS; Tveita AA, 2008, KIDNEY INT, V74, P1150, DOI 10.1038/ki.2008.308; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P485; Zhang Q, 2008, ANN RHEUM DIS, V67, P1633, DOI 10.1136/ard.2007.079574; Zykova SN, 2008, ARTHRITIS RHEUM-US, V58, P813, DOI 10.1002/art.23276	51	85	93	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8474	10.1371/journal.pone.0008474	http://dx.doi.org/10.1371/journal.pone.0008474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041189	Green Submitted, Green Published, gold			2022-12-27	WOS:000273105200010
J	Li, WLS; Rodrigo, AG				Li, Wai Lok Sibon; Rodrigo, Allen G.			Covariation of Branch Lengths in Phylogenies of Functionally Related Genes	PLOS ONE			English	Article							EVOLUTIONARY RATE VARIATION; INTERACTING PROTEINS; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; POSITIVE SELECTION; DIVERGENCE TIME; COEVOLUTION; PREDICTION; SEQUENCE; DATABASE	Recent studies have shown evidence for the coevolution of functionally-related genes. This coevolution is a result of constraints to maintain functional relationships between interacting proteins. The studies have focused on the correlation in gene tree branch lengths of proteins that are directly interacting with each other. We here hypothesize that the correlation in branch lengths is not limited only to proteins that directly interact, but also to proteins that operate within the same pathway. Using generalized linear models as a basis of identifying correlation, we attempted to predict the gene ontology (GO) terms of a gene based on its gene tree branch lengths. We applied our method to a dataset consisting of proteins from ten prokaryotic species. We found that the degree of accuracy to which we could predict the function of the proteins from their gene tree varied substantially with different GO terms. In particular, our model could accurately predict genes involved in translation and certain ribosomal activities with the area of the receiver-operator curve of up to 92%. Further analysis showed that the similarity between the trees of genes labeled with similar GO terms was not limited to genes that physically interacted, but also extended to genes functioning within the same pathway. We discuss the relevance of our findings as it relates to the use of phylogenetic methods in comparative genomics.	[Li, Wai Lok Sibon; Rodrigo, Allen G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; [Li, Wai Lok Sibon] Univ Auckland, Dept Comp Sci, Auckland 1, New Zealand; [Rodrigo, Allen G.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Li, WLS (corresponding author), Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand.	a.rodrigo@auckland.ac.nz	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317	Biomatters	Biomatters	Wai Lok Sibon Li was partially funded by Biomatters during the period of research outlined in this paper. The commercial funder was not involved in any of the following aspects of the research: study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit for publication. An early revision of the manuscript was first reviewed by the funder, but no changes were made as a result of the review. The algorithm described here may be implemented in the funding company's software packages. This will pose no restrictions toward anyone interested in reproducing or building on the algorithm, as the described algorithm uses generic statistical methods that are not exclusive to the authors' study, and that have previously been published. No patents have been placed on the methodology described. In addition, all data used in this paper is publicly available. The involvement of the funder does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; FOLEY DH, 1972, IEEE T INFORM THEORY, V18, P618, DOI 10.1109/TIT.1972.1054863; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Gertz J, 2003, BIOINFORMATICS, V19, P2039, DOI 10.1093/bioinformatics/btg278; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Jucovic M, 1996, P NATL ACAD SCI USA, V93, P2343, DOI 10.1073/pnas.93.6.2343; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kim WK, 2004, BIOINFORMATICS, V20, P1138, DOI 10.1093/bioinformatics/bth053; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; MARINORAMIREZ L, 2006, EVOLUTIONARY BIOINFO, P295; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2002, J VIROL, V76, P11715, DOI 10.1128/JVI.76.22.11715-11720.2002; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sato T., 2003, GENOME INFORM, V14, P496; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Shakhnovich BE, 2005, GENOME RES, V15, P385, DOI 10.1101/gr.3133605; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro BJ, 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.0040023.eor, 10.1371/journal.pgen.0040023]; SIEPEL A, 2006, NEW METHODS DETECTIN, DOI DOI 10.1007/11732990; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh S, 2008, EVOL BIOINFORM, V4, P217; Sumiyama K, 2002, MOL BIOL EVOL, V19, P1093, DOI 10.1093/oxfordjournals.molbev.a004167; Tan SH, 2004, NUCLEIC ACIDS RES, V32, pW69, DOI 10.1093/nar/gkh471; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wolf YI, 2006, P ROY SOC B-BIOL SCI, V273, P1507, DOI 10.1098/rspb.2006.3472; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wu CH, 2004, COMPUT BIOL CHEM, V28, P87, DOI 10.1016/j.compbiolchem.2003.10.003; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8487	10.1371/journal.pone.0008487	http://dx.doi.org/10.1371/journal.pone.0008487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041191	gold, Green Published, Green Submitted			2022-12-27	WOS:000273105200019
J	May, MR; Provance, MC; Sanders, AC; Ellstrand, NC; Ross-Ibarra, J				May, Michael R.; Provance, Mitchell C.; Sanders, Andrew C.; Ellstrand, Norman C.; Ross-Ibarra, Jeffrey			A Pleistocene Clone of Palmer's Oak Persisting in Southern California	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-VARIATION; WILD RADISH; ANCIENT	Background: The distribution of Palmer's oak (Quercus palmeri Engelm.) includes numerous isolated populations that are presumably relicts of a formerly larger range that has contracted due to spreading aridity following the end of the Pleistocene. Principal Findings: We investigated a recently discovered disjunct population of Palmer's oak in the Jurupa Mountains of Riverside County, California. Patterns of allozyme polymorphism, morphological homogeneity, widespread fruit abortion, and evidence of fire resprouting all strongly support the hypothesis that the population is a single clone. The size of the clone and estimates of annual growth from multiple populations lead us to conclude that the clone is in excess of 13,000 years old. Conclusions: The ancient age of the clone implies it originated during the Pleistocene and is a relict of a vanished vegetation community. Range contraction after climate change best explains the modern disjunct distribution of Q. palmeri and perhaps other plants in California.	[May, Michael R.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; [Provance, Mitchell C.; Sanders, Andrew C.; Ellstrand, Norman C.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Ellstrand, Norman C.] Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Davis	May, MR (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	rossibarra@ucdavis.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954				Alfonso-Corrado C, 2004, EVOL ECOL, V18, P585, DOI 10.1007/s10682-004-5145-5; Ally D, 2008, MOL ECOL, V17, P4897, DOI 10.1111/j.1365-294X.2008.03962.x; ASHTON GC, 1961, AUST J BIOL SCI, V14, P248, DOI 10.1071/BI9610248; DeWoody J, 2008, WEST N AM NATURALIST, V68, P493, DOI 10.3398/1527-0904-68.4.493; ELLSTRAND NC, 1985, AM NAT, V126, P606, DOI 10.1086/284442; ELLSTRAND NC, 1984, AM NAT, V123, P819, DOI 10.1086/284241; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; *FLOR N AM ED COMM, 1993, FLOR N AM MEX; Griffin J, 1978, FREMONTIA, V6, P8; GRIFFIN J R, 1976, Madrono, V23, P295; Griffin JR, 1972, PSW82 USDA FOR SERV; HANDEL SN, 1985, AM NAT, V125, P367, DOI 10.1086/284348; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Leskinen P. H., 1975, Madrono, V23, P234; Lynch AJJ, 1998, AUST J BOT, V46, P25, DOI 10.1071/BT96120; Mayes SG, 1998, AM J BOT, V85, P1609, DOI 10.2307/2446489; Miller M, 2000, US FOR SERV RMRS-P, P9; MITTON JB, 1979, J HERED, V70, P86, DOI 10.1093/oxfordjournals.jhered.a109220; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Montalvo AM, 1997, AM J BOT, V84, P1553, DOI 10.2307/2446617; Owen LA, 2003, GEOLOGY, V31, P729, DOI 10.1130/G19561.1; PAYSEN TE, 1991, FOREST SCI, V37, P17; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Provance Mitchell C., 2000, Madrono, V47, P139; ROBERTS FM, 2004, VASCULAR PLANTS W RI; TUCKER J M, 1982, Aliso, V10, P321; VASEK FC, 1980, AM J BOT, V67, P246, DOI 10.2307/2442649; WARTER JK, 1976, SPECIAL PUBL CALIFOR, V2; WHERRY E T, 1972, Castanea, V37, P94	31	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8346	10.1371/journal.pone.0008346	http://dx.doi.org/10.1371/journal.pone.0008346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20041136	Green Published, gold			2022-12-27	WOS:000272998100004
J	Welford, MR; Bossak, BH				Welford, Mark R.; Bossak, Brian H.			Validation of Inverse Seasonal Peak Mortality in Medieval Plagues, Including the Black Death, in Comparison to Modern Yersinia pestis-Variant Diseases	PLOS ONE			English	Article							PNEUMONIC PLAGUE; RECORDS; EXTENT	Background: Recent studies have noted myriad qualitative and quantitative inconsistencies between the medieval Black Death (and subsequent "plagues'') and modern empirical Y. pestis plague data, most of which is derived from the Indian and Chinese plague outbreaks of A.D. 1900 +/- 15 years. Previous works have noted apparent differences in seasonal mortality peaks during Black Death outbreaks versus peaks of bubonic and pneumonic plagues attributed to Y. pestis infection, but have not provided spatiotemporal statistical support. Our objective here was to validate individual observations of this seasonal discrepancy in peak mortality between historical epidemics and modern empirical data. Methodology/Principal Findings: We compiled and aggregated multiple daily, weekly and monthly datasets of both Y. pestis plague epidemics and suspected Black Death epidemics to compare seasonal differences in mortality peaks at a monthly resolution. Statistical and time series analyses of the epidemic data indicate that a seasonal inversion in peak mortality does exist between known Y. pestis plague and suspected Black Death epidemics. We provide possible explanations for this seasonal inversion. Conclusions/Significance: These results add further evidence of inconsistency between historical plagues, including the Black Death, and our current understanding of Y. pestis-variant disease. We expect that the line of inquiry into the disputed cause of the greatest recorded epidemic will continue to intensify. Given the rapid pace of environmental change in the modern world, it is crucial that we understand past lethal outbreaks as fully as possible in order to prepare for future deadly pandemics.	[Welford, Mark R.] Georgia So Univ, Dept Geol & Geog, Statesboro, GA 30460 USA; [Bossak, Brian H.] Georgia So Univ, Jiann Ping Hsu Coll Publ Hlth, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University; University System of Georgia; Georgia Southern University	Welford, MR (corresponding author), Georgia So Univ, Dept Geol & Geog, Statesboro, GA 30460 USA.	bbossak@georgiasouthern.edu						Abu--Lughod Janet L, 1991, EUROPEAN HEGEMONY WO; Alexander J. T., 1980, BUBONIC PLAGUE EARLY; Bailey Mark, 2007, MEDIEVAL SUFFOLK ECO; Bell John, 1665, LONDONS REMEMBRANCER; Bell Walter George, 1951, GREAT PLAGUE LONDON; Benedictow O.J., 2004, BLACK DEATH 1346 135; Biraben J. - N., 1975, HOMMES PESTE FRANCE, V2; Biraben Jean-Noel, 1975, HOMMES PESTE FRANCE, V1; BOCCACCIO G, 1353, DECAMERON PRENCIPE G; Bossak BH, 2009, MED HYPOTHESES, V72, P749, DOI 10.1016/j.mehy.2008.12.045; Christakos G, 2007, PUBLIC HEALTH, V121, P700, DOI 10.1016/j.puhe.2006.12.011; Cohn Samuel K., 2002, BLACK DEATH TRANSFOR; Creighton Charles, 1965, HIST EPIDEMICS BRITA; Curson P. H., 1989, PLAGUE SYDNEY ANATOM; Duncan CJ, 2005, POSTGRAD MED J, V81, P315, DOI 10.1136/pgmj.2004.024075; Gras Pierre, 1939, BIBLIOTHEQUE ECOLE C, V100, P295, DOI DOI 10.3406/BEC.1939.449196; Graunt J, 1662, NATURAL POLITICAL OB; GYUG R, 1983, MEDIAEVAL STUD, V45, P385, DOI 10.1484/J.MS.2.306308; HORVATH R, 1962, STAT PESTE DEBRECEN; *IND PLAG COMM, 189899 IND PLAG COMM; Karlsson G, 1996, J MEDIEVAL HIST, V22, P263, DOI 10.1016/S0304-4181(96)00017-6; Kool JL, 2005, CLIN INFECT DIS, V40, P1166, DOI 10.1086/428617; Megson B., 1998, MEDIEVAL PROSOPOGRAP, V19, P125; Nishiura H, 2006, INT J EPIDEMIOL, V35, P1059, DOI 10.1093/ije/dyl091; PICARD L, 2005, ELIZABETHS LONDON EV; POLLITZER R, 1953, Bull World Health Organ, V9, P131; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6; Razi Z., 1980, LIFE MARRIAGE DEATH; SCOTT S, 1995, THESIS U LIVERPOOL; Scott S., 2001, BIOL PLAGUES EVIDENC; Scott Susan, 2004, RETURN BLACK DEATH W; SHAFONSKII A, 1775, OPISANIE MOROVOI IAZ; SHAROV LA, 1960, LIFE SIBERIA MANCHUR; Shrewsbury J.F.D., 1971, HIST BUBONIC PLAGUE; THOMPSON AH, 1911, ARCHAEOL J, V68, P301; Twigg G., 1984, BLACK DEATH BIOL REA; Wood J, 2003, LANCET INFECT DIS, V3, P327, DOI 10.1016/S1473-3099(03)00651-0; Wood JW, 2003, HUM BIOL, V75, P427, DOI 10.1353/hub.2003.0067; Wu LT, 1936, PLAGUE MANUAL MED PU; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662; EYAM PLAGUE DATA	41	22	22	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8401	10.1371/journal.pone.0008401	http://dx.doi.org/10.1371/journal.pone.0008401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	535US	20027294	Green Published, gold			2022-12-27	WOS:000272998000008
J	Kwant-Mitchell, A; Pek, EA; Rosenthal, KL; Ashkar, AA				Kwant-Mitchell, Amanda; Pek, Elishka A.; Rosenthal, Kenneth L.; Ashkar, Ali A.			Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BONE-MARROW; CORD BLOOD; HEMATOPOIETIC-CELLS; POTENTIAL ROLE; IMMUNE-SYSTEM; IN-VITRO; T-CELLS; ENGRAFTMENT; DEFICIENT	Studies of human NK cells and their role in tumor suppression have largely been restricted to in vitro experiments which lack the complexity of whole organisms, or mouse models which differ significantly from humans. In this study we showed that, in contrast to C57BL/6 Rag2(-/-)/gamma(-/-)(c) and NOD/Scid mice, newborn BALB/c Rag2(-/-)/gamma(-/-)(c) mice can support the development of human NK cells and CD56+ T cells after intrahepatic injection with hematopoietic stem cells. The human CD56(+) cells in BALB/c Rag2(-/-)/gamma(-/-)(c) mice were able to produce IFN-gamma in response to human IL-15 and polyI:C. NK cells from reconstituted Rag2(-/-)/gamma(-/-)(c) mice were also able to kill and inhibit the growth of K562 cells in vitro and were able to produce IFN-gamma in response to stimulation with K562 cells. In vivo, reconstituted Rag2(-/-)/gamma(-/-)(c) mice had higher survival rates after K562 challenge compared to non-reconstituted Rag2(-/-)/gamma(-/-)(c) mice and were able to control tumor burden in various organs. Reconstituted Rag2(-/-)/gamma(-/-)(c) mice represent a model in which functional human NK and CD56+ T cells can develop from stem cells and can thus be used to study human disease in a more clinically relevant environment.	[Kwant-Mitchell, Amanda; Pek, Elishka A.; Rosenthal, Kenneth L.; Ashkar, Ali A.] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Kwant-Mitchell, A (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada.	ashkara@mcmaster.ca		Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research; Canadian Breast Cancer Foundation (Ontario Chaper); RxD/CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation (Ontario Chaper); RxD/CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research and Canadian Breast Cancer Foundation (Ontario Chaper). AAA is a recipient of a career award in Health Sciences from Rx&D/CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Baxevanis CN, 2003, J IMMUNOL, V171, P2953, DOI 10.4049/jimmunol.171.6.2953; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; Cashman JD, 1997, BLOOD, V89, P4307, DOI 10.1182/blood.V89.12.4307; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Dewan MZ, 2006, CANCER SCI, V97, P1381, DOI 10.1111/j.1349-7006.2006.00319.x; FEUER G, 1995, J VIROL, V69, P1328, DOI 10.1128/JVI.69.2.1328-1333.1995; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Gritzapis AD, 2002, CANCER IMMUNOL IMMUN, V51, P440, DOI 10.1007/s00262-002-0298-y; Guimaraes F, 2006, LEUKEMIA, V20, P833, DOI 10.1038/sj.leu.2404147; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kalberer CP, 2003, BLOOD, V102, P127, DOI 10.1182/blood-2002-07-2024; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Langhans B, 2005, J IMMUNOL METHODS, V306, P161, DOI 10.1016/j.jim.2005.08.010; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Nieda M, 2001, BLOOD, V97, P2067, DOI 10.1182/blood.V97.7.2067; ORTALDO JR, 1991, CELL IMMUNOL, V136, P486, DOI 10.1016/0008-8749(91)90369-M; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583; Wallace ME, 2005, SPRINGER SEMIN IMMUN, V27, P49, DOI 10.1007/s00281-004-0195-x; WHITESIDE TL, 1995, CURR OPIN IMMUNOL, V7, P704, DOI 10.1016/0952-7915(95)80080-8; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Woo SY, 2003, BRIT J HAEMATOL, V121, P148, DOI 10.1046/j.1365-2141.2003.04230.x; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Yoshino H, 2000, BONE MARROW TRANSPL, V26, P1211, DOI 10.1038/sj.bmt.1702702; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657	48	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8379	10.1371/journal.pone.0008379	http://dx.doi.org/10.1371/journal.pone.0008379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027308	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100015
J	Tenenbaum, J; Ayoub, MA; Perkovska, S; Adra-Delenne, AL; Mendre, C; Ranchin, B; Bricca, G; Geelen, G; Mouillac, B; Durroux, T; Morin, D				Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Ranchin, Bruno; Bricca, Giamperro; Geelen, Ghislaine; Mouillac, Bernard; Durroux, Thierry; Morin, Denis			The Constitutively Active V2 Receptor Mutants Conferring NSIAD Are Weakly Sensitive to Agonist and Antagonist Regulation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; INAPPROPRIATE ANTIDIURESIS; NEPHROGENIC SYNDROME; BETA-ARRESTIN; LIVING CELLS; HYPONATREMIA; MUTATION; BRET	Patients having the nephrogenic syndrome of inappropriate antidiuresis present either the R137C or R137L V2 mutated receptor. While the clinical features have been characterized, the molecular mechanisms of functioning of these two mutants remain elusive. In the present study, we compare the pharmacological properties of R137C and R137L mutants with the wild-type and the V2 D136A receptor, the latter being reported as a highly constitutively active receptor. We have performed binding studies, second messenger measurements and BRET experiments in order to evaluate the affinities of the ligands, their agonist and antagonist properties and the ability of the receptors to recruit beta-arrestins, respectively. The R137C and R137L receptors exhibit small constitutive activities regarding the G(s) protein activation. In addition, these two mutants induce a constitutive beta-arrestin recruitment. Of interest, they also exhibit weak sensitivities to agonist and to inverse agonist in term of G(s) protein coupling and beta-arrestin recruitment. The small constitutive activities of the mutants and the weak regulation of their functioning by agonist suggest a poor ability of the antidiuretic function to be adapted to the external stimuli, giving to the environmental factors an importance which can explain some of the phenotypic variability in patients having NSIAD.	[Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Mouillac, Bernard; Durroux, Thierry; Morin, Denis] CNRS, Inst Genom Fonct, UMR 5203, Montpellier, France; [Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Mouillac, Bernard; Durroux, Thierry; Morin, Denis] INSERM, U661, Montpellier, France; [Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Mouillac, Bernard; Durroux, Thierry; Morin, Denis] Univ Montpellier 1 2, Montpellier, France; [Ranchin, Bruno] Univ Lyon 1, Ctr Reference Malad Renales Rares, Dept Nephrol Rhumatol Neurol HDJ & Dialyse, Hosp Civils Lyon,HFME,UFR Med Lyon Est, F-69365 Lyon, France; [Ranchin, Bruno] Univ Lyon 1, INSERM, U499, F-69365 Lyon, France; [Bricca, Giamperro] Univ Lyon 1, Pharmacol Lab, UFR Med Lyon Est, F-69365 Lyon, France; [Bricca, Giamperro] Univ Lyon 1, INSERM, ERI 22, F-69365 Lyon, France; [Geelen, Ghislaine] UFR Med Lyon Est, EFEM, CBN, Hop Croix Rousse,Hosp Civils Lyon,Lab Physiol, Lyon, France; [Morin, Denis] Nephrol Pediat CHU Montpellier, Ctr Reference Malad Renales Rares Sud Ouest, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Montpellier; CHU de Montpellier	Tenenbaum, J (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, Montpellier, France.	tdurroux@igf.cnrs.fr	MOUILLAC, Bernard/M-3896-2014	MOUILLAC, Bernard/0000-0002-3906-8673; AYOUB, Mohammed Akli/0000-0003-0022-578X; Durroux, Thierry/0000-0003-1091-6066	CNRS; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by research grants from CNRS and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Bes DF, 2007, PEDIATR NEPHROL, V22, P463, DOI 10.1007/s00467-006-0344-7; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Decaux G, 2007, J AM SOC NEPHROL, V18, P606, DOI 10.1681/ASN.2006090987; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; GUPTA S, 2009, EUR J ENDOCRINOL; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Marcialis MA, 2008, PEDIATR NEPHROL, V23, P2267, DOI 10.1007/s00467-008-0913-z; Morin D, 1998, FEBS LETT, V441, P470, DOI 10.1016/S0014-5793(98)01585-3; Morin D, 1998, ADV EXP MED BIOL, V449, P391; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Orcel H, 2009, MOL PHARMACOL, V75, P637, DOI 10.1124/mol.108.049031; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Soule S, 2008, ANN CLIN BIOCHEM, V45, P520, DOI 10.1258/acb.2007.007211; Thompson Miles D., 2008, V448, P109, DOI 10.1007/978-1-59745-205-2_7	19	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8383	10.1371/journal.pone.0008383	http://dx.doi.org/10.1371/journal.pone.0008383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027297	Green Published, gold, Green Submitted			2022-12-27	WOS:000272940100018
J	Kinander, W; Bruvik, T; Dahle, UR				Kinander, Wibeke; Bruvik, Torbjorn; Dahle, Ulf R.			Dominant Mycobacterium tuberculosis Lineages in Elderly Patients Born in Norway	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; BEIJING STRAINS; CAUSE MORTALITY; HONG-KONG; TRANSMISSION; DIVERSITY; EMERGENCE; VIRULENCE; PATTERNS	Background: During the previous century Norway had a high incidence of tuberculosis, but no molecular epidemiological studies could be performed and these previously epidemic strains have been disappearing during the last decades. Currently, tuberculosis among native Norwegians is in the elimination phase, and it is still not known what type of M. tuberculosis was so efficiently controlled during the second half of the 20th century. However, many elderly Norwegian-born people still develop TB that cannot be clustered to imported or recently transmitted strains of M. tuberculosis. Thus, the majority of these cases are results of reactivation of disease that was transmitted many decades ago. Methodology/Principal Findings: A total of 213 strains of M. tuberculosis isolated during 1998-2005, from patients born in Norway before 1950 were genotyped in the current study. The findings demonstrated a highly homogenous M. tuberculosis population among the patients. A total of 40% belonged to the T-family, were 35% were assigned to T1 sub-family (T2 = 0, 93%, T3 = 1, 4% and T4 = 2, 3%). As many as 35% of the isolates belonged to the Haarlem family, were 15% were assigned to Haarlem1 and 19% to Haarlem3. The remaining 25% belonged to 15 different other families. The RFLP-patterns indicated that the isolates were not a result of recent transmission, but rather represented well established strains that apparently dominated in Norway many decades ago. Conclusions/Significance: The T 1, Haarlem 1, and Haarlem 3 families of M. tuberculosis were abundant among patients born in Norway before 1950. The M. tuberculosis cases represented reactivated disease that had been acquired before 1994 and were likely to have been latent for several decades. Thus, the current study indicated that the T 1, Haarlem 1, and Haarlem 3 families may have been common in Norway, when tuberculosis represented a serious public health threat during the first half of the 20th century.	[Kinander, Wibeke; Bruvik, Torbjorn; Dahle, Ulf R.] Norwegian Inst Publ Hlth, Oslo, Norway	Norwegian Institute of Public Health (NIPH)	Kinander, W (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	ulf.dahle@fhi.no		Dahle, Ulf/0000-0001-5909-7917	Norwegian Institute of Public Health	Norwegian Institute of Public Health	This study was funded by the Norwegian Institute of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chan-Yeung M, 2006, INT J TUBERC LUNG D, V10, P892; Chan-Yeung M, 2003, J CLIN MICROBIOL, V41, P2706, DOI 10.1128/JCM.41.6.2706-2708.2003; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; DRISCOLL JR, 2009, SPOLIGOTYPING MOL EP, P117; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Liestol K, 2009, INT J EPIDEMIOL, V38, P427, DOI 10.1093/ije/dyn347; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Tanaka MM, 2006, P NATL ACAD SCI USA, V103, P15266, DOI 10.1073/pnas.0603130103; Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; VITOL I, 2005, RECOMB 2005; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8373	10.1371/journal.pone.0008373	http://dx.doi.org/10.1371/journal.pone.0008373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020043	Green Published, gold, Green Submitted			2022-12-27	WOS:000272870600012
J	Dehmer, M; Barbarini, N; Varmuza, K; Graber, A				Dehmer, Matthias; Barbarini, Nicola; Varmuza, Kurt; Graber, Armin			A Large Scale Analysis of Information-Theoretic Network Complexity Measures Using Chemical Structures	PLOS ONE			English	Article							GRAPHS; ENTROPY; INDEX	This paper aims to investigate information-theoretic network complexity measures which have already been intensely used in mathematical- and medicinal chemistry including drug design. Numerous such measures have been developed so far but many of them lack a meaningful interpretation, e. g., we want to examine which kind of structural information they detect. Therefore, our main contribution is to shed light on the relatedness between some selected information measures for graphs by performing a large scale analysis using chemical networks. Starting from several sets containing real and synthetic chemical structures represented by graphs, we study the relatedness between a classical (partition-based) complexity measure called the topological information content of a graph and some others inferred by a different paradigm leading to partition-independent measures. Moreover, we evaluate the uniqueness of network complexity measures numerically. Generally, a high uniqueness is an important and desirable property when designing novel topological descriptors having the potential to be applied to large chemical databases.	[Barbarini, Nicola] Univ Pavia, Dept Comp Engn & Syst Sci, I-27100 Pavia, Italy; [Varmuza, Kurt] Vienna Univ Technol, Lab Chemometr, Inst Chem Engn, A-1040 Vienna, Austria	University of Pavia; Technische Universitat Wien		matthias.dehmer@umit.at			COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Tiroler Zukunftsstiftung (TZS); State of Styria; University for Health Sciences, Medical Informatics and Technology; BIOCRATES Life Sciences AG; FIRB ITALBIONET	COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Tiroler Zukunftsstiftung (TZS); State of Styria; University for Health Sciences, Medical Informatics and Technology; BIOCRATES Life Sciences AG; FIRB ITALBIONET(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by the COMET Center ONCOTYROL and funded by the Federal Ministry for Transport Innovation and Technology (BMVIT) and the Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ), the Tiroler Zukunftsstiftung (TZS) and the State of Styria represented by the Styrian Business Promotion Agency (SFG) [and supported by the University for Health Sciences, Medical Informatics and Technology and BIOCRATES Life Sciences AG]. Also, funding from the FIRB ITALBIONET Project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; ALBERT R, 2000, SCIENCE, V287, P130; [Anonymous], PHYSICA A; Antiqueira L, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013058; *AS, 2008, ASINEX PLAT COLL; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BALABAN AT, 1999, TOPOLOGICAL INDICES, P21; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BASAK SC, 1983, ARZNEIMITTEL-FORSCH, V33-1, P501; Basak SC, 1999, TOPOLOGICAL INDICES, P563; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D, 2000, J CHEM INF COMP SCI, V40, P934, DOI 10.1021/ci990120u; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; BONCHEV D, 1979, COMMUN MATH COMP CHE, V7, P65; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Bonchev D, 1983, INFORM THEORETIC IND; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Brandes U., 2005, LECT NOTES COMPUTER; Brillouin L., 1956, SCI INFORM THEORY; BRODER A, 2000, P 9 WWW C AMST; Chepoi V, 1997, J CHEM INF COMP SCI, V37, P752, DOI 10.1021/ci9700079; Constantine G., 1990, LINEAR MULTILINEAR A, V28, P49, DOI DOI 10.1080/03081089008818029; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; DAFCOSTA L, 2009, EPL-EUROPHYS LETT, V85; DAFCOSTA L, 2009, EPL-EUROPHYS LETT, V87; Dancoff SM, 1953, ESSAYS USE INFORM TH, P263; DEHMER M, 2009, ASPECTS DEGENE UNPUB; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Dehmer M, 2009, L N INST COMP SCI SO, V4, P707; Dehmer M, 2008, CYBERNET SYST, V39, P825, DOI 10.1080/01969720802435925; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Devillers J., 1999, TOPOLOGICAL INDICES; Diudea M.V., 2001, MOL TOPOLOGY; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; EmmertStreib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P1; EMMERTSTREIB F, 2009, BMC SYST BIOL, V3; ERDOS P, 1960, B INT STATIST INST, V38, P343; Garey MR, 1979, SERIES BOOKS MATH SC; Gasteiger J., 2003, CHEMOINFORMATICS TXB; HANSEN K, 2009, J CHEM INF MODEL; Harary F., 1969, GRAPH THEORY; HIRATA H, 1984, INT J SYST SCI, V15, P261, DOI 10.1080/00207728408926559; Jukna S, 2006, COMB PROBAB COMPUT, V15, P855, DOI 10.1017/S0963548306007620; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Konstantinova EV, 2006, LECT NOTES COMPUT SC, V4123, P831; Konstantinova EV, 2003, INDIAN J CHEM A, V42, P1227; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; LI M, 1997, INTRO KOLMOGOROV COM; Linshitz H, 1953, ESSAYS USE INFORM TH; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; MEHLER A, 2006, P 2006 INT C BIOINF, P496; Mehler A., 2009, GENRES WEB COMPUTATI; Minoli D., 1975, Atti della Accademia Nazionale dei Lincei. Rendiconti, Classe di Scienze Fisiche, Matematiche e Naturali, V59, P651; Morowitz H, 1953, B MATH BIOPHYS, V17, P81; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWI A, 1968, B MATH BIOPHYS, V30, P387, DOI 10.1007/BF02476603; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Mowshowitz A., 2009, ANAL COMPLEX NETWORK, P1; Mukherjee P, 2008, BIOORGAN MED CHEM, V16, P4138, DOI 10.1016/j.bmc.2008.01.011; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; OBOYLE NM, 2008, CHEM CENTRAL J, V2; Randic M, 2002, CROAT CHEM ACTA, V75, P107; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Schwaighofer A, 2008, J CHEM INF MODEL, V48, P785, DOI 10.1021/ci700142c; SCSIBRANY H, 2004, SOFTWARE SUBMAT; Shannon CE, 1997, MATH THEORY COMMUNIC; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Sommerfeld E., 1994, KNOWLEDGE STRUCTURES, P146, DOI [DOI 10.1007/978-3-642-52064-8_5, 10.1007/978-3-642-52064-8_5]; STEIN SE, 1998, 98 NIST; Todeschini R., 2002, HDB MOL DESCRIPTORS; Trinajstic N., 2018, CHEM GRAPH THEORY; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; Ulanowicz RE, 2001, COMPUT CHEM, V25, P393, DOI 10.1016/S0097-8485(01)00073-0; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilhelm T, 2001, INTEGRATIVE SYSTEMS APPROACHES TO NATURAL AND SOCIAL DYNAMICS, P263; Wilhelm T, 2007, PHYSICA A, V385, P385, DOI 10.1016/j.physa.2007.06.029	85	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8057	10.1371/journal.pone.0008057	http://dx.doi.org/10.1371/journal.pone.0008057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016828	Green Published, Green Submitted, gold			2022-12-27	WOS:000272833800001
J	Sakatani, S; Yamada, K; Homma, C; Munesue, S; Yamamoto, Y; Yamamoto, H; Hirase, H				Sakatani, Seiichi; Yamada, Kazuyuki; Homma, Chihiro; Munesue, Seiichi; Yamamoto, Yasuhiko; Yamamoto, Hiroshi; Hirase, Hajime			Deletion of RAGE Causes Hyperactivity and Increased Sensitivity to Auditory Stimuli in Mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CELL-SURFACE RECEPTOR; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; IN-VIVO; EXPRESSION; PROTEIN; BRAIN; ENDPRODUCTS	The receptor for advanced glycation end-products (RAGE) is a multi-ligand receptor that belongs to the immunoglobulin superfamily of cell surface receptors. In diabetes and Alzheimer's disease, pathological progression is accelerated by activation of RAGE. However, how RAGE influences gross behavioral activity patterns in basal condition has not been addressed to date. In search for a functional role of RAGE in normal mice, a series of standard behavioral tests were performed on adult RAGE knockout (KO) mice. We observed a solid increase of home cage activity in RAGE KO. In addition, auditory startle response assessment resulted in a higher sensitivity to auditory signal and increased prepulse inhibition in KO mice. There were no significant differences between KO and wild types in behavioral tests for spatial memory and anxiety, as tested by Morris water maze, classical fear conditioning, and elevated plus maze. Our results raise a possibility that systemic therapeutic treatments to occlude RAGE activation may have adverse effects on general activity levels or sensitivity to auditory stimuli.	[Sakatani, Seiichi; Hirase, Hajime] RIKEN, Brain Sci Inst, Hirase Res Unit, Wako, Saitama, Japan; [Yamada, Kazuyuki; Homma, Chihiro] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Munesue, Seiichi; Yamamoto, Yasuhiko; Yamamoto, Hiroshi] Kanazawa Univ, Dept Biochem & Mol Vasc Biol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Hirase, Hajime] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; RIKEN; Kanazawa University; Saitama University	Sakatani, S (corresponding author), RIKEN, Brain Sci Inst, Hirase Res Unit, Wako, Saitama, Japan.	hirase@brain.riken.jp	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905	Ministry of Education, Science, Sports and Culture [21700368, 19390085]; RIKEN intramural fundings	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN intramural fundings	Funding was received from the Ministry of Education, Science, Sports and Culture grant-in-aids for Young Scientists (B) (21700368, SS) and Scientific Research (B) (19390085, HY) and RIKEN intramural fundings (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRETT J, 1993, AM J PATHOL, V143, P1699; Chou DKH, 2004, J NEUROCHEM, V90, P1389, DOI 10.1111/j.1471-4159.2004.02609.x; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; GERLAI R, 1995, LEARN MEMORY, V2, P26, DOI 10.1101/lm.2.1.26; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kato T, 2008, NEUROSCI RES, V61, P143, DOI 10.1016/j.neures.2008.02.002; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Nozaki I, 2007, ARCH HISTOL CYTOL, V70, P279, DOI 10.1679/aohc.70.279; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sakatani S, 2007, EUR J NEUROSCI, V25, P1144, DOI 10.1111/j.1460-9568.2007.05337.x; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2005, J PHARMACOL SCI, V97, P305, DOI 10.1254/jphs.CPJ04005X	30	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2009	4	12							e8309	10.1371/journal.pone.0008309	http://dx.doi.org/10.1371/journal.pone.0008309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ON	20016851	gold, Green Published, Green Submitted			2022-12-27	WOS:000272833800008
J	Kitko, RD; Cleeton, RL; Armentrout, EI; Lee, GE; Noguchi, K; Berkmen, MB; Jones, BD; Slonczewski, JL				Kitko, Ryan D.; Cleeton, Rebecca L.; Armentrout, Erin I.; Lee, Grace E.; Noguchi, Ken; Berkmen, Melanie B.; Jones, Brian D.; Slonczewski, Joan L.			Cytoplasmic Acidification and the Benzoate Transcriptome in Bacillus subtilis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PHENOLIC-ACID DECARBOXYLASE; ESCHERICHIA-COLI; INTRACELLULAR-PH; STRESS-RESPONSE; SIGMA-FACTOR; OXALATE DECARBOXYLASE; FOOD PRESERVATIVES; TOLERANCE RESPONSE; PROTONMOTIVE FORCE	Background: Bacillus subtilis encounters a wide range of environmental pH. The bacteria maintain cytoplasmic pH within a narrow range. Response to acid stress is a poorly understood function of external pH and of permeant acids that conduct protons into the cytoplasm. Methods and Principal Findings: Cytoplasmic acidification and the benzoate transcriptome were observed in Bacillus subtilis. Cytoplasmic pH was measured with 4-s time resolution using GFPmut3b fluorimetry. Rapid external acidification (pH 7.5 to 6.0) acidified the B. subtilis cytoplasm, followed by partial recovery. Benzoate addition up to 60 mM at external pH 7 depressed cytoplasmic pH but left a transmembrane Delta pH permitting growth; this robust adaptation to benzoate exceeds that seen in E. coli. Cytoplasmic pH was depressed by 0.3 units during growth with 30 mM benzoate. The transcriptome of benzoate-adapted cells was determined by comparing 4,095 gene expression indices following growth at pH 7, +/- 30 mM benzoate. 164 ORFs showed >= 2-fold up-regulation by benzoate (30 mM benzoate/0 mM), and 102 ORFs showed >= 2-fold down-regulation. 42% of benzoate-dependent genes are regulated up or down, respectively, at pH 6 versus pH 7; they are candidates for cytoplasmic pH response. Acid-stress genes up-regulated by benzoate included drug resistance genes (yhbI, yhcA, yuxJ, ywoGH); an oligopeptide transporter (opp); glycine catabolism (gcvPA-PB); acetate degradation (acsA); dehydrogenases (ald, fdhD, serA, yrhEFG, yjgCD); the TCA cycle (citZ, icd, mdh, sucD); and oxidative stress (OYE-family yqjM, ohrB). Base-stress genes down-regulated by benzoate included malate metabolism (maeN), sporulation control (spo0M, spo0E), and the SigW alkali shock regulon. Cytoplasmic pH could mediate alkali-shock induction of SigW. Conclusions: B. subtilis maintains partial pH homeostasis during growth, and withstands high concentrations of permeant acid stress, higher than for gram-negative neutralophile E. coli. The benzoate adaptation transcriptome substantially overlaps that of external acid, contributing to a cytoplasmic pH transcriptome.	[Kitko, Ryan D.; Cleeton, Rebecca L.; Armentrout, Erin I.; Lee, Grace E.; Noguchi, Ken; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Berkmen, Melanie B.] Suffolk Univ, Dept Chem & Biochem, Boston, MA 02114 USA; [Jones, Brian D.] Kenyon Coll, Dept Math, Gambier, OH 43022 USA	Kenyon College; Suffolk University; Kenyon College	Kitko, RD (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu		Berkmen, Melanie/0000-0003-0365-6040	National Institutes of Health [R15 GM079731-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM079731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health AREA award no. R15 GM079731-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Browne N, 2002, J APPL MICROBIOL, V92, P404, DOI 10.1046/j.1365-2672.2002.01541.x; Brul S, 1999, INT J FOOD MICROBIOL, V50, P1, DOI 10.1016/S0168-1605(99)00072-0; Cao M, 2002, J MOL BIOL, V316, P443, DOI 10.1006/jmbi.2001.5372; Cavin JF, 1998, APPL ENVIRON MICROB, V64, P1466; Chen JL, 2009, INT J FOOD MICROBIOL, V128, P424, DOI 10.1016/j.ijfoodmicro.2008.09.015; CHENG JB, 1994, J BIOL CHEM, V269, P27365; COLLINS CM, 1993, MOL MICROBIOL, V9, P907, DOI 10.1111/j.1365-2958.1993.tb01220.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Critzer FJ, 2008, J FOOD PROTECT, V71, P1469, DOI 10.4315/0362-028X-71.7.1469; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DELL CL, 1994, MOL MICROBIOL, V14, P7, DOI 10.1111/j.1365-2958.1994.tb01262.x; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; EKLUND T, 1985, J GEN MICROBIOL, V131, P73; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; GRUNDY FJ, 1993, MOL MICROBIOL, V10, P259, DOI 10.1111/j.1365-2958.1993.tb01952.x; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Itaya M, 2001, BIOSCI BIOTECH BIOCH, V65, P579, DOI 10.1271/bbb.65.579; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Jobin MP, 2002, INT J FOOD MICROBIOL, V79, P65, DOI 10.1016/S0168-1605(02)00180-0; Kannan G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-37; KHAN S, 1980, J MOL BIOL, V138, P563, DOI 10.1016/S0022-2836(80)80018-0; KHAN S, 1980, J MOL BIOL, V138, P599, DOI 10.1016/S0022-2836(80)80019-2; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Kovacs T, 1998, FEMS MICROBIOL LETT, V165, P323, DOI 10.1111/j.1574-6968.1998.tb13164.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lambert LA, 1997, J BACTERIOL, V179, P7595, DOI 10.1128/jb.179.23.7595-7599.1997; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Lupa B, 2008, CAN J MICROBIOL, V54, P75, DOI [10.1139/W07-113, 10.1139/w07-113]; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; MAGILL NG, 1994, J BACTERIOL, V176, P2252, DOI 10.1128/JB.176.8.2252-2258.1994; Margot P, 1996, MICROBIOL-UK, V142, P3437, DOI 10.1099/13500872-142-12-3437; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mizuno M, 1996, MICROBIOL-UK, V142, P3103, DOI 10.1099/13500872-142-11-3103; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Mols M, 2008, APPL ENVIRON MICROB, V74, P2370, DOI 10.1128/AEM.02737-07; Monteiro SM, 2005, BIOTECHNOL PROGR, V21, P1026, DOI 10.1021/bp050062z; NEELY MN, 1994, J BACTERIOL, V176, P3278, DOI 10.1128/jb.176.11.3278-3285.1994; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Potenski CJ, 2003, FEMS MICROBIOL LETT, V220, P181, DOI 10.1016/S0378-1097(03)00099-5; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; REED PW, 1982, POLYETHER ANTIBIOTIC, V1, P185; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; SETLOW B, 1980, P NATL ACAD SCI-BIOL, V77, P2474, DOI 10.1073/pnas.77.5.2474; SHEU CW, 1975, ANTIMICROB AGENTS CH, V7, P349, DOI 10.1128/AAC.7.3.349; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Slonczewski J. L, 1996, ESCHERICHIA COLI SAL, P1539; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; Spilimbergo S, 2005, BIOTECHNOL BIOENG, V92, P447, DOI 10.1002/bit.20606; Ter Beek A, 2008, J BACTERIOL, V190, P1751, DOI 10.1128/JB.01516-07; Thomassin S, 2006, ARCH MICROBIOL, V186, P229, DOI 10.1007/s00203-006-0137-1; Tran NP, 2008, J BACTERIOL, V190, P3213, DOI 10.1128/JB.01936-07; Van Duy N, 2007, PROTEOMICS, V7, P698, DOI 10.1002/pmic.200600706; Wei Y, 2006, J BACTERIOL, V188, P7090, DOI 10.1128/JB.00885-06; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Zellmeier S, 2006, MOL MICROBIOL, V61, P1569, DOI 10.1111/j.1365-2958.2006.05323.x	80	32	32	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8255	10.1371/journal.pone.0008255	http://dx.doi.org/10.1371/journal.pone.0008255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011599	Green Submitted, gold, Green Published			2022-12-27	WOS:000272830300021
J	Linher, K; Dyce, P; Li, JL				Linher, Katja; Dyce, Paul; Li, Julang			Primordial Germ Cell-Like Cells Differentiated In Vitro from Skin-Derived Stem Cells	PLOS ONE			English	Article							OOCYTE-LIKE CELLS; DNA METHYLATION; PREIMPLANTATION EMBRYOS; PATERNAL METHYLATION; OVARIAN STRUCTURES; H19 LOCUS; EXPRESSION; GENE; SPECIFICATION; GENERATION	Background: We have previously demonstrated that stem cells isolated from fetal porcine skin have the potential to form oocyte-like cells (OLCs) in vitro. However, primordial germ cells (PGCs), which must also be specified during the stem cell differentiation to give rise to these putative oocytes at more advanced stages of culture, were not systematically characterized. The current study tested the hypothesis that a morphologically distinct population of cells derived from skin stem cells prior to OLC formation corresponds to putative PGCs, which differentiate further into more mature gametes. Methodology/Principal Findings: When induced to differentiate in an appropriate microenvironment, a subpopulation of morphologically distinct cells, some of which are alkaline phosphatase (AP)-positive, also express Oct4, Fragilis, Stella, Dazl, and Vasa, which are markers indicative of germ cell formation. A known differentially methylated region (DMR) within the H19 gene locus, which is demethylated in oocytes after establishment of the maternal imprint, is hypomethylated in PGC-like cells compared to undifferentiated skin-derived stem cells, suggesting that the putative germ cell population undergoes imprint erasure. Additional evidence supporting the germ cell identity of in vitro-generated PGC-like cells is that, when labeled with a Dazl-GFP reporter, these cells further differentiate into GFP-positive OLCs. Significance: The ability to generate germ cell precursors from somatic stem cells may provide an in vitro model to study some of the unanswered questions surrounding early germ cell formation.	[Linher, Katja; Dyce, Paul; Li, Julang] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Linher, K (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	jli@uoguelph.ca		Dyce, Paul/0000-0002-4574-3321	Canada Institutes for Health Research (CIHR); National Science and Research Engineering Council (NSERC); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); NSERC	Canada Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Research Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canada Institutes for Health Research (CIHR), National Science and Research Engineering Council (NSERC), and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA). Katja Linher and Paul Dyce are NSERC Doctoral Scholarship recipients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Buzina A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000051; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cauffman G, 2005, MOL HUM REPROD, V11, P405, DOI 10.1093/molehr/gah167; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; CURCHOE CL, 2009, ANIM REPROD SCI; Danner S, 2007, MOL HUM REPROD, V13, P11, DOI 10.1093/molehr/gal096; Dawn B, 2008, STEM CELLS, V26, P1646, DOI 10.1634/stemcells.2007-0715; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; Gebert C, 2006, GENOMICS, V88, P222, DOI 10.1016/j.ygeno.2006.03.011; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GODIN I, 1991, NATURE, V352, P807, DOI 10.1038/352807a0; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kehler J, 2005, SEMIN REPROD MED, V23, P222, DOI 10.1055/s-2005-872450; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia MJ, 2008, STEM CELLS, V26, P2083, DOI 10.1634/stemcells.2007-0922; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee CK, 2000, BIOL REPROD, V63, P887, DOI 10.1095/biolreprod63.3.887; Lee J, 2002, DEVELOPMENT, V129, P1807; Linher KJ, 2007, ENDOCRINOLOGY, V148, P4292, DOI 10.1210/en.2007-0021; Linher K, 2009, DIFFERENTIATION, V77, P335, DOI 10.1016/j.diff.2008.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamura D, 2005, MOL REPROD DEV, V70, P20, DOI 10.1002/mrd.20136; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Petkov SG, 2009, MOL REPROD DEV, V76, P22, DOI 10.1002/mrd.20926; Picton HM, 2001, THERIOGENOLOGY, V55, P1193, DOI 10.1016/S0093-691X(01)00478-2; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; Rajpert-De Meyts E, 2004, HUM REPROD, V19, P1338, DOI 10.1093/humrep/deh265; Ratajczak MZ, 2008, EXP HEMATOL, V36, P742, DOI 10.1016/j.exphem.2008.03.010; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Shim H, 1998, THERIOGENOLOGY, V49, P521, DOI 10.1016/S0093-691X(98)00003-X; Thorvaldsen JL, 2006, MOL CELL BIOL, V26, P1245, DOI 10.1128/MCB.26.4.1245-1258.2006; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zuba-Surma EK, 2009, MECH AGEING DEV, V130, P58, DOI 10.1016/j.mad.2008.02.003	65	65	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8263	10.1371/journal.pone.0008263	http://dx.doi.org/10.1371/journal.pone.0008263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011593	Green Published, gold, Green Submitted			2022-12-27	WOS:000272830300024
J	Sasaki, N; Hirano, T; Ichimiya, T; Wakao, M; Hirano, K; Kinoshita-Toyoda, A; Toyoda, H; Suda, Y; Nishihara, S				Sasaki, Norihiko; Hirano, Takuya; Ichimiya, Tomomi; Wakao, Masahiro; Hirano, Kazumi; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Suda, Yasuo; Nishihara, Shoko			The 3 '-Phosphoadenosine 5 '-Phosphosulfate Transporters, PAPST1 and 2, Contribute to the Maintenance and Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							INHIBITS NEURAL DIFFERENTIATION; HEPARAN-SULFATE PROTEOGLYCANS; SELF-RENEWAL; CHONDROITIN SULFATE; MOLECULAR-CLONING; LINEAGE COMMITMENT; RNA INTERFERENCE; ES CELLS; ACTIVATION; PLURIPOTENCY	Recently, we have identified two 3'-phosphoadenosine 5'-phosphosulfate (PAPS) transporters (PAPST1 and PAPST2), which contribute to PAPS transport into the Golgi, in both human and Drosophila. Mutation and RNA interference (RNAi) of the Drosophila PAPST have shown the importance of PAPST-dependent sulfation of carbohydrates and proteins during development. However, the functional roles of PAPST in mammals are largely unknown. Here, we investigated whether PAPST-dependent sulfation is involved in regulating signaling pathways required for the maintenance of mouse embryonic stem cells (mESCs), differentiation into the three germ layers, and neurogenesis. By using a yeast expression system, mouse PAPST1 and PAPST2 proteins were shown to have PAPS transport activity with an apparent K(m) value of 1.54 mu M or 1.49 mu M, respectively. RNAi-mediated knockdown of each PAPST induced the reduction of chondroitin sulfate (CS) chain sulfation as well as heparan sulfate (HS) chain sulfation, and inhibited mESC self-renewal due to defects in several signaling pathways. However, we suggest that these effects were due to reduced HS, not CS, chain sulfation, because knockdown of mouse N-deacetylase/N-sulfotransferase, which catalyzes the first step of HS sulfation, in mESCs gave similar results to those observed in PAPST-knockdown mESCs, but depletion of CS chains did not. On the other hand, during embryoid body formation, PAPST-knockdown mESCs exhibited abnormal differentiation, in particular neurogenesis was promoted, presumably due to the observed defects in BMP, FGF and Wnt signaling. The latter were reduced as a result of the reduction in both HS and CS chain sulfation. We propose that PAPST-dependent sulfation of HS or CS chains, which is regulated developmentally, regulates the extrinsic signaling required for the maintenance and normal differentiation of mESCs.	[Sasaki, Norihiko; Hirano, Takuya; Ichimiya, Tomomi; Hirano, Kazumi; Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Tokyo, Japan; [Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Dept Nanostruct & Adv Mat, Kagoshima 890, Japan; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Bioanalyt Chem, Shiga, Japan; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Suda, Yasuo; Nishihara, Shoko] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	Soka University; Kagoshima University; Ritsumeikan University; Japan Science & Technology Agency (JST)	Sasaki, N (corresponding author), Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Tokyo, Japan.	shoko@t.soka.ac.jp	Hirano, Kazumi/L-7031-2018; Hirano, Kazumi/R-5290-2019	Hirano, Kazumi/0000-0001-9717-5904; Hirano, Kazumi/0000-0001-9717-5904; Nishihara, Shoko/0000-0002-1668-2603	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20370051, S0901015]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by funds from Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Grant-in-Aid for Scientific Research (B) to SN, 20370051, 2008-2010, and from MEXT, the Matching Fund for Private Universities, S0901015, 2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; AURELIE C, 2008, PLOS GENET, V7; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Dvorak P, 1998, J CELL SCI, V111, P2945; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Gratsch TE, 2002, DEV BIOL, V245, P83, DOI 10.1006/dbio.2002.0629; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakayama K, 2003, GLYCOBIOLOGY, V13, P673, DOI 10.1093/glycob/cwg099; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tsuiji H, 1998, BIOCHEM BIOPH RES CO, V253, P374, DOI 10.1006/bbrc.1998.9726; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamada T, 2005, BIOINFORMATICS, V21, P1316, DOI 10.1093/bioinformatics/bti155; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009	73	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2009	4	12							e8262	10.1371/journal.pone.0008262	http://dx.doi.org/10.1371/journal.pone.0008262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NH	20011239	Green Submitted, Green Published, gold			2022-12-27	WOS:000272830200009
J	Schisler, JC; Charles, PC; Parker, JS; Hilliard, EG; Mapara, S; Meredith, D; Lineberger, RE; Wu, SS; Alder, BD; Stouffer, GA; Patterson, C				Schisler, Jonathan C.; Charles, Peter C.; Parker, Joel S.; Hilliard, Eleanor G.; Mapara, Sabeen; Meredith, Dane; Lineberger, Robert E.; Wu, Samuel S.; Alder, Brian D.; Stouffer, George A.; Patterson, Cam			Stable Patterns of Gene Expression Regulating Carbohydrate Metabolism Determined by Geographic Ancestry	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; MULTIPLE POPULATIONS; HAPTOGLOBIN GENOTYPE; RACIAL DISPARITIES; ETHNIC-DIFFERENCES; MICROARRAY DATA; RISK-FACTORS	Background: Individuals of African descent in the United States suffer disproportionately from diseases with a metabolic etiology (obesity, metabolic syndrome, and diabetes), and from the pathological consequences of these disorders (hypertension and cardiovascular disease). Methodology/Principal Findings: Using a combination of genetic/genomic and bioinformatics approaches, we identified a large number of genes that were both differentially expressed between American subjects self-identified to be of either African or European ancestry and that also contained single nucleotide polymorphisms that distinguish distantly related ancestral populations. Several of these genes control the metabolism of simple carbohydrates and are direct targets for the SREBP1, a metabolic transcription factor also differentially expressed between our study populations. Conclusions/Significance: These data support the concept of stable patterns of gene transcription unique to a geographic ancestral lineage. Differences in expression of several carbohydrate metabolism genes suggest both genetic and transcriptional mechanisms contribute to these patterns and may play a role in exacerbating the disproportionate levels of obesity, diabetes, and cardiovascular disease observed in Americans with African ancestry.	[Schisler, Jonathan C.; Charles, Peter C.; Hilliard, Eleanor G.; Mapara, Sabeen; Lineberger, Robert E.; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Charles, Peter C.; Meredith, Dane; Wu, Samuel S.; Stouffer, George A.; Patterson, Cam] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; [Parker, Joel S.] Express Anal, Durham, NC USA; [Alder, Brian D.] Duke Univ, Sch Med, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Schisler, JC (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27515 USA.	cpatters@med.unc.edu	Parker, Joel/AAG-1108-2019; Stouffer, George/AAK-4763-2021; Schisler, Jonathan C./C-1301-2008	Schisler, Jonathan C./0000-0001-7382-2783	American Heart Association [0635100N]; National Institutes of Health [HL072347]; Centers for Disease Control [H75/CCH424675, H75/CCH424677]; University of North Carolina School of Medicine; Doris Duke Charitable Foundation; BurroughsWellcome; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072347, T32HL083828] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of North Carolina School of Medicine; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); BurroughsWellcome(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by an American Heart Association Scientist Development Grant (#0635100N) to PCC, grants from the National Institutes of Health (HL072347), Centers for Disease Control (H75/CCH424675 and H75/CCH424677), and University of North Carolina School of Medicine ("Investments in the Future'' program) to CP, and a Doris Duke Charitable Foundation Fellowship to BDA. CP is an established investigator of the American Heart Association and a BurroughsWellcome Fund Clinician Scientist in Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; BAKER JR, 1983, BRIT MED J, V287, P863, DOI 10.1136/bmj.287.6396.863; Blum S, 2007, J AM COLL CARDIOL, V49, P82, DOI 10.1016/j.jacc.2006.08.044; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Charles PC, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-38; Chen MS, 2005, AM J MED, V118, P1019, DOI 10.1016/j.amjmed.2004.12.035; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; Diraison F, 2008, J LIPID RES, V49, P814, DOI 10.1194/jlr.M700533-JLR200; Drake TA, 2006, MAMM GENOME, V17, P466, DOI 10.1007/s00335-005-0175-z; Duster T, 2005, SCIENCE, V307, P1050, DOI 10.1126/science.1110303; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Flordellis CS, 2006, CURR TOP MED CHEM, V6, P1791, DOI 10.2174/156802606778194226; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Glinsky GV, 2006, CELL CYCLE, V5, P2613, DOI 10.4161/cc.5.22.3498; Goodman AH, 2000, AM J PUBLIC HEALTH, V90, P1699, DOI 10.2105/AJPH.90.11.1699; Gosmain Y, 2005, J LIPID RES, V46, P697, DOI 10.1194/jlr.M400261-JLR200; Gosmain Y, 2004, DIABETES, V53, P321, DOI 10.2337/diabetes.53.2.321; GRANT DJ, 1993, AM J HUM GENET, V52, P974; Grarup N, 2008, DIABETES, V57, P1136, DOI 10.2337/db07-1534; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Harding AH, 2006, DIABETOLOGIA, V49, P2642, DOI 10.1007/s00125-006-0430-1; Hatada S, 2003, GENE, V319, P55, DOI 10.1016/S0378-1119(03)00791-1; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kim Sung K, 2006, Genome Biol, V7, P310, DOI 10.1186/gb-2006-7-3-310; Kurian AK, 2007, ETHNIC DIS, V17, P143; Laudes M, 2004, DIABETES, V53, P842, DOI 10.2337/diabetes.53.3.842; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Levy AP, 2004, ISRAEL MED ASSOC J, V6, P308; Lindquist CH, 2000, AM J CLIN NUTR, V71, P725, DOI 10.1093/ajcn/71.3.725; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Mingrone G, 2003, ATHEROSCLEROSIS, V170, P155, DOI 10.1016/S0021-9150(03)00254-5; Montgomery Susanne, 2007, Prev Chronic Dis, V4, pA62; Ossorio P, 2005, AM PSYCHOL, V60, P115, DOI 10.1037/0003-066X.60.1.115; Park J, 2007, NUCLEIC ACIDS RES, V35, pD711, DOI 10.1093/nar/gkl962; Qi NR, 2005, HYPERTENSION, V45, P1004, DOI 10.1161/01.HYP.0000161995.64192.2b; Rbo HK, 2005, BIOCHEM BIOPH RES CO, V332, P288, DOI 10.1016/j.bbrc.2005.04.120; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Roguin A, 2003, DIABETES CARE, V26, P2628, DOI 10.2337/diacare.26.9.2628; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Smith SC, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.01.002; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Taillon-Miller P, 2004, GENOMICS, V84, P899, DOI 10.1016/j.ygeno.2004.08.009; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Regenmortel MHV, 2004, EMBO REP, V5, P1016, DOI 10.1038/sj.embor.7400284; Williams JE, 1999, ANN EPIDEMIOL, V9, P472, DOI 10.1016/S1047-2797(99)00029-0; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011	56	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8183	10.1371/journal.pone.0008183	http://dx.doi.org/10.1371/journal.pone.0008183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20016837	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829800005
J	Huang, J; Hao, P; Chen, H; Hu, W; Yan, Q; Liu, F; Han, ZG				Huang, Jian; Hao, Pei; Chen, Hui; Hu, Wei; Yan, Qing; Liu, Feng; Han, Ze-Guang			Genome-Wide Identification of Schistosoma japonicum MicroRNAs Using a Deep-Sequencing Approach	PLOS ONE			English	Article							GENE-EXPRESSION; EVOLUTION; MANSONI; RNAS; SYSTEM; MPSS	Background: Human schistosomiasis is one of the most prevalent and serious parasitic diseases worldwide. Schistosoma japonicum is one of important pathogens of this disease. MicroRNAs ( miRNAs) are a large group of non-coding RNAs that play important roles in regulating gene expression and protein translation in animals. Genome-wide identification of miRNAs in a given organism is a critical step to facilitating our understanding of genome organization, genome biology, evolution, and posttranscriptional regulation. Methodology/Principal Findings: We sequenced two small RNA libraries prepared from different stages of the life cycle of S. japonicum, immature schistosomula and mature pairing adults, through a deep DNA sequencing approach, which yielded,12 million high-quality short sequence reads containing a total of,2 million non-redundant tags. Based on a bioinformatics pipeline, we identified 176 new S. japonicum miRNAs, of which some exhibited a differential pattern of expression between the two stages. Although 21 S. japonicum miRNAs are orthologs of known miRNAs within the metazoans, some nucleotides at many positions of Schistosoma miRNAs, such as miR-8, let-7, miR-10, miR-31, miR-92, miR-124, and miR-125, are indeed significantly distinct from other bilaterian orthologs. In addition, both miR-71 and some miR-2 family members in tandem are found to be clustered in a reversal direction model on two genomic loci, and two pairs of novel S. japonicum miRNAs were derived from sense and antisense DNA strands at the same genomic loci. Conclusions/Significance: The collection of S. japonicum miRNAs could be used as a new platform to study the genomic structure, gene regulation and networks, evolutionary processes, development, and host-parasite interactions. Some S. japonicum miRNAs and their clusters could represent the ancestral forms of the conserved orthologues and a model for the genesis of novel miRNAs.	[Huang, Jian; Chen, Hui; Yan, Qing; Liu, Feng; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Hao, Pei] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Hu, Wei] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention	Huang, J (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China.	hanzg@chgc.sh.cn	HU, Wei/F-1004-2012	Hao, Pei/0000-0002-1498-7059; Han, Ze-Guang/0000-0002-1018-1752	China National Key Project for Basic Research (973) [2010CB529200-04, 2007CB513100, 2006CB910402]; National High-Tech RD Program (863) [2007AA02Z330]; China National Key Projects for Infectious Disease [2008ZX10004-011]; China Postdoctoral Science Foundation [20070420097]; Shanghai Postdoctoral Science Foundation [07R214138]; Shanghai Commission for Science and Technology [08JC1416400]	China National Key Project for Basic Research (973)(National Basic Research Program of China); National High-Tech RD Program (863)(National High Technology Research and Development Program of China); China National Key Projects for Infectious Disease; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Commission for Science and Technology	This work was mainly supported by the China National Key Project for Basic Research (973) (2010CB529200-04, 2007CB513100, and 2006CB910402), National High-Tech R&D Program (863) (2007AA02Z330), China National Key Projects for Infectious Disease (2008ZX10004-011), the China Postdoctoral Science Foundation (20070420097), the Shanghai Postdoctoral Science Foundation (07R214138), and the Shanghai Commission for Science and Technology (08JC1416400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Enright AJ, 2004, GENOME BIOL, V5; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giribet G, 2008, PHILOS T R SOC B, V363, P1513, DOI 10.1098/rstb.2007.2241; Gomes MS, 2009, PARASITOL INT, V58, P61, DOI 10.1016/j.parint.2008.10.002; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Huang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-207; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Krautz-Peterson G, 2008, MOL BIOCHEM PARASIT, V159, P54, DOI 10.1016/j.molbiopara.2007.12.011; Krautz-Peterson G, 2008, EXP PARASITOL, V118, P122, DOI 10.1016/j.exppara.2007.06.013; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MORALES ME, 2003, MOL BIOCHEM PARASIT, V157, P160; NAKAYASHIKI H, 2003, MOL BIOCHEM PARASIT, V128, P205; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Palakodeti D, 2006, RNA, V12, P1640, DOI 10.1261/rna.117206; Pereira TC, 2008, EXP PARASITOL, V118, P619, DOI 10.1016/j.exppara.2007.11.017; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; Smit A, 1996, REPEATMASKER OPEN 30; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Xue XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004034; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	38	75	83	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2009	4	12							e8206	10.1371/journal.pone.0008206	http://dx.doi.org/10.1371/journal.pone.0008206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533ND	19997615	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829700006
J	Chowell, G; Viboud, C; Wang, XH; Bertozzi, SM; Miller, MA				Chowell, Gerardo; Viboud, Cecile; Wang, Xiaohong; Bertozzi, Stefano M.; Miller, Mark A.			Adaptive Vaccination Strategies to Mitigate Pandemic Influenza: Mexico as a Case Study	PLOS ONE			English	Article							BACTERIAL PNEUMONIA; SOCIAL CONTACTS; MORTALITY; SPREAD; TRANSMISSIBILITY; EPIDEMIC; PATTERNS; AGE; BENEFITS; NUMBER	Background: We explore vaccination strategies against pandemic influenza in Mexico using an age-structured transmission model calibrated against local epidemiological data from the Spring 2009 A(H1N1) pandemic. Methods and Findings: In the context of limited vaccine supplies, we evaluate age-targeted allocation strategies that either prioritize youngest children and persons over 65 years of age, as for seasonal influenza, or adaptively prioritize age groups based on the age patterns of hospitalization and death monitored in real-time during the early stages of the pandemic. Overall the adaptive vaccination strategy outperformed the seasonal influenza vaccination allocation strategy for a wide range of disease and vaccine coverage parameters. Conclusions: This modeling approach could inform policies for Mexico and other countries with similar demographic features and vaccine resources issues, with regard to the mitigation of the S-OIV pandemic. We also discuss logistical issues associated with the implementation of adaptive vaccination strategies in the context of past and future influenza pandemics.	[Chowell, Gerardo; Wang, Xiaohong] Arizona State Univ, Sch Human Evolut & Social Change, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA; [Chowell, Gerardo; Viboud, Cecile; Miller, Mark A.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Bertozzi, Stefano M.] Ctr Evaluat Res & Surveys, Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Instituto Nacional de Salud Publica; University of California System; University of California Berkeley	Chowell, G (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA.	gchowell@asu.edu	Chowell, Gerardo/F-5038-2012	Chowell, Gerardo/0000-0003-2194-2251; Bertozzi, Stefano M/0000-0002-1723-7085	Quantitative Immunization and Vaccine-Related Research (QUIVER) program of the WHO; Fogarty International Center; National Institutes of Health	Quantitative Immunization and Vaccine-Related Research (QUIVER) program of the WHO; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by the Quantitative Immunization and Vaccine-Related Research (QUIVER) program of the WHO and the intra-mural program of the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon A, 2009, EUROSURVEILLANCE, V14; ANDERSON R M, 1991; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Chowell G, 2006, VACCINE, V24, P6747, DOI 10.1016/j.vaccine.2006.05.055; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; *DIR GEN EP, 2009, NAT SURV EP SYST; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Duerr HP, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-76; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Eichner M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-17; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fineberg HV, 2008, J INFECT DIS, V197, pS14, DOI 10.1086/524989; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; *HLTH MIN, NAT PLAN PREP RESP I; Kuri-Morales P, 2006, SALUD PUBLICA MEXICO, V48, P72, DOI 10.1590/S0036-36342006000100011; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCDONALD JC, 1958, P ROY SOC MED, V51, P1016; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Nishiura H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-20; Nishiura H, 2008, NEW ZEAL MED J, V121, P18; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Preciado JIS, 2004, SALUD PUBLICA MEXICO, V46, P498, DOI 10.1590/S0036-36342004000600003; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; SIMONSEN L, 2004, PANDEMIC INFLUENZA M, P26; SIMONSEN L, 2004, INT C SERIES; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Tennenbaum S, 2008, J THEOR BIOL, V250, P673, DOI 10.1016/j.jtbi.2007.10.021; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	52	70	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2009	4	12							e8164	10.1371/journal.pone.0008164	http://dx.doi.org/10.1371/journal.pone.0008164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MW	19997603	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829000014
J	Berney, M; Cook, GM				Berney, Michael; Cook, Gregory M.			Unique Flexibility in Energy Metabolism Allows Mycobacteria to Combat Starvation and Hypoxia	PLOS ONE			English	Article							CYTOPLASMIC MALATE-DEHYDROGENASES; CITRIC-ACID CYCLE; GENE-EXPRESSION; STATIONARY-PHASE; TUBERCULOSIS; HYDROGEN; ADAPTATION; SMEGMATIS; MODEL; TRANSFORMATION	Mycobacteria are a group of obligate aerobes that require oxygen for growth, but paradoxically have the ability to survive and metabolize under hypoxia. The mechanisms responsible for this metabolic plasticity are unknown. Here, we report on the adaptation of Mycobacterium smegmatis to slow growth rate and hypoxia using carbon-limited continuous culture. When M. smegmatis is switched from a 4.6 h to a 69 h doubling time at a constant oxygen saturation of 50%, the cells respond through the down regulation of respiratory chain components and the F1F0-ATP synthase, consistent with the cells lower demand for energy at a reduced growth rate. This was paralleled by an up regulation of molecular machinery that allowed more efficient energy generation (i.e. Complex I) and the use of alternative electron donors (e. g. hydrogenases and primary dehydrogenases) to maintain the flow of reducing equivalents to the electron transport chain during conditions of severe energy limitation. A hydrogenase mutant showed a 40% reduction in growth yield highlighting the importance of this enzyme in adaptation to low energy supply. Slow growing cells at 50% oxygen saturation subjected to hypoxia (0.6% oxygen saturation) responded by switching on oxygen scavenging cytochrome bd, proton-translocating cytochrome bc(1)-aa(3) supercomplex, another putative hydrogenase, and by substituting NAD(+)-dependent enzymes with ferredoxin-dependent enzymes thus highlighting a new pattern of mycobacterial adaptation to hypoxia. The expression of ferredoxins and a hydrogenase provides a potential conduit for disposing of and transferring electrons in the absence of exogenous electron acceptors. The use of ferredoxin-dependent enzymes would allow the cell to maintain a high carbon flux through its central carbon metabolism independent of the NAD(+)/NADH ratio. These data demonstrate the remarkable metabolic plasticity of the mycobacterial cell and provide a new framework for understanding their ability to survive under low energy conditions and hypoxia.	[Berney, Michael; Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin, New Zealand	University of Otago	Berney, M (corresponding author), Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin, New Zealand.	michael.berney@otago.ac.nz; gregory.cook@otago.ac.nz	Cook, Gregory/E-5665-2011; Berney, Michael/GQZ-2111-2022; Berney, Michael/C-2731-2009	Berney, Michael/0000-0002-4833-0573; 	New Zealand Lottery Health; Health Research Council NZ; Maurice Wilkins Centre for Molecular Biodiscovery; Swiss National Science Foundation; National Institute of Allergy and Infectious Diseases	New Zealand Lottery Health; Health Research Council NZ(Health Research Council of New Zealand); Maurice Wilkins Centre for Molecular Biodiscovery; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	New Zealand Lottery Health, Health Research Council NZ, The Maurice Wilkins Centre for Molecular Biodiscovery, Swiss National Science Foundation and National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Baughn AD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000662; Best Corliss A, 2009, Hand (N Y), V4, P165, DOI 10.1007/s11552-008-9147-6; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; da Silva SM, 2008, ANTON LEEUW INT J G, V93, P381, DOI 10.1007/s10482-007-9215-x; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; GARLAND PB, 1962, NATURE, V196, P987, DOI 10.1038/196987a0; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihssen J, 2005, ENVIRON MICROBIOL, V7, P1568, DOI 10.1111/j.1462-2920.2005.00846.x; Kana Bavesh D., 2009, P35; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; Mnatsakanyan N, 2004, CELL BIOCHEM BIOPHYS, V41, P357, DOI 10.1385/CBB:41:3:357; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Ratledge C., 1999, MYCOBACTERIA MOL BIO, P260; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tang YJ, 2009, BIOTECHNOL LETT, V31, P1233, DOI 10.1007/s10529-009-9991-7; Tran SL, 2005, J BACTERIOL, V187, P5023, DOI 10.1128/JB.187.14.5023-5028.2005; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; van der Rest ME, 2000, J BACTERIOL, V182, P6892, DOI 10.1128/JB.182.24.6892-6899.2000; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Zbell AL, 2007, MICROBIOL-SGM, V153, P3508, DOI 10.1099/mic.0.2007/009027-0; Zbell AL, 2009, APPL ENVIRON MICROB, V75, P1456, DOI 10.1128/AEM.02064-08	48	135	138	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8614	10.1371/journal.pone.0008614	http://dx.doi.org/10.1371/journal.pone.0008614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062806	gold, Green Published, Green Submitted			2022-12-27	WOS:000273414100008
J	Horwitz, GC; Lelli, A; Geleoc, GSG; Holt, JR				Horwitz, Geoffrey C.; Lelli, Andrea; Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.			HCN Channels Are Not Required for Mechanotransduction in Sensory Hair Cells of the Mouse Inner Ear	PLOS ONE			English	Article							PACEMAKER CHANNELS; MECHANOELECTRICAL TRANSDUCTION; DEVELOPMENTAL ACQUISITION; CYCLIC-AMP; ADAPTATION; ACTIVATION; TURTLE	The molecular composition of the hair cell transduction channel has not been identified. Here we explore the novel hypothesis that hair cell transduction channels include HCN subunits. The HCN family of ion channels includes four members, HCN1-4. They were orginally identified as the molecular correlates of the hyperpolarization-activated, cyclic nucleotide gated ion channels that carry currents known as I(f), I(Q) or I(h). However, based on recent evidence it has been suggested that HCN subunits may also be components of the elusive hair cell transduction channel. To investigate this hypothesis we examined expression of mRNA that encodes HCN1-4 in sensory epithelia of the mouse inner ear, immunolocalization of HCN subunits 1, 2 and 4, uptake of the transduction channel permeable dye, FM1-43 and electrophysiological measurement of mechanotransduction current. Dye uptake and transduction current were assayed in cochlear and vestibular hair cells of wildtype mice exposed to HCN channel blockers or a dominant-negative form of HCN2 that contained a pore mutation and in mutant mice that lacked HCN1, HCN2 or both. We found robust expression of HCNs 1, 2 and 4 but little evidence that localized HCN subunits in hair bundles, the site of mechanotransduction. Although high concentrations of the HCN antagonist, ZD7288, blocked 50-70% of the transduction current, we found no reduction of transduction current in either cochlear or vestibular hair cells of HCN1- or HCN2-deficient mice relative to wild-type mice. Furthermore, mice that lacked both HCN1 and HCN2 also had normal transduction currents. Lastly, we found that mice exposed to the dominant-negative mutant form of HCN2 had normal transduction currents as well. Taken together, the evidence suggests that HCN subunits are not required for mechanotransduction in hair cells of the mouse inner ear.	[Horwitz, Geoffrey C.] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Horwitz, GC (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	jeffholt@virginia.edu			National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) [DC05439]; Physik Instruments; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005439, R56DC005439, R01DC008853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Physik Instruments; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) grants DC05439 (J.R.H.) and a NanoInnovation Grant from Physik Instruments ( A. L., E. A. Stauffer, and J.R.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakondi G, 2009, NEUROSCIENCE, V158, P1469, DOI 10.1016/j.neuroscience.2008.10.056; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; CAO X, 2009, ARO ABSTR; Cho WJ, 2003, NEUROSCIENCE, V118, P525, DOI 10.1016/S0306-4522(02)00913-2; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Rusch A, 1998, J NEUROSCI, V18, P7487; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y	23	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8627	10.1371/journal.pone.0008627	http://dx.doi.org/10.1371/journal.pone.0008627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062532	Green Submitted, Green Published, gold			2022-12-27	WOS:000273414100012
J	Salzer, CL; Kumar, JP				Salzer, Claire L.; Kumar, Justin P.			Identification of Retinal Transformation Hot Spots in Developing Drosophila Epithelia	PLOS ONE			English	Article							EYE DEVELOPMENT; IMAGINAL DISCS; ECTOPIC EYES; MORPHOGENETIC FURROW; TARGETED EXPRESSION; GENE HEDGEHOG; EYELESS GENE; SINE-OCULIS; WINGLESS; TRANSDETERMINATION	Background: The retinal determination (RD) network is an evolutionarily conserved regulatory circuit that governs early events in the development of eyes throughout the animal kingdom. Ectopic expression of many members of this network leads to the transformation of non-retinal epithelia into eye tissue. An often-overlooked observation is that only particular cell-populations within a handful of tissues are capable of having their primary developmental instructions superseded and overruled. Methodology/Preliminary Findings: Here we confirm that indeed, only a discrete number of cell populations within the imaginal discs that give rise to the head, antenna, legs, wings and halteres have the cellular plasticity to have their developmental fates altered. In contrast to previous reports, we find that all transformable cell populations do not lie within the TGF beta or Hedgehog signaling domains. Additionally neither signaling cascade alone is sufficient for non-retinal cell types to be converted into retinal tissue. The transformation "hot spots'' that we have identified appear to coincide with several previously defined transdetermination "weak spots'', suggesting that ectopic eye formation is less the result of one network overriding the orders of another, as previously thought, but rather is the physical manifestation of redirecting cell populations of enormous cellular plasticity. We also demonstrate that the initiation of eye formation in non-retinal tissues occurs asynchronously compared to that of the normal eye suggesting that retinal development is not under the control of a global developmental clock. Conclusions/Significance: We conclude that the subregions of non-retinal tissues that are capable of supporting eye formation represent specialized cell-populations that have a different level of plasticity than other cells within these tissues and may be the founder cells of each tissue.	[Salzer, Claire L.; Kumar, Justin P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Salzer, CL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jkumar@indiana.edu			National Institutes of Health (NIH) [R01 EY014863]; NATIONAL EYE INSTITUTE [R01EY014863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health (NIH) R01 EY014863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; Bessa J, 2009, DEV DYNAM, V238, P19, DOI 10.1002/dvdy.21808; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Braid LR, 2008, GENETICS, V180, P283, DOI 10.1534/genetics.108.092155; Chen R, 1999, DEVELOPMENT, V126, P935; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Datta RR, 2009, DEV DYN; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Maves L, 1998, DEVELOPMENT, V125, P115; Maves L, 1999, CURR TOP DEV BIOL, V43, P115; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Salzer CL, 2009, DEV BIOL, V326, P121, DOI 10.1016/j.ydbio.2008.10.048; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Shen WP, 1997, DEVELOPMENT, V124, P45; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; WEASNER BM, 2009, DEV BIOL; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; WOLFF T, 1991, DEVELOPMENT, V113, P841	35	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8510	10.1371/journal.pone.0008510	http://dx.doi.org/10.1371/journal.pone.0008510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062803	gold, Green Submitted, Green Published			2022-12-27	WOS:000273414100003
J	Lambert, C; Chang, CY; Capeness, MJ; Sockett, RE				Lambert, Carey; Chang, Chien-Yi; Capeness, Michael J.; Sockett, R. Elizabeth			The First Bite- Profiling the Predatosome in the Bacterial Pathogen Bdellovibrio	PLOS ONE			English	Article							INTRAPERIPLASMIC GROWTH; BACTERIOVORUS 109J; ELONGATION; PROTEINS; MUTANTS; CYCLE; IDENTIFICATION; PREDATION; CLEAVAGE; MOTILITY	Bdellovibrio bacteriovorus is a Gram-negative bacterium that is a pathogen of other Gram-negative bacteria, including many bacteria which are pathogens of humans, animals and plants. As such Bdellovibrio has potential as a biocontrol agent, or living antibiotic. B. bacteriovorus HD100 has a large genome and it is not yet known which of it encodes the molecular machinery and genetic control of predatory processes. We have tried to fill this knowledge-gap using mixtures of predator and prey mRNAs to monitor changes in Bdellovibrio gene expression at a timepoint of early-stage prey infection and prey killing in comparison to control cultures of predator and prey alone and also in comparison to Bdellovibrio growing axenically (in a prey-or host independent "HI'' manner) on artificial media containing peptone and tryptone. From this we have highlighted genes of the early predatosome with predicted roles in prey killing and digestion and have gained insights into possible regulatory mechanisms as Bdellovibrio enter and establish within the prey bdelloplast. Approximately seven percent of all Bdellovibrio genes were significantly up-regulated at 30 minutes of infection-but not in HI growth-implicating the role of these genes in prey digestion. Five percent were down-regulated significantly, implicating their role in free-swimming, attack-phase physiology. This study gives the first post-genomic insight into the predatory process and reveals some of the important genes that Bdellovibrio expresses inside the prey bacterium during the initial attack.	[Lambert, Carey; Chang, Chien-Yi; Capeness, Michael J.; Sockett, R. Elizabeth] Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham	Lambert, C (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Biol, Nottingham NG7 2RD, England.	liz.sockett@nottingham.ac.uk	Chang, Chien-Yi/E-1338-2012; Lambert, Carey/AAY-9270-2020; Chang, Chien-Yi/ABH-6848-2020	Chang, Chien-Yi/0000-0003-3570-4019; Chang, Chien-Yi/0000-0003-3570-4019; Lambert, Carey/0000-0002-1844-457X	Wellcome Trust [AL-077459]; Human Frontier Science Programme [RGP0057/2005/C]	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Programme(Human Frontier Science Program)	This work was funded by Wellcome Trust Grant AL-077459 to RES for CL and by Human Frontier Science Programme Grant RGP0057/2005/C to RES for C-YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabote RD, 2007, GENOMICS, V90, P424, DOI 10.1016/j.ygeno.2007.06.002; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; BLUM P, 1992, J BACTERIOL, V174, P7436, DOI 10.1128/jb.174.22.7436-7444.1992; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Ding BJ, 2005, BIOCHEM J, V389, P797, DOI 10.1042/BJ20050405; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; Dori-Bachash M, 2009, FUNCT INTEGR GENOMIC, V9, P153, DOI 10.1007/s10142-008-0106-7; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Flower AM, 2007, TRENDS MICROBIOL, V15, P203, DOI 10.1016/j.tim.2007.03.001; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Galbis-Martinez M, 2004, GENETICS, V167, P1585, DOI 10.1534/genetics.104.029207; Golbik R, 2005, BIOCHEMISTRY-US, V44, P16026, DOI 10.1021/bi051442w; GOSHIMA N, 1994, GENE, V141, P17; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; Karring H, 2004, J BIOL CHEM, V279, P1878, DOI 10.1074/jbc.M306605200; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Lambert C, 2003, ENVIRON MICROBIOL, V5, P127, DOI 10.1046/j.1462-2920.2003.00385.x; Lambert Carey, 2008, Curr Protoc Microbiol, VChapter 7, DOI 10.1002/9780471729259.mc07b02s9; Lambert C, 2009, ADV MICROB PHYSIOL, V54, P313, DOI 10.1016/S0065-2911(08)00005-2; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Lee S, 2006, J AM CHEM SOC, V128, P11545, DOI 10.1021/ja063073c; Li X, 2007, MOL MICROBIOL, V63, P116, DOI 10.1111/j.1365-2958.2006.05498.x; MEDINA AA, 2009, RES MICROBIOL; Medina AA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-33; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; ROSSON RA, 1979, J BACTERIOL, V140, P620, DOI 10.1128/JB.140.2.620-633.1979; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; SRIVATSAN A, 2008, CURR OPIN MICROBIOL; Steyert SR, 2008, J BACTERIOL, V190, P8215, DOI 10.1128/JB.01009-08; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; THOMASHOW MF, 1978, J BACTERIOL, V135, P1008, DOI 10.1128/JB.135.3.1008-1014.1978; THOMASHOW MF, 1978, J BACTERIOL, V135, P998, DOI 10.1128/JB.135.3.998-1007.1978; Torres M, 2004, J BACTERIOL, V186, P1304, DOI 10.1128/JB.186.5.1304-1310.2004; Tudor JJ, 2008, APPL ENVIRON MICROB, V74, P5436, DOI 10.1128/AEM.00256-08; VARON M, 1975, J BACTERIOL, V124, P1191, DOI 10.1128/JB.124.3.1191-1197.1975; Williams HN, 1995, CAN J MICROBIOL, V41, P1142, DOI 10.1139/m95-159	46	66	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8599	10.1371/journal.pone.0008599	http://dx.doi.org/10.1371/journal.pone.0008599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062540	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600018
J	Whalen, KE; Lane, AL; Kubanek, J; Hahn, ME				Whalen, Kristen E.; Lane, Amy L.; Kubanek, Julia; Hahn, Mark E.			Biochemical Warfare on the Reef: The Role of Glutathione Transferases in Consumer Tolerance of Dietary Prostaglandins	PLOS ONE			English	Article							GORGONIAN PLEXAURA-HOMOMALLA; STOLONIFER CLAVULARIA-VIRIDIS; CYPHOMA-GIBBOSUM GASTROPODA; S-TRANSFERASES; CHEMICAL DEFENSE; FALL ARMYWORM; ANTIPROLIFERATIVE ACTIVITY; BIOTRANSFORMATION ENZYMES; BROMINATED PHENOL; GROWTH-INHIBITION	Background: Despite the profound variation among marine consumers in tolerance for allelochemically-rich foods, few studies have examined the biochemical adaptations underlying diet choice. Here we examine the role of glutathione S-transferases (GSTs) in the detoxification of dietary allelochemicals in the digestive gland of the predatory gastropod Cyphoma gibbosum, a generalist consumer of gorgonian corals. Controlled laboratory feeding experiments were used to investigate the influence of gorgonian diet on Cyphoma GST activity and isoform expression. Gorgonian extracts and semi-purified fractions were also screened to identify inhibitors and possible substrates of Cyphoma GSTs. In addition, we investigated the inhibitory properties of prostaglandins (PGs) structurally similar to antipredatory PGs found in high concentrations in the Caribbean gorgonian Plexaura homomalla. Principal Findings: Cyphoma GST subunit composition was invariant and activity was constitutively high regardless of gorgonian diet. Bioassay-guided fractionation of gorgonian extracts revealed that moderately hydrophobic fractions from all eight gorgonian species examined contained putative GST substrates/inhibitors. LC-MS and NMR spectral analysis of the most inhibitory fraction from P. homomalla subsequently identified prostaglandin A(2) (PGA(2)) as the dominant component. A similar screening of commercially available prostaglandins in series A, E, and F revealed that those prostaglandins most abundant in gorgonian tissues (e. g., PGA(2)) were also the most potent inhibitors. In vivo estimates of PGA(2) concentration in digestive gland tissues calculated from snail grazing rates revealed that Cyphoma GSTs would be saturated with respect to PGA(2) and operating at or near physiological capacity. Significance: The high, constitutive activity of Cyphoma GSTs is likely necessitated by the ubiquitous presence of GST substrates and/or inhibitors in this consumer's gorgonian diet. This generalist's GSTs may operate as 'all-purpose' detoxification enzymes, capable of conjugating or sequestering a broad range of lipophilic gorgonian compounds, thereby allowing this predator to exploit a range of chemically-defended prey, resulting in a competitive dietary advantage for this species.	[Whalen, Kristen E.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Lane, Amy L.; Kubanek, Julia] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kubanek, Julia] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Woods Hole Oceanographic Institution; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Whalen, KE (corresponding author), Univ New S Wales, Ctr Marine BioInnovat, Sydney, NSW, Australia.	whalen@msi.ucsb.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; Kubanek, Julia/0000-0003-4482-1831; Lane, Amy/0000-0002-8386-364X	Ocean Life Institute; Robert H. Cole Endowed Ocean Ventures Fund (WHOI); National Undersea Research Center - Program Development Proposal [CMRC-03PRMN0103A]; Hope Noyes Smith; National Science Foundation	Ocean Life Institute; Robert H. Cole Endowed Ocean Ventures Fund (WHOI); National Undersea Research Center - Program Development Proposal; Hope Noyes Smith; National Science Foundation(National Science Foundation (NSF))	Financial support for this work was provided by the Ocean Life Institute Tropical Research Initiative Grant (WHOI) to KEW and MEH; the Robert H. Cole Endowed Ocean Ventures Fund (WHOI) to KEW; the National Undersea Research Center - Program Development Proposal (CMRC-03PRMN0103A) to KEW; Walter A. and Hope Noyes Smith, and a National Science Foundation Graduate Research Fellowship to KEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalias A, 2000, Z NATURFORSCH C, V55, P425; ATSMON J, 1990, CANCER RES, V50, P1879; BAKER BJ, 1994, J NAT PROD, V57, P1346, DOI 10.1021/np50112a003; Beuckmann CT, 2000, NEUROCHEM RES, V25, P733, DOI 10.1023/A:1007579507804; Bogaards JJP, 1997, CHEM RES TOXICOL, V10, P310, DOI 10.1021/tx9601770; CAGEN LM, 1975, BIOCHIM BIOPHYS ACTA, V398, P205, DOI 10.1016/0005-2760(75)90184-8; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Chiappone M, 2003, CARIBB J SCI, V39, P116; CIERESZKO LS, 1987, B MAR SCI, V41, P634; CIERESZKO LS, 1985, EXPERIENTIA, V41, P37, DOI 10.1007/BF02005860; COLL JC, 1992, CHEM REV, V92, P613, DOI 10.1021/cr00012a006; DeBusk BC, 2000, COMP BIOCHEM PHYS C, V127, P133, DOI 10.1016/S0742-8413(00)00141-9; Fernandes S, 2009, J EXP ZOOL PART A, V311A, P226, DOI 10.1002/jez.524; Fukushima M, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P415; GERHART DJ, 1984, MAR ECOL PROG SER, V19, P181, DOI 10.3354/meps019181; GERHART DJ, 1991, AM J PHYSIOL, V260, pR839, DOI 10.1152/ajpregu.1991.260.5.R839; Guillet G, 2000, ENVIRON ENTOMOL, V29, P135, DOI 10.1603/0046-225X(2000)029[0135:BABAOG]2.0.CO;2; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HARVELL CD, 1989, LIMNOL OCEANOGR, V34, P382, DOI 10.4319/lo.1989.34.2.0382; HARVELL CD, 1987, MAR ECOL PROG SER, V38, P37, DOI 10.3354/meps038037; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HONDA A, 1987, MOL PHARMACOL, V32, P530; HONN KV, 1985, BIOCHEM BIOPH RES CO, V129, P34, DOI 10.1016/0006-291X(85)91398-1; Hubatsch I, 2002, CHEM RES TOXICOL, V15, P1114, DOI 10.1021/tx020027r; IGUCHI K, 1987, CHEM PHARM BULL, V35, P4375; KATO T, 1986, CANCER RES, V46, P3538; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; KETLEY JN, 1975, J BIOL CHEM, V250, P8670; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Kuhajek JM, 2003, COMP BIOCHEM PHYS C, V134, P473, DOI 10.1016/S1532-0456(03)00040-1; LASKER HR, 1988, BIOL BULL, V174, P254, DOI 10.2307/1541952; LEE K, 1992, BIOCHEM SYST ECOL, V20, P197, DOI 10.1016/0305-1978(92)90054-H; LEE KW, 1991, INSECT BIOCHEM, V21, P353, DOI 10.1016/0020-1790(91)90001-U; LEE RF, 1988, MAR ENVIRON RES, V24, P97, DOI 10.1016/0141-1136(88)90262-0; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Murphy RC, 2002, PROSTAG OTH LIPID M, V68-9, P471, DOI 10.1016/S0090-6980(02)00049-7; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P506; NOYORI R, 1993, SCIENCE, V259, P44, DOI 10.1126/science.8418493; O'Neal W, 2002, MAR ECOL PROG SER, V240, P117, DOI 10.3354/meps240117; Paumi CM, 2004, BIOCHEMISTRY-US, V43, P2345, DOI 10.1021/bi035936+; PAWLIK JR, 1987, J EXP MAR BIOL ECOL, V108, P55, DOI 10.1016/0022-0981(87)90130-4; PAWLIK JR, 1989, MAR ECOL PROG SER, V52, P95, DOI 10.3354/meps052095; Regoli F, 1997, HYDROBIOLOGIA, V355, P139, DOI 10.1023/A:1003094515903; RODRIGUEZ AD, 1995, TETRAHEDRON, V51, P4571, DOI 10.1016/0040-4020(95)00216-U; Sanchez-Gomez FJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P150, DOI 10.1016/j.abb.2006.10.032; SCHNEIDER WP, 1977, J AM CHEM SOC, V99, P1222, DOI 10.1021/ja00446a039; SCHNEIDER WP, 1972, J AM CHEM SOC, V94, P2122, DOI 10.1021/ja00761a060; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sotka E. E., 2008, P203, DOI 10.1007/978-3-540-74181-7_10; SOTKA EE, 2009, INTEGRATIVE IN PRESS, DOI DOI 10.1093/ICB/ICP1049; SPRAGGINS RL, 1972, TETRAHEDRON LETT, V42, P4343; Stanley DW, 2008, INSECT BIOCHEM MOLEC, V38, P275, DOI 10.1016/j.ibmb.2007.11.004; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Uchida K, 2000, MECH AGEING DEV, V116, P135, DOI 10.1016/S0047-6374(00)00129-9; van Iersel MLPS, 1999, BIOCHEM PHARMACOL, V57, P1383, DOI 10.1016/S0006-2952(99)00048-9; Vasconcelos VM, 2007, TOXICON, V50, P740, DOI 10.1016/j.toxicon.2007.06.010; VROLIJK NH, 1992, MAR ECOL PROG SER, V88, P237, DOI 10.3354/meps088237; WADLEIGH RW, 1988, J CHEM ECOL, V14, P1279, DOI 10.1007/BF01019352; WADLEIGH RW, 1987, INSECT BIOCHEM, V17, P759, DOI 10.1016/0020-1790(87)90046-1; WEINHEIMER AJ, 1969, TETRAHEDRON LETT, P5185; WHALEN KE, 2009, MOL ECOLOGY IN PRESS; WHALEN KE, 2008, FUNCTIONAL CHARACTER; Whalen KE, 2008, ARCH BIOCHEM BIOPHYS, V478, P7, DOI 10.1016/j.abb.2008.07.007; YU SJ, 1989, PESTIC BIOCHEM PHYS, V35, P97, DOI 10.1016/0048-3575(89)90107-7; Yu SJ, 2000, PESTIC BIOCHEM PHYS, V68, P173, DOI 10.1006/pest.2000.2514; Yu SJ, 1999, PESTIC BIOCHEM PHYS, V63, P163, DOI 10.1006/pest.1999.2402	68	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8537	10.1371/journal.pone.0008537	http://dx.doi.org/10.1371/journal.pone.0008537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20052279	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600005
J	Field, MC; Sergeenko, T; Wang, YN; Bohm, S; Carrington, M				Field, Mark C.; Sergeenko, Tatiana; Wang, Ya-Nan; Boehm, Susanne; Carrington, Mark			Chaperone Requirements for Biosynthesis of the Trypanosome Variant Surface Glycoprotein	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GPI-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; INTRACELLULAR-TRANSPORT; AFRICAN TRYPANOSOMES; MEMBRANE-PROTEIN; RNA INTERFERENCE; ER EXIT; BRUCEI	Background: Trypanosoma brucei does not respond transcriptionally to several endoplasmic reticulum ( ER) stress conditions, including tunicamycin or dithiothreitol, indicating the absence of a conventional unfolded protein response. This suggests divergent mechanisms for quality control (QC) of ER protein folding and export may be present in trypanosomes. As the variant surface glycoprotein (VSG) represents similar to 90% of trypanosome plasma membrane protein, it is possible that VSG has evolved to fold efficiently to minimize ER folding burden. Methodology/Principal Findings: We demonstrate the presence of a QC system by pharmacological inhibition of the trypanosome 26S proteasome. This indicates active proteasome-mediated VSG turnover as similar to 2.5 fold more VSG is recovered from cell lysates following MG132 inhibition. An in silico scan of the trypanosome genome identified 28 open reading frames likely to encode polypeptides participating in ER nascent chain maturation. By RNA interference we monitored the importance of these gene products to proliferation, VSG abundance and cell morphology. 68% of the cohort were required for normal proliferation, and depletion of most of these factors resulted in increased VSG abundance, suggesting involvement in ERQC and degradation. Conclusions/Significance: The retention of genes for, and the involvement of many gene products in, VSG folding indicates a substantial complexity within the pathways required to perform this role. Counterintuitively, for a super-abundant antigen VSG is apparently made in excess. The biosynthetic excess VSG appears to be turned over efficiently by the proteasome, implying that considerable VSG is rejected by the trypanosome ERQC mechanism. Accordingly, the VSG polypeptide is not well optimized for folding, as only similar to 30% attains the native state. Finally as much of the core ERQC system is functionally conserved in trypanosomes, the pathway has an ancient evolutionary origin, and was present in the last common eukaryotic ancestor.	[Field, Mark C.; Sergeenko, Tatiana; Wang, Ya-Nan; Boehm, Susanne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Wang, Ya-Nan] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England	University of Cambridge; China Agricultural University; University of Cambridge	Field, MC (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mcf34@cam.ac.uk	Field, Mark/AAD-6455-2021; Carrington, Mark/N-4892-2018; Carrington, Mark/N-3653-2019	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Field, Mark/0000-0002-4866-2885	Wellcome Trust; CamPOD	Wellcome Trust(Wellcome TrustEuropean Commission); CamPOD	This work was funded by project and program grant support from the Wellcome Trust (to MCF and MC) and benefited from equipment grant support from CamPOD, which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; BANGS JD, 1986, J CELL BIOL, V103, P255, DOI 10.1083/jcb.103.1.255; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bohme U, 2002, J CELL SCI, V115, P805; Bue CA, 2009, J BIOL CHEM, V284, P24049, DOI 10.1074/jbc.M109.022590; Campillo N, 2003, MOL BIOCHEM PARASIT, V127, P79, DOI 10.1016/S0166-6851(02)00306-7; Carrington M, 1996, MOL BIOCHEM PARASIT, V81, P119, DOI 10.1016/0166-6851(96)02706-5; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Chung WL, 2004, J BIOL CHEM, V279, P54887, DOI 10.1074/jbc.M409311200; Dhir V, 2004, MOL BIOCHEM PARASIT, V137, P253, DOI 10.1016/j.molbiopara.2004.06.007; DUSZENKO M, 1988, J CELL BIOL, V106, P77, DOI 10.1083/jcb.106.1.77; ENGSTLER M, 2007, TRYPANOSOMES GENOME; Field MC, 2009, INT REV CEL MOL BIO, V278, P1, DOI 10.1016/S1937-6448(09)78001-3; FIELD MC, 1994, J BIOL CHEM, V269, P10830; Goldshmidt H, 2008, J BIOL CHEM, V283, P32085, DOI 10.1074/jbc.M801499200; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEUNG KF, 2010, J BIOL CHEM UNPUB; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mehlert A, 2002, GLYCOBIOLOGY, V12, P607, DOI 10.1093/glycob/cwf079; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; Mitra T, 2008, INT J ECON THEORY, V4, P53, DOI 10.1111/j.1742-7363.2007.00068.x; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Parodi AJ, 1998, BRAZ J MED BIOL RES, V31, P601, DOI 10.1590/S0100-879X1998000500002; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Rubotham J, 2005, J BIOL CHEM, V280, P10410, DOI 10.1074/jbc.M409375200; SEYFANG A, 1990, J PROTOZOOL, V37, P546, DOI 10.1111/j.1550-7408.1990.tb01263.x; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Van Hellemond JJ, 2000, MOL BIOCHEM PARASIT, V111, P275, DOI 10.1016/S0166-6851(00)00318-2; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang J, 2003, MOL BIOCHEM PARASIT, V128, P135, DOI 10.1016/S0166-6851(03)00055-0; Watanabe R, 2004, CURR OPIN CELL BIOL, V16, P350, DOI 10.1016/j.ceb.2004.06.010; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10797	68	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8468	10.1371/journal.pone.0008468	http://dx.doi.org/10.1371/journal.pone.0008468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052285	gold, Green Published, Green Submitted			2022-12-27	WOS:000273338500004
J	Sorice, M; Matarrese, P; Manganelli, V; Tinari, A; Giammarioli, AM; Mattei, V; Misasi, R; Garofalo, T; Malorni, W				Sorice, Maurizio; Matarrese, Paola; Manganelli, Valeria; Tinari, Antonella; Giammarioli, Anna Maria; Mattei, Vincenzo; Misasi, Roberta; Garofalo, Tina; Malorni, Walter			Role of GD3-CLIPR-59 Association in Lymphoblastoid T Cell Apoptosis Triggered by CD95/Fas	PLOS ONE			English	Article							LIPID RAFTS; GD3 GANGLIOSIDE; PERMEABILITY TRANSITION; SIGNALING COMPLEX; MITOCHONDRIA; MICRODOMAINS; ACTIVATION; DYNAMICS; PROTEIN; DEATH	We previously found that a directional movement of the raft component GD3 towards mitochondria, by its association with microtubules, was mandatory to late apoptogenic events triggered by CD95/Fas. Since CLIPR-59, CLIP-170-related protein, has recently been identified as a microtubule binding protein associated with lipid rafts, we analyzed the role of GD3-CLIPR-59 association in lymphoblastoid T cell apoptosis triggered by CD95/Fas. To test whether CLIPR-59 could play a role at the raft-microtubule junction, we performed a series of experiments by using immunoelectron microscopy, static or flow cytometry and biochemical analyses. We first assessed the presence of CLIPR-59 molecule in lymphoblastoid T cells (CEM). Then, we demonstrated that GD3-microtubule interaction occurs via CLIPR-59 and takes place at early time points after CD95/Fas ligation, preceding the association GD3-tubulin. GD3-CLIPR-59 association was demonstrated by fluorescence resonance energy transfer (FRET) analysis. The key role of CLIPR-59 in this dynamic process was clarified by the observation that silencing CLIPR-59 by siRNA affected the kinetics of GD3-tubulin association, spreading of GD3 towards mitochondria and apoptosis execution. We find that CLIPR-59 may act as a typical chaperone, allowing a prompt interaction between tubulin and the raft component GD3 during cell apoptosis triggered by CD95/Fas. On the basis of the suggested role of lipid rafts in conveying pro-apoptotic signals these results disclose new perspectives in the understanding of the mechanisms by which raft-mediated pro-apoptotic signals can directionally reach their target, i.e. the mitochondria, and trigger apoptosis execution.	[Sorice, Maurizio; Manganelli, Valeria; Mattei, Vincenzo; Misasi, Roberta; Garofalo, Tina] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Sorice, Maurizio; Mattei, Vincenzo; Garofalo, Tina] Univ La Sapienza, Lab Expt Med & Environm Pathol, Rieti, Italy; [Matarrese, Paola; Malorni, Walter] Ist Super Sanita, Dept Drug Res & Evaluat, Sect Cell Aging & Degenerat, I-00161 Rome, Italy; [Tinari, Antonella; Giammarioli, Anna Maria] Ist Super Sanita, Dept Technol & Hlth, Sect Ultrastruct Infect Pathol, I-00161 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Sorice, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	maurizio.sorice@uniroma1.it	Sousa, Maria/HCI-9642-2022; Sorice, Maurizio/Q-5079-2019; Mattei, Vincenzo/AAQ-3667-2020; Giammarioli, Anna Maria/AAY-7686-2020; Matarrese, Paola/A-4369-2014; TINARI, ANTONELLA/F-2109-2015	Mattei, Vincenzo/0000-0003-4677-088X; matarrese, paola/0000-0001-5477-3752; Sorice, Maurizio/0000-0003-3534-1502; malorni, walter/0000-0002-1223-7000; Garofalo, Tina/0000-0003-0645-2510	Ministero dell'Istruzione, Universitae Ricerca (MIUR); FIRB-MIUR [RBPR05NWWC-011]; Telethon [GGP06254B]	Ministero dell'Istruzione, Universitae Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); FIRB-MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Telethon(Fondazione Telethon)	This work was supported by funds from Ministero dell'Istruzione, Universitae Ricerca (MIUR) to MS, from FIRB-MIUR RBPR05NWWC-011 and Telethon (Grant GGP06254B) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Garofalo T, 2003, J BIOL CHEM, V278, P8309, DOI 10.1074/jbc.M207618200; Giammarioli AM, 2001, FEBS LETT, V506, P45, DOI 10.1016/S0014-5793(01)02776-4; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; KOTANI M, 1994, GLYCOBIOLOGY, V4, P855, DOI 10.1093/glycob/4.6.855; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960; Malorni W, 2008, METHOD ENZYMOL, V442, P125, DOI 10.1016/S0076-6879(08)01406-7; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pizzo P, 2003, CURR OPIN IMMUNOL, V15, P255, DOI 10.1016/S0952-7915(03)00038-4; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Scheel-Toellner D, 2002, BIOCHEM BIOPH RES CO, V297, P876, DOI 10.1016/S0006-291X(02)02311-2; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorice M, 2009, FASEB J, V23, P3298, DOI 10.1096/fj.08-128140; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; YUASA H, 1990, TISSUE ANTIGENS, V36, P47, DOI 10.1111/j.1399-0039.1990.tb01799.x; Zamzami N, 2001, METHOD CELL BIOL, V65, P147, DOI 10.1016/S0091-679X(01)65009-X; Zhuang LY, 2002, CANCER RES, V62, P2227	28	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8567	10.1371/journal.pone.0008567	http://dx.doi.org/10.1371/journal.pone.0008567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052288	Green Submitted, gold, Green Published			2022-12-27	WOS:000273338500011
J	Khan, AA; Priya, S; Saha, B				Khan, Aslam Ali; Priya, Shilpee; Saha, Bhaskar			IL-2 Regulates SEB Induced Toxic Shock Syndrome in BALB/c Mice	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; IMMUNE ACTIVATION; CYTOKINE RELEASE; GENE-EXPRESSION; DENDRITIC CELLS; T-CELLS; SUPERANTIGENS; INTERLEUKIN-2; LYMPHOCYTES; DEFICIENT	Background: Toxic Shock Syndrome (TSS) is characterized by fever, rash, hypotension, constitutional symptoms, and multi-organ involvement and is caused by Staphylococcus aureus enterotoxins such as Staphylococcal Enterotoxin B (SEB). SEB binds to the MHC-II alpha chain and is recognized by the TCR beta chain of the V beta 8 TCR(+) T cells. The binding of SEB to V beta chain results in rapid activation of T cells and production of inflammatory cytokines, such as Interleukin-2 (IL-2), Interferon-gamma and Tumor Necrosis Factor-alpha which mediate TSS. Although IL2 was originally identified as the T cell growth factor and was proposed to contribute to T cell differentiation, its role in TSS remains unexplored. Methodology/Principal Findings: Mice were injected with D-Gal (25 mg/mouse). One hour after D-Galactosamine (D-Gal) injection each mouse was injected with SEB (20 mu g/mouse. Mice were then observed for 72 hrs and death was recorded at different times. We tested Interleukin-12, IFN gamma, and IL-2 deficient mice (IL-2(-/-)), but only the IL-2 deficient mice were resistant to SEB induced toxic shock syndrome. More importantly reconstitution of IL-2 in IL-2 deficient mice restored the shock. Interestingly, SEB induced IL-2 production from T cells was dependent on p38MAPK activation in macrophages as inhibition of it in macrophages significantly inhibited IL-2 production from T cells. Conclusion: This study shows the importance of IL-2 in TSS which has not been previously explored and it also shows that regulating macrophages function can regulate T cells and TSS.	[Khan, Aslam Ali] Washington Univ, St Louis, MO 63130 USA; [Priya, Shilpee; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Washington University (WUSTL); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Khan, AA (corresponding author), Washington Univ, St Louis, MO 63130 USA.	khana@vision.wustl.edu			Council of Scientific and Industrial Research (CSIR); Defence Research and Development Organization (DRDO), India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Defence Research and Development Organization (DRDO), India(Defence Research & Development Organisation (DRDO))	Council of Scientific and Industrial Research (CSIR), Defence Research and Development Organization (DRDO), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDPIRAK E, 1995, IMMUNOL LETT, V46, P9, DOI 10.1016/0165-2478(94)00005-C; ACHARYA KR, 1994, NATURE, V367, P94, DOI 10.1038/367094a0; Aicher A, 1999, J IMMUNOL, V163, P5786; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; BACHMANN MF, 1995, J VIROL, V69, P4842, DOI 10.1128/JVI.69.8.4842-4846.1995; Batten M, 2004, J IMMUNOL, V172, P812, DOI 10.4049/jimmunol.172.2.812; Baxter AG, 2002, NAT REV IMMUNOL, V2, P439, DOI 10.1038/nri823; Burns LJ, 2003, BONE MARROW TRANSPL, V32, P177, DOI 10.1038/sj.bmt.1704086; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Davison S, 1999, BRIT J DERMATOL, V140, P845, DOI 10.1046/j.1365-2133.1999.02813.x; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Khan AA, 2008, J LEUKOCYTE BIOL, V83, P1363, DOI 10.1189/jlb.1007686; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; LAGOO AS, 1994, J IMMUNOL, V152, P1641; LEE VTP, 1992, J INFECT DIS, V166, P911, DOI 10.1093/infdis/166.4.911; Matsuda Y, 2003, EMERG INFECT DIS, V9, P387, DOI 10.3201/eid0903.020360; MIETHKE T, 1993, IMMUNOBIOLOGY, V189, P270, DOI 10.1016/S0171-2985(11)80362-1; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Neumann B, 1997, J IMMUNOL, V158, P1862; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; SCHROCK CG, 1980, JAMA-J AM MED ASSOC, V243, P1231, DOI 10.1001/jama.1980.03300380013006; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; TRIZIO D, 1974, J IMMUNOL, V113, P1093	25	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8473	10.1371/journal.pone.0008473	http://dx.doi.org/10.1371/journal.pone.0008473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041187	gold, Green Published			2022-12-27	WOS:000273105200009
J	Madhavan, R; Gong, ZLL; Ma, JJ; Chan, AWS; Peng, HB				Madhavan, Raghavan; Gong, Zhuolin L.; Ma, Jin Jin; Chan, Ariel W. S.; Peng, H. Benjamin			The Function of Cortactin in the Clustering of Acetylcholine Receptors at the Vertebrate Neuromuscular Junction	PLOS ONE			English	Article							POSTSYNAPTIC DIFFERENTIATION; TYROSINE PHOSPHATASE; SYNAPSE FORMATION; ARP2/3 COMPLEX; MUSCLE-CELLS; P120 CATENIN; BETA-SUBUNIT; AGRIN; PHOSPHORYLATION; MUSK	Background: Postsynaptic enrichment of acetylcholine receptors (AChRs) at the vertebrate neuromuscular junction (NMJ) depends on the activation of the muscle receptor tyrosine MuSK by neural agrin. Agrin-stimulation of MuSK is known to initiate an intracellular signaling cascade that leads to the clustering of AChRs in an actin polymerization-dependent manner, but the molecular steps which link MuSK activation to AChR aggregation remain incompletely defined. Methodology/Principal Findings: In this study we used biochemical, cell biological and molecular assays to investigate a possible role in AChR clustering of cortactin, a protein which is a tyrosine kinase substrate and a regulator of F-actin assembly and which has also been previously localized at AChR clustering sites. We report that cortactin was co-enriched at AChR clusters in situ with its target the Arp2/3 complex, which is a key stimulator of actin polymerization in cells. Cortactin was further preferentially tyrosine phosphorylated at AChR clustering sites and treatment of myotubes with agrin significantly enhanced the tyrosine phosphorylation of cortactin. Importantly, forced expression in myotubes of a tyrosine phosphorylation-defective cortactin mutant (but not wild-type cortactin) suppressed agrin-dependent AChR clustering, as did the reduction of endogenous cortactin levels using RNA interference, and introduction of the mutant cortactin into muscle cells potently inhibited synaptic AChR aggregation in response to innervation. Conclusion: Our results suggest a novel function of phosphorylation-dependent cortactin signaling downstream from agrin/MuSK in facilitating AChR clustering at the developing NMJ.	[Madhavan, Raghavan; Gong, Zhuolin L.; Ma, Jin Jin; Chan, Ariel W. S.; Peng, H. Benjamin] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Madhavan, R (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China.	penghb@ust.hk			Research Grants Council (RGC) [HKUST6401/05M, HKUST6417/06M]; Academic Outreach Endowment (AOE) [B-15/01]	Research Grants Council (RGC)(Hong Kong Research Grants Council); Academic Outreach Endowment (AOE)	This work was supported by Research Grants Council (RGC) grants HKUST6401/05M and HKUST6417/06M, and Academic Outreach Endowment (AOE) grant grant/B-15/01 (http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Camilleri AA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-46; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daggett DF, 1996, MOL CELL NEUROSCI, V7, P75, DOI 10.1006/mcne.1996.0006; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; EDWARDS C, 1976, J NEUROBIOL, V7, P377, DOI 10.1002/neu.480070409; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Friese MB, 2007, DEVELOPMENT, V134, P4167, DOI 10.1242/dev.010702; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Geng L, 2008, CHEM-BIOL INTERACT, V175, P108, DOI 10.1016/j.cbi.2008.04.017; Geng L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-80; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hering H, 2003, J NEUROSCI, V23, P11759; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Luo ZG, 2003, J NEUROCYTOL, V32, P697, DOI 10.1023/B:NEUR.0000020618.65271.63; Madhavan R, 2005, IUBMB LIFE, V57, P719, DOI 10.1080/15216540500338739; Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005; Madhavan R, 2003, J NEUROCYTOL, V32, P685, DOI 10.1023/B:NEUR.0000020617.05656.68; Madhavan R, 2006, J NEUROBIOL, V66, P1511, DOI 10.1002/neu.20320; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moransard M, 2003, J BIOL CHEM, V278, P7350, DOI 10.1074/jbc.M210865200; Nizhynska V, 2007, DEV NEUROBIOL, V67, P1047, DOI 10.1002/dneu.20371; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Peng HB, 1997, J NEUROCYTOL, V26, P637, DOI 10.1023/A:1018545827369; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Qian YPK, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-70; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weston C, 2003, J BIOL CHEM, V278, P6450, DOI 10.1074/jbc.M210249200; Wiesner A, 2006, CELL MOL LIFE SCI, V63, P2818, DOI 10.1007/s00018-006-6081-z; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhao XTT, 2007, DEV NEUROBIOL, V67, P1789, DOI 10.1002/dneu.20556	55	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8478	10.1371/journal.pone.0008478	http://dx.doi.org/10.1371/journal.pone.0008478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041195	Green Published, gold, Green Submitted			2022-12-27	WOS:000273105200013
J	Kerbiriou, M; Teng, L; Benz, N; Trouve, P; Ferec, C				Kerbiriou, Mathieu; Teng, Ling; Benz, Nathalie; Trouve, Pascal; Ferec, Claude			The Calpain, Caspase 12, Caspase 3 Cascade Leading to Apoptosis Is Altered in F508del-CFTR Expressing Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNFOLDED PROTEIN RESPONSE; MUTANT CYSTIC-FIBROSIS; EPITHELIAL-CELLS; DELTA-F508 CFTR; DEATH PROGRAM; ACTIVATION; IDENTIFICATION; MECHANISM	In cystic fibrosis (CF), the most frequent mutant variant of the cystic fibrosis transmembrane conductance regulator (CFTR), F508del-CFTR protein, is misfolded and retained in the endoplasmic reticulum (ER). We previously showed that the unfolded protein response (UPR) may be triggered in CF. Since prolonged UPR activation leads to apoptosis via the calcium-calpain-caspase-12-caspase-3 cascade and because apoptosis is altered in CF, our aim was to compare the ER stress-induced apoptosis pathway between wild type (Wt) and F508del-CFTR expressing cells. Here we show that the calcium-calpain-caspase-12-caspase-3 cascade is altered in F508del-CFTR expressing cells. We propose that this alteration is involved in the altered apoptosis triggering observed in CF.	[Kerbiriou, Mathieu; Teng, Ling; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] INSERM, Brest, France; [Kerbiriou, Mathieu; Teng, Ling; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] Univ Brest, Fac Med & Sci Sante, Brest, France; [Ferec, Claude] Etab Francais du Sang Bretagne, Brest, France; [Ferec, Claude] CHU Brest, Hop Morvan, Genet Mol Lab, F-29285 Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale	Kerbiriou, M (corresponding author), INSERM, Brest, France.	pascal.trouve@univ-brest.fr; claude.ferec@univ-brest.fr	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710	Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose''; French foundation "Fondation pour la Recherche Medicale"	Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose''; French foundation "Fondation pour la Recherche Medicale"	This work was supported by grants from the association Gaetan Salaun, the "Etablissement Francais du Sang'' and the French CF foundation "Vaincre la Mucoviscidose''. Mathieu Kerbiriou was supported by the French foundation "Fondation pour la Recherche Medicale''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj G, 2006, BIOCHEM BIOPH RES CO, V345, P1558, DOI 10.1016/j.bbrc.2006.05.059; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Das A, 2006, INT J CANCER, V119, P2575, DOI 10.1002/ijc.22228; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P3587, DOI 10.1073/pnas.93.8.3587; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Konstan MW, 1997, PEDIATR PULM, V24, P137, DOI 10.1002/(SICI)1099-0496(199708)24:2<137::AID-PPUL13>3.0.CO;2-3; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Maiuri L, 1997, FEBS LETT, V408, P225, DOI 10.1016/S0014-5793(97)00347-5; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roy S, 2008, P NATL ACAD SCI USA, V105, P4133, DOI 10.1073/pnas.0706658105; Sergeev IN, 2004, J STEROID BIOCHEM, V89-90, P419, DOI 10.1016/j.jsbmb.2004.03.010; Shellman YG, 2008, J INVEST DERMATOL, V128, P949, DOI 10.1038/sj.jid.5701114; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wu AW, 2004, WORLD J GASTROENTERO, V10, P2323; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	49	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8436	10.1371/journal.pone.0008436	http://dx.doi.org/10.1371/journal.pone.0008436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041182	Green Submitted, gold, Green Published			2022-12-27	WOS:000273104000006
J	Giamarellos-Bourboulis, EJ; Raftogiannis, M; Antonopoulou, A; Baziaka, F; Koutoukas, P; Savva, A; Kanni, T; Georgitsi, M; Pistiki, A; Tsaganos, T; Pelekanos, N; Athanassia, S; Galani, L; Giannitsioti, E; Kavatha, D; Kontopidou, F; Mouktaroudi, M; Poulakou, G; Sakka, V; Panagopoulos, P; Papadopoulos, A; Kanellakopoulou, K; Giamarellou, H				Giamarellos-Bourboulis, Evangelos J.; Raftogiannis, Maria; Antonopoulou, Anastasia; Baziaka, Fotini; Koutoukas, Pantelis; Savva, Athina; Kanni, Theodora; Georgitsi, Marianna; Pistiki, Aikaterini; Tsaganos, Thomas; Pelekanos, Nikolaos; Athanassia, Sofia; Galani, Labrini; Giannitsioti, Efthymia; Kavatha, Dimitra; Kontopidou, Flora; Mouktaroudi, Maria; Poulakou, Garyfallia; Sakka, Vissaria; Panagopoulos, Periklis; Papadopoulos, Antonios; Kanellakopoulou, Kyriaki; Giamarellou, Helen			Effect of the Novel Influenza A (H1N1) Virus in the Human Immune System	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPRESSION	Background: The pandemic by the novel H1N1 virus has created the need to study any probable effects of that infection in the immune system of the host. Methodology/Principal Findings: Blood was sampled within the first two days of the presentation of signs of infection from 10 healthy volunteers; from 18 cases of flu-like syndrome; and from 31 cases of infection by H1N1 confirmed by reverse RTPCR. Absolute counts of subtypes of monocytes and of lymphocytes were determined after staining with monoclonal antibodies and analysis by flow cytometry. Peripheral blood mononuclear cells (PBMCs) were isolated from patients and stimulated with various bacterial stimuli. Concentrations of tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-18, interferon (FN)-alpha and of IFN-gamma were estimated in supernatants by an enzyme immunoassay. Infection by H1N1 was accompanied by an increase of monocytes. PBMCs of patients evoked strong cytokine production after stimulation with most of bacterial stimuli. Defective cytokine responses were shown in response to stimulation with phytohemagglutin and with heat-killed Streptococcus pneumoniae. Adaptive immune responses of H1N1-infected patients were characterized by decreases of CD4-lymphocytes and of B-lymphocytes and by increase of T-regulatory lymphocytes (Tregs). Conclusions/Significance: Infection by the H1N1 virus is accompanied by a characteristic impairment of the innate immune responses characterized by defective cytokine responses to S. pneumoniae. Alterations of the adaptive immune responses are predominated by increase of Tregs. These findings signify a predisposition for pneumococcal infections after infection by H1N1 influenza.	[Giamarellos-Bourboulis, Evangelos J.; Raftogiannis, Maria; Antonopoulou, Anastasia; Baziaka, Fotini; Koutoukas, Pantelis; Savva, Athina; Kanni, Theodora; Georgitsi, Marianna; Pistiki, Aikaterini; Tsaganos, Thomas; Pelekanos, Nikolaos; Athanassia, Sofia; Galani, Labrini; Giannitsioti, Efthymia; Kavatha, Dimitra; Kontopidou, Flora; Mouktaroudi, Maria; Poulakou, Garyfallia; Sakka, Vissaria; Panagopoulos, Periklis; Papadopoulos, Antonios; Kanellakopoulou, Kyriaki; Giamarellou, Helen] Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Giamarellos-Bourboulis, EJ (corresponding author), Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece.	giamarel@ath.forthnet.gr	Giannitsioti, Efthymia/AAQ-5897-2020; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Tsaganos, Thomas/AAK-8088-2020; PAPADOPOULOS, ANTONIOS/AAD-7808-2019; Sakka, Vissaria/GLN-7705-2022	Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; GIANNITSIOTI, EFTHYMIA/0000-0003-2715-7457; Giamarellou, Helen/0000-0002-7387-5065				Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; *EUR CTR DIS CONTR, 2009, PAND INFL H1N1; Giamarellos-Bourboulis EJ, 2009, DIAGN MICR INFEC DIS, V63, P62, DOI 10.1016/j.diagmicrobio.2008.09.003; *HLTH PROT AG HLTH, 2009, EP NEW INFL H1N1 VIR, P14; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Majlessi L, 2008, MICROBES INFECT, V10, P1030, DOI 10.1016/j.micinf.2008.07.017; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Shen LS, 2009, CLIN IMMUNOL, V131, P109, DOI 10.1016/j.clim.2008.11.010; Tschoeke SK, 2005, CRIT CARE MED, V33, P236, DOI 10.1097/01.CCM.0000150835.66819.CA; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384; World Health Organisation, WHO PAND H1N1 2009 U; Zhu X, 2009, J CLIN LAB ANAL, V23, P197, DOI 10.1002/jcla.20331; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	16	52	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8393	10.1371/journal.pone.0008393	http://dx.doi.org/10.1371/journal.pone.0008393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037642	Green Submitted, Green Published, gold			2022-12-27	WOS:000272998100007
J	Pascua, PNQ; Song, MS; Lee, JH; Park, KJ; Kwon, HI; Baek, YH; Hong, SP; Rho, JB; Kim, CJ; Poo, H; Ryoo, TS; Sung, MH; Choi, YK				Pascua, Philippe Noriel Q.; Song, Min-Suk; Lee, Jun Han; Park, Kuk Jin; Kwon, Hyeok-il; Baek, Yun Hee; Hong, Seung-Pyo; Rho, Jong-Bok; Kim, Chul-Joong; Poo, Haryoung; Ryoo, Thomas S.; Sung, Moon-Hee; Choi, Young Ki			Evaluation of the Efficacy and Cross-Protectivity of Recent Human and Swine Vaccines against the Pandemic (H1N1) 2009 Virus Infection	PLOS ONE			English	Article							INFLUENZA-A H1N1; MULTIPLE SEQUENCE ALIGNMENT; UNITED-STATES; CLUSTAL-X; PATHOGENESIS; PIGS; TRANSMISSION; VACCINATION; FERRETS; GENERATION	The current pandemic (H1N1) 2009 virus remains transmissible among humans worldwide with cases of reverse zoonosis, providing opportunities to produce more pathogenic variants which could pose greater human health concerns. To investigate whether recent seasonal human or swine H1N1 vaccines could induce cross-reactive immune responses against infection with the pandemic (H1N1) 2009 virus, mice, ferrets or mini-pigs were administered with various regimens (once or twice) and antigen content (1.77, 3.5 or 7.5 mu g HA) of a-Brsibane/59/07, a-CAN01/04 or RgCA/04/09xPR8 vaccine. Receipt of a-CAN01/04 (2-doses) but not a-Brisbane/59/07 induced detectable but modest (20-40 units) cross-reactive serum antibody against CA/04/09 by hemagglutinin inhibition (HI) assays in mice. Only double administration (7.5 mu g HA) of both vaccine in ferrets could elicit cross-reactivity (30-60 HI titers). Similar antigen content of a-CAN01/04 in mini-pigs also caused a modest similar to 30 HI titers (twice vaccinated). However, vaccine-induced antibody titers could not suppress active virus replication in the lungs (mice) or virus shedding (ferrets and pigs) of immunized hosts intranasally challenged with CA/04/09. Furthermore, neither ferrets nor swine could abrogate aerosol transmission of the virus into naive contact animals. Altogether, these results suggest that neither recent human nor animal H1N1 vaccine could provide complete protectivity in all animal models. Thus, this study warrants the need for strain-specific vaccines that could yield the optimal protection desired for humans and/or animals.	[Pascua, Philippe Noriel Q.; Song, Min-Suk; Lee, Jun Han; Park, Kuk Jin; Kwon, Hyeok-il; Baek, Yun Hee; Choi, Young Ki] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Pascua, Philippe Noriel Q.; Song, Min-Suk; Lee, Jun Han; Park, Kuk Jin; Kwon, Hyeok-il; Baek, Yun Hee; Choi, Young Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea; [Hong, Seung-Pyo; Rho, Jong-Bok; Sung, Moon-Hee] Bioleaders Corp, Taejon, South Korea; [Kim, Chul-Joong] Chungnam Natl Univ, Coll Vet Med, Taejon, South Korea; [Poo, Haryoung] Korean Res Inst Biosci & Biotechnol, Taejon, South Korea; [Ryoo, Thomas S.] Genet Korea Ltd, Prestige World Genet, Pyongtaek, South Korea	Chungbuk National University; Chungbuk National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Pascua, PNQ (corresponding author), Chungbuk Natl Univ, Coll Med, Cheongju, South Korea.	choiki55@chungbuk.ac.kr	Pascua, Philippe Noriel/H-3426-2019	Pascua, Philippe Noriel/0000-0001-6777-2994; Kim, Chul-Joong/0000-0001-8827-6332	Korea Research Council of Fundamental Science and Technology; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program [NTM1300811]; National Research Foundation of Korea [E00375]; National Veterinary Research and Quarantine Service, Korea (NVRQS) [Z-AD14-2009-13]; Bioleaders Corp.; PWG Genetics Korea	Korea Research Council of Fundamental Science and Technology; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea); National Veterinary Research and Quarantine Service, Korea (NVRQS); Bioleaders Corp.; PWG Genetics Korea	This research work was supported in part by a Top Brand Project grant from Korea Research Council of Fundamental Science and Technology, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program (NTM1300811), by grant E00375 from the National Research Foundation of Korea, by grant Z-AD14-2009-13 from the National Veterinary Research and Quarantine Service, Korea (NVRQS), Bioleaders Corp., and PWG Genetics Korea. The funders, Bioleaders Corporation and Prestige World Genetics (PWG), Genetics Korea, had input in data collection, but had no roles in the study design, data analysis, or preparation of the manuscript.	Aiyar A, 2000, Methods Mol Biol, V132, P221; Brookes SM, 2009, VET REC, V164, P760, DOI 10.1136/vr.164.24.760; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; MURPHY BR, 1989, CURR TOP MICROBIOL, V146, P107; Nicholls H, 2006, PLOS BIOL, V4, P156, DOI 10.1371/journal.pbio.0040050; *OIE, 2009, WORLD AN HLTH INF DA, V22; Palmer DF, 1975, IMMUNOLOGY SERIES, V6, P25; Pascua PNQ, 2008, VIRUS RES, V138, P43, DOI 10.1016/j.virusres.2008.08.005; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; REED LJ, 1938, AM J HYG, V27; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Song MS, 2009, VACCINE, V27, P3145, DOI 10.1016/j.vaccine.2009.03.061; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trifonov V, 2009, EURO SURVEILL, V14; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	36	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8431	10.1371/journal.pone.0008431	http://dx.doi.org/10.1371/journal.pone.0008431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037716	Green Published, Green Submitted, gold			2022-12-27	WOS:000272998100016
J	Holland, RA; Wikelski, M; Kummeth, F; Bosque, C				Holland, Richard A.; Wikelski, Martin; Kuemmeth, Franz; Bosque, Carlos			The Secret Life of Oilbirds: New Insights into the Movement Ecology of a Unique Avian Frugivore	PLOS ONE			English	Article							STEATORNIS-CARIPENSIS; PARADIGM; ANIMALS; BIRDS	Background: Steatornis caripensis (the oilbird) is a very unusual bird. It supposedly never sees daylight, roosting in huge aggregations in caves during the day and bringing back fruit to the cave at night. As a consequence a large number of the seeds from the fruit they feed upon germinate in the cave and spoil. Methodology/Principal Findings: Here we use newly developed GPS/acceleration loggers with remote UHF readout to show that several assumptions about the behaviour of Steatornis caripensis need to be revised. On average, they spend only every 3(rd) day in a cave, individuals spent most days sitting quietly in trees in the rainforest where they regurgitate seeds. Conclusions/Significance: This provides new data on the extent of seed dispersal and the movement ecology of Steatornis caripensis. It suggests that Steatornis caripensis is perhaps the most important long-distance seed disperser in Neotropical forests. We also show that colony-living comes with high activity costs to individuals.	[Holland, Richard A.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Kuemmeth, Franz] E Obs GmbH, Munich, Germany; [Bosque, Carlos] Univ Simon Bolivar, Dept Biol Organismos, Caracas, Venezuela	Max Planck Society; Simon Bolivar University	Holland, RA (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	rholland@orn.mpg.de	Bosque, Carlos/AAX-6038-2020; Holland, Richard A/A-6107-2010	Holland, Richard A/0000-0003-4495-8061				Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; BOSQUE C, 1988, WILSON BULL, V100, P675; BOSQUE C, 1992, CONDOR, V94, P557, DOI 10.2307/1369240; Bosque Carlos, 1996, Ornitologia Neotropical, V6, P67; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Damschen EI, 2008, P NATL ACAD SCI USA, V105, P19078, DOI 10.1073/pnas.0802037105; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; HUMBOLDT AV, 1833, OILBIRDS RECUEIL OBS; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Laurance WF, 2007, ENVIRON SCI ENG, P11; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; Mayr G, 2002, J ORNITHOL, V143, P82, DOI 10.1007/BF02465461; MOERMOND TC, 1985, NEOTROPICAL ORNITHOL; MURRAY DR, 1986, SEED DISPERSAL; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; PIETRI ED, 1979, B SOC VENEZOLANA CIE, V34; Roca RL, 1994, OILBIRDS VENEZUELA E; Rojas LM, 2004, BRAIN BEHAV EVOLUT, V64, P19, DOI 10.1159/000077540; SNOW D. W., 1961, ZOOLOGICA [NEW YORK], V46, P27; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; SNOW DW, 1976, IBIS, V118, P366, DOI 10.1111/j.1474-919X.1976.tb02026.x; SNOW DW, 1965, OIKOS, V15, P275; TANNENBAUM B, 1978, VENEZUELA B ACAD CIE, V38, P83; Tello NS, 2008, J ORNITHOL, V149, P267, DOI 10.1007/s10336-007-0266-6; THOMAS DW, 1993, PHYSIOL ZOOL, V66, P322, DOI 10.1086/physzool.66.3.30163696; WHEELWRIGHT NT, 1982, AM NAT, V119, P402, DOI 10.1086/283918; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064	30	52	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8264	10.1371/journal.pone.0008264	http://dx.doi.org/10.1371/journal.pone.0008264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20016844	Green Published, gold, Green Submitted			2022-12-27	WOS:000272834000008
J	Beck, Z; Brown, BK; Wieczorek, L; Peachman, KK; Matyas, GR; Polonis, VR; Rao, M; Alving, CR				Beck, Zoltan; Brown, Bruce K.; Wieczorek, Lindsay; Peachman, Kristina K.; Matyas, Gary R.; Polonis, Victoria R.; Rao, Mangala; Alving, Carl R.			Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUFFY ANTIGEN RECEPTOR; RED-BLOOD-CELLS; HUMORAL IMMUNITY; HEPARAN-SULFATE; TRANS-INFECTION; FC-RECEPTORS; DC-SIGN; COMPLEMENT; PROGRESSION	Although CD4(+) cells represent the major target for HIV infection in blood, claims of complement-independent binding of HIV-1 to erythrocytes and the possible role of Duffy blood group antigen, have generated controversy. To examine the question of binding to erythrocytes, HIV-1 was incubated in vitro with erythrocytes from 30 healthy leukapheresis donors, and binding was determined by p24 analysis and adsorption of HIV-1 with reduction of infectivity for CD4(+) target cells. All of the cells, regardless of blood group type, bound HIV-1 p24. A typical preparation of erythrocytes bound <2.4% of the added p24, but erythrocytes selectively removed essentially all of the viral infectivity as determined by decreased infection of CD4(+) target cells; however, cell-associated HIV-1 was approximately 100-fold more efficient, via trans infection, than unadsorbed virus for infection of CD4(+) cells. All of the bound HIV-1 p24 was released by treatment of the cells with EDTA, and binding was optimized by adding Ca2+ and Mg2+ during the washing of erythrocytes containing bound HIV-1. Although the small number of contaminating leukocytes in the erythrocyte preparation also bound HIV-1 p24, there was no significant binding to CD4, and it thus appears that the binding occurred on leukocytes at non-CD4 sites. Furthermore, binding occurred to erythrocyte ghosts from which contaminating leukocytes had been previously removed. The results demonstrate that erythrocytes incubated in vitro with HIV-1 differentially adsorb all of the infectious HIV-1 virions (as opposed to non-infectious or degraded virions) in the absence of complement and independent of blood group, and binding is dependent on divalent cations. By analogy with HIV-1 bound to DC-SIGN on dendritic cells, erythrocyte-bound HIV-1 might comprise an important surface reservoir for trans infection of permissive cells.	[Beck, Zoltan; Brown, Bruce K.; Wieczorek, Lindsay; Peachman, Kristina K.; Matyas, Gary R.; Polonis, Victoria R.; Rao, Mangala; Alving, Carl R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Div Retrovirol, Rockville, MD USA; [Beck, Zoltan; Brown, Bruce K.; Wieczorek, Lindsay; Peachman, Kristina K.] Henry M Jackson Fdn Advancement Mil Med, Rockville, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Beck, Z (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Div Retrovirol, Rockville, MD USA.	calving@hivresearch.org	Matyas, Gary/AAK-6785-2021		Henry M. Jackson Foundation [W81XWH-07-2-0067]; U.S. Army Medical Research and Material Command [W81XWH-07-2-0067]	Henry M. Jackson Foundation; U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported through Cooperative Agreement contract no. W81XWH-07-2-0067 between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Army Medical Research and Material Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2006, MOL MEMBR BIOL, V23, P453, DOI 10.1080/09687860600935348; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Fierer DS, 2007, J INFECT DIS, V196, P587, DOI 10.1086/519741; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; He WJ, 2009, CELL HOST MICROBE, V5, P418, DOI 10.1016/j.chom.2009.05.007; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Horne KC, 2009, CELL HOST MICROBE, V5, P415, DOI 10.1016/j.chom.2009.04.013; Huber M, 2007, J INTERN MED, V262, P5, DOI 10.1111/j.1365-2796.2007.01819.x; Julg B, 2009, CELL HOST MICROBE, V5, P413, DOI 10.1016/j.chom.2009.04.009; KULKARNI H, 2009, BLOOD IN PRESS; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Levy JA, 2002, LANCET, V359, P2212, DOI 10.1016/S0140-6736(02)09314-5; LEVY JA, 2007, HIV 1 PATHOGENESIS; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LIEBER MR, 1982, J BIOL CHEM, V257, P1660; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Montefiori DC, 1997, SPRINGER SEMIN IMMUN, V18, P371, DOI 10.1007/BF00813504; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Puri A, 1998, BIOCHEM BIOPH RES CO, V242, P219, DOI 10.1006/bbrc.1997.7941; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Terry VH, 2009, VIROLOGY, V388, P294, DOI 10.1016/j.virol.2009.03.022; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Walley NM, 2009, CELL HOST MICROBE, V5, P408, DOI 10.1016/j.chom.2009.04.011; Walton RT, 2008, CELL HOST MICROBE, V4, P3, DOI 10.1016/j.chom.2008.06.006; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Winkler CA, 2009, CELL HOST MICROBE, V5, P411, DOI 10.1016/j.chom.2009.04.010	41	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2009	4	12							e8297	10.1371/journal.pone.0008297	http://dx.doi.org/10.1371/journal.pone.0008297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NI	20011536	Green Submitted, Green Published, gold			2022-12-27	WOS:000272830300045
J	Bondar, IV; Leopold, DA; Richmond, BJ; Victor, JD; Logothetis, NK				Bondar, Igor V.; Leopold, David A.; Richmond, Barry J.; Victor, Jonathan D.; Logothetis, Nikos K.			Long-Term Stability of Visual Pattern Selective Responses of Monkey Temporal Lobe Neurons	PLOS ONE			English	Article							TWO-DIMENSIONAL PATTERNS; INFEROTEMPORAL CORTEX; SINGLE NEURONS; CORTICAL-NEURONS; STRIATE CORTEX; MACAQUE; REPRESENTATION; INFORMATION; CELLS; CATEGORIZATION	Many neurons in primate inferotemporal (IT) cortex respond selectively to complex, often meaningful, stimuli such as faces and objects. An important unanswered question is whether such response selectivity, which is thought to arise from experience-dependent plasticity, is maintained from day to day, or whether the roles of individual cells are continually reassigned based on the diet of natural vision. We addressed this question using microwire electrodes that were chronically implanted in the temporal lobe of two monkeys, often allowing us to monitor activity of individual neurons across days. We found that neurons maintained their selectivity in both response magnitude and patterns of spike timing across a large set of visual images throughout periods of stable signal isolation from the same cell that sometimes exceeded two weeks. These results indicate that stimulus-selectivity of responses in IT is stable across days and weeks of visual experience.	[Bondar, Igor V.; Leopold, David A.; Richmond, Barry J.; Victor, Jonathan D.; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Bondar, IV (corresponding author), RAS, Inst Higher Nervous Act & Neurophysiol, Moscow 117901, Russia.	bondar@ihna.ru	Bondar, Igor V/M-6416-2014; Logothetis, Nikos/U-9282-2019; Victor, Jonathan D./D-2931-2009	Bondar, Igor V/0000-0003-1307-5266; Victor, Jonathan D./0000-0002-9293-0111; Leopold, David/0000-0002-1345-6360	Max Planck Society; National Eye Institute [EY9314]; National Institute of Mental Health [MH68012]; NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068012, ZIAMH002898, ZIAMH002032] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Max Planck Society. JV is supported in part by grants EY9314 from the National Eye Institute, and from grant MH68012 (PI: D. Gardner) from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; AGGLETON JP, 1990, BEHAV BRAIN RES, V39, P262, DOI 10.1016/0166-4328(90)90032-A; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BAYLIS GC, 1987, J NEUROSCI, V7, P330; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Jagadeesh B, 2001, J NEUROPHYSIOL, V86, P290, DOI 10.1152/jn.2001.86.1.290; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kayaert G, 2005, EUR J NEUROSCI, V22, P212, DOI 10.1111/j.1460-9568.2005.04202.x; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Nicolelis M.A., 1998, METHODS NEURAL ENSEM; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Porada I, 2000, J NEUROSCI METH, V95, P13, DOI 10.1016/S0165-0270(99)00139-9; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006	45	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2009	4	12							e8222	10.1371/journal.pone.0008222	http://dx.doi.org/10.1371/journal.pone.0008222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NE	20011035	Green Submitted, Green Published, gold			2022-12-27	WOS:000272829800011
J	Hidaka, S; Manaka, Y; Teramoto, W; Sugita, Y; Miyauchi, R; Gyoba, J; Suzuki, Y; Iwaya, Y				Hidaka, Souta; Manaka, Yuko; Teramoto, Wataru; Sugita, Yoichi; Miyauchi, Ryota; Gyoba, Jiro; Suzuki, Yoiti; Iwaya, Yukio			Alternation of Sound Location Induces Visual Motion Perception of a Static Object	PLOS ONE			English	Article							VISION	Background: Audition provides important cues with regard to stimulus motion although vision may provide the most salient information. It has been reported that a sound of fixed intensity tends to be judged as decreasing in intensity after adaptation to looming visual stimuli or as increasing in intensity after adaptation to receding visual stimuli. This audiovisual interaction in motion aftereffects indicates that there are multimodal contributions to motion perception at early levels of sensory processing. However, there has been no report that sounds can induce the perception of visual motion. Methodology/Principal Findings: A visual stimulus blinking at a fixed location was perceived to be moving laterally when the flash onset was synchronized to an alternating left-right sound source. This illusory visual motion was strengthened with an increasing retinal eccentricity (2.5 deg to 20 deg) and occurred more frequently when the onsets of the audio and visual stimuli were synchronized. Conclusions/Significance: We clearly demonstrated that the alternation of sound location induces illusory visual motion when vision cannot provide accurate spatial information. The present findings strongly suggest that the neural representations of auditory and visual motion processing can bias each other, which yields the best estimates of external events in a complementary manner.	[Hidaka, Souta; Teramoto, Wataru; Gyoba, Jiro] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Manaka, Yuko; Sugita, Yoichi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Teramoto, Wataru; Miyauchi, Ryota; Suzuki, Yoiti; Iwaya, Yukio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Hidaka, S (corresponding author), Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan.	hidaka@sal.tohoku.ac.jp	Hidaka, Souta/L-6393-2019; Suzuki, Yoiti/AAC-3765-2019	Hidaka, Souta/0000-0001-6727-5322; Gyoba, Jiro/0000-0003-4198-6323	JSPS [19001004, 19004400]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for Specially Promoted Research (No. 19001004) and by JSPS Research Fellowship for Young Scientists (No. 19004400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DICK M, 1987, SCIENCE, V237, P400, DOI 10.1126/science.3603025; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1987, NATURE, V328, P645, DOI 10.1038/328645a0; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Soto-Faraco S, 2002, COGNITIVE BRAIN RES, V14, P139, DOI 10.1016/S0926-6410(02)00068-X; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, P25	14	37	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8188	10.1371/journal.pone.0008188	http://dx.doi.org/10.1371/journal.pone.0008188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533NB	19997648	gold, Green Submitted, Green Published			2022-12-27	WOS:000272829500014
J	Su, JJ; Yoon, BJ; Dougherty, ER				Su, Junjie; Yoon, Byung-Jun; Dougherty, Edward R.			Accurate and Reliable Cancer Classification Based on Probabilistic Inference of Pathway Activity	PLOS ONE			English	Article							MICROARRAY DATA; BREAST-CANCER; GENE; METASTASIS; PREDICTION; DISCOVERY; TOOL	With the advent of high-throughput technologies for measuring genome-wide expression profiles, a large number of methods have been proposed for discovering diagnostic markers that can accurately discriminate between different classes of a disease. However, factors such as the small sample size of typical clinical data, the inherent noise in high-throughput measurements, and the heterogeneity across different samples, often make it difficult to find reliable gene markers. To overcome this problem, several studies have proposed the use of pathway-based markers, instead of individual gene markers, for building the classifier. Given a set of known pathways, these methods estimate the activity level of each pathway by summarizing the expression values of its member genes, and use the pathway activities for classification. It has been shown that pathway-based classifiers typically yield more reliable results compared to traditional gene-based classifiers. In this paper, we propose a new classification method based on probabilistic inference of pathway activities. For a given sample, we compute the log-likelihood ratio between different disease phenotypes based on the expression level of each gene. The activity of a given pathway is then inferred by combining the log-likelihood ratios of the constituent genes. We apply the proposed method to the classification of breast cancer metastasis, and show that it achieves higher accuracy and identifies more reproducible pathway markers compared to several existing pathway activity inference methods.	[Su, Junjie; Yoon, Byung-Jun; Dougherty, Edward R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Dougherty, Edward R.] Translat Genom Res Inst, Computat Biol Div, Phoenix, AZ USA	Texas A&M University System; Texas A&M University College Station; Translational Genomics Research Institute	Su, JJ (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	bjyoon@ece.tamu.edu	Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Science Foundation [CCF-0634794]	National Science Foundation(National Science Foundation (NSF))	Edward R. Dougherty is supported in part by National Science Foundation, CCF-0634794. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Braga-Neto U, 2007, IEEE SIGNAL PROC MAG, V24, P91, DOI 10.1109/MSP.2007.273062; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cowell LG, 2002, GENOME BIOL, V3; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dougherty ER, 2001, COMPAR FUNCT GENOM, V2, P28, DOI 10.1002/cfg.62; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Hua JP, 2009, PATTERN RECOGN, V42, P409, DOI 10.1016/j.patcog.2008.08.001; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lewis D. D., 1998, LECT NOTES COMPUTER, P4, DOI DOI 10.1007/BFB0026666; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Rish I., 2001, P IJCAI 01 WORKSH EM, P41; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	35	90	96	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8161	10.1371/journal.pone.0008161	http://dx.doi.org/10.1371/journal.pone.0008161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997592	gold, Green Published, Green Submitted			2022-12-27	WOS:000272829500013
J	Tortajada, AM; Carmona, MJ; Serra, M				Tortajada, Ana M.; Jose Carmona, Maria; Serra, Manuel			Does Haplodiploidy Purge Inbreeding Depression in Rotifer Populations?	PLOS ONE			English	Article							BRACHIONUS-PLICATILIS ROTIFERA; RESTING EGG BANKS; GENETIC-STRUCTURE; SPECIES COMPLEX; OUTBREEDING DEPRESSION; DAPHNIA METAPOPULATIONS; ZOOPLANKTON POPULATIONS; MICROSATELLITE ANALYSIS; CYCLICAL PARTHENOGEN; PATTERNS	Background: Inbreeding depression is an important evolutionary factor, particularly when new habitats are colonized by few individuals. Then, inbreeding depression by drift could favour the establishment of later immigrants because their hybrid offspring would enjoy higher fitness. Rotifers are the only major zooplanktonic group where information on inbreeding depression is still critically scarce, despite the fact that in cyclical parthenogenetic rotifers males are haploid and could purge deleterious recessive alleles, thereby decreasing inbreeding depression. Methodology/Principal Findings: We studied the effects of inbreeding in two populations of the cyclical parthenogenetic rotifer Brachionus plicatilis. For each population, we compared both the parental fertilization proportion and F1 fitness components from intraclonal (selfed) and interclonal (outcrossed) crosses. The parental fertilization proportion was similar for both types of crosses, suggesting that there is no mechanism to avoid selfing. In the F1 generation of both populations, we found evidence of inbreeding depression for the fitness components associated with asexual reproduction; whereas inbreeding depression was only found for one of the two sexual reproduction fitness components measured. Conclusions/Significance: Our results show that rotifers, like other major zooplanktonic groups, can be affected by inbreeding depression in different stages of their life cycle. These results suggest that haplodiploidy does not purge efficiently deleterious recessive alleles. The inbreeding depression detected here has important implications when a rotifer population is founded and intraclonal crossing is likely to occur. Thus, during the foundation of new populations inbreeding depression may provide opportunities for new immigrants, increasing gene flow between populations, and affecting genetic differentiation.	[Tortajada, Ana M.; Jose Carmona, Maria; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain	University of Valencia	Tortajada, AM (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain.	ana.maria.tortajada@uv.es	Carmona, María José/AAM-4340-2020; Carmona, María José/H-6452-2015; Serra, Manuel/H-7817-2015	Carmona, María José/0000-0002-4835-6933; Carmona, María José/0000-0002-4835-6933; Serra, Manuel/0000-0003-1731-1529	Spanish Ministry of Science and Technology [BOS2003-00755]; Spanish Ministry of Education, Culture and Sport [AP2003-3390]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government)	The work was supported by a grant (BOS2003-00755) for the Spanish Ministry of Science and Technology (http://ciencia.micinn.fecyt.es/ciencia/) and by a fellowship (AP2003-3390) by the Spanish Ministry of Education, Culture and Sport (http://www.educacion.es) to A. M. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRKY CW, 1967, J EXP ZOOL, V164, P105, DOI 10.1002/jez.1401640110; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; BRUCKNER D, 1978, EVOLUTION, V32, P456, DOI [10.2307/2407613, 10.1111/j.1558-5646.1978.tb00661.x]; Caceres CE, 1997, INVERTEBR BIOL, V116, P371, DOI 10.2307/3226870; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; CARMONA MJ, 1993, HYDROBIOLOGIA, V255, P145, DOI 10.1007/BF00025832; CARVALHO GR, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P291; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Ciros-Perez J, 2001, J PLANKTON RES, V23, P1311, DOI 10.1093/plankt/23.12.1311; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Colbourne John K., 1997, P163; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; De Meester L, 1999, P ROY SOC B-BIOL SCI, V266, P2471; De Meester L, 2006, ARCH HYDROBIOL, V167, P217, DOI 10.1127/0003-9136/2006/0167-0217; DEMEESTER L, 1993, OECOLOGIA, V96, P80, DOI 10.1007/BF00318033; DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356; Deng HW, 1997, HEREDITY, V78, P182; Deng HW, 1997, GENETICS, V147, P147; DESTASIO BT, 1989, ECOLOGY, V70, P1377; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Garcia-Perez A, 2005, METODOS AVANZADOS ES; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Garcia-Roger EM, 2005, J EXP MAR BIOL ECOL, V314, P149, DOI 10.1016/j.jembe.2004.08.023; GARCIAROGER EM, 2006, THESIS U VALENCIA SP; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2002, J EVOLUTION BIOL, V15, P158, DOI 10.1046/j.1420-9101.2002.00368.x; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 1995, HYDROBIOLOGIA, V313, P111, DOI 10.1007/BF00025938; Gomez A, 1996, FUNCT ECOL, V10, P681, DOI 10.2307/2390502; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; Haag CR, 2005, GENETICS, V170, P1809, DOI 10.1534/genetics.104.036814; Haag CR, 2002, EVOLUTION, V56, P518; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; Hairston NG, 1996, HYDROBIOLOGIA, V320, P27, DOI 10.1007/BF00016802; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; Hertel Elmer W., 1942, PHYSIOL ZOOL, V15, P304; INNES DJ, 1993, J EVOLUTION BIOL, V6, P559, DOI 10.1046/j.1420-9101.1993.6040559.x; INNES DJ, 1989, J HERED, V80, P6, DOI 10.1093/oxfordjournals.jhered.a110791; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KING BH, 1995, J INSECT BEHAV, V8, P723, DOI 10.1007/BF01997241; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Louette G, 2007, OIKOS, V116, P728, DOI 10.1111/j.2007.0030-1299.15664.x; LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Lynch Michael, 1994, P109; Mills S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-225; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; ORTELLS R, 2002, THESIS U VALENCIA SP; Peer K, 2005, EVOLUTION, V59, P317; Quinn GP, 2003, EXPT DESIGN DATA ANA; Schroder T, 2005, HYDROBIOLOGIA, V546, P291, DOI 10.1007/s10750-005-4235-x; SNELL TW, 1987, INT J INVER REP DEV, V12, P103, DOI 10.1080/01688170.1987.10510306; SNELL TW, 1988, J EXP MAR BIOL ECOL, V124, P73, DOI 10.1016/0022-0981(88)90112-8; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Thornhill N.W., 1993, NATURAL HIST INBREED; WALLACE RL, 2006, ROTIFERA, V1; Waller Donald M., 1993, P97; Werren John H., 1993, P42; WILCOX RR, 2009, WRS COMPILED PACKAGE; [No title captured]; [No title captured]; [No title captured]	65	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8195	10.1371/journal.pone.0008195	http://dx.doi.org/10.1371/journal.pone.0008195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997616	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829500017
J	Zhang, W; Yang, SX; Ren, LP; Shen, Q; Cui, L; Fan, KZ; Huang, F; Kang, YJ; Shan, TL; Wei, JZ; Xiu, HF; Lou, YF; Liu, JF; Yang, ZB; Zhu, JG; Hua, XG				Zhang, Wen; Yang, Shixing; Ren, Liping; Shen, Quan; Cui, Li; Fan, Kezhang; Huang, Fen; Kang, Yanjun; Shan, Tongling; Wei, Jianzhong; Xiu, Haifeng; Lou, Yifang; Liu, Junfeng; Yang, Zhibiao; Zhu, Jianguo; Hua, Xiuguo			Hepatitis E Virus Infection in Central China Reveals No Evidence of Cross-Species Transmission between Human and Swine in This Area	PLOS ONE			English	Article							NON-B HEPATITIS; NON-A; EASTERN CHINA; STRAINS; SAMPLES; INDIA; IDENTIFICATION; PREVALENCE; ANTIBODIES; EPIDEMIC	Hepatitis E virus (HEV) is a zoonotic pathogen of which several species of animal were reported as reservoirs. Swine stands out as the major reservoir for HEV infection in humans, as suggested by the close genetic relationship of swine and human virus. Since 2000, Genotype 4 HEV has become the dominant cause of hepatitis E disease in China. Recent reports showed that genotype 4 HEV is freely transmitted between humans and swine in eastern and southern China. However, the infection status of HEV in human and swine populations in central China is still unclear. This study was conducted in a rural area of central China, where there are many commercial swine farms. A total of 1476 serum and 554 fecal specimens were collected from the general human and swine populations in this area, respectively. The seroepidemiological study was conducted by enzyme-linked immunosorbent assay. Conserved genomic sequences of open reading frame 2 were detected using reverse transcription-PCR. The results indicated that the overall viral burden of the general human subjects was 0.95% (14/1476), while 7.0% (39/554) of the swine excreted HEV in stool. The positive rate of anti-HEV IgG and IgM in the serum samples was 7.9% (117/1476) and 1.6% (24/1476), respectively. Phylogenetic analysis based on the 150 nt partial sequence of the capsid protein gene showed that the 53 swine and human HEV isolates in the current study all belonged to genotype 4, clustering into three major groups. However, the HEV isolates prevalent in the human and swine populations were classified into known distinct subgenotypes, which suggested that no cross-species transmission between swine and humans had taken place in this area. This result was confirmed by cloning and phylogenetic analysis of the complete capsid protein gene sequence of three representative HEV strains in the three major groups. The cross reactivity between anti-HEV IgG from human sera and the two representative strains from swine in central China was confirmed by Dot-blot assay. In conclusion, although all the HEV strains prevalent in central China belonged to genotype 4, there is no evidence of cross-species transmission between human and swine in this area.	[Zhang, Wen; Yang, Shixing; Shen, Quan; Cui, Li; Huang, Fen; Kang, Yanjun; Shan, Tongling; Liu, Junfeng; Yang, Zhibiao; Zhu, Jianguo; Hua, Xiuguo] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhang, Wen] Jiangsu Univ, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Wen] Jiangsu Univ, Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Ren, Liping; Fan, Kezhang] Fuyang Normal Univ, Sch Life Sci, Fuyang, Peoples R China; [Wei, Jianzhong] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Peoples R China; [Xiu, Haifeng] Fuyang Peoples Hosp, Fuyang, Peoples R China; [Lou, Yifang] First Peoples Hosp Sixian, Sixian, Peoples R China	Shanghai Jiao Tong University; Jiangsu University; Jiangsu University; Fuyang Normal University; Anhui Agricultural University	Zhang, W (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	hxg@sjtu.edu.cn	Shan, Tongling/AFG-8328-2022	Shan, Tongling/0000-0002-5329-6349; Shen, Quan/0000-0001-9041-8475	Key Project of Shanghai Science and Technology Committee of China [063919121]	Key Project of Shanghai Science and Technology Committee of China(Shanghai Science & Technology Committee)	This work was supported by Key Project of Shanghai Science and Technology Committee of China under Grant No. 063919121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Arankalle VA, 2002, J HEPATOL, V36, P417, DOI 10.1016/S0168-8278(01)00297-5; Bendall R, 2008, J MED VIROL, V80, P95, DOI 10.1002/jmv.21033; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Caron M, 2006, J CLIN MICROBIOL, V44, P3440, DOI 10.1128/JCM.00939-06; Chadha MS, 1999, J VIRAL HEPATITIS, V6, P457, DOI 10.1046/j.1365-2893.1999.00190.x; Fernandez-Barredo S, 2007, CAN J VET RES, V71, P236; Ge ShengXiang, 2005, Chinese Journal of Virology, V21, P181; Goens S. Denise, 2004, Animal Health Research Reviews, V5, P145, DOI 10.1079/AHR200495; HUANG RT, 1995, J MED VIROL, V47, P303, DOI 10.1002/jmv.1890470403; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li TC, 2005, EMERG INFECT DIS, V11, P1958, DOI 10.3201/eid1112.051041; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Ning HQ, 2007, VET MICROBIOL, V121, P125, DOI 10.1016/j.vetmic.2006.11.006; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Saad MD, 2007, INFECT GENET EVOL, V7, P368, DOI 10.1016/j.meegid.2006.07.007; Schlauder GG, 2001, J MED VIROL, V65, P282, DOI 10.1002/jmv.2031; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; Somani SK, 2003, J VIRAL HEPATITIS, V10, P446, DOI 10.1046/j.1365-2893.2003.00458.x; Takahashi M, 2003, J GEN VIROL, V84, P851, DOI 10.1099/vir.0.18918-0; Tanaka E, 2005, J VIRAL HEPATITIS, V12, P439, DOI 10.1111/j.1365-2893.2005.00616.x; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; WONG DC, 1980, LANCET, V2, P876; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhang JZ, 2002, J MED VIROL, V66, P40, DOI 10.1002/jmv.2109; Zhang JZ, 2001, J MED VIROL, V64, P125, DOI 10.1002/jmv.1027; Zhang W, 2008, EPIDEMIOL INFECT, V136, P1020, DOI 10.1017/S095026880700965X; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zheng YJ, 2006, J INFECT DIS, V193, P1643, DOI 10.1086/504293; ZHUANG H, 1991, INT CONGR SER, V895, P277; 王佑春, 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P618	37	27	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2009	4	12							e8156	10.1371/journal.pone.0008156	http://dx.doi.org/10.1371/journal.pone.0008156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533NB	19997619	Green Published, Green Submitted, gold			2022-12-27	WOS:000272829500011
J	Gabrielli, E; Pericolini, E; Cenci, E; Ortelli, F; Magliani, W; Ciociola, T; Bistoni, F; Conti, S; Vecchiarelli, A; Polonelli, L				Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Ortelli, Federica; Magliani, Walter; Ciociola, Tecla; Bistoni, Francesco; Conti, Stefania; Vecchiarelli, Anna; Polonelli, Luciano			Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity	PLOS ONE			English	Article							SYNTHETIC KILLER PEPTIDE; BLOOD-GROUP-A; THERAPEUTIC ACTIVITY; MONOCLONAL-ANTIBODY; ANTIIDIOTYPIC ANTIBODY; IN-VITRO; RECEPTOR (TLR)-2; HOST-DEFENSE; CANDIDIASIS; EXPRESSION	Background: It has been documented that, independently from the specificity of the native antibody ( Ab) for a given antigen (Ag), complementarity determining regions (CDR)-related peptides may display differential antimicrobial, antiviral and antitumor activities. Methodology/Principal Findings: In this study we demonstrate that a synthetic peptide with sequence identical to V(H)CDR3 of a mouse monoclonal Ab (mAb) specific for difucosyl human blood group A is easily taken up by macrophages with subsequent stimulation of: i) proinflammatory cytokine production; ii) PI3K-Akt pathway and iii) TLR-4 expression. Significantly, VHCDR3 exerts therapeutic effect against systemic candidiasis without possessing direct candidacidal properties. Conclusions/Significance: These results open a new scenario about the possibility that, beyond the half life of immunoglobulins, Ab fragments may effectively influence the antiinfective cellular immune response in a way reminiscent of regulatory peptides of innate immunity.	[Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Ortelli, Federica; Bistoni, Francesco; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Magliani, Walter; Ciociola, Tecla; Conti, Stefania; Polonelli, Luciano] Univ Parma, Dept Pathol & Lab Med, Microbiol Sect, I-43100 Parma, Italy	University of Perugia; University of Parma; University Hospital of Parma	Gabrielli, E (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it	Pericolini, Eva/AAZ-5848-2021; Ciociola, Tecla/HCH-2453-2022; Conti, Stefania/N-3558-2015; Ciociola, Tecla/AFN-5212-2022	Conti, Stefania/0000-0001-9973-8352; Ciociola, Tecla/0000-0001-6499-2545; CENCI, ELIO/0000-0003-0752-7262; Pericolini, Eva/0000-0002-5299-8197; Vecchiarelli, Anna/0000-0002-3185-6720	National Institutes of Health and Investment for Basic Research [AI14209]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014209, R01AI014209] Funding Source: NIH RePORTER	National Institutes of Health and Investment for Basic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI14209 from the National Institutes of Health and Investment for Basic Research, protocol No. RBLA03C9F4_006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Azuma M, 2006, J PERIODONTAL RES, V41, P361, DOI 10.1111/j.1600-0765.2006.00896.x; Bourgeois C, 1998, J VIROL, V72, P807, DOI 10.1128/JVI.72.1.807-810.1998; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2006, J LEUKOCYTE BIOL, V79, P40, DOI 10.1189/jlb.0205113; Cenci E, 2004, CELL MICROBIOL, V6, P953, DOI 10.1111/j.1462-5822.2004.00413.x; CHEN HT, 1987, J BIOL CHEM, V262, P13579; Conti G, 2008, ANTIMICROB AGENTS CH, V52, P4331, DOI 10.1128/AAC.00506-08; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Fan H, 2007, IMMUNOLOGY, V122, P116, DOI 10.1111/j.1365-2567.2007.02619.x; Fiori PL, 2006, J ANTIMICROB CHEMOTH, V57, P891, DOI 10.1093/jac/dkl051; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Manfredi M, 2005, ORAL MICROBIOL IMMUN, V20, P226, DOI 10.1111/j.1399-302X.2005.00217.x; Monari C, 2005, J IMMUNOL, V174, P3461, DOI 10.4049/jimmunol.174.6.3461; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Moragues MD, 2003, INFECT IMMUN, V71, P5273, DOI 10.1128/IAI.71.9.5273-5279.2003; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; NICKERSON KG, 1995, J BIOL CHEM, V270, P12457, DOI 10.1074/jbc.270.21.12457; PADLAN EA, 1995, FASEB J, V9, P133, DOI 10.1096/fasebj.9.1.7821752; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pertinhez TA, 2009, MOL PHARMACEUT, V6, P1036, DOI 10.1021/mp900024z; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; ROMANI L, 1993, J IMMUNOL, V150, P925; Savoia D, 2006, EXP PARASITOL, V113, P186, DOI 10.1016/j.exppara.2006.01.002; Sevilla MJ, 2006, INFECT IMMUN, V74, P3042, DOI 10.1128/IAI.74.5.3042-3045.2006; Shealy D. J., 2008, V181, P101; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Travassos LR, 2004, J ANTIMICROB CHEMOTH, V54, P956, DOI 10.1093/jac/dkh430; Tuteja R, 1999, IMMUNOLOGY, V97, P1, DOI 10.1046/j.1365-2567.1999.00743.x	43	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2009	4	12							e8187	10.1371/journal.pone.0008187	http://dx.doi.org/10.1371/journal.pone.0008187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MY	19997599	Green Published, gold, Green Submitted			2022-12-27	WOS:000272829200017
J	Chen, SL; Yao, H; Han, JP; Liu, C; Song, JY; Shi, LC; Zhu, YJ; Ma, XY; Gao, T; Pang, XH; Luo, K; Li, Y; Li, XW; Jia, XC; Lin, YL; Leon, C				Chen, Shilin; Yao, Hui; Han, Jianping; Liu, Chang; Song, Jingyuan; Shi, Linchun; Zhu, Yingjie; Ma, Xinye; Gao, Ting; Pang, Xiaohui; Luo, Kun; Li, Ying; Li, Xiwen; Jia, Xiaocheng; Lin, Yulin; Leon, Christine			Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant Species	PLOS ONE			English	Article							LAND PLANTS; AUTHENTICATION; IDENTIFICATION; TAXONOMY; PHYLOGENETICS; COMPLEMENTS; RBCL; TOOL	Background: The plant working group of the Consortium for the Barcode of Life recommended the two-locus combination of rbcL + matK as the plant barcode, yet the combination was shown to successfully discriminate among 907 samples from 550 species at the species level with a probability of 72%. The group admits that the two-locus barcode is far from perfect due to the low identification rate, and the search is not over. Methodology/Principal Findings: Here, we compared seven candidate DNA barcodes (psbA-trnH, matK, rbcL, rpoC1, ycf5, ITS2, and ITS) from medicinal plant species. Our ranking criteria included PCR amplification efficiency, differential intra-and inter-specific divergences, and the DNA barcoding gap. Our data suggest that the second internal transcribed spacer (ITS2) of nuclear ribosomal DNA represents the most suitable region for DNA barcoding applications. Furthermore, we tested the discrimination ability of ITS2 in more than 6600 plant samples belonging to 4800 species from 753 distinct genera and found that the rate of successful identification with the ITS2 was 92.7% at the species level. Conclusions: The ITS2 region can be potentially used as a standard DNA barcode to identify medicinal plants and their closely related species. We also propose that ITS2 can serve as a novel universal barcode for the identification of a broader range of plant taxa.	[Chen, Shilin; Yao, Hui; Han, Jianping; Song, Jingyuan; Shi, Linchun; Zhu, Yingjie; Ma, Xinye; Gao, Ting; Pang, Xiaohui; Li, Ying; Li, Xiwen; Jia, Xiaocheng; Lin, Yulin] Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100021, Peoples R China; [Liu, Chang] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Kun] Hubei Univ Chinese Med, Dept Pharm, Wuhan, Hubei, Peoples R China; [Leon, Christine] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; University of Hong Kong; Hubei University of Chinese Medicine; Royal Botanic Gardens, Kew	Chen, SL (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100021, Peoples R China.	slchen@implad.ac.cn; songjingyuan@hotmail.com	xiwen, li/W-1990-2019; Zhu, Yingjie/W-3315-2017; Yao, hui/AAM-2391-2021; Yang, Pengcheng/N-1037-2014; Wei, Yuanyuan/H-7963-2014	Zhu, Yingjie/0000-0003-1849-6019; Yang, Pengcheng/0000-0001-5496-8357; Jiang, Feng/0000-0002-7407-7604; Han, Jianping/0000-0002-7976-6708; Wei, Yuanyuan/0000-0003-0635-6879; Kang, Le/0000-0003-4262-2329	International Cooperation Program of Science and Technology [2007DFA30990]; Special Foundation of Ministry of Health [200802043]; Hong Kong Research Grant Council (HKU) [7526/06M]	International Cooperation Program of Science and Technology; Special Foundation of Ministry of Health; Hong Kong Research Grant Council (HKU)(University of Hong KongHong Kong Research Grants Council)	This work is supported by the International Cooperation Program of Science and Technology ( No. 2007DFA30990) and the Special Foundation of Ministry of Health ( No. 200802043) granted to S. L. C. This work is also supported by grants from the Hong Kong Research Grant Council (HKU 7526/06M) to C. L. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miao M, 2008, PROTIST, V159, P519, DOI 10.1016/j.protis.2008.05.002; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Min XJ, 2007, MOL ECOL NOTES, V7, P365, DOI 10.1111/j.1471-8286.2007.01698.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shaw D, 1997, DRUG SAFETY, V17, P342, DOI 10.2165/00002018-199717050-00006; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385	41	1051	1385	22	300	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8613	10.1371/journal.pone.0008613	http://dx.doi.org/10.1371/journal.pone.0008613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062805	Green Published, gold, Green Submitted			2022-12-27	WOS:000273414100007
